PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pearson, VM; Miller, CR; Rokyta, DR				Pearson, Victoria M.; Miller, Craig R.; Rokyta, Darin R.			The Consistency of Beneficial Fitness Effects of Mutations across Diverse Genetic Backgrounds	PLOS ONE			English	Article							DIMINISHING RETURNS; PARALLEL EVOLUTION; LANDSCAPE MODEL; RNA VIRUS; ADAPTATION; EPISTASIS; BACTERIOPHAGE; RESISTANCE; TRAJECTORIES; ARCHITECTURE	Parallel and convergent evolution have been remarkably common observations in molecular adaptation but primarily in the context of the same genotype adapting to the same conditions. These phenomena therefore tell us about the stochasticity and limitations of adaptation. The limited data on convergence and parallelism in the adaptation of different genotypes conflict as to the importance of such events. If the effects of beneficial mutations are highly context dependent (i.e., if they are epistatic), different genotypes should adapt through different mutations. Epistasis for beneficial mutations has been investigated but mainly through measurement of interactions between individually beneficial mutations for the same genotype. We examine epistasis for beneficial mutations at a broader genetic scale by measuring the fitness effects of two mutations beneficial for the ssDNA bacteriophage ID11 in eight different, related genotypes showing 0.3-3.7% nucleotide divergence from ID11. We found no evidence for sign epistasis, but the mutations tended to have much smaller or no effects on fitness in the new genotypes. We found evidence for diminishing-returns epistasis; the effects were more beneficial for lower-fitness genotypes. The patterns of epistasis were not determined by phylogenetic relationships to the original genotype. To improve our understanding of the patterns of epistasis, we fit the data to a model in which each mutation had a constant, nonepistatic phenotypic effect across genotypes and the phenotype-fitness map had a single optimum. This model fit the data well, suggesting that epistasis for these mutations was due to nonlinearity in the phenotype-fitness mapping and that the likelihood of parallel evolution depends more on phenotype than on genotype.	[Pearson, Victoria M.; Rokyta, Darin R.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Miller, Craig R.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Miller, Craig R.] Univ Idaho, Dept Math, Moscow, ID 83843 USA	State University System of Florida; Florida State University; Idaho; University of Idaho; Idaho; University of Idaho	Pearson, VM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	drokyta@bio.fsu.edu	Miller, Craig/GWQ-5012-2022	Rokyta, Darin/0000-0002-0356-2178	Florida State University; United States National Institutes of Health [NIH R01 GM076040]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076040] Funding Source: NIH RePORTER	Florida State University; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by Florida State University. Funding for CRM was provided by the United States National Institutes of Health (NIH R01 GM076040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollback JP, 2009, GENETICS, V181, P225, DOI 10.1534/genetics.107.085225; Bull JJ, 2000, MOL BIOL EVOL, V17, P942, DOI 10.1093/oxfordjournals.molbev.a026375; Bull JJ, 1997, GENETICS, V147, P1497; Burch CL, 1999, GENETICS, V151, P921; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dobzhansky T, 1936, GENETICS, V21, P113; Fisher RA, 1930, GENETICAL THEORY NAT; Hartl DL, 1998, GENETICA, V102-3, P525, DOI 10.1023/A:1017071901530; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; MacLean RC, 2010, GENETICS, V186, P1345, DOI 10.1534/genetics.110.123083; Manna F, 2011, GENETICS, V189, P923, DOI 10.1534/genetics.111.132944; Martin G, 2008, GENETICS, V179, P907, DOI 10.1534/genetics.108.087122; Martin G, 2007, NAT GENET, V39, P555, DOI 10.1038/ng1998; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; MCKENNA R, 1994, J MOL BIOL, V237, P517, DOI 10.1006/jmbi.1994.1253; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Orr HA, 2005, EVOLUTION, V59, P216; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 1997, THEOR POPUL BIOL, V51, P134, DOI 10.1006/tpbi.1997.1301; Peck JR, 1997, GENETICS, V145, P1171; Pepin KM, 2007, EVOLUTION, V61, P1710, DOI 10.1111/j.1558-5646.2007.00143.x; Pepin KM, 2006, GENETICS, V172, P2047, DOI 10.1534/genetics.105.049817; R Development Core Team, 2006, R LANG ENV STAT COMP; RICE SH, 1990, J THEOR BIOL, V143, P319, DOI 10.1016/S0022-5193(05)80033-5; Rokyta D, 2002, MOL BIOL EVOL, V19, P230, DOI 10.1093/oxfordjournals.molbev.a004076; Rokyta DR, 2008, J MOL EVOL, V67, P368, DOI 10.1007/s00239-008-9153-x; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Rokyta DR, 2009, J MOL EVOL, V69, P229, DOI 10.1007/s00239-009-9267-9; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sousa A, 2012, MOL BIOL EVOL, V29, P1417, DOI 10.1093/molbev/msr302; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wichman HA, 2000, PHILOS T R SOC B, V355, P1677, DOI 10.1098/rstb.2000.0731	43	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43864	10.1371/journal.pone.0043864	http://dx.doi.org/10.1371/journal.pone.0043864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937113	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500115
J	Godfrey, KM; Haugen, G; Kiserud, T; Inskip, HM; Cooper, C; Harvey, NCW; Crozier, SR; Robinson, SM; Davies, L; Hanson, MA				Godfrey, Keith M.; Haugen, Guttorm; Kiserud, Torvid; Inskip, Hazel M.; Cooper, Cyrus; Harvey, Nicholas C. W.; Crozier, Sarah R.; Robinson, Sian M.; Davies, Lucy; Hanson, Mark A.		Southampton Womens Survey Study	Fetal Liver Blood Flow Distribution: Role in Human Developmental Strategy to Prioritize Fat Deposition versus Brain Development	PLOS ONE			English	Article							DUCTUS-VENOSUS; GENE-EXPRESSION; GROWTH; PREGNANCY; OBESITY; RESTRICTION; VELOCIMETRY; MECHANISMS; CHILDHOOD; PROFILE	Among primates, human neonates have the largest brains but also the highest proportion of body fat. If placental nutrient supply is limited, the fetus faces a dilemma: should resources be allocated to brain growth, or to fat deposition for use as a potential postnatal energy reserve? We hypothesised that resolving this dilemma operates at the level of umbilical blood distribution entering the fetal liver. In 381 uncomplicated pregnancies in third trimester, we measured blood flow perfusing the fetal liver, or bypassing it via the ductus venosus to supply the brain and heart using ultrasound techniques. Across the range of fetal growth and independent of the mother's adiposity and parity, greater liver blood flow was associated with greater offspring fat mass measured by dual-energy X-ray absorptiometry, both in the infant at birth (r = 0.43, P<0.001) and at age 4 years (r = 0.16, P = 0.02). In contrast, smaller placentas less able to meet fetal demand for essential nutrients were associated with a brain-sparing flow pattern (r = 0.17, p = 0.02). This flow pattern was also associated with a higher degree of shunting through ductus venosus (P = 0.04). We propose that humans evolved a developmental strategy to prioritize nutrient allocation for prenatal fat deposition when the supply of conditionally essential nutrients requiring hepatic inter-conversion is limited, switching resource allocation to favour the brain if the supply of essential nutrients is limited. Facilitated placental transfer mechanisms for glucose and other nutrients evolved in environments less affluent than those now prevalent in developed populations, and we propose that in circumstances of maternal adiposity and nutrient excess these mechanisms now also lead to prenatal fat deposition. Prenatal developmental influences play important roles in the human propensity to deposit fat.	[Godfrey, Keith M.; Haugen, Guttorm; Hanson, Mark A.] Univ Southampton, Inst Dev Sci, Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Godfrey, Keith M.; Inskip, Hazel M.; Cooper, Cyrus; Harvey, Nicholas C. W.; Crozier, Sarah R.; Robinson, Sian M.; Davies, Lucy; Southampton Womens Survey Study] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Godfrey, Keith M.; Cooper, Cyrus; Hanson, Mark A.] Univ Hosp Southampton NHS Fdn Trust, Southampton Natl Inst Hlth Res Biomed Res Ctr, Southampton, Hants, England; [Haugen, Guttorm] Univ Oslo, Rikshosp, Dept Obstet, Oslo Univ Hosp, N-0027 Oslo, Norway; [Kiserud, Torvid] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Kiserud, Torvid] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital; University of Bergen	Godfrey, KM (corresponding author), Univ Southampton, Inst Dev Sci, Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.	guttorm.haugen@ous-hf.no	Hanson, Mark/AAE-8236-2019; Inskip, Hazel/L-5467-2018	Hanson, Mark/0000-0002-6907-613X; Crozier, Sarah/0000-0002-9524-1127; Inskip, Hazel/0000-0001-8897-1749; Robinson, Sian/0000-0003-1766-7269; Cooper, Cyrus/0000-0003-3510-0709; Kiserud, Torvid/0000-0003-1825-1660; Godfrey, Keith/0000-0002-4643-0618; Harvey, Nicholas/0000-0002-8194-2512	British Heart Foundation; Wessex Medical Trust; University of Southampton; UK Medical Research Council; Research Council of Norway; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; British Heart Foundation [RG/07/009/23120] Funding Source: researchfish; Medical Research Council [MC_UP_A620_1014, MC_UP_A620_1017, U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; MRC [MC_UP_A620_1017] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wessex Medical Trust; University of Southampton; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Council of Norway(Research Council of Norway); National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the charities the British Heart Foundation and Wessex Medical Trust, by the University of Southampton and by the UK Medical Research Council, and the Research Council of Norway. KMG is supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellotti M, 2004, AM J OBSTET GYNECOL, V190, P1347, DOI 10.1016/j.ajog.2003.11.018; Brawley L, 2004, J PHYSIOL-LONDON, V554, P497, DOI 10.1113/jphysiol.2003.052068; Desai M, 1997, AM J PHYSIOL-GASTR L, V273, pG899, DOI 10.1152/ajpgi.1997.273.4.G899; EDELSTONE D I, 1980, Journal of Developmental Physiology (Eynsham), V2, P219; Gluckman PD, 2006, MISMATCH LIFESTYLE D; Godfrey K, 1996, BRIT MED J, V312, P410, DOI 10.1136/bmj.312.7028.410; Godfrey K M, 2001, Public Health Nutr, V4, P611; Haugen G, 2005, CIRC RES, V96, P12, DOI 10.1161/01.RES.0000152391.45273.A2; Haugen G, 2004, ULTRASOUND OBST GYN, V24, P599, DOI 10.1002/uog.1744; HODGKIN DD, 1988, J DEV PHYSIOL, V10, P383; Hsieh YY, 2001, ULTRASOUND OBST GYN, V17, P125, DOI 10.1046/j.1469-0705.2001.00329.x; Inskip HM, 2006, INT J EPIDEMIOL, V35, P42, DOI 10.1093/ije/dyi202; Kessler J, 2008, PEDIATR RES, V63, P315, DOI 10.1203/PDR.0b013e318163a1de; Kessler J, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.038; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P143, DOI 10.1002/uog.2784; Kiserud T, 2000, AM J OBSTET GYNECOL, V182, P147, DOI 10.1016/S0002-9378(00)70504-7; Kiserud T, 1998, ULTRASOUND MED BIOL, V24, P1301, DOI 10.1016/S0301-5629(98)00131-8; Kiserud T, 1998, ULTRASOUND OBST GYN, V11, P419, DOI 10.1046/j.1469-0705.1998.11060419.x; KISERUD T, 1991, LANCET, V338, P1412, DOI 10.1016/0140-6736(91)92720-M; Kiserud T, 1997, AM J OBSTET GYNECOL, V177, P86, DOI 10.1016/S0002-9378(97)70442-3; Koletzko B, 1998, BRIT J NUTR, V80, pS5, DOI 10.1079/BJN19980104; Kuzawa CW, 1998, YEARB PHYS ANTHROPOL, V41, P177; Leary SD, 2003, PLACENTA, V24, P276, DOI 10.1053/plac.2002.0888; LEY D, 1992, EARLY HUM DEV, V31, P171, DOI 10.1016/0378-3782(92)90045-I; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Office of Population Censuses and Surveys, 1980, CLASS OCC; OWENS JA, 1987, J DEV PHYSIOL, V9, P137; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; PASSINGH.RE, 1973, BRAIN BEHAV EVOLUT, V7, P337, DOI 10.1159/000124422; PAULICK RP, 1991, AM J PHYSIOL, V260, pH1205, DOI 10.1152/ajpheart.1991.260.4.H1205; PEDERSEN JF, 1980, BRIT MED J, V281, P1253, DOI 10.1136/bmj.281.6250.1253; Pennati G, 1996, ULTRASOUND MED BIOL, V22, P1017, DOI 10.1016/S0301-5629(96)00117-2; Symonds ME, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P255, DOI 10.1017/CBO9780511544699.019; Tchirikov M, 2003, J PHYSIOL-LONDON, V548, P519, DOI 10.1113/jphysiol.2002.034470; Tchirikov M, 2002, PLACENTA, V23, pS153, DOI 10.1053/plac.2002.0810; Thompson NM, 2007, ENDOCRINOLOGY, V148, P2345, DOI 10.1210/en.2006-1641; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; WLADIMIROFF JW, 1987, OBSTET GYNECOL, V69, P705; ZAPOL WM, 1979, J APPL PHYSIOL, V47, P968, DOI 10.1152/jappl.1979.47.5.968; Zhang JL, 2000, AM J PHYSIOL-GASTR L, V278, pG128, DOI 10.1152/ajpgi.2000.278.1.G128	41	53	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41759	10.1371/journal.pone.0041759	http://dx.doi.org/10.1371/journal.pone.0041759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927915	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000308286300014
J	Oro, D; Jimenez, J; Curco, A				Oro, Daniel; Jimenez, Juan; Curco, Antoni			Some Clouds Have a Silver Lining: Paradoxes of Anthropogenic Perturbations from Study Cases on Long-Lived Social Birds	PLOS ONE			English	Article							POPULATION-DYNAMICS; FOOD AVAILABILITY; REGIME SHIFTS; CONSERVATION; DISPERSAL; RESILIENCE; ECOLOGY; DENSITY; CATASTROPHES; ECOSYSTEMS	In recent centuries and above all over the last few decades, human activities have generated perturbations (from mild to very severe or catastrophes) that, when added to those of natural origin, constitute a global threat to biodiversity. Predicting the effects of anthropogenic perturbations on species and communities is a great scientific challenge given the complexity of ecosystems and the need for detailed population data from both before and after the perturbations. Here we present three cases of well-documented anthropogenic severe perturbations (different forms of habitat loss and deterioration influencing fertility and survival) that have affected three species of birds (a raptor, a scavenger and a waterbird) for which we possess long-term population time series. We tested whether the perturbations caused serious population decline or whether the study species were resilient, that is, its population dynamics were relatively unaffected. Two of the species did decline, although to a relatively small extent with no shift to a state of lower population numbers. Subsequently, these populations recovered rapidly and numbers reached similar levels to before the perturbations. Strikingly, in the third species a strong breakpoint took place towards greater population sizes, probably due to the colonization of new areas by recruits that were queuing at the destroyed habitat. Even though it is difficult to draw patterns of resilience from only three cases, the study species were all long-lived, social species with excellent dispersal and colonization abilities, capable of skipping reproduction and undergoing a phase of significant long-term population increase. The search for such patterns is crucial for optimizing the limited resources allocated to conservation and for predicting the future impact of planned anthropogenic activities on ecosystems.	[Oro, Daniel] CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Esporles, Spain; [Curco, Antoni] Parc Nat Delta Ebre, Deltebre, Spain; [Jimenez, Juan] Generalitat Valenciana, Conselleria Medio Ambiente, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Oro, D (corresponding author), CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Esporles, Spain.	d.oro@uib.es	Oro, Daniel/H-4208-2012	Oro, Daniel/0000-0003-4782-3007	Spanish Ministry of Science [CGL2009-08298]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funds were provided by the Spanish Ministry of Science (grant ref. CGL2009-08298)(http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, PROG PHYS GEOG, V23, P1, DOI 10.1177/030913339902300101; Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Akcakaya HR, 1996, OECOLOGIA, V105, P475, DOI 10.1007/BF00330010; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Arroyo B., 2007, AGUILUCHO CENIZO AGU; Avise JC, 2008, LIGHT EVOLUTION; Balkiz O, 2010, J ANIM ECOL, V79, P1045, DOI 10.1111/j.1365-2656.2010.01721.x; Barnosky AD, 2004, P NATL ACAD SCI USA, V101, P9297, DOI 10.1073/pnas.0402592101; Blake S, 2004, CONSERV BIOL, V18, P1191, DOI 10.1111/j.1523-1739.2004.01860.x; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; CEZILLY F, 1995, ECOLOGY, V76, P20, DOI 10.2307/1940628; Curco A, 2009, FLAMINGO SPECIAL PUB, V1, P37; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Davidson Z, 2011, BIOL CONSERV, V144, P114, DOI 10.1016/j.biocon.2010.08.005; Fernandez-Chacon A, 2011, GLOBAL CHANGE BIOL, V17, P3075, DOI 10.1111/j.1365-2486.2011.02469.x; Gaillard JM, 2008, P ROY SOC B-BIOL SCI, V275, P2025, DOI 10.1098/rspb.2008.0393; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Genovart M, 2008, ZOOL STUD, V47, P11; Guitart R, 2010, VET J, V183, P260, DOI 10.1016/j.tvjl.2009.03.033; Hill D, 2012, J APPL ECOL, V49, P6, DOI 10.1111/j.1365-2664.2011.02095.x; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Iverson SA, 2010, ECOL APPL, V20, P1993, DOI 10.1890/09-1398.1; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Johnson A, 2007, GREATER FLAMINGO; Kotze DJ, 2004, J NEGATIVE RESULTS, V1, P1; Lachish S, 2011, HEREDITY, V106, P172, DOI 10.1038/hdy.2010.17; Leighton PA, 2010, BIOL CONSERV, V143, P2156, DOI 10.1016/j.biocon.2010.05.028; Liminana R, 2012, EUR J WILD IN PRESS, V58; Liminana R, 2006, BIRD STUDY, V53, P126, DOI 10.1080/00063650609461425; Lindenmayer DB, 2010, FRONT ECOL ENVIRON, V8, P527, DOI 10.1890/090184; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; MANGEL M, 1994, ECOLOGY, V75, P607, DOI 10.2307/1941719; Martinez-Abrain A, 2009, ANIM CONSERV, V12, P204, DOI 10.1111/j.1469-1795.2009.00239.x; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Massey JG, 2007, 9 INT EFF OIL WILDL; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; McDowall RM, 2010, REV FISH BIOL FISHER, V20, P87, DOI 10.1007/s11160-009-9125-2; Moller AP, 2011, BIOL CONSERV, V144, P2787, DOI 10.1016/j.biocon.2011.08.009; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Oro D, 1999, OECOLOGIA, V118, P438, DOI 10.1007/s004420050746; Oro D, 2011, OECOLOGIA, V165, P935, DOI 10.1007/s00442-010-1773-3; Parsons DM, 2010, BIOL CONSERV, V143, P2039, DOI 10.1016/j.biocon.2010.05.009; Penteriani V, 2011, ANIM CONSERV, V14, P233, DOI 10.1111/j.1469-1795.2010.00433.x; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; Reed DH, 2003, ANIM CONSERV, V6, P109, DOI 10.1017/S1367943003003147; Romme WH, 2011, ECOSYSTEMS, V14, P1196, DOI 10.1007/s10021-011-9470-6; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Sahasrabudhe S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1163; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Sole R, 2007, NATURE, V449, P151, DOI 10.1038/449151a; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Soutullo A, 2006, OECOLOGIA, V149, P543, DOI 10.1007/s00442-006-0465-5; Thibault KM, 2008, P NATL ACAD SCI USA, V105, P3410, DOI 10.1073/pnas.0712282105; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; Wiens JA, 2010, CURR ORNITHOL, V17, P131, DOI 10.1007/978-1-4419-6421-2_4; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	60	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42753	10.1371/journal.pone.0042753	http://dx.doi.org/10.1371/journal.pone.0042753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936988	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300024
J	Yuen, WS; Merriman, JA; O'Bryan, MK; Jones, KT				Yuen, Wai Shan; Merriman, Julie A.; O'Bryan, Moira K.; Jones, Keith T.			DNA Double Strand Breaks but Not Interstrand Crosslinks Prevent Progress through Meiosis in Fully Grown Mouse Oocytes	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ANEMIA CORE COMPLEX; FANCONI-ANEMIA; OXIDATIVE STRESS; HISTONE H2AX; CELL-CYCLE; TARGETED DISRUPTION; REDUCED FERTILITY; MALE-INFERTILITY; GENE-EXPRESSION	There is some interest in how mammalian oocytes respond to different types of DNA damage because of the increasing expectation of fertility preservation in women undergoing chemotherapy. Double strand breaks (DSBs) induced by ionizing radiation and agents such as neocarzinostatin (NCS), and interstrand crosslinks (ICLs) induced by alkylating agents such as mitomycin C (MMC), are toxic DNA lesions that need to be repaired for cell survival. Here we examined the effects of NCS and MMC treatment on oocytes collected from antral follicles in mice, because potentially such oocytes are readily collected from ovaries and do not need to be in vitro grown to achieve meiotic competency. We found that oocytes were sensitive to NCS, such that this ionizing radiation mimetic blocked meiosis I and caused fragmented DNA. In contrast, MMC had no impact on the completion of either meiosis I or II, even at extremely high doses. However, oocytes treated with MMC did show gamma-H2AX foci and following their in vitro maturation and parthenogenetic activation the development of the subsequent embryos was severely compromised. Addition of MMC to 1-cell embryos caused a similarly poor level of development, demonstrating oocytes have eventual sensitivity to this ICL-inducing agent but this does not occur during their meiotic division. In oocytes, the association of Fanconi Anemia protein, FANCD2, with sites of ICL lesions was not apparent until entry into the embryonic cell cycle. In conclusion, meiotic maturation of oocytes is sensitive to DSBs but not ICLs. The ability of oocytes to tolerate severe ICL damage and yet complete meiosis, means that this type of DNA lesion goes unrepaired in oocytes but impacts on subsequent embryo quality.	[Yuen, Wai Shan; Merriman, Julie A.; Jones, Keith T.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	University of Newcastle; Monash University	Yuen, WS (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	Keith.Jones@newcastle.edu.au	O'Bryan, Moira K/F-8256-2012; Jones, Keith/AAA-3479-2021; Jones, Keith/C-9821-2013	O'Bryan, Moira K/0000-0001-7298-4940; Jones, Keith/0000-0002-0294-0851; Jones, Keith/0000-0002-0294-0851	National Health and Medical Research Council (NHMRC); Australian Research Council; NHMRC fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC), and Australian Research Council funding to KTJ and MKOB. MKOB is the recipient of an NHMRC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Adriaens I, 2009, HUM REPROD UPDATE, V15, P359, DOI 10.1093/humupd/dmn063; Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Albertini DF, 2003, REPRODUCTION, P49; ALTER BP, 1991, BRIT J HAEMATOL, V77, P410, DOI 10.1111/j.1365-2141.1991.tb08593.x; BAKER RM, 1979, P NATL ACAD SCI USA, V76, P5249, DOI 10.1073/pnas.76.10.5249; Banuelos A, 2003, J PHARMACOL EXP THER, V306, P671, DOI 10.1124/jpet.103.051557; BEERMAN TA, 1977, BIOCHIM BIOPHYS ACTA, V475, P281, DOI 10.1016/0005-2787(77)90019-3; Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; BosMikich A, 1997, DEV BIOL, V182, P172, DOI 10.1006/dbio.1996.8468; BRADSHAW J, 1995, MOL REPROD DEV, V41, P503, DOI 10.1002/mrd.1080410413; Castillo P, 2011, DNA REPAIR, V10, P518, DOI 10.1016/j.dnarep.2011.02.007; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chang HY, 2011, J BIOL CHEM, V286, P14705, DOI 10.1074/jbc.M110.193227; Chang HY, 2009, DEVELOPMENT, V136, P4077, DOI 10.1242/dev.042143; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Choi E, 2012, DEV CELL, V22, P295, DOI 10.1016/j.devcel.2012.01.009; Collins NB, 2009, BLOOD, V113, P2181, DOI 10.1182/blood-2008-05-154294; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Derijck A, 2008, HUM MOL GENET, V17, P1922, DOI 10.1093/hmg/ddn090; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gharagozloo P, 2011, HUM REPROD, V26, P1628, DOI 10.1093/humrep/der132; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Hanoux V, 2007, CELL DEATH DIFFER, V14, P671, DOI 10.1038/sj.cdd.4402052; Hassold T, 2009, CURR OPIN PEDIATR, V21, P703, DOI 10.1097/MOP.0b013e328332c6ab; HATAYAMA T, 1979, BIOCHIM BIOPHYS ACTA, V563, P59, DOI 10.1016/0005-2787(79)90007-8; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Holt JE, 2010, DEVELOPMENT, V137, P1297, DOI 10.1242/dev.047555; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Jennings PC, 2011, HUM REPROD, V26, P878, DOI 10.1093/humrep/deq393; Jin SQ, 2009, J BIOL CHEM, V284, P22970, DOI 10.1074/jbc.M109.009134; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Kim JM, 2008, BLOOD, V111, P5215, DOI 10.1182/blood-2007-09-113092; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Kujjo LL, 2011, BIOL REPROD; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lee HJ, 2011, FERTIL STERIL, V95, P1344, DOI 10.1016/j.fertnstert.2010.08.034; Lee M, 2011, ONCOGENE, V30, P3360, DOI 10.1038/onc.2011.55; Li J, 2010, BLOOD, V115, P1545, DOI 10.1182/blood-2009-07-234385; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Marchetti F, 2007, P NATL ACAD SCI USA, V104, P17725, DOI 10.1073/pnas.0705257104; MATSUDA Y, 1989, INT J RADIAT BIOL, V55, P233, DOI 10.1080/09553008914550281; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Matzuk MM, 2012, ANNU REV PHYSIOL, V74, P503, DOI 10.1146/annurev-physiol-020911-153248; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Merriman JA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095711; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rego MA, 2009, MUTAT RES-FUND MOL M, V668, P27, DOI 10.1016/j.mrfmmm.2008.11.018; Revenkova E, 2010, CURR BIOL, V20, P1529, DOI 10.1016/j.cub.2010.08.024; Rodriguez-Mari A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001357; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rowley M, 2011, GASTROENTEROLOGY; Segal-Raz H, 2011, EMBO REP, V12, P713, DOI 10.1038/embor.2011.96; Shen X, 2009, MOL CELL, V35, P716, DOI 10.1016/j.molcel.2009.06.034; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Whitney MA, 1996, BLOOD, V88, P49; Wong JCY, 2003, HUM MOL GENET, V12, P2063, DOI 10.1093/hmg/ddg219; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81; Xiong B, 2008, BIOL REPROD, V79, P718, DOI 10.1095/biolreprod.108.069641	78	37	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43875	10.1371/journal.pone.0043875	http://dx.doi.org/10.1371/journal.pone.0043875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928046	gold, Green Accepted, Green Published			2022-12-27	WOS:000308286300096
J	Li, X; Lipowsky, R; Kierfeld, J				Li, Xin; Lipowsky, Reinhard; Kierfeld, Jan			Critical Motor Number for Fractional Steps of Cytoskeletal Filaments in Gliding Assays	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; HAND-OVER-HAND; MYOSIN-V; FORCE CLAMP; MECHANICS; CARGO; PROCESSIVITY; EQUILIBRIUM; SIMULATION; MOVEMENT	In gliding assays, filaments are pulled by molecular motors that are immobilized on a solid surface. By varying the motor density on the surface, one can control the number N of motors that pull simultaneously on a single filament. Here, such gliding assays are studied theoretically using Brownian (or Langevin) dynamics simulations and taking the local force balance between motors and filaments as well as the force-dependent velocity of the motors into account. We focus on the filament stepping dynamics and investigate how single motor properties such as stalk elasticity and step size determine the presence or absence of fractional steps of the filaments. We show that each gliding assay can be characterized by a critical motor number, N-c. Because of thermal fluctuations, fractional filament steps are only detectable as long as N < N-c. The corresponding fractional filament step size is l/N where l is the step size of a single motor. We first apply our computational approach to microtubules pulled by kinesin-1 motors. For elastic motor stalks that behave as linear springs with a zero rest length, the critical motor number is found to be N-c = 4, and the corresponding distributions of the filament step sizes are in good agreement with the available experimental data. In general, the critical motor number N-c depends on the elastic stalk properties and is reduced to N-c = 3 for linear springs with a nonzero rest length. Furthermore, N-c is shown to depend quadratically on the motor step size l. Therefore, gliding assays consisting of actin filaments and myosin-V are predicted to exhibit fractional filament steps up to motor number N = 31. Finally, we show that fractional filament steps are also detectable for a fixed average motor number < N > as determined by the surface density (or coverage) of the motors on the substrate surface.	[Li, Xin; Lipowsky, Reinhard; Kierfeld, Jan] Max Planck Inst Colloids & Interfaces, Potsdam, Germany; [Kierfeld, Jan] TU Dortmund Univ, Dept Phys, Dortmund, Germany	Max Planck Society; Dortmund University of Technology	Li, X (corresponding author), Max Planck Inst Colloids & Interfaces, Sci Pk Golm, Potsdam, Germany.	jan.kierfeld@tu-dortmund.de	Kierfeld, Jan/A-2659-2009; Li, Xin/H-6579-2014	Kierfeld, Jan/0000-0003-4291-0638; Li, Xin/0000-0002-2510-2236; Lipowsky, Reinhard/0000-0001-8417-8567				Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Doi M., 1986, THEORY POLYM DYNAMIC; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Driver JW, 2010, PHYS CHEM CHEM PHYS, V12, P10398, DOI 10.1039/c0cp00117a; ERMAK DL, 1975, J CHEM PHYS, V62, P4189, DOI 10.1063/1.430300; Fehr AN, 2008, BIOPHYS J, V94, pL20, DOI 10.1529/biophysj.107.126839; Flory P. J., 1969, STAT MECH CHAIN MOL, V8, P699, DOI [10.1002/bip.1969.360080514, DOI 10.1002/BIP.1969.360080514]; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard M, 2003, POLYM PHYS; Jeney S, 2004, CHEMPHYSCHEM, V5, P1150, DOI 10.1002/cphc.200301027; Kalafut B, 2008, COMPUT PHYS COMMUN, V179, P716, DOI 10.1016/j.cpc.2008.06.008; Kawaguchi K, 2003, BIOPHYS J, V84, P1103, DOI 10.1016/S0006-3495(03)74926-1; Kerssemakers J, 2006, P NATL ACAD SCI USA, V103, P15812, DOI 10.1073/pnas.0510400103; Kierfeld J, 2004, EUR PHYS J E, V14, P17, DOI 10.1140/epje/i2003-10089-3; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kraikivski P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258103; Lan GH, 2005, BIOPHYS J, V88, P999, DOI 10.1529/biophysj.104.047662; Landau D.P., 2000, MONTE CARLO SIMULATI; Leduc C, 2004, P NATL ACAD SCI USA, V101, P17096, DOI 10.1073/pnas.0406598101; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nagy A, 2009, BIOPHYS J, V97, P3123, DOI 10.1016/j.bpj.2009.09.033; Schilstra MJ, 2006, J R SOC INTERFACE, V3, P153, DOI 10.1098/rsif.2005.0098; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Scholey J, 1993, CELL BIOL, V39; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Vilfan A, 2005, BIOPHYS J, V88, P3792, DOI 10.1529/biophysj.104.046763; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	36	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43219	10.1371/journal.pone.0043219	http://dx.doi.org/10.1371/journal.pone.0043219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927953	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700028
J	Preukschas, M; Hagel, C; Schulte, A; Weber, K; Lamszus, K; Sievert, H; Pallmann, N; Bokemeyer, C; Hauber, J; Braig, M; Balabanov, S				Preukschas, Michael; Hagel, Christian; Schulte, Alexander; Weber, Kristoffer; Lamszus, Katrin; Sievert, Henning; Paellmann, Nora; Bokemeyer, Carsten; Hauber, Joachim; Braig, Melanie; Balabanov, Stefan			Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies	PLOS ONE			English	Article							DEOXYHYPUSINE SYNTHASE ACTIVITY; YEAST SACCHAROMYCES-CEREVISIAE; ONTOLOGY LEGO VECTORS; GLIOMA-CELL LINES; PROTEIN EXPRESSION; GROWTH-FACTOR; CANCER-CELLS; AMINO-ACID; INDEPENDENT PREDICTOR; MALIGNANT GLIOMAS	Glioblastomas are highly aggressive brain tumors of adults with poor clinical outcome. Despite a broad range of new and more specific treatment strategies, therapy of glioblastomas remains challenging and tumors relapse in all cases. Recent work demonstrated that the posttranslational hypusine modification of the eukaryotic initiation factor 5A (eIF-5A) is a crucial regulator of cell proliferation, differentiation and an important factor in tumor formation, progression and maintenance. Here we report that eIF-5A as well as the hypusine-forming enzymes deoxyhypusine synthase (DHS) and deoxyhypusine hydroxylase (DOHH) are highly overexpressed in glioblastoma patient samples. Importantly, targeting eIF-5A and its hypusine modification with GC7, a specific DHS-inhibitor, showed a strong antiproliferative effect in glioblastoma cell lines in vitro, while normal human astrocytes were not affected. Furthermore, we identified p53 dependent premature senescence, a permanent cell cycle arrest, as the primary outcome in U87-MG cells after treatment with GC7. Strikingly, combined treatment with clinically relevant alkylating agents and GC7 had an additive antiproliferative effect in glioblastoma cell lines. In addition, stable knockdown of eIF-5A and DHS by short hairpin RNA (shRNA) could mimic the antiproliferative effects of GC7. These findings suggest that pharmacological inhibition of eIF-5A may represent a novel concept to treat glioblastomas and may help to substantially improve the clinical course of this tumor entity.	[Preukschas, Michael; Sievert, Henning; Paellmann, Nora; Bokemeyer, Carsten; Braig, Melanie; Balabanov, Stefan] Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Tumorzentrum, Dept Oncol Haematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Neuropathol, Hamburg, Germany; [Schulte, Alexander; Lamszus, Katrin] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Weber, Kristoffer] Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, Hamburg, Germany; [Hauber, Joachim] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute	Preukschas, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Tumorzentrum, Dept Oncol Haematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany.	stefan.balabanov@usz.ch	Balabanov, Stefan/E-9765-2014; /H-8186-2012; Riecken, Kristoffer/AAD-2371-2020	Riecken, Kristoffer/0000-0001-9050-6766	Deutsche Forschungsgemeinschaft (DFG) [BA 3506/1-1, HA 2580/4-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	These studies were supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (BA 3506/1-1 and HA 2580/4-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE A, 1986, J BIOL CHEM, V261, P3085; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; BENNE R, 1978, J BIOL CHEM, V253, P3070; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Caraglia M, 1997, BIOCHEM J, V324, P737, DOI 10.1042/bj3240737; Caraglia M, 2003, J BIOCHEM, V133, P757, DOI 10.1093/jb/mvg097; Caraglia M, 2001, AMINO ACIDS, V20, P91, DOI 10.1007/s007260170050; Caraglia M, 2011, AMINO ACIDS, P1; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; Chen W, 2009, CANCER EPIDEM BIOMAR, V18, P400, DOI 10.1158/1055-9965.EPI-08-0754; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; COOPER HL, 1982, CELL, V29, P791, DOI 10.1016/0092-8674(82)90441-X; Eckerich C, 2009, J NEUROCHEM, V109, P969, DOI 10.1111/j.1471-4159.2009.06027.x; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; He LR, 2011, INT J CANCER, V129, P143, DOI 10.1002/ijc.25669; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hirose Y, 2001, CANCER RES, V61, P1957; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; JAKUS J, 1993, J BIOL CHEM, V268, P13151; Jenkins ZA, 2001, GENOMICS, V71, P101, DOI 10.1006/geno.2000.6418; KLIER H, 1995, BIOCHEMISTRY-US, V34, P14693, DOI 10.1021/bi00045a010; Kunkel P, 2001, NEURO-ONCOLOGY, V3, P82, DOI 10.1093/neuonc/3.2.82; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Lam FF, 2010, PROTEOM CLIN APPL, V4, P60, DOI 10.1002/prca.200900084; Lee NP, 2009, INT J CANC, V9999; Li AL, 2004, J BIOL CHEM, V279, P49251, DOI 10.1074/jbc.M407165200; Lu ZJ, 2011, ELECTROPHORESIS, V32, P3612, DOI 10.1002/elps.201100230; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Noda SE, 2009, SEMIN RADIAT ONCOL, V19, P171, DOI 10.1016/j.semradonc.2009.02.005; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Park MH, 1998, J BIOL CHEM, V273, P1677, DOI 10.1074/jbc.273.3.1677; PARK MH, 1994, J BIOL CHEM, V269, P27827; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahman-Roblick R, 2007, P NATL ACAD SCI USA, V104, P5401, DOI 10.1073/pnas.0700794104; Reardon DA, 2010, J NEURO-ONCOL, V96, P219, DOI 10.1007/s11060-009-9950-0; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Shi XP, 1996, BBA-MOL CELL RES, V1310, P119, DOI 10.1016/0167-4889(95)00165-4; SHIBA T, 1971, BIOCHIM BIOPHYS ACTA, V244, P523, DOI 10.1016/0304-4165(71)90069-9; Specht S, 2008, PARASITOL RES, V102, P1177, DOI 10.1007/s00436-008-0891-x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun Z, 2010, J CELL PHYSIOL, V223, P798, DOI 10.1002/jcp.22100; Taylor CA, 2007, EXP CELL RES, V313, P437, DOI 10.1016/j.yexcr.2006.09.030; Templin AT, 2011, CELL CYCLE, V10, P1043, DOI 10.4161/cc.10.7.15206; Tome ME, 1997, BIOCHEM J, V328, P847; Tome ME, 1997, BIOL SIGNAL, V6, P150; Van Meir E. G., 2009, CNS CANC MODELS MARK; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Weber K, 2010, GENE THER, V17, P511, DOI 10.1038/gt.2009.149; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wick W, 2010, J CLIN ONCOL, V28, pE188, DOI 10.1200/JCO.2009.26.9027; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Wolff EC, 2011, METHODS MOL BIOL, V720, P195, DOI 10.1007/978-1-61779-034-8_12; Yang GF, 2009, GYNECOL ONCOL, V112, P314, DOI 10.1016/j.ygyno.2008.10.024; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	65	40	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43468	10.1371/journal.pone.0043468	http://dx.doi.org/10.1371/journal.pone.0043468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927971	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000307789700035
J	Saubi, N; Mbewe-Mvula, A; Gea-Mallorqui, E; Rosario, M; Gatell, JM; Hanke, T; Joseph, J				Saubi, Narcis; Mbewe-Mvula, Alice; Gea-Mallorqui, Ester; Rosario, Maximillian; Maria Gatell, Josep; Hanke, Tomas; Joseph, Joan			Pre-Clinical Development of BCG.HIVA(CAT), an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-BOVIS BCG; IMMUNODEFICIENCY-VIRUS TYPE-1; FREE PLASMID SELECTION; TO-CHILD TRANSMISSION; TUBERCULOSIS COMPLEX; IMMUNE-RESPONSES; RECOMBINANT BCG; REPRESSOR TITRATION; CELL RESPONSES	In the past, we proposed to develop a heterologous recombinant BCG prime-recombinant modified vaccinia virus Ankara (MVA) boost dual pediatric vaccine platform against transmission of breast milk HIV-1 and Mycobacterium tuberculosis (Mtb). In this study, we assembled an E. coli-mycobacterial shuttle plasmid pJH222.HIVA(CAT) expressing HIV-1 clade A immunogen HIVA. This shuttle vector employs an antibiotic resistance-free mechanism based on Operator-Repressor Titration (ORT) system for plasmid selection and maintenance in E. coli and lysine complementation in mycobacteria. This shuttle plasmid was electroporated into parental lysine auxotroph (safer) strain of BCG to generate vaccine BCG.HIVA(CAT). All procedures complied with Good Laboratory Practices (GLPs). We demonstrated that the episomal plasmid pJH222.HIVA(CAT) was stable in vivo over a 20-week period, and genetically and phenotypically characterized the BCG.HIVA(CAT) vaccine strain. The BCG.HIVA(CAT) vaccine in combination with MVA.HIVA induced HIV-1- and Mtb-specific interferon gamma-producing T-cell responses in newborn and adult BALB/c mice. On the other hand, when adult mice were primed with BCG.HIVA(CAT) and boosted with MVA. HIVA. 85A, HIV-1-specific CD8(+) T-cells producing IFN-gamma, TNF-alpha, IL-2 and CD107a were induced. To assess the biosafety profile of BCG.HIVA(CAT)- MVA.HIVA regimen, body mass loss of newborn mice was monitored regularly throughout the vaccination experiment and no difference was observed between the vaccinated and naive groups of animals. Thus, we demonstrated T-cell immunogenicity of a novel, safer, GLP-compatible BCG-vectored vaccine using prototype immunogen HIVA. Second generation immunogens derived from HIV-1 as well as other major pediatric pathogens can be constructed in a similar fashion to prime protective responses soon after birth.	[Saubi, Narcis; Gea-Mallorqui, Ester; Maria Gatell, Josep; Joseph, Joan] Univ Barcelona, AIDS Res Grp, Hosp Clin IDIBAPS HIVACAT, Sch Med, Barcelona, Spain; [Mbewe-Mvula, Alice; Hanke, Tomas] Univ Oxford, Jenner Inst, Oxford, England; [Rosario, Maximillian; Hanke, Tomas] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oxford; Jenner Institute; University of Oxford	Saubi, N (corresponding author), Univ Barcelona, AIDS Res Grp, Hosp Clin IDIBAPS HIVACAT, Sch Med, Barcelona, Spain.	jjoseph@clinic.ub.es	Gatell, Jose M/ABC-3607-2020; rosario, maxim/O-6098-2019; Rosario, Max/P-3111-2017	Saubi, Narcis/0000-0001-5493-1044; Gea-Mallorqui, Ester/0000-0002-6915-074X	EDCTP [CT.2006.33111.002]; MRC, United Kingdom [G1001757]; HIVACAT: AIDS Vaccine Research Project; MRC [G1001757, MC_U137884179] Funding Source: UKRI; Medical Research Council [G1001757, MC_U137884179] Funding Source: researchfish	EDCTP; MRC, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HIVACAT: AIDS Vaccine Research Project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The sources of funding that have supported the work are: EDCTP (Grant: CT.2006.33111.002; http://www.edctp.org); MRC, United Kingdom (Grant: G1001757; http://www.mrc.ac.uk/); and HIVACAT: AIDS Vaccine Research Project (http://www.hivacat.org/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOVINI A, 1991, NATURE, V351, P479, DOI 10.1038/351479a0; Ami Y, 2005, J VIROL, V79, P12871, DOI 10.1128/JVI.79.20.12871-12879.2005; Andersson SGE, 1996, MICROBIOL-UK, V142, P915, DOI 10.1099/00221287-142-4-915; Andre S, 1998, J VIROL, V72, P1497; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P193; Bedwell J, 2001, VACCINE, V19, P2146, DOI 10.1016/S0264-410X(00)00369-8; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Behr MA, 1999, VACCINE, V17, P915, DOI 10.1016/S0264-410X(98)00277-1; Borkowsky W, 2000, J INFECT DIS, V181, P890, DOI 10.1086/315298; Bueno SM, 2008, P NATL ACAD SCI USA, V105, P20822, DOI 10.1073/pnas.0806244105; Castillo-Rodal AI, 2006, INFECT IMMUN, V74, P1718, DOI 10.1128/IAI.74.3.1718-1724.2006; Cavarelli M, 2011, J INTERN MED, V270, P561, DOI 10.1111/j.1365-2796.2011.02458.x; Cayabyab MJ, 2009, J VIROL, V83, P5505, DOI 10.1128/JVI.02544-08; Cayabyab MJ, 2006, J VIROL, V80, P1645, DOI 10.1128/JVI.80.4.1645-1652.2006; Chege GK, 2009, VACCINE, V27, P4857, DOI 10.1016/j.vaccine.2009.05.064; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cranenburgh RM, 2004, J MOL MICROB BIOTECH, V7, P197, DOI 10.1159/000079828; Cranenburgh RM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e26; European Pharmacopoeia, 2010, SECT 5 2 6 EUR PHARM; GHEORGHIU M, 1988, J BIOL STAND, V16, P15, DOI 10.1016/0092-1157(88)90025-X; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376; HONDA M, 1995, P NATL ACAD SCI USA, V92, P10693, DOI 10.1073/pnas.92.23.10693; Hopkins R, 2011, EUR J IMMUNOL, V41, P3542, DOI 10.1002/eji.201141962; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Hovav AH, 2007, J VIROL, V81, P12793, DOI 10.1128/JVI.01519-07; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Johnson DC, 2005, J INFECT DIS, V192, P2129, DOI 10.1086/498163; Joseph J, 2006, EXPERT REV VACCINES, V5, P827, DOI 10.1586/14760584.5.6.827; Joseph J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357370; Kasai, 1998, Genome Inform Ser Workshop Genome Inform, V9, P13; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; LAGRANDERIE M, 1993, VACCINE, V11, P1283, DOI 10.1016/0264-410X(93)90096-G; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Liebana E, 1996, J CLIN MICROBIOL, V34, P933; Lotte A, 1984, Adv Tuberc Res, V21, P107; Magdalena J, 1998, J CLIN MICROBIOL, V36, P2471, DOI 10.1128/JCM.36.9.2471-2476.1998; Marchant A, 1999, J IMMUNOL, V163, P2249; Matsuo Kazuhiro, 2011, Tuberc Res Treat, V2011, P574591, DOI 10.1155/2011/574591; McFarland EJ, 2006, AIDS, V20, P1481, DOI 10.1097/01.aids.0000237363.33994.45; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Nascimento IP, 2009, VACCINE, V27, P7346, DOI 10.1016/j.vaccine.2009.09.043; Niemann S, 2004, J CLIN MICROBIOL, V42, P3958, DOI 10.1128/JCM.42.9.3958-3962.2004; Niemann S, 2000, J CLIN MICROBIOL, V38, P3231, DOI 10.1128/JCM.38.9.3231-3234.2000; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Pan YL, 2011, J BACTERIOL, V193, P3152, DOI 10.1128/JB.00405-11; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Ranganathan UDK, 2009, VACCINE, V28, P152, DOI 10.1016/j.vaccine.2009.09.087; Richter E, 2003, J CLIN MICROBIOL, V41, P2672, DOI 10.1128/JCM.41.6.2672-2675.2003; Rosario M, 2010, J VIROL, V84, P7815, DOI 10.1128/JVI.00726-10; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Saubi N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/516219; STOVER CK, 1993, J EXP MED, V178, P197, DOI 10.1084/jem.178.1.197; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Talbot EA, 1997, J CLIN MICROBIOL, V35, P566, DOI 10.1128/JCM.35.3.566-569.1997; Trovero A, 2010, REV ARGENT MICROBIOL, V42, P4, DOI 10.1590/S0325-75412010000100002; UNAIDS, 2011, WORLD REF DAY 2019 H; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Williams SG, 1998, NUCLEIC ACIDS RES, V26, P2120, DOI 10.1093/nar/26.9.2120; Zhu YD, 1997, J INFECT DIS, V176, P1445, DOI 10.1086/514140	62	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42559	10.1371/journal.pone.0042559	http://dx.doi.org/10.1371/journal.pone.0042559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927933	Green Published, gold, Green Submitted			2022-12-27	WOS:000307789700013
J	Schmiedel, JM; Axmann, IM; Legewie, S				Schmiedel, Joern Matthias; Axmann, Ilka Maria; Legewie, Stefan			Multi-Target Regulation by Small RNAs Synchronizes Gene Expression Thresholds and May Enhance Ultrasensitive Behavior	PLOS ONE			English	Article							SMALL NONCODING RNAS; ESCHERICHIA-COLI; TRANSLATIONAL REPRESSION; NEGATIVE FEEDBACK; SIGNALING NETWORK; SOLUBLE-RNA; HFQ; TARGET; ROBUSTNESS; MICRORNA	Cells respond to external cues by precisely coordinating multiple molecular events. Co-regulation may be established by the so-called single-input module (SIM), where a common regulator controls multiple targets. Using mathematical modeling, we compared the ability of SIM architectures to precisely coordinate protein levels despite environmental fluctuations and uncertainties in parameter values. We find that post-transcriptional co-regulation as exemplified by bacterial small RNAs (sRNAs) is particularly robust: sRNA-mediated regulation establishes highly synchronous gene expression thresholds for all mRNA targets without a need for fine-tuning of kinetic parameters. Our analyses reveal that the non-catalytic nature of sRNA action is essential for robust gene expression synchronization, and that sRNA sequestration effects underlie coupling of multiple mRNA pools. This principle also operates in the temporal regime, implying that sRNAs could robustly coordinate the kinetics of mRNA induction as well. Moreover, we observe that multi-target regulation by a small RNA can strongly enhance ultrasensitivity in mRNA expression when compared to the single-target case. Our findings may explain why bacterial small RNAs frequently coordinate all-or-none responses to cellular stress.	[Schmiedel, Joern Matthias; Axmann, Ilka Maria] Charite, Inst Theoret Biol, D-13353 Berlin, Germany; [Legewie, Stefan] Inst Mol Biol, Mainz, Rheinland Pfalz, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institute of Molecular Biology (IMB)	Schmiedel, JM (corresponding author), Charite, Inst Theoret Biol, D-13353 Berlin, Germany.	s.legewie@imb-mainz.de	Schmiedel, Jörn/K-6833-2017	Schmiedel, Jörn/0000-0002-6842-9837; Axmann, Ilka Maria/0000-0002-0856-8667; Legewie, Stefan/0000-0003-4111-0567	Bundesministerium fur Bildung und Forschung (Virtual Liver Network) through the FORSYS partner program [0315294]; DFG research training group Computational Systems Biology; European Commission [248919]	Bundesministerium fur Bildung und Forschung (Virtual Liver Network) through the FORSYS partner program(Federal Ministry of Education & Research (BMBF)); DFG research training group Computational Systems Biology(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Bundesministerium fur Bildung und Forschung (Virtual Liver Network) to SL and through the FORSYS partner program, grant number 0315294 (IMA). JMS acknowledges support by the DFG research training group Computational Systems Biology. This work was further supported by the European Commission, FP7-ICT-2009-4, BACTOCOM, Project Number 248919, to JMS and IMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Argaman L, 2000, J MOL BIOL, V300, P1101, DOI 10.1006/jmbi.2000.3942; Babitzke P, 2009, ANNU REV MICROBIOL, V63, P27, DOI 10.1146/annurev.micro.091208.073514; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beisel CL, 2011, MOL CELL, V41, P286, DOI 10.1016/j.molcel.2010.12.027; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Hao Y, 2011, P NATL ACAD SCI USA, V108, P12473, DOI 10.1073/pnas.1100432108; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; Legewie S, 2008, BIOPHYS J, V95, P3232, DOI 10.1529/biophysj.108.133819; Legewie S, 2007, BIOPHYS J, V93, P2279, DOI 10.1529/biophysj.107.109132; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lovdok L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000171; Maki K, 2008, P NATL ACAD SCI USA, V105, P10332, DOI 10.1073/pnas.0803106105; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mather WH, 2010, BIOPHYS J, V99, P3172, DOI 10.1016/j.bpj.2010.09.057; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Mitarai N, 2007, PHYS BIOL, V4, P164, DOI 10.1088/1478-3975/4/3/003; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; Paulsen M, 2011, P NATL ACAD SCI USA, V108, P10202, DOI 10.1073/pnas.1100179108; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Santos SDM, 2008, NATURE, V454, P288, DOI 10.1038/454288a; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Ventura AC, 2010, P NATL ACAD SCI USA, V107, P10032, DOI 10.1073/pnas.0913815107; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zhdanov VP, 2011, CHAOS, V21, DOI 10.1063/1.3605464; Zhdanov VP, 2011, PHYS REP, V500, P1, DOI 10.1016/j.physrep.2010.12.002; Zhdanov VP, 2009, MOL BIOSYST, V5, P638, DOI 10.1039/b808095j	57	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42296	10.1371/journal.pone.0042296	http://dx.doi.org/10.1371/journal.pone.0042296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927924	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700008
J	Nejepinska, J; Malik, R; Moravec, M; Svoboda, P				Nejepinska, Jana; Malik, Radek; Moravec, Martin; Svoboda, Petr			Deep Sequencing Reveals Complex Spurious Transcription from Transiently Transfected Plasmids	PLOS ONE			English	Article							LUCIFERASE REPORTER GENE; MAMMALIAN-CELLS; PRL-TK; EXPRESSION; VECTORS; RNA; ASSAYS; DNA; INHIBITION; EFFICIENCY	Transient plasmid transfection is a common approach in studies in cultured mammalian cells. To examine behavior of transfected plasmids, we analyzed their transcriptional landscape by deep sequencing. We have found that the entire plasmid sequence is transcribed at different levels. Spurious transcription may have undesirable effects as some plasmids, when co-transfected, inhibited expression of luciferase reporters in a dose-dependent manner. In one case, we attributed this effect to a Kan/Neo resistance cassette, which generated a unique population of edited sense and antisense small RNAs. The unexpected complexity of expression from transiently transfected plasmids underscores the importance of appropriate experimental controls.	[Nejepinska, Jana; Malik, Radek; Moravec, Martin; Svoboda, Petr] Inst Mol Genet AS CR, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Nejepinska, J (corresponding author), Inst Mol Genet AS CR, Prague, Czech Republic.	petr.svoboda@img.cas.cz	Urbanova, Jana/G-2748-2014; Svoboda, Petr/G-3890-2012; Malik, Radek/G-3578-2014	Urbanova, Jana/0000-0001-9778-6289; Svoboda, Petr/0000-0002-4370-3705; Malik, Radek/0000-0002-6783-1146	Czech Science Foundation [GACR 204/09/0085]; RVO [68378050]; European Molecular Biology Organization Strategic Development Installation Grant [0001488];  [AV0Z50520514]	Czech Science Foundation(Grant Agency of the Czech Republic); RVO; European Molecular Biology Organization Strategic Development Installation Grant; 	This research was supported by the Czech Science Foundation (grant GACR 204/09/0085), institutional support AV0Z50520514 and RVO 68378050, and the European Molecular Biology Organization Strategic Development Installation Grant (program 0001488, partial). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHANG LJ, 1985, MOL CELL BIOL, V5, P2341, DOI 10.1128/MCB.5.9.2341; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; FARR A, 1992, NUCLEIC ACIDS RES, V20, P920, DOI 10.1093/nar/20.4.920; Ghazawi I, 2005, J INTERF CYTOK RES, V25, P92, DOI 10.1089/jir.2005.25.92; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hong SJ, 2002, BIOTECHNIQUES, V33, P1236, DOI 10.2144/02336bm11; KALVAKOLANU DVR, 1991, J BIOL CHEM, V266, P873; Kaname T, 2001, GENE, V266, P147, DOI 10.1016/S0378-1119(01)00375-4; Kaufman RJ, 1997, METHODS, V11, P361, DOI 10.1006/meth.1996.0434; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lorenz WW, 1996, J BIOLUM CHEMILUM, V11, P31, DOI 10.1002/(SICI)1099-1271(199601)11:1<31::AID-BIO398>3.0.CO;2-M; Nejepinska J, 2012, NUCLEIC ACIDS RES, V40, P399, DOI 10.1093/nar/gkr702; Osborne SA, 2002, BIOTECHNIQUES, V33, P1240, DOI 10.2144/02336bm12; Paguio A., 2005, PROMEGA NOTES, V89, P7; Schagat T, 2007, CELL NOTES, V17, P9; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; Shifera AS, 2010, ANAL BIOCHEM, V396, P167, DOI 10.1016/j.ab.2009.09.043; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; SORSCHER DH, 1994, CARCINOGENESIS, V15, P1093, DOI 10.1093/carcin/15.5.1093; Terenzi F, 1999, NUCLEIC ACIDS RES, V27, P4369, DOI 10.1093/nar/27.22.4369; Thavathiru E, 2001, BIOTECHNIQUES, V31, P528, DOI 10.2144/01313st06; Thirunavukkarasu K, 2000, BIOTECHNIQUES, V28, P506, DOI 10.2144/00283st09; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vopalensky V, 2008, RNA, V14, P1720, DOI 10.1261/rna.831808	28	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43283	10.1371/journal.pone.0043283	http://dx.doi.org/10.1371/journal.pone.0043283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916237	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300037
J	Chakrabarty, P; Davis, MP; Sparks, JS				Chakrabarty, Prosanta; Davis, Matthew P.; Sparks, John S.			The First Record of a Trans-Oceanic Sister-Group Relationship between Obligate Vertebrate Troglobites	PLOS ONE			English	Article							DIVERGENCE; TELEOSTEI; FISHES; MODEL; ELEOTRIDAE; SPECIATION; DISPERSAL; EVOLUTION; PATTERNS; CAVEFISH	We show using the most complete phylogeny of one of the most species-rich orders of vertebrates (Gobiiformes), and calibrations from the rich fossil record of teleost fishes, that the genus Typhleotris, endemic to subterranean karst habitats in southwestern Madagascar, is the sister group to Milyeringa, endemic to similar subterranean systems in northwestern Australia. Both groups are eyeless, and our phylogenetic and biogeographic results show that these obligate cave fishes now found on opposite ends of the Indian Ocean (separated by nearly 7,000 km) are each others closest relatives and owe their origins to the break up of the southern supercontinent, Gondwana, at the end of the Cretaceous period. Trans-oceanic sister-group relationships are otherwise unknown between blind, cave-adapted vertebrates and our results provide an extraordinary case of Gondwanan vicariance.	[Chakrabarty, Prosanta] Louisiana State Univ, Museum Nat Sci, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Davis, Matthew P.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Sparks, John S.] Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA	Louisiana State University System; Louisiana State University; Field Museum of Natural History (Chicago); American Museum of Natural History (AMNH)	Chakrabarty, P (corresponding author), Louisiana State Univ, Museum Nat Sci, Dept Biol Sci, Baton Rouge, LA 70803 USA.	prosanta@lsu.edu	Chakrabarty, Prosanta/E-3307-2010		Niarchos family (Niarchos Expedition Fund, AMNH) in Madagascar; Niarchos family (Niarchos Expedition Fund, AMNH) in New York	Niarchos family (Niarchos Expedition Fund, AMNH) in Madagascar; Niarchos family (Niarchos Expedition Fund, AMNH) in New York	JSS wishes to express his gratitude to the Niarchos family (Niarchos Expedition Fund, AMNH) for providing funding for this project in Madagascar and New York. PC would like to thank Sue Morrison, and Darren Brooks and his family for help with fieldwork and collections work in Australia. We thank Steve Goodman (FMNH, Vahatra.org) for providing a great deal of logistical support and for sharing his extensive knowledge of Malagasy karst formations and their inhabitants; this study would not have been possible without his generous assistance. Collecting efforts in Madagascar were facilitated by the efforts of Benjamin Andriamahaja and the MICET (Institute for the Conservation of Tropical Environments, Madagascar) staff, and we are grateful for their continued support of ichthyological research. Collection permits were obtained from the Direction des Eaux et Forets and the Association National pour la Gestion des Aires Protegees (ANGAP) in Madagascar and the Department of Environment and Conservation in Western Australia. We also thank Jason Ali for providing the paleomap in Figure 3, and Christine Thacker for several helpful discussions. We would also like to thank Philip Willink and Scott Holtz for their considerable assistance in the field.	Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; Ali JR, 2009, J BIOGEOGR, V36, P1778, DOI 10.1111/j.1365-2699.2009.02105.x; Arratia Gloria, 1999, P265; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Blum S.D., 1988, THESIS U HAWAII HONO; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; Case Judd A., 2002, Journal of Vertebrate Paleontology, V22, p42A; Chakrabarty P, 2010, ZOOTAXA, P67, DOI 10.11646/zootaxa.2632.1.4; Chakrabarty P, 2010, ZOOTAXA, P19; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Darwin C, 1859, ORIGIN SPECIES MEANS; Davis MP, 2010, MOL PHYLOGENET EVOL, V57, P1194, DOI 10.1016/j.ympev.2010.09.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Felsenstein J., 2004, INFERRING PHYLOGENIE; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Guyot L., 2002, THESIS U NANTES; Hamilton-Smith E, 1998, KARST MANAGEMENT CON; Hay WW, 1999, GEOL S AM S, P1; Humphreys WF, 2001, ENVIRON BIOL FISH, V62, P297, DOI 10.1023/A:1011880726946; Johnson GD, 2012, P ROY SOC B-BIOL SCI, V279, P934, DOI 10.1098/rspb.2011.1289; Jokat W, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045117; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Kallersjo M, 1999, CLADISTICS, V15, P91; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Konig M, 2010, GEOPHYS J INT, V180, P158, DOI [10.1111/J.1365-246X.2009.04433.X, 10.1111/j.1365-246X.2009.04433.x]; Lamoreux J, 2004, J CAVE KARST STUD, V66, P18; Maddison WP, 2019, MESQUITE MODULAR SYS; MILLER PJ, 1973, J ZOOL, V171, P397; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Neiber MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019627; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Patterson C., 1993, P621; Porter ML, 2007, J CAVE KARST STUD, V69, P179; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prasad GVR, 2009, B SOC GEOL FR, V180, P369, DOI 10.2113/gssgfbull.180.4.369; Proudlove G. S., 2006, SUBTERRANEAN FISHES; Proudlove GS, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P41, DOI 10.1201/EBK1578086702-c2; Rambaut A., 2007, TRACER V1 5; Ribera I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-29; ROSEN DE, 1975, SYST ZOOL, V24, P431, DOI 10.2307/2412905; Ruber L, 2012, BIOLOGY OF GOBIES, P23; Saitoh K, 2011, ZOOL J LINN SOC-LOND, V161, P633, DOI 10.1111/j.1096-3642.2010.00651.x; Sparks JS, 2005, SYST BIOL, V54, P158, DOI 10.1080/10635150590906019; Sparks JS, AM MUS NOVI IN PRESS; Thacker CE, 2005, MOL PHYLOGENET EVOL, V37, P858, DOI 10.1016/j.ympev.2005.05.004; Thacker C, 2012, Biology of Gobies, P79; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; WILEY EO, 1985, ANN MO BOT GARD, V72, P596, DOI 10.2307/2399217; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Zander CD, 2012, Biology of Gobies, P345; Zwickl DJ., 2006, THESIS	53	43	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44083	10.1371/journal.pone.0044083	http://dx.doi.org/10.1371/journal.pone.0044083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937155	Green Published, gold			2022-12-27	WOS:000308213600075
J	Mao, NY; Ji, YX; Xie, ZD; Wang, HH; Wang, HL; An, JJ; Zhang, XX; Zhang, Y; Zhu, Z; Cui, AL; Xu, ST; Shen, KL; Liu, CY; Yang, WZ; Xu, WB				Mao, Naiying; Ji, Yixin; Xie, Zhengde; Wang, Huanhuan; Wang, Huiling; An, Junjing; Zhang, Xinxin; Zhang, Yan; Zhu, Zhen; Cui, Aili; Xu, Songtao; Shen, Kunling; Liu, Chunyan; Yang, Weizhong; Xu, Wenbo			Human Parainfluenza Virus-Associated Respiratory Tract Infection among Children and Genetic Analysis of HPIV-3 Strains in Beijing, China	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; REAL-TIME PCR; SYNCYTIAL-VIRUS; HEMAGGLUTININ-NEURAMINIDASE; YOUNG-CHILDREN; MOLECULAR EPIDEMIOLOGY; HUMAN METAPNEUMOVIRUS; PEDIATRIC-PATIENTS; TYPE-3; EVOLUTION	The relevance of human parainfluenza viruses (HPIVs) to the epidemiology of acute respiratory infections (ARI) in China is unclear. From May 2008 to September 2010, 443 nasopharyngeal aspirates (NPAs) from hospitalized pediatric patients (age from 1 to 93 months) in Beijing were collected and screened for HPIVs and other common respiratory viruses by real-time RT-PCR. Sixty-two of 443 samples were positive for HPIVs with 4 positive for HPIV-2 and 58 positive for HPIV-3, indicating that HPIV-3 was the predominant virus present during the study period. A phylogenetic tree based on all the available HN (hemagglutinin-neuraminidase) sequences of HPIV-3 indicated that three distinct clusters (A, B, and C) were circulating with some temporal and regional clustering. Cluster C was further divided into sub-clusters, C1, C2, C3 and C4. HPIV-3 from Beijing isolates belonged to sub-cluster C3, and were grouped with the isolates from two Provinces of China and the neighboring country of Japan. Genetic analysis based on entire HN gene revealed that the HPIV-3 isolates from Beijing were highly similar with 97.2%-100% identity at the nucleotide level and these could be divided into two closely related lineages, C3a and C3b. These findings suggested that there was co-circulation of multiple lineages of HPIV-3 in the Beijing region during the study period. This is the first study to describe the epidemiology and molecular characterization of HPIVs in China.	[Mao, Naiying; Ji, Yixin; Wang, Huanhuan; Wang, Huiling; An, Junjing; Zhang, Xinxin; Zhang, Yan; Zhu, Zhen; Cui, Aili; Xu, Songtao; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, World Hlth Org Reg Off, Western Pacific Reg Reference Measles Lab, Beijing, Peoples R China; [Mao, Naiying; Ji, Yixin; Wang, Huanhuan; Wang, Huiling; An, Junjing; Zhang, Xinxin; Zhang, Yan; Zhu, Zhen; Cui, Aili; Xu, Songtao; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Xie, Zhengde; Wang, Huiling; Zhang, Xinxin; Shen, Kunling; Liu, Chunyan] Capital Med Univ, Beijing Childrens Hosp, Beijing, Peoples R China; [Wang, Huanhuan] Taishan Med Coll, Dept Neurobiol, Tai An, Shandong, Peoples R China; [Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; World Health Organization; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Chinese Center for Disease Control & Prevention	Mao, NY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, World Hlth Org Reg Off, Western Pacific Reg Reference Measles Lab, Beijing, Peoples R China.	Wenbo_xu1@yahoo.com.cn	Yang, Wei/HIA-0360-2022		Ministry of Science and Technology of the People's Republic of China [2009ZX1004-201, 2009ZX1004-202, 2007AA02Z463]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by grants 2009ZX1004-201 and 2009ZX1004-202 from the National Infectious Disease Surveillance Program of the Ministry of Science and Technology of the People's Republic of China and grant 2007AA02Z463 from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JC, 2000, J CLIN MICROBIOL, V38, P1191, DOI 10.1128/JCM.38.3.1191-1195.2000; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; COELINGH KLV, 1988, VIROLOGY, V162, P137, DOI 10.1016/0042-6822(88)90402-3; COELINGH KLV, 1987, J VIROL, V61, P1473, DOI 10.1128/JVI.61.5.1473-1477.1987; COLLINS KR, 1995, EPIDEMIOL INFECT, V114, P493, DOI 10.1017/S0950268800052201; Cortez KJ, 2001, J INFECT DIS, V184, P1093, DOI 10.1086/322041; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; DENNY FW, 1986, J PEDIATR-US, V108, P635, DOI 10.1016/S0022-3476(86)81034-4; Downham M A, 1973, Arch Dis Child, V48, P824; DOWNHAM MAP, 1974, ARCH DIS CHILD, V49, P8, DOI 10.1136/adc.49.1.8; EASTON AJ, 1989, EPIDEMIOL INFECT, V102, P531, DOI 10.1017/S0950268800030247; Echevarria JE, 2000, J VIROL METHODS, V88, P105, DOI 10.1016/S0166-0934(00)00163-4; Fabbiani M, 2009, J MED VIROL, V81, P750, DOI 10.1002/jmv.21457; Gambarino S, 2009, MOL BIOTECHNOL, V42, P350, DOI 10.1007/s12033-009-9164-x; GLEZEN WP, 1984, J INFECT DIS, V150, P851, DOI 10.1093/infdis/150.6.851; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hayden FG, 2006, CURR OPIN INFECT DIS, V19, P169, DOI 10.1097/01.qco.0000216628.51563.b1; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Henrickson KJ, 2003, CLIN MICROBIOL REV, V16, P242, DOI 10.1128/CMR.16.2.242-264.2003; HENRICKSON KJ, 1994, CLIN INFECT DIS, V18, P770, DOI 10.1093/clinids/18.5.770; HENRICKSON KJ, 1992, J INFECT DIS, V166, P995, DOI 10.1093/infdis/166.5.995; HETHERINGTON SV, 1994, J INFECT DIS, V169, P248, DOI 10.1093/infdis/169.2.248; Jalal H, 2007, J CLIN MICROBIOL, V45, P1690, DOI 10.1128/JCM.01912-06; Kim Sun Hyung, 2006, Korean J Lab Med, V26, P351, DOI 10.3343/kjlm.2006.26.5.351; KLIPPMARK E, 1990, J GEN VIROL, V71, P1577, DOI 10.1099/0022-1317-71-7-1577; KNOTT AM, 1994, PEDIATR INFECT DIS J, V13, P269, DOI 10.1097/00006454-199404000-00005; Lau SKP, 2009, J CLIN MICROBIOL, V47, P1549, DOI 10.1128/JCM.00047-09; Lu Rou-jian, 2008, Chinese Journal of Virology, V24, P305; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Marx A, 1997, J INFECT DIS, V176, P1423, DOI 10.1086/514137; Moisiuk SE, 1998, PEDIATR INFECT DIS J, V17, P49, DOI 10.1097/00006454-199801000-00011; MONTO AS, 1986, AM J EPIDEMIOL, V124, P359, DOI 10.1093/oxfordjournals.aje.a114406; Fe MMM, 2008, BRAZ J INFECT DIS, V12, P192, DOI 10.1590/S1413-86702008000300006; Muraki Y, 1996, J GEN VIROL, V77, P673, DOI 10.1099/0022-1317-77-4-673; MURPHY B, 1980, MED J AUSTRALIA, V1, P22, DOI 10.5694/j.1326-5377.1980.tb134568.x; Niederman MS, 2004, AM J MED, V117, P51, DOI 10.1016/j.amjmed.2004.07.008; Palermo LM, 2009, J VIROL, V83, P6900, DOI 10.1128/JVI.00475-09; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Pierangeli A, 2007, J MED VIROL, V79, P463, DOI 10.1002/jmv.20832; PRINOSKI K, 1992, VIRUS RES, V22, P55, DOI 10.1016/0168-1702(92)90089-R; Reed G, 1997, J INFECT DIS, V175, P807, DOI 10.1086/513975; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Ruth A, 2007, FIELDS VIROLOGY, P1498; Segal AO, 2005, PEDIATRICS, V116, P51, DOI 10.1542/peds.2004-1892; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; VAINIONPAA R, 1994, CLIN MICROBIOL REV, V7, P265; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; Vijgen L, 2005, J CLIN MICROBIOL, V43, P5452, DOI 10.1128/JCM.43.11.5452-5456.2005; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Zambon M, 1998, J CLIN MICROBIOL, V36, P2289, DOI 10.1128/JCM.36.8.2289-2293.1998	53	34	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43893	10.1371/journal.pone.0043893	http://dx.doi.org/10.1371/journal.pone.0043893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937119	gold, Green Submitted, Green Published			2022-12-27	WOS:000308213600055
J	Campitelli, M; Jeannot, E; Peter, M; Lappartient, E; Saada, S; de la Rochefordiere, A; Fourchotte, V; Alran, S; Petrow, P; Cottu, P; Pierga, JY; Lantz, O; Couturier, J; Sastre-Garau, X				Campitelli, Maura; Jeannot, Emmanuelle; Peter, Martine; Lappartient, Emmanuelle; Saada, Stephanie; de la Rochefordiere, Anne; Fourchotte, Virginie; Alran, Severine; Petrow, Peter; Cottu, Paul; Pierga, Jean-Yves; Lantz, Olivier; Couturier, Jerome; Sastre-Garau, Xavier			Human Papillomavirus Mutational Insertion: Specific Marker of Circulating Tumor DNA in Cervical Cancer Patients	PLOS ONE			English	Article							CELLULAR FUSION TRANSCRIPTS; PLASMA; SEQUENCES; HPV16; PCR	Introduction: In most cases of cervical cancers, HPV DNA is integrated into the genome of carcinoma cells. This mutational insertion constitutes a highly specific molecular marker of tumor DNA for every patient. Circulating tumor DNA (ctDNA) is an emerging marker of tumor dynamics which detection requires specific molecular motif. To determine whether the sequence of the cell-viral junction could be used in clinical practice as a specific marker of ctDNA, we analyzed a series of cervical cancer patient serums. Methods and Findings: Serum specimens of 16 patients diagnosed with HPV16/18-associated cervical cancer, and for which the viral integration locus had been previously localized, were analyzed. Sequential serum specimens, taken at different times during the course of the disease, were also available for two of these cases. ctDNA was found in 11 out of 13 patients with tumor size greater than 20 mm at diagnosis, and analysis of sequential serum specimens showed that ctDNA concentration in patients serum was related to tumor dynamics. Conclusions: We report that HPV mutational insertion constitutes a highly specific molecular marker of ctDNA in HPV-associated tumor patients. Using this original approach, ctDNA was detected in most cervical cancer patients over stage I and ctDNA concentration was found to reflect tumor burden. In addition to its potential prognostic and predictive value, HPV mutation insertion is likely to constitute a new molecular surrogate of minimal residual disease and of subclinical relapse in HPV-associated tumor. This is of major importance in the perspective of specific anti-HPV therapy.	[Campitelli, Maura; de la Rochefordiere, Anne] Hosp Paris, Inst Curie, Dept Radiat Oncol, Paris, France; [Jeannot, Emmanuelle; Peter, Martine; Lappartient, Emmanuelle; Saada, Stephanie; Lantz, Olivier; Couturier, Jerome; Sastre-Garau, Xavier] Hosp Paris, Inst Curie, Dept Biopathol, Paris, France; [Fourchotte, Virginie; Alran, Severine] Hosp Paris, Inst Curie, Dept Surg Oncol, Paris, France; [Petrow, Peter] Hosp Paris, Inst Curie, Dept Radiol, Paris, France; [Cottu, Paul; Pierga, Jean-Yves] Hosp Paris, Inst Curie, Dept Med Oncol, Paris, France	Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hopital Universitaire Sainte-Perine - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Campitelli, M (corresponding author), Hosp Paris, Inst Curie, Dept Radiat Oncol, Paris, France.	xavier.sastre@curie.net	Lantz, Olivier J/J-4960-2012; Cottu, Paul/ABC-8595-2020	Lantz, Olivier J/0000-0003-3161-7719; Sastre-Garau, Xavier/0000-0001-5992-2083	La Maison Goyard	La Maison Goyard	This work was supported in part by a partnership with La Maison Goyard and by a generous gift from Ms. A. Mauresmo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dong SM, 2002, CANCER EPIDEM BIOMAR, V11, P3; Gadducci A, 2008, CRIT REV ONCOL HEMAT, V66, P10, DOI 10.1016/j.critrevonc.2007.09.002; Hopman AHN, 2004, J PATHOL, V202, P23, DOI 10.1002/path.1490; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Liu VWS, 2001, GYNECOL ONCOL, V82, P269, DOI 10.1006/gyno.2001.6289; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Pornthanakasem W, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-2; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shimada T, 2010, JPN J CLIN ONCOL, V40, P420, DOI 10.1093/jjco/hyp193; Sung WK., 2012, NAT GENET       0527; Tseng CJ, 1999, J CLIN ONCOL, V17, P1391, DOI 10.1200/JCO.1999.17.5.1391; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; Yang HJ, 2004, INT J GYNECOL CANCER, V14, P903, DOI 10.1111/j.1048-891X.2004.014528.x	20	57	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43393	10.1371/journal.pone.0043393	http://dx.doi.org/10.1371/journal.pone.0043393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937045	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500047
J	Pfurtscheller, G; Daly, I; Bauernfeind, G; Muller-Putz, GR				Pfurtscheller, Gert; Daly, Ian; Bauernfeind, Guenther; Mueller-Putz, Gernot R.			Coupling between Intrinsic Prefrontal HbO2 and Central EEG Beta Power Oscillations in the Resting Brain	PLOS ONE			English	Article							BLOOD-PRESSURE FLUCTUATIONS; HEART-RATE-VARIABILITY; CARDIOVASCULAR-SYSTEM; CONSCIOUS INTENTION; TIME; RHYTHMS; MODEL; STATE; DESYNCHRONIZATION; EXCITABILITY	There is increasing interest in the intrinsic activity in the resting brain, especially that of ultraslow and slow oscillations. Using near-infrared spectroscopy (NIRS), electroencephalography (EEG), blood pressure (BP), respiration and heart rate recordings during 5 minutes of rest, combined with cross spectral and sliding cross correlation calculations, we identified a short-lasting coupling (duration approximate to 100 s) between prefrontal oxyhemoglobin (HbO2) in the frequency band between 0.07 and 0.13 Hz and central EEG alpha and/or beta power oscillations in 8 of the 9 subjects investigated. The HbO2 peaks preceded the EEG band power peaks by 3.7 s in 6 subjects, with moderate or no coupling between BP and HbO2 oscillations. HbO2 and EEG band power oscillations were approximately in phase with BP oscillations in the 2 subjects with an extremely high coupling (squared coherence >0.8) between BP and HbO2 oscillation. No coupling was identified in one subject. These results indicate that slow precentral (de) oxyhemoglobin concentration oscillations during awake rest can be temporarily coupled with EEG fluctuations in sensorimotor areas and modulate the excitability level in the brains' motor areas, respectively. Therefore, this provides support for the idea that resting state networks fluctuate with frequencies of between 0.01 and 0.1 Hz (Mantini et. al. PNAS 2007).	[Pfurtscheller, Gert; Daly, Ian; Bauernfeind, Guenther; Mueller-Putz, Gernot R.] Graz Univ Technol, Lab Brain Comp Interfaces, Inst Knowledge Discovery, A-8010 Graz, Austria	Graz University of Technology	Pfurtscheller, G (corresponding author), Graz Univ Technol, Lab Brain Comp Interfaces, Inst Knowledge Discovery, A-8010 Graz, Austria.	pfurtscheller@tugraz.at	Daly, Ian/Q-7322-2017	Daly, Ian/0000-0001-5489-0393; Muller-Putz, Gernot/0000-0002-0087-3720; Bauernfeind, Gunther/0000-0002-5205-8920	European ICT Programme Project [FP7-224631]; Land Steiermark [A3-22N-13/2009-8]; Neuro Center Styria; Allgemeine Unfallversicherungsanstalt in Austria	European ICT Programme Project; Land Steiermark; Neuro Center Styria; Allgemeine Unfallversicherungsanstalt in Austria	This work is supported by the European ICT Programme Project FP7-224631, Land Steiermark (project A3-22N-13/2009-8), the Neuro Center Styria and the Allgemeine Unfallversicherungsanstalt in Austria. This paper only reflects the authors' views and funding agencies are not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AG, 2005, IEEE T SIGNAL PROCES, V53, P26, DOI 10.1109/TSP.2004.838942; Bauernfeind G, 2008, BIOMED TECH, V53, P36, DOI 10.1515/BMT.2008.005; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; Chen R, 1999, EXP BRAIN RES, V128, P539, DOI 10.1007/s002210050878; Claus S, 2012, EPILEPSY RE IN PRESS; Daly I, 2012, PATTERN RECOGN, V45, P2123, DOI 10.1016/j.patcog.2011.04.034; DAMEN EJP, 1987, PSYCHOPHYSIOLOGY, V24, P700, DOI 10.1111/j.1469-8986.1987.tb00353.x; Darwin C., 1999, EXPRESSION EMOTIONS; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; de Munck JC, 2008, NEUROIMAGE, V42, P112, DOI 10.1016/j.neuroimage.2008.04.244; DEBOER RW, 1985, MED BIOL ENG COMPUT, V23, P352, DOI 10.1007/BF02441589; DEBOER RW, 1985, MED BIOL ENG COMPUT, V23, P359, DOI 10.1007/BF02441590; DEECKE L, 1976, BIOL CYBERN, V23, P99, DOI 10.1007/BF00336013; Florian G, 1998, INT J PSYCHOPHYSIOL, V28, P273, DOI 10.1016/S0167-8760(97)00075-5; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Hummel F, 2004, NEUROIMAGE, V23, P1391, DOI 10.1016/j.neuroimage.2004.07.070; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Lambertz M, 1998, J AUTONOM NERV SYST, V68, P58, DOI 10.1016/S0165-1838(97)00126-4; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Montano N, 1996, J AUTONOM NERV SYST, V57, P116, DOI 10.1016/0165-1838(95)00113-1; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Papakostopoulos D., 1990, J PSYCHOPHYSIOL, V4, P163; Perlitz V, 2004, PFLUG ARCH EUR J PHY, V448, P579, DOI 10.1007/s00424-004-1291-4; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2012, NEUROSCI LETT, V508, P89, DOI 10.1016/j.neulet.2011.12.025; Pfurtscheller G, 2011, IEEE T BIO-MED ENG, V58, P2064, DOI 10.1109/TBME.2011.2134851; Pfurtscheller K, 2008, NEUROSCI LETT, V437, P103, DOI 10.1016/j.neulet.2008.03.079; PIJN JP, 1991, ELECTROEN CLIN NEURO, V79, P371, DOI 10.1016/0013-4694(91)90202-F; Politis D. N., 1992, EXPLORING LIMITS BOO, V2635270; PREISS G, 1974, AM J PHYSIOL, V226, P724, DOI 10.1152/ajplegacy.1974.226.3.724; Roche-Labarbe N, 2007, NEUROIMAGE, V36, P718, DOI 10.1016/j.neuroimage.2007.04.002; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Sasai S, 2011, NEUROIMAGE, V56, P252, DOI 10.1016/j.neuroimage.2010.12.075; Schomer L., 2011, NIEDERMEYERS ELECTRO; Seidel H, 1998, PHYSICA D, V115, P145, DOI 10.1016/S0167-2789(97)00229-7; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Stancak A, 1996, COGNITIVE BRAIN RES, V4, P171, DOI 10.1016/S0926-6410(96)00031-6; Steriade M, 1999, TRENDS NEUROSCI, V22, P337, DOI 10.1016/S0166-2236(99)01407-1; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Van Roon AM, 2004, PSYCHOPHYSIOLOGY, V41, P961, DOI 10.1111/j.1469-8986.2004.00251.x; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Vanhatalo S., 2011, NIEDERMEYRS ELECTROE, P741; Vogel RM, 1996, WATER RESOUR RES, V32, P1875, DOI 10.1029/96WR00928; Wagner CD, 1998, CARDIOVASC RES, V40, P257, DOI 10.1016/S0008-6363(98)00251-X; Witte H, 2004, CLIN NEUROPHYSIOL, V115, P2308, DOI 10.1016/j.clinph.2004.05.014; Wolf M, 2002, NEUROIMAGE, V16, P704, DOI 10.1006/nimg.2002.1128; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zheng F, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3483466	51	43	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43640	10.1371/journal.pone.0043640	http://dx.doi.org/10.1371/journal.pone.0043640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937070	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000308225500071
J	Reddi, D; Belibasakis, GN				Reddi, Durga; Belibasakis, Georgios N.			Transcriptional Profiling of Bone Marrow Stromal Cells in Response to Porphyromonas gingivalis Secreted Products	PLOS ONE			English	Article							NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PERIODONTAL-LIGAMENT CELLS; HUMAN ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; MATRIX METALLOPROTEINASES; ANTIMICROBIAL PEPTIDES; SIGNALING PATHWAYS; RECEPTOR ACTIVATOR; CREVICULAR FLUID	Periodontitis is an infectious inflammatory disease that destroys the tooth-supporting (periodontal) tissues. Porphyromonas gingivalis is an oral pathogen highly implicated in the pathogenesis of this disease. It can exert its effects to a number of cells, including osteogenic bone marrow stromal cells which are important for homeostastic capacity of the tissues. By employing gene microarray technology, this study aimed to describe the overall transcriptional events (>2-fold regulation) elicited by P. gingivalis secreted products in bone marrow stromal cells, and to dissect further the categories of genes involved in bone metabolism, inflammatory and immune responses. After 6 h of challenge with P. gingivalis, 271 genes were up-regulated whereas 209 genes were down-regulated, whereas after 24 h, these numbers were 259 and 109, respectively. The early (6 h) response was characterised by regulation of genes associated with inhibition of cell cycle, induction of apoptosis and loss of structural integrity, whereas the late (24 h) response was characterised by induction of chemokines, cytokines and their associated intracellular pathways (such as NF-kappa B), mediators of connective tissue and bone destruction, and suppression of regulators of osteogenic differentiation. The most strongly up-regulated genes were lipocalin 2 (LCN2) and serum amyloid A3 (SAA3), both encoding for proteins of the acute phase inflammatory response. Collectively, these transcriptional changes elicited by P. gingivalis denote that the fundamental cellular functions are hindered, and that the cells acquire a phenotype commensurate with propagated innate immune response and inflammatory-mediated tissue destruction. In conclusion, the global transcriptional profile of bone marrow stromal cells in response to P. gingivalis is marked by deregulated homeostatic functions, with implications in the pathogenesis of periodontitis.	[Reddi, Durga; Belibasakis, Georgios N.] Queen Mary Univ London, Barts & London Inst Dent, Ctr Adult Oral Hlth, London, England; [Belibasakis, Georgios N.] Univ Zurich, Ctr Dent Med, Inst Oral Biol, Zurich, Switzerland	University of London; Queen Mary University London; University of Zurich	Reddi, D (corresponding author), Queen Mary Univ London, Barts & London Inst Dent, Ctr Adult Oral Hlth, London, England.	george.belibasakis@zzm.uzh.ch	Belibasakis, Georgios/AAL-3159-2020	Belibasakis, Georgios/0000-0002-8164-0653	Barts and the London Dental Institute; Research Advisory Board of Barts; London Charitable Foundation [453/592]; University of London Central Research Fund (AR/CRF/B)	Barts and the London Dental Institute; Research Advisory Board of Barts; London Charitable Foundation; University of London Central Research Fund (AR/CRF/B)	This study was supported by Barts and the London Dental Institute (Support for Oral Science Bursary), Research Advisory Board of Barts and the London Charitable Foundation (start-up grant 453/592) and University of London Central Research Fund (AR/CRF/B). Publication costs were covered by the Institute of Oral Biology, University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman H, 2006, J ANTIMICROB CHEMOTH, V58, P198, DOI 10.1093/jac/dkl181; Arabaci Taner, 2010, Eur J Dent, V4, P454; ARMITAGE GC, 1994, J PERIODONTOL, V65, P120, DOI 10.1902/jop.1994.65.2.120; Asai Y, 2001, INFECT IMMUN, V69, P7387, DOI 10.1128/IAI.69.12.7387-7395.2001; Bachrach G, 2008, ANTIMICROB AGENTS CH, V52, P638, DOI 10.1128/AAC.01271-07; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Belibasakis GN, 2007, MICROB PATHOGENESIS, V43, P46, DOI 10.1016/j.micpath.2007.03.001; Belibasakis GN, 2011, INFLAMMATION, V34, P133, DOI 10.1007/s10753-010-9216-1; Bishop KA, 2009, MOL ENDOCRINOL, V23, P2095, DOI 10.1210/me.2009-0209; Bostanci N, 2007, ORAL MICROBIOL IMMUN, V22, P52; Bostanci N, 2009, ORAL MICROBIOL IMMUN, V24, P146, DOI 10.1111/j.1399-302X.2008.00488.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; BRAMANTI TE, 1991, J BACTERIOL, V173, P7330, DOI 10.1128/jb.173.22.7330-7339.1991; Brozovic S, 2006, MICROBIOL-SGM, V152, P797, DOI 10.1099/mic.0.28472-0; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Cengiz M Inanc, 2010, J Med Case Rep, V4, P200, DOI 10.1186/1752-1947-4-200; Chang YC, 2002, J ENDODONT, V28, P90, DOI 10.1097/00004770-200202000-00010; Choi BK, 2005, J PERIODONTOL, V76, P813, DOI 10.1902/jop.2005.76.5.813; Choi EK, 2005, FEMS IMMUNOL MED MIC, V44, P51, DOI 10.1016/j.femsim.2004.12.003; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; Ebersole JL, 1997, CLIN EXP IMMUNOL, V107, P347, DOI 10.1111/j.1365-2249.1997.270-ce1162.x; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fujita Y, 2011, ODONTOLOGY, V1- 7; Gao JL, 2010, J BIOL CHEM, V285, P40028, DOI 10.1074/jbc.M110.163535; Garlet GP, 2003, J PERIODONTAL RES, V38, P210, DOI 10.1034/j.1600-0765.2003.02012.x; Glurich I, 2002, CLIN DIAGN LAB IMMUN, V9, P425, DOI 10.1128/CDLI.9.2.425-432.2002; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Grenier D, 2001, FEMS MICROBIOL LETT, V203, P161, DOI 10.1016/S0378-1097(01)00351-2; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hajishengallis G, 2012, ADV EXP MED BIOL, V946, P69, DOI 10.1007/978-1-4614-0106-3_5; Hajishengallis G, 2009, MICROBES INFECT, V11, P637, DOI 10.1016/j.micinf.2009.03.009; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hernandez M, 2007, J CLIN PERIODONTOL, V34, P729, DOI 10.1111/j.1600-051X.2007.01107.x; Hernandez M, 2006, J PERIODONTOL, V77, P1863, DOI 10.1902/jop.2006.050461; Imatani T, 2004, EUR J MED RES, V9, P528; Inaba H, 2009, CELL MICROBIOL, V11, P1517, DOI 10.1111/j.1462-5822.2009.01344.x; Into T, 2006, CLIN EXP IMMUNOL, V145, P545, DOI 10.1111/j.1365-2249.2006.03156.x; Jiang YL, 1999, J PERIODONTOL, V70, P1472, DOI 10.1902/jop.1999.70.12.1472; JIN LJ, 1995, EUR J ORAL SCI, V103, P84, DOI 10.1111/j.1600-0722.1995.tb00121.x; Johnson RB, 1999, J PERIODONTOL, V70, P848, DOI 10.1902/jop.1999.70.8.848; Kang IC, 2002, FEMS IMMUNOL MED MIC, V34, P311; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Kato T, 2008, ORAL MICROBIOL IMMUN, V23, P158, DOI 10.1111/j.1399-302X.2007.00405.x; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Khoury S, 2004, J AM DENT ASSOC, V135, P617, DOI 10.14219/jada.archive.2004.0250; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Krauss JL, 2010, PERIODONTOL 2000, V52, P141, DOI 10.1111/j.1600-0757.2009.00324.x; Kretschmar S, 2012, J PERIODONTAL RES, V47, P228, DOI 10.1111/j.1600-0765.2011.01425.x; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Laflamme C, 2009, PORPHYROMONAS GINIGI, P141; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Laugisch O, 2012, MOL ORAL MICROBIOL, V27, P45, DOI 10.1111/j.2041-1014.2011.00631.x; Leto G, 2011, CLIN REV BONE MINER, V9, P107, DOI 10.1007/s12018-011-9100-z; Liang SA, 2011, J IMMUNOL, V186, P869, DOI 10.4049/jimmunol.1003252; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Nakata K, 2000, J ENDODONT, V26, P410, DOI 10.1097/00004770-200007000-00008; Nemoto E, 2006, J DENT RES, V85, P733, DOI 10.1177/154405910608500809; Ng PKS, 2010, J CELL BIOCHEM, V110, P438, DOI 10.1002/jcb.22556; Nociti FH, 2004, J DENT RES, V83, P602, DOI 10.1177/154405910408300804; Noguchi K, 2007, PERIODONTOL 2000, V43, P85, DOI 10.1111/j.1600-0757.2006.00170.x; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; Ohno T, 2008, ORAL MICROBIOL IMMUN, V23, P96, DOI 10.1111/j.1399-302X.2007.00393.x; Ohno T, 2006, MICROBES INFECT, V8, P1025, DOI 10.1016/j.micinf.2005.10.021; Okahashi N, 2004, INFECT IMMUN, V72, P1706, DOI 10.1128/IAI.72.3.1706-1714.2004; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Ortega-Hernandez OD, 2009, SEMIN ARTHRITIS RHEU, V39, P38, DOI 10.1016/j.semarthrit.2008.03.006; Oyarzun A, 2010, ORAL DIS, V16, P388, DOI 10.1111/j.1601-0825.2009.01651.x; PALCANIS KG, 1992, J PERIODONTOL, V63, P237, DOI 10.1902/jop.1992.63.4.237; Pattamapun K, 2003, J PERIODONTAL RES, V38, P115, DOI 10.1034/j.1600-0765.2003.01650.x; Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Pradeep AR, 2011, J PERIODONTOL, V82, P734, DOI 10.1902/jop.2010.100526; Prapulla DV, 2007, J PERIODONTOL, V78, P1783, DOI 10.1902/jop.2007.070009; Rai B, 2010, SAUDI DENT J, V22, P129, DOI 10.1016/j.sdentj.2010.04.006; Rai Balwant, 2008, J Oral Sci, V50, P53, DOI 10.2334/josnusd.50.53; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reddi D, 2011, MICROB PATHOGENESIS, V51, P415, DOI 10.1016/j.micpath.2011.09.001; Reddi D, 2008, MICROBES INFECT, V10, P1459, DOI 10.1016/j.micinf.2008.08.007; Reife RA, 2006, CELL MICROBIOL, V8, P857, DOI 10.1111/j.1462-5822.2005.00672.x; Reigstad CS, 2010, GUT MICROBES, V1, P55, DOI 10.4161/gmic.1.1.10514; Roth GA, 2007, FEMS MICROBIOL LETT, V272, P106, DOI 10.1111/j.1574-6968.2007.00736.x; Sawada N, 2007, CLIN EXP IMMUNOL, V148, P529, DOI 10.1111/j.1365-2249.2007.03346.x; Silva N, 2008, J CLIN PERIODONTOL, V35, P206, DOI 10.1111/j.1600-051X.2007.01190.x; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sroka A, 2001, J BACTERIOL, V183, P5609, DOI 10.1128/JB.183.19.5609-5616.2001; Stathopoulou PG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-107; STETLER G, 1986, NUCLEIC ACIDS RES, V14, P7883, DOI 10.1093/nar/14.20.7883; Sun ZW, 2002, SHOCK, V18, P99, DOI 10.1097/00024382-200208000-00001; Suthin K, 2003, J PERIODONTAL RES, V38, P90, DOI 10.1034/j.1600-0765.2003.01646.x; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; Walter C, 2004, INFECT IMMUN, V72, P5910, DOI 10.1128/IAI.72.10.5910-5918.2004; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; WINGROVE JA, 1992, J BIOL CHEM, V267, P18902; Wojaczynski J, 2011, BIOCHEM BIOPH RES CO, V411, P299, DOI 10.1016/j.bbrc.2011.06.129; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xing QA, 2010, J CELL PHYSIOL, V225, P106, DOI 10.1002/jcp.22201; Yang HW, 2004, J PERIODONTOL, V75, P1077, DOI 10.1902/jop.2004.75.8.1077; Yanti, 2009, BIOL PHARM BULL, V32, P1770, DOI 10.1248/bpb.32.1770; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zanotti S, 2009, J ENDOCRINOL, V201, P263, DOI 10.1677/JOE-08-0514; Zhang D, 2011, J PERIODONTAL RES, V46, P31, DOI 10.1111/j.1600-0765.2010.01305.x; Zhou J, 2006, J PERIODONTAL RES, V41, P47, DOI 10.1111/j.1600.0765.2005.00835.x; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zhou QD, 2006, INFECT IMMUN, V74, P1204, DOI 10.1128/IAI.74.2.1204-1214.2006; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	114	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43899	10.1371/journal.pone.0043899	http://dx.doi.org/10.1371/journal.pone.0043899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937121	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000308225500121
J	Zhu, HL; Zhao, JF; Wang, RJ; Zhang, LX				Zhu, Huili; Zhao, Jinfeng; Wang, Rongjun; Zhang, Longxian			Molecular Identification of a Rare Subtype of Cryptosporidium hominis in Infants in China	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; CHILDREN; HUMANS; SPP.; RUMINANTS; DIARRHEA	Two Cryptosporidium isolates from separate infants suffering from diarrhea were obtained from a hospital in Zhengzhou, China and were genotyped by PCR amplification and sequence analysis of the small-subunit ribosomal RNA (rRNA) (SSU rRNA), 70-kDa heat shock protein (HSP70), and actin genes. Further subtyping was performed by PCR amplification and sequence analysis of the 60-kDa glycoprotein (gp60) gene. Both the isolates were identified as Cryptosporidium hominis subtype IdA21, a rare subtype previously found only in a human immunodeficiency virus-infected child in South Africa and another child in Jordan.	[Zhu, Huili; Zhao, Jinfeng; Wang, Rongjun; Zhang, Longxian] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Zhu, Huili; Wang, Rongjun; Zhang, Longxian] Int Joint Res Lab Zoonot Dis Henan, Zhengzhou, Peoples R China	Henan Agricultural University	Zhu, HL (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	zhanglx8999@yahoo.com.cn	Zhang, Longxian/R-7799-2019; Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/I-9223-2019	Zhang, Longxian/0000-0002-5706-131X	Key National Science and Technology Specific Projects [2012ZX10004220-001]; National Natural Science Foundation of China [31172311]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [012IRTSTHN005]	Key National Science and Technology Specific Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This study was supported in part by funds for the Key National Science and Technology Specific Projects (no. 2012ZX10004220-001, http://www.nmp.gov.cn/zxjs/crb/201012/t20101208_2127.htm), the National Natural Science Foundation of China (no. 31172311, http://www.nsfc.gov.cn/Portal0/default152.htm), and the Program for Innovative Research Team (in Science and Technology) in University of Henan Province (012IRTSTHN005, http://est.haedu.gov.cn/Article/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Alves M, 2006, PARASITOL RES, V99, P287, DOI 10.1007/s00436-006-0164-5; Cama VA, 2008, EMERG INFECT DIS, V14, P1567, DOI 10.3201/eid1410.071273; Chen XW, 2004, HUMAN PARASITOLOGY, P269; CHEN YG, 1992, J CLIN MICROBIOL, V30, P492, DOI 10.1128/JCM.30.2.492-494.1992; Das P, 2006, J CLIN MICROBIOL, V44, P4246, DOI 10.1128/JCM.00091-06; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng YY, 2012, EMERG INFECT DIS, V18, P312, DOI 10.3201/eid1802.110666; Hijjawi N, 2010, EXP PARASITOL, V125, P161, DOI 10.1016/j.exppara.2010.01.011; Leav BA, 2002, INFECT IMMUN, V70, P3881, DOI 10.1128/IAI.70.7.3881-3890.2002; Leoni F, 2006, J MED MICROBIOL, V55, P703, DOI 10.1099/jmm.0.46251-0; Morse TD, 2007, EPIDEMIOL INFECT, V135, P1307, DOI 10.1017/S0950268806007758; Peng MM, 2003, J EUKARYOT MICROBIOL, V50, P557, DOI 10.1111/j.1550-7408.2003.tb00628.x; Peng MM, 2001, J EUKARYOT MICROBIOL, p28S; Ren XP, 2012, EXP PARASITOL, V130, P274, DOI 10.1016/j.exppara.2011.07.012; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; Wang KX, 2002, WORLD J GASTROENTERO, V8, P371; Wang RJ, 2008, PARASITOL RES, V102, P915, DOI 10.1007/s00436-007-0851-x; Wang RJ, 2011, EXP PARASITOL, V127, P42, DOI 10.1016/j.exppara.2010.06.034; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xiao Lihua, 2007, P119; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	23	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43682	10.1371/journal.pone.0043682	http://dx.doi.org/10.1371/journal.pone.0043682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937078	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500080
J	Kothawala, A; Kilpatrick, K; Novoa, JA; Segatori, L				Kothawala, Ahmed; Kilpatrick, Kiri; Novoa, Jose Andres; Segatori, Laura			Quantitative Analysis of alpha-Synuclein Solubility in Living Cells Using Split GFP Complementation	PLOS ONE			English	Article							FAMILIAL PARKINSONS-DISEASE; GREEN FLUORESCENT PROTEIN; IN-VITRO; PROTEASOMAL INHIBITION; LEWY BODIES; AGGREGATION; MUTATIONS; FILAMENTS; NEUROINFLAMMATION; NEURODEGENERATION	Presently incurable, Parkinson's disease (PD) is the most common neurodegenerative movement disorder and affects 1% of the population over 60 years of age. The hallmarks of PD pathogenesis are the loss of dopaminergic neurons in the substantia nigra pars compacta, and the occurrence of proteinaceous cytoplasmic inclusions (Lewy bodies) in surviving neurons. Lewy bodies are mainly composed of the pre-synaptic protein alpha-synuclein (alpha syn), an intrinsically unstructured, misfolding-prone protein with high propensity to aggregate. Quantifying the pool of soluble asyn and monitoring asyn aggregation in living cells is fundamental to study the molecular mechanisms of alpha syn-induced cytotoxicity and develop therapeutic strategies to prevent asyn aggregation. In this study, we report the use of a split GFP complementation assay to quantify alpha syn solubility. Particularly, we investigated a series of naturally occurring and rationally designed asyn variants and showed that this method can be used to study how alpha syn sequence specificity affects its solubility. Furthermore, we demonstrated the utility of this assay to explore the influence of the cellular folding network on alpha syn solubility. The results presented underscore the utility of the split GFP assay to quantify alpha syn solubility in living cells.	[Kothawala, Ahmed; Kilpatrick, Kiri; Novoa, Jose Andres; Segatori, Laura] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77251 USA; [Segatori, Laura] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Segatori, Laura] Rice Univ, Dept Bioengn, Houston, TX USA	Rice University; Rice University; Rice University	Kothawala, A (corresponding author), Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77251 USA.	segatori@rice.edu			Div Of Chem, Bioeng, Env, & Transp Sys [1159640] Funding Source: National Science Foundation	Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Baba M, 1998, AM J PATHOL, V152, P879; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chun WJ, 2007, J NEUROCHEM, V103, P2529, DOI 10.1111/j.1471-4159.2007.04941.x; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Etzkorn M, 2011, J BIOMOL NMR, V49, P121, DOI 10.1007/s10858-011-9468-6; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Goncalves SA, 2010, TRENDS BIOCHEM SCI, V35, P643, DOI 10.1016/j.tibs.2010.05.007; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Koo HJ, 2008, BIOCHEM BIOPH RES CO, V368, P772, DOI 10.1016/j.bbrc.2008.01.140; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Schwach G, 2010, J MOL NEUROSCI, V41, P80, DOI 10.1007/s12031-009-9289-1; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Soldatenkov VA, 1997, CANCER RES, V57, P3881; Taschenberger G, 2011, ACTA NEUROPATHOL, P1; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	53	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43505	10.1371/journal.pone.0043505	http://dx.doi.org/10.1371/journal.pone.0043505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927976	gold, Green Submitted, Green Published			2022-12-27	WOS:000308286300057
J	Nasr, MAF; Nicol, CJ; Murrell, JC				Nasr, Mohammed A. F.; Nicol, Christine J.; Murrell, Joanna C.			Do Laying Hens with Keel Bone Fractures Experience Pain?	PLOS ONE			English	Article							FOWL GALLUS-GALLUS; DOMESTIC-FOWL; ARTICULAR PAIN; BROILER-CHICKENS; PERIOPERATIVE ANALGESIA; BUTORPHANOL TARTRATE; THERMAL NOCICEPTION; OPIOID RECEPTORS; MORPHINE; BEHAVIOR	The European ban on battery cages has forced a change towards the use of non-cage or furnished cage systems, but unexpectedly this has been associated with an increased prevalence of keel bone fractures in laying hens. Bone fractures are acutely painful in mammals, but the effect of fractures on bird welfare is unclear. We recently reported that keel bone fractures have an effect on bird mobility. One possible explanation for this is that flying becomes mechanically impaired. However it is also possible that if birds have a capacity to feel pain, then ongoing pain resulting from the fracture could contribute to decreased mobility. The aim was to provide proof of concept that administration of appropriate analgesic drugs improves mobility in birds with keel fracture; thereby contributing to the debate about the capacity of birds to experience pain and whether fractures are associated with pain in laying hens. In hens with keel fractures, butorphanol decreased the latency to land from perches compared with latencies recorded for these hens following saline (mean (SEM) landing time (seconds) birds with keel fractures treated with butorphanol and saline from the 50, 100 and 150 cm perch heights respectively 1.7 (0.3), 2.2 (0.3), p = 0.05, 50 cm; 12.5 (6.6), 16.9 (6.7), p = 0.03, 100 cm; 20.6 (7.4), 26.3 (7.6), p = 0.02 150 cm). Mobility indices were largely unchanged in birds without keel fractures following butorphanol. Critically, butorphanol can be considered analgesic in our study because it improved the ability of birds to perform a complex behaviour that requires both motivation and higher cognitive processing. This is the first study to provide a solid evidential base that birds with keel fractures experience pain, a finding that has significant implications for the welfare of laying hens that are housed in non-cage or furnished caged systems.	[Nasr, Mohammed A. F.; Nicol, Christine J.; Murrell, Joanna C.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Nasr, Mohammed A. F.] Zagazig Univ, Dept Anim Wealth Dev, Fac Vet Med, Sharkia, Egypt	University of Bristol; Egyptian Knowledge Bank (EKB); Zagazig University	Nasr, MAF (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	Jo.Murrell@bristol.ac.uk	Nasr, Mohammed/X-7106-2019; Nicol, Christine J/B-4841-2011	Nicol, Christine J/0000-0001-6734-2177	Biotechnology and Biological Sciences Research Council BSRC [BB/G000921/1]; Egyptian Government (The Egyptian Educational and Cultural Bureau); BBSRC [BB/G000921/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G000921/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council BSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Egyptian Government (The Egyptian Educational and Cultural Bureau); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Sources of funding for the study: Biotechnology and Biological Sciences Research Council BSRC Grant Ref. BB/G000921/1 (http://www.bbsrc.ac.uk/). The Egyptian Government (The Egyptian Educational and Cultural Bureau) funded Mohammed A.F. Nasr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDO MT, 1978, PHARMACOL BIOCHEM BE, V9, P147, DOI 10.1016/0091-3057(78)90027-8; Bove SE, 2009, BRAIN RES REV, V60, P187, DOI 10.1016/j.brainresrev.2008.12.012; Brown DC, 2010, JAVMA-J AM VET MED A, V237, P66, DOI 10.2460/javma.237.1.66; Capner CA, 1999, VET REC, V145, P95; Commiskey S, 2005, J PHARMACOL SCI, V98, P109, DOI 10.1254/jphs.CRJ05001X; Costantini R, 2011, INT J CLIN PHARM TH, V49, P116, DOI 10.5414/CP201401; Danbury TC, 1999, PAIN ASS LAMENESS BR; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; Freeman KT, 2008, ANESTHESIOLOGY, V108, P473, DOI 10.1097/ALN.0b013e3181649351; Gentle MJ, 1997, PHYSIOL BEHAV, V61, P493, DOI 10.1016/S0031-9384(96)00461-1; Gentle MJ, 1997, PHYSIOL BEHAV, V62, P581, DOI 10.1016/S0031-9384(97)00164-9; Gentle MJ, 2003, BRAIN RES, V968, P26, DOI 10.1016/S0006-8993(02)04245-2; Gentle MJ, 1999, PHARMACOL BIOCHEM BE, V63, P339, DOI 10.1016/S0091-3057(99)00029-5; Guzman DSM, 2011, J AVIAN MED SURG, V25, P185, DOI 10.1647/2009-054.1; Hawkins MG, 2009, VET CLIN N AM EXOT A, V14, P61; Hocking PM, 2005, RES VET SCI, V78, P69, DOI 10.1016/j.rvsc.2004.05.005; Hocking PM, 2001, RES VET SCI, V71, P161, DOI 10.1053/rvsc.2001.0510; Hocking PM, 1997, RES VET SCI, V63, P263, DOI 10.1016/S0034-5288(97)90031-X; Hothersall B, 2012, CHALLENGES DETERMINI; HUGHES RA, 1992, PHARMACOL BIOCHEM BE, V42, P535, DOI 10.1016/0091-3057(92)90151-5; HUGHES RA, 1990, BEHAV NEUROSCI, V104, P619, DOI 10.1037/0735-7044.104.4.619; HUGHES RA, 1991, PHARMACOL BIOCHEM BE, V38, P247, DOI 10.1016/0091-3057(91)90273-5; Hugonnard M, 2004, VET ANAESTH ANALG, V31, P154, DOI 10.1111/j.1467-2987.2004.00175.x; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jimenez-Andrade JM, 2009, NEUROSCIENCE, V162, P1244, DOI 10.1016/j.neuroscience.2009.05.065; Liang M, 2011, J NEUROSCI, V31, P8976, DOI 10.1523/JNEUROSCI.6207-10.2011; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; May A, 2007, NEUROL SCI, V28, pS101, DOI 10.1007/s10072-007-0760-x; Mc Geown D, 1999, VET REC, V144, P668, DOI 10.1136/vr.144.24.668; McKeegan DEF, 2004, BRAIN RES REV, V46, P146, DOI 10.1016/j.brainresrev.2004.07.012; Nagase H, 2012, J PHARMACOL TOX MET, V65, P29, DOI 10.1016/j.vascn.2011.10.002; Nasr MAF, 2012, ANIM WELFARE, V21, P127, DOI 10.7120/096272812799129376; Paul-Murphy JR, 2009, AM J VET RES, V70, P1211, DOI 10.2460/ajvr.70.10.1211; Paul-Murphy JR, 1999, AM J VET RES, V60, P1218; RAGER DR, 1986, PHYSIOL BEHAV, V37, P269, DOI 10.1016/0031-9384(86)90231-3; Richards GJ, 2011, VET REC, V169, P279, DOI 10.1136/vr.d4404; Robertson SA, 2004, J FELINE MED SURG, V6, P321, DOI 10.1016/j.jfms.2003.10.002; Santy J, 2001, J CLIN NURS, V10, P521, DOI 10.1046/j.1365-2702.2001.00506.x; SCHNEIDER C, 1961, NATURE, V191, P607, DOI 10.1038/191607b0; Silverman J, 2005, CONTEMP TOP LAB ANIM, V44, P34; Singh PM, 2011, VET REC, V168, DOI 10.1136/vr.d1191; Singh PM, 2010, J VET PHARMACOL THER, V33, P515, DOI 10.1111/j.1365-2885.2010.01182.x; Sladky KK, 2006, AM J VET RES, V67, P775, DOI 10.2460/ajvr.67.5.775; SUFKA KJ, 1994, PHYSIOL BEHAV, V55, P741, DOI 10.1016/0031-9384(94)90054-X; Waran N, 2010, NEW ZEAL VET J, V58, P274, DOI 10.1080/00480169.2010.69402; Weaver LA, 2010, J AM ASSOC LAB ANIM, V49, P845; Wilkins LJ, 2011, VET REC, V169, P414, DOI 10.1136/vr.d4831; Wilkins LJ, 2004, VET REC, V155, P547, DOI 10.1136/vr.155.18.547; Witter J, 2004, ARTHRITIS RES THER, V6, P279, DOI 10.1186/ar1450; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	51	93	94	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42420	10.1371/journal.pone.0042420	http://dx.doi.org/10.1371/journal.pone.0042420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927930	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300021
J	Rivera-Perez, C; Nouzova, M; Noriega, FG				Rivera-Perez, Crisalejandra; Nouzova, Marcela; Noriega, Fernando G.			A Quantitative Assay for the Juvenile Hormones and Their Precursors Using Fluorescent Tags	PLOS ONE			English	Article							CORPORA-ALLATA; MASS-SPECTROMETRY; CARBOXYLIC-ACIDS; ADULT STAGES; BENZOFURAZAN STRUCTURE; ORTHO-PHTHALALDEHYDE; FLUOROGENIC REAGENT; METHYL FARNESOATE; TOBACCO HORNWORM; SODIUM SULFIDE	Background: The juvenile hormones (JHs) are sesquiterpenoid compounds that play a central role in insect reproduction, development and behavior. The lipophilic nature of JHs and their precursors, in conjunction with their low concentration in tissues and susceptibility to degradation had made their quantification difficult. A variety of methods exist for JH quantification but few can quantify on the femtomole range. Currently applied methods are expensive and time consuming. In the present study we sought to develop a novel method for accurate detection and quantification of JHs and their precursors. Methods: A sensitive and robust method was developed to quantify the precursor, farnesoic acid (FA) and juvenile hormone III (JH III) in biological samples. The assay is based on the derivatization of analytes with fluorescent tags, with subsequent analysis by reverse phase high performance liquid chromatography coupled to a fluorescent detector (HPLC-FD). The carboxyl group of FA was derivatized with 4-Acetamido-7-mercapto-2,1,3-benzoxadiazole (AABD-SH). Tagging the epoxide group of JH III required a two-step reaction: the opening of the epoxide ring with sodium sulfide and derivatization with the fluorescent tag 4-(N,N-Dimethylaminosulfonyl)-7-(N-chloroformylmethyl-N-methylamino)-2,1,3-benzoxadiazole (DBD-COCI). Conclusions: The method developed in the present study showed high sensitivity, accuracy and reproducibility. Linear responses were obtained over the range of 10-20 to 1000 fmols. Recovery efficiencies were over 90% for JH III and 98% for FA with excellent reproducibility. Significance: The proposed method is applicable when sensitive detection and accurate quantification of limited amount of sample is needed. Examples include corpora allata, hemolymph and whole body of female adult Aedes aegypti and whole body Drosophila melanogaster. A variety of additional functional groups can be targeted to add fluorescent tags to the remaining JH III precursors.	[Rivera-Perez, Crisalejandra; Nouzova, Marcela; Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Rivera-Perez, C (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	noriegaf@fiu.edu	Nouzova, Marcela/AAK-8609-2021; Rivera-Perez, Crisalejandra/AAM-1269-2021	Nouzova, Marcela/0000-0002-4562-1383; Rivera Perez, Crisalejandra/0000-0002-9746-3225	National Institutes of Health Grant [AI 45545]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI 45545 to FGN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER FC, 1983, J LIPID RES, V24, P1586; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bendena WG, 2011, GEN COMP ENDOCR, V172, P56, DOI 10.1016/j.ygcen.2011.02.014; BERGOT BJ, 1981, J CHROMATOGR, V204, P231, DOI 10.1016/S0021-9673(00)81664-7; Bloch G, 2000, J INSECT PHYSIOL, V46, P47, DOI 10.1016/S0022-1910(99)00101-8; BOWNES M, 1987, EUR J BIOCHEM, V164, P709, DOI 10.1111/j.1432-1033.1987.tb11184.x; Cao L, 2009, BIOCHEM BIOPH RES CO, V380, P188, DOI 10.1016/j.bbrc.2009.01.079; Chen Z, 2007, INSECT BIOCHEM MOLEC, V37, P799, DOI 10.1016/j.ibmb.2007.05.019; DUCHATEAU ALL, 1993, J CHROMATOGR, V637, P29, DOI 10.1016/0021-9673(93)83095-A; EDWARDS JP, 1995, J INSECT PHYSIOL, V41, P641, DOI 10.1016/0022-1910(95)00031-O; FEYEREISEN R, 1981, ANAL BIOCHEM, V111, P372, DOI 10.1016/0003-2697(81)90575-3; Feyereisen R, 1985, METHOD ENZYMOL, P530; Gilbert LI, 1960, T AM MICROSC SOC, V70, P38; GOODMAN WG, 1993, ARCH INSECT BIOCHEM, V23, P147, DOI 10.1002/arch.940230306; GOODMAN WG, 2005, COMPREHENSIVE MOL IN, V3, P319; Hamnett A. F., 1981, JUVENILE HORMONE BIO, P93; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Henneman L, 2008, ANAL BIOCHEM, V383, P18, DOI 10.1016/j.ab.2008.08.023; IMAI K, 1994, ANAL CHIM ACTA, V290, P3, DOI 10.1016/0003-2670(94)80034-0; JUDY KJ, 1973, P NATL ACAD SCI USA, V70, P1509, DOI 10.1073/pnas.70.5.1509; Kubota K, 2005, BIOMED CHROMATOGR, V19, P788, DOI 10.1002/bmc.518; KUHNZ W, 1981, ORG MAGN RESONANCE, V16, P138, DOI 10.1002/mrc.1270160216; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Li YP, 2003, INSECT BIOCHEM MOLEC, V33, P1307, DOI 10.1016/j.ibmb.2003.07.003; Mayoral JG, 2009, P NATL ACAD SCI USA, V106, P21091, DOI 10.1073/pnas.0909938106; MEYER AS, 1970, ARCH BIOCHEM BIOPHYS, V137, P190, DOI 10.1016/0003-9861(70)90427-3; NAKAMURA H, 1982, ANAL LETT PT A, V15, P1393, DOI 10.1080/00032718208064437; Navare AT, 2010, ANAL BIOANAL CHEM, V398, P3005, DOI 10.1007/s00216-010-4269-4; PRATT GE, 1974, LIFE SCI, V14, P575, DOI 10.1016/0024-3205(74)90372-5; Qayum AA, 2011, JOVE-J VIS EXP, DOI 10.3791/2772; REMBOLD H, 1985, J CHROMATOGR, V323, P355, DOI 10.1016/S0021-9673(01)90397-8; Rembold H, 1981, JUVENILE HORMONE BIO, P11; SANO A, 1985, ANAL CHEM, V57, P1687, DOI 10.1021/ac00285a039; Santa T, 1999, ANALYST, V124, P1689, DOI 10.1039/a906204a; Santa T, 2008, BIOMED CHROMATOGR, V22, P343, DOI 10.1002/bmc.945; SHAPIRO AB, 1986, J INSECT PHYSIOL, V32, P867, DOI 10.1016/0022-1910(86)90102-2; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Shu SQ, 1997, J INSECT PHYSIOL, V43, P719, DOI 10.1016/S0022-1910(97)00048-6; SLAMA K, 1974, P477; SMITH JG, 1984, SYNTHESIS-STUTTGART, P629; STRAMBI C, 1981, EUR J BIOCHEM, V118, P401; Taub-Montemayor TE, 2005, J INSECT PHYSIOL, V51, P427, DOI 10.1016/j.jinsphys.2004.12.015; Teal PEA, 2000, ANAL BIOCHEM, V277, P206, DOI 10.1006/abio.1999.4377; TOBE SS, 1985, ADV INSECT PHYSIOL, V18, P305; TOBE SS, 1974, BIOCHEM J, V144, P107, DOI 10.1042/bj1440107; Trumbo ST, 2008, J INSECT PHYSIOL, V54, P630, DOI 10.1016/j.jinsphys.2007.12.012; Uchiyama S, 2001, ANAL CHEM, V73, P2165, DOI 10.1021/ac001232j; Vilaro F, 2012, J AGR FOOD CHEM, V60, P3020, DOI 10.1021/jf204621h; Westerlund SA, 2004, ANAL BIOANAL CHEM, V379, P540, DOI 10.1007/s00216-004-2598-x; Woodward FN, 1948, J CHEM SOC; Yagi KJ, 2001, J INSECT PHYSIOL, V47, P1227, DOI 10.1016/S0022-1910(01)00124-X; YAGI KJ, 1991, GEN COMP ENDOCR, V81, P284, DOI 10.1016/0016-6480(91)90013-V; YIN CM, 1995, J INSECT PHYSIOL, V41, P473, DOI 10.1016/0022-1910(94)00134-3	53	26	26	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43784	10.1371/journal.pone.0043784	http://dx.doi.org/10.1371/journal.pone.0043784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928033	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300089
J	Wang, F; Letort, V; Lu, Q; Bai, XF; Guo, Y; de Reffye, P; Li, BG				Wang, Feng; Letort, Veronique; Lu, Qi; Bai, Xuefeng; Guo, Yan; de Reffye, Philippe; Li, Baoguo			A Functional and Structural Mongolian Scots Pine (Pinus sylvestris var. mongolica) Model Integrating Architecture, Biomass and Effects of Precipitation	PLOS ONE			English	Article							TREE GROWTH-MODEL; STOCHASTIC-MODEL; PLANT-GROWTH; L-SYSTEMS; WATER; SIMULATION; GREENLAB; COMPETITION; PLASTICITY; CARBON	Mongolian Scots pine (Pinus sylvestris var. mongolica) is one of the principal tree species in the network of Three-North Shelterbelt for windbreak and sand stabilisation in China. The functions of shelterbelts are highly correlated with the architecture and eco-physiological processes of individual tree. Thus, model-assisted analysis of canopy architecture and function dynamic in Mongolian Scots pine is of value for better understanding its role and behaviour within shelterbelt ecosystems in these arid and semiarid regions. We present here a single-tree functional and structural model, derived from the GreenLab model, which is adapted for young Mongolian Scots pines by incorporation of plant biomass production, allocation, allometric rules and soil water dynamics. The model is calibrated and validated based on experimental measurements taken on Mongolian Scots pines in 2007 and 2006 under local meteorological conditions. Measurements include plant biomass, topology and geometry, as well as soil attributes and standard meteorological data. After calibration, the model allows reconstruction of three-dimensional (3D) canopy architecture and biomass dynamics for trees from one- to six-year-old at the same site using meteorological data for the six years from 2001 to 2006. Sensitivity analysis indicates that rainfall variation has more influence on biomass increment than on architecture, and the internode and needle compartments and the aboveground biomass respond linearly to increases in precipitation. Sensitivity analysis also shows that the balance between internode and needle growth varies only slightly within the range of precipitations considered here. The model is expected to be used to investigate the growth of Mongolian Scots pines in other regions with different soils and climates.	[Wang, Feng; Guo, Yan; Li, Baoguo] China Agr Univ, Key Lab Plant Soil Interact, Minist Educ, Dept Soil & Water Sci, Beijing 100094, Peoples R China; [Letort, Veronique] Ecole Cent Paris, Dept Appl Math, Chatenay Malabry, France; [Wang, Feng; Lu, Qi] Chinese Acad Forestry, Inst Desertificat, Beijing, Peoples R China; [Bai, Xuefeng] Liaoning Sand Stabilisat & Afforestat Inst, Fuxing, Peoples R China; [de Reffye, Philippe] UMR AMAP, CIRAD, Montpellier, France	China Agricultural University; UDICE-French Research Universities; Universite Paris Saclay; Chinese Academy of Forestry; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Wang, F (corresponding author), China Agr Univ, Key Lab Plant Soil Interact, Minist Educ, Dept Soil & Water Sci, Beijing 100094, Peoples R China.	luqi@caf.ac.cn; libg@cau.edu.cn	lu, qi/HHS-2115-2022		National Natural Science Foundation of China [31100518]; Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2012BAD16B0205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	This study was supported by National Natural Science Foundation of China (Grant No 31100518) and Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAD16B0205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MT, 2005, NEW PHYTOL, V166, P869, DOI 10.1111/j.1469-8137.2005.01348.x; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Almeida AC, 2007, FOREST ECOL MANAG, V251, P10, DOI 10.1016/j.foreco.2007.06.009; Balandier P, 2000, ANN FOREST SCI, V57, P571; Bang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011061; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Bosc A, 2000, ANN FOREST SCI, V57, P555; CHILDS SW, 1977, T ASAE, V20, P858, DOI 10.13031/2013.35664; Cournede PH, 2011, MATH MODEL NAT PHENO, V6, P133, DOI 10.1051/mmnp/20116205; Cournede PH, 2006, SIMUL-T SOC MOD SIM, V82, P427, DOI 10.1177/0037549706069341; Diao J, 2012, COMPUT ELECTRON AGR, V80, P105, DOI 10.1016/j.compag.2011.10.019; Dingkuhn M, 2005, AUST J AGR RES, V56, P1289, DOI 10.1071/AR05063; Dong QX, 2008, ANN BOT-LONDON, V101, P1195, DOI 10.1093/aob/mcm317; Drouet JL, 2007, ECOL MODEL, V206, P231, DOI 10.1016/j.ecolmodel.2007.03.036; Eschenbach C, 2005, ECOL MODEL, V186, P470, DOI 10.1016/j.ecolmodel.2005.02.013; Feng Wang, 2010, Proceedings of the Third International Symposium on Plant Growth Modeling, Simulation, Visualization and Applications (PMA 2009), P26, DOI 10.1109/PMA.2009.35; Godin C, 2005, NEW PHYTOL, V166, P705, DOI 10.1111/j.1469-8137.2005.01445.x; Guo H, 2012, TREES-STRUCT FUNCT, V26, P1057, DOI 10.1007/s00468-012-0683-x; Guo Y, 2006, ANN BOT-LONDON, V97, P217, DOI 10.1093/aob/mcj033; Host GE, 2008, FUNCT PLANT BIOL, V35, P976, DOI 10.1071/FP08075; James G. B., 1976, VEGETATION ATMOSPHER, V2; Kang MZ, 2008, ANN BOT-LONDON, V101, P1099, DOI 10.1093/aob/mcm212; Kang MZ, 2012, NEW PHYTOL, V195, P384, DOI 10.1111/j.1469-8137.2012.04177.x; Landsberg J., 2010, PHYSL ECOLOGY FOREST; Landsberg J. J, 1999, WAYS TREE USE WATER, P54; Le Chevalier V, 2007, J COMPUT SCI TECH-CH, V22, P835, DOI 10.1007/s11390-007-9105-8; Letort V, 2008, FUNCT PLANT BIOL, V35, P951, DOI 10.1071/FP08065; Lopez G, 2008, FUNCT PLANT BIOL, V35, P761, DOI 10.1071/FP08039; Ma Q, 2004, INT FOREST REV, V6, P327, DOI 10.1505/ifor.6.3.327.59972; Marcelis LFM, 1996, J EXP BOT, V47, P1281, DOI 10.1093/jxb/47.Special_Issue.1281; Mathieu A, 2009, ANN BOT-LONDON, V103, P1173, DOI 10.1093/aob/mcp054; Middleton N., 1992, WORLD ATLAS DESERTIF, P69; Pearcy RW, 2005, NEW PHYTOL, V166, P791, DOI 10.1111/j.1469-8137.2005.01328.x; Perttunen J, 1998, ECOL MODEL, V108, P189, DOI 10.1016/S0304-3800(98)00028-3; Perttunen J, 1996, ANN BOT-LONDON, V77, P87, DOI 10.1006/anbo.1996.0011; Purves DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000870; RAUSCHER HM, 1990, TREE PHYSIOL, V7, P255, DOI 10.1093/treephys/7.1-2-3-4.255; Renton M, 2005, ECOL MODEL, V184, P277, DOI 10.1016/j.ecolmodel.2004.10.008; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Sievanen R, 2000, ANN FOREST SCI, V57, P399; Simunek J, 2009, ECOL MODEL, V220, P505, DOI 10.1016/j.ecolmodel.2008.11.004; Steduto P, 2005, AGR FOREST METEOROL, V130, P269, DOI 10.1016/j.agrformet.2005.04.003; Steduto P, 2007, IRRIGATION SCI, V25, P189, DOI 10.1007/s00271-007-0064-1; Sterck FJ, 2005, NEW PHYTOL, V166, P827, DOI 10.1111/j.1469-8137.2005.01342.x; Wang F, 2007, NEW ZEAL J AGR RES, V50, P903, DOI 10.1080/00288230709510366; Wang F, 2011, ANN BOT-LONDON, V107, P781, DOI 10.1093/aob/mcq218; Wu L, 2007, ECOL MODEL, V200, P343, DOI 10.1016/j.ecolmodel.2006.08.010; Yan HP, 2004, ANN BOT-LONDON, V93, P591, DOI 10.1093/aob/mch078; Zhan ZG, 2003, PLANT GROWTH MODELING AND APPLICATIONS, PROCEEDINGS, P236; Zheng BY, 2008, FUNCT PLANT BIOL, V35, P900, DOI 10.1071/FP08060	50	10	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43531	10.1371/journal.pone.0043531	http://dx.doi.org/10.1371/journal.pone.0043531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927982	Green Published, gold			2022-12-27	WOS:000308286300062
J	Borrel, G; Lehours, AC; Crouzet, O; Jezequel, D; Rockne, K; Kulczak, A; Duffaud, E; Joblin, K; Fonty, G				Borrel, Guillaume; Lehours, Anne-Catherine; Crouzet, Olivier; Jezequel, Didier; Rockne, Karl; Kulczak, Amelie; Duffaud, Emilie; Joblin, Keith; Fonty, Gerard			Stratification of Archaea in the Deep Sediments of a Freshwater Meromictic Lake: Vertical Shift from Methanogenic to Uncultured Archaeal Lineages	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE-CHAIN-REACTION; MARINE BENTHIC ARCHAEA; RIBOSOMAL-RNA GENES; COMMUNITY STRUCTURE; MICROBIAL COMMUNITIES; ANAEROBIC OXIDATION; CRATER LAKE; HYPERSALINE LAKE; LAC-PAVIN	As for lineages of known methanogens, several lineages of uncultured archaea were recurrently retrieved in freshwater sediments. However, knowledge is missing about how these lineages might be affected and structured according to depth. In the present study, the vertical changes of archaeal communities were characterized in the deep sediment of the freshwater meromictic Lake Pavin. For that purpose, an integrated molecular approach was performed to gain information on the structure, composition, abundance and vertical stratification of archaeal communities thriving in anoxic freshwater sediments along a gradient of sediments encompassing 130 years of sedimentation. Huge changes occurred in the structure and composition of archaeal assemblages along the sediment core. Methanogenic taxa (i.e. Methanosaeta and Methanomicrobiales) were progressively replaced by uncultured archaeal lineages (i.e. Marine Benthic Group-D (MBG-D) and Miscellaneous Crenarchaeal Group (MCG)) which are suspected to be involved in the methane cycle.	[Borrel, Guillaume; Lehours, Anne-Catherine; Crouzet, Olivier; Kulczak, Amelie; Duffaud, Emilie; Joblin, Keith; Fonty, Gerard] Univ Blaise Pascal, Clermont Univ, UMR CNRS 6023, Lab Microorganismes Genome & Environm, Aubiere, France; [Borrel, Guillaume; Lehours, Anne-Catherine; Crouzet, Olivier; Kulczak, Amelie; Duffaud, Emilie; Joblin, Keith; Fonty, Gerard] Univ Auvergne, Aubiere, France; [Jezequel, Didier] Univ Paris 07, UMR CNRS 7154, Inst Phys Globe Paris, Lab Geochim Eaux, Paris, France; [Rockne, Karl] Univ Illinois, Dept Civil & Mat Engn, Chicago, IL USA	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Borrel, G (corresponding author), Univ Blaise Pascal, Clermont Univ, UMR CNRS 6023, Lab Microorganismes Genome & Environm, Aubiere, France.	Guillaume.borrel@univ-bpclermont.fr	JEZEQUEL, DIDIER/K-8269-2012; Rockne, Karl J/C-1281-2008	Rockne, Karl J/0000-0002-4976-4955; LEHOURS, Anne-catherine/0000-0001-9151-4389	French Centre National de la Recherche Scientifique; region Auvergne	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); region Auvergne(Region Auvergne-Rhone-Alpes)	This work was funded by the Programme EC2CO of the French Centre National de la Recherche Scientifique (Projects Methanolac and Interlac). The work was also supported by a grant to GB from the region Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbach-Hertig W, 1999, GEOCHIM COSMOCHIM AC, V63, P3357, DOI 10.1016/S0016-7037(99)00257-4; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2011, MOL ECOL, V20, P1988, DOI 10.1111/j.1365-294X.2011.05057.x; Bastviken D, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000608; Batisson I, 2007, MICROB ECOL, V54, P761, DOI 10.1007/s00248-007-9241-2; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Bhattarai S, MICROB ECOL IN PRESS; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borrel G, 2011, RES MICROBIOL, V162, P832, DOI 10.1016/j.resmic.2011.06.004; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Buckley DR, 2004, ENVIRON SCI TECHNOL, V38, P1732, DOI 10.1021/es034926t; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Cadillo-Quiroz H, 2006, ENVIRON MICROBIOL, V8, P1428, DOI 10.1111/j.1462-2920.2006.01036.x; CAPONE DG, 1988, LIMNOL OCEANOGR, V33, P725, DOI 10.4319/lo.1988.33.4_part_2.0725; Chan OC, 2005, ENVIRON MICROBIOL, V7, P1139, DOI 10.1111/j.1462-2920.2005.00790.x; Clarke K. R., 2001, CHANGES MARINE COMMU; Cole J, 2006, NUCLEIC ACIDS RES, V35, P169; Conrad R, 2010, LIMNOL OCEANOGR, V55, P689, DOI 10.4319/lo.2009.55.2.0689; Coolen MJL, 2007, ENVIRON MICROBIOL, V9, P238, DOI 10.1111/j.1462-2920.2006.01134.x; Danovaro R, 1999, DEEP-SEA RES PT I, V46, P1077, DOI 10.1016/S0967-0637(98)00101-0; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Falz KZ, 1999, APPL ENVIRON MICROB, V65, P2402; Fenchel T., 1979, BACTERIA MINERAL CYC; Galand PE, 2003, ENVIRON MICROBIOL, V5, P1133, DOI 10.1046/j.1462-2920.2003.00520.x; Glissmann K, 2004, MICROB ECOL, V48, P389, DOI 10.1007/s00248-003-2027-2; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P4983; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Jiang HC, 2008, ENVIRON MICROBIOL, V10, P2355, DOI 10.1111/j.1462-2920.2008.01661.x; Jiang HC, 2007, ENVIRON MICROBIOL, V9, P2603, DOI 10.1111/j.1462-2920.2007.01377.x; Jurgens G, 2000, FEMS MICROBIOL ECOL, V34, P45, DOI 10.1111/j.1574-6941.2000.tb00753.x; Kemnitz D, 2005, ENVIRON MICROBIOL, V7, P553, DOI 10.1111/j.1462-2920.2005.00723.x; Kerkhof L, 1999, FEMS MICROBIOL ECOL, V30, P253; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Koizumi Y, 2004, ENVIRON MICROBIOL, V6, P622, DOI 10.1111/j.1462-2920.2004.00620.x; Koizumi Y, 2003, FEMS MICROBIOL ECOL, V46, P147, DOI 10.1016/S0168-6496(03)00212-5; Koizumi Y, 2004, FEMS MICROBIOL ECOL, V48, P285, DOI 10.1016/j.femsec.2004.02.013; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lehours AC, 2005, APPL ENVIRON MICROB, V71, P7389, DOI 10.1128/AEM.71.11.7389-7400.2005; Lehours AC, 2007, APPL ENVIRON MICROB, V73, P2016, DOI 10.1128/AEM.01490-06; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lopes F, 2011, APPL GEOCHEM, V26, P1919, DOI 10.1016/j.apgeochem.2011.06.021; Loy A, 2008, ENVIRON MICROBIOL, V10, P2894, DOI 10.1111/j.1462-2920.2008.01706.x; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nam YD, 2008, J MICROBIOL, V46, P125, DOI 10.1007/s12275-007-0189-1; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Nusslein B, 2001, ENVIRON MICROBIOL, V3, P460, DOI 10.1046/j.1462-2920.2001.00215.x; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; OPPENHEIMER CH, 1960, GEOCHIM COSMOCHIM AC, V19, P244, DOI 10.1016/0016-7037(60)90032-6; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Purdy KJ, 2003, APPL ENVIRON MICROB, V69, P3181, DOI 10.1128/AEM.69.6.3181-3191.2003; Purdy KJ, 1996, APPL ENVIRON MICROB, V62, P3905, DOI 10.1128/AEM.62.10.3905-3907.1996; Reysenbach Anna-Louise, 1995, P101; Roussel EG, 2009, ENVIRON MICROBIOL, V11, P2446, DOI 10.1111/j.1462-2920.2009.01976.x; Schettler G, 2007, CHEM GEOL, V240, P11, DOI 10.1016/j.chemgeo.2007.01.003; Schink B., 1988, BIOL ANAEROBIC MICRO, P771; Schubert CJ, 2011, FEMS MICROBIOL ECOL, V76, P26, DOI 10.1111/j.1574-6941.2010.01036.x; Schwarz JIK, 2008, LIMNOL OCEANOGR, V53, P113, DOI 10.4319/lo.2008.53.1.0113; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; SEGERER A, 1988, SYST APPL MICROBIOL, V10, P161, DOI 10.1016/S0723-2020(88)80031-6; Skillman LC, 2004, ANAEROBE, V10, P277, DOI 10.1016/j.anaerobe.2004.05.003; SMITH PF, 1975, J BACTERIOL, V124, P884, DOI 10.1128/JB.124.2.884-892.1975; Swan BK, 2010, APPL ENVIRON MICROB, V76, P757, DOI 10.1128/AEM.02409-09; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Takano Y, 2010, NAT GEOSCI, V3, P858, DOI 10.1038/NGEO983; Tamura K, 2011, MOL BIOL EVOL, DOI [10.1093/molbev/msr1121, DOI 10.1093/MOLBEV/MSR1121]; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Vetriani C, 1999, APPL ENVIRON MICROB, V65, P4375; Viollier E, 1997, CHEM GEOL, V142, P225, DOI 10.1016/S0009-2541(97)00093-4; VIOLLIER E, 1995, CHEM GEOL, V125, P61, DOI 10.1016/0009-2541(95)00059-U; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Webster G, 2011, FEMS MICROBIOL ECOL, V77, P248, DOI 10.1111/j.1574-6941.2011.01109.x; WOLIN MJ, 1974, AM J CLIN NUTR, V27, P1320, DOI 10.1093/ajcn/27.11.1320; Ye WJ, 2009, FEMS MICROBIOL ECOL, V70, P263, DOI 10.1111/j.1574-6941.2009.00761.x; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhang Y, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-137	84	59	61	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43346	10.1371/journal.pone.0043346	http://dx.doi.org/10.1371/journal.pone.0043346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927959	Green Published, gold			2022-12-27	WOS:000307789700030
J	Davenport, CF; Neugebauer, J; Beckmann, N; Friedrich, B; Kameri, B; Kokott, S; Paetow, M; Siekmann, B; Wieding-Drewes, M; Wienhofer, M; Wolf, S; Tummler, B; Ahlers, V; Sprengel, F				Davenport, Colin F.; Neugebauer, Jens; Beckmann, Nils; Friedrich, Benedikt; Kameri, Burim; Kokott, Svea; Paetow, Malte; Siekmann, Bjoern; Wieding-Drewes, Matthias; Wienhoefer, Markus; Wolf, Stefan; Tuemmler, Burkhard; Ahlers, Volker; Sprengel, Frauke			Genometa - A Fast and Accurate Classifier for Short Metagenomic Shotgun Reads	PLOS ONE			English	Article							RIBOSOMAL-RNA; SEQUENCES; MICROBIOME; COMMUNITIES; ALIGNMENT; BACTERIA; TAXONOMY; ARCHAEA; SERVER; GENES	A: Metagenomic studies use high-throughput sequence data to investigate microbial communities in situ. However, considerable challenges remain in the analysis of these data, particularly with regard to speed and reliable analysis of microbial species as opposed to higher level taxa such as phyla. We here present Genometa, a computationally undemanding graphical user interface program that enables identification of bacterial species and gene content from datasets generated by inexpensive high-throughput short read sequencing technologies. Our approach was first verified on two simulated metagenomic short read datasets, detecting 100% and 94% of the bacterial species included with few false positives or false negatives. Subsequent comparative benchmarking analysis against three popular metagenomic algorithms on an Illumina human gut dataset revealed Genometa to attribute the most reads to bacteria at species level (i.e. including all strains of that species) and demonstrate similar or better accuracy than the other programs. Lastly, speed was demonstrated to be many times that of BLAST due to the use of modern short read aligners. Our method is highly accurate if bacteria in the sample are represented by genomes in the reference sequence but cannot find species absent from the reference. This method is one of the most user-friendly and resource efficient approaches and is thus feasible for rapidly analysing millions of short reads on a personal computer.	[Davenport, Colin F.; Neugebauer, Jens; Kokott, Svea; Tuemmler, Burkhard] Hannover Med Sch, D-3000 Hannover, Lower Saxony, Germany; [Beckmann, Nils; Friedrich, Benedikt; Kameri, Burim; Paetow, Malte; Siekmann, Bjoern; Wieding-Drewes, Matthias; Wienhoefer, Markus; Wolf, Stefan; Ahlers, Volker; Sprengel, Frauke] Univ Appl Sci & Arts, Dept Comp Sci, Hannover, Lower Saxony, Germany	Hannover Medical School; Hochschule Hannover-University of Applied Sciences & Arts	Davenport, CF (corresponding author), Hannover Med Sch, D-3000 Hannover, Lower Saxony, Germany.	davenport.colin@mh-hannover.de	Ahlers, Volker/AAC-8320-2019	Ahlers, Volker/0000-0003-2307-6553; Davenport, Colin/0000-0002-4764-6963; Sprengel, Frauke/0000-0001-6613-5002	Deutsche Forschungsgemeinschaft grant [GRK 653/3]; DFG [SFB 900, Z1]; US federal funds from the NIH Human Microbiome Project; Common Fund; Common Fund, National Institutes of Health, Department of Health and Human Services	Deutsche Forschungsgemeinschaft grant(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); US federal funds from the NIH Human Microbiome Project; Common Fund; Common Fund, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CD performed much of this research while a member of the international research training group 'Pseudomonas Pathogenicity and Biotechnology' sponsored by the Deutsche Forschungsgemeinschaft grant GRK 653/3, and is now supported by the DFG SFB 900 (project Z1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Frauke Stanke, Jens Klockgether and Lutz Wiehlmann for helpful discussions. Sequence data used in the reference sequences of this study were produced by multiple sources, including the Human Microbiome Project, the GEBA project, the Metahit project, and the US Department of Energy Joint Genome Institute. For the JGI data, the following statement applies: these sequence data were produced by the US Department of Energy Joint Genome Institute http://www.jgi.doe.gov/ in collaboration with the user community. For the HMP data, the following statement is to be noted: This project has been funded or data has been generated in part with US federal funds from the NIH Human Microbiome Project, the Common Fund, National Institutes of Health, Department of Health and Human Services. Lastly, the Sanger Institute data access policy states: These data were provided by the sequencing group at the Wellcome Trust Sanger Institute and can be obtained from http://www.sanger.ac.uk/resources/downloads/bacteria/metahit/. This research would not have been possible without the commitment of the bioinformatics community to open source software.	Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Gori F, 2011, BIOINFORMATICS, V27, P196, DOI 10.1093/bioinformatics/btq649; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Manichanh C, 2008, NUCLEIC ACIDS RES, V36, P5180, DOI 10.1093/nar/gkn496; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitra S, 2009, BIOINFORMATICS, V25, P1849, DOI 10.1093/bioinformatics/btp341; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Nakamura S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/eid1411.080589; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444	39	27	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e41224	10.1371/journal.pone.0041224	http://dx.doi.org/10.1371/journal.pone.0041224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927906	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700002
J	Perez-Gil, J; Uros, EM; Sauret-Gueto, S; Lois, LM; Kirby, J; Nishimoto, M; Baidoo, EEK; Keasling, JD; Boronat, A; Rodriguez-Concepcion, M				Perez-Gil, Jordi; Uros, Eva Maria; Sauret-Gueeto, Susanna; Maria Lois, L.; Kirby, James; Nishimoto, Minobu; Baidoo, Edward E. K.; Keasling, Jay D.; Boronat, Albert; Rodriguez-Concepcion, Manuel			Mutations in Escherichia coli aceE and ribB Genes Allow Survival of Strains Defective in the First Step of the Isoprenoid Biosynthesis Pathway	PLOS ONE			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; ISOPENTENYL DIPHOSPHATE ISOMERASE; PENTOSE-PHOSPHATE CYCLE; NON-MEVALONATE PATHWAY; 2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE; DIMETHYLALLYL DIPHOSPHATE; FOSMIDOMYCIN RESISTANCE; PYRUVATE-DEHYDROGENASE; DISTINCT PATHWAYS; MEP PATHWAY	A functional 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway is required for isoprenoid biosynthesis and hence survival in Escherichia coli and most other bacteria. In the first two steps of the pathway, MEP is produced from the central metabolic intermediates pyruvate and glyceraldehyde 3-phosphate via 1-deoxy-D-xylulose 5-phosphate (DXP) by the activity of the enzymes DXP synthase (DXS) and DXP reductoisomerase (DXR). Because the MEP pathway is absent from humans, it was proposed as a promising new target to develop new antibiotics. However, the lethal phenotype caused by the deletion of DXS or DXR was found to be suppressed with a relatively high efficiency by unidentified mutations. Here we report that several mutations in the unrelated genes aceE and ribB rescue growth of DXS-defective mutants because the encoded enzymes allowed the production of sufficient DXP in vivo. Together, this work unveils the diversity of mechanisms that can evolve in bacteria to circumvent a blockage of the first step of the MEP pathway.	[Perez-Gil, Jordi; Uros, Eva Maria; Sauret-Gueeto, Susanna; Maria Lois, L.; Boronat, Albert; Rodriguez-Concepcion, Manuel] CSIC IRTA UAB UB, CRAG, Barcelona, Spain; [Kirby, James; Nishimoto, Minobu; Baidoo, Edward E. K.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Boronat, Albert] Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of Barcelona	Perez-Gil, J (corresponding author), CSIC IRTA UAB UB, CRAG, Campus UAB Bellaterra, Barcelona, Spain.	manuel.rodriguez@cragenomica.es	Lois, L. Maria/N-3272-2019; Perez-Gil, Jordi/I-1853-2013; Rodriguez-Concepcion, Manuel/I-7229-2015; Keasling, Jay D/J-9162-2012; Lois, L.Maria/N-5822-2014	Lois, L. Maria/0000-0003-0638-1484; Perez-Gil, Jordi/0000-0002-5632-9556; Rodriguez-Concepcion, Manuel/0000-0002-1280-2305; Keasling, Jay D/0000-0003-4170-6088; Lois, L.Maria/0000-0003-0638-1484	Spanish Direccion General de Investigacion (DGI); FEDER [BIO2011-23680, BIO2009-09523]; US Department of Energy [DE-AC02-05CH11231]; DGI; Generalitat de Catalunya	Spanish Direccion General de Investigacion (DGI)(Spanish Government); FEDER(European Commission); US Department of Energy(United States Department of Energy (DOE)); DGI; Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported in part by grants from the Spanish Direccion General de Investigacion (DGI) and FEDER to MRC (BIO2011-23680) and AB (BIO2009-09523). Work performed at JBEI was supported by the US Department of Energy contract DE-AC02-05CH11231. JPG and SSG received PhD fellowships from DGI and Generalitat de Catalunya, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153; Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Brown AC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-78; Campos N, 2001, BIOCHEM J, V353, P59, DOI 10.1042/bj3530059; Davey MS, 2011, ANTIMICROB AGENTS CH, V55, P3635, DOI 10.1128/AAC.00382-11; Ershov YV, 2002, J BACTERIOL, V184, P5045, DOI 10.1128/JB.184.18.5045-5051.2002; Fujisaki S, 1996, GENE, V175, P83, DOI 10.1016/0378-1119(96)00128-X; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Kakinuma K, 2001, J AM CHEM SOC, V123, P1238, DOI 10.1021/ja003390y; Kaneda K, 2001, P NATL ACAD SCI USA, V98, P932, DOI 10.1073/pnas.020472198; Kirby J, 2008, NAT PROD REP, V25, P656, DOI 10.1039/b802939c; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P4509, DOI 10.1016/S0040-4039(98)00802-8; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Laupitz R, 2004, EUR J BIOCHEM, V271, P2658, DOI 10.1111/j.1432-1033.2004.04194.x; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Perez-Gil J, 2012, J BIOL CHEM, V287, P15803, DOI 10.1074/jbc.M112.354811; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Poliquin K, 2004, J BACTERIOL, V186, P4685, DOI 10.1128/JB.186.14.4685-4693.2004; Richter G, 1997, METHOD ENZYMOL, V280, P374; Rodriguez-Concepcion M, 2000, FEBS LETT, V473, P328, DOI 10.1016/S0014-5793(00)01552-0; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepcion M, 2012, ISOPRENOID SYNTHESIS; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rohdich F, 2005, BIOCHEM SOC T, V33, P785, DOI 10.1042/BST0330785; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Sakamoto Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2030, DOI 10.1271/bbb.67.2030; Sangari FJ, 2010, P NATL ACAD SCI USA, V107, P14081, DOI 10.1073/pnas.1001962107; Sauret-Gueto S, 2006, FEBS LETT, V580, P736, DOI 10.1016/j.febslet.2005.12.092; Schorken U, 1998, BBA-PROTEIN STRUCT M, V1385, P229, DOI 10.1016/S0167-4838(98)00071-5; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Steinbacher S, 2003, J BIOL CHEM, V278, P18401, DOI 10.1074/jbc.M300993200; Takahashi S, 1998, PSYCHIAT CLIN NEUROS, V52, P1; Wungsintaweekul J, 2001, EUR J BIOCHEM, V268, P310, DOI 10.1046/j.1432-1327.2001.01875.x; YOKOTA A, 1986, AGR BIOL CHEM TOKYO, V50, P2517, DOI 10.1080/00021369.1986.10867789; Zeidler J, 1998, Z NATURFORSCH C, V53, P980	42	22	23	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43775	10.1371/journal.pone.0043775	http://dx.doi.org/10.1371/journal.pone.0043775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928031	Green Published, gold, Green Submitted			2022-12-27	WOS:000307789700052
J	Wen, J; Shi, YK; Li, YP; Yuan, P; Wang, F				Wen, Jin; Shi, Ying-kang; Li, You-ping; Yuan, Ping; Wang, Fang			Quality of Life, Physical Diseases, and Psychological Impairment among Survivors 3 Years after Wenchuan Earthquake: A Population Based Survey	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PTSD CHECKLIST; FEMALE VETERANS; RISK-FACTORS; PREVALENCE; RELIABILITY; DEPRESSION; VALIDITY; SICHUAN	Background: Few research studies have addressed the long-term effects caused by catastrophes, and no study has ever explored the life quality, physical diseases, and psychological impairment of earthquake survivors at the same time. This study seeks to reveal survivors' quality of life, physical diseases, and mental health. Methods: A cross-sectional survey was conducted through multi-stage sampling approach three years after the Wenchuan earthquake. Results: A total of 2525 subjects were interviewed. Symptoms of PTSD were reported by 8.8% of the respondents from the seriously affected areas and 0.5%, the less hit areas. Prevalence of chronic diseases was 39.2% and 22.1% respectively, and two-week prevalence rate, 24.9% and 12.7% respectively. In the multivariate analysis, two-week prevalence, displacement, no regular income, receiving mental health support after the disaster, family members died or missing, injured due to the quake, and person who witnessed someone being killed or injured were independently associated with higher prevalence for symptoms of PTSD. Most subscales of SF-12 negatively correlated with age, chronic diseases, two-week prevalence, injured due to the disaster, home or property loss, and score of the 3-year PTSD symptoms, but positively correlated with higher education and higher household income. Conclusions: The rates of physical diseases and symptoms of PTSD were relatively high, and the quality of life was poor among victims in the hard-hit areas 3 years after the earthquake. Physical impairment correlated with symptom of PTSD, and both were negatively associated with quality of life.	[Wen, Jin; Shi, Ying-kang] Sichuan Univ, W China Hosp, Dept Hosp Management & Hlth Policy, Chengdu 610064, Peoples R China; [Li, You-ping] Sichuan Univ, W China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610064, Peoples R China; [Li, You-ping] Sichuan Univ, W China Hosp, Dept Clin Epidemiol, Chengdu 610064, Peoples R China; [Yuan, Ping; Wang, Fang] Sichuan Univ, W China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Wen, J (corresponding author), Sichuan Univ, W China Hosp, Dept Hosp Management & Hlth Policy, Chengdu 610064, Peoples R China.	huaxiwenjin@163.com			National Natural Science Foundation of China [81072376, 71131006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (Grant No. 81072376 and 71131006; and funder's website: http://www.nsfc.gov.cn/Portal0/default152.htm) financially supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004; Chou FHC, 2004, AUST NZ J PSYCHIAT, V38, P358, DOI 10.1111/j.1440-1614.2004.01364.x; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Ehring T, 2011, PSYCHIAT RES, V185, P161, DOI 10.1016/j.psychres.2009.10.018; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Jia ZB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-172; Ke X, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-573; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Luo XM, 2003, SPINE, V28, P1739, DOI 10.1097/00007632-200308010-00020; Nunnally J., 1978, PSYCHOMETRIC THEORY; Peng K., 2010, CHINESE HLTH EC, V29, P33; Ren ZJ, 2011, PSYCHIATRY, V74, P87, DOI 10.1521/psyc.2011.74.1.87; Salcioglu E, 2007, DISASTERS, V31, P115, DOI 10.1111/j.1467-7717.2007.01000.x; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Varela E, 2008, DISASTERS, V32, P280, DOI 10.1111/j.1467-7717.2008.01039.x; Wang XD, 2000, PSYCHIAT CLIN NEUROS, V54, P427, DOI 10.1046/j.1440-1819.2000.00732.x; [王相兰 WANG Xianglan], 2008, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V29, P367; Ware J. E., 2005, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; [肖至兰 XIAO Zhilan], 2011, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V11, P483; Xu JP, 2011, COMPR PSYCHIAT, V52, P431, DOI 10.1016/j.comppsych.2010.08.002; Zhang Y, 2011, PLOS ONE, V6, P223; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008	27	62	65	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43081	10.1371/journal.pone.0043081	http://dx.doi.org/10.1371/journal.pone.0043081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22937014	gold, Green Published, Green Submitted			2022-12-27	WOS:000307789700021
J	de Hoog, MLA; van Eijsden, M; Stronks, K; Gemke, RJBJ; Vrijkotte, TGM				de Hoog, Marieke L. A.; van Eijsden, Manon; Stronks, Karien; Gemke, Reinoud J. B. J.; Vrijkotte, Tanja G. M.			Ethnic Differences in Cardiometabolic Risk Profile at Age 5-6 Years: The ABCD Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; BODY-MASS INDEX; DENSITY-LIPOPROTEIN CHOLESTEROL; TYPE-2 DIABETES-MELLITUS; AMSTERDAM BORN CHILDREN; METABOLIC SYNDROME; RACIAL-DIFFERENCES; WAIST CIRCUMFERENCE	Background: To examine ethnic differences in cardiometabolic risk profile in early age, and explore whether such differences can be explained by differences in body mass index (BMI) or waist circumference (WC). Method: Anthropometric measurements, blood pressure and (in a subsample) fasting blood were collected during a health check of 2,509 children aged 5-6 years. Four ethnic groups were distinguished: Dutch (n = 2,008; blood n = 1,300), African descent (n = 199; blood n = 105), Turkish (n = 108; blood n = 57) and Moroccan (n = 194; blood n = 94). Ethnic differences in diastolic and systolic blood pressure (DBP/SBP), fasting glucose, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglyceride levels were determined and the explanatory role of BMI and WC was examined with regression analysis. Results: After adjustment for confounders, African descent children showed higher DBP (beta 2.22 mmHg; 95% CI: 1.09-3.36) and HDL levels (beta:0.09 mmol/l; 95% CI: 0.03-0.16) compared to Dutch children (reference group). Turkish children showed higher SBP (beta:1.89 mmHg; 95% CI: 0.25-3.54), DBP (beta:2.62 mmHg; 95% CI: 1.11-4.13), glucose (beta:0.12 mmol/L; 95% CI: 0.00-0.25) and triglyceride levels (beta:0.13 mmol/L; 95% CI: 0.02-0.25). Higher BMI values were found in all non-Dutch groups (differences ranged from 0.53-1.03 kg/m(2)) and higher WC in Turkish (beta:1.68 cm; 95% CI: 0.99-2.38) and Moroccan (beta:1.65 cm; 95% CI:1.11-2.19) children. BMI and WC partly explained the higher SBP/DBP and triglyceride levels in Turkish children. Conclusion: Ethnic differences in cardiometabolic profile exist early in life and are partly explained by differences in BMI and WC. African children showed favourable HDL levels and Turkish children the most unfavourable overall profile, whereas their Moroccan peers have less increased cardiometabolic risk in spite of their high BMI and WC.	[de Hoog, Marieke L. A.; Stronks, Karien; Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [de Hoog, Marieke L. A.; van Eijsden, Manon] Publ Hlth Serv, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands; [van Eijsden, Manon] Vrije Univ Amsterdam, Inst Hlth Sci, Amsterdam, Netherlands; [Gemke, Reinoud J. B. J.] Vrije Univ Amsterdam Med Ctr, Med Ctr, Inst Cardiovasc Res, Dept Paediat,EMGO Inst, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	de Hoog, MLA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.l.dehoog@amc.uva.nl		Stronks, Karien/0000-0002-0921-2232; Vrijkotte, Tanja/0000-0003-3641-4048	Academic Medical Centre, Amsterdam; Public Health Services, Amsterdam; Netherlands Organization for Health Research and Development (ZonMw) [2100.0076]	Academic Medical Centre, Amsterdam; Public Health Services, Amsterdam(United States Department of Health & Human ServicesUnited States Public Health Service); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Academic Medical Centre, Amsterdam, the Public Health Services, Amsterdam, and by the Netherlands Organization for Health Research and Development (ZonMw; grant number: 2100.0076), The Hague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; Allcock DM, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/108187; BECKETT LA, 1992, AM J EPIDEMIOL, V135, P1166, DOI 10.1093/oxfordjournals.aje.a116217; Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Corvalan C, 2010, AM J CLIN NUTR, V91, P166, DOI 10.3945/ajcn.2009.27547; Corvalan C, 2009, AM J CLIN NUTR, V90, P547, DOI 10.3945/ajcn.2008.27318; de Hoog MLA, 2011, BRIT J NUTR, V106, P1592, DOI 10.1017/S0007114511002327; de Hoog MLA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-611; Desilets MC, 2006, OBESITY, V14, P1019, DOI 10.1038/oby.2006.117; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Dijkshoorn H, 2003, Ned Tijdschr Geneeskd, V147, P1362; Donin AS, 2010, AM J CLIN NUTR, V92, P776, DOI 10.3945/ajcn.2010.29533; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; El Fakiri F, 2008, J IMMIGR MINOR HEALT, V10, P559, DOI 10.1007/s10903-008-9144-4; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Fredriks AM, 2005, ACTA PAEDIATR, V94, P496, DOI [10.1080/08035250410024240, 10.1111/j.1651-2227.2005.tb01923.x]; Freedman DS, 2005, OBES RES, V13, P928, DOI 10.1038/oby.2005.107; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Gootjes J, 2009, CLIN CHIM ACTA, V401, P152, DOI 10.1016/j.cca.2008.12.016; Harding S, 2006, J HYPERTENS, V24, P1507, DOI 10.1097/01.hjh.0000239285.20315.4d; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hirschler V, 2005, ARCH PEDIAT ADOL MED, V159, P740, DOI 10.1001/archpedi.159.8.740; Hoffman RP, 2009, CURR DIABETES REV, V5, P259, DOI 10.2174/157339909789804332; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Johnson ST, 2010, J PEDIATR-US, V156, P247, DOI 10.1016/j.jpeds.2009.08.010; Kolsgaard MLP, 2008, ACTA PAEDIATR, V97, P1557, DOI 10.1111/j.1651-2227.2008.00955.x; Kurian AK, 2007, ETHNIC DIS, V17, P143; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Lynch WC, 2007, BODY IMAGE, V4, P179, DOI 10.1016/j.bodyim.2007.01.001; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Morrison JA, 2008, J PEDIATR-US, V152, P201, DOI 10.1016/j.jpeds.2007.09.010; Morrison JA, 2007, PEDIATRICS, V120, P340, DOI 10.1542/peds.2006-1699; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Owen CG, 2010, DIABETOLOGIA, V53, P1620, DOI 10.1007/s00125-010-1781-1; Palacios C, 2010, AM J CLIN NUTR, V91, P597, DOI 10.3945/ajcn.2009.28400; Savica V, 2010, ANNU REV NUTR, V30, P365, DOI 10.1146/annurev-nutr-010510-103954; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Smith SC, 2005, CIRCULATION, V111, pE134, DOI 10.1161/01.CIR.0000157743.54710.04; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Sumner Anne E, 2009, J Pediatr, V155, DOI 10.1016/j.jpeds.2009.04.049; Thiering E, 2012, J HYPERTENS, V30, P1114, DOI 10.1097/HJH.0b013e328352d699; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Turban S, 2008, J AM SOC NEPHROL, V19, P1396, DOI 10.1681/ASN.2007101142; Uitewaal PJM, 2004, PREV MED, V39, P1068, DOI 10.1016/j.ypmed.2004.04.009; Ujcic-Voortman JK, 2011, ATHEROSCLEROSIS, V218, P511, DOI 10.1016/j.atherosclerosis.2011.06.051; Ujcic-Voortman JK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-740; van Dijk AE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-251; van Dis SJ, 2002, HART VAATZIEKTEN BIJ; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; van Vliet M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-106; van Vliet M, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-2; Vega GL, 1998, J LIPID RES, V39, P228; Walker SE, 2012, NUTR METAB CARDIOVAS, V22, P141, DOI 10.1016/j.numecd.2010.05.006; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; Whincup PH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000263; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; Winkleby MA, 1999, JAMA-J AM MED ASSOC, V281, P1006, DOI 10.1001/jama.281.11.1006; Zoratti R, 1998, EUR J EPIDEMIOL, V14, P9, DOI 10.1023/A:1007492202045	61	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43667	10.1371/journal.pone.0043667	http://dx.doi.org/10.1371/journal.pone.0043667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916294	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800092
J	Huart, AS; MacLaine, NJ; Narayan, V; Hupp, TR				Huart, Anne-Sophie; MacLaine, Nicola J.; Narayan, Vikram; Hupp, Ted R.			Exploiting the MDM2-CK1 alpha Protein-Protein Interface to Develop Novel Biologics That Induce UBL-Kinase-Modification and Inhibit Cell Growth	PLOS ONE			English	Article							MELANOMA-CELLS; I-ALPHA; P53; MDM2; PHOSPHORYLATION; DOMAIN; ACTIVATION; CANCER; BETA; UBIQUITINATION	Protein-protein interactions forming dominant signalling events are providing ever-growing platforms for the development of novel Biologic tools for controlling cell growth. Casein Kinase 1 alpha (CK1 alpha) forms a genetic and physical interaction with the murine double minute chromosome 2 (MDM2) oncoprotein resulting in degradation of the p53 tumour suppressor. Pharmacological inhibition of CK1 increases p53 protein level and induces cell death, whilst small interfering RNA-mediated depletion of CK1 alpha stabilizes p53 and induces growth arrest. We mapped the dominant protein-protein interface that stabilizes the MDM2 and CK1 alpha complex in order to determine whether a peptide derived from the core CK1 alpha-MDM2 interface form novel Biologics that can be used to probe the contribution of the CK1-MDM2 protein-protein interaction to p53 activation and cell viability. Overlapping peptides derived from CK1 alpha were screened for dominant MDM2 binding sites using (i) ELISA with recombinant MDM2; (ii) cell lysate pull-down towards endogenous MDM2; (iii) MDM2-CK1 alpha complex-based competition ELISA; and (iv) MDM2-mediated ubiquitination. One dominant peptide, peptide 35 was bioactive in all four assays and its transfection induced cell death/growth arrest in a p53-independent manner. Ectopic expression of flag-tagged peptide 35 induced a novel ubiquitin and NEDD8 modification of CK1 alpha, providing one of the first examples whereby NEDDylation of a protein kinase can be induced. These data identify an MDM2 binding motif in CK1 alpha which when isolated as a small peptide can (i) function as a dominant negative inhibitor of the CK1 alpha-MDM2 interface, (ii) be used as a tool to study NEDDylation of CK1 alpha, and (iii) reduce cell growth. Further, this approach provides a technological blueprint, complementing siRNA and chemical biology approaches, by exploiting protein-protein interactions in order to develop Biologics to manipulate novel types of signalling pathways such as cross-talk between NEDDylation, protein kinase signalling, and cell survival.	[Huart, Anne-Sophie; MacLaine, Nicola J.; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Signal Transduct Grp P53, Edinburgh, Midlothian, Scotland; [Narayan, Vikram] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Interferon & Cell Signalling Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Huart, AS (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Signal Transduct Grp P53, Edinburgh, Midlothian, Scotland.	ted.hupp@ed.ac.uk	Narayan, Vikram/AAF-3964-2020	Narayan, Vikram/0000-0002-6128-7944; Huart, Anne-Sophie/0000-0003-0913-1501	Cancer Research UK [C483/A10706]	Cancer Research UK(Cancer Research UK)	The research was supported by the Cancer Research UK (C483/A10706). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 1996, J BIOL CHEM, V271, P29231, DOI 10.1074/jbc.271.46.29231; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banerjee D, 2010, CELL CYCLE, V9, P4748, DOI 10.4161/cc.9.23.14092; Bedri S, 2007, ARCH BIOCHEM BIOPHYS, V466, P242, DOI 10.1016/j.abb.2007.06.010; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Budini M, 2009, J CELL BIOCHEM, V106, P399, DOI 10.1002/jcb.22019; Burzio V, 2002, J CELL BIOCHEM, V86, P805, DOI 10.1002/jcb.10263; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Dahlberg CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004766; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Fu Z, 2001, EXP CELL RES, V269, P275, DOI 10.1006/excr.2001.5324; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gross SD, 1997, J CELL SCI, V110, P3083; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Halasi M, 2009, CELL CYCLE, V8, P2850, DOI 10.4161/cc.8.17.9414; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Ikeda K, 2011, MOL BIOL CELL, V22, P1321, DOI 10.1091/mbc.E10-09-0741; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Kulikov R, 2006, J BIOL CHEM, V281, P28575, DOI 10.1074/jbc.M513311200; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee JY, 2009, PLANT SIGNAL BEHAV, V4, P652, DOI [10.1104/pp.108.129346, 10.4161/psb.4.7.8991]; MacLaine NJ, 2008, J BIOL CHEM, V283, P28563, DOI 10.1074/jbc.M804433200; MacLaine NJ, 2011, CELL CYCLE, V10, P916, DOI 10.4161/cc.10.6.15076; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; Meek DW, 2003, MOL CANCER RES, V1, P1017; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Perez DI, 2011, MED RES REV, V31, P924, DOI 10.1002/med.20207; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Pettersson S, 2009, BIOCHEM J, V418, P575, DOI 10.1042/BJ20082087; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rumpf C, 2010, CELL CYCLE, V9, P2657, DOI 10.4161/cc.9.13.12146; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sczaniecka M, 2012, J BIOL CHEM, V287, P14052, DOI 10.1074/jbc.M111.303875; Seigneuric R, 2011, ONCOTARGET, V2, P557, DOI 10.18632/oncotarget.297; Shallal HM, 2011, EUR J MED CHEM, V46, P2043, DOI 10.1016/j.ejmech.2011.02.057; Shanware NP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.224014; Sinnberg T, 2010, CANCER RES, V70, P6999, DOI 10.1158/0008-5472.CAN-10-0645; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Utz AC, 2010, J HISTOCHEM CYTOCHEM, V58, P1, DOI 10.1369/jhc.2009.954628; Venerando A, 2010, CELL MOL LIFE SCI, V67, P1105, DOI 10.1007/s00018-009-0236-7; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wallace M, 2006, AM BOOK REV, V27, P3, DOI 10.1353/abr.2006.0081; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Winter M, 2004, BIOCHEMISTRY-US, V43, P16356, DOI 10.1021/bi0489255; Worralll EG, 2010, J MOL BIOL, V398, P414, DOI 10.1016/j.jmb.2010.03.023; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yang WS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r92; Zhang JR, 1996, BIOCHEMISTRY-US, V35, P16319, DOI 10.1021/bi9614444	64	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43391	10.1371/journal.pone.0043391	http://dx.doi.org/10.1371/journal.pone.0043391			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916255	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800064
J	Duguez, S; Duddy, WJ; Gnocchi, V; Bowe, J; Dadgar, S; Partridge, TA				Duguez, Stephanie; Duddy, William J.; Gnocchi, Viola; Bowe, James; Dadgar, Sherry; Partridge, Terence A.			Atmospheric Oxygen Tension Slows Myoblast Proliferation via Mitochondrial Activation	PLOS ONE			English	Article							MUSCLE SATELLITE CELLS; PROTEIN-SYNTHESIS; DIFFERENTIATION; BIOGENESIS; MYOGENESIS; ENVIRONMENT; DERIVATION; CULTURE; GROWTH; RAPTOR	Background: Mitochondrial activity inhibits proliferation and is required for differentiation of myoblasts. Myoblast proliferation is also inhibited by the similar to 20% oxygen level used in standard tissue culture. We hypothesize that mitochondrial activity would be greater at hyperoxia (20% O-2) relative to more physiological oxygen (5% O-2). Methodology/Principal Findings: Murine primary myoblasts from isolated myofibres and conditionally immortalized H-2K myoblasts were cultured at 5% and 20% oxygen. Proliferation, assayed by cell counts, EdU labeling, and CFSE dilution, was slower at 20% oxygen. Expression of MyoD in primary myoblasts was delayed at 20% oxygen, but myogenicity, as measured by fusion index, was slightly higher. FACS-based measurement of mitochondrial activity indicators and luminometric measurement of ATP levels revealed that mitochondria exhibited greater membrane potential and higher levels of Reactive Oxygen Species (ROS) at 20% oxygen with concomitant elevation of intracellular ATP. Mitochondrial mass was unaffected. Low concentrations of CCCP, a respiratory chain uncoupler, and Oligomycin A, an ATP synthase inhibitor, each increased the rate of myoblast proliferation. ROS were investigated as a potential mechanism of mitochondrial retrograde signaling, but scavenging of ROS levels by N-acetyl-cysteine (NAC) or alpha-Phenyl-N-tert-butylnitrone (PBN) did not rescue the suppressed rate of cell division in hyperoxic conditions, suggesting other pathways. Primary myoblasts from older mice showed a slower proliferation than those from younger adult mice at 20% oxygen but no difference at 5% oxygen. Conclusions/Significance: These results implicate mitochondrial regulation as a mechanistic explanation for myoblast response to oxygen tension. The rescue of proliferation rate in myoblasts of aged mice by 5% oxygen suggests a major artefactual component to age-related decline of satellite cell proliferation in standard tissue culture at 20% oxygen. It lends weight to the idea that these age-related changes result at least in part from environmental factors rather than characteristics intrinsic to the satellite cell.	[Duguez, Stephanie; Duddy, William J.; Gnocchi, Viola; Bowe, James; Dadgar, Sherry; Partridge, Terence A.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Duguez, Stephanie; Duddy, William J.] Univ Paris 06, INSERM, CNRS, Inst Myol,UMR S 974,UMR 7215,U974, Paris, France	Children's National Health System; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Duguez, S (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	william.duddy@upmc.fr	Duddy, William/S-9773-2019; Duguez, Stephanie/J-1904-2016	Duddy, William/0000-0003-2239-9094; Duguez, Stephanie/0000-0001-6510-5426	Wellstone Muscular Dystrophy Center [U54HD053177]; Department of Defense United States Army Medical Research Acquisition Activity [W81XWH-09-1-0599, W81XWH-09-1-021]; Foundation to Eradicate Duchenne; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER	Wellstone Muscular Dystrophy Center; Department of Defense United States Army Medical Research Acquisition Activity(United States Department of Defense); Foundation to Eradicate Duchenne; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Wellstone Muscular Dystrophy Center grant U54HD053177, Department of Defense United States Army Medical Research Acquisition Activity grants W81XWH-09-1-0599 and W81XWH-09-1-021 and by The Foundation to Eradicate Duchenne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Barani AE, 2003, J APPL PHYSIOL, V95, P2089, DOI 10.1152/japplphysiol.00437.2003; Barani AE, 2003, EXP CELL RES, V283, P196, DOI 10.1016/S0014-4827(02)00030-7; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Duguez S, 2004, EXP CELL RES, V299, P27, DOI 10.1016/j.yexcr.2004.05.017; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jahnke VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008637; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KOROHODA W, 1993, FOLIA HISTOCHEM CYTO, V31, P9; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4; Lees SJ, 2008, CELL PROLIFERAT, V41, P193, DOI 10.1111/j.1365-2184.2008.00512.x; LI K, 1995, AM J PHYSIOL-CELL PH, V269, pC1265, DOI 10.1152/ajpcell.1995.269.5.C1265; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; Martin SD, 2009, CYTOTECHNOLOGY, V61, P93, DOI 10.1007/s10616-009-9247-3; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Passarino G, 2010, BIOGERONTOLOGY, V11, P575, DOI 10.1007/s10522-010-9294-3; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Shibata M, 2006, EUR J APPL PHYSIOL, V97, P327, DOI 10.1007/s00421-006-0200-2; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	40	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43853	10.1371/journal.pone.0043853	http://dx.doi.org/10.1371/journal.pone.0043853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937109	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500111
J	Qiao, L; Li, YH; Xiong, G; Liu, XF; He, SZ; Tong, XL; Wu, SY; Hu, H; Wang, RX; Hu, HW; Chen, LS; Zhang, L; Wu, J; Dai, FY; Lu, C; Xiang, ZH				Qiao, Liang; Li, Yuanhao; Xiong, Gao; Liu, Xiaofan; He, Songzhen; Tong, Xiaoling; Wu, Songyuan; Hu, Hai; Wang, Rixin; Hu, Hongwei; Chen, Lushi; Zhang, Li; Wu, Jie; Dai, Fangyin; Lu, Cheng; Xiang, Zhonghuai			Effects of Altered Catecholamine Metabolism on Pigmentation and Physical Properties of Sclerotized Regions in the Silkworm Melanism Mutant	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; BLATTELLA-GERMANICA L; BETA-ALANINE; WILD-TYPE; TRIBOLIUM-CASTANEUM; CUTICULAR SCLEROTIZATION; N-ACETYLTRANSFERASE; INSECT PIGMENTATION; COLOR PATTERNS; CUTICLE	Catecholamine metabolism plays an important role in the determination of insect body color and cuticle sclerotization. To date, limited research has focused on these processes in silkworm. In the current study, we analyzed the interactions between catecholamines and melanin genes and their effects on the pigmentation patterns and physical properties of sclerotized regions in silkworm, using the melanic mutant melanism (mln) silkworm strain as a model. Injection of beta-alanine into mln mutant silkworm induced a change in catecholamine metabolism and turned its body color yellow. Further investigation of the catecholamine content and expression levels of the corresponding melanin genes from different developmental stages of Dazao-mln (mutant) and Dazao (wild-type) silkworm revealed that at the larval and adult stages, the expression patterns of melanin genes precipitated dopamine accumulation corresponding to functional loss of Bm-iAANAT, a repressive effect of excess NBAD on ebony, and upregulation of tan in the Dazao-mln strain. During the early pupal stage, dopamine did not accumulate in Dazao-mln, since upregulation of ebony and black genes led to conversion of high amounts of dopamine into NBAD, resulting in deep yellow cuticles. Scanning electron microscope analysis of a cross-section of adult dorsal plates from both wild-type and mutant silkworm disclosed the formation of different layers in Dazaomln owing to lack of NADA, compared to even and dense layers in Dazao. Analysis of the mechanical properties of the anterior wings revealed higher storage modulus and lower loss tangent in Dazao-mln, which was closely associated with the altered catecholamine metabolism in the mutant strain. Based on these findings, we conclude that catecholamine metabolism is crucial for the color pattern and physical properties of cuticles in silkworm. Our results should provide a significant contribution to Lepidoptera cuticle tanning research.	[Qiao, Liang; Li, Yuanhao; Xiong, Gao; Liu, Xiaofan; He, Songzhen; Tong, Xiaoling; Wu, Songyuan; Hu, Hai; Wang, Rixin; Chen, Lushi; Zhang, Li; Wu, Jie; Dai, Fangyin; Lu, Cheng; Xiang, Zhonghuai] Southwest Univ, State Key Lab Silkworm Genome Biol, Inst Sericulture & Syst Biol, Chongqing, Peoples R China; [Tong, Xiaoling] Chongqing Univ, Inst Agr & Life Sci, Chongqing 630044, Peoples R China; [Hu, Hongwei; Dai, Fangyin] Southwest Univ, Coll Biotechnol, Chongqing, Peoples R China	Southwest University - China; Chongqing University; Southwest University - China	Qiao, L (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Inst Sericulture & Syst Biol, Chongqing, Peoples R China.	fydai@swu.edu.cn; lucheng@swu.edu.cn		Qiao, Liang/0000-0002-4638-3225; Tong, Xiaoling/0000-0002-2649-899X	National Basic Research 973 Program of China [2012CB114600]; National Natural Science Foundation of China [31072088, 30901053]; Fundamental Research Funds for the Central Universities in China [XDJK2009C192]	National Basic Research 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China	This work was supported by National Basic Research 973 Program of China Grant (No. 2012CB114600) (http://www.973.gov.cn/Default_3.aspx), the National Natural Science Foundation of China (No. 31072088, No. 30901053) (http://www.nsfc.gov.cn/Portal0/default152.htm), and Fundamental Research Funds for the Central Universities in China (No. XDJK2009C192) (http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SO, 1996, COMP BIOCHEM PHYS B, V113, P689, DOI 10.1016/0305-0491(95)02089-6; Andersen SO, 2007, INSECT BIOCHEM MOLEC, V37, P969, DOI 10.1016/j.ibmb.2007.05.002; Andersen SO, 2007, INSECT BIOCHEM MOLEC, V37, P223, DOI 10.1016/j.ibmb.2006.11.006; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Bear A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011563; CZAPLA TH, 1989, ARCH INSECT BIOCHEM, V12, P145, DOI 10.1002/arch.940120303; CZAPLA TH, 1990, J INSECT PHYSIOL, V36, P647, DOI 10.1016/0022-1910(90)90069-R; CZAPLA TH, 1990, J COMP PHYSIOL B, V160, P175, DOI 10.1007/BF00300950; Dai FY, 2010, J BIOL CHEM, V285, P19553, DOI 10.1074/jbc.M109.096743; Dittmer NT, 2009, INSECT BIOCHEM MOLEC, V39, P596, DOI 10.1016/j.ibmb.2009.06.006; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Ferguson LC, 2011, DEV GENES EVOL, V221, P297, DOI 10.1007/s00427-011-0380-6; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2011, INSECT BIOCHEM MOLEC, V41, P191, DOI 10.1016/j.ibmb.2010.12.003; Futahashi R, 2010, EVOL DEV, V12, P157, DOI 10.1111/j.1525-142X.2010.00401.x; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Gorman MJ, 2010, INSECT BIOCHEM MOLEC, V40, P267, DOI 10.1016/j.ibmb.2010.01.004; Hassan EB, 2009, J APPL POLYM SCI, V112, P1436, DOI 10.1002/app.29521; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; HOPKINS TL, 1984, INSECT BIOCHEM, V14, P533, DOI 10.1016/0020-1790(84)90008-8; Hu F, 2009, MICRON, V40, P320, DOI 10.1016/j.micron.2008.11.001; Ito K, 2010, J BIOL CHEM, V285, P5624, DOI 10.1074/jbc.M109.035741; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Koch PB, 2000, PIGM CELL RES, V13, P54, DOI 10.1111/j.0893-5785.2000.130811.x; KRAMER KJ, 1984, INSECT BIOCHEM, V14, P293, DOI 10.1016/0020-1790(84)90063-5; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Liu T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004574; Lomakin J, 2011, BIOMACROMOLECULES, V12, P321, DOI 10.1021/bm1009156; Lomakin J, 2010, J INSECT PHYSIOL, V56, P1901, DOI 10.1016/j.jinsphys.2010.08.012; Ma ZY, 2011, P NATL ACAD SCI USA, V108, P3882, DOI 10.1073/pnas.1015098108; Menard K.P., 1999, DYNAMIC MECH ANAL PR; MORGAN TD, 1987, INSECT BIOCHEM, V17, P255, DOI 10.1016/0020-1790(87)90066-7; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; Murayama T., 1978, DYNAMIC MECH ANAL PO; Pendleton RG, 2005, PHARMACOL BIOCHEM BE, V81, P849, DOI 10.1016/j.pbb.2005.06.008; ROSELAND CR, 1987, INSECT BIOCHEM, V17, P21, DOI 10.1016/0020-1790(87)90139-9; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Shirataki H, 2010, EVOL DEV, V12, P305, DOI 10.1111/j.1525-142X.2010.00416.x; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; TURI EA, 1997, THERMAL CHARACTERIZA; van't Hof AE, 2011, SCIENCE, V332, P958, DOI 10.1126/science.1203043; Walter MF, 1996, ARCH INSECT BIOCHEM, V31, P219, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;219::AID-ARCH9&gt;3.0.CO;2-U; WAPPNER P, 1995, INSECT BIOCHEM MOLEC, V25, P365, DOI 10.1016/0965-1748(94)00078-V; Wappner P, 1996, INSECT BIOCHEM MOLEC, V26, P585, DOI 10.1016/S0965-1748(96)00012-4; Wappner P, 1996, J INSECT PHYSIOL, V42, P455, DOI 10.1016/0022-1910(95)00131-X; Wicker-Thomas C, 2008, J INSECT PHYSIOL, V54, P1423, DOI 10.1016/j.jinsphys.2008.08.005; Wittkopp PJ, 2009, SCIENCE, V326, P540, DOI 10.1126/science.1176980; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Zhan SA, 2010, DEVELOPMENT, V137, P4083, DOI 10.1242/dev.053678	54	17	19	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42968	10.1371/journal.pone.0042968	http://dx.doi.org/10.1371/journal.pone.0042968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937004	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500023
J	Rashidian, A; Joudaki, H; Vian, T				Rashidian, Arash; Joudaki, Hossein; Vian, Taryn			No Evidence of the Effect of the Interventions to Combat Health Care Fraud and Abuse: A Systematic Review of Literature	PLOS ONE			English	Article							REIMBURSEMENT RULES; INSURANCE COMPANIES; CORRUPTION; PHYSICIANS; DECEPTION	Background: Despite the importance of health care fraud and the political, legislative and administrative attentions paid to it, combating fraud remains a challenge to the health systems. We aimed to identify, categorize and assess the effectiveness of the interventions to combat health care fraud and abuse. Methods: The interventions to combat health care fraud can be categorized as the interventions for 'prevention' and 'detection' of fraud, and 'response' to fraud. We conducted sensitive search strategies on Embase, CINAHL, and PsycINFO from 1975 to 2008, and Medline from 1975-2010, and on relevant professional and organizational websites. Articles assessing the effectiveness of any intervention to combat health care fraud were eligible for inclusion in our review. We considered including the interventional studies with or without a concurrent control group. Two authors assessed the studies for inclusion, and appraised the quality of the included studies. As a limited number of studies were found, we analyzed the data using narrative synthesis. Findings: The searches retrieved 2229 titles, of which 221 full-text studies were assessed. We found no studies using an RCT design. Only four original articles (from the US and Taiwan) were included: two studies within the detection category, one in the response category, one under the detection and response categories, and no studies under the prevention category. The findings suggest that data-mining may improve fraud detection, and legal interventions as well as investment in anti-fraud activities may reduce fraud. Discussion: Our analysis shows a lack of evidence of effect of the interventions to combat health care fraud. Further studies using robust research methodologies are required in all aspects of dealing with health care fraud and abuse, assessing the effectiveness and cost-effectiveness of methods to prevent, detect, and respond to fraud in health care.	[Rashidian, Arash; Joudaki, Hossein] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran; [Rashidian, Arash] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Tehran, Iran; [Joudaki, Hossein] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran; [Vian, Taryn] Boston Univ, Sch Publ Hlth, Boston, MA USA	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Boston University	Rashidian, A (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran.	arashidian@tums.ac.ir	Vian, Taryn/H-4609-2019	Vian, Taryn/0000-0002-6968-7002; Rashidian, Arash/0000-0002-4005-5183	Tehran University of Medical Sciences [6638-74-04-86]	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	AR and HJ received a small grant from the Tehran University of Medical Sciences (contract no: 6638-74-04-86) to conduct this study. Funder URL: www.tums.ac.ir. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of manuscript.	Ahern MM, 1996, NURS ECON, V14, P40; Alexander GC, 2003, ANN INTERN MED, V138, P472, DOI 10.7326/0003-4819-138-6-200303180-00011; Becker D, 2005, J HEALTH ECON, V24, P189, DOI 10.1016/j.jhealeco.2004.07.002; Blais E, 2007, J EXPT CRIMINOLOGY, V3, P337, DOI DOI 10.1007/S11292-007-9043-Z; Bolton RJ, 2002, STAT SCI, V17, P235; Busch Rebecca S., 2007, HEALTHCARE FRAUD AUD; EPOC (Can), CAN COCHR EFF PRACT; Fowler N, 1999, Radiol Manage, V21, P50; Gee J, FINANCIAL COST HEALT; Gottschalk P., 2010, THE J, V17, P441, DOI DOI 10.1108/13590791011082797; HCAA (US), CORP COMPL HLTH CAR; Holmberg S, 2011, HEALTH ECON POLICY L, V6, P529, DOI 10.1017/S174413311000023X; Joudaki H, 2010, SCI J FORENSIC MED, V16, P215; Kalb PE, 1999, JAMA-J AM MED ASSOC, V282, P1163, DOI 10.1001/jama.282.12.1163; Kotalik J, 2006, GLOB CURR REP 2006; KPMG International, FRAUD RISK MAN; Laleh N, 2009, INF SYST TECHNOL MAN, DOI [10.1007/978-3-642-00405-6_28, DOI 10.1007/978-3-642-00405-6_28]; Li J, 2008, HEALTH CARE MANAG SC, V11, P275, DOI 10.1007/s10729-007-9045-4; Liou FM, 2008, HEALTH CARE MANAG SC, V11, P353, DOI 10.1007/s10729-008-9054-y; Nasirirad N, 2010, HOSPITAL, V9, P7; NHCAA (US), PRIV PUBL PARTN HLTH; NHS Counter Fraud and Security Management Service (GB), 2008, NHS FRAUD RISK MEAS; NHS Counter Fraud and Security Management Service (GB), 2006, INT FRAUD CORR REP S; NOVACK DH, 1989, JAMA-J AM MED ASSOC, V261, P2980, DOI 10.1001/jama.261.20.2980; Olken BA, 2007, J POLIT ECON, V115, P200, DOI 10.1086/517935; Ortega PA, 2006, P 2006 INT C DAT MIN, P224; Phua C., COMPREHENSIVE SURVEY; Popay J., 2006, GUIDANCE CONDUCT NAR; Qureshi ZP, 2011, ARCH INTERN MED, V171, P785, DOI 10.1001/archinternmed.2011.142; Rashidian A, 2010, SCI J FORENSIC MED, V15, P234; Rivers PA, 2005, HEALTH CARE MANAGE R, V30, P93, DOI 10.1097/00004010-200504000-00003; Savedoff William, 2006, GLOBAL CORRUPTION RE, P4; Sokol L, 2001, Top Health Inf Manage, V22, P1; Sokol L, 2001, P 34 HAW INT C SYST, DOI 10.1109/HICSS.2001.926570; Sparrow M K, 1996, J Insur Med, V28, P86; Sparrow MK, 2006, GLOBAL CORRUPTION RE, P16; Torras HW, 2003, HLTH CARE FRAUD ABUS; Viaene S, 2004, GENEVA PAPERS RISK I; Vian T, 2008, HEALTH POLICY PLANN, V23, P83, DOI 10.1093/heapol/czm048; Werner RM, 2004, AM J BIOETHICS, V4, P53, DOI 10.1080/15265160490518566; Werner RM, 2002, ARCH INTERN MED, V162, P1134, DOI 10.1001/archinte.162.10.1134; Wynia MK, 2000, JAMA-J AM MED ASSOC, V283, P1858, DOI 10.1001/jama.283.14.1858; Yang WS, 2006, EXPERT SYST APPL, V31, P56, DOI 10.1016/j.eswa.2005.09.003	43	28	28	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e41988	10.1371/journal.pone.0041988	http://dx.doi.org/10.1371/journal.pone.0041988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22936981	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500009
J	Chiyomaru, T; Yamamura, S; Zaman, MS; Majid, S; Deng, GR; Shahryari, V; Saini, S; Hirata, H; Ueno, K; Chang, I; Tanaka, Y; Tabatabai, ZL; Enokida, H; Nakagawa, M; Dahiya, R				Chiyomaru, Takeshi; Yamamura, Soichiro; Zaman, Mohd Saif; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Saini, Sharanjot; Hirata, Hiroshi; Ueno, Koji; Chang, Inik; Tanaka, Yuichiro; Tabatabai, Z. Laura; Enokida, Hideki; Nakagawa, Masayuki; Dahiya, Rajvir			Genistein Suppresses Prostate Cancer Growth through Inhibition of Oncogenic MicroRNA-151	PLOS ONE			English	Article							GENE-EXPRESSION; JAPANESE MEN; CHROMOSOMAL-ABERRATIONS; RISK; ISOFLAVONES; CARCINOMA; FAMILY; CELLS; CONSUMPTION; INVASION	Genistein has been shown to suppress the growth of several cancers through modulation of various pathways. However, the effects of genistein on the regulation of oncogenic microRNA-151 (miR-151) have not been reported. In this study, we investigated whether genistein could alter the expression of oncogenic miR-151 and its target genes that are involved in the progression and metastasis of prostate cancer (PCa). Real-time RT-PCR showed that the expression of miR-151 was higher in PC3 and DU145 cells compared with RWPE-1 cells. Treatment of PC3 and DU145 cells with 25 mu M genistein down-regulated the expression of miR-151 compared with vehicle control. Inhibition of miR-151 in PCa cells by genistein significantly inhibited cell migration and invasion. In-silico analysis showed that several genes (CASZ1, IL1RAPL1, SOX17, N4BP1 and ARHGDIA) suggested to have tumor suppressive functions were target genes of miR-151. Luciferase reporter assays indicated that miR-151 directly binds to specific sites on the 3'UTR of target genes. Quantitative real-time PCR analysis showed that the mRNA expression levels of the five target genes in PC3 and DU145 were markedly changed with miR-151 mimics and inhibitor. Kaplan-Meier curves and log-rank tests revealed that high expression levels of miR-151 had an adverse effect on survival rate. This study suggests that genistein mediated suppression of oncogenic miRNAs can be an important dietary therapeutic strategy for the treatment of PCa.	[Chiyomaru, Takeshi; Yamamura, Soichiro; Zaman, Mohd Saif; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Saini, Sharanjot; Hirata, Hiroshi; Ueno, Koji; Chang, Inik; Tanaka, Yuichiro; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA; [Chiyomaru, Takeshi; Yamamura, Soichiro; Zaman, Mohd Saif; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Saini, Sharanjot; Hirata, Hiroshi; Ueno, Koji; Chang, Inik; Tanaka, Yuichiro; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Pathol, San Francisco, CA USA; [Chiyomaru, Takeshi; Yamamura, Soichiro; Zaman, Mohd Saif; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Saini, Sharanjot; Hirata, Hiroshi; Ueno, Koji; Chang, Inik; Tanaka, Yuichiro; Tabatabai, Z. Laura; Dahiya, Rajvir] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Enokida, Hideki; Nakagawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Kagoshima University	Chiyomaru, T (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA.	rdahiya@urology.ucsf.edu	Jackson, Benjamin L/C-4297-2012		National Center for Research Resources of the National Institutes of Health [R01CA160079, R01CA138642, T32DK007790]; VA Merit Review and VA Program Project; NATIONAL CANCER INSTITUTE [R01CA138642, R01CA160079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007790] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review and VA Program Project(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Center for Research Resources of the National Institutes of Health through Grant Numbers R01CA160079, R01CA138642, T32DK007790 and VA Merit Review and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaza H, 2004, JPN J CLIN ONCOL, V34, P86, DOI 10.1093/jjco/hyh015; Barnabas N, 2011, PROSTATE, V71, P857, DOI 10.1002/pros.21302; Barone I, 2011, JNCI-J NATL CANCER I, V103, P538, DOI 10.1093/jnci/djr058; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Caren H, 2007, BRIT J CANCER, V97, P1416, DOI 10.1038/sj.bjc.6604032; Chen Y, 2011, CANCER PREV RES, V4, P76, DOI 10.1158/1940-6207.CAPR-10-0167; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Climent J, 2007, CANCER RES, V67, P818, DOI 10.1158/0008-5472.CAN-06-3307; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; de Souza PL, 2010, NUTR REV, V68, P542, DOI 10.1111/j.1753-4887.2010.00314.x; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Enjuanes A, 2008, CANCER RES, V68, P10178, DOI 10.1158/0008-5472.CAN-08-2221; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Jia Y, 2010, EPIGENETICS-US, V5, P743, DOI 10.4161/epi.5.8.13104; Kurahashi N, 2007, CANCER EPIDEM BIOMAR, V16, P538, DOI 10.1158/1055-9965.EPI-06-0517; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lips EH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-314; Liu CL, 1996, J NEUROIMMUNOL, V66, P41, DOI 10.1016/0165-5728(96)00016-1; Liu Z, 2011, CELL DEATH DIFFER, V18, P1174, DOI 10.1038/cdd.2010.187; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Matsuda R, 2011, BRIT J CANCER, V104, P376, DOI 10.1038/sj.bjc.6605990; McAvoy S, 2007, CYTOGENET GENOME RES, V119, P196, DOI 10.1159/000112061; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; Monzon FA, 2011, MODERN PATHOL, V24, P1470, DOI 10.1038/modpathol.2011.107; Murillas R, 2002, J BIOL CHEM, V277, P2897, DOI 10.1074/jbc.M110047200; Nagata Y, 2007, J NUTR, V137, P1974, DOI 10.1093/jn/137.8.1974; Nelson CJ, 2008, CANCER, V113, P1097, DOI 10.1002/cncr.23658; Oberst A, 2007, P NATL ACAD SCI USA, V104, P11280, DOI 10.1073/pnas.0701773104; Ozasa K, 2004, CANCER SCI, V95, P65, DOI 10.1111/j.1349-7006.2004.tb03172.x; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Sun QM, 2009, ONCOL REP, V22, P563, DOI 10.3892/or_00000472; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Uchida M, 2010, J PATHOL, V221, P96, DOI 10.1002/path.2686; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Yan L, 2009, AM J CLIN NUTR, V89, P1155, DOI 10.3945/ajcn.2008.27029; Ye YW, 2011, CANCER LETT, V307, P124, DOI 10.1016/j.canlet.2011.03.024; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349; Zhu YZ, 2012, PROSTATE, V72, P392, DOI 10.1002/pros.21441	43	90	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43812	10.1371/journal.pone.0043812	http://dx.doi.org/10.1371/journal.pone.0043812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928040	gold, Green Published, Green Submitted			2022-12-27	WOS:000308224700028
J	Rai, V; Hapuarachchi, HC; Ng, LC; Soh, SH; Leo, YS; Toh, CS				Rai, Varun; Hapuarachchi, Hapuarachchige C.; Ng, Lee Ching; Soh, Siew Hwa; Leo, Yee Sin; Toh, Chee-Seng			Ultrasensitive cDNA Detection of Dengue Virus RNA Using Electrochemical Nanoporous Membrane-Based Biosensor	PLOS ONE			English	Article							SEQUENCE-SPECIFIC DETECTION; DNA; SENSOR; NANOBIOSENSOR	A nanoporous alumina membrane-based ultrasensitive DNA biosensor is constructed using 5'-aminated DNA probes immobilized onto the alumina channel walls. Alumina nanoporous membrane-like structure is carved over platinum wire electrode of 76 mm diameter dimension by electrochemical anodization. The hybridization of complementary target DNA with probe DNA molecules attached inside the pores influences the pore size and ionic conductivity. The biosensor demonstrates linear range over 6 order of magnitude with ultrasensitive detection limit of 9.55x10(-12) M for the quantification of ss-31 mer DNA sequence. Its applicability is challenged against real time cDNA PCR sample of dengue virus serotype1 derived from asymmetric PCR. Excellent specificity down to one nucleotide mismatch in target DNA sample of DENV3 is also demonstrated.	[Rai, Varun; Toh, Chee-Seng] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore, Singapore; [Hapuarachchi, Hapuarachchige C.; Ng, Lee Ching] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore; [Soh, Siew Hwa; Leo, Yee Sin] Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tan Tock Seng Hospital	Rai, V (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore, Singapore.	cstoh@ntu.edu.sg		Rai, Varun/0000-0002-5872-3303; Hapuarachchi, Hapuarachchige Chanditha/0000-0001-7079-8538	Nanyang Technological University; Singapore Immunology Network-Agency for Science (SIgN-A*STAR) [SIgN 09-023]; National Environment Agency; Ministry of Education - NUS scholarship	Nanyang Technological University(Nanyang Technological University); Singapore Immunology Network-Agency for Science (SIgN-A*STAR); National Environment Agency; Ministry of Education - NUS scholarship	We thankfully acknowledge financial support from Nanyang Technological University grant, the Singapore Immunology Network-Agency for Science (SIgN-A*STAR) for research grant (SIgN 09-023), National Environment Agency and the Ministry of Education - NUS scholarship for VR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2010, ACS NANO, V4, P7267, DOI 10.1021/nn102119q; Bockisch B, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni101; Cheng MS, 2011, ENVIRON SCI TECHNOL, V45, P6453, DOI 10.1021/es200884a; Ding S, 2009, ANAL CHEM, V81, P6649, DOI 10.1021/ac9006705; Du H, 2003, J AM CHEM SOC, V125, P4012, DOI 10.1021/ja0290781; Ekanayake EMIM, 2007, BIOSENS BIOELECTRON, V23, P107, DOI 10.1016/j.bios.2007.03.022; Heilmann A, 2003, J NANOSCI NANOTECHNO, V3, P375, DOI 10.1166/jnn.2003.224; Kang MC, 2005, ANAL CHEM, V77, P6243, DOI 10.1021/ac0508907; Koh G, 2007, ELECTROCHIM ACTA, V53, P803, DOI 10.1016/j.electacta.2007.07.055; Koh G, 2007, ELECTROCHIM ACTA, V52, P2815, DOI 10.1016/j.electacta.2006.08.065; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Liu G, 2008, J AM CHEM SOC, V130, P6820, DOI 10.1021/ja800554t; Long YT, 2004, ANAL CHEM, V76, P4059, DOI 10.1021/ac049482d; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Martin CR, 2007, SCIENCE, V317, P331, DOI 10.1126/science.1146126; Moretti M, 2008, BIOSENS BIOELECTRON, V24, P141, DOI 10.1016/j.bios.2008.03.047; Mussi V, 2010, J PHYS CONDENS MATT, V22, P225; Mussi V, 2011, BIOSENS BIOELECTRON, V29, P125, DOI 10.1016/j.bios.2011.08.005; Nguyen BTT, 2009, ANAL CHEM, V81, P7226, DOI 10.1021/ac900761a; Rai V, 2012, BIOSENS BIOELECTRON, V32, P133, DOI 10.1016/j.bios.2011.11.046; Takmakov P, 2006, ANALYST, V131, P1248, DOI 10.1039/b608084g; Vlassiouk I, 2004, LANGMUIR, V20, P9913, DOI 10.1021/la047959a; Wang QX, 2011, ELECTROCHIM ACTA, V56, P3829, DOI 10.1016/j.electacta.2011.02.042; Wei F, 2005, J AM CHEM SOC, V127, P5306, DOI 10.1021/ja043661v; Zairi S, 2001, APPL SURF SCI, V172, P225, DOI 10.1016/S0169-4332(00)00856-4	25	53	54	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42346	10.1371/journal.pone.0042346	http://dx.doi.org/10.1371/journal.pone.0042346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927927	Green Published, gold			2022-12-27	WOS:000308224700005
J	Caro, LN; Moreau, CJ; Estrada-Mondragon, A; Ernst, OP; Vivaudou, M				Caro, Lydia N.; Moreau, Christophe J.; Estrada-Mondragon, Argel; Ernst, Oliver P.; Vivaudou, Michel			Engineering of an Artificial Light-Modulated Potassium Channel	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; XENOPUS-OOCYTES; PROTEIN; RECEPTORS; ACTIVATION; TRANSDUCIN; EXPRESSION; MUTATIONS; DIFFUSION	Ion Channel-Coupled Receptors (ICCRs) are artificial receptor-channel fusion proteins designed to couple ligand binding to channel gating. We previously validated the ICCR concept with various G protein-coupled receptors (GPCRs) fused with the inward rectifying potassium channel Kir6.2. Here we characterize a novel ICCR, consisting of the light activated GPCR, opsin/rhodopsin, fused with Kir6.2. To validate our two-electrode voltage clamp (TEVC) assay for activation of the GPCR, we first co-expressed the apoprotein opsin and the G protein-activated potassium channel Kir3.1(F137S) (Kir3.1*) in Xenopus oocytes. Opsin can be converted to rhodopsin by incubation with 11-cis retinal and activated by light-induced retinal cis -> trans isomerization. Alternatively opsin can be activated by incubation of oocytes with all-trans-retinal. We found that illumination of 11-cis-retinal-incubated oocytes co-expressing opsin and Kir3.1* caused an immediate and long-lasting channel opening. In the absence of 11-cis retinal, all-trans-retinal also opened the channel persistently, although with slower kinetics. We then used the oocyte/TEVC system to test fusion proteins between opsin/rhodopsin and Kir6.2. We demonstrate that a construct with a C-terminally truncated rhodopsin responds to light stimulus independent of G protein. By extending the concept of ICCRs to the light-activatable GPCR rhodopsin we broaden the potential applications of this set of tools.	[Caro, Lydia N.; Moreau, Christophe J.; Estrada-Mondragon, Argel; Vivaudou, Michel] CNRS, Inst Biol Struct, Grenoble, France; [Caro, Lydia N.; Moreau, Christophe J.; Estrada-Mondragon, Argel; Vivaudou, Michel] CEA, Inst Biol Struct, LabEx ICST, Grenoble, France; [Caro, Lydia N.; Moreau, Christophe J.; Estrada-Mondragon, Argel; Vivaudou, Michel] Univ Grenoble 1, Inst Biol Struct, Grenoble, France; [Caro, Lydia N.; Ernst, Oliver P.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Toronto; University of Toronto	Caro, LN (corresponding author), CNRS, Inst Biol Struct, Grenoble, France.	vivaudou@ibs.fr	Vivaudou, Michel/C-5338-2008; MOREAU, Christophe J/D-3736-2009; MOREAU, Christophe/AAC-7912-2020	Vivaudou, Michel/0000-0002-9777-3127; MOREAU, Christophe J/0000-0002-5463-9593; MOREAU, Christophe/0000-0002-5463-9593; Estrada, Argel/0000-0002-1359-4659	Agence Nationale de la Recherche (ICCR project) [ANR-09-PIRI-0010]; Canada Excellence Research Chair program; ANR	Agence Nationale de la Recherche (ICCR project)(French National Research Agency (ANR)); Canada Excellence Research Chair program; ANR(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (ICCR project, grant ANR-09-PIRI-0010 to M.V.) and the Canada Excellence Research Chair program (to O.P.E.). The Vivaudou laboratory is a member of the French National Laboratory of Excellence "Ion Channel Science and Therapeutics" supported by a network grant from ANR. O.P.E. holds the Anne and Max Tanenbaum Chair in Neuroscience at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BORNANCIN F, 1992, EUR J BIOCHEM, V210, P33, DOI 10.1111/j.1432-1033.1992.tb17387.x; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Caro LN, 2012, BIOPHYS J, V102, p539A, DOI 10.1016/j.bpj.2011.11.2943; Caro LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018226; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Govardovskii VI, 2009, MOL VIS, V15, P1717; Hosy E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.043307; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; KNOWLES A, 1978, VISION RES, V18, P115, DOI 10.1016/0042-6989(78)90086-X; KNOX BE, 1993, J PHYSIOL-LONDON, V466, P157; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; Madani N, 1998, P NATL ACAD SCI USA, V95, P8005, DOI 10.1073/pnas.95.14.8005; Mangmool S, 2011, TOXINS, V3, P884, DOI 10.3390/toxins3070884; McAllister SD, 1999, J PHARMACOL EXP THER, V291, P618; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; Moreau CJ, 2008, NAT NANOTECHNOL, V3, P620, DOI 10.1038/nnano.2008.242; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Orsini F, 2009, EUR BIOPHYS J BIOPHY, V38, P903, DOI 10.1007/s00249-009-0464-7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Piechnick R, 2012, P NATL ACAD SCI USA, V109, P5247, DOI 10.1073/pnas.1117268109; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Sahlhollm K, 2007, EUR J PHARMACOL, V567, P206, DOI 10.1016/j.ejphar.2007.04.032; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Saugstad JA, 1996, J NEUROSCI, V16, P5979; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sui JL, 1999, ADV SEC MESS PHOSPH, V33, P179; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Werner P, 1996, MOL PHARMACOL, V49, P656; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	52	13	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43766	10.1371/journal.pone.0043766	http://dx.doi.org/10.1371/journal.pone.0043766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928030	gold, Green Submitted, Green Published			2022-12-27	WOS:000308286300087
J	Opondo, D; Eslami, S; Visscher, S; de Rooij, SE; Verheij, R; Korevaar, JC; Abu-Hanna, A				Opondo, Dedan; Eslami, Saied; Visscher, Stefan; de Rooij, Sophia E.; Verheij, Robert; Korevaar, Joke C.; Abu-Hanna, Ameen			Inappropriateness of Medication Prescriptions to Elderly Patients in the Primary Care Setting: A Systematic Review	PLOS ONE			English	Review							ADVERSE DRUG EVENTS; BEERS CRITERIA; OLDER-ADULTS; OUTPATIENTS; POPULATION; QUALITY; PREVALENCE; VETERANS; DISEASES	Background: Inappropriate medication prescription is a common cause of preventable adverse drug events among elderly persons in the primary care setting. Objective: The aim of this systematic review is to quantify the extent of inappropriate prescription to elderly persons in the primary care setting. Methods: We systematically searched Ovid-Medline and Ovid-EMBASE from 1950 and 1980 respectively to March 2012. Two independent reviewers screened and selected primary studies published in English that measured (in) appropriate medication prescription among elderly persons (>65 years) in the primary care setting. We extracted data sources, instruments for assessing medication prescription appropriateness, and the rate of inappropriate medication prescriptions. We grouped the reported individual medications according to the Anatomical Therapeutic and Chemical (ATC) classification and compared the median rate of inappropriate medication prescription and its range within each therapeutic class. Results: We included 19 studies, 14 of which used the Beers criteria as the instrument for assessing appropriateness of prescriptions. The median rate of inappropriate medication prescriptions (IMP) was 20.5% [IQR 18.1 to 25.6%.]. Medications with largest median rate of inappropriate medication prescriptions were propoxyphene 4.52(0.10-23.30)%, doxazosin 3.96 (0.32 15.70)%, diphenhydramine 3.30(0.02-4.40)% and amitriptiline 3.20 (0.05-20.5)% in a decreasing order of IMP rate. Available studies described unequal sets of medications and different measurement tools to estimate the overall prevalence of inappropriate prescription. Conclusions: Approximately one in five prescriptions to elderly persons in primary care is inappropropriate despite the attention that has been directed to quality of prescription. Diphenhydramine and amitriptiline are the most common inappropriately prescribed medications with high risk adverse events while propoxyphene and doxazoxin are the most commonly prescribed medications with low risk adverse events. These medications are good candidates for being targeted for improvement e. g. by computerized clinical decision support.	[Opondo, Dedan; Eslami, Saied; Abu-Hanna, Ameen] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [Visscher, Stefan; Verheij, Robert; Korevaar, Joke C.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [de Rooij, Sophia E.] Univ Amsterdam, Acad Med Ctr, Dept Geriatr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Institute for Health Services Research; University of Amsterdam; Academic Medical Center Amsterdam	Opondo, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.o.opondo@amc.uva.nl		Abu-Hanna, Ameen/0000-0003-4324-7954				Aparasu RR, 2000, ANN PHARMACOTHER, V34, P338, DOI 10.1345/aph.19006; Aparasu RR, 1997, ANN PHARMACOTHER, V31, P823, DOI 10.1177/106002809703100702; Aparasu RR, 1999, AM J HEALTH-SYST PH, V56, P433, DOI 10.1093/ajhp/56.5.433; Basger BJ, 2008, DRUG AGING, V25, P777, DOI 10.2165/00002512-200825090-00004; Bierman Arlene S, 2007, Am J Geriatr Pharmacother, V5, P147, DOI 10.1016/j.amjopharm.2007.06.005; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2011, J AM GERIATR SOC, V59, P797, DOI 10.1111/j.1532-5415.2011.03391.x; Chang CB, 2012, PHARMACOEPIDEM DR S, V21, P1269, DOI 10.1002/pds.3274; Curtis LH, 2004, ARCH INTERN MED, V164, P1621, DOI 10.1001/archinte.164.15.1621; Eslami S, 2010, BRIT J CLIN PHARMACO, V70, P619, DOI 10.1111/j.1365-2125.2010.03614.x; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2007, J CLIN PHARM THER, V32, P113, DOI 10.1111/j.1365-2710.2007.00793.x; Ghadimi H, 2011, PHARMACOEPIDEM DR S, V20, P482, DOI 10.1002/pds.2106; Goltz L, 2012, INT J CLIN PHARM TH, V50, P185, DOI 10.5414/CP201441; Guaraldo L, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-79; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; Lai HY, 2009, CLIN THER, V31, P1859, DOI 10.1016/j.clinthera.2009.08.023; Lin HY, 2008, DRUG AGING, V25, P49, DOI 10.2165/00002512-200825010-00006; Lund BC, 2010, ANN PHARMACOTHER, V44, P957, DOI 10.1345/aph.1M657; Maio V, 2010, J CLIN PHARM THER, V35, P219, DOI 10.1111/j.1365-2710.2009.01094.x; Maio V, 2006, AM J MED QUAL, V21, P162, DOI 10.1177/1062860605285475; Maio V, 2006, DRUG AGING, V23, P915, DOI 10.2165/00002512-200623110-00006; Martins SDO, 2006, PHARM WORLD SCI, V28, P296, DOI 10.1007/s11096-006-9046-2; Parker M, 2007, COLORECTAL DIS, V9, P2, DOI 10.1111/j.1463-1318.2007.01368.x; Pugh MJV, 2006, J MANAGE CARE PHARM, V12, P537, DOI 10.18553/jmcp.2006.12.7.537; Pugh MJV, 2005, J AM GERIATR SOC, V53, P1282, DOI 10.1111/j.1532-5415.2005.53402.x; Ryan C, 2009, BRIT J CLIN PHARMACO, V68, P936, DOI 10.1111/j.1365-2125.2009.03531.x; Smeets HM, 2011, J CLIN EPIDEMIOL, V64, P424, DOI 10.1016/j.jclinepi.2010.04.023; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Straand J, 1999, FAM PRACT, V16, P380, DOI 10.1093/fampra/16.4.380; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658; van der Hooft CS, 2005, BRIT J CLIN PHARMACO, V60, P137, DOI 10.1111/j.1365-2125.2005.02391.x; Wilde S, 2012, PHARMACOEPIDEM DR S, V16, P658; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A; Zaveri HG, 2010, INDIAN J PHARMACOL, V42, P95, DOI 10.4103/0253-7613.64499; Zhan CL, 2005, J AM GERIATR SOC, V53, P262, DOI 10.1111/j.1532-5415.2005.53112.x; Zhang YT, 2010, NEW ENGL J MED, V363, P1985, DOI 10.1056/NEJMp1010220	39	166	171	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43617	10.1371/journal.pone.0043617	http://dx.doi.org/10.1371/journal.pone.0043617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928004	Green Published, gold			2022-12-27	WOS:000308286300074
J	Wu, YH; Jiang, WJ; Wang, YM; Wu, J; Saiyin, H; Qiao, XJ; Mei, XY; Guo, B; Fang, X; Zhang, L; Lou, HL; Wu, CQ; Qiao, SY				Wu, Yanhua; Jiang, Wenjun; Wang, Yingming; Wu, Jun; Saiyin, Hexige; Qiao, Xiaojing; Mei, Xinyu; Guo, Bin; Fang, Xiao; Zhang, Lu; Lou, Huiling; Wu, Chaoqun; Qiao, Shouyi			Breast Cancer Metastasis Suppressor 1 Regulates Hepatocellular Carcinoma Cell Apoptosis via Suppressing Osteopontin Expression	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; DISEASE-FREE SURVIVAL; PROGNOSTIC-SIGNIFICANCE; TUMOR-METASTASIS; DOWN-REGULATION; CURATIVE RESECTION; ENDOTHELIAL-CELLS; CHROMOSOME 11Q13; BRMS1 EXPRESSION; GENE-EXPRESSION	Breast cancer metastasis suppressor 1 (BRMS1) was originally identified as an active metastasis suppressor in human breast cancer. Loss of BRMS1 expression correlates with tumor progression, and BRMS1 suppresses several steps required for tumor metastasis. However, the role of BRMS1 in hepatocellular carcinoma (HCC) remains elusive. In this study, we found that the expression level of BRMS1 was significantly down-regulated in HCC tissues. Expression of BRMS1 in SK-Hep1 cells did not affect cell growth under normal culture conditions, but sensitized cells to apoptosis induced by serum deprivation or anoikis. Consistently, knockdown of endogenous BRMS1 expression in Hep3B cells suppressed cell apoptosis. We identified that BRMS1 suppresses osteopontin (OPN) expression in HCC cells and that there is a negative correlation between BRMS1 and OPN mRNA expression in HCC tissues. Moreover, knockdown of endogenous OPN expression reversed the anti-apoptosis effect achieved by knockdown of BRMS1. Taken together, our results show that BRMS1 sensitizes HCC cells to apoptosis through suppressing OPN expression, suggesting a potential role of BRMS1 in regulating HCC apoptosis and metastasis.	[Wu, Yanhua; Jiang, Wenjun; Wang, Yingming; Wu, Jun; Saiyin, Hexige; Qiao, Xiaojing; Mei, Xinyu; Guo, Bin; Fang, Xiao; Zhang, Lu; Lou, Huiling; Wu, Chaoqun; Qiao, Shouyi] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University	Wu, YH (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	syqiao@fudan.edu.cn	Wu, Yanhua/GWU-9872-2022; wang, yingying/GRS-3058-2022	Wu, Yanhua/0000-0002-2803-809X; Saiyin, Hexige/0000-0003-2993-6817	National Natural Science foundation of China [31000558]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science foundation of China (31000558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi MS, 2004, BLOOD, V103, P4180, DOI 10.1182/blood-2003-06-2144; Champine PJ, 2007, CLIN EXP METASTAS, V24, P551, DOI 10.1007/s10585-007-9092-8; Chen RX, 2011, ONCOL REP, V25, P803, DOI 10.3892/or.2010.1116; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; Cook LM, 2012, CLIN EXP METASTAS, V29, P315, DOI 10.1007/s10585-012-9452-x; Courter D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009633; Edmonds MD, 2009, INT J CANCER, V125, P1778, DOI 10.1002/ijc.24616; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Giannelli G, 2001, LAB INVEST, V81, P613, DOI 10.1038/labinvest.3780270; Graessmann M, 2007, ONCOGENE, V26, P2840, DOI 10.1038/sj.onc.1210096; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hedley BD, 2008, INT J CANCER, V123, P526, DOI 10.1002/ijc.23542; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; Hsieh YH, 2006, CANCER RES, V66, P7119, DOI 10.1158/0008-5472.CAN-06-1002; Hu HZ, 2011, GUT, V60, P710, DOI 10.1136/gut.2010.220020; Huang CS, 2008, J NUTR, V138, P538, DOI 10.1093/jn/138.3.538; Huang H, 2010, CANCER SCI, V101, P1314, DOI 10.1111/j.1349-7006.2010.01524.x; Hurst DR, 2011, INT REV CEL MOL BIO, V286, P107, DOI 10.1016/B978-0-12-385859-7.00003-3; Ito Y, 1999, BRIT J CANCER, V81, P747, DOI 10.1038/sj.bjc.6690758; Ito Y, 2000, BRIT J CANCER, V82, P1211; Jiang C, 2001, CANCER RES, V61, P3062; Jiang Jie, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P398; Kapoor P, 2004, INT J CANCER, V111, P693, DOI 10.1002/ijc.20318; Kim J, 2006, AM J GASTROENTEROL, V101, P2051, DOI 10.1111/j.1572-0241.2006.00679.x; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Li HP, 2005, CELL RES, V15, P262, DOI 10.1038/sj.cr.7290295; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Lombardi G, 2007, INT J CANCER, V120, P1169, DOI 10.1002/ijc.22379; Malyankar UM, 2000, J BIOL CHEM, V275, P20959, DOI 10.1074/jbc.C000290200; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Metge BJ, 2008, CLIN EXP METASTAS, V25, P753, DOI 10.1007/s10585-008-9187-x; Nagai H, 1999, DNA Res, V6, P219, DOI 10.1093/dnares/6.4.219; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Phillips KK, 1996, CANCER RES, V56, P1222; Rivera J, 2007, J PROTEOME RES, V6, P4006, DOI 10.1021/pr0703167; Rytomaa M, 1999, CURR BIOL, V9, P1043, DOI 10.1016/S0960-9822(99)80454-0; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Samant RS, 2001, CLIN EXP METASTAS, V18, P683, DOI 10.1023/A:1013124725690; Saunders MM, 2001, CANCER RES, V61, P1765; Seraj MJ, 2000, CANCER RES, V60, P2764; Shevde LA, 2002, EXP CELL RES, V273, P229, DOI 10.1006/excr.2001.5452; Shi YH, 2008, HEPATOLOGY, V48, P497, DOI 10.1002/hep.22393; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Smith PW, 2009, CANCER LETT, V276, P196, DOI 10.1016/j.canlet.2008.11.024; Song G, 2008, CANCER SCI, V99, P1901, DOI 10.1111/j.1349-7006.2008.00911.x; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wu YH, 2009, CLIN CANCER RES, V15, P60, DOI 10.1158/1078-0432.CCR-08-1028; Xue YH, 2010, HEPATOLOGY, V52, P2012, DOI 10.1002/hep.23942; Yang GH, 2008, ONCOLOGIST, V13, P1155, DOI 10.1634/theoncologist.2008-0081; Yang JY, 2011, LUNG CANCER, V74, P305, DOI 10.1016/j.lungcan.2011.03.002; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yu MC, 2011, ANN SURG ONCOL; Zainabadi K, 2005, GENOMICS, V85, P704, DOI 10.1016/j.ygeno.2005.02.014; Zhang CH, 2012, INT J CANCER, V130, P2685, DOI 10.1002/ijc.26301; Zhang H, 2006, J CANCER RES CLIN, V132, P709, DOI 10.1007/s00432-006-0119-3; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x; Zhang ZH, 2006, CLIN CANCER RES, V12, P6410, DOI 10.1158/1078-0432.CCR-06-1347; Zhao J, 2008, GASTROENTEROLOGY, V135, P956, DOI 10.1053/j.gastro.2008.05.025; Zhao J, 2008, HEPATOLOGY, V48, P265, DOI 10.1002/hep.22280	65	22	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42976	10.1371/journal.pone.0042976	http://dx.doi.org/10.1371/journal.pone.0042976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927944	Green Submitted, Green Published, gold			2022-12-27	WOS:000307789700019
J	Dubois, F; Belzile, A				Dubois, Frederique; Belzile, Alexandra			Audience Effect Alters Male Mating Preferences in Zebra Finches (Taeniopygia guttata)	PLOS ONE			English	Article							MALE MATE CHOICE; SIAMESE FIGHTING FISH; SEXUAL SELECTION; PAIR	The social environment of animals strongly influences the mating preferences of both the choosing and the observing individuals. Notably, there is recent evidence that polygamous males decrease their selectivity when being observed by competitors in order to direct their rivals' attention away from their true interest and, consequently, reduce sperm competition risk. Yet, other mechanisms, whose importance remains unexplored, could induce similar effects. In monogamous species with mutual choice, particularly, if males adjust their selectivity according to the risk of being rejected by their preferred mate, they should as well become less selective when potential rivals are present. Here, we investigated whether the presence of bystanders modifies male mating preferences when the risk of sperm competition is low, by carrying out mate-choice experiments with male zebra finches (Taeniopygia guttata) whose preferences for two females were measured twice: with and without an audience. We found that the presence of potential rivals had no effect on the males' choosiness. However, with an audience, they spent more time with the female that was considered as the less attractive one in the control condition. These findings support the hypothesis that monogamous males alter their mate choice decisions in the presence of a male audience to reduce the risk of remaining unpaired. Thus, our results indicate that several explanations can account for the changes in male preferences due to the presence of competitors and highlight the importance of assessing the relative role of each mechanism potentially involved, to be able to make conclusions about the effect of an audience on signal evolution.	[Dubois, Frederique; Belzile, Alexandra] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Dubois, F (corresponding author), Univ Montreal, Dept Sci Biol, CP 6128, Montreal, PQ H3C 3J7, Canada.	frederique.dubois@UMontreal.ca			Natural Sciences and Engineering Research Council of Canada [312133]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	FD acknowledged financial support from Natural Sciences and Engineering Research Council of Canada www.crsng-nserc.gc.ca(#312133). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltz AP, 1997, ANIM BEHAV, V53, P1017, DOI 10.1006/anbe.1996.0354; Birkhead TR, 2010, EMU, V110, P189, DOI 10.1071/MU09086; BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BURLEY N, 1987, ETHOLOGY, V76, P133; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Burley NT, 2006, ANIM BEHAV, V72, P713, DOI 10.1016/j.anbehav.2006.01.017; Cote K-A, 2006, THESIS U QUEBEC MONT; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doutrelant C, 2001, BEHAV ECOL, V12, P283, DOI 10.1093/beheco/12.3.283; Drullion D, 2008, BEHAV ECOL SOCIOBIOL, V63, P269, DOI 10.1007/s00265-008-0658-5; DUGATKIN LA, 1993, BEHAV ECOL, V4, P289, DOI 10.1093/beheco/4.4.289; Dugatkin LA, 2000, IMITATION FACTOR EVO; Fisher HS, 2007, BIOL LETTERS, V3, P5, DOI 10.1098/rsbl.2006.0556; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Jones KM, 2001, ANIM BEHAV, V62, P1021, DOI 10.1006/anbe.2001.1843; Matos RJ, 2002, BEHAVIOUR, V139, P1211, DOI 10.1163/15685390260437344; McGregor PK, 2005, ANIMAL COMMUNICATION; Monaghan P, 1996, P ROY SOC B-BIOL SCI, V263, P1183, DOI 10.1098/rspb.1996.0173; Padur L, 2009, BEHAVIOUR, V146, P1739, DOI 10.1163/000579509X12483520922124; Plath M, 2008, ANIM BEHAV, V75, P21, DOI 10.1016/j.anbehav.2007.05.013; Plath M, 2010, ACTA ETHOL, V13, P49, DOI 10.1007/s10211-010-0074-5; Plath M, 2009, BEHAV ECOL SOCIOBIOL, V63, P381, DOI 10.1007/s00265-008-0672-7; PRUETTJONES S, 1992, AM NAT, V140, P1000, DOI 10.1086/285452; Royle NJ, 2006, ANIM BEHAV, V72, P123, DOI 10.1016/j.anbehav.2005.09.023; Stohr S, 1998, ANIM BEHAV, V55, P893, DOI 10.1006/anbe.1997.0674; Swaddle JP, 2005, P ROY SOC B-BIOL SCI, V272, P1053, DOI 10.1098/rspb.2005.3054; Ung D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022686; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Wagner RH, 2010, OIKOS, V119, P203, DOI 10.1111/j.1600-0706.2009.17315.x; White DJ, 2004, LEARN BEHAV, V32, P105; Witte K., 2006, FISH COGNITION BEHAV, P70, DOI DOI 10.1002/9780470996058.CH5; Witte K, 2006, ETHOL ECOL EVOL, V18, P195, DOI 10.1080/08927014.2006.9522707; Wong BBM, 2009, BEHAV ECOL, V20, P278, DOI 10.1093/beheco/arp010; Zann R. A., 1996, ZEBRA FINCHES SYNTHE; Ziege M, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-17	39	17	17	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43697	10.1371/journal.pone.0043697	http://dx.doi.org/10.1371/journal.pone.0043697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916298	gold, Green Submitted, Green Published			2022-12-27	WOS:000307733800096
J	Masloboeva, N; Reutimann, L; Stiefel, P; Follador, R; Leimer, N; Hennecke, H; Mesa, S; Fischer, HM				Masloboeva, Nadezda; Reutimann, Luzia; Stiefel, Philipp; Follador, Rainer; Leimer, Nadja; Hennecke, Hauke; Mesa, Socorro; Fischer, Hans-Martin			Reactive Oxygen Species-Inducible ECF sigma Factors of Bradyrhizobium japonicum	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; BACTERIAL 2-HYBRID SYSTEM; OXIDATIVE STRESS; SINGLET OXYGEN; TRANSCRIPTIONAL REGULATOR; MYXOCOCCUS-XANTHUS; SIGNALING CASCADE; HEAT-SHOCK; GENE; EXPRESSION	Extracytoplasmic function (ECF) sigma factors control the transcription of genes involved in different cellular functions, such as stress responses, metal homeostasis, virulence-related traits, and cell envelope structure. The genome of Bradyrhizobium japonicum, the nitrogen-fixing soybean endosymbiont, encodes 17 putative ECF sigma factors belonging to nine different ECF sigma factor families. The genes for two of them, ecfQ (bll1028) and ecfF (blr3038), are highly induced in response to the reactive oxygen species hydrogen peroxide (H2O2) and singlet oxygen (O-1(2)). The ecfF gene is followed by the predicted anti-sigma factor gene osrA (blr3039). Mutants lacking EcfQ, EcfF plus OsrA, OsrA alone, or both sigma factors plus OsrA were phenotypically characterized. While the symbiotic properties of all mutants were indistinguishable from the wild type, they showed increased sensitivity to singlet oxygen under free-living conditions. Possible target genes of EcfQ and EcfF were determined by microarray analyses, and candidate genes were compared with the H2O2-responsive regulon. These experiments disclosed that the two sigma factors control rather small and, for the most part, distinct sets of genes, with about half of the genes representing 13% of the members of H2O2-responsive regulon. To get more insight into transcriptional regulation of both sigma factors, the 5' ends of ecfQ and ecfF mRNA were determined. The presence of conserved sequence motifs in the promoter region of ecfQ and genes encoding EcfQ-like sigma factors in related alpha-proteobacteria suggests regulation via a yet unknown transcription factor. By contrast, we have evidence that ecfF is autoregulated by transcription from an EcfF-dependent consensus promoter, and its product is negatively regulated via protein-protein interaction with OsrA. Conserved cysteine residues 129 and 179 of OsrA are required for normal function of OsrA. Cysteine 179 is essential for release of EcfF from an EcfF-OsrA complex upon H2O2 stress while cysteine 129 is possibly needed for EcfF-OsrA interaction.	[Masloboeva, Nadezda; Reutimann, Luzia; Stiefel, Philipp; Follador, Rainer; Leimer, Nadja; Hennecke, Hauke; Mesa, Socorro; Fischer, Hans-Martin] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Masloboeva, N (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	fischerh@micro.biol.ethz.ch	Leimer, Nadja/AAC-3822-2022; Mesa, Socorro/G-7775-2015	Mesa, Socorro/0000-0001-7285-3940; Leimer, Nadja/0000-0002-5355-2197	ETH Zurich; Swiss National Foundation for Scientific Research [31003A-122371]	ETH Zurich(ETH Zurich); Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This work was supported by grants from ETH Zurich and from the Swiss National Foundation for Scientific Research (grant no. 31003A-122371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; ALEXEYEV MF, 1995, BIOTECHNIQUES, V18, P52; Alvarez-Martinez CE, 2006, J BACTERIOL, V188, P1835, DOI 10.1128/JB.188.5.1835-1846.2006; Alvarez-Martinez CE, 2007, MOL MICROBIOL, V66, P1240, DOI 10.1111/j.1365-2958.2007.06005.x; Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Atack JM, 2008, MICROBIOL-SGM, V154, P2219, DOI 10.1099/mic.0.2008/019711-0; Bastiat B, 2010, J BACTERIOL, V192, P2255, DOI 10.1128/JB.01666-09; Becana M, 2010, NEW PHYTOL, V188, P960, DOI 10.1111/j.1469-8137.2010.03512.x; Beck C, 1997, J BACTERIOL, V179, P364, DOI 10.1128/jb.179.2.364-369.1997; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Bussmann M, 2010, J BIOL CHEM, V285, P29305, DOI 10.1074/jbc.M110.156372; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Chang C, 2009, MOL PLANT, V2, P370, DOI 10.1093/mp/ssn090; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dolla A, 2006, J BIOTECHNOL, V126, P87, DOI 10.1016/j.jbiotec.2006.03.041; Donati AJ, 2011, APPL ENVIRON MICROB, V77, P3633, DOI 10.1128/AEM.00047-11; Dufour YS, 2008, J MOL BIOL, V383, P713, DOI 10.1016/j.jmb.2008.08.017; Evans PJ, 1999, PLANTA, V208, P73, DOI 10.1007/s004250050536; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Fontes M, 2003, MOL MICROBIOL, V47, P561, DOI 10.1046/j.1365-2958.2003.03319.x; Galbis-Martinez L, 2008, MICROBIOL-SGM, V154, P895, DOI 10.1099/mic.0.2007/013359-0; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; Gorham HC, 1996, MOL MICROBIOL, V19, P171, DOI 10.1046/j.1365-2958.1996.360888.x; GOTTFERT M, 1990, MOL PLANT MICROBE IN, V3, P308, DOI 10.1094/MPMI-3-308; Gourion B, 2009, MOL MICROBIOL, V73, P291, DOI 10.1111/j.1365-2958.2009.06769.x; Greenwell R, 2011, J MOL BIOL, V407, P477, DOI 10.1016/j.jmb.2011.01.055; Grote A, 2009, NUCLEIC ACIDS RES, V37, pD61, DOI 10.1093/nar/gkn837; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gunesekere IC, 2006, J BACTERIOL, V188, P3463, DOI 10.1128/JB.188.10.3463-3469.2006; HAHN M, 1984, PLANT MOL BIOL, V3, P159, DOI 10.1007/BF00016063; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hauser F, 2006, MOL GENET GENOMICS, V275, P55, DOI 10.1007/s00438-005-0059-7; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hoopman TC, 2011, INFECT IMMUN, V79, P745, DOI 10.1128/IAI.01060-10; Hopman CTP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-164; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jeon JM, 2011, MOL PLANT MICROBE IN, V24, P1472, DOI 10.1094/MPMI-03-11-0072; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawasaki S, 2005, APPL ENVIRON MICROB, V71, P8442, DOI 10.1128/AEM.71.12.8442-8450.2005; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Latch DE, 2006, SCIENCE, V311, P1743, DOI 10.1126/science.1121636; LEWIN A, 1990, MOL PLANT MICROBE IN, V3, P317, DOI 10.1094/MPMI-3-317; Lindemann A, 2007, J BACTERIOL, V189, P8928, DOI 10.1128/JB.01088-07; Liu X, 2001, Pac Symp Biocomput, P127; Lourenco RF, 2011, MOL MICROBIOL, V80, P1598, DOI 10.1111/j.1365-2958.2011.07668.x; Lourenco RF, 2009, MOL MICROBIOL, V72, P1159, DOI 10.1111/j.1365-2958.2009.06714.x; Martinez-Salazar JM, 2009, J BACTERIOL, V191, P4122, DOI 10.1128/JB.01626-08; Mesa S, 2005, J BACTERIOL, V187, P3329, DOI 10.1128/JB.187.10.3329-3338.2005; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; Mesa S, 2009, P NATL ACAD SCI USA, V106, P21860, DOI 10.1073/pnas.0908097106; Miller JH., 1972, EXPT MOL GENETICS; Mishra MN, 2011, MICROBIOL-SGM, V157, P988, DOI 10.1099/mic.0.046672-0; Mitchell JE, 2003, NUCLEIC ACIDS RES, V31, P4689, DOI 10.1093/nar/gkg694; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Nicholas Jr KBNHB, 1997, EMBNETNEWS, V4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Panek HR, 2004, J BACTERIOL, V186, P7874, DOI 10.1128/JB.186.23.7874-7880.2004; Pauly N, 2006, J EXP BOT, V57, P1769, DOI 10.1093/jxb/erj184; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Rudolph G, 2006, J BACTERIOL, V188, P2294, DOI 10.1128/JB.188.6.2294.2006; Sambrook J., 2001, MOL CLONING LAB MANU; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Stockwell SB, 2012, MOL PLANT MICROBE IN, V25, P119, DOI 10.1094/MPMI-07-11-0188; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; VANBOGELEN RA, 1987, J BACTERIOL, V169, P26, DOI 10.1128/jb.169.1.26-32.1987; Vattanaviboon P, 2005, J BACTERIOL, V187, P5831, DOI 10.1128/JB.187.16.5831-5836.2005; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yeoman KH, 2003, FEMS MICROBIOL LETT, V223, P239, DOI 10.1016/S0378-1097(03)00386-0; Yeoman KH, 1999, MOL PLANT MICROBE IN, V12, P994, DOI 10.1094/MPMI.1999.12.11.994; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	89	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43421	10.1371/journal.pone.0043421	http://dx.doi.org/10.1371/journal.pone.0043421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916258	gold, Green Published, Green Submitted			2022-12-27	WOS:000307824300047
J	Vatin, M; Burgio, G; Renault, G; Laissue, P; Firlej, V; Mondon, F; Montagutelli, X; Vaiman, D; Serres, C; Ziyyat, A				Vatin, Magalie; Burgio, Gaetan; Renault, Gilles; Laissue, Paul; Firlej, Virginie; Mondon, Francoise; Montagutelli, Xavier; Vaiman, Daniel; Serres, Catherine; Ziyyat, Ahmed			Refined Mapping of a Quantitative Trait Locus on Chromosome 1 Responsible for Mouse Embryonic Death	PLOS ONE			English	Article							RECURRENT MISCARRIAGE; SPONTANEOUS-ABORTION; CYTOGENETIC ANALYSIS; CELL-PROLIFERATION; GENE; MICE; DISRUPTION; LETHALITY; MUTATION; DEFECTS	Recurrent spontaneous abortion (RSA) is defined as the loss of three or more consecutive pregnancies during the first trimester of embryonic intrauterine development. This kind of human infertility is frequent among the general population since it affects 1 to 5% of women. In half of the cases the etiology remains unelucidated. In the present study, we used interspecific recombinant congenic mouse strains (IRCS) in the aim to identify genes responsible for embryonic lethality. Applying a cartographic approach using a genotype/phenotype association, we identified a minimal QTL region, of about 6 Mb on chromosome 1, responsible for a high rate of embryonic death (similar to 30%). Genetic analysis suggests that the observed phenotype is linked to uterine dysfunction. Transcriptomic analysis of the uterine tissue revealed a preferential deregulation of genes of this region compared to the rest of the genome. Some genes from the QTL region are associated with VEGF signaling, mTOR signaling and ubiquitine/proteasome-protein degradation pathways. This work may contribute to elucidate the molecular basis of a multifactorial and complex human disorder as RSA.	[Vatin, Magalie; Renault, Gilles; Firlej, Virginie; Mondon, Francoise; Vaiman, Daniel; Serres, Catherine; Ziyyat, Ahmed] Univ Paris 05, Inst Cochin Inserm CNRS UMR 8104 U1016, Paris, France; [Burgio, Gaetan; Montagutelli, Xavier] Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; [Burgio, Gaetan] Univ Tasmania, Menzies Res Inst, Dept Genet, Hobart, Tas, Australia; [Laissue, Paul] Univ Del Rosario, Fac Med, Unidad Genet, Bogota, Colombia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Tasmania; Menzies Institute for Medical Research	Vatin, M (corresponding author), Univ Paris 05, Inst Cochin Inserm CNRS UMR 8104 U1016, Paris, France.	ahmed.ziyyat@parisdescartes.fr	ZIYYAT, Ahmed/ABB-1861-2021; Burgio, Gaetan/B-6722-2015; Laissue, Paul/C-6787-2012; Vaiman, Daniel/O-6030-2015; Firlej, Virginie/AFQ-6362-2022; Firlej, Virginie/R-2065-2018; ZIYYAT, Ahmed/F-7617-2019	ZIYYAT, Ahmed/0000-0001-9724-3831; Burgio, Gaetan/0000-0002-7434-926X; Laissue, Paul/0000-0003-4180-4796; Vaiman, Daniel/0000-0002-1915-0717; Firlej, Virginie/0000-0003-4132-0695; ZIYYAT, Ahmed/0000-0001-9724-3831; Renault, Gilles/0000-0003-2273-1229	French Ministry of Research (Doctoral School Gc2ID, Universite Paris-Descartes)	French Ministry of Research (Doctoral School Gc2ID, Universite Paris-Descartes)	MV is a PhD student funded by the French Ministry of Research (Doctoral School Gc2ID, Universite Paris-Descartes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; Berbari NF, 2011, DEV BIOL, V360, P66, DOI 10.1016/j.ydbio.2011.09.001; Blois S, 2005, J IMMUNOL, V174, P1820, DOI 10.4049/jimmunol.174.4.1820; Bogdarina I, 2004, LIFE SCI, V74, P1407, DOI 10.1016/j.lfs.2003.08.017; Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800; Burgio G, 2007, GENETICS, V177, P2321, DOI 10.1534/genetics.107.078006; Clark DA, 1998, J IMMUNOL, V160, P545; CLARK DA, 1991, CRIT REV IMMUNOL, V11, P215; CLARK DA, 1994, AM J REPROD IMMUNOL, V32, P15, DOI 10.1111/j.1600-0897.1994.tb00874.x; Critchley HOD, 1996, HUM REPROD, V11, P2257; DEANESLY R, 1973, J REPROD FERTIL, V35, P183; Diao HL, 2011, BIOL REPROD, V84, P255, DOI 10.1095/biolreprod.110.086942; Dong YL, 2007, BIOL REPROD, V76, P892, DOI 10.1095/biolreprod.106.059089; DUCLOS AJ, 1995, AM J REPROD IMMUNOL, V33, P354, DOI 10.1111/j.1600-0897.1995.tb00904.x; Fogal V, 2009, ANGIOGENESIS, V12, P91, DOI 10.1007/s10456-009-9137-5; Foster FS, 2000, ULTRASOUND MED BIOL, V26, P1, DOI 10.1016/S0301-5629(99)00096-4; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaare M, 2006, MOL HUM REPROD, V12, P25, DOI 10.1093/molehr/gah255; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Laissue P, 2009, INT J DEV BIOL, V53, P623, DOI 10.1387/ijdb.082613pl; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Mercier E, 2007, NEW ENGL J MED, V357, P1984, DOI 10.1056/NEJMc071528; Norris W, 2011, PLACENTA, V32, pS182, DOI 10.1016/j.placenta.2011.01.009; Ouyang YQ, 2009, HYPERTENS PREGNANCY, V28, P56, DOI 10.1080/10641950802233064; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Philipp T, 2003, HUM REPROD, V18, P1724, DOI 10.1093/humrep/deg309; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Rey E, 2003, LANCET, V361, P901, DOI 10.1016/S0140-6736(03)12771-7; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Salim R, 2003, HUM REPROD, V18, P162, DOI 10.1093/humrep/deg030; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Stephenson MD, 2002, HUM REPROD, V17, P446, DOI 10.1093/humrep/17.2.446; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; TULPPALA M, 1993, HUM REPROD, V8, P764, DOI 10.1093/oxfordjournals.humrep.a138137; Wang ZG, 2010, BIOCHEM J, V428, P347, DOI 10.1042/BJ20100379; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Zheng K, 2010, J ANDROL, V31, P79, DOI 10.2164/jandrol.109.008193	44	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43356	10.1371/journal.pone.0043356	http://dx.doi.org/10.1371/journal.pone.0043356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916247	Green Published, Green Accepted, gold			2022-12-27	WOS:000307824300044
J	Berry, M; Wirtz, AL; Janayeva, A; Ragoza, V; Terlikbayeva, A; Amirov, B; Baral, S; Beyrer, C				Berry, Mark; Wirtz, Andrea L.; Janayeva, Assel; Ragoza, Valentina; Terlikbayeva, Assel; Amirov, Bauyrzhan; Baral, Stefan; Beyrer, Chris			Risk Factors for HIV and Unprotected Anal Intercourse among Men Who Have Sex with Men (MSM) in Almaty, Kazakhstan	PLOS ONE			English	Article							DRIVEN SAMPLING METHODOLOGY; MIDDLE-INCOME COUNTRIES; BEHAVIORAL SURVEILLANCE; INTERNATIONAL SETTINGS; EASTERN-EUROPE; EPIDEMIC	Introduction: Men who have sex with men (MSM) are at high risk for HIV infection. MSM in Central Asia, however, are not adequately studied to assess their risk of HIV transmission. Methods: This study used respondent driven sampling methods to recruit 400 MSM in Almaty, the largest city in Kazakhstan, into a cross-sectional study. Participation involved a one-time interviewer-administered questionnaire and rapid HIV screening test. Prevalence data were adjusted for respondent network size and recruitment patterns. Multivariate logistic regression was used to investigate the association between HIV and selected risk factors, and unprotected anal intercourse (UAI) and selected risk factors. Results: After respondent driven sampling (RDS) weighted analysis, 20.2% of MSM were HIV-positive, and 69.0% had unprotected sex with at least one male partner in the last 12 months. Regression analysis showed that HIV infection was associated with unprotected receptive anal sex (AOR: 2.00; 95% CI: 1.04-3.84). Having unprotected anal intercourse with male partners, a measure of HIV risk behaviors, was associated with being single (AOR: 0.38; 95% CI: 0.23-0.64); very difficult access to lubricants (AOR: 11.08; 95% CI: 4.93-24.91); STI symptoms (AOR: 3.45; 95% CI: 1.42-8.40); transactional sex (AOR: 3.21; 95% CI: 1.66-6.22); and non-injection drug use (AOR: 3.10; 95% CI: 1.51-6.36). Conclusions: This study found a high HIV prevalence among MSM in Almaty, and a population of MSM engaging in multiple high-risk behavior in Almaty. Greater access to HIV education and prevention interventions is needed to limit the HIV epidemic among MSM in Almaty.	[Berry, Mark; Wirtz, Andrea L.; Baral, Stefan; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Janayeva, Assel; Ragoza, Valentina] Amulet Publ Org, Alma Ata, Kazakhstan; [Terlikbayeva, Assel; Amirov, Bauyrzhan] Global Hlth Res Ctr Cent Asia, Alma Ata, Kazakhstan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Berry, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	mberry@jhsph.edu	Baral, Stefan/AAG-4818-2020; Baral, Stefan/D-2930-2013	Baral, Stefan/0000-0002-5482-2419; Terlikbayeva, Assel/0000-0002-4067-1998	Open Society Foundations (OSF)	Open Society Foundations (OSF)	The study in this manuscript was funded by the Open Society Foundations (OSF) (URL: www.soros.org). OSF had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Belguzhanova AKK, 2007, RESULTS SENTINEL SUR; Caceres C, 2006, SEX TRANSM INFECT, V82, pIII3, DOI 10.1136/sti.2005.019489; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; Cambiano V, 2011, CURR OPIN INFECT DIS, V24, P19, DOI 10.1097/QCO.0b013e3283422c8c; Colfax G, 2005, J URBAN HEALTH, V82, pI62, DOI 10.1093/jurban/jti025; EuroHIV, 2007, HIV AIDS SURV EUR; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Gelman A, 2007, STAT SCI, V22, P153, DOI 10.1214/088342306000000691; Goodreau SM, 2007, SEX TRANSM INFECT, V83, P458, DOI 10.1136/sti.2007.025627; Hamers FF, 2003, LANCET, V361, P1035, DOI 10.1016/S0140-6736(03)12831-0; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Kelly JA, 2003, INT J STD AIDS, V14, P361, DOI 10.1258/095646203765371231; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Thorne C, 2010, LANCET INFECT DIS, V10, P479, DOI 10.1016/S1473-3099(10)70118-3; World Health Organization, 2008, 2008 REP GLOB AIDS E	18	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43071	10.1371/journal.pone.0043071	http://dx.doi.org/10.1371/journal.pone.0043071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937013	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500029
J	Brockerhoff, EG; Suckling, DM; Kimberley, M; Richardson, B; Coker, G; Gous, S; Kerr, JL; Cowan, DM; Lance, DR; Strand, T; Zhang, AJ				Brockerhoff, Eckehard G.; Suckling, David M.; Kimberley, Mark; Richardson, Brian; Coker, Graham; Gous, Stefan; Kerr, Jessica L.; Cowan, David M.; Lance, David R.; Strand, Tara; Zhang, Aijun			Aerial Application of Pheromones for Mating Disruption of an Invasive Moth as a Potential Eradication Tool	PLOS ONE			English	Article							LIGHTBROWN APPLE MOTH; EPIPHYAS-POSTVITTANA LEPIDOPTERA; SEX-PHEROMONE; NEW-ZEALAND; TORTRICIDAE; FOREST; MANAGEMENT; DISCRIMINATION; POPULATIONS; ORCHARDS	Biological invasions can cause major ecological and economic impacts. During the early stages of invasions, eradication is desirable but tactics are lacking that are both effective and have minimal non-target effects. Mating disruption, which may meet these criteria, was initially chosen to respond to the incursion of light brown apple moth, Epiphyas postvittana (LBAM; Lepidoptera: Tortricidae), in California. The large size and limited accessibility of the infested area favored aerial application. Moth sex pheromone formulations for potential use in California or elsewhere were tested in a pine forest in New Zealand where LBAM is abundant. Formulations were applied by helicopter at a target rate of 40 g pheromone per ha. Trap catch before and after application was used to assess the efficacy and longevity of formulations, in comparison with plots treated with ground-applied pheromone dispensers and untreated control plots. Traps placed at different heights showed LBAM was abundant in the upper canopy of tall trees, which complicates control attempts. A wax formulation and polyethylene dispensers were most effective and provided trap shut-down near ground level for 10 weeks. Only the wax formulation was effective in the upper canopy. As the pheromone blend contained a behavioral antagonist for LBAM, 'false trail following' could be ruled out as a mechanism explaining trap shutdown. Therefore, 'sensory impairment' and 'masking of females' are the main modes of operation. Mating disruption enhances Allee effects which contribute to negative growth of small populations and, therefore, it is highly suitable for area-wide control and eradication of biological invaders.	[Brockerhoff, Eckehard G.; Coker, Graham; Kerr, Jessica L.] Scion, New Zealand Forest Res Inst, Christchurch, New Zealand; [Suckling, David M.] New Zealand Inst Plant & Food Res Ltd, Lincoln, New Zealand; [Kimberley, Mark; Richardson, Brian; Gous, Stefan; Strand, Tara] Scion, New Zealand Forest Res Inst, Rotorua, New Zealand; [Cowan, David M.; Lance, David R.] Anim & Plant Hlth Inspect Serv, USDA, Buzzards Bay, MA USA; [Strand, Tara] US Forest Serv, Pacific Wildland Fire Sci Lab, USDA, Seattle, WA USA; [Zhang, Aijun] ARS, Invas Insect Biocontrol & Behav Lab, USDA, Beltsville Agr Res Ctr W, Beltsville, MD USA	Scion; New Zealand Institute for Plant & Food Research Ltd; Scion; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA)	Brockerhoff, EG (corresponding author), Scion, New Zealand Forest Res Inst, Christchurch, New Zealand.	eckehard.brockerhoff@scionresearch.com	Suckling, David M/F-7005-2010; Suckling, David Maxwell/M-7730-2019; Brockerhoff, Eckehard Gustav/C-1528-2009; Richardson, Brian/B-9822-2013	Suckling, David M/0000-0001-7216-9348; Suckling, David Maxwell/0000-0001-7216-9348; Brockerhoff, Eckehard Gustav/0000-0002-5962-3208; 	United States Department of Agriculture (USDA); New Zealand government (NZ Foundation for Research, Science and Technology)	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); New Zealand government (NZ Foundation for Research, Science and Technology)	E.G.B. and D.M.S. declare having received research funds for this project from the United States Department of Agriculture (USDA) and the New Zealand government (NZ Foundation for Research, Science and Technology). The funders (in particular, USDA scientists who are listed as co-authors) contributed to the study design, aspects of the data collection, and the preparation of the manuscript. The funders had no role in the data analysis or the decision to publish.	Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; BARINAGA M, 1991, SCIENCE, V253, P1351, DOI 10.1126/science.1896843; BARTELL RJ, 1973, J INSECT PHYSIOL, V19, P845, DOI 10.1016/0022-1910(73)90156-X; BRADLEY SJ, 1995, J CHEM ECOL, V21, P745, DOI 10.1007/BF02033458; BRASIER CM, 1991, MYCOPATHOLOGIA, V115, P151, DOI 10.1007/BF00462219; Brockerhoff Eckehard G., 2010, New Zealand Journal of Forestry Science, V40, pS117; Brockerhoff EG, 2002, N Z PLANT PROTECT-SE, V55, P85, DOI 10.30843/nzpp.2002.55.3924; Carde R. T., 2007, P122, DOI 10.1017/CBO9780511752353.006; CARDE RT, 1995, ANNU REV ENTOMOL, V40, P559, DOI 10.1146/annurev.en.40.010195.003015; Carey JR, 2008, INVASION BIOL LIGHT; Clout M., 2002, TURNING TIDE ERADICA; El-Sayed AM, 2011, J CHEM ECOL, V37, P640, DOI 10.1007/s10886-011-9964-x; Fowler G., 2009, EC ANAL RISK US APPL; Holmes TP, 2009, ANN NY ACAD SCI, V1162, P18, DOI 10.1111/j.1749-6632.2009.04446.x; Liebhold A. M., 1995, FOREST SCI MONOGR, V30, P1; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Miller JR, 2010, P NATL ACAD SCI USA, V107, P22, DOI 10.1073/pnas.0908453107; Mo JH, 2006, J ECON ENTOMOL, V99, P421, DOI 10.1603/0022-0493-99.2.421; Myers JH, 1998, ANNU REV ENTOMOL, V43, P471, DOI 10.1146/annurev.ento.43.1.471; Poland TM, 2006, J FOREST, V104, P118; Richardson B, 2006, T ASABE, V49, P15, DOI 10.13031/2013.20230; ROELOFS WL, 1979, ESTABLISHING EFFICAC; Rogers DJ, 2003, N Z PLANT PROTECT-SE, V56, P168, DOI 10.30843/nzpp.2003.56.6037; RUMBO ER, 1993, J CHEM ECOL, V19, P953, DOI 10.1007/BF00992530; Sharov AA, 2002, J ECON ENTOMOL, V95, P1205, DOI 10.1603/0022-0493-95.6.1205; Simberloff D, 2003, WEED SCI, V51, P247, DOI 10.1614/0043-1745(2003)051[0247:EPIATO]2.0.CO;2; Stephens AEA, 2008, ENTOMOL EXP APPL, V127, P176, DOI 10.1111/j.1570-7458.2008.00694.x; Strand T, 2009, ECOL MODEL, V220, P640, DOI 10.1016/j.ecolmodel.2008.11.018; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; SUCKLING DM, 1992, ENVIRON ENTOMOL, V21, P949, DOI 10.1093/ee/21.5.949; Suckling DM, 1999, J CHEM ECOL, V25, P117, DOI 10.1023/A:1020893201446; Suckling DM, 1999, J CHEM ECOL, V25, P2011, DOI 10.1023/A:1021028621262; Suckling DM, 1996, ENVIRON ENTOMOL, V25, P101, DOI 10.1093/ee/25.1.101; SUCKLING DM, 1995, NEW ZEAL J CROP HORT, V23, P127, DOI 10.1080/01140671.1995.9513879; Suckling DM, 2012, J EC ENTOMO IN PRESS; Thistle HW, 2004, FOREST SCI, V50, P610; Varela LG, 2010, CALIF AGR, V64, P6, DOI 10.3733/ca.v064n01p6; Walters ML, 2000, JOINT P INT C AR WID, P201; Yamanaka T, 2009, POPUL ECOL, V51, P427, DOI 10.1007/s10144-009-0155-3	41	32	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43767	10.1371/journal.pone.0043767	http://dx.doi.org/10.1371/journal.pone.0043767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937092	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500094
J	Gandal, MJ; Nesbitt, AM; McCurdy, RM; Alter, MD				Gandal, Michael J.; Nesbitt, Addie May; McCurdy, Richard M.; Alter, Mark D.			Measuring the Maturity of the Fast-Spiking Interneuron Transcriptional Program in Autism, Schizophrenia, and Bipolar Disorder	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; PSYCHIATRIC-DISORDERS; GENE-EXPRESSION; PATERNAL AGE; SPECTRUM DISORDERS; PREFRONTAL CORTEX; NEURONS; PARVALBUMIN; DISEASE	Background: Emerging evidence suggests that fast-spiking (FS) interneurons are disrupted in multiple neuropsychiatric disorders including autism, schizophrenia, and bipolar disorder. FS cells, which are the primary source of synaptic inhibition, are critical for temporally organizing brain activity, regulating brain maturation, and modulating critical developmental periods in multiple cortical systems. Reduced expression of parvalbumin, a marker of mature FS cells, has been reported in individuals with schizophrenia and bipolar disorder and in mouse models of schizophrenia and autism. Although these results suggest that FS cells may be immature in neuropsychiatric disease, this possibility had not previously been formally assessed. Methods: This study used time-course global expression data from developing FS cells to create a maturation index that tracked with the developmental age of purified cortical FS cells. The FS cell maturation index was then applied to global gene expression data from human cortex to estimate the maturity of the FS cell developmental program in the context of various disease states. Specificity of the index for FS cells was supported by a highly significant correlation of maturation index measurements with parvalbumin expression levels that withstood correction for multiple covariates. Conclusions: Results suggest the FS cell developmental gene expression program is immature in autism, schizophrenia, and bipolar disorder. More broadly, the current study indicates that cell-type specific maturation indices can be used to measure the maturity of developmental programs even in data from mixed cell types such as those found in brain homogenates.	[Gandal, Michael J.; Nesbitt, Addie May; McCurdy, Richard M.; Alter, Mark D.] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Gandal, MJ (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	markalter1968@gmail.com	Gandal, Michael/AAE-4282-2020	Gandal, Michael/0000-0001-5800-5128	Simon's Foundation SFARI Explorer's Award [1K08MH08228-01A2]; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH080228] Funding Source: NIH RePORTER	Simon's Foundation SFARI Explorer's Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding provided by Simon's Foundation SFARI Explorer's Award 1K08MH08228-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Berghuis P, 2004, INT J DEV NEUROSCI, V22, P533, DOI 10.1016/j.ijdevneu.2004.07.012; Buchstaller J, 2004, J NEUROSCI, V24, P2357, DOI 10.1523/JNEUROSCI.4083-03.2004; Buizer-Voskamp JE, 2011, SCHIZOPHR RES, V129, P128, DOI 10.1016/j.schres.2011.03.021; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carlson GC, 2011, P NATL ACAD SCI USA, V108, pE962, DOI 10.1073/pnas.1109625108; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; DAWSON G, 1988, J AUTISM DEV DISORD, V18, P493, DOI 10.1007/BF02211869; de Geus EJC, 2010, GENOME MED, V2, DOI 10.1186/gm184; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Frye RE, 2011, PEDIATR RES, V69, p41R, DOI 10.1203/PDR.0b013e318212f16b; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Harris LW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-28; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lopez-Castroman J, 2010, SCHIZOPHR RES, V116, P184, DOI 10.1016/j.schres.2009.11.006; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; McAlonan GM, 2010, NEUROSIGNALS, V18, P129, DOI 10.1159/000321080; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Palmieri L, 2010, BBA-BIOENERGETICS, V1797, P1130, DOI 10.1016/j.bbabio.2010.04.018; Poling JS, 2006, J CHILD NEUROL, V21, P170, DOI 10.1177/08830738060210021401; Rich BA, 2007, AM J PSYCHIAT, V164, P309, DOI 10.1176/appi.ajp.164.2.309; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Saha S, 2009, SCHIZOPHR RES, V115, P130, DOI 10.1016/j.schres.2009.09.012; Scaglia F, 2010, DEV DISABIL RES REV, V16, P136, DOI 10.1002/ddrr.115; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Wang AY, 2011, ACTA NEUROPATHOL, V122, P615, DOI 10.1007/s00401-011-0881-4	35	51	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e41215	10.1371/journal.pone.0041215	http://dx.doi.org/10.1371/journal.pone.0041215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936973	Green Submitted, gold, Green Published			2022-12-27	WOS:000308225500005
J	Liu, SH; Bin Wang, K; Lan, KH; Lee, WJ; Pan, HC; Wu, SM; Peng, YC; Chen, YC; Shen, CC; Cheng, HC; Liao, KK; Sheu, ML				Liu, Shing Hwa; Bin Wang, Keh; Lan, Keng Hsin; Lee, Wen Jane; Pan, Hung Chuan; Wu, Sheng Mao; Peng, Yen Chun; Chen, Yi Ching; Shen, Chin Chang; Cheng, Hsu Chen; Liao, Ko Kaung; Sheu, Meei Ling			Calpain/SHP-1 Interaction by Honokiol Dampening Peritoneal Dissemination of Gastric Cancer in nu/nu Mice	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; ENDOTHELIAL GROWTH-FACTOR; WEIGHT NATURAL-PRODUCT; SIGNAL TRANSDUCER; TUMOR PROGRESSION; SMALL-MOLECULE; IN-VITRO; CELLS; ACTIVATION; INHIBITION	Background: Honokiol, a small-molecular weight natural product, has previously been reported to activate apoptosis and inhibit gastric tumorigenesis. Whether honokiol inhibits the angiogenesis and metastasis of gastric cancer cells remains unknown. Methodology/Principal Findings: We tested the effects of honokiol on angiogenic activity and peritoneal dissemination using in vivo, ex vivo and in vitro assay systems. The signaling responses in human gastric cancer cells, human umbilical vascular endothelial cells (HUVECs), and isolated tumors were detected and analyzed. In a xenograft gastric tumor mouse model, honokiol significantly inhibited the peritoneal dissemination detected by PET/CT technique. Honokiol also effectively attenuated the angiogenesis detected by chick chorioallantoic membrane assay, mouse matrigel plug assay, rat aortic ring endothelial cell sprouting assay, and endothelial cell tube formation assay. Furthermore, honokiol effectively enhanced signal transducer and activator of transcription (STAT-3) dephosphorylation and inhibited STAT-3 DNA binding activity in human gastric cancer cells and HUVECs, which was correlated with the up-regulation of the activity and protein expression of Src homology 2 (SH2)-containing tyrosine phosphatase-1 (SHP-1). Calpain-II inhibitor and siRNA transfection significantly reversed the honokiol-induced SHP-1 activity. The decreased STAT-3 phosphorylation and increased SHP-1 expression were also shown in isolated peritoneal metastatic tumors. Honokiol was also capable of inhibiting VEGF generation, which could be reversed by SHP-1 siRNA transfection. Conclusions/Significance: Honokiol increases expression and activity of SPH-1 that further deactivates STAT3 pathway. These findings also suggest that honokiol is a novel and potent inhibitor of angiogenesis and peritoneal dissemination of gastric cancer cells, providing support for the application potential of honokiol in gastric cancer therapy.	[Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Bin Wang, Keh] Kuang Tien Gen Hosp, Dept Nucl Med, Taichung, Taiwan; [Lan, Keng Hsin] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Lee, Wen Jane; Pan, Hung Chuan; Sheu, Meei Ling] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Peng, Yen Chun] Taichung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Taichung, Taiwan; [Shen, Chin Chang] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Shen, Chin Chang] Atom Energy Council, Inst Nucl Energy Res, Tao Yuan, Taiwan; [Liao, Ko Kaung] Chung Shan Med Univ, Dept Anat, Taichung, Taiwan; [Bin Wang, Keh; Pan, Hung Chuan; Wu, Sheng Mao; Chen, Yi Ching; Sheu, Meei Ling] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Cheng, Hsu Chen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	National Taiwan University; Taipei Veterans General Hospital; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Taiwan University; Institute of Nuclear Energy Research - Taiwan; Chung Shan Medical University; National Chung Hsing University; National Chung Hsing University	Liu, SH (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan.	mlsheu@nchu.edu.tw	Shen, Chin Chang/GXH-0183-2022; Sheu, Meei-Ling/AAT-3401-2020	Shen, Chin Chang/0000-0002-8508-8560; Sheu, Meei-Ling/0000-0002-0431-1282; Cheng, Hsu-Chen/0000-0002-6586-6425; LIU, SHING-HWA/0000-0002-9976-1197; Wu, Sheng-Mao/0000-0002-8569-5280	Taichung Veterans General Hospital, Taiwan [TCVGH-997314C, TCVGH-1007313C]; National Science Council of Taiwan [NSC99-2320-B-005-003-MY3]	Taichung Veterans General Hospital, Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Taichung Veterans General Hospital, Taiwan (TCVGH-997314C, TCVGH-1007313C) and the National Science Council of Taiwan (NSC99-2320-B-005-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Bai XH, 2003, J BIOL CHEM, V278, P35501, DOI 10.1074/jbc.M302967200; Banerjee A, 2011, J BIOL CHEM, V286, P29127, DOI 10.1074/jbc.M110.169771; Chiang CK, 2006, KIDNEY INT, V70, P682, DOI 10.1038/sj.ki.5001617; Coggeshall KM, 2002, MOL IMMUNOL, V39, P521, DOI 10.1016/S0161-5890(02)00209-2; Falet H, 1998, BIOCHEM BIOPH RES CO, V252, P51, DOI 10.1006/bbrc.1998.9593; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Fried LE, 2009, ANTIOXID REDOX SIGN, V11, P1139, DOI 10.1089/ARS.2009.2440; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gong WD, 2005, CLIN CANCER RES, V11, P1386, DOI 10.1158/1078-0432.CCR-04-0487; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kim KA, 2010, PARASITE IMMUNOL, V32, P176, DOI 10.1111/j.1365-3024.2009.01175.x; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Koyama Y, 2008, INVEST OPHTH VIS SCI, V49, P2376, DOI 10.1167/iovs.07-1067; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Liu SH, 2010, BRIT J PHARMACOL, V160, P1963, DOI 10.1111/j.1476-5381.2010.00804.x; Liu SH, 2010, CELL MOL LIFE SCI, V67, P1465, DOI 10.1007/s00018-009-0255-4; Min JK, 2004, CANCER RES, V64, P644, DOI 10.1158/0008-5472.CAN-03-3250; Munroe ME, 2007, J IMMUNOL, V179, P753, DOI 10.4049/jimmunol.179.2.753; Munroe ME, 2010, J IMMUNOL, V185, P5586, DOI 10.4049/jimmunol.1000630; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; Ohtsu A, 2006, J CLIN ONCOL, V24, P2188, DOI 10.1200/JCO.2006.05.9758; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pain S, 1999, FEBS LETT, V453, P119, DOI 10.1016/S0014-5793(99)00698-5; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Saif MW, 2010, EJSO-EUR J SURG ONC, V36, P709, DOI 10.1016/j.ejso.2010.05.023; Sako A, 2004, CANCER RES, V64, P3624, DOI 10.1158/0008-5472.CAN-04-0304; Sheu ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001096; Sheu ML, 2008, FREE RADICAL BIO MED, V44, P2043, DOI 10.1016/j.freeradbiomed.2008.03.014; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Takahashi Y, 1996, CLIN CANCER RES, V2, P1679; Tallquist MD, 1999, ONCOGENE, V18, P7917, DOI 10.1038/sj.onc.1203216; Tsui FWL, 2006, IMMUNOL RES, V35, P127, DOI 10.1385/IR:35:1:127; Vaid M, 2010, CARCINOGENESIS, V31, P2004, DOI 10.1093/carcin/bgq186; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhai H, 2003, EUR J PHARMACOL, V474, P199, DOI 10.1016/S0014-2999(03)02075-2	44	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43711	10.1371/journal.pone.0043711	http://dx.doi.org/10.1371/journal.pone.0043711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937084	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500086
J	Saunders, SE; Bartelt-Hunt, SL; Bartz, JC				Saunders, Samuel E.; Bartelt-Hunt, Shannon L.; Bartz, Jason C.			Resistance of Soil-Bound Prions to Rumen Digestion	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; IN-VITRO DIGESTION; ORAL-TRANSMISSION; INOCULUM SOURCE; SHEEP SCRAPIE; PROTEIN PRPSC; DEER; STRAIN; TRANSPORTATION; DEGRADATION	Before prion uptake and infection can occur in the lower gastrointestinal system, ingested prions are subjected to anaerobic digestion in the rumen of cervids and bovids. The susceptibility of soil-bound prions to rumen digestion has not been evaluated previously. In this study, prions from infectious brain homogenates as well as prions bound to a range of soils and soil minerals were subjected to in vitro rumen digestion, and changes in PrP levels were measured via western blot. Binding to clay appeared to protect noninfectious hamster PrPc from complete digestion, while both unbound and soil-bound infectious PrPSc proved highly resistant to rumen digestion. In addition, no change in intracerebral incubation period was observed following active rumen digestion of unbound hamster HY TME prions and HY TME prions bound to a silty clay loam soil. These results demonstrate that both unbound and soil-bound prions readily survive rumen digestion without a reduction in infectivity, further supporting the potential for soil-mediated transmission of chronic wasting disease (CWD) and scrapie in the environment.	[Saunders, Samuel E.; Bartelt-Hunt, Shannon L.] Univ Nebraska Lincoln, Peter Kiewit Inst, Dept Civil Engn, Omaha, NE USA; [Bartz, Jason C.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Nebraska System; University of Nebraska Lincoln; Creighton University	Saunders, SE (corresponding author), Stanford Law Sch, Stanford, CA USA.	sbartelt2@unl.edu		Bartz, Jason/0000-0003-4081-7886	National Science Foundation [CBET-1149242]; National Center for Research Resources [P20 RR0115635-6, C06 RR17417-01, G200RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001, C06RR017417] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Science Foundation (CBET-1149242) and the National Center for Research Resources (P20 RR0115635-6, C06 RR17417-01 and G200RR024001). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ammar H, 2008, ANIM FEED SCI TECH, V147, P90, DOI 10.1016/j.anifeedsci.2007.09.011; Balachandran A, 2010, CAN VET J, V51, P169; Bartz JC, 2007, J VIROL, V81, P689, DOI 10.1128/JVI.01751-06; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bueno ICS, 2005, ANIM FEED SCI TECH, V123, P95, DOI 10.1016/j.anifeedsci.2005.05.003; Cone JW, 2002, ANIM FEED SCI TECH, V99, P221, DOI 10.1016/S0377-8401(02)00073-1; Dagleish MP, 2010, J GEN VIROL, V91, P3116, DOI 10.1099/vir.0.025049-0; Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; FREUDENBERGER DO, 1994, BRIT J NUTR, V71, P489, DOI 10.1079/BJN19940157; Gordon IJ, 2002, CAN J ZOOL, V80, P1930, DOI 10.1139/Z02-179; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Hervas G, 2005, J SCI FOOD AGR, V85, P2495, DOI 10.1002/jsfa.2292; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; de Motes CM, 2008, VET MICROBIOL, V131, P205, DOI 10.1016/j.vetmic.2008.02.014; Mould FL, 2005, ANIM FEED SCI TECH, V123, P155, DOI 10.1016/j.anifeedsci.2005.05.002; Mould FL, 2005, ANIM FEED SCI TECH, V123, P31, DOI 10.1016/j.anifeedsci.2005.04.028; Nicholson EM, 2007, LETT APPL MICROBIOL, V44, P631, DOI 10.1111/j.1472-765X.2007.02124.x; Prusiner Stanley B., 2004, PRION BIOL DIS, P1; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Race B, 2009, J VIROL, V83, P9608, DOI 10.1128/JVI.01127-09; RUSELERVANEMBDEN JGH, 1985, FEMS MICROBIOL LETT, V28, P341, DOI 10.1016/0378-1097(85)90107-7; Rymer C, 2005, ANIM FEED SCI TECH, V123, P9, DOI 10.1016/j.anifeedsci.2005.04.055; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Saunders SE, 2008, ENVIRON SCI TECHNOL, V42, P6573, DOI 10.1021/es800590k; Saunders SE, 2012, CHEMOSPHERE, V87, P661, DOI 10.1016/j.chemosphere.2011.12.076; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Saunders SE, 2011, APPL ENVIRON MICROB, V77, P4313, DOI 10.1128/AEM.00421-11; Saunders SE, 2011, J VIROL, V85, P5476, DOI 10.1128/JVI.00282-11; Saunders SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018752; Saunders SE, 2010, ENVIRON SCI TECHNOL, V44, P4129, DOI 10.1021/es903520d; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P7728, DOI 10.1021/es901385t; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P5242, DOI 10.1021/es900502f; Scherbel C, 2007, ZOONOSES PUBLIC HLTH, V54, P185, DOI 10.1111/j.1863-2378.2007.01040.x; Scherbel C, 2006, VET RES, V37, P695, DOI 10.1051/vetres:2006024; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; van Keulen LJM, 2008, VET RES, V39, DOI 10.1051/vetres:2007061; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748	44	11	11	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e44051	10.1371/journal.pone.0044051	http://dx.doi.org/10.1371/journal.pone.0044051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937149	gold, Green Published			2022-12-27	WOS:000308225500136
J	Grynberg, D; Chang, B; Corneille, O; Maurage, P; Vermeulen, N; Berthoz, S; Luminet, O				Grynberg, Delphine; Chang, Betty; Corneille, Olivier; Maurage, Pierre; Vermeulen, Nicolas; Berthoz, Sylvie; Luminet, Olivier			Alexithymia and the Processing of Emotional Facial Expressions (EFEs): Systematic Review, Unanswered Questions and Further Perspectives	PLOS ONE			English	Review							ANTERIOR CINGULATE CORTEX; SOCIAL ANXIETY; AFFECT RECOGNITION; NEURAL SYSTEMS; INDIVIDUAL-DIFFERENCES; RECOGNIZING FEAR; FUSIFORM GYRUS; ITEM SELECTION; BRAIN; PERCEPTION	Alexithymia is characterized by difficulties in identifying, differentiating and describing feelings. A high prevalence of alexithymia has often been observed in clinical disorders characterized by low social functioning. This review aims to assess the association between alexithymia and the ability to decode emotional facial expressions (EFEs) within clinical and healthy populations. More precisely, this review has four main objectives: (1) to assess if alexithymia is a better predictor of the ability to decode EFEs than the diagnosis of clinical disorder; (2) to assess the influence of comorbid factors (depression and anxiety disorder) on the ability to decode EFE; (3) to investigate if deficits in decoding EFEs are specific to some levels of processing or task types; (4) to investigate if the deficits are specific to particular EFEs. Twenty four studies (behavioural and neuroimaging) were identified through a computerized literature search of Psycinfo, PubMed, and Web of Science databases from 1990 to 2010. Data on methodology, clinical characteristics, and possible confounds were analyzed. The review revealed that: (1) alexithymia is associated with deficits in labelling EFEs among clinical disorders, (2) the level of depression and anxiety partially account for the decoding deficits, (3) alexithymia is associated with reduced perceptual abilities, and is likely to be associated with impaired semantic representations of emotional concepts, and (4) alexithymia is associated with neither specific EFEs nor a specific valence. These studies are discussed with respect to processes involved in the recognition of EFEs. Future directions for research on emotion perception are also discussed.	[Grynberg, Delphine; Chang, Betty; Corneille, Olivier; Maurage, Pierre; Vermeulen, Nicolas] Catholic Univ Louvain, Res Inst Psychol Sci, B-1348 Louvain, Belgium; [Berthoz, Sylvie] Univ Paris Descartes & Paris Sud, Inserm U669, Paris, France; [Berthoz, Sylvie] Inst Mutualiste Montsouris, Paris, France; [Luminet, Olivier] Catholic Univ Louvain, Res Inst Psychol Sci, B-1348 Louvain, Belgium	Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain	Grynberg, D (corresponding author), Catholic Univ Louvain, Res Inst Psychol Sci, B-1348 Louvain, Belgium.	Delphine.Grynberg@uclouvain.be	Berthoz Landron, Sylvie/M-4517-2018; Grynberg, Delphine/K-6853-2019	Grynberg, Delphine/0000-0002-4588-4116; Corneille, Olivier/0000-0003-4005-4372; Maurage, Pierre/0000-0003-0197-0810; /0000-0001-8966-6148; Berthoz, Sylvie/0000-0002-6862-2362	Belgian National Funds for Scientific Research (FNRS-FRS) [1.1233.09]	Belgian National Funds for Scientific Research (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS)	This review was supported by grant 1.1233.09 from the Belgian National Funds for Scientific Research (FNRS-FRS) to Delphine Grynberg (Research Fellow). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Alpers GW, 2011, INT J PSYCHOPHYSIOL, V80, P173, DOI 10.1016/j.ijpsycho.2011.01.010; Atkinson AP, 2007, COGNITION, V104, P59, DOI 10.1016/j.cognition.2006.05.005; Austin EJ, 2004, PERS INDIV DIFFER, V36, P1855, DOI 10.1016/j.paid.2003.07.006; Bagby M.., 1997, DISORDERS AFFECT REG, P26, DOI [10.1017/cbo9780511526831.005, DOI 10.1017/CBO9780511526831.005]; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bagby RM, 2006, PSYCHOTHER PSYCHOSOM, V75, P25, DOI 10.1159/000089224; Baldaro B, 2003, INT J OBESITY, V27, P191, DOI 10.1038/sj.ijo.802228; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Berthoz S, 1999, EUR PSYCHIAT, V14, P372, DOI 10.1016/S0924-9338(99)00233-3; Berthoz S., 2011, OXFORD HDB SOCIAL NE, P906, DOI DOI 10.1093/OXFORDHB/9780195342161.013.0060; Berthoz S, 2008, CAN J PSYCHIAT, V53, P469, DOI 10.1177/070674370805300712; Bird G, 2011, J AUTISM DEV DISORDE; Blair RJR, 2001, J ABNORM CHILD PSYCH, V29, P491, DOI 10.1023/A:1012225108281; Bolte S, 2006, BEHAV NEUROSCI, V120, P211, DOI 10.1037/0735-7044.120.1.211; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bryson S. E., 2000, AUTISM, V4, P117, DOI [DOI 10.1177/1362361300004002002, 10.1177/1362361300004002002]; Budell L, 2010, NEUROIMAGE, V53, P355, DOI 10.1016/j.neuroimage.2010.05.037; Bydlowski S, 2005, INT J EAT DISORDER, V37, P321, DOI 10.1002/eat.20132; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Carton JS, 1999, J NONVERBAL BEHAV, V23, P91, DOI 10.1023/A:1021339410262; Casebeer WD, 2003, NAT REV NEUROSCI, V4, P840, DOI 10.1038/nrn1223; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Combs DR, 2007, SCHIZOPHR RES, V91, P112, DOI 10.1016/j.schres.2006.12.010; Cooney RE, 2006, PSYCHIAT RES-NEUROIM, V148, P55, DOI 10.1016/j.pscychresns.2006.05.003; Costa A, 2007, J INT NEUROPSYCH SOC, V13, P980, DOI 10.1017/S1355617707071329; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; De Waal MWM, 2004, BRIT J PSYCHIAT, V184, P470, DOI 10.1192/bjp.184.6.470; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Dinges DF, 2005, AVIAT SPACE ENVIR MD, V76, pB172; Duan XJ, 2010, NEUROIMAGE, V52, P401, DOI 10.1016/j.neuroimage.2010.04.021; Duncan S, 2007, TRENDS COGN SCI, V11, P190, DOI 10.1016/j.tics.2007.01.007; Dziobek I, 2010, ARCH GEN PSYCHIAT, V67, P397, DOI 10.1001/archgenpsychiatry.2010.31; Eichmann M, 2008, PERCEPT MOTOR SKILL, V107, P915, DOI 10.2466/PMS.107.3.915-922; Eizaguirre AE, 2004, PERS INDIV DIFFER, V36, P321, DOI 10.1016/S0191-8869(03)00099-0; Ekman P., 1976, PICTURES FACIAL AFFE; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Evren B, 2007, J CLIN PSYCHOL MED S, V14, P258, DOI 10.1007/s10880-007-9072-9; Fitzgerald M, 2004, AM J PSYCHIAT, V161, P2134, DOI 10.1176/appi.ajp.161.11.2134; Foa EB, 2000, J ANXIETY DISORD, V14, P501, DOI 10.1016/S0887-6185(00)00036-0; Franz M, 2008, SOC PSYCH PSYCH EPID, V43, P54, DOI 10.1007/s00127-007-0265-1; Fukunishi I, 1997, COMPR PSYCHIAT, V38, P166, DOI 10.1016/S0010-440X(97)90070-5; Fusar-Poli P, 2009, NEUROSCI LETT, V452, P262, DOI 10.1016/j.neulet.2009.01.065; Galderisi S, 2008, PSYCHOTHER PSYCHOSOM, V77, P182, DOI 10.1159/000119738; Gery I, 2009, PSYCHIAT RES, V165, P252, DOI 10.1016/j.psychres.2007.11.006; Godart NT, 2003, PSYCHIAT RES, V117, P245, DOI 10.1016/S0165-1781(03)00038-6; Godart NT, 2000, EUR PSYCHIAT, V15, P38, DOI 10.1016/S0924-9338(00)00212-1; Goodwin RD, 2002, INT J EAT DISORDER, V32, P103, DOI 10.1002/eat.10051; Grynberg D, 2010, PERS INDIV DIFFER, V49, P845, DOI 10.1016/j.paid.2010.07.013; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Guttman H, 2002, COMPR PSYCHIAT, V43, P448, DOI 10.1053/comp.2002.35905; Han SH, 2008, HUM BRAIN MAPP, V29, P945, DOI 10.1002/hbm.20439; Harnad S., 1987, CATEGORICAL PERCEPTI, P29; Harvey A., 2004, COGNITIVE BEHAV PROC; Haviland MG, 2000, PSYCHOSOMATICS, V41, P385, DOI 10.1176/appi.psy.41.5.385; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heinzel A, 2010, PSYCHOTHER PSYCHOSOM, V79, P363, DOI 10.1159/000320121; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Iacobini M, 2005, PERSPECTIVES IMITATI; Isaacowitz DM, 2007, PSYCHOL AGING, V22, P147, DOI 10.1037/0882-7974.22.1.147; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Jansch C, 2009, EAT BEHAV, V10, P184, DOI 10.1016/j.eatbeh.2009.06.001; Jessimer M, 1997, BRAIN COGNITION, V34, P246, DOI 10.1006/brcg.1997.0900; Kamachi M, 2001, PERCEPTION, V30, P875, DOI 10.1068/p3131; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Katsyri J, 2008, NEUROPSYCHOLOGIA, V46, P1888, DOI 10.1016/j.neuropsychologia.2008.01.005; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Kessler H, 2006, INT J EAT DISORDER, V39, P245, DOI 10.1002/eat.20228; Kessler H, 2002, VERHALTENSTHERAPIE V, V23, P297; Koelkebeck K, 2010, SCHIZOPHR RES, V119, P115, DOI 10.1016/j.schres.2009.12.015; KRYSTAL JH, 1986, PSYCHOSOM MED, V48, P84, DOI 10.1097/00006842-198601000-00007; Kucharska-Pietura K, 2004, INT J EAT DISORDER, V35, P42, DOI 10.1002/eat.10219; Kugel H, 2008, NEUROSCI LETT, V435, P40, DOI 10.1016/j.neulet.2008.02.005; Kuusikko S, 2008, J AUTISM DEV DISORD, V38, P1697, DOI 10.1007/s10803-008-0555-9; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; LANE RD, 1995, NEUROPSYCHOLOGIA, V33, P525, DOI 10.1016/0028-3932(94)00131-8; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Lecours S, 2009, EUR REV APPL PSYCHOL, V59, P187, DOI 10.1016/j.erap.2009.03.001; Legenbauer T, 2008, J CLIN PSYCHOL, V64, P687, DOI 10.1002/jclp.20483; Lemche E, 2008, BRIT J PSYCHIAT, V193, P222, DOI 10.1192/bjp.bp.107.044263; Louth SM, 1998, CAN J BEHAV SCI, V30, P91, DOI 10.1037/h0085809; Luminet O, 2001, PSYCHOTHER PSYCHOSOM, V70, P254, DOI 10.1159/000056263; Luminet O, 2006, J RES PERS, V40, P713, DOI 10.1016/j.jrp.2005.09.001; Lumley MA, 1996, J PSYCHOSOM RES, V41, P505, DOI 10.1016/S0022-3999(96)00222-X; Lundh LG, 1996, BEHAV RES THER, V34, P787, DOI 10.1016/0005-7967(96)00035-6; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; Machin GC, 2009, PERS INDIV DIFFER, V46, P412, DOI 10.1016/j.paid.2008.11.010; MANN LS, 1995, PERCEPT MOTOR SKILL, V81, P35, DOI 10.2466/pms.1995.81.1.35; MANN LS, 1994, PSYCHOL REP, V74, P563, DOI 10.2466/pr0.1994.74.2.563; Marsh AA, 2007, EMOTION, V7, P239, DOI 10.1037/1528-3542.7.2.239; MATSUMOTO D, 1989, MOTIV EMOTION, V13, P143, DOI 10.1007/BF00992959; MAYER JD, 1990, J PERS ASSESS, V54, P772, DOI 10.1207/s15327752jpa5403&4_29; MCDONALD PW, 1990, PSYCHOSOM MED, V52, P199, DOI 10.1097/00006842-199003000-00007; McDonald S, 2002, AWARENESS SOCIAL INF; McLellan T, 2008, ACTA NEUROPSYCHIATR, V20, P236, DOI 10.1111/j.1601-5215.2008.00315.x; Meriau K, 2006, NEUROIMAGE, V33, P1016, DOI 10.1016/j.neuroimage.2006.07.031; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Moll J, 2009, NEUROSCI BIOBEHAV R, V33, P456, DOI 10.1016/j.neubiorev.2008.12.001; Montagne B, 2005, PERS INDIV DIFFER, V38, P5, DOI 10.1016/j.paid.2004.02.008; Montebarocci O, 2010, PSYCHIAT Q; Moriguchi Y, 2006, NEUROIMAGE, V32, P1472, DOI 10.1016/j.neuroimage.2006.04.186; Naranjo C, 2011, J AFFECT DISORDERS, V128, P243, DOI 10.1016/j.jad.2010.06.039; Nemiah J.C., 1976, MODERN TRENDS PSYCHO, P430, DOI DOI 10.1016/J.IJNURSTU.2009.03.014; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Oatley K., 1987, COGNITION EMOTION, V1, P29, DOI [10.1080/02699938708408362, DOI 10.1080/02699938708408362]; Pandey R, 1997, BRIT J CLIN PSYCHOL, V36, P631, DOI 10.1111/j.2044-8260.1997.tb01269.x; Paradiso S, 2008, AM J GERIAT PSYCHIAT, V16, P760, DOI 10.1097/JGP.0b013e31817e73b0; Parker PD, 2005, J PERS, V73, P1087, DOI 10.1111/j.1467-6494.2005.00339.x; Patel Salil H, 2005, Int J Med Sci, V2, P147; Patterson JC, 2002, NEUROIMAGE, V17, P1797, DOI 10.1006/nimg.2002.1306; Pedrosa Gil Francisco, 2009, Depress Anxiety, V26, pE26, DOI 10.1002/da.20456; Pichon S, 2009, NEUROIMAGE, V47, P1873, DOI 10.1016/j.neuroimage.2009.03.084; Pollatos O, 2008, PSYCHOSOM MED, V70, P701, DOI 10.1097/PSY.0b013e31817e41e6; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Reker M, 2010, CORTEX, V46, P658, DOI 10.1016/j.cortex.2009.05.008; Ridout N, 2010, EAT BEHAV, V11, P1, DOI 10.1016/j.eatbeh.2009.07.008; Roedema TM, 1999, PSYCHOPHYSIOLOGY, V36, P379, DOI 10.1017/S0048577299980290; Rossignol M, 2005, NEUROSCI LETT, V377, P115, DOI 10.1016/j.neulet.2004.11.091; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Seitz RJ, 2008, NEUROSCIENCE, V152, P713, DOI 10.1016/j.neuroscience.2007.10.066; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; SIFNEOS PE, 1975, PSYCHOTHER PSYCHOSOM, V26, P65, DOI 10.1159/000286912; Silani G, 2008, SOC NEUROSCI-UK, V3, P97, DOI 10.1080/17470910701577020; Silver H, 2004, PSYCHIAT RES, V128, P147, DOI 10.1016/j.psychres.2004.06.002; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sinha R, 1996, COGNITION EMOTION, V10, P173, DOI 10.1080/026999396380321; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Suslow T, 2001, CAH PSYCHOL COGN, V20, P297; Suwazono S, 2000, CLIN NEUROPHYSIOL, V111, P29, DOI 10.1016/S1388-2457(99)00186-8; Swart M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005751; Taylor G.J., 1997, DISORDERS AFFECT REG; TAYLOR GJ, 1985, PSYCHOTHER PSYCHOSOM, V44, P191, DOI 10.1159/000287912; Taylor GJ, 2000, CAN J PSYCHIAT, V45, P134, DOI 10.1177/070674370004500203; Taylor SF, 2000, NEUROPSYCHOLOGIA, V38, P1415, DOI 10.1016/S0028-3932(00)00032-4; TRANEL D, 1994, PSYCHOPHYSIOLOGY, V31, P427, DOI 10.1111/j.1469-8986.1994.tb01046.x; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; van der Meer L, 2009, PSYCHIAT RES, V170, P108, DOI 10.1016/j.psychres.2009.07.010; Vanheule S, 2007, J CLIN PSYCHOL, V63, P109, DOI 10.1002/jclp.20324; Vermeulen N, 2006, COGNITION EMOTION, V20, P64, DOI 10.1080/02699930500304654; Vermeulen N, 2008, COGNITION EMOTION; Vermeulen N, 2007, EUR J PERSONALITY, V21, P359, DOI 10.1002/per.621; Vermeulen N, 2009, PERS INDIV DIFFER, V47, P305, DOI 10.1016/j.paid.2009.03.018; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Vrana SR, 2004, BIOL PSYCHOL, V66, P63, DOI 10.1016/j.biopsycho.2003.07.004; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518	156	183	192	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42429	10.1371/journal.pone.0042429	http://dx.doi.org/10.1371/journal.pone.0042429			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GE	22927931	Green Published, gold, Green Submitted			2022-12-27	WOS:000308224700006
J	Shi, M; Huang, WZ; Lin, L; Zheng, DY; Zuo, Q; Wang, L; Wang, NN; Wu, YJ; Liao, YL; Liao, WJ				Shi, Min; Huang, Weizhen; Lin, Li; Zheng, Dayong; Zuo, Qiang; Wang, Lin; Wang, Nina; Wu, Yajun; Liao, Yulin; Liao, Wangjun			Silencing of XB130 Is Associated with Both the Prognosis and Chemosensitivity of Gastric Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; ADAPTER PROTEIN; GROWTH-FACTOR; EXPRESSION; ONCOGENE; INVASION; P53	XB130 is a newly characterized adaptor protein that was reported to promote thyroid tumor growth, but its role in the progression of other kinds of cancer such as gastric cancer (GC) remains unknown. Accordingly, we investigated the association between XB130 expression and the prognosis of GC patients. The subjects were 411 patients with GC in stages I to IV. XB130 expression was examined in surgical specimens of GC. Kaplan-Meier analysis and the Cox proportional hazards model were used to assess the prognostic significance of XB130 for survival and recurrence. Moreover, GC cells stably transfected with XB130 short hairpin RNA were established to analyze the effect of XB130 on sensitivity of chemotherapy. The results show that both XB130 mRNA and protein expression were detectable in normal gastric tissues. The overall survival time of stage IV patients and the disease-free period after radical resection of GC in stage I-III patients were significantly shorter when immunohistochemical staining for XB130 was low than when staining was high (both p < 0.05). XB130 expression also predicted tumor sensitivity to several chemotherapy agents. Viability of both XB130-silenced SGC7901 cells and wild-type cells was suppressed by 5-fluorouracil (5-FU), cisplatin, and irinotecan in a dose-dependent way, but cisplatin and irinotecan were more sensitive against sXB130-silenced GC cells and 5-FU showed higher sensitivity to wild-type cells. When treated by 5-FU, patients with high expression of XB130 tumors had a higher survival rate than those with low expression tumors. These findings indicate that reduced XB130 protein expression is a prognostic biomarker for shorter survival and a higher recurrence rate in patients with GC, as well as for the response to chemotherapy.	[Shi, Min; Huang, Weizhen; Lin, Li; Zheng, Dayong; Zuo, Qiang; Wang, Lin; Wang, Nina; Wu, Yajun; Liao, Wangjun] So Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Liao, Yulin] So Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Liao, WJ (corresponding author), So Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China.	Liao18@msn.com; nfyyliaowj@163.com	Liao, Yulin/AAP-6315-2021	Wangjun, Liao/0000-0002-1364-8442	National Program on Key Basic Research Project [2012CB945100]; Natural Science Foundation of Guangdong Province, China [S2011030003134]	National Program on Key Basic Research Project(National Basic Research Program of China); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Program on Key Basic Research Project (2012CB945100, to WL and YL), the Team Program of Natural Science Foundation of Guangdong Province, China (S2011030003134, to WL and YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; DAMM K, 1993, FASEB J, V7, P904, DOI 10.1096/fasebj.7.10.8102105; Feng CW, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-8; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; Kos FT, 2011, CHEMOTHERAPY, V57, P230, DOI 10.1159/000327840; Kossatz U, 2007, CELL RES, V17, P832, DOI 10.1038/cr.2007.86; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Lodyga M, 2010, J CELL SCI, V123, P4156, DOI 10.1242/jcs.071050; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Montagnani F, 2011, GASTRIC CANCER, V14, P50, DOI 10.1007/s10120-011-0007-7; Murai T, 2006, BIOCHEM J, V395, P65, DOI 10.1042/BJ20050582; Pan WS, 2003, J SURG ONCOL, V82, P104, DOI 10.1002/jso.10204; Shiozaki Atsushi, 2011, J Clin Bioinforma, V1, P10, DOI 10.1186/2043-9113-1-10; Shiozaki A, 2011, AM J PATHOL, V178, P391, DOI 10.1016/j.ajpath.2010.11.024; Takiuchi H, 2011, GASTRIC CANCER, V14, P1, DOI 10.1007/s10120-011-0018-4; Testino G, 2002, PANMINERVA MED, V44, P369; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yamanaka D, 2012, MOL ENDOCRINOL, V26, P1043, DOI 10.1210/me.2011-1349; Zhang J, 2010, FUTURE ONCOL, V6, P587, DOI [10.2217/fon.10.15, 10.2217/FON.10.15]	19	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e41660	10.1371/journal.pone.0041660	http://dx.doi.org/10.1371/journal.pone.0041660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927913	Green Submitted, Green Published, gold			2022-12-27	WOS:000308224700003
J	Grenier, JG; Millet, GY; Peyrot, N; Samozino, P; Oullion, R; Messonnier, L; Morin, JB				Grenier, Jordane G.; Millet, Guillaume Y.; Peyrot, Nicolas; Samozino, Pierre; Oullion, Roger; Messonnier, Laurent; Morin, Jean-Benoit			Effects of Extreme-Duration Heavy Load Carriage on Neuromuscular Function and Locomotion: A Military-Based Study	PLOS ONE			English	Article							CONTRACTILE PROPERTIES; ENERGY-EXPENDITURE; QUADRICEPS FATIGUE; MECHANICAL WORK; WALKING; EXERCISE; SPEED; COST; GAIT; PERFORMANCE	Trekking and military missions generally consist of carrying heavy loads for extreme durations. These factors have been separately shown to be sources of neuromuscular (NM) fatigue and locomotor alterations. However, the question of their combined effects remains unresolved, and addressing this issue required a representative context. Purpose: The aim was to investigate the effects of extreme-duration heavy load carriage on NM function and walking characteristics. Methods: Ten experienced infantrymen performed a 21-h simulated military mission (SMM) in a middle-mountain environment with equipment weighing similar to 27 kg during battles and similar to 43 kg during marches. NM function was evaluated for knee extensors (KE) and plantar flexors (PF) pre- and immediately post-SMM using isometric maximal voluntary contraction (MVC) measurement, neural electrical stimulation and surface EMG. The twitch-interpolation method was used to assess central fatigue. Peripheral changes were examined by stimulating the muscle in the relaxed state. The energy cost, mechanical work and spatio-temporal pattern of walking were also evaluated pre-/post-SMM on an instrumented treadmill in three equipment conditions: Sportswear, Battle and March. Results: After the SMM, MVC declined by -10.2 +/- 3.6% for KE (P<0.01) and -10.7 +/- 16.1% for PF (P = 0.06). The origin of fatigue was essentially peripheral for both muscle groups. A trend toward low-frequency fatigue was detected for KE (5.5%, P = 0.08). These moderate NM alterations were concomitant with a large increase in perceived fatigue from pre-(rating of 8.3 +/- 2.2) to post-SMM (15.9 +/- 2.1, P<0.01). The SMM-related fatigue did not alter walking energetics or mechanics, and the different equipment carried on the treadmill did not interact with this fatigue either. Conclusion: this study reports the first data on physiological and biomechanical consequences of extreme-duration heavy load carriage. Unexpectedly, NM function alterations due to the 21-h SMM were moderate and did not alter walking characteristics.	[Grenier, Jordane G.; Millet, Guillaume Y.; Morin, Jean-Benoit] Univ Lyon, Exercise Physiol Lab, EA4338, St Etienne, Reunion, France; [Grenier, Jordane G.] Sagem, Safran Grp, Land Warfare, Massy, France; [Peyrot, Nicolas] Univ La Reunion, UFR SHE, CURAPS, DIMPS,EA4075, St Denis, Reunion, France; [Samozino, Pierre; Messonnier, Laurent] Univ Savoie, Exercise Physiol Lab, EA4338, Le Bourget Du Lac, France; [Oullion, Roger] Bellevue Hosp, Sports Med & Myol Unit, Univ Hosp Ctr, St Etienne, Reunion, France	Safran S.A.; University of La Reunion; Universite de Savoie; CHU de St Etienne	Grenier, JG (corresponding author), Univ Lyon, Exercise Physiol Lab, EA4338, St Etienne, Reunion, France.	jordane.grenier@gmail.com	Millet, Guillaume/AAO-6520-2020; Samozino, Pierre/R-1927-2019	Millet, Guillaume/0000-0002-6395-0762; Morin, Jean-Benoit/0000-0003-3808-6762				Ainslie PN, 2005, SPORTS MED, V35, P619, DOI 10.2165/00007256-200535070-00006; Ament W, 2009, SPORTS MED, V39, P389, DOI 10.2165/00007256-200939050-00005; Bastien GJ, 2005, EUR J APPL PHYSIOL, V94, P76, DOI 10.1007/s00421-004-1286-z; Bastien GJ, 2003, J EXP BIOL, V206, P2967, DOI 10.1242/jeb.00494; Beekley MD, 2007, MIL MED, V172, P592, DOI 10.7205/MILMED.172.6.592; Belli A, 2001, J BIOMECH, V34, P105, DOI 10.1016/S0021-9290(00)00125-1; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Birrell SA, 2008, ERGONOMICS, V51, P816, DOI 10.1080/00140130701811859; Bisiaux M, 2008, GAIT POSTURE, V28, P693, DOI 10.1016/j.gaitpost.2008.05.009; Blacker SD, 2010, AVIAT SPACE ENVIR MD, V81, P745, DOI 10.3357/ASEM.2659.2010; Booth CK., 2003, ASIA PACIFIC J CLIN, V12, pS2; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; CAVAGNA GA, 1975, J APPL PHYSIOL, V39, P174, DOI 10.1152/jappl.1975.39.1.174; CAVAGNA GA, 1963, J APPL PHYS, V18, P1; Clarke HH, 1955, RES QUART, V26, P253, DOI 10.1080/10671188.1955.10616440; Cohen J.E., 1988, STAT POWER ANAL BEHA; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Feasson L, 2002, J PHYSIOL-LONDON, V543, P297, DOI 10.1113/jphysiol.2002.018689; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gefen A, 2002, MED BIOL ENG COMPUT, V40, P302, DOI 10.1007/BF02344212; Grenier JG, 2012, MED SCI SPORT EXER, V44, P1131, DOI 10.1249/MSS.0b013e3182456057; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; Henning PC, 2011, MIL MED, V176, P991, DOI 10.7205/MILMED-D-11-00053; Jones DA, 1996, ACTA PHYSIOL SCAND, V156, P265, DOI 10.1046/j.1365-201X.1996.192000.x; Knapik J, 1996, APPL ERGON, V27, P207, DOI 10.1016/0003-6870(96)00013-0; Knapik JJ, 2012, J STRENGTH COND RES, V26, P585, DOI 10.1519/JSC.0b013e3182429853; Knicker AJ, 2011, SPORTS MED, V41, P307, DOI 10.2165/11586070-000000000-00000; Martin V, 2005, J SPORT MED PHYS FIT, V45, P143; Martin V, 2010, J APPL PHYSIOL, V108, P1224, DOI 10.1152/japplphysiol.01202.2009; Millet GY, 2011, EUR J APPL PHYSIOL, V111, P2489, DOI 10.1007/s00421-011-1996-y; Millet GY, 2011, SPORTS MED, V41, P489, DOI 10.2165/11588760-000000000-00000; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Millet GY, 2002, J APPL PHYSIOL, V92, P486, DOI 10.1152/japplphysiol.00122.2001; Morin JB, 2011, J BIOMECH, V44, P1104, DOI 10.1016/j.jbiomech.2011.01.028; Morin JB, 2011, MED SCI SPORT EXER, V43, P829, DOI 10.1249/MSS.0b013e3181fec518; Murdock GH, 2012, EUR J APPL PHYSIOL, V112, P439, DOI 10.1007/s00421-011-1990-4; Nindl BC, 2002, MED SCI SPORT EXER, V34, P1814, DOI 10.1097/00005768-200211000-00019; Pal MS, 2009, INT J IND ERGONOM, V39, P68, DOI 10.1016/j.ergon.2008.05.002; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Parijat P, 2008, GAIT POSTURE, V28, P568, DOI 10.1016/j.gaitpost.2008.04.001; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Qu XD, 2011, J BIOMECH, V44, P1259, DOI 10.1016/j.jbiomech.2011.02.016; RODGERS CD, 1995, SLEEP, V18, P30, DOI 10.1093/sleep/18.1.30; Schepens B, 2004, J EXP BIOL, V207, P587, DOI 10.1242/jeb.00793; Simpson KM, 2011, J ELECTROMYOGR KINES, V21, P782, DOI 10.1016/j.jelekin.2011.05.012; Stolwijk NM, 2010, MED SCI SPORT EXER, V42, P2264, DOI 10.1249/MSS.0b013e3181e305f4; Verges S, 2009, J APPL PHYSIOL, V106, P701, DOI 10.1152/japplphysiol.01051.2007; Wang H, 2012, MIL MED, V177, P152, DOI 10.7205/MILMED-D-11-00210; Weeks SR, 2010, PM&R, V2, P438, DOI 10.1016/j.pmrj.2010.03.023	51	21	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43586	10.1371/journal.pone.0043586	http://dx.doi.org/10.1371/journal.pone.0043586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927995	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300068
J	Ni, M; Martire, D; Scotet, E; Bonneville, M; Sanchez, F; Lafont, V				Ni, Ming; Martire, Delphine; Scotet, Emmanuel; Bonneville, Marc; Sanchez, Francoise; Lafont, Virginie			Full Restoration of Brucella-Infected Dendritic Cell Functionality through V gamma 9V delta 2 T Helper Type 1 Crosstalk	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CYTOKINE PRODUCTION; IN-VITRO; MATURATION; SUIS; LYMPHOCYTES; ACTIVATION; CARCINOMA; ANTIGEN; IMMUNOTHERAPY	V gamma 9V delta 2 T cells play an important role in the immune response to infectious agents but the mechanisms contributing to this immune process remain to be better characterized. Following their activation, V gamma 9V delta 2 T cells develop cytotoxic activity against infected cells, secrete large amounts of cytokines and influence the function of other effectors of immunity, notably cells playing a key role in the initiation of the adaptive immune response such as dendritic cells. Brucella infection dramatically impairs dendritic cell maturation and their capacity to present antigens to T cells. Herein, we investigated whether V T cells have the ability to restore the full functional capacities of Brucella-infected dendritic cells. Using an in vitro multicellular infection model, we showed that: 1/Brucella-infected dendritic cells activate V gamma 9V delta 2 T cells through contact-dependent mechanisms, 2/activated V gamma 9V delta 2 T cells induce full differentiation into IL-12 producing cells of Brucella-infected dendritic cells with functional antigen presentation activity. Furthermore, phosphoantigen-activated V gamma 9V delta 2 T cells also play a role in triggering the maturation process of dendritic cells already infected for 24 h. This suggests that activated V gamma 9V delta 2 T cells could be used to modulate the outcome of infectious diseases by promoting an adjuvant effect in dendritic cell-based cellular therapies.	[Ni, Ming; Martire, Delphine; Sanchez, Francoise; Lafont, Virginie] Univ Montpellier I, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France; [Ni, Ming; Martire, Delphine; Sanchez, Francoise; Lafont, Virginie] CNRS, UMR 5236, CPBS, F-34965 Montpellier, France; [Ni, Ming; Martire, Delphine; Sanchez, Francoise; Lafont, Virginie] Univ Montpellier 2, CPBS, F-34095 Montpellier, France; [Scotet, Emmanuel; Bonneville, Marc] Univ Nantes, INSERM, Unite Mixte Rech 892, Ctr Rech Canc Nantes Angers,Inst Rech Therapeut, Nantes, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Ni, M (corresponding author), Univ Montpellier I, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France.	virginie.lafont@cpbs.cnrs.fr	SCOTET, Emmanuel/AAC-9971-2019; SCOTET, Emmanuel/L-2576-2015; Lafont, Virginie/R-9356-2017	SCOTET, Emmanuel/0000-0001-8010-9556; SCOTET, Emmanuel/0000-0001-8010-9556; Lafont, Virginie/0000-0001-9612-3934	CNRS; Universites de Montpellier 1 and 2; Infectiopole fund	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universites de Montpellier 1 and 2; Infectiopole fund	This work was supported by CNRS, Universites de Montpellier 1 and 2 and the Infectiopole fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atluri VL, ANN REV MICROBIOL, V65, P523; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bennouna J, 2008, CANCER IMMUNOL IMMUN, V57, P1599, DOI 10.1007/s00262-008-0491-8; Billard E, 2005, INFECT IMMUN, V73, P8418, DOI 10.1128/IAI.73.12.8418-8424.2005; Billard E, 2007, INFECT IMMUN, V75, P4980, DOI 10.1128/IAI.00637-07; Bonneville M, NAT REV IMMUNOL, V10, P467; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Devilder MC, 2006, J IMMUNOL, V176, P1386, DOI 10.4049/jimmunol.176.3.1386; Dieli F, 2001, J INFECT DIS, V184, P1082, DOI 10.1086/323600; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dudal S, 2006, J IMMUNOL, V177, P5533, DOI 10.4049/jimmunol.177.8.5533; Dunne MR, CANC IMMUNOL IMMUNOT, V59, P1109; Hanekom WA, 2003, J INFECT DIS, V188, P257, DOI 10.1086/376451; HOLOSHITZ J, 1993, INT IMMUNOL, V5, P1437, DOI 10.1093/intimm/5.11.1437; Ismaili J, 2002, CLIN IMMUNOL, V103, P296, DOI 10.1006/clim.2002.5218; Jomaa H, 1999, FEMS IMMUNOL MED MIC, V25, P371, DOI 10.1111/j.1574-695X.1999.tb01362.x; Kobayashi H, 2007, CANCER IMMUNOL IMMUN, V56, P469, DOI 10.1007/s00262-006-0199-6; Kunzmann V, 1999, NEW ENGL J MED, V340, P737, DOI 10.1056/NEJM199903043400914; Kunzmann V, 2000, BLOOD, V96, P384; Lafont V, 2001, J BIOL CHEM, V276, P15961, DOI 10.1074/jbc.M008684200; Mattarollo SR, 2007, CANCER IMMUNOL IMMUN, V56, P1285, DOI 10.1007/s00262-007-0279-2; Meraviglia S, 2010, J IMMUNOL, V185, P1770, DOI 10.4049/jimmunol.1000966; Morel Y, 2001, J IMMUNOL, V167, P2479, DOI 10.4049/jimmunol.167.5.2479; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Oliaro J, 2005, J LEUKOCYTE BIOL, V77, P652, DOI 10.1189/jlb.0704433; Ottones F, 2000, J IMMUNOL, V165, P7133, DOI 10.4049/jimmunol.165.12.7133; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Sicard H, 2000, INFECT IMMUN, V68, P4375, DOI 10.1128/IAI.68.8.4375-4377.2000; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Thompson K, 2004, J BONE MINER RES, V19, P278, DOI 10.1359/JBMR.0301230; Viey E, 2005, J IMMUNOL, V174, P1338, DOI 10.4049/jimmunol.174.3.1338; Wurtzen PA, 2001, SCAND J IMMUNOL, V53, P579, DOI 10.1046/j.1365-3083.2001.00910.x	36	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43613	10.1371/journal.pone.0043613	http://dx.doi.org/10.1371/journal.pone.0043613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928003	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300073
J	Passalacqua, KD; Varadarajan, A; Weist, C; Ondov, BD; Byrd, B; Read, TD; Bergman, NH				Passalacqua, Karla D.; Varadarajan, Anjana; Weist, Charlotte; Ondov, Brian D.; Byrd, Benjamin; Read, Timothy D.; Bergman, Nicholas H.			Strand-Specific RNA-Seq Reveals Ordered Patterns of Sense and Antisense Transcription in Bacillus anthracis	PLOS ONE			English	Article							GENE-EXPRESSION; ESCHERICHIA-COLI; GENOME SEQUENCE; STERNE 34F(2); ORGANIZATION; SUBTILIS; GROWTH; ESSENTIALITY; REPLICATION; INHIBITION	Background: Although genome-wide transcriptional analysis has been used for many years to study bacterial gene expression, many aspects of the bacterial transcriptome remain undefined. One example is antisense transcription, which has been observed in a number of bacteria, though the function of antisense transcripts, and their distribution across the bacterial genome, is still unclear. Methodology/Principal Findings: Single-stranded RNA-seq results revealed a widespread and non-random pattern of antisense transcription covering more than two thirds of the B. anthracis genome. Our analysis revealed a variety of antisense structural patterns, suggesting multiple mechanisms of antisense transcription. The data revealed several instances of sense and antisense expression changes in different growth conditions, suggesting that antisense transcription may play a role in the ways in which B. anthracis responds to its environment. Significantly, genome-wide antisense expression occurred at consistently higher levels on the lagging strand, while the leading strand showed very little antisense activity. Intrasample gene expression comparisons revealed a gene dosage effect in all growth conditions, where genes farthest from the origin showed the lowest overall range of expression for both sense and antisense directed transcription. Additionally, transcription from both strands was verified using a novel strand-specific assay. The variety of structural patterns we observed in antisense transcription suggests multiple mechanisms for this phenomenon, suggesting that some antisense transcription may play a role in regulating the expression of key genes, while some may be due to chromosome replication dynamics and transcriptional noise. Conclusions/Significance: Although the variety of structural patterns we observed in antisense transcription suggest multiple mechanisms for antisense expression, our data also clearly indicate that antisense transcription may play a genome-wide role in regulating the expression of key genes in Bacillus species. This study illustrates the surprising complexity of prokaryotic RNA abundance for both strands of a bacterial chromosome.	[Passalacqua, Karla D.; Varadarajan, Anjana; Weist, Charlotte; Ondov, Brian D.; Byrd, Benjamin; Bergman, Nicholas H.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Ondov, Brian D.; Bergman, Nicholas H.] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA; [Passalacqua, Karla D.; Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Passalacqua, Karla D.; Read, Timothy D.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Emory University; Emory University	Passalacqua, KD (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	bergmann@nbacc.net	Passalacqua, Karla/AAU-8156-2021	Read, Timothy/0000-0001-8966-9680; Passalacqua, Karla/0000-0002-2672-3261	Georgia Institute of Technology	Georgia Institute of Technology	This work was supported by internal funding from the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; Carlson PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006988; Carninci P, 2010, DNA RES, V17, P51, DOI 10.1093/dnares/dsq006; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Chatterjee A, 2011, P NATL ACAD SCI US; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Dawid A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025007; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Francis AW, 2005, BBA-PROTEINS PROTEOM, V1748, P191, DOI 10.1016/j.bbapap.2005.01.007; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Gut IM, 2008, ANTIMICROB AGENTS CH, V52, P4281, DOI 10.1128/AAC.00625-08; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Kim J, 2009, CELL MOL LIFE SCI, V66, P3127, DOI 10.1007/s00018-009-0067-6; Koehler TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/j.mam.2009.07.004; Lei JZ, 2009, J THEOR BIOL, V256, P485, DOI 10.1016/j.jtbi.2008.10.028; Lindberg J, 2010, GENOMICS, V95, P1, DOI 10.1016/j.ygeno.2009.08.010; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; Martin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S10; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ondov BD, 2008, BIOINFORMATICS, V24, P2776, DOI 10.1093/bioinformatics/btn512; Passalacqua KD, 2007, J BACTERIOL, V189, P3996, DOI 10.1128/JB.00185-07; Passalacqua KD, 2006, J BACTERIOL, V188, P3837, DOI 10.1128/JB.00239-06; Passalacqua KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004904; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Ravel J, 2009, J BACTERIOL, V191, P445, DOI 10.1128/JB.01347-08; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Rocha EPC, 2004, CURR OPIN MICROBIOL, V7, P519, DOI 10.1016/j.mib.2004.08.006; Rocha EPC, 2003, NUCLEIC ACIDS RES, V31, P6570, DOI 10.1093/nar/gkg859; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; RONG JC, 1994, J BACTERIOL, V176, P5218, DOI 10.1128/JB.176.17.5218-5224.1994; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang MX, 2008, J THEOR BIOL, V253, P271, DOI 10.1016/j.jtbi.2008.03.023; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x	54	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43350	10.1371/journal.pone.0043350	http://dx.doi.org/10.1371/journal.pone.0043350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937038	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300045
J	Sriram, K; Rodriguez-Fernandez, M; Doyle, FJ				Sriram, K.; Rodriguez-Fernandez, Maria; Doyle, Francis J., III			A Detailed Modular Analysis of Heat-Shock Protein Dynamics under Acute and Chronic Stress and Its Implication in Anxiety Disorders	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HSF1; STIRRED-TANK REACTOR; MULTISITE PHOSPHORYLATION; DUAL PHOSPHORYLATION; MOLECULAR CHAPERONE; REGULATORY NETWORKS; SYSTEMS BIOLOGY; GENE-EXPRESSION; HSP90; ACTIVATION	Physiological and psychological stresses cause anxiety disorders such as depression and post-traumatic stress disorder (PTSD) and induce drastic changes at a molecular level in the brain. To counteract this stress, the heat-shock protein (HSP) network plays a vital role in restoring the homeostasis of the system. To study the stress-induced dynamics of heat-shock network, we analyzed three modules of the HSP90 network-namely trimerization reactions, phosphorylation-dephosphorylation reactions, and the conversion of HSP90 from an open to a closed conformation-and constructed a corresponding nonlinear differential equation model based on mass action kinetics laws. The kinetic parameters of the model were obtained through global optimization, and sensitivity analyses revealed that the most sensitive parameters are the kinase and phosphatase that drive the phosphorylation-dephosphorylation reactions. Bifurcation analysis carried out with the estimated kinetic parameters of the model with stress as bifurcation parameter revealed the occurrence of "mushroom", a type of complex dynamics in which S-shaped and Z-shaped hysteretic bistable forms are present together. We mapped the molecular events responsible for generating the mushroom dynamics under stress and interpreted the occurrence of the S-shaped hysteresis to a normal level of stress, and the Z-shaped hysteresis to the HSP90 variations under acute and chronic stress in the fear conditioned system, and further, we hypothesized that this can be extended to stress-related disorders such as depression and PTSD in humans. Finally, we studied the effect of parameter variations on the mushroom dynamics to get insight about the role of phosphorylation-dephosphorylation parameters in HSP90 network in bringing about complex dynamics such as isolas, where the stable steady states in a bistable system are isolated and separated from each other and not connected by an unstable steady state.	[Sriram, K.; Rodriguez-Fernandez, Maria; Doyle, Francis J., III] Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA; [Sriram, K.; Rodriguez-Fernandez, Maria; Doyle, Francis J., III] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Sriram, K.] IIIT, Delhi, India	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Indraprastha Institute of Information Technology Delhi	Sriram, K (corresponding author), Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA.	doyle@engineering.ucsb.edu	Rodriguez-Fernandez, Maria/I-7193-2016; Rodriguez-Fernandez, Maria/AAF-7049-2021	Rodriguez-Fernandez, Maria/0000-0003-1966-2920; Rodriguez-Fernandez, Maria/0000-0003-1966-2920	Institute for Collaborative Biotechnologies through the U.S. Army Research Office [W911NF-10-2-0111, W911NF-09-D-0001]	Institute for Collaborative Biotechnologies through the U.S. Army Research Office	The authors gratefully acknowledge the financial support from the Institute for Collaborative Biotechnologies through the U.S. Army Research Office (Grants W911NF-10-2-0111 and W911NF-09-D-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abravaya K, 1991, GENE DEV, V5, P2177; Association AP, 2000, DIAGNOSTIC STAT MANU, V4; BALAKOTAIAH V, 1987, P ROY SOC LOND A MAT, V411, P193, DOI 10.1098/rspa.1987.0061; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Conde R, 2005, J BIOL CHEM, V280, P28989, DOI 10.1074/jbc.M503594200; DANNA A, 1986, P ROY SOC LOND A MAT, V403, P341, DOI 10.1098/rspa.1986.0015; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Egea JA, 2007, J GLOBAL OPTIM, V37, P481, DOI 10.1007/s10898-006-9075-3; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; GASS P, 1994, NEUROSCI LETT, V182, P188, DOI 10.1016/0304-3940(94)90794-3; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; GRAY P, 1983, CHEM ENG SCI, V38, P29, DOI 10.1016/0009-2509(83)80132-8; Gupta S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-8; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; JACQUEZ JA, 1985, MATH BIOSCI, V77, P201, DOI 10.1016/0025-5564(85)90098-7; Kapuy O, 2009, PROG BIOPHYS MOL BIO, V100, P47, DOI 10.1016/j.pbiomolbio.2009.06.004; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Liberzon I., 2009, POSTTRAUMATIC STRESS, P219; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mayer MP, 2009, NAT STRUCT MOL BIOL, V16, P2, DOI 10.1038/nsmb0109-2; Mei B, 2005, BRAIN RES BULL, V67, P1, DOI 10.1016/j.brainresbull.2005.03.023; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Mizera A, 2010, J THEOR BIOL, V265, P455, DOI 10.1016/j.jtbi.2010.04.029; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Neckers L, 2009, NAT STRUCT MOL BIOL, V16, P235, DOI 10.1038/nsmb0309-235; Peper A, 1998, INT J HYPERTHER, V14, P97, DOI 10.3109/02656739809018218; Peters A, 2007, AM J PHYSIOL-REG I, V293, pR83, DOI 10.1152/ajpregu.00907.2006; Rieger TR, 2006, BIOPHYS J, V90, P886, DOI 10.1529/biophysj.105.066662; Rieger TR, 2005, BIOPHYS J, V88, P1646, DOI 10.1529/biophysj.104.055301; Rodriguez-Fernandez M, 2010, BIOINFORMATICS, V26, P1675, DOI 10.1093/bioinformatics/btq242; Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236; Sirri A, 2010, BRAIN RES, V1308, P14, DOI 10.1016/j.brainres.2009.10.049; Song H, 2006, BIOPHYS J, V90, P2309, DOI 10.1529/biophysj.105.074500; Sriram K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002379; Szymanska Z, 2009, J THEOR BIOL, V259, P562, DOI 10.1016/j.jtbi.2009.03.021; Thomas R, 1998, INT J DEV BIOL, V42, P479; Thomas R, 1981, SPRINGER SERIES SYNE, V9, P180; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Xia WL, 1997, J BIOL CHEM, V272, P4094, DOI 10.1074/jbc.272.7.4094; Yehuda R, 2005, HANDB EXP PHARM, V169, P371; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yehuda R, 2004, BIOL PSYCHIAT, V55, P1110, DOI 10.1016/j.biopsych.2004.02.010; Yehuda R, 2004, AM J PSYCHIAT, V161, P1397, DOI 10.1176/appi.ajp.161.8.1397; YEHUDA R, 1991, BIOL PSYCHIAT, V30, P1031, DOI 10.1016/0006-3223(91)90123-4; Yehuda R, 1996, BIOL PSYCHIAT, V40, P79, DOI 10.1016/0006-3223(95)00451-3; YEHUDA R, 1995, ARCH GEN PSYCHIAT, V52, P583; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83; Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zak DE, 2003, GENOME RES, V13, P2396, DOI 10.1101/gr.1198103; Zhang L, 2010, HEAT SHOCK PROTEINS, V5, P179, DOI 10.1007/978-90-481-3381-9_11; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; Zumsande M, 2010, J THEOR BIOL, V265, P481, DOI 10.1016/j.jtbi.2010.04.025	64	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42958	10.1371/journal.pone.0042958	http://dx.doi.org/10.1371/journal.pone.0042958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937003	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300031
J	Chiu, CH; Chou, CW; Takada, S; Liu, YW				Chiu, Chih-Hao; Chou, Chih-Wei; Takada, Shinji; Liu, Yi-Wen			Development and Fibronectin Signaling Requirements of the Zebrafish Interrenal Vessel	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FETAL ADRENAL-GLAND; EXTRACELLULAR-MATRIX COMPONENTS; BASEMENT-MEMBRANE; CELL BEHAVIOR; COLLAGEN-IV; EXPRESSION; IDENTIFICATION; LAMININ; SITE	Background: The early morphogenetic steps of zebrafish interrenal tissue, the teleostean counterpart of the mammalian adrenal gland, are modulated by the peri-interrenal angioblasts and blood vessels. While an organized distribution of intra-adrenal vessels and extracellular matrix is essential for the fetal adrenal cortex remodeling, whether and how an intra-interrenal buildup of vasculature and extracellular matrix forms and functions during interrenal organogenesis in teleosts remains unclear. Methodology and Principal Findings: We characterized the process of interrenal gland vascularization by identifying the interrenal vessel (IRV); which develops from the axial artery through angiogenesis and is associated with highly enriched Fibronectin (Fn) accumulation at its microenvironment. The loss of Fn1 by either antisense morpholino (MO) knockdown or genetic mutation inhibited endothelial invasion and migration of the steroidogenic tissue. The accumulation of peri-IRV Fn requires Integrin alpha 5 (Itga5), with its knockdown leading to interrenal and IRV morphologies phenocopying those in the fn1 morphant and mutant. fn1b, another known fn gene in zebrafish, is however not involved in the IRV formation. The distribution pattern of peri-IRV Fn could be modulated by the blood flow, while a lack of which altered angiogenic direction of the IRV as well as its ability to integrate with the steroidogenic tissue. The administration of Fn antagonist through microangiography exerted reducing effects on both interrenal vessel angiogenesis and steroidogenic cell migration. Conclusions and Significance: This work is the first to identify the zebrafish IRV and to characterize how its integration into the developing interrenal gland requires the Fn-enriched microenvironment, which leads to the possibility of using the IRV formation as a platform for exploring organ-specific angiogenesis. In the context of other developmental endocrinology studies, our results indicate a highly dynamic interrenal-vessel interaction immediately before the onset of stress response in the zebrafish embryo.	[Chiu, Chih-Hao; Chou, Chih-Wei; Liu, Yi-Wen] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Takada, Shinji] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Takada, Shinji] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Okazaki, Aichi, Japan	Tunghai University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Chiu, CH (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	dlslys@thu.edu.tw		Liu, Yi-Wen/0000-0003-0455-1013; Takada, Shinji/0000-0003-4125-6056	National Science Council (R.O.C) [96-2628-B-029-002-MY3, 99-2311-B-029-001, 99-2632-B-029-001-MY3, 100-2313-B-029-001, 100-2321-B-400-003]; Grants-in-Aid for Scientific Research [24111002, 23370094] Funding Source: KAKEN	National Science Council (R.O.C); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Science Council (R.O.C) grants (96-2628-B-029-002-MY3, 99-2311-B-029-001, 99-2632-B-029-001-MY3, 100-2313-B-029-001 and 100-2321-B-400-003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; BRESLOW MJ, 1992, AM J PHYSIOL, V262, pH1317, DOI 10.1152/ajpheart.1992.262.5.H1317; Chai C, 2003, DEV BIOL, V260, P226, DOI 10.1016/S0012-1606(03)00219-7; Chamoux E, 2005, BRAZ J MED BIOL RES, V38, P1495, DOI 10.1590/S0100-879X2005001000006; Chamoux E, 2002, ENDOCR RES, V28, P637, DOI 10.1081/ERC-120016978; Chamoux E, 2002, J CLIN ENDOCR METAB, V87, P1819, DOI 10.1210/jc.87.4.1819; Chamoux E, 2001, J CLIN ENDOCR METAB, V86, P2090, DOI 10.1210/jc.86.5.2090; Chou CW, 2010, DEV DYNAM, V239, P1995, DOI 10.1002/dvdy.22335; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Farhadian F, 1996, CARDIOVASC RES, V32, P433, DOI 10.1016/S0008-6363(96)00119-8; Garavito-Aguilar ZV, 2010, DEVELOPMENT, V137, P3215, DOI 10.1242/dev.052225; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; Heikkila P, 2000, ENDOCR RES, V26, P867, DOI 10.3109/07435800009048610; Hsu HJ, 2003, DEVELOPMENT, V130, P2107, DOI 10.1242/dev.00427; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ishimoto H, 2006, J CLIN ENDOCR METAB, V91, P1909, DOI 10.1210/jc.2005-2252; Ishimoto H, 2008, J CLIN ENDOCR METAB, V93, P2402, DOI 10.1210/jc.2007-2509; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Julich D, 2009, DEVELOPMENT, V136, P2913, DOI 10.1242/dev.038935; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; LINASK KK, 1986, DEV BIOL, V114, P87, DOI 10.1016/0012-1606(86)90385-4; Liu YW, 2006, DEV BIOL, V297, P44, DOI 10.1016/j.ydbio.2006.04.464; Liu Yi-Wen, 2007, Organogenesis, V3, P44; Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x; Milano EG, 1997, GEN COMP ENDOCR, V108, P483, DOI 10.1006/gcen.1997.7005; Miralem T, 2001, ONCOGENE, V20, P5511, DOI 10.1038/sj.onc.1204753; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Otis M, 2007, J ENDOCRINOL, V193, P331, DOI 10.1677/JOE-07-0055; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Pitynski K, 1996, ANN ANAT, V178, P215, DOI 10.1016/S0940-9602(96)80050-1; Pollard SM, 2006, DEV BIOL, V289, P64, DOI 10.1016/j.ydbio.2005.10.006; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Santoro MM, 2009, MECH DEVELOP, V126, P638, DOI 10.1016/j.mod.2009.06.1080; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Shifren JL, 1998, J CLIN ENDOCR METAB, V83, P1342, DOI 10.1210/jc.83.4.1342; Snow CJ, 2008, DEV DYNAM, V237, P2542, DOI 10.1002/dvdy.21670; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; To TT, 2007, MOL ENDOCRINOL, V21, P472, DOI 10.1210/me.2006-0216; Trinh LA, 2004, DEV CELL, V6, P371; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; Yin CY, 2010, DEV CELL, V18, P973, DOI 10.1016/j.devcel.2010.05.009; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	54	17	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43040	10.1371/journal.pone.0043040	http://dx.doi.org/10.1371/journal.pone.0043040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22937010	Green Submitted, Green Published, gold			2022-12-27	WOS:000307789700020
J	Liu, Q; Collin, RWJ; Cremers, FPM; den Hollander, AI; van den Born, LI; Pierce, EA				Liu, Qin; Collin, Rob W. J.; Cremers, Frans P. M.; den Hollander, Anneke I.; van den Born, L. Ingeborgh; Pierce, Eric A.			Expression of Wild-Type Rp1 Protein in Rp1 Knock-in Mice Rescues the Retinal Degeneration Phenotype	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; GENE-THERAPY; RNA SURVEILLANCE; MUTANT RHODOPSIN; TRANSGENIC MICE; MOUSE MODEL; MUTATIONS; FAMILIES; VISION	Mutations in the retinitis pigmentosa 1 (RP1) gene are a common cause of autosomal dominant retinitis pigmentosa (adRP), and have also been found to cause autosomal recessive RP (arRP) in a few families. The 33 dominant mutations and 6 recessive RP1 mutations identified to date are all nonsense or frameshift mutations, and almost exclusively (38 out of 39) are located in the 4th and final exon of RP1. To better understand the underlying disease mechanisms of and help develop therapeutic strategies for RP1 disease, we performed a series of human genetic and animal studies using gene targeted and transgenic mice. Here we report that a frameshift mutation in the 3rd exon of RP1 (c.686delC; p.P229QfsX35) found in a patient with recessive RP1 disease causes RP in the homozygous state, whereas the heterozygous carriers are unaffected, confirming that haploinsufficiency is not the causative mechanism for RP1 disease. We then generated Rp1 knock-in mice with a nonsense Q662X mutation in exon 4, as well as Rp1 transgenic mice carrying a wild-type BAC Rp1 transgene. The Rp1-Q662X allele produces a truncated Rp1 protein, and homozygous Rp1-Q662X mice experience a progressive photoreceptor degeneration characterized disorganization of photoreceptor outer segments. This phenotype could be prevented by expression of a normal amount of Rp1 protein from the BAC transgene without removal of the mutant Rp1-Q662X protein. Over-expression of Rp1 protein in additional BAC Rp1 transgenic lines resulted in retinal degeneration. These findings suggest that the truncated Rp1-Q662X protein does not exert a toxic gain-of-function effect. These results also imply that in principle gene augmentation therapy could be beneficial for both recessive and dominant RP1 patients, but the levels of RP1 protein delivered for therapy will have to be carefully controlled.	[Liu, Qin; Pierce, Eric A.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Ocular Genom Inst, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA; [Collin, Rob W. J.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Collin, Rob W. J.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Collin, Rob W. J.; Cremers, Frans P. M.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [van den Born, L. Ingeborgh] Rotterdam Eye Hosp, Rotterdam, Netherlands	Harvard University; Massachusetts Eye & Ear Infirmary; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Rotterdam Eye Hospital	Liu, Q (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Ocular Genom Inst, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA.	eric_pierce@meei.harvard.edu	Collin, Rob/N-3575-2014; Cremers, Frans/A-5625-2014; Hollander, Anneke den/N-4911-2014	Cremers, Frans/0000-0002-4954-5592; Pierce, Eric/0000-0002-2354-4102	NIH [EY12910]; Foundation Fighting Blindness USA; F.M. Kirby Foundation; Research to Prevent Blindness; Rosanne Silbermann Foundation; Mackall Foundation Trust; Stichting Wetenschappelijk; Onderzoek Oogziekenhuis Rotterdam Prof. dr. H.J. Flieringa Foundation, Rotterdam, the Netherlands [2005-13]; Netherlands Organisation for Scientific Research [91209047]; NATIONAL EYE INSTITUTE [R01EY012910] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness USA; F.M. Kirby Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Rosanne Silbermann Foundation; Mackall Foundation Trust; Stichting Wetenschappelijk; Onderzoek Oogziekenhuis Rotterdam Prof. dr. H.J. Flieringa Foundation, Rotterdam, the Netherlands; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by grants from the NIH (EY12910 to EAP), the Foundation Fighting Blindness USA (EAP, QL), the F.M. Kirby Foundation, Research to Prevent Blindness, Rosanne Silbermann Foundation (EAP), the Mackall Foundation Trust, Stichting Wetenschappelijk, Onderzoek Oogziekenhuis Rotterdam Prof. dr. H.J. Flieringa Foundation (grant 2005-13 to LIvdB, AIdH and FPMC), Rotterdam, the Netherlands, and the Netherlands Organisation for Scientific Research (ZonMw Topsubsidy grant 91209047 to FPMC and AIdH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Baum L, 2001, Hum Mutat, V17, P436, DOI 10.1002/humu.1127; Berson EL, 2001, INVEST OPHTH VIS SCI, V42, P2217; Bowne SJ, 1999, HUM MOL GENET, V8, P2121, DOI 10.1093/hmg/8.11.2121; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Chadderton N, 2009, MOL THER, V17, P593, DOI 10.1038/mt.2008.301; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chapple JP, 2001, TRENDS MOL MED, V7, P414, DOI 10.1016/S1471-4914(01)02103-7; Cheeseman I. M., 2005, SCI STKE, V2005, P11; Chen LJ, 2010, INVEST OPHTH VIS SCI, V51, P2236, DOI 10.1167/iovs.09-4437; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Collin RWJ, 2011, INVEST OPHTH VIS SCI, V52, P2227, DOI 10.1167/iovs.10-6185; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dietrich K, 2002, BRIT J OPHTHALMOL, V86, P328, DOI 10.1136/bjo.86.3.328; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Gamundi MJ, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-35; Gao JG, 2002, P NATL ACAD SCI USA, V99, P5698, DOI 10.1073/pnas.042122399; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gorbatyuk M, 2007, VISION RES, V47, P1202, DOI 10.1016/j.visres.2006.11.026; Gorbatyuk MS, 2008, ADV EXP MED BIOL, V613, P107, DOI 10.1007/978-0-387-74904-4_11; Guillonneau X, 1999, HUM MOL GENET, V8, P1541, DOI 10.1093/hmg/8.8.1541; Haider NB, 2002, HUM MOL GENET, V11, P1195, DOI 10.1093/hmg/11.10.1195; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jacobson SG, 2000, INVEST OPHTH VIS SCI, V41, P1898; Kawamura M, 2004, AM J OPHTHALMOL, V137, P1137, DOI 10.1016/j.ajo.2003.12.037; Khaliq S, 2005, J MED GENET, V42, P436, DOI 10.1136/jmg.2004.024281; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; Liu Q, 2009, INVEST OPHTH VIS SCI, V50, P1566, DOI 10.1167/iovs.08-2776; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Michaelson D, 2006, METHOD ENZYMOL, V406, P296, DOI 10.1016/S0076-6879(06)06022-8; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nagy A., 2003, MANIPULATING MOUSE E; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; Nour M, 2008, ADV EXP MED BIOL, V613, P129, DOI 10.1007/978-0-387-74904-4_14; O'Reilly M, 2007, AM J HUM GENET, V81, P127, DOI 10.1086/519025; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Payne A, 2000, INVEST OPHTH VIS SCI, V41, P4069; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2264, DOI 10.1167/iovs.04-1280; Roberts L, 2006, MOL VIS, V12, P177; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Saliba RS, 2002, J CELL SCI, V115, P2907; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Singh HP, 2009, INVEST OPHTH VIS SCI, V50, P4065, DOI 10.1167/iovs.09-3479; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Sullivan LS, 1999, NAT GENET, V22, P255, DOI 10.1038/10314; Tam LCS, 2008, HUM MOL GENET, V17, P2084, DOI 10.1093/hmg/ddn107; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Veitia RA, 2009, J PATHOL, V218, P409, DOI 10.1002/path.2583; Wilson JH, 2003, MOL NEUROBIOL, V28, P149, DOI 10.1385/MN:28:2:149; Xu L, 2006, EUR J OPHTHALMOL, V16, P865; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797; Ziviello C, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.031682	75	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43251	10.1371/journal.pone.0043251	http://dx.doi.org/10.1371/journal.pone.0043251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927954	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700029
J	Imanian, B; Pombert, JF; Dorrell, RG; Burki, F; Keeling, PJ				Imanian, Behzad; Pombert, Jean-Francois; Dorrell, Richard G.; Burki, Fabien; Keeling, Patrick J.			Tertiary Endosymbiosis in Two Dinotoms Has Generated Little Change in the Mitochondrial Genomes of Their Dinoflagellate Hosts and Diatom Endosymbionts	PLOS ONE			English	Article							SP-NOV DINOPHYCEAE; PERIDINIUM-BALTICUM; BINUCLEATE DINOFLAGELLATE; MOLECULAR-BIOLOGY; SOUTH-AFRICA; EVOLUTION; SEQUENCE; PLASTIDS; ULTRASTRUCTURE; NUCLEOMORPH	Background: Mitochondria or mitochondrion-derived organelles are found in all eukaryotes with the exception of secondary or tertiary plastid endosymbionts. In these highly reduced systems, the mitochondrion has been lost in all cases except the diatom endosymbionts found in a small group of dinoflagellates, called 'dinotoms', the only cells with two evolutionarily distinct mitochondria. To investigate the persistence of this redundancy and its consequences on the content and structure of the endosymbiont and host mitochondrial genomes, we report the sequences of these genomes from two dinotoms. Methodology/Principal Findings: The endosymbiont mitochondrial genomes of Durinskia baltica and Kryptoperidinium foliaceum exhibit nearly identical gene content with other diatoms, and highly conserved gene order (nearly identical to that of the raphid pennate diatom Fragilariopsis cylindrus). These two genomes are differentiated from other diatoms' by the fission of nad11 and by an insertion within nad2, in-frame and unspliced from the mRNA. Durinskia baltica is further distinguished from K. foliaceum by two gene fusions and its lack of introns. The host mitochondrial genome in D. baltica encodes cox1 and cob plus several fragments of LSU rRNA gene in a hugely expanded genome that includes numerous pseudogenes, and a trans-spliced cox3 gene, like in other dinoflagellates. Over 100 distinct contigs were identified through 454 sequencing, but intact full-length genes for cox1, cob and the 59 exon of cox3 were present as a single contig each, suggesting most of the genome is pseudogenes. The host mitochondrial genome of K. foliaceum was difficult to identify, but fragments of all the three protein-coding genes, corresponding transcripts, and transcripts of several LSU rRNA fragments were all recovered. Conclusions/Significance: Overall, the endosymbiont and host mitochondrial genomes in the two dinotoms have changed surprisingly little from those of free-living diatoms and dinoflagellates, irrespective of their long coexistence side by side in dinotoms.	[Imanian, Behzad; Pombert, Jean-Francois; Dorrell, Richard G.; Burki, Fabien; Keeling, Patrick J.] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada	Canadian Institute for Advanced Research (CIFAR); University of British Columbia	Imanian, B (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada.	pkeeling@mail.ubc.ca	Burki, Fabien/F-4818-2010; Dorrell, Richard G/I-8908-2012; Imanian, Behzad/CAJ-3190-2022	Dorrell, Richard G/0000-0001-6263-9115; Imanian, Behzad/0000-0002-8768-0453; Keeling, Patrick/0000-0002-7644-0745; Pombert, Jean-Francois/0000-0002-3449-8375; Burki, Fabien/0000-0002-8248-8462	Natural Sciences and Engineering Research Council of Canada (NSERC) [227301]; NSERC; Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec	This work was supported by a grant [227301] from the Natural Sciences and Engineering Research Council of Canada (NSERC). BI is supported by a doctoral scholarship from NSERC and J-FP by a Louis-Berlinguet Postdoctoral Fellowship from the Fonds Quebecois de la Recherche sur la Nature et les Technologies/Genome Quebec. PJK is a Fellow of the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Archibald JM, 2007, BIOESSAYS, V29, P392, DOI 10.1002/bies.20551; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; CHESNICK JM, 1987, BIOSYSTEMS, V21, P69, DOI 10.1016/0303-2647(87)90007-4; CHESNICK JM, 1989, AM J BOT, V76, P1060, DOI 10.2307/2444528; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; COX ER, 1976, J PHYCOL, V12, P21; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DODGE JD, 1971, PROTOPLASMA, V73, P145, DOI 10.1007/BF01275591; Ehara M, 2000, CURR GENET, V37, P29; Feagin JE, 1997, NUCLEIC ACIDS RES, V25, P438, DOI 10.1093/nar/25.2.438; Figueroa RI, 2009, PROTIST, V160, P285, DOI 10.1016/j.protis.2008.12.003; Gabrielsen TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019132; Gilson PR, 2006, P NATL ACAD SCI USA, V103, P9566, DOI 10.1073/pnas.0600707103; Gilson PR, 2002, GENETICA, V115, P13, DOI 10.1023/A:1016011812442; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Greenwood A. D., 1974, 8 INT C ELECT MICROS, P566; HORIGUCHI T, 1991, BOT MAR, V34, P123, DOI 10.1515/botm.1991.34.2.123; HORIGUCHI T, 1994, EUR J PHYCOL, V29, P237, DOI 10.1080/09670269400650691; Imanian B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-172; Imanian B, 2007, J EUKARYOT MICROBIOL, V54, P146, DOI 10.1111/j.1550-7408.2007.00245.x; Imanian B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010711; Jackson CJ, 2012, GENOME BIOL EVOL, V4, P59, DOI 10.1093/gbe/evr122; Jackson CJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-41; JEFFREY SW, 1976, J PHYCOL, V12, P450, DOI 10.1111/j.1529-8817.1976.tb02872.x; Kamikawa R, 2009, PROTIST, V160, P364, DOI 10.1016/j.protis.2009.02.003; Kaneko T, 1996, DNA Res, V3, P109; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lane CE, 2006, MOL BIOL EVOL, V23, P856, DOI 10.1093/molbev/msj066; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; Nash EA, 2007, MOL BIOL EVOL, V24, P1528, DOI 10.1093/molbev/msm074; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Norman JE, 2001, J MOL EVOL, V53, P351, DOI 10.1007/s002390010225; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Pienaar RN, 2007, J PLANT RES, V120, P247, DOI 10.1007/s10265-006-0047-y; Ravin NV, 2010, CURR GENET, V56, P215, DOI 10.1007/s00294-010-0293-3; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Secq MPOL, 2011, GENE, V476, P20, DOI 10.1016/j.gene.2011.02.001; Secq MPO, 2006, CURR GENET, V49, P47, DOI 10.1007/s00294-005-0031-4; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Takano Y, 2008, PHYCOLOGIA, V47, P41, DOI 10.2216/07-36.1; Tamura M, 2005, J PHYCOL, V41, P658, DOI 10.1111/j.1529-8817.2005.00085.x; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; TIPPIT DH, 1976, J CELL SCI, V21, P273; TOMAS RN, 1973, J PHYCOL, V9, P304; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; Zhang HA, 2005, J EUKARYOT MICROBIOL, V52, P538, DOI 10.1111/j.1550-7408.2005.00060.x	58	39	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43763	10.1371/journal.pone.0043763	http://dx.doi.org/10.1371/journal.pone.0043763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916303	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800100
J	Salmona, J; Salamolard, M; Fouillot, D; Ghestemme, T; Larose, J; Centon, JF; Sousa, V; Dawson, DA; Thebaud, C; Chikhi, L				Salmona, Jordi; Salamolard, Marc; Fouillot, Damien; Ghestemme, Thomas; Larose, Jerry; Centon, Jean-Francois; Sousa, Vitor; Dawson, Deborah A.; Thebaud, Christophe; Chikhi, Lounes			Signature of a Pre-Human Population Decline in the Critically Endangered Reunion Island Endemic Forest Bird Coracina newtoni	PLOS ONE			English	Article							GENETIC DIVERSITY; COMPUTER-PROGRAM; LA REUNION; MASCARENE ISLANDS; INDIAN-OCEAN; SIZE; CONSERVATION; DISTANCE; CUCKOOSHRIKE; CONTRACTION	The exceptional biodiversity of Reunion Island is threatened by anthropogenic landscape changes that took place during the 350 years of human colonization. During this period the human population size increased dramatically from 250 to 800,000. The arrival of humans together with the development of agriculture, invasive species such as rats and cats, and deforestation has lead to the extinction of more than half of the original vertebrate species of the island. For the remaining species, significant work is being carried out to identify threats and conservation status, but little genetic work has been carried on some of the most endangered species. In the last decade theoretical studies have shown the ability of neutral genetic markers to infer the demographic history of endangered species and identify and date past population size changes (expansions or bottlenecks). In this study we provide the first genetic data on the critically endangered species the Reunion cuckoo-shrike Coracina newtoni. The Reunion cuckoo-shrike is a rare endemic forest bird surviving in a restricted 12-km(2) area of forested uplands and mountains. The total known population consists of less than one hundred individuals out of which 45 were genotyped using seventeen polymorphic microsatellite loci. We found a limited level of genetic variability and weak population structure, probably due to the limited geographic distribution. Using Bayesian methods, we identified a strong decline in population size during the Holocene, most likely caused by an ancient climatic or volcanic event around 5000 years ago. This result was surprising as it appeared in apparent contradiction with the accepted theory of recent population collapse due to deforestation and predator introduction. These results suggest that new methods allowing for more complex demographic models are necessary to reconstruct the demographic history of populations.	[Salmona, Jordi; Salamolard, Marc; Fouillot, Damien; Ghestemme, Thomas; Larose, Jerry; Centon, Jean-Francois] SEOR, St Andre, Reunion, France; [Salmona, Jordi; Sousa, Vitor; Chikhi, Lounes] Inst Gulbenkian Cienca, Oeiras, Portugal; [Dawson, Deborah A.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Thebaud, Christophe; Chikhi, Lounes] Univ Toulouse 3, Lab Evolut & Divers Biol, F-31062 Toulouse, France; [Chikhi, Lounes] Univ Toulouse, Toulouse, France	Instituto Gulbenkian de Ciencia; University of Sheffield; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse	Salmona, J (corresponding author), SEOR, St Andre, Reunion, France.	jordi.salmona@gmail.com	Salmona, Jordi/P-5996-2017; Thébaud, Christophe/N-3916-2016; Sousa, Vitor C/P-1871-2016	Salmona, Jordi/0000-0002-1950-5805; Thébaud, Christophe/0000-0002-8586-1234; Sousa, Vitor C/0000-0003-3575-0875; Chikhi, Lounes/0000-0002-1140-0718	French "Ministere de l'Ecologie et du Developpement Durable"; European Fund for Regional Development (FEDER); Departement de La Reunion; Portuguese Science Foundation ('Fundacao para a Ciencia e a Tecnologia' FCT) [PTDC/BIA-BEC/100176/2008]; Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien [CD-AOOI-07-003]; Groupement de Recherche International (GDRI) Madagascar; Laboratoire d'Excellence (LABEX) [ANR -10-LABX-41]; FCT [H200741/re-equip/2005]; French "Ministere de l'Ecologie et du Developpement Durable"; European Fund for Regional Development (FEDER); Departement de La Reunion; Portuguese Science Foundation ('Fundacao para a Ciencia e a Tecnologia' FCT) [PTDC/BIA-BEC/100176/2008]; Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien [CD-AOOI-07-003]; Groupement de Recherche International (GDRI) Madagascar; Laboratoire d'Excellence (LABEX) [ANR -10-LABX-41]; FCT [H200741/re-equip/2005]; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	French "Ministere de l'Ecologie et du Developpement Durable"; European Fund for Regional Development (FEDER)(European Commission); Departement de La Reunion; Portuguese Science Foundation ('Fundacao para a Ciencia e a Tecnologia' FCT)(Portuguese Foundation for Science and Technology); Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien; Groupement de Recherche International (GDRI) Madagascar; Laboratoire d'Excellence (LABEX); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); French "Ministere de l'Ecologie et du Developpement Durable"; European Fund for Regional Development (FEDER)(European Commission); Departement de La Reunion; Portuguese Science Foundation ('Fundacao para a Ciencia e a Tecnologia' FCT)(Portuguese Foundation for Science and Technology); Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien; Groupement de Recherche International (GDRI) Madagascar; Laboratoire d'Excellence (LABEX); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The C.newtoni's conservation and research program managed by the "Societe d'Etudes Ornithologiques de La Reunion" (SEOR) was funded by the French "Ministere de l'Ecologie et du Developpement Durable" and European Fund for Regional Development (FEDER). The SEOR's work in the "Reserve Naturelle de la Roche Ecrite" is also supported the "Departement de La Reunion". Statistical and population genetics analyses were performed at the Instituto Gulbenkian de Ciencia (IGC), in LC's team partly funded by the Portuguese Science Foundation ('Fundacao para a Ciencia e a Tecnologia' FCT ref.PTDC/BIA-BEC/100176/2008), the Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien [ref. CD-AOOI-07-003], the Groupement de Recherche International (GDRI) Madagascar, and the "Laboratoire d'Excellence (LABEX)" entitled TULIP (ANR -10-LABX-41). The 'High-Performance Computing Center' (HERMES) was founded by FCT (grant H200741/re-equip/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-384; Barau A, 2005, OIS REUN ORPH; Baret S, 2006, AUSTRAL ECOL, V31, P747, DOI 10.1111/j.1442-9993.2006.01636.x; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2004, HEREDITY, V92, P365, DOI 10.1038/sj.hdy.6800447; Belkhir K., 2001, 5000 CNRS UMR LAB GE; Bourke BP, 2010, CONSERV GENET, P1; Bray TC, 2010, MOL ECOL RESOUR, V10, P538, DOI 10.1111/j.1755-0998.2009.02766.x; Cheke AS, 1987, ECOLOGICAL HIST MASC; CHEVALLIER L, 1982, B VOLCANOL, V45, P285, DOI DOI 10.1007/BF02597253; Chikhi L, 2008, HEREDITY, V101, P471, DOI 10.1038/hdy.2008.106; Chikhi L, 2004, MAMMALIAN GENOMICS, P539, DOI 10.1079/9780851999104.0539; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Coamteur J, 1999, COMPT REND SESS BAG, V9, P4; Cornuet JM, 1996, GENETICS, V144, P2001; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; Crowley BE, 2010, QUATERNARY SCI REV; Drake DR, 2009, BIOL INVASIONS, V11, P1483, DOI 10.1007/s10530-008-9392-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Falush D, 2003, GENETICS, V164, P1567; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Ghestemme T, 2007, OSTRICH, V78, P255, DOI 10.2989/OSTRICH.2007.78.2.21.101; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; *IUCN, 2010, 2010 IUCN RED LIST T; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson JA, 2009, MOL ECOL, V18, P54, DOI [10.1111/j.1365-294X.2009.04240.x, 10.1111/j.1365-294X.2008.04012.x]; Jonsson KA, 2010, J BIOGEOGR, V37, P1767, DOI 10.1111/j.1365-2699.2010.02328.x; JULVEZ J, 1990, ANN SOC BELG MED TR, V70, P249; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KIEFFER G, 1993, CR ACAD SCI II, V317, P835; Lagabrielle E, 2009, BIOL CONSERV, V142, P1523, DOI 10.1016/j.biocon.2009.02.022; Leblois R, 2006, MOL ECOL, V15, P3601, DOI 10.1111/j.1365-294X.2006.03046.x; Lopes JS, 2009, BIOINFORMATICS, V25, P2747, DOI 10.1093/bioinformatics/btp487; MANTEL N, 1967, CANCER RES, V27, P209; Mohamed-Abchir MA, 1996, THESIS; Mourer-Chauvire C, 1999, SM C PALEOB, P1; NEI M, 1978, GENETICS, V89, P583; Olivieri GL, 2008, BIOL CONSERV, V141, P1257, DOI 10.1016/j.biocon.2008.02.025; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peter BM, 2010, MOL ECOL, V19, P4648, DOI 10.1111/j.1365-294X.2010.04783.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pollen FPL, 1865, B SOC ACCLIMATATION; Pritchard JK, 2000, GENETICS, V155, P945; Probst JM, 1999, B PHAETHON, P24; Probst JM, 1995, B PHAETHON RIVIERE E; Quemere E, 2012, P NATL ACAD SCI; Quemere E, 2010, CONSERV GENET, V11, P675, DOI 10.1007/s10592-009-9837-9; Reed DH, 2010, ANIM CONSERV, V13, P448, DOI 10.1111/j.1469-1795.2010.00353.x; Rosenberg NA, 2004, DISTRUCT 1 1 PROGRAM; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Salamolard M, 2004, PLAN CONSERVATION EC; Salmona J, 2010, CONSERV GENET RESOUR, V2, P361, DOI 10.1007/s12686-010-9254-x; SEOR, 2008, COG RES ROCH ECR; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Sousa V, 2011, HEREDITY; Sousa V, 2008, CONSERV GENET, V9, P791, DOI 10.1007/s10592-007-9399-7; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; STAUDACHER T, 1993, EARTH PLANET SC LETT, V119, P395, DOI 10.1016/0012-821X(93)90147-2; Storz JF, 2002, EVOLUTION, V56, P154; Strasberg D, 2005, BIODIVERS CONSERV, V14, P3015, DOI 10.1007/s10531-004-0258-2; Thiollay JM, 1999, BIOL CONSERV, V87, P191, DOI 10.1016/S0006-3207(98)00062-7; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Virah-Sawmy M, 2010, J BIOGEOGR, V37, P506, DOI 10.1111/j.1365-2699.2009.02203.x; Wakeley J, 1999, GENETICS, V153, P1863; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5	75	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43524	10.1371/journal.pone.0043524	http://dx.doi.org/10.1371/journal.pone.0043524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916272	Green Published, gold, Green Accepted			2022-12-27	WOS:000307733800075
J	Sun, K; Liu, Y; Dai, M; Li, M; Yang, Z; Xu, M; Xu, Y; Lu, JL; Chen, YH; Liu, JM; Ning, G; Bi, YF				Sun, Kan; Liu, Yu; Dai, Meng; Li, Mian; Yang, Zhi; Xu, Min; Xu, Yu; Lu, Jieli; Chen, Yuhong; Liu, Jianmin; Ning, Guang; Bi, Yufang			Accessing Autonomic Function Can Early Screen Metabolic Syndrome	PLOS ONE			English	Article							SYMPATHETIC ACTIVITY; OBESITY; TOOL; HYPERTENSION; PREVALENCE; ACTIVATION; MECHANISMS; NEUROPATHY; CHILDREN; DISEASE	Background: Clinical diagnosis of the metabolic syndrome is time-consuming and invasive. Convenient instruments that do not require laboratory or physical investigation would be useful in early screening individuals at high risk of metabolic syndrome. Examination of the autonomic function can be taken as a directly reference and screening indicator for predicting metabolic syndrome. Methodology and Principal Findings: The EZSCAN test, as an efficient and noninvasive technology, can access autonomic function through measuring electrochemical skin conductance. In this study, we used EZSCAN value to evaluate autonomic function and to detect metabolic syndrome in 5,887 participants aged 40 years or older. The EZSCAN test diagnostic accuracy was analyzed by receiver operating characteristic curves. Among the 5,815 participants in the final analysis, 2,541 were diagnosed as metabolic syndrome and the overall prevalence was 43.7%. Prevalence of the metabolic syndrome increased with the elevated EZSCAN risk level (p for trend <0.0001). Moreover, EZSCAN value was associated with an increase in the number of metabolic syndrome components (p for trend <0.0001). Compared with the no risk group (EZSCAN value 0-24), participants at the high risk group (EZSCAN value: 50-100) had a 2.35 fold increased risk of prevalent metabolic syndrome after the multiple adjustments. The area under the curve of the EZSCAN test was 0.62 (95% confidence interval [CI], 0.61-0.64) for predicting metabolic syndrome. The optimal operating point for the EZSCAN value to detect a high risk of prevalent metabolic syndrome was 30 in this study, while the sensitivity and specificity were 71.2% and 46.7%, respectively. Conclusions and Significance: In conclusion, although less sensitive and accurate when compared with the clinical definition of metabolic syndrome,	[Sun, Kan; Liu, Yu; Dai, Meng; Li, Mian; Yang, Zhi; Xu, Min; Xu, Yu; Lu, Jieli; Chen, Yuhong; Liu, Jianmin; Ning, Guang; Bi, Yufang] Shanghai Jiao Tong Univ, Sch Med, Key Lab Endocrine & Metab Dis, Minist Hlth,Rui Jin Hosp,E Inst Shanghai Univ, Shanghai 200030, Peoples R China; [Sun, Kan; Liu, Yu; Dai, Meng; Li, Mian; Yang, Zhi; Xu, Min; Xu, Yu; Lu, Jieli; Chen, Yuhong; Liu, Jianmin; Ning, Guang; Bi, Yufang] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Key Lab Endocrine & Metab Dis, Minist Hlth,Rui Jin Hosp,E Inst Shanghai Univ, Shanghai 200030, Peoples R China.	byf10784@rjh.com.cn	Li, Mian/HGE-6038-2022		Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Sector Funds of Ministry of Health [201002002]; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology [2012ZX09303006-001]; Creative Research Group of Ministry of Education [IRT0932]; Major Project of Shanghai Committee of Science and Technology [09DZ1950200]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Sector Funds of Ministry of Health; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; Creative Research Group of Ministry of Education; Major Project of Shanghai Committee of Science and Technology	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the Sector Funds of Ministry of Health (201002002), the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001), the Creative Research Group of Ministry of Education (IRT0932), and the Major Project of Shanghai Committee of Science and Technology (09DZ1950200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Birklein F, 1999, FORTSCHR NEUROL PSYC, V67, P287, DOI 10.1055/s-2007-994979; Brunswick P, 2007, P ANN INT IEEE EMBS, P4544, DOI 10.1109/IEMBS.2007.4353350; Cheshire WP, 2003, SEMIN NEUROL, V23, P399; Chizmadzhev YA, 1998, BIOPHYS J, V74, P843, DOI 10.1016/S0006-3495(98)74008-1; Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024; Gallop RJ, 2003, UNDERSTAND STAT, V2, P219, DOI DOI 10.1207/S15328031US0204_01; Grassi G, 2006, J HYPERTENS, V24, P47, DOI 10.1097/01.hjh.0000198040.47128.4c; Grassi G, 2005, DIABETOLOGIA, V48, P1359, DOI 10.1007/s00125-005-1798-z; Grassi G, 1999, J HYPERTENS, V17, P719, DOI 10.1097/00004872-199917060-00001; Grassi G, 2007, HYPERTENSION, V49, P535, DOI 10.1161/01.HYP.0000255983.32896.b9; Grundy SM, 2004, CIRCULATION, V109, P551, DOI 10.1161/01.CIR.0000112379.88385.67; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hubert D, 2011, J CYST FIBROS, V10, P15, DOI 10.1016/j.jcf.2010.09.002; Huggett RJ, 2004, HYPERTENSION, V44, P847, DOI 10.1161/01.HYP.0000147893.08533.d8; Kimpinski K, 2009, NEUROLOGY, V73, P1501, DOI 10.1212/WNL.0b013e3181bf995f; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Low VA, 2006, MUSCLE NERVE, V34, P57, DOI 10.1002/mus.20551; Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004; Ozaki R, 2011, DIABETES TECHNOL THE, V13, P937, DOI 10.1089/dia.2011.0023; Peltier A, 2009, MUSCLE NERVE, V39, P529, DOI 10.1002/mus.21210; Ramachandran A, 2010, DIABETES RES CLIN PR, V88, P302, DOI 10.1016/j.diabres.2010.01.023; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-36; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Straznicky NE, 2005, J CLIN ENDOCR METAB, V90, P5998, DOI 10.1210/jc.2005-0961; Xu HQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-13; Yang SH, 2010, NEW ENGL J MED, V362, P2425; ZWEIG MH, 1993, CLIN CHEM, V39, P561	28	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43449	10.1371/journal.pone.0043449	http://dx.doi.org/10.1371/journal.pone.0043449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916265	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800069
J	Yan, F; Lu, YW; Lin, L; Zheng, HY; Chen, JP				Yan, Fei; Lu, Yuwen; Lin, Lin; Zheng, Hongying; Chen, Jianping			The Ability of PVX p25 to Form RL Structures in Plant Cells Is Necessary for Its Function in Movement, but Not for Its Suppression of RNA Silencing	PLOS ONE			English	Article							POTATO-VIRUS-X; TRIPLE GENE BLOCK; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; NICOTIANA-BENTHAMIANA; MOSAIC POTEXVIRUS; PROTEIN; TRAFFICKING; VESICLES; SIGNAL	The p25 triple gene block protein of Potato virus X (PVX) is multifunctional, participating in viral movement and acting as a suppressor of RNA silencing. The cell-to-cell movement of PVX is known to depend on the suppression function of p25. GFP-fused p25 accumulates in rod-like (RL) structures with intense fluorescence in cells. By monitoring the location of fluorescence at different times, we have now shown that the RL structure is composed of filaments. P25 mutants without the conditional ability to recover movement function could not form RL structures while the mutants that had the ability did form the structure, suggesting that the ability of p25 to form RL structures is necessary for its function in cell-to-cell movement, but not for its suppressor function. Moreover, chemical inhibition of microfilaments in cells destroyed the formation of the complete RL structure. Additionally, TGBp2 and TGBp3 were recruited into the RL structure, suggesting a relationship between the TGBps in virus movement.	[Yan, Fei; Lu, Yuwen; Lin, Lin; Zheng, Hongying; Chen, Jianping] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Yan, Fei; Lu, Yuwen; Lin, Lin; Zheng, Hongying; Chen, Jianping] Zhejiang Acad Agr Sci, Key Lab Biotechnol Plant Protect, Minist China, Hangzhou, Zhejiang, Peoples R China; [Yan, Fei; Lu, Yuwen; Lin, Lin; Zheng, Hongying] Zhejiang Acad Agr Sci, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences	Yan, F (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.	fei.yan@mail.zaas.ac.cn; jpchen2001@yahoo.com.cn		Yan, Fei/0000-0002-0049-8588	National Natural Science Foundation of China [30771402, 31101414]; Zhejiang Provincial Natural Science Foundation of China [Y3090148]; Department of Science and Technology, Zhejiang Provincial Government [2011R09032-05, 2011R09032-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Department of Science and Technology, Zhejiang Provincial Government	This work was financially supported by the National Natural Science Foundation of China (30771402, 31101414) and Zhejiang Provincial Natural Science Foundation of China (Y3090148) and a grant from the Department of Science and Technology, Zhejiang Provincial Government (2011R09032-05, 2011R09032-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne EH, 2005, PLANT J, V44, P471, DOI 10.1111/j.1365-313X.2005.02539.x; Chiu MH, 2010, MOL PLANT PATHOL, V11, P641, DOI [10.1111/j.1364-3703.2010.00634.x, 10.1111/J.1364-3703.2010.00634.X]; DAVIES C, 1993, VIROLOGY, V197, P166, DOI 10.1006/viro.1993.1577; Harries PA, 2009, P NATL ACAD SCI USA, V106, P17594, DOI 10.1073/pnas.0909239106; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hsu HT, 2004, ARCH VIROL, V149, P1027, DOI 10.1007/s00705-003-0254-y; Ju HJ, 2005, PLANT PHYSIOL, V138, P1877, DOI 10.1104/pp.105.066019; Ju HJ, 2007, J VIROL, V81, P1899, DOI 10.1128/JVI.02009-06; Krishnamurthy K, 2003, VIROLOGY, V309, P135, DOI 10.1016/S0042-6822(02)00102-2; Leshchiner AD, 2008, BIOCHEMISTRY-MOSCOW+, V73, P50, DOI 10.1134/S0006297908010070; Lough TJ, 2000, MOL PLANT MICROBE IN, V13, P962, DOI 10.1094/MPMI.2000.13.9.962; Lu YW, 2011, MOL PLANT PATHOL, V12, P666, DOI [10.1111/j.1364-3703.2010.00699.x, 10.1111/J.1364-3703.2010.00699.X]; Mitra R, 2003, VIROLOGY, V312, P35, DOI 10.1016/S0042-6822(03)00180-6; Morozov SY, 2003, J GEN VIROL, V84, P1351, DOI 10.1099/vir.0.18922-0; Qu F, 2005, J VIROL, V79, P15209, DOI 10.1128/JVI.79.24.15209-15217.2005; ROULEAU M, 1994, VIROLOGY, V204, P254, DOI 10.1006/viro.1994.1530; Sambrook J., 2002, MOL CLONING LAB MANU; Samuels TD, 2007, VIROLOGY, V367, P375, DOI 10.1016/j.virol.2007.05.022; Schepetilnikov MV, 2005, J GEN VIROL, V86, P2379, DOI 10.1099/vir.0.80865-0; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Tilsner J, 2012, PLANT PHYSL; Verchot-Lubicz J, 2007, J GEN VIROL, V88, P1643, DOI 10.1099/vir.0.82667-0; Verchot-Lubicz J, 2010, MOL PLANT MICROBE IN, V23, P1231, DOI 10.1094/MPMI-04-10-0086; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wu CH, 2011, J CELL BIOL, V193, P521, DOI 10.1083/jcb.201006023; Xie Q, 2006, VIRUS RES, V118, P1, DOI 10.1016/j.virusres.2005.11.012	26	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43242	10.1371/journal.pone.0043242	http://dx.doi.org/10.1371/journal.pone.0043242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916231	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300034
J	Streitburger, DP; Arelin, K; Kratzsch, J; Thiery, J; Steiner, J; Villringer, A; Mueller, K; Schroeter, ML				Streitbuerger, Daniel-Paolo; Arelin, Katrin; Kratzsch, Juergen; Thiery, Joachim; Steiner, Johann; Villringer, Arno; Mueller, Karsten; Schroeter, Matthias L.			Validating Serum S100B and Neuron-Specific Enolase as Biomarkers for the Human Brain - A Combined Serum, Gene Expression and MRI Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CALCIUM-BINDING PROTEINS; NO PREVIOUS HISTORY; SEX-RELATED CHANGES; ADULT HUMAN BRAINS; CEREBROSPINAL-FLUID; WHITE-MATTER; NEUROLOGICAL DISORDER; NEUROENDOCRINE CELLS; SPATIAL STATISTICS	Introduction: Former studies have investigated the potential of serum biomarkers for diseases affecting the human brain. In particular the glial protein S100B, a neuro-and gliotrophin inducing plasticity, seems to be involved in the pathogenesis and treatment of psychiatric diseases such as major depression and schizophrenia. Neuron-specific enolase (NSE) is a specific serum marker for neuronal damage. However, the specificity of these biomarkers for cell type and brain region has not been investigated in vivo until now. Methods: We acquired two magnetic resonance imaging parameters sensitive to changes in gray and white matter (T-1-weighted/diffusion tensor imaging) and obtained serum S100B and NSE levels of 41 healthy subjects. Additionally, we analyzed whole brain gene expressions of S100B in another male cohort of three subjects using the Allen Brain Atlas. Furthermore, a female post mortal brain was investigated using double immunofluorescence labelling with oligodendrocyte markers. Results: We show that S100B is specifically related to white matter structures, namely the corpus callosum, anterior forceps and superior longitudinal fasciculus in female subjects. This effect was observed in fractional anisotropy and radial diffusivity - the latest an indicator of myelin changes. Histological data confirmed a co-localization of S100B with oligodendrocyte markers in the human corpus callosum. S100B was most abundantly expressed in the corpus callosum according to the whole genome Allen Human Brain Atlas. In addition, NSE was related to gray matter structures, namely the amygdala. This effect was detected across sexes. Conclusion: Our data demonstrates a very high S100B expression in white matter tracts, in particular in human corpus callosum. Our study is the first in vivo study validating the specificity of the glial marker S100B for the human brain, and supporting the assumption that radial diffusivity represents a myelin marker. Our results open a new perspective for future studies investigating major neuropsychiatric disorders.	[Streitbuerger, Daniel-Paolo; Arelin, Katrin; Villringer, Arno; Mueller, Karsten; Schroeter, Matthias L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Arelin, Katrin; Villringer, Arno; Schroeter, Matthias L.] Univ Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Arelin, Katrin; Thiery, Joachim; Villringer, Arno; Schroeter, Matthias L.] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Kratzsch, Juergen; Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Steiner, Johann] Univ Magdeburg, Dept Psychiat, D-39106 Magdeburg, Germany; [Steiner, Johann] Univ Cambridge, Pembroke Coll, Cambridge, England; [Schroeter, Matthias L.] Consortium Frontotemporal Lobar Degenerat, Ulm, Germany	Max Planck Society; Leipzig University; Leipzig University; Leipzig University; Otto von Guericke University; University of Cambridge; Ulm University	Streitburger, DP (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	paolo@cbs.mpg.de		Villringer, Arno/0000-0003-2604-2404; Steiner, Johann/0000-0002-2611-2268	LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union; Free State of Saxony within the framework of the excellence initiative; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research	LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union(European Commission); Free State of Saxony within the framework of the excellence initiative; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	KA, JT, AV and MLS are supported by LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig - funded by the European Union, European Regional Development Fund and by Free State of Saxony within the framework of the excellence initiative. MLS is supported by the German Consortium for Frontotemporal Lobar Degeneration, funded by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and no additional external funding has been received for this study.	Abdul-Khaliq H, 2000, CLIN CHEM LAB MED, V38, P1169, DOI 10.1515/CCLM.2000.180; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bernstein HG, 2009, EXPERT REV NEUROTHER, V9, P1059, DOI [10.1586/ern.09.59, 10.1586/ERN.09.59]; Brandner FA, 1933, BIOMETRIKA, V25, P102, DOI 10.2307/2332265; Brenneis C, 2003, MOVEMENT DISORD, V18, P1132, DOI 10.1002/mds.10502; Busnello JV, 2006, LIFE SCI, V78, P3013, DOI 10.1016/j.lfs.2005.11.028; CAMMERMEYER J, 1960, AM J ANAT, V107, P107, DOI 10.1002/aja.1001070203; Casmiro M, 2005, EUR J NEUROL, V12, P369, DOI 10.1111/j.1468-1331.2004.01021.x; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Haglid KG, 1997, BRAIN RES, V753, P196, DOI 10.1016/S0006-8993(96)01463-1; Holtkamp K, 2008, J NEURAL TRANSM, V115, P937, DOI 10.1007/s00702-008-0041-8; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; KAISER E, 1989, CLIN CHIM ACTA, V183, P13, DOI 10.1016/0009-8981(89)90268-4; Karas GB, 2003, NEUROIMAGE, V18, P895, DOI 10.1016/S1053-8119(03)00041-7; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; Kochunov P, 2007, NEUROIMAGE, V35, P478, DOI 10.1016/j.neuroimage.2006.12.021; Lambert JC, 2007, MOL PSYCHIATR, V12, P870, DOI 10.1038/sj.mp.4001974; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Meyer-Lindenberg A, 2007, J CLIN INVEST, V117, P672, DOI 10.1172/JCI30413; Mueller K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018544; Nygaard O, 1997, CLIN CHEM, V43, P541; Nygaard O, 1998, SCAND J CLIN LAB INV, V58, P183; Otto M, 1998, BMJ-BRIT MED J, V316, P577, DOI 10.1136/bmj.316.7131.577; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Portela LVC, 2002, CLIN CHEM, V48, P950; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rothermundt M, 2002, SCHIZOPHR RES, V53, P152; Sacher J, 2011, J AFFECT DISORD; Schaf DV, 2005, PARKINSONISM RELAT D, V11, P39, DOI 10.1016/j.parkreldis.2004.07.002; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHMECHEL D, 1978, NATURE, V276, P834, DOI 10.1038/276834a0; Schmierer K, 2008, MAGN RESON MED, V59, P268, DOI 10.1002/mrm.21487; Schroeter ML, 2009, MOL PSYCHIATR, V14, P235, DOI 10.1038/mp.2008.85; Schroeter M.L., 2010, CARDIOVASC PSYCHIAT, V2010; Schroeter ML, 2011, J AFFECT DISORDERS, V134, P32, DOI 10.1016/j.jad.2010.11.008; Schroeter ML, 2009, PSYCHIAT RES, V167, P66, DOI 10.1016/j.psychres.2008.01.002; Schroeter ML, 2008, J AFFECT DISORDERS, V111, P271, DOI 10.1016/j.jad.2008.03.005; Schroeter ML, 2003, SCHIZOPHR RES, V62, P231, DOI 10.1016/S0920-9964(02)00383-3; Schroeter ML, 2002, NEUROREPORT, V13, P1675, DOI 10.1097/00001756-200209160-00021; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Steiner J, 2010, NEUROSCIENCE, V167, P1025, DOI 10.1016/j.neuroscience.2010.03.010; Steiner J, 2010, MOL PSYCHIATR, V15, P3, DOI 10.1038/mp.2009.87; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Steiner J, 2011, CLIN CHEM LAB MED, V49, P409, DOI 10.1515/CCLM.2011.083; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Stroick M, 2006, CURR MED CHEM, V13, P3053, DOI 10.2174/092986706778521751; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Whitford TJ, 2011, SCHIZOPHR RES, V132, P69, DOI 10.1016/j.schres.2011.07.010; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	73	55	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43284	10.1371/journal.pone.0043284	http://dx.doi.org/10.1371/journal.pone.0043284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916238	Green Published, gold			2022-12-27	WOS:000307500800071
J	Krishnamachary, B; Penet, MF; Nimmagadda, S; Mironchik, Y; Raman, V; Solaiyappan, M; Semenza, GL; Pomper, MG; Bhujwalla, ZM				Krishnamachary, Balaji; Penet, Marie-France; Nimmagadda, Sridhar; Mironchik, Yelena; Raman, Venu; Solaiyappan, Meiyappan; Semenza, Gregg L.; Pomper, Martin G.; Bhujwalla, Zaver M.			Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1 alpha in Triple Negative Breast Cancer	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; STEM-CELLS; EXPRESSION; PROTEIN; METASTASIS; RESISTANCE; IDENTIFICATION; CHEMOTHERAPY; HYALURONAN; POPULATION	Background: The CD44 transmembrane glycoproteins play multifaceted roles in tumor progression and metastasis. CD44 expression has also been associated with stem-like breast cancer cells. Hypoxia commonly occurs in tumors and is a major cause of radiation and chemo-resistance. Hypoxia is known to inhibit differentiation and facilitates invasion and metastasis. Here we have investigated the effect of hypoxia on CD44 and two of its isoforms in MDA-MB-231 and SUM-149 triple negative human breast cancer cells and MDA-MB-231 tumors using imaging and molecular characterization. Methods and Findings: The roles of hypoxia and hypoxia inducible factor (HIF) in regulating the expression of CD44 and its variant isoforms (CD44v6, CD44v7/8) were investigated in human breast cancer cells, by quantitative real-time polymerase chain reaction (qRT-PCR) to determine mRNA levels, and fluorescence associated cell sorting (FACS) to determine cell surface expression of CD44, under normoxic and hypoxic conditions. In vivo imaging studies with tumor xenografts derived from MDA-MD-231 cells engineered to express tdTomato red fluorescence protein under regulation of hypoxia response elements identified co-localization between hypoxic fluorescent regions and increased concentration of I-125-radiolabeled CD44 antibody. Conclusions: Our data identified HIF-1 alpha as a regulator of CD44 that increased the number of CD44 molecules and the percentage of CD44 positive cells expressing variant exons v6 and v7/8 in breast cancer cells under hypoxic conditions. Data from these cell studies were further supported by in vivo observations that hypoxic tumor regions contained cells with a higher concentration of CD44 expression.	[Krishnamachary, Balaji; Penet, Marie-France; Nimmagadda, Sridhar; Mironchik, Yelena; Raman, Venu; Solaiyappan, Meiyappan; Pomper, Martin G.; Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, JHU ICMIC Program,Div Canc Imaging Res, Baltimore, MD 21218 USA; [Raman, Venu; Semenza, Gregg L.; Pomper, Martin G.; Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Krishnamachary, B (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, JHU ICMIC Program,Div Canc Imaging Res, Baltimore, MD 21218 USA.	bkrishn1@jhu.edu; zaver@mri.jhu.edu	Nimmagadda, Sridhar/D-6135-2011; Penet, Marie-France/AGZ-6991-2022	Nimmagadda, Sridhar/0000-0002-6413-7191; 	National Institutes of Health [R01 CA136576]; NATIONAL CANCER INSTITUTE [R01CA136576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health R01 CA136576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Berner HS, 2003, HISTOPATHOLOGY, V42, P546, DOI 10.1046/j.1365-2559.2003.01622.x; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Diaz LK, 2005, CLIN CANCER RES, V11, P3309, DOI 10.1158/1078-0432.CCR-04-2184; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FUKAZAWA H, 1993, THYROID, V3, P285, DOI 10.1089/thy.1993.3.285; Gao F, 2005, ADV EXP MED BIOL, V566, P249; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hoffmeyer MR, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-11; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jothy S, 2003, CLIN EXP METASTAS, V20, P195, DOI 10.1023/A:1022931016285; Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207; Kopp R, 2009, INT J MOL MED, V24, P677, DOI 10.3892/ijmm_00000279; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krishnamachary B, 2003, CANCER RES, V63, P1138; Krishnamachary B, 2009, CANCER RES, V69, P3464, DOI 10.1158/0008-5472.CAN-08-4120; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Moeller B, 2006, BRIT J CANCER, V95, P1, DOI 10.1038/sj.bjc.6603201; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Peng ST, 2007, INT J ONCOL, V31, P1119; Raman V, 2006, CANCER RES, V66, P9929, DOI 10.1158/0008-5472.CAN-06-0886; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Turcotte S, 2004, AM J PHYSIOL-RENAL, V286, pF338, DOI 10.1152/ajprenal.00254.2003; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Zhong H, 1999, CANCER RES, V59, P5830	40	94	97	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44078	10.1371/journal.pone.0044078	http://dx.doi.org/10.1371/journal.pone.0044078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937154	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600074
J	Rabna, P; Andersen, A; Wejse, C; Oliveira, I; Gomes, VF; Haaland, MB; Aaby, P; Eugen-Olsen, J				Rabna, Paulo; Andersen, Andreas; Wejse, Christian; Oliveira, Ines; Gomes, Victor Francisco; Haaland, Maya Bonde; Aaby, Peter; Eugen-Olsen, Jesper			Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; SOLUBLE UROKINASE RECEPTOR; TUBERCULOSIS PATIENTS; BORRELIA-BURGDORFERI; PREDICTS MORTALITY; UP-REGULATION; SERUM LEVEL; EXPRESSION; RELEASE; BLOOD	Objective: To investigate whether changes in the plasma level of soluble urokinase plasminogen activator receptor (suPAR) can be used to monitor tuberculosis (TB) treatment efficacy. Design: This prospective cohort study included 278 patients diagnosed with active pulmonary TB and followed throughout the 8-month treatment period. Results: Mortality during treatment was higher in the highest inclusion quartile of suPAR (23%) compared to the lowest three quartiles (7%), the risk ratio being 3.1 (95% CI 1.65-6.07). No association between early smear conversion and subsequent mortality or inclusion suPAR was observed. After 1 and 2 months of treatment, an increase in suPAR compared to at diagnosis was associated with a Mortality Rate Ratio (MRR) of 4.5 (95% CI: 1.45-14.1) and 2.1 (95% CI 0.62-6.82), respectively, for the remaining treatment period. Conclusions: The present study confirmed that elevated suPAR level at time of initiation of TB treatment is associated with increased risk of mortality. Furthermore, increased suPAR levels after one month of treatment was associated with increased risk of mortality during the remaining 7-month treatment period.	[Rabna, Paulo; Andersen, Andreas; Wejse, Christian; Gomes, Victor Francisco; Aaby, Peter; Eugen-Olsen, Jesper] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Wejse, Christian] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Wejse, Christian; Haaland, Maya Bonde] Aarhus Univ, Sch Publ Hlth, Ctr Global Hlth, Aarhus, Denmark; [Oliveira, Ines] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr, DK-2650 Hvidovre, Denmark; [Aaby, Peter] Statens Serum Inst, Bandim Hlth Project, DK-2300 Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Statens Serum Institut	Rabna, P (corresponding author), Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau.	jespereugenolsen@gmail.com	Wejse, Christian/C-8468-2014; Oliveira Souto, Ines/L-2947-2017	Wejse, Christian/0000-0002-2534-2942; Eugen-Olsen, Jesper/0000-0002-4630-4275; Oliveira Souto, Ines/0000-0001-6018-5797; Bonde, Maya/0000-0001-9353-4789; Aaby, Peter/0000-0001-8331-1389	EU [LSSP-CT-2005-012173]	EU(European Commission)	This study was funded by the EU FP6 project number LSSP-CT-2005-012173. The funding institution had no role in study design, data collection, analysis, interpretation, preparation of the manuscript, or decision to publish.	Alfano M, 2003, J LEUKOCYTE BIOL, V74, P750, DOI 10.1189/jlb.0403176; Coleman JL, 2003, INFECT IMMUN, V71, P5556, DOI 10.1128/IAI.71.10.5556-5564.2003; Coleman JL, 2001, J IMMUNOL, V166, P473, DOI 10.4049/jimmunol.166.1.473; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; de Bock CE, 2004, MED RES REV, V24, P13, DOI 10.1002/med.10054; Dekkers PEP, 2000, INFECT IMMUN, V68, P2156, DOI 10.1128/IAI.68.4.2156-2160.2000; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Eugen-Olsen J, 2002, INT J TUBERC LUNG D, V6, P686; Florquin S, 2001, KIDNEY INT, V59, P2054, DOI 10.1046/j.1523-1755.2001.00719.x; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; Haupt TH, 2012, CRIT CARE, V16, DOI 10.1186/cc11434; Huttunen R, 2011, J INTERN MED, V270, P32, DOI 10.1111/j.1365-2796.2011.02363.x; Juffermans NP, 2001, INFECT IMMUN, V69, P5182, DOI 10.1128/IAI.69.8.5182-5185.2001; KIRCHHEIMER JC, 1988, J IMMUNOL, V141, P4229; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Lawn SD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-41; NYKJAER A, 1994, J IMMUNOL, V152, P505; Ostrowski SR, 2005, SCAND J IMMUNOL, V61, P347, DOI 10.1111/j.1365-3083.2005.01582.x; Ostrowski SR, 2005, J INFECT DIS, V191, P1331, DOI 10.1086/428854; Perch M, 2004, PARASITE IMMUNOL, V26, P207, DOI 10.1111/j.0141-9838.2004.00695.x; PLESNER T, 1994, AM J CLIN PATHOL, V102, P835, DOI 10.1093/ajcp/102.6.835; Plesner T, 1997, STEM CELLS, V15, P398, DOI 10.1002/stem.150398; Ploug M, 2003, CURR PHARM DESIGN, V9, P1499, DOI 10.2174/1381612033454630; Rabna P, 2009, TROP MED INT HEALTH, V14, P986, DOI 10.1111/j.1365-3156.2009.02328.x; Siawaya JFD, 2008, J INFECTION, V56, P340, DOI 10.1016/j.jinf.2008.02.007; Sidenius N, 2000, BLOOD, V96, P4091; SITRIN RG, 1994, BLOOD, V84, P1268; Slot O, 1999, ANN RHEUM DIS, V58, P488, DOI 10.1136/ard.58.8.488; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; Wittenhagen P, 2004, CLIN MICROBIOL INFEC, V10, P409, DOI 10.1111/j.1469-0691.2004.00850.x; World Health Organization, 2004, GUID DRINK WAT QUAL, P1, DOI DOI 10.1037/E333612004-001	33	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43933	10.1371/journal.pone.0043933	http://dx.doi.org/10.1371/journal.pone.0043933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937128	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600060
J	Benson, V; Ietswaart, M; Milner, D				Benson, Valerie; Ietswaart, Magdalena; Milner, David			Eye Movements and Verbal Report in a Single Case of Visual Neglect	PLOS ONE			English	Article							UNILATERAL NEGLECT; HEMISPATIAL NEGLECT; SPATIAL NEGLECT; PRISM ADAPTATION; ATTENTION; PATTERNS; SEARCH; SPACE	In this single case study, visuospatial neglect patient P1 demonstrated a dissociation between an intact ability to make appropriate reflexive eye movements to targets in the neglected field with latencies of <400 ms, while failing to report targets presented at such durations in a separate verbal detection task. In contrast, there was a failure to evoke the usually robust Remote Distractor Effect in P1, even though distractors in the neglected field were presented at above threshold durations. Together those data indicate that the tight coupling that is normally shown between attention and eye movements appears to be disrupted for low-level orienting in P1. A comparable disruption was also found for high-level cognitive processing tasks, namely reading and scene scanning. The findings are discussed in relation to sampling, attention and awareness in neglect.	[Benson, Valerie] Univ Southampton, Southampton, Hants, England; [Ietswaart, Magdalena] Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Milner, David] Univ Durham, Durham, England	University of Southampton; Northumbria University; Durham University	Benson, V (corresponding author), Univ Southampton, Southampton, Hants, England.	vb1@soton.ac.uk		Ietswaart, Magdalena/0000-0003-4576-9393; Benson, Valerie/0000-0002-0351-4563	UK MRC Cooperative Group grant [G0000003]; Medical Research Council [G0000003] Funding Source: researchfish; MRC [G0000003] Funding Source: UKRI	UK MRC Cooperative Group grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by a UK MRC Cooperative Group grant (#G0000003) awarded to DM, the third author on this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti S, 1997, BRAIN COGNITION, V34, P388, DOI 10.1006/brcg.1997.0915; Bartolomeo P, 1999, NEUROLOGY, V53, P2023, DOI 10.1212/WNL.53.9.2023; Benson V, 2008, COGNITIVE CULTURAL I; Brown V, 1999, NEUROCASE, V5, P129; Butler SH, 2009, NEUROPSYCHOLOGIA, V47, P2488, DOI 10.1016/j.neuropsychologia.2009.04.022; CUSICK CG, 1988, PROG BRAIN RES, V75, P1; Danckert J, 2006, NEUROPSYCHOLOGIA, V44, P987, DOI 10.1016/j.neuropsychologia.2005.09.004; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; ELLIS AW, 1987, COGNITIVE NEUROPSYCH, V4, P439, DOI 10.1080/02643298708252047; Ferber S, 2003, NEUROLOGY, V60, P1826, DOI 10.1212/01.WNL.0000061478.16239.5C; GIROTTI F, 1983, NEUROPSYCHOLOGIA, V21, P543, DOI 10.1016/0028-3932(83)90010-6; HALLIGAN PW, 1989, LANCET, V2, P908; Heilman KM, 1979, CLIN NEUROPSYCHOLOGY; ISHIAI S, 1987, NEUROPSYCHOLOGIA, V25, P675, DOI 10.1016/0028-3932(87)90058-3; KARNATH HO, 1992, NEUROPSYCHOLOGIA, V30, P593, DOI 10.1016/0028-3932(92)90062-Q; Kinsbourne M., 1987, NEUROPHYSIOLOGICAL N, P69, DOI DOI 10.1016/S0166-4115(08)61709-4; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Lock TM, 2003, EXP BRAIN RES, V151, P455, DOI 10.1007/s00221-003-1500-y; MARSHALL JC, 1988, NATURE, V336, P766, DOI 10.1038/336766a0; Mattingley JB, 1998, NEUROCASE, V4, P245; Parton A, 2006, NEUROREPORT, V17, P833, DOI 10.1097/01.wnr.0000220130.86349.a7; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1987, ATTENTION PERFORM, P327; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Sarri M, 2006, NEUROCASE, V12, P127, DOI 10.1080/13554790600598774; Sarri M, 2011, CORTEX, V47, P353, DOI 10.1016/j.cortex.2010.01.006; Van der Stigchel S, 2010, CONSCIOUS COGN, V19, P186, DOI 10.1016/j.concog.2009.11.003; WALKER R, 1995, EXP BRAIN RES, V103, P294; Walker R, 1996, NEUROPSYCHOLOGIA, V34, P493, DOI 10.1016/0028-3932(95)00156-5; Walker R, 1997, J NEUROPHYSIOL, V78, P1108, DOI 10.1152/jn.1997.78.2.1108; Wilson B. A., 1987, BEHAV INATTENTION TE; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	34	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43743	10.1371/journal.pone.0043743	http://dx.doi.org/10.1371/journal.pone.0043743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937090	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000308225500092
J	Chao, PK; Lu, KT; Lee, YL; Chen, JC; Wang, HL; Yang, YL; Cheng, MY; Liao, MF; Ro, LS				Chao, Po-Kuan; Lu, Kwok-Tung; Lee, Yun-Lin; Chen, Jin-Chung; Wang, Hung-Li; Yang, Yi-Ling; Cheng, Mei-Yun; Liao, Ming-Feng; Ro, Long-Sun			Early Systemic Granulocyte-Colony Stimulating Factor Treatment Attenuates Neuropathic Pain after Peripheral Nerve Injury	PLOS ONE			English	Article							CONTAINING POLYMORPHONUCLEAR CELLS; BONE CANCER PAIN; INFLAMMATORY PAIN; G-CSF; BETA-ENDORPHIN; NEUTROPHIL PRODUCTION; RECEPTOR EXPRESSION; OPIOID-PEPTIDES; IMMUNE CELLS; SPINAL-CORD	Recent studies have shown that opioid treatment can reduce pro-inflammatory cytokine production and counteract various neuropathic pain syndromes. Granulocyte colony-stimulating factor (G-CSF) can promote immune cell differentiation by increasing leukocytes (mainly opioid-containing polymorphonuclear (PMN) cells), suggesting a potential beneficial role in treating chronic pain. This study shows the effectiveness of exogenous G-CSF treatment (200 mg/kg) for alleviating thermal hyperalgesia and mechanical allodynia in rats with chronic constriction injury (CCI), during post-operative days 1-25, compared to that of vehicle treatment. G-CSF also increases the recruitment of opioid-containing PMN cells into the injured nerve. After CCI, single administration of G-CSF on days 0, 1, and 2, but not on day 3, relieved thermal hyperalgesia, which indicated that its effect on neuropathic pain had a therapeutic window of 0-48 h after nerve injury. CCI led to an increase in the levels of interleukin-6 (IL-6) mRNA and tumor necrosis factor-alpha (TNF-alpha) protein in the dorsal root ganglia (DRG). These high levels of IL-6 mRNA and TNF-alpha were suppressed by a single administration of G-CSF 48-144 h and 72-144 h after CCI, respectively. Furthermore, G-CSF administered 72-144 h after CCI suppressed the CCI-induced upregulation of microglial activation in the ipsilateral spinal dorsal horn, which is essential for sensing neuropathic pain. Moreover, the opioid receptor antagonist naloxone methiodide (NLXM) reversed G-CSF-induced antinociception 3 days after CCI, suggesting that G-CSF alleviates hyperalgesia via opioid/opioid receptor interactions. These results suggest that an early single systemic injection of G-CSF alleviates neuropathic pain via activation of PMN cell-derived endogenous opioid secretion to activate opioid receptors in the injured nerve, downregulate IL-6 and TNF-alpha inflammatory cytokines, and attenuate microglial activation in the spinal dorsal horn. This indicates that G-CSF treatment can suppress early inflammation and prevent the subsequent development of neuropathic pain.	[Chao, Po-Kuan; Lu, Kwok-Tung] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Lee, Yun-Lin; Cheng, Mei-Yun; Liao, Ming-Feng; Ro, Long-Sun] Chang Gung Univ, Chang Gung Mem Hosp & Univ, Dept Neurol, Div Neuromuscular Disorders, Tao Yuan, Taiwan; [Chen, Jin-Chung] Chang Gung Univ, Dept Pharmacol, Tao Yuan, Taiwan; [Wang, Hung-Li] Chang Gung Univ, Dept Physiol, Tao Yuan, Taiwan; [Yang, Yi-Ling] Natl Chia Yi Univ, Inst Biotechnol, Chiayi, Taiwan	National Taiwan Normal University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; National Chiayi University	Chao, PK (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	cgrols@adm.cgmh.org.tw		Chen, Jin-Chung/0000-0003-2996-5781	Chang Gung Medical Research Program [CMRP 351021-3]; National Science Council, Taiwan, ROC [NSC 96-2314-B-182A-111, 97-2314-B-182A-046, 98-2314-B-182A-076-MY3]	Chang Gung Medical Research Program; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the Chang Gung Medical Research Program (CMRP 351021-3) and a grant from the National Science Council (NSC 96-2314-B-182A-111, 97-2314-B-182A-046, 98-2314-B-182A-076-MY3), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker P S, 1997, Biol Blood Marrow Transplant, V3, P45; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Berrios I, 2008, P R HEALTH SCI J, V27, P119; Binder W, 2004, EUR J NEUROSCI, V20, P92, DOI 10.1111/j.1460-9568.2004.03459.x; Brack A, 2004, PAIN, V108, P67, DOI 10.1016/j.pain.2003.12.008; Brack A, 2004, ANESTHESIOLOGY, V100, P149, DOI 10.1097/00000542-200401000-00024; Brack A, 2004, PAIN, V112, P229, DOI 10.1016/j.pain.2004.08.029; Brack Alexander, 2004, Curr Opin Anaesthesiol, V17, P461, DOI 10.1097/00001503-200410000-00018; Busch-Dienstfertig M, 2010, BRAIN BEHAV IMMUN, V24, P683, DOI 10.1016/j.bbi.2009.10.013; Cabot PJ, 1997, J CLIN INVEST, V100, P142, DOI 10.1172/JCI119506; Cabot PJ, 2001, CLIN EXP PHARMACOL P, V28, P230, DOI 10.1046/j.1440-1681.2001.03425.x; Cabot PJ, 2001, PAIN, V93, P207, DOI 10.1016/S0304-3959(01)00322-0; Dale CS, 2005, MEM I OSWALDO CRUZ, V100, P105, DOI 10.1590/S0074-02762005000900017; Eyles JL, 2008, BLOOD, V112, P5193, DOI 10.1182/blood-2008-02-139535; Fecho K, 2007, BRAIN BEHAV IMMUN, V21, P68, DOI 10.1016/j.bbi.2006.02.003; Finley MJ, 2008, CELL IMMUNOL, V252, P146, DOI 10.1016/j.cellimm.2007.09.008; Hagiwara S, 2008, ANESTH ANALG, V107, P1058, DOI 10.1213/ane.0b013e31817ee43e; Hathway GJ, 2009, PAIN, V144, P110, DOI 10.1016/j.pain.2009.03.022; Hoggatt J, 2011, CURR OPIN HEMATOL, V18, P231, DOI 10.1097/MOH.0b013e3283477962; Iwasaka H, 2001, CAN J ANAESTH, V48, P81, DOI 10.1007/BF03019820; Kapitzke Daniel, 2005, Ther Clin Risk Manag, V1, P279; Labuz D, 2010, BRAIN BEHAV IMMUN, V24, P1045, DOI 10.1016/j.bbi.2010.04.001; Labuz D, 2009, J CLIN INVEST, V119, P278, DOI [10.1172/JCI36246, 10.1172/JCI36246C1]; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Leanez S, 2009, EUR J PHARMACOL, V602, P41, DOI 10.1016/j.ejphar.2008.11.019; Liou JT, 2011, J NEUROIMMUNOL, V232, P83, DOI 10.1016/j.jneuroim.2010.10.014; Lloyd CM, 2008, J IMMUNOL METHODS, V334, P70, DOI 10.1016/j.jim.2008.02.005; Machelska H, 2003, NAT MED, V9, P1353, DOI 10.1038/nm1103-1353; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Mousa SA, 2002, J NEUROIMMUNOL, V126, P5, DOI 10.1016/S0165-5728(02)00049-8; Mousa SA, 2004, ENDOCRINOLOGY, V145, P1331, DOI 10.1210/en.2003-1287; Mousa SA, 2007, NEUROPSYCHOPHARMACOL, V32, P2530, DOI 10.1038/sj.npp.1301393; Nguyen HX, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-26; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Poisbeau P, 2005, J NEUROSCI, V25, P11768, DOI 10.1523/JNEUROSCI.3841-05.2005; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; Rittner HL, 2008, NEUROSCI LETT, V437, P203, DOI 10.1016/j.neulet.2008.02.071; Rittner HL, 2006, FASEB J, V20, P2627, DOI 10.1096/fj.06-6077fje; Rittner HL, 2006, J LEUKOCYTE BIOL, V79, P1022, DOI 10.1189/jlb.0805452; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Rutella S, 2007, TRANSPLANTATION, V84, pS26, DOI 10.1097/01.tp.0000269611.66517.bf; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; Semerad CL, 1999, IMMUNITY, V11, P153, DOI 10.1016/S1074-7613(00)80090-4; Solaroglu I, 2007, FRONT BIOSCI-LANDMRK, V12, P712, DOI 10.2741/2095; STEIN C, 1990, P NATL ACAD SCI USA, V87, P5935, DOI 10.1073/pnas.87.15.5935; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Takemoto Y, 2000, DRUG EXP CLIN RES, V26, P1; Touw IP, 2007, FRONT BIOSCI-LANDMRK, V12, P800, DOI 10.2741/2103; Tsai RK, 2008, EXP EYE RES, V87, P242, DOI 10.1016/j.exer.2008.06.004; Ugolini G, 2007, P NATL ACAD SCI USA, V104, P2985, DOI 10.1073/pnas.0611253104; Wang FZ, 2010, PAIN, V148, P275, DOI 10.1016/j.pain.2009.11.011; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; Zhang YQ, 2009, PAIN, V146, P130, DOI 10.1016/j.pain.2009.07.011	55	25	25	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43680	10.1371/journal.pone.0043680	http://dx.doi.org/10.1371/journal.pone.0043680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937076	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500078
J	Monestier, O; Brun, C; Cocquempot, O; Petit, D; Blanquet, V				Monestier, Olivier; Brun, Caroline; Cocquempot, Olivier; Petit, Daniel; Blanquet, Veronique			GASP/WFIKKN Proteins: Evolutionary Aspects of Their Functions	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; PROTEASE INHIBITOR; BETA SUPERFAMILY; GENOME EVOLUTION; MULTIPLE TYPES; EXPRESSION; GROWTH; GENES; WFIKKN1; DOMAIN	Growth and differentiation factor Associated Serum Protein (GASP) 1 and 2 are proteins known to be involved in the control of myostatin activity at least in vitro. Most deuterostome GASPs share a modular organization including WAP, follistatin/kazal, IGc2, two kunitz, and NTR domains. Based on an exon shuffling model, we performed independent phylogenetic analyses on these modules and assessed that papilin is probably a sister sequence to GASP with a divergence date estimated from the last common ancestor to bilateria. The final organization was acquired by the addition of the FS domain in early deuterostomes. Our study revealed that Gasp genes diverged during the first round of genome duplication in early vertebrates. By evaluating the substitution rate at different sites on the proteins, we showed a better conservation of the follistatin/kazal domain of GASP1 than GASP2 in mammals, suggesting a stronger interaction with myostatin. We also observed a progressive increase in the conservation of follistatin and kunitz domains from the ancestor of Ciona to early vertebrates. In situ hybridization performed on mouse embryos showed a weak Gasp1 expression in the formed somites at 10.5 dpc and in limb buds from embryonic E10.0 to E12.5. Similar results were obtained for zebrafish embryos. We propose a synthetic view showing possible interactions between GASP1 and myostatin and highlighting the role of the second kunitz domain in preventing myostatin proteolysis.	[Monestier, Olivier; Brun, Caroline; Cocquempot, Olivier; Petit, Daniel; Blanquet, Veronique] INRA, UMR1061, Unite Genet Mol Anim, Limoges, France; [Monestier, Olivier; Brun, Caroline; Cocquempot, Olivier; Petit, Daniel; Blanquet, Veronique] Univ Limoges, Limoges, France	INRAE; Universite de Limoges	Monestier, O (corresponding author), INRA, UMR1061, Unite Genet Mol Anim, Limoges, France.	veronique.blanquet@unilim.fr	Monestier, Olivier/AAB-2220-2020; Monestier, Olivier/E-2926-2013	Monestier, Olivier/0000-0002-3236-0807; Monestier, Olivier/0000-0002-3236-0807; Brun, Caroline/0000-0003-2824-5221	French National Institute for Agriculture Research; Limousin Regional Council	French National Institute for Agriculture Research; Limousin Regional Council	This work was supported by the French National Institute for Agriculture Research and the Limousin Regional Council (http://www.inra.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fessler JH, 2004, INT J BIOCHEM CELL B, V36, P1079, DOI 10.1016/j.biocel.2003.12.010; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Kawaguchi M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-260; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Kondas K, 2011, BIOCHEM SOC T, V39, P1416, DOI 10.1042/BST0391416; Kramerova IA, 2000, DEVELOPMENT, V127, P5475; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; Martin Renaud, 2009, Recent Pat DNA Gene Seq, V3, P63; Matise MP, 1997, J NEUROSCI, V17, P7805; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Nagy A, 2003, EUR J BIOCHEM, V270, P2101, DOI 10.1046/j.1432-1033.2003.03593.x; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Petit D, 2006, J MOL EVOL, V63, P353, DOI 10.1007/s00239-005-0189-x; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Szlama G, 2010, FEBS J, V277, P5040, DOI 10.1111/j.1742-4658.2010.07909.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trexler M, 2002, BIOL CHEM, V383, P223, DOI 10.1515/BC.2002.023; Trexler M, 2001, P NATL ACAD SCI USA, V98, P3705, DOI 10.1073/pnas.061028398; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100	40	8	8	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43710	10.1371/journal.pone.0043710	http://dx.doi.org/10.1371/journal.pone.0043710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937083	Green Published, gold			2022-12-27	WOS:000308225500085
J	Pamenter, ME; Ryu, J; Hua, ST; Perkins, GA; Mendiola, VL; Gu, XQ; Ellisman, MH; Haddad, GG				Pamenter, Matthew E.; Ryu, Julie; Hua, Serena T.; Perkins, Guy A.; Mendiola, Vincent L.; Gu, Xiang Q.; Ellisman, Mark H.; Haddad, Gabriel G.			DIDS Prevents Ischemic Membrane Degradation in Cultured Hippocampal Neurons by Inhibiting Matrix Metalloproteinase Release	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; CELL-DEATH; SIGNALING PATHWAY; ARTERY OCCLUSION; RAT; INFLAMMATION; STROKE; REPERFUSION; DISRUPTION	During stroke, cells in the infarct core exhibit rapid failure of their permeability barriers, which releases ions and inflammatory molecules that are deleterious to nearby tissue (the penumbra). Plasma membrane degradation is key to penumbral spread and is mediated by matrix metalloproteinases (MMPs), which are released via vesicular exocytosis into the extracellular fluid in response to stress. DIDS (4,4'-diisothiocyanatostilbene-2,2'-disulphonic acid) preserves membrane integrity in neurons challenged with an in vitro ischemic penumbral mimic (ischemic solution: IS) and we asked whether this action was mediated via inhibition of MMP activity. In cultured murine hippocampal neurons challenged with IS, intracellular proMMP-2 and -9 expression increased 4-10 fold and extracellular latent and active MMP isoform expression increased 2-22 fold. MMP-mediated extracellular gelatinolytic activity increased similar to 20-50 fold, causing detachment of 32.1+/-4.5% of cells from the matrix and extensive plasma membrane degradation (>60% of cells took up vital dyes and >60% of plasma membranes were fragmented or blebbed). DIDS abolished cellular detachment and membrane degradation in neurons and the pathology-induced extracellular expression of latent and active MMPs. DIDS similarly inhibited extracellular MMP expression and cellular detachment induced by the pro-apoptotic agent staurosporine or the general proteinase agonist 4-aminophenylmercuric acetate (APMA). Conversely, DIDS-treatment did not impair stress-induced intracellular proMMP production, nor the intracellular cleavage of proMMP-2 to the active form, suggesting DIDS interferes with the vesicular extrusion of MMPs rather than directly inhibiting proteinase expression or activation. In support of this hypothesis, an antagonist of the V-type vesicular ATPase also inhibited extracellular MMP expression to a similar degree as DIDS. In addition, in a proteinase-independent model of vesicular exocytosis, DIDS prevented stimulus-evoked release of von Willebrand Factor from human umbilical vein endothelial cells. We conclude that DIDS inhibits MMP exocytosis and through this mechanism preserves neuronal membrane integrity during pathological stress.	[Pamenter, Matthew E.; Ryu, Julie; Hua, Serena T.; Gu, Xiang Q.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Perkins, Guy A.; Mendiola, Vincent L.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Perkins, Guy A.; Mendiola, Vincent L.; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Ellisman, Mark H.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Pamenter, ME (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	mpamenter@ucsd.edu	Pamenter, Matt/R-9216-2019	Pamenter, Matt/0000-0003-4035-9555; Mendiola, Vincent Louie/0000-0001-5287-0743; Perkins, Guy/0000-0002-1834-6646	NIH [5P01HD032573, P41-RR004050, P30-CA23100, P30 NS047101]; Natural Science and Engineering Research Council of Canada PDF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science and Engineering Research Council of Canada PDF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants 5P01HD032573 to GGH, P41-RR004050 and P30-CA23100 to MHE, and P30 NS047101 to the UCSD Neurosciences Microscopy Shared Facility; and a Natural Science and Engineering Research Council of Canada PDF to MEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amantea D, 2008, NEUROSCIENCE, V152, P8, DOI 10.1016/j.neuroscience.2007.12.030; Amantea D, 2007, INT REV NEUROBIOL, V82, P149, DOI 10.1016/S0074-7742(07)82008-3; Anderson RE, 1999, STROKE, V30, P160, DOI 10.1161/01.STR.30.1.160; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Benchoua A, 2001, J NEUROSCI, V21, P7127, DOI 10.1523/JNEUROSCI.21-18-07127.2001; BRANSTON NM, 1974, EXP NEUROL, V45, P195, DOI 10.1016/0014-4886(74)90112-5; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; Delcarlo M, 2006, AM J PHYSIOL-CELL PH, V290, pC802, DOI 10.1152/ajpcell.00214.2005; Dong WP, 2008, J VASC SURG, V48, P709, DOI 10.1016/j.jvs.2008.04.007; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Fukuda S, 2004, STROKE, V35, P998, DOI 10.1161/01.STR.0000119383.76447.05; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gao DK, 2006, LIFE SCI, V78, P2564, DOI 10.1016/j.lfs.2005.10.030; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Ju WK, 2009, MOL VIS, V15, P120; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004; Leppert D, 2001, BRAIN RES REV, V36, P249, DOI 10.1016/S0165-0173(01)00101-1; Liu AH, 2008, CELL PHYSIOL BIOCHEM, V22, P177, DOI 10.1159/000149795; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; Mun-Bryce S, 1998, AM J PHYSIOL-REG I, V274, pR1203, DOI 10.1152/ajpregu.1998.274.5.R1203; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; OLSEN TS, 1983, STROKE, V14, P332, DOI 10.1161/01.STR.14.3.332; Pamenter ME, 2012, BRAIN RES, V1452, P165, DOI 10.1016/j.brainres.2012.03.004; Pan XY, 2006, BRIT J HAEMATOL, V134, P491, DOI 10.1111/j.1365-2141.2006.06224.x; Ramasamy R, 2001, CARDIOVASC RES, V51, P275, DOI 10.1016/S0008-6363(01)00301-7; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Wang XM, 2005, CELL PHYSIOL BIOCHEM, V16, P147, DOI 10.1159/000089840; Xia ZL, 2003, NEUROSCI LETT, V340, P53, DOI 10.1016/S0304-3940(03)00075-2; Xue J, 2008, AM J PHYSIOL-REG I, V294, pR451, DOI 10.1152/ajpregu.00528.2007; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yao H, 2008, J NEUROCHEM; Yao H, 2007, J NEUROCHEM, V100, P1224, DOI 10.1111/j.1471-4159.2006.04299.x; Yao H, 2009, J NEUROCHEM, V108, P835, DOI 10.1111/j.1471-4159.2008.05838.x; Zalk R, 2006, FEBS LETT, V580, P5894, DOI 10.1016/j.febslet.2006.09.055; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	49	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43995	10.1371/journal.pone.0043995	http://dx.doi.org/10.1371/journal.pone.0043995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937143	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500134
J	Venet, S; Ravn, U; Buatois, V; Gueneau, F; Calloud, S; Kosco-Vilbois, M; Fischer, N				Venet, Sophie; Ravn, Ulla; Buatois, Vanessa; Gueneau, Franck; Calloud, Sebastien; Kosco-Vilbois, Marie; Fischer, Nicolas			Transferring the Characteristics of Naturally Occurring and Biased Antibody Repertoires to Human Antibody Libraries by Trapping CDRH3 Sequences	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; PHAGE DISPLAY APPROACH; V-GENE LIBRARIES; COMBINATORIAL LIBRARIES; CRYSTAL-STRUCTURE; IMMUNE-RESPONSE; SELECTION; CONSTRUCTION; REGIONS; LENGTH	Antibody repertoires are characterized by diversity as they vary not only amongst individuals and post antigen exposure but also differ significantly between vertebrate species. Such plasticity can be exploited to generate human antibody libraries featuring hallmarks of these diverse repertoires. In this study, the focus was to capture CDRH3 sequences, as this region generally accounts for most of the interaction energy with antigen. Sequences from human as well as non-human sources were successfully integrated into human antibody libraries. Next generation sequencing of these libraries proved that the CDRH3 lengths and amino acid composition corresponded to the species of origin. Specific CDRH3 sequences, biased towards the recognition of a model antigen either by immunizing mice or by selecting with phage display, were then integrated into another set of libraries. From these antigen biased libraries, highly potent antibodies were more frequently isolated, indicating that the characteristics of an immune repertoire is transferrable via CDRH3 sequences into a human antibody library. Taken together, these data demonstrate that the properties of naturally or experimentally biased repertoires can be effectively harnessed for the generation of targeted human antibody libraries, substantially increasing the probability of isolating antibodies suitable for therapeutic and diagnostic applications.	[Venet, Sophie; Ravn, Ulla; Buatois, Vanessa; Gueneau, Franck; Calloud, Sebastien; Kosco-Vilbois, Marie; Fischer, Nicolas] NovImmune SA, Geneva, Switzerland	NovImmune SA	Venet, S (corresponding author), NovImmune SA, Geneva, Switzerland.	nfischer@novimmune.com						Ackerman ME, 2011, PROTEIN ENG DES SEL, V24, P845, DOI 10.1093/protein/gzr046; Amersdorfer P, 1997, INFECT IMMUN, V65, P3743, DOI 10.1128/IAI.65.9.3743-3752.1997; Amersdorfer P, 2002, VACCINE, V20, P1640, DOI 10.1016/S0264-410X(01)00482-0; BARBAS CF, 1995, NAT MED, V1, P837, DOI 10.1038/nm0895-837; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P4457, DOI 10.1073/pnas.89.10.4457; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Barrios Y, JMR, V17, P332; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chassagne S, 2004, MOL IMMUNOL, V41, P539, DOI 10.1016/j.molimm.2004.03.040; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; DEKRUIF J, 1995, J MOL BIOL, V248, P97, DOI 10.1006/jmbi.1995.0204; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fisch I, 1996, P NATL ACAD SCI USA, V93, P7761, DOI 10.1073/pnas.93.15.7761; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Lee HW, 2006, BIOCHEM BIOPH RES CO, V346, P896, DOI 10.1016/j.bbrc.2006.05.202; Lloyd C, 2009, PROTEIN ENG DES SEL, V22, P159, DOI 10.1093/protein/gzn058; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Pelat T, 2009, MABS-AUSTIN, V1, P377, DOI 10.4161/mabs.1.4.8635; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Persson H, 2006, J MOL BIOL, V357, P607, DOI 10.1016/j.jmb.2006.01.004; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Rader C, 2000, J BIOL CHEM, V275, P13668, DOI 10.1074/jbc.275.18.13668; Rader C, 1998, P NATL ACAD SCI USA, V95, P8910, DOI 10.1073/pnas.95.15.8910; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Steinberger P, 2000, J BIOL CHEM, V275, P36073, DOI 10.1074/jbc.M002765200; Thie H, 2008, CURRENT PHARM BIOTEC, V9, P8; Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Wu BP, 2001, WORLD J GASTROENTERO, V7, P811, DOI 10.3748/wjg.v7.i6.811; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; Yin CC, 2008, J BIOCHEM, V144, P591, DOI 10.1093/jb/mvn103; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	42	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43471	10.1371/journal.pone.0043471	http://dx.doi.org/10.1371/journal.pone.0043471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937053	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500054
J	Choi, J; Song, SH; Bak, CW; Sung, SR; Yoon, TK; Lee, DR; Shim, SH				Choi, Jin; Song, Seung-Hun; Bak, Chong Won; Sung, Se Ra; Yoon, Tae Ki; Lee, Dong Ryul; Shim, Sung Han			Impaired Spermatogenesis and gr/gr Deletions Related to Y Chromosome Haplogroups in Korean Men	PLOS ONE			English	Article							HAN-CHINESE POPULATION; FACTOR-C REGION; MALE-INFERTILITY; AZFC REGION; DNA VARIATION; RISK-FACTOR; SUBDELETION; FAILURE; DUPLICATIONS; ASSOCIATION	Microdeletion of the Azoospermia Factor (AZF) regions in Y chromosome is a well-known genetic cause of male infertility resulting from spermatogenetic impairment. However, the partial deletions of AZFc region related to spermatogenetic impairment are controversial. In this study, we characterized partial deletion of AZFc region in Korean patients with spermatogenetic impairment and assessed whether the DAZ and CDY1 contributes to the phenotype in patients with gr/gr deletions. Total of 377 patients with azoo-/oligozoospermia and 217controls were analyzed using multiplex polymerase chain reaction (PCR), analysis of DAZ-CDY1 sequence family variants (SFVs), and quantitative fluorescent (QF)-PCR. Of the 377 men with impaired spermatogenesis, 59 cases (15.6%) had partial AZFc deletions, including 32 gr/gr (8.5%), 22 b2/b3 (5.8%), four b1/b3 (1.1%) and one b3/b4 (0.3%) deletion. In comparison, 14 of 217 normozoospermic controls (6.5%) had partial AZFc deletions, including five gr/gr (2.3%) and nine b2/b3 (4.1%) deletions. The frequency of gr/gr deletions was significantly higher in the azoo-/oligozoospermic group than in the normozoospermic control group (p = 0.003; OR = 3.933; 95% CI = 1.509-10.250). Concerning Y haplogroup, we observed no significant differences in the frequency of gr/gr deletions between the case and the control groups in the YAP+ lineages, while gr/gr deletion were significantly higher in azoo-/oligozoospermia than normozoospermia in the YAP- lineage (p = 0.004; OR = 6.341; 95% CI = 1.472-27.312). Our data suggested that gr/gr deletion is associated with impaired spermatogenesis in Koreans with YAP- lineage, regardless of the gr/gr subtypes.	[Choi, Jin; Sung, Se Ra; Shim, Sung Han] CHA Gangnam Med Ctr, Fertil Ctr, Genet Lab, Seoul, South Korea; [Song, Seung-Hun; Bak, Chong Won] CHA Univ, Dept Urol, Fertil Ctr, CHA Gangnam Med Ctr, Seoul, South Korea; [Yoon, Tae Ki] CHA Univ, Dept Obstet & Gynecol, Fertil Ctr, CHA Gangnam Med Ctr, Seoul, South Korea; [Lee, Dong Ryul; Shim, Sung Han] CHA Univ, Dept Biomed Sci, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Choi, J (corresponding author), CHA Gangnam Med Ctr, Fertil Ctr, Genet Lab, Seoul, South Korea.	shshim@cha.ac.kr			Ministry for Health, Welfare and Family Affairs, Republic of Korea [A084923]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant (A084923) of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Carvalho CMB, 2006, J HUM GENET, V51, P794, DOI 10.1007/s10038-006-0024-2; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Eloualid A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034902; Ferlin A, 2005, J MED GENET, V42, P209, DOI 10.1136/jmg.2004.025833; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Fernando L, 2006, ASIAN J ANDROL, V8, P39, DOI 10.1111/j.1745-7262.2006.00100.x; Ferras C, 2004, MOL HUM REPROD, V10, P755, DOI 10.1093/molehr/gah104; Giachini C, 2005, J MED GENET, V42, P497, DOI 10.1136/jmg.2004.028191; Giachini C, 2008, HUM GENET, V124, P399, DOI 10.1007/s00439-008-0561-1; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Jin HJ, 2003, HUM GENET, V114, P27, DOI 10.1007/s00439-003-1019-0; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kim W, 2000, J HUM GENET, V45, P76, DOI 10.1007/s100380050015; Krausz C, 2009, J MED GENET, V46, P21, DOI 10.1136/jmg.2008.059915; Kucklenbroich K, 2005, HUM REPROD, V20, P191, DOI 10.1098/humrep/deh558; Lin YW, 2007, HUM MUTAT, V28, P486, DOI 10.1002/humu.20473; Lu CC, 2011, HUM MOL GENET, V20, P4411, DOI 10.1093/hmg/ddr369; Lu CC, 2009, HUM MOL GENET, V18, P1122, DOI 10.1093/hmg/ddn427; Lynch M, 2005, MOL HUM REPROD, V11, P507, DOI 10.1093/molehr/gah191; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; Navarro-Costa P, 2010, HUM REPROD UPDATE, V16, P525, DOI 10.1093/humupd/dmq005; Noordam MJ, 2006, CURR OPIN GENET DEV, V16, P225, DOI 10.1016/j.gde.2006.04.018; Plaseski T, 2008, GENET TEST, V12, P595, DOI 10.1089/gte.2008.0068; Ravel C, 2006, FERTIL STERIL, V85, P229, DOI 10.1016/j.fertnstert.2005.07.1278; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Repping S, 2004, GENOMICS, V83, P1046, DOI 10.1016/j.ygeno.2003.12.018; Shahid M, 2011, EUR J HUM GENET, V19, P23, DOI 10.1038/ejhg.2010.151; Sin HS, 2010, HUM REPROD, V25, P2396, DOI 10.1093/humrep/deq191; Stouffs K, 2008, HUM REPROD, V23, P1193, DOI 10.1093/humrep/den069; Stouffs K, 2011, HUM REPROD UPDATE, V17, P197, DOI 10.1093/humupd/dmq046; Visser L, 2009, HUM REPROD, V24, P2667, DOI 10.1093/humrep/dep243; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; World Health Organization, 1999, WHO LAB MAN EX HUM S; Wu B, 2007, HUM REPROD, V22, P1107, DOI 10.1093/humrep/del499; Yang Y, 2006, FERTIL STERIL, V85, P1061, DOI 10.1016/j.fertnstert.2005.09.025; Yang Y, 2010, INT J ANDROL, V33, P745, DOI 10.1111/j.1365-2605.2009.01015.x; Yen P, 2001, NAT GENET, V29, P243, DOI 10.1038/ng1101-243; Zhang F, 2006, ANN HUM GENET, V70, P304, DOI 10.1111/j.1469-1809.2005.00231.x	39	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43550	10.1371/journal.pone.0043550	http://dx.doi.org/10.1371/journal.pone.0043550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927988	Green Published, gold			2022-12-27	WOS:000308224700017
J	Coviello, L; Franceschetti, M; McCubbins, MD; Paturi, R; Vattani, A				Coviello, Lorenzo; Franceschetti, Massimo; McCubbins, Mathew D.; Paturi, Ramamohan; Vattani, Andrea			Human Matching Behavior in Social Networks: An Algorithmic Perspective	PLOS ONE			English	Article							DYNAMICS	We argue that algorithmic modeling is a powerful approach to understanding the collective dynamics of human behavior. We consider the task of pairing up individuals connected over a network, according to the following model: each individual is able to propose to match with and accept a proposal from a neighbor in the network; if a matched individual proposes to another neighbor or accepts another proposal, the current match will be broken; individuals can only observe whether their neighbors are currently matched but have no knowledge of the network topology or the status of other individuals; and all individuals have the common goal of maximizing the total number of matches. By examining the experimental data, we identify a behavioral principle called prudence, develop an algorithmic model, analyze its properties mathematically and by simulations, and validate the model with human subject experiments for various network sizes and topologies. Our results include i) a 1/2-approximate maximum matching is obtained in logarithmic time in the network size for bounded degree networks; ii) for any constant epsilon>0, a (1-epsilon)-approximate maximum matching is obtained in polynomial time, while obtaining a maximum matching can require an exponential time; and iii) convergence to a maximum matching is slower on preferential attachment networks than on small-world networks. These results allow us to predict that while humans can find a "good quality" matching quickly, they may be unable to find a maximum matching in feasible time. We show that the human subjects largely abide by prudence, and their collective behavior is closely tracked by the above predictions.	[Coviello, Lorenzo; Franceschetti, Massimo] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [McCubbins, Mathew D.] Univ So Calif, Dept Polit Sci, Los Angeles, CA USA; [Paturi, Ramamohan; Vattani, Andrea] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Southern California; University of California System; University of California San Diego	Coviello, L (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	lcoviell@ucsd.edu		McCubbins, Mathew/0000-0003-0606-2109	National Science Foundation [0905645]; Army Research Office [W911NF-11-1-0363]	National Science Foundation(National Science Foundation (NSF)); Army Research Office	This work was partially supported by the National Science Foundation under grant number 0905645 and the Army Research Office under grant W911NF-11-1-0363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2011, IEEE DECIS CONTR P, P2329, DOI 10.1109/CDC.2011.6160999; Ashlagi I, 2011, P 12 ACM C EL COMM, P335; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bollobas B, 2001, RANDOM STRUCT ALGOR, V18, P279, DOI 10.1002/rsa.1009; Bovier A., 2006, STAT MECH DISORDERED, V18; Brandt C, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P789; Brautbar M, 2011, LECT NOTES COMPUT SC, V6982, P224, DOI 10.1007/978-3-642-24829-0_21; Cebrian M, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P775; Cook M., 2004, COMPLEX SYST, V15, P1; Enemark D.P., 2011, P 12 ACM C EL COMM; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; Goyal S, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P759; Hatfield J, 2010, P 11 ACM C EL COMM, P119; ISRAELI A, 1986, INFORM PROCESS LETT, V22, P77, DOI 10.1016/0020-0190(86)90144-4; Judd Stephen, 2011, Internet and Network Economics. Proceedings 7th International Workshop, WINE 2011, P242, DOI 10.1007/978-3-642-25510-6_21; Judd S, 2010, P NATL ACAD SCI USA, V107, P14978, DOI 10.1073/pnas.1001280107; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Karp, 1971, SWITCH AUT THEOR 197, P122, DOI [DOI 10.1109/SWAT.1971.1, 10.1109/SWAT.1971.1]; KARP RM, 1986, COMBINATORICA, V6, P35, DOI 10.1007/BF02579407; Kearns M, 2012, P ACM C EL COMM; Kearns M, 2006, SCIENCE, V313, P824, DOI 10.1126/science.1127207; Kearns M, 2009, P NATL ACAD SCI USA, V106, P1347, DOI 10.1073/pnas.0808147106; Kleinberg J, 2005, ANN IEEE SYMP FOUND, P132, DOI 10.1109/SFCS.2005.63; Liggett T. M, 1985, INTERACTING PARTICLE, V276; McCubbins MD, 2009, AM POLIT RES, V37, P899, DOI 10.1177/1532673X09337184; Montanari A, 2009, ANN IEEE SYMP FOUND, P303, DOI 10.1109/FOCS.2009.64; Pettie S, 2004, INFORM PROCESS LETT, V91, P271, DOI 10.1016/j.ipl.2004.05.007; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Roth A.E., 1992, 2 SIDED MATCHING STU, V18; Simon H, 1976, ADM BEHAV, V3; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; von Neumann J, 1966, THEORY SELF PRODUCIN; Wang J, 2012, P ACM C EL COMM; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; [No title captured]; [No title captured]	36	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41900	10.1371/journal.pone.0041900	http://dx.doi.org/10.1371/journal.pone.0041900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927918	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300016
J	Sewell, D; Guillera-Arroita, G; Griffiths, RA; Beebee, TJC				Sewell, David; Guillera-Arroita, Gurutzeta; Griffiths, Richard A.; Beebee, Trevor J. C.			When Is a Species Declining? Optimizing Survey Effort to Detect Population Changes in Reptiles	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; DETECTION PROBABILITIES; DESIGNING OCCUPANCY; IMPERFECT DETECTION; AMPHIBIAN DECLINES; CITIZEN SCIENCE; EXTINCTION; ABSENCE; MODELS	Biodiversity monitoring programs need to be designed so that population changes can be detected reliably. This can be problematical for species that are cryptic and have imperfect detection. We used occupancy modeling and power analysis to optimize the survey design for reptile monitoring programs in the UK. Surveys were carried out six times a year in 20092010 at multiple sites. Four out of the six species - grass snake, adder, common lizard, slow-worm -were encountered during every survey from March-September. The exceptions were the two rarest species - sand lizard and smooth snake - which were not encountered in July 2009 and March 2010 respectively. The most frequently encountered and most easily detected species was the slow-worm. For the four widespread reptile species in the UK, three to four survey visits that used a combination of directed transect walks and artificial cover objects resulted in 95% certainty that a species would be detected if present. Using artificial cover objects was an effective detection method for most species, considerably increased the detection rate of some, and reduced misidentifications. To achieve an 85% power to detect a decline in any of the four widespread species when the true decline is 15%, three surveys at a total of 886 sampling sites, or four surveys at a total of 688 sites would be required. The sampling effort needed reduces to 212 sites surveyed three times, or 167 sites surveyed four times, if the target is to detect a true decline of 30% with the same power. The results obtained can be used to refine reptile survey protocols in the UK and elsewhere. On a wider scale, the occupancy study design approach can be used to optimize survey effort and help set targets for conservation outcomes for regional or national biodiversity assessments.	[Sewell, David; Griffiths, Richard A.] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Sewell, David; Beebee, Trevor J. C.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Guillera-Arroita, Gurutzeta] Univ Kent, Natl Ctr Stat Ecol, Sch Math Stat & Actuarial Sci, Canterbury, Kent, England	University of Kent; University of Sussex; University of Kent	Sewell, D (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England.	R.A.Griffiths@kent.ac.uk	Guillera-Arroita, Gurutzeta/F-7461-2015	Guillera-Arroita, Gurutzeta/0000-0002-8387-5739	Esmee Fairburn Foundation; EPSRC/NCSE (Engineering and Physical Sciences Research Council/National Centre for Statistical Ecology); Engineering and Physical Sciences Research Council [EP/I000917/1] Funding Source: researchfish; Natural Environment Research Council [NE/I008403/1] Funding Source: researchfish; EPSRC [EP/I000917/1] Funding Source: UKRI; NERC [NE/I008403/1] Funding Source: UKRI	Esmee Fairburn Foundation; EPSRC/NCSE (Engineering and Physical Sciences Research Council/National Centre for Statistical Ecology); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank the Esmee Fairburn Foundation (http://www.esmeefairbairn.org.uk/) for financial support. The work of G.G.-A. was supported by an EPSRC/NCSE (Engineering and Physical Sciences Research Council/National Centre for Statistical Ecology; http://gow.epsrc.ac.uk/) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Beebee TJC, 2000, AMPHIBIANS REPTILES, P166; Beebee Trevor J.C., 2009, Diversity, V1, P67; BRAITHWAITE AC, 1989, HERPETOL J, V1, P370; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Deming WE, 1941, J AM STAT ASSOC, V36, P45, DOI 10.2307/2278811; Dorazio RM, 2007, ECOLOGY, V88, P2773, DOI 10.1890/07-0006.1; Engel Sarah R., 2002, American Entomologist, V48, P164; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Green DM, 1997, HERPETOLOGICAL CONSE, V1, P291; Griffiths RA, 2010, BIOL CONSERV, V143, P485, DOI 10.1016/j.biocon.2009.11.017; Guillera-Arroita G, METHODS ECO IN PRESS; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Harshbarger JC, 2000, MAR ENVIRON RES, V50, P247, DOI 10.1016/S0141-1136(00)00055-6; Hoffmann M, 2011, PHILOS T R SOC B, V366, P2598, DOI 10.1098/rstb.2011.0116; Holck MH, 2008, BIODIVERS CONSERV, V17, P2023, DOI 10.1007/s10531-007-9273-4; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Jiguet F, 2010, GLOBAL CHANGE BIOL, V16, P497, DOI 10.1111/j.1365-2486.2009.01963.x; Jones T, 2010, J ANIM ECOL, V79, P98, DOI 10.1111/j.1365-2656.2009.01610.x; Joppa LN, 2010, HERPETOL CONSERV BIO, V5, P143; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; King DI, 2008, BIODIVERS CONSERV, V17, P2691, DOI 10.1007/s10531-007-9244-9; Kostadinova I, 2011, CURR SCI INDIA, V100, P973; Light T, 2007, CONSERV BIOL, V21, P434, DOI 10.1111/j.1523-1739.2006.00643.x; Lotz A, 2007, J WILDLIFE MANAGE, V71, P675, DOI 10.2193/2005-759; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MCARDLE BH, 1990, OIKOS, V57, P276, DOI 10.2307/3565950; Morgan BJT, 2008, APPL STOCH MODEL BUS, P101; Pellet J, 2005, BIOL CONSERV, V123, P27, DOI 10.1016/j.biocon.2004.10.005; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; Reading CJ, 1997, J APPL ECOL, V34, P1057, DOI 10.2307/2405294; Reed JM, 1996, CONSERV BIOL, V10, P1283, DOI 10.1046/j.1523-1739.1996.10041283.x; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Tanadini LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028244; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Wee YC, 2011, RAFFLES B ZOOL, P23; Wintle BA, 2012, DIVERS DISTRIB, V18, P417, DOI 10.1111/j.1472-4642.2011.00874.x	48	49	53	5	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43387	10.1371/journal.pone.0043387	http://dx.doi.org/10.1371/journal.pone.0043387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937044	Green Published, gold			2022-12-27	WOS:000308286300048
J	Zhao, LY; Tian, J; Wang, W; Qin, W; Shi, J; Li, Q; Yuan, K; Dong, MH; Yang, WC; Wang, YR; Sun, LL; Lu, L				Zhao, Li-Yan; Tian, Jie; Wang, Wei; Qin, Wei; Shi, Jie; Li, Qiang; Yuan, Kai; Dong, Ming-Hao; Yang, Wei-Chuang; Wang, Ya-Rong; Sun, Li-Li; Lu, Lin			The Role of Dorsal Anterior Cingulate Cortex in the Regulation of Craving by Reappraisal in Smokers	PLOS ONE			English	Article							ATTENTIONAL CONTROL; EMOTION REGULATION; RESPONSE CONFLICT; NEGATIVE EMOTION; DRUG-ADDICTION; SMOKING CUES; FMRI; AVAILABILITY; NEUROBIOLOGY; SUPPRESSION	Rationale and Objective: Drug cues can induce craving for drugs of abuse. Dysfunctional regulation of emotion and motivation regarding rewarding objects appears to be an integral part of addiction. It has been found that cognitive strategies decreased the intensity of craving in addicts. Reappraisal strategy is a type of cognitive strategy that requires participants to reinterpret the meaning of an emotional situation. In addition, studies have found that activation of the dorsal anterior cingulate cortex (dACC) is associated with the selection and application of cognitive reappraisal. In present study, we sought to determine whether such cognitive regulation engages the dACC and improves inhibition of craving in smokers. Methods: Sixteen smokers underwent functional magnetic resonance imaging (fMRI) during performance of a cigarette reward-conditioning procedure with cognitive reappraisal. We focused our analyses on the dACC as a key structure of cognitive control of craving. Cue induced craving under different conditions was obtained. Correlational analysis between the functional response in the dACC and the subjective craving was performed. Results: We found that using a cognitive reappraisal was successful in decreasing the conditioned craving. Right dACC (BA 24/32) engaged in the cognitive reappraisal. In addition, the individual's subjective craving was negatively correlated with the right dACC activation. Conclusions: These findings suggest that the dACC are important substrates of Inhibition of cue induced craving in smokers. Cognitive regulation by cognitive reappraisal may help addicted individuals avoid the anticipated situations where they are exposed to conditioned cues.	[Zhao, Li-Yan; Shi, Jie; Sun, Li-Li; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Tian, Jie; Qin, Wei; Yuan, Kai; Dong, Ming-Hao] Xidian Univ, Xian, Peoples R China; [Wang, Wei; Li, Qiang; Yang, Wei-Chuang; Wang, Ya-Rong] Fourth Mil Med Univ, Tangdu Hosp, Xian 710032, Peoples R China	Peking University; Xidian University; Air Force Military Medical University	Zhao, LY (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	zgywyls2006@bjmu.edu.cn	SHI, JIE/GXG-3394-2022; Yuan, Kai/M-9403-2013; Tian, Jie/H-1190-2011; tian, jie/M-6336-2013; 秦, 伟/J-9770-2016; Yuan, Kai/I-4150-2016; Dong, Minghao/A-6425-2014	Tian, Jie/0000-0003-0498-0432; 秦, 伟/0000-0003-4583-0406; Yuan, Kai/0000-0002-3098-1124; Dong, Minghao/0000-0002-0190-6985	National Basic Research Program of China (973 Program) [2009CB522000, 2011CB707800]; Natural Science Foundation of China [91132716, 31070958]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2009CB522000 and 2011CB707800) and the Natural Science Foundation of China (No: 91132716 and 31070958). The URL of the funder's website: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Delgado MR, 2008, NAT NEUROSCI, V11, P880, DOI 10.1038/nn.2141; Domino EF, 2002, PROG NEURO-PSYCHOPH, V26, P1071, DOI 10.1016/S0278-5846(02)00224-5; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; DROUNGAS A, 1995, ADDICT BEHAV, V20, P657, DOI 10.1016/0306-4603(95)00029-C; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Engelmann JM, 2012, NEUROIMAGE, V60, P252, DOI 10.1016/j.neuroimage.2011.12.024; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Field M, 2001, BEHAV PHARMACOL, V12, P183, DOI 10.1097/00008877-200105000-00004; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Giuliani NR, 2011, NEUROIMAGE, V58, P10, DOI 10.1016/j.neuroimage.2011.06.028; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Heishman SJ, 2010, EXP CLIN PSYCHOPHARM, V18, P245, DOI 10.1037/a0019401; Juliano LM, 1998, EXP CLIN PSYCHOPHARM, V6, P45, DOI 10.1037/1064-1297.6.1.45; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kalisch R, 2006, NEUROIMAGE, V30, P1458, DOI 10.1016/j.neuroimage.2005.11.011; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; O'Connell KA, 2007, HEALTH PSYCHOL, V26, P77, DOI 10.1037/0278-6133.26.1.77; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Perkins K A, 2001, Nicotine Tob Res, V3, P141; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Ray RD, 2005, COGN AFFECT BEHAV NE, V5, P156, DOI 10.3758/CABN.5.2.156; Shiffman S, 2007, DRUG ALCOHOL DEPEN, V91, P159, DOI 10.1016/j.drugalcdep.2007.05.017; Staudinger MR, 2009, NEUROIMAGE, V47, P713, DOI 10.1016/j.neuroimage.2009.04.095; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	39	24	26	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43598	10.1371/journal.pone.0043598	http://dx.doi.org/10.1371/journal.pone.0043598			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928000	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300071
J	Yin, G; Wang, YX; Zheng, ZY; Yang, H; Xu, L; Jonas, JB				Yin, Guo; Wang, Ya Xing; Zheng, Zhi Yun; Yang, Hua; Xu, Liang; Jonas, Jost B.		Beijing Eye Study Grp	Ocular Axial Length and Its Associations in Chinese: The Beijing Eye Study	PLOS ONE			English	Article							TANJONG-PAGAR SURVEY; ANTERIOR-CHAMBER DEPTH; REFRACTIVE ERROR; ADULT-POPULATION; ANGLE-CLOSURE; RURAL MYANMAR; MEIKTILA EYE; HIGH MYOPIA; BIOMETRY; DIMENSIONS	Purpose: To investigate the normative data of ocular axial length and its associations in Chinese. Method: The population-based Beijing Eye Study 2011 is a cross-sectional study performed in Greater Beijing. The study included 3468 individuals (1963 (56.6%) women) with a mean age of 64.6 +/- 9.8 years (range: 50-93 years). A detailed ophthalmic and medical examination was performed. Axial length was measured by optical low-coherence reflectometry. Results: Axial length measurements were available for 3159 (91.1%) study participants. Mean axial length was 23.25 +/- 1.14 mm (range: 18.96-30.88 mm). In multivariate analysis, axial length was significantly associated with the systemic parameters of higher age (P < 0.001), higher body height (P = 0.003), higher level of education (P < 0.001) and urban region of habitation (P < 0.001), and with the ocular parameters of thicker central cornea (P = 0.001), higher corneal curvature radius (P < 0.001), deeper anterior chamber (P < 0.001), thicker lens (P < 0.001), more myopic refractive error (P < 0.001), larger pupil diameter (P = 0.018), and higher best corrected visual acuity (P < 0.001). It was additionally and negatively associated with the lens vault (P < 0.001). In highly myopic eyes, axial length was significantly associated with lower level of education (P = 0.008), more myopic refractive error (P < 0.001), and lower best corrected visual acuity (P = 0.034). Conclusions: Mean ocular axial length in the older adult population of Greater Beijing (23.25 +/- 1.14 mm) was similar to the value measured in other urban populations and was higher than in a rural Central Indian population. The association between axial length and older age may potentially be associated with a survival artifact. The association between axial length and body height agrees with the general association between anthropomorphic measures and eye globe size. The association with the level of education and urban region of habitation confirms with previous studies. In contrast in highly myopic eyes, axial length was negatively associated with educational level and best corrected visual acuity.	[Yin, Guo; Wang, Ya Xing; Yang, Hua; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Zheng, Zhi Yun] PLA Gen Armament Dept, Yayuncun Clin, Beijing, Peoples R China; [Jonas, Jost B.] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Yin, G (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com	You, Qisheng/A-3619-2014; You, Qisheng/AAG-7153-2020; Guo, Yin/ABC-2134-2020; wang, YA XING/K-9671-2016	You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320; Guo, Yin/0000-0003-3806-3771; wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eysteinsson T, 2005, ACTA OPHTHALMOL SCAN, V83, P734, DOI 10.1111/j.1600-0420.2005.00540.x; Foster PJ, 2010, BRIT J OPHTHALMOL, V94, P827, DOI 10.1136/bjo.2009.163899; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; He MG, 2009, INVEST OPHTH VIS SCI, V50, P5130, DOI 10.1167/iovs.09-3455; Iribarren R, 2012, INVEST OPHTH VIS SCI, V53, P543, DOI 10.1167/iovs.11-8523; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Lavanya R, 2010, INVEST OPHTH VIS SCI, V51, P6247, DOI 10.1167/iovs.10-5229; Lee KE, 2009, ARCH OPHTHALMOL-CHIC, V127, P88, DOI 10.1001/archophthalmol.2008.521; Liang YB, 2009, OPHTHAL EPIDEMIOL, V16, P115, DOI 10.1080/09286580902738159; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Nongpiur ME, 2010, OPHTHALMOLOGY, V117, P1967, DOI 10.1016/j.ophtha.2010.02.007; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P2748, DOI 10.1167/iovs.04-1324; Saw SM, 2007, AM J OPHTHALMOL, V144, P325, DOI 10.1016/j.ajo.2007.03.038; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Shufelt C, 2005, INVEST OPHTH VIS SCI, V46, P4450, DOI 10.1167/iovs.05-0435; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Warrier S, 2008, BRIT J OPHTHALMOL, V92, P1591, DOI 10.1136/bjo.2008.144477; Wickremasinghe S, 2004, INVEST OPHTH VIS SCI, V45, P776, DOI 10.1167/iovs.03-0456; Wojciechowski R, 2003, OPHTHALMOLOGY, V110, P365, DOI 10.1016/S0161-6420(02)01748-7; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P963, DOI 10.1136/bjo.86.9.963; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1237; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P73; Wu HM, 2007, CLIN EXP OPHTHALMOL, V35, P834, DOI 10.1111/j.1442-9071.2007.01638.x; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Xu L, 2007, ACTA OPHTHALMOL SCAN, V85, P914, DOI 10.1111/j.1600-0420.2007.00966.x; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050	27	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43172	10.1371/journal.pone.0043172	http://dx.doi.org/10.1371/journal.pone.0043172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927949	Green Submitted, gold, Green Published			2022-12-27	WOS:000307789700025
J	Sun, TT; Yan, YW; Zhao, Y; Guo, F; Jiang, CY				Sun, Tingting; Yan, Yiwu; Zhao, Yan; Guo, Feng; Jiang, Chengyu			Copper Oxide Nanoparticles Induce Autophagic Cell Death in A549 Cells	PLOS ONE			English	Article							PSEUDOKIRCHNERIELLA-SUBCAPITATA; BULK ZNO; IN-VIVO; TOXICITY; PARTICLES; CANCER; TIO2; NANO; CUO; NANOMATERIALS	Metal oxide nanoparticles (NPs) are among the most highly produced nanomaterials, and have many diverse functions in catalysis, environmental remediation, as sensors, and in the production of personal care products. In this study, the toxicity of several widely used metal oxide NPs such as copper oxide, silica, titanium oxide and ferric oxide NPs, were evaluated In vitro. We exposed A549, H1650 and CNE-2Z cell lines to metal oxide NPs, and found CuO NPs to be the most toxic, SiO2 mild toxic, while the other metal oxide NPs had little effect on cell viability. Furthermore, the autophagic biomarker LC3-II significantly increased in A549 cells treated with CuO NPs, and the use of the autophagy inhibitors wortmannin and 3-methyladenin significantly improved cell survival. These results indicate that the cytoxicity of CuO NPs may involve the autophagic pathway in A549 cells.	[Sun, Tingting; Yan, Yiwu; Zhao, Yan; Guo, Feng; Jiang, Chengyu] Tsinghua Univ, Peking Union Med Coll, Chinese Acad Med Sci, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University	Sun, TT (corresponding author), Tsinghua Univ, Peking Union Med Coll, Chinese Acad Med Sci, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100084, Peoples R China.	jiang@pumc.edu.cn	Yan, Yiwu/P-5499-2017	Yan, Yiwu/0000-0001-8289-7277; Guo, Feng/0000-0002-4506-7618	Ministry of Science and Technology of China [2009CB522105, 2011CB933504]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The funds supporting this work are all from Ministry of Science and Technology of China, grant numbers 2009CB522105 and 2011CB933504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, BIOCHEM BIOPH RES CO, V396, P578, DOI 10.1016/j.bbrc.2010.04.156; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bergmann A, 2007, CELL, V131, P1032, DOI 10.1016/j.cell.2007.11.027; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chen Y, 2005, BIOCHEM BIOPH RES CO, V337, P52, DOI 10.1016/j.bbrc.2005.09.018; Chen Z, 2006, TOXICOL LETT, V163, P109, DOI 10.1016/j.toxlet.2005.10.003; Cho WS, 2010, ENVIRON HEALTH PERSP, V118, P1699, DOI 10.1289/ehp.1002201; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Franklin NM, 2007, ENVIRON SCI TECHNOL, V41, P8484, DOI 10.1021/es071445r; Griffitt RJ, 2007, ENVIRON SCI TECHNOL, V41, P8178, DOI 10.1021/es071235e; Gupta AK, 2005, BIOMATERIALS, V26, P1565, DOI 10.1016/j.biomaterials.2004.05.022; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Jeng HA, 2006, J ENVIRON SCI HEAL A, V41, P2699, DOI 10.1080/10934520600966177; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; Kasemets K, 2009, TOXICOL IN VITRO, V23, P1116, DOI 10.1016/j.tiv.2009.05.015; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Lei RH, 2008, TOXICOL APPL PHARM, V232, P292, DOI 10.1016/j.taap.2008.06.026; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Li CG, 2009, J MOL CELL BIOL, V1, P37, DOI 10.1093/jmcb/mjp002; Li JJ, 2010, BIOMATERIALS, V31, P5996, DOI 10.1016/j.biomaterials.2010.04.014; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711; Service RF, 2003, SCIENCE, V300, P243; Yokohira M, 2008, TOXICOL PATHOL, V36, P620, DOI 10.1177/0192623308318214; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005; Zabirnyk O, 2007, AUTOPHAGY, V3, P278, DOI 10.4161/auto.3916	39	111	119	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43442	10.1371/journal.pone.0043442	http://dx.doi.org/10.1371/journal.pone.0043442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916263	gold, Green Submitted, Green Published			2022-12-27	WOS:000307733800067
J	Cantu, MA; Lupo, PJ; Bilgi, M; Hicks, MJ; Allen, CE; McClain, KL				Cantu, Maria A.; Lupo, Philip J.; Bilgi, Mrinalini; Hicks, M. John; Allen, Carl E.; McClain, Kenneth L.			Optimal Therapy for Adults with Langerhans Cell Histiocytosis Bone Lesions	PLOS ONE			English	Article							EOSINOPHILIC GRANULOMA; RADIOTHERAPY; EXPERIENCE	Background: There is little data on treatment of Langerhans cell histiocytosis (LCH) in adults. Available data is on small numbers of patients with short follow-up times and no comparison of results from different treatment regimens. We analyzed the responses of adult LCH patients with bone lesions to three primary chemotherapy treatments to define the optimal one. Methods and Findings: Fifty-eight adult patients with bone lesions, either as a solitary site or as a component of multisystem disease, were analyzed for disease location and response to surgery, curettage, steroids, radiation, vinblastine/prednisone, 2-Chlorodeoxyadenosine (2-CdA), or cytosine arabinoside (ARA-C). The mean age of patients was 32 years, with equal gender distribution. Twenty-nine patients had 1 lesion; 16, 2 lesions; 5, 3 lesions; and 8 had 4 or more. Most bone lesions were in the skull, spine, or jaw. Chemotherapy, surgery, curettage, or radiation, but not steroids alone, achieved improvement or resolution of lesions in a majority of patients. Comparison of the three chemotherapy regimens revealed 84% of patients treated with vinblastine/prednisone either did not respond or relapsed within a year, whereas 59% of patients treated with 2-CdA and 21% treated with ARA-C failed. Toxicity was worse with the vinblastine/prednisone group as 75% had grade 3-4 neuropathy. Grade 3-4 cytopenias occurred in 37% of the 2-CdA -treated patients and 20% of the ARA-C-treated patients. The major limitation of this study is it is retrospective and not a clinical trial. Conclusions: ARA-C is an effective and minimally toxic treatment for LCH bone lesions in adults. In contrast, vinblastine/prednisone results in poor overall responses and excessive toxicity.	[Cantu, Maria A.; Bilgi, Mrinalini; Allen, Carl E.; McClain, Kenneth L.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Lupo, Philip J.] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX USA; [Bilgi, Mrinalini; Allen, Carl E.; McClain, Kenneth L.] Baylor Coll Med, Hematol Ctr, Houston, TX 77030 USA; [Hicks, M. John] Texas Childrens Hosp, Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Texas Children's Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Baylor College of Medicine	Cantu, MA (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA.	klmcclai@txch.org	Lupo, Philip/R-8314-2019	Lupo, Philip/0000-0003-0978-5863; McClain, Kenneth/0000-0003-0725-6263	National Institutes of Health; Glaxo Smith Kline Company	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaxo Smith Kline Company	K. McClain owns common stock in the Johnson and Johnson Company, has research support from the National Institutes of Health, and clinical trial support from the Glaxo Smith Kline Company. C. Allen has research support for the National Institutes of Health and clinical trial support from the Glaxo Smith Kline Company. The other authors have no conflicts to report. The above is funding unrelated to this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online on the guide for authors.	Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Ardekian L, 1999, ORAL SURG ORAL MED O, V87, P238, DOI 10.1016/S1079-2104(99)70279-9; Arico M, 2003, EUR J CANCER, V39, P2341, DOI 10.1016/S0959-8049(03)00672-5; Atalar B, 2010, ACTA ORTHOP BELG, V76, P663; Baumgartner I, 1997, MED PEDIATR ONCOL, V28, P9, DOI 10.1002/(SICI)1096-911X(199701)28:1<9::AID-MPO3>3.0.CO;2-P; Derenzini E, 2010, ANN ONCOL, V21, P1173, DOI 10.1093/annonc/mdp455; EGELER RM, 1993, MED PEDIATR ONCOL, V21, P265, DOI 10.1002/mpo.2950210406; Gadner H, 2008, BLOOD, V111, P2556, DOI 10.1182/blood-2007-08-106211; Gotz G, 2004, EUR J MED RES, V9, P510; Grois N, 2006, PEDIATR BLOOD CANCER, V46, P228, DOI 10.1002/pbc.20425; Huang WD, 2010, ACTA NEUROCHIR, V152, P1129, DOI 10.1007/s00701-010-0644-3; Islinger RB, 2000, CLIN ORTHOP RELAT R, P231; Malpas JS, 1996, MED PEDIATR ONCOL, V27, P540; Matsuki E, 2011, INTERNAL MED, V50, P909, DOI 10.2169/internalmedicine.50.4808; McClain KL, 2010, WILLIAMS HEMATOLOGY, P1047; Mittheisz E, 2007, PEDIATR BLOOD CANCER, V48, P50, DOI 10.1002/pbc.20760; Olschewski T, 2006, STRAHLENTHER ONKOL, V182, P629, DOI 10.1007/s00066-006-1630-9; Sivendran S, 2011, INT J HEMATOL, V93, P782, DOI 10.1007/s12185-011-0839-2; SLATER JM, 1980, MED PEDIATR ONCOL, V8, P151, DOI 10.1002/mpo.2950080208; Titgemeyer C, 2001, MED PEDIATR ONCOL, V37, P108, DOI 10.1002/mpo.1178; Weitzman S, 2005, HISTIOCYTIC DISORDERS OF CHILDREN AND ADULTS, P254, DOI 10.1017/CBO9780511545252.014; Weitzman S, 2009, PEDIATR BLOOD CANCER, V53, P1271, DOI 10.1002/pbc.22229	22	77	80	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43257	10.1371/journal.pone.0043257	http://dx.doi.org/10.1371/journal.pone.0043257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916233	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600062
J	Flanagan, JU; Yosaatmadja, Y; Teague, RM; Chai, MZL; Turnbull, AP; Squire, CJ				Flanagan, Jack U.; Yosaatmadja, Yuliana; Teague, Rebecca M.; Chai, Matilda Z. L.; Turnbull, Andrew P.; Squire, Christopher J.			Crystal Structures of Three Classes of Non-Steroidal Anti-Inflammatory Drugs in Complex with Aldo-Keto Reductase 1C3	PLOS ONE			English	Article							PROSTAGLANDIN-F-SYNTHASE; PRE-RECEPTOR REGULATION; CANCER CELL-MIGRATION; PROSTATE-CANCER; 5 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); MACROMOLECULAR CRYSTALLOGRAPHY; CYCLOOXYGENASE INHIBITION; POTENT INHIBITOR	Aldo-keto reductase 1C3 (AKR1C3) catalyses the NADPH dependent reduction of carbonyl groups in a number of important steroid and prostanoid molecules. The enzyme is also over-expressed in prostate and breast cancer and its expression is correlated with the aggressiveness of the disease. The steroid products of AKR1C3 catalysis are important in proliferative signalling of hormone-responsive cells, while the prostanoid products promote prostaglandin-dependent proliferative pathways. In these ways, AKR1C3 contributes to tumour development and maintenance, and suggest that inhibition of AKR1C3 activity is an attractive target for the development of new anti-cancer therapies. Non-steroidal anti-inflammatory drugs (NSAIDs) are one well-known class of compounds that inhibits AKR1C3, yet crystal structures have only been determined for this enzyme with flufenamic acid, indomethacin, and closely related analogues bound. While the flufenamic acid and indomethacin structures have been used to design novel inhibitors, they provide only limited coverage of the NSAIDs that inhibit AKR1C3 and that may be used for the development of new AKR1C3 targeted drugs. To understand how other NSAIDs bind to AKR1C3, we have determined ten crystal structures of AKR1C3 complexes that cover three different classes of NSAID, N-phenylanthranilic acids (meclofenamic acid, mefenamic acid), arylpropionic acids (flurbiprofen, ibuprofen, naproxen), and indomethacin analogues (indomethacin, sulindac, zomepirac). The N-phenylanthranilic and arylpropionic acids bind to common sites including the enzyme catalytic centre and a constitutive active site pocket, with the arylpropionic acids probing the constitutive pocket more effectively. By contrast, indomethacin and the indomethacin analogues sulindac and zomepirac, display three distinctly different binding modes that explain their relative inhibition of the AKR1C family members. This new data from ten crystal structures greatly broadens the base of structures available for future structure-guided drug discovery efforts.	[Flanagan, Jack U.] Univ Auckland, Auckland Canc Soc, Res Ctr, Auckland 1, New Zealand; [Flanagan, Jack U.; Squire, Christopher J.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Yosaatmadja, Yuliana; Teague, Rebecca M.; Chai, Matilda Z. L.; Squire, Christopher J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Turnbull, Andrew P.] Wolfson Inst Biomed Res, Canc Res Technol Discovery Labs, London, England	University of Auckland; University of Auckland; University of Auckland; University of London; University College London	Flanagan, JU (corresponding author), Univ Auckland, Auckland Canc Soc, Res Ctr, Auckland 1, New Zealand.	c.squire@auckland.ac.nz		Squire, Christopher/0000-0001-9212-0461; Yosaatmadja, Yuliana/0000-0003-2875-5993	Lottery Health Research [265027]; Auckland Medical Research Foundation [1110004, 1109008]; National eScience Infrastructure; Maurice Wilkins Centre for Molecular Biodiscovery Flexible Research Seeding Programme; Maurice Wilkins Centre for Molecular Biodiscovery; Faculty of Science, University of Auckland	Lottery Health Research; Auckland Medical Research Foundation; National eScience Infrastructure; Maurice Wilkins Centre for Molecular Biodiscovery Flexible Research Seeding Programme; Maurice Wilkins Centre for Molecular Biodiscovery; Faculty of Science, University of Auckland	This work was funded by Lottery Health Research (CJS; grant number 265027), the Auckland Medical Research Foundation (JUF and CJS; grant number 1110004. JUF; grant number 1109008), the National eScience Infrastructure (JUF), and the Maurice Wilkins Centre for Molecular Biodiscovery Flexible Research Seeding Programme (JUF and CJS). We further acknowledge salary support from the Maurice Wilkins Centre for Molecular Biodiscovery (CJS, JUF) and Summer Studentship funding from the Faculty of Science, University of Auckland (CJS, RMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniji AO, 2012, J MED CHEM, V55, P2311, DOI 10.1021/jm201547v; Adeniji AO, 2011, BIOORG MED CHEM LETT, V21, P1464, DOI 10.1016/j.bmcl.2011.01.010; Andrews P, 2008, CANCER CHEMOTH PHARM, V61, P203, DOI 10.1007/s00280-007-0462-3; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Butler R, 2000, CELL GROWTH DIFFER, V11, P49; Byrns MC, 2008, BIOCHEM PHARMACOL, V75, P484, DOI 10.1016/j.bcp.2007.09.008; Byrns MC, 2011, J STEROID BIOCHEM, V125, P95, DOI 10.1016/j.jsbmb.2010.11.004; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Byrns MC, 2009, CHEM-BIOL INTERACT, V178, P221, DOI 10.1016/j.cbi.2008.10.024; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diers AR, 2010, BIOCHEM J, V430, P69, DOI 10.1042/BJ20091193; Dufort I, 1999, ENDOCRINOLOGY, V140, P568, DOI 10.1210/en.140.2.568; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Hofland J, 2010, CANCER RES, V70, P1256, DOI 10.1158/0008-5472.CAN-09-2092; Jabbour HN, 2005, ENDOCRINOLOGY, V146, P4657, DOI 10.1210/en.2005-0804; Jackson VJ, 2012, ACTA CRYSTALLOGR F, V68, P409, DOI 10.1107/S1744309112009049; Jansson AK, 2006, CANCER RES, V66, P11471, DOI 10.1158/0008-5472.CAN-06-1448; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan MNA, 2011, MED RES REV, V31, P161, DOI 10.1002/med.20182; Khanim FL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008147; Koda N, 2004, ARCH BIOCHEM BIOPHYS, V424, P128, DOI 10.1016/j.abb.2004.02.009; Komoto J, 2006, BIOCHEMISTRY-US, V45, P1987, DOI 10.1021/bi051861t; Komoto J, 2004, BIOCHEMISTRY-US, V43, P2188, DOI 10.1021/bi036046x; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Lin HK, 2004, STEROIDS, V69, P795, DOI 10.1016/j.steroids.2004.09.014; Lovering AL, 2004, CANCER RES, V64, P1802, DOI 10.1158/0008-5472.CAN-03-2847; Matsuura K, 1998, J BIOCHEM-TOKYO, V124, P940, DOI 10.1093/oxfordjournals.jbchem.a022211; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mostaghel EA, 2007, CANCER RES, V67, P5033, DOI 10.1158/0008-5472.CAN-06-3332; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura Y, 2005, ENDOCR-RELAT CANCER, V12, P101, DOI 10.1677/erc.1.00914; Nakata S, 2006, MOL CANCER THER, V5, P1827, DOI 10.1158/1535-7163.MCT-06-0023; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PENNING TM, 1984, BIOCHEM J, V222, P601, DOI 10.1042/bj2220601; Penning TM, 2008, MOL CELL ENDOCRINOL, V281, P1, DOI 10.1016/j.mce.2007.10.008; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Qiu W, 2007, J BIOL CHEM, V282, P8368, DOI 10.1074/jbc.M606784200; Rainsford K. D., 2007, V42, P3; Ray DM, 2006, J IMMUNOL, V177, P5068, DOI 10.4049/jimmunol.177.8.5068; Scher JU, 2009, J INVEST MED, V57, P703, DOI 10.2310/JIM.0b013e31819aaa76; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sharma KK, 2006, MOL CELL ENDOCRINOL, V248, P79, DOI 10.1016/j.mce.2005.10.024; Smuc T, 2009, MOL CELL ENDOCRINOL, V301, P74, DOI 10.1016/j.mce.2008.09.019; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Suzuki-Yamamoto T, 1999, FEBS LETT, V462, P335, DOI 10.1016/S0014-5793(99)01551-3; Verdonk ML, 2011, J MED CHEM, V54, P5422, DOI 10.1021/jm200558u; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Wynne S, 2010, MOL CANCER RES, V8, P1656, DOI 10.1158/1541-7786.MCR-10-0342	56	45	48	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43965	10.1371/journal.pone.0043965	http://dx.doi.org/10.1371/journal.pone.0043965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937138	Green Published, gold			2022-12-27	WOS:000308213600066
J	Agudelo, D; Bourassa, P; Bruneau, J; Berube, G; Asselin, E; Tajmir-Riahi, HA				Agudelo, Daniel; Bourassa, Philippe; Bruneau, Julie; Berube, Gervais; Asselin, Eric; Tajmir-Riahi, Heidar-Ali			Probing the Binding Sites of Antibiotic Drugs Doxorubicin and N-(trifluoroacetyl) Doxorubicin with Human and Bovine Serum Albumins	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE; CHITOSAN NANOPARTICLES; DELIVERY-SYSTEMS; SWISS-MODEL; SPECTROSCOPY; DENDRIMERS; ACID	We located the binding sites of doxorubicin (DOX) and N-(trifluoroacetyl) doxorubicin (FDOX) with bovine serum albumin (BSA) and human serum albumins (HSA) at physiological conditions, using constant protein concentration and various drug contents. FTIR, CD and fluorescence spectroscopic methods as well as molecular modeling were used to analyse drug binding sites, the binding constant and the effect of drug complexation on BSA and HSA stability and conformations. Structural analysis showed that doxorubicin and N-(trifluoroacetyl) doxorubicin bind strongly to BSA and HSA via hydrophilic and hydrophobic contacts with overall binding constants of KDOX-BSA = 7.8 (+/- 0.7) x10(3) M-1, KFDOX-BSA = 4.8 (+/- 0.5) x10(3) M-1 and KDOX-HSA = 1.1 (+/- 0.3) x10(4) M-1, KFDOX-HSA = 8.3 (+/- 0.6) x10(3) M-1. The number of bound drug molecules per protein is 1.5 (DOX-BSA), 1.3 (FDOX-BSA) 1.5 (DOX-HSA), 0.9 (FDOX-HSA) in these drug-protein complexes. Docking studies showed the participation of several amino acids in drug-protein complexation, which stabilized by H-bonding systems. The order of drug-protein binding is DOX-HSA. FDOX-HSA. DOX-BSA. FDOX. BSA. Drug complexation alters protein conformation by a major reduction of a-helix from 63% (free BSA) to 47-44% (drug-complex) and 57% (free HSA) to 51-40% (drug-complex) inducing a partial protein destabilization. Doxorubicin and its derivative can be transported by BSA and HSA in vitro.	[Agudelo, Daniel; Bourassa, Philippe; Bruneau, Julie; Berube, Gervais; Asselin, Eric; Tajmir-Riahi, Heidar-Ali] Univ Quebec Trois Rivieres, Dept Chim Biol, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Agudelo, D (corresponding author), Univ Quebec Trois Rivieres, Dept Chim Biol, CP 500, Trois Rivieres, PQ GA9 5H7, Canada.	tajmirri@uqtr.ca	Bérubé, Gervais/GQI-4209-2022	Berube, Gervais/0000-0001-8001-0150; Bourassa, Philippe/0000-0003-2662-2118; Agudelo Pinto, Daniel Steven/0000-0002-8794-4279	NSERC Canada (Natural Science and Engineering Research Council of Canada)	NSERC Canada (Natural Science and Engineering Research Council of Canada)	NSERC Canada (Natural Science and Engineering Research Council of Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACTON EM, 1981, J MED CHEM, V24, P669, DOI 10.1021/jm00138a005; AHMED A, 1995, FEBS LETT, V363, P65, DOI 10.1016/0014-5793(95)00282-E; Ahmed-Ouameur A, 2006, CELL BIOCHEM BIOPHYS, V45, P203, DOI 10.1385/CBB:45:2:203; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beauchemin R, 2007, BIOMACROMOLECULES, V8, P3177, DOI 10.1021/bm700697a; Belatik A, 2012, EUR J MED CHEM, V48, P114, DOI 10.1016/j.ejmech.2011.12.002; Belatik A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036723; BERUBE G, 1991, SYNTHETIC COMMUN, V21, P931, DOI 10.1080/00397919108019778; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; Choi KC, 2009, J PHARM SCI-US, V98, P2104, DOI 10.1002/jps.21588; DOUSSEAU F, 1989, APPL SPECTROSC, V43, P538, DOI 10.1366/0003702894202814; Dubeau S, 2010, BIOMACROMOLECULES, V11, P1507, DOI 10.1021/bm100144v; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Grdadolnik J, 2003, ACTA CHIM SLOV, V50, P777; He WY, 2005, BIOORGAN MED CHEM, V13, P1837, DOI 10.1016/j.bmc.2004.11.038; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2; Jiang M, 2004, J MOL STRUCT, V692, P71, DOI 10.1016/j.molstruc.2004.01.003; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; Kratz F, 2007, EXPERT OPIN INV DRUG, V16, P855, DOI 10.1517/13543784.16.6.855; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Li C, 2008, ADV DRUG DELIVER REV, V60, P886, DOI 10.1016/j.addr.2007.11.009; Mandeville JS, 2010, BIOMACROMOLECULES, V11, P465, DOI 10.1021/bm9011979; Mandeville JS, 2009, J PHARMACEUT BIOMED, V49, P468, DOI 10.1016/j.jpba.2008.11.035; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X; Painter L, 1998, J CHEM SOC PERK T 1, P3041, DOI 10.1039/a803429j; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Peters T., 1996, ALL ALBUMIN BIOCH GE; Qi JN, 2010, INT J PHARMACEUT, V393, P176, DOI 10.1016/j.ijpharm.2010.03.063; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Son YJ, 2003, J CONTROL RELEASE, V91, P135, DOI 10.1016/S0168-3659(03)00231-1; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Tan ML, 2009, J PHARM PHARMACOL, V61, P131, DOI 10.1211/jpp/61.02.0001; Tayeh N, 2009, J PHARMACEUT BIOMED, V50, P107, DOI 10.1016/j.jpba.2009.03.015; Tian J., 2005, ARTIC AM J IMMUNOL, V1, P21, DOI [DOI 10.3844/AJISP.2005.21.23, DOI 10.3844/ajisp.2005.21.23]; Yokoe JI, 2008, INT J PHARMACEUT, V353, P28, DOI 10.1016/j.ijpharm.2007.11.008; Zhang GW, 2008, J MOL STRUCT, V881, P132, DOI 10.1016/j.molstruc.2007.09.002	49	154	160	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43814	10.1371/journal.pone.0043814	http://dx.doi.org/10.1371/journal.pone.0043814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937101	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500103
J	Cao, C; Wang, R; Wang, JM; Bunjhoo, H; Xu, YJ; Xiong, WN				Cao, Chao; Wang, Ran; Wang, Jianmiao; Bunjhoo, Hansvin; Xu, Yongjian; Xiong, Weining			Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-Analysis	PLOS ONE			English	Article							AIR-FLOW OBSTRUCTION; TERM OXYGEN-THERAPY; NUTRITIONAL-STATUS; COPD PATIENTS; PROGNOSTIC VALUE; HOSPITALIZED-PATIENTS; PREDICTS MORTALITY; LUNG-DISEASE; SURVIVAL; EMPHYSEMA	Background: The association between body mass index (BMI) and mortality in patients suffering from chronic obstructive pulmonary disease (COPD) has been a subject of interest for decades. However, the evidence is inadequate to draw robust conclusions because some studies were generally small or with a short follow-up. Methods: We carried out a search in MEDLINE, Cochrane Central Register of Controlled Trials, and EMBASE database for relevant studies. Relative risks (RRs) with 95% confidence interval (CI) were calculated to assess the association between BMI and mortality in patients with COPD. In addition, a baseline risk-adjusted analysis was performed to investigate the strength of this association. Results: 22 studies comprising 21,150 participants were included in this analysis. Compared with patients having a normal BMI, underweight individuals were associated with higher mortality (RR = 1.34, 95% CI = 1.01-1.78), whereas overweight (RR = 0.47, 95% CI = 0.33-0.68) and obese (RR = 0.59, 95% CI = 0.38-0.91) patients were associated with lower mortality. We further performed a baseline risk-adjusted analysis and obtained statistically similar results. Conclusion: Our study showed that for patients with COPD being overweight or obese had a protective effect against mortality. However, the relationship between BMI and mortality in different classes of obesity needed further clarification in well-designed clinical studies.	[Cao, Chao; Wang, Ran; Wang, Jianmiao; Bunjhoo, Hansvin; Xu, Yongjian; Xiong, Weining] Huazhong Univ Sci & Technol, Dept Resp Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Cao, Chao] Ningbo Univ, Dept Resp Med, Affiliated Hosp, Coll Med, Ningbo 315211, Zhejiang, Peoples R China	Huazhong University of Science & Technology; Ningbo University	Cao, C (corresponding author), Huazhong Univ Sci & Technol, Dept Resp Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	xiongweining@tjh.tjmu.edu.cn			Chinese Ministry of Health [2007353, 201002008]	Chinese Ministry of Health	This work is supported by research grants from Clinical academic key funds of the Chinese Ministry of Health (2007353) and special funds for scientific research on public causes of the Chinese Ministry of Health (201002008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2010, THORAX, V65, P298, DOI 10.1136/thx.2009.124818; Aniwidyaningsih W, 2008, CURR OPIN CLIN NUTR, V11, P435, DOI 10.1097/MCO.0b013e3283023d37; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Blum A, 2011, ISR MED ASSOC J, V13, P672; Budweiser S, 2007, CHEST, V131, P1650, DOI 10.1378/chest.06-2124; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chailleux E, 1996, CHEST, V109, P741, DOI 10.1378/chest.109.3.741; Chailleux E, 2003, CHEST, V123, P1460, DOI 10.1378/chest.123.5.1460; Chang CL, 2007, INTERN MED J, V37, P236, DOI 10.1111/j.1445-5994.2006.01283.x; Collins PF, 2010, THORAX, V65, P74; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Coxson HO, 2004, AM J RESP CRIT CARE, V170, P748, DOI 10.1164/rccm.200405-651OC; De Benedetto F, 2003, Monaldi Arch Chest Dis, V59, P314; de Torres JP, 2008, CHEST, V133, P1336, DOI 10.1378/chest.07-2433; de Voogd JN, 2009, CHEST, V135, P619, DOI 10.1378/chest.08-0078; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eid AA, 2001, AM J RESP CRIT CARE, V164, P1414, DOI 10.1164/ajrccm.164.8.2008109; Esteban C, 2011, EUR RESP J IN PRESS; Esteban C, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-28; GrayDonald K, 1996, AM J RESP CRIT CARE, V153, P961, DOI 10.1164/ajrccm.153.3.8630580; Gunen H, 2005, EUR RESPIR J, V26, P234, DOI 10.1183/09031936.05.00024804; Hallin R, 2007, RESP MED, V101, P1954, DOI 10.1016/j.rmed.2007.04.009; Hansen EF, 2001, AM J RESP CRIT CARE, V163, P690, DOI 10.1164/ajrccm.163.3.2006120; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hospers JJ, 2000, LANCET, V356, P1313, DOI 10.1016/S0140-6736(00)02815-4; Ischaki E, 2007, CHEST, V132, P164, DOI 10.1378/chest.06-2789; Jordan JG, 2010, SOUTH MED J, V103, P323, DOI 10.1097/SMJ.0b013e3181d394b4; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Larsson SC, 2010, JAMA-J AM MED ASSOC, V303, P1077, DOI 10.1001/jama.2010.263; Machado MCL, 2006, AM J RESP CRIT CARE, V174, P524, DOI 10.1164/rccm.200507-1057OC; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Marti S, 2006, EUR RESPIR J, V27, P689, DOI 10.1183/09031936.06.00076405; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Planas M, 2005, CLIN NUTR, V24, P433, DOI 10.1016/j.clnu.2005.01.005; Pothirat Chaicharn, 2007, Journal of the Medical Association of Thailand, V90, P653; Prescott E, 2002, EUR RESPIR J, V20, P539, DOI 10.1183/09031936.02.00532002; Raherison C, 2009, EUR RESPIR REV, V18, P213, DOI 10.1183/09059180.00003609; Ringbaek T, 2005, EUR RESPIR J, V25, P891, DOI 10.1183/09031936.05.00099204; Ringbaek T J, 2004, Chron Respir Dis, V1, P71, DOI 10.1191/1479972304cd011oa; Ringbaek T, 2010, J CARDIOPULM REHABIL, V30, P409, DOI 10.1097/HCR.0b013e3181e1736b; Schembri S, 2009, RESP MED, V103, P1461, DOI 10.1016/j.rmed.2009.04.021; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; Seersholm N, 1997, RESP MED, V91, P77, DOI 10.1016/S0954-6111(97)90071-8; Slinde F, 2005, RESP MED, V99, P1004, DOI 10.1016/j.rmed.2004.09.024; Soler-Cataluna JJ, 2005, CHEST, V128, P2108, DOI 10.1378/chest.128.4.2108; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Tomoda K, 2007, CHEST, V132, P135, DOI 10.1378/chest.07-0227; Toth S, 2004, WIEN KLIN WOCHENSCHR, V116, P617, DOI 10.1007/s00508-004-0226-6; Tsimogianni AM, 2009, J GEN INTERN MED, V24, P1043, DOI 10.1007/s11606-009-1061-2; Velema MS, 2012, CURR OPIN PULM MED, V18, P118, DOI 10.1097/MCP.0b013e32834e9001; Vestbo J, 2006, AM J RESP CRIT CARE, V173, P79, DOI 10.1164/rccm.200505-969OC; Walda IC, 2002, EUR J CLIN NUTR, V56, P638, DOI 10.1038/sj.ejcn.1601370; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; WHO (World Health Organization), 2009, GLOB DAT BOD MASS IN; Yang L, 2010, INT J EPIDEMIOL, V39, P1027, DOI 10.1093/ije/dyq051	59	123	131	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43892	10.1371/journal.pone.0043892	http://dx.doi.org/10.1371/journal.pone.0043892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937118	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500119
J	Harand, C; Bertran, F; La Joie, R; Landeau, B; Mezenge, F; Desgranges, B; Peigneux, P; Eustache, F; Rauchs, G				Harand, Caroline; Bertran, Francoise; La Joie, Renaud; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Peigneux, Philippe; Eustache, Francis; Rauchs, Geraldine			The Hippocampus Remains Activated over the Long Term for the Retrieval of Truly Episodic Memories	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; AUTOBIOGRAPHICAL MEMORIES; RETROGRADE-AMNESIA; RECOGNITION MEMORY; EMOTIONAL MEMORY; PARIETAL CORTEX; CONSOLIDATION; RECOLLECTION; FAMILIARITY; AMYGDALA	The role of the hippocampus in declarative memory consolidation is a matter of intense debate. We investigated the neural substrates of memory retrieval for recent and remote information using functional magnetic resonance imaging (fMRI). 18 young, healthy participants learned a series of pictures. Then, during two fMRI recognition sessions, 3 days and 3 months later, they had to determine whether they recognized or not each picture using the "Remember/Know" procedure. Presentation of the same learned images at both delays allowed us to track the evolution of memories and distinguish consistently episodic memories from those that were initially episodic and then became familiar or semantic over time and were retrieved without any contextual detail. Hippocampal activation decreased over time for initially episodic, later semantic memories, but remained stable for consistently episodic ones, at least in its posterior part. For both types of memories, neocortical activations were observed at both delays, notably in the ventromedial prefrontal and anterior cingulate cortices. These activations may reflect a gradual reorganization of memory traces within neural networks. Our data indicate maintenance and strengthening of hippocampal and cortico-cortical connections in the consolidation and retrieval of episodic memories over time, in line with the Multiple Trace theory (Nadel and Moscovitch, 1997). At variance, memories becoming semantic over time consolidate through strengthening of cortico-cortical connections and progressive disengagement of the hippocampus.	[Harand, Caroline; Bertran, Francoise; La Joie, Renaud; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Rauchs, Geraldine] INSERM, U1077, Caen, France; [Harand, Caroline; Bertran, Francoise; La Joie, Renaud; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Rauchs, Geraldine] Univ Caen Basse Normandie, UMR S1077, Caen, France; [Harand, Caroline; Bertran, Francoise; La Joie, Renaud; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Rauchs, Geraldine] Ecole Prat Hautes Etud, UMR S1077, Caen, France; [Harand, Caroline; La Joie, Renaud; Landeau, Brigitte; Mezenge, Florence; Desgranges, Beatrice; Eustache, Francis; Rauchs, Geraldine] Ctr Hosp Univ, U1077, Caen, France; [Bertran, Francoise] CHU Caen, Serv Explorat Fonct Neurol, F-14000 Caen, France; [Peigneux, Philippe] Univ Libre Brussels, UR2NF, Brussels, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite Libre de Bruxelles	Harand, C (corresponding author), INSERM, U1077, Caen, France.	geraldine.rauchs@inserm.fr	RAUCHS, Géraldine/L-7921-2015; DESGRANGES, BEATRICE/AAK-4756-2021; Desgranges, Béatrice/L-7739-2015; Eustache, Francis/J-9465-2015; La Joie, Renaud/AAC-8569-2021	RAUCHS, Géraldine/0000-0001-7128-2189; DESGRANGES, BEATRICE/0000-0002-3657-9996; Eustache, Francis/0000-0003-4460-8686; La Joie, Renaud/0000-0003-2581-8100; Peigneux, Philippe/0000-0003-4745-1434	Institut National de la Sante et de la Recherche Medicale (INSERM); French "Ministere de la Recherche"	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French "Ministere de la Recherche"(Ministry of Research, France)	The study was funded by Institut National de la Sante et de la Recherche Medicale (INSERM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CH was supported by the French "Ministere de la Recherche". We thank Dr Dayan, Dr Schupp, and Cyceron neuroimaging staff for their help with data acquisition. We also thank Dr B. Bontempi for insightful comments on earlier versions of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bosshardt S, 2005, CORTEX, V41, P486, DOI 10.1016/S0010-9452(08)70189-8; Burianova H, 2010, NEUROIMAGE, V49, P865, DOI 10.1016/j.neuroimage.2009.08.066; Butters N., 1986, AUTOBIOGRAPHICAL MEM, P253, DOI DOI 10.1017/CBO9780511558313.021; Cabeza R, 2002, NEUROIMAGE, V16, P317, DOI 10.1006/nimg.2002.1063; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; Ciaramelli E, 2008, NEUROPSYCHOLOGIA, V46, P1828, DOI 10.1016/j.neuropsychologia.2008.03.022; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Eustache F, 2004, BRAIN, V127, P1549, DOI 10.1093/brain/awh166; Eustache F, 2008, NEUROPSYCHOL REV, V18, P53, DOI 10.1007/s11065-008-9052-3; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Friston K. J., 2003, HUMAN BRAIN FUNCTION, P599; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Gardiner JM, 1998, CONSCIOUS COGN, V7, P1, DOI 10.1006/ccog.1997.0321; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; La Joie R, 2010, NEUROIMAGE, V53, P506, DOI 10.1016/j.neuroimage.2010.06.024; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Maguire EA, 2003, J NEUROSCI, V23, P5302; Malykhin NV, 2007, PSYCHIAT RES-NEUROIM, V155, P155, DOI 10.1016/j.pscychresns.2006.11.011; Mangels JA, 1996, NEUROPSYCHOLOGY, V10, P32, DOI 10.1037/0894-4105.10.1.32; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Montaldi D, 2006, HIPPOCAMPUS, V16, P504, DOI 10.1002/hipo.20178; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nieuwenhuis ILC, 2011, BEHAV BRAIN RES, V218, P325, DOI 10.1016/j.bbr.2010.12.009; PENNY WD, 2003, HUMAN BRAIN FUNCTION, P843; Petrides M, 2002, NEUROBIOL LEARN MEM, V78, P528, DOI 10.1006/nlme.2002.4107; Piolino P, 2004, NEUROIMAGE, V22, P1371, DOI 10.1016/j.neuroimage.2004.02.025; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Rekkas PV, 2005, J COGNITIVE NEUROSCI, V17, P1950, DOI 10.1162/089892905775008652; Ryan L, 2001, HIPPOCAMPUS, V11, P707, DOI 10.1002/hipo.1086; Shtyrov Y, 2010, J NEUROSCI, V30, P16864, DOI 10.1523/JNEUROSCI.1376-10.2010; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Soderlund H, 2012, HIPPOCAMPUS, V22, P670, DOI 10.1002/hipo.20927; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Squire L. R., 2000, MEMORY MIND MOL; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Sterpenich V, 2007, PLOS BIOL, V5, P2709, DOI 10.1371/journal.pbio.0050282; Sterpenich V, 2009, J NEUROSCI, V29, P5143, DOI 10.1523/JNEUROSCI.0561-09.2009; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Villain N, 2010, J NEUROIMAGING, V20, P324, DOI 10.1111/j.1552-6569.2010.00470.x; Viskontas IV, 2009, HIPPOCAMPUS, V19, P265, DOI 10.1002/hipo.20503; Viskontas IV, 2000, J NEUROSCI, V20, P5853, DOI 10.1523/JNEUROSCI.20-15-05853.2000; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wais PE, 2008, J COGNITIVE NEUROSCI, V20, P400, DOI 10.1162/jocn.2008.20041; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Winocur G., 2011, J INT NEUROPSYCH SOC, V17, P1, DOI DOI 10.1017/; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	63	36	37	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43495	10.1371/journal.pone.0043495	http://dx.doi.org/10.1371/journal.pone.0043495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937055	Green Published, gold			2022-12-27	WOS:000308225500056
J	Lamana, A; Balsa, A; Rueda, B; Ortiz, AM; Nuno, L; Miranda-Carus, ME; Gonzalez-Escribano, MF; Lopez-Nevot, MA; Pascual-Salcedo, D; Martin, J; Gonzalez-Alvaro, I				Lamana, Amalia; Balsa, Alejandro; Rueda, Blanca; Ortiz, Ana M.; Nuno, Laura; Eugenia Miranda-Carus, Maria; Gonzalez-Escribano, Maria F.; Lopez-Nevot, Miguel A.; Pascual-Salcedo, Dora; Martin, Javier; Gonzalez-Alvaro, Isidoro			The TT Genotype of the STAT4 rs7574865 Polymorphism Is Associated with High Disease Activity and Disability in Patients with Early Arthritis	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASE; HLA-DRB1; PTPN22; PROGRESSION; GENETICS	Background: The number of copies of the HLA-DRB1 shared epitope, and the minor alleles of the STAT4 rs7574865 and the PTPN22 rs2476601 polymorphisms have all been linked with an increased risk of developing rheumatoid arthritis. In the present study, we investigated the effects of these genetic variants on disease activity and disability in patients with early arthritis. Methodology and Results: We studied 640 patients with early arthritis (76% women; median age, 52 years), recording disease-related variables every 6 months during a 2-year follow-up. HLA-DRB1 alleles were determined by PCR-SSO, while rs7574865 and rs2476601 were genotyped with the Taqman 5' allelic discrimination assay. Multivariate analysis was performed using generalized estimating equations for repeated measures. After adjusting for confounding variables such as gender, age and ACPA, the TT genotype of rs7574865 in STAT4 was associated with increased disease activity (DAS28) as compared with the GG genotype (beta coefficient [95% confidence interval] = 0.42 [0.01-0.83], p = 0.044). Conversely, the presence of the T allele of rs2476601 in PTPN22 was associated with diminished disease activity during follow-up in a dose-dependent manner (CT genotype = 20.27 [-0.56- -0.01], p = 0.042; TT genotype = -0.68 [-1.64- -0.27], p = 0.162). After adjustment for gender, age and disease activity, homozygosity for the T allele of rs7574865 in STAT4 was associated with greater disability as compared with the GG genotype. Conclusions: Our data suggest that patients with early arthritis who are homozygous for the T allele of rs7574865 in STAT4 may develop a more severe form of the disease with increased disease activity and disability.	[Lamana, Amalia; Ortiz, Ana M.; Gonzalez-Alvaro, Isidoro] Hosp Univ La Princesa, Rheumatol Serv, Inst Invest Sanitaria Princesa, Madrid, Spain; [Balsa, Alejandro; Nuno, Laura; Eugenia Miranda-Carus, Maria] Hosp Univ La Paz, Rheumatol Serv, Inst Invest Sanitaria La Paz, Madrid, Spain; [Rueda, Blanca] Univ Granada, Fac Ciencias Salud, Dept Enfermeria, Granada, Spain; [Gonzalez-Escribano, Maria F.] Hosp Univ Virgen del Rocio, Serv Immunol, Seville, Spain; [Lopez-Nevot, Miguel A.] Hosp Univ Virgen de las Nieves, Serv Immunol, Granada, Spain; [Pascual-Salcedo, Dora] Hosp Univ La Paz, Serv Immunol, IdiPaz, Inst Invest Sanitaria La Paz, Madrid, Spain; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Hospital Universitario La Paz; University of Granada; Virgen del Rocio University Hospital; Hospital Universitario Virgen de las Nieves; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Lamana, A (corresponding author), Hosp Univ La Princesa, Rheumatol Serv, Inst Invest Sanitaria Princesa, Madrid, Spain.	isidoro.ga@ser.es	Martín, Javier/AAV-5209-2021; Martin, Javier/B-8141-2008; Rueda-Medina, Blanca/F-3156-2019; Martín, María/HDL-9512-2022; González-Escribano, María Francisca/X-5554-2019; Miranda-Carus, Maria-Eugenia/S-7403-2019; LAMANA, AMALIA/I-6971-2017; Balsa, Alejandro/ABF-6456-2020	Martin, Javier/0000-0002-2202-0622; Rueda-Medina, Blanca/0000-0002-0263-7000; LAMANA, AMALIA/0000-0001-8779-5034; Lopez Nevot, Miguel Angel/0000-0002-3465-6062	RETICS (Redes Tematicas de Investigacion Cooperativa, Cooperative Research Thematic Networks) [RD08/0075 (RIER)]; FIS (Fondo de Investigacion en Salud) Health Research Fund from Instituto de Salud Carlos III (ISCIII) [FIS 08/0754]; European Innovative Medicines Initiative; BTCure Program; National Health Care System (Instituto Carlos III), Madrid, Spain; Roche; UCB; Bristol-Myers Squibb; Abbott Laboratories	RETICS (Redes Tematicas de Investigacion Cooperativa, Cooperative Research Thematic Networks); FIS (Fondo de Investigacion en Salud) Health Research Fund from Instituto de Salud Carlos III (ISCIII); European Innovative Medicines Initiative; BTCure Program; National Health Care System (Instituto Carlos III), Madrid, Spain(Instituto de Salud Carlos III); Roche(Roche Holding); UCB(UCB Pharma SA); Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott Laboratories(Abbott Laboratories)	This work was partially supported by the RETICS (Redes Tematicas de Investigacion Cooperativa, Cooperative Research Thematic Networks) Program, RD08/0075 (RIER) and FIS (Fondo de Investigacion en Salud) Health Research Fund grant FIS 08/0754 to IG-A from Instituto de Salud Carlos III (ISCIII; www.isciii.es) and by grants from the European Innovative Medicines Initiative and BTCure Program (http://www.life-sciences-europe.com/organisation/btcure-project-imiefpia-201103-innovative-medicines-initiative-2001-28657.html). The work of IG-A was in part supported by a Research Intensification Grant from the National Health Care System (Instituto Carlos III; www.isciii.es), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and some authors have the following conflicts: Unrestricted research grants have been provided by Roche, UCB and Bristol-Myers Squibb to IG-A; and by Abbott Laboratories and Roche to LN. All these research projects have no relation with the present study. AB holds an advisory board membership with Pfizer and UCB. The following authors hold Honoraria for speaking: IG-A (Spanish Society of Rheumatology (SER), Rheumatology Society of Madrid (SORCOM), Roche, Abbott Laboratories and Bristol-Myers Squibb); AB (Roche, Schering-Plough, Wyeth, Abbott, BMS, Janssen and UCB); AMO (Spanish Society of Rheumatology (SER), Laboratorios Esteve, Abbott Laboratories and MSD); JM (Spanish Society of Rheumatology (SER)); and LN (Abbott Laboratories). The remaining authors have declared that no competing interests exist. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online on the guide for authors.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032; de Vries-Bouwstra JK, 2008, ARTHRITIS RHEUM-US, V58, P1293, DOI 10.1002/art.23439; ESTEVEVIVES J, 1993, J RHEUMATOL, V20, P2116; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Goronzy JJ, 2004, ARTHRITIS RHEUM-US, V50, P43, DOI 10.1002/art.11445; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Kariuki SN, 2009, J IMMUNOL, V182, P34, DOI 10.4049/jimmunol.182.1.34; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Marinou I, 2010, ANN RHEUM DIS, V69, P476, DOI 10.1136/ard.2009.117721; Morgan AW, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2969; Orozco G, 2005, ARTHRITIS RHEUM-US, V52, P219, DOI 10.1002/art.20771; Orozco G, 2006, BIOMED PHARMACOTHER, V60, P656, DOI 10.1016/j.biopha.2006.09.003; Orozco G, 2008, ARTHRITIS RHEUM-US, V58, P1974, DOI 10.1002/art.23549; Pan W, 2001, BIOMETRICS, V57, P529, DOI 10.1111/j.0006-341X.2001.00529.x; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Scott DL, 1996, BRIT J RHEUMATOL, V35, P14; Taylor KE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000084; WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814	20	13	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43661	10.1371/journal.pone.0043661	http://dx.doi.org/10.1371/journal.pone.0043661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937072	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500074
J	Lin, XM; Ding, K; Liu, Y; Yan, XH; Song, SJ; Jiang, TZ				Lin, Xiaoming; Ding, Kun; Liu, Yong; Yan, Xiaohe; Song, Shaojie; Jiang, Tianzi			Altered Spontaneous Activity in Anisometropic Amblyopia Subjects: Revealed by Resting-State fMRI	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DIFFUSION TENSOR TRACTOGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; REGIONAL HOMOGENEITY CHANGES; LATERAL GENICULATE-NUCLEUS; VERGENCE EYE-MOVEMENTS; ABNORMAL VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; EARLY BLINDNESS; BRAIN ACTIVITY	Amblyopia, also known as lazy eye, usually occurs during early childhood and results in poor or blurred vision. Recent neuroimaging studies have found cortical structural/functional abnormalities in amblyopia. However, until now, it was still not known whether the spontaneous activity of the brain changes in amblyopia subjects. In the present study, regional homogeneity (ReHo), a measure of the homogeneity of functional magnetic resonance imaging signals, was used for the first time to investigate changes in resting-state local spontaneous brain activity in individuals with anisometropic amblyopia. Compared with age-and gender-matched subjects with normal vision, the anisometropic amblyopia subjects showed decreased ReHo of spontaneous brain activity in the right precuneus, the left medial prefrontal cortex, the left inferior frontal gyrus, and the left cerebellum, and increased ReHo of spontaneous brain activity was found in the bilateral conjunction area of the postcentral and precentral gyri, the left paracentral lobule, the left superior temporal gyrus, the left fusiform gyrus, the conjunction area of the right insula, putamen and the right middle occipital gyrus. The observed decreases in ReHo may reflect decreased visuo-motor processing ability, and the increases in ReHo in the somatosensory cortices, the motor areas and the auditory area may indicate compensatory plasticity in amblyopia.	[Lin, Xiaoming; Ding, Kun; Yan, Xiaohe; Song, Shaojie] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yong; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, LIAMA Ctr Computat Med, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Jiang, Tianzi] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Automation, CAS; University of Electronic Science & Technology of China; University of Queensland	Lin, XM (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	linxiaom@mail.sysu.edu.cn; yliu@nlpr.ia.ac.cn; jiangtz@nlpr.ia.ac.cn	Liu, Yong/F-2682-2011; Jiang, Tianzi/I-4256-2012	Liu, Yong/0000-0002-1862-3121; Jiang, Tianzi/0000-0001-9531-291X; lin, xiao ming/0000-0001-7161-1085	Natural Science Foundation of China [30900476, 30870694, 60831004]; Research Foundation of Science and Technology Plan Project, Guangdong, China [2008B060600031, 2011B061300067]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Science and Technology Plan Project, Guangdong, China	This work was supported by the Natural Science Foundation of China (Grant Numbers. 30900476, 30870694 and 60831004), and the Research Foundation of Science and Technology Plan Project, Guangdong, China (Grant Numbers: 2008B060600031, 2011B061300067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson SJ, 2006, STRABISMUS, V14, P21, DOI 10.1080/09273970500538082; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Barnes GR, 2010, INVEST OPHTH VIS SCI, V51, P1432, DOI 10.1167/iovs.09-3931; Barnes GR, 2001, J PHYSIOL-LONDON, V533, P281, DOI 10.1111/j.1469-7793.2001.0281b.x; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Burton H, 2004, HUM BRAIN MAPP, V23, P210, DOI 10.1002/hbm.20064; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Choi MY, 2002, J PEDIAT OPHTH STRAB, V39, P11, DOI 10.3928/0191-3913-20020101-05; Conner IP, 2007, J PHYSIOL-LONDON, V583, P159, DOI 10.1113/jphysiol.2007.136242; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Demer J L, 1997, J AAPOS, V1, P158, DOI 10.1016/S1091-8531(97)90059-8; Fadiga L, 2006, CORTEX, V42, P486, DOI 10.1016/S0010-9452(08)70383-6; Fiehler K, 2010, RESTOR NEUROL NEUROS, V28, P193, DOI 10.3233/RNN-2010-0500; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gamlin PDR, 1996, EYE, V10, P167, DOI 10.1038/eye.1996.42; Goodyear BG, 2000, J NEUROPHYSIOL, V84, P1907, DOI 10.1152/jn.2000.84.4.1907; Grant S, 2007, INVEST OPHTH VIS SCI, V48, P1139, DOI 10.1167/iovs.06-0976; Hadjidimitrakis K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023335; HASHIMOTO M, 1995, BRAIN, V118, P1185, DOI 10.1093/brain/118.5.1185; Hayakawa Y, 2002, OPHTHALMOLOGICA, V216, P399, DOI 10.1159/000067551; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hess RF, 2010, HUM BRAIN MAPP, V31, P1233, DOI 10.1002/hbm.20931; Hess RF, 2009, EUR J NEUROSCI, V29, P1064, DOI 10.1111/j.1460-9568.2009.06650.x; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Information from your family doctor, 2007, AM FAMILY PHYS, V75, P368; Jiang TZ, 2008, BRAIN IMAGING BEHAV, V2, P249, DOI 10.1007/s11682-008-9038-z; JUNCK L, 1988, J CEREBR BLOOD F MET, V8, P774, DOI 10.1038/jcbfm.1988.132; Kanonidou Evgenia, 2011, International Ophthalmology, V31, P249, DOI 10.1007/s10792-011-9434-z; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kiviniemi V, 2008, HUM BRAIN MAPP, V29, P810, DOI 10.1002/hbm.20582; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026; Liu C, 2011, NEUROREPORT, V22, P190, DOI 10.1097/WNR.0b013e3283447c09; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Lv B, 2008, NEUROSCI LETT, V437, P5, DOI 10.1016/j.neulet.2008.03.071; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; MARPLEHORVAT DE, 1990, J PHYSIOL-LONDON, V428, P595, DOI 10.1113/jphysiol.1990.sp018230; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Mendola JD, 2005, HUM BRAIN MAPP, V25, P222, DOI 10.1002/hbm.20109; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Miki A, 2003, OPHTHALMOLOGICA, V217, P365, DOI 10.1159/000071353; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Monti MM, 2007, NEUROIMAGE, V37, P1005, DOI 10.1016/j.neuroimage.2007.04.069; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; Negyessy L, 2006, EUR J NEUROSCI, V23, P1919, DOI 10.1111/j.1460-9568.2006.04678.x; Niechwiej-Szwedo E, 2011, INVEST OPHTH VIS SCI, V52, P5853, DOI 10.1167/iovs.11-7314; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; Ohtsuka K, 1998, BRAIN, V121, P429, DOI 10.1093/brain/121.3.429; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Sathian K, 2001, OPTOMETRY VISION SCI, V78, P276, DOI 10.1097/00006324-200105000-00010; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Shukla DK, 2010, NEUROSCI LETT, V476, P46, DOI 10.1016/j.neulet.2010.03.080; Simmers AJ, 2006, VISION RES, V46, P2571, DOI 10.1016/j.visres.2006.01.009; Simmers AJ, 2005, VISION RES, V45, P449, DOI 10.1016/j.visres.2004.08.026; Simmers AJ, 2003, VISION RES, V43, P729, DOI 10.1016/S0042-6989(02)00684-3; Straube A, 1997, ANN NEUROL, V42, P891, DOI 10.1002/ana.410420611; Suttle CM, 2011, INVEST OPHTH VIS SCI, V52, P1851, DOI 10.1167/iovs.10-6341; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; Thach WT, 1998, TRENDS COGN SCI, V2, P331, DOI 10.1016/S1364-6613(98)01223-6; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang LQ, 2011, NEUROSCI LETT, V488, P275, DOI 10.1016/j.neulet.2010.11.046; Winstein CJ, 1997, J NEUROPHYSIOL, V77, P1581, DOI 10.1152/jn.1997.77.3.1581; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xiao JX, 2007, AM J OPHTHALMOL, V143, P489, DOI 10.1016/j.ajo.2006.11.039; Yang T, 2010, NEUROREPORT, V21, P786, DOI 10.1097/WNR.0b013e32833cadf0; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Yu CS, 2007, NEUROIMAGE, V36, P411, DOI 10.1016/j.neuroimage.2007.03.003; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049	78	37	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43373	10.1371/journal.pone.0043373	http://dx.doi.org/10.1371/journal.pone.0043373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937041	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500045
J	Tsou, WL; Sheedlo, MJ; Morrow, ME; Blount, JR; McGregor, KM; Das, C; Todi, SV				Tsou, Wei-Ling; Sheedlo, Michael J.; Morrow, Marie E.; Blount, Jessica R.; McGregor, Kelly M.; Das, Chittaranjan; Todi, Sokol V.			Systematic Analysis of the Physiological Importance of Deubiquitinating Enzymes	PLOS ONE			English	Article							NF-KAPPA-B; UBIQUITIN-SPECIFIC PROTEASE; NONMUSCLE MYOSIN-II; VIRUS TYPE-1 TAX; DROSOPHILA OOGENESIS; EMERGING ROLES; ATAXIA MICE; FAT-FACETS; CELL-DEATH; GENE	Deubiquitinating enzymes (DUBs) are proteases that control the post-translational modification of proteins by ubiquitin and in turn regulate diverse cellular pathways. Despite a growing understanding of DUB biology at the structural and molecular level, little is known about the physiological importance of most DUBs. Here, we systematically identify DUBs encoded by the genome of Drosophila melanogaster and examine their physiological importance in vivo. Through domain analyses we uncovered 41 Drosophila DUBs, most of which have human orthologues. Systematic knockdown of the vast majority of DUBs throughout the fly or in specific cell types had dramatic consequences for Drosophila development, adult motility or longevity. Specific DUB subclasses proved to be particularly necessary during development, while others were important in adults. Several DUBs were indispensable in neurons or glial cells during developmental stages; knockdown of others perturbed the homeostasis of ubiquitinated proteins in adult flies, or had adverse effects on wing positioning as a result of neuronal requirements. We demonstrate the physiological significance of the DUB family of enzymes in intact animals, find that there is little functional redundancy among members of this family of proteases, and provide insight for future investigations to understand DUB biology at the molecular, cellular and organismal levels.	[Tsou, Wei-Ling; Blount, Jessica R.; McGregor, Kelly M.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Tsou, Wei-Ling; Blount, Jessica R.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Sheedlo, Michael J.; Morrow, Marie E.; Das, Chittaranjan] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Wayne State University; Wayne State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tsou, WL (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	stodi@med.wayne.edu	Das, Chittaranjan/AAM-1686-2020; Tsou, Wei-Ling/AAI-2655-2021	Tsou, Wei-Ling/0000-0001-9136-2581	National Institutes of Health [R00NS064097, 1R01RR026273]; National Ataxia Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR026273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS064097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Ataxia Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant R00NS064097 to SVT, 1R01RR026273 to CD and a Young Investigator Award to SVT from the National Ataxia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen PC, 2009, J NEUROSCI, V29, P10909, DOI 10.1523/JNEUROSCI.2635-09.2009; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Fischer JA, 2002, BIOESSAYS, V24, P13, DOI 10.1002/bies.10030; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Franke JD, 2010, DEV BIOL, V345, P117, DOI 10.1016/j.ydbio.2010.06.028; Goodrich JS, 2004, DEVELOPMENT, V131, P1949, DOI 10.1242/dev.01078; KING RC, 1988, BIOESSAYS, V8, P18, DOI 10.1002/bies.950080106; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Krzystanek K, 2012, HEART RHYTHM, V9, P440, DOI 10.1016/j.hrthm.2011.10.026; Lappe-Siefke C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000631; Lavorgna A, 2012, J VIROL, V86, P3357, DOI 10.1128/JVI.06456-11; Liu S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001237; Lui TTH, 2011, MOL CELL BIOL, V31, P2053, DOI 10.1128/MCB.01094-10; Luna-Vargas MPA, 2011, EMBO REP, V12, P365, DOI 10.1038/embor.2011.33; Mahul-Mellier AL, 2012, CELL DEATH DIFFER, V19, P891, DOI 10.1038/cdd.2011.185; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nongthomba U, 1999, GENETICS, V153, P261; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STEINHAUER WR, 1989, MOL CELL BIOL, V9, P5726, DOI 10.1128/MCB.9.12.5726; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Thevenon D, 2009, CELL HOST MICROBE, V6, P309, DOI 10.1016/j.chom.2009.09.007; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Yasunaga J, 2011, J VIROL, V85, P6212, DOI 10.1128/JVI.00079-11; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	45	51	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43112	10.1371/journal.pone.0043112	http://dx.doi.org/10.1371/journal.pone.0043112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937016	gold, Green Published			2022-12-27	WOS:000308225500030
J	Yang, RF; Sun, CL; Bai, JJ; Luo, ZX; Shi, BA; Zhang, JM; Yan, WG; Piao, ZZ				Yang, Ruifang; Sun, Chunlong; Bai, Jianjiang; Luo, Zhixiang; Shi, Biao; Zhang, Jianming; Yan, Wengui; Piao, Zhongze			A Putative Gene sbe3-rs for Resistant Starch Mutated from SBE3 for Starch Branching Enzyme in Rice (Oryza sativa L.)	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; PROLINE RESIDUES; FOOD; CLASSIFICATION; DIGESTIBILITY; CARBOHYDRATE; CONSUMPTION; INDEXES; HEALTH	Foods high in resistant starch (RS) are beneficial to prevent various diseases including diabetes, colon cancers, diarrhea and chronic renal or hepatic diseases. Elevated RS in rice is important for public health since rice is a staple food for half of the world population. A japonica mutant 'Jiangtangdao 1' (RS = 11.67%) was crossed with an indica cultivar 'Miyang 23' (RS = 0.41%). The mutant sbe3-rs that explained 60.4% of RS variation was mapped between RM6611 and RM13366 on chromosome 2 (LOD = 36) using 178 F-2 plants genotyped with 106 genome-wide polymorphic SSR markers. Using 656 plants from four F-3:4 families, sbe3-rs was fine mapped to a 573.3 Kb region between InDel 2 and InDel 6 using one STS, five SSRs and seven InDel markers. SBE3 which codes for starch branching enzyme was identified as a candidate gene within the putative region. Nine pairs of primers covering 22 exons were designed to sequence genomic DNA of the wild type for SBE3 and the mutant for sbe3-rs comparatively. Sequence analysis identified a missense mutation site where Leu-599 of the wild was changed to Pro-599 of the mutant in the SBE3 coding region. Because the point mutation resulted in the loss of a restriction enzyme site, sbe3-rs was not digested by a CAPS marker for SpeI site while SBE3 was. Co-segregation of the digestion pattern with RS content among 178 F2 plants further supported sbe3-rs responsible for RS in rice. As a result, the CAPS marker could be used in marker-assisted breeding to develop rice cultivars with elevated RS which is otherwise difficult to accurately assess in crops. Transgenic technology should be employed for a definitive conclusion of the sbe3-rs.	[Yang, Ruifang; Sun, Chunlong; Bai, Jianjiang; Shi, Biao; Zhang, Jianming; Piao, Zhongze] Shanghai Acad Agr Sci, Crop Breeding & Cultivat Res Inst, Shanghai, Peoples R China; [Luo, Zhixiang] Anhui Acad Agr Sci, Rice Res Inst, Hefei, Anhui, Peoples R China; [Yan, Wengui] ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Sun, Chunlong] Jilin Univ, Coll Plant Sci, Changchu, Peoples R China	Shanghai Academy of Agricultural Sciences; Anhui Academy of Agricultural Sciences; United States Department of Agriculture (USDA); Jilin University	Yang, RF (corresponding author), Shanghai Acad Agr Sci, Crop Breeding & Cultivat Res Inst, Shanghai, Peoples R China.	Wengui.Yan@ars.usda.gov; zzpiao@163.com			973 Program of China [2011CB111506]; 863 Program of China [2012AA101103]; Key Basic Research Project in Shanghai [10JC1413900]; Foundation of Shanghai Academy of Agricultural Sciences [2012 yf01]	973 Program of China(National Basic Research Program of China); 863 Program of China(National High Technology Research and Development Program of China); Key Basic Research Project in Shanghai; Foundation of Shanghai Academy of Agricultural Sciences	This study was partially supported by the 973 Program of China (2011CB111506), 863 Program of China (2012AA101103), Key Basic Research Project in Shanghai (10JC1413900) and Foundation of Shanghai Academy of Agricultural Sciences (2012 yf01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEMANNO L, 1994, PLANT CELL REP, V13, P432, DOI 10.1007/BF00231961; Asp N. G., 1992, Trends in Food Science & Technology, V3, P111, DOI 10.1016/0924-2244(92)90153-N; ASP NG, 1994, AM J CLIN NUTR, V59, p679S, DOI 10.1093/ajcn/59.3.679Sa; Bird AR, 2004, J NUTR, V134, P831, DOI 10.1093/jn/134.4.831; Birkett AM, 1997, EUR J CLIN NUTR, V51, P625, DOI 10.1038/sj.ejcn.1600456; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; Brown IL, 2004, J AOAC INT, V87, P727; Champ M, 2003, NUTR RES REV, V16, P143, DOI 10.1079/NRR200364; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Danjo K, 2003, J NUTR, V133, P2218, DOI 10.1093/jn/133.7.2218; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; Escarpa A, 1997, FOOD CHEM, V60, P527, DOI 10.1016/S0308-8146(97)00025-3; Frei M, 2003, FOOD CHEM, V83, P395, DOI 10.1016/S0308-8146(03)00101-8; Govers MJAP, 1999, GUT, V45, P840, DOI 10.1136/gut.45.6.840; Harrington SE, 1997, THEOR APPL GENET, V94, P564, DOI 10.1007/s001220050452; Higgins JA, 1996, J NUTR, V126, P596, DOI 10.1093/jn/126.3.596; Hu PS, 2004, J CEREAL SCI, V40, P231, DOI 10.1016/j.jcs.2004.06.001; Jacobasch G, 1999, INT J COLORECTAL DIS, V14, P201, DOI 10.1007/s003840050212; Jia LiMeng, 2007, The Open Agriculture Journal, V1, P5, DOI 10.2174/1874331500701010005; Jobling S, 2004, CURR OPIN PLANT BIOL, V7, P210, DOI 10.1016/j.pbi.2003.12.001; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Kim JH, 2006, FOOD CHEM, V99, P718, DOI 10.1016/j.foodchem.2005.08.054; Li HuiHui, 2010, Acta Agronomica Sinica, V36, P918, DOI 10.3724/SP.J.1006.2010.00918; Li Min, 2008, Acta Nutrimenta Sinica, V30, P588; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Madrid J., 2000, P NUTR SOC AUST, V24, P208; McCleary BV, 2002, J AOAC INT, V85, P1103; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; MIZUNO K, 1993, J BIOL CHEM, V268, P19084; [牟方贵 Mou Fanggui], 2008, [分子植物育种, Molecular Plant Breeding], V6, P432; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; Rahman S, 2007, J CEREAL SCI, V46, P251, DOI 10.1016/j.jcs.2007.05.001; Regina A, 2006, P NATL ACAD SCI USA, V103, P3546, DOI 10.1073/pnas.0510737103; Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x; Sluaghter S, 2001, BIOCH BIOPHY ACTA, V1525, P29; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Van Ooijen J., 2006, SOFTWARE CALCULATION; Wang Lin, 2009, Journal of Triticeae Crops, V29, P390; Wei CX, 2010, J AGR FOOD CHEM, V58, P1224, DOI 10.1021/jf9031316; WOOLFSON DN, 1990, FEBS LETT, V277, P185, DOI 10.1016/0014-5793(90)80839-B; Yang CZ, 2006, J AGR FOOD CHEM, V54, P523, DOI 10.1021/jf0524123; Yao Y, 2004, PLANT PHYSIOL, V136, P3515, DOI 10.1104/pp.104.043315; Younes H, 1997, AM J PHYSIOL-GASTR L, V272, pG515, DOI 10.1152/ajpgi.1997.272.3.G515; Zhu HM., 2010, CHIN AGR SCI B, V26, P108	45	40	52	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43026	10.1371/journal.pone.0043026	http://dx.doi.org/10.1371/journal.pone.0043026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937009	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500027
J	Krammer, F; Margine, I; Tan, GS; Pica, N; Krause, JC; Palese, P				Krammer, Florian; Margine, Irina; Tan, Gene S.; Pica, Natalie; Krause, Jens C.; Palese, Peter			A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates	PLOS ONE			English	Article							INFLUENZA-A VIRUS; MONOCLONAL-ANTIBODIES; NEUTRALIZING EPITOPE; H1N1; EFFICACY; H5N1; CELLS	Recently, a new class of broadly neutralizing anti-influenza virus antibodies that target the stalk domain of the viral hemagglutinin was discovered. As such, induction, isolation, characterization, and quantification of these novel antibodies has become an area of intense research and great interest. Since most of these antibodies bind to conformational epitopes, the structural integrity of hemagglutinin substrates for the detection and quantification of these antibodies is of high importance. Here we evaluate the binding of these antibodies to soluble, secreted hemagglutinins with or without a carboxy-terminal trimerization domain based on the natural trimerization domain of T4 phage fibritin. The lack of such a domain completely abolishes binding to group 1 hemagglutinins and also affects binding to group 2 hemagglutinins. Additionally, the presence of a trimerization domain positively influences soluble hemagglutinin stability during expression and purification. Our findings suggest that a carboxy-terminal trimerization domain is a necessary requirement for the structural integrity of stalk epitopes on recombinant soluble influenza virus hemagglutinin.	[Krammer, Florian; Margine, Irina; Tan, Gene S.; Pica, Natalie; Krause, Jens C.; Palese, Peter] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Palese, Peter] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Margine, Irina; Pica, Natalie] Mt Sinai Sch Med, Grad Sch Biol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Krammer, F (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY USA.	peter.palese@mssm.edu	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X; Tan, Gene/0000-0002-0975-0719; Palese, Peter/0000-0002-0337-5823	Erwin Schrodinger fellowship from the Austrian Science Fund (FWF) [J 3232]; PATH; CEIRS (Centers for Excellence for Influenza Research and Surveillance) [HHSN26620070010C]	Erwin Schrodinger fellowship from the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); PATH; CEIRS (Centers for Excellence for Influenza Research and Surveillance)	Florian Krammer was supported by an Erwin Schrodinger fellowship (J 3232) from the Austrian Science Fund (FWF). This work was partially supported by PATH and by CEIRS (Centers for Excellence for Influenza Research and Surveillance, HHSN26620070010C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cox MMJ, 2008, INFLUENZA OTHER RESP, V2, P211, DOI 10.1111/j.1750-2659.2008.00053.x; Dinca Luminita, 1993, Viral Immunology, V6, P75, DOI 10.1089/vim.1993.6.75; Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2011, VACCINE, V29, P5657, DOI 10.1016/j.vaccine.2011.06.014; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; KRAMMER F, 2010, MOL BIOTECHNOL; Krammer F, 2010, TRENDS MOL MED, V16, P313, DOI 10.1016/j.molmed.2010.05.002; Krammer F, 2010, BIOTECHNOL J, V5, P17, DOI 10.1002/biot.200900267; Krause JC, 2012, J VIROL, V86, P6334, DOI 10.1128/JVI.07158-11; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Meghrous J, 2009, VACCINE, V28, P309, DOI 10.1016/j.vaccine.2009.10.048; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; MORAN T, 1984, P NATL ACAD SCI-BIOL, V81, P1809, DOI 10.1073/pnas.81.6.1809; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Palese P., 2006, FIELDS VIROLOGY, P1648; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Treanor JJ, 2011, VACCINE, V29, P7733, DOI 10.1016/j.vaccine.2011.07.128; Vareckova E, 2003, ACTA VIROL, V47, P229; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466	34	123	139	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43603	10.1371/journal.pone.0043603	http://dx.doi.org/10.1371/journal.pone.0043603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928001	Green Published, Green Submitted, gold			2022-12-27	WOS:000308224700020
J	Hackstein, H; Hagel, N; Knoche, A; Kranz, S; Lohmeyer, J; von Wulffen, W; Kershaw, O; Gruber, AD; Bein, G; Baal, N				Hackstein, Holger; Hagel, Nicole; Knoche, Angela; Kranz, Sabine; Lohmeyer, Juergen; von Wulffen, Werner; Kershaw, Olivia; Gruber, Achim D.; Bein, Gregor; Baal, Nelli			Skin TLR7 Triggering Promotes Accumulation of Respiratory Dendritic Cells and Natural Killer Cells	PLOS ONE			English	Article							TOPICAL IMIQUIMOD; LIGANDS; ALPHA; TOLL-LIKE-RECEPTOR-7; RECOGNITION; LYMPHOCYTES; RNA	The TLR7 agonist imiquimod has been used successfully as adjuvant for skin treatment of virus-associated warts and basal cell carcinoma. The effects of skin TLR7 triggering on respiratory leukocyte populations are unknown. In a placebo-controlled experimental animal study we have used multicolour flow cytometry to systematically analyze the modulation of respiratory leukocyte subsets after skin administration of imiquimod. Compared to placebo, skin administration of imiquimod significantly increased respiratory dendritic cells (DC) and natural killer cells, whereas total respiratory leukocyte, alveolar macrophages, classical CD4+ T helper and CD8+ T killer cell numbers were not or only moderately affected. DC subpopulation analyses revealed that elevation of respiratory DC was caused by an increase of respiratory monocytic DC and CD11b(hi) DC subsets. Lymphocyte subpopulation analyses indicated a marked elevation of respiratory natural killer cells and a significant reduction of B lymphocytes. Analysis of cytokine responses of respiratory leukocytes after stimulation with Klebsiella pneumonia indicated reduced IFN-gamma and TNF-alpha expression and increased IL-10 and IL-12p70 production after 7 day low dose skin TLR7 triggering. Additionally, respiratory NK cytotoxic activity was increased after 7d skin TLR7 triggering. In contrast, lung histology and bronchoalveolar cell counts were not affected suggesting that skin TLR7 stimulation modulated respiratory leukocyte composition without inducing overt pulmonary inflammation. These data suggest the possibility to modulate respiratory leukocyte composition and respiratory cytokine responses against pathogens like Klebsiella pneumonia through skin administration of a clinically approved TLR7 ligand. Skin administration of synthetic TLR7 ligands may represent a novel, noninvasive means to modulate respiratory immunity.	[Hackstein, Holger; Hagel, Nicole; Knoche, Angela; Kranz, Sabine; Bein, Gregor; Baal, Nelli] Univ Giessen, Inst Clin Immunol & Transfus Med, D-6300 Giessen, Germany; [Lohmeyer, Juergen] Dept Internal Med 2, Giessen, Germany; [von Wulffen, Werner] Univ Munich, Klinikum Grosshadern, Dept Internal Med, Pulm Dis & Comprehens Pneumol Ctr 5, D-8000 Munich, Germany; [Kershaw, Olivia; Gruber, Achim D.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany	Justus Liebig University Giessen; University of Munich; Free University of Berlin	Hackstein, H (corresponding author), Univ Giessen, Inst Clin Immunol & Transfus Med, Langhansstr 7, D-6300 Giessen, Germany.	Holger.Hackstein@immunologie.med.uni-giessen.de	Gruber, Achim D./ABA-4514-2021		DFG, German Science Foundation [SFB Transregio 84]; Excellence cluster cardiopulmonary system (ECCPS, DFG); University of Giessen and Marburg Lung Center (UGMLC)	DFG, German Science Foundation(German Research Foundation (DFG)); Excellence cluster cardiopulmonary system (ECCPS, DFG)(German Research Foundation (DFG)); University of Giessen and Marburg Lung Center (UGMLC)	The work was supported by the SFB Transregio 84, DFG, German Science Foundation, Innate Immunity of the Lung: Mechanisms of Pathogen Attack and Host Defence in Pneumonia (SFB TR84, Project B3 HH, JL), the Excellence cluster cardiopulmonary system (ECCPS, DFG; HH) and the University of Giessen and Marburg Lung Center (UGMLC; HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Berghofer B, 2007, J IMMUNOL, V178, P4072, DOI 10.4049/jimmunol.178.7.4072; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Gaspari AA, 2009, J DRUGS DERMATOL, V8, P467; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Hackstein H, RESP RES UNPUB; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Kane KL, 1996, CLIN DIAGN LAB IMMUN, V3, P295, DOI 10.1128/CDLI.3.3.295-300.1996; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Lu HL, 2010, J IMMUNOL, V184, P5360, DOI 10.4049/jimmunol.0902997; Maus U, 2001, AM J PHYSIOL-LUNG C, V280, pL58, DOI 10.1152/ajplung.2001.280.1.L58; Miller RL, 2008, DRUG NEWS PERSPECT, V21, P69, DOI 10.1358/dnp.2008.21.2.1188193; Moisan J, 2006, AM J PHYSIOL-LUNG C, V290, pL987, DOI 10.1152/ajplung.00440.2005; Pasmatzi E, 2009, ACTA DERM-VENEREOL, V89, P134, DOI 10.2340/00015555-0597; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Smits ELJM, 2008, ONCOLOGIST, V13, P859, DOI 10.1634/theoncologist.2008-0097; Stein P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027911; Wagstaff AJ, 2007, DRUGS, V67, P2187, DOI 10.2165/00003495-200767150-00006; Xiong ZM, 2011, J IMMUNOTHER, V34, P264, DOI 10.1097/CJI.0b013e318209eed4; Xirakia C, 2010, AM J RESP CRIT CARE, V181, P1207, DOI 10.1164/rccm.200908-1255OC	29	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43320	10.1371/journal.pone.0043320	http://dx.doi.org/10.1371/journal.pone.0043320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927956	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300041
J	Kruidhof, HM; Pashalidou, FG; Fatouros, NE; Figueroa, IA; Vet, LEM; Smid, HM; Huigens, ME				Kruidhof, H. Marjolein; Pashalidou, Foteini G.; Fatouros, Nina E.; Figueroa, Ilich A.; Vet, Louise E. M.; Smid, Hans M.; Huigens, Martinus E.			Reward Value Determines Memory Consolidation in Parasitic Wasps	PLOS ONE			English	Article							LONG-TERM-MEMORY; TRICHOGRAMMA WASPS; COTESIA-GLOMERATA; PROTEIN-SYNTHESIS; NATURAL VARIATION; APIS-MELLIFERA; LEARNING RATE; C-RUBECULA; DROSOPHILA; QUALITY	Animals can store learned information in their brains through a series of distinct memory forms. Short-lasting memory forms can be followed by longer-lasting, consolidated memory forms. However, the factors determining variation in memory consolidation encountered in nature have thus far not been fully elucidated. Here, we show that two parasitic wasp species belonging to different families, Cotesia glomerata (Hymenoptera: Braconidae) and Trichogramma evanescens (Hymenoptera; Trichogrammatidae), similarly adjust the memory form they consolidate to a fitness-determining reward: egg-laying into a host-insect that serves as food for their offspring. Protein synthesis-dependent long-term memory (LTM) was consolidated after single-trial conditioning with a high-value host. However, single-trial conditioning with a low-value host induced consolidation of a shorter-lasting memory form. For Cotesia glomerata, we subsequently identified this shorter-lasting memory form as anesthesia-resistant memory (ARM) because it was not sensitive to protein synthesis inhibitors or anesthesia. Associative conditioning using a single reward of different value thus induced a physiologically different mechanism of memory formation in this species. We conclude that the memory form that is consolidated does not only change in response to relatively large differences in conditioning, such as the number and type of conditioning trials, but is also sensitive to more subtle differences, such as reward value. Reward-dependent consolidation of exclusive ARM or LTM provides excellent opportunities for within-species comparison of mechanisms underlying memory consolidation.	[Kruidhof, H. Marjolein; Vet, Louise E. M.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [Pashalidou, Foteini G.; Fatouros, Nina E.; Figueroa, Ilich A.; Vet, Louise E. M.; Smid, Hans M.; Huigens, Martinus E.] Wageningen Univ, Entomol Lab, Wageningen, Netherlands; [Figueroa, Ilich A.] Fdn PROINPA, Cochabamba, Bolivia	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Kruidhof, HM (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands.	marjolein.kruidhof@gmail.com	Vet, Louise E.M./B-1342-2009; Pashalidou, Foteini/Y-3913-2019; Fatouros, Nina/AAO-9698-2020; KNAW, NIOO-KNAW/A-4320-2012	Vet, Louise E.M./0000-0002-2287-1128; Fatouros, Nina/0000-0003-0841-3144; Smid, Hans/0000-0001-5867-2799; KNAW, NIOO-KNAW/0000-0002-3835-159X; Paschalidou, Foteini/0000-0001-5746-8227	Netherlands Organisation for Scientific Research (NWO/ALW) VENI grants [863.05.020, 863.09.002]; NWO/ALW open competition grants [820.01.012, 818.01.007]; German Research Foundation (DFG) [FA 824/1-11]	Netherlands Organisation for Scientific Research (NWO/ALW) VENI grants; NWO/ALW open competition grants; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by The Netherlands Organisation for Scientific Research (NWO/ALW) VENI grants 863.05.020 (to MEH) and 863.09.002 (to NEF), NWO/ALW open competition grants 820.01.012 (to HMS) and 818.01.007 (to LEMV), and the German Research Foundation (DFG) grant FA 824/1-11 (to NEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2003, J CHEM ECOL, V29, P1489, DOI 10.1023/A:1024277823101; BAI BR, 1992, ENTOMOL EXP APPL, V64, P37, DOI 10.1007/BF00688992; Bleeker MAK, 2006, ANIM BEHAV, V71, P1343, DOI 10.1016/j.anbehav.2005.09.016; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Camacho FJ, 2009, PHYSIOL BEHAV, V98, P602, DOI 10.1016/j.physbeh.2009.09.012; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Cnaani J, 2006, ETHOLOGY, V112, P278, DOI 10.1111/j.1439-0310.2006.01174.x; Dubnau J, 2003, J NEUROGENET, V17, P295, DOI 10.1080/01677060390441859; Eisenhardt D, 2006, ANIM BIOL, V56, P259, DOI 10.1163/157075606777304249; ERBER J, 1976, J COMP PHYSIOL PSYCH, V90, P41, DOI 10.1037/h0077258; Fatouros NE, 2005, NATURE, V433, P704, DOI 10.1038/433704a; Feltwell J., 1982, LARGE WHITE BUTTERFL; Geervliet JBF, 1997, J CHEM ECOL, V23, P2935, DOI 10.1023/A:1022583515142; GEERVLIET JBF, 1994, ENTOMOL EXP APPL, V73, P289, DOI 10.1007/BF02382480; Geervliet JBF, 1996, J INSECT BEHAV, V9, P525, DOI 10.1007/BF02213877; Geervliet JBF, 1998, ENTOMOL EXP APPL, V86, P241, DOI 10.1023/A:1003186706517; Harvey JA, 2000, ECOL ENTOMOL, V25, P267, DOI 10.1046/j.1365-2311.2000.00265.x; Hase A., 1925, Arbeiten aus der Biologischen Reichsanstalt fuer Land- u Forstwirtschaft Berlin, V14, P171; Hoedjes KM, 2011, P ROY SOC B-BIOL SCI, V278, P889, DOI 10.1098/rspb.2010.2199; Huigens ME, 2010, BEHAV ECOL, V21, P470, DOI 10.1093/beheco/arq007; Huigens ME, 2009, P NATL ACAD SCI USA, V106, P820, DOI 10.1073/pnas.0812277106; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Izquierdo LA, 2002, CELL MOL NEUROBIOL, V22, P269, DOI 10.1023/A:1020715800956; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; LEMASURIER AD, 1994, J ANIM ECOL, V63, P677, DOI 10.2307/5233; McCullagh P, 1989, GEN LINEAR MODELS; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; Reaume CJ, 2011, PHILOS T R SOC B, V366, P2100, DOI 10.1098/rstb.2011.0028; ROOT RB, 1984, ECOLOGY, V65, P147, DOI 10.2307/1939467; SALT G., 1940, PROC ROY ENT SOC LONDON SER A, V15, P81; Sara SJ, 2006, LEARN MEMORY, V13, P515, DOI 10.1101/lm.338406; SCHMIDT JM, 1987, SCIENCE, V237, P903, DOI 10.1126/science.237.4817.903; Smid HM, 2007, P ROY SOC B-BIOL SCI, V274, P1539, DOI 10.1098/rspb.2007.0305; Stearns FW, 2011, GENETICS, V187, P355, DOI 10.1534/genetics.110.125021; Sulikowski D, 2007, BIOL LETTERS, V3, P245, DOI 10.1098/rsbl.2007.0122; SUZUKI Y, 1984, ANIM BEHAV, V32, P478, DOI 10.1016/S0003-3472(84)80284-5; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; van den Berg M, 2011, ANIM BEHAV, V81, P325, DOI 10.1016/j.anbehav.2010.11.002; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Wackers F, 2006, ANIM BIOL, V56, P193, DOI 10.1163/157075606777304230; Wright GA, 2009, P ROY SOC B-BIOL SCI, V276, P2597, DOI 10.1098/rspb.2009.0040	48	40	42	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e39615	10.1371/journal.pone.0039615	http://dx.doi.org/10.1371/journal.pone.0039615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936971	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300002
J	Woodham, AW; Da Silva, DM; Skeate, JG; Raff, AB; Ambroso, MR; Brand, HE; Isas, JM; Langen, R; Kast, WM				Woodham, Andrew W.; Da Silva, Diane M.; Skeate, Joseph G.; Raff, Adam B.; Ambroso, Mark R.; Brand, Heike E.; Isas, J. Mario; Langen, Ralf; Kast, W. Martin			The S100A10 Subunit of the Annexin A2 Heterotetramer Facilitates L2-Mediated Human Papillomavirus Infection	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; VIRUS-LIKE PARTICLES; COMMON NEUTRALIZATION EPITOPE; CELL-SURFACE; HEPARAN-SULFATE; INHIBITOR SLPI; II BINDS; L2; ENTRY; INTEGRIN	Mucosotropic, high-risk human papillomaviruses (HPV) are sexually transmitted viruses that are causally associated with the development of cervical cancer. The most common high-risk genotype, HPV16, is an obligatory intracellular virus that must gain entry into host epithelial cells and deliver its double stranded DNA to the nucleus. HPV capsid proteins play a vital role in these steps. Despite the critical nature of these capsid protein-host cell interactions, the precise cellular components necessary for HPV16 infection of epithelial cells remains unknown. Several neutralizing epitopes have been identified for the HPV16 L2 minor capsid protein that can inhibit infection after initial attachment of the virus to the cell surface, which suggests an L2-specific secondary receptor or cofactor is required for infection, but so far no specific L2-receptor has been identified. Here, we demonstrate that the annexin A2 heterotetramer (A2t) contributes to HPV16 infection and co-immunoprecipitates with HPV16 particles on the surface of epithelial cells in an L2-dependent manner. Inhibiting A2t with an endogenous annexin A2 ligand, secretory leukocyte protease inhibitor (SLPI), or with an annexin A2 antibody significantly reduces HPV16 infection. With electron paramagnetic resonance, we demonstrate that a previously identified neutralizing epitope of L2 (aa 108-120) specifically interacts with the S100A10 subunit of A2t. Additionally, mutation of this L2 region significantly reduces binding to A2t and HPV16 pseudovirus infection. Furthermore, downregulation of A2t with shRNA significantly decreases capsid internalization and infection by HPV16. Taken together, these findings indicate that A2t contributes to HPV16 internalization and infection of epithelial cells and this interaction is dependent on the presence of the L2 minor capsid protein.	[Woodham, Andrew W.; Skeate, Joseph G.; Raff, Adam B.; Kast, W. Martin] Univ So Calif, Dept Mol Microbiol, Los Angeles, CA 90089 USA; [Woodham, Andrew W.; Skeate, Joseph G.; Raff, Adam B.; Kast, W. Martin] Univ So Calif, Dept Immunol, Los Angeles, CA USA; [Da Silva, Diane M.; Kast, W. Martin] Univ So Calif, Dept Obstet & Gynecol, Los Angeles, CA 90089 USA; [Da Silva, Diane M.; Brand, Heike E.; Kast, W. Martin] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Ambroso, Mark R.; Isas, J. Mario; Langen, Ralf] Univ So Calif, Dept Biochem, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Woodham, AW (corresponding author), Univ So Calif, Dept Mol Microbiol, Los Angeles, CA 90089 USA.	mkast@usc.edu		Skeate, Joseph/0000-0002-1765-5949; Kast, W Martin/0000-0003-2321-3159	National Institutes of Health [GM063915, R01 CA074397, RC2 CA148298]; NATIONAL CANCER INSTITUTE [R01CA074397, RC2CA148298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grants GM063915 to R. Langen, and R01 CA074397 and RC2 CA148298 to W.M. Kast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abban CY, 2010, VIROLOGY, V403, P1, DOI 10.1016/j.virol.2010.04.007; Bienkowska-Haba M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000524; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Buck C.B., 2007, PRODUCTION PAPILLOMA; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Compton T, 2004, TRENDS CELL BIOL, V14, P5, DOI 10.1016/j.tcb.2003.10.009; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016405; Cordes C, 2011, INT J ONCOL, V39, P185, DOI 10.3892/ijo.2011.1006; Cumming SA, 2008, BIOCHEM SOC T, V36, P522, DOI 10.1042/BST0360522; Dasgupta J, 2011, J BIOL CHEM, V286, P2617, DOI 10.1074/jbc.M110.160184; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Dreier R, 1998, HISTOCHEM CELL BIOL, V110, P137, DOI 10.1007/s004180050275; Duncan CJA, 2011, VIRUSES-BASEL, V3, P2255, DOI 10.3390/v3112255; Embers ME, 2004, VACCINE, V22, P670, DOI 10.1016/j.vaccine.2003.08.037; Evander M, 1997, J VIROL, V71, P2449, DOI 10.1128/JVI.71.3.2449-2456.1997; Fakioglu E, 2008, J VIROL, V82, P9337, DOI 10.1128/JVI.00603-08; Faridi R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-269; Fausch SC, 2003, CANCER RES, V63, P3478; Fligge C, 2001, J VIROL, V75, P7727, DOI 10.1128/JVI.75.16.7727-7731.2001; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Hayes MJ, 2009, BBA-MOL CELL RES, V1793, P1086, DOI 10.1016/j.bbamcr.2008.10.007; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Holmgren SC, 2005, J VIROL, V79, P3938, DOI 10.1128/JVI.79.7.3938-3948.2005; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kawana Y, 2001, J VIROL, V75, P2331, DOI 10.1128/JVI.75.5.2331-2336.2001; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; KRAMPS JA, 1984, AM REV RESPIR DIS, V129, P959; Langen R, 1998, J BIOL CHEM, V273, P22453, DOI 10.1074/jbc.273.35.22453; Longhi S, 2011, J PEPT SCI, V17, P315, DOI 10.1002/psc.1344; Ma G, 2004, J EXP MED, V200, P1337, DOI 10.1084/jem.20041115; Malhotra R, 2003, MICROBES INFECT, V5, P123, DOI 10.1016/S1286-4579(02)00079-5; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Moriyama A, 1999, MOL HUM REPROD, V5, P656, DOI 10.1093/molehr/5.7.656; PARK M, 1983, EMBO J, V2, P1029, DOI 10.1002/j.1460-2075.1983.tb01541.x; Pena-Alonso E, 2008, CANCER LETT, V263, P89, DOI 10.1016/j.canlet.2007.12.029; Pereira R, 2009, ARCH VIROL, V154, P187, DOI 10.1007/s00705-009-0310-3; Puisieux A, 1996, BIOCHEM J, V313, P51, DOI 10.1042/bj3130051; RAWLS WE, 1968, SCIENCE, V161, P1255, DOI 10.1126/science.161.3847.1255; Raynor CM, 1999, BIOCHEMISTRY-US, V38, P5089, DOI 10.1021/bi982095b; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Serrels B, 2012, J CELL BIOL, V196, P185, DOI 10.1083/jcb.201112128; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Sieczkarski SB, 2005, CURR TOP MICROBIOL, V285, P1; SIMON J W, 1976, Gynecologic Oncology, V4, P108, DOI 10.1016/0090-8258(76)90011-1; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Surviladze Z, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002519; VOGELMEIER C, 1991, J CLIN INVEST, V87, P482, DOI 10.1172/JCI115021; VOLPERS C, 1994, VIROLOGY, V200, P504, DOI 10.1006/viro.1994.1213; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Willis SH, 1998, J VIROL, V72, P5937, DOI 10.1128/JVI.72.7.5937-5947.1998; WRIGHT JF, 1994, BIOCHEM BIOPH RES CO, V198, P983, DOI 10.1006/bbrc.1994.1140; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003; Yang SL, 2011, J VIROL, V85, P11809, DOI 10.1128/JVI.00297-11; Zhang J, 2010, SAUDI MED J, V31, P374	76	104	106	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43519	10.1371/journal.pone.0043519	http://dx.doi.org/10.1371/journal.pone.0043519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927980	Green Submitted, gold, Green Published			2022-12-27	WOS:000308286300060
J	Ye, B; Huang, L; Gao, ZL; Chen, P; Ni, H; Guan, SD; Zhu, Y; Wang, JH				Ye, Bing; Huang, Li; Gao, Zilong; Chen, Ping; Ni, Hong; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui			The Functional Upregulation of Piriform Cortex Is Associated with Cross-Modal Plasticity in Loss of Whisker Tactile Inputs	PLOS ONE			English	Article							SEQUENTIAL SPIKES; INTERNEURONS; MOUSE; INHIBITION; SYNAPSES; NEURONS; OLFACTOMETER; TRANSMISSION; DYSFUNCTION; HOMEOSTASIS	Background: Cross-modal plasticity is characterized as the hypersensitivity of remaining modalities after a sensory function is lost in rodents, which ensures their awareness to environmental changes. Cellular and molecular mechanisms underlying cross-modal sensory plasticity remain unclear. We aim to study the role of different types of neurons in cross-modal plasticity. Methodology/Principal Findings: In addition to behavioral tasks in mice, whole-cell recordings at the excitatory and inhibitory neurons, and their two-photon imaging, were conducted in piriform cortex. We produced a mouse model of cross-modal sensory plasticity that olfactory function was upregulated by trimming whiskers to deprive their sensory inputs. In the meantime of olfactory hypersensitivity, pyramidal neurons and excitatory synapses were functionally upregulated, as well as GABAergic cells and inhibitory synapses were downregulated in piriform cortex from the mice of cross-modal sensory plasticity, compared with controls. A crosswire connection between barrel cortex and piriform cortex was established in cross-modal plasticity. Conclusion/Significance: An upregulation of pyramidal neurons and a downregulation of GABAergic neurons strengthen the activities of neuronal networks in piriform cortex, which may be responsible for olfactory hypersensitivity after a loss of whisker tactile input. This finding provides the clues for developing therapeutic strategies to promote sensory recovery and substitution.	[Ye, Bing; Huang, Li; Chen, Ping; Ni, Hong; Guan, Sudong; Zhu, Yan; Wang, Jin-Hui] Bengbu Med Coll, Dept Physiol, Bengbu, Anhui, Peoples R China; [Gao, Zilong; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Bengbu Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ye, B (corresponding author), Bengbu Med Coll, Dept Physiol, Bengbu, Anhui, Peoples R China.	jhw@ibp.ac.cn			National Award for Outstanding Young Scientist [30325021]; Natural Science Foundation of China [30870517, 30990261, 81171033]; National Basic Research Program [2011CB504405]	National Award for Outstanding Young Scientist; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	This study was supported by National Award for Outstanding Young Scientist (30325021), Natural Science Foundation of China (30870517, 30990261 and 81171033) and National Basic Research Program (2011CB504405) to JHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Buck LB, 2000, SMELL TASTE CHEM SEN; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P281, DOI 10.1016/j.bbrc.2006.05.120; Chen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011868; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Davies CW, 1999, J MED ENG TECHNOL, V23, P73, DOI 10.1080/030919099294320; Davies CW, 1998, J MED ENG TECHNOL, V22, P182, DOI 10.3109/03091909809032538; Davis E, 2007, CELL, V130, P593, DOI 10.1016/j.cell.2007.08.007; Dye MWG, 2008, ANN NY ACAD SCI, V1145, P71, DOI 10.1196/annals.1416.013; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fujii T, 2009, NEUROSCI RES, V65, P175, DOI 10.1016/j.neures.2009.06.014; Ge RJ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-19; Ge RJ, 2009, BIOCHEM BIOPH RES CO, V387, P585, DOI 10.1016/j.bbrc.2009.07.066; HABERLY LB, 1987, J COMP NEUROL, V266, P269, DOI 10.1002/cne.902660211; Halabisky B, 2006, J NEUROPHYSIOL, V96, P834, DOI 10.1152/jn.01079.2005; Huang L, 2010, BIOCHEM BIOPH RES CO, V394, P709, DOI 10.1016/j.bbrc.2010.03.056; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Kadosh RC, 2006, CURR BIOL, V16, pR962, DOI 10.1016/j.cub.2006.10.017; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lambertz N, 2005, COGNITIVE BRAIN RES, V25, P884, DOI 10.1016/j.cogbrainres.2005.09.010; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Neville H, 2002, PROG BRAIN RES, V138, P177, DOI 10.1016/S0079-6123(02)38078-6; Ni H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013736; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Owens JG, 1996, FUND APPL TOXICOL, V33, P60, DOI 10.1006/faat.1996.0143; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pho V, 2005, BEHAV BRAIN RES, V161, P245, DOI 10.1016/j.bbr.2005.02.011; Popp R, 2004, ACTA NEUROBIOL EXP, V64, P171; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito Maurice, 2005, Journal of Integrative Neuroscience, V4, P479, DOI 10.1142/S0219635205000951; Regehr WG, 2001, PHYSL SYNAPTIC TRANS; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sanchez-Vives MV, 2006, PROG BRAIN RES, V155, P287, DOI 10.1016/S0079-6123(06)55017-4; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Tsukatani T, 2005, LARYNGOSCOPE, V115, P1114, DOI 10.1097/01.MLG.0000163754.16475.43; VIGOUROUX M, 1988, J NEUROSCI METH, V24, P57, DOI 10.1016/0165-0270(88)90033-7; Wang JH, 2004, BRAIN RES, V1004, P125, DOI 10.1016/j.brainres.2004.01.025; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JH, 1996, J NEUROPHYSIOL, V75, P1687, DOI 10.1152/jn.1996.75.4.1687; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wei J, 2004, NEUROSCIENCE, V127, P637, DOI 10.1016/j.neuroscience.2004.05.056; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Yu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025219; Zhao J, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-12; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	60	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e41986	10.1371/journal.pone.0041986	http://dx.doi.org/10.1371/journal.pone.0041986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927919	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700007
J	Perez-Martinez, P; Perez-Caballero, AI; Garcia-Rios, A; Yubero-Serrano, EM; Camargo, A; Gomez-Luna, MJ; Marin, C; Gomez-Luna, P; Dembinska-Kiec, A; Rodriguez-Cantalejo, F; Tinahones, FJ; Roche, HM; Perez-Jimenez, F; Lopez-Miranda, J; Delgado-Lista, J				Perez-Martinez, Pablo; Perez-Caballero, Ana I.; Garcia-Rios, Antonio; Yubero-Serrano, Elena M.; Camargo, Antonio; Gomez-Luna, Maria J.; Marin, Carmen; Gomez-Luna, Purificacion; Dembinska-Kiec, Aldona; Rodriguez-Cantalejo, Fernando; Tinahones, Francisco J.; Roche, Helen M.; Perez-Jimenez, Francisco; Lopez-Miranda, Jose; Delgado-Lista, Javier			Effects of rs7903146 Variation in the Tcf7l2 Gene in the Lipid Metabolism of Three Different Populations	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; INSULIN-RESISTANCE; HEALTHY-MEN; ASSOCIATION; PLASMA; DISEASE; GLUCOSE; PROFILE; LIPGENE; SERUM	Background: TCF7L2 rs7903146 is an important genetic factor predicting type 2 diabetes (T2DM) which has also been linked to higher cardiovascular risk. To date, there is little information about the additional impact of this single nucleotide polymorphism (SNP) beyond glucose metabolism. Methodology/Principal Findings: We studied whether rs7903146 influenced postprandial lipid metabolism in three different populations (healthy young men, metabolic syndrome (MetS) patients and elderly persons). Eighty-eight healthy males were submitted to a single saturated fatty acid-rich test meal. Additionally, 110 middle-aged MetS patients and 20 healthy elderly persons (>= 65 years) were submitted to three different dietary models followed by test meals. Minor allele homozygotes for rs7903146 showed a worse postprandial lipemia profile in young males, as seen by a lower HDL-cholesterol and Apo A1 concentration during the postprandial lipemia and a trend towards higher triglycerides (TG), than the other genotypes. In healthy elderly persons, carriers of the minor allele showed higher total cholesterol, LDL-cholesterol, Apo B and TG in the fasting state, and a higher postprandial area under the curve for total cholesterol, Apo B, small-triglyceride rich lipoprotein (TRL) cholesterol and small-(TRL) triglycerides. These results were accompanied by differential changes in adipokines. We did not observe any influence of rs7903146 on the postprandium of MetS patients. Conclusions/Significance: Healthy young males and elderly persons who are carriers of the mutant allele for rs7903146 have an impaired postprandial lipid metabolism that may be mediated by an alteration in adipokine regulation, and may be related to the higher cardiovascular risk observed in these persons.	[Perez-Martinez, Pablo; Perez-Caballero, Ana I.; Garcia-Rios, Antonio; Yubero-Serrano, Elena M.; Camargo, Antonio; Gomez-Luna, Maria J.; Marin, Carmen; Gomez-Luna, Purificacion; Perez-Jimenez, Francisco; Lopez-Miranda, Jose; Delgado-Lista, Javier] Univ Cordoba, Hosp Univ Reina Sofia, IMIBIC, Lipids & Atherosclerosis Unit, Cordoba, Spain; [Perez-Martinez, Pablo; Perez-Caballero, Ana I.; Garcia-Rios, Antonio; Yubero-Serrano, Elena M.; Camargo, Antonio; Gomez-Luna, Maria J.; Marin, Carmen; Gomez-Luna, Purificacion; Tinahones, Francisco J.; Perez-Jimenez, Francisco; Lopez-Miranda, Jose; Delgado-Lista, Javier] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Dembinska-Kiec, Aldona] Jagiellonian Univ, Coll Med, Dept Clin Biochem, Krakow, Poland; [Dembinska-Kiec, Aldona] Off Patients Clin Dyslipidemia & Obes Treatment, Krakow, Poland; [Rodriguez-Cantalejo, Fernando] Hosp Univ Reina Sofia, Biochem Lab, Cordoba, Spain; [Tinahones, Francisco J.] Hosp Clin Virgen de la Victoria, Serv Endocrinol & Nutr, Malaga, Spain; [Roche, Helen M.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Publ Hlth & Populat Sci, Nutrigen Res Grp, Dublin 2, Ireland	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Jagiellonian University; Collegium Medicum Jagiellonian University; Hospital Universitario Reina Sofia - Cordoba; Hospital Virgen de la Victoria; University College Dublin	Perez-Martinez, P (corresponding author), Univ Cordoba, Hosp Univ Reina Sofia, IMIBIC, Lipids & Atherosclerosis Unit, Cordoba, Spain.	delgadolista@gmail.com	Jimenez, Francisco Perez/AAJ-9559-2021; Lopez-Miranda, Jose/Y-8306-2019; Tinahones, Francisco José/AAB-2882-2020; Camargo, Antonio/G-9720-2015; Roche, Helen M/AAF-4164-2019; Yubero-Serrano, Elena M/H-4832-2013; Marin Hinojosa, Carmen/AFO-1294-2022	Lopez-Miranda, Jose/0000-0002-8844-0718; Camargo, Antonio/0000-0002-0415-4184; Roche, Helen M/0000-0002-0628-3318; Marin Hinojosa, Carmen/0000-0003-2884-4806; Delgado Lista, Francisco Javier/0000-0002-2982-2716; Perez-Jimenez, Francisco/0000-0001-7499-7681; Yubero-Serrano, Elena M/0000-0002-2733-5359; Perez Jimenez, Francisco/0000-0001-9808-1280; Perez-Caballero, Ana Isabel/0000-0001-6315-1453; Tinahones, Francisco J/0000-0001-6871-4403; Perez Martinez, Pablo/0000-0001-7716-8117	Spanish Ministry of Science and Innovation [AGL 2004-07907, AGL2006-01979, AGL2009-12270, SAF07-62005, FIS PI10/01041, PI10/02412]; Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia [P06-CTS-01425, CTS5015, AGR922]; Consejeria de Salud, Junta de Andalucia [06/128, 07/43, PI0193/09, 06/129, 0118/08, PI-0252/09, PI-0058/10]; Fondo Europeo de Desarrollo Regional (FEDER); ISCIII (Program Rio-Hortega)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia(Junta de Andalucia); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); ISCIII (Program Rio-Hortega)	Supported in part by public funds: research grants from the Spanish Ministry of Science and Innovation (AGL 2004-07907, AGL2006-01979, and AGL2009-12270 to JL-M, SAF07-62005 to FP-J and FIS PI10/01041 to PP-M, PI10/02412 to FP-J); Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia (P06-CTS-01425 to JL-M, CTS5015 and AGR922 to FP-J); Consejeria de Salud, Junta de Andalucia (06/128, 07/43, and PI0193/09 to JL-M, 06/129 to FP-J, 0118/08 to FF-J, PI-0252/09 to JD-L, and PI-0058/10 to PP-M); Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The CIBEROBN is an initiative of the Instituto de Salud Carlos III, Madrid, Spain. Dr. Garcia-Rios is supported by a research contract from ISCIII (Program Rio-Hortega).	Delgado-Lista J, 2010, ATHEROSCLER IN PRESS; Delgado-Lista J, 2007, J NUTR, V137, P2024; Delgado-Lista J, 2011, J CLIN ENDOCR METAB, V96, pE816, DOI 10.1210/jc.2010-2455; Delgado-Lista J, 2010, ARTERIOSCL THROM VAS, V30, P1051, DOI 10.1161/ATVBAHA.109.202580; Delgado-Lista J, 2010, J LIPID RES, V51, P63, DOI 10.1194/jlr.M800527-JLR200; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Florez JC, 2007, CURR OPIN CLIN NUTR, V10, P391, DOI 10.1097/MCO.0b013e3281e2c9be; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fukushima H, 2004, J AM COLL CARDIOL, V43, P2219, DOI 10.1016/j.jacc.2003.09.074; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Gutierrez-Mariscal FM, 2011, AGE DORDR; Hartwich J, 2010, SCAND J CLIN LAB INV, V70, P201, DOI 10.3109/00365511003663630; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCaffery JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021518; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Mihas C, 2011, CURR VASC PHARMACOL, V9, P271, DOI 10.2174/157016111795495530; National Cholesterol Education Program, 2002, 3 NAT CHOL ED PROGR; Nedvidkova J, 2005, PHYSIOL RES, V54, P133, DOI 10.33549/physiolres.930600; Pang DX, 2012, NUTR METAB CARDIOVAS; Perez-Martinez P, 2011, NUTR METAB CARDIOVAS, V21, P39, DOI 10.1016/j.numecd.2009.07.008; Perez-Martinez P, 2008, AM J CLIN NUTR, V87, P744, DOI 10.1093/ajcn/87.3.744; Perez-Martinez P, 2011, CURR VASC PHARMACOL, V9, P287, DOI 10.2174/157016111795495495; Perez-Martinez P, 2010, ATHEROSCLEROSIS SUPP, V11, P39, DOI 10.1016/j.atherosclerosissup.2010.03.002; Pilgaard K, 2009, DIABETOLOGIA, V52, P1298, DOI 10.1007/s00125-009-1307-x; RIEPPONEN P, 1987, SCAND J CLIN LAB INV, V47, P739; Roche HM, 2005, P NUTR SOC, V64, P371, DOI 10.1079/PNS2005445; Ruano J, 2007, AM J CLIN NUTR, V86, P341, DOI 10.1093/ajcn/86.2.341; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Shaw DI, 2009, BRIT J NUTR, V101, P750, DOI 10.1017/S0007114508039962; Smushkin G, 2012, DIABETES, V61, P1082, DOI [10.2337/db11-1732, 10.2337/db12-0923]; Sousa AGP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007697; Stalenhoef AFH, 2008, CURR OPIN LIPIDOL, V19, P355, DOI 10.1097/MOL.0b013e328304b63c; Tabara Y, 2009, DIABETES, V58, P493, DOI 10.2337/db07-1785; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Taskinen MR, 2002, ATHEROSCLEROSIS SUPP, V3, P47, DOI 10.1016/S1567-5688(01)00006-X; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Warodomwichit D, 2009, J NUTR, V139, P439, DOI 10.3945/jn.108.096461; Williams KW, 2009, AM J CLIN NUTR, V89, p985S, DOI 10.3945/ajcn.2008.26788D; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Yubero-Serrano EM, 2011, J AM GERIATR SOC, V59, P938, DOI 10.1111/j.1532-5415.2011.03381.x	43	22	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43390	10.1371/journal.pone.0043390	http://dx.doi.org/10.1371/journal.pone.0043390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916254	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800063
J	Xue, ML; Ge, YL; Zhang, JY; Wang, Q; Hou, L; Liu, YC; Sun, LL; Li, Q				Xue, Meilan; Ge, Yinlin; Zhang, Jinyu; Wang, Qing; Hou, Lin; Liu, Yongchao; Sun, Lingling; Li, Quan			Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In Vivo	PLOS ONE			English	Article							CLADOSIPHON-OKAMURANUS-TOKIDA; BROWN SEAWEED; SARGASSUM-THUNBERGII; ANTITUMOR-ACTIVITY; CELL-DEATH; APOPTOSIS; POLYSACCHARIDE; METASTASIS; INHIBITION; ACTIVATION	Background: Fucoidan is a sulfated polysaccharide derived from brown algae that has been reported to perform multiple biological activities, including antitumor activity. In this study, we examined the influence of crude fucoidan on mouse breast cancer in vitro and in vivo. Materials and Methods: In vitro, fluorescent staining, flow cytometry and Western blot were performed to analyze apoptosis and vascular endothelial growth factor (VEGF) expression of mouse breast cancer 4T1 cells. In vivo, therapy experiments were conducted on Babl/c mice bearing breast cancer. The tumor volume and weight were measured. The number of apoptotic cells and microvascular density (MVD) in tumor tissues were assessed by TUNEL and CD34 immunostaining. Immunohistochemical assays and ELISA assay were used to detect the expression of VEGF in tissues. Results: In vitro studies showed that crude fucoidan significantly decreased the viable number of 4T1 cells, induced apoptosis and down-regulated the expression of VEGF. The expression of Bcl-2 was decreased, and the ratio of Bcl-2 to Bax was significantly decreased. The expression of Survivin and phosphorylated extracellular signal regulated protein kinases (ERKs) was decreased. Cytochrome C was released from mitochondria into cytosol, and the cleaved Caspase-3 protein rose after fucoidan treatment. Intraperitoneal injection of fucoidan in breast cancer models reduced the tumor volume and weight. The enhanced antitumor efficacy was associated with decreased angiogenesis and increased induction of apoptosis. Conclusion: These findings indicated that crude fucoidan inhibited mouse breast cancer growth in vitro and in vivo. These data suggest that fucoidan may serve as a potential therapeutic agent for breast cancer.	[Xue, Meilan; Ge, Yinlin; Zhang, Jinyu; Hou, Lin; Liu, Yongchao; Li, Quan] Qingdao Univ, Coll Med, Dept Biochem & Mol Biol, Qingdao 266071, Peoples R China; [Wang, Qing] Qingdao Univ, Affiliated Hosp, Dept Ophthalmol, Qingdao 266071, Peoples R China; [Sun, Lingling] Qingdao Univ, Affiliated Hosp, Dept Pathol, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Xue, ML (corresponding author), Qingdao Univ, Coll Med, Dept Biochem & Mol Biol, Qingdao 266071, Peoples R China.	geyinlin@126.com	Liu, Yong/GWQ-6163-2022					Aisa Y, 2005, AM J HEMATOL, V78, P7, DOI 10.1002/ajh.20182; Alekseyenko TV, 2007, B EXP BIOL MED+, V143, P730, DOI 10.1007/s10517-007-0226-4; Bilan MI, 2006, CARBOHYD RES, V341, P238, DOI 10.1016/j.carres.2005.11.009; Bilan MI, 2002, CARBOHYD RES, V337, P719, DOI 10.1016/S0008-6215(02)00053-8; Boo HJ, 2011, PHYTOTHER RES, V25, P1082, DOI 10.1002/ptr.3489; CARMICHAEL J, 1987, CANCER RES, V47, P943; Chevolot L, 2001, CARBOHYD RES, V330, P529, DOI 10.1016/S0008-6215(00)00314-1; COOMBE DR, 1987, INT J CANCER, V39, P82, DOI 10.1002/ijc.2910390115; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haneji K, 2005, NUTR CANCER, V52, P189, DOI 10.1207/s15327914nc5202_9; Ishii H, 2008, CANCER SCI, V99, P1871, DOI 10.1111/j.1349-7006.2008.00914.x; ITOH H, 1993, ANTICANCER RES, V13, P2045; Kim EJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-96; Koyanagi S, 2003, BIOCHEM PHARMACOL, V65, P173, DOI 10.1016/S0006-2952(02)01478-8; Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Maruyama H, 2006, PLANTA MED, V72, P1415, DOI 10.1055/s-2006-951703; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Philchenkov A, 2007, Exp Oncol, V29, P181; Poulaki V, 2002, J CLIN INVEST, V109, P805, DOI 10.1172/JCI200213776; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Riou D, 1996, ANTICANCER RES, V16, P1213; Shakibaei M, 2001, J BIOL CHEM, V276, P13289, DOI 10.1074/jbc.M010859200; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Teruya T, 2007, INT J BIOL MACROMOL, V41, P221, DOI 10.1016/j.ijbiomac.2007.02.010; Wang J, 2008, INT J BIOL MACROMOL, V42, P127, DOI 10.1016/j.ijbiomac.2007.10.003; Ye J, 2005, CYTOTECHNOLOGY, V47, P117, DOI 10.1007/s10616-005-3761-8; Zhang X, 2009, ONCOLOGY-BASEL, V77, P22, DOI 10.1159/000218201; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027441; ZHUANG C, 1995, BIOSCI BIOTECH BIOCH, V59, P563, DOI 10.1271/bbb.59.563	34	100	102	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43483	10.1371/journal.pone.0043483	http://dx.doi.org/10.1371/journal.pone.0043483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916270	gold, Green Published, Green Submitted			2022-12-27	WOS:000307733800073
J	Lee, HJ; Yang, YM; Kim, K; Shin, DM; Yoon, JH; Cho, HJ; Choi, JY				Lee, Hyun Jae; Yang, Yu-Mi; Kim, Kyubo; Shin, Dong Min; Yoon, Joo-Heon; Cho, Hyung-Ju; Choi, Jae Young			Protease-Activated Receptor 2 Mediates Mucus Secretion in the Airway Submucosal Gland	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; RESPIRATORY EPITHELIAL-CELLS; ION-TRANSPORT; CYSTIC-FIBROSIS; PAR-2; CFTR; EXPRESSION	Protease-activated receptor 2 (PAR2), a G protein-coupled receptor expressed in airway epithelia and smooth muscle, plays an important role in airway inflammation. In this study, we demonstrated that activation of PAR2 induces mucus secretion from the human airway gland and examined the underlying mechanism using the porcine and murine airway glands. The mucosa with underlying submucosal glands were dissected from the cartilage of tissues, pinned with the mucosal side up at the gas/bath solution interface of a physiological chamber, and covered with oil so that secretions from individual glands could be visualized as spherical bubbles in the oil. Secretion rates were determined by optical monitoring of the bubble diameter. The Ca2+-sensitive dye Fura2-AM was used to determine intracellular Ca2+ concentration ([Ca2+](i)) by means of spectrofluorometry. Stimulation of human tracheal mucosa with PAR2-activating peptide (PAR2-AP) elevated intracellular Ca2+ and induced glandular secretion equal to approximately 30% of the carbachol response in the human airway. Porcine gland tissue was more sensitive to PAR2-AP, and this response was dependent on Ca2+ and anion secretion. When the mouse trachea were exposed to PAR2-AP, large amounts of secretion were observed in both wild type and Delta F508 cystic fibrosis transmembrane conductance regulator mutant mice but there is no secretion from PAR-2 knock out mice. In conclusion, PAR2-AP is an agonist for mucus secretion from the airway gland that is Ca2+-dependent and cystic fibrosis transmembrane conductance regulator-independent.	[Lee, Hyun Jae; Yoon, Joo-Heon; Choi, Jae Young] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Yoon, Joo-Heon; Cho, Hyung-Ju; Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Yoon, Joo-Heon; Choi, Jae Young] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul, South Korea; [Lee, Hyun Jae; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul, South Korea; [Yang, Yu-Mi; Shin, Dong Min] Yonsei Univ, Coll Dent, Dept Oral Biol, Oral Sci Res Ctr,Brain Korea Project 21, Seoul 120749, South Korea; [Kim, Kyubo] Hallym Univ, Coll Med, Dept Otorhinolaryngol, Kang Dong Sacred Heart Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hallym University	Lee, HJ (corresponding author), Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea.	jychoi@yuhs.ac	Lee, Hyun Jae/AAV-6015-2021; Yoon, Joo-Heon/E-5781-2016	Yoon, Joo-Heon/0000-0003-2404-7156; Cho, Hyung-Ju/0000-0002-2851-3225; Shin, Dong Min/0000-0001-6042-0435; choi, jae young/0000-0001-9493-3458	Ministry of Health & Welfare, Republic of Korea [A110096]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Health Technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea (A110096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Cho HJ, 2011, J ALLERGY CLIN IMMUN; Cho HJ, 2010, J CELL BIOCHEM, V109, P1254, DOI 10.1002/jcb.22511; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Cocks TM, 2001, PULM PHARMACOL THER, V14, P183, DOI 10.1006/pupt.2001.0285; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; Danahay H, 2001, AM J PHYSIOL-CELL PH, V280, pC1455, DOI 10.1152/ajpcell.2001.280.6.C1455; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; HAWS C, 1994, AM J PHYSIOL, V266, pL502, DOI 10.1152/ajplung.1994.266.5.L502; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Joo NS, 2004, J BIOL CHEM, V279, P38854, DOI 10.1074/jbc.M407077200; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lin KW, 2008, INT J BIOCHEM CELL B, V40, P1379, DOI 10.1016/j.biocel.2007.10.031; Miotto D, 2002, THORAX, V57, P146, DOI 10.1136/thorax.57.2.146; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Palmer ML, 2006, AM J PHYSIOL-CELL PH, V290, pC1189, DOI 10.1152/ajpcell.00464.2005; Sato S, 2005, BRIT J PHARMACOL, V146, P397, DOI 10.1038/sj.bjp.0706330; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43188	10.1371/journal.pone.0043188	http://dx.doi.org/10.1371/journal.pone.0043188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916223	Green Submitted, gold, Green Published			2022-12-27	WOS:000307823600055
J	Yin, D; Yang, WRG; Weissberg, J; Goff, CB; Chen, WK; Kuwayama, Y; Leiter, A; Xing, HT; Meixel, A; Gaut, D; Kirkbir, F; Sawcer, D; Vernier, PT; Said, JW; Gundersen, MA; Koeffler, HP				Yin, Dong; Yang, Wangrong G.; Weissberg, Jack; Goff, Catherine B.; Chen, Weikai; Kuwayama, Yoshio; Leiter, Amanda; Xing, Hongtao; Meixel, Antonie; Gaut, Daria; Kirkbir, Fikret; Sawcer, David; Vernier, P. Thomas; Said, Jonathan W.; Gundersen, Martin A.; Koeffler, H. Phillip			Cutaneous Papilloma and Squamous Cell Carcinoma Therapy Utilizing Nanosecond Pulsed Electric Fields (nsPEF)	PLOS ONE			English	Article							SKIN TUMORIGENESIS; SELF-DESTRUCT; MELANOMAS; SENCAR; MICE; CONVERSION; TUMORS; CD-1	Nanosecond pulsed electric fields (nsPEF) induce apoptotic pathways in human cancer cells. The potential therapeutic effective of nsPEF has been reported in cell lines and in xenograft animal tumor model. The present study investigated the ability of nsPEF to cause cancer cell death in vivo using carcinogen-induced animal tumor model, and the pulse duration of nsPEF was only 7 and 14 nano second (ns). An nsPEF generator as a prototype medical device was used in our studies, which is capable of delivering 7-30 nanosecond pulses at various programmable amplitudes and frequencies. Seven cutaneous squamous cell carcinoma cell lines and five other types of cancer cell lines were used to detect the effect of nsPEF in vitro. Rate of cell death in these 12 different cancer cell lines was dependent on nsPEF voltage and pulse number. To examine the effect of nsPEF in vivo, carcinogen-induced cutaneous papillomas and squamous cell carcinomas in mice were exposed to nsPEF with three pulse numbers (50, 200, and 400 pulses), two nominal electric fields (40 KV/cm and 31 KV/cm), and two pulse durations (7 ns and 14 ns). Carcinogen-induced cutaneous papillomas and squamous carcinomas were eliminated efficiently using one treatment of nsPEF with 14 ns duration pulses (33/39 = 85%), and all remaining lesions were eliminated after a 2nd treatment (6/39 = 15%). 13.5% of carcinogen-induced tumors (5 of 37) were eliminated using 7 ns duration pulses after one treatment of nsPEF. Associated with tumor lysis, expression of the anti-apoptotic proteins Bcl-xl and Bcl-2 were markedly reduced and apoptosis increased (TUNEL assay) after nsPEF treatment. nsPEF efficiently causes cell death in vitro and removes papillomas and squamous cell carcinoma in vivo from skin of mice. nsPEF has the therapeutic potential to remove human squamous carcinoma.	[Yin, Dong; Goff, Catherine B.; Chen, Weikai; Kuwayama, Yoshio; Leiter, Amanda; Xing, Hongtao; Meixel, Antonie; Gaut, Daria; Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA; [Yang, Wangrong G.; Weissberg, Jack; Kirkbir, Fikret] Univ So Calif, Alfred E Mann Inst Biomed Engn, Los Angeles, CA USA; [Sawcer, David] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [Vernier, P. Thomas; Gundersen, Martin A.] Univ So Calif, Ming Hsieh Dept Elect Engn, Viterbi Sch Engn, Los Angeles, CA USA; [Said, Jonathan W.] Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA; [Koeffler, H. Phillip] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; National University of Singapore	Yin, D (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA.	yin_dong@yahoo.com	Vernier, P. Thomas/D-7926-2016	Vernier, P. Thomas/0000-0003-2335-1500	Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California; National Institutes of Health [1U54CA143930-02, 5R01CA026038-32]; Tom Collier Foundation; Parker Hughes Trust; A*STAR grant; NATIONAL CANCER INSTITUTE [R01CA026038, U54CA143930] Funding Source: NIH RePORTER	Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tom Collier Foundation; Parker Hughes Trust; A*STAR grant(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was supported in part by the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California, and with grants from the National Institutes of Health 1U54CA143930-02 and 5R01CA026038-32, Tom Collier Foundation, Parker Hughes Trust, A*STAR grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe SJ, 2005, J BIOMED BIOTECHNOL, P297, DOI 10.1155/JBB.2005.297; Beebe SJ, 2003, DNA CELL BIOL, V22, P785, DOI 10.1089/104454903322624993; Chen XH, 2009, MELANOMA RES, V19, P361, DOI 10.1097/CMR.0b013e32832f1558; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; Hall EH, 2005, DNA CELL BIOL, V24, P283, DOI 10.1089/dna.2005.24.283; Hall EH, 2007, APOPTOSIS, V12, P1721, DOI 10.1007/s10495-007-0083-7; HENNINGS H, 1986, ENVIRON HEALTH PERSP, V68, P69, DOI 10.2307/3430250; HENNINGS H, 1985, CARCINOGENESIS, V6, P1607, DOI 10.1093/carcin/6.11.1607; MCCORMICK DL, 1986, CANCER LETT, V31, P133, DOI 10.1016/0304-3835(86)90003-0; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2010, INT J CANCER, V127, P1727, DOI 10.1002/ijc.25364; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Simicevic N, 2005, PHYS MED BIOL, V50, P347, DOI 10.1088/0031-9155/50/2/012; SLAGA TJ, 1986, ENVIRON HEALTH PERSP, V68, P27, DOI 10.2307/3430244; Sylvester PW, 2005, CELL PROLIFERAT, V38, P153, DOI 10.1111/j.1365-2184.2005.00340.x; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Yang W, 2011, TECHNOL CANCER RES T, V10, P281, DOI 10.7785/tcrt.2012.500204	19	28	32	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43891	10.1371/journal.pone.0043891	http://dx.doi.org/10.1371/journal.pone.0043891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937117	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600054
J	Chen, X; Liu, MX; Cui, QH; Yan, GY				Chen, Xing; Liu, Ming-Xi; Cui, Qing-Hua; Yan, Gui-Ying			Prediction of Disease-Related Interactions between MicroRNAs and Environmental Factors Based on a Semi-Supervised Classifier	PLOS ONE			English	Article							EXPRESSION; CELLS; LIVER; PRIORITIZATION; PATHOGENESIS; MECHANISM; GENOMICS	Accumulated evidence has shown that microRNAs (miRNAs) can functionally interact with a number of environmental factors (EFs) and their interactions critically affect phenotypes and diseases. Therefore, in-silico inference of disease-related miRNA-EF interactions is becoming crucial not only for the understanding of the mechanisms by which miRNAs and EFs contribute to disease, but also for disease diagnosis, treatment, and prognosis. In this paper, we analyzed the human miRNA-EF interaction data and revealed that miRNAs (EFs) with similar functions tend to interact with similar EFs (miRNAs) in the context of a given disease, which suggests a potential way to expand the current relation space of miRNAs, EFs, and diseases. Based on this observation, we further proposed a semi-supervised classifier based method (miREFScan) to predict novel disease-related interactions between miRNAs and EFs. As a result, the leave-one-out cross validation has shown that miREFScan obtained an AUC of 0.9564, indicating that miREFScan has a reliable performance. Moreover, we applied miREFScan to predict acute promyelocytic leukemia-related miRNA-EF interactions. The result shows that forty-nine of the top 1% predictions have been confirmed by experimental literature. In addition, using miREFScan we predicted and publicly released novel miRNA-EF interactions for 97 human diseases. Finally, we believe that miREFScan would be a useful bioinformatic resource for the research about the relationships among miRNAs, EFs, and human diseases.	[Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Chen, Xing; Liu, Ming-Xi; Yan, Gui-Ying] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Liu, Ming-Xi] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cui, Qing-Hua] Peking Univ, Dept Biomed Informat, Sch Basic Med Sci, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University	Chen, X (corresponding author), Chinese Acad Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yangy@amss.ac.cn	Chen, Xing/G-6844-2016	Chen, Xing/0000-0001-9028-5342	National Natural Science of Foundation of China [10531070, 10721101]; NCMIS;  [KJCX-YW-S7]	National Natural Science of Foundation of China(National Natural Science Foundation of China (NSFC)); NCMIS; 	This work was supported by the National Natural Science of Foundation of China under Grant Nos. 10531070, 10721101, KJCX-YW-S7 and NCMIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Alisi A, 2011, LAB INVEST, V91, P283, DOI 10.1038/labinvest.2010.166; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belkin M, 2006, J MACH LEARN RES, V7, P2399; Bolton EE, 2008, ANN REP COMPUT CHEM, P217; Boren T, 2009, GYNECOL ONCOL, V113, P249, DOI 10.1016/j.ygyno.2009.01.014; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Catania AS, 2009, ARQ BRAS ENDOCRINOL, V53, P550, DOI 10.1590/S0004-27302009000500008; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Chen X, 2010, OMICS, V14, P337, DOI 10.1089/omi.2009.0143; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Das UN, 2010, NUTRITION, V26, P459, DOI 10.1016/j.nut.2009.09.020; Davis CD, 2008, NUTR REV, V66, P477, DOI 10.1111/j.1753-4887.2008.00080.x; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Gao SM, 2010, BIOCHEM BIOPH RES CO, V403, P203, DOI 10.1016/j.bbrc.2010.10.137; Ghaffari SH, 2012, TUMOR BIOL, V33, P157, DOI 10.1007/s13277-011-0259-1; Gidron Y, 2010, MOL MED REP, V3, P455, DOI 10.3892/mmr_00000279; Gu JY, 2011, MED ONCOL, V28, P211, DOI 10.1007/s12032-009-9413-7; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; Jardim MJ, 2011, MUTAT RES-FUND MOL M, V717, P38, DOI 10.1016/j.mrfmmm.2011.03.014; Jiang JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023271; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Landry Y, 2008, FUND CLIN PHARMACOL, V22, P1, DOI 10.1111/j.1472-8206.2007.00548.x; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Li YM, 2010, HEMATOLOGY, V15, P215, DOI 10.1179/102453310X12647083620840; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Lin Z, 2011, CANCER LETT, V305, P186, DOI 10.1016/j.canlet.2010.08.018; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pandolfi PP, 2007, ACUTE PROMYELOCYTIC; Qiu CX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00318; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Xi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013764; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Yang QQ, 2011, BIOINFORMATICS, V27, P3329, DOI 10.1093/bioinformatics/btr556; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	52	54	55	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43425	10.1371/journal.pone.0043425	http://dx.doi.org/10.1371/journal.pone.0043425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937049	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500050
J	Takenaka, A; Nakamura, S; Mitsunaga, F; Inoue-Murayama, M; Udono, T; Suryobroto, B				Takenaka, Akiko; Nakamura, Shin; Mitsunaga, Fusako; Inoue-Murayama, Miho; Udono, Toshifumi; Suryobroto, Bambang			Human-Specific SNP in Obesity Genes, Adrenergic Receptor Beta2 (ADRB2), Beta3 (ADRB3), and PPAR gamma 2 (PPARG), during Primate Evolution	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; BETA(3)-ADRENERGIC RECEPTOR; INSULIN-RESISTANCE; DIABETES-MELLITUS; BETA-3-ADRENERGIC RECEPTOR; BETA(2)-ADRENOCEPTOR GENE; TRP64ARG POLYMORPHISM; 3-ADRENERGIC RECEPTOR; JAPANESE MONKEYS; SEASONAL-CHANGES	Adrenergic-receptor beta2 (ADRB2) and beta3 (ADRB3) are obesity genes that play a key role in the regulation of energy balance by increasing lipolysis and thermogenesis. The Glu27 allele in ADRB2 and the Arg64 allele in ADRB3 are associated with abdominal obesity and early onset of non-insulin-dependent diabetes mellitus (NIDDM) in many ethnic groups. Peroxisome proliferator-activated receptor gamma (PPARG) is required for adipocyte differentiation. Pro12Ala mutation decreases PPARG activity and resistance to NIDDM. In humans, energy-expense alleles, Gln27 in ADRB2 and Trp64 in ADRB3, are at higher frequencies than Glu27 and Arg64, respectively, but Ala12 in PPARG is at lower frequency than Pro12. Adaptation of humans for lipolysis, thermogenesis, and reduction of fat accumulation could be considered by examining which alleles in these genes are dominant in non-human primates (NHP). All NHP (P. troglodytes, G. gorilla, P. pygmaeus, H. agilis and macaques) had energy-thrifty alleles, Gly16 and Glu27 in ADRB2, and Arg64 in ADRB3, but did not have energy-expense alleles, Arg16, Gln27 and Trp64 alleles. In PPARG gene, all NHP had large adipocyte accumulating type, the Pro12 allele. Conclusions: These results indicate that a tendency to produce much more heat through the energy-expense alleles developed only in humans, who left tropical rainforests for savanna and developed new features in their heat-regulation systems, such as reduction of body hair and increased evaporation of water, and might have helped the protection of entrails from cold at night, especially in glacial periods.	[Takenaka, Akiko] Nagoya Bunri Univ, Fac Hlth & Human Life, Dept Hlth & Nutr, Inazawa, Aichi, Japan; [Nakamura, Shin; Mitsunaga, Fusako] Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Inuyama, Aichi 484, Japan; [Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Udono, Toshifumi] Kyoto Univ, Kumamoto Sanctuary, Uki, Kumamoto, Japan; [Suryobroto, Bambang] Bogor Agr Univ, Fac Math & Nat Sci, Dept Biol, Bogor, Indonesia	Kyoto University; Kyoto University; Kyoto University; Bogor Agricultural University	Takenaka, A (corresponding author), Nagoya Bunri Univ, Fac Hlth & Human Life, Dept Hlth & Nutr, Inazawa, Aichi, Japan.	take105orc@oboe.ocn.ne.jp		Takenaka, Akiko/0000-0002-8517-5664; Suryobroto, Bambang/0000-0002-9393-4085	Cooperation Research Program of Primate Research Institute, Kyoto University	Cooperation Research Program of Primate Research Institute, Kyoto University	This study was financially supported by the Cooperation Research Program of Primate Research Institute, Kyoto University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agetsuma N, 1998, PRIMATES, V39, P275, DOI 10.1007/BF02573077; Aiello LC, 2002, ANNU REV ANTHROPOL, V31, P323, DOI 10.1146/annurev.anthro.31.040402.085403; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Barbe P, 1996, BRIT J PHARMACOL, V117, P907, DOI 10.1111/j.1476-5381.1996.tb15279.x; Biery AJ, 1997, INT J OBESITY, V21, P1176, DOI 10.1038/sj.ijo.0800532; Buettner R, 1998, J CLIN ENDOCR METAB, V83, P2892, DOI 10.1210/jc.83.8.2892; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; Cagliani R, 2009, AM J HUM GENET, V85, P64, DOI 10.1016/j.ajhg.2009.06.005; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; Corella D, 2001, J INTERN MED, V250, P348, DOI 10.1046/j.1365-2796.2001.00894.x; Dansgaard W, 2004, FROZEN ANN GREENL IC; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Ellsworth DL, 2002, INT J OBESITY, V26, P928, DOI 10.1038/sj.ijo.0802020; FOLK GE, 1991, INT J BIOMETEOROL, V35, P180, DOI 10.1007/BF01049065; Gabunia L, 2001, EVOL ANTHROPOL, V10, P158, DOI 10.1002/evan.1030; GIRARDIER L, 1981, DIABETOLOGIA, V20, P362, DOI 10.1007/BF00254504; Sanchez JLG, 2003, CLIN ENDOCRINOL, V59, P476, DOI 10.1046/j.1365-2265.2003.01871.x; Green SA, 1995, PULM PHARMACOL, V8, P1, DOI 10.1006/pulp.1995.1001; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Hara K, 2000, BIOCHEM BIOPH RES CO, V271, P212, DOI 10.1006/bbrc.2000.2605; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; HARRISON MJS, 1985, INT J PRIMATOL, V6, P351, DOI 10.1007/BF02736383; Hashimoto C, 2003, PRIMATES, V44, P77, DOI 10.1007/s10329-002-0026-4; Hayama S, 1994, AFRICA RES, V44, P97; Hayama S, 1993, CONSTATIONS CLONICOP; HEATON JM, 1972, J ANAT, V112, P35; Hellstrom L, 1999, J INTERN MED, V245, P253, DOI 10.1046/j.1365-2796.1999.0437e.x; HILEY PG, 1976, J PHYSIOL-LONDON, V254, P657, DOI 10.1113/jphysiol.1976.sp011251; Hirai H, 2003, CHROMOSOME RES, V11, P37, DOI 10.1023/A:1022006015379; Hong KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022144; Ishiyama-Shigemoto S, 1999, DIABETOLOGIA, V42, P98, DOI 10.1007/s001250051120; JOUZEL J, 1987, NATURE, V329, P403, DOI 10.1038/329403a0; KADOWAKI H, 1995, BIOCHEM BIOPH RES CO, V215, P555, DOI 10.1006/bbrc.1995.2500; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; KimMotoyama H, 1997, DIABETOLOGIA, V40, P469, DOI 10.1007/s001250050702; Kimura K, 2000, HORM METAB RES, V32, P91, DOI 10.1055/s-2007-978597; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Large V, 1997, J CLIN INVEST, V100, P3005, DOI 10.1172/JCI119854; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; LEAKEY MD, 1976, HUMAN ORIGINS L LEAK, P431; Lepre CJ, 2011, NATURE, V477, P82, DOI 10.1038/nature10372; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Macho-Azcarate T, 2003, J NUTR BIOCHEM, V14, P275, DOI 10.1016/S0955-2863(03)00035-4; Macho-Azcarate T, 2002, INT J OBESITY, V26, P1434, DOI 10.1038/sj.ijo.0802129; Masuo K, 2006, AM J HYPERTENS, V19, P1084, DOI 10.1016/j.amjhyper.2006.02.015; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; MCHENRY HM, 1994, P NATL ACAD SCI USA, V91, P6780, DOI 10.1073/pnas.91.15.6780; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Muroyama Y, 2006, PRIMATES, V47, P355, DOI 10.1007/s10329-006-0184-x; Nakagawa N, 1997, AM J PRIMATOL, V41, P267, DOI 10.1002/(SICI)1098-2345(1997)41:4<267::AID-AJP1>3.3.CO;2-E; Nakagawa N, 2000, AM J PRIMATOL, V52, P169, DOI 10.1002/1098-2345(200012)52:4<169::AID-AJP2>3.0.CO;2-B; NEEL JV, 1962, AM J HUM GENET, V14, P353; PietriRouxel F, 1997, EUR J BIOCHEM, V247, P1174, DOI 10.1111/j.1432-1033.1997.01174.x; Robertshaw D., 1975, HDB PHYSIOLOGY, P591; Ruff Christopher B., 1993, P234; Sakane N, 1997, DIABETOLOGIA, V40, P200, DOI 10.1007/s001250050663; SCHWARTZ GG, 1981, AM J PHYS ANTHROPOL, V55, P9, DOI 10.1002/ajpa.1330550103; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; Silver K, 1997, HUM GENET, V101, P306, DOI 10.1007/s004390050633; Silver K, 1996, J CLIN ENDOCR METAB, V81, P4155, DOI 10.1210/jc.81.11.4155; Sun L, 2000, Zhonghua Yi Xue Za Zhi, V80, P107; SUSMAN RL, 1982, SCIENCE, V217, P931, DOI 10.1126/science.217.4563.931; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; SYMINGTON MM, 1990, INT J PRIMATOL, V11, P47, DOI 10.1007/BF02193695; Takemoto H, 2004, AM J PHYS ANTHROPOL, V124, P81, DOI 10.1002/ajpa.10342; TAKENAKA A, 1993, PRIMATES, V34, P55, DOI 10.1007/BF02381280; Tappy L, 1996, REPROD NUTR DEV, V36, P391, DOI 10.1051/rnd:19960405; Thompson LG, 2002, SCIENCE, V298, P589, DOI 10.1126/science.1073198; Thompson ME, 2008, HORM BEHAV, V53, P526, DOI 10.1016/j.yhbeh.2007.12.005; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Tutin CEG, 1997, AM J PRIMATOL, V42, P1, DOI 10.1002/(SICI)1098-2345(1997)42:1<1::AID-AJP1>3.0.CO;2-0; UEHARA S, 1987, AM J PHYS ANTHROPOL, V72, P315, DOI 10.1002/ajpa.1330720305; Umekawa T, 1999, DIABETES, V48, P117, DOI 10.2337/diabetes.48.1.117; WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603; Walston J, 1997, GENE, V188, P207, DOI 10.1016/S0378-1119(96)00796-2; WHEELER PE, 1992, J HUM EVOL, V23, P379, DOI 10.1016/0047-2484(92)90086-O; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604; Wilson RH, 2010, AM J HUM GENET, V86, P490, DOI 10.1016/j.ajhg.2010.01.031; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wrangham R., 2009, COOKING MADE US HUMA; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Yamagiwa J, 2006, PRIMATES, V47, P74, DOI 10.1007/s10329-005-0147-7; Yen CJ, 1997, BIOCHEM BIOPH RES CO, V241, P270, DOI 10.1006/bbrc.1997.7798; YOSHIDA T, 1995, LANCET, V346, P1433, DOI 10.1016/S0140-6736(95)92452-3	93	24	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43461	10.1371/journal.pone.0043461	http://dx.doi.org/10.1371/journal.pone.0043461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937051	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500052
J	Weng, K; Hu, HY; Xu, AG; Khaitovich, P; Somel, M				Weng, Kai; Hu, Haiyang; Xu, Augix Guohua; Khaitovich, Philipp; Somel, Mehmet			Mechanisms of Dietary Response in Mice and Primates: A Role for EGR1 in Regulating the Reaction to Human-Specific Nutritional Content	PLOS ONE			English	Article							GENE-EXPRESSION; POSITIVE SELECTION; HUMAN GENOME; EVOLUTION; CELLS; MOUSE; ACTIVATION; INHIBITION; GROWTH; TRANSFORMATION	Background: Humans have a widely different diet from other primate species, and are dependent on its high nutritional content. The molecular mechanisms responsible for adaptation to the human diet are currently unknown. Here, we addressed this question by investigating whether the gene expression response observed in mice fed human and chimpanzee diets involves the same regulatory mechanisms as expression differences between humans and chimpanzees. Results: Using mouse and primate transcriptomic data, we identified the transcription factor EGR1 (early growth response 1) as a putative regulator of diet-related differential gene expression between human and chimpanzee livers. Specifically, we predict that EGR1 regulates the response to the high caloric content of human diets. However, we also show that close to 90% of the dietary response to the primate diet found in mice, is not observed in primates. This might be explained by changes in tissue-specific gene expression between taxa. Conclusion: Our results suggest that the gene expression response to the nutritionally rich human diet is partially mediated by the transcription factor EGR1. While this EGR1-driven response is conserved between mice and primates, the bulk of the mouse response to human and chimpanzee dietary differences is not observed in primates. This result highlights the rapid evolution of diet-related expression regulation and underscores potential limitations of mouse models in dietary studies.	[Weng, Kai; Hu, Haiyang; Xu, Augix Guohua; Khaitovich, Philipp; Somel, Mehmet] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Xu, Augix Guohua; Khaitovich, Philipp; Somel, Mehmet] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Somel, Mehmet] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Max Planck Society; University of California System; University of California Berkeley	Weng, K (corresponding author), Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China.	khaitovich@eva.mpg.de; somel.mehmet@gmail.com	Somel, Mehmet/B-1471-2016; Khaitovich, Philipp/HGC-8520-2022; Hu, Haiyang/AAA-6929-2022; Hu, Haiyang/F-7544-2016; hu, hai yang/F-7544-2016	Hu, Haiyang/0000-0002-5348-5641; Hu, Haiyang/0000-0002-5348-5641; Xu, Augix Guohua/0000-0002-8509-1137; Somel, Mehmet/0000-0002-3138-1307; hu, hai yang/0000-0003-1657-4765	Ministry of Science and Technology of the People's Republic of China [2007CB947004]; Chinese Academy of Sciences [KSCX2-YW-R-094, KSCX2-YW-R-251, 2009Y2BS12]; Shanghai Institutes for Biological Sciences [2008KIT104]; National Science Foundation of China [31010022, 31050110128]; Max Planck-Society; Bundesministerum fuer Bildung und Forschung; European Molecular Biology Organization [EMBO ALTF 1475-2010]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Max Planck-Society(Max Planck SocietyFoundation CELLEX); Bundesministerum fuer Bildung und Forschung; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	The study was funded by the Ministry of Science and Technology of the People's Republic of China (grant no. 2007CB947004), Chinese Academy of Sciences (grant nos. KSCX2-YW-R-094 and KSCX2-YW-R-251), the Shanghai Institutes for Biological Sciences (grant no. 2008KIT104), National Science Foundation of China research grant (grant nos. 31010022 and 31050110128), the Max Planck-Society, and the Bundesministerum fuer Bildung und Forschung. MS was supported by fellowships from the Chinese Academy of Sciences (2009Y2BS12) and European Molecular Biology Organization (EMBO ALTF 1475-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agner F, 2011, BIASEDURN BIASED URN; Aiello LC, 1995, CURR ANTHR, V36; Aljada A, 2004, AM J CLIN NUTR, V80, P51; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babbitt CC, 2011, P ROY SOC B-BIOL SCI, V278, P961, DOI 10.1098/rspb.2010.2433; Bae SH, 2007, BIOINFORMATICS, V23, P2619, DOI 10.1093/bioinformatics/btm288; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Cain CE, 2011, GENETICS, V187, P1225, DOI 10.1534/genetics.110.126177; Carlson M, 2007, GO DB SET ANNOTATION; Carmody RN, 2009, COLD SH Q B, V74, P427, DOI 10.1101/sqb.2009.74.019; Chan MY, 2008, OBESITY, V16, P972, DOI 10.1038/oby.2008.32; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V81, P498, DOI 10.1016/j.bcp.2010.11.011; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; DeLigio JT, 2009, CANCER BIOL THER, V8, P1889, DOI 10.4161/cbt.8.20.9804; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Francescatto M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S11-A8; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gibson G, 2008, NAT REV GENET, V9, P575, DOI 10.1038/nrg2383; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gokey NG, 2011, J BIOL CHEM, V286, P29501, DOI 10.1074/jbc.M111.263509; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hohmann G, 2006, FEEDING ECOLOGY APEA, pxvi; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Jiang MH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-192; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Khaitovich P, 2006, CURR BIOL, V16, pR356, DOI 10.1016/j.cub.2006.03.082; Kloting N, 2005, DIABETES-METAB RES, V21, P281, DOI 10.1002/dmrr.526; Koebnick C, 1999, ANN NUTR METAB, V43, P69, DOI 10.1159/000012770; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; Levitsky VG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-481; Liu CT, 1996, P NATL ACAD SCI USA, V93, P11831, DOI 10.1073/pnas.93.21.11831; Luca F, 2010, ANNU REV NUTR, V30, P291, DOI 10.1146/annurev-nutr-080508-141048; MCCRACKEN RD, 1971, CURR ANTHROPOL, V12, P479, DOI 10.1086/201234; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; NEEL JV, 1962, AM J HUM GENET, V14, P353; Organ C, 2011, P NATL ACAD SCI USA, V108, P14555, DOI 10.1073/pnas.1107806108; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Roche HM, 2005, P NUTR SOC, V64, P371, DOI 10.1079/PNS2005445; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tang C, 2010, ELECTROPHORESIS, V31, P2936, DOI 10.1002/elps.201000094; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Team R, 2010, R LANGUAGE ENV STAT; Ungar PS, 2004, EVOL ANTHROPOL, V13, P45, DOI 10.1002/evan.10126; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wrangham R, 2003, COMP BIOCHEM PHYS A, V136, P35, DOI 10.1016/S1095-6433(03)00020-5	70	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43915	10.1371/journal.pone.0043915	http://dx.doi.org/10.1371/journal.pone.0043915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937124	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500123
J	Zhao, YF; Guo, XJ; Zhang, ZS; Ma, XQ; Wang, R; Yan, XY; He, J				Zhao, Yan-Fang; Guo, Xiao-Jing; Zhang, Zhan-Sai; Ma, Xiu-Qiang; Wang, Rui; Yan, Xiao-Yan; He, Jia			Epidemiology of Functional Diarrhea and Comparison with Diarrhea-Predominant Irritable Bowel Syndrome: A Population-Based Survey in China	PLOS ONE			English	Article							ROME-II CRITERIA; GASTROINTESTINAL DISORDERS; UNITED-STATES; PREVALENCE; VALIDATION; COMMUNITY; SYMPTOMS; FREQUENCY; TRANSIT; CANADA	Background: The epidemiology of functional diarrhea and its impacts on Chinese remain unclear, and there are no data on the comparative epidemiology of functional diarrhea and diarrhea-predominant irritable bowel syndrome (IBS-D). This study was to explore the epidemiology of functional diarrhea and its impacts, and to identify its distinction from IBS-D. Methods and Findings: A cross-sectional survey was conducted in 16078 respondents, who were interviewed under a randomized stratified multi-stage sampling design in five cities of China. All respondents completed the modified Rome II questionnaire, and the 36-item Short Form health survey (SF-36) was used for assessing health-related quality of life in 20% of the sample. Overall, 248 respondents (1.54%) had functional diarrhea and 277 (1.72%) had IBS-D. Functional diarrhea was positively associated with increasing age and body mass index (trend test P<0.05). The three most common symptoms for at least 3 weeks in the past months were loose, mushy or watery stools (n = 203, 81.85%), more than three bowel movements a day (n = 100, 40.32%) and having to rush to the toilet to have a bowel movement (n = 72, 29.03%). Meaningful impairment was observed in 5 of the 8 SF-36 domains in respondents with functional diarrhea. The demographics are mostly similar between the respondents with functional diarrhea and IBS-D; however, respondents with IBS-D had more frequent symptoms of diarrhea and even lower scores in SF-36 domains than those with functional diarrhea. Conclusions: The prevalence of functional diarrhea in China is substantially lower than that in Western countries and relatively higher than that in other Asian countries. It impaired health-related quality of life, and respondents with IBS-D have even worse quality of life. Further population-based studies are needed to investigate the epidemiology of functional diarrhea and the differences between functional diarrhea and IBS-D.	[Zhao, Yan-Fang; Guo, Xiao-Jing; Ma, Xiu-Qiang; Wang, Rui; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Zhang, Zhan-Sai] Shanghai Inst Occupat Safety & Hlth, Testing Ctr Occupat Hlth, Shanghai, Peoples R China; [Yan, Xiao-Yan] Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China	Naval Medical University; Peking University	Zhao, YF (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com	zhao, yan/GWC-9174-2022; guo, xiaojing/GYJ-0885-2022	He, Jia/0000-0002-2338-9501	key discipline construction of evidence-based public health in Shanghai [12GWZX0602]	key discipline construction of evidence-based public health in Shanghai	Funding was provided by the key discipline construction of evidence-based public health in Shanghai (no. 12GWZX0602). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREUS L, 1994, SCAND J GASTROENTERO, V29, P102, DOI 10.3109/00365529409090447; Chang JY, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01328.x; Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Fine KD, 1999, GASTROENTEROLOGY, V116, P1464, DOI 10.1016/S0016-5085(99)70513-5; Fosnes Gunvor S, 2011, BMC Clin Pharmacol, V11, P2, DOI 10.1186/1472-6904-11-2; Hellard ME, 2003, J GASTROEN HEPATOL, V18, P322, DOI 10.1046/j.1440-1746.2003.02959.x; HINDS JP, 1989, AM J GASTROENTEROL, V84, P123; Jeong LJ, 2008, WORLD J GASTROENTERO, V14, P6388, DOI 10.3748/wjg.14.6388; Kwan ACP, 2003, J GASTROEN HEPATOL, V18, P796, DOI 10.1046/j.1440-1746.2003.03081.x; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Manabe N, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01442.x; Patel Kinesh, 2008, MEDICINE, V37, P23; Roshandel D, 2006, INT J COLORECTAL DIS, V21, P814, DOI 10.1007/s00384-006-0117-6; Sadik R, 2010, EUR J GASTROEN HEPAT, V22, P102, DOI 10.1097/MEG.0b013e32832ffd9b; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Sandler RS, 2000, DIGEST DIS SCI, V45, P1166, DOI 10.1023/A:1005554103531; Scallan E, 2005, INT J EPIDEMIOL, V34, P454, DOI 10.1093/ije/dyh413; Schmulson M, 2006, DIGEST DIS, V24, P342, DOI 10.1159/000092887; Sorouri Majid, 2010, Saudi J Gastroenterol, V16, P154, DOI 10.4103/1319-3767.65183; Talley NJ, 1999, GUT, V45, P37; Teff KL, 1999, AM J PHYSIOL-REG I, V276, pR707, DOI 10.1152/ajpregu.1999.276.3.R707; Thompson WG, 1999, GUT, V45, P43; Thompson WG, 2002, DIGEST DIS SCI, V47, P225, DOI 10.1023/A:1013208713670; Yan XY, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-86; Zhao Y, 2010, ALIMENT PHARM THER, V32, P562, DOI 10.1111/j.1365-2036.2010.04376.x	26	30	39	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43749	10.1371/journal.pone.0043749	http://dx.doi.org/10.1371/journal.pone.0043749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937091	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500093
J	Cresi, F; Castagno, E; Storm, H; Silvestro, L; Miniero, R; Savino, F				Cresi, Francesco; Castagno, Emanuele; Storm, Hanne; Silvestro, Leandra; Miniero, Roberto; Savino, Francesco			Combined Esophageal Intraluminal Impedance, pH and Skin Conductance Monitoring to Detect Discomfort in GERD Infants	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; NORTH-AMERICAN-SOCIETY; PEDIATRIC-GASTROENTEROLOGY; POSTOPERATIVE PAIN; SYMPTOM ANALYSIS; SKELETAL-MUSCLE; CHILDREN; STIMULATION; RECOMMENDATIONS; DEFINITION	Background: The clinical significance of weakly acidic reflux in infants is unclear. Skin conductance is a novel not-invasive method to evaluate discomfort. The aim of our study was to evaluate reflux-induced discomfort in infants with gastroesophageal reflux disease using simultaneously combined skin conductance and esophageal multichannel intraluminal impedance and pH monitoring. Methodology/Principal Findings: Infants with gastroesophageal reflux symptoms were investigated for almost 20 hours divided into 120-second intervals. Temporal relationships between refluxes and discomfort were evaluated calculating the symptom association probability. Twelve infants aged 17-45 days were studied. Out of 194.38 hours of adequate artifact-free MII/pH and skin conductance monitoring, 584 reflux events were observed; 35.78% were positive for stress, of which 16.27% were acid and 83.73% weakly acidic. A significant association between refluxes and discomfort (p < 0.05) was present in all infants. The intervals with reflux events showed increased skin conductance values compared to reflux-free intervals (p < 0.001); SC values were similar for acid and weakly acidic reflux events. Conclusion/Signficance: Discomfort was significantly associated with reflux events and did not differ between weakly acidic and acid refluxes. Our results may raise concerns about the over-prescription use of antacid drugs in the management of gastroesophageal reflux symptoms in infancy.	[Cresi, Francesco; Silvestro, Leandra; Savino, Francesco] Univ Turin, Dept Pediat, S Anna Regina Margherita Childrens Hosp, I-10124 Turin, Italy; [Castagno, Emanuele] S Anna Regina Margherita Childrens Hosp, Div Pediat Emergency, Turin, Italy; [Storm, Hanne] Univ Oslo, Fac Med, Skill Simulat Lab, Oslo, Norway; [Miniero, Roberto] Magna Graecia Univ Catanzaro, Dept Internal Med & Surg, Catanzaro, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Oslo; Magna Graecia University of Catanzaro	Cresi, F (corresponding author), Univ Turin, Dept Pediat, S Anna Regina Margherita Childrens Hosp, I-10124 Turin, Italy.	francesco.cresi@unito.it	Savino, Francesco/J-6935-2019; Castagno, Emanuele/AAU-2634-2021; cresi, francesco/R-3118-2017	Savino, Francesco/0000-0001-9163-1016; Castagno, Emanuele/0000-0001-7756-5075; SILVESTRO, LEANDRA/0000-0002-5564-1580; Cresi, Francesco/0000-0002-2139-6855	Lions' Club Torino Crimea Italy; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica; University of Turin	Lions' Club Torino Crimea Italy; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); University of Turin	This study was supported by a Research Grant from the Lions' Club Torino Crimea Italy, the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica and the University of Turin 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammari M, 2012, J SLEEP RES, V21, P80, DOI 10.1111/j.1365-2869.2011.00915.x; BINI G, 1980, J PHYSIOL-LONDON, V306, P537, DOI 10.1113/jphysiol.1980.sp013413; Blondeau K, 2009, AM J GASTROENTEROL, V104, P2664, DOI 10.1038/ajg.2009.568; Drug and Therapeutics Bulletin, 2010, BMJ, V341, pc4420, DOI 10.1136/bmj.c4420; Gjerstad AC, 2008, PEDIATRICS, V122, pE848, DOI 10.1542/peds.2007-2545; HABLER HJ, 1993, J NEUROPHYSIOL, V70, P920, DOI 10.1152/jn.1993.70.3.920; Ham J, 2008, DEV PSYCHOBIOL, V50, P626, DOI 10.1002/dev.20317; Hanada A, 2003, J PHYSIOL-LONDON, V551, P635, DOI 10.1113/jphysiol.2003.044024; Harrison D, 2006, EARLY HUM DEV, V82, P603, DOI 10.1016/j.earlhumdev.2005.12.008; Hassall E, 2012, J PEDIATR-US, V160, P193, DOI 10.1016/j.jpeds.2011.08.067; Hellerud BC, 2002, EARLY HUM DEV, V70, P35, DOI 10.1016/S0378-3782(02)00070-1; Hullett B, 2009, ANESTHESIOLOGY, V111, P513, DOI 10.1097/ALN.0b013e3181b27c18; Khoshoo V, 2007, PEDIATRICS, V120, P946, DOI 10.1542/peds.2007-1146; LAM HGT, 1994, DIGEST DIS SCI, V39, P402, DOI 10.1007/BF02090215; Ledowski T, 2006, BRIT J ANAESTH, V97, P862, DOI 10.1093/bja/ael280; Loots CM, 2011, J PEDIATR GASTR NUTR, V53, P120, DOI 10.1097/MPG.0b013e318214c3cc; Macefield VG, 1996, J AUTONOM NERV SYST, V61, P277, DOI 10.1016/S0165-1838(96)00095-1; Munsters J, 2012, EARLY HUM DEV, V88, P21, DOI 10.1016/j.earlhumdev.2011.06.010; Omari TI, 2011, J PEDIATR GASTR NUTR, V52, P408, DOI 10.1097/MPG.0b013e3181f474c7; Pereira-da-Silva L, 2012, J MATERN-FETAL NEO M, V25, P796, DOI 10.3109/14767058.2011.587919; Peter CS, 2004, BIOL NEONATE, V85, P11, DOI 10.1159/000074951; Pilic D, 2011, J PEDIATR-US, V158, P650, DOI 10.1016/j.jpeds.2010.09.033; Riis Povl, 2003, New Rev Bioeth, V1, P15, DOI 10.1080/1740028032000131396; Roeggen I, 2011, EARLY HUM DEV, V87, P37, DOI 10.1016/j.earlhumdev.2010.09.373; Rosen R, 2011, J PEDIATR GASTR NUTR, V52, P404, DOI 10.1097/MPG.0b013e3182078081; Rudolph CD, 2001, J PEDIATR GASTR NUTR, V32, pS1, DOI 10.1097/00005176-200100002-00001; Savino F, 2008, PEDIATRICS, V121, P1070, DOI 10.1542/peds.2008-0179; Sherman PM, 2009, AM J GASTROENTEROL, V104, P1278, DOI 10.1038/ajg.2009.129; Storm H, 2000, ARCH DIS CHILD-FETAL, V83, pF143, DOI 10.1136/fn.83.2.F143; Storm H, 2002, ACTA PAEDIATR, V91, P555, DOI 10.1080/080352502753711687; Storm H, 2001, EARLY HUM DEV, V62, P149, DOI 10.1016/S0378-3782(01)00129-3; Storm H, 2008, CURR OPIN ANESTHESIO, V21, P796, DOI 10.1097/ACO.0b013e3283183fe4; STROBEL CT, 1979, J PEDIATR-US, V94, P81, DOI 10.1016/S0022-3476(79)80361-3; Vakil N, 2010, BEST PRACT RES CL GA, V24, P759, DOI 10.1016/j.bpg.2010.09.009; van der Pol RJ, 2011, PEDIATRICS, V127, P925, DOI 10.1542/peds.2010-2719; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; WALLIN BG, 1975, PFLUG ARCH EUR J PHY, V358, P101, DOI 10.1007/BF00583921; Wenzl TG, 2012, J PEDIATR GASTR NUTR, V55, P230, DOI 10.1097/MPG.0b013e3182592b65; WEUSTEN BLAM, 1994, GASTROENTEROLOGY, V107, P1741, DOI 10.1016/0016-5085(94)90815-X; World Medical Association, 1991, Law Med Health Care, V19, P264	40	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43476	10.1371/journal.pone.0043476	http://dx.doi.org/10.1371/journal.pone.0043476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927972	gold, Green Submitted, Green Published			2022-12-27	WOS:000308224700015
J	Castro-Leyva, V; Espejel-Nunez, A; Barroso, G; Zaga-Clavellina, V; Flores-Pliego, A; Morales-Mendez, I; Giono-Cerezo, S; Walsh, SW; Estrada-Gutierrez, G				Castro-Leyva, Violeta; Espejel-Nunez, Aurora; Barroso, Gerardo; Zaga-Clavellina, Veronica; Flores-Pliego, Arturo; Morales-Mendez, Iyari; Giono-Cerezo, Silvia; Walsh, Scott W.; Estrada-Gutierrez, Guadalupe			Preserved Ex Vivo Inflammatory Status in Decidual Cells from Women with Preterm Labor and Subclinical Intrauterine Infection	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CERVICAL-MUCUS PLUG; MATRIX METALLOPROTEINASES; PROSTAGLANDIN BIOSYNTHESIS; AMNIOTIC-FLUID; BIRTH; PARTURITION; CYTOKINES; MEMBRANES; LIPOPOLYSACCHARIDE	Objective: To compare the inflammatory response preserved ex vivo by decidual cells isolated from women who experienced preterm labor with and without subclinical intrauterine infection. Methods: Fetal membranes were obtained after cesarean section from 35 women who delivered before 37 weeks of gestation following spontaneous preterm labor, with no clinical evidence of intrauterine infection. Decidua was microbiologically tested and cultured. Concentrations of anti-inflammatory cytokines (IL-2, IL-4, IL-10), pro-inflammatory cytokines (IL-6, IL-8, IL-1 beta and TNF-alpha), and matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9) were measured in the supernatants using Bio-Plex, and prostaglandin E-2 (PGE(2)) was measured by enzyme immunoassay. Results: Subclinical infection was confirmed in 10 women (28.5%). Microorganisms isolated were Ureaplasma urealyticum (4), group B streptococci (3), Gardnerella vaginalis (1), and Escherichia coli (2). We found a significant increase of proinflammatory cytokines and a significant decrease of anti-inflammatory cytokines in supernatants from decidual cells obtained from women with preterm labor and subclinical intrauterine infection compared to women without infection. Secretion of MMP-1, MMP-8, MMP-9 and PGE(2) was significantly higher in infected women. Secretion of IL-8 by decidual cells from infected women persisted upon repeated in vitro culture passages. Conclusions: Almost 30% of idiopathic preterm labor cases were associated with subclinical intrauterine infection, and decidual cells isolated from these cases preserved an ex vivo inflammatory status after in vivo bacterial exposure.	[Castro-Leyva, Violeta; Morales-Mendez, Iyari; Estrada-Gutierrez, Guadalupe] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Infectol, Mexico City, DF, Mexico; [Castro-Leyva, Violeta; Giono-Cerezo, Silvia] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Espejel-Nunez, Aurora; Flores-Pliego, Arturo] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Biochem & Mol Biol, Mexico City, DF, Mexico; [Barroso, Gerardo] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Div Clin Res, Mexico City, DF, Mexico; [Zaga-Clavellina, Veronica] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Cellular Biol, Mexico City, DF, Mexico; [Walsh, Scott W.] Virginia Commonwealth Univ, Dept Obstet & Gynecol & Physiol & Biophys, Med Ctr, Richmond, VA USA	Instituto Politecnico Nacional - Mexico; Virginia Commonwealth University	Castro-Leyva, V (corresponding author), Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Infectol, Mexico City, DF, Mexico.	gpestrad@yahoo.es	Estrada-Gutierrez, Guadalupe/AAM-4642-2021; Zaga-Clavellina, Veronica/ABB-9954-2020; Espejel, Aurora/AAO-6510-2021; Flores-Pliego, Arturo/GPK-6349-2022; Estrada, Guadalupe/AAT-3970-2021	Estrada-Gutierrez, Guadalupe/0000-0001-9551-9021; Zaga-Clavellina, Veronica/0000-0002-3365-2932; Flores-Pliego, Arturo/0000-0001-7876-6098; ESPEJEL NUNEZ, AURORA/0000-0001-9087-8017	Instituto Nacional de Perinatologia IER; CONACyT (Consejo Nacional de Ciencia y Tecnologia)	Instituto Nacional de Perinatologia IER; CONACyT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was funded by the Instituto Nacional de Perinatologia IER. VCL was sponsored by CONACyT (Consejo Nacional de Ciencia y Tecnologia.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechavaleta-Velasco F, 2002, BIOL REPROD, V67, P1952, DOI 10.1095/biolreprod.102.004721; Becher N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-113; Becher N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-45; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bowen JM, 2002, PLACENTA, V23, P257, DOI 10.1053/plac.2001.0782; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; DUDLEY DJ, 1992, J CLIN ENDOCR METAB, V75, P1081, DOI 10.1210/jc.75.4.1081; Estrada-Gutierrez G, 2005, MATRIX BIOL, V24, P306, DOI 10.1016/j.matbio.2005.05.001; Estrada-Gutierrez G, 2010, INFECT IMMUN, V78, P4792, DOI 10.1128/IAI.00522-10; Garcia-Lopez G, 2007, MOL HUM REPROD, V13, P409, DOI 10.1093/molehr/gam025; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; Gibbs R S, 2001, Ann Periodontol, V6, P153, DOI 10.1902/annals.2001.6.1.153; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Gonzalez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026877; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Jalava J, 1996, BRIT J OBSTET GYNAEC, V103, P664, DOI 10.1111/j.1471-0528.1996.tb09835.x; Jeffcoat MK, 2001, J AM DENT ASSOC, V132, P875, DOI 10.14219/jada.archive.2001.0299; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Klein LL, 2005, OBSTET GYN CLIN N AM, V32, P397, DOI 10.1016/j.ogc.2005.03.001; Lockwood CJ, 2006, AM J PATHOL, V169, P1294, DOI 10.2353/ajpath.2006.060185; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P94, DOI 10.1067/mob.2000.105344; MITCHELL MD, 1990, PROSTAG LEUKOTR ESS, V41, P35, DOI 10.1016/0952-3278(90)90128-8; MITCHELL MD, 1993, PLACENTA, V14, P615, DOI 10.1016/S0143-4004(05)80379-0; MITCHELL MD, 1993, PLACENTA, V14, P249, DOI 10.1016/S0143-4004(05)80426-6; *NAT AC I MED, 2006, PRET BIRTH CAUS CONS; Peltier Morgan R, 2003, Reprod Biol Endocrinol, V1, P122; Riggs MA, 2004, CLIN OBSTET GYNECOL, V47, P796, DOI 10.1097/01.grf.0000141450.61310.81; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SO T, 1992, BIOL REPROD, V46, P772, DOI 10.1095/biolreprod46.5.772; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x	31	13	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43605	10.1371/journal.pone.0043605	http://dx.doi.org/10.1371/journal.pone.0043605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928002	gold, Green Published			2022-12-27	WOS:000308286300072
J	Hoffman, KB; Kraus, C; Dimbil, M; Golomb, BA				Hoffman, Keith B.; Kraus, Christina; Dimbil, Mo; Golomb, Beatrice A.			A Survey of the FDA's AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class	PLOS ONE			English	Article							POSTMARKETING SURVEILLANCE; ROSUVASTATIN; METAANALYSIS; SAFETY; SIMVASTATIN; EFFICACY; THERAPY; DISEASE; TRIALS; RISK	Background: Cholesterol management drugs known as statins are widely used and often well tolerated; however, a variety of muscle-related side effects can arise. These adverse events (AEs) can have serious impact, and form a significant barrier to therapy adherence. Surveillance of post-marketing AEs is of vital importance to understand real-world AEs and reporting differences between individual statin drugs. We conducted a review of post-approval muscle and tendon AE reports in association with statin use, to assess differences within the drug class. Methods: We analyzed all case reports from the FDA AE Reporting System (AERS) database linking muscle-related AEs to statin use (07/01/2005-03/31/2011). Drugs examined were: atorvastatin, simvastatin, lovastatin, pravastatin, rosuvastatin, and fluvastatin. Results: Relative risk rates for rosuvastatin were consistently higher than other statins. Atorvastatin and simvastatin showed intermediate risks, while pravastatin and lovastatin appeared to have the lowest risk rates. Relative risk of muscle-related AEs, therefore, approximately tracked with per milligram LDL-lowering potency, with fluvastatin an apparent exception. Incorporating all muscle categories, rates for atorvastatin, simvastatin, pravastatin, and lovastatin were, respectively, 55%, 26%, 17%, and 7.5% as high, as rosuvastatin, approximately tracking per milligram potency (Rosuvastatin > Atorvastatin > Simvastatin > Pravastatin approximate to Lovastatin) and comporting with findings of other studies. Relative potency, therefore, appears to be a fundamental predictor of muscle-related AE risk, with fluvastatin, the least potent statin, an apparent exception (risk 74% vs rosuvastatin). Interpretation: AE reporting rates differed strikingly for drugs within the statin class, with relative reporting aligning substantially with potency. The data presented in this report offer important reference points for the selection of statins for cholesterol management in general and, especially, for the rechallenge of patients who have experienced muscle-related AEs (for whom agents of lower expected potency should be preferred). Interpretation: AE reporting rates differed strikingly for drugs within the statin class, with relative reporting aligning substantially with potency. The data presented in this report offer important reference points for the selection of statins for cholesterol management in general and, especially, for the rechallenge of patients who have experienced muscle-related AEs (for whom agents of lower expected potency should be preferred).	[Hoffman, Keith B.; Kraus, Christina; Dimbil, Mo] AdverseEvents Inc, Healdsburg, CA USA; [Golomb, Beatrice A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Golomb, Beatrice A.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hoffman, KB (corresponding author), AdverseEvents Inc, Healdsburg, CA USA.	bgolomb@ucsd.edu						Afilalo J, 2007, HEART, V93, P914, DOI 10.1136/hrt.2006.112508; Alsheikh-Ali AA, 2005, CIRCULATION, V111, P3051, DOI 10.1161/CIRCULATIONAHA.105.555482; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; Arnaiz JA, 2001, EUR J CLIN PHARMACOL, V57, P89, DOI 10.1007/s002280100265; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bruckert E, 1999, J CLIN EPIDEMIOL, V52, P589, DOI 10.1016/S0895-4356(99)00019-0; Cham S, 2010, PHARMACOTHERAPY, V30, P541, DOI 10.1592/phco.30.6.541; Collins R, 2003, LANCET, V361, P2005; Egan A, 2011, NEW ENGL J MED, V365, P285, DOI 10.1056/NEJMp1106689; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; GOLOMB BA, 2009, RISK, V25, P66; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; IMS Health, 2004, LIP LEADS WAY 2003; IMS Health website, 2010, IMS HLTH REP US PRES; *IMS HLTH, 2006, COMM REQ THER CLASS; *IMS HLTH, 2007, IMS GLOB INS IMS RET; Kones R, 2010, DRUG DES DEV THER, V4, P383, DOI 10.2147/DDDT.S10812; Kostapanos MS, 2010, AM J CARDIOVASC DRUG, V10, P11, DOI 10.2165/13168600-000000000-00000; McKenney JM, 2003, CLIN CARDIOL, V26, P32, DOI 10.1002/clc.4960261507; McNeil JJ, 1999, MED J AUSTRALIA, V170, P270, DOI 10.5694/j.1326-5377.1999.tb127751.x; McTaggart F, 2003, ATHEROSCLEROSIS SUPP, V4, P9, DOI 10.1016/S1567-5688(03)00004-7; Olsson GO, 2004, LANCET, V364, P135, DOI 10.1016/S0140-6736(04)16616-6; Paraskevas KI, 2010, NEW DEV STATIN TREAT; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Rallidis LS, 2011, INT J CARDIOL; Roberts WC, 1997, AM J CARDIOL, V80, P106, DOI 10.1016/S0002-9149(97)00298-1; Sakaeda T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028124; Silva M, 2007, CLIN THER, V29, P253, DOI 10.1016/j.clinthera.2007.02.008; Wolfe SM, 2004, LANCET, V363, P2189, DOI 10.1016/S0140-6736(04)16513-6; Zipes Douglas P, 2006, MedGenMed, V8, P73	30	70	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42866	10.1371/journal.pone.0042866	http://dx.doi.org/10.1371/journal.pone.0042866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936996	Green Published, gold			2022-12-27	WOS:000308286300028
J	Sun, JG; Yeung, CA; Co, NN; Tsang, TY; Yau, E; Luo, KW; Wu, P; Wa, JCY; Fung, KP; Kwok, TT; Liu, FY				Sun, Jianguo; Yeung, Chilam Au; Co, Ngai Na; Tsang, Tsun Yee; Yau, Esmond; Luo, Kewang; Wu, Ping; Wa, Judy Chan Yuet; Fung, Kwok-Pui; Kwok, Tim-Tak; Liu, Feiyan			Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Transcription Factor NF-kappa B in R-HepG2 Cell Line	PLOS ONE			English	Article							MDR1 GENE-EXPRESSION; BREAST-CANCER CELLS; ANTICANCER DRUGS; AMINO NUCLEOSIDE; PROMOTER REGION; HEAT-SHOCK; INHIBITION; INDUCTION; APOPTOSIS; BINDING	Multidrug resistance(MDR) is one of the major reasons for failure in cancer chemotherapy and its suppression may increase the efficacy of therapy. The human multidrug resistance 1 (MDR1) gene encodes the plasma membrane P-glycoprotein (P-gp) that pumps various anti-cancer agents out of the cancer cell. R-HepG2 and MES-SA/Dx5 cells are doxorubicin induced P-gp over-expressed MDR sublines of human hepatocellular carcinoma HepG2 cells and human uterine carcinoma MES-SA cells respectively. Herein, we observed that clitocine, a natural compound extracted from Leucopaxillus giganteus, presented similar cytotoxicity in multidrug resistant cell lines compared with their parental cell lines and significantly suppressed the expression of P-gp in R-HepG2 and MES-SA/Dx5 cells. Further study showed that the clitocine increased the sensitivity and intracellular accumulation of doxorubicin in R-HepG2 cells accompanying down-regulated MDR1 mRNA level and promoter activity, indicating the reversal effect of MDR by clitocine. A 5'-serial truncation analysis of the MDR1 promoter defined a region from position -450 to -193 to be critical for clitocine suppression of MDR1. Mutation of a consensus NF-kappa B binding site in the defined region and overexpression of NF-kappa B p65 could offset the suppression effect of clitocine on MDR1 promoter. By immunohistochemistry, clitocine was confirmed to suppress the protein levels of both P-gp and NF-kappa B p65 in R-HepG2 cells and tumors. Clitocine also inhibited the expression of NF-kappa B p65 in MES-SA/Dx5. More importantly, clitocine could suppress the NF-kappa B activation even in presence of doxorubicin. Taken together; our results suggested that clitocine could reverse P-gp associated MDR via down-regulation of NF-kappa B.	[Sun, Jianguo; Luo, Kewang; Wu, Ping; Liu, Feiyan] Zhejiang Univ, Res Ctr Siyuan Nat Pharm & Biotoxicol, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jianguo; Yeung, Chilam Au; Co, Ngai Na; Tsang, Tsun Yee; Yau, Esmond; Luo, Kewang; Wu, Ping; Wa, Judy Chan Yuet; Fung, Kwok-Pui; Kwok, Tim-Tak; Liu, Feiyan] Zhejiang Univ, Joint Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jianguo; Yeung, Chilam Au; Co, Ngai Na; Tsang, Tsun Yee; Yau, Esmond; Luo, Kewang; Wu, Ping; Wa, Judy Chan Yuet; Fung, Kwok-Pui; Kwok, Tim-Tak; Liu, Feiyan] Chinese Univ Hong Kong Nat Prod & Toxicol Res, Hangzhou, Zhejiang, Peoples R China; [Yeung, Chilam Au; Co, Ngai Na; Tsang, Tsun Yee; Yau, Esmond; Wa, Judy Chan Yuet; Fung, Kwok-Pui; Kwok, Tim-Tak] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Zhejiang University; Zhejiang University; Chinese University of Hong Kong; Chinese University of Hong Kong	Sun, JG (corresponding author), Zhejiang Univ, Res Ctr Siyuan Nat Pharm & Biotoxicol, Coll Life Sci, Zijinggang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	tkwok2020@yahoo.com.hk; liuf64@zju.edu.cn	Fung, Kwok Pui/R-9708-2018	Fung, Kwok Pui/0000-0001-6214-5123; Chan, Judy/0000-0003-0423-5950	Nature Science Foundation of Zhejiang Province [LY12C02001]; Siyuan Foundation	Nature Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Siyuan Foundation	Grant support from the Nature Science Foundation of Zhejiang Province (LY12C02001 to FL) and Siyuan Foundation (to FL and TTK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Aydin C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-584; Bauer JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001313; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Bentires-Alj M, 1999, CANCER RES, V59, P811; Bosch I, 1996, BBA-REV CANCER, V1288, pF37, DOI 10.1016/0304-419X(96)00022-4; CHIN KV, 1990, J BIOL CHEM, V265, P221; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Chung SY, 2005, ARCH PHARM RES, V28, P823, DOI 10.1007/BF02977349; CORNWELL MM, 1993, J BIOL CHEM, V268, P19505; David GL, 2004, CANCER BIOL THER, V3, P540, DOI 10.4161/cbt.3.6.845; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fine RL, 1996, STEM CELLS, V14, P47, DOI 10.1002/stem.140047; Fortin H, 2006, CHEMMEDCHEM, V1, P189, DOI 10.1002/cmdc.200500029; Fujita T, 2005, CLIN CANCER RES, V11, P8837, DOI 10.1158/1078-0432.CCR-05-0945; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hennessy M, 2007, PHARMACOL RES, V55, P1, DOI 10.1016/j.phrs.2006.10.007; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kim SN, 2009, MOL CANCER RES, V7, P735, DOI 10.1158/1541-7786.MCR-08-0296; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Kuo MT, 2002, ONCOGENE, V21, P1945, DOI 10.1038/sj.onc.1205117; Lee CH, 2001, BIOORG MED CHEM LETT, V11, P2419, DOI 10.1016/S0960-894X(01)00454-1; LING V, 1983, CANCER TREAT REP, V67, P869; Liu FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016241; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; MOSS RJ, 1988, J MED CHEM, V31, P786, DOI 10.1021/jm00399a017; Mothana RA, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-7; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Patanasethanont D, 2007, EUR J PHARMACOL, V566, P67, DOI 10.1016/j.ejphar.2007.04.001; Ren G, 2008, CANCER LETT, V262, P190, DOI 10.1016/j.canlet.2007.12.013; SLATER L, 1995, LEUKEMIA RES, V19, P543, DOI 10.1016/0145-2126(95)00029-N; Tang PMK, 2007, CANCER BIOL THER, V6, P504, DOI 10.4161/cbt.6.4.3814; Tang XY, 2008, J CHEMOTHERAPY, V20, P355, DOI 10.1179/joc.2008.20.3.355; UEDA K, 1987, J BIOL CHEM, V262, P17432; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Yatouji S, 2007, INT J ONCOL, V30, P1003; YUSA K, 1989, CANCER RES, V49, P5002; Zhou G, 1997, J BIOL CHEM, V272, P15174, DOI 10.1074/jbc.272.24.15174; Zhou G, 1998, J BIOL CHEM, V273, P15387, DOI 10.1074/jbc.273.25.15387	48	48	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e40720	10.1371/journal.pone.0040720	http://dx.doi.org/10.1371/journal.pone.0040720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927901	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300003
J	Zhao, L; Zheng, CF				Zhao, Lei; Zheng, Chunfu			The First Identified Nucleocytoplasmic Shuttling Herpesviral Capsid Protein: Herpes Simplex Virus Type 1 VP19C	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; INTRACELLULAR-LOCALIZATION; SEQUENCE; SPECIFICITY; RECEPTOR; IMPORT; CRM1	VP19C is a structural protein of herpes simplex virus type 1 viral particle, which is essential for assembly of the capsid. In this study, a nuclear export signal (NES) of VP19C is for the first time identified and mapped to amino acid residues 342 to 351. Furthermore, VP19C is demonstrated to shuttle between the nucleus and the cytoplasm through the NES in a chromosomal region maintenance 1 (CRM1)-dependent manner involving RanGTP hydrolysis. This makes VP19C the first herpesviral capsid protein with nucleocytoplasmic shuttling property and adds it to the list of HSV-1 nucleocytoplasmic shuttling proteins.	[Zhao, Lei; Zheng, Chunfu] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China; [Zhao, Lei] NW A&F Univ, Div Sci Res, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Northwest A&F University - China	Zhao, L (corresponding author), Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China.	zheng.alan@hotmail.com	zheng, Chunfu/F-2404-2012	zheng, Chunfu/0000-0002-8797-1322	Major State Basic Research Development Program of China [2011CB504802, 2010CB530105]; National Natural Science Foundation of China [30870120, 30900059, 81000736]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Major State Basic Research Development Program of China (2011CB504802 and 2010CB530105) and National Natural Science Foundation of China (30870120, 30900059 and 81000736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson WE, 2006, J VIROL, V80, P1537, DOI 10.1128/JVI.80.3.1537-1548.2006; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Boyle SM, 1999, J VIROL, V73, P6872, DOI 10.1128/JVI.73.8.6872-6881.1999; BRAUN DK, 1984, J VIROL, V50, P645, DOI 10.1128/JVI.50.2.645-648.1984; Cai MS, 2011, J GEN VIROL, V92, P621, DOI 10.1099/vir.0.027029-0; Cheng GF, 2002, J VIROL, V76, P9434, DOI 10.1128/JVI.76.18.9434-9445.2002; Ding Q, 2010, VIRUS RES, V149, P95, DOI 10.1016/j.virusres.2010.01.009; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Elfgang C, 1999, P NATL ACAD SCI USA, V96, P6229, DOI 10.1073/pnas.96.11.6229; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Isegawa Y, 2008, J VIROL, V82, P710, DOI 10.1128/JVI.00736-07; Kim FJ, 1996, MOL CELL BIOL, V16, P5147; Li ML, 2011, VIROLOGY, V417, P385, DOI 10.1016/j.virol.2011.06.004; Li Y, 2012, J GEN VIROL; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Mears WE, 1998, VIROLOGY, V242, P128, DOI 10.1006/viro.1997.9006; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; Okoye ME, 2006, J VIROL, V80, P929, DOI 10.1128/JVI.80.2.929-940.2006; Ossareh-Nazari B, 1999, EXP CELL RES, V252, P236, DOI 10.1006/excr.1999.4599; Person S, 1998, VIROLOGY, V242, P193, DOI 10.1006/viro.1997.9005; Rixon FJ, 1996, J GEN VIROL, V77, P2251, DOI 10.1099/0022-1317-77-9-2251; TATMAN JD, 1994, J GEN VIROL, V75, P1101, DOI 10.1099/0022-1317-75-5-1101; Wang JP, 2012, J VIROL, V86, P2273, DOI 10.1128/JVI.06010-11; Williams P, 2008, J VIROL, V82, P10946, DOI 10.1128/JVI.01403-08; Zheng CF, 2004, VIROLOGY, V324, P327, DOI 10.1016/j.virol.2004.03.042; Zheng CF, 2011, J VIROL METHODS, V177, P206, DOI 10.1016/j.jviromet.2011.08.004; ZWEIG M, 1979, VIROLOGY, V94, P442, DOI 10.1016/0042-6822(79)90474-4	30	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41825	10.1371/journal.pone.0041825	http://dx.doi.org/10.1371/journal.pone.0041825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927916	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300015
J	Yamaguchi, Y; Miyata, H; Uchiyama, K; Ootsuyama, A; Inubushi, S; Mori, T; Muramatsu, N; Katamine, S; Sakaguchi, S				Yamaguchi, Yoshitaka; Miyata, Hironori; Uchiyama, Keiji; Ootsuyama, Akira; Inubushi, Sachiko; Mori, Tsuyoshi; Muramatsu, Naomi; Katamine, Shigeru; Sakaguchi, Suehiro			Biological and Biochemical Characterization of Mice Expressing Prion Protein Devoid of the Octapeptide Repeat Region after Infection with Prions	PLOS ONE			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; PRP KNOCKOUT MICE; TRANSGENIC MICE; SCRAPIE; SUSCEPTIBILITY; IDENTIFICATION; ACCUMULATION; RESISTANT; STRAIN; AGENT	Accumulating lines of evidence indicate that the N-terminal domain of prion protein (PrP) is involved in prion susceptibility in mice. In this study, to investigate the role of the octapeptide repeat (OR) region alone in the N-terminal domain for the susceptibility and pathogenesis of prion disease, we intracerebrally inoculated RML scrapie prions into tg(PrP Delta OR)/Prnp(0/0) mice, which express mouse PrP missing only the OR region on the PrP-null background. Incubation times of these mice were not extended. Protease-resistant PrP Delta OR, or PrPSc Delta OR, was easily detectable but lower in the brains of these mice, compared to that in control wild-type mice. Consistently, prion titers were slightly lower and astrogliosis was milder in their brains. However, in their spinal cords, PrPSc Delta R and prion titers were abundant and astrogliosis was as strong as in control wild-type mice. These results indicate that the role of the OR region in prion susceptibility and pathogenesis of the disease is limited. We also found that the PrPSc Delta OR, including the pre-OR residues 23-50, was unusually protease-resistant, indicating that deletion of the OR region could cause structural changes to the pre-OR region upon prion infection, leading to formation of a protease-resistant structure for the pre-OR region.	[Yamaguchi, Yoshitaka; Uchiyama, Keiji; Inubushi, Sachiko; Mori, Tsuyoshi; Muramatsu, Naomi; Sakaguchi, Suehiro] Univ Tokushima, Div Mol Neurobiol, Inst Enzyme Res KOSOKEN, Tokushima 770, Japan; [Yamaguchi, Yoshitaka; Katamine, Shigeru; Sakaguchi, Suehiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki, Japan; [Miyata, Hironori] Univ Occupat & Environm Hlth, Sch Med, Anim Res Ctr, Kitakyushu, Fukuoka 807, Japan; [Ootsuyama, Akira] Univ Occupat & Environm Hlth, Sch Med, Dept Radiat Biol & Hlth, Kitakyushu, Fukuoka 807, Japan	Tokushima University; Nagasaki University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Yamaguchi, Y (corresponding author), Univ Tokushima, Div Mol Neurobiol, Inst Enzyme Res KOSOKEN, Tokushima 770, Japan.	sakaguch@ier.tokushima-u.ac.jp	Yamaguchi, Yoshitaka/ABD-2499-2020	UCHIYAMA, KEIJI/0000-0002-5667-3509	bovine spongiform encephalopathy (BSE); Ministry of Agriculture, Forestry and Fisheries of Japan; Research Committee of Prion Disease and Slow Virus infection; Ministry of Health, Labour and Welfare of Japan; Institute for Enzyme Research; University of Tokushima	bovine spongiform encephalopathy (BSE); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Research Committee of Prion Disease and Slow Virus infection; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Institute for Enzyme Research; University of Tokushima	This work was partly supported by a Grant-in-Aid from the bovine spongiform encephalopathy (BSE) and other Prion Disease Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan, and Grants-in-Aid from the Research Committee of Prion Disease and Slow Virus infection, the Ministry of Health, Labour and Welfare of Japan. H.M. is partly supported by a Cooperative Research Grant of the Institute for Enzyme Research, the University of Tokushima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Fujita K, 2011, CELL MOL NEUROBIOL, V31, P999, DOI 10.1007/s10571-011-9696-z; Gambetti P, 2011, ACTA NEUROPATHOL, V121, P79, DOI 10.1007/s00401-010-0761-3; MANSON JC, 1994, NEURODEGENERATION, V3, P331; PRIOLA SA, 1994, MOL NEUROBIOL, V8, P113, DOI 10.1007/BF02780661; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; REED J, 1938, AM J HYG, V27, P493; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Supattapone S, 2001, J VIROL, V75, P1408, DOI 10.1128/JVI.75.3.1408-1413.2001; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Weissmann C, 2002, ACTA NEUROBIOL EXP, V62, P153; Yoshikawa D, 2008, J BIOL CHEM, V283, P24202, DOI 10.1074/jbc.M804212200	24	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43540	10.1371/journal.pone.0043540	http://dx.doi.org/10.1371/journal.pone.0043540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927985	Green Submitted, Green Published, gold			2022-12-27	WOS:000307789700037
J	Gross, S; Krause, Y; Wuelling, M; Vortkamp, A				Gross, Stefanie; Krause, Yvonne; Wuelling, Manuela; Vortkamp, Andrea			Hoxa11 and Hoxd11 Regulate Chondrocyte Differentiation Upstream of Runx2 and Shox2 in Mice	PLOS ONE			English	Article							INDIAN-HEDGEHOG; BONE-DEVELOPMENT; GENE-EXPRESSION; HOMEOBOX GENES; SHORT-STATURE; GROWTH-PLATE; MOUSE; LIMB; PROLIFERATION; ULNALESS	During limb development, posterior Hox genes of the Hoxa-and Hoxd cluster provide positional information along the limb axis. Here we report a new function for Hoxa11 and Hoxd11 in regulating the early steps of chondrocyte differentiation. We analyzed forelimbs of Hoxa11(-/-); d11(-/-) and Ulnaless mice, which are characterized by specifically shortened zeugopods. By detailed morphological and molecular analyses, we show that loss of Hoxa11 and Hoxd11 in the ulna of both mutants leads to an arrest of chondrocyte differentiation at a step before the separation into round and columnar cells takes place. Furthermore, we demonstrate that Hoxa11 and Hoxd11 act upstream of Runx2 and Shox2, two key regulators of chondrocyte differentiation. We hypothesize that Runx2 activates Shox2 in early chondrocytes, which at later stages induces Runx2 expression to regulate hypertrophic differentiation. These results give insight into mechanisms by which positional information might be translated into a specific bone pattern.	[Gross, Stefanie; Krause, Yvonne; Wuelling, Manuela; Vortkamp, Andrea] Univ Duisburg Essen, Ctr Med Biotechnol, Dept Dev Biol, Essen, Germany	University of Duisburg Essen	Gross, S (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA.	andrea.vortkamp@uni-due.due		Wuelling, Manuela/0000-0003-4534-3528	Deutsche Forschungsgemeinschaft [VO620/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (VO620/5) to AV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Boulet AM, 2004, DEVELOPMENT, V131, P299, DOI 10.1242/dev.00936; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DAVISSON MT, 1990, J HERED, V81, P151; Deschamps J, 2004, SCIENCE, V304, P1610, DOI 10.1126/science.1099162; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1992, BIOESSAYS, V14, P375, DOI 10.1002/bies.950140606; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; ELIMA K, 1993, BIOCHEM J, V289, P247, DOI 10.1042/bj2890247; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Herault Y, 1997, DEVELOPMENT, V124, P3493; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Kahveci Z, 2000, BIOTECH HISTOCHEM, V75, P264, DOI 10.3109/10520290009085130; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; KRUMLAUF R, 1992, BIOESSAYS, V14, P245, DOI 10.1002/bies.950140408; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Long FX, 2001, DEVELOPMENT, V128, P5099; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Minina E, 2005, GENE EXPR PATTERNS, V6, P102, DOI 10.1016/j.modgep.2005.04.012; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Morris T, 1967, MOUSE NEWS LETT; Nelson CE, 1996, DEVELOPMENT, V122, P1449; NG LJ, 1993, DEV BIOL, V159, P403, DOI 10.1006/dbio.1993.1251; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Peichel CL, 1997, DEVELOPMENT, V124, P3481; Peichel CL, 1996, GENETICS, V144, P1757; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Tagariello A, 2008, MATRIX BIOL, V27, P3, DOI 10.1016/j.matbio.2007.07.004; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yu L, 2007, DEV BIOL, V306, P549, DOI 10.1016/j.ydbio.2007.03.518; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zinn AR, 2002, AM J MED GENET, V110, P158, DOI 10.1002/ajmg.10422	50	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43553	10.1371/journal.pone.0043553	http://dx.doi.org/10.1371/journal.pone.0043553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916278	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800077
J	Kim, HK; Park, WS; Warda, M; Park, SY; Ko, EA; Kim, MH; Jeong, SH; Heo, HJ; Choi, TH; Hwang, YW; Lee, SI; Ko, KS; Rhee, BD; Kim, N; Han, J				Kim, Hyoung Kyu; Park, Won Sun; Warda, Mohamad; Park, So Youn; Ko, Eun A.; Kim, Min Hee; Jeong, Seung Hun; Heo, Hye-Jin; Choi, Tae-Hoon; Hwang, Young-Won; Lee, Sun-Il; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Nari; Han, Jin			Beta Adrenergic Overstimulation Impaired Vascular Contractility via Actin-Cytoskeleton Disorganization in Rabbit Cerebral Artery	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; LEFT-VENTRICULAR HYPERTROPHY; INDUCED CARDIAC-HYPERTROPHY; OPPOSES RHO-KINASE; ANGIOTENSIN-II; RESISTANCE ARTERIES; CORONARY-ARTERY; PROTEIN-KINASES; ISCHEMIC-STROKE; K+ CHANNELS	Background and Purpose: Beta adrenergic overstimulation may increase the vascular damage and stroke. However, the underlying mechanisms of beta adrenergic overstimulation in cerebrovascular dysfunctions are not well known. We investigated the possible cerebrovascular dysfunction response to isoproterenol induced beta-adrenergic overstimulation (ISO) in rabbit cerebral arteries (CAs). Methods: ISO was induced in six weeks aged male New Zealand white rabbit (0.8-1.0 kg) by 7-days isoproterenol injection (300 mu g/kg/day). We investigated the alteration of protein expression in ISO treated CAs using 2DE proteomics and western blot analysis. Systemic properties of 2DE proteomics result were analyzed using bioinformatics software. ROS generation and following DNA damage were assessed to evaluate deteriorative effect of ISO on CAs. Intracellular Ca2+ level change and vascular contractile response to vasoactive drug, angiotensin II (Ang II), were assessed to evaluate functional alteration of ISO treated CAs. Ang II-induced ROS generation was assessed to evaluated involvement of ROS generation in CA contractility. Results: Proteomic analysis revealed remarkably decreased expression of cytoskeleton organizing proteins (e. g. actin related protein 1A and 2, alpha-actin, capping protein Z beta, and vimentin) and anti-oxidative stress proteins (e. g. heat shock protein 9A and stress-induced-phosphoprotein 1) in ISO-CAs. As a cause of dysregulation of actin-cytoskeleton organization, we found decreased level of RhoA and ROCK1, which are major regulators of actin-cytoskeleton organization. As functional consequences of proteomic alteration, we found the decreased transient Ca2+ efflux and constriction response to angiotensin II and high K+ in ISO-CAs. ISO also increased basal ROS generation and induced oxidative damage in CA; however, it decreased the Ang II-induced ROS generation rate. These results indicate that ISO disrupted actin cytoskeleton proteome network through down-regulation of RhoA/ROCK1 proteins and increased oxidative damage, which consequently led to contractile dysfunction in CA.	[Kim, Hyoung Kyu; Kim, Min Hee; Jeong, Seung Hun; Heo, Hye-Jin; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Nari; Han, Jin] Inje Univ, Cardiovasc & Metab Dis Ctr, Coll Med, Natl Res Lab Mitochondrial Signaling,Dept Physiol, Pusan, South Korea; [Park, Won Sun] Kangwon Natl Univ, Dept Physiol, Sch Med, Chunchon, South Korea; [Warda, Mohamad] Cairo Univ, Dept Biochem, Fac Vet Med, Cairo, Egypt; [Park, So Youn] Pusan Natl Univ, Dept Pharmacol, Coll Med, Pusan, South Korea; [Park, So Youn] Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Pusan, South Korea; [Ko, Eun A.] Univ Illinois, Dept Med, Sect Pulm Crit Care & Sleep Med, Chicago, IL USA; [Choi, Tae-Hoon] Andong Sci Coll, Dept Phys Educ, Andong, South Korea; [Hwang, Young-Won; Lee, Sun-Il] Inje Univ, Busan Paik Hosp, Coll Med, Dept Neurosurg, Pusan, South Korea	Inje University; Kangwon National University; Egyptian Knowledge Bank (EKB); Cairo University; Pusan National University; Pusan National University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Inje University	Kim, HK (corresponding author), Inje Univ, Cardiovasc & Metab Dis Ctr, Coll Med, Natl Res Lab Mitochondrial Signaling,Dept Physiol, Pusan, South Korea.	phyhanj@inje.ac.kr		Kim, Hyoung Kyu/0000-0002-1791-7865; Warda, Mohamed/0000-0001-7004-8526; Warda, Mohamad/0000-0003-0516-4023	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0020224, NRF-2009-0067574]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0020224 and NRF-2009-0067574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; BENJAMIN IJ, 1989, CIRC RES, V65, P657, DOI 10.1161/01.RES.65.3.657; BIKKINA M, 1994, JAMA-J AM MED ASSOC, V272, P33, DOI 10.1001/jama.272.1.33; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Canales-Aguirre A, 2011, INT J ENV RES PUB HE, V8, P540, DOI 10.3390/ijerph8020540; Cipolla MJ, 1998, STROKE, V29, P1223, DOI 10.1161/01.STR.29.6.1223; Davel APC, 2008, AM J PHYSIOL-HEART C, V295, pH211, DOI 10.1152/ajpheart.00581.2007; Davel APC, 2006, BRIT J PHARMACOL, V148, P629, DOI 10.1038/sj.bjp.0706749; Di Tullio MR, 2003, STROKE, V34, P2380, DOI 10.1161/01.STR.0000089680.77236.60; Du T, 2010, J NEUROCHEM, V115, P1007, DOI 10.1111/j.1471-4159.2010.06995.x; Ennis IL, 2003, HYPERTENSION, V41, P1324, DOI 10.1161/01.HYP.0000071180.12012.6E; Gokina NI, 2000, AM J PHYSIOL-HEART C, V278, pH2094, DOI 10.1152/ajpheart.2000.278.6.H2094; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; JENSEN LJ, 2008, NUCL ACIDS RES; Zhang J, 2010, MOL MED, V16, P307, DOI 10.2119/molmed.2009.00121; Keles MS, 2009, MOL CELL BIOCHEM, V328, P109, DOI 10.1007/s11010-009-0080-y; Kim HK, 2007, AM J PHYSIOL-CELL PH, V293, pC761, DOI 10.1152/ajpcell.00043.2007; Kim JE, 2009, BIOL PHARM BULL, V32, P1047, DOI 10.1248/bpb.32.1047; Kim N, 2006, PROTEOMICS, V6, P1237, DOI 10.1002/pmic.200500291; Kim N, 2003, CIRC RES, V93, P541, DOI 10.1161/01.RES.0000090087.66390.F2; Kim N, 2006, BBA-MOL CELL RES, V1763, P1067, DOI 10.1016/j.bbamcr.2006.08.002; Kim Nari, 2001, Korean Journal of Physiology and Pharmacology, V5, P33; KOHYA T, 1988, J MOL CELL CARDIOL, V20, P159, DOI 10.1016/S0022-2828(88)80029-4; Kolch Walter, 2002, Expert Opin Pharmacother, V3, P709, DOI 10.1517/14656566.3.6.709; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Leenen FHH, 2001, AM J PHYSIOL-HEART C, V281, pH2410, DOI 10.1152/ajpheart.2001.281.6.H2410; Li JM, 2002, CIRC RES, V90, P143, DOI 10.1161/hh0202.103615; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; Loufrani L, 2008, MED BIOL ENG COMPUT, V46, P451, DOI 10.1007/s11517-008-0306-2; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meloche S, 2000, AM J PHYSIOL-HEART C, V279, pH741, DOI 10.1152/ajpheart.2000.279.2.H741; Moniri NH, 2007, BIOCHEM PHARMACOL, V74, P64, DOI 10.1016/j.bcp.2007.03.016; Nakamura M, 2000, AM J PHYSIOL-CELL PH, V279, pC480, DOI 10.1152/ajpcell.2000.279.2.C480; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Park WS, 2007, ARTERIOSCL THROM VAS, V27, P1768, DOI 10.1161/ATVBAHA.107.143339; Pereira-Leal JB, 2006, PHILOS T R SOC B, V361, P507, DOI 10.1098/rstb.2005.1807; Pozzi A, 2006, MOL BIOL CELL, V17, P2046, DOI 10.1091/mbc.E05-08-0800; PYE MP, 1992, CARDIOVASC RES, V26, P740, DOI 10.1093/cvr/26.8.740; Remondino A, 2003, CIRC RES, V92, P136, DOI 10.1161/01.RES.0000054624.03539.B4; Rodriguez CJ, 2002, J AM COLL CARDIOL, V39, P1482, DOI 10.1016/S0735-1097(02)01799-0; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sakudo A, 2005, BIOCHEM BIOPH RES CO, V328, P14, DOI 10.1016/j.bbrc.2004.12.132; Samain E, 1999, AM J PHYSIOL-HEART C, V277, pH834, DOI 10.1152/ajpheart.1999.277.2.H834; Samain E, 2000, ANESTH ANALG, V90, P546, DOI 10.1097/00000539-200003000-00009; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Selvetella G, 2003, STROKE, V34, P1766, DOI 10.1161/01.STR.0000078310.98444.1D; Shcherbina A, 1999, BRIT J HAEMATOL, V106, P216, DOI 10.1046/j.1365-2141.1999.01508.x; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Tanaka Y, 1999, J IMMUNOL, V163, P6209; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Touyz RM, 2005, CAN J PHYSIOL PHARM, V83, P91, DOI 10.1139/Y05-006; Touyz RM, 1999, CIRCULATION, V99, P392, DOI 10.1161/01.CIR.99.3.392; Van Cuong D, 2007, AM J PHYSIOL-HEART C, V293, pH1457, DOI 10.1152/ajpheart.01282.2006; Verdecchia P, 2001, CIRCULATION, V104, P2039, DOI 10.1161/hc4201.097944; Voloboueva LA, 2008, J CEREBR BLOOD F MET, V28, P1009, DOI 10.1038/sj.jcbfm.9600600; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zou YZ, 2001, CIRCULATION, V104, P102, DOI 10.1161/hc2601.090987	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43884	10.1371/journal.pone.0043884	http://dx.doi.org/10.1371/journal.pone.0043884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916309	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800106
J	Kuramoto, T; Nakanishi, S; Ochiai, M; Nakagama, H; Voigt, B; Serikawa, T				Kuramoto, Takashi; Nakanishi, Satoshi; Ochiai, Masako; Nakagama, Hitoshi; Voigt, Birger; Serikawa, Tadao			Origins of Albino and Hooded Rats: Implications from Molecular Genetic Analysis across Modern Laboratory Rat Strains	PLOS ONE			English	Article							MISSENSE MUTATION; KIT EXPRESSION; MICE; ELEMENTS	Albino and hooded (or piebald) rats are one of the most frequently used laboratory animals for the past 150 years. Despite this fact, the origin of the albino mutation as well as the genetic basis of the hooded phenotype remained unclear. Recently, the albino mutation has been identified as the Arg299His missense mutation in the Tyrosinase gene and the hooded (H) locus has been mapped to the similar to 460-kb region in which only the Kit gene exists. Here, we surveyed 172 laboratory rat strains for the albino mutation and the hooded (h) mutation that we identified by positional cloning approach to investigate possible genetic roots and relationships of albino and hooded rats. All of 117 existing laboratory albino rats shared the same albino missense mutation, indicating they had only one single ancestor. Genetic fine mapping followed by de novo sequencing of BAC inserts covering the H locus revealed that an endogenous retrovirus (ERV) element was inserted into the first intron of the Kit gene where the hooded allele maps. A solitary long terminal repeat (LTR) was found at the same position to the ERV insertion in another allele of the H locus, which causes the so called Irish (h(i)) phenotype. The ERV and the solitary LTR insertions were completely associated with the hooded and Irish coat patterns, respectively, across all colored rat strains examined. Interestingly, all 117 albino rat strains shared the ERV insertion without any exception, which strongly suggests that the albino mutation had originally occurred in hooded rats.	[Kuramoto, Takashi; Nakanishi, Satoshi; Voigt, Birger; Serikawa, Tadao] Kyoto Univ, Fac Med, Inst Lab Anim, Grad Sch Med,Sakyo Ku, Kyoto 606, Japan; [Ochiai, Masako; Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Chuo Ku, Tokyo 104, Japan	Kyoto University; National Cancer Center - Japan	Kuramoto, T (corresponding author), Kyoto Univ, Fac Med, Inst Lab Anim, Grad Sch Med,Sakyo Ku, Kyoto 606, Japan.	tkuramot@anim.med.kyoto-u.ac.jp			Japan Society for the Promotion of Science [21300153]; Ministry of Health, Labour and Welfare; Fujiwara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Fujiwara Memorial Foundation	This work was supported in part by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (21300153 to T. Kuramoto), a Grant-in-aid for Cancer Research from the Ministry of Health, Labour and Welfare, and the Fujiwara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter LL, 2004, PIGM CELL RES, V17, P215, DOI 10.1111/j.1600-0749.2004.00147.x; Beermann F, 2004, MAMM GENOME, V15, P749, DOI 10.1007/s00335-004-4002-8; Blaszczyk WM, 2005, PIGM CELL RES, V18, P144, DOI 10.1111/j.1600-0749.2005.00227.x; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; CASTLE WE, 1951, GENETICS, V36, P254; Crampe II, 1885, LANDWIRTHSCHAFTLICHE; Donaldson HH, 1915, RAT DATA REFERENCE T; DUTTLINGER R, 1993, DEVELOPMENT, V118, P705; GERSHONIBARUCH R, 1994, AM J HUM GENET, V54, P586; Hofmann M, 1998, GENOMICS, V52, P107, DOI 10.1006/geno.1998.5409; Jurka J, 2009, REPBASE REPORTS, V9, P1214; KESHET E, 1991, EMBO J, V10, P2425, DOI 10.1002/j.1460-2075.1991.tb07782.x; Kluppel M, 1997, DEVELOPMENT, V124, P65; Kuramoto T, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-91; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Nakamuta M, 1989, Virus Genes, V3, P69, DOI 10.1007/BF00301988; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; SERIKAWA T, 1992, GENETICS, V131, P701; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Tokuda S, 2007, BRAIN RES, V1133, P168, DOI 10.1016/j.brainres.2006.10.086; Torigoe D, 2011, J VET MED SCI, V73, P707, DOI 10.1292/jvms.10-0529	22	22	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43059	10.1371/journal.pone.0043059	http://dx.doi.org/10.1371/journal.pone.0043059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916206	Green Submitted, Green Published, gold			2022-12-27	WOS:000307824300027
J	Marit, MR; Chohan, M; Matthew, N; Huang, K; Kuntz, DA; Rose, DR; Barber, DL				Marit, Michael R.; Chohan, Manprit; Matthew, Natasha; Huang, Kai; Kuntz, Douglas A.; Rose, David R.; Barber, Dwayne L.			Random Mutagenesis Reveals Residues of JAK2 Critical in Evading Inhibition by a Tyrosine Kinase Inhibitor	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; BCR-ABL; BLAST CRISIS; DOMAIN MUTATIONS; IMATINIB STI571; IN-VITRO; PROTEIN; RESISTANCE	Background: The non-receptor tyrosine kinase JAK2 is implicated in a group of myeloproliferative neoplasms including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. JAK2-selective inhibitors are currently being evaluated in clinical trials. Data from drug-resistant chronic myeloid leukemia patients demonstrate that treatment with a small-molecule inhibitor generates resistance via mutation or amplification of BCR-ABL. We hypothesize that treatment with small molecule inhibitors of JAK2 will similarly generate inhibitor-resistant mutants in JAK2. Methodology: In order to identify inhibitor-resistant JAK2 mutations a priori, we utilized TEL-JAK2 to conduct an in vitro random mutagenesis screen for JAK2 alleles resistant to JAK Inhibitor-I. Isolated mutations were evaluated for their ability to sustain cellular growth, stimulate downstream signaling pathways, and phosphorylate a novel JAK2 substrate in the presence of inhibitor. Conclusions: Mutations were found exclusively in the kinase domain of JAK2. The panel of mutations conferred resistance to high concentrations of inhibitor accompanied by sustained activation of the Stat5, Erk1/2, and Akt pathways. Using a JAK2 substrate, enhanced catalytic activity of the mutant JAK2 kinase was observed in inhibitor concentrations 200-fold higher than is inhibitory to the wild-type protein. When testing the panel of mutations in the context of the Jak2 V617F allele, we observed that a subset of mutations conferred resistance to inhibitor, validating the use of TEL-JAK2 in the initial screen. These results demonstrate that small-molecule inhibitors select for JAK2 inhibitor-resistant alleles, and the design of next-generation JAK2 inhibitors should consider the location of mutations arising in inhibitor-resistant screens.	[Marit, Michael R.; Chohan, Manprit; Matthew, Natasha; Huang, Kai; Kuntz, Douglas A.; Rose, David R.; Barber, Dwayne L.] Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada; [Marit, Michael R.; Chohan, Manprit; Matthew, Natasha; Huang, Kai; Kuntz, Douglas A.; Rose, David R.; Barber, Dwayne L.] Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M4X 1K9, Canada; [Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Waterloo	Marit, MR (corresponding author), Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada.	dbarber@uhnres.utoronto.ca		Barber, Dwayne/0000-0001-5528-8150	Canadian Institutes of Health Research [FRN-42428, FRN-79400]; Leukemia and Lymphoma Society of Canada; Doctoral Research Award from Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society of Canada; Doctoral Research Award from Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (FRN-42428 to DLB and FRN-79400 to DRR) and Leukemia and Lymphoma Society of Canada. MRM was supported by a Doctoral Research Award from Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; BARBER DL, 1994, MOL CELL BIOL, V14, P2257, DOI 10.1128/MCB.14.4.2257; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Buchdunger E, 1996, CANCER RES, V56, P100; Chan WW, 2011, CANCER CELL, V19, P556, DOI 10.1016/j.ccr.2011.03.003; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Deshpande A, 2011, LEUKEMIA OFFICIAL J; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Grandage VL, 2006, BRIT J HAEMATOL, V135, P303, DOI 10.1111/j.1365-2141.2006.06291.x; Haan C, 2009, J IMMUNOL, V182, P2969, DOI 10.4049/jimmunol.0800572; Haan S, 2009, ONCOGENE, V28, P3069, DOI 10.1038/onc.2009.155; Hart S, 2011, LEUKEMIA, V25, P1751, DOI 10.1038/leu.2011.148; Hofmann WK, 2003, BLOOD, V102, P659, DOI 10.1182/blood-2002-06-1756; Hornakova T, 2011, HAEMATOL-HEMATOL J, V96, P845, DOI 10.3324/haematol.2010.036350; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2008, LEUKEMIA, V22, P2011, DOI 10.1038/leu.2008.290; Ju W, 2011, BLOOD, V117, P1938, DOI 10.1182/blood-2010-09-305425; Kantarjian HM, 2011, BLOOD, V117, P1141, DOI 10.1182/blood-2010-03-277152; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Li Z, 2007, EXP HEMATOL, V35, P1624, DOI 10.1016/j.exphem.2007.07.003; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Opar A, 2010, NAT REV DRUG DISCOV, V9, P257, DOI 10.1038/nrd3155; Pardanani A, 2011, CURR OPIN HEMATOL, V18, P105, DOI 10.1097/MOH.0b013e3283439964; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Pradhan A, 2010, J BIOL CHEM, V285, P16651, DOI 10.1074/jbc.M109.071191; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Schaub FX, 2010, BLOOD, V115, P2003, DOI 10.1182/blood-2009-09-245381; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Stein BL, 2011, HAEMATOLOGICA; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Vijayakrishnan L, 2011, TRENDS PHARMACOL SCI, V32, P25, DOI 10.1016/j.tips.2010.10.004; Weigert O, 2012, J EXP MED, V209, P259, DOI 10.1084/jem.20111694; Weisberg E, 2010, LEUKEMIA, V24, P1375, DOI 10.1038/leu.2010.107; Willis SG, 2005, BLOOD, V106, P2128, DOI 10.1182/blood-2005-03-1036; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	55	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43437	10.1371/journal.pone.0043437	http://dx.doi.org/10.1371/journal.pone.0043437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916261	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300049
J	van Rijen, MML; Bode, LGM; Baak, DA; Kluytmans, JAJW; Vos, MC				van Rijen, Miranda M. L.; Bode, Lonneke G. M.; Baak, Diane A.; Kluytmans, Jan A. J. W.; Vos, Margreet C.			Reduced Costs for Staphylococcus aureus Carriers Treated Prophylactically with Mupirocin and Chlorhexidine in Cardiothoracic and Orthopaedic Surgery	PLOS ONE			English	Article							SURGICAL-SITE INFECTIONS; NASAL CARRIAGE; WOUND INFECTIONS; DOUBLE-BLIND; IMPACT; PREVALENCE; RESISTANCE; OINTMENT	Background: A multi centre double-blind randomised-controlled trial (M-RCT), carried out in the Netherlands in 2005-2007, showed that hospitalised patients with S. aureus nasal carriage who were treated prophylactically with mupirocin nasal ointment and chlorhexidine gluconate medicated soap (MUP-CHX), had a significantly lower risk of health-care associated S. aureus infections than patients receiving placebo (3.4% vs. 7.7%, RR 0.42, 95% CI 0.23-0.75). The objective of the present study was to determine whether treatment of patients undergoing elective cardiothoracic or orthopaedic surgery with MUP-CHX (screen-and-treat strategy) affected the costs of patient care. Methods: We compared hospital costs of patients undergoing cardiothoracic or orthopaedic surgery (n = 415) in one of the participating centres of the M-RCT. Data from the 'Planning and Control' department were used to calculate total hospital costs of the patients. Total costs were calculated including nursing days, costs of surgery, costs for laboratory and radiological tests, functional assessments and other costs. Costs for personnel, materials and overhead were also included. Mean costs in the two treatment arms were compared using the t-test for equality of means (two-tailed). Subgroup analysis was performed for cardiothoracic and orthopaedic patients. Results: An investigator-blinded analysis revealed that costs of care in the treatment arm (MUP-CHX, n = 210) were on average (sic)1911 lower per patient than costs of care in the placebo arm (n = 205) (sic)8602 vs. (sic)10513, p = 0.01). Subgroup analysis showed that MUP-CHX treated cardiothoracic patients cost (sic)2841 less (n = 280, (sic)9628 vs (sic)12469, p = 0.006) and orthopaedic patients (sic)955 less than non-treated patients (n = 135, (sic)6097 vs (sic)7052, p = 0.05). Conclusions: In conclusion, in patients undergoing cardiothoracic or orthopaedic surgery, screening for S. aureus nasal carriage and treating carriers with MUP-CHX results in a substantial reduction of hospital costs.	[van Rijen, Miranda M. L.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Bode, Lonneke G. M.; Vos, Margreet C.] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Baak, Diane A.] Amphia Hosp, Business Informat Ctr, Breda, Netherlands; [Kluytmans, Jan A. J. W.] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Med Ctr, Amsterdam, Netherlands	Amphia Hospital; Erasmus University Rotterdam; Erasmus MC; Amphia Hospital; Vrije Universiteit Amsterdam	van Rijen, MML (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	mvrijen@amphia.nl						Bending M, 1996, J AM SOC NEPHROL, V7, P2403; Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; BOELAERT JR, 1989, NEPHROL DIAL TRANSPL, V4, P278, DOI 10.1093/oxfordjournals.ndt.a091872; Cookson BD, 1998, J ANTIMICROB CHEMOTH, V41, P11, DOI 10.1093/jac/41.1.11; Courville XF, 2012, INFECT CONT HOSP EP, V33, P152, DOI 10.1086/663704; Garcia Ana Maria, 2003, Biomedica, V23, P173; Harbarth S, 1999, ANTIMICROB AGENTS CH, V43, P1412, DOI 10.1128/AAC.43.6.1412; Kalmeijer MD, 2002, CLIN INFECT DIS, V35, P353, DOI 10.1086/341025; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Konvalinka A, 2006, J HOSP INFECT, V64, P162, DOI 10.1016/j.jhin.2006.06.010; Lee AS, 2011, CLIN INFECT DIS, V52, P1422, DOI 10.1093/cid/cir233; MANGRAM A. J., 1999, EPIDEMIOLOGY, V20, P247; Noskin GA, 2008, INFECT CONT HOSP EP, V29, P16, DOI 10.1086/524327; PEREZFONTAN M, 1992, ADV PERIT D, V8, P242; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wassenberg MWM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014815; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, ANN INTERN MED, V140, P419, DOI 10.7326/0003-4819-140-6-200403160-00007; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963	23	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43065	10.1371/journal.pone.0043065	http://dx.doi.org/10.1371/journal.pone.0043065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916209	Green Published, Green Submitted, gold			2022-12-27	WOS:000307500800041
J	Pallu, S; Rochefort, GY; Jaffre, C; Refregiers, M; Maurel, DB; Benaitreau, D; Lespessailles, E; Jamme, F; Chappard, C; Benhamou, CL				Pallu, Stephane; Rochefort, Gael Y.; Jaffre, Christelle; Refregiers, Matthieu; Maurel, Delphine B.; Benaitreau, Delphine; Lespessailles, Eric; Jamme, Frederic; Chappard, Christine; Benhamou, Claude-Laurent			Synchrotron Ultraviolet Microspectroscopy on Rat Cortical Bone: Involvement of Tyrosine and Tryptophan in the Osteocyte and Its Environment	PLOS ONE			English	Article							MASS-SPECTROMETRY; ALCOHOL; GROWTH; PHOSPHATASE; ACTIVATION; LOCALIZATION; SPECTROSCOPY; OSTEOSTATIN; METABOLISM; DEPENDENCE	Alcohol induced osteoporosis is characterized by a bone mass decrease and microarchitecture alterations. Having observed an excess in osteocyte apoptosis, we aimed to assess the bone tissue biochemistry, particularly in the osteocyte and its environment. For this purpose, we used a model of alcohol induced osteoporosis in rats. Bone sections of cortical bone were investigated using synchrotron UV-microspectrofluorescence at subcellular resolution. We show that bone present three fluorescence peaks at 305, 333 and 385 nm, respectively corresponding to tyrosine, tryptophan and collagen. We have determined that tyrosine/collagen and tryptophan/collagen ratios were higher in the strong alcohol consumption group. Tryptophan is related to the serotonin metabolism involved in bone formation, while tyrosine is involved in the activity of tyrosine kinases and phosphatases in osteocytes. Our experiment represents the first combined synchrotron UV microspectroscopy analysis of bone tissue with a quantitative biochemical characterization in the osteocyte and surrounding matrix performed separately.	[Pallu, Stephane; Rochefort, Gael Y.; Jaffre, Christelle; Maurel, Delphine B.; Benaitreau, Delphine; Lespessailles, Eric; Benhamou, Claude-Laurent] Univ Orleans, INSERM, U658, Orleans, France; [Refregiers, Matthieu; Jamme, Frederic] Synchrotron SOLEIL, DISCO Beamline, Gif Sur Yvette, France; [Jamme, Frederic] INRA, Unite Caracterisat & Elaborat Prod Iss Agr U1008, CEPIA, Nantes, France; [Chappard, Christine] CNRS, Unite Mixte Rech Biomecan & Biomat Osteo Articula, UMR 7052 B2OA, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Orleans; SOLEIL Synchrotron; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite	Pallu, S (corresponding author), Univ Orleans, INSERM, U658, Orleans, France.	stephane.pallu@univ-orleans.fr	LESPESSAILLES, Eric/AAA-2946-2022; Rochefort, Gaël Y./H-3359-2019; Réfrégiers, Matthieu/AAE-2075-2022; Réfrégiers, Matthieu/A-4249-2011; Chappard, Christine/AAB-2613-2022; Soleil, SMIS/I-3166-2014; JAMME, Frederic/E-2170-2011	Rochefort, Gaël Y./0000-0001-6428-3570; Réfrégiers, Matthieu/0000-0002-3281-2308; JAMME, Frederic/0000-0002-7398-7868	SOLEIL Synchrotron [20090113]; FEDER; Region Centre grant "IBIFOS"	SOLEIL Synchrotron; FEDER(European Commission); Region Centre grant "IBIFOS"(Region Centre-Val de Loire)	This work was supported by beam time allocations at SOLEIL Synchrotron (proposal 20090113) and by the FEDER and Region Centre grant "IBIFOS". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso V, 2008, J CELL PHYSIOL, V217, P717, DOI 10.1002/jcp.21547; Asikainen AJ, 2006, J R SOC INTERFACE, V3, P629, DOI 10.1098/rsif.2006.0119; Badawy AAB, 2002, NUTR RES REV, V15, P123, DOI 10.1079/NRR200133; BALLENGER JC, 1979, ARCH GEN PSYCHIAT, V36, P224; Batard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019440; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Bliziotes M, 2006, BONE, V39, P1313, DOI 10.1016/j.bone.2006.06.009; Bodine PVN, 2009, BONE, V44, P1063, DOI 10.1016/j.bone.2009.02.013; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonnet N, 2006, J PHARMACOL EXP THER, V318, P1118, DOI 10.1124/jpet.106.105437; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chengalvala MV, 2001, BIOCHEMISTRY-US, V40, P814, DOI 10.1021/bi0019996; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Dumas P, 2007, TRENDS BIOTECHNOL, V25, P40, DOI 10.1016/j.tibtech.2006.11.002; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Haorah J, 2008, GLIA, V56, P78, DOI 10.1002/glia.20596; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Jamme F, 2010, MICROSC MICROANAL, V16, P507, DOI 10.1017/S1431927610093852; Lemonnier J, 2000, EXP CELL RES, V256, P158, DOI 10.1006/excr.2000.4820; Lotinun S, 2004, J BONE MINER RES, V19, P1165, DOI 10.1359/JBMR.040404; Lozano D, 2010, ACTA BIOMATER, V6, P797, DOI 10.1016/j.actbio.2009.08.033; Maddalozzo GF, 2009, OSTEOPOROSIS INT, V20, P1529, DOI 10.1007/s00198-009-0836-y; Maurel DB, 2011, BONE, V49, P543, DOI 10.1016/j.bone.2011.06.001; Maurel DB, 2011, JOINT BONE SPINE; McLaughlin F, 2002, BONE, V30, P924, DOI 10.1016/S8756-3282(02)00737-8; Miao DS, 2008, P NATL ACAD SCI USA, V105, P20309, DOI 10.1073/pnas.0805690105; Nesic J, 2008, ALCOHOL ALCOHOLISM, V43, P151, DOI 10.1093/alcalc/agm179; Nguyen TM, 2002, J BONE MINER RES, V17, P1728, DOI 10.1359/jbmr.2002.17.9.1728; Pallu S, 2003, PEPTIDES, V24, P1349, DOI 10.1016/j.peptides.2003.09.003; Pastor IJ, 2009, EUR PSYCHIAT, V24, P191, DOI 10.1016/j.eurpsy.2008.08.007; Petit VW, 2010, ANAL CHEM, V82, P3963, DOI 10.1021/ac100581y; RihaniBasharat S, 1997, CALCIFIED TISSUE INT, V61, P426, DOI 10.1007/s002239900359; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; Schiller KR, 2005, J CELL BIOCHEM, V96, P262, DOI 10.1002/jcb.20515; Schinke T, 2008, BONE, V42, P524, DOI 10.1016/j.bone.2007.11.009; Schumann G, 2003, BIOL PSYCHIAT, V54, P1422, DOI 10.1016/S0006-3223(03)00635-8; Smirnov V. Yu., 2003, Ukrainskii Biokhimicheskii Zhurnal, V75, P101; Takai E., 2006, Molecular & Cellular Biomechanics, V3, P1; Vatsa A, 2008, BIOCHEM BIOPH RES CO, V377, P1019, DOI 10.1016/j.bbrc.2007.12.174; Voicescu M, 2009, J FLUORESC, V19, P257, DOI 10.1007/s10895-008-0411-5; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; Wei JW, 2010, ARCH BIOCHEM BIOPHYS, V503, P35, DOI 10.1016/j.abb.2010.05.021; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zeskind BJ, 2007, NAT METHODS, V4, P567, DOI 10.1038/NMETH1053; Zhang ZY, 2003, J IMMUNOL, V171, P3620, DOI 10.4049/jimmunol.171.7.3620; ZHENG MH, 1994, J CELL BIOCHEM, V54, P145, DOI 10.1002/jcb.240540203; Zimmerman TA, 2008, METHOD CELL BIOL, V89, P361, DOI 10.1016/S0091-679X(08)00613-4	48	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43930	10.1371/journal.pone.0043930	http://dx.doi.org/10.1371/journal.pone.0043930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937127	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600059
J	Carnegie, NB; Morris, M				Carnegie, Nicole Bohme; Morris, Martina			Size Matters: Concurrency and the Epidemic Potential of HIV in Small Networks	PLOS ONE			English	Article							TRANSMITTED-DISEASE TRANSMISSION; UNITED-STATES; PREVALENCE; PARTNERSHIPS; DYNAMICS; SPREAD; SYPHILIS; AFRICA	Background: Generalized heterosexual epidemics are responsible for the largest share of the global burden of HIV. These occur in populations that do not have high rates of partner acquisition, and research suggests that a pattern of fewer, but concurrent, partnerships may be the mechanism that provides the connectivity necessary for sustained transmission. We examine how network size affects the impact of concurrency on network connectivity. Methodology/Principal Findings: We use a stochastic network model to generate a sample of networks, varying the size of the network and the level of concurrency, and compare the largest components for each scenario to the asymptotic expected values. While the threshold for the growth of a giant component does not change, the transition is more gradual in the smaller networks. As a result, low levels of concurrency generate more connectivity in small networks. Conclusions/Significance: Generalized HIV epidemics are by definition those that spread to a larger fraction of the population, but the mechanism may rely in part on the dynamics of transmission in a set of linked small networks. Examples include rural populations in sub-Saharan Africa and segregated minority populations in the US, where the effective size of the sexual network may well be in the hundreds, rather than thousands. Connectivity emerges at lower levels of concurrency in smaller networks, but these networks can still be disconnected with small changes in behavior. Concurrency remains a strategic target for HIV combination prevention programs in this context.	[Carnegie, Nicole Bohme] NYU, Dept Humanities & Social Sci Profess, New York, NY 10012 USA; [Morris, Martina] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Morris, Martina] Univ Washington, Dept Sociol, Seattle, WA 98195 USA	New York University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Carnegie, NB (corresponding author), NYU, Dept Humanities & Social Sci Profess, New York, NY 10012 USA.	morrism@u.washington.edu	Morris, Martina/I-7510-2012	Carnegie, Nicole/0000-0001-7664-6682	National Institutes of Health [HDR24 056799, HDR24 042828l]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041877, R24HD056799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by National Institutes of Health grants HDR24 056799 and HDR24 042828l. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Acevedo-Garcia D, 2000, SOC SCI MED, V51, P1143, DOI 10.1016/S0277-9536(00)00016-2; Admiraal R., 2008, J STAT SOFTW, DOI [DOI 10.18637/JSS.V024.I08, 10.18637/jss.v024.i08]; [Anonymous], 1998, AM APARTHEID SEGREGA; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bauch C, 2000, P ROY SOC B-BIOL SCI, V267, P2019, DOI 10.1098/rspb.2000.1244; Butts C. T., 2008, J STAT SOFTW, V24, P1, DOI [10.18637/jss.v024.i06, DOI 10.18637/JSS.V024.I06, 10.18637/jss.v024.i02]; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Ferguson NM, 2000, SEX TRANSM DIS, V27, P600, DOI 10.1097/00007435-200011000-00008; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hethcote H, 1984, GENORRHEA TRANSMISSI; HUDSON CP, 1993, INT J STD AIDS, V4, P249, DOI 10.1177/095646249300400501; Hudson CP, 1996, INT J STD AIDS, V7, P236, DOI 10.1258/0956462961917906; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kenya National Bureau of Statistics ICF Macro, 2010, 2008 09 KEN DEM HLTH; Kenyon C, 2009, AJAR-AFR J AIDS RES, V8, P243, DOI 10.2989/AJAR.2009.8.3.1.922; Koumans EH, 2001, SEX TRANSM DIS, V28, P497, DOI 10.1097/00007435-200109000-00004; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2001, SEX TRANSM DIS, V28, P504, DOI 10.1097/00007435-200109000-00005; Morris M, 1996, AIDS, V10, P1265, DOI 10.1097/00002030-199609000-00013; Morris M, 2006, AM J PUBLIC HEALTH, V96, P1091, DOI 10.2105/AJPH.2004.054759; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; National Bureau of Statistics (NBS) [Tanzania] Macro International Inc, 2009, TANZ HIV AIDS MAL IN; Newman MEJ, 2007, PHYS REV E, V76; Potterat JJ, 1999, AM J EPIDEMIOL, V150, P1331, DOI 10.1093/oxfordjournals.aje.a009965; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; UNAIDS Reference Grp Estimates Mod, 2010, LANCET, V375, P621, DOI 10.1016/S0140-6736(09)62040-7; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Wilson WJ., 1990, TRULY DISADVANTAGED	35	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43048	10.1371/journal.pone.0043048	http://dx.doi.org/10.1371/journal.pone.0043048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937011	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500028
J	Guo, JY; Dong, SZ; Yang, XL; Cheng, L; Wan, FH; Liu, SS; Zhou, XP; Ye, GY				Guo, Jian-Yang; Dong, Sheng-Zhang; Yang, Xiu-ling; Cheng, Lu; Wan, Fang-Hao; Liu, Shu-Sheng; Zhou, Xue-ping; Ye, Gong-Yin			Enhanced Vitellogenesis in a Whitefly via Feeding on a Begomovirus-Infected Plant	PLOS ONE			English	Article							BEMISIA-TABACI; GENE-EXPRESSION; BIOCHEMICAL-CHARACTERIZATION; PTEROMALUS-PUPARUM; MOLECULAR-CLONING; YOLK PROTEINS; SWEET-POTATO; B-BIOTYPE; VIRUS; HYMENOPTERA	Background: The MEAM1 (B biotype) Bemisia tabaci (Gennadius) is one of the most widespread and damaging whitefly cryptic species. Our previous studies discovered that the MEAM1 whitefly indirectly benefits from interactions with the tomato yellow leaf curl China virus (TYLCCNV) via accelerated ovarian development and increased fecundity. However, the physiological mechanism of begomoviruse-infected plants acting on the reproduction of the insect vector was unknown. Methodology/Principal Findings: Biochemical and molecular properties of vitellogenin (Vg) and vitellin (Vt) were characterized in the MEAM1 whitefly. In addition, kinetics of Vt levels in ovary and Vg levels in hemolymph in different stages were detected using a sandwich ELISA. The level of hemolymph Vg increased rapidly after eclosion. A significantly higher level of hemolymph Vg and ovary Vt were observed in whiteflies feeding on virus-infected tobacco plants than those feeding on uninfected plants. In order to detect the levels of Vg mRNA transcription, complete vitellogenin (Vg) mRNA transcripts of 6474 bp were sequenced. Vg mRNA level in whiteflies feeding on virus-infected plants was higher than those feeding on uninfected plants. However, virus-infection of the whiteflies per se, as demonstrated using an artificial diet system, did not produce significant changes in Vg mRNA level. Conclusions/Significance: In MEAM1 whitefly, increased levels of both vitellin and vitellogenin as well as increased transcription of Vg mRNA are associated with feeding on begomovirus-infected plants, thus providing a mechanism for accelerated vitellogenesis. We conclude that MEAM1 whitefly profits from feeding on begomovirus-infected plants for yolk protein synthesis and uptake, and thereby increases its fecundity. These results not only provide insights into the molecular and physiological mechanisms underlying the elevated reproduction of a whitefly species through its association with a begomovirus-infected plant, but also provide a better understanding of the molecular mechanisms related to whitefly reproduction.	[Guo, Jian-Yang; Cheng, Lu; Liu, Shu-Sheng; Ye, Gong-Yin] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China; [Dong, Sheng-Zhang] China Jiliang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Yang, Xiu-ling; Zhou, Xue-ping] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; China Jiliang University; Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Guo, JY (corresponding author), Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310003, Zhejiang, Peoples R China.	chu@zju.edu.cn	Liu, Shu-Sheng/D-2300-2013	Dong, Shengzhang/0000-0002-8218-4688; Yang, Xiuling/0000-0002-7355-5643	China National Science Fund for Distinguished Young Scholars [31025021]; China National Science Fund for Innovative Research Groups of Biological Control [31021003]; National Nature Science Foundation of China [30730061]; National Basic Research Programme of China [2009CB119203]	China National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China National Science Fund for Innovative Research Groups of Biological Control(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Programme of China(National Basic Research Program of China)	This work was supported by grants from China National Science Fund for Distinguished Young Scholars (Grant no. 31025021), China National Science Fund for Innovative Research Groups of Biological Control (Grant no. 31021003), the National Nature Science Foundation of China (30730061)(http://www.nsfc.gov.cn/Portal0/default124.htm) and the National Basic Research Programme of China (2009CB119203) (http://www.most.gov.cn/) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Bosque-Perez NA, 2011, VIRUS RES, V159, P201, DOI 10.1016/j.virusres.2011.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Cui XF, 2004, J VIROL, V78, P13966, DOI 10.1128/JVI.78.24.13966-13974.2004; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dong SZ, 2007, J INSECT PHYSIOL, V53, P468, DOI 10.1016/j.jinsphys.2007.01.008; Dong SZ, 2009, GEN COMP ENDOCR, V160, P102, DOI 10.1016/j.ygcen.2008.11.007; Dong Shengzhang, 2008, Acta Phytophylacica Sinica, V35, P193; GAMEEL O I, 1974, Revue de Zoologie Africaine, V88, P784; Ghanim M, 2001, J MORPHOL, V248, P22, DOI 10.1002/jmor.1018; Gildow FE, 1993, J PHYTOPATHOL, V83, P270; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Guo JY, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9001; Guo JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011713; Hagedorn HH, 1998, ADV INSECT PHYSIOL, V27, P335, DOI 10.1016/S0065-2806(08)60015-6; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hirai M, 1998, INSECT BIOCHEM MOLEC, V28, P537, DOI 10.1016/S0965-1748(98)00052-6; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Jimenez-Martinez ES, 2004, ENVIRON ENTOMOL, V33, P1207, DOI 10.1603/0046-225X-33.5.1207; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; KAGEYAMA Y, 1994, INSECT BIOCHEM MOLEC, V24, P599, DOI 10.1016/0965-1748(94)90096-5; Leshkowitz D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-79; Li ZH, 2005, PHYTOPATHOLOGY, V95, P902, DOI 10.1094/PHYTO-95-0902; Liu J, 2009, ANN APPL BIOL, V155, P439, DOI 10.1111/j.1744-7348.2009.00366.x; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Nose Y, 1997, INSECT BIOCHEM MOLEC, V27, P1047, DOI 10.1016/S0965-1748(97)00091-X; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raikhel Alexander S., 2005, P329; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Shen HH, 2009, J MED MICROBIOL, V58, P531, DOI 10.1099/jmm.0.002246-0; Shu YH, 2009, J INSECT PHYSIOL, V55, P608, DOI 10.1016/j.jinsphys.2009.03.005; Tang Q., 2007, DPS DATA PROCESSING; Tu ZJ, 1997, ARCH INSECT BIOCHEM, V34, P223, DOI 10.1002/(SICI)1520-6327(1997)34:2<223::AID-ARCH7>3.3.CO;2-Z; Tufail M, 2005, INSECT MOL BIOL, V14, P389, DOI 10.1111/j.1365-2583.2005.00570.x; Tufail M, 2010, INSECT MOL BIOL, V19, P787, DOI 10.1111/j.1365-2583.2010.01035.x; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; Wang J, 2012, ENTOMOL EXP APPL, V144, P191, DOI 10.1111/j.1570-7458.2012.01278.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; WU SJ, 1986, INSECT BIOCHEM, V16, P789, DOI 10.1016/0020-1790(86)90115-0; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x; Zang Lian-Sheng, 2005, Acta Entomologica Sinica, V48, P742; Zhang T, 2012, MOL ECOL, V21, P1294, DOI 10.1111/j.1365-294X.2012.05457.x; Zhou XP, 2003, J GEN VIROL, V84, P237, DOI 10.1099/vir.0.18608-0	51	33	43	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43567	10.1371/journal.pone.0043567	http://dx.doi.org/10.1371/journal.pone.0043567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937062	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500063
J	Kaushal, M; Mishra, AK; Sharma, J; Zomawia, E; Kataki, A; Kapur, S; Saxena, S				Kaushal, Mishi; Mishra, Ashwani K.; Sharma, Jagannath; Zomawia, Eric; Kataki, Amal; Kapur, Sujala; Saxena, Sunita			Genomic Alterations in Breast Cancer Patients in Betel Quid and Non Betel Quid Chewers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; COPY NUMBER ALTERATIONS; GENE-EXPRESSION; CHROMOSOMAL-ABERRATIONS; THERAPEUTIC TARGET; COLORECTAL-CANCER; CIGARETTE-SMOKING; FRAGILE SITES; LUNG-CANCER; BONE-MARROW	Betel Quid (BQ) chewing independently contributes to oral, hepatic and esophageal carcinomas. Strong association of breast cancer risk with BQ chewing in Northeast Indian population has been reported where this habit is prodigal. We investigated genomic alterations in breast cancer patients with and without BQ chewing exposure. Twenty six BQ chewers (BQC) and 17 non BQ chewer (NBQC) breast cancer patients from Northeast India were analyzed for genomic alterations and pathway networks using SNP array and IPA. BQC tumors showed significantly (P<0.01) higher total number of alterations, as compared with NBQC tumors, 48 +/- 17% versus 32 +/- 25 respectively. Incidence of gain in fragile sites in BQC tumors were significantly (P<0.001) higher as compared with NBQC tumors, 34 versus 23% respectively. Two chromosomal regions (7q33 and 21q22.13) were significantly (p<0.05) associated with BQC tumors while two regions (19p13.3-19p12 and 20q11.22) were significantly associated with NBQC tumors. GO terms oxidoreductase and aldo-keto reductase activity in BQC tumors in contrast to G-protein coupled receptor protein signaling pathway and cell surface receptor linked signal transduction in NBQC tumors were enriched in DAVID. One network "Drug Metabolism, Molecular Transport, Nucleic Acid Metabolism" including genes AKR1B1, AKR1B10, ETS2 etc in BQC and two networks "Molecular Transport, Nucleic Acid Metabolism, Small Molecule Biochemistry" and "Cellular Development, Embryonic Development, Organismal Development" including genes RPN2, EMR3, VAV1, NNAT and MUC16 etc were seen in NBQC. Common alterations (>30%) were seen in 27 regions. Three networks were significant in common regions with key roles of PTK2, RPN2, EMR3, VAV1, NNAT, MUC16, MYC and YWHAZ genes. These data show that breast cancer arising by environmental carcinogens exemplifies genetic alterations differing from those observed in the non exposed ones. A number of genetic changes are shared in both tumor groups considered as crucial in breast cancer progression.	[Kaushal, Mishi; Mishra, Ashwani K.; Kapur, Sujala; Saxena, Sunita] ICMR, Natl Inst Pathol, New Delhi, India; [Sharma, Jagannath; Kataki, Amal] Dr B Borrooah Canc Inst, Gauhati, India; [Zomawia, Eric] Civil Hosp, Aizwal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Tata Memorial Centre (TMC); Dr. Bhubaneswar Borooah Cancer Institute	Kaushal, M (corresponding author), ICMR, Natl Inst Pathol, Safdarjung Hosp Campus, New Delhi, India.	sunita_saxena@yahoo.com	Mishra, Ashwani Kumar/AAA-3998-2020	Mishra, Ashwani Kumar/0000-0002-8872-1886; Wasson, Mishi/0000-0003-4347-417X	Indian Council of Medical Research (ICMR), New Delhi, India [123/4/RMRC/NE/2005-NCD-II/III, 3/2/2/183/2009/NCD-III]	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	This study was supported by grants from Indian Council of Medical Research (ICMR), New Delhi, India(Ref no, 123/4/RMRC/NE/2005-NCD-II/III. Mishi Kaushal is a recipient of a Senior Research Fellowship of Indian Council of Medical Research (ICMR), New Delhi, India (Ref. No. 3/2/2/183/2009/NCD-III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambatipudi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017250; BAN S, 1995, MUTAT RES-ENVIR MUTA, V334, P197, DOI 10.1016/0165-1161(95)90011-X; Baras A, 2009, ONCOGENE, V28, P2919, DOI 10.1038/onc.2009.150; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Beaber EF, 2008, CANCER EPIDEM BIOMAR, V17, P3427, DOI 10.1158/1055-9965.EPI-08-0641; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Chatterjee A, 1999, CANCER LETT, V139, P23, DOI 10.1016/S0304-3835(98)00364-4; Chiang WF, 2011, ORAL DIS, V17, P53, DOI 10.1111/j.1601-0825.2010.01702.x; Dal Maso L, 2008, INT J CANCER, V123, P2188, DOI 10.1002/ijc.23747; Das A. J., 2012, International Food Research Journal, V19, P377; Diez-Dacal B, 2011, CANCER RES, V71, P4161, DOI 10.1158/0008-5472.CAN-10-3816; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fang M, 2011, CANCER-AM CANCER SOC, V117, P2024, DOI 10.1002/cncr.25770; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Ferroni P, 2004, INT J CANCER, V111, P404, DOI 10.1002/ijc.20189; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Ghayad SE, 2009, J MOL ENDOCRINOL, V42, P87, DOI 10.1677/JME-08-0076; Gu J, 2008, CANCER EPIDEM BIOMAR, V17, P2445, DOI 10.1158/1055-9965.EPI-07-2890; Herzog CR, 2006, BIOCHEM BIOPH RES CO, V341, P856, DOI 10.1016/j.bbrc.2006.01.043; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang KT, 2008, INT J CANCER, V123, P1807, DOI 10.1002/ijc.23672; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Kane AJ, 2010, NEUROREPORT, V21, P1018, DOI 10.1097/WNR.0b013e32833f19f2; KAOSHAN CS, 1987, CANCER RES, V47, P6278; Kaushal M, 2010, MUTAT RES-GEN TOX EN, V703, P143, DOI 10.1016/j.mrgentox.2010.08.011; Korenaga Y, 2005, CANCER GENET CYTOGEN, V163, P7, DOI 10.1016/j.cancergencyto.2005.03.015; Lakshmanan I, 2012, ONCOGENE, V31, P805, DOI 10.1038/onc.2011.297; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Lin CF, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-271; Lin MT, 2009, INT J CANCER, V125, P603, DOI 10.1002/ijc.24346; Liu JH, 2009, RECENT PAT ANTI-CANC, V4, P246, DOI 10.2174/157489209789206931; Liu SY, 2007, ORAL ONCOL, V43, P1026, DOI 10.1016/j.oraloncology.2006.11.018; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Luo LZ, 2004, MUTAT RES-FUND MOL M, V554, P375, DOI 10.1016/j.mrfmmm.2004.06.031; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Muenphon K, 2006, WORLD J GASTROENTERO, V12, P4143, DOI 10.3748/wjg.v12.i26.4143; Nair U, 2004, MUTAGENESIS, V19, P251, DOI 10.1093/mutage/geh036; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Narayan S, 2004, ONCOGENE, V23, P5880, DOI 10.1038/sj.onc.1207792; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Nowak NJ, 2005, CANCER GENET CYTOGEN, V161, P36, DOI 10.1016/j.cancergencyto.2005.01.009; Ouellet V, 2011, AM J PATHOL, V178, P2377, DOI 10.1016/j.ajpath.2011.01.033; Pang H, 2011, EUR J HUM GENET, V19, P704, DOI 10.1038/ejhg.2011.3; Purdie KJ, 2007, GENE CHROMOSOME CANC, V46, P661, DOI 10.1002/gcc.20447; Reinartz S, 2012, EUR J CANCER, V48, P1558, DOI 10.1016/j.ejca.2011.07.004; Saama PM, 2006, PHYSIOL GENOMICS, V28, P62, DOI 10.1152/physiolgenomics.00108.2006; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Sangrajrang S, 2009, INT J CANCER, V125, P837, DOI 10.1002/ijc.24434; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Singh B, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-22; Tchatchou S, 2008, CYTOGENET GENOME RES, V123, P183, DOI 10.1159/000184707; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Tzeng HE, 2011, J CELL PHYSIOL, V226, P3181, DOI 10.1002/jcp.22672; Uchihara T, 2007, J THORAC ONCOL, V2, P796, DOI 10.1097/JTO.0b013e318145af5e; Vasudev NS, 2011, ARCH GYNECOL OBSTET, V284, P221, DOI 10.1007/s00404-010-1655-2; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Yeh PY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-53; Zabuawala T, 2010, CANCER RES, V70, P1323, DOI 10.1158/0008-5472.CAN-09-1474; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	66	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43789	10.1371/journal.pone.0043789	http://dx.doi.org/10.1371/journal.pone.0043789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937096	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500098
J	Lagrange, PH; Thangaraj, SK; Dayal, R; Despande, A; Ganguly, NK; Girardi, E; Joshi, B; Katoch, K; Katoch, VM; Kumar, M; Lakshmi, V; Leportier, M; Longuet, C; Malladi, SVS; Mukerjee, D; Nair, D; Raja, A; Raman, B; Rodrigues, C; Sharma, P; Singh, A; Singh, S; Sodha, A; Kabeer, BSA; Vernet, G; Goletti, D				Lagrange, Philippe H.; Thangaraj, Satheesh K.; Dayal, Rajeshwar; Despande, Alka; Ganguly, Nirmal K.; Girardi, Enrico; Joshi, Beenu; Katoch, Kiran; Katoch, Vishwa M.; Kumar, Manoj; Lakshmi, Vemu; Leportier, Marc; Longuet, Christophe; Malladi, Subbalaxmi V. S.; Mukerjee, Deepali; Nair, Deepthi; Raja, Alamelu; Raman, Balambal; Rodrigues, Camilla; Sharma, Pratibha; Singh, Amit; Singh, Sarman; Sodha, Archana; Kabeer, Basirudeen Syed Ahamed; Vernet, Guy; Goletti, Delia			A Toolbox for Tuberculosis Diagnosis: An Indian Multicentric Study (2006-2008): Microbiological Results	PLOS ONE			English	Article							ACID AMPLIFICATION TESTS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; BACTEC; IDENTIFICATION; PREVALENCE; SPECIMENS; RECOVERY; GROWTH	Background: The aim of this multicentric prospective study in India was to assess the value of several microbiological tools that contribute to the diagnosis of tuberculosis (TB) according to HIV status. Methods: Standard microbiological tools on individual specimens were analyzed. Results: Among the 807 patients with active TB, 131 were HIV-infected, 316 HIV-uninfected and 360 had HIV-unknown status. Among the 980 non-active TB subjects, 559 were at low risk and 421 were at high risk of M. tuberculosis (Mtb) exposure. Sensitivity of smear microscopy (SM) was significantly lower in HIV-infected (42.2%) than HIV-uninfected (75.9%) (p = 0.0001) and HIV-unknown pulmonary TB patients (61.4%) (p = 0.004). Specificity was 94.5% in non-TB patients and 100% in health care workers (HCW) and healthy family contacts. Automated liquid culture has significantly higher diagnostic performances than solid culture, measured by sensitivity (74.7% vs. 55.9%) (p = 0.0001) and shorter median time to detection (TTD) (12.0 vs. 34.0 days) (p = 0.0001). Specificity was 100% in HCW and cured-TB patients, but was lower in non-TB patients (89%) due to isolation of Mycobacteria other than tuberculosis (MOTT). TTD by both methods was related to AFB score. Contamination rate was low (1.4%). AccuProbe hybridization technique detected Mtb in almost all culture-positive specimens, but MOTT were found in 4.7% with a significantly higher frequency in HIV-infected (15%) than HIV-uninfected TB patients (0.5%) (p = 0.0007). Pre-test classification significantly increased the diagnostic value of all microbiological tests in pulmonary TB patients (p<0.0001) but to a lesser degree in extrapulmonary TB patients. Conclusions: Conventional microbiological tools led to results similar to those already described in India special features for HIV-infected TB patients included lower detection by SM and culture. New microbiological assays, such as the automated liquid culture system, showed increased accuracy and speed of detection.	[Lagrange, Philippe H.] Univ Paris 07, Hop St Louis, Microbiol Serv, Assistance Publ Hop Paris, Paris, France; [Thangaraj, Satheesh K.; Leportier, Marc] BioMerieux, Marcy Letoile, France; [Thangaraj, Satheesh K.; Leportier, Marc] BioMerieux, New Delhi, India; [Dayal, Rajeshwar; Singh, Amit] SN Med Coll & Hosp, Agra, Uttar Pradesh, India; [Despande, Alka] JJ Hosp, Grant Med Coll, Bombay, Maharashtra, India; [Ganguly, Nirmal K.; Mukerjee, Deepali] Indian Council Med Res, New Delhi, India; [Girardi, Enrico; Goletti, Delia] L Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Rome, Italy; [Joshi, Beenu; Katoch, Kiran; Katoch, Vishwa M.] Natl JALMA Inst Leprosy & Other Mycrobacterial Di, Agra, Uttar Pradesh, India; [Kumar, Manoj; Singh, Sarman] All India Inst Med Sci, New Delhi, India; [Lakshmi, Vemu; Malladi, Subbalaxmi V. S.] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Longuet, Christophe; Vernet, Guy] Fondat Merieux, Lyon, France; [Nair, Deepthi; Sharma, Pratibha] Safdarjang Hosp, New Delhi, India; [Raja, Alamelu; Raman, Balambal; Kabeer, Basirudeen Syed Ahamed] TB Res Ctr, ICMR, Madras, Tamil Nadu, India; [Rodrigues, Camilla; Sodha, Archana] PD Hinduja Natl Hosp & Res Ctr, Bombay, Maharashtra, India	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; bioMerieux; Indian Council of Medical Research (ICMR); IRCCS Lazzaro Spallanzani; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; All India Institute of Medical Sciences (AIIMS) New Delhi; Nizam's Institute of Medical Sciences; Vardhman Mahavir Medical College & Safdarjung Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Lagrange, PH (corresponding author), Univ Paris 07, Hop St Louis, Microbiol Serv, Assistance Publ Hop Paris, Paris, France.	plagrange@sfr.fr	KUMAR, MANOJ/HHC-0782-2022; Kabeer, Basirudeen Syed Ahamed/AAQ-7599-2020; Singh, Sarman/AAR-8914-2020; goletti, delia/AAM-6577-2020; Singh, Amit/D-3917-2015	Kabeer, Basirudeen Syed Ahamed/0000-0002-7287-1636; Singh, Sarman/0000-0002-0749-9647; Singh, Amit/0000-0003-3012-5245; Goletti, Delia/0000-0001-8360-4376; Girardi, Enrico/0000-0001-8182-5896	Fondation Merieux	Fondation Merieux	This work was supported by Fondation Merieux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler H, 2005, EUR J CLIN MICROBIOL, V24, P499, DOI 10.1007/s10096-005-1362-2; Alcaide F, 2000, J CLIN MICROBIOL, V38, P398; Archibald LK, 1998, CLIN INFECT DIS, V26, P290, DOI 10.1086/516297; BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bruchfeld J, 2002, SCAND J INFECT DIS, V34, P331, DOI 10.1080/00365540110080025; Catanzaro A, 2000, JAMA-J AM MED ASSOC, V283, P639, DOI 10.1001/jama.283.5.639; Cornfield DB, 1997, J CLIN MICROBIOL, V35, P2068, DOI 10.1128/JCM.35.8.2068-2071.1997; Dayal R, 2012, INDIAN J PEDIATR, V79, P183, DOI 10.1007/s12098-011-0469-y; Dewan PK, 2010, INT J TUBERC LUNG D, V14, P247; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Garcia FG, 2008, CLIN MICROBIOL INFEC, V4, P339; GITHUI W, 1992, TUBERCLE LUNG DIS, V73, P203, DOI 10.1016/0962-8479(92)90087-Z; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Gopinath K, 2008, EUR J CLIN MICROBIOL, V27, P423, DOI 10.1007/s10096-007-0450-x; Gopinath K, 2009, J APPL MICROBIOL, V107, P425, DOI 10.1111/j.1365-2672.2009.04218.x; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Hanscheid T, 2005, J CLIN MICROBIOL, V43, P890, DOI 10.1128/JCM.43.2.890-891.2005; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Lanjewar DN, 2001, HIV MED, V2, P226; Lee JJ, 2003, INT J TUBERC LUNG D, V7, P569; Ling DI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001536; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Migliori GB, 2006, EUR RESPIR J, V28, P687, DOI 10.1183/09031936.06.00097506; MORGAN MA, 1983, J CLIN MICROBIOL, V18, P384, DOI 10.1128/JCM.18.2.384-388.1983; Narang R, 2009, INDIAN J MED MICROBI, V27, P247, DOI 10.4103/0255-0857.53208; Oberoi A, 2004, Indian J Med Microbiol, V22, P44; Pai M, 2004, NATL MED J INDIA, V17, P233; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P509, DOI 10.1586/14737159.6.4.509; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Perkins MD, 2006, INT J TUBERC LUNG D, V10, P1; Pheiffer C, 2008, INT J TUBERC LUNG D, V12, P792; Revised National TB Control Programme, 2009, TB IND 2009; SHAW JB, 1954, AM REV TUBERC PULM, V69, P724; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; von Gottberg A, 2001, INT J TUBERC LUNG D, V5, P80; World Health Organization, 1998, WHOTB98253; World Health Organization [WHO], 2011, WHO GLOB TUB CONTR W; World Health Organization (WHO), 1998, LAB SERVICES TUBERCU	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43739	10.1371/journal.pone.0043739	http://dx.doi.org/10.1371/journal.pone.0043739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937088	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000308225500090
J	Liu, L; Beck, H; Wang, XL; Hsieh, HP; Mason, RP; Liu, XL				Liu, Li; Beck, Haley; Wang, Xiaolei; Hsieh, Hsing-Pang; Mason, Ralph P.; Liu, Xinli			Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts	PLOS ONE			English	Article							COMBRETASTATIN A4 PHOSPHATE; ASSESSING TUMOR BURDEN; ACTIVITY IN-VIVO; THERAPEUTIC STRATEGY; TARGETING AGENTS; HIGH-THROUGHPUT; BLOOD-VESSELS; ANGIOGENESIS; VITRO; COMBINATION	BPR0L075, 6-methoxy-3-(39,49,59-trimethoxy-benzoyl)-1H-indole, is a tubulin-binding agent that inhibits tubulin polymerization by binding to the colchicine-binding site. BPR0L075 has shown antimitotic and antiangiogenic activity in vitro. The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. A time-dependent reduction of tumor perfusion after BPR0L075 treatment was confirmed by immunohistological staining of the perfusion marker Hoechst 33342 and tumor vasculature marker CD31. The vasculature showed distinct recovery within 24 hours post therapy. A single i.p. injection of 50 mg/kg of BPR0L075 initially produced plasma concentrations in the micromolar range within 6 hours, but subsequent drug distribution and elimination caused BPR0L075 plasma levels to drop rapidly into the nanomolar range within 24 h. Tests with human umbilical vein endothelial (HUVEC) cells and tumor cells in culture showed that BPR0L075 was cytotoxic to both tumor cells and proliferating endothelial cells, and disrupted preestablished vessels in vitro and ex vivo. In conclusion, BPR0L075 caused rapid, albeit, temporary tumor vascular shutdown and led to reduction of tumor perfusion in orthotopic human breast cancer xenografts, suggesting that this antimitotic agent may be useful as a vascular-disrupting cancer therapy.	[Liu, Li; Beck, Haley; Mason, Ralph P.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Canc Imaging Program, Dallas, TX 75390 USA; [Hsieh, Hsing-Pang] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Taipei, Taiwan; [Wang, Xiaolei; Liu, Xinli] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Health Research Institutes - Taiwan; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Liu, L (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, Canc Imaging Program, Dallas, TX 75390 USA.	ralph.mason@utsouthwestern.edu; xinli.liu@ttuhsc.edu	Liu, LI/B-6912-2013; Mason, Ralph/C-8472-2012; Hsieh, Hsing-Pang/B-2649-2010	Liu, LI/0000-0002-9731-6145; Mason, Ralph/0000-0001-7517-3721; Hsieh, Hsing-Pang/0000-0002-1332-005X	Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy; National Cancer Institute [NCI U24 CA126608]; Harold C. Simmons Cancer Center through an NCI Cancer Center Support Grant [1P30 CA142543]; Department of Radiology; National Institutes of Health, NIH [1S10RR024757]; National Health Research Institutes; National Science Council (Taiwan, ROC) [NSC 100-2325-B-400-003]; NATIONAL CANCER INSTITUTE [U24CA126608, P30CA142543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024757] Funding Source: NIH RePORTER	Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Harold C. Simmons Cancer Center through an NCI Cancer Center Support Grant; Department of Radiology; National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes(National Health Research Institutes, Japan); National Science Council (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by funds from Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy (to XL). The authors would also like to acknowledge the assistance of the Southwestern Small Animal Imaging Resource (SW-SAIRP), which is supported in part by the National Cancer Institute, NCI U24 CA126608, the Harold C. Simmons Cancer Center through an NCI Cancer Center Support Grant, 1P30 CA142543 and the Department of Radiology, and in particular a supplement under the American Recovery and Reinvestment Act (ARRA) 3 U24 CA126608-02S1 (to HB, RPM). The Caliper IVIS Spectrum was purchased under a Shared Instrumentation grant from the National Institutes of Health, NIH 1S10RR024757. The support from National Health Research Institutes and National Science Council (NSC 100-2325-B-400-003, Taiwan, ROC) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakey DC, 2002, INT J RADIAT ONCOL, V54, P1497, DOI 10.1016/S0360-3016(02)03922-6; Brown KJ, 1996, LAB INVEST, V75, P539; Cai WB, 2008, METHOD ENZYMOL, V445, P141, DOI 10.1016/S0076-6879(08)03007-3; Chaplin DJ, 1999, BRIT J CANCER, V80, P57; Chen CP, 2010, ANTICANCER RES, V30, P2813; Contero A, 2009, METHODS MOL BIOL, V574, P37, DOI 10.1007/978-1-60327-321-3_4; Davis PD, 2002, CANCER RES, V62, P7247; DENEKAMP J, 1990, CANCER METAST REV, V9, P267, DOI 10.1007/BF00046365; DENEKAMP J, 1982, BRIT J CANCER, V46, P711, DOI 10.1038/bjc.1982.263; DENEKAMP J, 1984, ACTA RADIOL ONCOL, V23, P217, DOI 10.3109/02841868409136015; Galbraith SM, 2001, ANTICANCER RES, V21, P93; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Helmlinger G, 2000, NATURE, V405, P139, DOI 10.1038/35012132; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Liou JP, 2002, J MED CHEM, V45, P2556, DOI 10.1021/jm010365+; Liu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012024; Mason RP, 2011, INTEGR BIOL-UK, V3, P375, DOI 10.1039/c0ib00135j; Masunaga S, 2007, J CANCER RES CLIN, V133, P47, DOI 10.1007/s00432-006-0145-1; Maye P, 2011, GENESIS, V49, P410, DOI 10.1002/dvg.20733; McKeage MJ, 2010, CANCER-AM CANCER SOC, V116, P1859, DOI 10.1002/cncr.24975; Nicholson B, 2006, ANTI-CANCER DRUG, V17, P25, DOI 10.1097/01.cad.0000182745.01612.8a; Nicosia RF, 1997, AM J PATHOL, V151, P1379; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Siemann DW, 2009, CELL TISSUE RES, V335, P241, DOI 10.1007/s00441-008-0646-0; Siemann DW, 2010, CANC TREAT REV; Sun A, NEUROSURGERY, V66, P751; Tozer GM, 2008, BRIT J RADIOL, V81, pS12, DOI 10.1259/bjr/36205483; Tozer GM, 2002, INT J EXP PATHOL, V83, P21, DOI 10.1046/j.1365-2613.2002.00211.x; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Zhao DW, 2008, FASEB J, V22, P2445, DOI 10.1096/fj.07-103713; Zhao DW, 2005, INT J RADIAT ONCOL, V62, P872, DOI 10.1016/j.ijrobp.2005.03.009	36	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43314	10.1371/journal.pone.0043314	http://dx.doi.org/10.1371/journal.pone.0043314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937031	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500038
J	Llaurado, G; Gonzalez-Clemente, JM; Maymo-Masip, E; Subias, D; Vendrell, J; Chacon, MR				Llaurado, Gemma; Gonzalez-Clemente, Jose-Miguel; Maymo-Masip, Elsa; Subias, David; Vendrell, Joan; Chacon, Matilde R.			Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A Case-Control Study	PLOS ONE			English	Article							SOLUBLE TWEAK; ARTERIAL STIFFNESS; IDENTIFICATION; MORTALITY; DISEASE; STWEAK; COMPLICATIONS; INFLAMMATION; MACROPHAGES; PREDICTION	Objective: To test the usefulness of serum concentrations of tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and soluble scavenger receptor CD163 (sCD163) as markers of subtle inflammation in patients with type 1 diabetes mellitus (T1DM) without clinical cardiovascular (CV) disease and to evaluate their relationship with arterial stiffness (AS). Methods: Sixty-eight patients with T1DM and 68 age and sex-matched, healthy subjects were evaluated. Anthropometrical variables and CV risk factors were recorded. Serum concentrations of sTWEAK and sCD163 were measured. AS was assessed by aortic pulse wave velocity (aPWV). All statistical analyses were stratified by gender. Results: T1DM patients showed lower serum concentrations of sTWEAK (Men: 1636.5 (1146.3-3754.8) pg/mL vs. 765.9 (650.4-1097.1) pg/mL; p < 0.001. Women: 1401.0 (788.0-2422.2) pg/mL vs. 830.1 (562.6-1175.9) pg/mL; p = 0.011) compared with their respective controls. Additionally, T1DM men had higher serum concentrations of sCD163 (285.0 (247.7-357.1) ng/mL vs. 224.8 (193.3-296.5) ng/mL; p = 0.012) compared with their respective controls. sTWEAK correlated negatively with aPWV in men (r = -0.443; p < 0.001). However, this association disappeared after adjusting for potential confounders. In men, the best multiple linear regression model showed that the independent predictors of sTWEAK were T1DM and WHR (R-2 = 0.640; p < 0.001). In women, T1DM and SBP were the independent predictors for sTWEAK (R-2 = 0.231; p = 0.001). Conclusion: sTWEAK is decreased in T1DM patients compared with age and sex-matched healthy subjects after adjusting for classic CV risk factors, although sTWEAK levels may be partially influenced by some of them. Additionally, T1DM men have higher serum concentrations of sCD163. These results point out an association between the inflammatory system and CV risk in T1DM.	[Llaurado, Gemma; Gonzalez-Clemente, Jose-Miguel; Subias, David] Univ Autonoma Barcelona, Hosp Sabadell, Dept Diabet Endocrinol & Nutr, Corp Sanitaria Univ, Sabadell, Spain; [Maymo-Masip, Elsa; Vendrell, Joan; Chacon, Matilde R.] Univ Rovira & Virgili, Insitut Pere Virgili, Hosp Univ Joan XXIII Tarragona, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Tarragona, Spain	Autonomous University of Barcelona; Parc Tauli Hospital Universitari; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili	Llaurado, G (corresponding author), Univ Autonoma Barcelona, Hosp Sabadell, Dept Diabet Endocrinol & Nutr, Corp Sanitaria Univ, Univ Parc Tauli, Sabadell, Spain.	gllauradoc@gmail.com; mrodriguez.hj23.ics@gencat.cat	Llauradó, Gemma/AAB-9839-2020; Maymó Masip, Elsa/T-1828-2017; Vendrell, Joan j/V-4034-2018; Chacón, Matilde R./E-5574-2019	Maymó Masip, Elsa/0000-0002-9133-3120; Vendrell, Joan j/0000-0002-6994-6115; Chacón, Matilde R./0000-0003-1531-2165; Subias, David/0000-0003-3589-7842	Fundacio la Marato de TV3-2008 [081410]; Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain [FIS PS09/01360, PI08/0733, PI11/00049]; Fondo de Investigacion Sanitaria (FIS) [CP06/00119]; European Regional Development Fund (ERDF) [PI08/0733, PI11/00049, CP06/00119]	Fundacio la Marato de TV3-2008; Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission)	Financial support was provided by: 1) Fundacio la Marato de TV3-2008 (Project No 081410); 2) FIS PS09/01360 (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain); 3) PI08/0733 (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain); 4) PI11/00049 (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain); and 5) Matilde R. Chacon is supported by a fellowship from the Fondo de Investigacion Sanitaria (FIS) CP06/00119. CP06/00119 PI08/0733 and PI11/00049 are co-financed by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Axelsson J, 2006, AM J KIDNEY DIS, V48, P916, DOI 10.1053/j.ajkd.2006.08.022; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, P110, DOI 10.2215/CJN.02790608; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Chorianopoulos E, 2010, ATHEROSCLEROSIS, V211, P322, DOI 10.1016/j.atherosclerosis.2010.02.016; Gonzalez-Clemente JM, 2005, EUR J ENDOCRINOL, V153, P687, DOI 10.1530/eje.1.02016; Guetta J, 2007, ATHEROSCLEROSIS, V191, P48, DOI 10.1016/j.atherosclerosis.2006.04.032; Jelic-Ivanovic Z, 2009, CLIN BIOCHEM, V42, P1381, DOI 10.1016/j.clinbiochem.2009.06.001; Koivistoinen T, 2011, ATHEROSCLER IN PRESS; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levy AP, 2007, CIRC RES, V101, P106, DOI 10.1161/CIRCRESAHA.107.149435; Libby P, 2005, CIRCULATION, V111, P3489, DOI 10.1161/CIRCULATIONAHA.104.529651; Llaurado G, 2012, DIABETES CARE, V35, P1083, DOI 10.2337/dc11-1475; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2011, CLIN CHEM, V57, P291, DOI 10.1373/clinchem.2010.154724; Moreno JA, 2010, ARTERIOSCL THROM VAS, V30, P1253, DOI 10.1161/ATVBAHA.110.203364; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Richter B, 2010, ATHEROSCLEROSIS, V213, P545, DOI 10.1016/j.atherosclerosis.2010.08.061; Schram MT, 2005, DIABETOLOGIA, V48, P370, DOI 10.1007/s00125-004-1628-8; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V219, P892, DOI 10.1016/j.atherosclerosis.2011.09.016; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Williams KV, 2000, DIABETES, V49, P626, DOI 10.2337/diabetes.49.4.626; Yilmaz MI, 2010, CLIN J AM SOC NEPHRO, V5, P1174, DOI 10.2215/CJN.01110210	32	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43919	10.1371/journal.pone.0043919	http://dx.doi.org/10.1371/journal.pone.0043919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937125	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500124
J	Tan, S; Lam, WP; Wai, MSM; Yu, WHA; Yew, DT				Tan, Sijie; Lam, Wai Ping; Wai, Maria S. M.; Yu, Wan-Hua Amy; Yew, David T.			Chronic Ketamine Administration Modulates Midbrain Dopamine System in Mice	PLOS ONE			English	Article							NMDA RECEPTOR BLOCKADE; EMERGENCY-DEPARTMENT; INDUCED APOPTOSIS; ACTIVATION; TRANSCRIPTION; SEROTONIN; RELEASE; SIGNALS; ABUSERS; MODELS	Ketamine is an anesthetic and a popular abusive drug. As an anesthetic, effects of ketamine on glutamate and GABA transmission have been well documented but little is known about its long-term effects on the dopamine system. In the present study, the effects of ketamine on dopamine were studied in vitro and in vivo. In pheochromocytoma (PC 12) cells and NGF differentiated-PC 12 cells, ketamine decreased the cell viability while increasing dopamine (DA) concentrations in a dose-related manner. However, ketamine did not affect the expression of genes involved in DA synthesis. In the long-term (3 months) ketamine treated mice, significant increases of DA contents were found in the midbrain. Increased DA concentrations were further supported by up-regulation of tyrosine hydroxylase (TH), the rate limiting enzyme in catecholamine synthesis. Activation of midbrain dopaminergic neurons could be related to ketamine modulated cortical-subcortical glutamate connections. Using western blotting, significant increases in BDNF protein levels were found in the midbrain, suggesting that perhaps BDNF pathways in the cortical-subcortical connections might contribute to the long-term ketamine induced TH upregulation. These data suggest that long-term ketamine abuse caused a delayed and persistent upregulation of subcortical DA systems, which may contribute to the altered mental status in ketamine abusers.	[Tan, Sijie; Lam, Wai Ping; Wai, Maria S. M.; Yew, David T.] Chinese Univ Hong Kong, Fac Med, Brain Res Inst, Shatin, Hong Kong, Peoples R China; [Yu, Wan-Hua Amy] CUNY, Sch Med, Dept Cell Biol & Anat Sci, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA	Chinese University of Hong Kong; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education	Tan, S (corresponding author), Chinese Univ Hong Kong, Fac Med, Brain Res Inst, Shatin, Hong Kong, Peoples R China.	david-yew@cuhk.edu.hk		tan, Sijie/0000-0002-8389-7372	Beat Drugs Fund Association, Hong Kong Government [100052]	Beat Drugs Fund Association, Hong Kong Government	This work was supported by the Beat Drugs Fund Association (100052), Hong Kong Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman S A, 1999, Anesth Prog, V46, P10; Boundy VA, 1998, J NEUROSCI, V18, P9989; CRDA and drug statistics, CRDA DRUG STAT; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; du Bois TM, 2008, NEUROCHEM RES, V33, P1224, DOI 10.1007/s11064-007-9571-y; Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y; Fukuchi M, 2010, BRAIN RES, V1366, P18, DOI 10.1016/j.brainres.2010.10.034; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Hevers W, 2008, J NEUROSCI, V28, P5383, DOI 10.1523/JNEUROSCI.5443-07.2008; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Irifune M, 2000, ANESTH ANALG, V91, P230, DOI 10.1097/00000539-200007000-00043; Jones DC, 2000, J NEUROCHEM, V74, P2296, DOI 10.1046/j.1471-4159.2000.0742296.x; Kapur S, 2002, MOL PSYCHIATR, V7, P837, DOI 10.1038/sj.mp.4001093; Kegeles LS, 2000, BIOL PSYCHIAT, V48, P627, DOI 10.1016/S0006-3223(00)00976-8; Kobori N, 2004, J BIOL CHEM, V279, P2182, DOI 10.1074/jbc.M310734200; Lee ST, 2009, BRIT J ANAESTH, V102, P80, DOI 10.1093/bja/aen322; Lindefors N, 1997, BRAIN RES, V759, P205, DOI 10.1016/S0006-8993(97)00255-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mak YT, 2010, MICROSC RES TECHNIQ, V73, P195, DOI 10.1002/jemt.20774; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Morgan CJA, 2012, ADDICTION, V107, P27, DOI 10.1111/j.1360-0443.2011.03576.x; Morgan CJA, 2009, ADDICTION, V104, P77, DOI 10.1111/j.1360-0443.2008.02394.x; Ng S. H., 2010, Hong Kong Medical Journal, V16, P6; Okamoto T, 1996, Masui, V45, P1083; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rodvelt KR, 2008, NEUROSCI LETT, V440, P319, DOI 10.1016/j.neulet.2008.05.106; ROTHMAN DL, 1985, P NATL ACAD SCI USA, V82, P1633, DOI 10.1073/pnas.82.6.1633; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021328; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Wang C, 2006, TOXICOL SCI, V91, P192, DOI 10.1093/toxsci/kfj144; Wang C, 2005, NEUROSCIENCE, V132, P967, DOI 10.1016/j.neuroscience.2005.01.053; Weiner AL, 2000, J EMERG MED, V18, P447, DOI 10.1016/S0736-4679(00)00162-1; Yeung LY, 2010, TOXICOL LETT, V193, P189, DOI 10.1016/j.toxlet.2010.01.008	35	47	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43947	10.1371/journal.pone.0043947	http://dx.doi.org/10.1371/journal.pone.0043947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937133	gold, Green Published			2022-12-27	WOS:000308225500128
J	Jha, S; Allen, D; Liere, H; Perfecto, I; Vandermeer, J				Jha, Shalene; Allen, David; Liere, Heidi; Perfecto, Ivette; Vandermeer, John			Mutualisms and Population Regulation: Mechanism Matters	PLOS ONE			English	Article							ANT ATTENDANCE; BIODIVERSITY; PEST; PREDATORS; HOMOPTERA; HONEYDEW; BENEFITS; PATTERN; APHIDS; COSTS	For both applied and theoretical ecological science, the mutualism between ants and their hemipteran partners is iconic. In this well-studied interaction, ants are assumed to provide hemipterans protection from natural enemies in exchange for nutritive honeydew. Despite decades of research and the potential importance in pest control, the precise mechanism producing this mutualism remains contested. By analyzing maximum likelihood parameter estimates of a hemipteran population model, we show that the mechanism of the mutualism is direct, via improved hemipteran growth rates, as opposed to the frequently assumed indirect mechanism, via harassment of the specialist parasites and predators of the hemipterans. Broadly, this study demonstrates that the management of mutualism-based ecosystem services requires a mechanistic understanding of mutualistic interactions. A consequence of this finding is the counter intuitive demonstration that preserving ant participation in the ant-hemipteran mutualism may be the best way of insuring pest control.	[Jha, Shalene] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Allen, David] Middlebury Coll, Dept Biol, Middlebury, VT 05753 USA; [Liere, Heidi] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Perfecto, Ivette] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Vandermeer, John] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Austin; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jha, S (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	sjha@austin.utexas.edu		Allen, David/0000-0002-0712-9603	National Science Foundation [DEB-0349388]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by a National Science Foundation grant to I.P. and J.V. (DEB-0349388). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BANKS C. J., 1958, BULL ENT RES, V49, P701, DOI 10.1017/S0007485300053979; BANKS CJ, 1967, ANN APPL BIOL, V60, P445, DOI 10.1111/j.1744-7348.1967.tb04499.x; BARTLETT B. R., 1961, ANN ENT SOC AMER, V54, P543, DOI 10.1093/aesa/54.4.543; Bolker B, 2008, ECOLOGICAL MODELS DA, P169; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; BUCKLEY RC, 1987, ANNU REV ECOL SYST, V18, P111, DOI 10.1146/annurev.es.18.110187.000551; Caswell, 2000, MATRIX POPULATION MO; FOKKEMA NJ, 1983, T BRIT MYCOL SOC, V81, P355, DOI 10.1016/S0007-1536(83)80087-4; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; HAINES IH, 1978, B ENTOMOL RES, V68, P627, DOI 10.1017/S0007485300009603; Harmon JP, 2007, OIKOS, V116, P1030, DOI 10.1111/j.2007.0030-1299.15578.x; Hsieh H, ECOLOGY EVO IN PRESS; Hsieh H, 2012, PSYCHE J ENTOMOLOGY, V2012, P1; Jha S, 2009, B INSECTOL, V62, P183; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Liere H, 2008, ENVIRON ENTOMOL, V37, P143, DOI 10.1603/0046-225X(2008)37[143:COAMIB]2.0.CO;2; Liere H, 2010, OIKOS, V119, P1394, DOI 10.1111/j.1600-0706.2010.17985.x; MANTEL N, 1967, CANCER RES, V27, P209; MATLAB, 2003, VERS 6 5 1; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; NAULT LR, 1976, SCIENCE, V192, P1349, DOI 10.1126/science.1273595; Nixon G.E.J., 1951, ASS ANTS APHIDS COCC; Oliver TH, 2008, ECOL ENTOMOL, V33, P523, DOI 10.1111/j.1365-2311.2008.01009.x; Perfecto I, 2008, ECOLOGY, V89, P915, DOI 10.1890/06-2121.1; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; Stadler B, 2002, ECOL LETT, V5, P216, DOI 10.1046/j.1461-0248.2002.00300.x; Stadler B, 1998, J ANIM ECOL, V67, P454, DOI 10.1046/j.1365-2656.1998.00209.x; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; VANDERMEER J, 1995, ANNU REV ECOL SYST, V26, P201, DOI 10.1146/annurev.es.26.110195.001221; Vandermeer J, 2008, NATURE, V451, P457, DOI 10.1038/nature06477; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8; Volkl W, 1996, OECOLOGIA, V107, P498, DOI 10.1007/BF00333941; VOLKL W, 1995, J INSECT BEHAV, V8, P653, DOI 10.1007/BF01997236; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Wimp GM, 2001, ECOLOGY, V82, P440, DOI 10.1890/0012-9658(2001)082[0440:BCOPAH]2.0.CO;2; Yao I, 2000, OIKOS, V89, P3, DOI 10.1034/j.1600-0706.2000.890101.x	40	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43510	10.1371/journal.pone.0043510	http://dx.doi.org/10.1371/journal.pone.0043510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927978	Green Published, gold			2022-12-27	WOS:000308224700016
J	Pauwels, E; Surdez, D; Stoll, G; Lescure, A; Del Nery, E; Delattre, O; Stoven, V				Pauwels, Edouard; Surdez, Didier; Stoll, Gautier; Lescure, Aurianne; Del Nery, Elaine; Delattre, Olivier; Stoven, Veronique			A Probabilistic Model for Cell Population Phenotyping Using HCS Data	PLOS ONE			English	Article							GENOME; RNAI; RECOGNITION; MICROSCOPY; REGRESSION	High Content Screening (HCS) platforms allow screening living cells under a wide range of experimental conditions and give access to a whole panel of cellular responses to a specific treatment. The outcome is a series of cell population images. Within these images, the heterogeneity of cellular response to the same treatment leads to a whole range of observed values for the recorded cellular features. Consequently, it is difficult to compare and interpret experiments. Moreover, the definition of phenotypic classes at a cell population level remains an open question, although this would ease experiments analyses. In the present work, we tackle these two questions. The input of the method is a series of cell population images for which segmentation and cellular phenotype classification has already been performed. We propose a probabilistic model to represent and later compare cell populations. The model is able to fully exploit the HCS-specific information: "dependence structure of population descriptors" and "within-population variability". The experiments we carried out illustrate how our model accounts for this specific information, as well as the fact that the model benefits from considering them. We underline that these features allow richer HCS data analysis than simpler methods based on single cellular feature values averaged over each well. We validate an HCS data analysis method based on control experiments. It accounts for HCS specificities that were not taken into account by previous methods but have a sound biological meaning. Biological validation of previously unknown outputs of the method constitutes a future line of work.	[Pauwels, Edouard; Stoven, Veronique] Mines ParisTech, Ctr Computat Biol, Fontainebleau, France; [Delattre, Olivier] Inst Curie, Unite Genet Somat, Paris, France; [Surdez, Didier; Delattre, Olivier] Inst Natl Sante & Rech Med, Unite Genet & Biol Canc, Paris, France; [Lescure, Aurianne; Del Nery, Elaine] Inst Curie, Dept Translat Res, Biophen Automated Imaging Lab, Paris, France	UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Pauwels, E (corresponding author), Mines ParisTech, Ctr Computat Biol, Fontainebleau, France.	edouard.pauwels@ensmp.fr	Surdez, Didier/ABG-4565-2020	DEL NERY, Elaine/0000-0002-9654-5202; Stoll, Gautier/0000-0002-0862-4139; delattre, olivier/0000-0002-8730-2276	Institut National du Cancer (SYBEwing project); European Union [n259348]	Institut National du Cancer (SYBEwing project); European Union(European Commission)	This work was supported by a grant from the Institut National du Cancer (SYBEwing project). The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement n259348 (ASSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Chang GT, 2007, COMPUT STAT DATA AN, V51, P6242, DOI 10.1016/j.csda.2007.01.008; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Cox DR, 1974, THEORETICAL STAT; Elidan G., 2010, PROC INT C NEURAL IN, P559; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; GENEST C, 1995, BIOMETRIKA, V82, P543, DOI 10.2307/2337532; Genest C, 2007, J HYDROL ENG, V12, P347, DOI 10.1061/(ASCE)1084-0699(2007)12:4(347); Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hoffman MD, 2010, ADV NEURAL INFORM PR, V23, P559; Hollander M., 1973, NONPARAMETRIC STAT M; Jajuga K, 2006, STUD CLASS DATA ANAL, P606, DOI 10.1007/3-540-31314-1_74; Joe H., 1996, 166 U BRIT COL DEP S; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Kim G, 2007, COMPUT STAT DATA AN, V51, P2836, DOI 10.1016/j.csda.2006.10.009; Kim JM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-225; KOLLER D., 2009, PROBABILISTIC GRAPHI; Li D., 2000, J FIXED INCOME, V9, P43, DOI DOI 10.3905/JFI.2000.319253; Nelsen R.B., 1998, LECT NOTES STAT; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Onken A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000577; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Rieber N, 2009, BIOINFORMATICS, V25, P678, DOI 10.1093/bioinformatics/btp014; Scholzel C, 2008, NONLINEAR PROC GEOPH, V15, P761, DOI 10.5194/npg-15-761-2008; Shih JH, 1995, BIOMETRICS, V51, P1384, DOI 10.2307/2533269; Sklar A., 1959, PUBL I STAT U PARIS, V8, P229, DOI DOI 10.1007/978-3-642-33590-7; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Smola AJ, 1998, ALGORITHMICA, V22, P211, DOI 10.1007/PL00013831; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Song PXK, 2000, SCAND J STAT, V27, P305, DOI 10.1111/1467-9469.00191; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Wang J, 2008, J BIOMOL SCREEN, V13, P29, DOI 10.1177/1087057107311223	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42715	10.1371/journal.pone.0042715	http://dx.doi.org/10.1371/journal.pone.0042715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927936	Green Published, gold			2022-12-27	WOS:000308224700007
J	Abbott, AD; Colman, RJ; Tiefenthaler, R; Dumesic, DA; Abbott, DH				Abbott, Andrew D.; Colman, Ricki J.; Tiefenthaler, Ross; Dumesic, Daniel A.; Abbott, David H.			Early-to-Mid Gestation Fetal Testosterone Increases Right Hand 2D:4D Finger Length Ratio in Polycystic Ovary Syndrome-Like Monkeys	PLOS ONE			English	Article							FEMALE RHESUS-MONKEYS; CONGENITAL ADRENAL-HYPERPLASIA; PRENATAL ANDROGEN EXPOSURE; 4TH DIGIT LENGTH; FOLLICLE-STIMULATING-HORMONE; NONHUMAN PRIMATE MODEL; IN-VITRO FERTILIZATION; HUMAN 2D INDEX; LUTEINIZING-HORMONE; ANATOMICAL EVIDENCE	A smaller length ratio for the second relative to the fourth finger (2D:4D) is repeatedly associated with fetal male-typical testosterone (T) and is implicated as a biomarker for a variety of traits and susceptibility to a number of diseases, but no experimental human studies have been performed. The present study utilizes the rhesus monkey, a close relative of humans, and employs discrete gestational exposure of female monkeys to fetal male-typical T levels for 15-35 days during early-to-mid (40-76 days; n = 7) or late (94-139 days; n = 7) gestation (term:165 days) by daily subcutaneous injection of their dams with 10 mg T propionate. Such gestational exposures are known to enhance male-typical behavior. In this study, compared to control females (n = 19), only early-to-mid gestation T exposure virilizes female external genitalia while increasing 2D:4D ratio in the right hand (RH) by male-like elongation of RH2D. RH2D length and 2D:4D positively correlate with androgen-dependent anogenital distance (AG), and RH2D and AG positively correlate with duration of early-to-mid gestation T exposure. Male monkeys (n = 9) exhibit a sexually dimorphic 2D:4D in the right foot, but this trait is not emulated by early-to-mid or late gestation T exposed females. X-ray determined phalanx measurements indicate elongated finger and toe phalanx length in males, but no other phalanx-related differences. Discrete T exposure during early-to-mid gestation in female rhesus monkeys thus appears to increase RH2D:4D through right-side biased, non-skeletal tissue growth. As variation in timing and duration of gestational T exposure alter male-like dimensions of RH2D independently of RH4D, postnatal RH2D:4D provides a complex biomarker for fetal T exposure.	[Abbott, Andrew D.; Colman, Ricki J.; Tiefenthaler, Ross; Dumesic, Daniel A.; Abbott, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Abbott, David H.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Abbott, David H.] Univ Wisconsin, Endocrinol Reprod Physiol Program, Madison, WI USA; [Dumesic, Daniel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Abbott, AD (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.	aabbott@primate.wisc.edu		Dumesic, Daniel/0000-0003-0387-1277; Colman, Ricki/0000-0001-9706-0525	National Institutes of Health [R01 RR013635, U01 HD044650, P51 RR000167]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD044650] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167, C06RR020141, R01RR013635, C06RR015459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by National Institutes of Health grants R01 RR013635, U01 HD044650, P51 RR000167 (Wisconsin National Primate Research Centre (WNPRC) base operating grant), and was partly conducted at a facility (WNPRC) constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2008, BIOL REPROD, V79, P154, DOI 10.1095/biolreprod.108.067702; Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Abbott DH, 2009, AM J PRIMATOL, V71, P776, DOI 10.1002/ajp.20679; Abbott David H., 2008, V13, P145, DOI 10.1159/000134831; Abbott DH, 2005, HUM REPROD UPDATE, V11, P357, DOI 10.1093/humupd/dmi013; Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001; Abbott DH, 1998, TRENDS ENDOCRIN MET, V9, P62, DOI 10.1016/S1043-2760(98)00019-8; ADAMS J, 1986, BRIT MED J, V293, P355, DOI 10.1136/bmj.293.6543.355; Alpanes M, 2012, EXPERT REV ENDOCRINO, V7, P91, DOI [10.1586/EEM.11.85, 10.1586/eem.11.85]; Anderson H, 2010, J CLIN ENDOCR METAB, V95, P2180, DOI 10.1210/jc.2009-2651; Angwin J, 2004, J RHEUMATOL, V31, P1050; Auger J, 2011, INT J ANDROL, V34, pE49, DOI 10.1111/j.1365-2605.2010.01124.x; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; BARBIERI RL, 1986, AM J OBSTET GYNECOL, V154, P1039, DOI 10.1016/0002-9378(86)90746-5; Barry JA, 2010, J OBSTET GYNAECOL, V30, P444, DOI 10.3109/01443615.2010.485254; Beaton AA, 2011, LATERALITY, V16, P136, DOI 10.1080/13576500903410369; BECKPECCOZ P, 1991, J CLIN ENDOCR METAB, V73, P525, DOI 10.1210/jcem-73-3-525; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Bescos R, 2009, J SPORT SCI, V27, P625, DOI 10.1080/02640410802707029; Boets B, 2007, NEUROREPORT, V18, P1487, DOI 10.1097/WNR.0b013e3282e9a754; Bourne VJ, 2009, PSYCHONEUROENDOCRINO, V34, P1214, DOI 10.1016/j.psyneuen.2009.03.010; Brabin L, 2008, AM J HUM BIOL, V20, P337, DOI 10.1002/ajhb.20731; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Bruns CM, 2007, INT J OBESITY, V31, P1579, DOI 10.1038/sj.ijo.0803638; Buck JJ, 2003, HUM REPROD, V18, P976, DOI 10.1093/humrep/deg198; Carmina E, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.008; Cattrall FR, 2005, FERTIL STERIL, V84, P1689, DOI 10.1016/j.fertnstert.2005.05.061; Chen XQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002709; Chura LR, 2010, PSYCHONEUROENDOCRINO, V35, P122, DOI 10.1016/j.psyneuen.2009.09.009; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen-Bendahan CCC, 2005, NEUROSCI BIOBEHAV R, V29, P353, DOI 10.1016/j.neubiorev.2004.11.004; Cole B, 2006, J CLIN ENDOCR METAB, V91, P3654, DOI 10.1210/jc.2006-0641; Colman RJ, 1999, J CLIN ENDOCR METAB, V84, P4144, DOI 10.1210/jc.84.11.4144; Dawson PA, 2011, SEMIN CELL DEV BIOL, V22, P653, DOI 10.1016/j.semcdb.2011.03.004; De Bruin EI, 2009, AUTISM, V13, P511, DOI 10.1177/1362361309335720; DIERSCHKE DJ, 1976, J MED PRIMATOL, V5, P100; Dressler SG, 2011, DEV PSYCHOBIOL, V53, P69, DOI 10.1002/dev.20488; Dumesic DA, 2002, J CLIN ENDOCR METAB, V87, P1111, DOI 10.1210/jc.87.3.1111; Dumesic DA, 2003, BIOL REPROD, V69, P1213, DOI 10.1095/biolreprod.102.015164; Dumesic DA, 1997, FERTIL STERIL, V67, P155, DOI 10.1016/S0015-0282(97)81873-0; Dumesic DA, 2007, REV ENDOCR METAB DIS, V8, P127, DOI 10.1007/s11154-007-9046-0; Ecker A, 1875, ARCH ANTHR, V8, P68; Eisner JR, 2003, OBES RES, V11, P279, DOI 10.1038/oby.2003.42; Eisner JR, 2002, FERTIL STERIL, V77, P167, DOI 10.1016/S0015-0282(01)02947-8; Eisner JR, 2000, J CLIN ENDOCR METAB, V85, P1206, DOI 10.1210/jc.85.3.1206; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Foecking EM, 2005, BIOL REPROD, V72, P1475, DOI 10.1095/biolreprod.105.039800; Fowler PA, 2011, J CLIN ENDOCR METAB, V96, pE1502, DOI 10.1210/jc.2011-1100; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; GARN SM, 1975, AM J PHYS ANTHROPOL, V43, P327, DOI 10.1002/ajpa.1330430305; Gillam L, 2008, J ANAT, V213, P325, DOI 10.1111/j.1469-7580.2008.00940.x; Goy R W, 1972, Recent Prog Horm Res, V28, P707; GOY RW, 1988, HORM BEHAV, V22, P552, DOI 10.1016/0018-506X(88)90058-X; Goy RW, 1988, TOXICITY HORMONES PE, P127; GOY RW, 1982, BANBURY REPORT, V11, P355; GOY RW, 1976, HDB SEXOLOGY, P139; Herman RA, 2000, HORM BEHAV, V38, P52, DOI 10.1006/hbeh.2000.1608; Hickey M, 2011, HUM REPROD, V26, P1469, DOI 10.1093/humrep/der102; Hickey M, 2009, J CLIN ENDOCR METAB, V94, P3714, DOI 10.1210/jc.2009-0544; Hill R, 2012, J SPORT SCI, V30, P129, DOI 10.1080/02640414.2011.637947; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Hopp RN, 2011, AM J HUM BIOL, V23, P423, DOI 10.1002/ajhb.21144; JAMISON CS, 1994, AM J PHYS ANTHROPOL, V94, P409, DOI 10.1002/ajpa.1330940309; JAMISON CS, 1993, AM J PHYS ANTHROPOL, V90, P185, DOI 10.1002/ajpa.1330900205; KEMNITZ JW, 1994, DIABETES, V43, P204, DOI 10.2337/diabetes.43.2.204; Lorda-Diez CI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024546; Lujan ME, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-156; Lujan ME, 2010, HUM REPROD, V25, P204, DOI 10.1093/humrep/dep363; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2009, LATERALITY, V14, P528, DOI 10.1080/13576500802637872; Manning JT, 2006, ANN HUM BIOL, V33, P480, DOI 10.1080/03014460600802551; Manning JT, 2011, P NATL ACAD SCI USA, V108, P16143, DOI 10.1073/pnas.1113312108; Manning JT, 2003, MED HYPOTHESES, V60, P340, DOI 10.1016/S0306-9877(02)00400-0; Manning JT, 2001, BREAST, V10, P355, DOI 10.1054/brst.2001.0284; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; Manning JT., 2002, DIGIT RATIO POINTER; Martel MM, 2008, BEHAV NEUROSCI, V122, P273, DOI 10.1037/0735-7044.122.2.273; Mayhew TM, 2007, J ANAT, V211, P630, DOI 10.1111/j.1469-7580.2007.00801.x; McFadden D, 2005, HORM BEHAV, V47, P99, DOI 10.1016/j.yhbeh.2004.08.013; McFadden D, 2002, HORM BEHAV, V42, P492, DOI 10.1006/hbeh.2002.1833; McFadden D, 2005, ARCH SEX BEHAV, V34, P341, DOI 10.1007/s10508-005-3123-9; McFadden D, 2009, EARLY HUM DEV, V85, P117, DOI 10.1016/j.earlhumdev.2008.07.001; McIntyre MH, 2009, J HUM EVOL, V56, P361, DOI 10.1016/j.jhevol.2008.12.004; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; McIntyre MH, 2006, AM J PHYS ANTHROPOL, V129, P143, DOI 10.1002/ajpa.20240; McIntyre MH, 2005, P ROY SOC B-BIOL SCI, V272, P1473, DOI 10.1098/rspb.2005.3100; MEIER RJ, 1993, FOLIA PRIMATOL, V60, P164, DOI 10.1159/000156685; Muller DC, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-57; Nelson E, 2010, AM J PHYS ANTHROPOL, V141, P395, DOI 10.1002/ajpa.21157; Nelson E, 2010, PRIMATES, V51, P1, DOI 10.1007/s10329-009-0173-y; New MI, 1999, P NATL ACAD SCI USA, V96, P12790, DOI 10.1073/pnas.96.22.12790; Noipayak Pongsak, 2009, Journal of the Medical Association of Thailand, V92, P1040; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Poretsky L, 1999, ENDOCR REV, V20, P535, DOI 10.1210/er.20.4.535; RESKO JA, 1987, BIOL REPROD, V37, P1185, DOI 10.1095/biolreprod37.5.1185; Roney JR, 2004, HORM BEHAV, V45, P285, DOI 10.1016/j.yhbeh.2003.12.008; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Sir-Petermann T, 2009, J CLIN ENDOCR METAB, V94, P1923, DOI 10.1210/jc.2008-2836; Smith AR, 2010, INT J EAT DISORDER, V43, P543, DOI 10.1002/eat.20736; Speiser PW, 2010, J CLIN ENDOCR METAB, V95, P4133, DOI 10.1210/jc.2009-2631; Stoyanov Z, 2009, INT J NEUROSCI, V119, P1006, DOI 10.1080/03008200802323883; Stricker S, 2011, DEV DYNAM, V240, P990, DOI 10.1002/dvdy.22565; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Talarovicova A, 2009, HORM BEHAV, V55, P235, DOI 10.1016/j.yhbeh.2008.10.010; Thornton J, 2009, HORM BEHAV, V55, P633, DOI 10.1016/j.yhbeh.2009.03.015; Vehmas T, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-12; Voracek M, 2007, AM J HUM BIOL, V19, P142, DOI 10.1002/ajhb.20581; Voracek M, 2006, PERCEPT MOTOR SKILL, V103, P427, DOI 10.2466/PMS.103.2.427-446; Voracek M, 2010, PERCEPT MOTOR SKILL, V110, P33, DOI 10.2466/PMS.110.1.33-47; Voracek M, 2010, SCAND J PSYCHOL, V51, P146, DOI 10.1111/j.1467-9450.2009.00758.x; Voracek M, 2009, AM J PHYS ANTHROPOL, V140, P376, DOI 10.1002/ajpa.21105; Wallen K, 2009, ENDOCRINOLOGY, V150, P4819, DOI 10.1210/en.2009-0986; West C, 2001, MOL CELL ENDOCRINOL, V185, P51, DOI 10.1016/S0303-7207(01)00632-3; Witchel SF, 2011, J PEDIATR ADOL GYNEC, V24, P116, DOI 10.1016/j.jpag.2010.10.001; Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286; Zawadski J., 1992, POLYCYSTIC OVARY SYN, P377; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108; Zhou R, 2005, J CLIN ENDOCR METAB, V90, P6630, DOI 10.1210/jc.2005-0691; Zhou R, 2007, REPROD TOXICOL, V23, P438, DOI 10.1016/j.reprotox.2006.12.009	126	49	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42372	10.1371/journal.pone.0042372	http://dx.doi.org/10.1371/journal.pone.0042372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927929	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300020
J	Bonechi, C; Martini, S; Ciani, L; Lamponi, S; Rebmann, H; Rossi, C; Ristori, S				Bonechi, Claudia; Martini, Silvia; Ciani, Laura; Lamponi, Stefania; Rebmann, Herbert; Rossi, Claudio; Ristori, Sandra			Using Liposomes as Carriers for Polyphenolic Compounds: The Case of Trans-Resveratrol	PLOS ONE			English	Article							IN-VIVO; CANCER; SPECTROSCOPY; PERSPECTIVES; RESONANCE; MEMBRANES	Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a polyphenol found in various plants, especially in the skin of red grapes. The effect of resveratrol on human health is the topic of numerous studies. In fact this molecule has shown anti-cancer, anti-inflammatory, blood-sugar-lowering ability and beneficial cardiovascular effects. However, for many polyphenol compounds of natural origin bioavailability is limited by low solubility in biological fluids, as well as by rapid metabolization in vivo. Therefore, appropriate carriers are required to obtain efficient therapeutics along with low administration doses. Liposomes are excellent candidates for drug delivery purposes, due to their biocompatibility, wide choice of physico-chemical properties and easy preparation. In this paper liposome formulations made by a saturated phosphatidyl-choline (DPPC) and cholesterol (or its positively charged derivative DC-CHOL) were chosen to optimize the loading of a rigid hydrophobic molecule such as resveratrol. Plain and resveratrol loaded liposomes were characterized for size, surface charge and structural details by complementary techniques, i.e. Dynamic Light Scattering (DLS), Zeta potential and Small Angle X-ray Scattering (SAXS). Nuclear and Electron Spin magnetic resonances (NMR and ESR, respectively) were also used to gain information at the molecular scale. The obtained results allowed to give an account of loaded liposomes in which resveratrol interacted with the bilayer, being more deeply inserted in cationic liposomes than in zwitterionic liposomes. Relevant properties such as the mean size and the presence of oligolamellar structures were influenced by the loading of RESV guest molecules. The toxicity of all these systems was tested on stabilized cell lines (mouse fibroblast NIH-3T3 and human astrocytes U373-MG), showing that cell viability was not affected by the administration of liposomial resveratrol.	[Bonechi, Claudia; Martini, Silvia; Lamponi, Stefania; Rossi, Claudio] Univ Siena, Dept Pharmaceut, I-53100 Siena, Italy; [Bonechi, Claudia; Martini, Silvia; Lamponi, Stefania; Rossi, Claudio] Univ Siena, Dept Appl Chem, I-53100 Siena, Italy; [Bonechi, Claudia; Martini, Silvia; Lamponi, Stefania; Rossi, Claudio] Univ Siena, CSGI, I-53100 Siena, Italy; [Ciani, Laura; Ristori, Sandra] Univ Florence, Chem Dept Ugo Schiff, Sesto Fiorentino, Italy; [Ciani, Laura; Ristori, Sandra] Univ Florence, CSGI, Sesto Fiorentino, Italy; [Rebmann, Herbert] Phospholipid Res Ctr, Heidelberg, Germany	University of Siena; University of Siena; University of Siena; University of Florence; University of Florence	Bonechi, C (corresponding author), Univ Siena, Dept Pharmaceut, Via Laterina 8, I-53100 Siena, Italy.	ristori@unifi.it	Ristori, Sandra/J-9887-2014; lamponi, stefania/AAM-5490-2021; Ristori, Sandra/ABC-4731-2020	Ristori, Sandra/0000-0003-0708-3956; lamponi, stefania/0000-0002-2788-8797; BONECHI, CLAUDIA/0000-0002-4328-3253; ROSSI, CLAUDIO/0000-0001-6032-1015	Phospholipids Research Center (Heidelberg, Germany)	Phospholipids Research Center (Heidelberg, Germany)	This study was conducted in the framework of a Phospholipids Research Center (Heidelberg, Germany) funded research project. Dr. Herbert Rebmann, a member of the Phospholipids Research Center, took part to the work and co-authored this manuscript. Apart from Dr. Rebmann, who contributed as co-author, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Aziz MH, 2003, INT J ONCOL, V23, P17; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bonechi C, 2008, MAGN RESON CHEM, V46, P625, DOI 10.1002/mrc.2217; Caddeo C, 2008, INT J PHARMACEUT, V363, P183, DOI 10.1016/j.ijpharm.2008.07.024; CEVC G, 1993, CHEM PHYS LIPIDS, V64, P163, DOI 10.1016/0009-3084(93)90064-A; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fahr A, 2005, EUR J PHARM SCI, V26, P251, DOI 10.1016/j.ejps.2005.05.012; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Gregoriadis G., 1993, LIPOSOMES DRUG DELIV; Hunter R. J., 1988, ZETA POTENTIAL COLLO; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kolouchova-Hanzlikova I, 2004, FOOD CHEM, V87, P151, DOI 10.1016/j.foodchem.2004.01.028; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Lindner P, 2002, NEUTRON XRAYS LIGHT; Mauer N, 2001, EXPERT OPIN BIOL TH, V6, P923; Morandi S, 2004, BBA-BIOMEMBRANES, V1664, P53, DOI 10.1016/j.bbamem.2004.04.002; Narayanan NK, 2009, INT J CANCER, V125, P1, DOI 10.1002/ijc.24336; Pabst Georg, 2006, Biophysical Reviews and Letters, V1, P57, DOI 10.1142/S1793048006000069; Padamwar MN, 2006, INT J PHARMACEUT, V320, P37, DOI 10.1016/j.ijpharm.2006.04.001; Rius C, 2012, IMMUNOLOGY, V185, P3718; Romberg B, 2006, BIOCONJUGATE CHEM, V17, P860, DOI 10.1021/bc060045a; Rossi C, 2011, SEMIN CANCER BIOL, V21, P207, DOI 10.1016/j.semcancer.2011.04.003; Shu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027484; Shu XH, 2010, BIOCHEM PHARMACOL, V79, P1516, DOI 10.1016/j.bcp.2010.01.022; Vartorelli MR, 2008, J PHYS CHEM B, V112, P16830, DOI 10.1021/jp806476a	26	81	81	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41438	10.1371/journal.pone.0041438	http://dx.doi.org/10.1371/journal.pone.0041438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936976	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300007
J	Gavidia, R; Fuentes, SL; Vasquez, R; Bonilla, M; Ethier, MC; Diorio, C; Caniza, M; Howard, SC; Sung, LL				Gavidia, Ronald; Fuentes, Soad L.; Vasquez, Roberto; Bonilla, Miguel; Ethier, Marie-Chantal; Diorio, Caroline; Caniza, Miguela; Howard, Scott C.; Sung, Lillian			Low Socioeconomic Status Is Associated with Prolonged Times to Assessment and Treatment, Sepsis and Infectious Death in Pediatric Fever in El Salvador	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEALTH LITERACY; CHILDREN; PREDICTORS; MORTALITY; ADHERENCE; THERAPY	Background: Infection remains the most common cause of death from toxicity in children with cancer in low-and middle-income countries. Rapid administration of antibiotics when fever develops can prevent progression to sepsis and shock, and serves as an important indicator of the quality of care in children with acute lymphoblastic leukemia and acute myeloid leukemia. We analyzed factors associated with (1) Longer times from fever onset to hospital presentation/antibiotic treatment and (2) Sepsis and infection-related mortality. Method: This prospective cohort study included children aged 0-16 years with newly diagnosed acute leukemia treated at Benjamin Bloom Hospital, San Salvador. We interviewed parents/caregivers within one month of diagnosis and at the onset of each new febrile episode. Times from initial fever to first antibiotic administration and occurrence of sepsis and infection-related mortality were documented. Findings: Of 251 children enrolled, 215 had acute lymphoblastic leukemia (85.7%). Among 269 outpatient febrile episodes, median times from fever to deciding to seek medical care was 10.0 hours (interquartile range [IQR] 5.0-20.0), and from decision to seek care to first hospital visit was 1.8 hours (IQR 1.0-3.0). Forty-seven (17.5%) patients developed sepsis and 7 (2.6%) died of infection. Maternal illiteracy was associated with longer time from fever to decision to seek care (P = 0.029) and sepsis (odds ratio [OR] 3.06, 95% confidence interval [CI] 1.09-8.63; P = 0.034). More infectious deaths occurred in those with longer travel time to hospital (OR 1.36, 95% CI 1.03-1.81; P = 0.031) and in families with an annual household income <US$2,000 (OR 13.90, 95% CI 1.62-119.10; P = 0.016). Interpretation: Illiteracy, poverty, and longer travel times are associated with delays in assessment and treatment of fever and with sepsis and infectious mortality in pediatric leukemia. Providing additional education to high-risk families and staying at a nearby guest house during periods of neutropenia may decrease sepsis and infectious mortality.	[Gavidia, Ronald; Fuentes, Soad L.; Vasquez, Roberto; Bonilla, Miguel] Benjamin Bloom Natl Childrens Hosp, San Salvador, El Salvador; [Sung, Lillian] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Caniza, Miguela] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Howard, Scott C.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Caniza, Miguela; Howard, Scott C.] St Jude Childrens Res Hosp, Int Outreach Program, Memphis, TN 38105 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gavidia, R (corresponding author), Benjamin Bloom Natl Childrens Hosp, San Salvador, El Salvador.	lillian.sung@sickkids.ca	caniza, miguela a/N-8138-2018; Howard, Scott C/K-3401-2013; Gavidia, Ronald/GQP-2855-2022; Gavidia, Ronald/CAH-3976-2022	caniza, miguela a/0000-0002-7846-9605; Howard, Scott C/0000-0003-2244-1686; Gavidia, Ronald/0000-0002-2090-693X; Gavidia, Ronald/0000-0002-2090-693X; Diorio, Caroline/0000-0002-8005-3836	Canadian Institutes of Health Research [87719]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Dr. Sung is supported by a New Investigator Award from the Canadian Institutes of Health Research (Grant No. 87719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bonilla M, 2009, INT J CANCER, V125, P2144, DOI 10.1002/ijc.24534; Bouza E, 2000, CLIN INFECT DIS, V30, P306, DOI 10.1086/313648; Chirouze C, 2002, CLIN INFECT DIS, V35, P156, DOI 10.1086/341023; Creutzig U, 2001, J CLIN ONCOL, V19, P2705, DOI 10.1200/JCO.2001.19.10.2705; FENAUX P, 1993, BLOOD, V82, P3241; Fronkova E, 2008, LEUKEMIA, V22, P989, DOI 10.1038/leu.2008.22; Gellad WF, 2011, AM J GERIATR PHARMAC, V9, P11, DOI 10.1016/j.amjopharm.2011.02.004; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gupta S, 2009, BRIT J CANCER, V100, P1026, DOI 10.1038/sj.bjc.6604895; Gupta S, 2011, J PEDIAT HEMATOL ONC, V33, P276, DOI 10.1097/MPH.0b013e31820ff632; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Lie SO, 2003, BRIT J HAEMATOL, V122, P217, DOI 10.1046/j.1365-2141.2003.04418.x; Murray MD, 2009, CLIN PHARMACOL THER, V85, P651, DOI 10.1038/clpt.2009.7; Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002; Phillips B, 2010, EUR J CANCER, V46, P2950, DOI 10.1016/j.ejca.2010.05.024; Pui C.-H., 2004, Annals of Hematology, V83, pS124; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Ribeiro RC, 2008, LANCET ONCOL, V9, P721, DOI 10.1016/S1470-2045(08)70194-3; Seliverstov I, 2011, J THROMB THROMBOLYS, V31, P321, DOI 10.1007/s11239-011-0560-2	20	33	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43639	10.1371/journal.pone.0043639	http://dx.doi.org/10.1371/journal.pone.0043639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928008	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300077
J	Lange, R; Gerlach, T; Beninde, J; Werminghausen, J; Reichel, V; Anthes, N				Lange, Rolanda; Gerlach, Tobias; Beninde, Joscha; Werminghausen, Johanna; Reichel, Verena; Anthes, Nils			Female Fitness Optimum at Intermediate Mating Rates under Traumatic Mating	PLOS ONE			English	Article							BATEMAN GRADIENTS; SEXUAL SELECTION; SPERM TRANSFER; INSEMINATION; ALLOCATION; CONFLICT; SIZE; COPULATION; EVOLUTION; COSTS	Traumatic mating behaviors often bear signatures of sexual conflict and are then typically considered a male strategy to circumvent female choice mechanisms. In an extravagant mating ritual, the hermaphroditic sea slug Siphopteron quadrispinosum pierces the integument of their mating partners with a syringe-like penile stylet that injects prostate fluids. Traumatic injection is followed by the insertion of a spiny penis into the partner's gonopore to transfer sperm. Despite traumatic mating, field mating rates exceed those required for female fertilization insurance, possibly because costs imposed on females are balanced by direct or indirect benefits of multiple sperm receipt. To test this idea, we exposed animals to a relevant range of mating opportunity regimes and assessed the effects on mating behavior and proxies of female fitness. We find penis intromission duration to decrease with mating rates, and a female fecundity maximum at intermediate mating rates. The latter finding indicates that benefits beyond fertilization insurance can make higher mating rates also beneficial from a female perspective in this traumatically mating species.	[Lange, Rolanda; Gerlach, Tobias; Werminghausen, Johanna; Reichel, Verena; Anthes, Nils] Univ Tubingen, Fac Sci, Anim Evolutionary Ecol Grp, Tubingen, Germany; [Beninde, Joscha] Univ Trier, Dept Biogeog, Trier, Germany	Eberhard Karls University of Tubingen; Universitat Trier	Lange, R (corresponding author), Univ Tubingen, Fac Sci, Anim Evolutionary Ecol Grp, Tubingen, Germany.	rolanda.lange@uni-tuebingen.de	Anthes, Nils/A-2434-2009	Anthes, Nils/0000-0003-4189-7849	German Science Foundation [An549/2-1]	German Science Foundation(German Research Foundation (DFG))	The German Science Foundation (grant An549/2-1) provided funds for field work and during manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2011, P ROY SOC B-BIOL SCI, V278, P161, DOI 10.1098/rspb.2010.1401; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anthes N, 2006, BEHAV ECOL SOCIOBIOL, V60, P359, DOI 10.1007/s00265-006-0173-5; Anthes N, 2007, INVERTEBR BIOL, V126, P335, DOI 10.1111/j.1744-7410.2007.00096.x; Anthes N, 2007, BIOL LETTERS, V3, P121, DOI 10.1098/rsbl.2006.0596; Anthes N, 2010, AM NAT, V176, P249, DOI 10.1086/655218; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Bedhomme S, 2009, BIOL LETTERS, V5, P717, DOI 10.1098/rsbl.2009.0401; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; Brauer VS, 2007, EVOLUTION, V61, P216, DOI 10.1111/j.1558-5646.2007.00018.x; Cayetano L, 2011, EVOLUTION, V65, P2171, DOI 10.1111/j.1558-5646.2011.01309.x; CHARNOV E L, 1982; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Engqvist L, 2003, J EVOLUTION BIOL, V16, P1196, DOI 10.1046/j.1420-9101.2003.00613.x; GOSLINER TM, 1989, VELIGER, V32, P333; Koene JM, 2005, INVERTEBR REPROD DEV, V48, P101, DOI 10.1080/07924259.2005.9652176; Koene JM, 2001, J COMP PHYSIOL A, V187, P323, DOI 10.1007/s003590100214; Koene JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010117; Lange R, 2012, ANIM BEHAV, V83, P469, DOI 10.1016/j.anbehav.2011.11.021; Michiels NK, 1998, SPERM COMPETITION SE, P219; Morrow EH, 2003, P ROY SOC B-BIOL SCI, V270, P2377, DOI 10.1098/rspb.2003.2514; Parker G.A., 1979, P123; Pelissie B, 2012, EVOLUTION, V66, P66, DOI 10.1111/j.1558-5646.2011.01442.x; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Puurtinen M, 2009, AM NAT, V174, P741, DOI 10.1086/606024; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Rezac M, 2009, P ROY SOC B-BIOL SCI, V276, P2697, DOI 10.1098/rspb.2009.0104; Ronn J, 2006, ANIM BEHAV, V72, P335, DOI 10.1016/j.anbehav.2005.10.024; Sato T, 2005, MAR ECOL PROG SER, V296, P251, DOI 10.3354/meps296251; Scharer L, 2011, P NATL ACAD SCI USA, V108, P1490, DOI 10.1073/pnas.1013892108; Scharer L, 2009, EVOLUTION, V63, P1377, DOI 10.1111/j.1558-5646.2009.00669.x; Scharer L, 2005, J EVOLUTION BIOL, V18, P396, DOI 10.1111/j.1420-9101.2004.00827.x; Simmons LW, 2011, J EVOLUTION BIOL, V24, P132, DOI 10.1111/j.1420-9101.2010.02158.x; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; Smolensky N, 2009, BIOL BULL-US, V216, P188; Sprenger D, 2008, J ANIM ECOL, V77, P696, DOI 10.1111/j.1365-2656.2008.01376.x; Sprenger D, 2008, MAR BIOL, V153, P891, DOI 10.1007/s00227-007-0861-3; Sprenger D, 2010, EVOL ECOL, V24, P185, DOI 10.1007/s10682-009-9300-x; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Tatarnic NJ, 2010, J EVOLUTION BIOL, V23, P1321, DOI 10.1111/j.1420-9101.2010.01991.x; Wang Q, 2008, J INSECT BEHAV, V21, P89, DOI 10.1007/s10905-007-9110-3; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	49	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43234	10.1371/journal.pone.0043234	http://dx.doi.org/10.1371/journal.pone.0043234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937024	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300036
J	van der Meer, WJ; Andriessen, FS; Wismeijer, D; Ren, YJ				van der Meer, Wicher J.; Andriessen, Frank S.; Wismeijer, Daniel; Ren, Yijin			Application of Intra-Oral Dental Scanners in the Digital Workflow of Implantology	PLOS ONE			English	Article							ACCURACY; IMPRESSION; REGISTRATION; PROSTHESIS; IMAGES; CASTS; RANGE	Intra-oral scanners will play a central role in digital dentistry in the near future. In this study the accuracy of three intra-oral scanners was compared. Materials and methods: A master model made of stone was fitted with three high precision manufactured PEEK cylinders and scanned with three intra-oral scanners: the CEREC (Sirona), the iTero (Cadent) and the Lava COS (3M). In software the digital files were imported and the distance between the centres of the cylinders and the angulation between the cylinders was assessed. These values were compared to the measurements made on a high accuracy 3D scan of the master model. Results: The distance errors were the smallest and most consistent for the Lava COS. The distance errors for the Cerec were the largest and least consistent. All the angulation errors were small. Conclusions: The Lava COS in combination with a high accuracy scanning protocol resulted in the smallest and most consistent errors of all three scanners tested when considering mean distance errors in full arch impressions both in absolute values and in consistency for both measured distances. For the mean angulation errors, the Lava COS had the smallest errors between cylinders 1-2 and the largest errors between cylinders 1-3, although the absolute difference with the smallest mean value (iTero) was very small (0,0529 degrees). An expected increase in distance and/or angular errors over the length of the arch due to an accumulation of registration errors of the patched 3D surfaces could be observed in this study design, but the effects were statistically not significant. Clinical relevance: For making impressions of implant cases for digital workflows, the most accurate scanner with the scanning protocol that will ensure the most accurate digital impression should be used. In our study model that was the Lava COS with the high accuracy scanning protocol.	[van der Meer, Wicher J.; Ren, Yijin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthodont, Groningen, Netherlands; [Andriessen, Frank S.] Acad Ctr Dent Amsterdam, Sect Oral Implantol, NL-1066 EA Amsterdam, Netherlands; [Wismeijer, Daniel] Acad Ctr Dent Amsterdam, Sect Oral Implantol & Prosthodont, NL-1066 EA Amsterdam, Netherlands; [Wismeijer, Daniel] Acad Ctr Dent Amsterdam, Dept Oral Funct & Restorat Dent, NL-1066 EA Amsterdam, Netherlands	University of Groningen; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	van der Meer, WJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthodont, Groningen, Netherlands.	w.j.van.der.meer@umcg.nl		Ren, Yijin/0000-0002-2374-1771				Abduo J, 2010, INT J ORAL MAX IMPL, V25, P506; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2; Caputi S, 2008, J PROSTHET DENT, V99, P274, DOI 10.1016/S0022-3913(08)60061-X; CHEN Y, 1992, IMAGE VISION COMPUT, V10, P145, DOI 10.1016/0262-8856(92)90066-C; Del'Acqua MA, 2008, INT J ORAL MAX IMPL, V23, P226; Ender A, 2011, Int J Comput Dent, V14, P11; Franco EB, 2011, ISRN DENT, V2011; JOHNSON GH, 1985, J PROSTHET DENT, V53, P484, DOI 10.1016/0022-3913(85)90630-4; Kachalia Parag R, 2010, J Calif Dent Assoc, V38, P323; Kang AH, 2009, J PROSTHET DENT, V101, P332, DOI 10.1016/S0022-3913(09)60066-4; Karl Matthias, 2005, Implant Dent, V14, P157, DOI 10.1097/01.id.0000163809.37466.ac; Kim Y, 2005, CLIN ORAL IMPLAN RES, V16, P26, DOI 10.1111/j.1600-0501.2004.01067.x; Kunavisarut Chatchai, 2002, J Prosthodont, V11, P30, DOI 10.1111/j.1532-849X.2002.00030.x; Luthardt R G, 2005, Int J Comput Dent, V8, P283; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Mehl A, 2009, Int J Comput Dent, V12, P11; MILLSTEIN PL, 1992, J ORAL REHABIL, V19, P239, DOI 10.1111/j.1365-2842.1992.tb01098.x; Ongul D, 2012, AUST DENT J, V57, P184, DOI 10.1111/j.1834-7819.2012.01685.x; Park J, 2005, STUD COMP INTELL, V7, P203; Sahin S, 2001, Implant Dent, V10, P85; Sahin S, 2002, J DENT, V30, P271, DOI 10.1016/S0300-5712(02)00065-9; Schenk O, 2009, Int J Comput Dent, V12, P41; SONES AD, 1989, J PROSTHET DENT, V62, P581, DOI 10.1016/0022-3913(89)90084-X; Syrek A, 2010, J DENT, V38, P553, DOI 10.1016/j.jdent.2010.03.015; Wang TM, 2002, INT J ORAL MAX IMPL, V17, P231	26	174	178	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43312	10.1371/journal.pone.0043312	http://dx.doi.org/10.1371/journal.pone.0043312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937030	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300040
J	Yassai, M; Cooley, B; Gorski, J				Yassai, Maryam; Cooley, Brian; Gorski, Jack			Developmental Dynamics of Post-Selection Thymic DN iNKT	PLOS ONE			English	Article							NKT-CELL-DEVELOPMENT; POSITIVE THYMOCYTES; ALPHA-CHAIN; MATURATION; CD4; PRECURSORS; LINEAGE; CD1D	Background: Invariant natural killer T (iNKT) cells develop in the thymus and branch off from the maturation pathway of conventional T cell at the DP stage. While different stages of iNKT cellular development have been defined, the actual time that iNKT cell precursors spend at each stage is still unknown. Methodology/Principal Finding: Here we report on maturation dynamics of post-selection DN iNKT cells by injecting wild-type DPdim thymocytes into the thymus of TCR alpha(-/-) mice and using the V alpha 14-J alpha 18 rearrangements as a molecular marker to follow the maturation dynamics of these cells. Conclusion/Significance: This study shows that the developmental dynamics of DN iNKT cells in DPdim are very rapid and that it takes less than 1 day to down-regulate CD4 and CD8 and become DN. These DN cells are precursors of peripheral DN iNKT cells and appear in the spleen in 1-2 days. Thymic DN iNKT residents are predominantly derived from cells that quickly return from the periphery. The expansion of a very small subset of DN iNKT precursors could also play a small role in this process. These data are an example of measuring T cell maturation in the thymus and show that the maturation dynamics of selected DN iNKT cells fall within the same general time frame as conventional alpha beta T cells.	[Yassai, Maryam; Gorski, Jack] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Cooley, Brian] Med Coll Wisconsin, Dept Orthoped Surg, Milwaukee, WI 53226 USA; [Gorski, Jack] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Yassai, M (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA.	maryam.yassai@bcw.edu			Blood Center Research Foundation; National Institutes of Health (NIH) grant [RO1-AI26085]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026085] Funding Source: NIH RePORTER	Blood Center Research Foundation; National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Blood Center Research Foundation and National Institutes of Health (NIH) grant RO1-AI26085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARASE H, 1992, P NATL ACAD SCI USA, V89, P6506, DOI 10.1073/pnas.89.14.6506; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Berzins SP, 2006, J IMMUNOL, V176, P4059, DOI 10.4049/jimmunol.176.7.4059; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chen XX, 2007, J LEUKOCYTE BIOL, V82, P1455, DOI 10.1189/jlb.0307163; Dao T, 2004, EUR J IMMUNOL, V34, P3542, DOI 10.1002/eji.200425546; Das R, 2010, IMMUNOL REV, V238, P195, DOI 10.1111/j.1600-065X.2010.00962.x; Dose M, 2009, P NATL ACAD SCI USA, V106, P8641, DOI 10.1073/pnas.0812255106; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; Kronenberg M, 2007, CURR OPIN IMMUNOL, V19, P186, DOI 10.1016/j.coi.2007.02.009; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; MACDONALD HR, 1990, CURR TOP MICROBIOL, V159, P97; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; McNab FW, 2005, J IMMUNOL, V175, P3762, DOI 10.4049/jimmunol.175.6.3762; NIKOLICZUGIC J, 1988, P NATL ACAD SCI USA, V85, P8633, DOI 10.1073/pnas.85.22.8633; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; SPANGRUDE GJ, 1988, J EXP MED, V167, P1671, DOI 10.1084/jem.167.5.1671; Thedrez A, 2007, BLOOD, V110, P251, DOI 10.1182/blood-2007-01-066217; Yassai M, 2000, J IMMUNOL, V165, P3706, DOI 10.4049/jimmunol.165.7.3706; Yassai M, 2002, J IMMUNOL, V168, P3801, DOI 10.4049/jimmunol.168.8.3801; YASSAI M, 1997, ANTIGEN T CELL RECEP, P326	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43509	10.1371/journal.pone.0043509	http://dx.doi.org/10.1371/journal.pone.0043509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927977	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300058
J	Hernandez-Zimbron, LF; Luna-Munoz, J; Mena, R; Vazquez-Ramirez, R; Kubli-Garfias, C; Cribbs, DH; Manoutcharian, K; Gevorkian, G				Fernando Hernandez-Zimbron, Luis; Luna-Munoz, Jose; Mena, Raul; Vazquez-Ramirez, Ricardo; Kubli-Garfias, Carlos; Cribbs, David H.; Manoutcharian, Karen; Gevorkian, Goar			Amyloid-beta Peptide Binds to Cytochrome C Oxidase Subunit 1	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; OXIDATIVE STRESS; MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; PROTEIN; ACCUMULATION; PATHOLOGY; NEURODEGENERATION; TOXICITY	Extracellular and intraneuronal accumulation of amyloid-beta aggregates has been demonstrated to be involved in the pathogenesis of Alzheimer's disease (AD). However, the precise mechanism of amyloid-beta neurotoxicity is not completely understood. Previous studies suggest that binding of amyloid-beta to a number of macromolecules has deleterious effects on cellular functions. Mitochondria were found to be the target for amyloid-beta, and mitochondrial dysfunction is well documented in AD. In the present study we have shown for the first time that A beta 1-42 bound to a peptide comprising the amino-terminal region of cytochrome c oxidase subunit 1. Phage clone, selected after screening of a human brain cDNA library expressed on M13 phage and bearing a 61 amino acid fragment of cytochrome c oxidase subunit 1, bound to A beta 142 in ELISA as well as to A beta aggregates present in AD brain. A beta 1-42 and cytochrome c oxidase subunit 1 coimmunoprecipitated from mitochondrial fraction of differentiated human neuroblastoma cells. Likewise, molecular dynamics simulation of the cytochrome c oxidase subunit 1 and the A beta 1-42 peptide complex resulted in a reliable helix-helix interaction, supporting the experimental results. The interaction between A beta 1-42 and cytochrome c oxidase subunit 1 may explain, in part, the diminished enzymatic activity of respiratory chain complex IV and subsequent neuronal metabolic dysfunction observed in AD.	[Fernando Hernandez-Zimbron, Luis; Vazquez-Ramirez, Ricardo; Kubli-Garfias, Carlos; Manoutcharian, Karen; Gevorkian, Goar] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Luna-Munoz, Jose; Mena, Raul] CINVESTAV IPN, Dept Neurosci, Mexico City, DF, Mexico; [Cribbs, David H.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA; [Cribbs, David H.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of California System; University of California Irvine; University of California System; University of California Irvine	Hernandez-Zimbron, LF (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	gokar@servidor.unam.mx		HERNANDEZ ZIMBRON, LUIS FERNANDO/0000-0002-5098-367X; VAZQUEZ-RAMIREZ, RICARDO/0000-0002-7002-0934	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) [IN209610]; Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [58081]; CONACyT; Doctorado en Ciencias Biomedicas, UNAM, Mexico	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Doctorado en Ciencias Biomedicas, UNAM, Mexico	This work was supported by grants from Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) grant number IN209610, and Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico, grant number 58081 to GG. LFHZ is the recipient of a doctoral scholarship from CONACyT and Doctorado en Ciencias Biomedicas, UNAM, Mexico. These funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleardi AM, 2005, J BIOENERG BIOMEMBR, V37, P207, DOI 10.1007/s10863-005-6631-3; [Anonymous], 2007, HYPERCHEM PROF REL 8; ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Blass JP, 2000, ANN NY ACAD SCI, V903, P204, DOI 10.1111/j.1749-6632.2000.tb06370.x; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5; Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cassano T, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.021; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Dragicevic N, 2010, J ALZHEIMERS DIS, V20, pS535, DOI 10.3233/JAD-2010-100342; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Eckert A, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt74; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Frautschy SA, 2010, MOL NEUROBIOL, V41, P392, DOI 10.1007/s12035-010-8137-1; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Gevorkian G, 2008, NEUROCHEM INT, V52, P1030, DOI 10.1016/j.neuint.2007.10.020; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang XD, 2004, ANN NY ACAD SCI, V1012, P153, DOI 10.1196/annals.1306.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Luna-Munoz J, 2008, ACTA NEUROPATHOL, V116, P507, DOI 10.1007/s00401-008-0431-x; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medecigo M, 2010, J NEUROIMMUNOL, V223, P104, DOI 10.1016/j.jneuroim.2010.03.023; Moreira PI, 2002, J NEUROSCI RES, V69, P257, DOI 10.1002/jnr.10282; Munguia ME, 2006, NEUROSCI LETT, V397, P79, DOI 10.1016/j.neulet.2005.11.061; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; Pavlov PF, 2011, FASEB J, V25, P78, DOI 10.1096/fj.10-157230; Perez-Garmendia R, 2010, J NEUROIMMUNOL, V229, P248, DOI 10.1016/j.jneuroim.2010.08.020; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Santos RX, 2010, J ALZHEIMERS DIS, V20, pS401, DOI 10.3233/JAD-2010-100666; Singh P, 2009, BIOINFORMATION, V3, P440, DOI 10.6026/97320630003440; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Tillement L, 2006, STEROIDS, V71, P725, DOI 10.1016/j.steroids.2006.05.003; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yan SD, 1997, NATURE, V389, P689; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	59	67	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42344	10.1371/journal.pone.0042344	http://dx.doi.org/10.1371/journal.pone.0042344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927926	Green Published, gold			2022-12-27	WOS:000307789700010
J	Liu, JK; Tang, XF; Gao, LY; Gao, YF; Li, YX; Huang, SX; Sun, XC; Miao, M; Zeng, H; Tian, XF; Niu, XL; Zheng, L; Giovannoni, J; Xiao, FM; Liu, YS				Liu, Jikai; Tang, Xiaofeng; Gao, Lanyang; Gao, Yongfeng; Li, Yuxiang; Huang, Shengxiong; Sun, Xiaochun; Miao, Min; Zeng, Hui; Tian, Xuefen; Niu, Xiangli; Zheng, Lei; Giovannoni, Jim; Xiao, Fangming; Liu, Yongsheng			A Role of Tomato UV-Damaged DNA Binding Protein 1 (DDB1) in Organ Size Control via an Epigenetic Manner	PLOS ONE			English	Article							HISTONE H4; SIGNAL-TRANSDUCTION; GENE; CELL; METHYLTRANSFERASE; METHYLATION; INTERACTS; WEE1; CUL4-DDB1; INTEGRITY	Epigenetic modification generally refers to phenotypic changes by a mechanism other than changes in DNA sequence and plays a significant role in developmental processes. In this study, we found that overexpression of one alternatively spliced tomato DDB1 transcript, DDB1 F that is prevalently present in all tested tissues, resulted in reduction of organ size. Transgenic plants constitutively expressing the DDB1 F from a strong cauliflower mosaic virus (CaMV) 35S promoter displayed moderately reduced size in vegetative organs (leaves and stems) and radically decreased size in reproductive organs (flowers, seeds and fruits), in which several genes encoding negative regulators for cell division were upregulated. Significantly, reduction of organ size conferred by overexpression of DDB1 F transgene appears not to segregate in the subsequent generations, suggesting the phenotypic alternations are manipulated in an epigenetic manner and can be transmitted over generations. This notion was further substantiated by analysis of DNA methylation level at the SlWEE1 gene (encoding a negative regulator of cell division), revealing a correlation between less methylation in the promoter region and elevated expression level of this gene. Thus, our results suggest DDB1 plays an important role in regulation of the epigenetic state of genes involved in organogenesis, despite the underlying mechanism remains to be elucidated.	[Liu, Jikai; Tang, Xiaofeng; Gao, Lanyang; Gao, Yongfeng; Li, Yuxiang; Huang, Shengxiong; Sun, Xiaochun; Miao, Min; Zeng, Hui; Tian, Xuefen; Liu, Yongsheng] Sichuan Univ, Minist Educ, State Key Lab Hydraul & Mt River Engn, Key Lab Bioresource & Ecoenvironm,Coll Life Sci, Chengdu 610064, Peoples R China; [Liu, Jikai; Tang, Xiaofeng; Niu, Xiangli; Zheng, Lei; Liu, Yongsheng] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Miao, Min; Xiao, Fangming] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA; [Giovannoni, Jim] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Giovannoni, Jim] Cornell Univ, USDA ARS, Robert Holly Ctr, Ithaca, NY 14853 USA	Sichuan University; Hefei University of Technology; Idaho; University of Idaho; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; United States Department of Agriculture (USDA)	Liu, JK (corresponding author), Sichuan Univ, Minist Educ, State Key Lab Hydraul & Mt River Engn, Key Lab Bioresource & Ecoenvironm,Coll Life Sci, Chengdu 610064, Peoples R China.	fxiao@uidaho.edu; liuyongsheng1122@yahoo.com.cn	Li, Yuxiang/GXH-5272-2022; huang, shengxiong/E-8111-2012; Zheng, Lei/AAF-6159-2019	Li, Yuxiang/0000-0002-7284-3985; Huang, Shengxiong/0000-0003-2268-3001	National Science Fund for Distinguished Young Scholars [30825030]; National Natural Science Foundation of China [31171179]; National Science and Technology Key Project of China [2009ZX08001-011B, 2009ZX08009-072B, 2011CB100401]; University of Idaho Startup Funding	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Key Project of China; University of Idaho Startup Funding	This work was supported by the National Science Fund for Distinguished Young Scholars (No. 30825030), the National Natural Science Foundation of China (No. 31171179), the National Science and Technology Key Project of China (Nos. 2009ZX08001-011B, 2009ZX08009-072B and 2011CB100401) to Y. Liu and the University of Idaho Startup Funding for F. Xiao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Azari R, 2010, J EXP BOT, V61, P3627, DOI 10.1093/jxb/erq176; Azari R, 2010, BIOTECHNOL ADV, V28, P108, DOI 10.1016/j.biotechadv.2009.10.003; Biedermann S, 2010, PLANT J, V62, P404, DOI 10.1111/j.1365-313X.2010.04157.x; Bino RJ, 2005, NEW PHYTOL, V166, P427, DOI 10.1111/j.1469-8137.2005.01362.x; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Caspi N, 2008, PLANT SIGNAL BEHAV, V3, P641, DOI 10.4161/psb.3.9.6413; Castells E, 2011, EMBO J, V30, P1162, DOI 10.1038/emboj.2011.20; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen HD, 2010, PLANT CELL, V22, P108, DOI 10.1105/tpc.109.065490; Cheniclet C, 2005, PLANT PHYSIOL, V139, P1984, DOI 10.1104/pp.105.068767; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Dumbliauskas E, 2011, EMBO J, V30, P731, DOI 10.1038/emboj.2010.359; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; FILLATTI JJ, 1987, BIO-TECHNOL, V5, P726, DOI 10.1038/nbt0787-726; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Gonzalez N, 2004, PLANT MOL BIOL, V56, P849, DOI 10.1007/s11103-004-5110-2; Gonzalez N, 2007, PLANT J, V51, P642, DOI 10.1111/j.1365-313X.2007.03167.x; Gu XF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002366; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Kolotilin I, 2007, PLANT PHYSIOL, V145, P389, DOI 10.1104/pp.107.102962; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Kotake Y, 2009, CANCER RES, V69, P1809, DOI 10.1158/0008-5472.CAN-08-2739; Lee JH, 2010, PLANT CELL, V22, P1716, DOI 10.1105/tpc.109.073783; Lewis ZA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001196; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; Lieberman M, 2004, THEOR APPL GENET, V108, P1574, DOI 10.1007/s00122-004-1584-1; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Liu JK, 2012, MOL PLANT PATHOL, V13, P123, DOI 10.1111/j.1364-3703.2011.00735.x; Liu YS, 2004, P NATL ACAD SCI USA, V101, P9897, DOI 10.1073/pnas.0400935101; Mathieu-Rivet E, 2010, PLANT J, V62, P727, DOI 10.1111/j.1365-313X.2010.04198.x; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Pazhouhandeh M, 2011, P NATL ACAD SCI USA, V108, P3430, DOI 10.1073/pnas.1018242108; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Sambrook J., 2001, MOL CLONING LAB MANU; Sun YJ, 1999, P NATL ACAD SCI USA, V96, P4180, DOI 10.1073/pnas.96.7.4180; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Vanstraelen M, 2009, P NATL ACAD SCI USA, V106, P11806, DOI 10.1073/pnas.0901193106; Wang SH, 2008, PLANT J, V55, P89, DOI 10.1111/j.1365-313X.2008.03489.x; Xu H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001132; Yen HC, 1997, THEOR APPL GENET, V95, P1069, DOI 10.1007/s001220050664; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710	52	13	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42621	10.1371/journal.pone.0042621	http://dx.doi.org/10.1371/journal.pone.0042621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927934	Green Submitted, gold, Green Published			2022-12-27	WOS:000307789700014
J	Seo, KW; Holt, R; Jung, YS; Rodriguez, CO; Chen, X; Rebhun, RB				Seo, Kyoung Won; Holt, Roseline; Jung, Yong-Sam; Rodriguez, Carlos O., Jr.; Chen, Xinbin; Rebhun, Robert B.			Fluoroquinolone-Mediated Inhibition of Cell Growth, S-G(2)/M Cell Cycle Arrest, and Apoptosis in Canine Osteosarcoma Cell Lines	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; IN-VITRO; METABOLITE CIPROFLOXACIN; CORTICAL ALLOGRAFT; OSTEOBLASTIC CELLS; TENDON CELLS; DOGS; PROLIFERATION; ENROFLOXACIN; DNA	Despite significant advancements in osteosarcoma research, the overall survival of canine and human osteosarcoma patients has remained essentially static over the past 2 decades. Post-operative limb-spare infection has been associated with improved survival in both species, yet a mechanism for improved survival has not been clearly established. Given that the majority of canine osteosarcoma patients experiencing post-operative infections were treated with fluoroquinolone antibiotics, we hypothesized that fluoroquinolone antibiotics might directly inhibit the survival and proliferation of canine osteosarcoma cells. Ciprofloxacin or enrofloxacin were found to inhibit p21(WAF1) expression resulting in decreased proliferation and increased S-G(2)/M accumulation. Furthermore, fluoroquinolone exposure induced apoptosis of canine osteosarcoma cells as demonstrated by cleavage of caspase-3 and PARP, and activation of caspase-3/7. These results support further studies examining the potential impact of quinolones on survival and proliferation of osteosarcoma.	[Seo, Kyoung Won] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Seo, Kyoung Won; Holt, Roseline; Jung, Yong-Sam; Rodriguez, Carlos O., Jr.; Chen, Xinbin; Rebhun, Robert B.] Chungnam Natl Univ, Coll Vet Med, Dept Internal Med, Taejon, South Korea	University of California System; University of California Davis; Chungnam National University	Seo, KW (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	rbrebhun@ucdavis.edu		Rebhun, Robert/0000-0002-8047-3494; Seo, Kyoung won/0000-0002-1561-3278; Rodriguez Jr, Carlos O/0000-0001-8865-2684	Anne Keleman Estate; Center for Companion Animal Health; UC Davis School of Veterinary Medicine; Bernice Barbour Foundation; NCRR [K01 RR031272]; Office of Research Infrastructure Programs [8K01OD011111-02]; NATIONAL CANCER INSTITUTE [R01CA081237, R01CA123227, P30CA093373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR031272] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD011111] Funding Source: NIH RePORTER	Anne Keleman Estate; Center for Companion Animal Health; UC Davis School of Veterinary Medicine; Bernice Barbour Foundation; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a gift from the Anne Keleman Estate, Center for Companion Animal Health, UC Davis School of Veterinary Medicine, the Bernice Barbour Foundation, and NCRR K01 RR031272 (currently supported by the Office of Research Infrastructure Programs 8K01OD011111-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranha O, 2000, CLIN CANCER RES, V6, P891; Aranha O, 2003, INT J ONCOL, V22, P787; Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; Bezwada P, 2008, CURR MED RES OPIN, V24, P419, DOI 10.1185/030079908X261005; Boothe D M, 2001, Vet Ther, V2, P120; Cole LK, 2009, VET DERMATOL, V20, P51, DOI 10.1111/j.1365-3164.2008.00730.x; Dalhoff A, 2003, LANCET INFECT DIS, V3, P359, DOI 10.1016/S1473-3099(03)00658-3; Donato NJ, 1998, J BIOL CHEM, V273, P5067, DOI 10.1074/jbc.273.9.5067; Dow S, 2005, HUM GENE THER, V16, P937, DOI 10.1089/hum.2005.16.937; Gartel AL, 2002, MOL CANCER THER, V1, P639; Herold C, 2002, BRIT J CANCER, V86, P443, DOI 10.1038/sj.bjc.6600079; Holtom PD, 2000, J ORTHOP RES, V18, P721, DOI 10.1002/jor.1100180507; Jackson JR, 2000, CANCER RES, V60, P566; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Jeys LM, 2007, ANN SURG ONCOL, V14, P2887, DOI 10.1245/s10434-007-9483-8; Jun YT, 2003, ANTIMICROB AGENTS CH, V47, P1161, DOI 10.1128/AAC.47.3.1161-1164.2003; Khanna C, 2003, CURR CANCER DRUG TAR, V3, P265, DOI 10.2174/1568009033481903; KUNG K, 1993, J VET PHARMACOL THER, V16, P462, DOI 10.1111/j.1365-2885.1993.tb00212.x; Kurzman ID, 1995, CLIN CANCER RES, V1, P1595; Lascelles BDX, 2005, ANN SURG ONCOL, V12, P1073, DOI 10.1245/ASO.2005.01.011; Lawrence JW, 1996, MOL PHARMACOL, V50, P1178; Legare ME, 2011, J CANCER, V2, P262, DOI 10.7150/jca.2.262; Lim S, 2008, VET RES COMMUN, V32, P243, DOI 10.1007/s11259-007-9024-8; Liptak JM, 2006, VET SURG, V35, P518, DOI 10.1111/j.1532-950X.2006.00185.x; Miclau T, 1998, J ORTHOPAED RES, V16, P509, DOI 10.1002/jor.1100160417; Multhaupt HAB, 2001, J BONE JOINT SURG AM, V83A, P56, DOI 10.2106/00004623-200100021-00012; Norris MD, 2001, MED PEDIATR ONCOL, V36, P177, DOI 10.1002/1096-911X(20010101)36:1<177::AID-MPO1042>3.0.CO;2-Q; OWEN LN, 1974, EUR J CANCER, V10, P775, DOI 10.1016/0014-2964(74)90133-9; Senderowicz AM, 2000, JNCI-J NATL CANCER I, V92, P376, DOI 10.1093/jnci/92.5.376; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Sottnik JL, 2010, CANCER IMMUNOL IMMUN, V59, P367, DOI 10.1007/s00262-009-0755-y; SPODNICK GJ, 1992, J AM VET MED ASSOC, V200, P995; THRALL DE, 1990, INT J RADIAT ONCOL, V18, P1351, DOI 10.1016/0360-3016(90)90308-7; Tsai WC, 2008, ARTHRITIS RHEUM-US, V58, P1657, DOI 10.1002/art.23518; WALKER RD, 1992, AM J VET RES, V53, P2315; Withrow S., 2007, WITHROW MACEWENS SMA; Zhang J, 2009, MOL CANCER RES, V7, P67, DOI 10.1158/1541-7786.MCR-08-0347	37	28	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42960	10.1371/journal.pone.0042960	http://dx.doi.org/10.1371/journal.pone.0042960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927942	Green Published, gold, Green Submitted			2022-12-27	WOS:000307789700017
J	Spanswick, SC; Dyck, RH				Spanswick, Simon C.; Dyck, Richard H.			Object/Context Specific Memory Deficits following Medial Frontal Cortex Damage in Mice	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; PREFRONTAL CORTEX; PERIRHINAL CORTEX; TEMPORAL-ORDER; HIPPOCAMPUS; RAT; LESIONS; PLACE; FEAR; PROJECTIONS	Recent evidence suggests that the medial prefrontal cortex (MFC) is important for processing contextual information. Here we evaluate the performance of mice with MFC damage in a discrimination task that requires an association between an object and the context in which it was experienced (the object/context mismatch task), as well as a version of the novel object preference task that does not require knowledge of contextual information to resolve. Adult C57/BL6 mice received aspiration lesions of the MFC or control surgery. Upon recovery, mice were tested in the object/context mismatch and novel object preference tasks. The object/context mismatch task involved exposing mice to two different contexts, each of which housed a unique pair of identical objects. After a brief delay, mice were re-exposed to one of the contexts, this time with one object that was congruent with that context and one that was not. Novel object preference was performed within a single context, housing an identical pair of objects. After the initial exposure and following a brief delay, mice were re-exposed to the context, this time housing a familiar and a novel object. Control mice were able to successfully resolve the object/context mismatch and novel object preference discriminations, investigating the incongruent/novel object within each task significantly greater than chance. Mice with MFC damage experienced deficits in the object/context mismatch task but not the novel object preference task. These findings add to a growing body of evidence that demonstrate a critical role for the MFC in contextual information processing.	[Spanswick, Simon C.; Dyck, Richard H.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Spanswick, Simon C.; Dyck, Richard H.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Spanswick, SC (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	scspansw@ucalgary.ca		Dyck, Richard/0000-0002-3254-8332	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research; Alberta Innovates; Hotchkiss Brain Institute Provincial Program on Perinatal Determinants of Brain and Mental Health	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates; Hotchkiss Brain Institute Provincial Program on Perinatal Determinants of Brain and Mental Health	The authors wish to acknowledge funding support from the Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes for Health Research and the CIHR Training Program in Genetics, Child Development and Health, as well as the Alberta Innovates and Hotchkiss Brain Institute Provincial Program on Perinatal Determinants of Brain and Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker GRI, 2011, EUR J NEUROSCI, V33, P705, DOI 10.1111/j.1460-9568.2010.07555.x; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Bossert JM, 2011, NAT NEUROSCI, V14, P420, DOI 10.1038/nn.2758; Browning PGF, 2005, EUR J NEUROSCI, V22, P3281, DOI 10.1111/j.1460-9568.2005.04477.x; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Coutellier L, 2009, BEHAV BRAIN RES, V203, P312, DOI 10.1016/j.bbr.2009.05.001; Devito LM, 2010, BEHAV BRAIN RES, V20, P108; DeVito LM, 2011, J NEUROSCI, V31, P3169, DOI 10.1523/JNEUROSCI.4202-10.2011; DeVito LM, 2010, BEHAV BRAIN RES, V215, P318, DOI 10.1016/j.bbr.2009.09.014; DeVito LM, 2010, LEARN MEMORY, V17, P161, DOI 10.1101/lm.1685710; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Ennaceur A, 1997, BEHAV BRAIN RES, V88, P181, DOI 10.1016/S0166-4328(97)02297-3; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hannesson DK, 2004, BEHAV BRAIN RES, V153, P273, DOI 10.1016/j.bbr.2003.12.004; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Judo C, 2010, NEUROSCIENCE, V169, P1705, DOI 10.1016/j.neuroscience.2010.06.035; Kesner RP, 2003, BEHAV BRAIN RES, V146, P159, DOI 10.1016/j.bbr.2003.09.024; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Li JS, 2011, BEHAV BRAIN RES, V218, P94, DOI 10.1016/j.bbr.2010.11.044; Mitchell JB, 1998, BEHAV BRAIN RES, V97, P107, DOI 10.1016/S0166-4328(98)00032-1; Mouton P.R., 2001, PRINCIPLES PRACTICES; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; O'Brien N, 2006, BEHAV BRAIN RES, V170, P156, DOI 10.1016/j.bbr.2006.02.008; Piterkin P, 2008, LEARN MEMORY, V15, P785, DOI 10.1101/lm.1035508; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Sannino S, 2012, LEARN MEMORY, V19, P211, DOI 10.1101/lm.025213.111; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Stanahan AM, 2011, BEHAV NEUROSCI, V125, P791; Sutherland RJ, 2010, NEUROPSYCHOLOGIA, V48, P2357, DOI 10.1016/j.neuropsychologia.2010.04.015; Van De Werd HJJM, 2010, BRAIN STRUCT FUNCT, V214, P339, DOI 10.1007/s00429-010-0247-z; Van der Jeugd A, 2009, BEHAV NEUROSCI, V123, P109, DOI 10.1037/a0013990; Verwer RWH, 1997, HIPPOCAMPUS, V7, P397, DOI 10.1002/(SICI)1098-1063(1997)7:4<397::AID-HIPO5>3.0.CO;2-G; Wan HM, 1999, J NEUROSCI, V19, P1142	35	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43698	10.1371/journal.pone.0043698	http://dx.doi.org/10.1371/journal.pone.0043698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928019	gold, Green Published, Green Submitted			2022-12-27	WOS:000307789700047
J	Zhou, P; Ye, HF; Jiang, YX; Yang, J; Zhu, XJ; Sun, XH; Luo, Y; Dou, GR; Wang, YS; Lu, Y				Zhou, Peng; Ye, Hong-Fei; Jiang, Yong-Xiang; Yang, Jin; Zhu, Xiang-Jia; Sun, Xing-Huai; Luo, Yi; Dou, Guo-Rui; Wang, Yu-Sheng; Lu, Yi			alpha A Crystallin May Protect against Geographic Atrophy-Meta-Analysis of Cataract vs. Cataract Surgery for Geographic Atrophy and Experimental Studies	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; RETINAL-PIGMENT EPITHELIUM; TOLL-LIKE RECEPTOR-3; HEAT-SHOCK-PROTEIN; MACULAR DEGENERATION; EYE DISEASE; LENS; RISK; PROGRESSION; ZEBULARINE	Background: Cataract and geographic atrophy (GA, also called advanced "dry" age-related macular degeneration) are the two major causes of visual impairment in the developed world. The association between cataract surgery and the development of GA was controversial in previous studies. Methods/Principal Findings: We performed a meta-analysis by pooling the current evidence in literature and found that cataract is associated with an increased risk of geographic atrophy with a summary odds ratio (OR) of 3.75 (95% CI: 95% CI: 1.84-7.62). However, cataract surgery is not associated with the risk of geographic atrophy (polled OR = 3.23, 95% CI: 0.63-16.47). Further experiments were performed to analyze how the alpha A-crystallin, the major component of the lens, influences the development of GA in a mouse model. We found that the alpha A-crystallin mRNA and protein expression increased after oxidative stress induced by NaIO3 in immunohistochemistry of retinal section and western blot of posterior eyecups. Both functional and histopathological evidence confirmed that GA is more severe in alpha A-crystallin knockout mice compared to wild-type mice. Conclusions: Therefore, alpha A-crystallin may protect against geographic atrophy. This study provides a better understanding of the relationship between cataract, cataract surgery, and GA.	[Zhou, Peng; Ye, Hong-Fei; Jiang, Yong-Xiang; Yang, Jin; Zhu, Xiang-Jia; Sun, Xing-Huai; Luo, Yi; Lu, Yi] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Dou, Guo-Rui; Wang, Yu-Sheng] Fourth Mil Med Univ, Dept Ophthalmol, Xijing Hosp, Xian 710032, Peoples R China	Fudan University; Air Force Military Medical University	Zhou, P (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China.	luyi0705@yahoo.com.cn	Zhou, Peng/C-6054-2008	Zhou, Peng/0000-0002-1744-5167; Ye, Hongfei/0000-0001-6129-8507	National Basic Research Program of China (973 Program) [2011CB510200]; National Natural Science Foundation of China (NSFC) [81070740, 81070717]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by grant from the National Basic Research Program of China (973 Program) No. 2011CB510200, National Natural Science Foundation of China (NSFC) No. 81070740 and No. 81070717. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; Andley UP, 2009, CURR MOL MED, V9, P887, DOI 10.2174/156652409789105598; Bockelbrink A, 2008, SURV OPHTHALMOL, V53, P359, DOI 10.1016/j.survophthal.2008.04.001; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Cai X, 2012, FRONT BIOSCI-LANDMRK, V17, P1976, DOI 10.2741/4033; Chang JR, 2011, OPHTHALMOLOGY, V118, P2113, DOI 10.1016/j.ophtha.2011.03.032; Chew EY, 2009, OPHTHALMOLOGY, V116, P297, DOI 10.1016/j.ophtha.2008.09.019; Cugati S, 2006, OPHTHALMOLOGY, V113, P2020, DOI 10.1016/j.ophtha.2006.05.047; Derham BK, 1999, PROG RETIN EYE RES, V18, P463, DOI 10.1016/S1350-9462(98)00030-5; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Franco LM, 2009, INVEST OPHTH VIS SCI, V50, P4004, DOI 10.1167/iovs.08-2898; Fraser-Bell S, 2010, AM J OPHTHALMOL, V149, P735, DOI 10.1016/j.ajo.2009.11.013; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Kase S, 2010, BLOOD, V115, P3398, DOI 10.1182/blood-2009-01-197095; Kiuchi K, 2002, CURR EYE RES, V25, P373, DOI 10.1076/ceyr.25.6.373.14227; Klein R, 2002, ARCH OPHTHALMOL-CHIC, V120, P1551, DOI 10.1001/archopht.120.11.1551; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Machalinska A, 2010, NEUROCHEM RES, V35, P1819, DOI 10.1007/s11064-010-0248-6; Maulucci G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018906; Meekins LC, 2011, CURR OPIN OPHTHALMOL; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Neal RE, 2005, EXP EYE RES, V80, P337, DOI 10.1016/j.exer.2004.09.015; Nolan JM, 2009, INVEST OPHTH VIS SCI, V50, P4777, DOI 10.1167/iovs.08-3277; Patel JI, 2007, CURR OPIN OPHTHALMOL, V18, P9, DOI 10.1097/ICU.0b013e3280112a0f; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; Rao NA, 2008, INVEST OPHTH VIS SCI, V49, P1161, DOI 10.1167/iovs.07-1259; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yaung J, 2008, EXP EYE RES, V86, P355, DOI 10.1016/j.exer.2007.11.007; Yaung J, 2007, MOL VIS, V13, P566; Zhou P, 2007, CURR EYE RES, V32, P973, DOI 10.1080/02713680701658323; Zhou P, 2012, MOL VIS, V18, P22; Zhou P, 2011, MOL VIS, V17, P2717; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258	34	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43173	10.1371/journal.pone.0043173	http://dx.doi.org/10.1371/journal.pone.0043173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916220	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800050
J	Boerner, S; McGinnis, KM				Boerner, Susan; McGinnis, Karen M.			Computational Identification and Functional Predictions of Long Noncoding RNA in Zea mays	PLOS ONE			English	Article							MESSENGER-RNA; REGULATORY ROLES; DNA METHYLATION; GENE-EXPRESSION; POLYMERASE-IV; GENOME-WIDE; TRANSCRIPTION; MAIZE; PROTEIN; PARAMUTATION	Background: Computational analysis of cDNA sequences from multiple organisms suggests that a large portion of transcribed DNA does not code for a functional protein. In mammals, noncoding transcription is abundant, and often results in functional RNA molecules that do not appear to encode proteins. Many long noncoding RNAs (IncRNAs) appear to have epigenetic regulatory function in humans, including HOTAIR and XIST. While epigenetic gene regulation is clearly an essential mechanism in plants, relatively little is known about the presence or function of IncRNAs in plants. Methodology/Principal Findings: To explore the connection between IncRNA and epigenetic regulation of gene expression in plants, a computational pipeline using the programming language Python has been developed and applied to maize full length cDNA sequences to identify, classify, and localize potential IncRNAs. The pipeline was used in parallel with an SVM tool for identifying ncRNAs to identify the maximal number of ncRNAs in the dataset. Although the available library of sequences was small and potentially biased toward protein coding transcripts, 15% of the sequences were predicted to be noncoding. Approximately 60% of these sequences appear to act as precursors for small RNA molecules and may function to regulate gene expression via a small RNA dependent mechanism. ncRNAs were predicted to originate from both genic and intergenic loci. Of the IncRNAs that originated from genic loci, similar to 20% were antisense to the host gene loci. Conclusions/Significance: Consistent with similar studies in other organisms, noncoding transcription appears to be widespread in the maize genome. Computational predictions indicate that maize IncRNAs may function to regulate expression of other genes through multiple RNA mediated mechanisms.	[Boerner, Susan; McGinnis, Karen M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Boerner, S (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	mcginnis@bio.fsu.edu			National Science Foundation and Genome Systems [MCB-027129]	National Science Foundation and Genome Systems	This work was funded by the National Science Foundation and Genome Systems grant through award number MCB-027129 to KMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bardou F, 2011, BIOCHIMIE, V93, P1950, DOI 10.1016/j.biochi.2011.07.028; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Castrignano T, 2004, NUCLEIC ACIDS RES, V32, pW624, DOI 10.1093/nar/gkh486; Chen DJ, 2011, RNA, V17, P1012, DOI 10.1261/rna.2589011; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Haun WJ, 2007, PLANT J, V49, P325, DOI 10.1111/j.1365-313X.2006.02965.x; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Hennig L, 2009, TRENDS GENET, V25, P414, DOI 10.1016/j.tig.2009.07.002; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Jia Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000737; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kloc M, 2005, DEVELOPMENT, V132, P3445, DOI 10.1242/dev.01919; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Liang CZ, 2009, GENOME RES, V19, P1912, DOI 10.1101/gr.088997.108; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; McGinnis KM, 2006, GENETICS, V173, P1637, DOI 10.1534/genetics.106.058669; Meng YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031163; Mercer TR, 2010, GENOME RES, V20, P1639, DOI 10.1101/gr.112128.110; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nobuta K, 2008, P NATL ACAD SCI USA, V105, P14958, DOI 10.1073/pnas.0808066105; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Voss B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-123; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wen Jiayu, 2007, In Silico Biology, V7, P485; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	78	132	144	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43047	10.1371/journal.pone.0043047	http://dx.doi.org/10.1371/journal.pone.0043047			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916204	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300026
J	McLain, AT; Meyer, TJ; Faulk, C; Herke, SW; Oldenburg, JM; Bourgeois, MG; Abshire, CF; Roos, C; Batzer, MA				McLain, Adam T.; Meyer, Thomas J.; Faulk, Christopher; Herke, Scott W.; Oldenburg, J. Michael; Bourgeois, Matthew G.; Abshire, Camille F.; Roos, Christian; Batzer, Mark A.			An Alu-Based Phylogeny of Lemurs (Infraorder: Lemuriformes)	PLOS ONE			English	Article							PRIMED REVERSE TRANSCRIPTION; EVOLUTIONARY HISTORY; PRIMATE PHYLOGENY; MOLECULAR SYSTEMATICS; MALAGASY PRIMATES; MADAGASCAR LEMURS; SINE INSERTIONS; SINGLE ORIGIN; DNA; EULEMUR	Lemurs (infraorder: Lemuriformes) are a radiation of strepsirrhine primates endemic to the island of Madagascar. As of 2012, 101 lemur species, divided among five families, have been described. Genetic and morphological evidence indicates all species are descended from a common ancestor that arrived in Madagascar similar to 55-60 million years ago (mya). Phylogenetic relationships in this species-rich infraorder have been the subject of debate. Here we use Alu elements, a family of primate-specific Short INterspersed Elements (SINEs), to construct a phylogeny of infraorder Lemuriformes. Alu elements are particularly useful SINEs for the purpose of phylogeny reconstruction because they are identical by descent and confounding events between loci are easily resolved by sequencing. The genome of the grey mouse lemur (Microcebus murinus) was computationally assayed for synapomorphic Alu elements. Those that were identified as Lemuriformes-specific were analyzed against other available primate genomes for orthologous sequence in which to design primers for PCR (polymerase chain reaction) verification. A primate phylogenetic panel of 24 species, including 22 lemur species from all five families, was examined for the presence/absence of 138 Alu elements via PCR to establish relationships among species. Of these, 111 were phylogenetically informative. A phylogenetic tree was generated based on the results of this analysis. We demonstrate strong support for the monophyly of Lemuriformes to the exclusion of other primates, with Daubentoniidae, the aye-aye, as the basal lineage within the infraorder. Our results also suggest Lepilemuridae as a sister lineage to Cheirogaleidae, and Indriidae as sister to Lemuridae. Among the Cheirogaleidae, we show strong support for Microcebus and Mirza as sister genera, with Cheirogaleus the sister lineage to both. Our results also support the monophyly of the Lemuridae. Within Lemuridae we place Lemur and Hapalemur together to the exclusion of Eulemur and Varecia, with Varecia the sister lineage to the other three genera.	[McLain, Adam T.; Meyer, Thomas J.; Faulk, Christopher; Herke, Scott W.; Oldenburg, J. Michael; Bourgeois, Matthew G.; Abshire, Camille F.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Meyer, Thomas J.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Faulk, Christopher] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Abshire, Camille F.] Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA; [Roos, Christian] German Primate Ctr, Primates & Primate Genet Lab, Gene Bank, Gottingen, Germany	Louisiana State University System; Louisiana State University; Oregon Health & Science University; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Deutsches Primatenzentrum (DPZ)	McLain, AT (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu		Faulk, Christopher/0000-0002-9749-9658	National Institutes of Health [R01 GM59290]; National Science Foundation [CNS-1126739]; Louisiana Board of Regents Governor's Biotechnology Initiative [GBI 2002-005]; Louisiana Board of Regents; Louisiana Biomedical Research Network (LBRN); National Center for Research Resources [P20RR016456]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Louisiana Board of Regents Governor's Biotechnology Initiative; Louisiana Board of Regents; Louisiana Biomedical Research Network (LBRN); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health R01 GM59290 (M. A. B.), National Science Foundation CNS-1126739 (M. A. B.), and Louisiana Board of Regents Governor's Biotechnology Initiative GBI 2002-005 (M. A. B.). A. T. McLain was supported in part by the Louisiana Board of Regents Fellowship. C. F. Abshire was supported in part by the Louisiana Biomedical Research Network (LBRN) with funding from the National Center for Research Resources (Grant Number P20RR016456) and by the Louisiana Board of Regents Support Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; BATZER MA, 1991, GENOMICS, V9, P481, DOI 10.1016/0888-7543(91)90414-A; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; Bochkov AV, 2011, ZOOL J LINN SOC-LOND, V162, P1, DOI 10.1111/j.1096-3642.2010.00666.x; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Churakov G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-376; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Delpero M, 2001, ZOOL J LINN SOC-LOND, V133, P83, DOI 10.1111/j.1096-3642.2001.tb00624.x; Djlelati R, 1997, AM J PRIMATOL, V42, P235; EAGLEN RH, 1983, INT J PRIMATOL, V4, P249, DOI 10.1007/BF02735549; Eckhardt RB, 1970, AM J PHYS ANTHROPOL, V31, P85; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Groves C.P., 2001, PRIMATE TAXONOMY; GROVES CP, 1988, J HUM EVOL, V17, P513, DOI 10.1016/0047-2484(88)90040-1; Herke SW, 2007, GENE, V390, P39, DOI 10.1016/j.gene.2006.08.015; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; ISHAK B, 1988, AM J PRIMATOL, V15, P275, DOI 10.1002/ajp.1350150309; Karanth KP, 2005, P NATL ACAD SCI USA, V102, P5090, DOI 10.1073/pnas.0408354102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Konkel MK, 2010, EVOL ANTHROPOL, V19, P236, DOI 10.1002/evan.20283; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Lebrun R, 2010, J ANAT, V216, P368, DOI 10.1111/j.1469-7580.2009.01177.x; Li J, 2009, GENE, V448, P242, DOI 10.1016/j.gene.2009.05.013; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu GE, 2009, GENOME RES, V19, P876, DOI 10.1101/gr.083972.108; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; Maddison WP, 2011, MESQUITE MODULAR SYS; Masters JC, 2006, FOLIA PRIMATOL, V77, P399, DOI 10.1159/000095388; Meyer TJ, 2012, MOL BIOL EV IN PRESS; Mittermeier RA, 2010, CONSERVATION INT TRO; Mittermeier R, 2008, INT J PRIMATOL, V29, P1607, DOI 10.1007/s10764-008-9317-y; MURATA S, 1993, P NATL ACAD SCI USA, V90, P6995, DOI 10.1073/pnas.90.15.6995; Okada N, 2004, METH MOL B, V260, P189, DOI 10.1385/1-59259-755-6:189; Orlando L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-121; Osterholz M, 2009, MOL PHYLOGENET EVOL, V50, P507, DOI 10.1016/j.ympev.2008.12.014; Pastorini J, 2000, MOL PHYLOGENET EVOL, V16, P418, DOI 10.1006/mpev.2000.0796; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Poux C, 2004, AM J PHYS ANTHROPOL, V124, P1, DOI 10.1002/ajpa.10322; RABARIVOLA C, 1991, PRIMATES, V32, P269, DOI 10.1007/BF02381186; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; Ray DA, 2006, SYSTEMATIC BIOL, V55, P928, DOI 10.1080/10635150600865419; Ray DA, 2007, MOL ECOL, V16, P19, DOI 10.1111/j.1365-294X.2006.03104.x; Roos C, 2004, P NATL ACAD SCI USA, V101, P10650, DOI 10.1073/pnas.0403852101; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; RUMPLER Y, 1985, FOLIA PRIMATOL, V44, P108, DOI 10.1159/000156202; Rumpler Y, 2004, EVOL ANTHROPOL, V13, P67, DOI 10.1002/evan.20010; Salem AH, 2003, P NATL ACAD SCI USA, V100, P12787, DOI 10.1073/pnas.2133766100; Sanger F, 1992, Biotechnology, V24, P104; Schmitz J, 2005, CYTOGENET GENOME RES, V108, P26, DOI 10.1159/000080799; Schmitz J, 2001, GENETICS, V157, P777; Shapiro LJ, 2005, AM J PHYS ANTHROPOL, V128, P823, DOI 10.1002/ajpa.20122; Shedlock AM, 2000, BIOESSAYS, V22, P148, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;148::AID-BIES6&gt;3.0.CO;2-Z; Shedlock AM, 2004, TRENDS ECOL EVOL, V19, P545, DOI 10.1016/j.tree.2004.08.002; SIMONS EL, 1988, CR ACAD SCI III-VIE, V307, P547; Smit A, 1996, REPEATMASKER OPEN 30; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TATTERSALL I, 1991, ANTHROPOL PAP AM MUS, V69, P1; Tattersall I, 2007, LEMURS ECOLOGY ADAPT, P3; Tattersall I, 2007, EVOL ANTHROPOL, V16, P12, DOI 10.1002/evan.20126; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Waddell P J, 2001, Genome Inform, V12, P141; Wells N, 2003, NATURAL HIST MADAGAS, P16; Wyner Y, 2000, MOL PHYLOGENET EVOL, V15, P124, DOI 10.1006/mpev.1999.0723; Xing J, 2005, MOL PHYLOGENET EVOL, V37, P872, DOI 10.1016/j.ympev.2005.04.015; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Yoder AD, 1997, EVOL ANTHROPOL, V6, P11, DOI 10.1002/(SICI)1520-6505(1997)6:1<11::AID-EVAN6>3.0.CO;2-Z; YODER AD, 1994, AM J PHYS ANTHROPOL, V94, P25, DOI 10.1002/ajpa.1330940104; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoder Anne D., 1999, Lemur News, V4, P31	72	18	18	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44035	10.1371/journal.pone.0044035	http://dx.doi.org/10.1371/journal.pone.0044035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937148	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600071
J	De Pisapia, N; Sandrini, M; Braver, TS; Cattaneo, L				De Pisapia, Nicola; Sandrini, Marco; Braver, Todd S.; Cattaneo, Luigi			Integration in Working Memory: A Magnetic Stimulation Study on the Role of Left Anterior Prefrontal Cortex	PLOS ONE			English	Article							INVOLVEMENT; FACILITATION; INFORMATION; RETENTION; RETRIEVAL; LANGUAGE; ACCESS; MODEL; EYE	Integration is a fundamental working memory operation, requiring the insertion of information from one task into the execution of another concurrent task. Previous neuroimaging studies have suggested the involvement of left anterior prefrontal cortex (L-aPFC) in relation to working memory integration demands, increasing during presentation of information to be integrated (loading), throughout its maintenance during a secondary task, up to the integration step, and then decreasing afterward (unloading). Here we used short bursts of 5 Hz repetitive Transcranic Magnetic Stimulation (rTMS) to modulate L-aPFC activity and to assess its causal role in integration. During experimental blocks, rTMS was applied (N = 10) over L-aPFC or vertex (control site) at different time-points of a task involving integration of a preloaded digit into a sequence of arithmetical steps, and contrasted with a closely matched task without integration demand (segregation). When rTMS was applied during the loading phase, reaction times during secondary task were faster, without significant changes in error rates. RTMS instead worsened performance when applied during information unloading. In contrast, no effects were observed when rTMS was applied during the other phases of integration, or during the segregation condition. These results confirm the hypothesis that L-aPFC is causally and selectively involved in the integration of information in working memory. They additionally suggest that pre-integration loading and post-integration unloading of information involving this area may be active and resource-consuming processes.	[De Pisapia, Nicola; Sandrini, Marco; Cattaneo, Luigi] Univ Trento, CIMeC Ctr Mind Brain Sci, Rovereto, TN, Italy; [De Pisapia, Nicola] Univ Trento, DiSCoF Dept Cognit Sci & Educ, Rovereto, TN, Italy; [Sandrini, Marco] Uniformed Serv Univ Hlth Sci, Henry M Jackson Fdn, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Sandrini, Marco] NINDS, Human Cort Physiol & Stroke Neuro Rehabil Sect, NIH, Bethesda, MD USA; [Braver, Todd S.] Washington Univ, Dept Psychol, Cognit Control & Psychopathol CCP Lab, St Louis, MO 63130 USA	University of Trento; University of Trento; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Washington University (WUSTL)	De Pisapia, N (corresponding author), Univ Trento, CIMeC Ctr Mind Brain Sci, Rovereto, TN, Italy.	nicola.depisapia@unitn.it	De Pisapia, Nicola/AHE-1410-2022; Sandrini, Marco/J-2276-2014	Sandrini, Marco/0000-0002-1664-5722; Braver, Todd/0000-0002-2631-3393; Cattaneo, Luigi/0000-0001-8905-7529; De Pisapia, Nicola/0000-0002-1089-8841	Societa Scienze Mente Cervello (SMC)/Fondazione Cassa di Risparmio di Trento e Rovereto; Provincia Autonoma di Trento	Societa Scienze Mente Cervello (SMC)/Fondazione Cassa di Risparmio di Trento e Rovereto; Provincia Autonoma di Trento(Autonomous Province of Trento)	Study supported by the Societa Scienze Mente Cervello (SMC)/Fondazione Cassa di Risparmio di Trento e Rovereto and by the Provincia Autonoma di Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 1996, COGNITIVE PSYCHOL, V30, P221, DOI 10.1006/cogp.1996.0007; Aramideh M, 2002, MUSCLE NERVE, V26, P14, DOI 10.1002/mus.10120; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Bour LJ, 2000, J NEUROPHYSIOL, V83, P166, DOI 10.1152/jn.2000.83.1.166; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Cattaneo L, 2005, CLIN NEUROPHYSIOL, V116, P2348, DOI 10.1016/j.clinph.2005.06.018; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; De Pisapia N, 2008, NEUROREPORT, V19, P15, DOI 10.1097/WNR.0b013e3282f31530; De Pisapia N, 2007, CEREB CORTEX, V17, P993, DOI 10.1093/cercor/bhl010; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Fangmeier T, 2006, J COGNITIVE NEUROSCI, V18, P320, DOI 10.1162/jocn.2006.18.3.320; Fedorenko E, 2007, J MEM LANG, V56, P246, DOI 10.1016/j.jml.2006.06.007; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Luber B, 2007, BRAIN RES, V1128, P120, DOI 10.1016/j.brainres.2006.10.011; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Monti MM, 2009, P NATL ACAD SCI USA, V106, P12554, DOI 10.1073/pnas.0902422106; Mottaghy FM, 2006, NEUROSCIENCE, V139, P85, DOI 10.1016/j.neuroscience.2005.05.037; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Oberauer K, 2001, MEM COGNITION, V29, P18, DOI 10.3758/BF03195737; Oliveri M, 2001, CEREB CORTEX, V11, P606, DOI 10.1093/cercor/11.7.606; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Postle BR, 2006, J COGNITIVE NEUROSCI, V18, P1712, DOI 10.1162/jocn.2006.18.10.1712; Postle BR, 2010, CORTEX, V46, P121, DOI 10.1016/j.cortex.2008.12.008; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Reynolds JR, 2006, CEREB CORTEX, V16, P519, DOI 10.1093/cercor/bhi131; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Topper R, 1998, EXP BRAIN RES, V121, P371, DOI 10.1007/s002210050471; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125	43	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43731	10.1371/journal.pone.0043731	http://dx.doi.org/10.1371/journal.pone.0043731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937085	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500087
J	Gupta, S; Saxena, M; Saini, N; Mahmooduzzafar; Kumar, R; Kumar, A				Gupta, Saurabh; Saxena, Mritunjay; Saini, Neeru; Mahmooduzzafar; Kumar, Rita; Kumar, Anil			An Effective Strategy for a Whole-Cell Biosensor Based on Putative Effector Interaction Site of the Regulatory DmpR Protein	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; PHENOLS; BINDING; BIODEGRADATION; TYROSINASE; STRAIN; MODEL	Introduction and Rationale: The detection of bioavailable phenol is a very important issue in environmental and human hazard assessment. Despite modest developments recently, there is a stern need for development of novel biosensors with high sensitivity for priority phenol pollutants. DmpR (Dimethyl phenol regulatory protein), an NtrC-like regulatory protein for the phenol degradation of Pseudomonas sp. strain CF600, represents an attractive biosensor regimen. Thus, we sought to design a novel biosensor by modifying the phenol detection capacity of DmpR by using mutagenic PCR. Methods: Binding sites of 'A' domain of DmpR were predicted by LIGSITE, and molecular docking was performed by using GOLD to identify the regions where phenol may interact with DmpR. Total five point mutations, one single at position 42 (Phe-to-Leu), two double at 140 (Asp-to-Glu) and 143 (Gln-to-Leu), and two double at L113M (Leu-to-Met) and D116A (Asp-to- Ala) were created in DmpR by site-directed mutagenesis to construct the reporter plasmids pRLuc42R, pRLuc140p143R, and pRLuc113p116R, respectively. Luciferase assays were performed to measure the activity of luc gene in the presence of phenol and its derivatives, while RT-PCR was used to check the expression of luc gene in the presence of phenol. Results: Only pRLuc42R and pRLuc113p116R showed positive responses to phenolic effectors. The lowest detectable concentration of phenol was 0.5 mu M (0.047 mg/L), 0.1 mu M for 2, 4-dimethylphenol and 2-nitrophenol, 10 mu M for 2, 4, 6-trichlorophenol and 2-chlorophenol, 100 mu M for 2, 4-dichlorophenol, 0.01 mu M for 4-nitrophenol, and 1 mu M for o-cresol. These concentrations were measured by modified luciferase assay within 3 hrs compared to 6-7 hrs in previous studies. Importantly, increased expression of luciferase gene of pRLuc42R was observed by RT-PCR. Conclusions: The present study offers an effective strategy to design a quick and sensitive biosensor for phenol by constructing recombinant bacteria having DmpR gene.	[Gupta, Saurabh; Saxena, Mritunjay; Saini, Neeru; Kumar, Rita] Inst Genom & Integrat Biol, Delhi, India; [Kumar, Anil] Natl Inst Immunol, New Delhi 110067, India; [Gupta, Saurabh; Mahmooduzzafar] Jamia Hamdard, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jamia Hamdard University	Gupta, S (corresponding author), Inst Genom & Integrat Biol, Mall Rd, Delhi, India.	rita@igib.res.in; anilk@nii.ac.in	Kumar, Anil/L-3294-2016; Kumar, Anil/AAT-4547-2020	Kumar, Anil/0000-0002-8785-6033; Kumar, Anil/0000-0002-8785-6033	Council for Scientific and Industrial Research (CSIR), India	Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	We would like to thank the Council for Scientific and Industrial Research (CSIR), India for providing necessary facilities and funding to accomplish this work.	Abdullah J, 2006, TALANTA, V70, P527, DOI 10.1016/j.talanta.2005.12.061; Altschmied J, 1997, BIOTECHNIQUES, V23, P436, DOI 10.2144/97233bm19; Association AWW, 1998, STAND METH EST WAT W; Cabrera C, J STRUCTURAL BIOL, P371; Ceto X, 2012, ANALYST, V137, P349, DOI 10.1039/c1an15456g; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devos D, 2002, ENVIRON MICROBIOL, V4, P29, DOI 10.1046/j.1462-2920.2002.00265.x; Escher BI, 1997, ENVIRON TOXICOL CHEM, V16, P405, DOI 10.1002/etc.5620160303; Escher BI, 1996, ENVIRON SCI TECHNOL, V30, P3071, DOI 10.1021/es960153f; Hakkila K, 2002, ANAL BIOCHEM, V301, P235, DOI 10.1006/abio.2001.5517; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Herchi W, 2011, FOOD CHEM, V129, P437, DOI 10.1016/j.foodchem.2011.04.096; Jiang HL, 2002, LETT APPL MICROBIOL, V35, P439, DOI 10.1046/j.1472-765X.2002.01217.x; Johansson LUM, 2008, MOL MICROBIOL, V70, P709, DOI 10.1111/j.1365-2958.2008.06440.x; Kelsey JW, 1997, ENVIRON SCI TECHNOL, V31, P214, DOI 10.1021/es960354j; Kohler S, 2000, FRESEN J ANAL CHEM, V366, P769, DOI 10.1007/s002160051571; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Leedjarv A, 2006, CHEMOSPHERE, V64, P1910, DOI 10.1016/j.chemosphere.2006.01.026; Lei Y, 2006, ANAL CHIM ACTA, V568, P200, DOI 10.1016/j.aca.2005.11.065; Liu C, 2011, TALANTA, V84, P766, DOI 10.1016/j.talanta.2011.02.006; Liu XM, 2010, SENSORS-BASEL, V10, P1377, DOI 10.3390/s100201377; Michalowicz J, 2007, POL J ENVIRON STUD, V16, P347; Mulchandani B, 1998, ENZYME MICROBIAL BIO; O'Neill E, 1998, MOL MICROBIOL, V28, P131, DOI 10.1046/j.1365-2958.1998.00780.x; Park SM, 2003, J BIOTECHNOL, V103, P227, DOI 10.1016/S0168-1656(03)00122-6; Peng ZX, 2010, BIOTECHNOL LETT, V32, P1265, DOI 10.1007/s10529-010-0317-6; Sambrook J., 2001, MOL CLONING LAB MANU; Sarand I, 2001, APPL ENVIRON MICROB, V67, P162, DOI 10.1128/AEM.67.1.162-171.2001; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SHINGLER V, 1989, J GEN MICROBIOL, V135, P1083; SHINGLER V, 1994, J BACTERIOL, V176, P1555, DOI 10.1128/jb.176.6.1555-1560.1994; SHINGLER V, 1993, J BACTERIOL, V175, P1596, DOI 10.1128/JB.175.6.1596-1604.1993; SHINGLER V, 1995, MOL MICROBIOL, V17, P505, DOI 10.1111/j.1365-2958.1995.mmi_17030505.x; Silva LMC, 2011, ENVIRON TECHNOL, V32, P493, DOI 10.1080/09593330.2010.504234; Suresh Panneer Selvam, 2010, In Silico Biology, V10, P223, DOI 10.3233/ISB-2010-0434; Vogne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016539; Willardson BM, 1998, APPL ENVIRON MICROB, V64, P1006; Wise AA, 2000, APPL ENVIRON MICROB, V66, P163, DOI 10.1128/AEM.66.1.163-169.2000; Wise AA, 2007, USA Patent, Patent No. [7,303,894, 7303894]; Yagi K, 2007, APPL MICROBIOL BIOT, V73, P1251, DOI 10.1007/s00253-006-0718-6; Yildiz HB, 2007, MICROCHIM ACTA, V159, P27, DOI 10.1007/s00604-007-0768-1	43	25	25	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43527	10.1371/journal.pone.0043527	http://dx.doi.org/10.1371/journal.pone.0043527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937060	Green Submitted, gold, Green Published			2022-12-27	WOS:000308225500061
J	Huang, KP; Liu, WH; Lan, T; Xie, X; Peng, J; Huang, J; Wang, SG; Shen, XY; Liu, PQ; Huang, HQ				Huang, Kaipeng; Liu, Weihua; Lan, Tian; Xie, Xi; Peng, Jing; Huang, Juan; Wang, Shaogui; Shen, Xiaoyan; Liu, Peiqing; Huang, Heqing			Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor Pathway in Experimental Diabetic Nephropathy Models	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; MESANGIAL CELLS; SPHINGOSINE 1-PHOSPHATE; PATHOGENETIC MECHANISMS; MATRIX ACCUMULATION; KINASE; SPHINGOSINE-1-PHOSPHATE; MICE; SPHINGOLIPIDS; SURVIVAL	The accumulation of glomerular extracellular matrix (ECM) is one of the critical pathological characteristics of diabetic renal fibrosis. Fibronectin (FN) is an important constituent of ECM. Our previous studies indicate that the activation of the sphingosine kinase 1 (SphK1)-sphingosine 1- phosphate (S1P) signaling pathway plays a key regulatory role in FN production in glomerular mesangial cells (GMCs) under diabetic condition. Among the five S1P receptors, the activation of S1P2 receptor is the most abundant. Berberine (BBR) treatment also effectively inhibits SphK1 activity and S1P production in the kidneys of diabetic models, thus improving renal injury. Based on these data, we further explored whether BBR could prevent FN production in GMCs under diabetic condition via the S1P2 receptor. Here, we showed that BBR significantly down-regulated the expression of S1P2 receptor in diabetic rat kidneys and GMCs exposed to high glucose (HG) and simultaneously inhibited S1P2 receptor-mediated FN overproduction. Further, BBR also obviously suppressed the activation of NF-kappa B induced by HG, which was accompanied by reduced S1P2 receptor and FN expression. Taken together, our findings suggest that BBR reduces FN expression by acting on the S1P2 receptor in the mesangium under diabetic condition. The role of BBR in S1P2 receptor expression regulation could closely associate with its inhibitory effect on NF-kappa B activation.	[Huang, Kaipeng; Xie, Xi; Peng, Jing; Huang, Juan; Wang, Shaogui; Shen, Xiaoyan; Liu, Peiqing; Huang, Heqing] Sun Yat Sen Univ, Lab Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Weihua] GuangZhou Med Univ, Guangzhou Inst Cardiovasc Dis, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Lan, Tian] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Guangdong Pharmaceutical University	Huang, KP (corresponding author), Sun Yat Sen Univ, Lab Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	huangheq@mail.sysu.edu.cn			National Natural Science Foundation of China [81170676]; critical Project of Guangdong Science and Technology, People's Republic of China [2011A080502004]; Guangzhou Science and Technology Project [10A32060084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); critical Project of Guangdong Science and Technology, People's Republic of China; Guangzhou Science and Technology Project	This work was supported by research grants from the National Natural Science Foundation of China (No. 81170676), the critical Project of Guangdong Science and Technology, People's Republic of China (No. 2011A080502004) and Guangzhou Science and Technology Project (No. 10A32060084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarthi JJ, 2011, J DENT RES, V90, P841, DOI 10.1177/0022034510389178; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; English D, 2001, CARDIOVASC RES, V49, P588, DOI 10.1016/S0008-6363(00)00230-3; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Giunti S, 2006, Minerva Med, V97, P241; Hanafusa N, 2002, NEPHROL DIAL TRANSPL, V17, P580, DOI 10.1093/ndt/17.4.580; Imasawa T, 2010, EXP TOXICOL PATHOL, V62, P53, DOI 10.1016/j.etp.2009.02.068; Jia HJ, 2009, REGUL PEPTIDES, V154, P69, DOI 10.1016/j.regpep.2008.12.004; Jiang Q, 2011, MOL CELL ENDOCRINOL, V331, P34, DOI 10.1016/j.mce.2010.07.023; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Katsuma S, 2005, FEBS LETT, V579, P2576, DOI 10.1016/j.febslet.2005.03.073; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lan T, 2011, MOL ENDOCRINOL, V25, P2094, DOI 10.1210/me.2011-0095; Lan TA, 2010, ARCH BIOCHEM BIOPHYS, V502, P112, DOI 10.1016/j.abb.2010.07.012; Liu WH, 2008, ARCH BIOCHEM BIOPHYS, V475, P128, DOI 10.1016/j.abb.2008.04.022; Liu WH, 2012, EXP CELL RES, V318, P936, DOI 10.1016/j.yexcr.2012.02.020; Liu WH, 2010, EUR J PHARMACOL, V638, P150, DOI 10.1016/j.ejphar.2010.04.033; Liu WH, 2009, MOL CELL BIOCHEM, V325, P99, DOI 10.1007/s11010-008-0024-y; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; Randriamboavonjy V, 2009, BASIC RES CARDIOL, V104, P333, DOI 10.1007/s00395-008-0769-1; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Wahab N, 2007, BIOCHEM J, V406, P131, DOI 10.1042/BJ20061817; Wang F, 2010, J CLIN INVEST, V120, P3979, DOI 10.1172/JCI42315; Whetzel AM, 2006, CIRC RES, V99, P731, DOI 10.1161/01.RES.0000244088.33375.52; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404	31	49	54	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43874	10.1371/journal.pone.0043874	http://dx.doi.org/10.1371/journal.pone.0043874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937115	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500117
J	Le, TMV; Ngo, NQM; Thuong, TC; Khuong, HD; Tran, VTN; Thompson, C; Campbell, JI; de Jong, M; Farrar, JJ; Schultsz, C; van Doorn, HR; Baker, S				Le Thi Minh Vien; Ngo Ngoc Quang Minh; Tang Chi Thuong; Huynh Duy Khuong; Tran Vu Thieu Nga; Thompson, Corinne; Campbell, James I.; de Jong, Menno; Farrar, Jeremy J.; Schultsz, Constance; van Doorn, H. Rogier; Baker, Stephen			The Co-Selection of Fluoroquinolone Resistance Genes in the Gut Flora of Vietnamese Children	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; COMPLETE NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; BETA-LACTAMASE; STREPTOCOCCUS-PNEUMONIAE; KLEBSIELLA-PNEUMONIAE; DETERMINANTS QNR; RAPID DETECTION; HIGH PREVALENCE; ANTIBIOTIC USE	Antimicrobial consumption is one of the major contributing factors facilitating the development and maintenance of bacteria exhibiting antimicrobial resistance. Plasmid-mediated quinolone resistance (PMQR) genes, such as the qnr family, can be horizontally transferred and contribute to reduced susceptibility to fluoroquinolones. We performed an observational study, investigating the copy number of PMQR after antimicrobial therapy. We enrolled 300 children resident in Ho Chi Minh City receiving antimicrobial therapy for acute respiratory tract infections (ARIs). Rectal swabs were taken on enrollment and seven days subsequently, counts for Enterobacteriaceae were performed and qnrA, qnrB and qnrS were quantified by using real-time PCR on metagenomic stool DNA. On enrollment, we found no association between age, gender or location of the participants and the prevalence of qnrA, qnrB or qnrS. Yet, all three loci demonstrated a proportional increase in the number of samples testing positive between day 0 and day 7. Furthermore, qnrB demonstrated ;a significant increase in copy number between paired samples (p<0.001; Wilcoxon rank-sum), associated with non-fluoroquinolone combination antimicrobial therapy. To our knowledge, this is the first study describing an association between the use of non-fluoroquinolone antimicrobials and the increasing relative prevalence and quantity of qnr genes. Our work outlines a potential mechanism for the selection and maintenance of PMQR genes and predicts a strong effect of co-selection of these resistance determinants through the use of unrelated and potentially unnecessary antimicrobial regimes.	[Le Thi Minh Vien; Ngo Ngoc Quang Minh; Huynh Duy Khuong; Tran Vu Thieu Nga; Thompson, Corinne; Campbell, James I.; de Jong, Menno; Farrar, Jeremy J.; Schultsz, Constance; van Doorn, H. Rogier; Baker, Stephen] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Farrar, Jeremy J.; van Doorn, H. Rogier; Baker, Stephen] Univ Oxford, Ctr Trop Dis, Oxford, England; [Ngo Ngoc Quang Minh; Tang Chi Thuong] Childrens Hosp, Ho Chi Minh City, Vietnam; [de Jong, Menno; Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands	University of Oxford; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Le, TMV (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.	sbaker@oucru.org	van Doorn, H. Rogier/H-3080-2019; Farrar, Jeremy J./HGA-7610-2022	van Doorn, H. Rogier/0000-0002-9807-1821; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust of Great Britain; OAK Foundation through Oxford University, United Kingdom	Wellcome Trust of Great Britain(Wellcome Trust); OAK Foundation through Oxford University, United Kingdom	This work was supported by The Wellcome Trust of Great Britain. Stephen Baker is funded by an OAK Foundation through Oxford University, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alali WQ, 2009, FOODBORNE PATHOG DIS, V6, P917, DOI 10.1089/fpd.2009.0271; Bailey JK, 2010, J MED MICROBIOL, V59, P1331, DOI 10.1099/jmm.0.022475-0; Bell JM, 2010, ANTIMICROB AGENTS CH, V54, P1378, DOI 10.1128/AAC.01476-09; Bergman M, 2009, ANTIMICROB AGENTS CH, V53, P912, DOI 10.1128/AAC.00856-08; BLOOD RM, 1995, INT J FOOD MICROBIOL, V26, P93, DOI 10.1016/0168-1605(94)00040-D; Brink AJ, 2004, SAMJ S AFR MED J, V94, P475; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V59, P751, DOI 10.1093/jac/dkl547; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chmelnitsky I, 2008, ANTIMICROB AGENTS CH, V52, P2962, DOI 10.1128/AAC.01341-07; CLARKE JS, 1974, WESTERN J MED, V121, P390; Garcia-Fulgueiras V, 2011, J ANTIMICROB CHEMOTH, V66, P1725, DOI 10.1093/jac/dkr222; Garnier F, 2006, ANTIMICROB AGENTS CH, V50, P3200, DOI 10.1128/AAC.00293-06; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Guillard T, 2011, DIAGN MICR INFEC DIS, V70, P253, DOI 10.1016/j.diagmicrobio.2011.01.004; Guillard T, 2010, J CLIN MICROBIOL, V48, P286, DOI 10.1128/JCM.01498-09; Hidalgo-Grass C, 2010, ANTIMICROB AGENTS CH, V54, P3509, DOI 10.1128/AAC.00485-10; Hu FP, 2008, ACTA PHARMACOL SIN, V29, P320, DOI 10.1111/j.1745-7254.2008.00757.x; Huang SY, 2009, FOODBORNE PATHOG DIS, V6, P1203, DOI 10.1089/fpd.2009.0348; Jacoby G, 2008, ANTIMICROB AGENTS CH, V52, P2297, DOI 10.1128/AAC.00147-08; Jiang Y, 2008, J ANTIMICROB CHEMOTH, V61, P1003, DOI 10.1093/jac/dkn063; Kehrenberg C, 2007, J ANTIMICROB CHEMOTH, V60, P903, DOI 10.1093/jac/dkm283; Kirjavainen PV, 1999, ANN MED, V31, P288, DOI 10.3109/07853899908995892; Lautenbach E, 2005, CLIN INFECT DIS, V41, P923, DOI 10.1086/432940; Le TMV, 2011, ANTIMICROB AGENTS CH, V55, P1798, DOI 10.1128/AAC.01200-10; Le TMV, 2009, J MED MICROBIOL, V58, P1585, DOI 10.1099/jmm.0.010033-0; Levy J, 2000, AM J GASTROENTEROL, V95, pS8, DOI 10.1016/S0002-9270(99)00808-4; Luo YP, 2011, INT J ANTIMICROB AG, V37, P352, DOI 10.1016/j.ijantimicag.2010.12.018; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; Madigan M.T., 2006, BROCK BIOL MICROORGA; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Nguyen TKN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000702; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P1021, DOI 10.1111/j.1469-0691.2006.01531.x; Poirel L, 2007, ANTIMICROB AGENTS CH, V51, P631, DOI 10.1128/AAC.01082-06; Pomba C, 2009, ANTIMICROB AGENTS CH, V53, P327, DOI 10.1128/AAC.00896-08; Quagliarello AB, 2003, J HEALTH POPUL NUTR, V21, P316; Rasmussen R, 2000, RAPID CYCLE REAL TIM; Robicsek A, 2005, ANTIMICROB AGENTS CH, V49, P3001, DOI 10.1128/AAC.49.7.3001-3003.2005; Saito R, 2007, INT J ANTIMICROB AG, V29, P600, DOI 10.1016/j.ijantimicag.2006.11.016; Schultsz C, 2007, T ROY SOC TROP MED H, V101, P484, DOI 10.1016/j.trstmh.2006.08.010; Shen P, 2008, J ANTIMICROB CHEMOTH, V62, P1252, DOI 10.1093/jac/dkn397; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Travers K, 2002, CLIN INFECT DIS, V34, pS131, DOI 10.1086/340251; van der Veen EL, 2009, J ANTIMICROB CHEMOTH, V63, P1011, DOI 10.1093/jac/dkp050; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; Whichard JM, 2007, EMERG INFECT DIS, V13, P1681, DOI 10.3201/eid1311.061438; WHO, 2002, AC RESP INF; Yue L, 2008, VET MICROBIOL, V132, P414, DOI 10.1016/j.vetmic.2008.05.009; Zhang R, 2012, MICROBES ENVIRON, V27, P158, DOI 10.1264/jsme2.ME11308	50	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42919	10.1371/journal.pone.0042919	http://dx.doi.org/10.1371/journal.pone.0042919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937000	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000308225500021
J	Pimenta, J; Domingos, A; Santos, P; Marques, CC; Cantante, C; Santos, A; Barbas, JP; Baptista, MC; Horta, AEM; Viegas, A; Mesquita, P; Goncalves, J; Fontes, CA; Prates, JAM; Pereira, RMLN				Pimenta, Jorge; Domingos, Ana; Santos, Pedro; Marques, Carla C.; Cantante, Catia; Santos, Ana; Barbas, Joao P.; Baptista, Maria C.; Horta, Antonio E. M.; Viegas, Aldino; Mesquita, Patricia; Goncalves, Joao; Fontes, Carlos A.; Prates, Jose A. M.; Pereira, Rosa M. L. N.			Is prnt a Pseudogene? Identification of Ram Prt in Testis and Ejaculated Spermatozoa	PLOS ONE			English	Article							PRION-LIKE PROTEIN; COMPLETE GENOMIC SEQUENCE; AGGREGATION-PRONE; MALE-INFERTILITY; DOPPEL GENE; I-TASSER; EXPRESSION; BOVINE; MICE; PREDICTION	A hallmark of prion diseases or transmissible spongiform encephalopaties is the conversion of the cellular prion protein (PrPC), expressed by the prion gene (prnp), into an abnormally folded isoform (PrPSc) with amyloid-like features that causes scrapie in sheep among other diseases. prnp together with prnd (which encodes a prion-like protein designated as Doppel), and prnt (that encodes the prion protein testis specific - Prt) with sprn (shadow of prion protein gene, that encodes Shadoo or Sho) genes, constitute the "prion gene complex". Whereas a role for prnd in the proper functioning of male reproductive system has been confirmed, the function of prnt, a recently discovered prion family gene, comprises a conundrum leading to the assumption that ruminant prnt is a pseudogene with no protein expression. The main objective of the present study was to identify Prt localization in the ram reproductive system and simultaneously to elucidate if ovine prnt gene is transcribed into protein-coding RNA. Moreover, as Prt is a prnp-related protein, the amyloid propensity was also tested for ovine and caprine Prt. Recombinant Prt was used to immunize BALB/c mice, and the anti-Prt polyclonal antibody (APPA) immune response was evaluated by ELISA and Western Blot. When tested by indirect immunofluorescence, APPA showed high avidity to the ram sperm head apical ridge subdomain, before and after induced capacitation, but did not show the same behavior against goat spermatozoa, suggesting high antibody specificity against ovine-Prt. Prt was also found in the testis when assayed by immunohistochemistry during ram spermatogenesis, where spermatogonia, spermatocytes, spermatids and spermatozoa, stained positive. These observations strongly suggest ovine prnt to be a translated protein-coding gene, pointing to a role for Prt protein in the ram reproductive physiology. Besides, caprine Prt appears to exhibit a higher amyloid propensity than ovine Prt, mostly associated with its phenylalanine residue.	[Pimenta, Jorge; Marques, Carla C.; Barbas, Joao P.; Baptista, Maria C.; Horta, Antonio E. M.; Mesquita, Patricia; Pereira, Rosa M. L. N.] Inst Nacl Recursos Biol INRB L INIA Santarem, Unidade Recursos Genet Reprod & Melhoramento Anim, Quinta Da Fonte Boa, Vale De Santare, Portugal; [Pimenta, Jorge; Fontes, Carlos A.; Prates, Jose A. M.] Univ Tecn Lisboa, CIISA, FMV, P-1100 Lisbon, Portugal; [Domingos, Ana] Ctr Malaria & Doencas Tropicais, IHMT CMDT Inst Higiene Med Trop, Lisbon, Portugal; [Santos, Pedro] Hosp Univ Coimbra, Coimbra, Portugal; [Cantante, Catia; Santos, Ana; Goncalves, Joao] Univ Lisbon, URIA, ADEIM Ctr Patogenese Mol, IMM,Fac Farm, P-1699 Lisbon, Portugal; [Viegas, Aldino] Univ Nova Lisboa, REQUIMTE CQFB Dept Quim, Fac Ciencias & Tecnol, Caparica, Portugal; [Pereira, Rosa M. L. N.] Escola Univ Vasco da Gama, Coimbra, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Lisboa; Universidade Nova de Lisboa	Pimenta, J (corresponding author), Inst Nacl Recursos Biol INRB L INIA Santarem, Unidade Recursos Genet Reprod & Melhoramento Anim, Quinta Da Fonte Boa, Vale De Santare, Portugal.	rosalnp@gmail.com	Pereira, Rosa MLN/I-4003-2012; Viegas, Aldino/A-1889-2011; Goncalves, Joao/B-2013-2008; iMed.ULisboa, M2B/B-5277-2014; Cunha-Santos, Catarina/ABA-7417-2020; Domingos, Ana G/I-8409-2012; Prates, José A M/K-9934-2013; Pimenta, Jorge/N-3132-2016; Pereira, Rosa Maria Rodrigues/C-5192-2012	Pereira, Rosa MLN/0000-0002-7514-6130; Viegas, Aldino/0000-0003-1733-136X; Goncalves, Joao/0000-0002-1245-3715; iMed.ULisboa, M2B/0000-0002-1245-3715; Domingos, Ana G/0000-0002-4570-2060; Prates, José A M/0000-0003-1032-5987; barbas, joao/0000-0001-8991-4009; Pimenta, Jorge/0000-0002-3796-0238; Pereira, Rosa Maria Rodrigues/0000-0002-3723-5028; marques, carla/0000-0002-8529-3812; Mesquita, Patricia/0000-0002-4766-9831; Fontes, Carlos/0000-0002-1219-9753; Cunha-Santos, Catarina/0000-0001-8789-1966	Portuguese Foundation for Science and Technology (FCT); Portuguese Ministry of Science and Technology [PTDC/CVT/98607/2008]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Portuguese Ministry of Science and Technology	This research was funded by the Portuguese Foundation for Science and Technology (FCT), Portuguese Ministry of Science and Technology, under the project PTDC/CVT/98607/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Baptista MC, 2008, REPROD DOMEST ANIM, V43, P53; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Bryan Jr AW, 2011, PROTEINS; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Choi SH, 2006, GENOMICS, V87, P598, DOI 10.1016/j.ygeno.2005.12.012; Comincini S, 2001, MAMM GENOME, V12, P729, DOI 10.1007/s00335-001-2064-4; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Dattena M, 2000, THERIOGENOLOGY, V53, P1511, DOI 10.1016/S0093-691X(00)00293-4; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Diaz-Espinoza R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031678; Espenes A, 2006, INT J ANDROL, V29, P400, DOI 10.1111/j.1365-2605.2005.00618.x; Essalmani R, 2002, GENE, V285, P287, DOI 10.1016/S0378-1119(02)00391-8; Franca LR, 1999, TISSUE CELL, V31, P274, DOI 10.1054/tice.1999.0044; Guan Feng, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P170; Gupta SK, 2011, ASIAN J ANDROL, V13, P97, DOI 10.1038/aja.2010.72; Harrison PM, 2010, GENOMICS, V95, P268, DOI 10.1016/j.ygeno.2010.02.008; Hills D, 2001, ANIM GENET, V32, P231, DOI 10.1046/j.1365-2052.2001.0769a.x; Jiang B, 1998, BIOPOLYMERS, V45, P35, DOI 10.1002/(SICI)1097-0282(199801)45:1<35::AID-BIP4>3.0.CO;2-#; Kamaruddin M, 2004, ANDROLOGIA, V36, P327, DOI 10.1111/j.1439-0272.2004.00629.x; Kocer A, 2007, DEV DYNAM, V236, P836, DOI 10.1002/dvdy.21066; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee IY, 1998, GENOME RES, V8, P1022, DOI 10.1101/gr.8.10.1022; Li G, 1997, BRAIN RES, V751, P265, DOI 10.1016/S0006-8993(96)01407-2; Makrinou E, 2002, MAMM GENOME, V13, P696, DOI 10.1007/s00335-002-3043-0; Mesquita P, 2010, ANIM GENET, V41, P311, DOI 10.1111/j.1365-2052.2009.01992.x; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Paisley D, 2004, AM J PATHOL, V164, P2279, DOI 10.1016/S0002-9440(10)63784-4; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Peoc'h K, 2002, J BIOL CHEM, V277, P43071, DOI 10.1074/jbc.M206357200; Pereira RM, 2009, ANIM REPROD SCI, V114, P157, DOI 10.1016/j.anireprosci.2008.10.003; Pimenta J, 2012, REPROD DOMEST ANIM, V47, P196, DOI 10.1111/j.1439-0531.2011.01827.x; Pimenta J, 2012, HORIZONS NEUROSCIENC, P283; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Premzl M, 2003, GENE, V314, P89, DOI 10.1016/S0378-1119(03)00707-8; Premzl M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-1; Preuss S, 2004, GENE, V329, P197, DOI 10.1016/j.gene.2003.12.030; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rondena M, 2005, THERIOGENOLOGY, V63, P1195, DOI 10.1016/j.theriogenology.2004.06.009; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saiki M, 2012, BIOCHEMISTRY-US, V51, P1566, DOI 10.1021/bi201688r; Silverman GL, 2000, J BIOL CHEM, V275, P26834; SPARKES RS, 1986, P NATL ACAD SCI USA, V83, P7358, DOI 10.1073/pnas.83.19.7358; Staut J, 2009, CORRELACAO MORFOLOGI; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tranulis MA, 2001, MAMM GENOME, V12, P376, DOI 10.1007/s003350010285; Whyte SM, 2003, BIOCHEM J, V373, P485, DOI 10.1042/BJ20021911; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	51	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42957	10.1371/journal.pone.0042957	http://dx.doi.org/10.1371/journal.pone.0042957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937002	Green Published, gold			2022-12-27	WOS:000308225500022
J	Chung, D; Farkas, J; Huddleston, JR; Olivar, E; Westpheling, J				Chung, Daehwan; Farkas, Joel; Huddleston, Jennifer R.; Olivar, Estefania; Westpheling, Janet			Methylation by a Unique alpha-class N4-Cytosine Methyltransferase Is Required for DNA Transformation of Caldicellulosiruptor bescii DSM6725	PLOS ONE			English	Article							ESCHERICHIA-COLI; THERMOPHILIC BACTERIUM; PLANT BIOMASS; HYPERTHERMOPHILIC ARCHAEA; GENOME SEQUENCE; RESTRICTION; GENE; THERMOANAEROBACTER; ETHANOL; SYSTEM	Thermophilic microorganisms capable of using complex substrates offer special advantages for the conversion of lignocellulosic biomass to biofuels and bioproducts. Members of the Gram-positive bacterial genus Caldicellulosiruptor are anaerobic thermophiles with optimum growth temperatures between 65 degrees C and 78 degrees C and are the most thermophilic cellulolytic organisms known. In fact, they efficiently use biomass non-pretreated as their sole carbon source and in successive rounds of application digest 70% of total switchgrass substrate. The ability to genetically manipulate these organisms is a prerequisite to engineering them for use in conversion of these complex substrates to products of interest as well as identifying gene products critical for their ability to utilize non-pretreated biomass. Here, we report the first example of DNA transformation of a member of this genus, C. bescii. We show that restriction of DNA is a major barrier to transformation (in this case apparently absolute) and that methylation with an endogenous unique alpha-class N4-Cytosine methyltransferase is required for transformation of DNA isolated from E. coli. The use of modified DNA leads to the development of an efficient and reproducible method for DNA transformation and the combined frequencies of transformation and recombination allow marker replacement between non-replicating plasmids and chromosomal genes providing the basis for rapid and efficient methods of genetic manipulation.	[Chung, Daehwan; Farkas, Joel; Huddleston, Jennifer R.; Olivar, Estefania; Westpheling, Janet] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Chung, Daehwan; Farkas, Joel; Huddleston, Jennifer R.; Olivar, Estefania; Westpheling, Janet] Oak Ridge Natl Lab, Dept Energy, BioEnergy Sci Ctr, Oak Ridge, TN USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Chung, D (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	janwest@uga.edu			BioEnergy Science Center, which is a U.S. Department of Energy Bioenergy Research Center; Office of Biological and Environmental Research in the DOE Office of Science [FG02-08ER64690]; predoctoral Graduate Training In Genetics grant [NIH 5T32GM007103-30]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER	BioEnergy Science Center, which is a U.S. Department of Energy Bioenergy Research Center; Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); predoctoral Graduate Training In Genetics grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the BioEnergy Science Center, which is a U.S. Department of Energy Bioenergy Research Center administered by Oak Ridge National Laboratory and supported by the Office of Biological and Environmental Research (FG02-08ER64690) in the DOE Office of Science. JF was supported by a predoctoral Graduate Training In Genetics grant (NIH 5T32GM007103-30) to the Genetics Department of the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetto T, 2005, FEMS MICROBIOL LETT, V247, P177, DOI 10.1016/j.femsle.2005.05.016; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; ARBER W, 1962, J MOL BIOL, V5, P18, DOI 10.1016/S0022-2836(62)80058-8; Argyros DA, 2011, APPL ENVIRON MICROB, V77, P8288, DOI 10.1128/AEM.00646-11; Bart A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni121; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blumer-Schuette SE, 2008, CURR OPIN BIOTECH, V19, P210, DOI 10.1016/j.copbio.2008.04.007; Blumer-Schuette SE, 2011, J BACTERIOL, V193, P1483, DOI 10.1128/JB.01515-10; Blumer-Schuette SE, 2010, APPL ENVIRON MICROB, V76, P8084, DOI 10.1128/AEM.01400-10; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Broschard TH, 1998, CARCINOGENESIS, V19, P305, DOI 10.1093/carcin/19.2.305; Cannio R, 2001, EXTREMOPHILES, V5, P153, DOI 10.1007/s007920100189; Chen CK, 1996, FEMS MICROBIOL LETT, V140, P185, DOI 10.1016/0378-1097(96)00177-2; Chung DH, 2011, J IND MICROBIOL BIOT, V38, P1867, DOI 10.1007/s10295-011-0976-x; Cohen HM, 2002, NUCLEIC ACIDS RES, V30, P3880, DOI 10.1093/nar/gkf507; Crowe ML, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-133; Cue D, 1997, APPL ENVIRON MICROB, V63, P1406, DOI 10.1128/AEM.63.4.1406-1420.1997; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Donahue JP, 2000, MOL MICROBIOL, V37, P1066, DOI 10.1046/j.1365-2958.2000.02036.x; EHRLICH M, 1985, NUCLEIC ACIDS RES, V13, P1399, DOI 10.1093/nar/13.4.1399; Elkins JG, 2010, J BACTERIOL, V192, P6099, DOI 10.1128/JB.00950-10; Gallagher LA, 2008, J BACTERIOL, V190, P7830, DOI 10.1128/JB.01188-08; Grogan DW, 2003, J BACTERIOL, V185, P4657, DOI 10.1128/JB.185.15.4657-4661.2003; Guss Adam M, 2012, Biotechnol Biofuels, V5, P30, DOI 10.1186/1754-6834-5-30; Hethke C, 1996, NUCLEIC ACIDS RES, V24, P2369, DOI 10.1093/nar/24.12.2369; Jennert KCB, 2000, MICROBIOL-SGM, V146, P3071, DOI 10.1099/00221287-146-12-3071; KARNIK SS, 1983, ARCH MICROBIOL, V136, P275, DOI 10.1007/BF00425216; Kataeva IA, 2009, J BACTERIOL, V191, P3760, DOI 10.1128/JB.00256-09; Kawarabayasi Y, 1998, DNA Res, V5, P147, DOI 10.1093/dnares/5.2.147; KLIMASAUSKAS S, 1989, NUCLEIC ACIDS RES, V17, P9823, DOI 10.1093/nar/17.23.9823; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Lucas S, 2002, APPL ENVIRON MICROB, V68, P5528, DOI 10.1128/AEM.68.11.5528-5536.2002; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Mai V, 1997, FEMS MICROBIOL LETT, V148, P163, DOI 10.1016/S0378-1097(97)00028-1; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Matveyev AV, 2001, NUCLEIC ACIDS RES, V29, P1491, DOI 10.1093/nar/29.7.1491; Negro MJ, 2003, APPL BIOCHEM BIOTECH, V105, P87, DOI 10.1385/ABAB:105:1-3:87; Noll KM, 1997, ARCH MICROBIOL, V168, P73, DOI 10.1007/s002030050472; Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x; Peng H, 2006, BIOTECHNOL LETT, V28, P1913, DOI 10.1007/s10529-006-9184-6; PETERANDERL R, 1993, APPL ENVIRON MICROB, V59, P3498, DOI 10.1128/AEM.59.10.3498-3501.1993; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Rao BS, 1998, NUCLEIC ACIDS RES, V26, P2505, DOI 10.1093/nar/26.10.2505; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Shaw AJ, 2010, APPL ENVIRON MICROB, V76, P4713, DOI 10.1128/AEM.00402-10; Shaw AJ, 2009, J BACTERIOL, V191, P6457, DOI 10.1128/JB.00497-09; TIMINSKAS A, 1995, GENE, V157, P3, DOI 10.1016/0378-1119(94)00783-O; TRIEUCUOT P, 1987, FEMS MICROBIOL LETT, V48, P289, DOI 10.1111/j.1574-6968.1987.tb02558.x; Tyurin MV, 2004, APPL ENVIRON MICROB, V70, P883, DOI 10.1128/AEM.70.2.883-890.2004; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Zhang YHP, 2007, BIOTECHNOL BIOENG, V97, P214, DOI 10.1002/bit.21386	58	62	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43844	10.1371/journal.pone.0043844	http://dx.doi.org/10.1371/journal.pone.0043844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928042	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300093
J	Dirks, JH; Taylor, D				Dirks, Jan-Henning; Taylor, David			Veins Improve Fracture Toughness of Insect Wings	PLOS ONE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; MICRO-AIR VEHICLES; DESERT LOCUST; FUNCTIONAL-MORPHOLOGY; MECHANICAL-PROPERTIES; FLEXURAL STIFFNESS; FLIGHT; CUTICLE; MEMBRANE; REPAIR	During the lifetime of a flying insect, its wings are subjected to mechanical forces and deformations for millions of cycles. Defects in the micrometre thin membranes or veins may reduce the insect's flight performance. How do insects prevent crack related material failure in their wings and what role does the characteristic vein pattern play? Fracture toughness is a parameter, which characterises a material's resistance to crack propagation. Our results show that, compared to other body parts, the hind wing membrane of the migratory locust S. gregaria itself is not exceptionally tough (1.04 +/- 0.25 MPa root m). However, the cross veins increase the wing's toughness by 50% by acting as barriers to crack propagation. Using fracture mechanics, we show that the morphological spacing of most wing veins matches the critical crack length of the material (1132 mu m). This finding directly demonstrates how the biomechanical properties and the morphology of locust wings are functionally correlated in locusts, providing a mechanically 'optimal' solution with high toughness and low weight. The vein pattern found in insect wings thus might inspire the design of more durable and lightweight artificial 'venous' wings for micro-air-vehicles. Using the vein spacing as indicator, our approach might also provide a basis to estimate the wing properties of endangered or extinct insect species.	[Dirks, Jan-Henning; Taylor, David] Trinity Coll Dublin, Dept Mech & Mfg Engn, Trinity Ctr Bioengn, Dublin, Ireland	Trinity College Dublin	Dirks, JH (corresponding author), Trinity Coll Dublin, Dept Mech & Mfg Engn, Trinity Ctr Bioengn, Dublin, Ireland.	jan-henning.dirks@web.de	Dirks, Jan-Henning/B-9706-2011		Irish Research Council for Science, Engineering and Technology (IRCSET)	Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This study was financially supported by a postdoctoral fellowship of the Irish Research Council for Science, Engineering and Technology (IRCSET, http://www.ircset.ie) to Dr. Dirks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCH ROBERT, 1941, BOT REV, V7, P110, DOI 10.1007/BF02872446; Combes SA, 2003, J EXP BIOL, V206, P2979, DOI 10.1242/jeb.00523; Combes SA, 2003, J EXP BIOL, V206, P2989, DOI 10.1242/jeb.00524; Dirks JH, 2012, J EXP BIOL, V215, P1502, DOI 10.1242/jeb.068221; Dirks JH, 2011, J MECH BEHAV BIOMED, V4, P2031, DOI 10.1016/j.jmbbm.2011.07.002; Dudley R., 2000, BIOMECHANICS INSECT; Ellington CP, 1999, J EXP BIOL, V202, P3439; ENNOS AR, 1989, ZOOL J LINN SOC-LOND, V96, P27, DOI 10.1111/j.1096-3642.1989.tb01820.x; Ha NS, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046003; HAMILTON K G A, 1972, Journal of the Kansas Entomological Society, V45, P145; Herbert RC, 2000, J EXP BIOL, V203, P2945; Jongerius SR, 2010, EXP MECH, V50, P1323, DOI 10.1007/s11340-010-9411-x; Kesel AB, 2000, J EXP BIOL, V203, P3125; Khan ZA, 2011, AIAA J, V49, P1354, DOI 10.2514/1.J050447; LAIFOOK J, 1968, J MORPHOL, V124, P37, DOI 10.1002/jmor.1051240104; Lovejoy NR, 2006, P ROY SOC B-BIOL SCI, V273, P767, DOI 10.1098/rspb.2005.3381; Marcus JM, 2001, J ANAT, V199, P211, DOI 10.1046/j.1469-7580.2001.19910211.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Meng XG, 2011, J EXP BIOL, V214, P432, DOI 10.1242/jeb.046375; Nel Andre, 2001, Revue Francaise d'Entomologie (Nouvelle Serie), V23, P257; Park JH, 2008, J BIONIC ENG, V5, P39, DOI 10.1016/S1672-6529(08)60005-0; Richter C, 2011, ARTIF LIFE, V17, P73, DOI 10.1162/artl_a_00020; Smith CW, 2000, J EXP BIOL, V203, P2933; Song F, 2007, MAT SCI ENG A-STRUCT, V457, P254, DOI 10.1016/j.msea.2007.01.136; Sutton G, 2011, J EXP BIOL, V214, P2997, DOI 10.1242/jeb.056663; Taylor D, 2007, THEORY CRITICAL DIST; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Tofilski A, 2004, J INSECT SCI, V4, DOI [10.1093/JIS/4.1.17, 10.1093/jis/4.1.17]; TORVIK PJ, 1979, J APPL MECH-T ASME, V46, P611, DOI 10.1115/1.3424615; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435; WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P415, DOI 10.1098/rstb.1956.0007; WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P459, DOI 10.1098/rstb.1956.0008; Wootton RJ, 2000, J EXP BIOL, V203, P2921; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; Wootton RJ, 1998, SCIENCE, V282, P749, DOI 10.1126/science.282.5389.749; Wootton Robin J., 1995, Proceedings of the Royal Society of London Series B Biological Sciences, V262, P181, DOI 10.1098/rspb.1995.0194	37	59	61	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43411	10.1371/journal.pone.0043411	http://dx.doi.org/10.1371/journal.pone.0043411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927966	Green Submitted, gold, Green Published			2022-12-27	WOS:000308286300049
J	Dong, HL; Jin, XW; Hu, J; Li, HF; He, XL; Liu, XN; Bao, GQ				Dong, Honglin; Jin, Xiaowei; Hu, Jie; Li, Haifeng; He, Xianli; Liu, Xiaonan; Bao, Guoqiang			High gamma-Radiation Sensitivity Is Associated with Increased Gastric Cancer Risk in a Chinese Han Population: A Case-Control Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; UPPER AERODIGESTIVE TRACT; DNA-REPAIR CAPACITY; MUTAGEN SENSITIVITY; BREAST-CANCER; DIOL-EPOXIDE; LUNG-CANCER; CHROMOSOME SENSITIVITY; BIOLOGICAL MARKER; CHROMATID BREAKS	Hypersensitivity to radiation exposure has been suggested to be a risk factor for the development of several malignancies, but not including gastric cancer. In this case-control study, radiation sensitivity as measured by chromatid breaks per cell (b/c) was examined in cultured peripheral blood lymphocytes (PBLs) from 517 patients with gastric cancer and 525 healthy controls. Our results showed that b/c values were significantly higher in cases than in controls (Mean [SD], 0.47 [0.20] vs. 0.34 [0.17]; P<0.001). Using the 50th percentile value for controls (0.34 b/c) as the cutoff point, unconditional logistic regression analysis revealed that gamma-radiation-sensitive individuals were at significantly higher risk for gastric cancer (adjusted odds ratio [OR] 2.01, 95% confidence interval [CI] 1.49-3.13). Quartile stratification analysis indicated a dose-response relationship between gamma-radiation sensitivity and gastric cancer risk (P for trend <0.001). When using the subjects in first quartile of b/c values as reference, the adjusted ORs and corresponding CIs for the subjects in second, third, and fourth quartiles were 1.48 (0.91-2.17), 2.42 (1.76-3.64), and 3.40 (2.11-5.29), respectively. The gamma-radiation sensitivity was related to age and smoking status. In addition, a clear joint effect on cancer risk was found between gamma-Radiation sensitivity and smoking status. The risk for ever smokers with high sensitivity was higher than those for never smokers with high sensitivity and ever smokers with low sensitivity (OR [CI], 4.67 [2.31-6.07] vs. 2.14 [1.40-3.06] vs. 2.42 [1.57-3.95], respectively). No significant interaction was found between both factors (P for interaction = 0.42). We conclude that chromatid radiosensitivity is associated with gastric cancer susceptibility in a Chinese population.	[Dong, Honglin; Hu, Jie; Li, Haifeng] Shanxi Med Univ, Dept Gen Surg, Hosp 2, Taiyuan, Peoples R China; [Jin, Xiaowei] Gen Hosp Air Forces PLA, Dept Digest Dis, Beijing, Peoples R China; [He, Xianli; Bao, Guoqiang] Fourth Mil Med Univ, Dept Gen Surg, Tangdu Hosp, Xian 710032, Peoples R China; [Liu, Xiaonan] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Shanxi Medical University; Air Force Military Medical University; Air Force Military Medical University	Dong, HL (corresponding author), Shanxi Med Univ, Dept Gen Surg, Hosp 2, Taiyuan, Peoples R China.	liuxnys@fmmu.edu.cn; Guoqiang@fmmu.edu.cn			National Natural Science Foundation of China [30700810, 30972930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 30700810 and 30972930 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Au WW, 2005, ENVIRON MOL MUTAGEN, V45, P222, DOI 10.1002/em.20114; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Bondy ML, 2001, J NATL CANCER I, V93, P1553, DOI 10.1093/jnci/93.20.1553; Buchholz TA, 2001, INT J RADIAT ONCOL, V49, P533, DOI 10.1016/S0360-3016(00)01502-9; Chao DL, 2006, CANCER EPIDEM BIOMAR, V15, P1935, DOI 10.1158/1055-9965.EPI-06-0492; Cheng L, 1999, CANCER EPIDEM BIOMAR, V8, P801; CHERRY LM, 1983, ANTICANCER RES, V3, P367; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; El-Zein RA, 2006, CANCER RES, V66, P6449, DOI 10.1158/0008-5472.CAN-06-0326; Erdei E, 2006, MUTAGENESIS, V21, P261, DOI 10.1093/mutage/gel030; Gajecka M, 2004, ONCOL REP, V12, P153; Gianfagna F, 2008, CURR GENOMICS, V9, P361, DOI 10.2174/138920208785699544; Gu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028971; Gu J, 1999, CANCER GENET CYTOGEN, V110, P65, DOI 10.1016/S0165-4608(98)00189-7; HAGMAR L, 1994, CANCER RES, V54, P2919; HSU TC, 1991, CANCER EPIDEM BIOMAR, V1, P83; HSU TC, 1985, CANCER GENET CYTOGEN, V17, P307, DOI 10.1016/0165-4608(85)90114-1; HSU TC, 1989, INT J CANCER, V43, P403, DOI 10.1002/ijc.2910430310; HSU TC, 1983, HEREDITAS, V98, P1, DOI 10.1111/j.1601-5223.1983.tb00574.x; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Lee JJ, 1996, CANCER EPIDEM BIOMAR, V5, P191; Malik Manzoor A, 2009, J Gastrointest Cancer, V40, P26, DOI 10.1007/s12029-009-9072-0; Natarajan TG, 2006, CANCER EPIDEM BIOMAR, V15, P437, DOI 10.1158/1055-9965.EPI-05-0353; PANDITA TK, 1995, INT J CANCER, V61, P738, DOI 10.1002/ijc.2910610524; Patel RK, 1997, INT J CANCER, V73, P20, DOI 10.1002/(SICI)1097-0215(19970926)73:1<20::AID-IJC4>3.0.CO;2-3; SEETHARAM S, 1991, MUTAT RES, V254, P97, DOI 10.1016/0921-8777(91)90045-Q; Setiawan VW, 2001, CANCER CAUSE CONTROL, V12, P673, DOI 10.1023/A:1011261602940; Shao L, 2005, GENE CHROMOSOME CANC, V44, P415, DOI 10.1002/gcc.20254; Shen HB, 2003, INT J CANCER, V107, P84, DOI 10.1002/ijc.11346; Spitz MR, 1996, J CELL BIOCHEM, P80; SPITZ MR, 1995, CANCER EPIDEM BIOMAR, V4, P99; SPITZ MR, 1989, CANCER RES, V49, P4626; Udumudi A, 1998, MUTAT RES-GEN TOX EN, V412, P195, DOI 10.1016/S1383-5718(97)00164-2; Wang LE, 2005, JNCI-J NATL CANCER I, V97, P1822, DOI 10.1093/jnci/dji429; Wang LE, 2000, RADIAT RES, V154, P20, DOI 10.1667/0033-7587(2000)154[0020:GDISEO]2.0.CO;2; Wang LE, 1998, CLIN CANCER RES, V4, P1773; Wang LE, 2006, J INVEST DERMATOL; Wang LE, 2012, BREAST CANC RES TREA; Wei QY, 1996, CANCER EPIDEM BIOMAR, V5, P199; Wu XF, 1998, CANCER EPIDEM BIOMAR, V7, P567; Wu XF, 1998, J NATL CANCER I, V90, P1393, DOI 10.1093/jnci/90.18.1393; Wu XF, 2002, CANCER RES, V62, P2813; Wu XF, 2006, CANCER RES, V66, P5993, DOI 10.1158/0008-5472.CAN-06-1007; Xia HHX, 2002, ALIMENT PHARM THERAP, V16, P521, DOI 10.1046/j.1365-2036.2002.01176.x; Xiong P, 2001, CANCER RES, V61, P8465	46	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43625	10.1371/journal.pone.0043625	http://dx.doi.org/10.1371/journal.pone.0043625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928006	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300076
J	Sun, Y; Li, Y; Luo, DZ; Liao, DJ				Sun, Yuan; Li, Yan; Luo, Dianzhong; Liao, D. Joshua			Pseudogenes as Weaknesses of ACTB (Actb) and GAPDH (Gapdh) Used as Reference Genes in Reverse Transcription and Polymerase Chain Reactions	PLOS ONE			English	Article							UCSC GENOME BROWSER; RT-PCR; FREE AMPLIFICATION; CYCLIN D1; C-MYC; EXPRESSION; NORMALIZATION; RNA; SELECTION; CANCER	The genes encoding beta-actin (ACTB in human or Actb in mouse) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH in human or Gapdh in mouse) are the two most commonly used references for sample normalization in determination of the mRNA level of interested genes by reverse transcription (RT) and ensuing polymerase chain reactions (PCR). In this study, bioinformatic analyses revealed that the ACTB, Actb, GAPDH and Gapdh had 64, 69, 67 and 197 pseudogenes (PGs), respectively, in the corresponding genome. Most of these PGs are intronless and similar in size to the authentic mRNA. Alignment of several PGs of these genes with the corresponding mRNA reveals that they are highly homologous. In contrast, the hypoxanthine phosphoribosyltransferase-1 gene (HPRT1 in human or Hprt in mouse) only had 3 or 1 PG, respectively, and the mRNA has unique regions for primer design. PCR with cDNA or genomic DNA (gDNA) as templates revealed that our HPRT1, Hprt and GAPDH primers were specific, whereas our ACTB and Actb primers were not specific enough both vertically (within the cDNA) and horizontally (compared cDNA with gDNA). No primers could be designed for the Gapdh that would not mis-prime PGs. Since most of the genome is transcribed, we suggest to peers to forgo ACTB (Actb) and GAPDH (Dapdh) as references in RT-PCR and, if there is no surrogate, to use our primers with extra caution. We also propose a standard operation procedure in which design of primers for RT-PCR starts from avoiding mis-priming PGs and all primers need be tested for specificity with both cDNA and gDNA.	[Sun, Yuan; Li, Yan; Liao, D. Joshua] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Sun, Yuan; Luo, Dianzhong] Guangxi Med Univ, Dept Pathol, Nanning, Guangxi, Peoples R China	University of Minnesota System; Guangxi Medical University	Sun, Y (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	luodianzhong@yahoo.com.cn; djliao@hi.umn.edu	Li, Yan/L-2129-2013		United States Department of Defense (DOD Award) [W81XWH-11-1-0119]	United States Department of Defense (DOD Award)	This work was supported by a grant from the United States Department of Defense (DOD Award W81XWH-11-1-0119) to DJL. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biliran H, 2007, CLIN CANCER RES, V13, P2811, DOI 10.1158/1078-0432.CCR-06-1844; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Calabrese FM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S15; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Cinar Mehmet Ulas, 2012, BMC Res Notes, V5, P107, DOI 10.1186/1756-0500-5-107; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Dupont M, 2002, BIOTECHNIQUES, V33, P158, DOI 10.2144/02331md04; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Guo R, 2011, EUR J PROTISTOL, DOI org/10.1016/j.ejop.2011.11.001; Guo XP, 2012, CLIN EXP MED, V12, P207, DOI 10.1007/s10238-011-0163-4; Harper LV, 2003, MOL CELL PROBE, V17, P261, DOI 10.1016/S0890-8508(03)00063-X; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; Ledderose Carola, 2011, BMC Res Notes, V4, P427, DOI 10.1186/1756-0500-4-427; Lehmann MH, 2002, BIOTECHNIQUES, V33, P766, DOI 10.2144/02334bm10; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Louhichi A, 2011, GENE, V488, P35, DOI 10.1016/j.gene.2011.08.013; Manjarin R, 2011, J DAIRY SCI, V94, P4950, DOI 10.3168/jds.2011-4147; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; McDonell L, 2012, GENOME, V55, P147, DOI 10.1139/G2012-002; Penna I, 2011, INT J MOL SCI, V12, P5461, DOI 10.3390/ijms12095461; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Stecyk JAW, 2012, COMP BIOCHEM PHYS D, V7, P59, DOI 10.1016/j.cbd.2011.11.001; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Sun JH, 2012, INT J LEGAL MED, V126, P113, DOI 10.1007/s00414-011-0604-3; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang Y, 2007, CANCER RES, V67, P3698, DOI 10.1158/0008-5472.CAN-06-4000; Williams TK, 2008, CANCER LETT, V271, P81, DOI 10.1016/j.canlet.2008.05.033; Zhang G, 2012, MOL BIOL REP, V39, P5905, DOI 10.1007/s11033-011-1402-1; Zhao SD, 2011, J PATHOL, V223, P672, DOI 10.1002/path.2827	37	57	61	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41659	10.1371/journal.pone.0041659	http://dx.doi.org/10.1371/journal.pone.0041659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927912	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300012
J	Murray, BD; Holmes, SA; Webster, CR; Witt, JC				Murray, Bryan D.; Holmes, Stacie A.; Webster, Christopher R.; Witt, Jill C.			Post-Disturbance Plant Community Dynamics following a Rare Natural-Origin Fire in a Tsuga canadensis Forest	PLOS ONE			English	Article							GREAT-LAKES REGION; HEMLOCK-HARDWOOD FORESTS; OLD-GROWTH; EASTERN HEMLOCK; VEGETATION DYNAMICS; DEER; PATTERNS; REGENERATION; ASSEMBLAGES; RECRUITMENT	Opportunities to directly study infrequent forest disturbance events often lead to valuable information about vegetation dynamics. In mesic temperate forests of North America, stand-replacing crown fire occurs infrequently, with a return interval of 2000-3000 years. Rare chance events, however, may have profound impacts on the developmental trajectories of forest ecosystems. For example, it has been postulated that stand-replacing fire may have been an important factor in the establishment of eastern hemlock (Tsuga canadensis) stands in the northern Great Lakes region. Nevertheless, experimental evidence linking hemlock regeneration to non-anthropogenic fire is limited. To clarify this potential relationship, we monitored vegetation dynamics following a rare lightning-origin crown fire in a Wisconsin hemlock-hardwood forest. We also studied vegetation in bulldozer-created fire breaks and adjacent undisturbed forest. Our results indicate that hemlock establishment was rare in the burned area but moderately common in the scarified bulldozer lines compared to the reference area. Early-successional, non-arboreal species including Rubus spp., Vaccinium angustifolium, sedges (Carex spp.), grasses, Epilobium ciliatum, and Pteridium aquilinium were the most abundant post-fire species. Collectively, our results suggest that competing vegetation and moisture stress resulting from drought may reduce the efficacy of scarification treatments as well as the usefulness of fire for preparing a suitable seedbed for hemlock. The increasing prevalence of growing-season drought suggests that silvicultural strategies based on historic disturbance regimes may need to be reevaluated for mesic species.	[Murray, Bryan D.; Webster, Christopher R.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Ecosyst Sci Ctr, Houghton, MI 49931 USA; [Holmes, Stacie A.] U S Dept Interior, Bur Indian Affairs, Branch Forest Resources Planning, Lakewood, CO USA; [Witt, Jill C.] Little River Band Ottawa Indians, Dept Nat Resources, Manistee, MI USA	Michigan Technological University; United States Department of the Interior	Murray, BD (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Ecosyst Sci Ctr, Houghton, MI 49931 USA.	bdmurray@mtu.edu	Murray, Bryan/K-5934-2019		McIntire-Stennis Cooperative Forestry Research Program; Ecosystem Science Center; School of Forest Resources and Environmental Science, Michigan Technological University	McIntire-Stennis Cooperative Forestry Research Program; Ecosystem Science Center; School of Forest Resources and Environmental Science, Michigan Technological University	The research was supported by the McIntire-Stennis Cooperative Forestry Research Program, the Ecosystem Science Center (http://www.ecosystem.mtu.edu), and the School of Forest Resources and Environmental Science, Michigan Technological University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 1998, BIOSCIENCE, V48, P355, DOI 10.2307/1313374; ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; ANDERSON RC, 1979, J APPL ECOL, V16, P855, DOI 10.2307/2402859; [Anonymous], 1972, P C CONSERVATION PRO; Becker C, 1996, HENLOCK ECOLOGY MANA; Calcote R, 2003, HOLOCENE, V13, P215, DOI 10.1191/0959683603hl608rp; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Davis MB, 1998, ECOLOGY, V79, P2641, DOI 10.2307/176507; Donoso PJ, 2006, NORTH J APPL FOR, V23, P288, DOI 10.1093/njaf/23.4.288; Duchesne LC, 1999, CAN FIELD NAT, V113, P264; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Eckstein R.G., 1980, 104 WISC DEP NAT RES; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Foster DR, 2006, ECOLOGY, V87, P2959, DOI 10.1890/0012-9658(2006)87[2959:ACDFAM]2.0.CO;2; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; FOSTER DR, 1988, J ECOL, V76, P105, DOI 10.2307/2260457; Frelich L.E., 2002, FOREST DYNAMICS DIST, Vfirst; FRELICH LE, 1994, CAN J FOREST RES, V24, P1939, DOI 10.1139/x94-249; FRELICH LE, 1991, ECOL MONOGR, V61, P145, DOI 10.2307/1943005; FRELICH LE, 1993, ECOLOGY, V74, P513, DOI 10.2307/1939312; FRELICH LE, 1985, BIOL CONSERV, V34, P99, DOI 10.1016/0006-3207(85)90103-X; George Lisa O., 2003, P265; George LO, 1999, ECOLOGY, V80, P846, DOI 10.1890/0012-9658(1999)080[0846:TFUAAE]2.0.CO;2; Gilliam Frank S., 2003, P3; Godman R.M., 1990, SILVICS N AM 1 CONIF; Goff FG, 1967, WISCONSIN GEOLOGICAL; Goff FG, 1967, SOIL SERIES U WISCON; GRAHAM S. A., 1941, JOUR FOREST, V39, P567; Hayhoe K, 2010, J GREAT LAKES RES, V36, P7, DOI 10.1016/j.jglr.2010.03.012; He HS, 1999, ECOLOGY, V80, P81, DOI 10.1890/0012-9658(1999)080[0081:SEASSO]2.0.CO;2; HIBBS DE, 1982, CAN J FOREST RES, V12, P522, DOI 10.1139/x82-081; Hough A. F., 1943, ECOL MONOGR, V13, P299, DOI 10.2307/1943224; Houle G, 1999, J ECOL, V87, P413, DOI 10.1046/j.1365-2745.1999.00352.x; Howe R. W., 1996, HEMLOCK ECOLOGY MANA, P125; Iverson L, 2008, MITIG ADAPT STRAT GL, V13, P487, DOI 10.1007/s11027-007-9129-y; Jenkins MA, 2004, FOREST SCI, V50, P781; Johnston W., 1990, SILVICS N AM; Kartesz JT, 1999, SYNTHESIS N AM FLORA; Krapfl KJ, 2011, J TORREY BOT SOC, V138, P93, DOI 10.3159/10-RA-031.1; MAISSUROW D. K., 1941, JOUR FOREST, V39, P201; Marx L, 2008, J ECOL, V96, P505, DOI 10.1111/j.1365-2745.2008.01360.x; McCune B., 2006, PC ORD MULTIVARIATE; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Mielke P. W., 2001, PERMUTATION METHODS; MILES M. L., 1960, FOREST CHRON, V36, P375; Minitab Inc, 2010, MIN REL 16 WIND; MLADENOFF DJ, 1993, CONSERV BIOL, V7, P889, DOI 10.1046/j.1523-1739.1993.740889.x; National Climatic Data Center, 2012, CLIM MON REP PROD PD; Pubanz DM, 1996, HEMLOCK ECOLOGY MANA, P175; Roberts Mark R., 2003, P302; Rooney TP, 1998, FOREST ECOL MANAG, V111, P211, DOI 10.1016/S0378-1127(98)00333-8; Rooney TP, 2000, ECOL APPL, V10, P1119, DOI 10.1890/1051-0761(2000)010[1119:RVIROH]2.0.CO;2; RUNKLE JR, 1982, ECOLOGY, V63, P1533, DOI 10.2307/1938878; Salk TT, 2011, FOREST ECOL MANAG, V261, P1998, DOI 10.1016/j.foreco.2011.02.026; SIMPSON TB, 1990, LANDSCAPE ECOSYSTEMS; Snyder CD, 2002, CAN J FISH AQUAT SCI, V59, P262, DOI 10.1139/F02-003; Stueve KM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00062.1; Turner MG, 2003, FRONT ECOL ENVIRON, V1, P351, DOI 10.2307/3868187; Walters RS, 1990, SILVICS N AM; Western Regional Climate Center, 2012, US DIV CLIM DAT; WinSCANOPY, 2005, WINSCANOPY 2005A HEM; Witt JC, 2010, FOREST ECOL MANAG, V260, P519, DOI 10.1016/j.foreco.2010.05.007; Wydeven AP, 1996, HEMLOCK ECOLOGY MANA, P115; Yamasaki M, 2000, USDA NE EXP, V267, P135; Ziegler SS, 2000, GLOBAL ECOL BIOGEOGR, V9, P373, DOI 10.1046/j.1365-2699.2000.00191.x	65	2	2	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43867	10.1371/journal.pone.0043867	http://dx.doi.org/10.1371/journal.pone.0043867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928044	gold, Green Submitted, Green Published			2022-12-27	WOS:000307789700053
J	Sager, KL; Wuu, J; Herskowitz, JH; Mufson, EJ; Levey, AI; Lah, JJ				Sager, Kristen L.; Wuu, Joanne; Herskowitz, Jeremy H.; Mufson, Elliott J.; Levey, Allan I.; Lah, James J.			Neuronal LR11 Expression Does Not Differentiate between Clinically-Defined Alzheimer's Disease and Control Brains	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; LR11/SORLA EXPRESSION; GENETIC-VARIANTS; NUCLEUS BASALIS; RECEPTOR LR11; SORL1 GENE; ASSOCIATION; CONSORTIUM; ESTABLISH	Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Because the pathological changes underlying this disease can begin decades prior to the onset of cognitive impairment, identifying the earliest events in the AD pathological cascade has critical implications for both the diagnosis and treatment of this disease. We previously reported that compared to autopsy confirmed healthy control brain, expression of LR11 (or SorLA) is markedly reduced in AD brain as well as in a subset of people with mild cognitive impairment (MCI), a prodromal clinical stage of AD. Recent studies of the LR11 gene SORL1 have suggested that the association between SORL1 single nucleotide polymorphisms (SNPs) and AD risk may not be universal. Therefore, we sought to confirm our earlier findings in a population chosen solely based on clinical criteria, as in most genetic studies. Quantitative immunohistochemistry was used to measure LR11 expression in 43 cases from the Religious Orders Study that were chosen based on a final pre-mortem clinical diagnosis of MCI, mild/moderate AD or no cognitive impairment (NCI). LR11 expression was highly variable in all three diagnostic groups, with no significant group differences. Low LR11 cases were identified using the lowest tertile of LR11 expression observed across all cases as a threshold. Contrary to previous reports, low LR11 expression was found in only 29% of AD cases. A similar proportion of both the MCI and NCI cases also displayed low LR11 expression. AD-associated lesions were present in the majority of cases regardless of diagnostic group, although we found no association between LR11 levels and pathological variables. These findings suggest that the relationship between LR11 expression and the development of AD may be more complicated than originally believed.	[Sager, Kristen L.; Herskowitz, Jeremy H.; Levey, Allan I.; Lah, James J.] Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Wuu, Joanne] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Mufson, Elliott J.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Herskowitz, Jeremy H.; Levey, Allan I.; Lah, James J.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	Emory University; University of Miami; Rush University; Emory University	Sager, KL (corresponding author), Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA.	jlah@emory.edu	Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X	NIH [PO1AG14449, P50AG025688, F31NS054436]; ADR, a program of the American Health Assistance Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, P01AG014449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADR, a program of the American Health Assistance Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants PO1AG14449, P50AG025688, and F31NS054436. Acknowledgement is also made to the donors of ADR, a program of the American Health Assistance Foundation, for support of this research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bettens K, 2008, HUM MUTAT, V29, P769, DOI 10.1002/humu.20725; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chow N, 1998, P NATL ACAD SCI USA, V95, P9620, DOI 10.1073/pnas.95.16.9620; Cochran EJ, 1998, J NEUROPATH EXP NEUR, V57, P508, DOI 10.1097/00005072-199805000-00175; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Fillenbaum GG, 2008, ALZHEIMERS DEMENT, V4, P96, DOI 10.1016/j.jalz.2007.08.005; Gilmor ML, 1999, J COMP NEUROL, V411, P693; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Herskowitz JH, 2011, J BIOL CHEM, V286, P6117, DOI 10.1074/jbc.M110.167239; Herskowitz JH, 2010, J PROTEOME RES, V9, P6368, DOI 10.1021/pr100666c; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kauwe JSK, 2010, J ALZHEIMERS DIS, V21, P833, DOI 10.3233/JAD-2010-091711; Kolsch H, 2009, BRAIN RES, V1264, P1, DOI 10.1016/j.brainres.2009.01.044; Laumet G, 2010, J ALZHEIMERS DIS, V20, P1181, DOI 10.3233/JAD-2010-100126; Lee JH, 2007, NEUROSCI LETT, V425, P105, DOI 10.1016/j.neulet.2007.08.042; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; Li Y, 2008, NEUROBIOL DIS, V29, P293, DOI 10.1016/j.nbd.2007.09.001; Liu F, 2009, J ALZHEIMERS DIS, V18, P51, DOI 10.3233/JAD-2009-1137; Markesbery WR, 2006, ARCH NEUROL-CHICAGO, V63, P38, DOI 10.1001/archneur.63.1.38; Meng Y, 2007, NEUROREPORT, V18, P1761, DOI 10.1097/WNR.0b013e3282f13e7a; Minster RL, 2008, NEUROSCI LETT, V440, P190, DOI 10.1016/j.neulet.2008.05.082; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mufson EJ, 1997, EXP NEUROL, V146, P91, DOI 10.1006/exnr.1997.6504; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sager KL, 2007, ANN NEUROL, V62, P640, DOI 10.1002/ana.21190; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; TOMLINSON BE, 1968, J NEUROL SCI, V7, P331, DOI 10.1016/0022-510X(68)90154-8; Wolk DA, 2009, ANN NEUROL, V65, P557, DOI 10.1002/ana.21598; Zaudig M, 1992, Int Psychogeriatr, V4 Suppl 2, P203	40	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e40527	10.1371/journal.pone.0040527	http://dx.doi.org/10.1371/journal.pone.0040527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927900	Green Published, gold, Green Submitted			2022-12-27	WOS:000307789700001
J	Chamie, G; Kwarisiima, D; Clark, TD; Kabami, J; Jain, V; Geng, E; Petersen, ML; Thirumurthy, H; Kamya, MR; Havlir, DV; Charlebois, ED				Chamie, Gabriel; Kwarisiima, Dalsone; Clark, Tamara D.; Kabami, Jane; Jain, Vivek; Geng, Elvin; Petersen, Maya L.; Thirumurthy, Harsha; Kamya, Moses R.; Havlir, Diane V.; Charlebois, Edwin D.		SEARCH Collaboration	Leveraging Rapid Community-Based HIV Testing Campaigns for Non-Communicable Diseases in Rural Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INCOME COUNTRIES; HEALTH-CARE; HYPERTENSION; KENYA; TUBERCULOSIS; PREVENTION; INITIATION; TANZANIA; COSTS	Background: The high burden of undiagnosed HIV in sub-Saharan Africa limits treatment and prevention efforts. Community-based HIV testing campaigns can address this challenge and provide an untapped opportunity to identify non-communicable diseases (NCDs). We tested the feasibility and diagnostic yield of integrating NCD and communicable diseases into a rapid HIV testing and referral campaign for all residents of a rural Ugandan parish. Methods: A five-day, multi-disease campaign, offering diagnostic, preventive, treatment and referral services, was performed in May 2011. Services included point-of-care screening for HIV, malaria, TB, hypertension and diabetes. Finger-prick diagnostics eliminated the need for phlebotomy. HIV-infected adults met clinic staff and peer counselors on-site; those with CD4 <= 100/mu L underwent intensive counseling and rapid referral for antiretroviral therapy (ART). Community participation, case-finding yield, and linkage to care three months post-campaign were analyzed. Results: Of 6,300 residents, 2,323/3,150 (74%) adults and 2,020/3,150 (69%) children participated. An estimated 95% and 52% of adult female and male residents participated respectively. Adult HIV prevalence was 7.8%, with 46% of HIV-infected adults newly diagnosed. Thirty-nine percent of new HIV diagnoses linked to care. In a pilot subgroup with CD4 <= 100, 83% linked and started ART within 10 days. Malaria was identified in 10% of children, and hypertension and diabetes in 28% and 3.5% of adults screened, respectively. Sixty-five percent of hypertensives and 23% of diabetics were new diagnoses, of which 43% and 61% linked to care, respectively. Screening identified suspected TB in 87% of HIV-infected and 19% of HIV-uninfected adults; 52% percent of HIV-uninfected TB suspects linked to care. Conclusions: In an integrated campaign engaging 74% of adult residents, we identified a high burden of undiagnosed HIV, hypertension and diabetes. Improving male attendance and optimizing linkage to care require new approaches. The campaign demonstrates the feasibility of integrating hypertension, diabetes and communicable diseases into HIV initiatives.	[Chamie, Gabriel; Clark, Tamara D.; Jain, Vivek; Geng, Elvin; Havlir, Diane V.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA; [Chamie, Gabriel; Clark, Tamara D.; Kabami, Jane; Jain, Vivek; Geng, Elvin; Kamya, Moses R.; Havlir, Diane V.; Charlebois, Edwin D.] Makerere Univ Univ Calif San Francisco MU UCSF Re, Mbarara, Uganda; [Kwarisiima, Dalsone] Mulago Mbarara Joint AIDS Program, Kampala, Uganda; [Kwarisiima, Dalsone] Mulago Mbarara Joint AIDS Program, Mbarara, Uganda; [Petersen, Maya L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Thirumurthy, Harsha] Univ N Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda; [Charlebois, Edwin D.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; Makerere University; University of California System; University of California San Francisco	Chamie, G (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA.	Gabriel.chamie@ucsf.edu		Thirumurthy, Harsha/0000-0002-3308-7603	National Institutes of Health/National Institute of Allergy and Infectious Diseases [3P30AI027763-19S1]; National Institute of Mental Health's Traineeships in AIDS Prevention Studies [T32 MH-19105-21]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI099959, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health's Traineeships in AIDS Prevention Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The National Institutes of Health/National Institute of Allergy and Infectious Diseases (grant 3P30AI027763-19S1 to D. V. H.), and the National Institute of Mental Health's Traineeships in AIDS Prevention Studies (grant T32 MH-19105-21 to G. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; [Anonymous], 2010, WHO GUID INT TUB CAS; [Anonymous], 2006, DEF DIAGN DIAB MELL, P1; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Boehme CC, 2010, N ENGL J MED; Bovet P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-407; Buregyeya E, 2011, INT J TUBERC LUNG D, V15, P938, DOI 10.5588/ijtld.10.0211; Bwambale FM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-263; Clark CM, 2000, JAMA-J AM MED ASSOC, V284, P363, DOI 10.1001/jama.284.3.363; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kahn JG, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-346; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; MarquesVidal P, 1997, J HUM HYPERTENS, V11, P213, DOI 10.1038/sj.jhh.1000426; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Mills EJ, 2009, LANCET, V374, P275, DOI 10.1016/S0140-6736(09)61348-9; Ministry of Health, 2009, NAT ANT TREATM GUID; Ministry of Health, 2005, UG NAT POL GUID HIV; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sendagire I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014459; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; Uganda Bureau of Statistics, 2008, POP PROJ 2008 2012; United Nations, 2011, UN HIGH LEV M NONC D; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2004, ADD DEW VIT A DISTR; World Health Organization,, 2011, GUID VIT A SUPPL INF; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; 2000, LANCET, V356, P103	35	103	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43400	10.1371/journal.pone.0043400	http://dx.doi.org/10.1371/journal.pone.0043400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916256	gold, Green Published, Green Submitted			2022-12-27	WOS:000307733800065
J	Malik, DJ; Trochimczuk, AW; Ronka, S				Malik, Danish J.; Trochimczuk, Andrzej W.; Ronka, Sylwia			Nanostructured Synthetic Carbons Obtained by Pyrolysis of Spherical Acrylonitrile/Divinylbenzene Copolymers	PLOS ONE			English	Article							STYRENE-DIVINYLBENZENE COPOLYMER; PHOSPHORIC-ACID; HEAT-TREATMENT; ADSORPTION; POLYCARBODIIMIDE; STABILIZATION; CARBONIZATION; POLYSTYRENE; PRECURSORS; SORBENTS	Novel carbon materials have been prepared by the carbonization of acrylonitrile (AN)/divinylbenzene (DVB) suspension porous copolymers having nominal crosslinking degrees in the range of 30-70% and obtained in the presence of various amounts of porogens. The carbons were obtained by pre-oxidation of AN/DVB copolymers at 250-350 degrees C in air followed by pyrolysis at 850 degrees C in an N-2 atmosphere. Both processes were carried out in one furnace and the resulting material needed no further activation. Resulting materials were characterized by XPS and low temperature nitrogen adsorption/desorption. It was found that maximum pyrolysis yield was ca. 50% depending on the oxidation conditions but almost independent of the crosslinking degree of the polymers. Porous structure of the carbons was characterized for the presence of micropores and macropores, when obtained from highly crosslinked polymers or polymers oxidized at 350 degrees C and meso-and macropores in all other cases. The latter pores are prevailing in the structure of carbons obtained from less porous AN/DVB resins. Specific surface area (BET) of polymer derived carbons can vary between 440 m(2)/g and 250 m(2)/g depending on the amount of porogen used in the synthesis of the AN/DVB polymeric precursors.	[Malik, Danish J.] Univ Loughborough, Dept Chem Engn, Loughborough, Leics, England; [Trochimczuk, Andrzej W.; Ronka, Sylwia] Wroclaw Univ Technol, Fac Chem, PL-50370 Wroclaw, Poland	Loughborough University; Wroclaw University of Science & Technology	Malik, DJ (corresponding author), Univ Loughborough, Dept Chem Engn, Loughborough, Leics, England.	d.j.malik@lboro.ac.uk	Ronka, Sylwia/AAH-8700-2020	Ronka, Sylwia/0000-0003-4754-1798	Engineering and Physical Sciences Research Council [EP/C517660/1, EP/D033837/1] Funding Source: researchfish; EPSRC [EP/D033837/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Duranoglu D, 2012, CHEM ENG J, V187, P193, DOI 10.1016/j.cej.2012.01.120; Ermolenko N, 1990, CHEM MODIFIED CARBON, P147; Gupta A, 1997, CARBON, V35, P809, DOI 10.1016/S0008-6223(97)00025-0; Inomata K, 2009, J MATER SCI, V44, P4200, DOI 10.1007/s10853-009-3560-2; Kocirik M, 2001, CARBON, V39, P1919, DOI 10.1016/S0008-6223(00)00326-2; KOLARZ BN, 1994, J POLYM SCI POL PHYS, V32, P1977, DOI 10.1002/polb.1994.090321204; Laszlo K, 2000, CARBON, V38, P1965, DOI 10.1016/S0008-6223(00)00038-5; Lenghaus K, 2002, CARBON, V40, P743, DOI 10.1016/S0008-6223(01)00194-4; Li WJ, 1996, ADSORPTION, V3, P67; Malik DJ, 2008, CARBON, V46, P310, DOI 10.1016/j.carbon.2007.11.041; Malik DJ, 2005, CARBON, V43, P2317, DOI 10.1016/j.carbon.2005.04.038; MATSUDA M, 1987, J POLYM SCI POL CHEM, V25, P669, DOI 10.1002/pola.1987.080250218; Moon S, 2009, CARBON, V47, P2829, DOI 10.1016/j.carbon.2009.06.027; Morawski AW, 1997, J MATER SCI, V32, P789, DOI 10.1023/A:1018520709777; Nakagawa H, 1999, CARBON, V37, P1455, DOI 10.1016/S0008-6223(99)00008-1; NEELY JW, 1981, CARBON, V19, P27, DOI 10.1016/0008-6223(81)90101-9; PELS JR, 1995, CARBON, V33, P1641, DOI 10.1016/0008-6223(95)00154-6; Puziy AM, 2007, APPL SURF SCI, V253, P5736, DOI 10.1016/j.apsusc.2006.12.034; Puziy AM, 2002, CARBON, V40, P1493, DOI 10.1016/S0008-6223(01)00317-7; Puziy AM, 2002, CARBON, V40, P1507, DOI 10.1016/S0008-6223(01)00318-9; Rahaman MSA, 2007, POLYM DEGRAD STABIL, V92, P1421, DOI 10.1016/j.polymdegradstab.2007.03.023; Ronka S, 2008, CARBON, V46, P1098, DOI 10.1016/j.carbon.2008.02.026; Schmiers H, 1999, CARBON, V37, P1965, DOI 10.1016/S0008-6223(99)00071-8; Shioya M, 1996, CARBON, V34, P1229, DOI 10.1016/0008-6223(96)00083-8; Trochimczuk AW, 2001, REACT FUNCT POLYM, V46, P259, DOI 10.1016/S1381-5148(00)00056-0; Wang Q, 2009, FUEL PROCESS TECHNOL, V90, P381, DOI 10.1016/j.fuproc.2008.10.008; WINSLOW FH, 1955, J POLYM SCI, V16, P101, DOI 10.1002/pol.1955.120168202; Yamashita J, 1999, CARBON, V37, P71, DOI 10.1016/S0008-6223(98)00188-2	28	6	6	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43354	10.1371/journal.pone.0043354	http://dx.doi.org/10.1371/journal.pone.0043354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916245	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300042
J	Pioz, M; Guis, H; Crespin, L; Gay, E; Calavas, D; Durand, B; Abrial, D; Ducrot, C				Pioz, Maryline; Guis, Helene; Crespin, Laurent; Gay, Emilie; Calavas, Didier; Durand, Benoit; Abrial, David; Ducrot, Christian			Why Did Bluetongue Spread the Way It Did? Environmental Factors Influencing the Velocity of Bluetongue Virus Serotype 8 Epizootic Wave in France	PLOS ONE			English	Article							BREVITARSIS KIEFFER DIPTERA; CULICOIDES BITING MIDGES; SPATIAL AUTOCORRELATION; OBSOLETUS COMPLEX; ARBOVIRUS VECTOR; ABIOTIC FACTORS; WESTERN-EUROPE; CLIMATE-CHANGE; CATTLE; RISK	Understanding where and how fast an infectious disease will spread during an epidemic is critical for its control. However, the task is a challenging one as numerous factors may interact and drive the spread of a disease, specifically when vector-borne diseases are involved. We advocate the use of simultaneous autoregressive models to identify environmental features that significantly impact the velocity of disease spread. We illustrate this approach by exploring several environmental factors influencing the velocity of bluetongue (BT) spread in France during the 2007-2008 epizootic wave to determine which ones were the most important drivers. We used velocities of BT spread estimated in 4,495 municipalities and tested sixteen covariates defining five thematic groups of related variables: elevation, meteorological-related variables, landscape-related variables, host availability, and vaccination. We found that ecological factors associated with vector abundance and activity (elevation and meteorological-related variables), as well as with host availability, were important drivers of the spread of the disease. Specifically, the disease spread more slowly in areas with high elevation and when heavy rainfall associated with extreme temperature events occurred one or two months prior to the first clinical case. Moreover, the density of dairy cattle was correlated negatively with the velocity of BT spread. These findings add substantially to our understanding of BT spread in a temperate climate. Finally, the approach presented in this paper can be used with other infectious diseases, and provides a powerful tool to identify environmental features driving the velocity of disease spread.	[Pioz, Maryline; Crespin, Laurent; Abrial, David; Ducrot, Christian] INRA, Epidemiol Anim UR346, Paris, France; [Pioz, Maryline; Guis, Helene] CIRAD, UMR CMAEE, Montpellier, France; [Crespin, Laurent] Univ Lyon, Lab Biometrie & Biol Evolut, Lyon, France; [Crespin, Laurent] Univ Lyon 1, F-69622 Villeurbanne, France; [Crespin, Laurent] CNRS, UMR5558, Villeurbanne, France; [Gay, Emilie; Calavas, Didier] French Agcy Food Environm & Occupat Hlth Safety, Lyon, France; [Durand, Benoit] French Agcy Food Environm & Occupat Hlth Safety, Maisons Alfort, France	INRAE; CIRAD; VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Pioz, M (corresponding author), INRA, Epidemiol Anim UR346, Paris, France.	maryline.pioz@hotmail.fr	Durand, Benoit/GSE-2511-2022; Pioz, Maryline/AAI-3325-2020	Pioz, Maryline/0000-0003-0331-4403; Durand, Benoit/0000-0003-0669-1394; Crespin, Laurent/0000-0001-8930-215X; Guis, Helene/0000-0002-0355-0898	French Ministry of Agriculture	French Ministry of Agriculture	This study was funded by the French Ministry of Agriculture. The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Agency T, 2007, CLC 2006 TECHN GUID; Allepuz A, 2010, PREV VET MED, V96, P263, DOI 10.1016/j.prevetmed.2010.06.005; Anselin L, 1996, REG SCI URBAN ECON, V26, P77, DOI 10.1016/0166-0462(95)02111-6; Backer JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023066; Baylis M, 2010, MED VET ENTOMOL, V24, P38, DOI 10.1111/j.1365-2915.2009.00842.x; Bishop AL, 2000, PREV VET MED, V47, P243, DOI 10.1016/S0167-5877(00)00175-6; Bishop AL, 2004, PREV VET MED, V65, P135, DOI 10.1016/j.prevetmed.2004.06.011; Bivand RS, 2008, USE R, P1; Bivand RS, 2002, J GEOGRAPHICAL SYSTE, V4, P405, DOI [DOI 10.1007/S101090300096, 10.1007/s101090300096]; Boyer TC, 2010, AM J TROP MED HYG, V83, P789, DOI 10.4269/ajtmh.2010.10-0132; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calvete C, 2009, VET J, V182, P235, DOI 10.1016/j.tvjl.2008.06.010; Caporale V, 2010, REV SCI TECH OIE, V29, P573, DOI 10.20506/rst.29.3.2001; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; De Liberato C, 2005, VET REC, V156, P301, DOI 10.1136/vr.156.10.301; De Liberato C, 2010, J MED ENTOMOL, V47, P313, DOI 10.1603/ME09148; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Ducheyne E, 2007, GEOSPATIAL HEALTH, V1, P177, DOI 10.4081/gh.2007.266; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Fassotte C, 2008, PREV VET MED, V87, P74, DOI 10.1016/j.prevetmed.2008.06.007; Gerbier G, 2008, PREV VET MED, V87, P119, DOI 10.1016/j.prevetmed.2008.06.012; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Guis H, 2007, VET RES, V38, P669, DOI 10.1051/vetres:2007025; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Haining R., 2003, SPATIAL DATA ANAL TH; Haining R, 1990, SPATIAL DATA ANAL SO; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Hendrickx G, 2008, PREV VET MED, V87, P162, DOI 10.1016/j.prevetmed.2008.06.009; Kao RR, 2002, TRENDS MICROBIOL, V10, P279, DOI 10.1016/S0966-842X(02)02371-5; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kuhn I, 2007, DIVERS DISTRIB, V13, P66, DOI 10.1111/j.1472-4642.2006.00293.x; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; LILLIE TH, 1985, J AM MOSQUITO CONTR, V1, P463; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MELLOR PS, 1979, B ENTOMOL RES, V69, P229, DOI 10.1017/S0007485300017697; Mellor PS, 2009, BIOL ANIM INFECT, P1; Mullens BA, 2004, VETER ITAL SER, V40, P160; MURRAY JD, 1986, PROC R SOC SER B-BIO, V229, P111, DOI 10.1098/rspb.1986.0078; MURRAY MD, 1995, VET MICROBIOL, V46, P91, DOI 10.1016/0378-1135(95)00075-L; Olden JD, 2000, ECOSCIENCE, V7, P501, DOI 10.1080/11956860.2000.11682622; Patta C, 2004, Vet Ital, V40, P601; Pioz M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-60; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; R Development Core Team, 2010, R FDN STAT COMP R ST; R package version 0.5-37, 2011, R PACKAGE VERSION 0; R package version 1.6-35, 2001, R PACKAGE VERSION 1; Racloz V, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-42; Sanders CJ, 2011, J APPL ECOL, V48, P1355, DOI 10.1111/j.1365-2664.2011.02051.x; Santman-Berends IMGA, 2010, VET MICROBIOL, V142, P268, DOI 10.1016/j.vetmic.2009.10.026; Savill Nicholas J, 2006, BMC Vet Res, V2, P3, DOI 10.1186/1746-6148-2-3; Savini G, 2004, VETER ITAL SER, V40, P286; Savini G, 2005, VET REC, V157, P133, DOI 10.1136/vr.157.5.133; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Smith GC, 2002, ECOL MODEL, V150, P45, DOI 10.1016/S0304-3800(01)00471-9; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; Szmaragd C, 2010, EPIDEMICS-NETH, V2, P139, DOI 10.1016/j.epidem.2010.05.002; Szmaragd C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009353; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Tognelli MF, 2004, ECOGRAPHY, V27, P427, DOI 10.1111/j.0906-7590.2004.03732.x; Vidal JP, 2010, INT J CLIMATOL, V30, P1627, DOI 10.1002/joc.2003; WARD MP, 1995, PREV VET MED, V24, P129, DOI 10.1016/0167-5877(94)00458-U; Ward MP, 1996, VET RES COMMUN, V20, P273, DOI 10.1007/BF00366925; WARD MP, 1994, VET REC, V134, P407, DOI 10.1136/vr.134.16.407; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Wittmann EJ, 2000, VET J, V160, P107, DOI 10.1053/tvjl.2000.0470; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020891	79	37	37	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43360	10.1371/journal.pone.0043360	http://dx.doi.org/10.1371/journal.pone.0043360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916249	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600073
J	Pajula, J; Kauppi, JP; Tohka, J				Pajula, Juha; Kauppi, Jukka-Pekka; Tohka, Jussi			Inter-Subject Correlation in fMRI: Method Validation against Stimulus-Model Based Analysis	PLOS ONE			English	Article							FALSE DISCOVERY RATE; HUMAN BRAIN; INTERSUBJECT CORRELATIONS; DEFAULT-MODE; BOLD FMRI; IMAGES; CORTEX; ROBUST; OPTIMIZATION; REGISTRATION	Within functional magnetic resonance imaging (fMRI), the use of the traditional general linear model (GLM) based analysis methods is often restricted to strictly controlled research setups requiring a parametric activation model. Instead, Inter-Subject Correlation (ISC) method is based on voxel-wise correlation between the time series of the subjects, which makes it completely non-parametric and thus suitable for naturalistic stimulus paradigms such as movie watching. In this study, we compared an ISC based analysis results with those of a GLM based in five distinct controlled research setups. We used International Consortium for Brain Mapping functional reference battery (FRB) fMRI data available from the Laboratory of Neuro Imaging image data archive. The selected data included measurements from 37 right-handed subjects, who all had performed the same five tasks from FRB. The GLM was expected to locate activations accurately in FRB data and thus provide good grounds for investigating relationship between ISC and stimulus induced fMRI activation. The statistical maps of ISC and GLM were compared with two measures. The first measure was the Pearson's correlation between the non-thresholded ISC test-statistics and absolute values of the GLM Z-statistics. The average correlation value over five tasks was 0.74. The second was the Dice index between the activation regions of the methods. The average Dice value over the tasks and three threshold levels was 0.73. The results of this study indicated how the data driven ISC analysis found the same foci as the model-based GLM analysis. The agreement of the results is highly interesting, because ISC is applicable in situations where GLM is not suitable, for example, when analyzing data from a naturalistic stimuli experiment.	[Pajula, Juha; Tohka, Jussi] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Kauppi, Jukka-Pekka] Univ Helsinki, Dept Comp Sci, SF-00510 Helsinki, Finland	Tampere University; University of Helsinki	Pajula, J (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	juha.pajula@tut.fi	Tohka, Jussi/D-2385-2013	Tohka, Jussi/0000-0002-1048-5860; Tohka, Jussi/0000-0002-6748-5116	International Consortium for Brain Mapping (ICBM); National Institute of Biomedical Imaging and BioEngineering; Academy of Finland [129657]; Finnish Programme for Centres of Excellence in Research [130275]	International Consortium for Brain Mapping (ICBM); National Institute of Biomedical Imaging and BioEngineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Academy of Finland(Academy of Finland); Finnish Programme for Centres of Excellence in Research	Data collection and sharing for this project was provided by the International Consortium for Brain Mapping (ICBM; Principal Investigator: John Mazziotta, MD, PhD). ICBM funding was provided by the National Institute of Biomedical Imaging and BioEngineering. ICBM data are disseminated by the Laboratory of Neuro Imaging at the University of California, Los Angeles.; This research was supported by the Academy of Finland (application number 129657, Finnish Programme for Centres of Excellence in Research, 2006 2011 and grant number 130275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Bellec P, 2009, MAGN RESON IMAGING, V27, P1382, DOI 10.1016/j.mri.2009.05.034; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calhoun VD, 2012, NEUROIMAGE, V59, P25, DOI 10.1016/j.neuroimage.2011.06.037; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Finch H, 2005, J DATA SCI, V3, P85; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hamilton LS, 2009, HUM BRAIN MAPP, V30, P3958, DOI 10.1002/hbm.20820; Hanson SJ, 2009, J COMPUT NEUROSCI, V27, P103, DOI 10.1007/s10827-008-0129-z; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Hasson U, 2009, AUTISM RES, V2, P220, DOI 10.1002/aur.89; Hejnar MR, 2007, HUM BRAIN MAPP, V28, P860, DOI 10.1002/hbm.20321; Jaaskelainen Iiro P, 2008, Open Neuroimag J, V2, P14, DOI 10.2174/1874440000802010014; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kauppi J- P, 2010, INF TECHN APPL BIOM, P1, DOI [10.1109/ITAB.2010.5687650, DOI 10.1109/ITAB.2010.5687650]; Kauppi Jukka-Pekka, 2010, Front Neuroinform, V4, P5, DOI 10.3389/fninf.2010.00005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Logan BR, 2004, NEUROIMAGE, V22, P95, DOI 10.1016/j.neuroimage.2003.12.047; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Smith J. O, SPECTRAL AUDIO SIGNA; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spiers HJ, 2007, TRENDS COGN SCI, V11, P356, DOI 10.1016/j.tics.2007.06.002; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	38	52	53	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41196	10.1371/journal.pone.0041196	http://dx.doi.org/10.1371/journal.pone.0041196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22924089	gold, Green Published			2022-12-27	WOS:000307331100011
J	Hedin, M; Starrett, J; Akhter, S; Schonhofer, AL; Shultz, JW				Hedin, Marshal; Starrett, James; Akhter, Sajia; Schoenhofer, Axel L.; Shultz, Jeffrey W.			Phylogenomic Resolution of Paleozoic Divergences in Harvestmen (Arachnida, Opiliones) via Analysis of Next-Generation Transcriptome Data	PLOS ONE			English	Article							FOSSIL CALIBRATIONS; BAYESIAN-ESTIMATION; VENOM GLAND; RNA-SEQ; GENES; INFORMATIVENESS; EVOLUTIONARY; SEQUENCES; TIMES; MULTILOCUS	Next-generation sequencing technologies are rapidly transforming molecular systematic studies of non-model animal taxa. The arachnid order Opiliones (commonly known as "harvestmen") includes more than 6,400 described species placed into four well-supported lineages (suborders). Fossil plus molecular clock evidence indicates that these lineages were diverging in the late Silurian to mid-Carboniferous, with some fossil harvestmen representing the earliest known land animals. Perhaps because of this ancient divergence, phylogenetic resolution of subordinal interrelationships within Opiliones has been difficult. We present the first phylogenomics analysis for harvestmen, derived from comparative RNA-Seq data for eight species representing all suborders. Over 30 gigabases of original Illumina short-read data were used in de novo assemblies, resulting in 50-80,000 transcripts per taxon. Transcripts were compared to published scorpion and tick genomics data, and a stringent filtering process was used to identify over 350 putatively single-copy, orthologous protein-coding genes shared among taxa. Phylogenetic analyses using various partitioning strategies, data coding schemes, and analytical methods overwhelmingly support the "classical" hypothesis of Opiliones relationships, including the higher-level clades Palpatores and Phalangida. Relaxed molecular clock analyses using multiple alternative fossil calibration strategies corroborate ancient divergences within Opiliones that are possibly deeper than the recorded fossil record indicates. The assembled data matrices, comprising genes that are conserved, highly expressed, and varying in length and phylogenetic informativeness, represent an important resource for future molecular systematic studies of Opiliones and other arachnid groups.	[Hedin, Marshal; Schoenhofer, Axel L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Starrett, James] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Akhter, Sajia] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Shultz, Jeffrey W.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	California State University System; San Diego State University; University of California System; University of California Riverside; California State University System; San Diego State University; University System of Maryland; University of Maryland College Park	Hedin, M (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	mhedin@sciences.sdsu.edu			National Science Foundation [0640179, 0640173]; California State University Program for Education and Research in Biotechnology (CSUPERB); Maryland Agricultural Experiment Station; Deutsche Forschungsgemeinschaft (DFG)	National Science Foundation(National Science Foundation (NSF)); California State University Program for Education and Research in Biotechnology (CSUPERB); Maryland Agricultural Experiment Station; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Research funding was provided by a collaborative National Science Foundation grant awarded to JWS (award no. 0640179) and MH (award no. 0640173), and a California State University Program for Education and Research in Biotechnology (CSUPERB) grant to MH. JWS was also supported by the Maryland Agricultural Experiment Station, and AS was supported by a postdoc grant from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andrews S, 2011, FASTQC QUALITY CONTR; Bellgard MI, 2012, INT J PARASITOL, V42, P161, DOI 10.1016/j.ijpara.2011.11.006; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Drummond A., 2011, GENEIOUS V5 5; Dunlop J.A., 2007, HARVESTMEN BIOL OPIL, DOI [10.4159/9780674276833-007, DOI 10.4159/9780674276833-007]; Dunlop JA, 2004, T ROY SOC EDIN-EARTH, V94, P341, DOI 10.1017/S0263593300000730; Dunlop JA, 2003, NATURE, V425, P916, DOI 10.1038/425916a; Dunlop Jason A., 2007, P247; Dunlop JA, 2010, ARTHROPOD STRUCT DEV, V39, P124, DOI 10.1016/j.asd.2010.01.003; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Fong JJ, 2011, MOL PHYLOGENET EVOL, V61, P300, DOI 10.1016/j.ympev.2011.06.016; Garwood RJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1458; Giribet G, 2005, P ROY SOC B-BIOL SCI, V272, P1007, DOI 10.1098/rspb.2005.3063; Giribet G, 1999, MOL PHYLOGENET EVOL, V11, P296, DOI 10.1006/mpev.1998.0583; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Giribet G, 2002, CLADISTICS, V18, P5, DOI 10.1006/clad.2001.0185; Giribet Gonzalo, 2007, P62; Giribet G, 2012, BIOL J LINN SOC, V105, P92, DOI 10.1111/j.1095-8312.2011.01774.x; Giribet G, 2010, CLADISTICS, V26, P408, DOI 10.1111/j.1096-0031.2009.00296.x; Hansen H. J., 1904, 2 ORDERS ARACHNIDA O; Hartmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029843; Harvey MS, 2002, J ARACHNOL, V30, P357, DOI 10.1636/0161-8202(2002)030[0357:TNCWDW]2.0.CO;2; Hedin M, 2010, J ARACHNOL, V38, P9, DOI 10.1636/HA09-49.1; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Huang DY, 2009, NATURWISSENSCHAFTEN, V96, P955, DOI 10.1007/s00114-009-0556-3; Inoue J, 2010, SYST BIOL, V59, P74, DOI 10.1093/sysbio/syp078; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Kury A.B., 2011, CLASSIFICATION OPILI; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2008, PHYLOBAYES 2 3 BAYES; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Machado Glauco, 2007, P1; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Martens J., 1980, P355; Martens J., 1986, P289; MARTENS J, 1976, Entomologica Germanica, V3, P51; Masta SE, 2010, GENE, V449, P9, DOI 10.1016/j.gene.2009.09.009; Mattila TM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-70; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McCormack JE, 2012, MOL PHYLO E IN PRESS; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moeller AH, 2011, MOL PHYLOGENET EVOL, V60, P271, DOI 10.1016/j.ympev.2011.04.023; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pick C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-167; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Sanders KL, 2010, SYST BIODIVERS, V8, P63, DOI 10.1080/14772000903562012; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Schaefer I, 2010, MOL PHYLOGENET EVOL, V57, P113, DOI 10.1016/j.ympev.2010.04.015; Schultz Jeffrey W., 2007, P14; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Sharma PP, 2011, INVERTEBR SYST, V25, P106, DOI 10.1071/IS11002; Shultz JW, 2007, ZOOL J LINN SOC-LOND, V150, P221, DOI 10.1111/j.1096-3642.2007.00284.x; Shultz JW, 1998, J ARACHNOL, V26, P257; SHULTZ JW, 1990, CLADISTICS, V6, P1, DOI 10.1111/j.1096-0031.1990.tb00523.x; Shultz JW, 2001, J ARACHNOL, V29, P189, DOI 10.1636/0161-8202(2001)029[0189:PAOPAO]2.0.CO;2; Shulz MH, 2012, BIOINFORMATICS; Stamatakis A., 2008, RAXML 7 0 4 MANUAL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Townsend JP, 2008, J MOL EVOL, V67, P437, DOI 10.1007/s00239-008-9142-0; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Van Zee JP, 2007, INT J PARASITOL, V37, P1297, DOI 10.1016/j.ijpara.2007.05.011; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452	79	52	52	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42888	10.1371/journal.pone.0042888	http://dx.doi.org/10.1371/journal.pone.0042888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936998	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500019
J	Ledberg, A; Montagnini, A; Coppola, R; Bressler, SL				Ledberg, Anders; Montagnini, Anna; Coppola, Richard; Bressler, Steven L.			Reduced Variability of Ongoing and Evoked Cortical Activity Leads to Improved Behavioral Performance	PLOS ONE			English	Article							VISUAL-CORTEX V1; CEREBRAL-CORTEX; PSYCHOPHYSICS TOOLBOX; RESPONSE VARIABILITY; NEURAL ACTIVITY; STRIATE CORTEX; EYE-MOVEMENTS; REACTION-TIME; AREA V4; ATTENTION	Sensory responses of the brain are known to be highly variable, but the origin and functional relevance of this variability have long remained enigmatic. Using the variable foreperiod of a visual discrimination task to assess variability in the primate cerebral cortex, we report that visual evoked response variability is not only tied to variability in ongoing cortical activity, but also predicts mean response time. We used cortical local field potentials, simultaneously recorded from widespread cortical areas, to gauge both ongoing and visually evoked activity. Trial-to-trial variability of sensory evoked responses was strongly modulated by foreperiod duration and correlated both with the cortical variability before stimulus onset as well as with response times. In a separate set of experiments we probed the relation between small saccadic eye movements, foreperiod duration and manual response times. The rate of eye movements was modulated by foreperiod duration and eye position variability was positively correlated with response times. Our results indicate that when the time of a sensory stimulus is predictable, reduction in cortical variability before the stimulus can improve normal behavioral function that depends on the stimulus.	[Ledberg, Anders] Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain; [Montagnini, Anna] Ctr Natl Rech Sci, Inst Neurosci Timone, Marseille, France; [Montagnini, Anna] Aix Marseille Univ, Marseille, France; [Coppola, Richard] NIMH, Clin Brain Disorders Branch, Bethesda, MD 20892 USA; [Bressler, Steven L.] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Dept Psychol, Boca Raton, FL 33431 USA	Pompeu Fabra University; University of Barcelona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); State University System of Florida; Florida Atlantic University	Ledberg, A (corresponding author), Univ Pompeu Fabra, Ctr Brain & Cognit, Dept Informat & Commun Technol, Barcelona, Spain.	anders.ledberg@gmail.com		Coppola, Richard/0000-0003-0273-0675; Ledberg, Anders/0000-0003-3827-8721	European Union [269921]; Ramon y Cajal program from the Spanish government; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002890] Funding Source: NIH RePORTER	European Union(European Commission); Ramon y Cajal program from the Spanish government(Spanish Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 269921 (BrainScaleS). AL is supported by the Ramon y Cajal program from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BERTELSON P, 1969, ACTA PSYCHOL, V30, P145, DOI 10.1016/0001-6918(69)90047-X; BERTELSON P, 1967, Q J EXP PSYCHOL, V19, P272, DOI 10.1080/14640746708400102; Bosman CA, 2009, J NEUROSCI, V29, P9471, DOI 10.1523/JNEUROSCI.1193-09.2009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRESSLER SL, 1993, COMPUTATION AND NEURAL SYSTEMS, P515; Carpenter RHS, 2009, J PHYSIOL-LONDON, V587, P4051, DOI 10.1113/jphysiol.2009.173955; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Cover T. M., 1991, ELEMENTS INFORM THEO; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FUSTER JM, 1962, EXP NEUROL, V6, P384, DOI 10.1016/0014-4886(62)90020-1; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GREEN DM, 1983, PERCEPT PSYCHOPHYS, V34, P195, DOI 10.3758/BF03202946; Gur M, 1997, J NEUROSCI, V17, P2914; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; Hafed ZM, 2011, J NEUROSCI, V31, P15219, DOI 10.1523/JNEUROSCI.3106-11.2011; Jasper HH, 1954, BRAIN MECH CONCIOUSN; KRAUT MA, 1985, ELECTROEN CLIN NEURO, V62, P300, DOI 10.1016/0168-5597(85)90007-3; LANSING RW, 1959, J EXP PSYCHOL, V58, P1, DOI 10.1037/h0041016; Ledberg A, 2007, CEREB CORTEX, V17, P44, DOI 10.1093/cercor/bhj123; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Luce R. D., 1986, RESPONSE TIMES; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PURPURA DP, 1959, INT REV NEUROBIOL, V1, P47, DOI 10.1016/S0074-7742(08)60314-1; Rajkai C, 2008, CEREB CORTEX, V18, P200, DOI 10.1093/cercor/bhm046; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Rieke F., 1997, SPIKES EXPLORING NEU; Rolfs M, 2008, J VISION, V8, DOI 10.1167/8.11.5; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; WERNER G, 1963, J NEUROPHYSIOL, V26, P958, DOI 10.1152/jn.1963.26.6.958; WHITSEL BL, 1977, J NEUROPHYSIOL, V40, P589, DOI 10.1152/jn.1977.40.3.589; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P975, DOI 10.1152/jn.1969.32.6.975; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	53	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43166	10.1371/journal.pone.0043166	http://dx.doi.org/10.1371/journal.pone.0043166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937021	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500033
J	Ye, L; Su, XM; Wu, ZC; Zheng, XR; Wang, J; Zi, C; Zhu, GQ; Wu, SL; Bao, WB				Ye, Lan; Su, Xianmin; Wu, Zhengchang; Zheng, Xianrui; Wang, Jin; Zi, Chen; Zhu, Guoqiang; Wu, Shenglong; Bao, Wenbin			Analysis of Differential miRNA Expression in the Duodenum of Escherichia coli F18-Sensitive and -Resistant Weaned Piglets	PLOS ONE			English	Article							CANCER; GENE; IDENTIFICATION; MICRORNAS; MECHANISM; DISEASE; GROWTH	Small RNA duodenal libraries were constructed for Escherichia coli F18-sensitive and -resistant weaned piglets in full-sib pair groups and sequenced using Illumina Solexa high-throughput sequencing technology. The identification of differentially expressed miRNAs provides the basis for improved database information on pig miRNAs, understanding the genetic basics of differences in resistance to E. coli F18 between local Chinese and exotic pig breeds, and finding new resistance markers for E. coli F18 infection. The duodenum of all individuals contained more than 90% of known swine miRNAs. A total of 58 differentially expressing miRNAs were identified, of which 46 were increased and 12 were decreased in E. coli F18-sensitive pigs. Of miRNAs with increased expression, ssc-miR-143 was most highly expressed, followed by ssc-let-7f, ssc-miR-192, and ssc-miR-21. We identified a total of 2036 intersection target genes by comparing TargetScan data and previous gene expression profile results. Gene ontology and pathway analysis of intersection genes showed that differentially expressed miRNAs were mainly involved in the immune response and transcriptional regulation. Combining information on differential miRNA expression and their regulatory relationships with transcription factors, identified 12 candidate miRNA disease markers, including 11 miRNAs with increased expression, ssc-miR-143, ssc-let-7f, ssc-miR-30e, ssc-miR-148a, ssc-miR-148b, ssc-miR-181a, ssc-miR-192, ssc-miR-27b, ssc-miR-15b, ssc-miR-21, and ssc-miR-215, and one with decreased expression, ssc-miR-152. Quantitative real-time PCR analysis of candidate miRNA expression in a larger cohort of E coli F18-sensitive and resistant animals confirmed the high-throughput sequencing results.	[Ye, Lan; Su, Xianmin; Wu, Zhengchang; Zheng, Xianrui; Wang, Jin; Zi, Chen; Wu, Shenglong; Bao, Wenbin] Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China; [Zhu, Guoqiang] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Ye, L (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China.	slwu@yzu.edu.cn; wenbinbao74@yahoo.com			National Natural Science Funds [31140027, 31172183]; Science and Technology Supporting Project (agriculture) of Jiangsu Province [BE2009330-2, BE2010450]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Science and Technology Supporting Project (agriculture) of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by funding from the National Natural Science Funds (31140027, 31172183), Science and Technology Supporting Project (agriculture) of Jiangsu Province (BE2009330-2 and BE2010450) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bao WB, 2008, J ANIM BREED GENET, V125, P427, DOI 10.1111/j.1439-0388.2008.00722.x; Bao WB, 2012, ANIM GENET, V43, P525, DOI 10.1111/j.1365-2052.2011.02287.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liao YL, 2009, FASEB J, V23; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Reiner G, 2011, BERL MUNCH TIERARZTL, V124, P102, DOI 10.2376/0005-9366-124-102; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Song B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-96; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Vogeli P, 1997, SCHWEIZ ARCH TIERH, V139, P479; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Ye L, 2010, CHINA ANIMAL HUSBAND, V37, P158; Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021	29	21	26	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43741	10.1371/journal.pone.0043741	http://dx.doi.org/10.1371/journal.pone.0043741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937089	gold, Green Published			2022-12-27	WOS:000308225500091
J	Zhu, W; Miao, Q; Sun, D; Yang, GD; Wu, CG; Huang, JG; Zheng, CC				Zhu, Wei; Miao, Qing; Sun, Dan; Yang, Guodong; Wu, Changai; Huang, Jinguang; Zheng, Chengchao			The Mitochondrial Phosphate Transporters Modulate Plant Responses to Salt Stress via Affecting ATP and Gibberellin Metabolism in Arabidopsis thaliana	PLOS ONE			English	Editorial Material							MAIZE ROOT-TIPS; ABIOTIC STRESS; SACCHAROMYCES-CEREVISIAE; SOLUBLE SUGARS; ENERGY-CHARGE; COLD STRESSES; LIFE-CYCLE; CARRIER; TOLERANCE; EXPRESSION	The mitochondrial phosphate transporter (MPT) plays crucial roles in ATP production in plant cells. Three MPT genes have been identified in Arabidopsis thaliana. Here we report that the mRNA accumulations of AtMPTs were up-regulated by high salinity stress in A. thaliana seedlings. And the transgenic lines overexpressing AtMPTs displayed increased sensitivity to salt stress compared with the wild-type plants during seed germination and seedling establishment stages. ATP content and energy charge was higher in overexpressing plants than those in wild-type A. thaliana under salt stress. Accordingly, the salt-sensitive phenotype of overexpressing plants was recovered after the exogenous application of atractyloside due to the change of ATP content. Interestingly, Genevestigator survey and qRT-PCR analysis indicated a large number of genes, including those related to gibberellin synthesis could be regulated by the energy availability change under stress conditions in A. thaliana. Moreover, the exogenous application of uniconazole to overexpressing lines showed that gibberellin homeostasis was disturbed in the overexpressors. Our studies reveal a possible link between the ATP content mediated by AtMPTs and gibberellin metabolism in responses to high salinity stress in A. thaliana.	[Zhu, Wei; Miao, Qing; Sun, Dan; Yang, Guodong; Wu, Changai; Huang, Jinguang; Zheng, Chengchao] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Zheng, CC (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	cczheng@sdau.edu.cn	Wu, Changai/AFF-1493-2022	Wu, Changai/0000-0003-4053-8262				Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Alonso-Ramirez A, 2009, PLANT PHYSIOL, V150, P1335, DOI 10.1104/pp.109.139352; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Claeys H, 2012, PLANT PHYSIOL, V159, P739, DOI 10.1104/pp.112.195032; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Croos JNA, 2004, J BIOENERG BIOMEMBR, V36, P229, DOI 10.1023/B:JOBB.0000031974.35812.c9; DOLCE V, 1994, J BIOL CHEM, V269, P10451; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Haferkamp I, 2007, FEBS LETT, V581, P2375, DOI 10.1016/j.febslet.2007.02.020; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Hayashi M, 2005, P NATL ACAD SCI USA, V102, P7020, DOI 10.1073/pnas.0502556102; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Huang JG, 2009, PLANT CELL ENVIRON, V32, P1132, DOI 10.1111/j.1365-3040.2009.01995.x; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Jacoby RP, 2011, TRENDS PLANT SCI, V16, P614, DOI 10.1016/j.tplants.2011.08.002; Kasahara H, 2002, J BIOL CHEM, V277, P45188, DOI 10.1074/jbc.M208659200; Kiiskinen M, 1997, PLANT MOL BIOL, V35, P271, DOI 10.1023/A:1005868715571; Liu F, 2011, MOL PLANT, V4, P1105, DOI 10.1093/mp/ssr058; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Nakamori K, 2002, PLANT CELL PHYSIOL, V43, P1250, DOI 10.1093/pcp/pcf141; NAMBARA E, 1991, PLANT PHYSIOL, V97, P736, DOI 10.1104/pp.97.2.736; Nelson DC, 2009, PLANT PHYSIOL, V149, P863, DOI 10.1104/pp.108.131516; Noctor G, 2006, J EXP BOT, V57, P1603, DOI 10.1093/jxb/erj202; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Phelps A, 1996, BIOCHEMISTRY-US, V35, P10757, DOI 10.1021/bi961052x; Poirier Yves, 2002, Arabidopsis Book, V1, pe0024, DOI 10.1199/tab.0024; Rawyler A, 2002, ANN BOT-LONDON, V90, P499, DOI 10.1093/aob/mcf126; Ribeiro DM, 2012, J EXPT BOT; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Rustin P, 2009, PHYSIOL PLANTARUM, V137, P362, DOI 10.1111/j.1399-3054.2009.01249.x; SAGLIO PH, 1980, PLANT PHYSIOL, V66, P516, DOI 10.1104/pp.66.3.516; SAGLIO PH, 1980, PLANT PHYSIOL, V66, P1053, DOI 10.1104/pp.66.6.1053; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Schroers A, 1998, J BIOL CHEM, V273, P14269, DOI 10.1074/jbc.273.23.14269; Shan DP, 2007, NEW PHYTOL, V176, P70, DOI 10.1111/j.1469-8137.2007.02160.x; Takabatake R, 2001, J BIOCHEM, V129, P827, DOI 10.1093/oxfordjournals.jbchem.a002926; Takabatake R, 1999, PLANT MOL BIOL, V40, P479, DOI 10.1023/A:1006285009435; TALON M, 1990, P NATL ACAD SCI USA, V87, P7983, DOI 10.1073/pnas.87.20.7983; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	53	70	83	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43530	10.1371/journal.pone.0043530	http://dx.doi.org/10.1371/journal.pone.0043530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937061	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500062
J	Alves, H; van Ginkel, J; Groen, N; Hulsman, M; Mentink, A; Reinders, M; van Blitterswijk, C; de Boer, J				Alves, Hugo; van Ginkel, Jetty; Groen, Nathalie; Hulsman, Marc; Mentink, Anouk; Reinders, Marcel; van Blitterswijk, Clemens; de Boer, Jan			A Mesenchymal Stromal Cell Gene Signature for Donor Age	PLOS ONE			English	Article							STEM-CELLS; BONE TISSUE; SKELETAL-MUSCLE; MESSENGER-RNA; EXPRESSION; FOLLISTATIN; ACTIVIN; OVEREXPRESSION; IDENTIFICATION; TELOMERASE	Human aging is associated with loss of function and regenerative capacity. Human bone marrow derived mesenchymal stromal cells (hMSCs) are involved in tissue regeneration, evidenced by their capacity to differentiate into several lineages and therefore are considered the golden standard for cell-based regeneration therapy. Tissue maintenance and regeneration is dependent on stem cells and declines with age and aging is thought to influence therapeutic efficacy, therefore, more insight in the process of aging of hMSCs is of high interest. We, therefore, hypothesized that hMSCs might reflect signs of aging. In order to find markers for donor age, early passage hMSCs were isolated from bone marrow of 61 donors, with ages varying from 17-84, and clinical parameters, in vitro characteristics and microarray analysis were assessed. Although clinical parameters and in vitro performance did not yield reliable markers for aging since large donor variations were present, genome-wide microarray analysis resulted in a considerable list of genes correlating with human age. By comparing the transcriptional profile of aging in human with the one from rat, we discovered follistatin as a common marker for aging in both species. The gene signature presented here could be a useful tool for drug testing to rejuvenate hMSCs or for the selection of more potent, hMSCs for cell-based therapy.	[Alves, Hugo; van Ginkel, Jetty; Groen, Nathalie; Mentink, Anouk; van Blitterswijk, Clemens; de Boer, Jan] Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [Hulsman, Marc; Reinders, Marcel] Delft Univ Technol, Informat & Commun Theory Grp, Fac Elect Engn Math & Comp Sci, Delft, Netherlands	University of Twente; Delft University of Technology	Alves, H (corresponding author), Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	j.deboer@tnw.utwente.nl		de Boer, Jan/0000-0001-9188-9324; van Blitterswijk, Clemens/0000-0003-2371-4615	Netherlands Technology Foundation [TGT.6745]; Senter/Novem research grant	Netherlands Technology Foundation(Technologiestichting STW); Senter/Novem research grant	This work was supported by The Netherlands Technology Foundation (STW grant TGT.6745) and Senter/Novem research grant (RS, RL, JdB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves H, 2009, J CELL MOL MED; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Bellantuono Ilaria, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S146239940700049X; Bellantuono I, 2009, BBA-MOL BASIS DIS, V1792, P364, DOI 10.1016/j.bbadis.2009.01.008; Both SK, 2007, TISSUE ENG, V13, P3, DOI 10.1089/ten.2005.0513; Browner WS, 2004, AM J MED, V117, P851, DOI 10.1016/j.amjmed.2004.06.033; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Carey KA, 2007, J GERONTOL A-BIOL, V62, P9, DOI 10.1093/gerona/62.1.9; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dalbo VJ, 2011, J GERONTOL A-BIOL, V66, P855, DOI 10.1093/gerona/glr091; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; de Magalhaes JP, 2003, BIOGERONTOLOGY, V4, P119, DOI 10.1023/A:1023356005749; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eijken M, 2007, FASEB J, V21, P2949, DOI 10.1096/fj.07-8080com; FRIEDENSTEIN AJ, 1992, BONE MINER, V18, P199, DOI 10.1016/0169-6009(92)90807-P; Gaddy-Kurten D, 2002, ENDOCRINOLOGY, V143, P74, DOI 10.1210/en.143.1.74; Gajos-Michniewicz A, 2012, J BONE MINER METAB, V30, P426, DOI 10.1007/s00774-011-0347-8; Greenwood MJ, 2003, ARCH MED RES, V34, P489, DOI 10.1016/j.arcmed.2003.07.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensky NE, 2007, EUR J APPL PHYSIOL, V101, P473, DOI 10.1007/s00421-007-0521-9; Kerber RA, 2009, AGING CELL, V8, P239, DOI 10.1111/j.1474-9726.2009.00467.x; Klein NA, 2000, J CLIN ENDOCR METAB, V85, P4520, DOI 10.1210/jc.85.12.4520; Koc ON, 1999, EXP HEMATOL, V27, P1675, DOI 10.1016/S0301-472X(99)00101-0; Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017; Li HW, 2006, BIOCHEM BIOPH RES CO, V341, P320, DOI 10.1016/j.bbrc.2005.12.182; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009; Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Ryu E, 2008, BIOCHEM BIOPH RES CO, V371, P431, DOI 10.1016/j.bbrc.2008.04.111; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Teixeira S, 2010, J BIOMED MATER RES A, V93A, P567, DOI 10.1002/jbm.a.32532; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wang J, 2006, J HUM GENET, V51, P934, DOI 10.1007/s10038-006-0042-0; Wennmalm K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r109; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052	44	49	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42908	10.1371/journal.pone.0042908	http://dx.doi.org/10.1371/journal.pone.0042908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927939	Green Published, Green Submitted, gold			2022-12-27	WOS:000308224700009
J	Lorey, B; Kaletsch, M; Pilgramm, S; Bischoff, M; Kindermann, S; Sauerbier, I; Stark, R; Zentgraf, K; Munzert, J				Lorey, Britta; Kaletsch, Morten; Pilgramm, Sebastian; Bischoff, Matthias; Kindermann, Stefan; Sauerbier, Isabell; Stark, Rudolf; Zentgraf, Karen; Munzert, Joern			Confidence in Emotion Perception in Point-Light Displays Varies with the Ability to Perceive Own Emotions	PLOS ONE			English	Article							BIOLOGICAL MOTION; FACIAL EXPRESSIONS; RECOGNITION; ALEXITHYMIA; CHILDREN; MIRROR	One central issue in social cognitive neuroscience is that perceiving emotions in others relates to activating the same emotion in oneself. In this study we sought to examine how the ability to perceive own emotions assessed with the Toronto Alexithymia Scale related to both the ability to perceive emotions depicted in point-light displays and the confidence in these perceptions. Participants observed video scenes of human interactions, rated the depicted valence, and judged their confidence in this rating. Results showed that people with higher alexithymia scores were significantly less confident about their decisions, but did not differ from people with lower alexithymia scores in the valence of their ratings. Furthermore, no modulating effect of social context on the effect of higher alexithymia scores was found. It is concluded that the used stimuli are fit to investigate the kinematic aspect of emotion perception and possibly separate people with high and low alexithymia scores via confidence differences. However, a general difference in emotion perception was not detected in the present setting.	[Lorey, Britta; Pilgramm, Sebastian; Bischoff, Matthias; Kindermann, Stefan; Sauerbier, Isabell; Munzert, Joern] Univ Giessen, Inst Sports Sci, Giessen, Germany; [Lorey, Britta; Pilgramm, Sebastian; Bischoff, Matthias; Stark, Rudolf; Zentgraf, Karen] Univ Giessen, Bender Inst Neuroimaging, Giessen, Germany; [Zentgraf, Karen] Univ Munster, Inst Sports Sci, Munster, Germany; [Kaletsch, Morten] Univ Giessen, Cognit Neurosci Grp, Ctr Psychiat & Psychotherapy, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Munster; Justus Liebig University Giessen	Lorey, B (corresponding author), Univ Giessen, Inst Sports Sci, Giessen, Germany.	Britta.Lorey@sport.uni-giessen.de						Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Berthoz S, 2001, NEUROIMAGE, V13, pS382; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Blaustein JP, 1998, B MENNINGER CLIN, V62, P351; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Goldman A, 2000, TRENDS COGN SCI, V4, P255, DOI 10.1016/S1364-6613(00)01505-9; Goldman A., 1989, MIND LANGUAGE, V4, P161, DOI DOI 10.1111/J.1468-0017.1989.TB00249.X; Goleman D, 2020, EMOTIONAL INTELLIGEN, V25th; Hesse C, 2008, J SOC PERS RELAT, V25, P793, DOI 10.1177/0265407508096696; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Hubert B, 2007, J AUTISM DEV DISORD, V37, P1386, DOI 10.1007/s10803-006-0275-y; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Knoblich G, 2002, Q J EXP PSYCHOL-A, V55, P1027, DOI 10.1080/02724980143000631; Krystal H., 1988, INTEGRATION SELF HEA; Kupfer J, 2001, TAS 26 TORONTO ALEXI; Lane RD, 1996, PSYCHOSOM MED, V58, P581; Moore DG, 1997, BRIT J DEV PSYCHOL, V15, P401, DOI 10.1111/j.2044-835X.1997.tb00738.x; Morin O, 2008, NEUROPHYSIOL CLIN, V38, P189, DOI 10.1016/j.neucli.2008.02.005; Nemiah J.C., 1976, MODERN TRENDS PSYCHO, P430, DOI DOI 10.1016/J.IJNURSTU.2009.03.014; NEMIAH JC, 1970, PSYCHOTHER PSYCHOSOM, V18, P154, DOI 10.1159/000286074; PARKER JDA, 1993, PSYCHOTHER PSYCHOSOM, V59, P197, DOI 10.1159/000288664; Parker JDA, 2001, PERS INDIV DIFFER, V30, P107, DOI 10.1016/S0191-8869(00)00014-3; Parron C, 2008, AUTISM, V12, P261, DOI 10.1177/1362361307089520; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; PRINCE JD, 1993, J RES PERS, V27, P15, DOI 10.1006/jrpe.1993.1002; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roh D, 2011, J NERV MENT DIS, V199, P690, DOI 10.1097/NMD.0b013e318229d209; Sifneos PE, 1996, AM J PSYCHIAT, V153, P137; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Stone LA, 2001, PSYCHOTHER PSYCHOSOM, V70, P92, DOI 10.1159/000056232; Vanheule S, 2007, J CLIN PSYCHOL, V63, P109, DOI 10.1002/jclp.20324; White KS, 2011, J BEHAV THER EXP PSY, V42, P432, DOI 10.1016/j.jbtep.2011.04.001; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Zentgraf K, 2011, VISION RES, V51, P827, DOI 10.1016/j.visres.2011.01.007	44	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42169	10.1371/journal.pone.0042169	http://dx.doi.org/10.1371/journal.pone.0042169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22927921	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300018
J	Yu, B; Morales, JF; O'Rourke, SM; Tatsuno, GP; Berman, PW				Yu, Bin; Morales, Javier F.; O'Rourke, Sara M.; Tatsuno, Gwen P.; Berman, Phillip W.			Glycoform and Net Charge Heterogeneity in gp120 Immunogens Used in HIV Vaccine Trials	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; SUBTYPE-C; GLYCOSYLATION; POTENT; BROAD; INFECTION; VARIANTS; GLYCANS	Background: The RV144 clinical trial showed for the first time that vaccination could provide modest but significant protection from HIV-1 infection. To understand the protective response, and to improve upon the vaccine's efficacy, it is important to define the structure of the immunogens used in the prime/boost regimen. Here we examined the heterogeneity in net charge, attributable to glycoform variation, of the gp120 immunogens contained in the AIDSVAX B/E vaccine. Methodology/Principal Findings: Isoelectric focusing and glycosidase digestion were used to assess variation in net charge of the gp120s contained in the AIDSVAX B/E vaccine used in the RV144 trial. We observed 16 variants of MN-rgp120 and 24 variants of A244-rgp120. Glycoform variation in gp120 produced in Chinese hamster ovary cells was compared to glycoform variation in gp120 produced in the 293F human embryonic kidney cell line, often used for neutralization assays. We found that gp120 variants produced in CHO cells were distinctly more acidic than gp120 variants produced in 293 cells. The effect of glycoform heterogeneity on antigenicity was assessed using monoclonal antibodies. The broadly neutralizing PG9 MAb bound to A244-rgp120, but not to MN-rgp120, whether produced in CHO or in 293. However, PG9 was able to bind with high affinity to MN-rgp120 and A244-rgp120 produced in 293 cells deficient in N-acetylglucosaminyltransferase I. Conclusions/Significance: MN- and A244-rgp120 used in the RV144 trial exhibited extensive heterogeneity in net charge due to variation in sialic acid-containing glycoforms. These differences were cell line-dependent, affected the antigenicity of recombinant envelope proteins, and may affect assays used to measure neutralization. These studies, together with recent reports documenting broadly neutralizing antibodies directed against carbohydrate epitopes of gp120, suggest that glycoform variation is a key variable to be considered in the production and evaluation of subunit vaccines designed to prevent HIV infection.	[Yu, Bin; Morales, Javier F.; O'Rourke, Sara M.; Tatsuno, Gwen P.; Berman, Phillip W.] Univ Calif Santa Cruz, Dept Biomol Engn, Baskin Sch Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Yu, B (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Baskin Sch Engn, Santa Cruz, CA 95064 USA.	pwb@soe.ucsc.edu			University of California; Jack Baskin Chair Fund; National Institutes of Health, NIAID, NIH [R01 AI 089378-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089378] Funding Source: NIH RePORTER	University of California(University of California System); Jack Baskin Chair Fund; National Institutes of Health, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the University of California, the Jack Baskin Chair Fund, and the National Institutes of Health (R01 AI 089378-01, NIAID, NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman PW, 1999, VIROLOGY, V265, P1, DOI 10.1006/viro.1999.0031; BERMAN PW, 1983, SCIENCE, V222, P524, DOI 10.1126/science.6312563; BERMAN PW, 1988, J VIROL, V62, P3135, DOI 10.1128/JVI.62.9.3135-3142.1988; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; GEYER H, 1988, J BIOL CHEM, V263, P11760; Go EP, 2011, J VIROL, V85, P8270, DOI 10.1128/JVI.05053-11; GOOCHEE CF, 1990, BIO-TECHNOL, V8, P421, DOI 10.1038/nbt0590-421; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Kang SM, 2005, VIROLOGY, V331, P20, DOI 10.1016/j.virol.2004.10.005; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Kong L, 2010, J MOL BIOL, V403, P131, DOI 10.1016/j.jmb.2010.08.033; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; KORNFELD R, 1976, ANNU REV BIOCHEM, V45, P217, DOI 10.1146/annurev.bi.45.070176.001245; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; Lavine CL, 2012, J VIROL, V86, P2153, DOI 10.1128/JVI.06201-11; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Lian Y, 2005, J VIROL, V79, P13338, DOI 10.1128/JVI.79.21.13338-13349.2005; Mascola JR, 2003, NAT MED, V9, P393, DOI 10.1038/nm0403-393; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MIZUOCHI T, 1988, BIOCHEM J, V254, P599, DOI 10.1042/bj2540599; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pejchal R, 2011, SCIENCE; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; SHELIKOFF M, 1994, CYTOTECHNOLOGY, V15, P195, DOI 10.1007/BF00762394; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walker LM, 2011, NATURE; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weikert S, 1999, NAT BIOTECHNOL, V17, P1116, DOI 10.1038/15104; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yu B, 2010, J VIROL, V84, P1513, DOI 10.1128/JVI.01765-09; Zhu JW, 2012, BIOTECHNOL ADV, V30, P1158, DOI 10.1016/j.biotechadv.2011.08.022; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	54	22	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43903	10.1371/journal.pone.0043903	http://dx.doi.org/10.1371/journal.pone.0043903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928048	Green Published, gold			2022-12-27	WOS:000308286300098
J	Cornman, RS; Tarpy, DR; Chen, YP; Jeffreys, L; Lopez, D; Pettis, JS; vanEngelsdorp, D; Evans, D				Cornman, R. Scott; Tarpy, David R.; Chen, Yanping; Jeffreys, Lacey; Lopez, Dawn; Pettis, Jeffery S.; vanEngelsdorp, Dennis; Evans, D.			Pathogen Webs in Collapsing Honey Bee Colonies	PLOS ONE			English	Article							ACUTE PARALYSIS VIRUS; DICISTROVIRUS AFFECTING HONEYBEES; NOSEMA-CERANAE; SEQUENCES; INFECTION; MICROBES; DISORDER; LOSSES; ISRAEL	Recent losses in honey bee colonies are unusual in their severity, geographical distribution, and, in some cases, failure to present recognized characteristics of known disease. Domesticated honey bees face numerous pests and pathogens, tempting hypotheses that colony collapses arise from exposure to new or resurgent pathogens. Here we explore the incidence and abundance of currently known honey bee pathogens in colonies suffering from Colony Collapse Disorder (CCD), otherwise weak colonies, and strong colonies from across the United States. Although pathogen identities differed between the eastern and western United States, there was a greater incidence and abundance of pathogens in CCD colonies. Pathogen loads were highly covariant in CCD but not control hives, suggesting that CCD colonies rapidly become susceptible to a diverse set of pathogens, or that co-infections can act synergistically to produce the rapid depletion of workers that characterizes the disorder. We also tested workers from a CCD-free apiary to confirm that significant positive correlations among pathogen loads can develop at the level of individual bees and not merely as a secondary effect of CCD. This observation and other recent data highlight pathogen interactions as important components of bee disease. Finally, we used deep RNA sequencing to further characterize microbial diversity in CCD and non-CCD hives. We identified novel strains of the recently described Lake Sinai viruses (LSV) and found evidence of a shift in gut bacterial composition that may be a biomarker of CCD. The results are discussed with respect to host-parasite interactions and other environmental stressors of honey bees.	[Cornman, R. Scott; Chen, Yanping; Lopez, Dawn; Pettis, Jeffery S.; Evans, D.] ARS, Bee Res Lab, USDA, Beltsville, MD USA; [Tarpy, David R.; Jeffreys, Lacey] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [vanEngelsdorp, Dennis] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; University System of Maryland; University of Maryland College Park	Cornman, RS (corresponding author), ARS, Bee Res Lab, USDA, Beltsville, MD USA.	Jay.evans@ars.usda.gov	vanEngelsdorp, Dennis/E-7934-2010; Evans, Jay/C-8408-2012	Tarpy, David/0000-0001-8601-6094; Evans, Jay/0000-0002-0036-4651	National Honey Board; Pennsylvania Department of Agriculture; North American Pollinator Protection Campaign; Apiary Inspectors of America; USDA-CSREES Coordinated Agricultural Project for Pollinator Health	National Honey Board; Pennsylvania Department of Agriculture; North American Pollinator Protection Campaign; Apiary Inspectors of America; USDA-CSREES Coordinated Agricultural Project for Pollinator Health	This work was supported by the National Honey Board, the Pennsylvania Department of Agriculture, the North American Pollinator Protection Campaign, the Apiary Inspectors of America and the USDA-CSREES Coordinated Agricultural Project for Pollinator Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Blanchard P, 2008, J INVERTEBR PATHOL, V99, P348, DOI 10.1016/j.jip.2008.07.006; Boncristiani H, 2011, APIDOLOGIE, V42, P457, DOI 10.1007/s13592-011-0009-9; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Cornman SR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-602; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Foster LJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006387; Fujiyuki T, 2005, ADV VIRUS RES, V65, P1, DOI 10.1016/S0065-3527(05)65001-4; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Ghabrial S.A., 2008, ENCY VIROLOGY, V5, P68, DOI DOI 10.1016/B978-012374410-4.00573-2; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Morse R.A., 1997, HONEY BEE PESTS PRED; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Ribiere M, 2010, J INVERTEBR PATHOL, V103, pS120, DOI 10.1016/j.jip.2009.06.013; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; Shimanuki H, 1997, HONEY BEE PESTS PRED, P534; Underwood R., 2007, BEE CULTURE, V35, P13; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WILSON WT, 1979, AM BEE J, V119, P184; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	51	291	304	6	376	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43562	10.1371/journal.pone.0043562	http://dx.doi.org/10.1371/journal.pone.0043562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927991	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700040
J	Boyle, PA; Yu, L; Wilson, RS; Gamble, K; Buchman, AS; Bennett, DA				Boyle, Patricia A.; Yu, Lei; Wilson, Robert S.; Gamble, Keith; Buchman, Aron S.; Bennett, David A.			Poor Decision Making Is a Consequence of Cognitive Decline among Older Persons without Alzheimer's Disease or Mild Cognitive Impairment	PLOS ONE			English	Article							MEDICARE PART-D; CAPACITY; MEMORY; ADULTS	Objective: Decision making is an important determinant of health and well-being across the lifespan but is critical in aging, when many influential decisions are made just as cognitive function declines. Increasing evidence suggests that older adults, even those without dementia, often make poor decisions and are selectively vulnerable to scams. To date, however, the factors associated with poor decision making in old age are unknown. The objective of this study was to test the hypothesis that poor decision making is a consequence of cognitive decline among older persons without Alzheimer's disease or mild cognitive impairment. Methods: Participants were 420 non-demented persons from the Memory and Aging Project, a longitudinal, clinical-pathologic cohort study of aging in the Chicago metropolitan area. All underwent repeated cognitive evaluations and subsequently completed assessments of decision making and susceptibility to scams. Decision making was measured using 12 items from a previously established performance-based measure and a self-report measure of susceptibility to scams. Results: Cognitive function data were collected over an average of 5.5 years prior to the decision making assessment. Regression analyses were used to examine whether the prior rate of cognitive decline predicted the level of decision making and susceptibility to scams; analyses controlled for age, sex, education, and starting level of cognition. Among 420 persons without dementia, more rapid cognitive decline predicted poorer decision making and increased susceptibility to scams (p's<0.001). Further, the relations between cognitive decline, decision making and scams persisted in analyses restricted to persons without any cognitive impairment (i.e., no dementia or even mild cognitive impairment). Conclusions: Poor decision making is a consequence of cognitive decline among older persons without Alzheimer's disease or mild cognitive impairment, those widely considered "cognitively healthy.'' These findings suggest that even very subtle age-related changes in cognition have detrimental effects on judgment.	[Boyle, Patricia A.; Yu, Lei; Wilson, Robert S.; Gamble, Keith; Buchman, Aron S.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Boyle, Patricia A.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Yu, Lei; Wilson, Robert S.; Buchman, Aron S.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Gamble, Keith] Depaul Univ, Dept Finance, Chicago, IL 60604 USA	Rush University; Rush University; Rush University; DePaul University	Boyle, PA (corresponding author), Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA.	Patricia_Boyle@Rush.edu	Yu, Lei/AAT-3685-2020		National Institute on Aging [R01AG17917, R01AG34374, R01AG33678, R21AG30765]; Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING [R01AG017917, R01AG034374, R01AG033678, R21AG030765] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging Grants R01AG17917 (DAB), R01AG34374 (PAB), R01AG33678 (PAB), R21AG30765 (DAB), and the Illinois Department of Public Health. The funding agencies had no role in the design, conduct, or interpretation of the data or preparation of the manuscript.	AARP, 1996, TEL FRAUD OLD PERS A; Agarwal S, 2009, BROOKINGS PAP ECO AC, P51, DOI 10.1353/eca.0.0067; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; [Anonymous], 2009, SAS 9 2 HELP DOC COM; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Boyle PA, 2006, NEUROLOGY, V67, P441, DOI 10.1212/01.wnl.0000228244.10416.20; Denburg NL, 2009, ANN BEHAV MED, V37, P164, DOI 10.1007/s12160-009-9094-7; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Finucane ML, 2010, PSYCHOL AGING, V25, P271, DOI 10.1037/a0019106; Finucane ML, 2005, PSYCHOL AGING, V20, P71, DOI 10.1037/0882-7974.20.1.71; Griffith HR, 2005, NEUROLOGY, V65, P483, DOI 10.1212/01.wnl.0000171346.02965.80; Grober E, 2008, J INT NEUROPSYCH SOC, V14, P266, DOI 10.1017/S1355617708080302; Heiss F, 2006, HEALTH AFFAIR, V25, pW344, DOI 10.1377/hlthaff.25.w344; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; Karlawish J, 2008, NEUROSIGNALS, V16, P91, DOI 10.1159/000109763; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Okonkwo OC, 2008, NEUROLOGY, V71, P1474, DOI 10.1212/01.wnl.0000334301.32358.48; Skarupski KA, 2009, GERONTOLOGIST, V49, P828, DOI 10.1093/geront/gnp055; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Triebel KL, 2009, NEUROLOGY, V73, P928, DOI 10.1212/WNL.0b013e3181b87971; Van Wielingen LE, 2004, AGING MENT HEALTH, V8, P374, DOI 10.1080/13607860410001709728; Zamarian L, 2011, J GERONTOL B-PSYCHOL, V66, P23, DOI 10.1093/geronb/gbq067	23	103	103	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43647	10.1371/journal.pone.0043647	http://dx.doi.org/10.1371/journal.pone.0043647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	991WJ	22916287	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800086
J	Fogg, PCM; Westbye, AB; Beatty, JT				Fogg, Paul C. M.; Westbye, Alexander B.; Beatty, J. Thomas			One for All or All for One: Heterogeneous Expression and Host Cell Lysis Are Key to Gene Transfer Agent Activity in Rhodobacter capsulatus	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; BACTERIOPHAGE; PEPTIDOGLYCAN; BIOSYNTHESIS; BACTERIAL; PROTEINS; ENZYMES; BACTERIOCHLOROPHYLL	The gene transfer agent (RcGTA) of Rhodobacter capsulatus is the model for a family of novel bacteriophage-related genetic elements that carry out lateral transfer of essentially random host DNA. Genuine and putative gene transfer agents have been discovered in diverse genera and are becoming recognized as potentially an important source of genetic exchange and microbial evolution in the oceans. Despite being discovered over 30 years ago, little is known about many essential aspects of RcGTA biology. Here, we validate the use of direct fluorescence reporter constructs, which express the red fluorescent protein mCherry in R. capsulatus. A construct containing the RcGTA promoter fused to mCherry was used to examine the single-cell expression profiles of wild type and RcGTA overproducer R. capsulatus populations, under different growth conditions and growth phases. The majority of RcGTA production clearly arises from a small, distinct sub-set of the population in the wild type strain and a larger sub-set in the overproducer. The most likely RcGTA release mechanism concomitant with this expression pattern is host cell lysis and we present direct evidence for the release of an intracellular enzyme accompanying RcGTA release. RcGTA ORF s is annotated as a 'cell wall peptidase' but we rule out a role in host lysis and propose an alternative function as a key contributor to RcGTA invasion of a target cell during infection.	[Fogg, Paul C. M.; Westbye, Alexander B.; Beatty, J. Thomas] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Fogg, PCM (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	j.beatty@ubc.ca		Fogg, Paul/0000-0001-5324-4293; Westbye, Alexander B/0000-0003-2619-4192	Canadian Institutes of Health Research [MOP93779]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Research was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), Operating Grant MOP93779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ADAMS CW, 1989, J BACTERIOL, V171, P473, DOI 10.1128/jb.171.1.473-482.1989; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Barbian KD, 2000, MICROBIOL-UK, V146, P599, DOI 10.1099/00221287-146-3-599; BEATTY JT, 1981, ARCH MICROBIOL, V129, P335, DOI 10.1007/BF00406457; Berglund EC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000546; Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Chen F, 2009, J PROTEOME RES, V8, P967, DOI 10.1021/pr8006045; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eiserling F, 1999, J GEN VIROL, V80, P3305, DOI 10.1099/0022-1317-80-12-3305; FEICK R, 1980, BIOCHIM BIOPHYS ACTA, V593, P241, DOI 10.1016/0005-2728(80)90062-6; Florizone SM, 2006, STUDIES REGULATION G; Fogg PCM, 2011, VIROLOGY, V421, P211, DOI 10.1016/j.virol.2011.09.028; Fraser JS, 2007, CURR OPIN MICROBIOL, V10, P382, DOI 10.1016/j.mib.2007.05.018; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Hasmann A, 2011, DIAGN MICR INFEC DIS, V71, P12, DOI 10.1016/j.diagmicrobio.2010.09.009; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; HOFSCHNEIDER PH, 1963, J MOL BIOL, V7, P450, DOI 10.1016/S0022-2836(63)80038-8; Huang SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-124; Humphrey SB, 1997, J BACTERIOL, V179, P323, DOI 10.1128/jb.179.2.323-329.1997; Hynes AP, 2012, MOL MICROBIOL; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Lang AS, 2012, NAT REV MICROBIOL, V10, P472, DOI 10.1038/nrmicro2802; Lang AS, 2002, J MOL EVOL, V55, P534, DOI 10.1007/s00239-002-2348-7; Leung MM, 2010, CTRA GTAR 2 SYSTEMS; Leung MM, 2012, MOL MICROBIOL, V83, P759, DOI 10.1111/j.1365-2958.2011.07963.x; LONGCHAMP PF, 1994, MICROBIOL-UK, V140, P1855, DOI 10.1099/13500872-140-8-1855; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margot P, 1998, J BACTERIOL, V180, P749, DOI 10.1128/JB.180.3.749-752.1998; MARRS B, 1974, P NATL ACAD SCI USA, V71, P971, DOI 10.1073/pnas.71.3.971; Matson EG, 2005, J BACTERIOL, V187, P5885, DOI 10.1128/JB.187.17.5885-5892.2005; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; Mercer RG, 2010, J BACTERIOL, V192, P2701, DOI 10.1128/JB.00160-10; Pradel N, 2007, BIOCHEM BIOPH RES CO, V353, P493, DOI 10.1016/j.bbrc.2006.12.054; RAPP BJ, 1987, P NATL ACAD SCI USA, V84, P9128, DOI 10.1073/pnas.84.24.9128; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Rodriguez L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-138; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; SOLIOZ M, 1975, J BACTERIOL, V123, P651, DOI 10.1128/JB.123.2.651-657.1975; Strnad H, 2010, J BACTERIOL, V192, P3545, DOI 10.1128/JB.00366-10; Taylor TA, 2000, EVOLUTION REGULATION; van Niel CB, 1944, BACTERIOL REV, V8, P1; WALL JD, 1975, ARCH MICROBIOL, V105, P217, DOI 10.1007/BF00447140; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; YEN HC, 1976, J BACTERIOL, V126, P619, DOI 10.1128/JB.126.2.619-629.1976; YEN HC, 1979, J MOL BIOL, V131, P157, DOI 10.1016/0022-2836(79)90071-8; ZHU YS, 1986, P NATL ACAD SCI USA, V83, P7613, DOI 10.1073/pnas.83.20.7613	57	34	34	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43772	10.1371/journal.pone.0043772	http://dx.doi.org/10.1371/journal.pone.0043772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916305	gold, Green Published, Green Submitted			2022-12-27	WOS:000307733800102
J	Galeotti, P; Bernini, G; Locatello, L; Sacchi, R; Fasola, M; Rubolini, D				Galeotti, Paolo; Bernini, Guido; Locatello, Lisa; Sacchi, Roberto; Fasola, Mauro; Rubolini, Diego			Sperm Traits Negatively Covary with Size and Asymmetry of a Secondary Sexual Trait in a Freshwater Crayfish	PLOS ONE			English	Article							WHITE-CLAWED CRAYFISH; AUSTROPOTAMOBIUS-PALLIPES LEREBOULLET; COLORFUL MALE GUPPIES; MALE BODY-SIZE; MALE PHENOTYPE; COPULATION BEHAVIOR; EJACULATE QUALITY; MATE CHOICE; TRADE-OFF; COMPETITION	In species where females mate promiscuously, the reproductive success of males depends both on their ability to acquire mates (pre-copulatory sexual selection) and ability of their ejaculates to outcompete those of other males (post-copulatory sexual selection). Sperm competition theory predicts a negative relationship between investment in body traits favouring mate acquisition (secondary sexual characters, SSCs) and investment in ejaculate size or quality, due to the inherent costs of sperm production. In contrast, the phenotype-linked fertility hypothesis posits that male fertilizing efficiency is reliably reflected by the phenotypic expression of male SSCs, allowing females to obtain direct benefits by selecting more ornamented males as copulation partners. In this study, we investigated the relationships between male SSCs and size and quality (viability and longevity) of ejaculates allocated to females in mating trials of the freshwater crayfish Austropotamobius italicus. We showed that the relative size of male weapons, the chelae, was negatively related to ejaculate size, and that chelae asymmetry, resulting from regeneration of lost chelipeds, negatively covaried with sperm longevity. Moreover, males allocated more viable sperm to mates from their own rather than different stream of origin. Our findings thus suggest that, according to sperm competition theory, pre-copulatory sexual selection for large weapons used in male fighting may counteract post-copulatory sperm competition in this crayfish species, and that investment in cheliped regeneration may impair ejaculate quality.	[Galeotti, Paolo; Bernini, Guido; Sacchi, Roberto; Fasola, Mauro] Univ Pavia, Dipartimento Sci Terra & Ambiente, I-27100 Pavia, Italy; [Locatello, Lisa] Univ Padua, Dipartimento Biol, Padua, Italy; [Rubolini, Diego] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Pavia; University of Padua; University of Milan	Galeotti, P (corresponding author), Univ Pavia, Dipartimento Sci Terra & Ambiente, Via Palestro 3, I-27100 Pavia, Italy.	diego.rubolini@unimi.it	LOCATELLO, LISA/AAC-5612-2020; Sacchi, Roberto/E-2141-2011; Rubolini, Diego/F-2851-2011	Sacchi, Roberto/0000-0002-6199-0074; Rubolini, Diego/0000-0003-2703-5783; LOCATELLO, LISA/0000-0002-3530-2565; FASOLA, MAURO/0000-0002-7366-5893	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [CUP F11J10000010001]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was funded by a Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) grant to PG (PRIN 2008, CUP F11J10000010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquistapace P, 2002, CAN J ZOOL, V80, P2041, DOI [10.1139/z02-171, 10.1139/Z02-171]; Barki A, 2003, J EXP BIOL, V206, P1791, DOI 10.1242/jeb.00335; Bernasconi G, 2002, J INSECT PHYSIOL, V48, P197, DOI 10.1016/S0022-1910(01)00164-0; Birkhead TR, 1995, P ROY SOC B-BIOL SCI, V262, P329, DOI 10.1098/rspb.1995.0213; Bluhm CK, 2004, ANIM BEHAV, V68, P985, DOI 10.1016/j.anbehav.2004.01.012; Bolund E, 2009, P R SOC B, V276, P707, DOI 10.1098/rspb.2008.1251; DUDENHAUSEN EE, 1983, CAN J ZOOL, V61, P182, DOI 10.1139/z83-023; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Evans JP, 2010, P ROY SOC B-BIOL SCI, V277, P3195, DOI 10.1098/rspb.2010.0826; Fitzpatrick JL, 2007, BIOL REPROD, V77, P280, DOI 10.1095/biolreprod.106.059550; Fratini S, 2005, HEREDITY, V94, P108, DOI 10.1038/sj.hdy.6800581; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Galeotti P, 2006, P ROY SOC B-BIOL SCI, V273, P1105, DOI 10.1098/rspb.2005.3345; Galeotti P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1739, DOI 10.1007/s00265-008-0602-8; Galeotti P, 2007, BEHAV ECOL SOCIOBIOL, V61, P711, DOI 10.1007/s00265-006-0301-2; Galeotti P, 2009, BEHAVIOUR, V146, P45, DOI 10.1163/156853908X390922; Gherardi F, 2000, MAR FRESHW BEHAV PHY, V33, P187, DOI 10.1080/10236240009387090; Gherardi F, 2006, ARCH HYDROBIOL, V165, P557, DOI 10.1127/0003-9136/2006/0165-0557; Grandjean F, 1997, CRUSTACEANA, V70, P31, DOI 10.1163/156854097X00320; Grandjean F, 2000, J CRUSTACEAN BIOL, V20, P522, DOI 10.1651/0278-0372(2000)020[0522:SOTEEC]2.0.CO;2; Holman L, 2009, BEHAV ECOL SOCIOBIOL, V63, P1679, DOI 10.1007/s00265-009-0816-4; Ingle RW, 1977, REP UNDERWATER ASS, V2, P1; JAMIESON B G M, 1991, Memoirs of the Queensland Museum, V31, P109; Janhunen M, 2009, BIOL J LINN SOC, V98, P794, DOI 10.1111/j.1095-8312.2009.01317.x; Juanes F, 1995, J EXP MAR BIOL ECOL, V193, P197, DOI 10.1016/0022-0981(95)00118-2; Kilgallon SJ, 2005, BIOL LETTERS, V1, P253, DOI 10.1098/rsbl.2005.0324; Klaus SP, 2011, ETHOLOGY, V117, P154, DOI 10.1111/j.1439-0310.2010.01857.x; Locatello L, 2008, J FISH BIOL, V73, P1600, DOI 10.1111/j.1095-8649.2008.02034.x; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; MARCONATO A, 1995, J FISH BIOL, V47, P292, DOI 10.1006/jfbi.1995.0134; Matthews MA, 1995, BIOL ENVIRON, V95B, P99; McClelland EK, 2007, CONSERV GENET, V8, P397, DOI 10.1007/s10592-006-9178-x; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; PARKER GA, 1998, SPERM COMPETITION SE, P1; Pilastro A, 2002, P ROY SOC B-BIOL SCI, V269, P1325, DOI 10.1098/rspb.2002.2017; Pilastro A, 2008, BEHAV ECOL, V19, P374, DOI 10.1093/beheco/arm140; Pitcher TE, 2009, J FISH BIOL, V74, P1450, DOI 10.1111/j.1095-8649.2009.02210.x; Pizzari T, 2004, P ROY SOC B-BIOL SCI, V271, P51, DOI 10.1098/rspb.2003.2577; Pizzari T, 2007, P ROY SOC B-BIOL SCI, V274, P853, DOI 10.1098/rspb.2006.0080; Rasband WS, 1997, IMAGEJ; Rasotto MB, 2010, J ZOOL, V281, P161, DOI 10.1111/j.1469-7998.2009.00688.x; Reinhardt K, 2005, AM NAT, V165, P718, DOI 10.1086/430010; REYNOLDS JD, 1992, INVERTEBR REPROD DEV, V22, P253, DOI 10.1080/07924259.1992.9672278; Reynolds JD, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P152; RHODES CP, 1979, AQUACULTURE, V17, P345, DOI 10.1016/0044-8486(79)90089-9; Rogers DW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-236; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; Rubolini D, 2007, FRESHWATER BIOL, V52, P1898, DOI 10.1111/j.1365-2427.2007.01814.x; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V60, P212, DOI 10.1007/s00265-005-0158-9; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1729, DOI 10.1098/rspb.2002.2088; Sato T, 2007, ANIM BEHAV, V74, P903, DOI 10.1016/j.anbehav.2006.09.027; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; SIMMONS LW, 2001, SPERM COMPETITION; SNEDDEN WA, 1990, BEHAVIOUR, V115, P100, DOI 10.1163/156853990X00301; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; STEIN RA, 1976, CAN J ZOOL, V54, P220, DOI 10.1139/z76-024; Tazzyman SJ, 2009, AM NAT, V174, pE71, DOI 10.1086/603612; Thomas ML, 2007, AM NAT, V170, P190, DOI 10.1086/519404; Tudge Christopher, 2009, Crustacean Issues, V18, P101; Villanelli F, 1998, FRESHWATER BIOL, V40, P305, DOI 10.1046/j.1365-2427.1998.00355.x; Vogt G, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P53; Wedell N, 1999, P ROY SOC B-BIOL SCI, V266, P1033, DOI 10.1098/rspb.1999.0740; Wilson RS, 2007, AM NAT, V170, P284, DOI 10.1086/519399	67	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43771	10.1371/journal.pone.0043771	http://dx.doi.org/10.1371/journal.pone.0043771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916304	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800101
J	Kearney, BD; Byrne, PG; Reina, RD				Kearney, Brian D.; Byrne, Phillip G.; Reina, Richard D.			Larval Tolerance to Salinity in Three Species of Australian Anuran: An Indication of Saline Specialisation in Litoria aurea	PLOS ONE			English	Article							CRAB-EATING FROG; TADPOLES; ADAPTATION; WATER; SALINIZATION; POPULATIONS; SURVIVAL	Recent anthropogenic influences on freshwater habitats are forcing anuran populations to rapidly adapt to high magnitude changes in environmental conditions or face local extinction. We examined the effects of ecologically relevant elevated salinity levels on larval growth, metamorphosis and survival of three species of Australian anuran; the spotted marsh frog (Limnodynastes tasmaniensis), the painted burrowing frog (Neobatrachus sudelli) and the green and golden bell frog (Litoria aurea), in order to better understand the responses of these animals to environmental change. Elevated salinity (16% seawater) negatively impacted on the survival of L. tasmaniensis (35% survival) and N sudelli (0% survival), while reduced salinity had a negative impact on L. aurea. (16% seawater: 85% survival; 0.4% seawater: 35% survival). L. aurea tadpoles survived in salinities much higher than previously reported for this species, indicating the potential for inter-populations differences in salinity tolerance. In L. tasmaniensis and L. aurea, development to metamorphosis was fastest in low and high salinity treatments suggesting it is advantageous for tadpoles to invest energy in development in both highly favourable and developmentally challenging environments. We propose that this response might either maximise potential lifetime fecundity when tadpoles experience favourable environments, or, facilitate a more rapid escape from pond environments where there is a reduced probability of survival.	[Kearney, Brian D.; Reina, Richard D.] Monash Univ, Sch Biol Sci, Australian Ctr Biodivers, Clayton, Vic, Australia; [Byrne, Phillip G.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Byrne, Phillip G.] Univ Wollongong, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia	Monash University; Monash University; University of Wollongong	Kearney, BD (corresponding author), Monash Univ, Sch Biol Sci, Australian Ctr Biodivers, Clayton, Vic, Australia.	brian.kearney@monash.edu	Reina, Richard/AAC-7017-2019	Kearney, Brian/0000-0002-6971-1850; Byrne, Phillip/0000-0003-2183-9959	Monash University	Monash University(Monash University)	Funding was supplied by Monash University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstis M., 2002, TADPOLES S E AUSTR G; Bailey PCE, 2006, ECOLOGY OF DESERT RIVERS, P280; BALINSKY JB, 1981, J EXP ZOOL, V215, P335, DOI 10.1002/jez.1402150311; BENNETT AF, 1993, EVOLUTION, V47, P1, DOI 10.1111/j.1558-5646.1993.tb01194.x; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Boutilier Robert G., 1992, P81; Byrne PG, 2011, BEHAV ECOL, V22, P385, DOI 10.1093/beheco/arq153; CADEH, 2006, THREAT AB PLAN INF A; Chinathamby K, 2006, AUST J ZOOL, V54, P97, DOI 10.1071/ZO06006; Christy MT, 2002, AMPHIBIA-REPTILIA, V23, P1, DOI 10.1163/156853802320877582; Gomez-Mestre I, 2004, PHYSIOL BIOCHEM ZOOL, V77, P267, DOI 10.1086/378143; Gomez-Mestre I, 2003, EVOLUTION, V57, P1889; GORDON MS, 1965, J EXP BIOL, V42, P437; Gosner K. L., 1960, Herpetologica, V16, P183; HART BT, 1991, HYDROBIOLOGIA, V210, P105, DOI 10.1007/BF00014327; Hazell D, 2003, WILDLIFE RES, V30, P193, DOI 10.1071/WR02075; Herczeg AL, 2001, MAR FRESHWATER RES, V52, P41, DOI 10.1071/MF00040; Laurila A, 2000, FRESHWATER BIOL, V43, P161, DOI 10.1046/j.1365-2427.2000.00533.x; LENSKI RE, 1993, AM NAT, V142, pS47, DOI 10.1086/285522; MAHAJAN CL, 1979, INDIAN J EXP BIOL, V17, P1244; Mann RM, 2009, ENVIRON POLLUT, V157, P2903, DOI 10.1016/j.envpol.2009.05.015; Marshall NA, 2004, MAR FRESHWATER RES, V55, P509, DOI 10.1071/MF03018; Mayr E., 1963, ANIMAL SPECIES EVOLU, P12; NICIEZA AG, 1994, OECOLOGIA, V99, P243, DOI 10.1007/BF00627736; Nielsen DL, 2003, AUST J BOT, V51, P655, DOI 10.1071/BT02115; Reznick David, 1996, P243; Sinervo Barry, 1996, P149; Smekens MJ, 2001, ACTA OECOL, V22, P187, DOI 10.1016/S1146-609X(01)01120-1; Smith MJ, 2007, FRESHWATER BIOL, V52, P75, DOI 10.1111/j.1365-2427.2006.01672.x; UCHIYAMA M, 1992, CELL TISSUE RES, V267, P35, DOI 10.1007/BF00318689; Viertel B, 1999, AMPHIBIA-REPTILIA, V20, P161, DOI 10.1163/156853899X00178; VIERTEL B., 1999, TADPOLES BIOL ANURAN; Williams WD, 2001, HYDROBIOLOGIA, V466, P329, DOI 10.1023/A:1014598509028	33	34	34	0	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43427	10.1371/journal.pone.0043427	http://dx.doi.org/10.1371/journal.pone.0043427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916260	Green Published, gold			2022-12-27	WOS:000307733800066
J	Linkersdorfer, J; Lonnemann, J; Lindberg, S; Hasselhorn, M; Fiebach, CJ				Linkersdoerfer, Janosch; Lonnemann, Jan; Lindberg, Sven; Hasselhorn, Marcus; Fiebach, Christian J.			Grey Matter Alterations Co-Localize with Functional Abnormalities in Developmental Dyslexia: An ALE Meta-Analysis	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; BRAIN ACTIVATION; SENTENCE COMPREHENSION; LEARNING-DIFFICULTIES; ANGULAR GYRUS; NEURAL BASIS; CHILDREN; FMRI; CONNECTIVITY; DEFICITS	The neural correlates of developmental dyslexia have been investigated intensively over the last two decades and reliable evidence for a dysfunction of left-hemispheric reading systems in dyslexic readers has been found in functional neuroimaging studies. In addition, structural imaging studies using voxel-based morphometry (VBM) demonstrated grey matter reductions in dyslexics in several brain regions. To objectively assess the consistency of these findings, we performed activation likelihood estimation (ALE) meta-analysis on nine published VBM studies reporting 62 foci of grey matter reduction in dyslexic readers. We found six significant clusters of convergence in bilateral temporo-parietal and left occipito-temporal cortical regions and in the cerebellum bilaterally. To identify possible overlaps between structural and functional deviations in dyslexic readers, we conducted additional ALE meta-analyses of imaging studies reporting functional underactivations (125 foci from 24 studies) or overactivations (95 foci from 11 studies) in dyslexics. Subsequent conjunction analyses revealed overlaps between the results of the VBM meta-analysis and the meta-analysis of functional underactivations in the fusiform and supramarginal gyri of the left hemisphere. An overlap between VBM results and the meta-analysis of functional overactivations was found in the left cerebellum. The results of our study provide evidence for consistent grey matter variations bilaterally in the dyslexic brain and substantial overlap of these structural variations with functional abnormalities in left hemispheric regions.	[Linkersdoerfer, Janosch; Lindberg, Sven; Hasselhorn, Marcus; Fiebach, Christian J.] Ctr Individual Dev & Adapt Educ Children Risk, Frankfurt, Germany; [Linkersdoerfer, Janosch; Lonnemann, Jan; Lindberg, Sven; Hasselhorn, Marcus] German Inst Int Educ Res, Frankfurt, Germany; [Lonnemann, Jan; Hasselhorn, Marcus; Fiebach, Christian J.] Goethe Univ Frankfurt, Inst Psychol, Frankfurt, Germany; [Fiebach, Christian J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	German Institute for International Educational Research; Goethe University Frankfurt; Radboud University Nijmegen	Linkersdorfer, J (corresponding author), Ctr Individual Dev & Adapt Educ Children Risk, Frankfurt, Germany.	j.linkersdoerfer@idea-frankfurt.eu	Linkersdörfer, Janosch/L-1223-2016; Fiebach, Christian/D-9540-2012	Linkersdörfer, Janosch/0000-0002-1577-1233; Fiebach, Christian/0000-0003-0827-1721; Lonnemann, Jan/0000-0002-6619-0981	Hessian initiative for the development of scientific and economic excellence (LOEWE)	Hessian initiative for the development of scientific and economic excellence (LOEWE)	This research was funded by the Hessian initiative for the development of scientific and economic excellence (LOEWE; http://www.hmwk.hessen.de/irj/HMWK_Internet?cid=a2396939885f8c8c0a3ba39bda517cbd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Blau V, 2010, BRAIN, V133, P868, DOI 10.1093/brain/awp308; Blau V, 2009, CURR BIOL, V19, P503, DOI 10.1016/j.cub.2009.01.065; Booth JR, 2007, NEUROPSYCHOLOGIA, V45, P775, DOI 10.1016/j.neuropsychologia.2006.08.015; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Brambati SM, 2006, BRAIN RES, V1113, P174, DOI 10.1016/j.brainres.2006.06.099; Brambati SM, 2004, NEUROLOGY, V63, P742, DOI 10.1212/01.WNL.0000134673.95020.EE; Brown WE, 2001, NEUROLOGY, V56, P781, DOI 10.1212/WNL.56.6.781; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Cao F, 2006, J CHILD PSYCHOL PSYC, V47, P1041, DOI 10.1111/j.1469-7610.2006.01684.x; Chein JM, 2002, PHYSIOL BEHAV, V77, P635, DOI 10.1016/S0031-9384(02)00899-5; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Cykowski MD, 2008, CEREB CORTEX, V18, P571, DOI 10.1093/cercor/bhm093; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Eckert M, 2004, NEUROSCIENTIST, V10, P362, DOI 10.1177/1073858404263596; Eckert MA, 2005, CORTEX, V41, P304, DOI 10.1016/S0010-9452(08)70268-5; Eckert MA, 2003, BRAIN, V126, P482, DOI 10.1093/brain/awg026; Eden GF, 2004, NEURON, V44, P411, DOI 10.1016/j.neuron.2004.10.019; Eickhoff S.B., 2011, NEUROIMAGE; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; GALABURDA A, 1993, ANN NY ACAD SCI, V682, P70, DOI 10.1111/j.1749-6632.1993.tb22960.x; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Galaburda AM, 2005, ANN DYSLEXIA, V55, P151, DOI 10.1007/s11881-005-0009-4; GALABURDA AM, 1979, ANN NEUROL, V6, P94, DOI 10.1002/ana.410060203; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; GALABURDA AM, 1994, P NATL ACAD SCI USA, V91, P8010, DOI 10.1073/pnas.91.17.8010; Georgiewa P, 1999, NEUROREPORT, V10, P3459, DOI 10.1097/00001756-199911080-00036; Grunling C, 2004, J NEURAL TRANSM, V111, P951, DOI 10.1007/s00702-004-0117-z; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; Heim S, 2004, EUR CHILD ADOLES PSY, V13, P125, DOI 10.1007/s00787-004-0361-7; Heim S, 2008, ACTA NEUROBIOL EXP, V68, P73; Herbert MR, 2007, PEDIATR CLIN N AM, V54, P563, DOI 10.1016/j.pcl.2007.02.007; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hoeft F, 2006, J NEUROSCI, V26, P10700, DOI 10.1523/JNEUROSCI.4931-05.2006; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Hu W, 2010, BRAIN, V133, P1694, DOI 10.1093/brain/awq106; Ingvar M, 2002, BRAIN LANG, V83, P249, DOI 10.1016/S0093-934X(02)00055-X; Krafnick AJ, 2011, NEUROIMAGE, V57, P733, DOI 10.1016/j.neuroimage.2010.10.062; Kronbichler M, 2008, HUM BRAIN MAPP, V29, P613, DOI 10.1002/hbm.20425; Kronbichler M, 2006, NEUROPSYCHOLOGIA, V44, P1822, DOI 10.1016/j.neuropsychologia.2006.03.010; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Maisog JM, 2008, ANN NY ACAD SCI, V1145, P237, DOI 10.1196/annals.1416.024; Maurer U, 2011, NEUROIMAGE, V57, P714, DOI 10.1016/j.neuroimage.2010.10.055; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; McCrory EJ, 2005, BRAIN, V128, P261, DOI 10.1093/brain/awh340; Meyler A, 2008, NEUROPSYCHOLOGIA, V46, P2580, DOI 10.1016/j.neuropsychologia.2008.03.012; Meyler A, 2007, CEREB CORTEX, V17, P2780, DOI 10.1093/cercor/bhm006; Murdoch BE, 2010, CORTEX, V46, P858, DOI 10.1016/j.cortex.2009.07.018; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Pecini C, 2011, COGN BEHAV NEUROL, V24, P85, DOI 10.1097/WNN.0b013e318222a4c2; Pernet C, 2009, HUM BRAIN MAPP, V30, P2278, DOI 10.1002/hbm.20670; Pernet CR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-67; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Price CJ, NEUROIMAGE IN PRESS; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; Raberger T, 2003, NEUROPSYCHOLOGIA, V41, P1493, DOI 10.1016/S0028-3932(03)00078-2; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Rae C, 1998, LANCET, V351, P1849, DOI 10.1016/S0140-6736(97)99001-2; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; Raschle NM, 2011, NEUROIMAGE, V57, P742, DOI 10.1016/j.neuroimage.2010.09.055; Richardson FM, 2009, BRAIN STRUCT FUNCT, V213, P511, DOI 10.1007/s00429-009-0211-y; Richlan F, 2011, NEUROIMAGE, V56, P1735, DOI 10.1016/j.neuroimage.2011.02.040; Richlan F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012073; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Robichon F, 2000, EUR J NEUROL, V7, P35, DOI 10.1046/j.1468-1331.2000.00020.x; Rumsey JM, 1997, ARCH NEUROL-CHICAGO, V54, P562, DOI 10.1001/archneur.1997.00550170042013; Salimi-Khorshidi G, 2009, NEUROIMAGE, V45, P810, DOI 10.1016/j.neuroimage.2008.12.039; Sandak R, 2004, SCI STUD READ, V8, P273, DOI 10.1207/s1532799xssr0803_6; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; Schulz E, 2008, NEUROIMAGE, V41, P153, DOI 10.1016/j.neuroimage.2008.02.012; Schulz E, 2009, NEUROPSYCHOLOGIA, V47, P2544, DOI 10.1016/j.neuropsychologia.2009.04.028; Shaywitz SE, 2008, ANNU REV PSYCHOL, V59, P451, DOI 10.1146/annurev.psych.59.103006.093633; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; SNOWLING MJ, 1981, PSYCHOL RES-PSYCH FO, V43, P219, DOI 10.1007/BF00309831; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Steinbrink C, 2008, NEUROPSYCHOLOGIA, V46, P3170, DOI 10.1016/j.neuropsychologia.2008.07.015; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Turkeltaub P.E., 2011, HUM BRAIN MAPP; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; van der Mark S, 2011, NEUROIMAGE, V54, P2426, DOI 10.1016/j.neuroimage.2010.10.002; Van der Mark S, 2009, NEUROIMAGE, V47, P1940, DOI 10.1016/j.neuroimage.2009.05.021; Vellutino F.R., 1979, DYSLEXIA RES THEORY; Vinckenbosch E, 2005, NEUROPSYCHOLOGIA, V43, P324, DOI 10.1016/j.neuropsychologia.2004.06.023; Webster RI, 2004, J CHILD NEUROL, V19, P471, DOI 10.1177/08830738040190070101; Wimmer H, 1999, J LEARN DISABIL, V32, P473, DOI 10.1177/002221949903200513; Wimmer H, 2010, CORTEX, V46, P1284, DOI 10.1016/j.cortex.2010.06.004	96	118	121	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43122	10.1371/journal.pone.0043122	http://dx.doi.org/10.1371/journal.pone.0043122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916214	gold, Green Published, Green Submitted			2022-12-27	WOS:000307733800048
J	Al-Abdulrazzak, D; Naidoo, R; Palomares, MLD; Pauly, D				Al-Abdulrazzak, Dalal; Naidoo, Robin; Palomares, Maria Lourdes D.; Pauly, Daniel			Gaining Perspective on What We've Lost: The Reliability of Encoded Anecdotes in Historical Ecology	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; ABUNDANCE	Historical data are essential in fisheries management and conservation, especially for species that suffered significant population declines prior to ecological data collection. Within the field of historical marine ecology, studies have relied on anecdotal evidence, such as written accounts by explorers and interviews of different generations of resource users, to demonstrate the former abundance of certain species and the extent of their ranges. Yet, do we all agree on how these anecdotes are interpreted? This study examines the way that different people interpret anecdotes extracted from historical narratives. We outsource a survey to 50 randomly selected people using Amazon Mechanical Turk (www.mturk.com) and ask them to 'code' historical anecdotes based on their perceived abundance of species. We perform intercoder reliability tests to show that people's perceptions of historical anecdotes are generally consistent. The results speak to the reliability of using people's perceptions to acquire quantitative data, and provide novel insights into the use of anecdotal evidence to inform historical ecology.	[Al-Abdulrazzak, Dalal; Palomares, Maria Lourdes D.; Pauly, Daniel] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Naidoo, Robin] WWF US, Conservat Sci Program, Washington, DC USA	University of British Columbia; World Wildlife Fund	Al-Abdulrazzak, D (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada.	d.alabdulrazzak@fisheries.ubc.ca	Pauly, Daniel Marc/AAY-2316-2021; Palomares, Maria Lourdes D./K-1641-2019	Pauly, Daniel/0000-0003-3756-4793; Chiaradia, Andre/0000-0002-6178-4211; Palomares, Maria Lourdes/0000-0001-5905-1556				Battutah I, 2002, TRAVELS IBNBATTUTAH; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Eklund J, 2000, FISH RES, V46, P147, DOI 10.1016/S0165-7836(00)00141-7; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; HUGHES MA, 1990, J MARKETING RES, V27, P185, DOI 10.2307/3172845; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Kittur A, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P453; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; Lombard M, 2002, HUM COMMUN RES, V28, P587, DOI 10.1111/j.1468-2958.2002.tb00826.x; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; Marriott RJ, 2010, MAR FRESHWATER RES, V61, P1171, DOI 10.1071/MF09280; McClenachan L, 2012, CONSERVATION LETT NO; McClenachan L, 2008, P ROY SOC B-BIOL SCI, V275, P1351, DOI 10.1098/rspb.2007.1757; Neuendorf K. A, 2002, CONTENT ANAL GUIDEBO; Palomares MLD, 2007, HIST PHIL LIFE SCI, V29, P33; Palomares MLD, 2006, ENVIRON HIST, V11, P835, DOI 10.1093/envhis/11.4.835; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Paxton CGM, 2009, J ZOOL, V279, P381, DOI 10.1111/j.1469-7998.2009.00630.x; Pernety AJ, 1771, HIST VOYAGE MALOUINE; Rosenberg AA, 2005, FRONT ECOL ENVIRON, V3, P84, DOI 10.2307/3868514; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569; Saenz-Arroyo A, 2006, FISH FISH, V7, P128, DOI 10.1111/j.1467-2979.2006.00214.x; Saenz-Arroyo A, 2005, FISH FISH, V6, P121, DOI 10.1111/j.1467-2979.2005.00185.x; Shermer M, 2003, SHOW ME BODY; Shermer Michael., 2002, WHY PEOPLE BELIEVE W; Streeter Edwin W., 1886, PEARLS PEARLING LIFE; Vickers D, 2011, HISTORY; Villiers A, 1940, SONS SINBAD ACCOUNT; Whyte AVT and International Council of Scientific Unions, 1977, GUIDELINES FIELD STU	34	29	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43386	10.1371/journal.pone.0043386	http://dx.doi.org/10.1371/journal.pone.0043386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937043	gold, Green Published			2022-12-27	WOS:000308225500046
J	Escalante, AE; Inouye, S; Travisano, M				Escalante, Ana E.; Inouye, Sumiko; Travisano, Michael			A Spectrum of Pleiotropic Consequences in Development Due to Changes in a Regulatory Pathway	PLOS ONE			English	Article							BACTERIUM MYXOCOCCUS-XANTHUS; FRUITING BODY FORMATION; PROTEIN SER/THR KINASE; EVO-DEVO; DICTYOSTELIUM-DISCOIDEUM; EVOLUTIONARY SYNTHESIS; SALTATIONAL EVOLUTION; ADAPTIVE EVOLUTION; SOCIAL AMEBA; 6-PHOSPHOFRUCTOKINASE	Regulatory evolution has frequently been proposed as the primary mechanism driving morphological evolution. This is because regulatory changes may be less likely to cause deleterious pleiotropic effects than changes in protein structure, and consequently have a higher likelihood to be beneficial. We examined the potential for mutations in trans acting regulatory elements to drive phenotypic change, and the predictability of such change. We approach these questions by the study of the phenotypic scope and size of controlled alteration in the developmental network of the bacterium Myxococcus xanthus. We perturbed the expression of a key regulatory gene (fruA) by constructing independent in-frame deletions of four trans acting regulatory loci that modify its expression. While mutants retained developmental capability, the deletions caused changes in the expression of fruA and a dramatic shortening of time required for completion of development. We found phenotypic changes in the majority of traits measured, indicating pleiotropic effects of changes in regulation. The magnitude of the change for different traits was variable but the extent of differences between the mutants and parental type were consistent with changes in fruA expression. We conclude that changes in the expression of essential regulatory regions of developmental networks may simultaneously lead to modest as well as dramatic morphological changes upon which selection may subsequently act.	[Escalante, Ana E.; Travisano, Michael] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Escalante, Ana E.] Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Inst Ecol, Mexico City 04510, DF, Mexico; [Escalante, Ana E.; Travisano, Michael] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Inouye, Sumiko] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ USA	University of Minnesota System; University of Minnesota Twin Cities; Universidad Nacional Autonoma de Mexico; University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick; Rutgers State University Medical Center	Escalante, AE (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	anaelena.escalante@gmail.com	Escalante, Ana/D-5479-2011; Travisano, Michael/AAI-4809-2020	Escalante, Ana/0000-0001-8147-4598; Travisano, Michael/0000-0001-8168-0842	University of Minnesota; CONACyT [126166]; Foundation of Medicine and Dentistry of New Jersey; US National Science Foundation [DEB-0918897, SES-0959134, MCB-1042335, DEB-1146463]	University of Minnesota(University of Minnesota System); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Foundation of Medicine and Dentistry of New Jersey; US National Science Foundation(National Science Foundation (NSF))	Ana E. Escalante was supported by University of Minnesota and CONACyT postdoctoral Fellowship 126166, Sumiko Inouye by the Foundation of Medicine and Dentistry of New Jersey, and Michael Travisano by the US National Science Foundation (DEB-0918897, SES-0959134, MCB-1042335, DEB-1146463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Atallah J, 2009, INT REV CEL MOL BIO, V278, P119, DOI 10.1016/S1937-6448(09)78003-7; BARTON NH, 1984, ANNU REV ECOL SYST, V15, P133, DOI 10.1146/annurev.es.15.110184.001025; Canestro C, 2007, NAT REV GENET, V8, P932, DOI 10.1038/nrg2226; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Davelos AL, 2004, APPL ENVIRON MICROB, V70, P1051, DOI 10.1128/AEM.70.2.1051-1058.2004; de Vries H, 1906, SPECIES VARIETIES TH; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; DYKHUIZEN DE, 1990, TRENDS ECOL EVOL, V5, P257, DOI 10.1016/0169-5347(90)90067-N; Fortunato A, 2003, MOL ECOL, V12, P1031, DOI 10.1046/j.1365-294X.2003.01792.x; Goldschmidt R., 1940, MAT BASIS EVOLUTION; Higgs PI, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P465; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Huntley S, 2011, MOL BIOL EVOL, V28, P1083, DOI 10.1093/molbev/msq292; Inouye S, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P191; Jenner RA, 2007, NAT REV GENET, V8, P311, DOI 10.1038/nrg2062; Kraemer SA, 2010, FEMS MICROBIOL ECOL, V73, P226, DOI 10.1111/j.1574-6941.2010.00888.x; KROOS L, 1987, GENE DEV, V1, P840, DOI 10.1101/gad.1.8.840; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Liao BY, 2010, P NATL ACAD SCI USA, V107, P7353, DOI 10.1073/pnas.0910339107; Minelli A, 2009, EVOL DEV, V11, P318, DOI 10.1111/j.1525-142X.2009.00334.x; MORRISON CE, 1979, J BACTERIOL, V140, P1036, DOI 10.1128/JB.140.3.1036-1042.1979; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; Nariya H, 2005, MOL MICROBIOL, V56, P1314, DOI 10.1111/j.1365-2958.2005.04619.x; Nariya H, 2003, MOL MICROBIOL, V49, P517, DOI 10.1046/j.1365-2958.2003.03572.x; Nariya H, 2002, MOL MICROBIOL, V46, P1353, DOI 10.1046/j.1365-2958.2002.03251.x; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Pighucci M, 2009, ANN NY ACAD SCI, V1168, P218, DOI 10.1111/j.1749-6632.2009.04578.x; Pigliucci M, 2010, PHILOS T R SOC B, V365, P557, DOI 10.1098/rstb.2009.0241; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Rice SH, 2008, ANN NY ACAD SCI, V1133, P67, DOI 10.1196/annals.1438.002; Rubinoff D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004035; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Stefanic P, 2009, J BACTERIOL, V191, P1756, DOI 10.1128/JB.01290-08; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Suzuki Y, 2008, J EVOLUTION BIOL, V21, P57, DOI 10.1111/j.1420-9101.2007.01464.x; Travisano M, 1996, GENETICS, V143, P15; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Ueki T, 2006, APPL MICROBIOL BIOT, V72, P21, DOI 10.1007/s00253-006-0455-x; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Velicer GJ, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P17; Vos M, 2008, CURR BIOL, V18, P386, DOI 10.1016/j.cub.2008.02.050; Whitlock M. C., 2009, ANAL BIOL DATA; Yu YTN, 2010, SCIENCE, V328, P993, DOI 10.1126/science.1187200; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhang YQ, 2005, APPL ENVIRON MICROB, V71, P3331, DOI 10.1128/AEM.71.6.3331-3336.2005; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	53	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43413	10.1371/journal.pone.0043413	http://dx.doi.org/10.1371/journal.pone.0043413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937047	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500049
J	Hu, G; Wu, JG; Feeley, KJ; Xu, GF; Yu, MJ				Hu, Guang; Wu, Jianguo; Feeley, Kenneth J.; Xu, Gaofu; Yu, Mingjian			The Effects of Landscape Variables on the Species-Area Relationship during Late-Stage Habitat Fragmentation	PLOS ONE			English	Article							THREE-GORGES DAM; SPATIAL COMPONENT; LIFE-HISTORY; RICHNESS; ISLANDS; BIRDS; PATCH; IMMIGRATION; PATTERNS; SIZE	Few studies have focused explicitly on the later stages of the fragmentation process, or "late-stage fragmentation", during which habitat area and patch number decrease simultaneously. This lack of attention is despite the fact that many of the anthropogenically fragmented habitats around the world are, or soon will be, in late-stage fragmentation. Understanding the ecological processes and patterns that occur in late-stage fragmentation is critical to protect the species richness in these fragments. We investigated plant species composition on 152 islands in the Thousand Island Lake, China. A random sampling method was used to create simulated fragmented landscapes with different total habitat areas and numbers of patches mimicking the process of late-stage fragmentation. The response of the landscape-scale species-area relationship (LSAR) to fragmentation per se was investigated, and the contribution of inter-specific differences in the responses to late-stage fragmentation was tested. We found that the loss of species at small areas was compensated for by the effects of fragmentation per se, i.e., there were weak area effects on species richness in landscapes due to many patches with irregular shapes and high variation in size. The study also illustrated the importance of inter-specific differences for responses to fragmentation in that the LSARs of rare and common species were differently influenced by the effects of fragmentation per se. In conclusion, our analyses at the landscape scale demonstrate the significant influences of fragmentation per se on area effects and the importance of inter-specific differences for responses to fragmentation in late-stage fragmentation. These findings add to our understanding of the effects of habitat fragmentation on species diversity.	[Hu, Guang; Yu, Mingjian] Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Jianguo] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Wu, Jianguo] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Wu, Jianguo] Inner Mongolia Univ, Sino US Ctr Conservat Energy & Sustainabil, Hohhot, Peoples R China; [Feeley, Kenneth J.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Feeley, Kenneth J.] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Coral Gables, FL USA; [Xu, Gaofu] Xinan River Dev Corp, Chunan, South Korea	Zhejiang University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Inner Mongolia University; State University System of Florida; Florida International University	Hu, G (corresponding author), Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fishmj202@hotmail.com	Feeley, Kenneth James/A-7631-2009; Hu, Guang/AAF-1689-2020; Wu, Jianguo/G-6267-2010	Feeley, Kenneth James/0000-0002-3618-1144; Wu, Jianguo/0000-0002-1182-3024; Hu, Guang/0000-0002-4390-6166	Zhejiang Provincial Natural Science Foundation of China [Z5100053]; National Nature Science Foundation of China [30770371]; Fundamental Research Funds for the Central Universities; Graduate Innovation Program of Zhejiang Province; Florida International University; Fairchild Tropical Botanic Garden	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Graduate Innovation Program of Zhejiang Province; Florida International University; Fairchild Tropical Botanic Garden	Funding provided by Zhejiang Provincial Natural Science Foundation of China (No. Z5100053) (http://www.zjnsf.gov.cn), National Nature Science Foundation of China (No. 30770371) (http://www.nsfc.gov.cn), Fundamental Research Funds for the Central Universities (http://www.dost.moe.edu.cn), and the Graduate Innovation Program of Zhejiang Province (http://www.zjedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our field work has obtained the permission from the responsible authority, Chun'an Forestry Bureau and Xin'an River Development Corporation of Chun'an County - we are grateful to them for support with field work. We thank the Florida International University and the Fairchild Tropical Botanic Garden for their support.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; Bascompte J, 2001, ECOL LETT, V4, P417, DOI 10.1046/j.1461-0248.2001.00242.x; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borges PAV, 2009, ACTA OECOL, V35, P149, DOI 10.1016/j.actao.2008.09.003; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Caley MJ, 2001, ECOLOGY, V82, P3435, DOI 10.2307/2680163; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Collins CD, 2009, ECOLOGY, V90, P2577, DOI 10.1890/08-1405.1; Conceicao KS, 2010, PHYSICA A, V389, P3496, DOI 10.1016/j.physa.2010.04.036; Davis JD, 2007, LANDSCAPE ECOL, V22, P1341, DOI 10.1007/s10980-007-9111-9; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Debuse VJ, 2007, LANDSCAPE ECOL, V22, P731, DOI 10.1007/s10980-006-9068-0; Dengler J, 2009, J BIOGEOGR, V36, P728, DOI 10.1111/j.1365-2699.2008.02038.x; Diamond J, 2001, SCIENCE, V294, P1847, DOI 10.1126/science.1067012; Editorial Committee of Flora of Zhejiang, 1993, FLOR ZHEJ; ESRI, 2009, ARCGIS DESKT REL 9 3; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fletcher RJ, 2007, CAN J ZOOL, V85, P1017, DOI 10.1139/Z07-100; Gardner RH, 2008, PERSPECT PLANT ECOL, V9, P211, DOI 10.1016/j.ppees.2007.08.003; Gilbert B, 2006, AM NAT, V168, P304, DOI 10.1086/506969; GUSTAFSON EJ, 1992, LANDSCAPE ECOL, V7, P101, DOI 10.1007/BF02418941; Hamer TL, 2006, LANDSCAPE ECOL, V21, P569, DOI 10.1007/s10980-005-2167-5; He FL, 2005, ECOLOGY, V86, P360, DOI 10.1890/04-1449; He FL, 1996, AM NAT, V148, P719, DOI 10.1086/285950; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Hu G, 2011, LANDSCAPE ECOL, V26, P1405, DOI 10.1007/s10980-011-9662-7; Kim S, 2011, PPCOR PARTIAL SEMIPA; Kitamura K, 2005, PLANT SPEC BIOL, V20, P133, DOI 10.1111/j.1442-1984.2005.00132.x; Koper N, 2007, LANDSCAPE ECOL, V22, P811, DOI 10.1007/s10980-007-9083-9; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Lees AC, 2009, OIKOS, V118, P280, DOI 10.1111/j.1600-0706.2008.16842.x; Levin S, 2009, PRINCETON GUIDE ECOL, P438; Magness DR, 2006, WILDLIFE SOC B, V34, P473, DOI 10.2193/0091-7648(2006)34[473:QRAGWO]2.0.CO;2; Marks B.J., 1995, 351 PNV US FOR SERV; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Meot A, 1998, ENVIRON ECOL STAT, V5, P1, DOI 10.1023/A:1009693501830; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Panitsa M, 2006, J BIOGEOGR, V33, P1223, DOI 10.1111/j.1365-2699.2006.01481.x; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Qie L, 2011, J BIOGEOGR, V38, P792, DOI 10.1111/j.1365-2699.2010.02439.x; R Core Team, 2020, R LANG ENV STAT COMP; Rosenberg KV, 1999, CONSERV BIOL, V13, P568, DOI 10.1046/j.1523-1739.1999.98020.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Santos AMC, 2010, GLOBAL ECOL BIOGEOGR, V19, P527, DOI 10.1111/j.1466-8238.2010.00536.x; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Sizling AL, 2009, AM NAT, V174, P82, DOI 10.1086/599305; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Sonderegger D., 2011, SIZER SIGNIFICANT ZE; Sondgerath D, 2002, LANDSCAPE ECOL, V17, P57, DOI 10.1023/A:1015237002145; Terborgh JW, 2008, TROPICAL FOREST COMM; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Triantis KA, 2012, J BIOGEOGR, V39, P215, DOI 10.1111/j.1365-2699.2011.02652.x; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.1890/1051-0761(2002)012[0354:COSHFT]2.0.CO;2; Wang Y, 2009, ANIM CONSERV, V12, P329, DOI 10.1111/j.1469-1795.2009.00257.x; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; Wilcove D.S., 1986, P237; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wright DH, 1998, OECOLOGIA, V113, P1, DOI 10.1007/s004420050348; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.1890/1540-9295(2004)002[0241:TTGDAE]2.0.CO;2; Wu JG, 2003, SCIENCE, V300, P1239, DOI 10.1126/science.1083312; Yaacobi G, 2007, P ROY SOC B-BIOL SCI, V274, P2409, DOI 10.1098/rspb.2007.0674; Yu MJ, 2012, J BIOGEOGR, V39, P1124, DOI 10.1111/j.1365-2699.2011.02676.x; Zheng C., 2005, KEYS SEED PLANTS ZHE	73	19	24	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43894	10.1371/journal.pone.0043894	http://dx.doi.org/10.1371/journal.pone.0043894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937120	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500120
J	Li, L; Chang, SH; Xiang, JF; Li, Q; Liang, HH; Tang, YL; Liu, YF				Li, Lin; Chang, Shenghai; Xiang, Junfeng; Li, Qian; Liang, Huanhuan; Tang, Yalin; Liu, Yingfang			Screen Anti-influenza Lead Compounds That Target the PA(C) Subunit of H5N1 Viral RNA Polymerase	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; PA SUBUNIT; CRYSTAL-STRUCTURE; ACTIVE-SITE; ENDONUCLEASE; INFECTION; AGENTS; STRATEGIES; MUTATION; BINDING	The avian influenza (H5N1) viral RNA polymerase protein PA(C) was used as a target to screen nine chlorogenic acid derivatives for their polymerase inhibitor activity. Among them, seven compounds were PAC ligands, and four inhibited influenza RNA polymerase activity. These results aid in the design of anti-influenza agents based on caffeoylquinic acid.	[Li, Lin; Xiang, Junfeng; Li, Qian; Tang, Yalin] Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, BNLMS,Ctr Mol Sci, Beijing 100080, Peoples R China; [Chang, Shenghai; Liang, Huanhuan; Liu, Yingfang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Li, Lin; Chang, Shenghai; Li, Qian] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Chem, State Key Lab Struct Chem Unstable & Stable Speci, BNLMS,Ctr Mol Sci, Beijing 100080, Peoples R China.	tangyl@iccas.ac.cn; liuy@ibp.ac.cn			National Natural Science Foundation of China [81072576, 30925011]; Ministry of Science and Technology 863 Project [2006AA02A314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology 863 Project(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (81072576) to Y. L. Tang, the National Natural Science Foundation of China (30925011) and the Ministry of Science and Technology 863 Project (2006AA02A314) to Y. F. Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; De Clereq E, 2007, TRENDS PHARMACOL SCI, V28, P280, DOI 10.1016/j.tips.2007.04.005; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Ge F, 2007, PHYTOCHEM ANALYSIS, V18, P213, DOI 10.1002/pca.974; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Iwai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019825; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Ko HC, 2006, J ETHNOPHARMACOL, V107, P205, DOI 10.1016/j.jep.2006.03.004; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Lepre CA, 2004, CHEM REV, V104, P3641, DOI 10.1021/cr030409h; Li L, 2011, CHEM LETT, V40, P801, DOI 10.1246/cl.2011.801; Luo RS, 1999, SPECTROCHIM ACTA A, V55, P1897, DOI 10.1016/S1386-1425(99)00052-9; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Nakazawa M, 2008, ANTIVIR RES, V78, P194, DOI 10.1016/j.antiviral.2007.12.010; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Su CY, 2010, P NATL ACAD SCI USA, V107, P19151, DOI 10.1073/pnas.1013592107; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhang SJ, 2010, J BIOL CHEM, V285, P41194, DOI 10.1074/jbc.M110.130062	26	12	13	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e35234	10.1371/journal.pone.0035234	http://dx.doi.org/10.1371/journal.pone.0035234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936968	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500001
J	Martial, FP; Hartell, NA				Martial, Franck P.; Hartell, Nicholas A.			Programmable Illumination and High-Speed, Multi-Wavelength, Confocal Microscopy Using a Digital Micromirror	PLOS ONE			English	Article							FLUORESCENT PROTEIN; DEVICE	Confocal microscopy is routinely used for high-resolution fluorescence imaging of biological specimens. Most standard confocal systems scan a laser across a specimen and collect emitted light passing through a single pinhole to produce an optical section of the sample. Sequential scanning on a point-by-point basis limits the speed of image acquisition and even the fastest commercial instruments struggle to resolve the temporal dynamics of rapid cellular events such as calcium signals. Various approaches have been introduced that increase the speed of confocal imaging. Nipkov disk microscopes, for example, use arrays of pinholes or slits on a spinning disk to achieve parallel scanning which significantly increases the speed of acquisition. Here we report the development of a microscope module that utilises a digital micromirror device as a spatial light modulator to provide programmable confocal optical sectioning with a single camera, at high spatial and axial resolution at speeds limited by the frame rate of the camera. The digital micromirror acts as a solid state Nipkov disk but with the added ability to change the pinholes size and separation and to control the light intensity on a mirror-by-mirror basis. The use of an arrangement of concave and convex mirrors in the emission pathway instead of lenses overcomes the astigmatism inherent with DMD devices, increases light collection efficiency and ensures image collection is achromatic so that images are perfectly aligned at different wavelengths. Combined with non-laser light sources, this allows low cost, high-speed, multi-wavelength image acquisition without the need for complex wavelength-dependent image alignment. The micromirror can also be used for programmable illumination allowing spatially defined photoactivation of fluorescent proteins. We demonstrate the use of this system for high-speed calcium imaging using both a single wavelength calcium indicator and a genetically encoded, ratiometric, calcium sensor.	[Martial, Franck P.; Hartell, Nicholas A.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Martial, FP (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	nh88@le.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E00461X/1, BB/J019046/1, BB/E001246/1]; East Midlands Development Agency; Biotechnology and Biological Sciences Research Council [BB/E001246/1, BB/E00461X/1, BB/J019046/1] Funding Source: researchfish; BBSRC [BB/J019046/1, BB/E001246/1, BB/E00461X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); East Midlands Development Agency; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported directly by Biotechnology and Biological Sciences Research Council (BBSRC) grants BB/E00461X/1 and BB/J019046/1 and in part by BB/E001246/1 awarded to NAH and the East Midlands Development Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal V, 2004, PRO BIOMED OPT IMAG, V5, P47, DOI 10.1117/12.529432; Bansal V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2209562; Callamaras N, 1999, METHOD ENZYMOL, V307, P152; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; EILERS J, 1995, P NATL ACAD SCI USA, V92, P10272, DOI 10.1073/pnas.92.22.10272; Fukano T, 2003, APPL OPTICS, V42, P4119, DOI 10.1364/AO.42.004119; HAGEN GM, 2007, P SPIE, V6441; Hanley QS, 1999, J MICROSC-OXFORD, V196, P317, DOI 10.1046/j.1365-2818.1999.00602.x; Heintzmann R, 2001, J MICROSC-OXFORD, V204, P119, DOI 10.1046/j.1365-2818.2001.00945.x; Jiang SH, 2005, OPT COMMUN, V256, P35, DOI 10.1016/j.optcom.2005.06.055; Jiang SH, 2010, APPL OPTICS, V49, P497, DOI 10.1364/AO.49.000497; Liang MH, 1997, OPT LETT, V22, P751, DOI 10.1364/OL.22.000751; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Nakano A, 2002, CELL STRUCT FUNCT, V27, P349, DOI 10.1247/csf.27.349; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103	16	30	32	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43942	10.1371/journal.pone.0043942	http://dx.doi.org/10.1371/journal.pone.0043942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937130	Green Published, gold			2022-12-27	WOS:000308225500126
J	McWilliam, SJ; Antoine, DJ; Sabbisetti, V; Turner, MA; Farragher, T; Bonventre, JV; Park, BK; Smyth, RL; Pirmohamed, M				McWilliam, Stephen J.; Antoine, Daniel J.; Sabbisetti, Venkata; Turner, Mark A.; Farragher, Tracey; Bonventre, Joseph V.; Park, B. Kevin; Smyth, Rosalind L.; Pirmohamed, Munir			Mechanism-Based Urinary Biomarkers to Identify the Potential for Aminoglycoside-Induced Nephrotoxicity in Premature Neonates: A Proof-of-Concept Study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; GELATINASE-ASSOCIATED LIPOCALIN; CRITICALLY-ILL CHILDREN; ACUTE-RENAL-FAILURE; MARKER; NGAL; APOPTOSIS; TOXICITY; VALUES	Premature infants are frequently exposed to aminoglycoside antibiotics. Novel urinary biomarkers may provide a non-invasive means for the early identification of aminoglycoside-related proximal tubule renal toxicity, to enable adjustment of treatment and identification of infants at risk of long-term renal impairment. In this proof-of-concept study, urine samples were collected from 41 premature neonates (<= 32 weeks gestation) at least once per week, and daily during courses of gentamicin, and for 3 days afterwards. Significant increases were observed in the three urinary biomarkers measured (Kidney Injury Molecule-1 (KIM-1), Neutrophil Gelatinase-associated Lipocalin (NGAL), and N-acetyl-beta-D-glucosaminidase (NAG)) during treatment with multiple courses of gentamicin. When adjusted for potential confounders, the treatment effect of gentamicin remained significant only for KIM-1 (mean difference from not treated, 1.35 ng/mg urinary creatinine; 95% CI 0.05-2.65). Our study shows that (a) it is possible to collect serial urine samples from premature neonates, and that (b) proximal tubule specific urinary biomarkers can act as indicators of aminoglycoside-associated nephrotoxicity in this age group. Further studies to investigate the clinical utility of novel urinary biomarkers in comparison to serum creatinine need to be undertaken.	[McWilliam, Stephen J.; Antoine, Daniel J.; Park, B. Kevin; Pirmohamed, Munir] Univ Liverpool, MRC Ctr Drug Safety Sci, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Antoine, Daniel J.; Sabbisetti, Venkata; Bonventre, Joseph V.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Renal Div,Med Sch, Boston, MA 02115 USA; [Turner, Mark A.] Univ Liverpool, Dept Womens & Childrens Hlth, Neonatal Unit, Liverpool Womens Hosp, Liverpool L69 3BX, Merseyside, England; [Farragher, Tracey] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Smyth, Rosalind L.] Univ Liverpool, Inst Child Hlth, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Liverpool; University of Leeds; University of Liverpool	McWilliam, SJ (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England.	d.antoine@liv.ac.uk	Farragher, Tracey/P-5847-2019; McWilliam, Stephen/J-3811-2019; Pirmohamed, Munir/H-6004-2011	McWilliam, Stephen/0000-0002-0509-7425; Pirmohamed, Munir/0000-0002-7534-7266; Farragher, Tracey/0000-0002-1968-6378; Turner, Mark/0000-0002-5299-8656	Medical Research Council [G0700654, G1000417/94909]; Royal Society for an International Travelling Fellowship; US National Institutes of Health [DK39773, DK072381]; North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics; ICON; GlaxoSmithKline; AstraZeneca; Medical Evaluation Unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039773, R01DK039773, R01DK072381] Funding Source: NIH RePORTER; Medical Research Council [G0700654B, G1000417] Funding Source: researchfish; MRC [G1000417, G0700654] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society for an International Travelling Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ICON; GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Medical Evaluation Unit; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to acknowledge financial support from the Medical Research Council (grant number G0700654) and to the Royal Society for an International Travelling Fellowship awarded to DJA. JVB is supported by US National Institutes of Health grants DK39773 and DK072381. SMcW is an MRC Clinical Training Fellow supported by the North West England Medical Research Council Fellowship Scheme in Clinical Pharmacology and Therapeutics which is funded by the Medical Research Council (grant number G1000417/94909), ICON, GlaxoSmithKline, AstraZeneca and the Medical Evaluation Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli SP, 2004, SEMIN PERINATOL, V28, P112, DOI 10.1053/j.semperi.2003.11.003; Askenazi DJ, 2011, J PEDIATR-US, V159, P907, DOI 10.1016/j.jpeds.2011.05.045; Askenazi DJ, 2011, PEDIATR RES, V70, P302, DOI 10.1203/PDR.0b013e3182275164; Askenazi DJ, 2009, PEDIATR NEPHROL, V24, P265, DOI 10.1007/s00467-008-1060-2; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Davidovic-Plavsic B, 2010, J MED BIOCHEM, V29, P44, DOI 10.2478/v10011-010-0002-2; Devarajan P, 2008, SCAND J CLIN LAB INV, V68, P89, DOI 10.1080/00365510802150158; Du Y, 2011, PEDIATR NEPHROL, V26, P267, DOI 10.1007/s00467-010-1673-0; Espandiari P, 2007, TOXICOL SCI, V99, P637, DOI 10.1093/toxsci/kfm184; Huynh TK, 2009, PEDIATR RES, V66, P528, DOI 10.1203/PDR.0b013e3181baa3dd; Jetton JG, 2012, CURR OPIN PEDIATR, V24, P191, DOI 10.1097/MOP.0b013e32834f62d5; Karlowicz MG, 1995, PEDIATR NEPHROL, V9, P718, DOI 10.1007/BF00868721; Koralkar R, 2011, PEDIATR RES, V69, P354, DOI 10.1203/PDR.0b013e31820b95ca; LANGHENDRIES JP, 1989, BIOL NEONATE, V56, P76; Lavery AP, 2008, PEDIATR RES, V64, P423, DOI 10.1203/PDR.0b013e318181b3b2; MATHEWS A, 1987, J CLIN PHARM THER, V12, P273, DOI 10.1111/j.1365-2710.1987.tb00539.x; Nestaas E, 2005, ARCH DIS CHILD-FETAL, V90, pF294, DOI 10.1136/adc.2004.056317; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Parravicini E, 2010, PEDIATR RES, V67, P636, DOI 10.1203/PDR.0b013e3181da75c1; Parravicini E, 2009, AM J PERINAT, V26, P437, DOI 10.1055/s-0029-1214242; Royston P, 2005, METHOD INFORM MED, V44, P561; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Schmitz C, 2002, J BIOL CHEM, V277, P618, DOI 10.1074/jbc.M109959200; Servais H, 2008, APOPTOSIS, V13, P11, DOI 10.1007/s10495-007-0151-z; Servais H, 2005, TOXICOL APPL PHARM, V206, P321, DOI 10.1016/j.taap.2004.11.024; Slaughter RL, 1998, PHARMACOECONOMICS, V14, P385, DOI 10.2165/00019053-199814040-00005; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x; Victor S, 2011, ARCH DIS CHILD-FETAL, V96, pF144, DOI 10.1136/adc.2008.152454; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Wasilewska A, 2011, PEDIATR NEPHROL, V26, P579, DOI 10.1007/s00467-011-1773-5; Wheeler DS, 2008, CRIT CARE MED, V36, P1297, DOI 10.1097/CCM.0b013e318169245a; Willis F, 1997, ARCH DIS CHILD-FETAL, V77, pF57, DOI 10.1136/fn.77.1.F57; Zappitelli M, 2007, CRIT CARE, V11, DOI 10.1186/cc6089	35	64	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43809	10.1371/journal.pone.0043809	http://dx.doi.org/10.1371/journal.pone.0043809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937100	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500102
J	Kim, C; Choi, H; Jung, ES; Lee, W; Oh, S; Jeon, NL; Mook-Jung, I				Kim, Chaeyoung; Choi, Heesun; Jung, Eun Sun; Lee, Wonik; Oh, Soojung; Jeon, Noo Li; Mook-Jung, Inhee			HDAC6 Inhibitor Blocks Amyloid Beta-Induced Impairment of Mitochondrial Transport in Hippocampal Neurons	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; A-BETA; TUBULIN; DYSFUNCTION; INTERACTS; ABNORMALITIES; TRAFFICKING; DYNAMICS; DEFICITS	Even though the disruption of axonal transport is an important pathophysiological factor in neurodegenerative diseases including Alzheimer's disease (AD), the relationship between disruption of axonal transport and pathogenesis of AD is poorly understood. Considering that alpha-tubulin acetylation is an important factor in axonal transport and that A beta impairs mitochondrial axonal transport, we manipulated the level of alpha-tubulin acetylation in hippocampal neurons with A beta cultured in a microfluidic system and examined its effect on mitochondrial axonal transport. We found that inhibiting histone deacetylase 6 (HDAC6), which deacetylates alpha-tubulin, significantly restored the velocity and motility of the mitochondria in both anterograde and retrograde axonal transports, which would be otherwise compromised by A beta. The inhibition of HDAC6 also recovered the length of the mitochondria that had been shortened by A beta to a normal level. These results suggest that the inhibition of HDAC6 significantly rescues hippocampal neurons from A beta-induced impairment of mitochondrial axonal transport as well as mitochondrial length. The results presented in this paper identify HDAC6 as an important regulator of mitochondrial transport as well as elongation and, thus, a potential target whose pharmacological inhibition contributes to improving mitochondrial dynamics in Ab treated neurons.	[Kim, Chaeyoung; Choi, Heesun; Jung, Eun Sun; Lee, Wonik; Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea; [Oh, Soojung; Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Program Multiscale Design, WCU, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, C (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea.	inhee@snu.ac.kr	Kim, Chaeyoung/GPW-6531-2022; Mook, Inhee/J-2754-2012; JUNG, EUN SUN/C-2042-2018	JUNG, EUN SUN/0000-0002-3887-987X	21C Frontier Functional Proteomics Project [FPR08K1301-02210]; National Research Foundation [2009-0081673]; World Class University-Neurocytomics; Korean National Institute of Health R&D Program Project [2009-0443]; Basic Research Program [2008-05943]; MRC at SNU [2011-0030738]	21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation; World Class University-Neurocytomics; Korean National Institute of Health R&D Program Project; Basic Research Program; MRC at SNU	This work was supported by grants from the 21C Frontier Functional Proteomics Project (FPR08K1301-02210), National Research Foundation 2009-0081673, World Class University-Neurocytomics, and the Korean National Institute of Health R&D Program Project (2009-0443) and supported in part by the Basic Research Program (2008-05943) and MRC at SNU (2011-0030738). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Boo JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004172; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; Henriques AG, 2010, J NEUROCHEM, V113, P761, DOI 10.1111/j.1471-4159.2010.06643.x; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Lee JS, 2012, J CELL PHYSIOL, V227, P2856, DOI 10.1002/jcp.23027; Lei Peng, 2011, Int J Alzheimers Dis, V2011, P189246, DOI 10.4061/2011/189246; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rice SE, 2006, J CELL BIOL, V173, P459, DOI 10.1083/jcb.200604071; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Sigala R, 2007, CURR BIOL, V17, pR18, DOI 10.1016/j.cub.2006.11.036; Silva DFF, 2011, J ALZHEIMERS DIS, V26, P565, DOI 10.3233/JAD-2011-110423; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	44	98	106	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42983	10.1371/journal.pone.0042983	http://dx.doi.org/10.1371/journal.pone.0042983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937007	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300032
J	Lerman, SB; Warren, PS; Gan, H; Shochat, E				Lerman, Susannah B.; Warren, Paige S.; Gan, Hilary; Shochat, Eyal			Linking Foraging Decisions to Residential Yard Bird Composition	PLOS ONE			English	Article							PREDATION RISK; PATCH-USE; LONG-TERM; HABITAT; CONSERVATION; BEHAVIOR; BIODIVERSITY; COMMUNITY; URBANIZATION; STRATEGIES	Urban bird communities have higher densities but lower diversity compared with wildlands. However, recent studies show that residential urban yards with native plantings have higher native bird diversity compared with yards with exotic vegetation. Here we tested whether landscape designs also affect bird foraging behavior. We estimated foraging decisions by measuring the giving-up densities (GUD; amount of food resources remaining when the final forager quits foraging on an artificial food patch, i.e seed trays) in residential yards in Phoenix, AZ, USA. We assessed how two yard designs (mesic: lush, exotic vegetation; xeric: drought-tolerant and native vegetation) differed in foraging costs. Further, we developed a statistical model to calculate GUDs for every species visiting the seed tray. Birds foraging in mesic yards depleted seed trays to a lower level (i.e. had lower GUDs) compared to birds foraging in xeric yards. After accounting for bird densities, the lower GUDs in mesic yards appeared largely driven by invasive and synanthropic species. Furthermore, behavioral responses of individual species were affected by yard design. Species visiting trays in both yard designs had lower GUDs in mesic yards. Differences in resource abundance (i.e., alternative resources more abundant and of higher quality in xeric yards) contributed to our results, while predation costs associated with foraging did not. By enhancing the GUD, a common method for assessing the costs associated with foraging, our statistical model provided insights into how individual species and bird densities influenced the GUD. These differences we found in foraging behavior were indicative of differences in habitat quality, and thus our study lends additional support for native landscapes to help reverse the loss of urban bird diversity.	[Warren, Paige S.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Gan, Hilary; Shochat, Eyal] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Shochat, Eyal] Yeruham Ctr Ornithol & Ecol, Yeruham, Israel; [Lerman, Susannah B.] Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; Arizona State University; Arizona State University-Tempe; University of Massachusetts System; University of Massachusetts Amherst	Lerman, SB (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	slerman@cns.umass.edu		Warren, Paige/0000-0003-0787-4635; Shochat, Eyal/0000-0003-0991-9366; Lerman, Susannah/0000-0002-2331-8439	Switzer Environmental Fellowship from the Robert and Patricia Switzer Foundation; National Science Foundation, Central Arizona-Phoenix Long-Term Ecological Research (CAP LTER) [DEB-0423704]; Division Of Environmental Biology [1026865] Funding Source: National Science Foundation	Switzer Environmental Fellowship from the Robert and Patricia Switzer Foundation; National Science Foundation, Central Arizona-Phoenix Long-Term Ecological Research (CAP LTER); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	S. B. Lerman was supported by a Switzer Environmental Fellowship from the Robert and Patricia Switzer Foundation. This material is based upon work supported by the National Science Foundation under Grant No. DEB-0423704, Central Arizona-Phoenix Long-Term Ecological Research (CAP LTER). Any opinions, findings and conclusions or recommendation expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker PJ, 2005, MAMMAL REV, V35, P302, DOI 10.1111/j.1365-2907.2005.00071.x; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bormann F. H., 2001, REDESIGNING AM LAWN; Bowers MA, 1996, ECOL APPL, V6, P1135, DOI 10.2307/2269597; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Buchholz R, 2007, TRENDS ECOL EVOL, V22, P401, DOI 10.1016/j.tree.2007.06.002; Burghardt KT, 2009, CONSERV BIOL, V23, P219, DOI 10.1111/j.1523-1739.2008.01076.x; Carrascal LM, 2006, OIKOS, V112, P51, DOI 10.1111/j.0030-1299.2006.13787.x; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chiron F, 2007, J WILDLIFE MANAGE, V71, P2624, DOI 10.2193/2006-105; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; EMLEN JT, 1974, CONDOR, V76, P184, DOI 10.2307/1366729; Fokidis HB, 2011, HORM BEHAV, V59, P133, DOI 10.1016/j.yhbeh.2010.11.002; Gammage G., 1999, PHOENIX PERSPECTIVE; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Green DA, 2003, LANDSCAPE URBAN PLAN, V63, P225, DOI 10.1016/S0169-2046(02)00195-0; KOTLER BP, 1994, AUST J ZOOL, V42, P449, DOI 10.1071/ZO9940449; Kotler BP, 2007, ISR J ECOL EVOL, V53, P237, DOI 10.1560/IJEE.53.3.237; Kotler BP, 2010, P ROY SOC B-BIOL SCI, V277, P1469, DOI 10.1098/rspb.2009.2036; Lerman SB, 2011, ECOL APPL, V21, P1327, DOI 10.1890/10-0423.1; Leston LFV, 2006, BIOL CONSERV, V131, P566, DOI 10.1016/j.biocon.2006.03.003; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1990, OIKOS, V58, P151, DOI 10.2307/3545422; Major RE, 1996, AUST J ECOL, V21, P399, DOI 10.1111/j.1442-9993.1996.tb00626.x; Marzluff John M., 2001, P19; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Morris DW, 2000, ECOLOGY, V81, P2061, DOI 10.1890/0012-9658(2000)081[2061:OFMMPU]2.0.CO;2; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Olsson O, 1999, OIKOS, V87, P264, DOI 10.2307/3546741; Olsson O, 2002, ANIM BEHAV, V63, P981, DOI 10.1006/anbe.2001.1985; Olsson O, 2007, ISR J ECOL EVOL, V53, P263, DOI 10.1560/IJEE.53.3.263; Ovadia O, 2001, BEHAV ECOL, V12, P219, DOI 10.1093/beheco/12.2.219; Oyugi JO, 2003, CONDOR, V105, P130, DOI 10.1650/0010-5422(2003)105[130:GUDAHP]2.0.CO;2; R Core Team, 2018, R LANG ENV STAT COMP; ROSENBERG KV, 1987, WILSON BULL, V99, P642; Schmidt KA, 1999, OIKOS, V85, P151, DOI 10.2307/3546801; Shochat E, 2004, AM NAT, V164, P232, DOI 10.1086/422222; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sorace A, 2002, ORNIS FENNICA, V79, P60; Stenberg M, 2006, OIKOS, V112, P332, DOI 10.1111/j.0030-1299.2006.13459.x; Stephens D.W., 1986, pi; VALONE TJ, 1989, ECOLOGY, V70, P1800, DOI 10.2307/1938113; Whelan CJ, 2005, FUNCT ECOL, V19, P529, DOI 10.1111/j.1365-2435.2005.00996.x; [No title captured]	48	19	19	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43497	10.1371/journal.pone.0043497	http://dx.doi.org/10.1371/journal.pone.0043497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927974	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300056
J	Rae, BD; Long, BM; Badger, MR; Price, GD				Rae, Benjamin D.; Long, Benedict M.; Badger, Murray R.; Price, G. Dean			Structural Determinants of the Outer Shell of beta-Carboxysomes in Synechococcus elongatus PCC 7942: Roles for CcmK2, K3-K4, CcmO, and CcmL	PLOS ONE			English	Article							INORGANIC CARBON LIMITATION; CO2 CONCENTRATING MECHANISMS; NITRATE ASSIMILATION OPERON; SP STRAIN PCC-7942; CO2-CONCENTRATING MECHANISM; PCC7942 REVEALS; CYANOBACTERIUM; PROTEIN; GENE; EXPRESSION	Cyanobacterial CO2-fixation is supported by a CO2-concentrating mechanism which improves photosynthesis by saturating the primary carboxylating enzyme, ribulose 1, 5-bisphosphate carboxylase/oxygenase (RuBisCO), with its preferred substrate CO2. The site of CO2-concentration is a protein bound micro-compartment called the carboxysome which contains most, if not all, of the cellular RuBisCO. The shell of beta-type carboxysomes is thought to be composed of two functional layers, with the inner layer involved in RuBisCO scaffolding and bicarbonate dehydration, and the outer layer in selective permeability to dissolved solutes. Here, four genes (ccmK2-4, ccmO), whose products were predicted to function in the outer shell layer of beta-carboxysomes from Synechococcus elongatus PCC 7942, were investigated by analysis of defined genetic mutants. Deletion of the ccmK2 and ccmO genes resulted in severe high-CO2-requiring mutants with aberrant carboxysomes, whilst deletion of ccmK3 or ccmK4 resulted in cells with wild-type physiology and normal ultrastructure. However, a tandem deletion of ccmK3-4 resulted in cells with wild-type carboxysome structure, but physiologically deficient at low CO2 conditions. These results revealed the minimum structural determinants of the outer shell of beta-carboxysomes from this strain: CcmK2, CcmO and CcmL. An accessory set of proteins was required to refine the function of the pre-existing shell: CcmK3 and CcmK4. These data suggested a model for the facet structure of beta-carboxysomes with CcmL forming the vertices, CcmK2 forming the bulk facet, and CcmO, a "zipper protein," interfacing the edges of carboxysome facets.	[Rae, Benjamin D.; Long, Benedict M.; Badger, Murray R.; Price, G. Dean] Australian Natl Univ, Div Plant Sci, Res Sch Biol, Canberra, ACT 0200, Australia	Australian National University	Rae, BD (corresponding author), Australian Natl Univ, Div Plant Sci, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	dean.price@anu.edu.au	Price, G Dean/C-9505-2009; Rae, Benjamin D/C-3045-2011; Badger, Murray R/C-8153-2009; Long, Benedict M/B-3799-2008	Price, G Dean/0000-0001-5906-4912; Rae, Benjamin D/0000-0003-2199-1205; Long, Benedict M/0000-0002-4616-2967	Australian National University; Australian Research Council	Australian National University(Australian National University); Australian Research Council(Australian Research Council)	The work was supported by an Australian National University PhD scholarship and partial funding from an Australian Research Council grant to GDP and MRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aichi M, 1997, J BACTERIOL, V179, P4671, DOI 10.1128/jb.179.15.4671-4675.1997; ALLEN MM, 1968, J GEN MICROBIOL, V51, P199, DOI 10.1099/00221287-51-2-199; BADGER MR, 1982, PLANT PHYSIOL, V70, P517, DOI 10.1104/pp.70.2.517; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; BADGER MR, 1991, CAN J BOT, V69, P974, DOI 10.1139/b91-125; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Baker SH, 2000, ARCH MICROBIOL, V173, P278, DOI 10.1007/s002030000141; Baker SH, 1999, ARCH MICROBIOL, V172, P233, DOI 10.1007/s002030050765; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; Cai F, 2012, ADV PHOTOSYNTH RESP, V33, P345, DOI 10.1007/978-94-007-1533-2_14; Cai F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007521; CANNON GC, 1983, ARCH MICROBIOL, V134, P52, DOI 10.1007/BF00429407; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Choudhary S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033342; CODD GA, 1984, BIOL REV, V59, P389, DOI 10.1111/j.1469-185X.1984.tb00710.x; Cot SSW, 2008, J BACTERIOL, V190, P936, DOI 10.1128/JB.01283-07; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; DZELZKALNS VA, 1984, NUCLEIC ACIDS RES, V12, P8917, DOI 10.1093/nar/12.23.8917; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; FRIEDBERG D, 1989, J BACTERIOL, V171, P6069, DOI 10.1128/jb.171.11.6069-6076.1989; FRIEDBERG D, 1993, MOL MICROBIOL, V9, P1193, DOI 10.1111/j.1365-2958.1993.tb01248.x; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kinney JN, 2011, PHOTOSYNTH RES, V109, P21, DOI 10.1007/s11120-011-9624-6; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; KUHLEMEIER CJ, 1983, PLASMID, V10, P156, DOI 10.1016/0147-619X(83)90068-9; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Long BM, 2011, PHOTOSYNTH RES, V109, P33, DOI 10.1007/s11120-011-9659-8; Long BM, 2010, PLANT PHYSIOL, V153, P285, DOI 10.1104/pp.110.154948; Long BM, 2005, CAN J BOT, V83, P746, DOI 10.1139/B05-058; Maeda S, 1998, J BACTERIOL, V180, P4080, DOI 10.1128/JB.180.16.4080-4088.1998; MARCO E, 1994, APPL ENVIRON MICROB, V60, P1018, DOI 10.1128/AEM.60.3.1018-1020.1994; Marin B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-85; Martinez I, 1997, PLANT PHYSIOL BIOCH, V35, P137; Pang A, 2011, ACTA CRYSTALLOGR D, V67, P91, DOI 10.1107/S0907444910050201; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Price GD, 2011, PHOTOSYNTH RES, V109, P47, DOI 10.1007/s11120-010-9608-y; PRICE GD, 1989, PLANT PHYSIOL, V91, P514, DOI 10.1104/pp.91.2.514; PRICE GD, 1992, PLANT PHYSIOL, V100, P784, DOI 10.1104/pp.100.2.784; PRICE GD, 1991, CAN J BOT, V69, P963, DOI 10.1139/b91-124; PRICE GD, 1989, PLANT PHYSIOL, V89, P37, DOI 10.1104/pp.89.1.37; Price GD, 1998, CAN J BOT, V76, P973, DOI 10.1139/b98-081; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Rae BD, 2011, PHOTOSYNTH RES, V109, P59, DOI 10.1007/s11120-011-9641-5; Rippka R., 1981, PROKARYOTES HDB HABI, V1, P212, DOI DOI 10.1007/978-3-662-13187-9_8; Roberts EW, 2012, J BACTERIOL, V194, P787, DOI 10.1128/JB.06444-11; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; SCHWARZ R, 1988, PLANT PHYSIOL, V88, P284, DOI 10.1104/pp.88.2.284; Slabas AR, 2006, PROTEOMICS, V6, P845, DOI 10.1002/pmic.200500196; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; SULTEMEYER D, 1995, PLANTA, V196, P217; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Woodger FJ, 2005, PLANT PHYSIOL, V139, P1959, DOI 10.1104/pp.105.069146; Woodger FJ, 2003, PLANT PHYSIOL, V133, P2069, DOI 10.1104/pp.103.029728; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418; Zhang SL, 2004, J BACTERIOL, V186, P875, DOI 10.1128/JB.186.3.875-879.2004	67	60	66	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43871	10.1371/journal.pone.0043871	http://dx.doi.org/10.1371/journal.pone.0043871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928045	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300095
J	Yukich, J; Briet, O; Bretscher, MT; Bennett, A; Lemma, S; Berhane, Y; Eisele, TP; Keating, J; Smith, T				Yukich, Joshua; Briet, Olivier; Bretscher, Michael T.; Bennett, Adam; Lemma, Seblewengel; Berhane, Yemane; Eisele, Thomas P.; Keating, Joseph; Smith, Thomas			Estimating Plasmodium falciparum Transmission Rates in Low-Endemic Settings Using a Combination of Community Prevalence and Health Facility Data	PLOS ONE			English	Article							MALARIA TRANSMISSION; INOCULATION RATES; INFECTION; INTENSITY; INDICATOR; TANZANIA; VACCINE; TRIAL; PROSPECTS; EXPOSURE	As some malaria control programs shift focus from disease control to transmission reduction, there is a need for transmission data to monitor progress. At lower levels of transmission, it becomes increasingly more difficult to measure precisely, for example through entomological studies. Many programs conduct regular cross sectional parasite prevalence surveys, and have access to malaria treatment data routinely collected by ministries of health, often in health management information systems. However, by themselves, these data are poor measures of transmission. In this paper, we propose an approach for combining annual parasite incidence and treatment data with cross-sectional parasite prevalence and treatment seeking survey data to estimate the incidence of new infections in the human population, also known as the force of infection. The approach is based on extension of a reversible catalytic model. The accuracy of the estimates from this model appears to be highly dependent on levels of detectability and treatment in the community, indicating the importance of information on private sector treatment seeking and access to effective and appropriate treatment.	[Yukich, Joshua; Bennett, Adam; Eisele, Thomas P.; Keating, Joseph] Tulane Univ, Med Ctr, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70112 USA; [Briet, Olivier; Smith, Thomas] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Briet, Olivier; Smith, Thomas] Univ Basel, Basel, Switzerland; [Bretscher, Michael T.] London Sch Hyg & Trop Med, London WC1, England; [Lemma, Seblewengel; Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia	Tulane University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of London; London School of Hygiene & Tropical Medicine; Addis Continental Institute of Public Health	Yukich, J (corresponding author), Tulane Univ, Med Ctr, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70112 USA.	jyukich@tulane.edu	Smith, Thomas/B-5569-2015; Eisele, Thom/AAE-8958-2020; Berhane, Yemane/ABB-8154-2020; Briet, Olivier/K-1917-2015	Smith, Thomas/0000-0002-3650-9381; Briet, Olivier/0000-0003-1186-2688; Lemma, Seblewengel/0000-0001-5910-3723; Berhane, Yemane/0000-0002-2527-1339	Bill & Melinda Gates Foundation [0PP1032350]; United States Agency for International Development [663-A-00-09-00431-00]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); United States Agency for International Development(United States Agency for International Development (USAID))	This study was partly financially supported by the Bill & Melinda Gates Foundation (www.gatesfoundation.org/), Award number 0PP1032350 to Swiss Tropical and Public Health Institute (Swiss TPH). Collection of data in Ethiopia was funded by the United States Agency for International Development (www.usaid.gov/) (Associate Cooperative Agreement: No. 663-A-00-09-00431-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; BEIER JC, 1994, AM J TROP MED HYG, V50, P529, DOI 10.4269/ajtmh.1994.50.529; BEKESSY A, 1976, B WORLD HEALTH ORGAN, V54, P685; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Bretscher MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-234; BURATTINI MN, 1993, EPIDEMIOL INFECT, V111, P525, DOI 10.1017/S0950268800057253; Charlwood JD, 1998, AM J TROP MED HYG, V59, P243, DOI 10.4269/ajtmh.1998.59.243; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Crowell VYJ, 2012, MEASURING BURDEN UNC; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Felger I, 2003, TRENDS PARASITOL, V19, P60, DOI 10.1016/S1471-4922(02)00066-1; Gething PW, 2007, COMPUT GEOSCI-UK, V33, P1337, DOI 10.1016/j.cageo.2007.05.006; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; *MALERA CONS GROUP, 2011, PLOS MED, V0008; MSUYA FHM, 1991, ACTA TROP, V49, P165, DOI 10.1016/0001-706X(91)90035-I; Muench H., CATALYTIC MODELS EPI, P8928; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Owusu-Agyei S, 2001, AM J TROP MED HYG, V65, P197, DOI 10.4269/ajtmh.2001.65.197; PULL JH, 1974, B WORLD HEALTH ORGAN, V51, P507; Roca-Feltrer A, 2012, AM J TROP MED HYG, V86, P96, DOI 10.4269/ajtmh.2012.11-0397; Ross A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-132; Smith DL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1107; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yukich JK J, 2011, MALARIA EPIDEMIC DET	35	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42861	10.1371/journal.pone.0042861	http://dx.doi.org/10.1371/journal.pone.0042861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936995	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000308286300027
J	Lee, JH; Skalnik, DG				Lee, Jeong-Heon; Skalnik, David G.			Rbm15-Mkl1 Interacts with the Setd1b Histone H3-Lys4 Methyltransferase via a SPOC Domain That Is Required for Cytokine-Independent Proliferation	PLOS ONE			English	Article							ACUTE MEGAKARYOBLASTIC LEUKEMIA; SERUM RESPONSE FACTOR; CPG-BINDING PROTEIN; STEM-CELL; HUMAN TRITHORAX; MESSENGER-RNA; MOTIF PROTEIN; SPEN PROTEINS; COMPLEX; GENES	The Rbm15-Mkl1 fusion protein is associated with acute megakaryoblastic leukemia (AMKL), although little is known regarding the molecular mechanism(s) whereby this fusion protein contributes to leukemogenesis. Here, we show that both Rbm15 and the leukemogenic Rbm15-Mkl1 fusion protein interact with the Setd1b histone H3-Lys4 methyltransferase (also known as KMT2G). This interaction is direct and requires the Rbm15 SPOC domain and the Setd1b LSD motif. Over-expression of Rbm15-Mkl1 in the 6133 megakaryoblastic leukemia cell line, previously established by expression of the Rbm15-Mkl1 fusion protein in mice (Mercher et al., [2009] J. Clin. Invest. 119, 852-864), leads to decreased levels of endogenous Rbm15 and increased levels of endogenous Mkl1. These cells exhibit enhanced proliferation and cytokine-independent cell growth, which requires an intact Rbm15 SPOC domain that mediates interaction between the Rbm15-Mkl1 fusion protein and the Setd1b methyltransferase. These results reveal altered Setd1b complex function and consequent altered epigenetic regulation as a possible molecular mechanism that mediates the leukemogenic activity of the Rbm15-Mkl1 fusion protein in AMKL.	[Lee, Jeong-Heon; Skalnik, David G.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA; [Lee, Jeong-Heon; Skalnik, David G.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Skalnik, David G.] Indiana Univ Purdue Univ, Dept Biol, Sch Sci, Indianapolis, IN 46205 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Lee, JH (corresponding author), Indiana Univ Sch Med, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA.	jeonglee@iupui.edu; dskalnik@iupui.edu			National Science Foundation grant [MCB-0641851]; Simmon's Clinical study funds; Riley Children's Foundation; Lilly Endowment	National Science Foundation grant(National Science Foundation (NSF)); Simmon's Clinical study funds; Riley Children's Foundation; Lilly Endowment	This work was supported by the National Science Foundation grant MCB-0641851 (to DGS), Simmon's Clinical study funds (to JHL), the Riley Children's Foundation, and the Lilly Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; CARROLL A, 1991, BLOOD, V78, P748; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Cheng EC, 2009, BLOOD, V113, P2826, DOI 10.1182/blood-2008-09-180596; Descot A, 2008, MOL CELL BIOL, V28, P6171, DOI 10.1128/MCB.00303-08; Dorrance AM, 2006, J CLIN INVEST, V116, P2707, DOI 10.1172/JCI25546; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kuang B, 2000, DEVELOPMENT, V127, P1517; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Lindtner S, 2006, J BIOL CHEM, V281, P36915, DOI 10.1074/jbc.M608745200; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Ma XY, 2007, MOL CELL BIOL, V27, P3056, DOI 10.1128/MCB.01339-06; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Mercher T, 2009, J CLIN INVEST, V119, P852, DOI 10.1172/JCI35901; Niu C, 2009, BLOOD, V114, P2087, DOI 10.1182/blood-2009-01-197921; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Paredes-Aguilera R, 2003, AM J HEMATOL, V73, P71, DOI 10.1002/ajh.10320; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Raffel GD, 2007, P NATL ACAD SCI USA, V104, P6001, DOI 10.1073/pnas.0609041104; Raffel GD, 2009, MOL CELL BIOL, V29, P333, DOI 10.1128/MCB.00370-08; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Sanchez-Pulido L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-91; Sawada T, 2008, J BIOL CHEM, V283, P26820, DOI 10.1074/jbc.M802315200; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Somervaille TCP, 2010, INT J HEMATOL, V91, P735, DOI 10.1007/s12185-010-0579-8; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Uranishi H, 2009, J BIOL CHEM, V284, P26106, DOI 10.1074/jbc.M109.040113; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Zolotukhin AS, 2009, NUCLEIC ACIDS RES, V37, P7151, DOI 10.1093/nar/gkp782	42	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42965	10.1371/journal.pone.0042965	http://dx.doi.org/10.1371/journal.pone.0042965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927943	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700018
J	Sun, SB; Wang, JJ; Zhu, LL; Liao, DH; Gu, MA; Ren, LX; Kapulnik, Y; Xu, GH				Sun, Shubin; Wang, Jingjing; Zhu, Lingling; Liao, Dehua; Gu, Mian; Ren, Lixuan; Kapulnik, Yoram; Xu, Guohua			An Active Factor from Tomato Root Exudates Plays an Important Role in Efficient Establishment of Mycorrhizal Symbiosis	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZA; DIFFUSIBLE FACTOR; FUNGI; EXPRESSION; INFECTION; RESPONSES; SIGNALS; SPORES; GROWTH; MUTANT	Root exudates play an important role in the early signal exchange between host plants and arbuscular mycorrhizal fungi. M161, a pre-mycorrhizal infection (pmi) mutant of the tomoto (Solanum lycopersicum) cultivar Micro-Tom, fails to establish normal arbuscular mycorrhizal symbioses, and produces exudates that are unable to stimulate hyphal growth and branching of Glomus intraradices. Here, we report the identification of a purified active factor (AF) that is present in the root exudates of wild-type tomato, but absent in those of M161. A complementation assay using the dual root organ culture system showed that the AF could induce fungal growth and branching at the pre-infection stage and, subsequently, the formation of viable new spores in the M161 background. Since the AF-mediated stimulation of hyphal growth and branching requires the presence of the M161 root, our data suggest that the AF is essential but not sufficient for hyphal growth and branching. We propose that the AF, which remains to be chemically determined, represents a plant signal molecule that plays an important role in the efficient establishment of mycorrhizal symbioses.	[Sun, Shubin; Wang, Jingjing; Zhu, Lingling; Liao, Dehua; Gu, Mian; Ren, Lixuan; Xu, Guohua] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Sun, Shubin; Wang, Jingjing; Zhu, Lingling; Liao, Dehua; Gu, Mian; Ren, Lixuan; Xu, Guohua] Nanjing Agr Univ, Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China; [Kapulnik, Yoram] Agr Res Org, Volcani Ctr, Dept Agron & Nat Resources, IL-50250 Bet Dagan, Israel	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Sun, SB (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	ghxu@njau.edu.cn	dehua, liao/AGW-5646-2022; Xu, Guohua/J-1840-2012	Xu, Guohua/0000-0002-3283-2392	China National Natural Science Foundation [30971855]; China 863 project [2006AA10Z134]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China 863 project(National High Technology Research and Development Program of China)	This work was supported by the China National Natural Science Foundation (30971855) and the China 863 project (2006AA10Z134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; BECARD G, 1992, METHOD MICROBIOL, V24, P89, DOI 10.1016/S0580-9517(08)70089-8; Becard G., 1992, APPL ENVIRON MICROB, V68, P1260; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Bonfante P, 2011, CURR OPIN PLANT BIOL, V14, P451, DOI 10.1016/j.pbi.2011.03.014; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Bucher M, 2009, CURR OPIN PLANT BIOL, V12, P500, DOI 10.1016/j.pbi.2009.06.001; Buee M, 2000, MOL PLANT MICROBE IN, V13, P693, DOI 10.1094/MPMI.2000.13.6.693; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; David-Schwartz R, 2003, MOL PLANT MICROBE IN, V16, P382, DOI 10.1094/MPMI.2003.16.5.382; David-Schwartz R, 2001, PLANT J, V27, P561, DOI 10.1046/j.1365-313X.2001.01113.x; DONER LW, 1995, CARBOHYD RES, V273, P225, DOI 10.1016/0008-6215(95)00115-A; Fortin JA, 2002, CAN J BOT, V80, P1, DOI 10.1139/b01-139; Gadkar V, 2003, FEMS MICROBIOL LETT, V223, P193, DOI 10.1016/S0378-1097(03)00357-4; Giovannetti M, 1996, NEW PHYTOL, V133, P65, DOI 10.1111/j.1469-8137.1996.tb04342.x; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Harrison MJ, 1999, ANNU REV PLANT PHYS, V50, P361, DOI 10.1146/annurev.arplant.50.1.361; Kosuta S, 2003, PLANT PHYSIOL, V131, P952, DOI 10.1104/pp.011882; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Nagahashi G, 2000, MYCOL RES, V104, P1453, DOI 10.1017/S0953756200002860; Nagahashi G, 2011, FUNGAL BIOL-UK, V115, P351, DOI 10.1016/j.funbio.2011.01.006; Navazio L, 2007, PLANT PHYSIOL, V144, P673, DOI 10.1104/pp.106.086959; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Paszkowski U, 2006, NEW PHYTOL, V172, P35, DOI 10.1111/j.1469-8137.2006.01840.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Tamasloukht M, 2003, PLANT PHYSIOL, V131, P1468, DOI 10.1104/pp.012898; VOLPIN H, 1994, PLANT PHYSIOL, V104, P683, DOI 10.1104/pp.104.2.683	30	12	13	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43385	10.1371/journal.pone.0043385	http://dx.doi.org/10.1371/journal.pone.0043385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927963	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700033
J	Dal Piaz, F; Vassallo, A; Chini, MG; Cordero, FM; Cardona, F; Pisano, C; Bifulco, G; De Tommasi, N; Brandi, A				Dal Piaz, Fabrizio; Vassallo, Antonio; Chini, Maria Giovanna; Cordero, Franca M.; Cardona, Francesca; Pisano, Claudio; Bifulco, Giuseppe; De Tommasi, Nunziatina; Brandi, Alberto			Natural Iminosugar (+)-Lentiginosine Inhibits ATPase and Chaperone Activity of Hsp90	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GLYCOSIDASE INHIBITORS; CLIENT PROTEIN; CANCER; HYDROLYSIS; MOLECULES; UPDATE; DOMAIN; BINDS	Heat shock protein 90 (Hsp90) is a significant target in the development of rational cancer therapy due to its role at the crossroads of multiple signaling pathways associated with cell proliferation and cell viability. The relevance of Hsp90 as a therapeutic target for numerous diseases states has prompted the identification and optimization of novel Hsp90 inhibitors as an emerging therapeutic strategy. We performed a screening aimed to identify novel Hsp90 inhibitors among several natural compounds and we focused on the iminosugar (+)-lentiginosine, a natural amyloglucosidases inhibitor, for its peculiar bioactivity profile. Characterization of Hsp90 inhibition was performed using a panel of chemical and biological approaches, including limited proteolysis, biochemical and cellular assays. Our result suggested that the middle domain of Hsp90, as opposed to its ATP-binding pocket, is a promising binding site for new classes of Hsp90 inhibitors with multi-target anti-cancer potential.	[Dal Piaz, Fabrizio; Chini, Maria Giovanna; Bifulco, Giuseppe; De Tommasi, Nunziatina] Univ Salerno, Dipartimento Sci Farmaceut & Biomed, Fisciano, Italy; [Vassallo, Antonio] Univ Basilicata, Dipartimento Chim, I-85100 Potenza, Italy; [Cordero, Franca M.; Cardona, Francesca; Brandi, Alberto] Univ Florence, Dept Chim Ugo Schiff, Sesto Fiorentino, Italy; [Pisano, Claudio] Sigma Tau Pharmaceut Co, Pomezia, Italy	University of Salerno; University of Basilicata; University of Florence; Leadiant Biosciences	Dal Piaz, F (corresponding author), Univ Salerno, Dipartimento Sci Farmaceut & Biomed, Fisciano, Italy.	detommasi@unisa.it	Chini, Maria Giovanna/C-8066-2014; Cardona, Francesca/AAA-4098-2022; De Tommasi, Nunziatina/A-7768-2011; Dal Piaz, Fabrizio/D-1843-2010; Vassallo, Antonio/R-4508-2019; Cordero, Franca M./J-3102-2012; Bifulco, Giuseppe/A-5413-2011; Brandi, Alberto/B-5699-2014	Cardona, Francesca/0000-0002-6766-4624; De Tommasi, Nunziatina/0000-0003-1707-4156; Dal Piaz, Fabrizio/0000-0002-8643-5018; Vassallo, Antonio/0000-0001-7937-3309; Cordero, Franca M./0000-0001-6005-5941; Bifulco, Giuseppe/0000-0002-1788-5170; Brandi, Alberto/0000-0001-8273-6369; pisano, claudio/0000-0001-8624-2980; Chini, Maria Giovanna/0000-0002-3943-5883	University of Salerno	University of Salerno	This work was supported by the following grant: University of Salerno (Intramural ex 60% (FARB) funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; Asano N, 2000, TETRAHEDRON-ASYMMETR, V11, P1645, DOI 10.1016/S0957-4166(00)00113-0; BRANDI A, 1995, J ORG CHEM, V60, P6806, DOI 10.1021/jo00126a033; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Calderwood SK, 2008, INT J HYPERTHER, V24, P31, DOI 10.1080/02656730701858305; Cardona F, 2007, EUR J ORG CHEM, V2007, P1551, DOI 10.1002/ejoc.200600633; Cordero FM, 2012, CHEMPLUSCHEM, V77, P224, DOI 10.1002/cplu.201100069; Cordero FM, 2011, TETRAHEDRON, V67, P9555, DOI 10.1016/j.tet.2011.10.008; Cordero FM, 2009, ADV SYNTH CATAL, V351, P1155, DOI 10.1002/adsc.200800806; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Dal Piaz F, 2012, PHYTOCHEMISTRY, V75, P78, DOI 10.1016/j.phytochem.2011.12.002; Dal Piaz F, 2010, CHEMBIOCHEM, V11, P818, DOI 10.1002/cbic.200900721; Dal Piaz F, 2009, J MED CHEM, V52, P3814, DOI 10.1021/jm801637f; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Giommarelli C, 2010, CELL MOL LIFE SCI, V67, P995, DOI 10.1007/s00018-009-0233-x; Hahn JS, 2009, BMB REP, V42, P623, DOI 10.5483/BMBRep.2009.42.10.623; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Lee CC, 2011, PLOS ONE, V6, p[e1996, 11]; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Macchi B, 2010, GLYCOBIOLOGY, V20, P500, DOI 10.1093/glycob/cwp202; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/FMC.11.117, 10.4155/fmc.11.117]; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Sellers RP, 2010, BIOORGAN MED CHEM, V18, P6822, DOI 10.1016/j.bmc.2010.07.042; Shu LM, 2010, CANCER METAST REV, V29, P483, DOI 10.1007/s10555-010-9239-y; Sirangelo I, 2003, BIOCHEMISTRY-US, V42, P312, DOI 10.1021/bi020447f; SWOPE WC, 1982, J CHEM PHYS, V76, P637, DOI 10.1063/1.442716; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Watson AA, 2001, PHYTOCHEMISTRY, V56, P265, DOI 10.1016/S0031-9422(00)00451-9	39	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43316	10.1371/journal.pone.0043316	http://dx.doi.org/10.1371/journal.pone.0043316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916240	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800059
J	Xu, RG; Wang, JM; Li, CD; Johnson, P; Lu, C; Zhou, MX				Xu, Rugen; Wang, Junmei; Li, Chengdao; Johnson, Peter; Lu, Chao; Zhou, Meixue			A Single Locus Is Responsible for Salinity Tolerance in a Chinese Landrace Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SALT TOLERANCE; WATERLOGGING TOLERANCE; COMBINING ABILITY; GENETIC DIVERSITY; SEEDLING STAGE; CONSENSUS MAP; DART MARKERS; K+ FLUX; GROWTH	Introduction: Salinity and waterlogging are two major abiotic stresses severely limiting barley production. The lack of a reliable screening method makes it very hard to improve the tolerance through breeding programs. Methods: This work used 188 DH lines from a cross between a Chinese landrace variety, TX9425 (waterlogging and salinity tolerant), and a Japanese malting barley, Naso Nijo (waterlogging and salinity sensitive), to identify QTLs associated with the tolerance. Results: Four QTLs were found for waterlogging tolerance. The salinity tolerance was evaluated with both a hydroponic system and in potting mixture. In the trial with potting mixture, only one major QTL was identified to associate with salinity tolerance. This QTL explained nearly 50% of the phenotypic variation, which makes it possible for further fine mapping and cloning of the gene. This QTL was also identified in the hydroponic experiment for different salt-related traits. The position of this QTL was located at a similar position to one of the major QTLs for waterlogging tolerance, indicating the possibility of similar mechanisms controlling both waterlogging and salinity tolerance. Conclusion: The markers associated with the QTL provided a unique opportunity in breeding programs for selection of salinity and waterlogging tolerance.	[Xu, Rugen; Lu, Chao] Yangzhou Univ, Jiangsu Prov Key Lab Crop Genet & Physiol, Yangzhou, Peoples R China; [Xu, Rugen; Lu, Chao] Yangzhou Univ, Barley Res Inst, Yangzhou, Peoples R China; [Wang, Junmei] Zhejiang Acad Agr Sci, Inst Crop & Nucl Technol Utilizat, Hangzhou, Zhejiang, Peoples R China; [Li, Chengdao] Govt Western Australia, Dept Agr & Food, S Perth, WA, Australia; [Johnson, Peter; Zhou, Meixue] Univ Tasmania, Tasmanian Inst Agr, Kings Meadows, Tas, Australia	Yangzhou University; Yangzhou University; Zhejiang Academy of Agricultural Sciences; Government of Western Australia; Department of Agriculture & Food - Western Australia; University of Tasmania	Xu, RG (corresponding author), Yangzhou Univ, Jiangsu Prov Key Lab Crop Genet & Physiol, Yangzhou, Peoples R China.	Meixue.Zhou@utas.edu.au	, Meixue/C-2387-2014	, Meixue/0000-0003-3009-7854	National Natural Science Foundation of China [31128014, 30971779, 31071407]; Grains Research and Development Corporation of Australia; Jiangsu Natural Science Foundation [11KJA210002]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grains Research and Development Corporation of Australia(Grains R&D Corp); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China (31128014, 30971779, 31071407); Grains Research and Development Corporation of Australia; Jiangsu Natural Science Foundation (11KJA210002); the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop BP, 2011, MOL BREEDING, V27, P77, DOI 10.1007/s11032-010-9415-3; [Anonymous], 2011, SAV GROW; ASLAM M, 1993, PLANT SOIL, V150, P99, DOI 10.1007/BF00779180; Barrett-Lennard EG, 2003, PLANT SOIL, V253, P35, DOI 10.1023/A:1024574622669; Chen HT, 2008, AUST J AGR RES, V59, P1086, DOI 10.1071/AR08104; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen Z, 2005, PLANT CELL ENV, P28; Chen ZG, 2008, CROP SCI, V48, P1382, DOI 10.2135/cropsci2007.10.0557; Compagnucci R, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P191; Eleuch L, 2008, J INTEGR PLANT BIOL, V50, P1004, DOI 10.1111/j.1744-7909.2008.00670.x; FAO, 2000, CROPS DROPS MAKING B; Farshadfar E., 2008, Asian Journal of Plant Sciences, V7, P149; Foolad MR, 2001, GENOME, V44, P444, DOI 10.1139/gen-44-3-444; HAMACHI Y, 1990, JPN J BREED, V40, P361; Jaradat AA, 2004, CROP SCI, V44, P997, DOI 10.2135/cropsci2004.0997; Lee SY, 2007, PLANT BREEDING, V126, P43, DOI 10.1111/j.1439-0523.2007.01265.x; Lee SY, 2006, MOL CELLS, V21, P192; Li HB, 2011, MOL BREEDING, V27, P479, DOI 10.1007/s11032-010-9445-x; Li HB, 2009, THEOR APPL GENET, V118, P903, DOI 10.1007/s00122-008-0948-3; Li HB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-401; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pang JY, 2006, PLANT CELL ENVIRON, V29, P1107, DOI 10.1111/j.1365-3040.2005.01486.x; Pang JY, 2007, PLANT PHYSIOL, V145, P266, DOI 10.1104/pp.107.102624; Pang JY, 2004, AUST J AGR RES, V55, P895, DOI 10.1071/AR03097; Rivandi J, 2011, J EXP BOT, V62, P1201, DOI 10.1093/jxb/erq346; Setter TL, 2003, PLANT SOIL, V253, P1, DOI 10.1023/A:1024573305997; Shavrukov Y, 2010, FUNCT INTEGR GENOMIC, V10, P277, DOI 10.1007/s10142-009-0153-8; Siahsar BA, 2009, NEW BIOTECHNOL, V25, pS304, DOI 10.1016/j.nbt.2009.06.761; SLAVICH PG, 1990, AUST J EXP AGR, V30, P551, DOI 10.1071/EA9900551; Tajbakhsh M, 2006, AUST J EXP AGR, V46, P555, DOI 10.1071/EA05026; Teakle NL, 2007, J EXP BOT, V58, P2169, DOI 10.1093/jxb/erm102; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang JM, 2010, EUPHYTICA, V175, P331, DOI 10.1007/s10681-010-0175-2; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Xue DW, 2010, J ZHEJIANG UNIV-SC B, V11, P169, DOI 10.1631/jzus.B0900332; Xue DW, 2009, EUPHYTICA, V169, P187, DOI 10.1007/s10681-009-9919-2; Zhou GF, 2012, MOL BREEDING, V29, P427, DOI 10.1007/s11032-011-9559-9; Zhou M, 2011, PLANT BREEDING, V130, P203, DOI 10.1111/j.1439-0523.2010.01792.x; Zhou MX, 2007, CROP SCI, V47, P278, DOI 10.2135/cropsci2006.02.0065; Zhou MX, 2009, ADV TOP SCI TECH CHI, P1, DOI 10.1007/978-3-642-01279-2_1; Zhou MX, 2012, CROP SCI, DOI [10.2135/cropsci201, DOI 10.2135/CROPSCI201]	47	44	47	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43079	10.1371/journal.pone.0043079	http://dx.doi.org/10.1371/journal.pone.0043079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916210	gold, Green Published			2022-12-27	WOS:000307733800045
J	Sarkar, R; Lenders, L; Wilkinson, KA; Wilkinson, RJ; Nicol, MP				Sarkar, Rajesh; Lenders, Laura; Wilkinson, Katalin A.; Wilkinson, Robert J.; Nicol, Mark P.			Modern Lineages of Mycobacterium tuberculosis Exhibit Lineage-Specific Patterns of Growth and Cytokine Induction in Human Monocyte-Derived Macrophages	PLOS ONE			English	Article							SOUTH-AFRICA; INTRACELLULAR GROWTH; BEIJING/W STRAINS; IMMUNE-RESPONSE; CAPE-TOWN; VIRULENT; INTERLEUKIN-12; PHAGOCYTOSIS; PATHOGENESIS; DEFICIENCY	Background: Strains of Mycobacterium tuberculosis vary in virulence. Strains that have caused outbreaks in the United States and United Kingdom have been shown to subvert the innate immune response as a potential immune evasion mechanism. There is, however, little information available as to whether these patterns of immune subversion are features of individual strains or characteristic of broad clonal lineages of M. tuberculosis. Methods: Strains from two major modern lineages (lineage 2 [East-Asian] and lineage 4 [Euro-American]) circulating in the Western Cape in South Africa as well as a comparator modern lineage (lineage 3 [CAS/Delhi]) were identified. We assessed two virulence associated characteristics: mycobacterial growth (in liquid broth and monocyte derived macrophages) and early pro-inflammatory cytokine induction. Results: In liquid culture, Lineage 4 strains grew more rapidly and reached higher plateau levels than other strains (lineage 4 vs. lineage 2 p = 0.0024; lineage 4 vs. lineage 3 p = 0.0005). Lineage 3 strains were characterized by low and early plateau levels, while lineage 2 strains showed an intermediate growth phenotype. In monocyte-derived macrophages, lineage 2 strains grew faster than lineage 3 strains (p<0.01) with lineage 4 strains having an intermediate phenotype. Lineage 2 strains induced the lowest levels of pro-inflammatory TNF and IL-12p40 as compared to other lineages (lineage 2: median TNF 362 pg/ml, IL-12p40 91 pg/ml; lineage 3: median TNF 1818 pg/ml, IL-12p40 123 pg/ml; lineage 4: median TNF 1207 pg/ml, IL-12p40 205 pg/ml;). In contrast, lineage 4 strains induced high levels of IL-12p40 and intermediate level of TNF. Lineage 3 strains induced high levels of TNF and intermediate levels of IL-12p40. Conclusions: Strains of M. tuberculosis from the three major modern strain lineages possess distinct patterns of growth and cytokine induction. Rapid growth and immune subversion may be key characteristics to the success of these strains in different human populations.	[Sarkar, Rajesh; Lenders, Laura; Nicol, Mark P.] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Nicol, Mark P.] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Wilkinson, Katalin A.; Wilkinson, Robert J.; Nicol, Mark P.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Wilkinson, Katalin A.; Wilkinson, Robert J.] MRC Natl Inst Med Res, London, England	University of Cape Town; University of Cape Town; University of Cape Town; Imperial College London; MRC National Institute for Medical Research	Sarkar, R (corresponding author), Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa.	Mark.Nicol@uct.ac.za	Wilkinson, Katalin/AAQ-7713-2021; Nicol, Mark/W-4149-2019; Wilkinson, Katalin/AAF-6805-2020	Wilkinson, Katalin/0000-0002-9796-2040; Nicol, Mark/0000-0002-1366-4805; Wilkinson, Robert/0000-0002-2753-1800	Wellcome Trust [084323, 088316, 085251/Z/08/Z]; Medical Research Council [U.1175.02.002.00014.01]; National Research Foundation of South Africa; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of South Africa(National Research Foundation - South Africa); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for R.J. Wilkinson from Wellcome Trust (084323 and 088316) and Medical Research Council (U.1175.02.002.00014.01), the Wellcome Trust (085251/Z/08/Z), and the National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Altare F, 2001, J INFECT DIS, V184, P231, DOI 10.1086/321999; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gascoyne-Binzi DM, 2002, INT J TUBERC LUNG D, V6, P492; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; HIRSCH CS, 1994, J INFECT DIS, V170, P1229, DOI 10.1093/infdis/170.5.1229; Hoal-Van Helden EG, 2001, CELL BIOL INT, V25, P71, DOI 10.1006/cbir.2000.0679; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Li Q, 2002, INFECT IMMUN, V70, P6489, DOI 10.1128/IAI.70.11.6489-6493.2002; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 1999, J IMMUNOL, V162, P6740; Mankia S, 2011, CLIN RHEUMATOL, V30, P399, DOI 10.1007/s10067-010-1605-1; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Nicol MP, 2005, J CLIN MICROBIOL, V43, P5779, DOI 10.1128/JCM.43.11.5779-5781.2005; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Rakotosamimanana N, 2010, CLIN VACCINE IMMUNOL, V17, P1094, DOI 10.1128/CVI.00049-10; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Tanveer M, 2009, T ROY SOC TROP MED H, V103, P581, DOI 10.1016/j.trstmh.2009.03.014; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594; WHO, 2010, WHO TUB GLOB FACTSH; Wong KC, 2007, CLIN VACCINE IMMUNOL, V14, P1279, DOI 10.1128/CVI.00190-07; Zhang M, 1999, J INFECT DIS, V179, P1213, DOI 10.1086/314738; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998	41	48	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43170	10.1371/journal.pone.0043170	http://dx.doi.org/10.1371/journal.pone.0043170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916219	gold, Green Published, Green Submitted			2022-12-27	WOS:000307824300032
J	Peccoud, J; Isalan, M				Peccoud, Jean; Isalan, Mark			The PLOS ONE Synthetic Biology Collection: Six Years and Counting	PLOS ONE			English	Article							CELLULAR DECISION-MAKING; GENE-EXPRESSION; NETWORK; CONSTRUCTION; DESIGN; INKJET; SWITCH; NOISE	Since it was launched in 2006, PLOS ONE has published over fifty articles illustrating the many facets of the emerging field of synthetic biology. This article reviews these publications by organizing them into broad categories focused on DNA synthesis and assembly techniques, the development of libraries of biological parts, the use of synthetic biology in protein engineering applications, and the engineering of gene regulatory networks and metabolic pathways. Finally, we review articles that describe enabling technologies such as software and modeling, along with new instrumentation. In order to increase the visibility of this body of work, the papers have been assembled into the PLOS ONE Synthetic Biology Collection (www.ploscollections.org/synbio). Many of the innovative features of the PLOS ONE web site will help make this collection a resource that will support a lively dialogue between readers and authors of PLOS ONE synthetic biology papers. The content of the collection will be updated periodically by including relevant articles as they are published by the journal. Thus, we hope that this collection will continue to meet the publishing needs of the synthetic biology community.	[Peccoud, Jean] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Peccoud, Jean] Virginia Tech, Inst Crit Technol & Appl Sci, Ctr Syst Biol Engineered Tissues, Blacksburg, VA USA; [Isalan, Mark] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Isalan, Mark] UPF, Barcelona, Spain	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Peccoud, J (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	peccoud@vt.edu	Peccoud, Jean/A-2374-2008	Peccoud, Jean/0000-0001-7649-6127; Isalan, Mark/0000-0002-4652-0365	National Science Foundation Awards [0850100, 0963988]; National Institutes of Health [R01-GM078989, R01-GM095955]; FP7 ERC [201249]; ZINC-HUBS, Ministerio de Ciencia e Innovacion [MICINN BFU2010-17953]; MEC-EMBL agreement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078989, R01GM095955] Funding Source: NIH RePORTER	National Science Foundation Awards(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FP7 ERC; ZINC-HUBS, Ministerio de Ciencia e Innovacion; MEC-EMBL agreement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JP is supported by National Science Foundation Awards 0850100 and 0963988 and by grants R01-GM078989 and R01-GM095955 from the National Institutes of Health. MI is funded by FP7 ERC 201249 ZINC-HUBS, Ministerio de Ciencia e Innovacion grant MICINN BFU2010-17953 and the MEC-EMBL agreement. The funders had no role in the preparation of the manuscript.	Adam L, 2011, NAT BIOTECHNOL, V29, P208, DOI 10.1038/nbt.1802; Agapakis CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018877; Antunes MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016292; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Beal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022490; Bhomkar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027559; Bilitchenko L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018882; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Brawley CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013960; Brenner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016791; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Cohen DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007086; Constante M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023685; Dennig A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026222; Di Ventura B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001507; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fisher MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015364; Galdzicki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Gidijala L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008317; Grabherr MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020136; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Hansen LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019912; Hesselman MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036982; Hu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010619; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; Jiang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030267; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Koseska A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004872; Luo JJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009182, 10.1371/journal.pone.0009582]; Marguet P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011909; Martin L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007569; Marucci L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008083; May T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002372; Merrin J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000663; Oldham P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034368; Peccoud J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002671; Purcell O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016140; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Salvado B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031095; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Senum P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021414; Shin YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009376; Steiner T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001680; Stomel JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007385; Svensen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024906; Tanaka H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006946; Tsuruta H, 2009, PLOS ONE, V4; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Widder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005399; Yang RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027062; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456	59	7	10	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43231	10.1371/journal.pone.0043231	http://dx.doi.org/10.1371/journal.pone.0043231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916228	gold, Green Submitted, Green Published			2022-12-27	WOS:000307823600061
J	Almon, R; Alvarez-Leon, EE; Serra-Majem, L				Almon, Ricardo; Elisa Alvarez-Leon, Eva; Serra-Majem, Lluis			Association of the European Lactase Persistence Variant (LCT-13910 C > T Polymorphism) with Obesity in the Canary Islands	PLOS ONE			English	Article							ADULT-TYPE HYPOLACTASIA; MENDELIAN RANDOMIZATION; LACTOSE-INTOLERANCE; PYROSEQUENCING(TM) TECHNOLOGY; GENETIC EPIDEMIOLOGY; DIETARY CALCIUM; HEIGHT GROWTH; MILK; POPULATIONS; CONSUMPTION	Background: European lactose tolerance genotype (LCT -13910 C>T, rs4988234) has been positively associated to body mass indexes (BMI) in a meta-analysis of 31,720 individuals of northern and central European descent. A strong association of lactase persistence (LP) with BMI and obesity has also been traced in a Spanish Mediterranean population. The aim of this study was to analyze a potential association of LP compared to lactase non-persistence (LNP) with BMI in inhabitants of the Canary Islands of Spain using Mendelian randomization. Methods: A representative, randomly sampled population of adults belonging to the Canary Islands Nutrition Survey (ENCA) in Spain, aged 18-75 years (n = 551), was genotyped for the LCT - 13910 C>T polymorphism. Milk consumption was assessed by a validated questionnaire. Anthropometric variables were directly measured. WHO classification of BMI was used. Results: LP individuals were significantly more obese than LNP subjects (chi(2) = 10.59; p < 0.005). LP showed in a multivariate linear regression analysis showed a positive association of LP with BMI compared to LNP, (beta = 0.96; 95% CI: 0.08-1.85, p = 0.033). In a multinomial logistic regression analysis normal range weight LP subjects showed an odds ratio for obesity of 2.41; 95% CI 1.39-418, (p = 0.002) compared to LNP. Conclusions: The T-13910 of the allele LCT-13910 C>T polymorphism is positively associated with BMI. LP increases significantly the risk to develop obesity in the studied population. The LCT-13910 C>T polymorphism stands proxy for the lifetime exposure pattern, milk intake, that may increase susceptibility to obesity and to obesity related pathologies.	[Almon, Ricardo] Univ Orebro, Sch Hlth & Med Sci, Family Med Res Ctr, Orebro, Sweden; [Elisa Alvarez-Leon, Eva; Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Fac Hlth Sci, Dept Clin Sci, Prevent Med Serv,Canary Hlth Serv, Las Palmas Gran Canaria, Canary Islands, Spain	Orebro University; Universidad de Las Palmas de Gran Canaria	Almon, R (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Family Med Res Ctr, Orebro, Sweden.	ricardo.almon@orebroll.se	Serra-Majem, Lluis/I-6708-2019	Serra-Majem, Lluis/0000-0002-9658-9061	Spanish Canarian Health Service and Orebro County, Sweden	Spanish Canarian Health Service and Orebro County, Sweden	This project has been funded by the Spanish Canarian Health Service and Orebro County, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebamowo CA, 2008, J AM ACAD DERMATOL, V58, P787, DOI 10.1016/j.jaad.2007.08.049; Almon R, 2010, LACTASE PERSISTENCE; Almon R, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.7253; Almon R, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5141; Almon R, 2010, EUR J NUTR, V49, P141, DOI 10.1007/s00394-009-0058-2; Aranceta J, 2005, LECHE LACTEOS SALUD, P31; Aranceta-Bartrina J, 2005, MED CLIN-BARCELONA, V125, P460, DOI 10.1157/13079612; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Berkey CS, 2009, CANCER EPIDEM BIOMAR, V18, P1881, DOI 10.1158/1055-9965.EPI-08-1163; Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Corella D, 2011, CURR CARDIOVASC RISK; Corella D, 2010, OBESITY SILVER SPRIN; Corella D, 2009, CIRC-CARDIOVASC GENE, V2, P637, DOI 10.1161/CIRCGENETICS.109.891366; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; Enattah N, 2004, CALCIFIED TISSUE INT, V75, P488, DOI 10.1007/s00223-004-0029-9; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Enattah NS, 2007, WORLD J GASTROENTERO, V13, P3508, DOI 10.3748/wjg.v13.i25.3508; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; FLATZ G, 1973, LANCET, V2, P76; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Heid IM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000694; Kettunen J, 2010, HUM MOL GENET, V19, P1129, DOI 10.1093/hmg/ddp561; Lehtimaki T, 2006, PEDIATRICS, V118, P1553, DOI 10.1542/peds.2006-0542; Lewis SJ, 2010, CIRC-CARDIOVASC GENE, V3, P109, DOI 10.1161/CIRCGENETICS.109.880955; Majem LS, 2000, ARCH LATINOAM NUTR, V50, P62; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; Nilsson TK, 2004, SCAND J GASTROENTERO, V39, P287, DOI 10.1080/00365520310008304; Nilsson TK, 2008, CLIN CHEM LAB MED, V46, P80, DOI 10.1515/CCLM.2008.015; Obermayer-Pietsch BM, 2007, OSTEOPOROSIS INT, V18, P445, DOI 10.1007/s00198-006-0251-6; Pino-Yanes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018389; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Rasinpera H, 2004, GUT, V53, P1571, DOI 10.1136/gut.2004.040048; SAHI T, 1994, SCAND J GASTROENTERO, V29, P7, DOI 10.3109/00365529409091740; Sanchez PH, 2000, ARCH LATINOAM NUTR, V50, P43; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Soedamah-Muthu SS, 2011, AM J CLIN NUTR, V93, P158, DOI 10.3945/ajcn.2010.29866; Suarez FL, 1997, AM J CLIN NUTR, V65, P1502, DOI 10.1093/ajcn/65.5.1502; Suchy FJ, 2010, ANN INTERN MED, V152, P792, DOI 10.7326/0003-4819-152-12-201006150-00248; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang RQ, 2011, BIOMED ENVIRON SCI, V24, P200, DOI 10.3967/0895-3988.2011.02.015; World Healths Organization, WHO GLOB DAT BOD MAS	47	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43978	10.1371/journal.pone.0043978	http://dx.doi.org/10.1371/journal.pone.0043978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937140	Green Published, Green Submitted			2022-12-27	WOS:000308225500131
J	Datta, K; Suman, S; Kallakury, BVS; Fornace, AJ				Datta, Kamal; Suman, Shubhankar; Kallakury, Bhaskar V. S.; Fornace, Albert J., Jr.			Exposure to Heavy Ion Radiation Induces Persistent Oxidative Stress in Mouse Intestine	PLOS ONE			English	Article							NADPH-OXIDASE; DNA-DAMAGE; MITOCHONDRIAL DYSFUNCTION; BIOLOGICAL EFFECTIVENESS; GENOMIC INSTABILITY; ANTIOXIDANT ENZYMES; EPITHELIAL-CELLS; CANCER; EXPRESSION; INJURY	Ionizing radiation-induced oxidative stress is attributed to generation of reactive oxygen species (ROS) due to radiolysis of water molecules and is short lived. Persistent oxidative stress has also been observed after radiation exposure and is implicated in the late effects of radiation. The goal of this study was to determine if long-term oxidative stress in freshly isolated mouse intestinal epithelial cells (IEC) is dependent on radiation quality at a dose relevant to fractionated radiotherapy. Mice (C57BL/6J; 6 to 8 weeks; female) were irradiated with 2 Gy of gamma-rays, a low-linear energy transfer (LET) radiation, and intestinal tissues and IEC were collected 1 year after radiation exposure. Intracellular ROS, mitochondrial function, and antioxidant activity in IEC were studied by flow cytometry and biochemical assays. Oxidative DNA damage, cell death, and mitogenic activity in IEC were assessed by immunohistochemistry. Effects of gamma radiation were compared to Fe-56 radiation (iso-toxic dose: 1.6 Gy; energy: 1000 MeV/nucleon; LET: 148 keV/mm), we used as representative of high-LET radiation, since it's one of the important sources of high Z and high energy (HZE) radiation in cosmic rays. Radiation quality affected the level of persistent oxidative stress with higher elevation of intracellular ROS and mitochondrial superoxide in high-LET Fe-56 radiation compared to unirradiated controls and gamma radiation. NADPH oxidase activity, mitochondrial membrane damage, and loss of mitochondrial membrane potential were greater in Fe-56-irradiated mice. Compared to gamma radiation oxidative DNA damage was higher, cell death ratio was unchanged, and mitotic activity was increased after Fe-56 radiation. Taken together our results indicate that long-term functional dysregulation of mitochondria and increased NADPH oxidase activity are major contributing factors towards heavy ion radiation-induced persistent oxidative stress in IEC with potential for neoplastic transformation.	[Datta, Kamal; Suman, Shubhankar; Fornace, Albert J., Jr.] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cell Biol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Kallakury, Bhaskar V. S.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Fornace, Albert J., Jr.] King Abdulaziz Univ, Ctr Excellence Genom Med Res CEGMR, Jeddah 21413, Saudi Arabia	Georgetown University; Georgetown University; King Abdulaziz University	Datta, K (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cell Biol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	kd257@georgetown.edu	Fornace, Albert/A-7407-2008; Suman, Shubhankar/H-4610-2011	Fornace, Albert/0000-0001-9695-085X; Suman, Shubhankar/0000-0002-9197-0461	National Aeronautics and Space Administration (NASA) [NNX07AH70G, NNX09AU95G]	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	This work is supported in part by National Aeronautics and Space Administration (NASA) Grants NNX07AH70G and NNX09AU95G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Asaithamby A, 2008, RADIAT RES, V169, P437, DOI 10.1667/RR1165.1; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BISSONNETTE R, 1990, J CELL SCI, V95, P247; BRENNER DJ, 1995, RADIAT RES, V142, P61, DOI 10.2307/3578967; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; Clutton SM, 1996, CARCINOGENESIS, V17, P1633, DOI 10.1093/carcin/17.8.1633; Council NR, 1999, HLTH EFF EXP RAD BEI; CUCINOTTA FA, 1994, ADV SPACE RES, V14, P661, DOI 10.1016/0273-1177(94)90523-1; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; Cui XL, 1997, P NATL ACAD SCI USA, V94, P3771, DOI 10.1073/pnas.94.8.3771; Datta K, 2000, NATL MED J INDIA, V13, P304; Datta K, 2012, INT J RADIAT BIOL, V88, P213, DOI 10.3109/09553002.2012.639434; Datta K, 2011, RADIAT RES, V175, P97, DOI 10.1667/RR2332.1; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; Desai N, 2005, RADIAT RES, V164, P518, DOI 10.1667/RR3431.1; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Dupree-Ellis E, 2000, AM J EPIDEMIOL, V152, P91, DOI 10.1093/aje/152.1.91; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Fornace Albert J Jr, 2002, Mil Med, V167, P13; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Goodhead DT, 1999, J RADIAT RES, V40, P1, DOI 10.1269/jrr.40.S1; GRIBBIN MA, 1993, RADIAT RES, V133, P375, DOI 10.2307/3578225; Hamada N, 2009, J RADIAT RES, V50, P1, DOI 10.1269/jrr.08070; Hayatsu K, 2009, J PHYS SOC JPN, V78, P149, DOI 10.1143/JPSJS.78SA.149; Hickling KC, 2010, TOXICOL PATHOL, V38, P230, DOI 10.1177/0192623309357946; Huigsloot M, 2002, J BIOL CHEM, V277, P35869, DOI 10.1074/jbc.M200378200; Iborra M, 2011, BIOCHEM SOC T, V39, P1102, DOI 10.1042/BST0391102; Jacobson J, 2002, J NEUROCHEM, V82, P224, DOI 10.1046/j.1471-4159.2002.00945.x; Jain Mohit R, 2011, Curr Mol Pharmacol, V4, P106; KATZ R, 1974, PHYS MED BIOL, V19, P413, DOI 10.1088/0031-9155/19/4/001; Keskek M, 2006, J SURG RES, V135, P76, DOI 10.1016/j.jss.2006.03.031; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim GJ, 2006, CANCER RES, V66, P10377, DOI 10.1158/0008-5472.CAN-05-3036; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Leach JK, 2001, CANCER RES, V61, P3894; Lenarczyk M, 2009, RADIAT RES, V171, P164, DOI 10.1667/RR1454.1; Leverkoehne I, 2006, HISTOCHEM CELL BIOL, V126, P239, DOI 10.1007/s00418-006-0164-7; Limoli CL, 2007, RADIAT ENVIRON BIOPH, V46, P167, DOI 10.1007/s00411-006-0077-9; Limoli CL, 1998, CANCER RES, V58, P3712; Macartney KK, 2000, J VIROL, V74, P5597, DOI 10.1128/JVI.74.12.5597-5603.2000; Machella N, 2004, MAR ENVIRON RES, V58, P725, DOI 10.1016/j.marenvres.2004.03.022; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Miro O, 1999, CARCINOGENESIS, V20, P1331, DOI 10.1093/carcin/20.7.1331; Morgan WF, 2003, ONCOGENE, V22, P7094, DOI 10.1038/sj.onc.1206992; Pazhanisamy SK, 2011, MUTAGENESIS, V26, P431, DOI 10.1093/mutage/ger001; Petrosillo G, 2006, FEBS LETT, V580, P6311, DOI 10.1016/j.febslet.2006.10.036; REITZ G, 1993, CLIN INVESTIGATOR, V71, P710; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Robbins MEC, 2002, MICRON, V33, P133, DOI 10.1016/S0968-4328(01)00006-3; Roig AI, 2009, RADIAT RES, V171, P33, DOI 10.1667/RR1415.1; Rugo RE, 2004, RADIAT RES, V162, P416, DOI 10.1667/RR3238; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Schimmerling W, 2010, RADIAT ENVIRON BIOPH, V49, P325, DOI 10.1007/s00411-010-0286-0; Setlow RB, 2003, EMBO REP, V4, P1013, DOI 10.1038/sj.embor.7400016; Setlow RB, 1999, MUTAT RES-FUND MOL M, V430, P169, DOI 10.1016/S0027-5107(99)00127-X; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Stewart LH, 2007, J EMERG MED, V32, P45, DOI 10.1016/j.jemermed.2006.05.031; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Takahashi A, 2008, J RADIAT RES, V49, P645, DOI 10.1269/jrr.08007; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trani D, 2010, RADIAT ENVIRON BIOPH, V49, P389, DOI 10.1007/s00411-010-0292-2; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Yano S, 2002, MOL CELL BIOCHEM, V240, P119, DOI 10.1023/A:1020680131754; Yoshida T, 2011, FREE RADICAL RES	72	104	107	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42224	10.1371/journal.pone.0042224	http://dx.doi.org/10.1371/journal.pone.0042224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936983	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500011
J	Gu, YR; Li, MZ; Wang, T; Liang, Y; Zhong, ZJ; Wang, XY; Zhou, Q; Chen, L; Lang, QL; He, ZP; Chen, XH; Gong, JJ; Gao, XL; Li, XW; Lv, XB				Gu, Yiren; Li, Mingzhou; Wang, Tao; Liang, Yan; Zhong, Zhijun; Wang, Xiaoyan; Zhou, Qi; Chen, Lei; Lang, Qiulei; He, Zhiping; Chen, Xiaohui; Gong, Jianjun; Gao, Xiaolian; Li, Xuewei; Lv, Xuebin			Lactation-Related MicroRNA Expression Profiles of Porcine Breast Milk Exosomes	PLOS ONE			English	Article							IMMUNE-SYSTEM; SIGNATURE; EVOLUTION; RECEPTOR; TARGET	Breast milk is the primary source of nutrition for newborns, and is rich in immunological components. MicroRNAs (miRNAs) are present in various body fluids and are selectively packaged inside the exosomes, a type of membrane vesicles, secreted by most cell types. These exosomal miRNAs could be actively delivered into recipient cells, and could regulate target gene expression and recipient cell function. Here, we analyzed the lactation-related miRNA expression profiles in porcine milk exosomes across the entire lactation period (newborn to 28 days after birth) by a deep sequencing. We found that immune-related miRNAs are present and enriched in breast milk exosomes (p<10(-16), chi(2) test) and are generally resistant to relatively harsh conditions. Notably, these exosomal miRNAs are present in higher numbers in the colostrums than in mature milk. It was higher in the serum of colostrum-only fed piglets compared with the mature milk-only fed piglets. These immune-related miRNA-loaded exosomes in breast milk may be transferred into the infant body via the digestive tract. These observations are a prelude to in-depth investigations of the essential roles of breast milk in the development of the infant's immune system.	[Gu, Yiren; Liang, Yan; Zhong, Zhijun; He, Zhiping; Chen, Xiaohui; Gong, Jianjun; Lv, Xuebin] Sichuan Anim Sci Acad, Chengdu, Sichuan, Peoples R China; [Li, Mingzhou; Wang, Tao; Zhong, Zhijun; Wang, Xiaoyan; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Li, Mingzhou] Peking Univ, Biodynam Opt Imaging Ctr, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Li, Mingzhou] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Zhou, Qi] Yaan Vocat Coll, Dept Nursing, Yaan, Sichuan, Peoples R China; [Chen, Lei] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Lang, Qiulei] LC Bio, Hangzhou, Zhejiang, Peoples R China; [Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Sichuan Agricultural University; Peking University; Peking University; University of Houston System; University of Houston	Gu, YR (corresponding author), Sichuan Anim Sci Acad, Chengdu, Sichuan, Peoples R China.	xuewei.li@sicau.edu.cn; lvxuebin1965@gmail.com			Key Technology Research and Development Program of Sichuan [16]; Key Projects in the National Science & Technology Pillar Program [2011BAD28B01]; National Swine Industry Technology System Program [CARS-36]; National Natural Science Foundation of China [30901024]; International Science & Technology Cooperation Program of China [2011DFB30340]	Key Technology Research and Development Program of Sichuan; Key Projects in the National Science & Technology Pillar Program; National Swine Industry Technology System Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was supported by grants from the Key Technology Research and Development Program of Sichuan (Project-16), the Key Projects in the National Science & Technology Pillar Program (2011BAD28B01), the National Swine Industry Technology System Program (CARS-36), the National Natural Science Foundation of China (30901024) and the International Science & Technology Cooperation Program of China (2011DFB30340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Brabletz T, 1999, INT IMMUNOL, V11, P1701, DOI 10.1093/intimm/11.10.1701; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Dawson HD, 2012, MINIPIG IN BIOMEDICAL RESEARCH, P323; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goldman AS, 2007, BREASTFEED MED, V2, P195, DOI 10.1089/bfm.2007.0024; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kuhn AR, 2010, AM J RESP CELL MOL, V42, P506, DOI 10.1165/rcmb.2009-0123OC; Lawrence Robert M, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P7, DOI 10.1016/j.cppeds.2006.10.002; Lefevre CM, 2010, ANNU REV GENOM HUM G, V11, P219, DOI 10.1146/annurev-genom-082509-141806; Li MZ, 2011, INT J BIOL SCI, V7, P1045, DOI 10.7150/ijbs.7.1045; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Meurens F, 2011, TRENDS MICROBIOLOGY; O'Hara AJ, 2008, BLOOD, V111, P2347, DOI 10.1182/blood-2007-08-104463; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Paramasivam K, 2006, INT J FERTIL WOMEN M, V51, P208; Petherick A, 2010, NATURE, V468, pS5, DOI 10.1038/468S5a; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang L, 2011, CELL RES; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	38	156	177	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43691	10.1371/journal.pone.0043691	http://dx.doi.org/10.1371/journal.pone.0043691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937080	Green Published, gold			2022-12-27	WOS:000308225500082
J	Lin, ZS; Chu, HC; Yen, YC; Lewis, BC; Chen, YW				Lin, Ze-Shiang; Chu, Hsiao-Chien; Yen, Yi-Chen; Lewis, Brian C.; Chen, Ya-Wen			Kruppel-Like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug Expression	PLOS ONE			English	Article							DOWN-REGULATION; LINE RKO; C-MYC; KLF4; GENE; METASTASIS; IDENTIFICATION; PROLIFERATION; INVASION; KRUPPEL-LIKE-FACTOR-4	Kruppel-like factor 4 (KLF4) is a zinc-finger transcription factor that plays an important role in differentiation and pathogenesis. KLF4 has been suggested to act as an oncogene or tumor suppressor in different tumor types. However, the role of KLF4 in hepatocellular carcinoma (HCC) remains unclear. Here, we demonstrate that forced expression of Klf4 in murine HCC cell lines reduced anchorage-independent growth in soft agar as well as cell migration and invasion activities in vitro. Ectopic Klf4 expression impaired subcutaneous tumor growth and lung colonization in vivo. By contrast, Klf4 knockdown enhanced HCC cell migration. Interestingly, ectopic expression of Klf4 changed the morphology of murine HCC cells to a more epithelial phenotype. Associated with this, we found that expression of Slug, a critical epithelial mesenchymal transition (EMT)-related transcription factor, was significantly down-regulated in Klf4-expressing cells. Chromatin immunoprecipitation (ChIP) and luciferase reporter assays showed that Klf4 is able to bind and repress the activity of the Slug promoter. Furthermore, ectopic Slug expression partially reverts the Klf4-mediated phenotypes. Consistent with a role as a tumor suppressor in HCC, analysis of the public microarray databases from Oncomine revealed reduced KLF4 expression in human HCC tissues in comparison with normal liver tissues in 3 out of 4 data sets. By quantitative reverse transcription-polymerase chain reaction (qRT-PCR), we found reduced KLF4 mRNA in 50% of HCC tissues. Importantly, an inverse correlation between the expression of KLF4 and SLUG was found in HCC tissues. Our data suggest that KLF4 acts as a tumor suppressor in HCC cells, in part by suppressing SLUG transcription.	[Lin, Ze-Shiang; Chu, Hsiao-Chien; Yen, Yi-Chen; Chen, Ya-Wen] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA USA	National Health Research Institutes - Taiwan; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lin, ZS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.	ywc@nhri.org.tw	Chen, Ya-Wen/B-1100-2010; Chen, Ya-Wen/AAG-7549-2019	Chen, Ya-Wen/0000-0002-6080-8859	National Science Council [NSC 100-2320-B-400-008, NSC 94-3112-B-182-002, NSC 97-3112-B-182-004]; National Health Research Institutes [NHRI CA-100-PP-03]; Department of Health [DOH101-TD-C-111-004]; National Research Program for Genomic Medicine Grants of NSC [NSC 97-3112-B-001-016]; National Health Research Institutes, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Department of Health; National Research Program for Genomic Medicine Grants of NSC; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by NSC 100-2320-B-400-008 (National Science Council; web1.nsc.gov.tw), NHRI CA-100-PP-03 (National Health Research Institutes; www.nhri.org.tw) and DOH101-TD-C-111-004 (Department of Health; www.doh.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Zhi-Xiang Li and Ju-Ching Yu for assistance in construction of plasmids. We thank Dr. Cheng-Wen Wu for proving the SLUG-Luc plasmid, Dr. Jer-Wei Chang for technical support in ChIP experiments, Dr. Shih-Sheng Jiang for data mining in Oncomine and GEO, Dr. Jang-Yang Chang for HCC samples and Drs Shankuang Lin and Hui-Lin Wu for critical review of the manuscript. RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by the National Research Program for Genomic Medicine Grants of NSC (NSC 97-3112-B-001-016). We would like to thank Taiwan Liver Cancer Network (TLCN) for providing the liver tumor tissue samples and related clinical data (all are anonymous) for our research work. TLCN is supported by grants from National Science Council (NSC 94-3112-B-182-002, NSC 97-3112-B-182-004) and National Health Research Institutes, Taiwan.	Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen YW, 2008, CANCER RES, V68, P476, DOI 10.1158/0008-5472.CAN-07-1960; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Chen YW, 2009, NEOPLASIA, V11, P835, DOI 10.1593/neo.09476; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Flandez M, 2008, EXP CELL RES, V314, P3712, DOI 10.1016/j.yexcr.2008.10.004; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kremer-Tal S, 2004, HEPATOLOGY, V40, P1047, DOI 10.1002/hep.20460; Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liu YN, 2012, MOL CELL BIOL; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; NAKABAYASHI H, 1984, GANN, V75, P151; Nakahara Y, 2010, NEOPLASIA, V12, P20, DOI 10.1593/neo.91122; NAMBU S, 1987, JPN J CANCER RES, V78, P695; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; ROBINSON WS, 1994, ANNU REV MED, V45, P297; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Roussos ET, 2010, CANCER RES, V70, P7360, DOI 10.1158/0008-5472.CAN-10-1208; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Wang J, 2004, CANCER RES, V70, P10182; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yuan F, 2012, MOL CELL BIOCHEM, V343, P155; Zammarchi F, 2011, AM J PATHOL, V178, P361, DOI 10.1016/j.ajpath.2010.11.021; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	48	67	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43593	10.1371/journal.pone.0043593	http://dx.doi.org/10.1371/journal.pone.0043593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937066	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500067
J	Zhang, N; Qiao, ZY; Liang, Z; Mei, B; Xu, ZK; Song, RT				Zhang, Nan; Qiao, Zhenyi; Liang, Zheng; Mei, Bing; Xu, Zhengkai; Song, Rentao			Zea mays Taxilin Protein Negatively Regulates Opaque-2 Transcriptional Activity by Causing a Change in Its Sub-Cellular Distribution	PLOS ONE			English	Article							MAIZE ENDOSPERM; LEUCINE-ZIPPER; BINDING PROTEIN; GENE-EXPRESSION; LOCUS OPAQUE-2; TARGET SITE; BONE MASS; ACTIVATOR; FIAT; MUTATIONS	Zea mays (maize) Opaque-2 (ZmO2) protein is an important bZIP transcription factor that regulates the expression of major storage proteins (22-kD zeins) and other important genes during maize seed development. ZmO2 is subject to functional regulation through protein-protein interactions. To unveil the potential regulatory network associated with ZmO2, a protein-protein interaction study was carried out using the truncated version of ZmO2 (O2-2) as bait in a yeast two-hybrid screen with a maize seed cDNA library. A protein with homology to Taxilin was found to have stable interaction with ZmO2 in yeast and was designated as ZmTaxilin. Sequence analysis indicated that ZmTaxilin has a long coiled-coil domain containing three conserved zipper motifs. Each of the three zipper motifs is individually able to interact with ZmO2 in yeast. A GST pull-down assay demonstrated the interaction between GST-fused ZmTaxilin and ZmO2 extracted from developing maize seeds. Using onion epidermal cells as in vivo assay system, we found that ZmTaxilin could change the sub-cellular distribution of ZmO2. We also demonstrated that this change significantly repressed the transcriptional activity of ZmO2 on the 22-kD zein promoter. Our study suggests that a Taxilin-mediated change in sub-cellular distribution of ZmO2 may have important functional consequences for ZmO2 activity.	[Zhang, Nan; Qiao, Zhenyi; Liang, Zheng; Mei, Bing; Xu, Zhengkai; Song, Rentao] Shanghai Univ, Shanghai Key Lab Bioenergy Crops, Sch Life Sci, Shanghai, Peoples R China	Shanghai University	Zhang, N (corresponding author), Shanghai Univ, Shanghai Key Lab Bioenergy Crops, Sch Life Sci, Shanghai, Peoples R China.	rentaosong@staff.shu.edu.cn	Song, Rentao/A-6544-2012; Song, Rentao/AAG-9107-2021	Song, Rentao/0000-0003-1810-9875; Song, Rentao/0000-0003-1810-9875; Zhang, Nan/0000-0002-8097-6876	Ministry of Science and Technology of China [2012AA10A305, 2009CB118400]; Natural Sciences Foundation of China [30671303]; Shanghai Science and Technology Committee [11DZ2272100]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by the Ministry of Science and Technology of China (2012AA10A305, 2009CB118400; http://www.most.gov.cn/eng/index.htm), the Natural Sciences Foundation of China (30671303; http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and Shanghai Science and Technology Committee (11DZ2272100; http://www.stcsm.gov.cn/structure/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aukerman M J, 1994, Results Probl Cell Differ, V20, P209; Bhat RA, 2004, PLANT MOL BIOL, V55, P239, DOI 10.1007/s11103-004-0553-z; Brennecke K, 1996, PHYTOCHEMISTRY, V41, P707, DOI 10.1016/0031-9422(95)00634-6; Burnett RJ, 1999, MOL GEN GENET, V261, P908, DOI 10.1007/s004380051038; BURR FA, 1982, J CELL BIOL, V94, P201, DOI 10.1083/jcb.94.1.201; Ciceri P, 1997, PLANT CELL, V9, P97, DOI 10.1105/tpc.9.1.97; Ciceri P, 1999, PLANT PHYSIOL, V121, P1321, DOI 10.1104/pp.121.4.1321; DOLFINI SF, 1992, DEV GENET, V13, P264, DOI 10.1002/dvg.1020130404; Feng LN, 2009, PLANT MOL BIOL, V69, P649, DOI 10.1007/s11103-008-9444-z; GALLUSCI P, 1994, MOL GEN GENET, V244, P391, DOI 10.1007/BF00286691; Gavazzi F, 2007, PLANT PHYSIOL, V145, P933, DOI 10.1104/pp.107.103606; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; HARTINGS H, 1989, EMBO J, V8, P2795, DOI 10.1002/j.1460-2075.1989.tb08425.x; Hunter BG, 2002, PLANT CELL, V14, P2591, DOI 10.1105/tpc.003905; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kemper EL, 1999, PLANT CELL, V11, P1981, DOI 10.1105/tpc.11.10.1981; KODRZYCKI R, 1989, PLANT CELL, V1, P105, DOI 10.1105/tpc.1.1.105; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; LOHMER S, 1991, EMBO J, V10, P617, DOI 10.1002/j.1460-2075.1991.tb07989.x; Maddaloni M, 1996, MOL GEN GENET, V250, P647, DOI 10.1007/s004380050117; Matsuo N, 2008, PLANT PHYSIOL BIOCH, V46, P1045, DOI 10.1016/j.plaphy.2008.07.007; Muth JR, 1996, MOL GEN GENET, V252, P723, DOI 10.1007/s004380050282; Nogami S, 2004, BIOCHEM BIOPH RES CO, V319, P936, DOI 10.1016/j.bbrc.2004.05.073; Nogami S, 2003, BIOCHEM BIOPH RES CO, V311, P797, DOI 10.1016/j.bbrc.2003.10.069; Nogami S, 2003, GENES CELLS, V8, P17, DOI 10.1046/j.1365-2443.2003.00612.x; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Prioul JL, 2008, CR BIOL, V331, P772, DOI 10.1016/j.crvi.2008.07.019; PYSH LD, 1993, PLANT CELL, V5, P227, DOI 10.1105/tpc.5.2.227; Sakakibara S, 2008, J COMP NEUROL, V511, P65, DOI 10.1002/cne.21817; SCHMIDT RJ, 1987, SCIENCE, V238, P960, DOI 10.1126/science.2823388; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Schmitz D, 1997, NUCLEIC ACIDS RES, V25, P756, DOI 10.1093/nar/25.4.756; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; VicenteCarbajosa J, 1997, P NATL ACAD SCI USA, V94, P7685, DOI 10.1073/pnas.94.14.7685; Yoshida K, 2005, GENES CELLS, V10, P465, DOI 10.1111/j.1365-2443.2005.00848.x; Yu VWC, 2006, ANN NY ACAD SCI, V1068, P131, DOI 10.1196/annals.1346.027; Yu VWC, 2009, GENE EXPR PATTERNS, V9, P335, DOI 10.1016/j.gep.2009.02.002; Yu VWC, 2008, J CELL BIOCHEM, V105, P859, DOI 10.1002/jcb.21881; Yu VWC, 2009, J CELL BIOCHEM, V106, P186, DOI 10.1002/jcb.21995; Yu VWC, 2005, J CELL BIOL, V169, P591, DOI 10.1083/jcb.200412139	43	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43822	10.1371/journal.pone.0043822	http://dx.doi.org/10.1371/journal.pone.0043822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937104	Green Submitted, gold, Green Published			2022-12-27	WOS:000308225500106
J	Garcia, PB; Cai, A; Bates, JG; Nolla, H; Schlissel, MS				Garcia, Patty B.; Cai, Amie; Bates, Jamie G.; Nolla, Hector; Schlissel, Mark S.			miR290-5p/292-5p Activate the Immunoglobulin kappa Locus in B Cell Development	PLOS ONE			English	Article							CHAIN INTRONIC ENHANCER; V(D)J RECOMBINATION; GENE-TRANSCRIPTION; REARRANGEMENT; MICRORNAS; DIFFERENTIATION; LYMPHOCYTES; MECHANISMS; EXPRESSION; ABLATION	Regulated expression of miRNAs influences development in a wide variety of contexts. We report here that miR290-5p (100049710) and miR292-5p (100049711) are induced at the pre-B stage of murine B cell development and that they influence assembly of the Ig kappa light chain gene (243469) by contributing to the activation of germline Ig kappa transcription (kappa GT). We found that upon forced over-expression of miR290-5p/292-5p in Abelson Murine Leukemia Virus (AMuLV) transformed pro-B cells, two known activators of kappa GT, E2A (21423) and NF-kappa B (19697), show increased chromosomal binding to the kappa intronic enhancer. Conversely, knockdown of miR290-5p/292-5p in AMuLV pro-B cells blunts drug-induced activation of kappa GT. Furthermore, miR290-5p/292-5p knockdown also diminishes kappa GT activation, but not Rag1/2 (19373, 19374) expression, in an IL-7 dependent primary pro-B cell culture system. In addition, we identified a deficiency in kappa GT induction in miR290 cluster knockout mice. We hypothesize that increased expression of miR290-5p and miR292-5p contributes to the induction of kappa GT at the pre-B stage of B cell development through increased binding of NF-kappa B and E2A to kappa locus regulatory sequences.	[Garcia, Patty B.; Cai, Amie; Nolla, Hector; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bates, Jamie G.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University	Garcia, PB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mark_schlissel@brown.edu			NIH [RO1 HL48702]; NSF; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by NIH RO1 HL48702 (MSS, http://grants.nih.gov/grants/oer.htm) and an NSF Predoctoral Fellowship (PG, http://www.nsfgrfp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cadera EJ, 2009, J EXP MED, V206, P1803, DOI 10.1084/jem.20082815; Chaulk SG, 2011, RNA BIOL, V8, P1105, DOI 10.4161/rna.8.6.17410; CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Derudder E, 2009, NAT IMMUNOL, V10, P647, DOI 10.1038/ni.1732; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Greenbaum S, 2002, P NATL ACAD SCI USA, V99, P15030, DOI 10.1073/pnas.232299999; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; KLUG CA, 1994, GENE DEV, V8, P678, DOI 10.1101/gad.8.6.678; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kuo TC, 2011, MOL CELL BIOL, V31, P2566, DOI 10.1128/MCB.01349-10; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; McDevit DC, 2005, J IMMUNOL, V174, P2834, DOI 10.4049/jimmunol.174.5.2834; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Rizzo M, 2011, PHYSIOL GENOMICS, V43, P1153, DOI 10.1152/physiolgenomics.00064.2011; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; SCHLISSEL MS, 1994, J IMMUNOL, V153, P1645; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shaffer AL, 1997, IMMUNITY, V6, P131, DOI 10.1016/S1074-7613(00)80420-3; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	40	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43805	10.1371/journal.pone.0043805	http://dx.doi.org/10.1371/journal.pone.0043805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928038	Green Submitted, Green Published, gold			2022-12-27	WOS:000308224700026
J	Liu, F; Yuan, D; Wei, YG; Wang, WT; Yan, LN; Wen, TF; Xu, MQ; Yang, JY; Li, B				Liu, Fei; Yuan, Ding; Wei, Yonggang; Wang, Wentao; Yan, Lvnan; Wen, Tianfu; Xu, Mingqing; Yang, Jiayin; Li, Bo			Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and Colorectal Cancer Risk	PLOS ONE			English	Article							MICROSOMAL EPOXIDE HYDROLASE; CARCINOGEN-METABOLIZING ENZYMES; GENE POLYMORPHISMS; CIGARETTE-SMOKING; LUNG-CANCER; ASSOCIATION; SUSCEPTIBILITY; GENOTYPES; MEAT; 2E1	Background: Microsomal epoxide hydrolase (EPHX1) plays an important role in both the activation and detoxification of PAHs, which are carcinogens found in cooked meat and tobacco smoking. Polymorphisms at exons 3 and 4 of the EPHX1 gene have been reported to be associated with variations in EPHX1 activity. The aim of this study is to quantitatively summarize the relationship between EPHX1 polymorphisms and colorectal cancer (CRC) risk. Methods: Two investigators independently searched the Medline, Embase, CNKI, and Chinese Biomedicine Databases for studies published before June 2012. Summary odds ratios (ORs) and 95% confidence intervals (CIs) for EPHX1 Tyr113His (rs1051740) and His139Arg (rs2234922) polymorphisms and CRC were calculated in a fixed-effects model and a random-effects model when appropriate. Results: This meta-analysis yielded 14 case-control studies, which included 13 studies for Tyr113His (6395 cases and 7893 controls) and 13 studies for His139Arg polymorphisms (5375 cases and 6962 controls). Overall, the pooled results indicated that EPHX1 Tyr113His polymorphism was not associated with CRC risk; while the His139Arg polymorphism was significantly associated with decreased CRC risk (Arg/His vs. His/His, OR = 0.90, 95% CI = 0.83-0.98; dominant model, OR = 0.92, 95% CI = 0.85-0.99). The statistically significant association between EPHX1 His139Arg polymorphism and CRC was observed among Caucasians and population-based case-control studies. This association showed little heterogeneity and remained consistently strong when analyses were limited to studies in which genotype frequencies were in Hardy-Weinberg equilibrium, or limited to studies with matched controls. When cumulative meta-analyses of the two associations were conducted by studies' publication time, the results were persistent and robust. Conclusion: This meta-analysis suggests that EPHX1 Tyr113His polymorphism may be not associated with CRC development; while the EPHX1 His139Arg polymorphism may have a potential protective effect on CRC.	[Liu, Fei; Yuan, Ding; Wei, Yonggang; Wang, Wentao; Yan, Lvnan; Wen, Tianfu; Xu, Mingqing; Yang, Jiayin; Li, Bo] Sichuan Univ, W China Hosp, Dept Liver & Vasc Surg, Div Liver Transplantat, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Liu, F (corresponding author), Sichuan Univ, W China Hosp, Dept Liver & Vasc Surg, Div Liver Transplantat, Chengdu 610064, Sichuan Provinc, Peoples R China.	yourwyg@163.com; cdlibo688@163.com	Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-7294-6888	National Natural Science Foundation of China [30901720]; Ph.D. Programs Foundation of Ministry of Education of China [20090181120111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China (No. 30901720) and Ph.D. Programs Foundation of Ministry of Education of China (No. 20090181120111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2010, CANC FACTS FIG; Arand M, 2005, METHOD ENZYMOL, V400, P569, DOI 10.1016/S0076-6879(05)00032-7; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benhamou S, 2002, CARCINOGENESIS, V23, P1343, DOI 10.1093/carcin/23.8.1343; Benhamou S, 1998, CANCER RES, V58, P5291; Cleary SP, 2010, AM J EPIDEMIOL, V172, P1000, DOI 10.1093/aje/kwq245; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cotterchio M, 2008, CANCER EPIDEM BIOMAR, V17, P3098, DOI 10.1158/1055-9965.EPI-08-0341; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Harrison DJ, 1999, BRIT J CANCER, V79, P168, DOI 10.1038/sj.bjc.6690028; Hassett C, 1997, ARCH BIOCHEM BIOPHYS, V337, P275, DOI 10.1006/abbi.1996.9794; HASSETT C, 1994, HUM MOL GENET, V3, P421, DOI 10.1093/hmg/3.3.421; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hlavata I, 2010, ONCOL REP, V24, P1347, DOI 10.3892/or_0000992; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kiss I, 2007, ANTICANCER RES, V27, P2931; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Li XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014749; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu L, 2011, J CANCER RES CLIN, V137, P1027, DOI 10.1007/s00432-010-0966-9; Ma HX, 2006, INT J CANCER, V119, P2173, DOI 10.1002/ijc.22094; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nisa H, 2013, MOL CARCINOGEN, V52, P619, DOI 10.1002/mc.21897; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; OESCH F, 1973, XENOBIOTICA, V3, P305, DOI 10.3109/00498257309151525; Omiecinski CJ, 2000, TOXICOL LETT, V112, P365, DOI 10.1016/S0378-4274(99)00235-0; Robien K, 2005, CANCER EPIDEM BIOMAR, V14, P1350, DOI 10.1158/1055-9965.EPI-04-0877; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Sahin O, 2012, GENET TEST MOL BIOMA, V16, P423, DOI 10.1089/gtmb.2011.0223; Skjelbred Camilla F, 2007, BMC Cancer, V7, P228; Smith CAD, 1997, LANCET, V350, P630, DOI 10.1016/S0140-6736(96)08061-0; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Tranah GJ, 2005, MOL CARCINOGEN, V44, P21, DOI 10.1002/mc.20112; van der Logt EMJ, 2006, MUTAT RES-FUND MOL M, V593, P39, DOI 10.1016/j.mrfmmm.2005.06.018; WP Yu, 2004, EPIDEMIOLOGICAL STUD; Zhang JH, 2003, WORLD J GASTROENTERO, V9, P2654; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187; Zhao ZQ, 2012, TUMOR BIOL, V33, P523, DOI 10.1007/s13277-011-0287-x	43	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43821	10.1371/journal.pone.0043821	http://dx.doi.org/10.1371/journal.pone.0043821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928041	Green Submitted, Green Published, gold			2022-12-27	WOS:000308224700029
J	Bousema, T; Dinglasan, RR; Morlais, I; Gouagna, LC; van Warmerdam, T; Awono-Ambene, PH; Bonnet, S; Diallo, M; Coulibaly, M; Tchuinkam, T; Mulder, B; Targett, G; Drakeley, C; Sutherland, C; Robert, V; Doumbo, O; Toure, Y; Graves, PM; Roeffen, W; Sauerwein, R; Birkett, A; Locke, E; Morin, M; Wu, YM; Churcher, TS				Bousema, Teun; Dinglasan, Rhoel R.; Morlais, Isabelle; Gouagna, Louis C.; van Warmerdam, Travis; Awono-Ambene, Parfait H.; Bonnet, Sarah; Diallo, Mouctar; Coulibaly, Mamadou; Tchuinkam, Timoleon; Mulder, Bert; Targett, Geoff; Drakeley, Chris; Sutherland, Colin; Robert, Vincent; Doumbo, Ogobara; Toure, Yeya; Graves, Patricia M.; Roeffen, Will; Sauerwein, Robert; Birkett, Ashley; Locke, Emily; Morin, Merribeth; Wu, Yimin; Churcher, Thomas S.			Mosquito Feeding Assays to Determine the Infectiousness of Naturally Infected Plasmodium falciparum Gametocyte Carriers	PLOS ONE			English	Article							TRANSMISSION-BLOCKING IMMUNITY; ANOPHELES-GAMBIAE; MALARIA TRANSMISSION; WESTERN KENYA; SEX-RATIO; INFECTIVITY; REDUCTION; CAMEROON; HOST; PYRIMETHAMINE	Introduction: In the era of malaria elimination and eradication, drug-based and vaccine-based approaches to reduce malaria transmission are receiving greater attention. Such interventions require assays that reliably measure the transmission of Plasmodium from humans to Anopheles mosquitoes. Methods: We compared two commonly used mosquito feeding assay procedures: direct skin feeding assays and membrane feeding assays. Three conditions under which membrane feeding assays are performed were examined: assays with i) whole blood, ii) blood pellets resuspended with autologous plasma of the gametocyte carrier, and iii) blood pellets resuspended with heterologous control serum. Results: 930 transmission experiments from Cameroon, The Gambia, Mali and Senegal were included in the analyses. Direct skin feeding assays resulted in higher mosquito infection rates compared to membrane feeding assays (odds ratio 2.39, 95% confidence interval 1.94-2.95) with evident heterogeneity between studies. Mosquito infection rates in membrane feeding assays and direct skin feeding assays were strongly correlated (p < 0.0001). Replacing the plasma of the gametocyte donor with malaria naive control serum resulted in higher mosquito infection rates compared to own plasma (OR 1.92, 95% CI 1.68-2.19) while the infectiousness of gametocytes may be reduced during the replacement procedure (OR 0.60, 95% CI 0.52-0.70). Conclusions: Despite a higher efficiency of direct skin feeding assays, membrane feeding assays appear suitable tools to compare the infectiousness between individuals and to evaluate transmission-reducing interventions. Several aspects of membrane feeding procedures currently lack standardization; this variability makes comparisons between laboratories challenging and should be addressed to facilitate future testing of transmission-reducing interventions.	[Bousema, Teun; Targett, Geoff; Drakeley, Chris; Sutherland, Colin] London Sch Hyg & Trop Med, Dept Immun & Infect, London WC1, England; [Bousema, Teun; Roeffen, Will; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Dinglasan, Rhoel R.; van Warmerdam, Travis] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Dinglasan, Rhoel R.; van Warmerdam, Travis] Malaria Res Inst, Baltimore, MD USA; [Morlais, Isabelle; Awono-Ambene, Parfait H.; Tchuinkam, Timoleon] Inst Rech Dev, Org Coordinat Lutte Endemies Afrique Cent OCEAC, Lab Rech Paludisme, Yaounde, Cameroon; [Morlais, Isabelle; Gouagna, Louis C.; Robert, Vincent] Inst Rech Dev, MIVEGEC, Montpellier, France; [Bonnet, Sarah] Agence Natl Secur Sanit, USC INRA Bartonella Tiques, Maisons Alfort, France; [Diallo, Mouctar; Coulibaly, Mamadou; Doumbo, Ogobara; Toure, Yeya] Univ Sci Tech & Technol, Malaria Res & Training Ctr, Bamako, Mali; [Tchuinkam, Timoleon] Univ Dschang, Lab Appl Biol & Ecol, Malaria Res Unit, Dschang, Cameroon; [Mulder, Bert] Microbiol Lab Twente, Dept Med Microbiol, Enschede, Netherlands; [Graves, Patricia M.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Cairns, Qld, Australia; [Birkett, Ashley; Locke, Emily; Morin, Merribeth] PATH Malaria Vaccine Initiat, Washington, DC USA; [Wu, Yimin] NIAID, Lab Malaria Immunol & Vaccinol, Rockville, MD USA; [Churcher, Thomas S.] Univ London Imperial Coll Sci Technol & Med, Infect Dis Epidemiol MRC Ctr Outbreak Anal & Mode, London, England	University of London; London School of Hygiene & Tropical Medicine; Radboud University Nijmegen; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; University of Science & Technology of Bamako; James Cook University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Imperial College London	Bousema, T (corresponding author), London Sch Hyg & Trop Med, Dept Immun & Infect, London WC1, England.	teun.bousema@lshtm.ac.uk	Roeffen, W.F.G./L-4607-2015; Morlais, Isabelle/F-5078-2014; Morlais, Isabelle/Q-2171-2019; Bonnet, Sarah I/AAD-4191-2020; Sutherland, Colin/AAN-3939-2020; Bousema, Teun/N-3574-2014; Sauerwein, Robert/C-8519-2013; Coulibaly, Mamadou/AAE-7006-2019; Graves, Patricia M/J-8691-2014	Morlais, Isabelle/0000-0002-2962-7670; Morlais, Isabelle/0000-0002-2962-7670; Bonnet, Sarah I/0000-0002-6365-6117; Sutherland, Colin/0000-0003-1592-6407; Bousema, Teun/0000-0003-2666-094X; Graves, Patricia M/0000-0002-5215-3901; ROBERT, Vincent/0000-0003-1738-1842; Gouagna, Louis Clement/0000-0003-0957-4484; Churcher, Thomas/0000-0002-8442-0525; Dinglasan, Rhoel/0000-0001-5433-8179; Dinglasan, Rhoel/0000-0001-6563-1506	Bill & Melinda Gates Foundation; European FP7 framework (REDMAL) [242079]; PATH Malaria Vaccine Initiative (MVI); MVI; Bloomberg Family Foundation; Johns Hopkins Malaria Research Institute; Institut de Recherche pour le Developpement; TMRC; NIAID/NIH; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; Imperial College London; EC FP7 Collaborative project TransMalariaBloc [HEALTH-F3-2008-223736]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); European FP7 framework (REDMAL); PATH Malaria Vaccine Initiative (MVI); MVI; Bloomberg Family Foundation; Johns Hopkins Malaria Research Institute; Institut de Recherche pour le Developpement; TMRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Imperial College London(General Electric); EC FP7 Collaborative project TransMalariaBloc	The work of TB is supported by grants from the Bill & Melinda Gates Foundation and the European FP7 framework (REDMAL project, # 242079) and the PATH Malaria Vaccine Initiative (MVI). RRD and TW were supported by MVI, the Bloomberg Family Foundation and the Johns Hopkins Malaria Research Institute. IM, LCG, PHAA, SB and VR were partly supported by the Institut de Recherche pour le Developpement. The MRTC group in Mali is supported by extramural (TMRC) and intramural grants from NIAID/NIH. YW is supported by Division of Intramural Research, National Institute of Allergy and Infectious Diseases. TSC is supported by a Junior Research Fellowship from Imperial College London and an EC FP7 Collaborative project TransMalariaBloc (HEALTH-F3-2008-223736). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awono-Ambene Herman P., 2001, American Journal of Tropical Medicine and Hygiene, V64, P32; Babiker HA, 2008, TRENDS PARASITOL, V24, P525, DOI 10.1016/j.pt.2008.08.001; BEIER MS, 1988, AM J TROP MED HYG, V39, P323, DOI 10.4269/ajtmh.1988.39.323; Bell AS, 2004, INT J PARASITOL, V34, P795, DOI 10.1016/j.ijpara.2004.03.008; Berghe L. van den, 1953, Anais do Instituto de Medicina Tropica Lisboa, V9, P553; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonnet S, 2000, T ROY SOC TROP MED H, V94, P103, DOI 10.1016/S0035-9203(00)90456-5; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700; Boudin C, 2004, PARASITE IMMUNOL, V26, P105, DOI 10.1111/j.0141-9838.2004.00689.x; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2011, INT J PARASITOL, V41, P293, DOI 10.1016/j.ijpara.2010.09.008; Buchholz K, 2011, J INFECT DIS, V203, P1445, DOI 10.1093/infdis/jir037; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Chardome M., 1952, Annales de la Societe Belge de Medecine Tropicale, V32, P209; Coulibaly MB, 1999, THESIS U BAMAKO MALI; Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diallo M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-248; Drakeley CJ, 1999, TROP MED INT HEALTH, V4, P131, DOI 10.1046/j.1365-3156.1999.00361.x; Drakeley CJ, 2004, PARASITE IMMUNOL, V26, P159, DOI 10.1111/j.0141-9838.2004.00696.x; Drakeley CJ, 2004, TROP MED INT HEALTH, V9, P53, DOI 10.1046/j.1365-3156.2003.01169.x; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; GAMAGEMENDIS AC, 1992, PARASITE IMMUNOL, V14, P385, DOI 10.1111/j.1365-3024.1992.tb00013.x; Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209; Gouagna LC, 2004, TROP MED INT HEALTH, V9, P937, DOI 10.1111/j.1365-3156.2004.01300.x; Gouagna LC, 2004, PARASITOLOGY, V128, P235, DOI 10.1017/S003118200300444X; Gouagna LC, 1999, THESIS U YAOUNDE CAM; GRAVES PM, 1988, PARASITOLOGY, V96, P251, DOI 10.1017/S003118200005825X; GRAVES PM, 1980, T ROY SOC TROP MED H, V74, P738, DOI 10.1016/0035-9203(80)90189-3; GRAVES PM, 1992, AM J TROP MED HYG, V46, P711, DOI 10.4269/ajtmh.1992.46.711; Hallett RL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010015; Harris C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030849; Hogh B, 1998, AM J TROP MED HYG, V58, P176, DOI 10.4269/ajtmh.1998.58.176; Joice RC, 2011, C AM SOC TROP MED HY; Kone A, 2010, INT J PARASITOL, V40, P1221, DOI 10.1016/j.ijpara.2010.05.004; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; *MALERA CONS GROUP, 2011, PLOS MED, V0008; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; MEIS JFGM, 1992, ACTA TROP, V50, P227, DOI 10.1016/0001-706X(92)90079-D; Mharakurwa S, 2011, P NATL ACAD SCI USA, V108, P18796, DOI 10.1073/pnas.1116162108; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Mitri C, 2009, P ROY SOC B-BIOL SCI, V276, P3721, DOI 10.1098/rspb.2009.0962; MULDER B, 1994, T ROY SOC TROP MED H, V88, P121, DOI 10.1016/0035-9203(94)90534-7; Mulder B, 1999, EXP PARASITOL, V92, P81, DOI 10.1006/expr.1999.4398; Mwangangi Joseph M., 2007, Journal of Vector Borne Diseases, V44, P44; Nacher M, 2004, MED HYPOTHESES, V62, P618, DOI 10.1016/j.mehy.2003.11.011; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Peatey CL, 2011, MOL BIOCHEM PARASIT, V180, P127, DOI 10.1016/j.molbiopara.2011.09.002; Pichon G, 2000, PARASITOLOGY, V121, P115, DOI 10.1017/S0031182099006277; Robert V, 1996, T ROY SOC TROP MED H, V90, P621, DOI 10.1016/S0035-9203(96)90408-3; Robert V, 2000, AM J TROP MED HYG, V62, P210, DOI 10.4269/ajtmh.2000.62.210; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Seufi AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-65; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Sutherland CJ, 2009, MOL BIOCHEM PARASIT, V166, P93, DOI 10.1016/j.molbiopara.2009.03.007; Tanaka TQ, 2011, MOL BIOCHEM PARASIT, V177, P160, DOI 10.1016/j.molbiopara.2011.02.005; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; TCHUINKAM T, 1993, TROP MED PARASITOL, V44, P271; Telang A, 2007, J EXP BIOL, V210, P854, DOI 10.1242/jeb.02715; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; van der Kolk M, 2006, INT J PARASITOL, V36, P1091, DOI 10.1016/j.ijpara.2006.05.004; World Health Organization, 2010, MALVAC 2010 SCI FOR	63	130	130	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42821	10.1371/journal.pone.0042821	http://dx.doi.org/10.1371/journal.pone.0042821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936993	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300026
J	Li, XN; He, YQ				Li, Xinna; He, Yongqun			Caspase-2-Dependent Dendritic Cell Death, Maturation, and Priming of T Cells in Response to Brucella abortus Infection	PLOS ONE			English	Article							IFN-GAMMA-PRODUCTION; ANTIGEN PRESENTATION; CYTOKINE PRODUCTION; INTERFERON-GAMMA; ROUGH MUTANTS; IN-VIVO; IMMUNE; APOPTOSIS; SUIS; ACTIVATION	Smooth virulent Brucella abortus strain 2308 (S2308) causes zoonotic brucellosis in cattle and humans. Rough B. abortus strain RB51, derived from S2308, is a live attenuated cattle vaccine strain licensed in the USA and many other countries. Our previous report indicated that RB51, but not S2308, induces a caspase-2-dependent apoptotic and necrotic macrophage cell death. Dendritic cells (DCs) are professional antigen presenting cells critical for bridging innate and adaptive immune responses. In contrast to Brucella-infected macrophages, here we report that S2308 induced higher levels of apoptotic and necrotic cell death in wild type bone marrow-derived DCs (WT BMDCs) than RB51. The RB51 and S2308-induced BMDC cell death was regulated by caspase-2, indicated by the minimal cell death in RB51 and S2308-infected BMDCs isolated from caspase-2 knockout mice (Casp2KO BMDCs). More S2308 bacteria were taken up by Casp2KO BMDCs than wild type BMDCs. Higher levels of S2308 and RB51 cells were found in infected Casp2KO BMDCs compared to infected WT BMDCs at different time points. RB51-infected wild type BMDCs were mature and activated as shown by significantly up-regulated expression of CD40, CD80, CD86, MHC-I, and MHC-II. RB51 induced the production of cytokines TNF-alpha, IL-6, IFN-gamma and IL12/IL23p40 in infected BMDCs. RB51-infected WT BMDCs also stimulated the proliferation of CD4(+) and CD8(+) T cells compared to uninfected WT BMDCs. However, the maturation, activation, and cytokine secretion are significantly impaired in Casp2KO BMDCs infected with RB51 or Salmonella (control). S2308-infected WT and Casp2KO BMDCs were not activated and could not induce cytokine production. These results demonstrated that virulent smooth strain S2308 induced more apoptotic and necrotic dendritic cell death than live attenuated rough vaccine strain RB51; however, RB51, but not its parent strain S2308, induced caspase-2-mediated DC maturation, cytokine production, antigen presentation, and T cell priming.	[Li, Xinna; He, Yongqun] Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA; [Li, Xinna; He, Yongqun] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Li, XN (corresponding author), Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.	yongqunh@umich.edu		He, Yongqun/0000-0001-9189-9661	Endowment for Basic Science (EBS) bridging fund from the University of Michigan	Endowment for Basic Science (EBS) bridging fund from the University of Michigan	These studies were supported by an Endowment for Basic Science (EBS) bridging fund from the University of Michigan to Y.H. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Banchereau J, 2001, CANCER RES, V61, P6451; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bergner PM, 2006, J IMMUNOL, V176, P2366, DOI 10.4049/jimmunol.176.4.2366; Billard E, 2005, INFECT IMMUN, V73, P8418, DOI 10.1128/IAI.73.12.8418-8424.2005; Billard E, 2008, FEMS IMMUNOL MED MIC, V53, P404, DOI 10.1111/j.1574-695X.2008.00441.x; Billard E, 2007, INFECT IMMUN, V75, P5916, DOI 10.1128/IAI.00931-07; Billard E, 2007, INFECT IMMUN, V75, P4980, DOI 10.1128/IAI.00637-07; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Cao SB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-39; Chase AJ, 2011, J INFECT DIS, V203, P1763, DOI 10.1093/infdis/jir197; Chen F, 2011, INFECT IMMUN, V79, P2460, DOI 10.1128/IAI.00050-11; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; DEBAGUES MPJ, 1994, INFECT IMMUN, V62, P4990; Erfurth SE, 2004, INFECT IMMUN, V72, P7045, DOI 10.1128/IAI.72.12.7045-7054.2004; Fleeton MN, 2004, J EXP MED, V200, P235, DOI 10.1084/jem.20041132; Fong L, 2000, ANNU REV IMMUNOL, V18, P245, DOI 10.1146/annurev.immunol.18.1.245; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Haspot F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034795; He YQ, 2001, INFECT IMMUN, V69, P5502, DOI 10.1128/IAI.69.9.5502-5508.2001; Hort GM, 2003, MICROBES INFECT, V5, P95, DOI 10.1016/S1286-4579(02)00076-X; Huang LY, 2001, J IMMUNOL, V167, P1423, DOI 10.4049/jimmunol.167.3.1423; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Kalupahana R, 2003, INFECT IMMUN, V71, P6132, DOI 10.1128/IAI.71.11.6132-6140.2003; Ko J, 2002, J IMMUNOL, V168, P2433, DOI 10.4049/jimmunol.168.5.2433; Krumschnabel G, 2009, ONCOGENE, V28, P3093, DOI 10.1038/onc.2009.173; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Langhorne J, 2004, IMMUNOL REV, V201, P35, DOI 10.1111/j.0105-2896.2004.00182.x; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Loof TG, 2008, INFECT IMMUN, V76, P2785, DOI 10.1128/IAI.01680-07; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Nogueira CV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000478; Paranavitana C, 2005, CYTOKINE, V30, P86, DOI 10.1016/j.cyto.2004.12.009; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Ritter U, 2003, J LEUKOCYTE BIOL, V74, P216, DOI 10.1189/jlb.1202587; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; SantiagoSchwarz F, 1996, STEM CELLS, V14, P225, DOI 10.1002/stem.140225; SCHURIG GG, 1991, VET MICROBIOL, V28, P171, DOI 10.1016/0378-1135(91)90091-S; Schuurhuis DH, 2006, INT ARCH ALLERGY IMM, V140, P53, DOI 10.1159/000092002; Surendran N, 2010, FEMS IMMUNOL MED MIC, V60, P147, DOI 10.1111/j.1574-695X.2010.00729.x; Tam MA, 2008, IMMUNOL REV, V225, P140, DOI 10.1111/j.1600-065X.2008.00679.x; Troy CM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.138pe42; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Zhang XN, 2005, INT J CANCER, V113, P397, DOI 10.1002/ijc.20553; Zhu JG, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00010; Zwerdling A, 2008, MICROBES INFECT, V10, P1346, DOI 10.1016/j.micinf.2008.07.035	55	22	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43512	10.1371/journal.pone.0043512	http://dx.doi.org/10.1371/journal.pone.0043512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927979	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300059
J	Yu, HR; Watt, H; Kesavan, C; Johnson, PJ; Wergedal, JE; Mohan, S				Yu, Hongrun; Watt, Heather; Kesavan, Chandrasekhar; Johnson, Patrick J.; Wergedal, Jon E.; Mohan, Subburaman			Lasting Consequences of Traumatic Events on Behavioral and Skeletal Parameters in a Mouse Model for Post-Traumatic Stress Disorder (PTSD)	PLOS ONE			English	Article							BONE-MINERAL DENSITY; PARTIAL INVERSE AGONIST; FELINE PREDATOR STRESS; GULF-WAR VETERANS; MICE; RECEPTOR; HORMONE; ANXIETY; FG-7142; GROWTH	Background: Post-traumatic stress disorder (PTSD) is an anxiety disorder that not only affects mental health, but may also affect bone health. However, there have been no studies to examine the direct relationship between PTSD and bone. Methodology/Principal Findings: We employed electric shocks in mice to simulate traumatic events that cause PTSD. We also injected the anxiogenic drug FG-7142 prior to electric shocks. Electric shocks created lasting conditioned fear memory in all mice. In young mice, electric shocks elicited not only behavioral response but also skeletal response, and injection of FG-7142 appeared to increase both types of response. For example in behavioral response within the first week, mice shocked alone froze an average of 6.2 sec in 10 sec tests, and mice injected with FG-7142 froze 7.6 sec, both significantly different (P<0.05) from control mice, which only froze 1.3 sec. In skeletal response at week 2, shocks alone reduced 6% bone mineral content (BMC) in total body (P = 0.06), while shocks with FG-7142 injection reduced not only 11% BMC (P<0.05) but also 6% bone mineral density (BMD) (P<0.05). In addition, FG-7142 injection also caused significant reductions of BMC in specific bones such as femur, lumbar vertebra, and tibia at week 3. Strong negative correlations (R-2 = -0.56, P<0.05) and regression (y = 0.2527-0.0037 * x, P<0.01) between freezing behavior and total body BMC in young mice indicated that increased contextual PTSD-like behavior was associated with reduced bone mass acquisition. Conclusions/Significance: This is the first study to document evidence that traumatic events induce lasting consequences on both behavior and skeletal growth, and electric shocks coupled with injection of anxiogenic FG-7142 in young mice can be used as a model to study the effect of PTSD-like symptoms on bone development.	[Yu, Hongrun; Watt, Heather; Kesavan, Chandrasekhar; Johnson, Patrick J.; Wergedal, Jon E.; Mohan, Subburaman] Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA; [Yu, Hongrun; Kesavan, Chandrasekhar; Wergedal, Jon E.; Mohan, Subburaman] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA	Loma Linda University	Yu, HR (corresponding author), Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA.	subburaman.mohan@va.gov			Merit Review Program of the Department of Veterans Affairs	Merit Review Program of the Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Merit Review Program of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 2004, PHYSIOL BEHAV, V83, P401, DOI 10.1016/j.physbeh.2004.08.029; Adamec R, 2006, PHYSIOL BEHAV, V88, P12, DOI 10.1016/j.physbeh.2006.03.005; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Canalis Ernesto, 2005, Curr Osteoporos Rep, V3, P98, DOI 10.1007/s11914-005-0017-7; Chaki S, 2003, EUR J PHARMACOL, V464, P49, DOI 10.1016/S0014-2999(03)01368-2; Chida Y, 2004, HEPATOLOGY, V39, P1131, DOI 10.1002/hep.20158; Cizza G, 2001, TRENDS ENDOCRIN MET, V12, P198, DOI 10.1016/S1043-2760(01)00407-6; Compston JE, 2002, J CLIN PATHOL, V55, P897, DOI 10.1136/jcp.55.12.897; Dorn LD, 2008, ARCH PEDIAT ADOL MED, V162, P1181, DOI 10.1001/archpedi.162.12.1181; DOROW R, 1983, LANCET, V2, P98; Evans AK, 2007, CNS DRUG REV, V13, P475, DOI 10.1111/j.1527-3458.2007.00025.x; Freemont AJ, 2002, J CLIN PATHOL, V55, P884, DOI 10.1136/jcp.55.12.884; Golier JA, 2007, BIOL PSYCHIAT, V62, P1175, DOI 10.1016/j.biopsych.2007.04.027; Golub Y, 2009, BEHAV BRAIN RES, V205, P544, DOI 10.1016/j.bbr.2009.08.019; Hage WE, 2004, PROG NEURO-PSYCHOPH, V28, P123, DOI 10.1016/j.pnpbp.2003.09.028; Hain RE, 2011, MIL MED, V176, P270, DOI 10.7205/MILMED-D-10-00365; Hammack SE, 2004, BEHAV NEUROSCI, V118, P443, DOI 10.1037/0735-7044.118.2.443; Hebert MA, 2005, J NEUROCHEM, V95, P484, DOI 10.1111/j.1471-4159.2005.03386.x; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; King JA, 2001, BIOL PSYCHIAT, V50, P231, DOI 10.1016/S0006-3223(01)01071-X; Kuljic Blagoje, 2004, Vojnosanit Pregl, V61, P283, DOI 10.2298/VSP0403283K; Kung JC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-29; Laugero KD, 2000, AM J PHYSIOL-ENDOC M, V279, pE44, DOI 10.1152/ajpendo.2000.279.1.E44; LITTLE HJ, 1984, BRIT J PHARMACOL, V83, P951, DOI 10.1111/j.1476-5381.1984.tb16536.x; Louvart N, 2005, PSYCHONEUROENDOCRINO, V30, P316, DOI 10.1016/j.psyneuen.2004.09.003; Ma Y, 2011, ENDOCRINOLOGY, V152, P1412, DOI 10.1210/en.2010-0881; Masinde GL, 2002, CALCIFIED TISSUE INT, V71, P421, DOI 10.1007/s00223-001-1113-z; Mazziotti G, 2006, TRENDS ENDOCRIN MET, V17, P144, DOI 10.1016/j.tem.2006.03.009; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Mirza NR, 2006, J PHARMACOL EXP THER, V316, P1378, DOI 10.1124/jpet.105.094474; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Mohan S, 2005, J ENDOCRINOL, V185, P415, DOI 10.1677/joe.1.06141; Morris P, 2004, PSYCHONEUROENDOCRINO, V29, P269, DOI 10.1016/S0306-4530(03)00027-1; Olson VG, 2011, BIOL PSYCHIAT; Papadopoulos A, 2011, EUR NEUROPSYCHOPHARM, V21, P316, DOI 10.1016/j.euroneuro.2010.05.005; Patel MS, 2007, CALCIFIED TISSUE INT, V80, P337, DOI 10.1007/s00223-007-9015-3; Patterson-Buckendahl P, 2007, STRESS, V10, P163, DOI 10.1080/10253890701317601; Philbert J, 2011, BEHAV BRAIN RES, V221, P149, DOI 10.1016/j.bbr.2011.02.039; Pibiri F, 2008, P NATL ACAD SCI USA, V105, P5567, DOI 10.1073/pnas.0801853105; Rasmussen DD, 2008, PSYCHONEUROENDOCRINO, V33, P282, DOI 10.1016/j.psyneuen.2007.11.010; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Rigo JM, 2002, BRIT J PHARMACOL, V136, P659, DOI 10.1038/sj.bjp.0704766; Sartori SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016849; Sawamura T, 2004, NEUROSCI LETT, V357, P37, DOI 10.1016/j.neulet.2003.12.039; Schwab CL, 2005, TOXICOL SCI, V83, P101, DOI 10.1093/toxsci/kfi014; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Srivastava AK, 2003, BONE, V33, P179, DOI 10.1016/S8756-3282(03)00156-X; Stevenson CW, 2007, SYNAPSE, V61, P646, DOI 10.1002/syn.20414; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Wang W, 2008, NEUROSCI LETT, V441, P237, DOI 10.1016/j.neulet.2008.06.031; Williams LJ, 2011, J AFFECT DISORDERS, V131, P164, DOI 10.1016/j.jad.2010.11.019; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yirmiya R, 2006, P NATL ACAD SCI USA, V103, P16876, DOI 10.1073/pnas.0604234103; Young EA, 2004, ARCH GEN PSYCHIAT, V61, P394, DOI 10.1001/archpsyc.61.4.394; Zhang L, 2006, MED HYPOTHESES, V66, P309, DOI 10.1016/j.mehy.2005.06.034; Zhang XM, 2005, TOHOKU J EXP MED, V206, P203, DOI 10.1620/tjem.206.203	60	13	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42684	10.1371/journal.pone.0042684	http://dx.doi.org/10.1371/journal.pone.0042684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927935	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300022
J	Correnti, C; Richardson, V; Sia, AK; Bandaranayake, AD; Ruiz, M; Rahmanto, YS; Kovacevic, Z; Clifton, MC; Holmes, MA; Kaiser, BK; Barasch, J; Raymond, KN; Richardson, DR; Strong, RK				Correnti, Colin; Richardson, Vera; Sia, Allyson K.; Bandaranayake, Ashok D.; Ruiz, Mario; Rahmanto, Yohan Suryo; Kovacevic, Zaklina; Clifton, Matthew C.; Holmes, Margaret A.; Kaiser, Brett K.; Barasch, Jonathan; Raymond, Kenneth N.; Richardson, Des R.; Strong, Roland K.			Siderocalin/Lcn2/NGAL/24p3 Does Not Drive Apoptosis Through Gentisic Acid Mediated Iron Withdrawal in Hematopoietic Cell Lines	PLOS ONE			English	Article							EFFECTIVE ANTIPROLIFERATIVE AGENTS; ISONICOTINOYL HYDRAZONE CLASS; METASTASIS SUPPRESSOR; MOLECULAR TARGETS; GENE-EXPRESSION; IMMUNE-SYSTEM; ENTEROBACTIN; TRANSFERRIN; METABOLISM; IDENTIFICATION	Siderocalin (also lipocalin 2, NGAL or 24p3) binds iron as complexes with specific siderophores, which are low molecular weight, ferric ion-specific chelators. In innate immunity, siderocalin slows the growth of infecting bacteria by sequestering bacterial ferric siderophores. Siderocalin also binds simple catechols, which can serve as siderophores in the damaged urinary tract. Siderocalin has also been proposed to alter cellular iron trafficking, for instance, driving apoptosis through iron efflux via BOCT. An endogenous siderophore composed of gentisic acid (2,5-dihydroxybenzoic acid) substituents was proposed to mediate cellular efflux. However, binding studies reported herein contradict the proposal that gentisic acid forms high-affinity ternary complexes with siderocalin and iron, or that gentisic acid can serve as an endogenous siderophore at neutral pH. We also demonstrate that siderocalin does not induce cellular iron efflux or stimulate apoptosis, questioning the role siderocalin plays in modulating iron metabolism.	[Correnti, Colin; Holmes, Margaret A.; Kaiser, Brett K.; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Richardson, Vera; Rahmanto, Yohan Suryo; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Iron Metab & Chelat Program, Discipline Pathol, Sydney, NSW 2006, Australia; [Richardson, Vera; Rahmanto, Yohan Suryo; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Sia, Allyson K.; Raymond, Kenneth N.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bandaranayake, Ashok D.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Ruiz, Mario] Univ Valladolid, Inst Biol & Genet Mol, UVa CSIC, Valladolid, Spain; [Clifton, Matthew C.] Emerald Biostruct, Bainbridge Isl, WA USA; [Barasch, Jonathan] Columbia Univ, Coll Phys & Surg, New York, NY USA	Fred Hutchinson Cancer Center; University of Sydney; University of Sydney; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Columbia University	Correnti, C (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	d.richardson@sydney.edu.au; rstrong@fhcrc.org	Ruiz, Mario/B-3507-2013; Suryo Rahmanto, Yohan/K-8043-2018; Kovacevic, Zaklina/ABD-9581-2021	Ruiz, Mario/0000-0002-7149-6600; Suryo Rahmanto, Yohan/0000-0003-1453-7872; Kovacevic, Zaklina/0000-0002-4742-4690; Richardson, Des/0000-0002-5506-3274; Richardson, Des/0000-0003-0960-6415	National Institutes of Health [AI117448, AI59432, DK55388, DK58872]; National Institute of Allergy and Infectious Disease Federal Contract [HHSN272200700057C]; Emerald Foundation; March of Dimes; National Health and Medical Research Council of Australia [571123, 512408]; Cancer Institute New South Wales Early Career Development Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059432, R01AI011744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055388, R01DK058872, R01DK073462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease Federal Contract; Emerald Foundation; March of Dimes(March of Dimes); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Early Career Development Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health grants AI117448 (Dr. Raymond), AI59432 (Dr. Strong), DK55388 and DK58872 (Dr. Barasch), and National Institute of Allergy and Infectious Disease Federal Contract No. HHSN272200700057C (SSGCID); the Emerald Foundation and the March of Dimes (Dr. Barasch); National Health and Medical Research Council of Australia Senior Principal Research Fellowship 571123 and Project grant 512408 (Dr. Richardson); and a Cancer Institute New South Wales Early Career Development Fellowship (Dr. Rahmanto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Baes C.F., 1976, HYDROLYSIS CATIONS, DOI 10.1002/bbpc.19770810252; Bandaranayake AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr706; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bennett KM, 2011, MOL CELL BIOCHEM, V352, P143, DOI 10.1007/s11010-011-0748-y; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; BUNDGAARD JR, 1994, BIOCHEM BIOPH RES CO, V202, P1468, DOI 10.1006/bbrc.1994.2096; CASS ME, 1989, J AM CHEM SOC, V111, P1677, DOI 10.1021/ja00187a021; Cohen SM, 1998, J AM CHEM SOC, V120, P6277, DOI 10.1021/ja973442s; Darnell G, 1999, BLOOD, V94, P781, DOI 10.1182/blood.V94.2.781.414k32_781_792; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Fischbach MA, 2006, P NATL ACAD SCI US; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FORD S, 1988, EUR J BIOCHEM, V178, P477, DOI 10.1111/j.1432-1033.1988.tb14473.x; Gans P, 1996, TALANTA, V43, P1739, DOI 10.1016/0039-9140(96)01958-3; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hoette TM, 2008, J AM CHEM SOC, V130, P17584, DOI 10.1021/ja8074665; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; KAPLAN J, 1991, J BIOL CHEM, V266, P2997; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; KHANOLKAR VD, 1973, INDIAN J CHEM, V11, P286; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; MOORE CH, 1995, J BACTERIOL, V177, P1116, DOI 10.1128/jb.177.4.1116-1118.1995; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; Rahmanto YS, 2007, CARCINOGENESIS, V28, P2172, DOI 10.1093/carcin/bgm096; RAYMOND KN, 1984, TOP CURR CHEM, V123, P49; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Rouault T, 1997, CURR TOP CELL REGUL, V35, P1, DOI 10.1016/S0070-2137(97)80001-5; SAKAITANI M, 1990, BIOCHEMISTRY-US, V29, P6789, DOI 10.1021/bi00481a006; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STURROCK A, 1990, J BIOL CHEM, V265, P3139; Welcher FJ., 1958, ANAL USES ETHYLENEDI; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	51	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43696	10.1371/journal.pone.0043696	http://dx.doi.org/10.1371/journal.pone.0043696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928018	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700046
J	van Dijk, AE; van Eijsden, M; Stronks, K; Gemke, RJBJ; Vrijkotte, TGM				van Dijk, Aimeee E.; van Eijsden, Manon; Stronks, Karien; Gemke, Reinoud J. B. J.; Vrijkotte, Tanja G. M.			The Association between Prenatal Psychosocial Stress and Blood Pressure in the Child at Age 5-7 Years	PLOS ONE			English	Article							CYTOKINE PRODUCTION; MATERNAL CORTISOL; BIRTH-WEIGHT; HPA AXIS; FETAL; DEXAMETHASONE; RISK; HYPERTENSION; PREGNANCY; EXPOSURE	Objective: Prenatal maternal stress could have permanent effects on the offspring's tissue structure and function, which may predispose to cardiovascular diseases. We investigated whether maternal psychosocial stress is a prenatal factor affecting the blood pressure (BP) of offspring. Study Design: In the Amsterdam Born Children and their Development (ABCD) study, around gestational week 16, depressive symptoms, state-anxiety, pregnancy-related anxiety, parenting daily hassles and job strain were recorded by questionnaire. A cumulative stress score was also calculated (based on 80th percentiles). Systolic and diastolic BP and mean arterial pressure (MAP) were measured in the offspring at age 5-7 years. Inclusion criteria were: no use of antihypertensive medication during pregnancy; singleton birth; no reported cardiovascular problems in the child (N = 2968 included). Results: After adjustment for confounders, the single stress scales were not associated with systolic and diastolic BP, MAP and hypertension (p>0.05). The presence of 3-4 psychosocial stressors prenatally (4%) was associated with 1.5 mmHg higher systolic and diastolic BP (p = 0.046; p = 0.04) and 1.5 mmHg higher MAP in the offspring (p = 0.02) compared to no stressors (46%). The presence of 3-4 stressors did not significantly increase the risk for hypertension (OR 1.8; 95% CI 0.93.4). Associations did not differ between sexes. Bonferroni correction for multiple testing rendered all associations non-significant. Conclusion: The presence of multiple psychosocial stressors during pregnancy was associated with higher systolic and diastolic BP and MAP in the child at age 5-7. Further investigation of maternal prenatal stress may be valuable for later life cardiovascular health.	[van Dijk, Aimeee E.; Stronks, Karien; Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [van Dijk, Aimeee E.; van Eijsden, Manon] Publ Hlth Serv Amsterdam GGD, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands; [van Eijsden, Manon] Vrije Univ Amsterdam, Inst Hlth Sci, Amsterdam, Netherlands; [Gemke, Reinoud J. B. J.] Vrije Univ Amsterdam Med Ctr, Dept Pediat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Dijk, AE (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.e.vandijk@amc.uva.nl		Vrijkotte, Tanja/0000-0003-3641-4048; Stronks, Karien/0000-0002-0921-2232	Netherlands Heart Foundation	Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by the Netherlands Heart Foundation (Nederlandse Hartstichting). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HR, 2010, PEDIATRICS, V126, pE1425, DOI 10.1542/peds.2010-1899; [Anonymous], 1987, CES D NEDERLANDSE VE; BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bekedam DJ, 2002, AM J OBSTET GYNECOL, V187, P1605, DOI 10.1067/mob.2002.127379; Berry LM, 1997, AM J PHYSIOL-REG I, V272, pR1972, DOI 10.1152/ajpregu.1997.272.6.R1972; Breslin MB, 1998, J STEROID BIOCHEM, V67, P369, DOI 10.1016/S0960-0760(98)00138-1; Bruckner TA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-273; Rondo PHC, 2010, EARLY HUM DEV, V86, P127, DOI 10.1016/j.earlhumdev.2010.02.002; Christian LM, 2009, BRAIN BEHAV IMMUN, V23, P750, DOI 10.1016/j.bbi.2009.02.012; Clifton VL, 2004, PLACENTA, V25, pS45, DOI 10.1016/j.placenta.2004.01.004; Cohen G, 2008, CIRCULATION, V118, P1848, DOI 10.1161/CIRCULATIONAHA.108.783902; Coussons-Read ME, 2007, BRAIN BEHAV IMMUN, V21, P343, DOI 10.1016/j.bbi.2006.08.006; Coussons-Read ME, 2005, PSYCHOSOM MED, V67, P625, DOI 10.1097/01.psy.0000170331.74960.ad; CRNIC KA, 1990, CHILD DEV, V61, P1628, DOI 10.2307/1130770; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; de Vries A, 2007, J CLIN INVEST, V117, P1058, DOI 10.1172/JCI30982; Defares P, 1980, PSYCHOLOOG, V15, P460; Diego MA, 2006, PSYCHOSOM MED, V68, P747, DOI 10.1097/01.psy.0000238212.21598.7b; Docherty CC, 2001, AM J PHYSIOL-REG I, V281, pR261, DOI 10.1152/ajpregu.2001.281.1.R261; Dodic M, 2001, CLIN EXP PHARMACOL P, V28, P952, DOI 10.1046/j.1440-1681.2001.03556.x; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Doyle LW, 2000, CLIN SCI, V98, P137, DOI 10.1042/CS19990211; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Entringer S, 2008, DEV PSYCHOBIOL, V50, P579, DOI 10.1002/dev.20316; Entringer S, 2011, PSYCHOSOM MED, V73, P469, DOI 10.1097/PSY.0b013e31821fbf9a; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; GILLMAN MW, 1993, J PEDIATR-US, V122, P837, DOI 10.1016/S0022-3476(09)90005-1; Glover V, 2010, NEUROSCI BIOBEHAV R, V35, P17, DOI 10.1016/j.neubiorev.2009.11.008; Glover V, 2009, PSYCHONEUROENDOCRINO, V34, P430, DOI 10.1016/j.psyneuen.2008.10.005; Gluckman PD, 2005, FETAL MATRIX EVOLUTI, P78; Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066; Goedhart G, 2010, PSYCHOSOM MED, V72, P769, DOI 10.1097/PSY.0b013e3181ee4a62; Groenendaal JH, 1996, DAGELIJKSE BESLOMMER; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Himes KP, 2011, AM J PERINAT, V28, P443, DOI 10.1055/s-0030-1270119; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Holst S, 2002, AUTON NEUROSCI-BASIC, V99, P85, DOI 10.1016/S1566-0702(02)00134-0; Houtman ILD, 1998, OCCUP ENVIRON MED, V55, P73, DOI 10.1136/oem.55.2.73; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; KARI MA, 1994, PEDIATRICS, V93, P730; Levitt NS, 1996, NEUROENDOCRINOLOGY, V64, P412, DOI 10.1159/000127146; LOBEL M, 1994, J BEHAV MED, V17, P225, DOI 10.1007/BF01857952; Lu NZ, 2004, ANN NY ACAD SCI, V1024, P102, DOI 10.1196/annals.1321.008; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; MCCORMICK CM, 1995, DEV BRAIN RES, V84, P55, DOI 10.1016/0165-3806(94)00153-Q; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Menghetti E, 1999, J HYPERTENS, V17, P1363, DOI 10.1097/00004872-199917100-00002; Miller DB, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.33184; Molnar J, 2003, J PHYSIOL-LONDON, V547, P61, DOI 10.1113/jphysiol.2002.032565; Molnar J, 2002, AM J PHYSIOL-REG I, V283, pR561, DOI 10.1152/ajpregu.00031.2002; Moritz KM, 2010, PLACENTA, V31, pS40, DOI 10.1016/j.placenta.2010.01.006; Moritz KM, 2002, ENDOCRINOLOGY, V143, P4455, DOI 10.1210/en.2002-220534; Moss TJM, 2001, AM J PHYSIOL-REG I, V281, pR960, DOI 10.1152/ajpregu.2001.281.3.R960; Munkhaugen J, 2008, J HYPERTENS, V26, P1912, DOI 10.1097/HJH.0b013e328308da43; Noorlander CW, 2006, J COMP NEUROL, V499, P924, DOI 10.1002/cne.21162; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; OConnor T., 2011, PSYCHONEUROENDOCRINO; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; Owen D, 2003, ENDOCRINOLOGY, V144, P2775, DOI 10.1210/en.2002-0145; Park MK, 2001, ARCH PEDIAT ADOL MED, V155, P50, DOI 10.1001/archpedi.155.1.50; Paul K, 2008, J NATL MED ASSOC, V100, P540, DOI 10.1016/S0027-9684(15)31300-6; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reynolds RM, 2001, J CLIN ENDOCR METAB, V86, P245, DOI 10.1210/jc.86.1.245; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; Rondo PHC, 2011, J DEV ORIG HLTH DIS, V2, P56, DOI 10.1017/S2040174410000620; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Spielberger C., 1983, STAI MANUAL; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Tse AC, 2011, PSYCHONEUROENDOCRINO; Van Den Bergh BRH., 1990, PREPERINAT PSYCHOL J, V5, P119; van Dijk AE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-251; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Wadhwa PD., 2006, PERINATAL PROGRAMMIN, P29; Wintour EM, 2003, J PHYSIOL-LONDON, V549, P929, DOI 10.1113/jphysiol.2003.042408; Woods SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.041	83	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43548	10.1371/journal.pone.0043548	http://dx.doi.org/10.1371/journal.pone.0043548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22927987	gold, Green Submitted, Green Published			2022-12-27	WOS:000307789700038
J	Vogler, C; Benzie, J; Barber, PH; Erdmann, MV; Ambariyanto; Sheppard, C; Tenggardjaja, K; Gerard, K; Worheide, G				Vogler, Catherine; Benzie, John; Barber, Paul H.; Erdmann, Mark V.; Ambariyanto; Sheppard, Charles; Tenggardjaja, Kimberly; Gerard, Karin; Woerheide, Gert			Phylogeography of the Crown-of-Thorns Starfish in the Indian Ocean	PLOS ONE			English	Article							ACANTHASTER-PLANCI L.; CORAL-REEFS; POPULATION-GENETICS; SPECIES BOUNDARIES; SEQUENCE ALIGNMENT; CIRCULATION; OUTBREAKS; MODEL; BIOGEOGRAPHY; SPECIATION	Background: Understanding the limits and population dynamics of closely related sibling species in the marine realm is particularly relevant in organisms that require management. The crown-of-thorns starfish Acanthaster planci, recently shown to be a species complex of at least four closely related species, is a coral predator infamous for its outbreaks that have devastated reefs throughout much of its Indo-Pacific distribution. Methodology/Principal Findings: In this first Indian Ocean-wide genetic study of a marine organism we investigated the genetic structure and inferred the paleohistory of the two Indian Ocean sister-species of Acanthaster planci using mitochondrial DNA sequence analyses. We suggest that the first of two main diversification events led to the formation of a Southern and Northern Indian Ocean sister-species in the late Pliocene-early Pleistocene. The second led to the formation of two internal clades within each species around the onset of the last interglacial. The subsequent demographic history of the two lineages strongly differed, the Southern Indian Ocean sister-species showing a signature of recent population expansion and hardly any regional structure, whereas the Northern Indian Ocean sister-species apparently maintained a constant size with highly differentiated regional groupings that were asymmetrically connected by gene flow. Conclusions/Significance: Past and present surface circulation patterns in conjunction with ocean primary productivity were identified as the processes most likely to have shaped the genetic structure between and within the two Indian Ocean lineages. This knowledge will help to understand the biological or ecological differences of the two sibling species and therefore aid in developing strategies to manage population outbreaks of this coral predator in the Indian Ocean.	[Vogler, Catherine; Woerheide, Gert] Univ Munich, Dept Geo & Umweltwissensch, Munich, Germany; [Vogler, Catherine; Woerheide, Gert] Univ Munich, GeoBioctr LMU, Munich, Germany; [Benzie, John] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Barber, Paul H.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Erdmann, Mark V.] Indonesia Marine Program, Conservat Int, Bali, Indonesia; [Ambariyanto] Diponegoro Univ, Fac Fisheries & Marine Sci, Semarang, Indonesia; [Sheppard, Charles] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Tenggardjaja, Kimberly] Univ Calif Santa Cruz, Ecol & Evolutionary Biol Dept, Santa Cruz, CA 95064 USA; [Gerard, Karin] Univ Mediterranee, Marine Endoume Stn, Marseille, France; [Woerheide, Gert] Bavarian State Collect Palaeontol & Geol, Munich, Germany	University of Munich; University of Munich; University College Cork; University of California System; University of California Los Angeles; Conservation International - Indonesia; Diponegoro University; University of Warwick; University of California System; University of California Santa Cruz; UDICE-French Research Universities; Aix-Marseille Universite	Vogler, C (corresponding author), Univ Munich, Dept Geo & Umweltwissensch, Munich, Germany.	woerheide@lmu.de	Gerard, Karin/H-6245-2014; Wörheide, Gert/C-1080-2008; Gérard, Karin/AAC-4911-2021; Ambariyanto, Ambariyanto/GQY-4999-2022; Benzie, John A.H./L-6208-2018	Wörheide, Gert/0000-0002-6380-7421; Gérard, Karin/0000-0003-0596-1348; Benzie, John/0000-0001-9599-8683; sheppard, charles/0000-0002-2579-5124	Indonesian government [1187/SU/KS/2006, 04239/SU.3/KS/2006]; Oman Ministry of Environment and Climate Affairs; EU [MEST-CT-2005-020561]; National Science Foundation (NSF) [OCE-0349177]; GIS LAGMAY and Service des Peches (Mayotte); Fujeirah Municipality (UAE)	Indonesian government(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Oman Ministry of Environment and Climate Affairs; EU(European Commission); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); GIS LAGMAY and Service des Peches (Mayotte); Fujeirah Municipality (UAE)	We acknowledge the Indonesian government for permits 1187/SU/KS/2006 and 04239/SU.3/KS/2006, as well as the Oman Ministry of Environment and Climate Affairs and the Fujeirah Municipality (UAE). For logistic and/or financial support, thanks to GIS LAGMAY and Service des Peches (Mayotte), to Five Oceans LLC (Oman) and CORDIO (Kenya). Support for Indonesian data collection came from the US National Science Foundation (Biological Oceanography, OCE-0349177). We also wish to thank Elisabeth Illidge-Evans, Gordon Kirkwood, Emre Turak, Sven Uthicke and Shakil Visram for providing samples, as well as all the institutions and individuals who supported the authors of this study during fieldwork. We thank Oliver Voigt for helpful comments on the manuscript.; This work was funded by the EU Marie-Curie Early Stage Research Training HOTSPOTS MEST-CT-2005-020561 and National Science Foundation (NSF) grant OCE-0349177. GIS LAGMAY and Service des Peches (Mayotte) gave financial support during field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PH, 2011, CRUSTACEAN ISS, V19, P129; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Benzie JAH, 1999, EVOLUTION, V53, P1782, DOI 10.1111/j.1558-5646.1999.tb04562.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Bonjean F, 2002, J PHYS OCEANOGR, V32, P2938, DOI 10.1175/1520-0485(2002)032<2938:DMAAOT>2.0.CO;2; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Celliers Louis, 2006, Western Indian Ocean Journal of Marine Science, V5, P105; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Fu YX, 1997, GENETICS, V147, P915; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gerard K, 2008, CR BIOL, V331, P137, DOI 10.1016/j.crvi.2007.11.005; Glynn Peter W., 1993, Atoll Research Bulletin, V379, P1; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Houk P, 2007, J OCEANOGR, V63, P149, DOI 10.1007/s10872-007-0013-x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; HUTSON WH, 1980, SCIENCE, V207, P64, DOI 10.1126/science.207.4426.64; Ivanova EV, 2009, GLOBAL THERMOHALINE PALEOCIRCULATION, P1, DOI 10.1007/978-90-481-2415-2; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; LUCAS JS, 1982, J EXP MAR BIOL ECOL, V65, P173, DOI 10.1016/0022-0981(82)90043-0; Lynch J.D., 1989, P527; Mendonca VM, 2010, ZOOL STUD, V49, P108; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Montaggioni LF, 2005, EARTH-SCI REV, V71, P1, DOI 10.1016/j.earscirev.2005.01.002; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Palumbi SR, 1996, J EXP MAR BIOL ECOL, V203, P75, DOI 10.1016/0022-0981(96)02571-3; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; POLLOCK DE, 1993, B MAR SCI, V53, P937; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Reid DG, 2006, J BIOGEOGR, V33, P990, DOI 10.1111/j.1365-2699.2006.01469.x; Ridgway Tyrone, 2005, Western Indian Ocean Journal of Marine Science, V4, P1; Rousset F, 1997, GENETICS, V145, P1219; Schleyer M, 2004, REEF ENCOUNTER, V23, P25; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schott FA, 2002, PROG OCEANOGR, V53, P57, DOI 10.1016/S0079-6611(02)00039-3; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sheppard Charles R.C., 2000, P3; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; VERON JEN, 1995, CORALS SPACE TIME BI; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; Wilkinson C.R., 2008, STATUS CORAL REEFS W; Winter A, 1990, PALEOCEANOGRAPHY, V5, P479, DOI 10.1029/PA005i004p00479; Yamaguchi M., 1973, P369; Yasuda N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-17; Yasuda N, 2009, MOL ECOL, V18, P1574, DOI 10.1111/j.1365-294X.2009.04133.x; Zann LP, 2000, CORAL REEFS INDIAN O, P59	67	43	43	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43499	10.1371/journal.pone.0043499	http://dx.doi.org/10.1371/journal.pone.0043499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927975	Green Submitted, Green Published, gold			2022-12-27	WOS:000307789700036
J	Bateman, RM; Ellis, CG; Suematsu, M; Walley, KR				Bateman, Ryon M.; Ellis, Christopher G.; Suematsu, Makoto; Walley, Keith R.			S-Nitrosoglutathione Acts as a Small Molecule Modulator of Human Fibrin Clot Architecture	PLOS ONE			English	Article							RED-BLOOD-CELLS; NITRIC-OXIDE; PLATELET ACTIVATION; FACTOR-XIII; BETA-CHAIN; PLASMA; NITROSOTHIOLS; NETWORKS; INHIBITION; GLUTATHIONE	Background: Altered fibrin clot architecture is increasingly associated with cardiovascular diseases; yet, little is known about how fibrin networks are affected by small molecules that alter fibrinogen structure. Based on previous evidence that S-nitrosoglutathione (GSNO) alters fibrinogen secondary structure and fibrin polymerization kinetics, we hypothesized that GSNO would alter fibrin microstructure. Methodology/Principal Findings: Accordingly, we treated human platelet-poor plasma with GSNO (0.01-3.75 mM) and imaged thrombin induced fibrin networks using multiphoton microscopy. Using custom designed computer software, we analyzed fibrin microstructure for changes in structural features including fiber density, diameter, branch point density, crossing fibers and void area. We report for the first time that GSNO dose-dependently decreased fibrin density until complete network inhibition was achieved. At low dose GSNO, fiber diameter increased 25%, maintaining clot void volume at approximately 70%. However, at high dose GSNO, abnormal irregularly shaped fibrin clusters with high fluorescence intensity cores were detected and clot void volume increased dramatically. Notwithstanding fibrin clusters, the clot remained stable, as fiber branching was insensitive to GSNO and there was no evidence of fiber motion within the network. Moreover, at the highest GSNO dose tested, we observed for the first time, that GSNO induced formation of fibrin agglomerates. Conclusions/Significance: Taken together, low dose GSNO modulated fibrin microstructure generating coarse fibrin networks with thicker fibers; however, higher doses of GSNO induced abnormal fibrin structures and fibrin agglomerates. Since GSNO maintained clot void volume, while altering fiber diameter it suggests that GSNO may modulate the remodeling or inhibition of fibrin networks over an optimal concentration range.	[Bateman, Ryon M.; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Bateman, Ryon M.; Walley, Keith R.] Univ British Columbia, Heart Lung Inst, Vancouver, BC V5Z 1M9, Canada; [Ellis, Christopher G.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada	Keio University; University of British Columbia; Western University (University of Western Ontario)	Bateman, RM (corresponding author), Keio Univ, Sch Med, Dept Biochem, Tokyo, Japan.	rbateman@z6.keio.jp	Ellis, Christopher G/AAV-2325-2020; Ellis, Christopher G/G-8649-2013; Suematsu, Makoto/O-5762-2018; Suematsu, Makoto/I-8135-2013	Ellis, Christopher G/0000-0002-7760-1846; Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336	Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research; MSFHR; Ministry of Education, Culture, Sports, Science and Technology, Japan, Global COE Program for Human Metabolomic Systems Biology	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); MSFHR(Michael Smith Foundation for Health Research); Ministry of Education, Culture, Sports, Science and Technology, Japan, Global COE Program for Human Metabolomic Systems Biology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Heart and Stroke Foundation of Canada (http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.BF8B/Home.htm) and Michael Smith Foundation for Health Research (http://www.msfhr.org/) Fellowships (R. M. B.), MSFHR Distinguished Scholar Award (K. R. W.), and the Ministry of Education, Culture, Sports, Science and Technology, Japan, Global COE Program for Human Metabolomic Systems Biology (M. S., M. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2008, BLOOD, V111, P643, DOI 10.1182/blood-2007-05-091231; Akhter S, 2002, P NATL ACAD SCI USA, V99, P9172, DOI 10.1073/pnas.142136499; Allen BW, 2009, TRENDS MOL MED, V15, P452, DOI 10.1016/j.molmed.2009.08.002; Ariens RAS, 2000, BLOOD, V96, P988, DOI 10.1182/blood.V96.3.988.015k57_988_995; BARADET TC, 1995, BIOPHYS J, V68, P1551, DOI 10.1016/S0006-3495(95)80327-9; Bateman RM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2822882; BLOMBACK B, 1989, BIOCHIM BIOPHYS ACTA, V997, P96, DOI 10.1016/0167-4838(89)90140-4; Bramanti E, 2010, TALANTA, V81, P1295, DOI 10.1016/j.talanta.2010.02.024; CARR ME, 1988, THROMB HAEMOSTASIS, V59, P535; Catani MV, 1998, BIOCHEM BIOPH RES CO, V249, P275, DOI 10.1006/bbrc.1998.9130; Chernysh IN, 2008, BLOOD, V111, P4854, DOI 10.1182/blood-2007-08-105247; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Cote HCF, 1998, BLOOD, V92, P2195, DOI 10.1182/blood.V92.7.2195.2195_2195_2212; Diesen DL, 2008, CIRC RES, V103, P545, DOI 10.1161/CIRCRESAHA.108.176867; FERRY JD, 1947, J AM CHEM SOC, V69, P388, DOI 10.1021/ja01194a066; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Geer CB, 2008, BIOMACROMOLECULES, V9, P1876, DOI 10.1021/bm800146j; Gersh KC, 2011, BLOOD, V117, P4964, DOI 10.1182/blood-2010-10-310409; Gkaliagkousi E, 2007, CIRC RES, V101, P654, DOI 10.1161/CIRCRESAHA.107.158410; Hogg N, 2000, FREE RADICAL BIO MED, V28, P1478, DOI 10.1016/S0891-5849(00)00248-3; LANGFORD EJ, 1994, LANCET, V344, P1458, DOI 10.1016/S0140-6736(94)90287-9; Langford EJ, 1996, ARTERIOSCL THROM VAS, V16, P51, DOI 10.1161/01.ATV.16.1.51; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Marchi RC, 2004, BLOOD COAGUL FIBRIN, V15, P559, DOI 10.1097/00001721-200410000-00005; MENDELSOHN ME, 1990, J BIOL CHEM, V265, P19028; Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/01.CIR.0000033221.73082.06; MOSESSON MW, 1989, P NATL ACAD SCI USA, V86, P1113, DOI 10.1073/pnas.86.4.1113; MOSESSON MW, 1993, BLOOD, V82, P1517; OKADA M, 1983, THROMB RES, V29, P269, DOI 10.1016/0049-3848(83)90039-7; Parastatidis I, 2008, J BIOL CHEM, V283, P33846, DOI 10.1074/jbc.M805522200; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x; Riba R, 2004, ATHEROSCLEROSIS, V175, P69, DOI 10.1016/j.atherosclerosis.2004.02.008; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Sakharov DV, 1996, J BIOL CHEM, V271, P2133, DOI 10.1074/jbc.271.4.2133; Scott DJA, 2011, ARTERIOSCL THROM VAS, V31, P3004, DOI 10.1161/ATVBAHA.111.236786; SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4; SHAH GA, 1987, THROMB RES, V45, P257, DOI 10.1016/0049-3848(87)90193-9; SIMON DI, 1993, ARTERIOSCLER THROMB, V13, P791, DOI 10.1161/01.ATV.13.6.791; Sorragi CD, 2011, CELL BIOCHEM FUNCT, V29, P207, DOI 10.1002/cbf.1738; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 2004, CIRC RES, V94, P414, DOI 10.1161/01.RES.0000122071.55721.BC; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Undas A, 2009, STROKE, V40, P1499, DOI 10.1161/STROKEAHA.108.532812; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	50	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43660	10.1371/journal.pone.0043660	http://dx.doi.org/10.1371/journal.pone.0043660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916291	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800089
J	Zhang, XF; Dai, DQ; Le, OY; Wu, MY				Zhang, Xiao-Fei; Dai, Dao-Qing; Le Ou-Yang; Wu, Meng-Yun			Exploring Overlapping Functional Units with Various Structure in Protein Interaction Networks	PLOS ONE			English	Article							BIOLOGICAL NETWORKS; SACCHAROMYCES-CEREVISIAE; COMPLEX PREDICTION; GENE ONTOLOGY; MODULES; ALGORITHMS; MODELS; GRAPH; IDENTIFICATION; ORGANIZATION	Revealing functional units in protein-protein interaction (PPI) networks are important for understanding cellular functional organization. Current algorithms for identifying functional units mainly focus on cohesive protein complexes which have more internal interactions than external interactions. Most of these approaches do not handle overlaps among complexes since they usually allow a protein to belong to only one complex. Moreover, recent studies have shown that other non-cohesive structural functional units beyond complexes also exist in PPI networks. Thus previous algorithms that just focus on non-overlapping cohesive complexes are not able to present the biological reality fully. Here, we develop a new regularized sparse random graph model (RSRGM) to explore overlapping and various structural functional units in PPI networks. RSRGM is principally dominated by two model parameters. One is used to define the functional units as groups of proteins that have similar patterns of connections to others, which allows RSRGM to detect non-cohesive structural functional units. The other one is used to represent the degree of proteins belonging to the units, which supports a protein belonging to more than one revealed unit. We also propose a regularizer to control the smoothness between the estimators of these two parameters. Experimental results on four S. cerevisiae PPI networks show that the performance of RSRGM on detecting cohesive complexes and overlapping complexes is superior to that of previous competing algorithms. Moreover, RSRGM has the ability to discover biological significant functional units besides complexes.	[Zhang, Xiao-Fei] Sun Yat Sen Univ, Ctr Comp Vis, Guangzhou 510275, Guangdong, Peoples R China; Sun Yat Sen Univ, Dept Math, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, XF (corresponding author), Sun Yat Sen Univ, Ctr Comp Vis, Guangzhou 510275, Guangdong, Peoples R China.	stsddq@mail.sysu.edu.cn			National Science Foundation of China [90920007, 11171354]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by National Science Foundation of China (90920007, 11171354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Ball B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036103; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Becker E, 2012, BIOINFORMATICS, V28, P84, DOI 10.1093/bioinformatics/btr621; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cho YR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-265; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Higham DJ, 2008, BIOINFORMATICS, V24, P1093, DOI 10.1093/bioinformatics/btn079; Jiang P, 2010, BIOINFORMATICS, V26, P1105, DOI 10.1093/bioinformatics/btq078; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Lee DD, 2001, ADV NEUR IN, V13, P556; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Luo F, 2007, BIOINFORMATICS, V23, P207, DOI 10.1093/bioinformatics/btl562; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Pinkert S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000659; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Ranola JMO, 2010, BIOINFORMATICS, V26, P2004, DOI 10.1093/bioinformatics/btq309; Rhrissorrakrai K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-192; Saul ZM, 2007, BIOINFORMATICS, V23, P2604, DOI 10.1093/bioinformatics/btm370; Schweiger R, 2011, BIOINFORMATICS, V27, pI142, DOI 10.1093/bioinformatics/btr201; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Xie ZP, 2011, BIOINFORMATICS, V27, pI159, DOI 10.1093/bioinformatics/btr212; Zhang XF, 2012, IEEE ACM T COMPUT BI, V9, P857, DOI 10.1109/TCBB.2012.20; Zhang XF, 2012, IEEE ACM T COMPUT BI, V9, P740, DOI 10.1109/TCBB.2011.148	45	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43092	10.1371/journal.pone.0043092	http://dx.doi.org/10.1371/journal.pone.0043092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916212	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800047
J	Dietmair, S; Hodson, MP; Quek, LE; Timmins, NE; Gray, P; Nielsen, LK				Dietmair, Stefanie; Hodson, Mark P.; Quek, Lake-Ee; Timmins, Nicholas E.; Gray, Peter; Nielsen, Lars K.			A Multi-Omics Analysis of Recombinant Protein Production in Hek293 Cells	PLOS ONE			English	Article							TRANSIENT GENE-EXPRESSION; HAMSTER OVARY CELLS; MAMMALIAN-CELLS; PYRUVATE-CARBOXYLASE; MOLECULE-BETA; CYTOSOLIC CHAPERONIN; EUKARYOTIC PREFOLDIN; MONOCLONAL-ANTIBODY; BINDING PROTEINS; GLUCOSE-UPTAKE	Hek293 cells are the predominant hosts for transient expression of recombinant proteins and are used for stable expression of proteins where post-translational modifications performed by CHO cells are inadequate. Nevertheless, there is little information available on the key cellular features underpinning recombinant protein production in Hek293 cells. To improve our understanding of recombinant protein production in Hek293 cells and identify targets for the engineering of an improved host cell line, we have compared a stable, recombinant protein producing Hek293 cell line and its parental cell line using a combination of transcriptomics, metabolomics and fluxomics. Producer cultures consumed less glucose than non-producer cultures while achieving the same growth rate, despite the additional burden of recombinant protein production. Surprisingly, there was no indication that producer cultures compensated for the reduction in glycolytic energy by increasing the efficiency of glucose utilization or increasing glutamine consumption. In contrast, glutamine consumption was lower and the majority of genes involved in oxidative phosphorylation were downregulated in producer cultures. We observed an overall downregulation of a large number of genes associated with broad cellular functions (e. g., cell growth and proliferation) in producer cultures, and therefore speculate that a broad adaptation of the cellular network freed up resources for recombinant protein production while maintaining the same growth rate. Increased abundance of genes associated with endoplasmic reticulum stress indicated a possible bottleneck at the point of protein folding and assembly.	[Dietmair, Stefanie; Hodson, Mark P.; Quek, Lake-Ee; Timmins, Nicholas E.; Gray, Peter; Nielsen, Lars K.] Univ Queensland, Australian Inst Bioengn & Nanotechnol AIBN, Brisbane, Qld, Australia	University of Queensland	Dietmair, S (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol AIBN, Brisbane, Qld, Australia.	stefanie.dietmair@googlemail.com	Hodson, Mark P/J-7609-2013; Nielsen, Lars K/A-5519-2011; Gray, Peter/AAC-3737-2019	Hodson, Mark P/0000-0002-5436-1886; Nielsen, Lars K/0000-0001-8191-3511; 				Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Backliwal G, 2008, BIOTECHNOL BIOENG, V101, P182, DOI 10.1002/bit.21882; Backliwal G, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn423; Baldi L, 2007, BIOTECHNOL LETT, V29, P677, DOI 10.1007/s10529-006-9297-y; Carlage T, 2009, ANAL CHEM, V81, P7357, DOI 10.1021/ac900792z; Clarke C, 2011, J BIOTECHNOL, V151, P159, DOI 10.1016/j.jbiotec.2010.11.016; Dietmair S, 2012, BIOTECHNOLOGY J; Dietmair S, 2012, BIOTECHNOL J, V7, P75, DOI 10.1002/biot.201100369; Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031; Dinnis DM, 2006, BIOTECHNOL BIOENG, V94, P830, DOI 10.1002/bit.20899; Doolan P, 2008, MOL BIOTECHNOL, V39, P187, DOI 10.1007/s12033-008-9039-6; Dorai H, 2007, BIOTECHNOL PROGR, V23, P911, DOI 10.1021/bp0700051; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Europa AF, 2000, BIOTECHNOL BIOENG, V67, P25, DOI 10.1002/(SICI)1097-0290(20000105)67:1<25::AID-BIT4>3.0.CO;2-K; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Geisse S, 2009, METHOD ENZYMOL, V463, P223, DOI 10.1016/S0076-6879(09)63015-9; Geisse S, 2009, PROTEIN EXPRES PURIF, V64, P99, DOI 10.1016/j.pep.2008.10.017; George A, 2010, BLOOD CELL MOL DIS, V45, P41, DOI 10.1016/j.bcmd.2010.02.006; Grabenhorst E, 1999, GLYCOCONJUGATE J, V16, P81, DOI 10.1023/A:1026466408042; Henry O, 2011, METAB ENG, V13, P499, DOI 10.1016/j.ymben.2011.05.004; Henry O, 2011, BIOPROC BIOSYST ENG, V34, P263, DOI 10.1007/s00449-010-0468-9; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Irani N, 2002, J BIOTECHNOL, V93, P269, DOI 10.1016/S0168-1656(01)00409-6; Irani N, 1999, BIOTECHNOL BIOENG, V66, P238, DOI 10.1002/(SICI)1097-0290(1999)66:4<238::AID-BIT5>3.0.CO;2-6; Jenkins N, 2007, CYTOTECHNOLOGY, V53, P121, DOI 10.1007/s10616-007-9075-2; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; Kim SH, 2007, APPL MICROBIOL BIOT, V76, P659, DOI 10.1007/s00253-007-1041-6; Korke R, 2004, J BIOTECHNOL, V107, P1, DOI 10.1016/j.jbiotec.2003.09.007; Kushiyama A, 2005, J BIOL CHEM, V280, P42016, DOI 10.1074/jbc.M503065200; Kusudo T, 2011, GENES CELLS, V16, P681, DOI 10.1111/j.1365-2443.2011.01517.x; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Luo J, 2012, BIOTECHNOL BIOENG, V109, P146, DOI 10.1002/bit.23291; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Meissner P, 2001, BIOTECHNOL BIOENG, V75, P197, DOI 10.1002/bit.1179; Meleady P, 2008, PROTEOMICS, V8, P2611, DOI 10.1002/pmic.200700854; Mitchell T, 2008, AM J PHYSIOL-CELL PH, V295, pC1354, DOI 10.1152/ajpcell.00239.2008; Moon B, 2003, AM J PHYSIOL-ENDOC M, V285, pE106, DOI 10.1152/ajpendo.00457.2002; Neilson AP, 2011, CANCER EPIDEMIOL, V35, P485, DOI 10.1016/j.canep.2010.10.007; Norman JC, 1996, MOL BIOL CELL, V7, P1429, DOI 10.1091/mbc.7.9.1429; Paredes C, 1999, CYTOTECHNOLOGY, V30, P85, DOI 10.1023/A:1008012518961; Pham PL, 2005, BIOTECHNOL BIOENG, V90, P332, DOI 10.1002/bit.20428; Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Schroder M, 2008, BIOTECHNOL LETT, V30, P187, DOI 10.1007/s10529-007-9524-1; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Seth G, 2007, BIOTECHNOL BIOENG, V97, P933, DOI 10.1002/bit.21234; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Simons CT, 2004, J BIOL CHEM, V279, P4196, DOI 10.1074/jbc.M306053200; Singh V, 1996, BIOTECHNOL BIOENG, V52, P443, DOI 10.1002/(SICI)1097-0290(19961105)52:3<443::AID-BIT12>3.0.CO;2-K; Song M, 2011, J CHEM TECHNOL BIOT, V86, P935, DOI 10.1002/jctb.2618; Stansfield SH, 2007, BIOTECHNOL BIOENG, V97, P410, DOI 10.1002/bit.21263; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Stewart JM, 2006, ENCY MOL CELL BIOL M; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tigges M, 2006, METAB ENG, V8, P264, DOI 10.1016/j.ymben.2006.01.006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Wulhfard S, 2008, BIOTECHNOL PROGR, V24, P458, DOI 10.1021/bp070286c; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Zhang XW, 2010, BIOTECHNOL LETT, V32, P1587, DOI 10.1007/s10529-010-0331-8	68	81	81	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43394	10.1371/journal.pone.0043394	http://dx.doi.org/10.1371/journal.pone.0043394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937046	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500048
J	Patterson, SK; Borewicz, K; Johnson, T; Xu, W; Isaacson, RE				Patterson, Sheila K.; Borewicz, Klaudyna; Johnson, Timothy; Xu, Wayne; Isaacson, Richard E.			Characterization and Differential Gene Expression between Two Phenotypic Phase Variants in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							PYELONEPHRITIS-ASSOCIATED PILI; ESCHERICHIA-COLI; IN-VIVO; TRANSCRIPTIONAL CONTROL; GENOMIC SEQUENCE; TYPE-1 FIMBRIAE; RNA GENES; SWINE; PATHOGENESIS; INFECTIONS	Salmonella enterica serovar Typhimurium strain 798 has previously been shown to undergo phenotypic phase variation. One of the phenotypes expresses virulence traits such as adhesion, while the other phenotype does not. Phenotypic phase variation appears to correlate with the ability of this strain to cause persistent, asymptomatic infections of swine. A new method to detect cells in either phenotypic phase was developed using Evans Blue-Uranine agar plates. Using this new assay, rates of phenotypic phase variation were obtained. The rate of phase variation from non-adhesive to adhesive phenotype was approximately 10(-4) per cell per generation while phase variation from the adhesive to the non-adhesive phenotype was approximately 10(-6) per cell per generation. Two highly virulent S. Typhimurium strains, SL1344 and ATCC 14028, were also shown to undergo phase variation. However, while the rate from adhesive to non-adhesive phenotype was approximately the same as for strain 798, the non-adhesive to adhesive phenotype shift was 37-fold higher. Differential gene expression was measured using RNA-Seq. Eighty-three genes were more highly expressed by 798 cells in the adhesive phenotype compared to the non-adhesive cells. Most of the up-regulated genes were in virulence genes and in particular all genes in the Salmonella pathogenicity island 1 were up-regulated. When compared to the virulent strain SL1344, expression of the virulence genes was approximately equal to those up-regulated in the adhesive phenotype of strain 798. A comparison of invasive ability demonstrated that strain SL1344 was the most invasive followed by the adhesive phenotype of strain 798, then the non-adhesive phenotype of strain 798. The least invasive strain was ATCC 14028. The genome of strain 798 was sequenced and compared to SL1344. Both strains had very similar genome sequences and gene deletions could not readily explain differences in the rates of phase variation from non-adhesive to the adhesive phenotype.	[Patterson, Sheila K.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Borewicz, Klaudyna; Johnson, Timothy; Isaacson, Richard E.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Xu, Wayne] Univ Minnesota, Minnesota Supercomp Inst, St Paul, MN 55108 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Patterson, SK (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA.	isaac015@umn.edu	xu, wayne/ABA-1961-2020	xu, wayne/0000-0003-0484-7340	United States Department of Agriculture, National Research Initiative; USDA [NRI: 2002-35201-12542]	United States Department of Agriculture, National Research Initiative(United States Department of Agriculture (USDA)); USDA(United States Department of Agriculture (USDA))	This work was supported by a grant from the United States Department of Agriculture, National Research Initiative. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Kevin Lange for assistance in preparing Table S3. This work was supported by a grant from the USDA, NRI: 2002-35201-12542.	Althouse C, 2003, INFECT IMMUN, V71, P6446, DOI 10.1128/IAI.71.11.6446-6452.2003; Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Batz M. B., 2011, RANKING RISKS 10 PAT, P1; BLYN LB, 1989, EMBO J, V8, P613, DOI 10.1002/j.1460-2075.1989.tb03416.x; BLYN LB, 1990, EMBO J, V9, P4045, DOI 10.1002/j.1460-2075.1990.tb07626.x; BRAATEN BA, 1994, CELL, V76, P577, DOI 10.1016/0092-8674(94)90120-1; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chen CY, 1996, INFECT IMMUN, V64, P4739, DOI 10.1128/IAI.64.11.4739-4743.1996; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; EISENSTEIN BI, 1981, SCIENCE, V214, P337, DOI 10.1126/science.6116279; FEDORKACRAY PJ, 1994, VET MICROBIOL, V41, P333, DOI 10.1016/0378-1135(94)90029-9; FINLAY BB, 1989, SCIENCE, V243, P940, DOI 10.1126/science.2919285; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Gray JT, 1996, AM J VET RES, V57, P313; Guerrant RL, 1999, ADV EXP MED BIOL, V473, P103; Guiney DG, 1997, J CLIN INVEST, V99, P565, DOI 10.1172/JCI119196; ISAACSON RE, 1983, INFECT IMMUN, V40, P633, DOI 10.1128/IAI.40.2.633-639.1983; Isaacson RE, 1999, AM J VET RES, V60, P1155; Isaacson RE, 1999, ADV EXP MED BIOL, V473, P281; ISAACSON RE, 1992, INFECT IMMUN, V60, P3193, DOI 10.1128/IAI.60.8.3193-3200.1992; KAMPELMACHER E H, 1969, Zentralblatt fuer Veterinaermedizin Reihe B, V16, P717; Kwan LY, 1998, INFECT IMMUN, V66, P5725, DOI 10.1128/IAI.66.12.5725-5730.1998; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Layton Abigail N., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000373; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Letellier A, 1999, VET MICROBIOL, V67, P299, DOI 10.1016/S0378-1135(99)00049-8; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lucas RL, 2000, MOL MICROBIOL, V36, P1024, DOI 10.1046/j.1365-2958.2000.01961.x; Maloy SR., 1996, GENETIC ANAL PATHOGE; Norris TL, 1998, MOL MICROBIOL, V29, P311, DOI 10.1046/j.1365-2958.1998.00934.x; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; Smith H, 1998, TRENDS MICROBIOL, V6, P239, DOI 10.1016/S0966-842X(98)01250-5; Song J, 2005, BIOINFORMATICS, V21, P2083, DOI 10.1093/bioinformatics/bti176; Stevens MP, 2009, PHILOS T R SOC B, V364, P2709, DOI 10.1098/rstb.2009.0094; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Thiennimitr P, 2011, P NAT AC SCI; Torres-Cruz J, 2003, J BACTERIOL, V185, P6990, DOI 10.1128/JB.185.23.6990-6994.2003; WOOD RL, 1989, AM J VET RES, V50, P1015; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0	47	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43592	10.1371/journal.pone.0043592	http://dx.doi.org/10.1371/journal.pone.0043592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937065	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500066
J	Purdue, MP; Hofmann, JN; Colt, JS; Hoxha, M; Ruterbusch, JJ; Davis, FG; Rothman, N; Wacholder, S; Schwartz, KL; Baccarelli, A; Chow, WH				Purdue, Mark P.; Hofmann, Jonathan N.; Colt, Joanne S.; Hoxha, Mirjam; Ruterbusch, Julie J.; Davis, Faith G.; Rothman, Nathaniel; Wacholder, Sholom; Schwartz, Kendra L.; Baccarelli, Andrea; Chow, Wong-Ho			A Case-Control Study of Peripheral Blood Mitochondrial DNA Copy Number and Risk of Renal Cell Carcinoma	PLOS ONE			English	Article							ACTIVATION; CANCER	Background: Low mitochondrial DNA (mtDNA) copy number is a common feature of renal cell carcinoma (RCC), and may influence tumor development. Results from a recent case-control study suggest that low mtDNA copy number in peripheral blood may be a marker for increased RCC risk. In an attempt to replicate that finding, we measured mtDNA copy number in peripheral blood DNA from a U. S. population-based case-control study of RCC. Methodology/Principal Findings: Relative mtDNA copy number was measured in triplicate by a quantitative real-time PCR assay using DNA extracted from peripheral whole blood. Cases (n = 603) had significantly lower mtDNA copy number than controls (n = 603; medians 0.85, 0.91 respectively; P = 0.0001). In multiple logistic regression analyses, the lowest quartile of mtDNA copy number was associated with a 60% increase in RCC risk relative to the highest quartile (OR = 1.6, 95% CI = 1.1-2.2; P-trend = 0.009). This association remained in analyses restricted to cases treated by surgery alone (OR (Q1) = 1.4, 95% CI = 1.0-2.1) and to localized tumors (2.0, 1.3-2.8). Conclusions/Significance: Our findings from this investigation, to our knowledge the largest of its kind, offer important confirmatory evidence that low mtDNA copy number is associated with increased RCC risk. Additional research is needed to assess whether the association is replicable in prospective studies.	[Purdue, Mark P.; Hofmann, Jonathan N.; Colt, Joanne S.; Rothman, Nathaniel; Wacholder, Sholom; Chow, Wong-Ho] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hoxha, Mirjam; Baccarelli, Andrea] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Mol & Genet Epidemiol, Dept Prevent Med, Milan, Italy; [Hoxha, Mirjam; Baccarelli, Andrea] Univ Milan, Dept Environm & Occupat Hlth, Milan, Italy; [Ruterbusch, Julie J.] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Ruterbusch, Julie J.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Inst, Detroit, MI USA; [Davis, Faith G.; Schwartz, Kendra L.] Univ Illinois, Sch Publ Hlth, Dept Epidemiol, Chicago, IL USA; [Baccarelli, Andrea] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Purdue, MP (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	purduem@mail.nih.gov	Purdue, Mark P/C-9228-2016; Hofmann, Jonathan/I-4168-2017	Purdue, Mark P/0000-0003-1177-3108; Hofmann, Jonathan/0000-0002-1043-5812; Baccarelli, Andrea/0000-0002-3436-0640	Intramural Research Program of the National Institutes of Health; National Cancer Institute	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Colt JS, 2011, EPIDEMIOLOGY, V22, P797, DOI 10.1097/EDE.0b013e3182300720; Higuchi M, 1997, J CLIN INVEST, V99, P1751, DOI 10.1172/JCI119339; Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48; Lee HC, 2005, MITOCHONDRIAL GENOME; Liao LM, 2011, CANCER EPIDEM BIOMAR, V20, P1944, DOI 10.1158/1055-9965.EPI-11-0379; Lin Chen-Sung, 2008, Interact Cardiovasc Thorac Surg, V7, P954, DOI 10.1510/icvts.2008.177006; Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104; Selvanayagam P, 1996, LAB INVEST, V74, P592; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213	14	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43149	10.1371/journal.pone.0043149	http://dx.doi.org/10.1371/journal.pone.0043149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937019	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500032
J	Wang, TT; Lv, MM; Shen, SN; Zhou, S; Wang, P; Chen, YQ; Liu, BR; Yu, LK; Hou, YY				Wang, Tingting; Lv, Mingming; Shen, Sunan; Zhou, Sheng; Wang, Ping; Chen, Yueqiu; Liu, Baorui; Yu, Like; Hou, Yayi			Cell-Free MicroRNA Expression Profiles in Malignant Effusion Associated with Patient Survival in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PLEURAL EFFUSION; MESSENGER-RNA; GENE; CARCINOMA; PROGNOSIS; ONCOGENES; DIAGNOSIS; LEUKEMIA; BIOLOGY; RELAPSE	Objective: MicroRNAs (miRNAs) expression is altered in cancer cells, and miRNAs could serve as diagnostic and prognostic biomarker for cancer patients. This study was designed to analyze circulating miRNAs expression in the malignant pleural effusion (MPE) and their association with patient survival in non-small cell lung cancer (NSCLC). Methods: Pleural effusion from 184 patients with NSCLC and MPE were collected. MiRNA microarray and bioinformatics interpretation were used to evaluate miRNA expression profiles in 10 NSCLC patients with different survival prognosis. Associations were validated in 184 patients (randomly classified into training and validation set with equal number in each group) using quantitative RT-PCR. Risk scores were formulated based on the expression signature of miRNAs. Clinical data, such as patient survival, were collected for correlation analysis. Results: Thirty-three miRNAs were found to be altered more than two-fold by microarray in malignant effusions between longer-survival and shorter-survival groups, and levels of five miRNAs (miRNA-93, miRNA-100, miRNA-134, miRNA-151 and miRNA-345) were significantly associated with overall survival. High expression of miR-100 and low expression of miRNA-93, miRNA-134, miRNA-151 and miRNA-345 were associated with poor survival in both the training and validation cohort. Patients with high risk scores had overall poor survival compared to the patients with low risk scores. Risk score was an independent predictor of patient survival. Conclusions: Expression patterns of miRNAs are systematically altered in MPE of patient with NSCLC. The five miRNA signature from the effusion may serve as a predictor for the overall survival of patients with lung cancers.	[Wang, Tingting; Lv, Mingming; Shen, Sunan; Zhou, Sheng; Wang, Ping; Chen, Yueqiu; Hou, Yayi] Nanjing Univ, Immunol & Reprod Biol Lab, Sch Med, Nanjing, Jiangsu, Peoples R China; [Wang, Tingting; Lv, Mingming; Shen, Sunan; Zhou, Sheng; Wang, Ping; Chen, Yueqiu; Hou, Yayi] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Wang, Tingting; Lv, Mingming; Shen, Sunan; Zhou, Sheng; Wang, Ping; Chen, Yueqiu; Hou, Yayi] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China; [Wang, Tingting; Liu, Baorui] Nanjing Univ, Dept Oncol, Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China; [Wang, Tingting; Liu, Baorui] Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China; [Yu, Like] Nanjing Chest Hosp, Dept Resp Med 1, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Wang, TT (corresponding author), Nanjing Univ, Immunol & Reprod Biol Lab, Sch Med, Nanjing, Jiangsu, Peoples R China.	yayihou@nju.edu.cn	lv, mingming/C-2891-2013; zhou, sheng/GYJ-6012-2022; wang, tingting/AAK-2640-2020		National Natural Science Foundation of China [81101552]; Natural Science Foundation of Jiangsu Province [BK2011571]; Specialized Research Fund for the Doctoral Program of Higher Education [20100091120002]; Fundamental Research Funds for the Central Universities [1118021418, 1118021406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (81101552), the Natural Science Foundation of Jiangsu Province (BK2011571), Specialized Research Fund for the Doctoral Program of Higher Education (20100091120002), and the Fundamental Research Funds for the Central Universities (1118021418 and 1118021406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bielsa S, 2008, EUR J INTERN MED, V19, P334, DOI 10.1016/j.ejim.2007.09.014; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Guo LL, 2010, EUR J CANCER, V46, P1692, DOI 10.1016/j.ejca.2010.02.043; Hsu IL, 2009, LUNG CANCER, V65, P371, DOI 10.1016/j.lungcan.2008.12.007; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; SIYAMEK NM, 2006, LUNG CANCER, V54, P1; Su WC, 2003, ONCOLOGY-BASEL, V64, P18, DOI 10.1159/000066516; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang TT, 2009, INT J CANCER, V125, P1921, DOI 10.1002/ijc.24516; Xie L, 2011, CLIN BIOCHEM, V44, P216, DOI 10.1016/j.clinbiochem.2010.11.002; Xie L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-591; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208	29	52	56	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43268	10.1371/journal.pone.0043268	http://dx.doi.org/10.1371/journal.pone.0043268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937028	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500037
J	Naor, A; Thiaville, PC; Altman-Price, N; Cohen-Or, I; Allers, T; de Crecy-Lagard, V; Gophna, U				Naor, Adit; Thiaville, Patrick C.; Altman-Price, Neta; Cohen-Or, Ifat; Allers, Thorsten; de Crecy-Lagard, Valerie; Gophna, Uri			A Genetic Investigation of the KEOPS Complex in Halophilic Archaea	PLOS ONE			English	Article							TRANSFER-RNA; HALOFERAX-VOLCANII; PROTEIN; YEAST; TRANSCRIPTION; BIOSYNTHESIS; ANTICODON; ADENOSINE; CYTIDINE; ANCIENT	KEOPS is an important cellular complex conserved in Eukarya, with some subunits conserved in Archaea and Bacteria. This complex was recently found to play an essential role in formation of the tRNA modification threonylcarbamoyladenosine (t(6)A), and was previously associated with telomere length maintenance and transcription. KEOPS subunits are conserved in Archaea, especially in the Euryarchaea, where they had been studied in vitro. Here we attempted to delete the genes encoding the four conserved subunits of the KEOPS complex in the euryarchaeote Haloferax volcanii and study their phenotypes in vivo. The fused kae1-bud32 gene was shown to be essential as was cgi121, which is dispensable in yeast. In contrast, pcc1 (encoding the putative dimerizing unit of KEOPS) was not essential in H. volcanii. Deletion of pcc1 led to pleiotropic phenotypes, including decreased growth rate, reduced levels of t(6)A modification, and elevated levels of intracellular glycation products.	[Naor, Adit; Altman-Price, Neta; Cohen-Or, Ifat; Gophna, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Thiaville, Patrick C.; de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Allers, Thorsten] Univ Nottingham, Sch Biol, Queens Med Ctr, Nottingham NG7 2RD, England	Tel Aviv University; State University System of Florida; University of Florida; University of Nottingham	Naor, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	vcrecy@ufl.edu; urigo@tauex.tau.ac.il	de Crecy-Lagard, Valerie/AAN-8995-2020; Gophna, Uri/AAS-8376-2020; Allers, Thorsten/G-5503-2010	Gophna, Uri/0000-0001-5129-5652; Allers, Thorsten/0000-0002-7308-3332	Israel Science Foundation; German-Israeli Project Cooperation (DIP); Federation of the Societies of Biochemistry and Molecular Biology; National Institutes of Health [R01 GM70641]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070641] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); German-Israeli Project Cooperation (DIP); Federation of the Societies of Biochemistry and Molecular Biology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	UG was supported by the Israel Science Foundation and the German-Israeli Project Cooperation (DIP), AN was funded by the Federation of the Societies of Biochemistry and Molecular Biology short term fellowship grant, and VdC by National Institutes of Health (grant no. R01 GM70641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAH KM, 1991, J BACTERIOL, V173, P5597, DOI 10.1128/jb.173.18.5597-5603.1991; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Bergmiller T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-118; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Blaby IK, 2010, ARCHAEA, V2010, DOI 10.1155/2010/426239; Chen CC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002258; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; Cohen-Or I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017974; Daugeron MC, 2011, NUCL ACIDS RES; de Crecy-Lagard V, 2010, MOL BIOL EVOL, V27, P2062, DOI 10.1093/molbev/msq096; Deutsch C, 2012, J BIOL CHEM, V287, P13666, DOI 10.1074/jbc.M112.344028; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Guy CP, 2006, J MOL BIOL, V358, P46, DOI 10.1016/j.jmb.2006.02.010; Hashimoto C, 2011, J BACTERIOL, V193, P6075, DOI 10.1128/JB.05733-11; Hecker A, 2008, EMBO J, V27, P2340, DOI 10.1038/emboj.2008.157; Hecker A, 2007, NUCLEIC ACIDS RES, V35, P6042, DOI 10.1093/nar/gkm554; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Katz C, 2010, MBIO, V1, DOI 10.1128/mBio.00195-10; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Mandal D, 2010, P NATL ACAD SCI USA, V107, P2872, DOI 10.1073/pnas.0914869107; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Mehlgarten C, 2010, MOL MICROBIOL, V76, P1082, DOI 10.1111/j.1365-2958.2010.07163.x; Naor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015833; Oberto J, 2009, NUCLEIC ACIDS RES, V37, P5343, DOI 10.1093/nar/gkp557; Peggion C, 2008, FEBS J, V275, P5919, DOI 10.1111/j.1742-4658.2008.06721.x; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Zalacain M, 2003, J MOL MICROB BIOTECH, V6, P109, DOI 10.1159/000076741	36	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43013	10.1371/journal.pone.0043013	http://dx.doi.org/10.1371/journal.pone.0043013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927945	Green Published, gold, Green Submitted			2022-12-27	WOS:000308224700010
J	Su, HM; Lin, TH; Hsu, PC; Chu, CY; Lee, WH; Chen, SC; Lee, CS; Voon, WC; Lai, WT; Sheu, SH				Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Lee, Wen-Hsien; Chen, Szu-Chia; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Association of Interarm Systolic Blood Pressure Difference with Atherosclerosis and Left Ventricular Hypertrophy	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ANKLE-BRACHIAL INDEX; PERIPHERAL ARTERIAL-DISEASE; CHRONIC KIDNEY-DISEASE; ARM DIFFERENCES; VASCULAR-DISEASE; PRIMARY-CARE; MORTALITY; PREVALENCE; PREDICTOR	An interarm systolic blood pressure (SBP) difference of 10 mmHg or more have been associated with peripheral artery disease and adverse cardiovascular outcomes. We investigated whether an association exists between this difference and ankle-brachial index (ABI), brachial-ankle pulse wave velocity (baPWV), and echocardiographic parameters. A total of 1120 patients were included in the study. The bilateral arm blood pressures were measured simultaneously by an ABI-form device. The values of ABI and baPWV were also obtained from the same device. Clinical data, ABI < 0.9, baPWV, echocariographic parameters, and an interarm SBP difference >= 10 mmHg were compared and analyzed. We performed two multivariate forward analyses for determining the factors associated with an interarm SBP difference >= 10 mmHg [model 1: significant variables in univariate analysis except left ventricular mass index (LVMI); model 2: significant variables in univariate analysis except ABI < 0.9 and baPWV]. The ABI < 0.9 and high baPWV in model 1 and high LVMI in model 2 were independently associated with an interarm SBP difference >= 10 mmHg. Female, hypertension, and high body mass index were also associated with an interarm SBP difference >= 10 mmHg. Our study demonstrated that ABI < 0.9, high baPWV, and high LVMI were independently associated with an interarm SBP difference of 10 mmHg or more. Detection of an interarm SBP difference may provide a simple method of detecting patients at increased risk of atherosclerosis and left ventricular hypertrophy.	[Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Lee, Wen-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol,Div Nephrol, Kaohsiung, Taiwan; [Su, Ho-Ming; Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Su, Ho-Ming; Lin, Tsung-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Mecicine, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Su, HM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol,Div Nephrol, Kaohsiung, Taiwan.	scarchenone@yahoo.com.tw	蘇, 河名/AAE-9843-2019	Lin, Tsung-Hsien/0000-0002-7226-8730; Su, Ho-Ming/0000-0003-0247-3250; Chu, Chun-Yuan/0000-0001-5550-102X				AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; Bosevski M, 2012, ANGIOLOGY; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; Chung CM, 2012, AM J MED SCI; Clark CE, 2007, J HUM HYPERTENS, V21, P633, DOI 10.1038/sj.jhh.1002209; Clark CE, 2006, J HUM HYPERTENS, V20, P923, DOI 10.1038/sj.jhh.1002093; Clark CE, 2002, FAM PRACT, V19, P439, DOI 10.1093/fampra/19.5.439; Clark CE, 2007, FAM PRACT, V24, P420, DOI 10.1093/fampra/cmm035; Clark CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1327; Clark CE, 2012, LANCET, V379, P905, DOI 10.1016/S0140-6736(11)61710-8; Cyriax EF, 1920, Q J MED, V13, P148, DOI 10.1093/qjmed/os-13.50.148; Dellegrottaglie S, 2011, NEPHROL DIAL TRANSPL, V26, P2891, DOI 10.1093/ndt/gfr186; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; FISHBANE S, 1995, AM J KIDNEY DIS, V25, P34, DOI 10.1016/0272-6386(95)90622-3; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Fu WC, 2006, NEPHROLOGY, V11, P9, DOI 10.1111/j.1440-1797.2006.00534.x; Hayashi C, 2004, DIABETES RES CLIN PR, V66, P269, DOI 10.1016/j.diabres.2004.03.013; KELLY R, 1989, CIRCULATION, V80, P1652, DOI 10.1161/01.CIR.80.6.1652; Kimura A, 2004, J HYPERTENS, V22, P2277, DOI 10.1097/00004872-200412000-00009; Kitahara T, 2005, AM J KIDNEY DIS, V46, P688, DOI 10.1053/j.ajkd.2005.06.016; Lane D, 2002, J HYPERTENS, V20, P1089, DOI 10.1097/00004872-200206000-00019; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lehmann ED, 1999, LANCET, V354, P528, DOI 10.1016/S0140-6736(99)00179-8; Leskinen Y, 2002, AM J KIDNEY DIS, V40, P472, DOI 10.1053/ajkd.2002.34885; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lohmann FW, 2011, BLOOD PRESS MONIT, V16, P37, DOI 10.1097/MBP.0b013e328343317a; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; Orme S, 1999, AGE AGEING, V28, P537, DOI 10.1093/ageing/28.6.537; Pasqualini L, 2012, EUR J INTERN MED, V23, P240, DOI 10.1016/j.ejim.2011.09.004; Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489; ROMAN MJ, 1995, J AM COLL CARDIOL, V25, P83, DOI 10.1016/0735-1097(94)00316-I; Singer AJ, 1996, ARCH INTERN MED, V156, P2005, DOI 10.1001/archinte.156.17.2005; Sodhi H S, 2007, Kathmandu Univ Med J (KUMJ), V5, P12; Su HM, 2012, ATHEROSCLER IN PRESS; Su HM, 2009, AM J HYPERTENS, V22, P871, DOI 10.1038/ajh.2009.94; Verberk WJ, 2011, AM J HYPERTENS, V24, P1201, DOI 10.1038/ajh.2011.125; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359	43	58	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e41173	10.1371/journal.pone.0041173	http://dx.doi.org/10.1371/journal.pone.0041173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927905	Green Published, gold, Green Submitted			2022-12-27	WOS:000308224700002
J	Hirschhorn, T; Barizilay, L; Smorodinsky, NI; Ehrlich, M				Hirschhorn, Tal; Barizilay, Lior; Smorodinsky, Nechama I.; Ehrlich, Marcelo			Differential Regulation of Smad3 and of the Type II Transforming Growth Factor-beta Receptor in Mitosis: Implications for Signaling	PLOS ONE			English	Article							TGF-BETA; UBIQUITIN LIGASE; CELL-CYCLE; MEDIATED ENDOCYTOSIS; NEGATIVE REGULATION; SPINDLE CHECKPOINT; MITOTIC SPINDLE; DEGRADATION; ACTIVATION; SMURF2	The response to transforming growth factor-beta (TGF-beta) depends on cellular context. This context is changed in mitosis through selective inhibition of vesicle trafficking, reduction in cell volume and the activation of mitotic kinases. We hypothesized that these alterations in cell context may induce a differential regulation of Smads and TGF-beta receptors. We tested this hypothesis in mesenchymal-like ovarian cancer cells, arrested (or not) in mitosis with 2-methoxyestradiol (2ME2). In mitosis, without TGF-beta stimulation, Smad3 was phosphorylated at the C-terminus and linker regions and localized to the mitotic spindle. Phosphorylated Smad3 interacted with the negative regulators of Smad signaling, Smurf2 and Ski, and failed to induce a transcriptional response. Moreover, in cells arrested in mitosis, Smad3 levels were progressively reduced. These phosphorylations and reduction in the levels of Smad3 depended on ERK activation and Mps1 kinase activity, and were abrogated by increasing the volume of cells arrested in mitosis with hypotonic medium. Furthermore, an Mps1-dependent phosphorylation of GFP-Smad3 was also observed upon its over-expression in interphase cells, suggesting a mechanism of negative regulation which counters increases in Smad3 concentration. Arrest in mitosis also induced a block in the clathrin-mediated endocytosis of the type II TGF-beta receptor (T beta RII). Moreover, following the stimulation of mitotic cells with TGF-beta, the proteasome-mediated attenuation of TGF-beta receptor activity, the degradation and clearance of T beta RII from the plasma membrane, and the clearance of the TGF-beta ligand from the medium were compromised, and the C-terminus phosphorylation of Smad3 was prolonged. We propose that the reduction in Smad3 levels, its linker phosphorylation, and its association with negative regulators (observed in mitosis prior to ligand stimulation) represent a signal attenuating mechanism. This mechanism is balanced by the retention of active TGF-beta receptors at the plasma membrane. Together, both mechanisms allow for a regulated cellular response to TGF-beta stimuli in mitosis.	[Hirschhorn, Tal; Barizilay, Lior; Smorodinsky, Nechama I.; Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Smorodinsky, Nechama I.] Tel Aviv Univ, George S Wise Fac Life Sci, Alec & Myra Marmot Hybridoma Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Hirschhorn, T (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	marceloe@post.tau.ac.il		Ehrlich, Marcelo/0000-0002-2352-1808	Israeli Science Foundation (ISF) [1592/11]	Israeli Science Foundation (ISF)(Israel Science Foundation)	The study was funded in part through a grant (1592/11 to ME) of the Israeli Science Foundation (ISF; http://www.isf.org.il/); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Chetrit D, 2011, J BIOL CHEM, V286, P5392, DOI 10.1074/jbc.M110.161851; Clarke DC, 2008, TRENDS CELL BIOL, V18, P430, DOI 10.1016/j.tcb.2008.06.006; Clarke DC, 2009, MOL CELL BIOL, V29, P2443, DOI 10.1128/MCB.01443-08; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Daly AC, 2010, J BIOL CHEM, V285, P6489, DOI 10.1074/jbc.M109.043877; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Dore JJE, 2001, MOL BIOL CELL, V12, P675, DOI 10.1091/mbc.12.3.675; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Ehrlich M, 2011, CELL SIGNAL, V23, P1424, DOI 10.1016/j.cellsig.2011.04.004; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Habela CW, 2007, CELL CYCLE, V6, P1613, DOI 10.4161/cc.6.13.4357; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Jin Q, 2007, J BIOL CHEM, V282, P19122, DOI 10.1074/jbc.M609915200; Jin QY, 2009, J CELL PHYSIOL, V221, P707, DOI 10.1002/jcp.21910; Kamath K, 2006, MOL CANCER THER, V5, P2225, DOI 10.1158/1535-7163.MCT-06-0113; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Luo KX, 1997, EMBO J, V16, P1970, DOI 10.1093/emboj/16.8.1970; Marcelain K, 2005, ONCOGENE, V24, P4321, DOI 10.1038/sj.onc.1208631; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Matsuzaki K, 2011, CARCINOGENESIS, V32, P1578, DOI 10.1093/carcin/bgr172; Meyer C, 2011, J HEPATOL, V55, P369, DOI 10.1016/j.jhep.2010.11.027; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Osmundson EC, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-14; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Penheiter SG, 2010, MOL BIOL CELL, V21, P4009, DOI 10.1091/mbc.E09-12-1019; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Sivan G, 2008, CELL CYCLE, V7, P741, DOI 10.4161/cc.7.6.5596; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Wartlick O, 2011, NAT REV MOL CELL BIO, V12, P594, DOI 10.1038/nrm3169; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yang Y, 2006, ONCOGENE, V25, P7235, DOI 10.1038/sj.onc.1209712; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200; Zieba A, 2012, MOL CELLULAR PROTOMI; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	67	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43459	10.1371/journal.pone.0043459	http://dx.doi.org/10.1371/journal.pone.0043459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927969	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300053
J	Konopka, KH; Harbers, M; Houghton, A; Kortekaas, R; van Vliet, A; Timmerman, W; den Boer, JA; Struys, MMRF; van Wijhe, M				Konopka, Karl-Heinz; Harbers, Marten; Houghton, Andrea; Kortekaas, Rudie; van Vliet, Andre; Timmerman, Wia; den Boer, Johan A.; Struys, Michel M. R. F.; van Wijhe, Marten			Somatosensory Profiles but Not Numbers of Somatosensory Abnormalities of Neuropathic Pain Patients Correspond with Neuropathic Pain Grading	PLOS ONE			English	Article							MECHANISMS; HYPERALGESIA; NOCICEPTORS; SYMPTOMS; PROTOCOL; INJURY	Due to the lack of a specific diagnostic tool for neuropathic pain, a grading system to categorize pain as 'definite', 'probable', 'possible' and 'unlikely' neuropathic was proposed. Somatosensory abnormalities are common in neuropathic pain and it has been suggested that a greater number of abnormalities would be present in patients with 'probable' and 'definite' grades. To test this hypothesis, we investigated the presence of somatosensory abnormalities by means of Quantitative Sensory Testing (QST) in patients with a clinical diagnosis of neuropathic pain and correlated the number of sensory abnormalities and sensory profiles to the different grades. Of patients who were clinically diagnosed with neuropathic pain, only 60% were graded as 'definite' or 'probable', while 40% were graded as 'possible' or 'unlikely' neuropathic pain. Apparently, there is a mismatch between a clinical neuropathic pain diagnosis and neuropathic pain grading. Contrary to the expectation, patients with 'probable' and 'definite' grades did not have a greater number of abnormalities. Instead, similar numbers of somatosensory abnormalities were identified for each grade. The profiles of sensory signs in 'definite' and 'probable' neuropathic pain were not significantly different, but different from the 'unlikely' grade. This latter difference could be attributed to differences in the prevalence of patients with a mixture of sensory gain and loss and with sensory loss only. The grading system allows a separation of neuropathic and non-neuropathic pain based on profiles but not on the total number of sensory abnormalities. Our findings indicate that patient selection based on grading of neuropathic pain may provide advantages in selecting homogenous groups for clinical research.	[Konopka, Karl-Heinz; Struys, Michel M. R. F.; van Wijhe, Marten] Univ Groningen, Dept Anesthesiol, Pain Management Unit, Univ Med Ctr Groningen, Groningen, Netherlands; [Harbers, Marten; den Boer, Johan A.] Univ Groningen, Dept Psychiat, Univ Med Ctr Groningen, Groningen, Netherlands; [Houghton, Andrea] Merck & Co Inc, West Point, PA USA; [Kortekaas, Rudie] Univ Groningen, Dept Neurosci, Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [van Vliet, Andre; Timmerman, Wia] PRA Int, Zuidlaren, Netherlands	University of Groningen; University of Groningen; Merck & Company; University of Groningen	Konopka, KH (corresponding author), Univ Groningen, Dept Anesthesiol, Pain Management Unit, Univ Med Ctr Groningen, Groningen, Netherlands.	k.h.konopka@umcg.nl		Struys, Michel/0000-0003-0421-536X; van Wijhe, Marten/0000-0001-6873-4092	Dutch Top Institute Pharma project [T5-108]	Dutch Top Institute Pharma project	This study was performed within the framework of Dutch Top Institute Pharma project T5-108. Partners in this project include Merck Co., PRA International and UMC Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2000, CLIN J PAIN, V16, pS12, DOI 10.1097/00002508-200006001-00004; Baumgartner U, 2002, PAIN, V96, P141, DOI 10.1016/S0304-3959(01)00438-9; Dworkin RH, 2007, J PAIN, V8, P118, DOI 10.1016/j.jpain.2006.06.005; FAGIUS J, 1981, J NEUROL SCI, V51, P11, DOI 10.1016/0022-510X(81)90056-3; Felix ER, 2009, J REHABIL RES DEV, V46, P69, DOI 10.1682/JRRD.2008.04.0058; Freynhagen R, 2008, PAIN, V135, P65, DOI 10.1016/j.pain.2007.05.004; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Gierthmuhlen J, 2011, PAIN; Hansson P, 2003, EUR J PAIN, V7, P353, DOI 10.1016/S1090-3801(03)00051-X; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Jensen TS, 2001, EUR J PHARMACOL, V429, P1, DOI 10.1016/S0014-2999(01)01302-4; Konopka KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037524; Liu XG, 2000, PAIN, V84, P309, DOI 10.1016/S0304-3959(99)00211-0; Macrae WA, 2008, BRIT J ANAESTH, V101, P77, DOI 10.1093/bja/aen099; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; Maier C, 2010, PAIN; Moore D.S., 2003, MATH GAZ, V4th, DOI DOI 10.2307/3619120; Ochoa JL, 2005, MUSCLE NERVE, V32, P459, DOI 10.1002/mus.20367; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Scholz J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000047; Serra J, 2009, PAIN, V147, P46, DOI 10.1016/j.pain.2009.07.028; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Uceyler N, 2011, EUR NEUROL REV, V6, P128; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43526	10.1371/journal.pone.0043526	http://dx.doi.org/10.1371/journal.pone.0043526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927981	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300061
J	Zamft, BM; Marblestone, AH; Kording, K; Schmidt, D; Martin-Alarcon, D; Tyo, K; Boyden, ES; Church, G				Zamft, Bradley Michael; Marblestone, Adam H.; Kording, Konrad; Schmidt, Daniel; Martin-Alarcon, Daniel; Tyo, Keith; Boyden, Edward S.; Church, George			Measuring Cation Dependent DNA Polymerase Fidelity Landscapes by Deep Sequencing	PLOS ONE			English	Article							Y-FAMILY; IN-VIVO; AMPLIFICATION; MOLECULE; CALCIUM; SYSTEMS; DPO4	High-throughput recording of signals embedded within inaccessible micro-environments is a technological challenge. The ideal recording device would be a nanoscale machine capable of quantitatively transducing a wide range of variables into a molecular recording medium suitable for long-term storage and facile readout in the form of digital data. We have recently proposed such a device, in which cation concentrations modulate the misincorporation rate of a DNA polymerase (DNAP) on a known template, allowing DNA sequences to encode information about the local cation concentration. In this work we quantify the cation sensitivity of DNAP misincorporation rates, making possible the indirect readout of cation concentration by DNA sequencing. Using multiplexed deep sequencing, we quantify the misincorporation properties of two DNA polymerases - Dpo4 and Klenow exo(-) - obtaining the probability and base selectivity of misincorporation at all positions within the template. We find that Dpo4 acts as a DNA recording device for Mn2+ with a misincorporation rate gain of similar to 2%/mM. This modulation of misincorporation rate is selective to the template base: the probability of misincorporation on template T by Dpo4 increases >50-fold over the range tested, while the other template bases are affected less strongly. Furthermore, cation concentrations act as scaling factors for misincorporation: on a given template base, Mn2+ and Mg2+ change the overall misincorporation rate but do not alter the relative frequencies of incoming misincorporated nucleotides. Characterization of the ion dependence of DNAP misincorporation serves as the first step towards repurposing it as a molecular recording device.	[Zamft, Bradley Michael; Church, George] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Marblestone, Adam H.; Church, George] Harvard Univ, Biophys Program, Boston, MA 02115 USA; [Kording, Konrad] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Kording, Konrad] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Kording, Konrad] Northwestern Univ, Dept Appl Math, Chicago, IL 60611 USA; [Schmidt, Daniel; Martin-Alarcon, Daniel; Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Schmidt, Daniel; Martin-Alarcon, Daniel; Boyden, Edward S.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Tyo, Keith] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Schmidt, Daniel; Martin-Alarcon, Daniel; Boyden, Edward S.] MIT, McGovern Inst, Cambridge, MA 02139 USA; [Kording, Konrad] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Marblestone, Adam H.] Harvard Univ, Wyss Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Northwestern University; Northwestern University; Northwestern University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwestern University; Massachusetts Institute of Technology (MIT); Shirley Ryan AbilityLab; Harvard University	Zamft, BM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu	Kording, Konrad P/A-1233-2007; Tyo, Keith/AAM-4543-2020; Tyo, Keith/H-6227-2012	Kording, Konrad P/0000-0001-8408-4499; Tyo, Keith/0000-0002-2342-0687; church, george/0000-0001-6232-9969; Marblestone, Adam/0000-0001-9833-9931	Fannie and John Hertz Foundation; Damon Runyon Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health (NIH); National Science Foundation; MIT McGovern Institute and Media Lab; New York Stem Cell Foundation Robertson Investigator Award; Human Frontiers Science Program; Paul Allen Distinguished Investigator in Neuroscience Award; Office of Naval Research; NIH Centers of Excellence in Genomic Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER	Fannie and John Hertz Foundation; Damon Runyon Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); MIT McGovern Institute and Media Lab; New York Stem Cell Foundation Robertson Investigator Award; Human Frontiers Science Program(Human Frontier Science Program); Paul Allen Distinguished Investigator in Neuroscience Award; Office of Naval Research(Office of Naval Research); NIH Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Adam Marblestone is supported by the Fannie and John Hertz Foundation. Daniel Schmidt is supported by the Damon Runyon Foundation. Konrad Kording and Keith Tyo are funded in part by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust. Ed Boyden is supported by National Institutes of Health (NIH), National Science Foundation, the MIT McGovern Institute and Media Lab, the New York Stem Cell Foundation Robertson Investigator Award, the Human Frontiers Science Program, and the Paul Allen Distinguished Investigator in Neuroscience Award. Bradley Zamft and George Church acknowledge support from the Office of Naval Research and the NIH Centers of Excellence in Genomic Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar S, 2006, DNA REPAIR, V5, P479, DOI 10.1016/j.dnarep.2006.01.001; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; BARNES WM, 1992, GENE, V112, P29, DOI 10.1016/0378-1119(92)90299-5; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Braman J, 2002, IN VITRO MUTAGENESIS, P259; Broyde S, 2008, TRENDS BIOCHEM SCI, V33, P209, DOI 10.1016/j.tibs.2008.02.004; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Church GM, 2003, US Patent, Patent No. 20030228611; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Dorjsuren D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp641; ELDEIRY WS, 1984, P NATL ACAD SCI-BIOL, V81, P7378, DOI 10.1073/pnas.81.23.7378; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Irimia A, 2006, BIOCHEMISTRY-US, V45, P5949, DOI 10.1021/bi052511+; Jozwiakowski SK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp494; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kording KP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002291; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; MacKay D. J. C., 2003, INFORM THEORY INFERE; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; PROVOST GS, 1993, MUTAT RES, V288, P133; Purves D, 2001, NEUROSCIENCE, P39; Rider TH, 2003, SCIENCE, V301, P213, DOI 10.1126/science.1084920; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	32	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43876	10.1371/journal.pone.0043876	http://dx.doi.org/10.1371/journal.pone.0043876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928047	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300097
J	Conley, NJ; Pavlinac, PB; Guthrie, BL; Mackelprang, RD; Muiru, AN; Choi, RY; Bosire, R; Gatuguta, A; Farquhar, C				Conley, N. Jeanne; Pavlinac, Patricia B.; Guthrie, Brandon L.; Mackelprang, Romel D.; Muiru, Anthony N.; Choi, Robert Y.; Bosire, Rose; Gatuguta, Ann; Farquhar, Carey			Distance from Home to Study Clinic and Risk of Follow-Up Interruption in a Cohort of HIV-1-Discordant Couples in Nairobi, Kenya	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAMS; HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; WESTERN KENYA; PATIENTS LOST; MISSING DATA; SCALING-UP; RETENTION; HEALTH; TRIALS	Background: Longitudinal studies of HIV-1-infected individuals or those at risk of infection are subject to missed study visits that may have negative consequences on the care of participants and can jeopardize study validity due to bias and loss of statistical power. Distance between participant residence and study clinic, as well as other socioeconomic and demographic factors, may contribute to interruptions in patient follow-up. Methods: HIV-1-serodiscordant couples were enrolled between May 2007 and October 2009 and followed for two years in Nairobi, Kenya. At baseline, demographic and home location information was collected and linear distance from each participant's home to the study clinic was determined. Participants were asked to return to the study clinic for quarterly visits, with follow-up interruptions (FUI) defined as missing two consecutive visits. Cox proportional hazards regression was used to assess crude and adjusted associations between FUI and home-to-clinic distance, and other baseline characteristics. Results: Of 469 enrolled couples, 64% had a female HIV-1-infected partner. Overall incidence of FUI was 13.4 per 100 person-years (PY), with lower incidence of FUI in HIV-1-infected (10.8 per 100 PY) versus - uninfected individuals (16.1 per 100 PY) (hazard ratio [HR] = 0.66; 95% confidence interval [CI]: 0.50, 0.88). Among HIV-1-infected participants, those living between 5 and 10 kilometers (km) from the study clinic had a two-fold increased rate of FUI compared to those living < 5 km away (HR = 2.17; 95% CI: 1.09, 4.34). Other factors associated with FUI included paying higher rent (HR = 1.67; 95% CI: 1.05, 2.65), having at least primary school education (HR = 1.96; 95% CI: 1.02, 3.70), and increased HIV-1 viral load (HR = 1.23 per log(10) increase; 95% CI: 1.01, 1.51). Conclusions: Home-to-clinic distance, indicators of socioeconomic status, and markers of disease progression may affect compliance with study follow-up schedules. Retention strategies should focus on participants at greatest risk of FUI to ensure study validity.	[Conley, N. Jeanne; Pavlinac, Patricia B.; Guthrie, Brandon L.; Mackelprang, Romel D.; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Choi, Robert Y.; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA USA; [Guthrie, Brandon L.; Mackelprang, Romel D.; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Muiru, Anthony N.] Harvard Univ, Sch Med, Boston, MA USA; [Bosire, Rose] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Gatuguta, Ann] Kenyatta Univ, Dept Publ Hlth, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Kenya Medical Research Institute; Kenyatta University	Conley, NJ (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	brguth@u.washington.edu	Fazli, Ghazal/AAE-8320-2022		U.S. NIH NIAID [R01 684316]; University of Washington Center for AIDS Research (CFAR); NIH-funded program [P30 A1027757]; NIAID; NCI; NIMH; NIDA; NICHD; NHLBI; NIA; NIH [K24 AI087399]; International Research Scientist Development Award [K01TW008406]; National Institutes of Health [R24 TW007988]; Fogarty International Center through Vanderbilt University; NIH FIC [D43 TW000007]; FOGARTY INTERNATIONAL CENTER [D43TW000007, R24TW007988, K01TW008406] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140, K24AI087399] Funding Source: NIH RePORTER	U.S. NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research (CFAR); NIH-funded program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Research Scientist Development Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center through Vanderbilt University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the U.S. NIH NIAID R01 684316 and the University of Washington Center for AIDS Research (CFAR), an NIH-funded program (P30 A1027757) which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, and NIA. CF received support from NIH grant K24 AI087399 and RC was supported by the International Research Scientist Development Award, K01TW008406. RC, AG and AM were supported by grant number R24 TW007988 from the National Institutes of Health, Fogarty International Center through Vanderbilt University and PP was supported by NIH FIC D43 TW000007. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or Fogarty International Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Andersen JW, 2007, CONTEMP CLIN TRIALS, V28, P583, DOI 10.1016/j.cct.2007.02.002; Baron G, 2008, ARTHRIT RHEUM-ARTHR, V59, P25, DOI 10.1002/art.23253; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Buor D, 2003, INT J HEALTH PLAN M, V18, P293, DOI 10.1002/hpm.729; Davis LL, 2002, J NURS SCHOLARSHIP, V34, P47, DOI 10.1111/j.1547-5069.2002.00047.x; de Bruyn G, 2005, JAIDS-J ACQ IMM DEF, V39, P499, DOI 10.1097/01.qai.0000148532.12329.df; DeVita DA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-19; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Ezechi OC, 2009, ARCH GYNECOL OBSTET, V280, P745, DOI 10.1007/s00404-009-0956-9; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Getz KA, 2008, AM J THER, V15, P450, DOI 10.1097/MJT.0b013e31816b9027; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728; Ioannidis JPA, 1997, J ACQ IMMUN DEF SYND, V16, P22, DOI 10.1097/00042560-199709010-00004; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Marcellus L, 2004, CJNR, V36, P16; Maru DSR, 2008, AIDS BEHAV, V12, P284, DOI 10.1007/s10461-007-9336-2; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P102, DOI 10.2471/BLT.10.080796; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, V88, P681, DOI 10.2471/BLT.09.064329; Otieno PA, 2010, AIDS CARE, V22, P729, DOI 10.1080/09540120903373565; Painter TM, 2004, BMJ-BRIT MED J, V329, P543, DOI 10.1136/bmj.329.7465.543; RAHAMAN MM, 1982, AM J PUBLIC HEALTH, V72, P1124, DOI 10.2105/AJPH.72.10.1124; Republic of Kenya Ministry of Transport, 2009, INT NAT TRANSP POL M; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Roura M, 2009, SEX TRANSM INFECT, V85, P308, DOI 10.1136/sti.2008.033183; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Snow WM, 2007, CONTEMP CLIN TRIALS, V28, P25, DOI 10.1016/j.cct.2006.08.010; Touloumi G, 2002, EPIDEMIOLOGY, V13, P347, DOI 10.1097/00001648-200205000-00017; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Vestbo J, 2011, CLIN RESPIR J, V5, P44, DOI 10.1111/j.1752-699X.2010.00198.x; Wasike WSK, 2001, ROAD INFRASTRUCTURE; Wood Angela M, 2004, Clin Trials, V1, P368; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43138	10.1371/journal.pone.0043138	http://dx.doi.org/10.1371/journal.pone.0043138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22937017	Green Published, gold, Green Submitted			2022-12-27	WOS:000307789700024
J	Minton, AZ; Phatak, NR; Stankowska, DL; He, SQ; Ma, HY; Mueller, BH; Jiang, M; Luedtke, R; Yang, SH; Brownlee, C; Krishnamoorthy, RR				Minton, Alena Z.; Phatak, Nitasha R.; Stankowska, Dorota L.; He, Shaoqing; Ma, Hai-Ying; Mueller, Brett H.; Jiang, Ming; Luedtke, Robert; Yang, Shaohua; Brownlee, Colby; Krishnamoorthy, Raghu R.			Endothelin B Receptors Contribute to Retinal Ganglion Cell Loss in a Rat Model of Glaucoma	PLOS ONE			English	Article							OPTIC-NERVE DAMAGE; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; AQUEOUS-HUMOR; IN-VIVO; CIRCULATING ENDOTHELIN-1; ET(B) RECEPTORS; GENE-EXPRESSION; AXONAL LOSS; ADULT-RATS	Glaucoma is an optic neuropathy, commonly associated with elevated intraocular pressure (IOP) characterized by optic nerve degeneration, cupping of the optic disc, and loss of retinal ganglion cells which could lead to loss of vision. Endothelin-1 (ET-1) is a 21-amino acid vasoactive peptide that plays a key role in the pathogenesis of glaucoma; however, the receptors mediating these effects have not been defined. In the current study, endothelin B (ETB) receptor expression was assessed in vivo, in the Morrison's ocular hypertension model of glaucoma in rats. Elevation of IOP in Brown Norway rats produced increased expression of ETB receptors in the retina, mainly in retinal ganglion cells (RGCs), nerve fiber layer (NFL), and also in the inner plexiform layer (IPL) and inner nuclear layer (INL). To determine the role of ETB receptors in neurodegeneration, Wistar-Kyoto wild type (WT) and ETB receptor-deficient (KO) rats were subjected to retrograde labeling with Fluoro-Gold (FG), following which IOP was elevated in one eye while the contralateral eye served as control. IOP elevation for 4 weeks in WT rats caused an appreciable loss of RGCs, which was significantly attenuated in KO rats. In addition, degenerative changes in the optic nerve were greatly reduced in KO rats compared to those in WT rats. Taken together, elevated intraocular pressure mediated increase in ETB receptor expression and its activation may contribute to a decrease in RGC survival as seen in glaucoma. These findings raise the possibility of using endothelin receptor antagonists as neuroprotective agents for the treatment of glaucoma.	[Minton, Alena Z.; Phatak, Nitasha R.; Stankowska, Dorota L.; He, Shaoqing; Brownlee, Colby; Krishnamoorthy, Raghu R.] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA; [Ma, Hai-Ying; Mueller, Brett H.; Jiang, Ming; Luedtke, Robert; Yang, Shaohua] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Minton, AZ (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA.	Raghu.Krishnamoorthy@unthsc.edu	Yang, Shaohua/D-1738-2013; Phatak, Nitasha/ABI-5989-2020	Phatak, Nitasha/0000-0002-2107-985X	National Glaucoma Research grant from the American Health Assistance Foundation (AHAF); National Eye Institute [1RO1EY019952]; NATIONAL EYE INSTITUTE [R01EY019952] Funding Source: NIH RePORTER	National Glaucoma Research grant from the American Health Assistance Foundation (AHAF)(BrightFocus Foundation); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a National Glaucoma Research grant from the American Health Assistance Foundation (AHAF) and by funding from National Eye Institute (1RO1EY019952) to RRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BEGG IS, 1971, EXP EYE RES, V11, P141; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Cellini M, 1997, ACTA OPHTHALMOL SCAN, V75, P11; Chauhan BC, 2008, CAN J OPHTHALMOL, V43, P356, DOI 10.3129/i08-060; Chauhan BC, 2006, INVEST OPHTH VIS SCI, V47, P634, DOI 10.1167/iovs.05-1206; Chauhan BC, 2004, INVEST OPHTH VIS SCI, V45, P144, DOI 10.1167/iovs.03-0687; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; CHAUHAN BC, 1992, GRAEF ARCH CLIN EXP, V230, P521, DOI 10.1007/BF00181772; Cioffi GA, 1996, J GLAUCOMA, V5, pA12; Cioffi GA, 1999, EUR J OPHTHALMOL, V9, pS34, DOI 10.1177/112067219900901S12; COCKBURN DM, 1983, AM J OPTOM PHYS OPT, V60, P705; DRAGER UC, 1981, INVEST OPHTH VIS SCI, V20, P285; Dupuis J, 1996, J APPL PHYSIOL, V81, P1510, DOI 10.1152/jappl.1996.81.4.1510; FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P1461, DOI 10.1006/bbrc.1994.1395; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Gariepy CE, 1998, J CLIN INVEST, V102, P1092, DOI 10.1172/JCI3702; Good TJ, 2010, EXPERT OPIN THER TAR, V14, P647, DOI 10.1517/14728222.2010.487065; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hayreh S S, 1971, Trans Ophthalmol Soc U K, V91, P291; HOLLANDER H, 1968, Brain Research, V10, P120, DOI 10.1016/0006-8993(68)90117-0; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Husak PJ, 2000, J VIROL, V74, P10975, DOI 10.1128/JVI.74.23.10975-10983.2000; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kallberg ME, 2002, J GLAUCOMA, V11, P105; Kermer P, 2000, MOL BRAIN RES, V85, P144, DOI 10.1016/S0169-328X(00)00256-4; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Koliakos GG, 2004, BRIT J OPHTHALMOL, V88, P523, DOI 10.1136/bjo.2003.028290; Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f; Krishnamoorthy RR, 2008, CAN J PHYSIOL PHARM, V86, P380, DOI 10.1139/Y08-040; Lau J, 2006, EXP EYE RES, V82, P132, DOI 10.1016/j.exer.2005.06.002; LEE ME, 1990, J CLIN INVEST, V86, P141, DOI 10.1172/JCI114677; LEPPLEWIENHUES A, 1992, CURR EYE RES, V11, P1041, DOI 10.3109/02713689209015075; Levin LA, 1999, SURV OPHTHALMOL, V43, pS98, DOI 10.1016/S0039-6257(99)00027-2; MACCUMBER MW, 1991, ARCH OPHTHALMOL-CHIC, V109, P705, DOI 10.1001/archopht.1991.01080050121041; MACCUMBER MW, 1994, ARCH OPHTHALMOL-CHIC, V112, P1231, DOI 10.1001/archopht.1994.01090210119024; MACCUMBER MW, 1989, P NATL ACAD SCI USA, V86, P7285, DOI 10.1073/pnas.86.18.7285; MACCUMBER MW, 1990, P NATL ACAD SCI USA, V87, P2359, DOI 10.1073/pnas.87.6.2359; McKinnon SJ, 2002, MOL THER, V5, P780, DOI 10.1006/mthe.2002.0608; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Murphy JA, 2010, BRIT J OPHTHALMOL, V94, P1233, DOI 10.1136/bjo.2009.172098; Nie XJ, 1996, REV NEUROSCIENCE, V7, P177; Orgul S, 1996, INVEST OPHTH VIS SCI, V37, P1860; Osborne NN, 2008, PROG BRAIN RES, V173, P339, DOI 10.1016/S0079-6123(08)01124-2; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; Prasanna G, 2005, PHARMACOL RES, V51, P41, DOI 10.1016/j.phrs.2004.04.006; Prasanna G, 2003, MOL CELL BIOCHEM, V253, P71, DOI 10.1023/A:1026005418874; Prasanna G, 2011, EXP EYE RES, V93, P170, DOI 10.1016/j.exer.2010.09.006; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1995, AUST NZ J OPHTHALMOL, V23, P85, DOI 10.1111/j.1442-9071.1995.tb00135.x; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P135, DOI 10.1001/archopht.1982.01030030137016; Rao VR, 2007, EXP EYE RES, V84, P1115, DOI 10.1016/j.exer.2007.02.010; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Resch H, 2009, INVEST OPHTH VIS SCI, V50, P358, DOI 10.1167/iovs.08-2460; Rodieck RW, 1973, VERTEBRATE RETINA PR, Vx; Rosenthal R, 2011, BRIT J PHARMACOL, V162, P806, DOI 10.1111/j.1476-5381.2010.01103.x; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; SCATCHARD G, 1949, CHEM REV, V44, P7, DOI 10.1021/cr60137a002; Schlamp CL, 2001, MOL VIS, V7, P192; Stitt AW, 1996, CURR EYE RES, V15, P111, DOI 10.3109/02713689609017618; SUGIYAMA T, 1995, SURV OPHTHALMOL, V39, pS49, DOI 10.1016/S0039-6257(05)80073-6; Tao WH, 1998, CURR EYE RES, V17, P31, DOI 10.1076/ceyr.17.1.31.5256; Tezel G, 1997, J GLAUCOMA, V6, P83; Torbidoni V, 2005, EXP EYE RES, V81, P265, DOI 10.1016/j.exer.2004.12.024; Varela HJ, 1997, J GLAUCOMA, V6, P303; Vorwerk CK, 1996, INVEST OPHTH VIS SCI, V37, P1618; Wang L, 2006, ARCH OPHTHALMOL-CHIC, V124, P717, DOI 10.1001/archopht.124.5.717; Wang X, 2009, EXP EYE RES, V88, P378, DOI 10.1016/j.exer.2008.09.009; Watanabe M, 2002, PROG RETIN EYE RES, V21, P529, DOI 10.1016/S1350-9462(02)00037-X; Weishaupt JH, 2003, NEUROBIOL DIS, V13, P124, DOI 10.1016/S0969-9961(03)00032-9; Wollensak G, 1998, CURR EYE RES, V17, P541, DOI 10.1076/ceyr.17.5.541.5187; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016	81	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43199	10.1371/journal.pone.0043199	http://dx.doi.org/10.1371/journal.pone.0043199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916224	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800053
J	Saur, M; Moeller, V; Kapetanopoulos, K; Braukmann, S; Gebauer, W; Tenzer, S; Markl, J				Saur, Michael; Moeller, Vanessa; Kapetanopoulos, Katharina; Braukmann, Sandra; Gebauer, Wolfgang; Tenzer, Stefan; Markl, Juergen			Acetylcholine-Binding Protein in the Hemolymph of the Planorbid Snail Biomphalaria glabrata Is a Pentagonal Dodecahedron (60 Subunits)	PLOS ONE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; RECEPTOR GENE FAMILY; CYS-LOOP RECEPTORS; MOLECULAR-MODEL; QUATERNARY STRUCTURE; NICOTINIC RECEPTORS; CRYSTAL-STRUCTURE; OXYGEN-TRANSPORT; FUNCTIONAL UNITS; CRYOEM STRUCTURE	Nicotinic acetylcholine receptors (nAChR) play important neurophysiological roles and are of considerable medical relevance. They have been studied extensively, greatly facilitated by the gastropod acetylcholine-binding proteins (AChBP) which represent soluble structural and functional homologues of the ligand-binding domain of nAChR. All these proteins are ring-like pentamers. Here we report that AChBP exists in the hemolymph of the planorbid snail Biomphalaria glabrata (vector of the schistosomiasis parasite) as a regular pentagonal dodecahedron, 22 nm in diameter (12 pentamers, 60 active sites). We sequenced and recombinantly expressed two similar to 25 kDa polypeptides (BgAChBP1 and BgAChBP2) with a specific active site, N-glycan site and disulfide bridge variation. We also provide the exon/intron structures. Recombinant BgAChBP1 formed pentamers and dodecahedra, recombinant BgAChBP2 formed pentamers and probably disulfide-bridged di-pentamers, but not dodecahedra. Three-dimensional electron cryo-microscopy (3D-EM) yielded a 3D reconstruction of the dodecahedron with a resolution of 6 angstrom. Homology models of the pentamers docked to the 6 angstrom structure revealed opportunities for chemical bonding at the inter-pentamer interfaces. Definition of the ligand-binding pocket and the gating C-loop in the 6 angstrom structure suggests that 3D-EM might lead to the identification of functional states in the BgAChBP dodecahedron.	[Saur, Michael; Moeller, Vanessa; Kapetanopoulos, Katharina; Braukmann, Sandra; Gebauer, Wolfgang; Markl, Juergen] Johannes Gutenberg Univ Mainz, Inst Zool, D-6500 Mainz, Germany; [Tenzer, Stefan] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Saur, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Saarstr 21, D-6500 Mainz, Germany.	markl@uni-mainz.de	Tenzer, Stefan/AAE-2180-2020	Tenzer, Stefan/0000-0003-3034-0017; Saur, Michael/0000-0002-6612-6656; Moeller, Arne/0000-0003-1101-5366	DFG (German Research Foundation); Government of Rhineland-Palatinate via the Center of Immunology of the Johannes Gutenberg University in Mainz	DFG (German Research Foundation)(German Research Foundation (DFG)); Government of Rhineland-Palatinate via the Center of Immunology of the Johannes Gutenberg University in Mainz	This work was funded in part by the DFG (German Research Foundation [www.dfg.de]) in the framework of the research training group 1043 "Immunotherapy'' (VM: grant; JM: consumables), and by the Government of Rhineland-Palatinate via the Center of Immunology of the Johannes Gutenberg University in Mainz [www.uni-mainz.de] (ST: financial support of Core Facility "mass spectrometry'', JM: financial support of Core Facility "3D-EM''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2007, ZOOLOGICA SCRIPTA, V36, P13; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amos FF, 2009, BIOMACROMOLECULES, V10, P3298, DOI 10.1021/bm900893f; Babakhani A, 2009, COMPUT BIOL CHEM, V33, P160, DOI 10.1016/j.compbiolchem.2008.12.002; Banks G, 2009, FASEB J, V23, P3030, DOI 10.1096/fj.08-117135; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bourne Y, 2010, P NATL ACAD SCI USA, V107, P6076, DOI 10.1073/pnas.0912372107; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Fornasari MS, 2004, MOL BIOL EVOL, V21, P97, DOI 10.1093/molbev/msg244; Fuschiotti P, 2006, J MOL BIOL, V356, P510, DOI 10.1016/j.jmb.2005.11.048; Gatsogiannis C, 2007, J MOL BIOL, V374, P465, DOI 10.1016/j.jmb.2007.09.036; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Grant T., 2007, THESIS IMPERIAL COLL; Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; HARRIS JR, 1994, EUR J BIOCHEM, V225, P521, DOI 10.1111/j.1432-1033.1994.00521.x; HERSKOVITS TT, 1994, COMP BIOCHEM PHYS B, V107, P433, DOI 10.1016/0305-0491(94)90208-9; HERSKOVITS TT, 1990, COMP BIOCHEM PHYS B, V95, P321, DOI 10.1016/0305-0491(90)90083-6; Huang J, 2009, MAR BIOTECHNOL, V11, P596, DOI 10.1007/s10126-008-9176-8; Ilan E, 1986, BIOCHEMISTRY-US, V25, P4; Jaenicke E, 2003, BIOCHEM J, V375, P681, DOI 10.1042/BJ20030726; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P67, DOI 10.1007/s10158-006-0039-6; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; Jorgensen A, 2004, MOL PHYLOGENET EVOL, V32, P778, DOI 10.1016/j.ympev.2004.02.011; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lieb B, 2001, P NATL ACAD SCI USA, V98, P4546, DOI 10.1073/pnas.071049998; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Maksay Gabor, 2009, Curr Mol Pharmacol, V2, P253; MANGUM CP, 1975, J EXP ZOOL, V191, P279, DOI 10.1002/jez.1401910213; MANGUM CP, 1985, AM J PHYSIOL, V248, pR505, DOI 10.1152/ajpregu.1985.248.5.R505; Markl J, 2009, J MOL BIOL, V392, P362, DOI 10.1016/j.jmb.2009.06.082; McCormack T, 2010, BIOCHEMISTRY-US, V49, P2279, DOI 10.1021/bi902023y; Meissner U, 2007, MICRON, V38, P29, DOI 10.1016/j.micron.2006.04.010; Moeller V, 2011, IUBMB LIFE, V63, P323, DOI 10.1002/iub.453; Page R.D., 2002, CURRENT PROTOCOLS BI, V6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Romanelli MN, 2003, MED RES REV, V23, P393, DOI 10.1002/med.10037; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shao YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-324; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; TERWILLIGER NB, 1976, BIOCHIM BIOPHYS ACTA, V453, P101, DOI 10.1016/0005-2795(76)90254-3; Tsetlin V, 2011, J NEUROCHEM, V116, P734, DOI 10.1111/j.1471-4159.2010.07060.x; TZARTOS SJ, 1991, AUTOIMMUNITY, V8, P259, DOI 10.3109/08916939109007633; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wigand P, 2009, J AGR FOOD CHEM, V57, P4328, DOI 10.1021/jf8034836; WOOD EJ, 1975, BIOCHEM J, V149, P437, DOI 10.1042/bj1490437; Yakel JL, 2010, J PHYSIOL-LONDON, V588, P597, DOI 10.1113/jphysiol.2009.182691	58	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43685	10.1371/journal.pone.0043685	http://dx.doi.org/10.1371/journal.pone.0043685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916297	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800095
J	Thakur, S; Feng, XL; Shi, ZQ; Ganapathy, A; Mishra, MK; Atadja, P; Morris, D; Riabowol, K				Thakur, Satbir; Feng, Xiaolan; Shi, Zhong Qiao; Ganapathy, Amudha; Mishra, Manoj Kumar; Atadja, Peter; Morris, Don; Riabowol, Karl			ING1 and 5-Azacytidine Act Synergistically to Block Breast Cancer Cell Growth	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; DEACETYLASE INHIBITORS; MESSENGER-RNA; APOPTOSIS; P33(ING1); EXPRESSION; P53; CARCINOMA; GENE; CHEMOSENSITIVITY	Background: Inhibitor of Growth (ING) proteins are epigenetic "readers'' that recognize trimethylated lysine 4 of histone H3 (H3K4Me3) and target histone acetyl transferase (HAT) and histone deacetylase (HDAC) complexes to chromatin. Methods and Principal Findings: Here we asked whether dysregulating two epigenetic pathways with chemical inhibitors showed synergistic effects on breast cancer cell line killing. We also tested whether ING1 could synergize better with chemotherapeutics that target the same epigenetic mechanism such as the HDAC inhibitor LBH589 (Panobinostat) or a different epigenetic mechanism such as 5-azacytidine (5azaC), which inhibits DNA methyl transferases. Simultaneous treatment of breast cancer cell lines with LBH589 and 5azaC did not show significant synergy in killing cells. However, combination treatment of ING1 with either LBH589 or 5azaC did show synergy. The combination of ING1b with 5azaC, which targets two distinct epigenetic mechanisms, was more effective at lower doses and enhanced apoptosis as determined by Annexin V staining and cleavage of caspase 3 and poly-ADP-ribose polymerase (PARP). ING1b plus 5azaC also acted synergistically to increase gamma H2AX staining indicating significant levels of DNA damage were induced. Adenoviral delivery of ING1b with 5azaC also inhibited cancer cell growth in a murine xenograft model and led to tumor regression when viral concentration was optimized in vivo. Conclusions: These data show that targeting distinct epigenetic pathways can be more effective in blocking cancer cell line growth than targeting the same pathway with multiple agents, and that using viral delivery of epigenetic regulators can be more effective in synergizing with a chemical agent than using two chemotherapeutic agents. This study also indicates that the ING1 epigenetic regulator may have additional activities in the cell when expressed at high levels.	[Thakur, Satbir; Feng, Xiaolan; Ganapathy, Amudha; Riabowol, Karl] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Thakur, Satbir; Feng, Xiaolan; Shi, Zhong Qiao; Ganapathy, Amudha; Morris, Don; Riabowol, Karl] So Alberta Canc Res Inst, Calgary, AB, Canada; [Shi, Zhong Qiao; Morris, Don] Univ Calgary, Tom Baker Canc Ctr, Dept Med & Oncol, Calgary, AB, Canada; [Mishra, Manoj Kumar] Univ Calgary, Dept Oncol & Clin Neurosci, Calgary, AB, Canada; [Atadja, Peter] Novartis Inst Biomed Res, Shanghai, Peoples R China	University of Calgary; Tom Baker Cancer Clinic; University of Calgary; University of Calgary; Novartis	Thakur, S (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	karl@ucalgary.ca	Ganapathy, Amudha/ABI-6930-2020; Feng, Xiaolan/J-9997-2019; Mishra, Manoj/A-7105-2018	Mishra, Manoj/0000-0001-9636-4930; Feng, Xiaolan/0000-0002-7333-8198	Alberta Cancer Foundation; Alberta Innovates Health Solutions; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Alberta Cancer Foundation; Alberta Innovates Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This study was supported by grants to DM from the Alberta Cancer Foundation and Alberta Innovates Health Solutions, and to KR from Alberta Innovates Health Solutions and the Canadian Institutes of Health Research. XF is recipient of an Alberta Heritage Foundation for Medical Research Studentship and KR is a Scientist of the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Atadja PW, 2011, PROG DRUG RES, V67, P175, DOI 10.1007/978-3-7643-8989-5_9; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Cheung KJ, 2002, EXP CELL RES, V279, P291, DOI 10.1006/excr.2002.5610; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eastman A, 1999, SEMIN ONCOL, V26, P7; Garkavtsev I, 2005, CANCER BIOL THER, V4, P48; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Han XJ, 2008, NAT CELL BIOL, V10, P1333, DOI 10.1038/ncb1792; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Helbing CC, 1997, CANCER RES, V57, P1255; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Kim TY, 2006, EPIGENETICS-US, V1, P14; Kiziltepe T, 2007, MOL CANCER THER, V6, P1718, DOI 10.1158/1535-7163.MCT-07-0010; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; Kuendgen A, 2008, ANN HEMATOL, V87, P601, DOI 10.1007/s00277-008-0477-9; Li ZY, 2010, CANCER BIOTHER RADIO, V25, P427, DOI 10.1089/cbr.2010.0778; Liu Jian-ying, 2003, Zhonghua Bing Li Xue Za Zhi, V32, P48; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Maher Stacey K, 2009, Curr Drug Targets, V10, P392; Mandili G, 2012, FEBS J, V279, P2182, DOI 10.1111/j.1742-4658.2012.08602.x; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Nouman GS, 2003, J CLIN PATHOL, V56, P507, DOI 10.1136/jcp.56.7.507; Oki Y, 2007, CRIT REV ONCOL HEMAT, V61, P140, DOI 10.1016/j.critrevonc.2006.07.010; Raguz S, 2008, BRIT J CANCER, V99, P387, DOI 10.1038/sj.bjc.6604510; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Sanchez-Abarca LI, 2010, BLOOD, V115, P107, DOI 10.1182/blood-2009-03-210393; Scott M, 2001, J CELL SCI, V114, P3455; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shimada H, 2002, ONCOGENE, V21, P1208, DOI 10.1038/sj.onc.1205176; Shinoura N, 1999, CANCER RES, V59, P5521; Smith KT, 2010, CHEM BIOL, V17, P65, DOI 10.1016/j.chembiol.2009.12.010; Soriano AO, 2007, BLOOD, V110, P2302, DOI 10.1182/blood-2007-03-078576; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; Tallen G, 2003, ANTICANCER RES, V23, P1631; Thalappilly S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021065; Tokunaga E, 2000, CANCER LETT, V152, P15, DOI 10.1016/S0304-3835(99)00434-6; Toyama T, 1999, ONCOGENE, V18, P5187, DOI 10.1038/sj.onc.1202905; Toyama T, 2003, J STEROID BIOCHEM, V87, P57, DOI 10.1016/S0960-0760(03)00388-1; Toyama Tatsuya, 2004, Breast Cancer, V11, P33, DOI 10.1007/BF02967999; Vieyra D, 2002, CANCER RES, V62, P4445; Wu J C, 1985, Prog Clin Biol Res, V198, P119; Xie Y, 2011, CANCER GENE THER, V18, P176, DOI 10.1038/cgt.2010.67; Xie YF, 2008, CANCER LETT, V271, P105, DOI 10.1016/j.canlet.2008.05.050; Zhang X, 2004, FEBS LETT, V570, P7, DOI 10.1016/j.febslet.2004.06.010; Zhao Y, 2011, CANC LETT; Zhu Jin-Jun, 2004, Ai Zheng, V23, P640; Zhu Y, 2011, CANCER GENE THER, V18, P627, DOI 10.1038/cgt.2011.31; Zhu Z, 2005, WORLD J GASTROENTERO, V11, P1903	53	25	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43671	10.1371/journal.pone.0043671	http://dx.doi.org/10.1371/journal.pone.0043671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916295	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800093
J	Wang, Y; Zhou, GS				Wang, Yu; Zhou, Guangsheng			Light Use Efficiency over Two Temperate Steppes in Inner Mongolia, China	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; CARBON-DIOXIDE EXCHANGE; ECOSYSTEM CO2 EXCHANGE; NET ECOSYSTEM; PRIMARY PRODUCTIVITY; TERRESTRIAL BIOSPHERE; SATELLITE; MODIS; RESPIRATION; VARIABILITY	Vegetation light use efficiency (LUE) is a key parameter of Production Efficiency Models (PEMs) for simulating gross primary production (GPP) of vegetation, from regional to global scales. Previous studies suggest that grasslands have the largest inter-site variation of LUE and controlling factors of grassland LUE differ from those of other biomes, since grasslands are usually water-limited ecosystems. Combining eddy covariance flux data with the fraction of photosynthetically active radiation absorbed by the plant canopy from MODIS, we report LUE on a typical steppe and a desert steppe in Inner Mongolia, northern China. Results show that both annual average LUE and maximum LUE were higher on the desert steppe (0.51 and 1.13 g C MJ(-1)) than on the typical steppe (0.34 and 0.88 g C MJ(-1)), despite the higher GPP of the latter. Water availability was the primary limiting factor of LUE at both sites. Evaporative fraction (EF) or the ratio of actual evapotranspiration to potential evapotranspiration (AET/PET) can explain 50-70% of seasonal LUE variations at both sites. However, the slope of linear regression between LUE and EF (or AET/PET) differed significantly between the two sites. LUE increased with the diffuse radiation ratio on the typical steppe; however, such a trend was not found for the desert steppe. Our results suggest that a biome-dependent LUEmax is inappropriate, because of the large inter-site difference of LUEmax within the biome. EF could be a promising down-regulator on grassland LUE for PEMs, but there may be a site-specific relationship between LUE and EF.	[Wang, Yu; Zhou, Guangsheng] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Wang, Yu] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Meteorological Sciences (CAMS)	Wang, Y (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	gszhou@ibcas.ac.cn		Wang, Yu/0000-0003-2085-0064	State Key Development Program of Basic Research [2010CB951303]; Strategic Priority Research Program Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences [XDA05050408]	State Key Development Program of Basic Research; Strategic Priority Research Program Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences	This research was jointly supported by State Key Development Program of Basic Research (2010CB951303) and Strategic Priority Research Program Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences (XDA05050408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Canadell JG, 2000, ECOSYSTEMS, V3, P115, DOI 10.1007/s100210000014; Choudhury BJ, 2001, REMOTE SENS ENVIRON, V75, P1, DOI 10.1016/S0034-4257(00)00151-6; Connolly J, 2009, BIOGEOSCIENCES, V6, P225, DOI 10.5194/bg-6-225-2009; Fang HL, 2012, REMOTE SENS ENVIRON, V119, P43, DOI 10.1016/j.rse.2011.12.006; Fensholt R, 2004, REMOTE SENS ENVIRON, V91, P490, DOI 10.1016/j.rse.2004.04.009; Garbulsky MF, 2010, GLOBAL ECOL BIOGEOGR, V19, P253, DOI 10.1111/j.1466-8238.2009.00504.x; Gilmanov TG, 2007, AGR ECOSYST ENVIRON, V121, P93, DOI 10.1016/j.agee.2006.12.008; Gong Z., 2014, CHINESE SOIL GEOGRAP; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Gu LH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001242; Guindin-Garcia N, 2012, AGR FOREST METEOROL, V161, P15, DOI 10.1016/j.agrformet.2012.03.012; Horn JE, 2011, BIOGEOSCIENCES, V8, P999, DOI 10.5194/bg-8-999-2011; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Letts MG, 2005, ECOSCIENCE, V12, P53, DOI 10.2980/i1195-6860-12-1-53.1; Li LH, 1998, ACTA BOT SIN, V40, P955; Li SG, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2006JG000349; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; Murray S., 2000, PILOT ANAL GLOBAL EC; Myneni R. B., 2003, USERS GUIDE FPAR LAI; Niyogi D, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020915; Nouvellon Y, 2000, AGR FOREST METEOROL, V105, P21, DOI 10.1016/S0168-1923(00)00194-5; Polley HW, 2011, ECOSYSTEMS, V14, P15, DOI 10.1007/s10021-010-9389-3; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schwalm CR, 2006, AGR FOREST METEOROL, V140, P269, DOI 10.1016/j.agrformet.2006.06.010; Serrano-Ortiz P, 2010, AGR FOREST METEOROL, V150, P321, DOI 10.1016/j.agrformet.2010.01.002; SHABANOV N, 2007, COLLECTION 5 MODIS L; Turner DP, 2009, REMOTE SENS ENVIRON, V113, P1529, DOI 10.1016/j.rse.2009.03.003; Turner DP, 2003, GLOBAL CHANGE BIOL, V9, P383, DOI 10.1046/j.1365-2486.2003.00573.x; Turner DP, 2005, GLOBAL CHANGE BIOL, V11, P666, DOI 10.1111/j.1365-2486.2005.00936.x; Wang HS, 2010, REMOTE SENS ENVIRON, V114, P2248, DOI 10.1016/j.rse.2010.05.001; Wang YL, 2008, AGR FOREST METEOROL, V148, P714, DOI 10.1016/j.agrformet.2008.01.013; World Resources Institute, 2000, WORLD RES 2000 2001, P119; Xiao XM, 2006, IEEE T GEOSCI REMOTE, V44, P1933, DOI 10.1109/TGRS.2006.874796; Xiao XM, 2005, REMOTE SENS ENVIRON, V94, P105, DOI 10.1016/j.rse.2004.08.015; Xiao XM, 2004, REMOTE SENS ENVIRON, V89, P519, DOI 10.1016/j.rse.2003.11.008; Yang FL, 2011, AGR ECOSYST ENVIRON, V142, P318, DOI 10.1016/j.agee.2011.05.032; Yuan H, 2011, REMOTE SENS ENVIRON, V115, P1171, DOI 10.1016/j.rse.2011.01.001; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; Zhang M, 2011, AGR FOREST METEOROL, V151, P803, DOI 10.1016/j.agrformet.2011.01.011	44	11	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43614	10.1371/journal.pone.0043614	http://dx.doi.org/10.1371/journal.pone.0043614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916283	Green Published, gold			2022-12-27	WOS:000307733800082
J	Wu, BTF; Dyer, RA; King, DJ; Richardson, KJ; Innis, SM				Wu, Brian T. F.; Dyer, Roger A.; King, D. Janette; Richardson, Kelly J.; Innis, Sheila M.			Early Second Trimester Maternal Plasma Choline and Betaine Are Related to Measures of Early Cognitive Development in Term Infants	PLOS ONE			English	Article							N-3 FATTY-ACIDS; HIPPOCAMPAL PLASTICITY; EMBRYONIC-DEVELOPMENT; PREGNANT-WOMEN; AVAILABILITY; ALTERS; SUPPLEMENTATION; HOMOCYSTEINE; MEMORY; DIMETHYLGLYCINE	Background: The importance of maternal dietary choline for fetal neural development and later cognitive function has been well-documented in experimental studies. Although choline is an essential dietary nutrient for humans, evidence that low maternal choline in pregnancy impacts neurodevelopment in human infants is lacking. We determined potential associations between maternal plasma free choline and its metabolites betaine and dimethylglycine in pregnancy and infant neurodevelopment at 18 months of age. Methodology: This was a prospective study of healthy pregnant women and their full-term, single birth infants. Maternal blood was collected at 16 and 36 weeks of gestation and infant neurodevelopment was assessed at 18 months of age for 154 mother-infant pairs. Maternal plasma choline, betaine, dimethylglycine, methionine, homocysteine, cysteine, total B12, holotranscobalamin and folate were quantified. Infant neurodevelopment was evaluated using the Bayley Scales of Infant Development-III. Multivariate regression, adjusting for covariates that impact development, was used to determine the associations between maternal plasma choline, betaine and dimethylglycine and infant neurodevelopment. Results: The maternal plasma free choline at 16 and 36 weeks gestation was median (interquartile range) 6.70 (5.78-8.03) and 9.40 (8.10-11.3) mu mol/L, respectively. Estimated choline intakes were (mean +/- SD) 383 +/- 98.6 mg/day, and lower than the recommended 450 mg/day. Betaine intakes were 142 +/- 70.2 mg/day. Significant positive associations were found between infant cognitive test scores and maternal plasma free choline (B = 6.054, SE = 2.283, p = 0.009) and betaine (B = 7.350, SE = 1.933, p = 0.0002) at 16 weeks of gestation. Maternal folate, total B12, or holotranscobalamin were not related to infant development. Conclusion: We show that choline status in the first half of pregnancy is associated with cognitive development among healthy term gestation infants. More work is needed on the potential limitation of choline or betaine in the diets of pregnant women.	[Wu, Brian T. F.; Dyer, Roger A.; King, D. Janette; Richardson, Kelly J.; Innis, Sheila M.] Univ British Columbia, Fac Med, Dept Paediat, Nutr & Metab Res Program,Child & Family Res Inst, Vancouver, BC, Canada	Child & Family Research Institute; University of British Columbia	Wu, BTF (corresponding author), Univ British Columbia, Fac Med, Dept Paediat, Nutr & Metab Res Program,Child & Family Res Inst, Vancouver, BC, Canada.	sinnis@mail.ubc.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded by a grant from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; Bayley N, 1993, BAYLEY SCALES INFANT; Brown L., 1997, TEST NONVERBAL INTEL; Cheng RK, 2008, LEARN MEMORY, V15, P153, DOI 10.1101/lm.729408; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Depeint F, 2006, CHEM-BIOL INTERACT, V163, P113, DOI 10.1016/j.cbi.2006.05.010; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Friesen RW, 2007, J NUTR, V137, P2641; Glenn MJ, 2008, BRAIN RES, V1237, P110, DOI 10.1016/j.brainres.2008.08.049; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Ilcol Y. Ozarda, 2002, Archives of Physiology and Biochemistry, V110, P393, DOI 10.1076/apab.110.5.393.11832; Ilcol YO, 2005, J NUTR BIOCHEM, V16, P489, DOI 10.1016/j.jnutbio.2005.01.011; Innis SM, 2008, AM J CLIN NUTR, V87, P548, DOI 10.1093/ajcn/87.3.548; Innis SM, 2006, J NUTR, V136, P2226, DOI 10.1093/jn/136.8.2226; Innis SM, 2003, AM J CLIN NUTR, V77, P473, DOI 10.1093/ajcn/77.2.473; Institute of Medicine National Academy of Sciences, 1998, DIET REF INT FOL THI, P390; Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mehedint MG, 2010, FASEB J, V24, P184, DOI 10.1096/fj.09-140145; Molloy AM, 2005, AM J CLIN NUTR, V82, P836, DOI 10.1093/ajcn/82.4.836; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; Patterson KY., 2008, USDA DATABASE CHOLIN; Signore C, 2008, AM J CLIN NUTR, V87, P896, DOI 10.1093/ajcn/87.4.896; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Velzing-Aarts FV, 2005, AM J CLIN NUTR, V81, P1383; WHO: World Health Organization, 2010, WHO CHILD GROWTH STA; Wong-Goodrich SJE, 2008, BRAIN RES, V1237, P153, DOI 10.1016/j.brainres.2008.08.074; Wu BT, 2012, BR J NUTR IN PRESS; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zeisel SH, 2011, SEMIN CELL DEV BIOL, V22, P624, DOI 10.1016/j.semcdb.2011.06.002	39	93	96	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43448	10.1371/journal.pone.0043448	http://dx.doi.org/10.1371/journal.pone.0043448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916264	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800068
J	Soffler, C; Bosco-Lauth, AM; Aboellail, TA; Marolf, AJ; Bowen, RA				Soffler, Carl; Bosco-Lauth, Angela M.; Aboellail, Tawfik A.; Marolf, Angela J.; Bowen, Richard A.			Development and Characterization of a Caprine Aerosol Infection Model of Melioidosis	PLOS ONE			English	Article							PSEUDOMONAS-PSEUDOMALLEI; BURKHOLDERIA-PSEUDOMALLEI; PULMONARY MELIOIDOSIS; SEPTICEMIC MELIOIDOSIS; DIAGNOSIS; THAILAND; GOATS; EPIDEMIOLOGY; AUSTRALIA; SPECTRUM	Infection with Burkholderia pseudomallei causes the disease melioidosis, which often presents as a serious suppurative infection that is typically fatal without intensive treatment and is a significant emerging infectious disease in Southeast Asia. Despite intensive research there is still much that remains unknown about melioidosis pathogenesis. New animal models of melioidosis are needed to examine novel aspects of pathogenesis as well as for the evaluation of novel therapeutics. The objective of the work presented here was to develop a subacute to chronic caprine model of melioidosis and to characterize the progression of disease with respect to clinical presentation, hematology, clinical microbiology, thoracic radiography, and gross and microscopic pathology. Disease was produced in all animals following an intratracheal aerosol of 10(4) CFU delivered, with variable clinical manifestations indicative of subacute and chronic disease. Bronchointerstitial pneumonia was apparent microscopically by day 2 and radiographically and grossly apparent by day 7 post infection (PI). Early lesions of bronchopneumonia soon progressed to more severe bronchointerstitial pneumonia with pyogranuloma formation. Extrapulmonary dissemination appeared to be a function of pyogranuloma invasion of pulmonary vasculature, which peaked around day 7 PI. Histopathology indicated that leukocytoclastic vasculitis was the central step in dissemination of B. pseudomallei from the lungs as well as in the establishment of new lesions. While higher doses of organism in goats can produce acute fatal disease, the dose investigated and resulting disease had many similarities to human melioidosis and may warrant further development to provide a model for the study of both natural and bioterrorism associated disease.	[Soffler, Carl; Aboellail, Tawfik A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bosco-Lauth, Angela M.; Bowen, Richard A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Marolf, Angela J.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Soffler, C (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	richard.bowen@colostate.edu	Aboellail, Tawfik/AAB-8990-2019	Aboellail, Tawfik/0000-0003-0989-5333	NIH/NCRR (National Center for Research Resources) Ruth L. Kirschstein Institutional NIH [T32-RR-007072]; NIAID (National Institute of Allergy and Infectious Diseases), NIH [AI065357]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER	NIH/NCRR (National Center for Research Resources) Ruth L. Kirschstein Institutional NIH; NIAID (National Institute of Allergy and Infectious Diseases), NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NCRR (National Center for Research Resources) Ruth L. Kirschstein Institutional NIH T32-RR-007072 and AI065357 from NIAID (National Institute of Allergy and Infectious Diseases), NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAID or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATISOOK K, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P637; Bateson E M, 1981, Australas Radiol, V25, P239, DOI 10.1111/j.1440-1673.1981.tb02255.x; BRUNDAGE WG, 1968, AM J TROP MED HYG, V17, P183, DOI 10.4269/ajtmh.1968.17.183; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chong V F, 1996, Australas Radiol, V40, P244, DOI 10.1111/j.1440-1673.1996.tb00395.x; Choy JL, 2000, ACTA TROP, V74, P153, DOI 10.1016/S0001-706X(99)00065-0; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; DHIENSIRI T, 1988, RADIOLOGY, V166, P711, DOI 10.1148/radiology.166.3.3340766; EVERETT ED, 1975, AM REV RESPIR DIS, V112, P331; FATIMAH I, 1984, VET REC, V114, P67, DOI 10.1136/vr.114.3.67; Gilad J, 2007, ISR MED ASSOC J, V9, P499; GREENAWALD KA, 1969, AM J CLIN PATHOL, V52, P188; HARRIES EJ, 1948, LANCET, V254, P363; Huisin't Veld D, 2005, AM J TROP MED HYG, V73, P657; IP M, 1995, CHEST, V108, P1420, DOI 10.1378/chest.108.5.1420; Ketai L, 2006, J THORAC IMAG, V21, P265, DOI 10.1097/01.rti.0000213575.01657.4e; LAWS L., 1964, AUSTRALIAN VETERINARY J, V40, P309, DOI 10.1111/j.1751-0813.1964.tb04524.x; LAWS L., 1963, Queensland J. Agric. Sci, V20, P499; LEWIS F. A., 1952, AUSTRALIAN VET JOUR, V28, P145, DOI 10.1111/j.1751-0813.1952.tb05152.x; Lim KS, 2010, CLIN RADIOL, V65, P66, DOI 10.1016/j.crad.2009.08.008; Limmathurotsakul D, 2005, J CLIN MICROBIOL, V43, P2274, DOI 10.1128/JCM.43.5.2274-2276.2005; Limmathurotsakul D, 2011, BR MED B; Limmathurotsakul D, 2012, EMERG INFECT DIS, V18, P325, DOI 10.3201/eid1802.111347; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Limmathurotsakul D, 2009, AM J TROP MED HYG, V81, P335, DOI 10.4269/ajtmh.2009.81.335; Muttarak M, 2009, BRIT J RADIOL, V82, P514, DOI 10.1259/bjr/15785231; NARITA M, 1982, NATL I ANIM HEALTH Q, V22, P170; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; OLDS R. J., 1954, Australian Veterinary Journal, V30, P253, DOI 10.1111/j.1751-0813.1954.tb05416.x; OMAR AR, 1963, J COMP PATHOL THERAP, V73, P359, DOI 10.1016/S0368-1742(63)80038-7; PATTERSON MC, 1967, J AMER MED ASSOC, V200, P447; Pearson T, 2007, INFECT GENET EVOL, V7, P416, DOI 10.1016/j.meegid.2006.12.002; PIGGOTT JA, 1970, ARCH PATHOL, V90, P101; PUTHUCHEARY SD, 1992, T ROY SOC TROP MED H, V86, P683, DOI 10.1016/0035-9203(92)90191-E; Reechaipichitkul Wipa, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P664; RETNASABAPATHY A, 1966, VET REC, V79, P166, DOI 10.1136/vr.79.6.166-a; Simpson AJH, 1999, J CLIN PATHOL, V52, P616, DOI 10.1136/jcp.52.8.616; Sprague LD, 2004, J VET MED B, V51, P305, DOI 10.1111/j.1439-0450.2004.00797.x; Stanton AT, 1925, LANCET, V1, P10; Strauss J M, 1969, Med J Malaya, V24, P94; SUTMO'LLER P., 1957, JOUR AMER VET MED ASSOC, V130, P415; THOMAS AD, 1988, AUST VET J, V65, P43, DOI 10.1111/j.1751-0813.1988.tb07350.x; Titball Richard W, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS111, DOI 10.1016/S0035-9203(08)70026-9; VANDERLUGT JJ, 1995, J S AFR VET ASSOC, V66, P71; Whitmore A, 1912, Ind Med Gaz, V47, P262; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x; Wuthiekanun V, 2007, AM J TROP MED HYG, V77, P812, DOI 10.4269/ajtmh.2007.77.812	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43207	10.1371/journal.pone.0043207	http://dx.doi.org/10.1371/journal.pone.0043207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916225	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600060
J	Dahodwala, N; Karlawish, J; Shea, JA; Zubritsky, C; Stern, M; Mandell, DS				Dahodwala, Nabila; Karlawish, Jason; Shea, Judy A.; Zubritsky, Cynthia; Stern, Matthew; Mandell, David S.			Validation of an Instrument to Measure Older Adults' Expectations Regarding Movement (ERM)	PLOS ONE			English	Article							EARLY PARKINSONS-DISEASE; CONTROLLED-TRIAL; PREVALENCE; AGE; LEVODOPA; ATTRIBUTION; POPULATION; RASAGILINE; DISABILITY; HEALTH	Background: Many individuals with Parkinson's disease are not diagnosed and treated. Attitudes about aging and related help-seeking may affect the timely diagnosis of Parkinson's disease. Our objectives were to develop measures of older adults' expectations regarding movement with aging, specifically related to parkinsonism, and their beliefs about seeking healthcare for the diagnosis and treatment of parkinsonism. Methods: We established content and face validity from interviews with experts, review of the literature, and pre-testing with key informants. Two 9-item instruments resulted: Expectations Regarding Movement (ERM) and Healthcare Seeking Beliefs for parkinsonism (HSB). These instruments were administered to 210 older adults at senior centers to investigate internal consistency and construct validity. Results: 192 (91%) of the older adults completed more than 90% of the survey. The mean age was 76; 17 (9%) reported parkinsonism. Both scales demonstrated good internal consistency (alpha = 0.90). Factor analysis supported construct validity of the ERM and HSB scores. Older age, lower education, worse self-reported health and African American race each were associated with lower ERM scores, but not HSB scores. Conclusion: The ERM, a brief measure of expectations regarding movement with aging, shows reliability and validity. This scale may be useful in identifying older adults at increased risk for under-identification of Parkinson's disease. Further work is needed to measure healthcare seeking for parkinsonism.	[Dahodwala, Nabila; Stern, Matthew] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Karlawish, Jason; Shea, Judy A.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Zubritsky, Cynthia; Mandell, David S.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Dahodwala, N (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	dahodwan@mail.med.upenn.edu	Mandell, David S/H-2730-2012	Mandell, David S/0000-0001-8240-820X	Leonard Davis Institute of Health Economics at the University of Pennsylvania; Robert Wood Johnson Foundation Clinical Scholars Program; Philadelphia VA medical center; NATIONAL INSTITUTE ON AGING [K23AG034236] Funding Source: NIH RePORTER	Leonard Davis Institute of Health Economics at the University of Pennsylvania; Robert Wood Johnson Foundation Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF)); Philadelphia VA medical center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Leonard Davis Institute of Health Economics at the University of Pennsylvania, the Robert Wood Johnson Foundation Clinical Scholars Program and the Philadelphia VA medical center provided support for this research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P267, DOI 10.1002/mds.10362; Dahodwala N, 2011, NEUROEPIDEMIOLOGY, V36, P150, DOI 10.1159/000324935; Dahodwala N, 2009, MOVEMENT DISORD, V24, P1200, DOI 10.1002/mds.22557; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Dilworth-Anderson P, 2002, ALZ DIS ASSOC DIS, V16, pS56, DOI 10.1097/00002093-200200002-00005; Dotchin C, 2008, MOVEMENT DISORD, V23, P1567, DOI 10.1002/mds.21898; ETTINGER WH, 1994, J AM GERIATR SOC, V42, P1035, DOI 10.1111/j.1532-5415.1994.tb06206.x; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; KELLER ML, 1989, RES NURS HEALTH, V12, P247, DOI 10.1002/nur.4770120407; KESSLER II, 1972, AM J EPIDEMIOL, V96, P242, DOI 10.1093/oxfordjournals.aje.a121455; Kis B, 2002, NEUROLOGY, V58, P1820, DOI 10.1212/WNL.58.12.1820; Koller WC, 1997, NEUROLOGY S1, V49, P10; Lukwago SN, 2001, FAM COMMUNITY HEALTH, V24, P63, DOI 10.1097/00003727-200110000-00008; McInerney-Leo A, 2004, J NATL MED ASSOC, V96, P974; Melcon MO, 1997, MOVEMENT DISORD, V12, P197, DOI 10.1002/mds.870120210; PADDISON RM, 1974, NEUROLOGY, V24, P688, DOI 10.1212/WNL.24.7.688; PEARLMAN RA, 1988, J GERONTOL, V43, P25; Penney JB, 1996, ANN NEUROL, V39, P37; PROHASKA TR, 1987, HEALTH PSYCHOL, V6, P495, DOI 10.1037/0278-6133.6.6.495; RAKOWSKI W, 1992, AM J PUBLIC HEALTH, V82, P1139, DOI 10.2105/AJPH.82.8.1139; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Sarkisian CA, 2005, J GEN INTERN MED, V20, P911, DOI 10.1111/j.1525-1497.2005.0204.x; Sarkisian CA, 2005, GERONTOLOGIST, V45, P240, DOI 10.1093/geront/45.2.240; Sarkisian CA, 2003, J GEN INTERN MED, V18, P1001, DOI 10.1111/j.1525-1497.2003.30215.x; Sarkisian CA, 2002, J AM GERIATR SOC, V50, P1837, DOI 10.1046/j.1532-5415.2002.50513.x; Sarkisian CA, 2001, J AM GERIATR SOC, V49, P134, DOI 10.1046/j.1532-5415.2001.49033.x; Sarkisian CA, 2007, J AM GERIATR SOC, V55, P1842, DOI 10.1111/j.1532-5415.2007.01427.x; SCHOENBERG BS, 1985, NEUROLOGY, V35, P841, DOI 10.1212/WNL.35.6.841; Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937; Siderowf A, 2004, ARCH NEUROL-CHICAGO, V61, P561; Stern MB, 2004, MOVEMENT DISORD, V19, P916, DOI 10.1002/mds.20145; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; TANNER CM, 1990, ANN NEUROL, V28, P267; TISON F, 1994, ACTA NEUROL SCAND, V90, P111; UITTI RJ, 1993, NEUROLOGY, V43, P1918, DOI 10.1212/WNL.43.10.1918; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Williamson JD, 1996, J AM GERIATR SOC, V44, P1429, DOI 10.1111/j.1532-5415.1996.tb04066.x; Willis AW, 2010, NEUROEPIDEMIOLOGY, V34, P143, DOI 10.1159/000275491	39	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43854	10.1371/journal.pone.0043854	http://dx.doi.org/10.1371/journal.pone.0043854			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937110	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500112
J	Kumar, N; Cai, HY; von Mering, C; Baudis, M				Kumar, Nitin; Cai, Haoyang; von Mering, Christian; Baudis, Michael			Specific Genomic Regions Are Differentially Affected by Copy Number Alterations across Distinct Cancer Types, in Aggregated Cytogenetic Data	PLOS ONE			English	Article							HIGH-RESOLUTION ANALYSIS; ACUTE MYELOID-LEUKEMIA; GERM-CELL TUMORS; CGH DATA; MYELODYSPLASTIC SYNDROME; CHROMOSOMAL-ABERRATIONS; HYBRIDIZATION; LYMPHOMA; DNA; IMBALANCES	Background: Regional genomic copy number alterations (CNA) are observed in the vast majority of cancers. Besides specifically targeting well-known, canonical oncogenes, CNAs may also play more subtle roles in terms of modulating genetic potential and broad gene expression patterns of developing tumors. Any significant differences in the overall CNA patterns between different cancer types may thus point towards specific biological mechanisms acting in those cancers. In addition, differences among CNA profiles may prove valuable for cancer classifications beyond existing annotation systems. Principal Findings: We have analyzed molecular-cytogenetic data from 25579 tumors samples, which were classified into 160 cancer types according to the International Classification of Disease (ICD) coding system. When correcting for differences in the overall CNA frequencies between cancer types, related cancers were often found to cluster together according to similarities in their CNA profiles. Based on a randomization approach, distance measures from the cluster dendrograms were used to identify those specific genomic regions that contributed significantly to this signal. This approach identified 43 non-neutral genomic regions whose propensity for the occurrence of copy number alterations varied with the type of cancer at hand. Only a subset of these identified loci overlapped with previously implied, highly recurrent (hot-spot) cytogenetic imbalance regions. Conclusions: Thus, for many genomic regions, a simple null-hypothesis of independence between cancer type and relative copy number alteration frequency can be rejected. Since a subset of these regions display relatively low overall CNA frequencies, they may point towards second-tier genomic targets that are adaptively relevant but not necessarily essential for cancer development.	[Kumar, Nitin; Cai, Haoyang; von Mering, Christian; Baudis, Michael] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Kumar, Nitin; Cai, Haoyang; von Mering, Christian; Baudis, Michael] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Zurich; Swiss Institute of Bioinformatics	Kumar, N (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	mering@imls.uzh.ch; mbaudis@imls.uzh.ch	von Mering, Christian/B-3300-2008; Baudis, Michael/J-4602-2012	von Mering, Christian/0000-0001-7734-9102; Baudis, Michael/0000-0002-9903-4248				Aktas D, 2006, CANCER GENET CYTOGEN, V171, P72, DOI 10.1016/j.cancergencyto.2006.06.010; Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036944; Cheung KJJ, 2010, GENE CHROMOSOME CANC, V49, P669, DOI 10.1002/gcc.20780; Cordoba I, 2012, CANCER-AM CANCER SOC, V118, P127, DOI 10.1002/cncr.26279; Ferreira BI, 2008, HAEMATOLOGICA, V93, P670, DOI 10.3324/haematol.12221; JOOS S, 1993, HUM GENET, V90, P584, DOI 10.1007/BF00202475; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kuhn MWM, 2012, BLOOD; Kumar N, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-21; Liu J, 2007, BIOINFORMATICS, V23, P450, DOI 10.1093/bioinformatics/btl624; Liu J, 2009, BIOINFORMATICS, V25, P2208, DOI 10.1093/bioinformatics/btp365; McIntyre A, 2007, BRIT J CANCER, V97, P1707, DOI 10.1038/sj.bjc.6604079; Myllykangas S, 2006, ONCOGENE, V25, P7324, DOI 10.1038/sj.onc.1209717; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Schwaenen C, 2009, GENE CHROMOSOME CANC, V48, P39, DOI 10.1002/gcc.20617; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Sun Ya-jing, 2010, Chinese Journal of Pathology, V39, P606, DOI 10.3760/cma.j.issn.0529-5807.2010.09.007; Takeuchi I, 2009, HAEMATOL-HEMATOL J, V94, P61, DOI 10.3324/haematol.12986; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Van Wieringen WN, 2008, BIOSTATISTICS, V9, P484, DOI 10.1093/biostatistics/kxm048; Veltman I, 2005, GENE CHROMOSOME CANC, V43, P367, DOI 10.1002/gcc.20208; Wong JCY, 2010, BLOOD, V115, P4524, DOI 10.1182/blood-2009-07-232504; Woo KS, 2009, CANCER GENET CYTOGEN, V194, P71, DOI 10.1016/j.cancergencyto.2009.04.017	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43689	10.1371/journal.pone.0043689	http://dx.doi.org/10.1371/journal.pone.0043689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937079	Green Published, Green Accepted, gold			2022-12-27	WOS:000308225500081
J	Wang, QJ; Yang, LD; Alexander, C; Temple, S				Wang, Qingjie; Yang, Landi; Alexander, Caroline; Temple, Sally			The Niche Factor Syndecan-1 Regulates the Maintenance and Proliferation of Neural Progenitor Cells during Mammalian Cortical Development	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; NEURONS ARISE; BETA-CATENIN; N-SYNDECAN; EXPRESSION; LOCALIZATION; NEUROGENESIS; BINDING; STEM; MATURATION	Neural progenitor cells (NPCs) divide and differentiate in a precisely regulated manner over time to achieve the remarkable expansion and assembly of the layered mammalian cerebral cortex. Both intrinsic signaling pathways and environmental factors control the behavior of NPCs during cortical development. Heparan sulphate proteoglycans (HSPG) are critical environmental regulators that help modulate and integrate environmental cues and downstream intracellular signals. Syndecan-1 (Sdc1), a major transmembrane HSPG, is highly enriched in the early neural germinal zone, but its function in modulating NPC behavior and cortical development has not been explored. In this study we investigate the expression pattern and function of Sdc1 in the developing mouse cerebral cortex. We found that Sdc1 is highly expressed by cortical NPCs. Knockdown of Sdc1 in vivo by in utero electroporation reduces NPC proliferation and causes their premature differentiation, corroborated in isolated cells in vitro. We found that Sdc1 knockdown leads to reduced levels of beta-catenin, indicating reduced canonical Wnt signaling. Consistent with this, GSK3 beta inhibition helps rescue the Sdc1 knockdown phenotype, partially restoring NPC number and proliferation. Moreover, exogenous Wnt protein promotes cortical NPC proliferation, but this is prevented by Sdc1 knockdown. Thus, Sdc1 in the germinal niche is a key HSPG regulating the maintenance and proliferation of NPCs during cortical neurogenesis, in part by modulating the ability of NPCs to respond to Wnt ligands.	[Wang, Qingjie; Yang, Landi; Temple, Sally] Neural Stem Cell Inst, Rensselaer, NY USA; [Wang, Qingjie] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Alexander, Caroline] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	Albany Medical College; University of Wisconsin System; University of Wisconsin Madison	Wang, QJ (corresponding author), Neural Stem Cell Inst, Rensselaer, NY USA.	sallytemple@nynsci.org			National Institutes of Health (NIH) [NS033529]; New York State Department of Health (NYSDOH) from the Empire State Stem Cell Fund [C024352]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033529, R37NS033529] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health (NYSDOH) from the Empire State Stem Cell Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project was supported by Grant Number NS033529 from the National Institutes of Health (NIH) and by the New York State Department of Health (NYSDOH) Contract C024352 from the Empire State Stem Cell Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Carey DJ, 1997, BIOCHEM J, V327, P1; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ford-Perriss M, 2003, DEV DYNAM, V227, P170, DOI 10.1002/dvdy.10298; Fuerer C, 2010, DEV DYNAM, V239, P184, DOI 10.1002/dvdy.22067; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Khotskaya YB, 2009, J BIOL CHEM, V284, P26085, DOI 10.1074/jbc.M109.018473; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Avalos AM, 2009, J CELL SCI, V122, P3462, DOI 10.1242/jcs.034827; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; McDermott SP, 2007, ONCOGENE, V26, P1407, DOI 10.1038/sj.onc.1209930; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Nakanishi T, 1997, J BIOCHEM-TOKYO, V121, P197; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Olivares GH, 2009, DEV BIOL, V329, P338, DOI 10.1016/j.ydbio.2009.03.007; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Phoenix TN, 2010, GENE DEV, V24, P45, DOI 10.1101/gad.1839510; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Skorupa A, 2012, J NEUROSCI, V32, P5024, DOI 10.1523/JNEUROSCI.6366-11.2012; Srinivasan K, 2008, DEVELOPMENT, V135, P1781, DOI 10.1242/dev.013847; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toba Y, 2002, EUR J NEUROSCI, V15, P1461, DOI 10.1046/j.1460-9568.2002.01983.x; Vaccarino FM, 1999, NAT NEUROSCI, V2, P485, DOI 10.1038/8163; Watanabe A, 2006, J NEURO-ONCOL, V77, P25, DOI 10.1007/s11060-005-9010-3; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	50	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42883	10.1371/journal.pone.0042883	http://dx.doi.org/10.1371/journal.pone.0042883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936997	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500018
J	Wojtal, KA; Rogler, G; Scharl, M; Biedermann, L; Frei, P; Fried, M; Weber, A; Eloranta, JJ; Kullak-Ublick, GA; Vavricka, SR				Wojtal, Kacper A.; Rogler, Gerhard; Scharl, Michael; Biedermann, Luc; Frei, Pascal; Fried, Michael; Weber, Achim; Eloranta, Jyrki J.; Kullak-Ublick, Gerd A.; Vavricka, Stephan R.			Fc Gamma Receptor CD64 Modulates the Inhibitory Activity of Infliximab	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; TRANSMEMBRANE TNF-ALPHA; CELL-LINE THP-1; CROHNS-DISEASE; HUMAN CYTOMEGALOVIRUS; CROSS-LINKING; IN-VITRO; RHEUMATOID-ARTHRITIS; CERTOLIZUMAB PEGOL	Background: Tumor necrosis factor (TNF) is an important cytokine in the pathogenesis of inflammatory bowel disease (IBD). Anti-TNF antibodies have been successfully implemented in IBD therapy, however their efficacies differ among IBD patients. Here we investigate the influence of CD64 Fc receptor on the inhibitory activity of anti-TNFs in cells of intestinal wall. Methods: Intestinal cell lines, monocytes/macrophages and peripheral blood mononuclear cells (PBMCs) were used as models. The efficacies of adalimumab, infliximab and certolizumab-pegol were assessed by RT-PCR for target genes. Protein levels and localizations were examined by Western blotting and immunofluorescence. Antibody fragments were obtained by proteolytic digestion, immunoprecipitation and protein chip analysis. Knock-down of specific gene expression was performed using siRNAs. Results: Infliximab had limited efficacy towards soluble TNF in cell types expressing Fc gamma receptor CD64. Both adalimumab and infliximab had lower efficacies in PBMCs of IBD patients, which express elevated levels of CD64. Infliximab-TNF complexes were more potent in activating CD64 in THP-1 cells than adalimumab, which was accompanied by distinct phospho-tyrosine signals. Blocking Fc parts and isolation of Fab fragments of infliximab improved its efficacy. IFN-gamma-induced expression of CD64 correlated with a loss of efficacy of infliximab, whereas reduction of CD64 expression by either siRNA or PMA treatment improved inhibitory activity of this drug. Colonic mRNA expression levels of CD64 and other Fc gamma receptors were significantly increased in the inflamed tissues of infliximab non-responders. Conclusions: CD64 modulates the efficacy of infliximab both in vitro and ex vivo, whereas the presence of this receptor has no impact on the inhibitory activity of certolizumab-pegol, which lacks Fc fragment. These data could be helpful in both predicting and evaluating the outcome of anti-TNF therapy in IBD patients with elevated systemic and local levels of Fc receptors.	[Wojtal, Kacper A.; Rogler, Gerhard; Scharl, Michael; Biedermann, Luc; Frei, Pascal; Fried, Michael; Vavricka, Stephan R.] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Rogler, Gerhard; Vavricka, Stephan R.] SwissIBD Cohort Study, Zurich, Switzerland; [Weber, Achim] Univ Zurich Hosp, Inst Surg Pathol, Dept Pathol, CH-8091 Zurich, Switzerland; [Eloranta, Jyrki J.; Kullak-Ublick, Gerd A.] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Vavricka, Stephan R.] Hosp Triemli, Div Gastroenterol & Hepatol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Triemli Hospital	Wojtal, KA (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	kacper.wojtal@usz.ch	Rogler, Gerhard/O-5308-2015; Biedermann, Luc/J-2654-2017	Rogler, Gerhard/0000-0002-1733-9188; Weber, Achim/0000-0003-0073-3637; Scharl, Michael/0000-0002-6729-1469	Swiss National Science Foundation (SNF) [320000-114009/3, 32473B_135694/1, 310030-120312, 320030_120463]; Swiss IBD Cohort [3347CO-108792]; Essex Chemie, Switzerland; European Crohn's and Colitis Organisation (ECCO); Swiss Philanthropy Foundation; Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich; Essex; Abbot; UCB Pharma; Essex Chemie	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss IBD Cohort; Essex Chemie, Switzerland; European Crohn's and Colitis Organisation (ECCO); Swiss Philanthropy Foundation; Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich; Essex; Abbot; UCB Pharma(UCB Pharma SA); Essex Chemie	This research was supported by research grants from the Swiss National Science Foundation (SNF) to SRV (Grant No. 320000-114009/3 and 32473B_135694/1), to GR (Grant No. 310030-120312), and to GAKU and JJE (Grant No. 320030_120463), by the Swiss IBD Cohort (Grant No. 3347CO-108792), an educational grant from Essex Chemie, Switzerland, to MS, a research grant from the European Crohn's and Colitis Organisation (ECCO) to MS, a grant from the Swiss Philanthropy Foundation to MS and GR, by the Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich, and by unrestricted research grants from Essex, Abbot, and UCB Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: this study was partly funded by Essex Chemie, Abbot, and UCB Pharma. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alonso A, 2000, INT IMMUNOL, V12, P547, DOI 10.1093/intimm/12.4.547; An Z, 2009, GLYCOSYLATION THERAP, P73; Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; AUWERX J, 1992, LEUKEMIA RES, V16, P317, DOI 10.1016/0145-2126(92)90070-N; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOLTZNITULESCU G, 1995, J LEUKOCYTE BIOL, V58, P256, DOI 10.1002/jlb.58.2.256; Brenmoehl J, 2009, WORLD J GASTROENTERO, V15, P1431, DOI 10.3748/wjg.15.1431; Canete JD, 2009, ANN RHEUM DIS, V68, P1547, DOI 10.1136/ard.2008.096982; Chang JT, 2006, NAT CLIN PRACT GASTR, V3, P220, DOI 10.1038/ncpgasthep0447; Chen X, 2008, AM J PATHOL, V173, P1647, DOI 10.2353/ajpath.2008.080487; Davis PM, 2007, J RHEUMATOL, V34, P2204; Ericson SG, 1998, BLOOD, V91, P2099, DOI 10.1182/blood.V91.6.2099.2099_2099_2107; FLEIT HB, 1991, J LEUKOCYTE BIOL, V49, P556, DOI 10.1002/jlb.49.6.556; Fries Walter, 2008, Int J Med Sci, V5, P169; Grip O, 2007, INFLAMM BOWEL DIS, V13, P566, DOI 10.1002/ibd.20025; Habbal W, 2009, J MED MICROBIOL, V58, P878, DOI 10.1099/jmm.0.010587-0; Hanai H, 2008, AM J GASTROENTEROL, V103, P1210, DOI 10.1111/j.1572-0241.2007.01714.x; Hommes DW, 1996, GUT, V38, P564, DOI 10.1136/gut.38.4.564; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; KELLER R, 1976, J IMMUNOL, V116, P772; Kobayashi R, 2007, CLIN IMMUNOL, V125, P149, DOI 10.1016/j.clim.2007.07.008; Koch S, 2010, CLIN EXP IMMUNOL, V161, P332, DOI 10.1111/j.1365-2249.2010.04177.x; KRUTMANN J, 1990, J IMMUNOL, V145, P1337; Kuwabara A, 2007, J GASTROENTEROL, V42, P823, DOI 10.1007/s00535-007-2103-3; Lawlor G, 2010, INFLAMM BOWEL DIS, V16, P1620, DOI 10.1002/ibd.21275; Leveque N, 2010, J MED VIROL, V82, P1694, DOI 10.1002/jmv.21877; Lloyd S, 2010, RHEUMATOLOGY, V49, P2313, DOI 10.1093/rheumatology/keq169; Louis E, 2004, ALIMENT PHARM THER, V19, P511, DOI 10.1111/j.1365-2036.2004.01871.x; Lugering A, 2001, GASTROENTEROLOGY, V121, P1145, DOI 10.1053/gast.2001.28702; LUND J, 1995, FASEB J, V9, P115, DOI 10.1096/fasebj.9.1.7821750; MARSH CB, 1995, J IMMUNOL, V155, P3161; Miller DM, 1998, J EXP MED, V187, P675, DOI 10.1084/jem.187.5.675; Mitoma H, 2005, GASTROENTEROLOGY, V128, P376, DOI 10.1053/j.gastro.2004.11.060; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; MURAYAMA T, 1986, J GEN VIROL, V67, P1475, DOI 10.1099/0022-1317-67-7-1475; Nesbitt A, 2007, INFLAMM BOWEL DIS, V13, P1323, DOI 10.1002/ibd.20225; Okuyama A, 2011, ANN RHEUM DIS, V70, P299, DOI 10.1136/ard.2010.136283; PAN L, 1990, J IMMUNOL, V145, P267; RAHMAN AA, 1976, J IMMUNOL, V117, P253; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Roblin X, 2011, AM J GASTROENTEROL, V106, P2001, DOI 10.1038/ajg.2011.202; Rogler G, 1997, EUR J GASTROEN HEPAT, V9, P893, DOI 10.1097/00042737-199709000-00013; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; Ryan MH, 2008, MOL IMMUNOL, V45, P1837, DOI 10.1016/j.molimm.2007.10.043; Sandborn WJ, 2011, CLIN GASTROENTEROL H, V9, P670, DOI 10.1016/j.cgh.2011.04.031; Shen C, 2005, ALIMENT PHARM THER, V21, P251, DOI 10.1111/j.1365-2036.2005.02309.x; Siberil S, 2006, IMMUNOL LETT, V106, P111, DOI 10.1016/j.imlet.2006.05.009; Steel AW, 2011, ALIMENT PHARM THER, V33, P115, DOI 10.1111/j.1365-2036.2010.04499.x; Tanaka M, 2009, J IMMUNOL, V183, P2349, DOI 10.4049/jimmunol.0801683; Tillinger W, 2009, AM J GASTROENTEROL, V104, P102, DOI 10.1038/ajg.2008.6; Tomita K, 2010, HEPATO-GASTROENTEROL, V57, P535; van Vugt MJ, 1999, BLOOD, V94, P808, DOI 10.1182/blood.V94.2.808.414k31_808_817; Vos ACW, 2012, INFLAMM BOWEL DIS, V18, P401, DOI 10.1002/ibd.21818; Vos ACW, 2011, GASTROENTEROLOGY, V140, P221, DOI 10.1053/j.gastro.2010.10.008; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342	58	38	39	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43361	10.1371/journal.pone.0043361	http://dx.doi.org/10.1371/journal.pone.0043361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937039	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308225500043
J	Lasek-Nesselquist, E				Lasek-Nesselquist, Erica			A Mitogenomic Re-Evaluation of the Bdelloid Phylogeny and Relationships among the Syndermata	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; DEGENERATE TETRAPLOIDY; PHYLUM ROTIFERA; EVOLUTION; POSITION; TREE; ACCURACY; SEQUENCE; GENE; MICROGNATHOZOA	Molecular and morphological data regarding the relationships among the three classes of Rotifera (Bdelloidea, Seisonidea, and Monogononta) and the phylum Acanthocephala are inconclusive. In particular, Bdelloidea lacks molecular-based phylogenetic appraisal. I obtained coding sequences from the mitochondrial genomes of twelve bdelloids and two monogononts to explore the molecular phylogeny of Bdelloidea and provide insight into the relationships among lineages of Syndermata (Rotifera+Acanthocephala). With additional sequences taken from previously published mitochondrial genomes, the total dataset included nine species of bdelloids, three species of monogononts, and two species of acanthocephalans. A supermatrix of these 10-12 mitochondrial proteins consistently recovered a bdelloid phylogeny that questions the validity of a generally accepted classification scheme despite different methods of inference and various parameter adjustments. Specifically, results showed that neither the family Philodinidae nor the order Philodinida are monophyletic as currently defined. The application of a similar analytical strategy to assess syndermate relationships recovered either a tree with Bdelloidea and Monogononta as sister taxa (Eurotatoria) or Bdelloidea and Acanthocephala as sister taxa (Lemniscea). Both outgroup choice and method of inference affected the topological outcome emphasizing the need for sequences from more closely related outgroups and more sophisticated methods of analysis that can account for the complexity of the data.	Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA	University of Connecticut	Lasek-Nesselquist, E (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA.	elasekness@gmail.com			National Science Foundation [MCB 0923628]; National Institutes of Health [R01AG037960];  [NSF MCB 0923676]; NATIONAL INSTITUTE ON AGING [R01AG037960] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0923676] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research expenses and the sole support for this project were provided by funding from the National Science Foundation grant MCB 0923628 awarded to M. Meselson at Harvard University, Boston, MA. Genomic and transcriptome data were generated by funding from the grants NSF MCB 0923676 and National Institutes of Health R01AG037960 awarded to David Mark Welch at the Marine Biological Laboratory, Woods Hole, MA. URLs: http://www.nih.gov/, http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Alhlrichs WH, 1997, ZOOMORPHOLOGY, V117, P41; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cummings MP, 2003, SYST BIOL, V52, P477, DOI 10.1080/10635150390218213; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Fontaneto D, 2011, ZOOL ANZ, V250, P80, DOI 10.1016/j.jcz.2010.11.005; Funch P, 2005, HYDROBIOLOGIA, V546, P11, DOI 10.1007/s10750-005-4093-6; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garey JR, 1998, AM ZOOL, V38, P907; Garey JR, 1998, HYDROBIOLOGIA, V387, P83, DOI 10.1023/A:1017060902909; Garey JR, 1996, J MOL EVOL, V43, P287, DOI 10.1007/BF02338837; Gazi M, 2012, PARASITOL INT, V61, P307, DOI 10.1016/j.parint.2011.12.001; Giribet G, 2004, CLADISTICS, V20, P1, DOI 10.1111/j.1096-0031.2004.00004.x; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Herlyn H, 2003, MOL PHYLOGENET EVOL, V26, P155, DOI 10.1016/S1055-7903(02)00309-3; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hur JH, 2009, MOL BIOL EVOL, V26, P375, DOI 10.1093/molbev/msn260; Kelchner SA, 2007, TRENDS ECOL EVOL, V22, P87, DOI 10.1016/j.tree.2006.10.004; Kristensen RM, 2000, J MORPHOL, V246, P1; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lorenzen S., 1985, Systematics Association Special Volume Series, P210; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mark Welch D, 2005, HYDROBIOLOGIA, V546, P47, DOI 10.1007/s10750-005-4100-y; Melone G, 1998, HYDROBIOLOGIA, V387, P101, DOI 10.1023/A:1017057619574; Melone G, 1995, HYDROBIOLOGIA, V313, P91, DOI 10.1007/BF00025935; Min GS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-533; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Pennak RW, 1989, FRESH WATER INVERTEB; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; Philippe H, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-91; REMANE A, 1929, TIERWELT NORD OSTSEE; RICCI C, 1993, HYDROBIOLOGIA, V255, P495, DOI 10.1007/BF00025879; Ricci C, 1998, HYDROBIOLOGIA, V387, P321, DOI 10.1023/A:1017086425934; Ricci C, 1998, HYDROBIOLOGIA, V387, P93, DOI 10.1023/A:1017091104243; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Segers Hendrik, 2007, Zootaxa, V1564, P1; Segers H, 2008, HYDROBIOLOGIA, V595, P49, DOI 10.1007/s10750-007-9003-7; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sorensen MV, 2006, MOL PHYLOGENET EVOL, V40, P585, DOI 10.1016/j.ympev.2006.04.001; Sorensen MV, 2005, ZOOL STUD, V44, P34; Sorensen MV, 2000, ACTA ZOOL-STOCKHOLM, V81, P9, DOI 10.1046/j.1463-6395.2000.00032.x; Sorensen MV, 2002, J ZOOL SYST EVOL RES, V40, P129, DOI 10.1046/j.1439-0469.2002.00188.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinauer ML, 2005, J MOL EVOL, V60, P706, DOI 10.1007/s00239-004-0159-8; Suga K, 2008, MOL BIOL EVOL, V25, P1129, DOI 10.1093/molbev/msn058; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WALLACE RL, 1989, HYDROBIOLOGIA, V186, P311; Welch DBM, 2008, P NATL ACAD SCI USA, V105, P5145, DOI 10.1073/pnas.0800972105; Welch DBM, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P259, DOI 10.1007/978-90-481-2770-2_13; Welch DBM, 2000, INVERTEBR BIOL, V119, P17; Witek A, 2009, MOL PHYLOGENET EVOL, V53, P1037, DOI 10.1016/j.ympev.2009.07.031; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345	72	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43554	10.1371/journal.pone.0043554	http://dx.doi.org/10.1371/journal.pone.0043554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927990	Green Published, Green Submitted, gold			2022-12-27	WOS:000308224700018
J	Strodl, MA; Schausberger, P				Strodl, Markus Andreas; Schausberger, Peter			Social Familiarity Reduces Reaction Times and Enhances Survival of Group-Living Predatory Mites under the Risk of Predation	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; LIMITED ATTENTION; PHYTOSEIID MITES; ADULT FEMALES; RECOGNITION; CANNIBALISM; SPECIALIST; EVOLUTION; ACARI	Background: Social familiarity, which is based on the ability to recognise familiar conspecific individuals following prior association, may affect all major life activities of group-living animals such as foraging, reproduction and anti-predator behaviours. A scarcely experimentally tested explanation why social familiarity is beneficial for group-living animals is provided by limited attention theory. Limited attention theory postulates that focusing on a given task, such as inspection and assessment of unfamiliar group members, has cognitive and associated physiological and behavioural costs with respect to the attention paid to other tasks, such as anti-predator vigilance and response. Accordingly, we hypothesised that social familiarity enhances the anti-predator success of group-living predatory mites, Phytoseiulus persimilis, confronted with an intraguild predator, the predatory mite Amblyseius andersoni. Methodology/Principal Findings: We videotaped and analysed the response of two P. persimilis larvae, held in familiar or unfamiliar pairs, to attacks by a gravid A. andersoni female, using the behavioural analyses software EthoVision Pro (R). Familiar larvae were more frequently close together, reacted more quickly to predator attacks, survived more predator encounters and survived longer than unfamiliar larvae. Significance: In line with the predictions of limited attention theory, we suggest that social familiarity improves antipredator behaviours because it allows prey to shift attention to other tasks rather than group member assessment.	[Strodl, Markus Andreas; Schausberger, Peter] Univ Nat Resources & Life Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Dept Crop Sci, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Strodl, MA (corresponding author), Univ Nat Resources & Life Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Dept Crop Sci, Vienna, Austria.	markus.strodl@boku.ac.at		Schausberger, Peter/0000-0002-1529-3198	Austrian Science Fund (FWF) [P20743-B17]; Austrian Science Fund (FWF) [P 20743] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financially supported by the Austrian Science Fund (FWF): P20743-B17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK J, 2005, ANIMAL BEHAV EVOLUTI; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Chant D, 1985, SPIDER MITES THEIR B, V1A, P5; CHIVERS DP, 1995, CAN J ZOOL, V73, P955, DOI 10.1139/z95-111; Clark CW, 2003, BEHAV ECOL, V14, P151, DOI 10.1093/beheco/14.2.151; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Earley Ryan L., 2010, P285; Griffiths SW, 2004, P ROY SOC B-BIOL SCI, V271, P695, DOI 10.1098/rspb.2003.2648; GRIFFITHS SW, 2006, FISH COGNITION BEHAV, P139; Hojesjo J, 1998, BEHAV ECOL, V9, P445, DOI 10.1093/beheco/9.5.445; Janssen A, 1997, J ANIM ECOL, V66, P223, DOI 10.2307/6024; KELLEY JL, 2006, FISH COGNITION BEHAV, P28; Krause J, 2002, LIVING GROUPS; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; McMurtry JA, 1997, ANNU REV ENTOMOL, V42, P291, DOI 10.1146/annurev.ento.42.1.291; Noldus, 2005, ETHOVISION VID TRACK; Nonacs Peter, 2010, P207; Palphramand KL, 2007, ANIM BEHAV, V74, P429, DOI 10.1016/j.anbehav.2006.10.026; POWELL GVN, 1974, ANIM BEHAV, V22, P501, DOI 10.1016/S0003-3472(74)80049-7; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Sabelis M.W., 1985, P141; Sabelis M.W., 1985, SPIDER MITES THEIR B, P43; Sareen P, 2011, P NATL ACAD SCI USA, V108, P7230, DOI 10.1073/pnas.1102522108; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2005, BEHAV ECOL SOCIOBIOL, V58, P53, DOI 10.1007/s00265-004-0898-y; Schausberger P, 2004, ANIM BEHAV, V67, P1031, DOI 10.1016/j.anbehav.2003.10.006; Schausberger P, 2003, EXP APPL ACAROL, V29, P173, DOI 10.1023/A:1025839206394; Schausberger P, 2001, ANIM BEHAV, V61, P459, DOI 10.1006/anbe.2000.1611; Schausberger P, 1999, ENVIRON ENTOMOL, V28, P322, DOI 10.1093/ee/28.2.322; SILLENTULLBERG B, 1988, AM NAT, V132, P723, DOI 10.1086/284884; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Strodl MA, 2012, NATURWISSENSCHAFTEN, V99, P303, DOI 10.1007/s00114-012-0903-7; Utne-Palm AC, 2000, OIKOS, V91, P225, DOI 10.1034/j.1600-0706.2000.910203.x; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; Walzer A, 2006, J INSECT BEHAV, V19, P305, DOI 10.1007/s10905-006-9025-4; Walzer A, 2011, ANIM BEHAV, V81, P177, DOI 10.1016/j.anbehav.2010.09.031; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	40	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43590	10.1371/journal.pone.0043590	http://dx.doi.org/10.1371/journal.pone.0043590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927997	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300070
J	Hamdi, Y; Kaddour, H; Vaudry, D; Bahdoudi, S; Douiri, S; Leprince, J; Castel, H; Vaudry, H; Tonon, MC; Amri, M; Masmoudi-Kouki, O				Hamdi, Yosra; Kaddour, Hadhemi; Vaudry, David; Bahdoudi, Seyma; Douiri, Salma; Leprince, Jerome; Castel, Helene; Vaudry, Hubert; Tonon, Marie-Christine; Amri, Mohamed; Masmoudi-Kouki, Olfa			The Octadecaneuropeptide ODN Protects Astrocytes against Hydrogen Peroxide-Induced Apoptosis via a PKA/MAPK-Dependent Mechanism	PLOS ONE			English	Article							DIAZEPAM-BINDING INHIBITOR; CYCLASE-ACTIVATING POLYPEPTIDE; CULTURED RAT ASTROCYTES; STIMULATES ENDOZEPINE RELEASE; CELL-DEATH; OXIDATIVE STRESS; POSSIBLE INVOLVEMENT; RADICAL SCAVENGER; FOCAL ISCHEMIA; UP-REGULATION	Astrocytes synthesize and release endozepines, a family of regulatory peptides, including the octadecaneuropeptide (ODN) an endogenous ligand of both central-type benzodiazepine (CBR) and metabotropic receptors. We have recently shown that ODN exerts a protective effect against hydrogen peroxide (H2O2)-induced oxidative stress in astrocytes. The purpose of the present study was to determine the type of receptor and the transduction pathways involved in the protective effect of ODN in cultured rat astrocytes. We have first observed a protective activity of ODN at very low concentrations that was abrogated by the metabotropic ODN receptor antagonist cyclo(1-8)[DLeu(5)]OP, but not by the CBR antagonist flumazenil. We have also found that the metabotropic ODN receptor is positively coupled to adenylyl cyclase in astrocytes and that the glioprotective action of ODN upon H2O2-induced astrocyte death is PKA- and MEK-dependent, but PLC/PKC-independent. Downstream of PKA, ODN induced ERK phosphorylation, which in turn activated the expression of the anti-apoptotic gene Bcl-2 and blocked the stimulation by H2O2 of the pro-apoptotic gene Bax. The effect of ODN on the Bax/Bcl-2 balance contributed to abolish the deleterious action of H2O2 on mitochondrial membrane integrity and caspase-3 activation. Finally, the inhibitory effect of ODN on caspase-3 activity was shown to be PKA and MEK-dependent. In conclusion, the present results demonstrate that the potent glioprotective action of ODN against oxidative stress involves the metabotropic ODN receptor coupled to the PKA/ERK-kinase pathway to inhibit caspase-3 activation.	[Hamdi, Yosra; Kaddour, Hadhemi; Bahdoudi, Seyma; Douiri, Salma; Amri, Mohamed; Masmoudi-Kouki, Olfa] Univ Tunis El Manar, Fac Sci Tunis, Lab Funct Neurophysiol & Pathol, Dept Biol Sci,Res Unit UR 11ES09, Tunis, Tunisia; [Vaudry, David; Leprince, Jerome; Castel, Helene; Vaudry, Hubert; Tonon, Marie-Christine] Univ Rouen, INSERM, Lab Neuronal & Neuroendocrine Commun & Differenti, U982, Mont St Aignan, France; [Vaudry, David; Leprince, Jerome; Vaudry, Hubert] Int Associated Lab Samuel de Champlain, Mont St Aignan, France; [Vaudry, David; Leprince, Jerome; Vaudry, Hubert] Univ Rouen, Inst Med Res & Innovat IRIB, Reg Platform Cell Imaging Haute Normandie PRIMACE, Mont St Aignan, France	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie	Hamdi, Y (corresponding author), Univ Tunis El Manar, Fac Sci Tunis, Lab Funct Neurophysiol & Pathol, Dept Biol Sci,Res Unit UR 11ES09, Tunis, Tunisia.	hubert.vaudry@univ-rouen.fr; mohamed.amri@fst.rnu.tn	VAUDRY, David/M-1454-2018; castel, helene/B-8675-2009; Leprince, Jerome/N-9083-2017	VAUDRY, David/0000-0003-3567-7452; castel, helene/0000-0002-8972-5555; Amri, Mohamed/0000-0001-5309-7633; Leprince, Jerome/0000-0002-7814-9927	University of Tunis El Manar; France-Tunisia exchange program CMCU-Utique [07G0822]; France-Tunisia exchange program Inserm-DGRS; Research Unit [UR/11ES09]; Inserm-DGRS program [M 10/M]; Inserm [U982]; Institute for Medical Research and Innovation (IRIB); Region Haute-Normandie	University of Tunis El Manar; France-Tunisia exchange program CMCU-Utique; France-Tunisia exchange program Inserm-DGRS; Research Unit; Inserm-DGRS program; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institute for Medical Research and Innovation (IRIB); Region Haute-Normandie(Region Normandie)	The authors wish to thank Mr Samir Elbahi for skillful technical assistance. Y.H. and K.H. were recipients of fellowships from the University of Tunis El Manar and a France-Tunisia exchange program CMCU-Utique. B.S. and S.D. were recipients of fellowships from the University of Tunis El Manar and a France-Tunisia exchange program Inserm-DGRS. This study was supported by the Research Unit UR/11ES09, an Inserm-DGRS program (to M.A. and M.C.T.; grant number M 10/M), Inserm (U982), the Institute for Medical Research and Innovation (IRIB), the Region Haute-Normandie and a France-Tunisia exchange program CMCU-Utique (grant number 07G0822). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi J, 2008, NEUROSCI LETT, V442, P224, DOI 10.1016/j.neulet.2008.07.029; BORMANN J, 1991, NEUROPHARMACOLOGY, V30, P1387, DOI 10.1016/S0028-3908(11)80006-7; Brown DR, 1999, GLIA, V25, P282, DOI 10.1002/(SICI)1098-1136(19990201)25:3<282::AID-GLIA8>3.0.CO;2-N; Burgi B, 1999, J NEUROENDOCRINOL, V11, P85; Burton M, 2005, BIOCHEM J, V392, P299, DOI 10.1042/BJ20050664; Castel H, 2006, J NEUROCHEM, V99, P582, DOI 10.1111/j.1471-4159.2006.04130.x; Chen SH, 2000, GLIA, V31, P249, DOI 10.1002/1098-1136(200009)31:3<249::AID-GLIA60>3.0.CO;2-L; Chen YM, 2001, GLIA, V33, P343, DOI 10.1002/1098-1136(20010315)33:4<343::AID-GLIA1033>3.0.CO;2-H; Choi JH, 2007, EUR J PHARMACOL, V571, P106, DOI 10.1016/j.ejphar.2007.06.042; Compere V, 2010, J MOL ENDOCRINOL, V44, P295, DOI 10.1677/JME-09-0176; Cui M, 2011, GLIA, V59, P641, DOI 10.1002/glia.21134; De Mateos-Verchere JG, 1998, PEPTIDES, V19, P841; de Mateos-Verchere JG, 2001, EUR J PHARMACOL, V414, P225; do Rego JC, 2007, NEUROPSYCHOPHARMACOL, V32, P1641, DOI 10.1038/sj.npp.1301280; Dong EB, 1999, LIFE SCI, V64, P1779, DOI 10.1016/S0024-3205(99)00116-2; Eiden LE, 2008, ANN NY ACAD SCI, V1144, P6, DOI 10.1196/annals.1418.019; Faergeman NJ, 2002, BIOCHEM J, V368, P679, DOI 10.1042/BJ20021413; Feeney CJ, 2008, BRAIN RES, V1198, P1, DOI 10.1016/j.brainres.2007.12.049; FERRARESE C, 1990, NEUROLOGY, V40, P632, DOI 10.1212/WNL.40.4.632; FERRERO P, 1984, NEUROPHARMACOLOGY, V23, P1359, DOI 10.1016/0028-3908(84)90061-3; Gabryel B, 2002, NEUROTOXICOLOGY, V23, P385, DOI 10.1016/S0161-813X(02)00084-0; Gandolfo P, 1999, NEUROPHARMACOLOGY, V38, P725, DOI 10.1016/S0028-3908(98)00231-7; Giffard RG, 2005, GLIA, V50, P299, DOI 10.1002/glia.20167; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; Hamdi Y, 2011, J NEUROCHEM, V118, P416, DOI 10.1111/j.1471-4159.2011.07315.x; Hashimoto H, 2003, BIOCHEM BIOPH RES CO, V311, P337, DOI 10.1016/j.bbrc.2003.10.005; Hisano K, 2009, J ANESTH, V23, P363, DOI 10.1007/s00540-009-0766-z; Iwashita A, 2003, J PHARMACOL EXP THER, V307, P961, DOI 10.1124/jpet.103.056572; Jang JH, 2004, J BIOL CHEM, V279, P38779, DOI 10.1074/jbc.M406371200; Juknat AA, 2005, J PINEAL RES, V38, P84, DOI 10.1111/j.1600-079X.2004.00166.x; KAVALIERS M, 1986, BRAIN RES, V383, P343, DOI 10.1016/0006-8993(86)90037-5; Leprince J, 1998, J MED CHEM, V41, P4433, DOI 10.1021/jm980275d; Leprince J, 2001, EUR J BIOCHEM, V268, P6045, DOI 10.1046/j.0014-2956.2001.02533.x; Lesouhaitier O, 2000, ENDOCRINOLOGY, V141, P197, DOI 10.1210/en.141.1.197; Lewerenz J, 2003, J NEUROCHEM, V87, P522, DOI 10.1046/j.1471-4159.2003.02019.x; MALAGON M, 1993, NEUROSCIENCE, V57, P777, DOI 10.1016/0306-4522(93)90023-9; Marino F, 2003, CELL SIGNAL, V15, P511, DOI 10.1016/S0898-6568(02)00134-1; Masmoudi O, 2005, J NEUROCHEM, V94, P561, DOI 10.1111/j.1471-4159.2005.03076.x; Masmoudi O, 2003, FASEB J, V17, P17, DOI 10.1096/fj.02-0317com; Masmoudi-Kouki O, 2011, J NEUROCHEM, V117, P403, DOI 10.1111/j.1471-4159.2011.07185.x; Matsuda K, 2007, NEUROSCIENCE, V150, P425, DOI 10.1016/j.neuroscience.2007.09.012; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; MENTLEIN R, 1994, J NEUROCHEM, V62, P27; PAPADOPOULOS V, 1991, NEUROPHARMACOLOGY, V30, P1417, DOI 10.1016/S0028-3908(11)80011-0; PATTE C, 1995, FEBS LETT, V362, P106, DOI 10.1016/0014-5793(95)00209-R; Rathinam ML, 2006, J NEUROCHEM, V96, P1289, DOI 10.1111/j.1471-4159.2006.03674.x; Rathke-Hartlieb S, 2000, FEBS LETT, V481, P227, DOI 10.1016/S0014-5793(00)02011-1; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Sakurai T, 2003, BRAIN RES, V959, P160, DOI 10.1016/S0006-8993(02)03611-9; Seaborn T, 2011, CURR PHARM DESIGN, V17, P204, DOI 10.2174/138161211795049679; Shin JH, 2009, NEUROSCI RES, V64, P355, DOI 10.1016/j.neures.2009.04.006; SHOYAB M, 1986, J BIOL CHEM, V261, P1968; Stumm R, 2007, J NEUROCHEM, V103, P1666, DOI 10.1111/j.1471-4159.2007.04895.x; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Takuma K, 2000, EUR J PHARMACOL, V399, P1, DOI 10.1016/S0014-2999(00)00334-4; Tokay T, 2005, J NEUROCHEM, V94, P607, DOI 10.1111/j.1471-4159.2005.03102.x; Tokay T, 2008, GLIA, V56, P1380, DOI 10.1002/glia.20705; Tonon MC, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P813, DOI 10.1016/B978-012369442-3/50114-8; TONON MC, 1990, NEUROPEPTIDES, V15, P17, DOI 10.1016/0143-4179(90)90155-R; Vallejo M, 2009, MOL NEUROBIOL, V39, P90, DOI 10.1007/s12035-009-8055-2; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Watts LT, 2005, J NEUROSCI RES, V80, P655, DOI 10.1002/jnr.20502; Yanase H, 2002, ARCH HISTOL CYTOL, V65, P27, DOI 10.1679/aohc.65.27; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	65	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42498	10.1371/journal.pone.0042498	http://dx.doi.org/10.1371/journal.pone.0042498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927932	Green Published, gold, Green Submitted			2022-12-27	WOS:000307789700012
J	Bergval, I; Sengstake, S; Brankova, N; Levterova, V; Abadia, E; Tadumaze, N; Bablishvili, N; Akhalaia, M; Tuin, K; Schuitema, A; Panaiotov, S; Bachiyska, E; Kantardjiev, T; de Zwaan, R; Schurch, A; van Soolingen, D; van 't Hoog, A; Cobelens, F; Aspindzelashvili, R; Sola, C; Klatser, P; Anthony, R				Bergval, Indra; Sengstake, Sarah; Brankova, Nadia; Levterova, Viktoria; Abadia, Edgar; Tadumaze, Nino; Bablishvili, Nino; Akhalaia, Maka; Tuin, Kiki; Schuitema, Anja; Panaiotov, Stefan; Bachiyska, Elizabeta; Kantardjiev, Todor; de Zwaan, Rina; Schurch, Anita; van Soolingen, Dick; van 't Hoog, Anja; Cobelens, Frank; Aspindzelashvili, Rusudan; Sola, Christophe; Klatser, Paul; Anthony, Richard			Combined Species Identification, Genotyping, and Drug Resistance Detection of Mycobacterium tuberculosis Cultures by MLPA on a Bead-Based Array	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; RAPID DETECTION; RELATIVE QUANTIFICATION; STRAIN DIFFERENTIATION; DNA POLYMORPHISM; MULTIPLEX ASSAY; MOLECULAR-BASIS; RPOB MUTATIONS; COMPLEX; RIFAMPIN	The population structure of Mycobacterium tuberculosis is typically clonal therefore genotypic lineages can be unequivocally identified by characteristic markers such as mutations or genomic deletions. In addition, drug resistance is mainly mediated by mutations. These issues make multiplexed detection of selected mutations potentially a very powerful tool to characterise Mycobacterium tuberculosis. We used Multiplex Ligation-dependent Probe Amplification (MLPA) to screen for dispersed mutations, which can be successfully applied to Mycobacterium tuberculosis as was previously shown. Here we selected 47 discriminative and informative markers and designed MLPA probes accordingly to allow analysis with a liquid bead array and robust reader (Luminex MAGPIX technology). To validate the bead-based MLPA, we screened a panel of 88 selected strains, previously characterised by other methods with the developed multiplex assay using automated positive and negative calling. In total 3059 characteristics were screened and 3034 (99.2%) were consistent with previous molecular characterizations, of which 2056 (67.2%) were directly supported by other molecular methods, and 978 (32.0%) were consistent with but not directly supported by previous molecular characterizations. Results directly conflicting or inconsistent with previous methods, were obtained for 25 (0.8%) of the characteristics tested. Here we report the validation of the bead-based MLPA and demonstrate its potential to simultaneously identify a range of drug resistance markers, discriminate the species within the Mycobacterium tuberculosis complex, determine the genetic lineage and detect and identify the clinically most relevant non-tuberculous mycobacterial species. The detection of multiple genetic markers in clinically derived Mycobacterium tuberculosis strains with a multiplex assay could reduce the number of TB-dedicated screening methods needed for full characterization. Additionally, as a proportion of the markers screened are specific to certain Mycobacterium tuberculosis lineages each profile can be checked for internal consistency. Strain characterization can allow selection of appropriate treatment and thereby improve treatment outcome and patient management.	[Bergval, Indra; Sengstake, Sarah; Schuitema, Anja; Klatser, Paul; Anthony, Richard] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Brankova, Nadia; Levterova, Viktoria; Panaiotov, Stefan; Bachiyska, Elizabeta; Kantardjiev, Todor] Natl Ctr Infect & Parasit Dis, Sofia, Bulgaria; [Abadia, Edgar; Sola, Christophe] UPS11, CNRS, UMR 8621, Inst Genet & Microbiol, Orsay, France; [Abadia, Edgar] Venezuelan Inst Sci Res, Caracas, Venezuela; [Tadumaze, Nino; Bablishvili, Nino; Akhalaia, Maka; Aspindzelashvili, Rusudan] Natl Ctr TB & Lung Dis, Natl TB Reference Lab, Tbilisi, Georgia; [Tuin, Kiki] MRC Holland, Amsterdam, Netherlands; [de Zwaan, Rina; Schurch, Anita; van Soolingen, Dick] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, TB Reference Lab, NL-3720 BA Bilthoven, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Centre, Univ Lung Ctr Dekkerswald, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Centre, Univ Lung Ctr Dekkerswald, Dept Pulm Dis, NL-6525 ED Nijmegen, Netherlands; [van 't Hoog, Anja; Cobelens, Frank] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	Ministry of Health Bulgaria; National Centre of Infectious & Parasitic Diseases; Centre National de la Recherche Scientifique (CNRS); Venezuelan Institute Science Research; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen	Bergval, I (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	r.anthony@kit.nl	Sola, Christophe/A-7992-2016; Anthony, Richard/AAP-3406-2020; Panaiotov, Stefan/AAR-6396-2021; Anthony, Richard M/G-5654-2010	Sola, Christophe/0000-0003-4672-2140; Anthony, Richard/0000-0002-0550-5273; Anthony, Richard M/0000-0002-0550-5273; Schurch, Anita/0000-0003-1894-7545; Bachiyska, Elizabeta/0000-0003-2949-5011; Panaiotov, Stefan/0000-0001-9997-5198; Klatser, Paul/0000-0003-2127-9138; Cobelens, Frank/0000-0002-4367-1133; Klatser, Paul/0000-0003-3868-2409	ZonMW [205100005]; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER	ZonMW(Netherlands Organization for Health Research and Development); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by ZonMW project nr. 205100005. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abadia E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-110; Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Ahmed A, 2010, INFECT GENET EVOL, V10, P955, DOI 10.1016/j.meegid.2010.06.002; Alland D, 2003, J BACTERIOL, V185, P3392, DOI 10.1128/JB.185.11.3392-3399.2003; Anthony RM, 2009, INT J TUBERC LUNG D, V13, P1051; Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.50.1.104-112.2006; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bergal IL, 2008, J CLIN MICROBIOL, V46, P689, DOI 10.1128/JCM.01821-07; Brodin P, 2002, INFECT IMMUN, V70, P5568, DOI 10.1128/IAI.70.10.5568-5578.2002; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brown TJ, 2006, J MICROBIOL METH, V65, P294, DOI 10.1016/j.mimet.2005.08.002; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Brzostek A, 2004, INT J TUBERC LUNG D, V8, P1032; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chuang PC, 2010, INFECT GENET EVOL, V10, P459, DOI 10.1016/j.meegid.2010.03.003; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Deshpande A, 2010, J MICROBIOL METH, V80, P155, DOI 10.1016/j.mimet.2009.12.001; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Dobner P, 1997, MOL CELL PROBE, V11, P123, DOI 10.1006/mcpr.1996.0086; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Edwards KJ, 2001, J CLIN MICROBIOL, V39, P3350, DOI 10.1128/JCM.39.9.3350-3352.2001; Feuerriegel S, 2009, ANTIMICROB AGENTS CH, V53, P3353, DOI 10.1128/AAC.00050-09; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gegia M, 2008, ANTIMICROB AGENTS CH, V52, P725, DOI 10.1128/AAC.01124-07; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Heep M, 2001, J CLIN MICROBIOL, V39, P107, DOI 10.1128/JCM.39.1.107-110.2001; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1409; Hillemann D, 2005, J CLIN MICROBIOL, V43, P3699, DOI 10.1128/JCM.43.8.3699-3703.2005; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Huard RC, 2006, J BACTERIOL, V188, P4271, DOI 10.1128/JB.01783-05; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Kam KM, 2006, MICROB DRUG RESIST, V12, P7, DOI 10.1089/mdr.2006.12.7; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kontsevaya I, 2011, J CLIN MICROBIOL, V49, P2832, DOI 10.1128/JCM.01889-10; KOX LFF, 1995, J CLIN MICROBIOL, V33, P3225, DOI 10.1128/JCM.33.12.3225-3233.1995; Kroutter EN, 2011, LUM PLAN XMAP M VIEN; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Li J, 1999, ELECTROPHORESIS, V20, P1258, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1258::AID-ELPS1258>3.0.CO;2-V; Luo T, 2012, J CLIN MICROBIOL, V50, P633, DOI 10.1128/JCM.05539-11; Marmiesse M, 2004, MICROBIOL-SGM, V150, P483, DOI 10.1099/mic.0.26662-0; Mijs W, 2002, EUR J CLIN MICROBIOL, V21, P794, DOI 10.1007/s10096-002-0825-y; Mostowy S, 2004, J CLIN MICROBIOL, V42, P3594, DOI 10.1128/jcm.42.8.3594-3599.2004; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Nguyen D, 2004, J CLIN MICROBIOL, V42, P2573, DOI 10.1128/JCM.42.6.2573-2580.2004; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; NIKIFOROV TT, 1994, PCR METH APPL, V3, P285; Perdigao J, 2008, MICROB DRUG RESIST, V14, P133, DOI 10.1089/mdr.2008.0798; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Reyes JF, 2012, INFECT GENET EVOL, V12, P811, DOI 10.1016/j.meegid.2011.05.018; Richter E, 2004, J CLIN MICROBIOL, V42, P4303, DOI 10.1128/JCM.42.9.4303-4306.2004; Riska PF, 2000, INT J TUBERC LUNG D, V4, pS4; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schurch AC, 2011, INFECT GENET EVOL, V11, P587, DOI 10.1016/j.meegid.2011.01.009; Schurch AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028365; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Telenti A, 1997, CLIN CHEST MED, V18, P55, DOI 10.1016/S0272-5231(05)70355-5; Terefework Z, 2008, J MICROBIOL METH, V75, P558, DOI 10.1016/j.mimet.2008.08.012; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Tudo G, 2010, J ANTIMICROB CHEMOTH, V65, P2341, DOI 10.1093/jac/dkq322; van der Spuy GD, 2009, INT J TUBERC LUNG D, V13, P419; van Ingen J., 2009, THESIS RADBOUD U NIJ; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Vo SK, 2010, J CLIN MICROBIOL, V48, P2934, DOI 10.1128/JCM.00201-10; Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0; Zozio T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-44	81	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43240	10.1371/journal.pone.0043240	http://dx.doi.org/10.1371/journal.pone.0043240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916230	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800056
J	Kim, J; Kim, CS; Sohn, E; Lee, YM; Jo, K; Kim, JS				Kim, Junghyun; Kim, Chan-Sik; Sohn, Eunjin; Lee, Yun Mi; Jo, Kyuhyung; Kim, Jin Sook			KIOM-79 Protects AGE-Induced Retinal Pericyte Apoptosis via Inhibition of NF-kappaB Activation In Vitro and In Vivo	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; ENDOTHELIAL GROWTH-FACTOR; GOTO-KAKIZAKI RATS; DIABETIC-RETINOPATHY; HIGH GLUCOSE; SERUM-LEVELS; CELLS; EXPRESSION; MICE; STREPTOZOTOCIN	KIOM-79 is an herbal mixture of parched Puerariae radix, gingered Magnoliae cortex, Glycyrrhizae radix and Euphorbiae radix. In the present study, we determined the efficacy and possible mechanism of KIOM-79 on the advanced glycation end product (AGE)-modified bovine serum albumin (BSA)-induced apoptosis of cultured bovine retinal pericytes and rat retinal pericytes in Zucker diabetic fatty (ZDF) rats. Seven-week-old male ZDF rats were treated with KIOM-79 (50 mg/kg body weight) once a day orally for 13 weeks. KIOM-79 significantly inhibited pericyte apoptosis which were induced by the AGE-BSA treatment. The KIOM-79 treatment markedly suppressed the activation of nuclear factor-kappaB (NF-kappa B) through the inhibition of inhibitory kappa B kinase complex. In addition, the oral administration of KIOM-79 inhibited the changes in retinal vasculature (vascular hyperpermeability, acellular capillary). KIOM-79 strongly inhibited pericyte apoptosis, NF-kappa B activation and the expression of pro-apoptotic Bax and tumor necrosis factor-alpha. Our results suggest that KIOM-79 may exert inhibitory effects on AGE-induced pericyte apoptosis by blocking NF-kappa B activation, thereby ameliorating retinal microvascular dysfunction.	[Kim, Junghyun; Kim, Chan-Sik; Sohn, Eunjin; Lee, Yun Mi; Jo, Kyuhyung; Kim, Jin Sook] Korea Inst Oriental Med, Herbal Med Res Div, Tradit Korean Med Based Herbal Drug Res Grp, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Kim, J (corresponding author), Korea Inst Oriental Med, Herbal Med Res Div, Tradit Korean Med Based Herbal Drug Res Grp, Taejon, South Korea.	jskim@kiom.re.kr			Korea Institute of Oriental Medicine (KIOM) [K12010]	Korea Institute of Oriental Medicine (KIOM)	This research was supported by a grant [K12010] from the Korea Institute of Oriental Medicine (KIOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA K, 1990, PLANTA MED, V56, P254, DOI 10.1055/s-2006-960950; Alarcon-Aguilara FJ, 1998, J ETHNOPHARMACOL, V61, P101, DOI 10.1016/S0378-8741(98)00020-8; Asnaghi V, 2003, DIABETES, V52, P506, DOI 10.2337/diabetes.52.2.506; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Cacicedo JM, 2005, DIABETES, V54, P1838, DOI 10.2337/diabetes.54.6.1838; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; CAPETANDES A, 1990, INVEST OPHTH VIS SCI, V31, P1738; Chen WC, 2004, PLANTA MED, V70, P113, DOI 10.1055/s-2004-815486; Clements RS, 1998, J DIABETES COMPLICAT, V12, P28, DOI 10.1016/S1056-8727(97)00051-2; Denis U, 2002, FREE RADICAL BIO MED, V33, P236, DOI 10.1016/S0891-5849(02)00879-1; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; ENGERMAN RL, 1989, DIABETES, V38, P1203, DOI 10.2337/diabetes.38.10.1203; Hammes HP, 1999, DIABETOLOGIA, V42, P728, DOI 10.1007/s001250051221; Hernandez-Presa MA, 1999, KIDNEY INT, V55, P209, DOI 10.1046/j.1523-1755.1999.00226.x; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Jeon YJ, 2006, J ETHNOPHARMACOL, V108, P38, DOI 10.1016/j.jep.2006.04.007; Kaji Y, 2003, INVEST OPHTH VIS SCI, V44, P521, DOI 10.1167/iovs.02-0268; Kang KA, 2005, BIOL PHARM BULL, V28, P1154, DOI 10.1248/bpb.28.1154; Kang KA, 2007, BIOL PHARM BULL, V30, P852, DOI 10.1248/bpb.30.852; Kasper M, 2000, AM J RESP CELL MOL, V23, P485, DOI 10.1165/ajrcmb.23.4.4117; Kim CS, 2007, J ETHNOPHARMACOL, V111, P240, DOI 10.1016/j.jep.2006.11.023; Kim J, 2006, VET PATHOL, V43, P718, DOI 10.1354/vp.43-5-718; Kim KM, 2010, TOXICOL APPL PHARM, V244, P106, DOI 10.1016/j.taap.2009.12.023; Kim YS, 2007, J ETHNOPHARMACOL, V112, P166, DOI 10.1016/j.jep.2007.02.017; Koga K, 2002, INT J CLIN PHARM RES, V22, P13; Kondo T, 2003, CELL STRUCT FUNCT, V28, P145; Kowluru RA, 2003, FREE RADICAL RES, V37, P1169, DOI 10.1080/10715760310001604189; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lecleire-Collet A, 2005, BRIT J OPHTHALMOL, V89, P1631, DOI 10.1136/bjo.2005.079491; Lee HJ, 2006, CARCINOGENESIS, V27, P2455, DOI 10.1093/carcin/bgl104; Meezan E, 2005, J AGR FOOD CHEM, V53, P8760, DOI 10.1021/jf058105e; Mitsuhashi T, 1997, J IMMUNOL METHODS, V207, P79, DOI 10.1016/S0022-1759(97)00110-5; Miura J, 2003, J DIABETES COMPLICAT, V17, P16, DOI 10.1016/S1056-8727(02)00183-6; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Moore TCB, 2003, INVEST OPHTH VIS SCI, V44, P4457, DOI 10.1167/iovs.02-1063; Podesta F, 2000, AM J PATHOL, V156, P1025, DOI 10.1016/S0002-9440(10)64970-X; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sohn EJ, 2007, LIFE SCI, V80, P468, DOI 10.1016/j.lfs.2006.09.037; Stitt Alan W., 2000, Molecular Cell Biology Research Communications, V3, P380, DOI 10.1006/mcbr.2000.0243; Takii H, 2001, BIOL PHARM BULL, V24, P484, DOI 10.1248/bpb.24.484; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Wang YL, 2007, EYE, V21, P1501, DOI 10.1038/sj.eye.6702716; Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V296, P877, DOI 10.1016/S0006-291X(02)00940-3; Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V290, P973, DOI 10.1006/bbrc.2001.6312; Yamagishi Sho-ichi, 2006, Curr Drug Discov Technol, V3, P83, DOI 10.2174/157016306776637555; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; YAMAGISHI SI, 1995, BIOCHEM BIOPH RES CO, V213, P681, DOI 10.1006/bbrc.1995.2185	49	12	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43591	10.1371/journal.pone.0043591	http://dx.doi.org/10.1371/journal.pone.0043591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916281	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800080
J	Stolla, M; Pelisek, J; Von Bruhl, ML; Schafer, A; Barocke, V; Heider, P; Lorenz, M; Tirniceriu, A; Steinhart, A; Bauersachs, J; Bray, PF; Massberg, S; Schulz, C				Stolla, Moritz; Pelisek, Jaroslav; von Bruehl, Marie-Luise; Schaefer, Andreas; Barocke, Verena; Heider, Peter; Lorenz, Michael; Tirniceriu, Anca; Steinhart, Alexander; Bauersachs, Johann; Bray, Paul F.; Massberg, Steffen; Schulz, Christian			Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; CORONARY-ARTERY-DISEASE; IN-VIVO; RECEPTOR CX(3)CR1; PLATELET-ADHESION; VASCULAR-LESIONS; UNSTABLE ANGINA; TISSUE FACTOR; AORTIC-WALL; CHEMOKINE	Fractalkine (CX3CL1, FKN) is expressed in the inflamed vascular wall and absence of FKN reduces atherogenesis. Whether FKN is expressed throughout all stages of atherosclerotic disease and whether it directly contributes to monocyte recruitment to atherosclerotic lesions is not known. We collected human atherosclerotic plaque material and blood samples from patients with carotid artery disease undergoing endarterectomy. Plaques were analyzed by immunohistochemistry and qPCR. We found that FKN is expressed at all stages of atherosclerotic lesion formation, and that the number of FKN-expressing cells positively correlates with the number of CX3CR1-positive cells in human carotid artery plaques. In the circulation, soluble FKN levels are significantly elevated in the presence of high-grade (sub-occlusive) stenosis. To determine the role of the FKN-CX3CR1 axis for monocyte adhesion in vivo we then performed intravital videofluorescence microscopy of the carotid artery in ApoE(-/-) mice. Notably, FKN-CX3CR1 interactions are critical for recruitment of circulating monocytes to the injured atherosclerotic vascular wall. Thus, this chemokine dyad could represent an attractive target for anti-atherosclerotic strategies.	[Stolla, Moritz; Bray, Paul F.] Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn, Philadelphia, PA 19107 USA; [Stolla, Moritz; Bray, Paul F.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; [Pelisek, Jaroslav; Heider, Peter] Tech Univ Munich, Klinikum Rechts Isar, Abt Gefasschirurgie, D-8000 Munich, Germany; [von Bruehl, Marie-Luise; Barocke, Verena; Lorenz, Michael; Tirniceriu, Anca; Steinhart, Alexander; Massberg, Steffen; Schulz, Christian] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, Deutsch Herzzentrum, D-8000 Munich, Germany; [von Bruehl, Marie-Luise; Barocke, Verena; Lorenz, Michael; Tirniceriu, Anca; Steinhart, Alexander; Massberg, Steffen; Schulz, Christian] Munich Heart Alliance, Munich, Germany; [Schaefer, Andreas; Bauersachs, Johann] Hannover Med Sch, Klin Kardiol & Angiol, D-30623 Hannover, Germany	Jefferson University; Jefferson University; Technical University of Munich; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Munich Heart Alliance; Hannover Medical School	Stolla, M (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn, Philadelphia, PA 19107 USA.	chrisschulz@mytum.de	Massberg, Steffen/AAN-6054-2021; Schulz, Christian/J-8545-2012; Schäfer, Andreas/AAQ-9512-2021	Schulz, Christian/0000-0003-3878-7833; 	Wilhelm-Vaillant-Stiftung; Technische Universitat Muenchen; German National Academy of Sciences Leopoldina [LPDS 2009-31]; American Heart Association	Wilhelm-Vaillant-Stiftung; Technische Universitat Muenchen; German National Academy of Sciences Leopoldina; American Heart Association(American Heart Association)	The study was supported in by the Wilhelm-Vaillant-Stiftung and grants of the Technische Universitat Muenchen. Christian Schulz is recipient of a fellowship program of the German National Academy of Sciences Leopoldina (LPDS 2009-31). Moritz Stolla is recipient of a fellowship of the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chou J, 2004, BLOOD, V104, P3190, DOI 10.1182/blood-2004-03-0935; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; CROUSE JR, 1993, CIRCULATION, V87, P17; Damas JK, 2005, ARTERIOSCL THROM VAS, V25, P2567, DOI 10.1161/01.ATV.0000190672.36490.7b; Damas JK, 2003, CIRCULATION, V107, P2670, DOI 10.1161/01.CIR.0000070542.18001.87; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Egorina EM, 2005, ARTERIOSCL THROM VAS, V25, P1493, DOI 10.1161/01.ATV.0000168413.29874.d7; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Galkina E, 2007, CIRCULATION, V116, P1801, DOI 10.1161/CIRCULATIONAHA.106.678474; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Greaves DR, 2001, ARTERIOSCL THROM VAS, V21, P923, DOI 10.1161/01.ATV.21.6.923; Hasegawa M, 2005, ANN RHEUM DIS, V64, P21, DOI 10.1136/ard.2003.018705; Ikejima H, 2010, CIRC J, V74, P337, DOI 10.1253/circj.CJ-09-0484; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kerfoot SM, 2003, EUR J IMMUNOL, V33, P729, DOI 10.1002/eji.200323502; Kim KW, 2011, BLOOD; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF; Ludwig A, 2007, THROMB HAEMOSTASIS, V97, P694; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Massberg S, 2005, CIRCULATION, V112, P1180, DOI 10.1161/CIRCULATIONAHA.105.539221; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Robinson LA, 2000, J IMMUNOL, V165, P6067, DOI 10.4049/jimmunol.165.11.6067; Robinson LA, 2003, CELL IMMUNOL, V225, P122, DOI 10.1016/j.cellimm.2003.09.010; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulz C, 2011, J THROMB HAEMOST, V9, P1007, DOI 10.1111/j.1538-7836.2011.04235.x; Schulz C, 2008, BASIC RES CARDIOL, V103, P356, DOI 10.1007/s00395-008-0722-3; Schulz C, 2007, CIRCULATION, V116, P764, DOI 10.1161/CIRCULATIONAHA.107.695189; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Umehara H, 2001, IMMUNOL CELL BIOL, V79, P298, DOI 10.1046/j.1440-1711.2001.01004.x; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; WALKER EB, 1982, J IMMUNOL, V128, P852; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4; Yi GW, 2011, CYTOKINE, V53, P320, DOI 10.1016/j.cyto.2010.11.016	51	47	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43572	10.1371/journal.pone.0043572	http://dx.doi.org/10.1371/journal.pone.0043572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916279	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800078
J	Al-Wadei, HAN; Al-Wadei, MH; Ullah, MF; Schuller, HM				Al-Wadei, Hussein A. N.; Al-Wadei, Mohammed H.; Ullah, Mohammad F.; Schuller, Hildegard M.			Celecoxib and GABA Cooperatively Prevent the Progression of Pancreatic Cancer In Vitro and in Xenograft Models of Stress-Free and Stress-Exposed Mice	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; TOBACCO-SPECIFIC CARCINOGEN; GAMMA-AMINOBUTYRIC-ACID; CELL LUNG-CANCER; CYCLOOXYGENASE-2 EXPRESSION; ARACHIDONIC-ACID; TUMOR-ANGIOGENESIS; HUMAN PROSTATE; BETA-BLOCKERS; BREAST-CANCER	Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis and is associated with high levels of psychological distress. We have shown that beta-adrenergic receptors (beta-ARs), which are activated by stress neurotransmitters, regulate PDAC cells via cyclic AMP (cAMP)-dependent signaling in vitro, that social stress promotes PDAC progression in mouse xenografts and that gamma-aminobutyric acid (GABA) inhibits these responses in vitro and in vivo. The targeted inhibition of stress-induced regulatory pathways may abolish the potentially negative impact of psychological stress on clinical outcomes. Our current data show that chronic exposure of PDAC cell lines Panc-1 (activating point mutations in K-ras) and BXPC-3 (no mutations in K-ras) in vitro to the stress neurotransmitter epinephrine at the concentration (15 nM) previously measured in the serum of mice exposed to social stress significantly increased proliferation and migration. These responses were inhibited in a concentration-dependent manner by celecoxib. The effects of celecoxib alone and in combination with gamma-aminobutyric acid (GABA) on the progression of subcutaneous mouse xenografts from the cell line (BXPC-3) most responsive to epinephrine were then investigated in the presence and absence of social stress. Cancer-stimulating factors (VEGF & prostaglandin E-2 [PGE(2)]) and levels of cAMP were measured by immunoassays in blood and xenograft tissue. Phosphorylation of the signaling proteins ERK, CREB, Src, and AKT was assessed by ELISA assays and Western blotting. Expression of COX-2, 5-lipoxygenase, and p-5-LOX were determined by semi-quantitative Western blotting. Celecoxib alone significantly inhibited xenograft progression and decreased systemic and tumor VEGF, PGE2, and cAMP as well as phosphorylated signaling proteins in stress-exposed and stress-free mice. These responses were significantly enhanced by co-treatment with GABA. The celecoxib-induced downregulation of COX-2 protein and p-5-LOX was also significantly enhanced by GABA under both experimental conditions. Our findings identify the targeted inhibition of stress-induced pathways as a promising area for more effective cancer intervention in pancreatic cancer.	[Al-Wadei, Hussein A. N.; Al-Wadei, Mohammed H.; Ullah, Mohammad F.; Schuller, Hildegard M.] Univ Tennessee, Coll Vet Med, Expt Oncol Lab, Dept Biomed & Diagnost Sci, Knoxville, TN 37901 USA; [Al-Wadei, Hussein A. N.] Sanaa Univ, Dept Prevent Med, Sanaa, Yemen	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Al-Wadei, HAN (corresponding author), Univ Tennessee, Coll Vet Med, Expt Oncol Lab, Dept Biomed & Diagnost Sci, Knoxville, TN 37901 USA.	hmsch@utk.edu	Ullah, Mohammad Fahad/AGH-2871-2022		National Cancer Institute; College of Veterinary Medicine;  [RC1CA144640];  [RO1CA042829]; NATIONAL CANCER INSTITUTE [R01CA042829, RC1CA144640] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); College of Veterinary Medicine; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was financially supported by grants RC1CA144640 and RO1CA042829 with the National Cancer Institute. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Misty Bailey (whose position is fully funded by the College of Veterinary Medicine) for her textual editorial assistance with the manuscript.	Al-Wadei HA, 2009, ANTI-CANCER DRUG, V20, P477, DOI 10.1097/CAD.0b013e32832bd1e3; Al-Wadei HAN, 2012, CANCER PREV RES, V5, P189, DOI 10.1158/1940-6207.CAPR-11-0177; Al-Wadei HAN, 2009, CARCINOGENESIS, V30, P506, DOI 10.1093/carcin/bgp010; Al-Wadei MH, 2012, MOL CANCER RES, V10, P239, DOI 10.1158/1541-7786.MCR-11-0332; Ali S, 2005, MOL CANCER THER, V4, P1943, DOI 10.1158/1535-7163.MCT-05-0065; Almhanna K, 2011, CURR TREAT OPTION ON, V12, P111, DOI 10.1007/s11864-011-0150-8; Askari MDF, 2005, J CANCER RES CLIN, V131, P639, DOI 10.1007/s00432-005-0002-7; Chan G, 1999, CANCER RES, V59, P991; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Ding Xian-Zhong, 2003, Mol Cancer, V2, P10, DOI 10.1186/1476-4598-2-10; Ding XZ, 2001, PANCREATOLOGY, V1, P291, DOI 10.1159/000055827; Elder DJE, 2002, INT J CANCER, V99, P323, DOI 10.1002/ijc.10330; Gately S, 2000, CANCER METAST REV, V19, P19, DOI 10.1023/A:1026575610124; Half E, 2002, CANCER RES, V62, P1676; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Jacobs EJ, 2004, J NATL CANCER I, V96, P524, DOI 10.1093/jnci/djh084; Jendrossek V, 2011, CANC LETT IN PRESS; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Kirschenbaum A, 2000, UROLOGY, V56, P671, DOI 10.1016/S0090-4295(00)00674-9; Kulkarni S, 2001, CLIN CANCER RES, V7, P429; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; Lim HY, 2000, CLIN CANCER RES, V6, P519; Liu XL, 2006, ADV ANAT PATHOL, V13, P270, DOI 10.1097/01.pap.0000213046.61941.5c; Longo R, 2008, CRIT REV ONCOL HEMAT, V68, P197, DOI 10.1016/j.critrevonc.2008.03.003; Lowenfels AB, 2005, J CELL BIOCHEM, V95, P649, DOI 10.1002/jcb.20461; Masur K, 2001, CANCER RES, V61, P2866; Melhem-Bertrandt A, 2012, CANCER PREV RES, V5, P147, DOI 10.1158/1940-6207.CAPR-11-0579; Moreno-Smith M, 2010, FUTURE ONCOL, V6, P1863, DOI [10.2217/fon.10.142, 10.2217/FON.10.142]; Nieto J, 2008, ONCOLOGIST, V13, P562, DOI 10.1634/theoncologist.2007-0181; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Parsons CM, 2010, ANTICANCER RES, V30, P3279; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Sapolsky R.M., 1998, WHY ZEBRAS DONT GET; Schernhammer ES, 2004, JNCI-J NATL CANCER I, V96, P22, DOI 10.1093/jnci/djh001; Schmidt C, 1996, Eur J Med Res, V1, P528; Schuller HM, 2008, CANCER-AM CANCER SOC, V112, P767, DOI 10.1002/cncr.23231; Schuller HM, 2012, CARCINOGENESIS, V33, P191, DOI 10.1093/carcin/bgr251; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Schuller HM, 1999, CANCER RES, V59, P4510; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Shields DJ, 2011, ONCOGENE, V30, P2123, DOI 10.1038/onc.2010.589; Shin VY, 2007, TOXICOL SCI, V96, P21, DOI 10.1093/toxsci/kfl118; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Sterlemann V, 2008, HORM BEHAV, V53, P386, DOI 10.1016/j.yhbeh.2007.11.001; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tucker ON, 1999, CANCER RES, V59, P987; Waldner MJ, 2012, EXPERT OPIN THER TAR, V16, P5, DOI 10.1517/14728222.2011.641951; Weddle DL, 2001, CARCINOGENESIS, V22, P473, DOI 10.1093/carcin/22.3.473; Werz O, 2002, J BIOL CHEM, V277, P14793, DOI 10.1074/jbc.M111945200; World Health Organization, 2012, CANC FACT SHEET; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.3.CO;2-Y	55	33	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43376	10.1371/journal.pone.0043376	http://dx.doi.org/10.1371/journal.pone.0043376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916251	gold, Green Published			2022-12-27	WOS:000307824300045
J	Eynon, N; Ruiz, JR; Femia, P; Pushkarev, VP; Cieszczyk, P; Maciejewska-Karlowska, A; Sawczuk, M; Dyatlov, DA; Lekontsev, EV; Kulikov, LM; Birk, R; Bishop, DJ; Lucia, A				Eynon, Nir; Ruiz, Jonatan R.; Femia, Pedro; Pushkarev, Vladimir P.; Cieszczyk, Pawel; Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek; Dyatlov, Dmitry A.; Lekontsev, Evgeny V.; Kulikov, Leonid M.; Birk, Ruth; Bishop, David J.; Lucia, Alejandro			The ACTN3 R577X Polymorphism across Three Groups of Elite Male European Athletes	PLOS ONE			English	Article							ALPHA-ACTININ-3 DEFICIENCY; ENDURANCE PERFORMANCE; ASSOCIATION; GENE; GENOTYPE; EXPRESSION; EVOLUTION; STRENGTH; ALLELE; SPEED	The ACTN3 R577X polymorphism (rs1815739) is a strong candidate to influence elite athletic performance. Yet, controversy exists in the literature owing to between-studies differences in the ethnic background and sample size of the cohorts, the latter being usually low, which makes comparisons difficult. In this case: control genetic study we determined the association between elite athletic status and the ACTN3 R577X polymorphism within three cohorts of European Caucasian men, i.e. Spanish, Polish and Russian [ 633 cases (278 elite endurance and 355 power athletes), and 808 non-athletic controls]. The odds ratio (OR) of a power athlete harbouring the XX versus the RR genotype compared with sedentary controls was 0.54 [95% confidence interval (CI): 0.34-0.48; P = 0.006]. We also observed that the OR of an endurance athlete having the XX versus the RR genotype compared with power athletes was 1.88 (95% CI: 1.07-3.31; P = 0.028). In endurance athletes, the OR of a "world-class" competitor having the XX genotype versus the RR+RX genotype was 3.74 (95% CI: 1.08-12.94; P = 0.038) compared with those of a lower ("national") competition level. No association (P>0.1) was noted between the ACTN3 R577X polymorphism and competition level (world-class versus national-level) in power athletes. Our data provide comprehensive support for the influence of the ACTN3 R577X polymorphism on elite athletic performance.	[Eynon, Nir; Bishop, David J.] Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia; [Eynon, Nir; Bishop, David J.] Victoria Univ, Sch Sports & Exercise Sci, Melbourne, Vic 8001, Australia; [Ruiz, Jonatan R.] Univ Granada, Sch Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Ruiz, Jonatan R.] Karolinska Inst, Novum, Unit Prevent Nutr Dept Biosci & Nutr, Huddinge, Sweden; [Femia, Pedro] Univ Granada, Sch Med, Dept Biostat, Granada, Spain; [Pushkarev, Vladimir P.; Dyatlov, Dmitry A.; Lekontsev, Evgeny V.; Kulikov, Leonid M.] Ural State Univ Phys Culture, Ural, Russia; [Cieszczyk, Pawel] Univ Szczecin, Dept Phys Culture & Hlth Promot, Szczecin, Poland; [Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek] Univ Szczecin, Dept Genet, Szczecin, Poland; [Birk, Ruth] Ariel Univ Ctr, Dept Nutr, Fac Hlth Sci, Ariel, Israel; [Lucia, Alejandro] Univ Europea Madrid, Madrid, Spain	Victoria University; Victoria University; University of Granada; Karolinska Institutet; University of Granada; University of Szczecin; University of Szczecin; Ariel University; European University of Madrid	Eynon, N (corresponding author), Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia.	Nir.Eynon@vu.edu.au	RUIZ, JONATAN R/M-1338-2015; Cieszczyk, Pawel/AAG-3328-2022; Sawczuk, Marek/S-3609-2017; Femia, Pedro/C-1367-2011; Lucia, Alejandro/M-2759-2014; Cieszczyk, Pawel/AFK-4645-2022; Bishop, David John/X-9826-2019	RUIZ, JONATAN R/0000-0002-7548-7138; Cieszczyk, Pawel/0000-0002-7735-7580; Femia, Pedro/0000-0002-1746-5619; Lucia, Alejandro/0000-0002-3025-2060; Cieszczyk, Pawel/0000-0002-7735-7580; Bishop, David John/0000-0002-6956-9188; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; birk, ruth/0000-0001-5770-4277; Eynon, Nir/0000-0003-4046-8276; Sawczuk, Marek/0000-0002-5730-5249; Lucia, Alejandro/0000-0002-5565-0997	Consejo Superior de Deportes [001/UPR10/12]; Spanish Ministry of Science and Innovation [RYC-2010-05957]; Fondo de Investigaciones Sanitarias [PS09/00194]; Polish Ministry of Science and Higher Education [404166334]; Ministry of Sport, Tourism and Youth Policy of the Russian Federation	Consejo Superior de Deportes; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Ministry of Sport, Tourism and Youth Policy of the Russian Federation	This work was supported by the Consejo Superior de Deportes (grant #001/UPR10/12), Spanish Ministry of Science and Innovation (RYC-2010-05957), Fondo de Investigaciones Sanitarias (ref. # PS09/00194), the Polish Ministry of Science and Higher Education (grant#404166334), and the Ministry of Sport, Tourism and Youth Policy of the Russian Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmetov II, 2010, BRIT J SPORT MED, V44, P649, DOI 10.1136/bjsm.2008.051540; Ahmetov II, 2011, EXP PHYSIOL, V96, P1302, DOI 10.1113/expphysiol.2011.060293; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; Bishop D, 2000, MED SCI SPORT EXER, V32, P1088, DOI 10.1097/00005768-200006000-00008; Bouchard C, 2011, EXERC SPORT SCI REV, V39, P212, DOI 10.1097/JES.0b013e31822643f6; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Doring FE, 2010, J SPORT SCI, V28, P1355, DOI 10.1080/02640414.2010.507675; Druzhevskaya AM, 2008, EUR J APPL PHYSIOL, V103, P631, DOI 10.1007/s00421-008-0763-1; Eynon N, 2009, INT J SPORTS MED, V30, P695, DOI 10.1055/s-0029-1220731; Eynon N, 2011, J PHYSIOL-LONDON, V589, P3063, DOI 10.1113/jphysiol.2011.207035; Gineviciene V, 2011, MEDICINA-LITHUANIA, V47, P284, DOI 10.3390/medicina47050040; Gomez-Gallego F, 2009, INT J SPORTS MED, V30, P66, DOI 10.1055/s-2008-1038677; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Lucia A, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.034199; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MacArthur DG, 2007, EXERC SPORT SCI REV, V35, P30, DOI 10.1097/JES.0b013e31802d8874; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Muniesa CA, 2010, BRIT J SPORT MED, V44, P898, DOI 10.1136/bjsm.2008.051680; Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438; Norman B, 2009, J APPL PHYSIOL, V106, P959, DOI 10.1152/japplphysiol.91435.2008; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Papadimitriou ID, 2008, INT J SPORTS MED, V29, P352, DOI 10.1055/s-2007-965339; Roth SM, 2008, EUR J HUM GENET, V16, P391, DOI 10.1038/sj.ejhg.5201964; Ruiz JR, 2011, SCAND J MED SCI SPOR, V21, pE34, DOI 10.1111/j.1600-0838.2010.01134.x; Saunders CJ, 2007, ANN HUM GENET, V71, P777, DOI 10.1111/j.1469-1809.2006.00385.x; Tejedor D, 2005, CLIN CHEM, V51, P1137, DOI 10.1373/clinchem.2004.045203; Vincent B, 2012, ACTA PHYSIOL, V204, P555, DOI 10.1111/j.1748-1716.2011.02366.x; Vincent B, 2007, PHYSIOL GENOMICS, V32, P58, DOI 10.1152/physiolgenomics.00173.2007; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang N, 2007, MED SCI SPORT EXER, V39, P1985, DOI 10.1249/mss.0b013e31814844c9	32	59	61	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43132	10.1371/journal.pone.0043132	http://dx.doi.org/10.1371/journal.pone.0043132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916217	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000307824300031
J	Smith, ML				Smith, Michael L.			The Honey Bee Parasite Nosema ceranae: Transmissible via Food Exchange?	PLOS ONE			English	Article							APIS-MELLIFERA; MICROSPORIDIAN PARASITE; COLONY COLLAPSE; INFECTION; EUROPE	Nosema ceranae, a newly introduced parasite of the honey bee, Apis mellifera, is contributing to worldwide colony losses. Other Nosema species, such as N. apis, tend to be associated with increased defecation and spread via a fecal-oral pathway, but because N. ceranae does not induce defecation, it may instead be spread via an oral-oral pathway. Cages that separated older infected bees from young uninfected bees were used to test whether N. ceranae can be spread during food exchange. When cages were separated by one screen, food could be passed between the older bees and the young bees, but when separated by two screens, food could not be passed between the two cages. Young uninfected bees were also kept isolated in cages, as a solitary control. After 4 days of exposure to the older bees, and 10 days to incubate infections, young bees were more likely to be infected in the 1-Screen Test treatment vs. the 2-Screen Test treatment (P = 0.0097). Young bees fed by older bees showed a 13-fold increase in mean infection level relative to young bees not fed by older bees (1-Screen Test 40.8%; 2-Screen Test 3.4%; Solo Control 2.8%). Although fecal-oral transmission is still possible in this experimental design, oral-oral infectivity could help explain the rapid spread of N. ceranae worldwide.	Wageningen Univ, Bees WUR, Wageningen, Netherlands	Wageningen University & Research	Smith, ML (corresponding author), Wageningen Univ, Bees WUR, Wageningen, Netherlands.	mls453@cornell.edu		Smith, Michael/0000-0002-3454-962X	Rotary Ambassadorial Scholarship Program; United States National Science Foundation (NSF)	Rotary Ambassadorial Scholarship Program; United States National Science Foundation (NSF)(National Science Foundation (NSF))	The author would like to thank the Rotary Ambassadorial Scholarship Program for financial support to do research at Wageningen University. This material is based on work supported by a United States National Science Foundation (NSF) Graduate Research Fellowship. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	BAILEY L, 1952, J EXP BIOL, V29, P310; Bailey L, 1955, ANN APPL BIOL, V43, P379, DOI 10.1111/j.1744-7348.1955.tb02488.x; Bourgeois AL, 2010, J INVERTEBR PATHOL, V103, P53, DOI 10.1016/j.jip.2009.10.009; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2009, J EUKARYOT MICROBIOL, V56, P142, DOI 10.1111/j.1550-7408.2008.00374.x; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Free J. B., 1957, British Journal of Animal Behaviour, V5, P41, DOI 10.1016/S0950-5601(57)80023-9; Fries I, 2006, J APICULT RES, V45, P230; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2008, J INVERTEBR PATHOL, V97, P76, DOI 10.1016/j.jip.2007.06.002; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2009, ENV MICROBIOL REP, V1, P495, DOI 10.1111/j.1758-2229.2009.00052.x; Invernizzi C, 2009, J INVERTEBR PATHOL, V101, P150, DOI 10.1016/j.jip.2009.03.006; Kasprzak Sylwia, 2007, Wiadomosci Parazytologiczne, V53, P281; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Larsson R., 1986, Progress in Protistology, V1, P325; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; PENG YS, 1986, PHYSIOL ENTOMOL, V11, P433, DOI 10.1111/j.1365-3032.1986.tb00434.x; Winston, 1987, BIOL HONEYBEE	22	89	92	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43319	10.1371/journal.pone.0043319	http://dx.doi.org/10.1371/journal.pone.0043319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916241	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300039
J	Hagiwara, K; Nagamori, S; Umemura, YM; Ohgaki, R; Tanaka, H; Murata, D; Nakagomi, S; Nomura, KH; Kage-Nakadai, E; Mitani, S; Nomura, K; Kanai, Y				Hagiwara, Kohei; Nagamori, Shushi; Umemura, Yasuhiro M.; Ohgaki, Ryuichi; Tanaka, Hidekazu; Murata, Daisuke; Nakagomi, Saya; Nomura, Kazuko H.; Kage-Nakadai, Eriko; Mitani, Shohei; Nomura, Kazuya; Kanai, Yoshikatsu			NRFL-1, the C. elegans NHERF Orthologue, Interacts with Amino Acid Transporter 6 (AAT-6) for Age-Dependent Maintenance of AAT-6 on the Membrane	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DOMAIN INTERACTION CONTROLS; PROTEIN-KINASE-A; CAENORHABDITIS-ELEGANS; NA+/H+ EXCHANGER; TARGETED DISRUPTION; APICAL MEMBRANE; PDZ DOMAINS; GENE; BINDING	The NHERF (Na+/H+ exchanger regulatory factor) family has been proposed to play a key role in regulating transmembrane protein localization and retention at the plasma membrane. Due to the high homology between the family members, potential functional compensations have been a concern in sorting out the function of individual NHERF numbers. Here, we studied C. elegans NRFL-1 (C01F6.6) (nherf-like protein 1), the sole C. elegans orthologue of the NHERF family, which makes worm a model with low genetic redundancy of NHERF homologues. Integrating bioinformatic knowledge of C. elegans proteins into yeast two-hybrid scheme, we identified NRFL-1 as an interactor of AAT-6, a member of the C. elegans AAT (amino acid transporter) family. A combination of GST pull-down assay, localization study, and co-immunoprecipitation confirmed the binding and characterized the PDZ interaction. AAT-6 localizes to the luminal membrane even in the absence of NRFL-1 when the worm is up to four-day old. A fluorescence recovery after photobleaching (FRAP) analysis suggested that NRFL-1 immobilizes AAT-6 at the luminal membrane. When the nrfl-1 deficient worm is six-day or older, in contrast, the membranous localization of AAT-6 is not observed, whereas AAT-6 tightly localizes to the membrane in worms with NRFL-1. Sorting out the in vivo functions of the C. elegans NHERF protein, we found that NRFL-1, a PDZ-interactor of AAT-6, is responsible for the immobilization and the age-dependent maintenance of AAT-6 on the intestinal luminal membrane.	[Hagiwara, Kohei; Nagamori, Shushi; Umemura, Yasuhiro M.; Ohgaki, Ryuichi; Tanaka, Hidekazu; Nakagomi, Saya; Kanai, Yoshikatsu] Osaka Univ, Div Biosyst Pharmacol, Dept Pharmacol, Grad Sch Med, Osaka, Japan; [Hagiwara, Kohei] Osaka Univ, Sch Med, Osaka, Japan; [Murata, Daisuke] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Murata, Daisuke; Nomura, Kazuko H.; Nomura, Kazuya; Kanai, Yoshikatsu] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan; [Nomura, Kazuko H.; Nomura, Kazuya] Kyushu Univ, Fac Sci, Dept Biol Sci, Fukuoka 812, Japan; [Kage-Nakadai, Eriko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan	Osaka University; Osaka University; Kyushu University; Japan Science & Technology Agency (JST); Kyushu University; Tokyo Women's Medical University	Hagiwara, K (corresponding author), Osaka Univ, Div Biosyst Pharmacol, Dept Pharmacol, Grad Sch Med, Osaka, Japan.	ykanai@pharma1.med.osaka-u.ac.jp	Nakagomi, Saya/ABE-4676-2020; Nagamori, Shushi/P-4530-2018	Nakagomi, Saya/0000-0002-8272-6192; Nagamori, Shushi/0000-0003-0203-2754; Ohgaki, Ryuichi/0000-0002-6894-7239	Ministry of Education, Culture, Sports, Science and Technology of Japan [17081015]; Japan Society for the Promotion of Science [21390264, 22659052]; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST); Ajinomoto Amino Acid Research Program; Grants-in-Aid for Scientific Research [24591198, 23790334, 12J40095] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ajinomoto Amino Acid Research Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on Priority Areas of 'Transportsome' from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 17081015 (http://www.mext.go.jp/english/); Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant numbers 21390264 and 22659052) (http://www.mext.go.jp/english/); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST) (http://www.jst.go.jp/kisoken/crest/en/index.html); and Ajinomoto Amino Acid Research Program (http://www.3arp.ajinomoto.com/). Saya Nakagomi is a research fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altun ZF, 2009, WORMATLAS, DOI [10.3908/wormatlas.1.4, DOI 10.3908/W0RMATLAS.1.4]; Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; Bossinger O, 2004, DEV BIOL, V268, P448, DOI 10.1016/j.ydbio.2004.01.003; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Broere N, 2007, J BIOL CHEM, V282, P37575, DOI 10.1074/jbc.M704878200; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gloerich M, 2012, NAT CELL BIOL, V14, P793, DOI 10.1038/ncb2537; Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Harris BZ, 2001, J CELL SCI, V114, P3219; Hughes SC, 2010, J CELL SCI, V123, P1099, DOI 10.1242/jcs.059469; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li M, 2010, J BIOL CHEM, V285, P19299, DOI 10.1074/jbc.M109.096081; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miyazaki H, 2005, J AM SOC NEPHROL, V16, P3498, DOI 10.1681/ASN.2005030306; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Nomura KH, 2011, GLYCOBIOLOGY, V21, P834, DOI 10.1093/glycob/cwr019; Noshiro R, 2006, KIDNEY INT, V70, P275, DOI 10.1038/sj.ki.5001522; Portman DS, 2006, C ELEGANS GENE EXPRE; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Samuel ADT, 2003, J NEUROSCI, V23, P373, DOI 10.1523/JNEUROSCI.23-02-00373.2003; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Spradling AC, 1999, GENETICS, V153, P135; Stiernagle T, 2006, MAINTENANCE C ELEGAN; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Veljkovic E, 2004, J BIOL CHEM, V279, P49268, DOI 10.1074/jbc.M404470200; Veljkovic E, 2004, J BIOL CHEM, V279, P7655, DOI 10.1074/jbc.M309528200; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	67	7	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43050	10.1371/journal.pone.0043050	http://dx.doi.org/10.1371/journal.pone.0043050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916205	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600043
J	Bratton, EW; El Husseini, N; Chastain, CA; Lee, MS; Poole, C; Sturmer, T; Juliano, JJ; Weber, DJ; Perfect, JR				Bratton, Emily W.; El Husseini, Nada; Chastain, Cody A.; Lee, Michael S.; Poole, Charles; Stuermer, Til; Juliano, Jonathan J.; Weber, David J.; Perfect, John R.			Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; NERVOUS-SYSTEM CRYPTOCOCCOSIS; HIGH-DOSE FLUCONAZOLE; APPARENTLY IMMUNOCOMPETENT PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; CALCINEURIN-INHIBITOR AGENTS; LIPOSOMAL AMPHOTERICIN-B; RANDOMIZED-TRIAL; RISK-FACTORS; PRACTICE GUIDELINES	Background: The Infectious Disease Society of America (IDSA) 2010 Clinical Practice Guidelines for the management of cryptococcosis outlined three key populations at risk of disease: (1) HIV-infected, (2) transplant recipient, and (3) HIV-negative/non-transplant. However, direct comparisons of management, severity and outcomes of these groups have not been conducted. Methodology/Principal Findings: Annual changes in frequency of cryptococcosis diagnoses, cryptococcosis-attributable mortality and mortality were captured. Differences examined between severe and non-severe disease within the context of the three groups included: demographics, symptoms, microbiology, clinical management and treatment. An average of nearly 15 patients per year presented at Duke University Medical Center (DUMC) with cryptococcosis. Out of 207 study patients, 86 (42%) were HIV-positive, 42 (20%) were transplant recipients, and 79 (38%) were HIV-negative/non-transplant. HIV-infected individuals had profound CD4 lymphocytopenia and a majority had elevated intracranial pressure. Transplant recipients commonly (38%) had renal dysfunction. Nearly one-quarter (24%) had their immunosuppressive regimens stopped or changed. The HIV-negative/non-transplant population reported longer duration of symptoms than HIV-positive or transplant recipients and 28% (22/79) had liver insufficiency or underlying hematological malignancies. HIV-positive and HIV-negative/non-transplant patients accounted for 89% of severe disease cryptococcosis-attributable deaths and 86% of all-cause mortality. Conclusions/Significance: In this single-center study, the frequency of cryptococcosis did not change in the last two decades, although the underlying case mix shifted (fewer HIV-positive cases, stable transplant cases, more cases with neither). Cryptococcosis had a relatively uniform and informed treatment strategy, but disease-attributable mortality was still common.	[Bratton, Emily W.; Poole, Charles; Stuermer, Til; Weber, David J.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [El Husseini, Nada; Perfect, John R.] Duke Univ, Dept Med, Durham, NC USA; [Chastain, Cody A.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Lee, Michael S.; Juliano, Jonathan J.; Weber, David J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Vanderbilt University; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill	Bratton, EW (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.	emily_bratton@unc.edu	Stürmer, Til/AAB-5459-2022		United States National Institutes of Health Public Health Service [AI73896]; Enzon; Pfizer; Merck; Astellas; Schering-Plough; UNC Center of Excellence in Pharmacoepidemiology and Public Health; UNC-DEcIDE center from the Agency for Healthcare Research and Quality; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073896] Funding Source: NIH RePORTER	United States National Institutes of Health Public Health Service; Enzon; Pfizer(Pfizer); Merck(Merck & Company); Astellas(Astellas Pharmaceuticals); Schering-Plough(Merck & CompanySchering Plough Corporation); UNC Center of Excellence in Pharmacoepidemiology and Public Health; UNC-DEcIDE center from the Agency for Healthcare Research and Quality; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States National Institutes of Health Public Health Service Grant [grant number AI73896]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; EWB, NEH, MSL, CAC, CP, JJJ and DJW have declared that they have no competing interests. The following authors have the following conflicts to declare: JRP has research grants, consulting and honorariums from Enzon, Pfizer, Merck, Astellas and Schering-Plough. TS does not accept personal compensation of any kind from any pharmaceutical company, though he receives salary support from the UNC Center of Excellence in Pharmacoepidemiology and Public Health and from unrestricted research grants from pharmaceutical companies to UNC. TS also receives research funding as Principal Investigator of the UNC-DEcIDE center from the Agency for Healthcare Research and Quality. However, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Bicanic T, 2009, JAIDS-J ACQ IMM DEF, V51, P130, DOI 10.1097/QAI.0b013e3181a56f2e; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, Vviii; Chen JH, 2008, EMERG INFECT DIS, V14, P755, DOI 10.3201/eid1405.071312; Del Poeta M, 2000, ANTIMICROB AGENTS CH, V44, P739, DOI 10.1128/AAC.44.3.739-746.2000; DISMUKES WE, 1987, NEW ENGL J MED, V317, P334, DOI 10.1056/NEJM198708063170602; Dromer F, 2004, AIDS, V18, P555, DOI 10.1097/00002030-200402200-00024; Dromer F, 1996, CLIN INFECT DIS, V22, pS154, DOI 10.1093/clinids/22.Supplement_2.S154; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; Ecevit IZ, 2006, CLIN INFECT DIS, V42, P1443, DOI 10.1086/503570; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Galanis E, 2009, CAN J INFECT DIS MED, V20, P23, DOI 10.1155/2009/719659; Hajjeh RA, 1999, J INFECT DIS, V179, P449, DOI 10.1086/314606; Hamill RJ, 2010, CLIN INFECT DIS, V51, P225, DOI 10.1086/653606; Jarvis JN, 2008, CURR OPIN INFECT DIS, V21, P596, DOI 10.1097/QCO.0b013e3283177f6c; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kontoyiannis DP, 2008, ANTIMICROB AGENTS CH, V52, P735, DOI 10.1128/AAC.00990-07; Kontoyiannis DP, 2003, J ANTIMICROB CHEMOTH, V51, P313, DOI 10.1093/jac/dkg090; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2011, CURR OPIN INFECT DIS, V24, P34, DOI 10.1097/QCO.0b013e3283420f76; Leenders ACAP, 1997, AIDS, V11, P1463, DOI 10.1097/00002030-199712000-00010; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Lortholary O, 2006, AIDS, V20, P2183, DOI 10.1097/01.aids.0000252060.80704.68; Loyse A, 2012, CLIN INFECT DIS, V54, P121, DOI 10.1093/cid/cir745; Lui G, 2006, QJM-INT J MED, V99, P143, DOI 10.1093/qjmed/hcl014; MacDougall L, 2011, EMERG INFECT DIS, V17, P193, DOI 10.3201/eid1702.101020; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2373, DOI 10.1128/AAC.44.9.2373-2381.2000; Milefchik E, 2008, MED MYCOL, V46, P393, DOI 10.1080/13693780701851695; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; Nguyen MH, 2010, J INFECTION, V61, P419, DOI 10.1016/j.jinf.2010.08.004; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Pappas PG, 2009, CLIN INFECT DIS, V48, P1775, DOI 10.1086/599112; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Person AK, 2010, INFECT DIS CLIN N AM, V24, P439, DOI 10.1016/j.idc.2010.01.002; ROZENBAUM R, 1994, CLIN INFECT DIS, V18, P369, DOI 10.1093/clinids/18.3.369; Rust D M, 1998, Oncol Nurs Forum, V25, P35; Saag MS, 2000, CLIN INFECT DIS, V30, P710, DOI 10.1086/313757; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Singh N, 2008, CLIN INFECT DIS, V47, P1321, DOI 10.1086/592690; Singh N, 2008, TRANSPLANTATION, V86, P647, DOI 10.1097/TP.0b013e3181814e76; Singh N, 2007, LANCET INFECT DIS, V7, P395, DOI 10.1016/S1473-3099(07)70085-3; Singh N, 2007, J INFECT DIS, V195, P756, DOI 10.1086/511438; Sun HY, 2009, CLIN INFECT DIS, V49, P1721, DOI 10.1086/647948; Sungkanuparph S, 2007, JAIDS-J ACQ IMM DEF, V45, P595, DOI 10.1097/QAI.0b013e318061b5eb; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Wu G, 2002, Transpl Infect Dis, V4, P183, DOI 10.1034/j.1399-3062.2002.t01-1-02005.x	56	123	123	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43582	10.1371/journal.pone.0043582	http://dx.doi.org/10.1371/journal.pone.0043582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937064	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500065
J	Keswani, SG; Balaji, S; Le, L; Leung, A; Katz, AB; Lim, FY; Habli, M; Jones, HN; Wilson, JM; Crombleholme, TM				Keswani, Sundeep G.; Balaji, Swathi; Le, Louis; Leung, Alice; Katz, Anna B.; Lim, Foong-Yen; Habli, Mounira; Jones, Helen N.; Wilson, James M.; Crombleholme, Timothy M.			Pseudotyped AAV Vector-Mediated Gene Transfer in a Human Fetal Trachea Xenograft Model: Implications for In Utero Gene Therapy for Cystic Fibrosis	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; AIRWAY EPITHELIAL-CELLS; SUBMUCOSAL GLAND; RECOMBINANT ADENOVIRUS; APICAL SURFACES; RHESUS-MONKEYS; VIRAL VECTORS; RABBIT AIRWAY; PHASE-I; EXPRESSION	Background: Lung disease including airway infection and inflammation currently causes the majority of morbidities and mortalities associated with cystic fibrosis (CF), making the airway epithelium and the submucosal glands (SMG) novel target cells for gene therapy in CF. These target cells are relatively inaccessible to postnatal gene transfer limiting the success of gene therapy. Our previous work in a human-fetal trachea xenograft model suggests the potential benefit for treating CF in utero. In this study, we aim to validate adeno-associated virus serotype 2 (AAV2) gene transfer in a human fetal trachea xenograft model and to compare transduction efficiencies of pseudotyping AAV2 vectors in fetal xenografts and postnatal xenograft controls. Methodology/Principal Findings: Human fetal trachea or postnatal bronchus controls were xenografted onto immunocompromised SCID mice for a four-week engraftment period. After injection of AAV2/2, 2/1, 2/5, 2/7 or 2/8 with a LacZ reporter into both types of xenografts, we analyzed for transgene expression in the respiratory epithelium and SMGs. At 1 month, transduction by AAV2/2 and AAV2/8 in respiratory epithelium and SMG cells was significantly greater than that of AAV2/1, 2/5, and 2/7 in xenograft tracheas. Efficiency in SMG transduction was significantly greater in AAV2/8 than AAV2/2. At 3 months, AAV2/2 and AAV2/8 transgene expression was >99% of respiratory epithelium and SMG. At 1 month, transduction efficiency of AAV2/2 and AAV2/8 was significantly less in adult postnatal bronchial xenografts than in fetal tracheal xenografts. Conclusions/Significance: Based on the effectiveness of AAV vectors in SMG transduction, our findings suggest the potential utility of pseudotyped AAV vectors for treatment of cystic fibrosis. The human fetal trachea xenograft model may serve as an effective tool for further development of fetal gene therapy strategies for the in utero treatment of cystic fibrosis.	[Keswani, Sundeep G.; Balaji, Swathi; Le, Louis; Leung, Alice; Lim, Foong-Yen; Habli, Mounira; Jones, Helen N.; Crombleholme, Timothy M.] Cincinnati Childrens Hosp Med Ctr, Ctr Mol Fetal Therapy, Div Pediat Gen Thorac & Fetal Surg, Cincinnati, OH USA; [Keswani, Sundeep G.; Balaji, Swathi; Le, Louis; Leung, Alice; Lim, Foong-Yen; Habli, Mounira; Jones, Helen N.; Crombleholme, Timothy M.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Keswani, Sundeep G.; Katz, Anna B.; Lim, Foong-Yen; Crombleholme, Timothy M.] Childrens Hosp Philadelphia, Childrens Inst Surg Sci, Philadelphia, PA 19104 USA; [Wilson, James M.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Keswani, SG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Mol Fetal Therapy, Div Pediat Gen Thorac & Fetal Surg, Cincinnati, OH USA.	sundeep.keswani@cchmc.org	Crombleholme, Timothy/Y-1477-2019; Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131	National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK074055, R01-DK072446, R01-DK59242]; Wound Healing Foundation 3 M Award; National Institute of General Medical Sciences [K08 GM098831-01]; affiliates of ReGenX Holdings; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072446, R01DK059242, R01DK074055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM098831] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wound Healing Foundation 3 M Award; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); affiliates of ReGenX Holdings; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK074055, R01-DK072446 and R01-DK59242) (TMC), Wound Healing Foundation 3 M Award, and National Institute of General Medical Sciences (K08 GM098831-01) (SGK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: JMW is a consultant to ReGenX Holdings, and is a founder of, holds equity in, and receives a grant from affiliates of ReGenX Holdings. In addition, he is an inventor on patents licensed to various biopharmaceutical companies, including affiliates of ReGenX Holdings. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. All other authors have declared that no competing interests exist.	Aitken ML, 2001, HUM GENE THER, V12, P1907, DOI 10.1089/104303401753153956; Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Arbetman AE, 2005, J VIROL, V79, P15238, DOI 10.1128/JVI.79.24.15238-15245.2005; Beck SE, 1999, J VIROL, V73, P9446, DOI 10.1128/JVI.73.11.9446-9455.1999; Bilbao R, 2005, HUM GENE THER, V16, P678, DOI 10.1089/hum.2005.16.678; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; Bouchard S, 2003, J GENE MED, V5, P941, DOI 10.1002/jgm.421; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Carter BJ, 2005, HUM GENE THER, V16, P541, DOI 10.1089/hum.2005.16.541; Colletti E, 2008, EXP HEMATOL, V36, P816, DOI 10.1016/j.exphem.2008.02.007; Conese M, 2011, J CYST FIBROS, V10, pS114, DOI 10.1016/S1569-1993(11)60017-9; Davies JC, 2001, J GENE MED, V3, P409, DOI 10.1002/jgm.200; Ding W, 2003, J VIROL, V77, P7361, DOI 10.1128/JVI.77.13.7361-7366.2003; Driskell RA, 2003, ANNU REV PHYSIOL, V65, P585, DOI 10.1146/annurev.physiol.65.092101.142426; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Duan DS, 1998, AM J RESP CELL MOL, V18, P750, DOI 10.1165/ajrcmb.18.6.2987; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Flotte TR, 2010, MOL THER, V18, P594, DOI 10.1038/mt.2009.230; Flume PA, 2011, CURR OPIN PULM MED, V17, P220, DOI 10.1097/MCP.0b013e328345e1f8; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; GOLDMAN MJ, 1995, NAT GENET, V9, P126, DOI 10.1038/ng0295-126; Gray SJ, 2010, MOL THER, V18, P570, DOI 10.1038/mt.2009.292; Griesenbach Uta, 2009, Expert Rev Respir Med, V3, P363, DOI 10.1586/ers.09.25; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Halbert CL, 2000, J VIROL, V74, P1524, DOI 10.1128/JVI.74.3.1524-1532.2000; Harvey BG, 1999, J CLIN INVEST, V104, P1245, DOI 10.1172/JCI7935; Hida K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019919; Hildinger M, 2001, J VIROL, V75, P6199, DOI 10.1128/JVI.75.13.6199-6203.2001; Jani JC, 2009, ULTRASOUND OBST GYN, V34, P304, DOI 10.1002/uog.6450; Jerebtsova M, 2002, PEDIATR RES, V52, P95, DOI 10.1203/00006450-200207000-00018; Keswani Sundeep G, 2004, Semin Pediatr Surg, V13, P44, DOI 10.1053/j.sempedsurg.2003.09.007; Keswani SG, 2012, WOUND REPAIR REGEN, V20, P592, DOI 10.1111/j.1524-475X.2012.00810.x; Keswani SG, 2011, J PEDIATR SURG, V46, P33, DOI 10.1016/j.jpedsurg.2010.09.064; Knight AK, 1999, SURG FORUM, P509; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Lim FY, 2003, J PEDIATR SURG, V38, P834, DOI 10.1016/S0022-3468(03)00106-4; Lim FY, 2002, J PEDIATR SURG, V37, P1051, DOI 10.1053/jpsu.2002.33843; Lu Y, 2004, STEM CELLS DEV, V13, P133, DOI 10.1089/154732804773099335; Michelfelder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023101; Nakai H, 2000, NAT BIOTECHNOL, V18, P527, DOI 10.1038/75390; Ostedgaard LS, 2005, P NATL ACAD SCI USA, V102, P2952, DOI 10.1073/pnas.0409845102; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; PEAULT B, 1994, HUM GENE THER, V5, P1131, DOI 10.1089/hum.1994.5.9-1131; Pergolizzi RG, 2003, MOL THER, V8, P999, DOI 10.1016/j.ymthe.2003.08.022; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Tarantal AF, 2010, HUM GENE THER, V21, P143, DOI 10.1089/hum.2009.126; THURLBECK WM, 1961, BRIT J DIS CHEST, V55, P54, DOI 10.1016/S0007-0971(61)80002-8; Wagner JA, 1998, HUM GENE THER, V9, P889, DOI 10.1089/hum.1998.9.6-889; Wang XR, 2001, AM J RESP CELL MOL, V24, P195, DOI 10.1165/ajrcmb.24.2.3918; Weiss Daniel J, 2004, Methods Mol Biol, V246, P53; Welsh Michael J, 2009, Trans Am Clin Climatol Assoc, V120, P149; White AF, 2008, HUM GENE THER, V19, P1407, DOI [10.1089/hum.2008.117, 10.1089/hgt.2008.117]; Xie W, 2011, J CLIN INVESTIGATION; Yan ZY, 2004, J VIROL, V78, P2863, DOI 10.1128/JVI.78.6.2863-2874.2004; Zabner J, 2000, J VIROL, V74, P3852, DOI 10.1128/JVI.74.8.3852-3858.2000; Zuckerman JB, 1999, HUM GENE THER, V10, P2973, DOI 10.1089/10430349950016384	60	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43633	10.1371/journal.pone.0043633	http://dx.doi.org/10.1371/journal.pone.0043633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937069	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500070
J	Lin, HC; Lin, JL; Lin-Tan, DT; Ma, HK; Chen, HC				Lin, Hsin-Chiung; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Ma, Hui-Kang; Chen, Hung-Chi			Early Keratectomy in the Treatment of Moderate Fusarium Keratitis	PLOS ONE			English	Article							FUNGAL KERATITIS; MICROBIAL KERATITIS; RISK-FACTORS; PENETRATING KERATOPLASTY; ACANTHAMOEBA-KERATITIS; PRACTICE PATTERNS; CORNEAL ULCERS; MANAGEMENT; SPECTRUM	Purpose: To evaluate the treatment outcomes and costs of early keratectomy in the management of moderate Fusarium keratitis. Methodology/Principal Findings: Consecutive cases of culture proven Fusarium keratitis treated at our hospital between January 2004 to December 2010 were included in this retrospective study. There were 38 cases of moderate keratitis with infiltrates between 3 to 6 mm in diameter and depth of infiltration not exceeding the inner 1/3 of the cornea. After excluding 5 patients with incomplete follow-up data, 13 patients who received early keratectomy within 1 week of admission were compared with a group of 20 patients treated medically. The significance of the association between early keratectomy and visual acuity, progression to perforation, secondary glaucoma and cataract formation, adjuvant therapy, hospitalization days and cost were assessed. There were no differences between the keratectomy and medication groups in regards to age, sex, presence of systemic diseases, and hypopyon formation on presentation. The early keratectomy group had a shorter hospital stay than the medical therapy group. Disease duration was significantly lower in the early keratectomy group (median: 29.0 vs. 54.5 days, P<0.001). Median hospitalization costs per patient were lower with early keratectomy (mean ward fee: 15175.4 vs. 44159.5 NTD, P<0.001; mean donor fee: 0 vs. 900.0 NTD, P<0.001), primarily because of reductions in hospital stay. More patients in the medication group developed perforations than in the keratectomy group (20% vs. 0%, respectively) and the perforation-free rate was higher in those with early keratectomy, but the results were not statistically significant. Conclusions/Significance: Early keratectomy in moderate Fusarium keratitis may reduce length of hospital stay, hospital costs, and perforation rates.	[Lin, Hsin-Chiung; Ma, Hui-Kang; Chen, Hung-Chi] Chang Gung Univ, Chang Gung Mem Hosp, Dept Ophthalmol, Coll Med, Tao Yuan, Taiwan; [Lin, Ja-Liang; Lin-Tan, Dan-Tzu] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lin, HC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Ophthalmol, Coll Med, Tao Yuan, Taiwan.	hclinn@adm.cgmh.org.tw						Alexandrakis G, 2000, AM J OPHTHALMOL, V129, P571, DOI 10.1016/S0002-9394(99)00449-3; Alfonso E, 2005, MOSBY, V1, P1101; [Anonymous], 2009, J CATARACT REFRACT S, V35, pA4; Bharathi MJ, 2009, INDIAN J MED RES, V130, P749; Bhartiya P, 2007, CLIN EXP OPHTHALMOL, V35, P124, DOI 10.1111/j.1442-9071.2006.01405.x; Chen HC, 2006, CORNEA, V25, P564, DOI 10.1097/01.ico.0000227885.19124.6f; Chen WL, 2001, CORNEA, V20, P141, DOI 10.1097/00003226-200103000-00004; Day S, 2009, BRIT J OPHTHALMOL, V93, P116, DOI 10.1136/bjo.2008.142364; Doczi I, 2004, CLIN MICROBIOL INFEC, V10, P773, DOI 10.1111/j.1469-0691.2004.00909.x; FORSTER RK, 1975, ARCH OPHTHALMOL-CHIC, V93, P1134, DOI 10.1001/archopht.1975.01010020850004; Furlanetto R, 2010, EUR J OPHTHALMOL; Galarreta DJ, 2007, CORNEA, V26, P1082, DOI 10.1097/ICO.0b013e318142bff3; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Gupta G, 2009, CORNEA, V28, P930, DOI 10.1097/ICO.0b013e31819b3213; Hariprasad SM, 2008, BRIT J OPHTHALMOL, V92, P871, DOI 10.1136/bjo.2007.136515; JONES DB, 1981, OPHTHALMOLOGY, V88, P814; Jurkunas U, 2009, CORNEA, V28, P638, DOI 10.1097/ICO.0b013e318191695b; Keay L, 2006, OPHTHALMOLOGY, V113, P109, DOI 10.1016/j.ophtha.2005.08.013; Lin CP, 2005, CORNEA, V24, P262, DOI 10.1097/01.ico.0000148313.78933.68; Lin HC, 2005, INT J CLIN PRACT, V59, P549, DOI 10.1111/j.1368-5031.2005.00399.x; Lin HC, 2009, ACTA OPHTHALMOL, V87, P199, DOI 10.1111/j.1755-3768.2008.01192.x; Loh AR, 2009, CORNEA, V28, P856, DOI 10.1097/ICO.0b013e318199fa77; Meleod S, 1996, OPHTHALMOLOGY, V103, P479; Munir WM, 2007, CORNEA, V26, P621, DOI 10.1097/ICO.0b013e318033e7e1; ROSA RH, 1994, OPHTHALMOLOGY, V101, P1005; Shi WY, 2010, OPHTHALMOLOGY, V117, P890, DOI 10.1016/j.ophtha.2009.10.004; Srinivasan M, 2004, Curr Opin Ophthalmol, V15, P321, DOI 10.1097/00055735-200408000-00008; Tananuvat Napaporn, 2008, Journal of the Medical Association of Thailand, V91, P316; Tanure MAG, 2000, CORNEA, V19, P307, DOI 10.1097/00003226-200005000-00010; Thomas PA, 2003, CLIN MICROBIOL REV, V16, P730, DOI 10.1128/CMR.16.4.730-797.2003; Vajpayee RB, 2000, CORNEA, V19, P52, DOI 10.1097/00003226-200001000-00011; Vemuganti GK, 2002, OPHTHALMOLOGY, V109, P1538, DOI 10.1016/S0161-6420(02)01088-6; Wang LY, 2009, CLIN EXP OPHTHALMOL, V37, P763, DOI 10.1111/j.1442-9071.2009.02155.x; Xie LX, 2002, CORNEA, V21, P33, DOI 10.1097/00003226-200201000-00008; Xie LX, 2001, BRIT J OPHTHALMOL, V85, P1070, DOI 10.1136/bjo.85.9.1070	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42126	10.1371/journal.pone.0042126	http://dx.doi.org/10.1371/journal.pone.0042126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936982	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500010
J	Xing, LY; Hoshijima, K; Grunwald, DJ; Fujimoto, E; Quist, TS; Sneddon, J; Chien, CB; Stevenson, TJ; Bonkowsky, JL				Xing, Lingyan; Hoshijima, Kazuyuki; Grunwald, David J.; Fujimoto, Esther; Quist, Tyler S.; Sneddon, Jacob; Chien, Chi-Bin; Stevenson, Tamara J.; Bonkowsky, Joshua L.			Zebrafish foxP2 Zinc Finger Nuclease Mutant Has Normal Axon Pathfinding	PLOS ONE			English	Article							LANGUAGE DISORDER; DEVELOPMENTAL EXPRESSION; BRAIN ABNORMALITIES; MOLECULAR-CLONING; INHERITED SPEECH; GENE-EXPRESSION; DYSPRAXIA; DEFICITS; CNTNAP2; PROTEIN	foxP2, a forkhead-domain transcription factor, is critical for speech and language development in humans, but its role in the establishment of CNS connectivity is unclear. While in vitro studies have identified axon guidance molecules as targets of foxP2 regulation, and cell culture assays suggest a role for foxP2 in neurite outgrowth, in vivo studies have been lacking regarding a role for foxP2 in axon pathfinding. We used a modified zinc finger nuclease methodology to generate mutations in the zebrafish foxP2 gene. Using PCR-based high resolution melt curve analysis (HRMA) of G0 founder animals, we screened and identified three mutants carrying nonsense mutations in the 2(nd) coding exon: a 17 base-pair (bp) deletion, an 8bp deletion, and a 4bp insertion. Sequence analysis of cDNA confirmed that these were frameshift mutations with predicted early protein truncations. Homozygous mutant fish were viable and fertile, with unchanged body morphology, and no apparent differences in CNS apoptosis, proliferation, or patterning at embryonic stages. There was a reduction in expression of the known foxP2 target gene cntnap2 that was rescued by injection of wild-type foxP2 transcript. When we examined axon pathfinding using a pan-axonal marker or transgenic lines, including a foxP2-neuron-specific enhancer, we did not observe any axon guidance errors. Our findings suggest that foxP2 is not necessary for axon pathfinding during development.	[Xing, Lingyan; Fujimoto, Esther; Quist, Tyler S.; Sneddon, Jacob; Stevenson, Tamara J.; Bonkowsky, Joshua L.] Univ Utah, Sch Med, Dept Pediat, Div Pediat Neurol, Salt Lake City, UT 84112 USA; [Xing, Lingyan; Chien, Chi-Bin; Bonkowsky, Joshua L.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Xing, Lingyan; Chien, Chi-Bin; Bonkowsky, Joshua L.] Univ Utah, Sch Med, Interdept Program Neurosci, Salt Lake City, UT USA; [Bonkowsky, Joshua L.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Hoshijima, Kazuyuki; Grunwald, David J.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Xing, LY (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Pediat Neurol, Salt Lake City, UT 84112 USA.	joshua.bonkowsky@hsc.utah.edu	Xing, Lingyan/GPS-6294-2022	Xing, Lingyan/0000-0002-7646-2522	Primary Children's Medical Center (PCMC) Foundation; National Institutes of Health (NIH) [K12 5HD001410, K08 DA024753, P01 HD048886]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001410] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD048886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA024753] Funding Source: NIH RePORTER	Primary Children's Medical Center (PCMC) Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a Primary Children's Medical Center (PCMC) Foundation grant to JLB, National Institutes of Health (NIH) K12 5HD001410 and K08 DA024753 to JLB, and NIH P01 HD048886 to KH, DJG, and CBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bonkowsky JL, 2005, DEV DYNAM, V234, P740, DOI 10.1002/dvdy.20504; Bonkowsky Joshua L, 2008, BMC Dev Biol, V8, P103, DOI 10.1186/1471-213X-8-103; Cheng L, 2007, DEV GENES EVOL, V217, P699, DOI 10.1007/s00427-007-0177-9; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Fujimoto E, 2011, DEV BIOL, V352, P393, DOI 10.1016/j.ydbio.2011.01.023; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Gupta A, 2011, NUCLEIC ACIDS RES, V39, P381, DOI 10.1093/nar/gkq787; Gutnick A, 2011, DEV CELL, V21, P642, DOI 10.1016/j.devcel.2011.09.004; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hoshijima K, INDEX EXPT PROTOCOLS; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lennon PA, 2007, AM J MED GENET A, V143A, P791, DOI 10.1002/ajmg.a.31632; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Parant JM, 2009, DEV DYNAM, V238, P3168, DOI 10.1002/dvdy.22143; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sanek NA, 2009, DEVELOPMENT, V136, P3791, DOI 10.1242/dev.037820; Schon C, 2006, DEV GENES EVOL, V216, P641, DOI 10.1007/s00427-006-0073-8; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Stevenson TJ, 2012, PLOS GENET, V8, P257, DOI 10.1371/journal.pgen.1002638; Suh Y, 2009, MOL CELL NEUROSCI, V42, P308, DOI 10.1016/j.mcn.2009.08.003; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2006, HUM MOL GENET, V15, P3154, DOI 10.1093/hmg/ddl392; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Williams CA, 2010, GENET MED, V12, P385, DOI 10.1097/GIM.0b013e3181def138; WILSON SW, 1990, DEVELOPMENT, V108, P121; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110	57	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43968	10.1371/journal.pone.0043968	http://dx.doi.org/10.1371/journal.pone.0043968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937139	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500130
J	Zhan, M; Riordon, DR; Yan, B; Tarasova, YS; Bruweleit, S; Tarasov, KV; Li, RA; Wersto, RP; Boheler, KR				Zhan, Ming; Riordon, Daniel R.; Yan, Bin; Tarasova, Yelena S.; Bruweleit, Sarah; Tarasov, Kirill V.; Li, Ronald A.; Wersto, Robert P.; Boheler, Kenneth R.			The B-MYB Transcriptional Network Guides Cell Cycle Progression and Fate Decisions to Sustain Self-Renewal and the Identity of Pluripotent Stem Cells	PLOS ONE			English	Article							DEVELOPMENTAL REGULATORS; CHROMATIN STATE; POLYCOMB; PHOSPHORYLATION; METHYLATION; GENES; DNA; DIFFERENTIATION; ESTABLISHMENT; COMPLEX	Embryonic stem cells (ESCs) are pluripotent and have unlimited self-renewal capacity. Although pluripotency and differentiation have been examined extensively, the mechanisms responsible for self-renewal are poorly understood and are believed to involve an unusual cell cycle, epigenetic regulators and pluripotency-promoting transcription factors. Here we show that B-MYB, a cell cycle regulated phosphoprotein and transcription factor critical to the formation of inner cell mass, is central to the transcriptional and co-regulatory networks that sustain normal cell cycle progression and self-renewal properties of ESCs. Phenotypically, B-MYB is robustly expressed in ESCs and induced pluripotent stem cells (iPSCs), and it is present predominantly in a hypo-phosphorylated state. Knockdown of B-MYB results in functional cell cycle abnormalities that involve S, G2 and M phases, and reduced expression of critical cell cycle regulators like ccnb1 and plk1. By conducting gene expression profiling on control and B-MYB deficient cells, ChIP-chip experiments, and integrative computational analyses, we unraveled a highly complex B-MYB-mediated transcriptional network that guides ESC self-renewal. The network encompasses critical regulators of all cell cycle phases and epigenetic regulators, pluripotency transcription factors, and differentiation determinants. B-MYB along with E2F1 and c-MYC preferentially co-regulate cell cycle target genes. B-MYB also co-targets genes regulated by OCT4, SOX2 and NANOG that are significantly associated with stem cell differentiation, embryonic development, and epigenetic control. Moreover, loss of B-MYB leads to a breakdown of the transcriptional hierarchy present in ESCs. These results coupled with functional studies demonstrate that B-MYB not only controls and accelerates cell cycle progression in ESCs it contributes to fate decisions and maintenance of pluripotent stem cell identity.	[Zhan, Ming; Yan, Bin] NIA, Bioinformat Unit, NIH, Baltimore, MD 21224 USA; [Riordon, Daniel R.; Tarasova, Yelena S.; Bruweleit, Sarah; Tarasov, Kirill V.; Boheler, Kenneth R.] NIA, Mol Cardiol & Stem Cell Unit, NIH, Baltimore, MD 21224 USA; [Wersto, Robert P.] NIA, Flow Cytometry Unit, NIH, Baltimore, MD 21224 USA; [Zhan, Ming] Cornell Univ, Weill Cornell Med Coll, Methodist Hosp, Res Inst, Houston, TX USA; [Yan, Bin] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Li, Ronald A.; Boheler, Kenneth R.] Univ Hong Kong, Stem Cell & Regenerat Med Consortium, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Hong Kong Baptist University; University of Hong Kong	Zhan, M (corresponding author), Cornell Univ, Weill Cornell Med Coll, Methodist Hosp, Res Inst, Houston, TX USA.	bohelerk@grc.nia.nih.gov		Tarasov, Kirill/0000-0001-7799-4670; /0000-0002-2168-3379	Intramural Research Program of the NIH, National Institute on Aging; Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine (Heidesheim, Germany); NATIONAL INSTITUTE ON AGING [ZIAAG000847, ZICAG000618] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine (Heidesheim, Germany); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in by the Intramural Research Program of the NIH, National Institute on Aging, and by a scholarship (SB) from Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine (Heidesheim, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bessa M, 2001, ONCOGENE, V20, P3376, DOI 10.1038/sj.onc.1204439; Boheler KR, 2009, J CELL PHYSIOL, V221, P10, DOI 10.1002/jcp.21866; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Johnson TK, 1999, J BIOL CHEM, V274, P36741, DOI 10.1074/jbc.274.51.36741; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lorvellec M, 2010, STEM CELLS, V28, P1751, DOI 10.1002/stem.496; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller-Tidow C, 2001, BLOOD, V97, P2091, DOI 10.1182/blood.V97.7.2091; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakajima Y, 2007, BIOCHEM BIOPH RES CO, V364, P1050, DOI 10.1016/j.bbrc.2007.10.130; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Petrovas C, 2003, ONCOGENE, V22, P2011, DOI 10.1038/sj.onc.1206231; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Santilli G, 2001, ONCOGENE, V20, P8167, DOI 10.1038/sj.onc.1204943; Schwab R, 2007, BLOOD CELL MOL DIS, V39, P263, DOI 10.1016/j.bcmd.2007.04.006; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith K, 2010, REGEN MED, V5, P947, DOI 10.2217/RME.10.79; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003406; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Tarasov KV, 2008, CELLS TISSUES ORGANS, V27, P27; Tarasova YS, 2006, EMBRYONIC STEM CELLS, P130; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yamanaka S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003896; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	77	25	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42350	10.1371/journal.pone.0042350	http://dx.doi.org/10.1371/journal.pone.0042350			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936984	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500012
J	Caspers, S; Heim, S; Lucas, MG; Stephan, E; Fischer, L; Amunts, K; Zilles, K				Caspers, Svenja; Heim, Stefan; Lucas, Marc G.; Stephan, Egon; Fischer, Lorenz; Amunts, Katrin; Zilles, Karl			Dissociated Neural Processing for Decisions in Managers and Non-Managers	PLOS ONE			English	Article							HUMAN PARIETAL OPERCULUM; PREFRONTAL CORTEX; FRONTAL-CORTEX; SYSTEMS; MODEL; MAPS; ACTIVATION; AUTOMATICITY; RATIONALITY; INTEGRATION	Functional neuroimaging studies of decision-making so far mainly focused on decisions under uncertainty or negotiation with other persons. Dual process theory assumes that, in such situations, decision making relies on either a rapid intuitive, automated or a slower rational processing system. However, it still remains elusive how personality factors or professional requirements might modulate the decision process and the underlying neural mechanisms. Since decision making is a key task of managers, we hypothesized that managers, facing higher pressure for frequent and rapid decisions than non-managers, prefer the heuristic, automated decision strategy in contrast to non-managers. Such different strategies may, in turn, rely on different neural systems. We tested managers and non-managers in a functional magnetic resonance imaging study using a forced-choice paradigm on word-pairs. Managers showed subcortical activation in the head of the caudate nucleus, and reduced hemodynamic response within the cortex. In contrast, non-managers revealed the opposite pattern. With the head of the caudate nucleus being an initiating component for process automation, these results supported the initial hypothesis, hinting at automation during decisions in managers. More generally, the findings reveal how different professional requirements might modulate cognitive decision processing.	[Caspers, Svenja; Heim, Stefan; Amunts, Katrin; Zilles, Karl] Res Ctr Julich, Inst Neurosci & Med, Julich, Germany; [Heim, Stefan; Amunts, Katrin; Zilles, Karl] Julich Aachen Res Alliance, BRAIN, Julich, Germany; [Heim, Stefan; Amunts, Katrin] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, D-52062 Aachen, Germany; [Heim, Stefan] Rhein Westfal TH Aachen, Dept Neurol, Sect Neurol Cognit Res, Aachen, Germany; [Lucas, Marc G.; Stephan, Egon] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany; [Lucas, Marc G.] Fernuniv, Dept Business Studies Leadership & Org, Hagen, Germany; [Fischer, Lorenz] Univ Cologne, Inst Econ & Social Psychol, D-50931 Cologne, Germany; [Zilles, Karl] Univ Dusseldorf, C&O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University; University of Cologne; Fern University Hagen; University of Cologne; Heinrich Heine University Dusseldorf	Caspers, S (corresponding author), Res Ctr Julich, Inst Neurosci & Med, Julich, Germany.	s.caspers@fz-juelich.de	Zilles, Karl/J-9704-2013; Zilles, Karl/Y-3784-2019; Heim, Stefan/G-6348-2013; Caspers, Svenja/H-9346-2013; Amunts, Katrin/I-3470-2013	Zilles, Karl/0000-0001-9296-9959; Zilles, Karl/0000-0002-4705-4175; Heim, Stefan/0000-0002-5818-8355; Caspers, Svenja/0000-0001-5083-4669; Amunts, Katrin/0000-0001-5828-0867	Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model); Helmholtz Alliance for Mental Health in an Aging Society; German Federal Ministry of Education and Research [01GW0613]	Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model); Helmholtz Alliance for Mental Health in an Aging Society; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (Human Brain Model, K.Z.), the Helmholtz Alliance for Mental Health in an Aging Society (K.Z., K. A.), and a grant of the German Federal Ministry of Education and Research (No. 01GW0613; K. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashby FG, 2007, PSYCHOL REV, V114, P632, DOI 10.1037/0033-295X.114.3.632; Ashby FG, 2010, J NEUROSCI, V14, P191; Bandettini PA, 2009, ANN NY ACAD SCI, V1156, P260, DOI 10.1111/j.1749-6632.2009.04420.x; Barnard C. I., 1968, FUNCT EXECUTIVE; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Benhabib J, 2005, GAME ECON BEHAV, V52, P460, DOI 10.1016/j.geb.2004.10.004; Boas DA, 2008, NEUROIMAGE, V40, P1116, DOI 10.1016/j.neuroimage.2007.12.061; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; BOWMAN EH, 1963, MANAGE SCI, V9, P310, DOI 10.1287/mnsc.9.2.310; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Brocas I, 2006, BRAIN HIERARCHICAL O; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Busenitz LW, 1997, J BUS VENTURING, V12, P9, DOI 10.1016/S0883-9026(96)00003-1; Caspers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018451; CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752; Chan RCK, 2001, BRAIN INJURY, V15, P819, DOI 10.1080/02699050119721; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Dane E, 2007, ACAD MANAGE REV, V32, P33, DOI [10.2307/20159279, 10.5465/AMR.2007.23463682]; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dean D, 1974, EXECUTIVE ESP; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Doeller CF, 2006, NEUROIMAGE, V31, P1802, DOI 10.1016/j.neuroimage.2006.02.006; Duden-Das Worterbuch der Synonyme, 2009, DUD WORT SYN; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; Geyer S, 2004, ADV ANATOMY EMBRYOLO, V174; Goldstein DG, 2002, PSYCHOL REV, V109, P75, DOI 10.1037//0033-295X.109.1.75; GRAVES CW, 1970, J HUMANIST PSYCHOL, V10, P131, DOI 10.1177/002216787001000205; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Heim S, 2006, NEUROREPORT, V17, P1097, DOI 10.1097/01.wnr.0000224775.05023.42; Helie S, 2010, ATTEN PERCEPT PSYCHO, V72, P1013, DOI 10.3758/APP.72.4.1013; Hester RL, 2004, J COGNITIVE NEUROSCI, V16, P776, DOI 10.1162/089892904970726; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kompus K, 2009, NEUROSCI LETT, V467, P76, DOI 10.1016/j.neulet.2009.10.005; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Loewenstein G, 2008, ANNU REV PSYCHOL, V59, P647, DOI 10.1146/annurev.psych.59.103006.093710; Loewenstein George, 2004, ANIMAL SPIRITS AFFEC; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Mintzberg, 1973, NATURE MANAGERIAL WO; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Muhammad R, 2006, J COGNITIVE NEUROSCI, V18, P974, DOI 10.1162/jocn.2006.18.6.974; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; Petty R.E., 1986, COMMUN PERSUATION, P123; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Price CJ, 1999, NEUROIMAGE, V10, P36, DOI 10.1006/nimg.1999.0447; Reyna VF, 2004, CURR DIR PSYCHOL SCI, V13, P60, DOI 10.1111/j.0963-7214.2004.00275.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rokeach M., 1973, NATURE HUMAN VALUES; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Salehnejad R, 2006, RATIONALITY, BOUNDED RATIONALITY AND MICROFOUNDATIONS, P1, DOI 10.1057/9780230625150; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; Salton G, 2000, MANAGERS GUIDE ORG E; Scheperjans F, 2008, CEREB CORTEX, V18, P2141, DOI 10.1093/cercor/bhm241; Scheperjans F, 2008, CEREB CORTEX, V18, P846, DOI 10.1093/cercor/bhm116; SCHWARTZ SH, 1987, J PERS SOC PSYCHOL, V53, P550, DOI 10.1037/0022-3514.53.3.550; Seger CA, 2006, CEREB CORTEX, V16, P1546, DOI 10.1093/cercor/bhj092; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Simon H.A., 1987, ACAD MANAGE PERSPECT, V1, P57, DOI [10.5465/ame.1987.4275905, DOI 10.5465/AME.1987.4275905]; SIMON HA, 1959, AM ECON REV, V49, P253; Stackman RW, 2000, HDB ORG CULTURE CLIM, P37; Teichmann M, 2005, BRAIN, V128, P1155, DOI 10.1093/brain/awh472; Vaughan FE, 1979, AWAKENING INTUITION; Waldschmidt JG, 2011, NEUROIMAGE, V56, P1791, DOI 10.1016/j.neuroimage.2011.02.011; Weiss RH, 1998, TEST BASIC INTELLIGE; WESTCOTT MR, 1961, PSYCHOL REP, V9, P267; Westerhausen R, 2010, NEUROPSYCHOLOGIA, V48, P2075, DOI 10.1016/j.neuropsychologia.2010.03.028; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	87	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43537	10.1371/journal.pone.0043537	http://dx.doi.org/10.1371/journal.pone.0043537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22927984	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300064
J	Pineda, SS; Wilson, D; Mattick, JS; King, GF				Pineda, Sandy Steffany; Wilson, David; Mattick, John S.; King, Glenn F.			The Lethal Toxin from Australian Funnel-Web Spiders Is Encoded by an Intronless Gene	PLOS ONE			English	Article							BUTHUS-MARTENSI KARSCH; GATED SODIUM-CHANNEL; VENOM PEPTIDES; GENOMIC DNA; ORNITHOCTONUS-HUWENA; MOLECULAR DIVERSITY; ATRAX-ROBUSTUS; CYSTINE KNOT; NEUROTOXINS; SEQUENCES	Australian funnel-web spiders are generally considered the most dangerous spiders in the world, with envenomations from the Sydney funnel-web spider Atrax robustus resulting in at least 14 human fatalities prior to the introduction of an effective anti-venom in 1980. The clinical envenomation syndrome resulting from bites by Australian funnel-web spiders is due to a single 42-residue peptide known as delta-hexatoxin. This peptide delays the inactivation of voltage-gated sodium channels, which results in spontaneous repetitive firing and prolongation of action potentials, thereby causing massive neurotransmitter release from both somatic and autonomic nerve endings. Here we show that delta-hexatoxin from the Australian funnel-web spider Hadronyche versuta is produced from an intronless gene that encodes a prepropeptide that is post-translationally processed to yield the mature toxin. A limited sampling of genes encoding unrelated venom peptides from this spider indicated that they are all intronless. Thus, in distinct contrast to cone snails and scorpions, whose toxin genes contain introns, spiders may have developed a quite different genetic strategy for evolving their venom peptidome.	[Pineda, Sandy Steffany; Wilson, David; Mattick, John S.; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Pineda, SS (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	glenn.king@imb.uq.edu.au	Wilson, David/Q-9865-2019; Mattick, John/ABH-6130-2020; King, Glenn F/J-5059-2012; Pineda, Sandy S/J-2131-2014; Mattick, John S/I-7789-2012	Wilson, David/0000-0001-5047-0711; Mattick, John/0000-0002-7680-7527; King, Glenn F/0000-0002-2308-2200; Pineda, Sandy S/0000-0002-9003-0101; Mattick, John S/0000-0002-7680-7527	Australian Research Council [DP1095728]; University of Queensland	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland)	The authors acknowledge financial support from the Australian Research Council (Discovery Grant DP1095728 to G. F. K.). S. S. P. was supported by an International Postgraduate Research Scholarship from The University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Ballweber P, 2002, J BIOL CHEM, V277, P14451, DOI 10.1074/jbc.M111368200; Bazaa A, 2007, J MOL EVOL, V64, P261, DOI 10.1007/s00239-006-0161-4; Bohlen CJ, 2012, TOXICON, V60, P254, DOI 10.1016/j.toxicon.2012.04.336; Cao ZJ, 2006, TOXICON, V47, P348, DOI 10.1016/j.toxicon.2005.11.013; Chang LS, 1997, BIOCHEM BIOPH RES CO, V239, P756, DOI 10.1006/bbrc.1997.7549; Chen J, 2008, CELL MOL LIFE SCI, V65, P2431, DOI 10.1007/s00018-008-8135-x; Diego-Garcia E, 2005, TOXICON, V45, P273, DOI 10.1016/j.toxicon.2004.10.014; Escoubas P, 2000, BIOCHIMIE, V82, P893, DOI 10.1016/S0300-9084(00)01166-4; Escoubas P, 2006, TOXICON, V47, P650, DOI 10.1016/j.toxicon.2006.01.018; Escoubas P, 2007, EXPERT OPIN DRUG DIS, V2, P823, DOI 10.1517/17460441.2.6.823; Fletcher JI, 1997, STRUCTURE, V5, P1525, DOI 10.1016/S0969-2126(97)00301-8; Fujimi TJ, 2003, GENE, V313, P111, DOI 10.1016/S0378-1119(03)00637-1; Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3; Gray MR, 2010, REC AUST MUS, V62, P285, DOI 10.3853/j.0067-1975.62.2010.1556; Gregory TR, 2003, J HERED, V94, P285, DOI 10.1093/jhered/esg070; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Isbister GK, 2004, TOXICON, V43, P477, DOI 10.1016/j.toxicon.2004.02.002; Jiang LP, 2008, PEPTIDES, V29, P1679, DOI 10.1016/j.peptides.2008.06.001; Jiang LP, 2010, COMP BIOCHEM PHYS D, V5, P81, DOI 10.1016/j.cbd.2010.01.001; Kato L, 2012, J IMMUNOL, V188, P3559, DOI 10.4049/jimmunol.1102397; King GF, 2004, TOXICON, V43, P471, DOI 10.1016/j.toxicon.2004.02.001; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; KRAPCHO KJ, 1995, INSECT BIOCHEM MOLEC, V25, P991, DOI 10.1016/0965-1748(95)00029-U; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; Lan ZD, 1999, TOXICON, V37, P815, DOI 10.1016/S0041-0101(98)00221-9; Maggio F, 2002, TOXICON, V40, P1355, DOI 10.1016/S0041-0101(02)00154-X; Nicholson GM, 1998, PFLUG ARCH EUR J PHY, V436, P117, DOI 10.1007/s004240050612; Nicholson GM, 2004, TOXICON, V43, P587, DOI 10.1016/j.toxicon.2004.02.006; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Pallaghy PK, 1997, FEBS LETT, V419, P191, DOI 10.1016/S0014-5793(97)01452-X; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Platnick, 2011, WORLD SPIDER CATALOG; Qiao P, 2004, ACTA BIOCH BIOPH SIN, V36, P656, DOI 10.1093/abbs/36.10.656; Rasch EM, 2005, J MORPHOL, V265, P209, DOI 10.1002/jmor.10352; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; Roy SW, 2006, TRENDS GENET, V22, P468, DOI 10.1016/j.tig.2006.07.002; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Schroeder FC, 2008, P NATL ACAD SCI USA, V105, P14283, DOI 10.1073/pnas.0806840105; Selden PA, 1999, J ARACHNOL, V27, P401; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Sutherland S, 1981, VENOMOUS CREATURES A; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Tedford HW, 2004, TOXICON, V43, P601, DOI 10.1016/j.toxicon.2004.02.010; Thompson J.D., 2002, CURRENT PROTOCOLS BI; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Wang XH, 2001, J BIOL CHEM, V276, P40306, DOI 10.1074/jbc.M105206200; Wen SP, 2005, PEPTIDES, V26, P2412, DOI 10.1016/j.peptides.2005.05.012; Yee JSP, 2004, BIOCHIMIE, V86, P137, DOI 10.1016/j.biochi.2003.11.012	55	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43699	10.1371/journal.pone.0043699	http://dx.doi.org/10.1371/journal.pone.0043699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928020	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000308286300083
J	Wang, DJ; Yang, D; Su, LD; Xie, YJ; Zhou, L; Sun, CL; Wang, Y; Wang, XX; Zhou, L; Shen, Y				Wang, De-Juan; Yang, Dong; Su, Li-Da; Xie, Ya-jun; Zhou, Lin; Sun, Cheng-Long; Wang, Yin; Wang, Xin-Xin; Zhou, Liang; Shen, Ying			Cytosolic Phospholipase A(2) alpha/Arachidonic Acid Signaling Mediates Depolarization-Induced Suppression of Excitation in the Cerebellum	PLOS ONE			English	Article							TERM SYNAPTIC PLASTICITY; MONOACYLGLYCEROL LIPASE; ENDOCANNABINOID RELEASE; RETROGRADE INHIBITION; ANANDAMIDE; DEPRESSION; SYNAPSES; TRIGGERS; 2-ARACHIDONOYLGLYCEROL; BIOSYNTHESIS	Background: Depolarization-induced suppression of excitation (DSE) at parallel fiber-Purkinje cell synapse is an endocannabinoid-mediated short-term retrograde plasticity. Intracellular Ca2+ elevation is critical for the endocannabinoid production and DSE. Nevertheless, how elevated Ca2+ leads to DSE is unclear. Methodology/Principal Findings: We utilized cytosolic phospholipase A(2) alpha (cPLA(2)alpha) knock-out mice and whole-cell patch clamp in cerebellar slices to observed the action of cPLA(2)alpha/arachidonic acid signaling on DSE at parallel fiber-Purkinje cell synapse. Our data showed that DSE was significantly inhibited in cPLA(2)alpha knock-out mice, which was rescued by arachidonic acid. The degradation enzyme of 2-arachidonoylglycerol (2-AG), monoacylglycerol lipase (MAGL), blocked DSE, while another catabolism enzyme for N-arachidonoylethanolamine (AEA), fatty acid amide hydrolase (FAAH), did not affect DSE. These results suggested that 2-AG is responsible for DSE in Purkinje cells. Co-application of paxilline reversed the blockade of DSE by internal K+, indicating that large conductance Ca2+-activated potassium channel (BK) is sufficient to inhibit cPLA(2)alpha/arachidonic acid-mediated DSE. In addition, we showed that the release of 2-AG was independent of soluble NSF attachment protein receptor (SNARE), protein kinase C and protein kinase A. Conclusions/Significance: Our data first showed that cPLA(2)alpha/arachidonic acid/2-AG signaling pathway mediates DSE at parallel fiber-Purkinje cell synapse.	[Wang, De-Juan; Yang, Dong; Xie, Ya-jun; Zhou, Lin; Sun, Cheng-Long; Wang, Xin-Xin; Zhou, Liang; Shen, Ying] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth,Dept Neurobiol, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Li-Da] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Neurosci Care Unit, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yin] Ningxia Med Univ, Dept Neurobiol, Ctr Sci Technol, Cranial Cerebral Dis Lab, Yinchuan, Peoples R China	Zhejiang University; Zhejiang University; Ningxia Medical University	Wang, DJ (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth,Dept Neurobiol, Hangzhou 310003, Zhejiang, Peoples R China.	yshen@zju.edu.cn	shen, ying/HHS-5635-2022; Xie, Yajun/AFS-3223-2022; wang, xinxin/HIR-2598-2022; Yang, Dong/AAE-7987-2020; Xie, Yajun/ABE-8877-2020	Yang, Dong/0000-0003-0612-1439; Xie, Yajun/0000-0003-2988-2708; Wang, Dejuan/0000-0002-4877-1213	National Basic Research Program (973) of the Ministry of Science and Technology of China [2009CB94140, 2011CB5044000]; National Foundation of Natural Science of China [30600168, 31070945, 31100780]; National Foundation of Natural Science [30731160616]; Research Grants Council of Hong Kong, China [30731160616]; Ministry of Education of China [NCET-07-0751]; Zhejiang Provincial Foundation of Natural Science of China [R206018]	National Basic Research Program (973) of the Ministry of Science and Technology of China(National Basic Research Program of China); National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); National Foundation of Natural Science(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong, China(Hong Kong Research Grants Council); Ministry of Education of China(Ministry of Education, China); Zhejiang Provincial Foundation of Natural Science of China	This work was supported by grants from the National Basic Research Program (973) of the Ministry of Science and Technology of China (2009CB94140 and 2011CB5044000), the National Foundation of Natural Science of China (30600168, 31070945 and 31100780), a joint grant from the National Foundation of Natural Science and the Research Grants Council of Hong Kong, China (30731160616), a New Century Talent Award of the Ministry of Education of China (NCET-07-0751) and the Zhejiang Provincial Foundation of Natural Science of China (R206018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Anwar H, 2010, CEREBELLUM; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brenowitz SD, 2006, J NEUROSCI, V26, P6841, DOI 10.1523/JNEUROSCI.1280-06.2006; Carroll RC, 1998, J NEUROPHYSIOL, V80, P2797, DOI 10.1152/jn.1998.80.5.2797; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Daniel H, 2001, J PHYSIOL-LONDON, V537, P793; Di Marzo V, 1998, FEBS LETT, V436, P449, DOI 10.1016/S0014-5793(98)01175-2; Diana MA, 2004, BRIT J PHARMACOL, V142, P9, DOI 10.1038/sj.bjp.0705726; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Hoggatt J, 2010, LEUKEMIA, V24, P1993, DOI 10.1038/leu.2010.216; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Kalyvas A, 2004, NEURON, V41, P323, DOI 10.1016/S0896-6273(04)00003-0; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Malcher-Lopes R, 2008, EUR J PHARMACOL, V583, P322, DOI 10.1016/j.ejphar.2007.12.033; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Pan B, 2009, J PHARMACOL EXP THER, V331, P591, DOI 10.1124/jpet.109.158162; Rancz EA, 2006, J NEUROSCI, V26, P5428, DOI 10.1523/JNEUROSCI.5284-05.2006; Roloff AM, 2010, J NEUROSCI, V30, P3072, DOI 10.1523/JNEUROSCI.4603-09.2010; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sang N, 2006, J PHYSIOL-LONDON, V572, P735, DOI 10.1113/jphysiol.2006.105569; Shen Y, 2007, P NATL ACAD SCI USA, V104; Shin JH, 2008, P NATL ACAD SCI USA, V105, P746, DOI 10.1073/pnas.0709407105; Smith AJ, 2010, J NEUROSCI, V30, P6116, DOI 10.1523/JNEUROSCI.0170-10.2010; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Straiker A, 2011, BRIT J PHARMACOL, V164, P1672, DOI 10.1111/j.1476-5381.2011.01486.x; Straiker A, 2009, MOL PHARMACOL, V76, P1220, DOI 10.1124/mol.109.059030; Su LD, 2010, ALCOHOL CLIN EXP RES, V34, P1140, DOI 10.1111/j.1530-0277.2010.01190.x; Su LD, 2009, NEUROREPORT, V20, P502, DOI 10.1097/WNR.0b013e328328f397; Sugiura T, 2002, PROSTAG LEUKOTR ESS, V66, P173, DOI 10.1054/plef.2001.0356; Sun CL, 2011, CEREBELLUM, V10, P88, DOI 10.1007/s12311-010-0233-2; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Vila A, 2007, BIOCHEMISTRY-US, V46, P9578, DOI 10.1021/bi7005898; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Xiang ZH, 2005, DEV BRAIN RES, V156, P147, DOI 10.1016/j.devbrainres.2005.02.015; Xu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010306; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhong P, 2011, J PHYSIOL-LONDON, V589, P4847, DOI 10.1113/jphysiol.2011.215509	50	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41499	10.1371/journal.pone.0041499	http://dx.doi.org/10.1371/journal.pone.0041499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927908	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300009
J	Karolemeas, K; de la Rua-Domenech, R; Cooper, R; Goodchild, AV; Clifton-Hadley, RS; Conlan, AJK; Mitchell, AP; Hewinson, RG; Donnelly, CA; Wood, JLN; McKinley, TJ				Karolemeas, Katerina; de la Rua-Domenech, Ricardo; Cooper, Roderick; Goodchild, Anthony V.; Clifton-Hadley, Richard S.; Conlan, Andrew J. K.; Mitchell, Andrew P.; Hewinson, R. Glyn; Donnelly, Christl A.; Wood, James L. N.; McKinley, Trevelyan J.			Estimation of the Relative Sensitivity of the Comparative Tuberculin Skin Test in Tuberculous Cattle Herds Subjected to Depopulation	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; ERADICATION; DIAGNOSIS; WINBUGS; LESIONS	Bovine tuberculosis (bTB) is one of the most serious economic animal health problems affecting the cattle industry in Great Britain (GB), with incidence in cattle herds increasing since the mid-1980s. The single intradermal comparative cervical tuberculin (SICCT) test is the primary screening test in the bTB surveillance and control programme in GB and Ireland. The sensitivity (ability to detect infected cattle) of this test is central to the efficacy of the current testing regime, but most previous studies that have estimated test sensitivity (relative to the number of slaughtered cattle with visible lesions [VL] and/or positive culture results) lacked post-mortem data for SICCT test-negative cattle. The slaughter of entire herds ("whole herd slaughters'' or "depopulations'') that are infected by bTB are occasionally conducted in GB as a last-resort control measure to resolve intractable bTB herd breakdowns. These provide additional post-mortem data for SICCT test-negative cattle, allowing a rare opportunity to calculate the animal-level sensitivity of the test relative to the total number of SICCT test-positive and negative VL animals identified post-mortem (rSe). In this study, data were analysed from 16 whole herd slaughters (748 SICCT test-positive and 1031 SICCT test-negative cattle) conducted in GB between 1988 and 2010, using a Bayesian hierarchical model. The overall rSe estimate of the SICCT test at the severe interpretation was 85% (95% credible interval [CI]: 78-91%), and at standard interpretation was 81% (95% CI: 70-89%). These estimates are more robust than those previously reported in GB due to inclusion of post-mortem data from SICCT test-negative cattle.	[Karolemeas, Katerina; Conlan, Andrew J. K.; Wood, James L. N.; McKinley, Trevelyan J.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England; [de la Rua-Domenech, Ricardo] Anim Hlth & Vet Labs Agcy, London, England; [de la Rua-Domenech, Ricardo] Dept Environm Food & Rural Affairs, Bovine TB Programme, London, England; [Cooper, Roderick] Anim Hlth & Vet Labs Agcy, W Midlands Reg Off, Stafford, England; [Goodchild, Anthony V.; Clifton-Hadley, Richard S.; Mitchell, Andrew P.; Hewinson, R. Glyn] Anim Hlth & Vet Labs Agcy, Weybridge, Surrey, England; [Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England	University of Cambridge; Veterinary Laboratories Agency; Imperial College London	Karolemeas, K (corresponding author), Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England.	tjm44@cam.ac.uk	Goodchild, Anthony/C-8810-2011; Hewinson, Glyn/J-1902-2014; Wood, James/A-1626-2008; Mitchell, Andrew P/L-6141-2014; Conlan, Andrew/Q-3861-2019; Hewinson, Glyn/AAA-2364-2019	Goodchild, Anthony/0000-0002-6230-0338; Wood, James/0000-0002-0258-3188; Conlan, Andrew/0000-0002-2593-6353; Hewinson, Glyn/0000-0002-5517-4281; Donnelly, Christl/0000-0002-0195-2463	Veterinary Training and Research Initiative programme at Cambridge (Defra) [VT0105]; Biotechnology and Biological Sciences Research Council [BB/I012192/1]; Alborada Trust; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, Fogarty International Center, National Institutes of Health; Defra [SE3230, PU/T/WL/07/46]; Veterinary Laboratories Agency; Defra, United Kingdom [SE3230]; Medical Research Council for Centre; BBSRC [BB/I012192/1] Funding Source: UKRI; Medical Research Council [G0600719B] Funding Source: researchfish	Veterinary Training and Research Initiative programme at Cambridge (Defra); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alborada Trust; Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, Fogarty International Center, National Institutes of Health; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Veterinary Laboratories Agency; Defra, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Medical Research Council for Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	KK was supported by a fellowship from the Veterinary Training and Research Initiative programme at Cambridge (Defra grant VT0105). TJM is supported by the Biotechnology and Biological Sciences Research Council grant (BB/I012192/1). JLNW is supported by the Alborada Trust and the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, Fogarty International Center, National Institutes of Health. AJKC was funded by Defra grant SE3230 (Cambridge reference PU/T/WL/07/46), sponsored by the Veterinary Laboratories Agency. The work was also funded by Defra, United Kingdom, under contract SE3230. CAD thanks the Medical Research Council for Centre funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animal Health and Veterinary Laboratories Agency, 2012, TB PAR TEST INT; Animal Health and Veterinary Laboratories Agency, 2011, BOV TUB INF STAT CAT; Asselbergs M, 2010, IN PRACTICE, V32, P414, DOI 10.1136/inp.cc4602; *BOV TB ADV GROUP, 2009, BOV TUB ENGL ER; Buddle BM, 2009, NEW ZEAL VET J, V57, P173, DOI 10.1080/00480169.2009.36899; Cassidy JP, 1999, J COMP PATHOL, V121, P321, DOI 10.1053/jcpa.1999.0330; Coad M, 2010, VET RES, V41, DOI 10.1051/vetres/2009062; Costello E, 1997, VET REC, V141, P222, DOI 10.1136/vr.141.9.222; de Jong H, 1969, N Z Vet J, V17, P213, DOI 10.1080/00480169.1969.33833; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; *DEFR, 2008, BOV TB DAT; *DEFR, 2008, BOV TB TUB SKIN TEST; Defra, 2011, BOV TB ERAD PROGR EN; Defra, 2005, REP IND SCI REV GROU; Defra, 2009, BOV TB GAMM INT; Defra, 2009, GAMM INT DIAGN BLOOD; Defra, 2010, BOV TB ER GROUP ENGL; DNV Consulting, 2006, 2211520402 DNV CONS; DOHERTY ML, 1995, RES VET SCI, V58, P217, DOI 10.1016/0034-5288(95)90105-1; Enticott G, 2010, IN PRACTICE, V32, P318, DOI 10.1136/inp.c3677; Gordejo FJR, 2006, VET MICROBIOL, V112, P101, DOI 10.1016/j.vetmic.2005.11.034; Karolemeas K, 2011, PREV VET MED, V102, P22, DOI 10.1016/j.prevetmed.2011.06.004; KERR W. R., 1949, VET REC, V61, P466; Kerr W. R., 1946, VET REC, V58, P443; LESSLIE IW, 1975, VET REC, V96, P332, DOI 10.1136/vr.96.15.332; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; O'Reilly L. M., 1975, Irish Veterinary Journal, V29, P63; O'Reilly L M, 1986, Dev Biol Stand, V58 ( Pt B), P695; Office International des Epizooties, 2009, OIE TERR MAN; PATERSON A. B., 1958, JOUR HYGIENE, V56, P1; R Development Core Team, 2012, R LANG ENV STAT COMP; Radunz B, 2006, VET MICROBIOL, V112, P283, DOI 10.1016/j.vetmic.2005.11.017; RADUNZ BL, 1985, AUST VET J, V62, P191, DOI 10.1111/j.1751-0813.1985.tb07294.x; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Veterinary Laboratories Agency, 2007, TUB US	36	34	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43217	10.1371/journal.pone.0043217	http://dx.doi.org/10.1371/journal.pone.0043217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927952	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700027
J	Badilita, V; Fassbender, B; Kratt, K; Wong, A; Bonhomme, C; Sakellariou, D; Korvink, JG; Wallrabe, U				Badilita, Vlad; Fassbender, Birgit; Kratt, Kai; Wong, Alan; Bonhomme, Christian; Sakellariou, Dimitris; Korvink, Jan G.; Wallrabe, Ulrike			Microfabricated Inserts for Magic Angle Coil Spinning (MACS) Wireless NMR Spectroscopy	PLOS ONE			English	Article							HIGH-RESOLUTION; HIGH-SENSITIVITY; TEMPERATURE; MICROCOILS; MICROSCOPY	This article describes the development and testing of the first automatically microfabricated probes to be used in conjunction with the magic angle coil spinning (MACS) NMR technique. NMR spectroscopy is a versatile technique for a large range of applications, but its intrinsically low sensitivity poses significant difficulties in analyzing mass- and volume-limited samples. The combination of microfabrication technology and MACS addresses several well-known NMR issues in a concerted manner for the first time: (i) reproducible wafer-scale fabrication of the first-in-kind on-chip LC microresonator for inductive coupling of the NMR signal and reliable exploitation of MACS capabilities; (ii) improving the sensitivity and the spectral resolution by simultaneous spinning the detection microcoil together with the sample at the "magic angle" of 54.74 degrees with respect to the direction of the magnetic field (magic angle spinning - MAS), accompanied by the wireless signal transmission between the microcoil and the primary circuit of the NMR spectrometer; (iii) given the high spinning rates (tens of kHz) involved in the MAS methodology, the microfabricated inserts exhibit a clear kinematic advantage over their previously demonstrated counterparts due to the inherent capability to produce small radius cylindrical geometries, thus tremendously reducing the mechanical stress and tearing forces on the sample. In order to demonstrate the versatility of the microfabrication technology, we have designed MACS probes for various Larmor frequencies (194, 500 and 700 MHz) testing several samples such as water, Drosophila pupae, adamantane solid and LiCl at different magic angle spinning speeds.	[Badilita, Vlad; Kratt, Kai; Wallrabe, Ulrike] Univ Freiburg, Lab Microactuators, Dept Microsyst Engn IMTEK, D-79106 Freiburg, Germany; [Fassbender, Birgit; Bonhomme, Christian] Univ Paris 06, Paris, France; [Fassbender, Birgit; Bonhomme, Christian] Coll France, UMR Chim Matiere Condensee Paris 7574, CNRS, F-75231 Paris, France; [Fassbender, Birgit; Wong, Alan; Sakellariou, Dimitris] CEA Saclay, CNRS UMR3299, DSM, IRAMIS,SIS2M, F-91191 Gif Sur Yvette, France; [Korvink, Jan G.] Univ Freiburg, Lab Simulat, Dept Microsyst Engn IMTEK, D-79106 Freiburg, Germany; [Korvink, Jan G.] Freiburg Inst Adv Studies FRIAS, Freiburg, Germany	University of Freiburg; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Chimie ParisTech; College de France; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg	Badilita, V (corresponding author), Univ Freiburg, Lab Microactuators, Dept Microsyst Engn IMTEK, Hugstetter Str 55, D-79106 Freiburg, Germany.	vlad.badilita@imtek.de	Korvink, Jan G./C-6136-2009; Wong, Alan/C-4862-2011; Badilita, Vlad/W-5407-2019; Wallrabe, Ulrike/F-5217-2013; Sakellariou, Dimitrios/F-2846-2010; Sakellariou, Dimitrios/O-7949-2019; Badilita, Vlad/G-2862-2012	Korvink, Jan G./0000-0003-4354-7295; Wong, Alan/0000-0002-0917-3165; Badilita, Vlad/0000-0002-7956-345X; Wallrabe, Ulrike/0000-0003-0532-1519; Sakellariou, Dimitrios/0000-0001-7424-5543; Sakellariou, Dimitrios/0000-0001-7424-5543; 				Aguiar PM, 2009, J MAGN RESON, V200, P6, DOI 10.1016/j.jmr.2009.05.010; ANDREW ER, 1958, NATURE, V182, P1659, DOI 10.1038/1821659a0; ANTZUTKIN ON, 1995, J MAGN RESON SER A, V115, P7, DOI 10.1006/jmra.1995.1142; Badilita V, 2010, LAB CHIP, V10, P1387, DOI 10.1039/c000840k; Bart J, 2009, J MAGN RESON, V201, P175, DOI 10.1016/j.jmr.2009.09.007; Bart J, 2009, J AM CHEM SOC, V131, P5014, DOI 10.1021/ja900389x; BLACK RD, 1993, SCIENCE, V259, P793, DOI 10.1126/science.8430331; Ciobanu L, 2002, J MAGN RESON, V158, P178, DOI 10.1016/S1090-7807(02)00071-X; Fitzgerald RJ, 1998, CHEM PHYS LETT, V284, P87, DOI 10.1016/S0009-2614(97)01332-8; Grey CP, 2004, CHEM REV, V104, P4493, DOI 10.1021/cr020734p; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; HU JZ, 1995, J MAGN RESON SER A, V113, P210, DOI 10.1006/jmra.1995.1082; Hugon C, 2010, J MAGN RESON, V202, P1, DOI 10.1016/j.jmr.2009.08.005; Jacquinot JF, 2011, CONCEPT MAGN RESON A, V38A, P33, DOI 10.1002/cmr.a.20205; Janssen H, 2006, J AM CHEM SOC, V128, P8722, DOI 10.1021/ja061350+; Key B, 2009, J AM CHEM SOC, V131, P9239, DOI 10.1021/ja8086278; Kratt K, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/1/015021; Kratt K, 2009, SENSOR ACTUAT A-PHYS, V156, P328, DOI 10.1016/j.sna.2009.10.010; Lacey ME, 1999, CHEM REV, V99, P3133, DOI 10.1021/cr980140f; LOWE IJ, 1959, PHYS REV LETT, V2, P285, DOI 10.1103/PhysRevLett.2.285; Maguire Y, 2007, P NATL ACAD SCI USA, V104, P9198, DOI 10.1073/pnas.0703001104; MCFARLAND EW, 1992, MAGN RESON IMAGING, V10, P279, DOI 10.1016/0730-725X(92)90487-K; Mohmmadzadeh M, 2011, J MAGN RESON, V208, P20, DOI 10.1016/j.jmr.2010.09.021; OLSON DL, 1995, SCIENCE, V270, P1967, DOI 10.1126/science.270.5244.1967; PECK TL, 1995, J MAGN RESON SER B, V108, P114, DOI 10.1006/jmrb.1995.1112; Sakellariou D, 2007, NATURE, V447, P694, DOI 10.1038/nature05897; Terman F. E., 1955, ELECT RADIO ENG; Utz M, 2009, J MAGN RESON, V198, P132, DOI 10.1016/j.jmr.2009.01.028; van Bentum PJM, 2007, J MAGN RESON, V189, P104, DOI 10.1016/j.jmr.2007.08.019; Wheeler HA, 1928, P IRE, V16, P1398, DOI 10.1109/JRPROC.1928.221309; Wong A, 2012, ANAL CHEM, V84, P3843, DOI 10.1021/ac300153k; Wong A, 2010, MAGN RESON MED, V63, P269, DOI 10.1002/mrm.22231; Yamauchi K, 2004, J MAGN RESON, V167, P87, DOI 10.1016/j.jmr.2003.12.003; Yamauchi K, 2006, CHEM LETT, V35, P426, DOI 10.1246/cl.2006.426	34	24	25	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e42848	10.1371/journal.pone.0042848	http://dx.doi.org/10.1371/journal.pone.0042848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22936994	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800032
J	Albantakis, L; Branzi, FM; Costa, A; Deco, G				Albantakis, Larissa; Branzi, Francesca M.; Costa, Albert; Deco, Gustavo			A Multiple-Choice Task with Changes of Mind	PLOS ONE			English	Article							DECISION-MAKING; MODELS; AREA	The role of changes of mind and multiple choices has recently received increased attention in the study of perceptual decision-making. Previously, these extensions to standard two-alternative tasks have been studied separately. Here we explored how changes of mind depend on the number of choice-alternatives. To this end, we tested 14 human subjects on a 2- and 4-alternative direction-discrimination task. Changes of mind in the participants' movement trajectories could be observed for two and for four choice alternatives. With fewer alternatives, participants responded faster and more accurately. The frequency of changes of mind, however, did not significantly differ for the different numbers of choice alternatives. Nevertheless, mind-changing improved the participants' final performance, particularly for intermediate difficulty levels, in both experimental conditions. Moreover, the mean reaction times of individual participants were negatively correlated with their overall tendency to make changes of mind. We further reproduced these findings with a multi-alternative attractor model for decision-making, while a simple race model could not account for the experimental data. Our experiment, combined with the theoretical models allowed us to shed light on: (1) the differences in choice behavior between two and four alternatives, (2) the differences between the data of our human subjects and previous monkey data, (3) individual differences between participants, and (4) the inhibitory interaction between neural representations of choice alternatives.	[Albantakis, Larissa; Branzi, Francesca M.; Costa, Albert; Deco, Gustavo] Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain; [Albantakis, Larissa] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Costa, Albert; Deco, Gustavo] Univ Pompeu Fabra, ICREA, Barcelona, Spain	Pompeu Fabra University; University of Wisconsin System; University of Wisconsin Madison; ICREA; Pompeu Fabra University	Albantakis, L (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain.	albantakis@wisc.edu	DECO, GUSTAVO/A-6341-2008; Albantakis, Larissa/K-5235-2019; 2010, BRAINGLOT Consolider Ingenio/D-1235-2009; Costa, Albert/D-2850-2009; Branzi, Francesca Martina/I-9503-2014	DECO, GUSTAVO/0000-0002-8995-7583; Albantakis, Larissa/0000-0003-1000-9917; Costa, Albert/0000-0002-8477-5609; Branzi, Francesca Martina/0000-0002-3780-9693	"CONSOLIDER-INGENIO'' Programme in the "Brainglot'' project (Bilingualism and Cognitive Neuroscience) [CSD2007-00012]; Spanish Ministry of Science in the project "Communication and Information Processing Between Cortical Circuits: Oscillations and Plasticity'' [SAF2010-16085]; Spanish Government; ICREA Funding Source: Custom	"CONSOLIDER-INGENIO'' Programme in the "Brainglot'' project (Bilingualism and Cognitive Neuroscience); Spanish Ministry of Science in the project "Communication and Information Processing Between Cortical Circuits: Oscillations and Plasticity''; Spanish Government(Spanish GovernmentEuropean Commission); ICREA(ICREA)	This work was supported by the "CONSOLIDER-INGENIO 2010'' Programme in the "Brainglot'' project (Bilingualism and Cognitive Neuroscience) CSD2007-00012. FMB was supported by a predoctoral fellowship from the Spanish Government (FPU 2009-2013). GD was further supported by the Spanish Ministry of Science in the project "Communication and Information Processing Between Cortical Circuits: Oscillations and Plasticity'' SAF2010-16085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albantakis L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002086; Albantakis L, 2009, P NATL ACAD SCI USA, V106, P10308, DOI 10.1073/pnas.0901621106; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; Furman M, 2008, NEURON, V60, P1153, DOI 10.1016/j.neuron.2008.12.003; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Kleiner M, 2007, PERCEPTION, V36, P14; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Luce R.D., 1991, RESPONSE TIMES THEIR; Niwa M, 2008, J NEUROSCI, V28, P4435, DOI 10.1523/JNEUROSCI.5564-07.2008; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Roitman JD, 2002, J NEUROSCI, V22, P9475; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Usher M, 2002, J MATH PSYCHOL, V46, P704, DOI 10.1006/jmps.2002.1420; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Vickers D., 1979, DECISION PROCESSES V; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9	29	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43131	10.1371/journal.pone.0043131	http://dx.doi.org/10.1371/journal.pone.0043131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	993AN	22916216	Green Submitted, Green Published, gold			2022-12-27	WOS:000307824300030
J	Van Brussel, I; Schrijvers, DM; Martinet, W; Pintelon, I; Deschacht, M; Schnorbusch, K; Maes, L; Bosmans, JM; Vrints, CJ; Adriaensen, D; Cos, P; Bult, H				Van Brussel, Ilse; Schrijvers, Dorien M.; Martinet, Wim; Pintelon, Isabel; Deschacht, Maartje; Schnorbusch, Kathy; Maes, Louis; Bosmans, Johan M.; Vrints, Christiaan J.; Adriaensen, Dirk; Cos, Paul; Bult, Hidde			Transcript and Protein Analysis Reveals Better Survival Skills of Monocyte-Derived Dendritic Cells Compared to Monocytes during Oxidative Stress	PLOS ONE			English	Article							T-CELLS; ATHEROSCLEROSIS; DIFFERENTIATION; GLUTATHIONE; PEROXIDASE; ACTIVATION; EXPRESSION; PROTECTION; APOPTOSIS; PITFALLS	Background: Dendritic cells (DCs), professional antigen-presenting cells with the unique ability to initiate primary T-cell responses, are present in atherosclerotic lesions where they are exposed to oxidative stress that generates cytotoxic reactive oxygen species (ROS). A large body of evidence indicates that cell death is a major modulating factor of atherogenesis. We examined antioxidant defence systems of human monocyte-derived (mo)DCs and monocytes in response to oxidative stress. Methods: Oxidative stress was induced by addition of tertiary-butylhydroperoxide (tert-BHP, 30 min). Cellular responses were evaluated using flow cytometry and confocal live cell imaging (both using 5-(and-6)-chloromethyl-2,7-dichlorodihydrofluorescein diacetate, CM-H(2)DCFDA). Viability was assessed by the neutral red assay. Total RNA was extracted for a PCR profiler array. Five genes were selected for confirmation by Taqman gene expression assays, and by immunoblotting or immunohistochemistry for protein levels. Results: Tert-BHP increased CM-H2DCFDA fluorescence and caused cell death. Interestingly, all processes occurred more slowly in moDCs than in monocytes. The mRNA profiler array showed more than 2-fold differential expression of 32 oxidative stress-related genes in unstimulated moDCs, including peroxiredoxin-2 (PRDX2), an enzyme reducing hydrogen peroxide and lipid peroxides. PRDX2 upregulation was confirmed by Taqman assays, immunoblotting and immunohistochemistry. Silencing PRDX2 in moDCs by means of siRNA significantly increased CM-DCF fluorescence and cell death upon tert-BHP-stimulation. Conclusions: Our results indicate that moDCs exhibit higher intracellular antioxidant capacities, making them better equipped to resist oxidative stress than monocytes. Upregulation of PRDX2 is involved in the neutralization of ROS in moDCs. Taken together, this points to better survival skills of DCs in oxidative stress environments, such as atherosclerotic plaques.	[Van Brussel, Ilse; Bosmans, Johan M.; Vrints, Christiaan J.] Univ Antwerp, Lab Cellular & Mol Cardiol, B-2020 Antwerp, Belgium; [Schrijvers, Dorien M.; Martinet, Wim] Univ Antwerp, Lab Physiopharmacol, B-2020 Antwerp, Belgium; [Pintelon, Isabel; Schnorbusch, Kathy; Adriaensen, Dirk] Univ Antwerp, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium; [Deschacht, Maartje; Maes, Louis; Cos, Paul] Univ Antwerp, LMPH, B-2020 Antwerp, Belgium; [Bosmans, Johan M.; Vrints, Christiaan J.] Univ Antwerp Hosp, Dept Cardiol, Antwerp, Belgium; [Bult, Hidde] Univ Antwerp, Pharmacol Lab, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp	Van Brussel, I (corresponding author), Univ Antwerp, Lab Cellular & Mol Cardiol, B-2020 Antwerp, Belgium.	ilse.vanbrussel@ua.ac.be	Bult, Hidde/J-5342-2013; Maes, Louis JRM/A-2384-2017; Martinet, Wim/I-7375-2015; Cos, Paul/L-9717-2015; cos, paul/AAU-3896-2020; Schrijvers, Dorien/I-7535-2013	Maes, Louis JRM/0000-0002-2324-9509; Martinet, Wim/0000-0003-1967-9343; Cos, Paul/0000-0003-4361-8911; cos, paul/0000-0003-4361-8911; Schrijvers, Dorien/0000-0003-0826-4943	University of Antwerp [GOA-BOF 2407]; agency of Innovation by Science and Technology; Fund for Scientific Research (FWO); Flanders (Belgium)	University of Antwerp; agency of Innovation by Science and Technology; Fund for Scientific Research (FWO)(FWO); Flanders (Belgium)	This work was supported by the University of Antwerp (GOA-BOF 2407; http://www.ua.ac.be/main.aspx?c=ONDERZK&n=86348), and the agency of Innovation by Science and Technology (IWT-TBM; http://www.iwt.be/subsidies/tbm). Paul Cos is a postdoctoral researcher awarded by the Fund for Scientific Research (FWO; www.fwo.be) - Flanders (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Berggren MI, 2001, ARCH BIOCHEM BIOPHYS, V392, P103, DOI 10.1006/abbi.2001.2435; BOBRYSHEV YV, 1995, ARCH HISTOL CYTOL, V58, P307, DOI 10.1679/aohc.58.307; Cromheeke KM, 1999, CARDIOVASC RES, V43, P744, DOI 10.1016/S0008-6363(99)00148-0; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Del Prete A, 2008, FREE RADICAL BIO MED, V44, P1443, DOI 10.1016/j.freeradbiomed.2007.12.037; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Funke F, 2011, NEUROIMAGE, V54, P2590, DOI 10.1016/j.neuroimage.2010.11.031; Graf R, 2005, ADV BIOCHEM ENG BIOT, V95, P57, DOI 10.1007/b102210; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Kanupriya D, 2005, MOL CELL BIOCHEM, V275, P1, DOI 10.1007/s11010-005-7637-1; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; Koltsova EK, 2011, TRENDS IMMUNOL, V32, P540, DOI 10.1016/j.it.2011.07.001; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Manandhar G, 2009, BIOL REPROD, V80, P1168, DOI 10.1095/biolreprod.108.071738; Manthey HD, 2011, THROMB HAEMOSTASIS, V106, P772, DOI 10.1160/TH11-05-0296; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Martin C, 2001, BIOCHEM PHARMACOL, V62, P705, DOI 10.1016/S0006-2952(01)00704-3; Martinet W, 2008, BRIT J PHARMACOL, V154, P1236, DOI 10.1038/bjp.2008.181; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Preynat-Seauve O, 2003, CELL STRESS CHAPERON, V8, P162, DOI 10.1379/1466-1268(2003)008<0162:OSIIEI>2.0.CO;2; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Rivollier A, 2006, MOL CELL PROTEOMICS, V5, P726, DOI 10.1074/mcp.M500262-MCP200; Schwaab V, 1998, MOL REPROD DEV, V51, P362, DOI 10.1002/(SICI)1098-2795(199812)51:4&lt;362::AID-MRD2&gt;3.0.CO;2-L; Thomson MJ, 2007, CARDIOVASC DRUG THER, V21, P195, DOI 10.1007/s10557-007-6027-1; Thoren FB, 2007, J IMMUNOL, V179, P21, DOI 10.4049/jimmunol.179.1.21; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Van Vre EA, 2008, ARTERIOSCL THROM VAS, V28, P511, DOI 10.1161/ATVBAHA.107.157016; Van Vre EA, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/941396; Van Vre EA, 2011, PATHOLOGY, V43, P239, DOI 10.1097/PAT.0b013e328344e266; Wang E, 2005, J MICROSC-OXFORD, V218, P148, DOI 10.1111/j.1365-2818.2005.01473.x; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43357	10.1371/journal.pone.0043357	http://dx.doi.org/10.1371/journal.pone.0043357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916248	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600072
J	Pieramico, V; Esposito, R; Sensi, F; Cilli, F; Mantini, D; Mattei, PA; Frazzini, V; Ciavardelli, D; Gatta, V; Ferretti, A; Romani, GL; Sensi, SL				Pieramico, Valentina; Esposito, Roberto; Sensi, Francesca; Cilli, Franco; Mantini, Dante; Mattei, Peter A.; Frazzini, Valerio; Ciavardelli, Domenico; Gatta, Valentina; Ferretti, Antonio; Romani, Gian Luca; Sensi, Stefano L.			Combination Training in Aging Individuals Modifies Functional Connectivity and Cognition, and Is Potentially Affected by Dopamine-Related Genes	PLOS ONE			English	Article							RESTING-STATE NETWORKS; ALZHEIMERS-DISEASE; DEFAULT-MODE; RECEPTOR GENE; BRAIN; POLYMORPHISMS; ASSOCIATION; EXERCISE; HIPPOCAMPUS; DYSFUNCTION	Background: Aging is a major co-risk factor in many neurodegenerative diseases. Cognitive enrichment positively affects the structural plasticity of the aging brain. In this study, we evaluated effects of a set of structured multimodal activities (Combination Training; CT) on cognitive performances, functional connectivity, and cortical thickness of a group of healthy elderly individuals. CT lasted six months. Methodology: Neuropsychological and occupational performances were evaluated before and at the end of the training period. fMRI was used to assess effects of training on resting state network (RSN) functional connectivity using Independent Component Analysis (ICA). Effects on cortical thickness were also studied. Finally, we evaluated whether specific dopamine-related genes can affect the response to training. Principal Findings: Results of the study indicate that CT improves cognitive/occupational performances and reorganizes functional connectivity. Intriguingly, individuals responding to CT showed specific dopamine-related genotypes. Indeed, analysis of dopamine-related genes revealed that carriers of DRD3 ser9gly and COMT Val158Met polymorphisms had the greatest benefits from exposure to CT. Conclusions and Significance: Overall, our findings support the idea that exposure to a set of structured multimodal activities can be an effective strategy to counteract aging-related cognitive decline and also indicate that significant capability of functional and structural changes are maintained in the elderly.	[Pieramico, Valentina; Esposito, Roberto; Mantini, Dante; Mattei, Peter A.; Frazzini, Valerio; Ferretti, Antonio; Romani, Gian Luca; Sensi, Stefano L.] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Pieramico, Valentina; Sensi, Francesca; Cilli, Franco; Frazzini, Valerio; Ciavardelli, Domenico; Sensi, Stefano L.] Univ G dAnnunzio, Ctr Excellence Aging, Mol Neurol Unit, Chieti, Italy; [Mantini, Dante] Catholic Univ Louvain, Dept Neurosci, Lab Neuro & Psychophysiol, B-3000 Louvain, Belgium; [Ciavardelli, Domenico] Kore Univ Enna, Sch Motor Sci, Dept Biochem, Enna, Italy; [Gatta, Valentina] Univ G dAnnunzio, Dept Psychol Sci, Chieti, Italy; [Gatta, Valentina] Univ G dAnnunzio, Ctr Excellence Aging, Funct Genom Unit, Chieti, Italy; [Sensi, Stefano L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Sensi, Stefano L.] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Universite Catholique Louvain; Universita Kore di ENNA; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of California System; University of California Irvine; University of California System; University of California Irvine	Pieramico, V (corresponding author), Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy.	ssensi@uci.edu	Sensi, Stefano L./O-1335-2019; Mantini, Dante/D-6989-2014; Sensi, Stefano L./J-3164-2016; Mattei, Peter/J-6661-2012; Gatta, Valentina/G-5765-2014; Frazzini, Valerio/R-3643-2016	Sensi, Stefano L./0000-0002-0710-2574; Mantini, Dante/0000-0001-6485-5559; Sensi, Stefano L./0000-0002-0710-2574; Mattei, Peter A./0000-0002-7343-5625; FERRETTI, Antonio/0000-0002-8459-0129; Esposito, Roberto/0000-0003-4708-6860; Frazzini, Valerio/0000-0003-1187-3352; GATTA, Valentina/0000-0002-9999-5823	Italian Department of Education	Italian Department of Education	SLS is supported by funds from the Italian Department of Education [Fondo per gli Investimenti della Ricerca di Base (FIRB) 2003; programmi di ricerca di rilevante interesse nazionale (PRIN) 2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman L, 2010, NEUROSCI BIOBEHAV R, V34, P670, DOI 10.1016/j.neubiorev.2009.12.008; BEISCHLAG TV, 1995, BIOCHEMISTRY-US, V34, P5960, DOI 10.1021/bi00017a025; Belleville S, 2011, BRAIN, V134, P1623, DOI 10.1093/brain/awr037; Bennett S, 2011, AUST OCCUP THER J, V58, P155, DOI 10.1111/j.1440-1630.2011.00930.x; Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Black KJ, 2002, P NATL ACAD SCI USA, V99, P17113, DOI 10.1073/pnas.012260599; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daniels JK, 1996, AM J PSYCHIAT, V153, P268; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deweerdt S, 2011, NATURE, V475, pS16, DOI 10.1038/475S16a; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Fisher Anne G, 2007, Scand J Occup Ther, V14, P240, DOI 10.1080/11038120601182958; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; GRANDY DK, 1993, HUM MOL GENET, V2, P2197, DOI 10.1093/hmg/2.12.2197-a; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Ho AMC, 2008, ANN NY ACAD SCI, V1139, P20, DOI 10.1196/annals.1432.054; Horner Michael David, 2002, Appl Neuropsychol, V9, P114, DOI 10.1207/S15324826AN0902_7; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Izaki Y, 2008, EUR J NEUROSCI, V27, P3029, DOI 10.1111/j.1460-9568.2008.06284.x; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; Kikuchi M, 2011, J NEUROSCI, V31, P11193, DOI 10.1523/JNEUROSCI.2535-11.2011; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Lu Y, 2011, J NEUROSCI, V31, P11762, DOI 10.1523/JNEUROSCI.2707-11.2011; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, RADIOLOGY, V253, P797, DOI 10.1148/radiol.2533090602; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Mill J, 2004, AM J MED GENET B, V125B, P38, DOI 10.1002/ajmg.b.20127; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Retz W, 2003, J NEURAL TRANSM, V110, P561, DOI 10.1007/s00702-002-0805-5; Reuter-Lorenz PA, 2005, NEUROPSYCHOLOGIA, V43, P1307, DOI 10.1016/j.neuropsychologia.2004.12.007; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; ROSSINI ED, 1994, PERCEPT MOTOR SKILL, V78, P625, DOI 10.2466/pms.1994.78.2.625; Rybakowski JK, 2005, J NEURAL TRANSM, V112, P1575, DOI 10.1007/s00702-005-0292-6; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Stokes PRA, 2011, NEUROPSYCHOPHARMACOL, V36, P763, DOI 10.1038/npp.2010.210; Swart M, 2011, NEUROIMAGE, V55, P338, DOI 10.1016/j.neuroimage.2010.12.017; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wong AHC, 2000, EUR J PHARMACOL, V410, P183	70	51	55	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43901	10.1371/journal.pone.0043901	http://dx.doi.org/10.1371/journal.pone.0043901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937122	Green Published, gold			2022-12-27	WOS:000308213600056
J	Aklilu, E; Zakaria, Z; Hassan, L; Cheng, CH				Aklilu, Erkihun; Zakaria, Zunita; Hassan, Latiffah; Cheng, Chen Hui			Molecular Relatedness of Methicillin-Resistant S. aureus Isolates from Staff, Environment and Pets at University Veterinary Hospital in Malaysia	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; STAPHYLOCOCCUS-AUREUS; OXACILLIN-RESISTANT; NASAL CARRIAGE; MRSA; PREVALENCE; PERSONNEL; SURVIVAL; ANIMALS; RISK	Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a problem in veterinary medicine and is no longer considered as a mere nosocomial pathogen. We studied the occurrence of MRSA in veterinary personnel, cats and dogs and the environmental premises in University Veterinary Hospital (UVH). We found the prevalence of MRSA as follows: UVH 2/28 (7.1%) staff, 8/100 (8%) of the pets [5/50 (10%) of the dogs and 3/50 (6%) of the cats)], and 9/28 (4.5%) of the environmental samples. Antibiotic sensitivity tests (AST) show multi-resistance characteristics of the MRSA and the minimum inhibitory concentration (MIC) values for the isolates ranged from 1.5 mu g to >256 mu g/ml. Molecular typing by using multi-locus sequence typing (MLST), staphylococcal protein A typing (spa typing) and pulsed-field gel electrophoresis (PFGE) was conducted and the results from MLST indicated that an isolate from a veterinary personnel (PG21), typed as ST1241 belonged to the same clonal complex (CC) as the two isolates from two dogs (DG16 and DG20), both being typed as ST59. The PFGE results revealed that the two isolates from two veterinary personnel, PG21 and PG16 belonged to closely related MRSA strains with isolates from dog (DG36) and from environmental surface (EV100) respectively. The fact that PFGE revealed close similarity between isolates from humans, a dog and environmental surfaces indicates the possibility for either of them to be the source of MRSA and the potential routes and risks of spread.	[Aklilu, Erkihun; Zakaria, Zunita; Hassan, Latiffah; Cheng, Chen Hui] Univ Putra Malaysia, Fac Vet Med, Serdang, Malaysia; [Aklilu, Erkihun] Univ Malaysia Kelantan, Fac Vet Med, Pengkalan Chepa, Kota Bharu, Malaysia	Universiti Putra Malaysia; Universiti Malaysia Kelantan	Aklilu, E (corresponding author), Univ Putra Malaysia, Fac Vet Med, Serdang, Malaysia.	erkihun@umk.edu.my	Aklilu, Erkihun/L-8601-2015; Zakaria, Zunita/AAF-5110-2020; hassan, latiffah/H-4795-2019	Aklilu, Erkihun/0000-0003-1031-3935; hassan, latiffah/0000-0003-0731-9906; Chen, Hui Cheng/0000-0003-3717-0831	Ministry of Science Technology and Innovation MOSTI ScienceFund; Ministry of Science, Technology and Innovation (MOSTI)	Ministry of Science Technology and Innovation MOSTI ScienceFund; Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This research was supported by the Ministry of Science Technology and Innovation MOSTI ScienceFund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the laboratory technicians and assistants at Bacteriology laboratory and staff at UVH, Faculty of Veterinary Medicine, Universiti Putra Malaysia for their kind cooperation over the course of this study. We also like to thank Ministry of Science, Technology and Innovation (MOSTI) for funding the research project.	Anderson MEC, 2008, VET MICROBIOL, V129, P410, DOI 10.1016/j.vetmic.2007.11.031; Baptiste KE, 2005, EMERG INFECT DIS, V11, P1942, DOI 10.3201/eid1112.050241; Boost MV, 2007, CLIN MICROBIOL INFEC, V13, P731, DOI 10.1111/j.1469-0691.2007.01737.x; Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622; Clinical and Laboratory Standards Institute (CLSI), 2006, M100S16 CLSI NAT COM; de Boer HEL, 2006, INFECT CONT HOSP EP, V27, P1120, DOI 10.1086/507966; Deplano A, 2000, CLIN MICROBIOL INFEC, V6, P239, DOI 10.1046/j.1469-0691.2000.00064.x; Dietze B, 2001, J HOSP INFECT, V49, P255, DOI 10.1053/jhin.2001.1094; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Ghaznavi-Rad E, 2010, J CLIN MICROBIOL, V48, P867, DOI 10.1128/JCM.01112-09; Hanselman BA, 2006, EMERG INFECT DIS, V12, P1933; Hardy KJ, 2006, INFECT CONT HOSP EP, V27, P127, DOI 10.1086/500622; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hawkey PM, 2008, BRIT J PHARMACOL, V153, pS406, DOI 10.1038/sj.bjp.0707632; Heller J, 2010, RISK ANAL, V30, P458, DOI 10.1111/j.1539-6924.2009.01342.x; Hoet AE, 2011, VECTOR-BORNE ZOONOT, V11, P609, DOI 10.1089/vbz.2010.0181; Ishihara K, 2010, APPL ENVIRON MICROB, V76, P5165, DOI 10.1128/AEM.02780-09; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Jones RD, 2007, JAVMA-J AM VET MED A, V230, P221, DOI 10.2460/javma.230.2.221; Loeffler A, 2005, J ANTIMICROB CHEMOTH, V56, P692, DOI 10.1093/jac/dki312; Louie L, 2002, J CLIN MICROBIOL, V40, P2786, DOI 10.1128/JCM.40.8.2786-2790.2002; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219; Moodley A, 2006, J ANTIMICROB CHEMOTH, V58, P1118, DOI 10.1093/jac/dkl394; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; Nulens E, 2008, J CLIN MICROBIOL, V46, P2438, DOI 10.1128/JCM.00808-08; O'Mahony R, 2005, VET MICROBIOL, V109, P285, DOI 10.1016/j.vetmic.2005.06.003; Rich M, 2004, VET REC, V154, P310; Safdar N, 2003, J CLIN MICROBIOL, V41, P3163, DOI 10.1128/JCM.41.7.3163-3166.2003; Stein RA, 2009, INT J INFECT DIS, V13, P299, DOI 10.1016/j.ijid.2008.09.008; Stranden A, 2003, J CLIN MICROBIOL, V41, P3181, DOI 10.1128/JCM.41.7.3181-3186.2003; STRUELENS MJ, 1992, J CLIN MICROBIOL, V30, P2599, DOI 10.1128/JCM.30.10.2599-2605.1992; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; van Duijkeren E, 2004, EMERG INFECT DIS, V10, P2235, DOI 10.3201/eid1012.040387; Vitale CB, 2006, EMERG INFECT DIS, V12, P1998; Walther B, 2008, VET MICROBIOL, V127, P171, DOI 10.1016/j.vetmic.2007.07.018; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Weese JS, 2005, EMERG INFECT DIS, V11, P430, DOI 10.3201/eid1103.040481; Weese JS, 2004, J VET INTERN MED, V18, P468, DOI 10.1892/0891-6640(2004)18&lt;468:IOMSAF&gt;2.0.CO;2; Wulf M, 2006, EMERG INFECT DIS, V12, P1939	43	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43329	10.1371/journal.pone.0043329	http://dx.doi.org/10.1371/journal.pone.0043329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937034	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500041
J	Feikin, DR; Njenga, MK; Bigogo, G; Aura, B; Aol, G; Audi, A; Jagero, G; Muluare, PO; Gikunju, S; Nderitu, L; Balish, A; Winchell, J; Schneider, E; Erdman, D; Oberste, MS; Katz, MA; Breiman, RF				Feikin, Daniel R.; Njenga, M. Kariuki; Bigogo, Godfrey; Aura, Barrack; Aol, George; Audi, Allan; Jagero, Geoffrey; Muluare, Peter Ochieng; Gikunju, Stella; Nderitu, Leonard; Balish, Amanda; Winchell, Jonas; Schneider, Eileen; Erdman, Dean; Oberste, M. Steven; Katz, Mark A.; Breiman, Robert F.			Etiology and Incidence of Viral and Bacterial Acute Respiratory Illness among Older Children and Adults in Rural Western Kenya, 2007-2010	PLOS ONE			English	Article							HIV-INFECTED ADULTS; COMMUNITY-ACQUIRED PNEUMONIA; REAL-TIME PCR; HOSPITALIZED CHILDREN; SYNCYTIAL VIRUS; MYCOPLASMA-PNEUMONIAE; HUMAN BOCAVIRUS; UGANDAN ADULTS; MORTALITY; DIAGNOSIS	Background: Few comprehensive data exist on disease incidence for specific etiologies of acute respiratory illness (ARI) in older children and adults in Africa. Methodology/Principal Findings: From March 1, 2007, to February 28, 2010, among a surveillance population of 21,420 persons >5 years old in rural western Kenya, we collected blood for culture and malaria smears, nasopharyngeal and oropharyngeal swabs for quantitative real-time PCR for ten viruses and three atypical bacteria, and urine for pneumococcal antigen testing on outpatients and inpatients meeting a ARI case definition (cough or difficulty breathing or chest pain and temperature >38.0 degrees C or oxygen saturation <90% or hospitalization). We also collected swabs from asymptomatic controls, from which we calculated pathogen-attributable fractions, adjusting for age, season, and HIV-status, in logistic regression. We calculated incidence by pathogen, adjusting for health-seeking for ARI and pathogen-attributable fractions. Among 3,406 ARI patients >5 years old (adjusted annual incidence 12.0 per 100 person-years), influenza A virus was the most common virus (22% overall; 11% inpatients, 27% outpatients) and Streptococcus pneumoniae was the most common bacteria (16% overall; 23% inpatients, 14% outpatients), yielding annual incidences of 2.6 and 1.7 episodes per 100 person-years, respectively. Influenza A virus, influenza B virus, respiratory syncytial virus (RSV) and human metapneumovirus were more prevalent in swabs among cases (22%, 6%, 8% and 5%, respectively) than controls. Adenovirus, parainfluenza viruses, rhinovirus/enterovirus, parechovirus, and Mycoplasma pneumoniae were not more prevalent among cases than controls. Pneumococcus and non-typhi Salmonella were more prevalent among HIV-infected adults, but prevalence of viruses was similar among HIV-infected and HIV-negative individuals. ARI incidence was highest during peak malaria season. Conclusions/Signficance: Vaccination against influenza and pneumococcus (by potential herd immunity from childhood vaccination or of HIV-infected adults) might prevent much of the substantial ARI incidence among persons >5 years old in similar rural African settings.	[Feikin, Daniel R.; Njenga, M. Kariuki; Bigogo, Godfrey; Aura, Barrack; Aol, George; Audi, Allan; Jagero, Geoffrey; Muluare, Peter Ochieng; Gikunju, Stella; Nderitu, Leonard; Breiman, Robert F.] Ctr Dis Control & Prevent, Global Dis Detect Div, Int Emerging Infect Program, Kisumu, Kenya; [Feikin, Daniel R.; Njenga, M. Kariuki; Bigogo, Godfrey; Aura, Barrack; Aol, George; Audi, Allan; Jagero, Geoffrey; Muluare, Peter Ochieng; Gikunju, Stella; Nderitu, Leonard; Katz, Mark A.; Breiman, Robert F.] Ctr Dis Control & Prevent, Kenya Med Res Inst, Publ Hlth & Res Collaborat, Kisumu, Kenya; [Balish, Amanda; Winchell, Jonas; Schneider, Eileen; Erdman, Dean; Oberste, M. Steven; Katz, Mark A.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	Feikin, DR (corresponding author), Ctr Dis Control & Prevent, Global Dis Detect Div, Int Emerging Infect Program, Kisumu, Kenya.	dfeikin@jhsph.edu	Jagero, Geofrey/AAE-6835-2021; Bigogo, Godfrey/W-3591-2019	Audi, Allan/0000-0003-1683-554X	Core Funding of the International Emerging Infections Program of CDC	Core Funding of the International Emerging Infections Program of CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The funding for this project is from Core Funding of the International Emerging Infections Program of CDC. The findings and conclusions are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; [Anonymous], 2011, WORLD HLTH STAT; Bassat Q, 2011, AM J TROP MED HYG, V85, P626, DOI 10.4269/ajtmh.2011.11-0223; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bickel P.J., 2001, MATH STAT BASIC IDEA; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Butler JC, 2003, J INFECT DIS, V187, P1416, DOI 10.1086/374623; CLSI, 2009, M100S19 CLSI; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; Dalal W, J AIDS IN PRESS; DAVIDSON M, 1976, JAMA-J AM MED ASSOC, V235, P158, DOI 10.1001/jama.235.2.158; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Fry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017780; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Grant AD, 1998, INT J TUBERC LUNG D, V2, P926; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Hartung TK, 2011, AM J TROP MED HYG, V85, P105, DOI 10.4269/ajtmh.2011.10-0640; Hicks LA, 2006, J AM GERIATR SOC, V54, P284, DOI 10.1111/j.1532-5415.2005.00529.x; Ideh RC, 2011, INT J TUBERC LUNG D, V15, P729, DOI 10.5588/ijtld.10.0468; Imamura Tadatsugu, 2011, Morbidity and Mortality Weekly Report, V60, P1301; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jokinen J, 2010, EPIDEMIOLOGY, V21, P719, DOI 10.1097/EDE.0b013e3181e4c4d5; JOOSTING ACC, 1979, S AFR MED J, V55, P403; Karstaedt AS, 2009, SAMJ S AFR MED J, V99, P750; Katz MA, J INFECT DI IN PRESS; Kenya National Bureau of Statistics, 2010, 2009 KEN POP HOUS CE; Kim C, 2011, J IMMIGR MINOR HEALT; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Lockman S, 2003, INT J TUBERC LUNG D, V7, P714; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; MAARTENS G, 1994, S AFR MED J, V84, P678; MACFARLANE JT, 1979, THORAX, V34, P713, DOI 10.1136/thx.34.6.713; Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09; Murdoch DR, 2001, J CLIN MICROBIOL, V39, P3495, DOI 10.1128/JCM.39.10.3495-3498.2001; Murray JF, 2005, INT J TUBERC LUNG D, V9, P826; Nix WA, 2008, J CLIN MICROBIOL, V46, P2519, DOI 10.1128/JCM.00277-08; Nkinin SW, 2009, ACTA TROP, V112, P219, DOI 10.1016/j.actatropica.2009.07.030; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; Olsen SJ, 2010, EPIDEMIOL INFECT, V138, P1811, DOI 10.1017/S0950268810000646; Ope MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020111; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P38; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Smith MD, 2009, J CLIN MICROBIOL, V47, P1046, DOI 10.1128/JCM.01480-08; Thurman KA, 2011, DIAGN MICR INFEC DIS, V70, P1, DOI 10.1016/j.diagmicrobio.2010.11.014; Tornheim JA, 2007, INT J INFECT DIS, V11, P536, DOI 10.1016/j.ijid.2007.03.006; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Vray M, 2008, AIDS, V22, P1323, DOI 10.1097/QAD.0b013e3282fdf8bf; Vuori-Holopainen E, 2001, CLIN INFECT DIS, V32, P715, DOI 10.1086/319213; World Health Organization, 2003, WHOCDSCSRRMD20036; Worodria W, 2003, INT J TUBERC LUNG D, V7, P117; Zaki ME, 2009, MICROBIOL IMMUNOL, V53, P603, DOI 10.1111/j.1348-0421.2009.00162.x	68	96	100	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43656	10.1371/journal.pone.0043656	http://dx.doi.org/10.1371/journal.pone.0043656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937071	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500073
J	Gu, T; Su, X; Zhou, QY; Li, XY; Yu, M; Ding, Y; Zhao, SH; Li, CC				Gu, Ting; Su, Xi; Zhou, Quanyong; Li, Xinyun; Yu, Mei; Ding, Yi; Zhao, Shuhong; Li, Changchun			Molecular Characterization of the Neuronatin Gene in the Porcine Placenta	PLOS ONE			English	Article							INSULIN-SECRETION; LARGE WHITE; EXPRESSION; GESTATION; MEISHAN; ROLES; CELLS; PIGS	Imprinted genes play important roles in placental and embryonic development. Neuronatin (NNAT), first identified as an imprinted gene in human and mouse brains, played important roles in neuronal differentiation in the brain and in glucose-mediated insulin secretion in pancreatic beta cells. In the pig, NNAT was reported to be imprinted in eleven tissues. Our previous microarray hybridization study showed that NNAT was differentially expressed in Yorkshire and Meishan pig placentas, but the imprinting status and function of NNAT in the placenta have not been investigated. We demonstrated for the first time that NNAT was monoallelically expressed in the placenta. Immunochemistry analysis showed that NNAT was located in the uterine luminal and glandular epithelium in placentas. We also confirmed the differential expression of NNAT in Meishan and Yorkshire pig placentas by qPCR. Using IPA software and the published literature, we created a model network of the possible relationships between NNAT and glucose transporter genes. A dual luciferase reporter assay demonstrated that the crucial promoter region of NNAT contained a CANNTG sequence in the +210 to +215 positions, which corresponded to the E-box. Our findings demonstrated important roles of NNAT in placenta function.	[Gu, Ting; Su, Xi; Li, Xinyun; Yu, Mei; Ding, Yi; Zhao, Shuhong; Li, Changchun] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [Gu, Ting; Su, Xi; Li, Xinyun; Yu, Mei; Ding, Yi; Zhao, Shuhong; Li, Changchun] Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Wuhan, Peoples R China; [Zhou, Quanyong] Jiangxi Acad Agr Sci, Inst Anim Husb & Vet, Nanchang, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Gu, T (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China.	lichangchun@mail.hzau.edu.cn		Gu, Ting/0000-0002-8732-7377	National Natural Science Foundation of China [30972082, 31060300]; key project of Transgenetics of the Ministry of Agriculture; Creative team project of the Ministry of Education [IRT-0831]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of Transgenetics of the Ministry of Agriculture; Creative team project of the Ministry of Education	This work was supported by National Natural Science Foundation of China (30972082 and 31060300), the key project of Transgenetics of the Ministry of Agriculture, and the Creative team project (IRT-0831) of the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAZER FW, 1988, J REPROD FERTIL, V84, P37, DOI 10.1530/jrf.0.0840037; Burton GJ, 2007, PLACENTA, V28, pS64, DOI 10.1016/j.placenta.2007.01.007; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Chen H., MOL IMMUNOL, V47, P1601; Cheng HC, 2007, GENET SEL EVOL, V39, P599, DOI 10.1051/gse:2007024; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Evans HK, 2001, GENOMICS, V77, P99, DOI 10.1006/geno.2001.6612; Fu JJ, 2009, PLACENTA, V30, P305, DOI 10.1016/j.placenta.2009.01.005; Joe MK, 2008, CELL SIGNAL, V20, P907, DOI 10.1016/j.cellsig.2008.01.005; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Suh YH, 2005, BIOCHEM BIOPH RES CO, V337, P481, DOI 10.1016/j.bbrc.2005.09.078; Wilson ME, 1998, BIOL REPROD, V58, P905, DOI 10.1095/biolreprod58.4.905; Zhou QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-337	16	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43325	10.1371/journal.pone.0043325	http://dx.doi.org/10.1371/journal.pone.0043325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937033	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500040
J	Jeon, E; Yun, YR; Kang, W; Lee, S; Koh, YH; Kim, HW; Suh, CK; Jang, JH				Jeon, Eunyi; Yun, Ye-Rang; Kang, Wonmo; Lee, Sujin; Koh, Young-Hyag; Kim, Hae-Won; Suh, Chang Kook; Jang, Jun-Hyeog			Investigating the Role of FGF18 in the Cultivation and Osteogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR (FGF)-18; OSTEOBLAST; PROLIFERATION; FACTOR-18; FGF-18; EXPRESSION; THERAPY; SIGNALS; PROTEIN	Fibroblast growth factor18 (FGF18) belongs to the FGF family and is a pleiotropic protein that stimulates proliferation in several tissues. Bone marrow mesenchymal stem cells (BMSCs) participate in the normal replacement of damaged cells and in disease healing processes within bone and the haematopoietic system. In this study, we constructed FGF18 and investigated its effects on rat BMSCs (rBMSCs). The proliferative effects of FGF18 on rBMSCs were examined using an MTS assay. To validate the osteogenic differentiation effects of FGF18, ALP and mineralization activity were examined as well as osteogenic differentiation-related gene levels. FGF18 significantly enhanced rBMSCs proliferation (p < 0.001) and induced the osteogenic differentiation by elevating ALP and mineralization activity of rBMSCs (p < 0.001). Furthermore, these osteogenic differentiation effects of FGF18 were confirmed via increasing the mRNA levels of collagen type I (Col I), bone morphogenetic protein 4 (BMP4), and Runt-related transcription factor 2 (Runx2) at 3 and 7 days. These results suggest that FGF18 could be used to improve bone repair and regeneration.	[Jeon, Eunyi; Kang, Wonmo; Lee, Sujin; Jang, Jun-Hyeog] Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea; [Yun, Ye-Rang; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea; [Koh, Young-Hyag] Korea Univ, Dept Denatal Lab Sci & Engn, Seoul, South Korea; [Kim, Hae-Won] Dankook Univ, Grad Sch, Dept Nanobiomed Sci, Cheonan, South Korea; [Kim, Hae-Won] Dankook Univ, Grad Sch, WCU Res Ctr, Cheonan, South Korea; [Kim, Hae-Won] Dankook Univ, Sch Dent, Dept Biomat Sci, Cheonan, South Korea; [Suh, Chang Kook] Inha Univ, Sch Med, Dept Physiol & Biophys, Inchon, South Korea	Inha University; Dankook University; Korea University; Dankook University; Dankook University; Dankook University; Inha University	Jeon, E (corresponding author), Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea.	kimhw@dku.edu; juhjang@inha.ac.kr			Priority Research Centers Program through the National Research Foundation (NRF) [2009-0093829]; WCU (World Class University) through the National Research Foundation (NRF) [R31-10069]; Basic Science Research program through the National Research Foundation (NRF); Ministry of Education, Science and Technology through the National Research Foundation (NRF) [2010-0022628]; Ministry of Education, Science and Technology; Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A110416]; Inha University	Priority Research Centers Program through the National Research Foundation (NRF); WCU (World Class University) through the National Research Foundation (NRF); Basic Science Research program through the National Research Foundation (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology through the National Research Foundation (NRF); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Inha University	This work was supported by Priority Research Centers Program (grant#: 2009-0093829) and WCU (World Class University) program (grant#: R31-10069) and Basic Science Research program through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology (grant#: 2010-0022628) through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology and a grant of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A110416) and Inha University Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr B, 2011, TISSUE ENG PT A, V17, P2061, DOI [10.1089/ten.tea.2010.0719, 10.1089/ten.TEA.2010.0719]; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Bond SR, 2011, J BONE MINER RES, V26, P2911, DOI 10.1002/jbmr.509; Davidson D, 2005, J BIOL CHEM, V280, P20509, DOI 10.1074/jbc.M410148200; Ellsworth JL, 2002, OSTEOARTHR CARTILAGE, V10, P308, DOI 10.1053/joca.2002.0514; Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z; Hamidouche Z, 2010, J CELL PHYSIOL, V224, P509, DOI 10.1002/jcp.22152; Hu MCT, 1999, ONCOGENE, V18, P2635, DOI 10.1038/sj.onc.1202616; Hu MCT, 1998, MOL CELL BIOL, V18, P6063, DOI 10.1128/MCB.18.10.6063; Hwang S, 2011, CELL BIOL I IN PRESS; Kassem M, 2006, ANN NY ACAD SCI, V1067, P436, DOI 10.1196/annals.1354.062; Kimelman N, 2006, REGEN MED, V1, P549, DOI 10.2217/17460751.1.4.549; Li YG, 2011, KNEE SURG SPORT TR A, V19, P2153, DOI 10.1007/s00167-011-1506-0; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003; Oh SA, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/475260; Ohbayashi N, 1998, J BIOL CHEM, V273, P18161, DOI 10.1074/jbc.273.29.18161; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pri-Chen S, 1998, BONE, V23, P111, DOI 10.1016/S8756-3282(98)00087-8; Shimoaka T, 2002, J BIOL CHEM, V277, P7493, DOI 10.1074/jbc.M108653200; Smith SML, 2007, ARCH BIOCHEM BIOPHYS, V468, P244, DOI 10.1016/j.abb.2007.10.006; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142	31	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43982	10.1371/journal.pone.0043982	http://dx.doi.org/10.1371/journal.pone.0043982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937141	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500132
J	Onodera, CS; Underwood, JG; Katzman, S; Jacobs, F; Greenberg, D; Salama, SR; Haussler, D				Onodera, Courtney S.; Underwood, Jason G.; Katzman, Sol; Jacobs, Frank; Greenberg, David; Salama, Sofie R.; Haussler, David			Gene Isoform Specificity through Enhancer-Associated Antisense Transcription	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NEURAL DIFFERENTIATION; NONCODING RNAS; DNA METHYLATION; HUMAN PROMOTERS; HUMAN GENOME; REVEALS; EXPRESSION; CHROMATIN; IDENTIFICATION	Enhancers and antisense RNAs play key roles in transcriptional regulation through differing mechanisms. Recent studies have demonstrated that enhancers are often associated with non-coding RNAs (ncRNAs), yet the functional role of these enhancer: ncRNA associations is unclear. Using RNA-Sequencing to interrogate the transcriptomes of undifferentiated mouse embryonic stem cells (mESCs) and their derived neural precursor cells (NPs), we identified two novel enhancer-associated antisense transcripts that appear to control isoform-specific expression of their overlapping protein-coding genes. In each case, an enhancer internal to a protein-coding gene drives an antisense RNA in mESCs but not in NPs. Expression of the antisense RNA is correlated with expression of a shorter isoform of the associated sense gene that is not present when the antisense RNA is not expressed. We demonstrate that expression of the antisense transcripts as well as expression of the short sense isoforms correlates with enhancer activity at these two loci. Further, overexpression and knockdown experiments suggest the antisense transcripts regulate expression of their associated sense genes via cis-acting mechanisms. Interestingly, the protein-coding genes involved in these two examples, Zmynd8 and Brd1, share many functional domains, yet their antisense ncRNAs show no homology to each other and are not present in non-murine mammalian lineages, such as the primate lineage. The lack of homology in the antisense ncRNAs indicates they have evolved independently of each other and suggests that this mode of lineage-specific transcriptional regulation may be more widespread in other cell types and organisms. Our findings present a new view of enhancer action wherein enhancers may direct isoform-specific expression of genes through ncRNA intermediates.	[Onodera, Courtney S.; Underwood, Jason G.; Katzman, Sol; Jacobs, Frank; Greenberg, David; Salama, Sofie R.; Haussler, David] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Underwood, Jason G.; Katzman, Sol; Jacobs, Frank; Salama, Sofie R.; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Underwood, Jason G.; Salama, Sofie R.; Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Greenberg, David] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Onodera, CS (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	ssalama@soe.ucsc.edu	Jacobs, Frank/O-1809-2014; Salama, Sofie/K-6412-2019; Jacobs, Frank/GSD-3616-2022	Jacobs, Frank/0000-0003-4423-1479; Salama, Sofie/0000-0001-6999-7193	California Institute for Regenerative Medicine [T3-00006]; National Institutes of Health (NIH)/National Human Genome Research Institute [U41 HG004568-01]; NIH [1R03DA026061-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG004568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA026061] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health (NIH)/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	CSO was supported in part by California Institute for Regenerative Medicine training grant T3-00006, and by National Institutes of Health (NIH)/National Human Genome Research Institute U41 HG004568-01. This study was funded in part by NIH 1R03DA026061-01 to SRS. DH is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ideue T, 2009, RNA, V15, P1578, DOI 10.1261/rna.1657609; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Morrissy AS, 2011, GENOME RES, V21, P1203, DOI 10.1101/gr.113431.110; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Sambrook J., 2006, COLD SPRING HARBOR P; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2005, STAT BIOL HEALTH, P325, DOI 10.1007/0-387-27733-1_12; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Smit A, 1996, REPEATMASKER OPEN 30; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Tikole S, 2008, BIOCHEM BIOPH RES CO, V369, P1166, DOI 10.1016/j.bbrc.2008.03.008; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Werner Andreas, 2005, RNA Biol, V2, P53, DOI 10.4161/rna.2.2.1852; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115	63	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43511	10.1371/journal.pone.0043511	http://dx.doi.org/10.1371/journal.pone.0043511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937057	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500058
J	Burger, KNJ; Beulens, JWJ; van der Schouw, YT; Sluijs, I; Spijkerman, AMW; Sluik, D; Boeing, H; Kaaks, R; Teucher, B; Dethlefsen, C; Overvad, K; Tjonneland, A; Kyro, C; Barricarte, A; Bendinelli, B; Krogh, V; Tumino, R; Sacerdote, C; Mattiello, A; Nilsson, PM; Orho-Melander, M; Rolandsson, O; Huerta, JM; Crowe, F; Allen, N; Nothlings, U				Burger, Koert N. J.; Beulens, Joline W. J.; van der Schouw, Yvonne T.; Sluijs, Ivonne; Spijkerman, Annemieke M. W.; Sluik, Diewertje; Boeing, Heiner; Kaaks, Rudolf; Teucher, Birgit; Dethlefsen, Claus; Overvad, Kim; Tjonneland, Anne; Kyro, Cecilie; Barricarte, Aurelio; Bendinelli, Benedetta; Krogh, Vittorio; Tumino, Rosario; Sacerdote, Carlotta; Mattiello, Amalia; Nilsson, Peter M.; Orho-Melander, Marju; Rolandsson, Olov; Maria Huerta, Jose; Crowe, Francesca; Allen, Naomi; Noethlings, Ute			Dietary Fiber, Carbohydrate Quality and Quantity, and Mortality Risk of Individuals with Diabetes Mellitus	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; CORONARY-HEART-DISEASE; GLYCEMIC-LOAD DIET; RESTING ENERGY-EXPENDITURE; LIFE-STYLE INTERVENTION; OBESE YOUNG-ADULTS; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; RELATIVE VALIDITY; EPIC PROJECT	Background: Dietary fiber, carbohydrate quality and quantity are associated with mortality risk in the general population. Whether this is also the case among diabetes patients is unknown. Objective: To assess the associations of dietary fiber, glycemic load, glycemic index, carbohydrate, sugar, and starch intake with mortality risk in individuals with diabetes. Methods: This study was a prospective cohort study among 6,192 individuals with confirmed diabetes mellitus (mean age of 57.4 years, and median diabetes duration of 4.4 years at baseline) from the European Prospective Investigation into Cancer and Nutrition (EPIC). Dietary intake was assessed at baseline (1992-2000) with validated dietary questionnaires. Cox proportional hazards analysis was performed to estimate hazard ratios (HRs) for all-cause and cardiovascular mortality, while adjusting for CVD-related, diabetes-related, and nutritional factors. Results: During a median follow-up of 9.2 y, 791 deaths were recorded, 306 due to CVD. Dietary fiber was inversely associated with all-cause mortality risk (adjusted HR per SD increase, 0.83 [95% CI, 0.75-0.91]) and CVD mortality risk (0.76[0.64-0.89]). No significant associations were observed for glycemic load, glycemic index, carbohydrate, sugar, or starch. Glycemic load (1.42[1.07-1.88]), carbohydrate (1.67[1.18-2.37]) and sugar intake (1.53[1.12-2.09]) were associated with an increased total mortality risk among normal weight individuals (BMI <= 25 kg/m(2); 22% of study population) but not among overweight individuals (P interaction <= 0.04). These associations became stronger after exclusion of energy misreporters. Conclusions: High fiber intake was associated with a decreased mortality risk. High glycemic load, carbohydrate and sugar intake were associated with an increased mortality risk in normal weight individuals with diabetes.	[Burger, Koert N. J.; Beulens, Joline W. J.; van der Schouw, Yvonne T.; Sluijs, Ivonne] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands; [Sluik, Diewertje; Boeing, Heiner; Noethlings, Ute] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Kaaks, Rudolf; Teucher, Birgit] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Dethlefsen, Claus; Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Ctr Cardiovasc Res, Dept Cardiol, Aalborg, Denmark; [Overvad, Kim] Aarhus Univ, Dept Epidemiol, Sch Publ Hlth, Aarhus, Denmark; [Tjonneland, Anne; Kyro, Cecilie] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Barricarte, Aurelio] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Pamplona, Spain; [Barricarte, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Bendinelli, Benedetta] Ist Studio & Prevenz Oncol, Mol & Nutr Epidemiol Unit, Florence, Italy; [Krogh, Vittorio] IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, Milan, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry & Histopathol Unit, Ragusa, Italy; [Sacerdote, Carlotta] Ctr Canc Prevent Piedmont, Turin, Italy; [Sacerdote, Carlotta] Human Genet Fdn, Turin, Italy; [Mattiello, Amalia] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Nilsson, Peter M.; Orho-Melander, Marju] Univ Lund Hosp, Dept Clin Sci, Malmo, Sweden; [Rolandsson, Olov] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Maria Huerta, Jose] Murcia Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Maria Huerta, Jose] CIBER Epidemiol & Salud Publ CIBERESP, Murcia, Spain; [Crowe, Francesca; Allen, Naomi] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Noethlings, Ute] Univ Kiel, Epidemiol Sect, Inst Expt Med, Kiel, Germany	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; German Cancer Research Center (DKFZ); Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Danish Cancer Society; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; University of Naples Federico II; Lund University; Skane University Hospital; Umea University; Murcia Regional Health Council; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Oxford; University of Kiel	Burger, KNJ (corresponding author), Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	J.Beulens@umcutrecht.nl	Nöthlings, Ute/B-2713-2010; Teucher, Birgit/J-6380-2015; Huerta, José María/N-8654-2015; Krogh, Vittorio/K-2628-2016; Mattiello, Amalia AM/K-5112-2016; Krogh, Vittorio/AAA-9171-2019; van der Schouw, Yvonne T./F-8327-2014	Huerta, José María/0000-0002-9637-3869; Krogh, Vittorio/0000-0003-0122-8624; Mattiello, Amalia AM/0000-0003-3676-7353; Krogh, Vittorio/0000-0003-0122-8624; van der Schouw, Yvonne T./0000-0002-4605-435X; Tjonneland, Anne/0000-0003-4385-2097; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Overvad, Kim/0000-0001-6429-7921; Beulens, Joline/0000-0002-4181-0937; Kyro, Cecilie/0000-0002-9083-8960; Dethlefsen, Claus/0000-0003-3994-6189; Sluik, Diewertje/0000-0001-6304-0913; Bendinelli, Benedetta/0000-0002-4796-1517; Sacerdote, Carlotta/0000-0002-8008-5096; tumino, rosario/0000-0003-2666-414X; Crowe, Francesca/0000-0003-4026-1726	European Foundation for the Study of Diabetes (EFSD)/Sanofi-Aventis grant	European Foundation for the Study of Diabetes (EFSD)/Sanofi-Aventis grant	This study was supported by a European Foundation for the Study of Diabetes (EFSD)/Sanofi-Aventis grant. The funding organizations played no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; ARNER P, 1991, DIABETOLOGIA, V34, P483, DOI 10.1007/BF00403284; Aryangat AV, 2010, VASC HEALTH RISK MAN, V6, P145; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Beulens JWJ, 2007, J AM COLL CARDIOL, V50, P14, DOI 10.1016/j.jacc.2007.02.068; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS71, DOI 10.1093/ije/26.suppl_1.S71; BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS59, DOI 10.1093/ije/26.suppl_1.S59; Brand-Miller J, 2003, DIABETES CARE, V26, P2261, DOI 10.2337/diacare.26.8.2261; Brown L, 1999, AM J CLIN NUTR, V69, P30; Burger KNJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025955; Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; Deedwania PC, 2010, ARCH INTERN MED, V170, P1575, DOI 10.1001/archinternmed.2010.333; Dickinson S, 2008, AM J CLIN NUTR, V87, P1188; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Du HD, 2009, BRIT J NUTR, V102, P601, DOI 10.1017/S0007114508207269; Ebbeling CB, 2005, AM J CLIN NUTR, V81, P976; FONTVIEILLE AM, 1992, DIABETOLOGIA, V35, P753; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hardy DS, 2010, ANN EPIDEMIOL, V20, P610, DOI 10.1016/j.annepidem.2010.05.008; He MA, 2010, CIRCULATION, V121, P2162, DOI 10.1161/CIRCULATIONAHA.109.907360; Henry CJK, 2005, BRIT J NUTR, V94, P917, DOI 10.1079/BJN20051571; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS26, DOI 10.1093/ije/26.suppl_1.S26; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lau C, 2006, AM J CLIN NUTR, V84, P641, DOI 10.1093/ajcn/84.3.641; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Livesey G, 2008, AM J CLIN NUTR, V87, p258S, DOI 10.1093/ajcn/87.1.258S; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Ma YS, 2006, AM J CLIN NUTR, V83, P760, DOI 10.1093/ajcn/83.4.760; Ma YS, 2008, NUTRITION, V24, P941, DOI 10.1016/j.nut.2008.04.005; Maki KC, 2007, AM J CLIN NUTR, V85, P724, DOI 10.1093/ajcn/85.3.724; Margetts BM, 1997, INT J EPIDEMIOL, V26, pS1, DOI 10.1093/ije/26.suppl_1.S1; McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nothlings U, 2011, EUR J CLIN NUTR, V65, P635, DOI 10.1038/ejcn.2011.11; Nothlings U, 2008, J NUTR, V138, P775, DOI 10.1093/jn/138.4.775; Oba S, 2010, METABOLISM, V59, P1574, DOI 10.1016/j.metabol.2010.02.004; Ocke MC, 2009, EUR J CLIN NUTR, V63, pS3, DOI 10.1038/ejcn.2009.72; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Pereira MA, 2004, JAMA-J AM MED ASSOC, V292, P2482, DOI 10.1001/jama.292.20.2482; Pereira MA, 2002, AM J CLIN NUTR, V75, P848, DOI 10.1093/ajcn/75.5.848; Pisani P, 1997, INT J EPIDEMIOL, V26, pS152, DOI 10.1093/ije/26.suppl_1.S152; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Ryan M, 2006, BRIT J NUTR, V96, P945, DOI 10.1017/BJN20061744; Salle A, 2006, DIABETES CARE, V29, P2726, DOI 10.2337/dc06-1582; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Sluijs I, 2010, AM J CLIN NUTR, V92, P905, DOI 10.3945/ajcn.2010.29620; Sluik D, 2011, AM J EPIDEMIOL, V174, P22, DOI 10.1093/aje/kwr048; Song SH, 2008, QJM-INT J MED, V101, P875, DOI 10.1093/qjmed/hcn109; Spencer EA, 2003, INT J OBESITY, V27, P728, DOI 10.1038/sj.ijo.0802300; Streppel MT, 2005, ARCH INTERN MED, V165, P150, DOI 10.1001/archinte.165.2.150; Thomas DE, 2010, BR J NUTR, V104, P1; van Bakel MME, 2009, EUR J CLIN NUTR, V63, pS188, DOI 10.1038/ejcn.2009.81; van Bakel MME, 2009, J NUTR, V139, P568, DOI 10.3945/jn.108.097121; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; WOLEVER TMS, 1994, AM J CLIN NUTR, V59, P1265, DOI 10.1093/ajcn/59.6.1265	73	64	69	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43127	10.1371/journal.pone.0043127	http://dx.doi.org/10.1371/journal.pone.0043127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927948	Green Published, gold, Green Submitted			2022-12-27	WOS:000308224700011
J	Sugiyama, C; Yamamoto, M; Kotani, T; Kikkawa, F; Murata, Y; Hayashi, Y				Sugiyama, Chisato; Yamamoto, Michiyo; Kotani, Tomomi; Kikkawa, Fumitaka; Murata, Yoshiharu; Hayashi, Yoshitaka			Fertility and Pregnancy-Associated beta-Cell Proliferation in Mice Deficient in Proglucagon-Derived Peptides	PLOS ONE			English	Article							INSULIN-SECRETION; PLACENTAL LACTOGENS; GLUCAGON; RECEPTOR; ISLETS; HYPOGLYCEMIA; HORMONES; GROWTH; MOUSE; MASS	Proglucagon, which is encoded by the glucagon gene (Gcg), is the precursor of several peptide hormones, including glucagon and glucagon-like peptide 1 (GLP-1). Whereas glucagon stimulates hepatic glycogenolysis and gluconeogenesis, GLP-1 stimulates insulin secretion to lower blood glucose and also supports beta-cell proliferation and protection from apoptotic stimuli. Pregnancy is a strong inducer of change in islet function, however the roles of proglucagon-derived peptides in pregnancy are only partially understood. In the present study, we analyzed fertility and pregnancy-associated changes in homozygous glucagon-green fluorescent protein (gfp) knock-in mice (Gcg(gfp/gfp)), which lack all the peptides derived from proglucagon. Female Gcg(gfp/gfp) mice could deliver and raise Gcg(gfp/gfp) pups to weaning and Gcg(gfp/gfp) pups from Gcg(gfp/gfp) dams were viable and fertile. Pregnancy induced beta-cell proliferation in Gcg(gfp/gfp) mice as well as in control mice. However, serum insulin levels in pregnant Gcg(gfp/gfp) females were lower than those in control pregnant females under ad libitum feeding, and blood glucose levels in pregnant Gcg(gfp/gfp) females were higher after gestational day 12. Gcg(gfp/gfp) females showed a decreased pregnancy rate and smaller litter size. The rate of successful breeding was significantly lower in Gcg(gfp/gfp) females and was not improved by experience of breeding. Taken together, proglucagon-derived peptides are not required for pregnancy-associated beta-cell proliferation, however, are required for regulation of blood glucose levels and normal reproductive capacity. Gcg(gfp/gfp) mice may serve as a novel model to analyze the effect of mild hyperglycemia during late gestational periods.	[Sugiyama, Chisato; Yamamoto, Michiyo; Murata, Yoshiharu; Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 464, Japan; [Sugiyama, Chisato; Kotani, Tomomi; Kikkawa, Fumitaka] Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Sugiyama, C (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 464, Japan.	hayashiy@riem.nagoya-u.ac.jp	Hayashi, Yoshitaka/I-6168-2014; KIKKAWA, Fumitaka/I-7341-2014; Kotani, Tomomi/I-7360-2014	Hayashi, Yoshitaka/0000-0002-7557-4303; Kotani, Tomomi/0000-0002-3082-6116	Japan Society for the Promotion of Science [21659232]; Ministry of Education, Culture, Sports, Science and Technology, Japan [23122507]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (21659232 to Y. H.) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (23122507 to Y. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, BEHAV BRAIN RES, V205, P265, DOI 10.1016/j.bbr.2009.06.035; Ali S, 2011, J CLIN INVEST, V121, P1917, DOI 10.1172/JCI43615; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Dey A, 2005, ENDOCRINOLOGY, V146, P713, DOI 10.1210/en.2004-1118; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; FIELDER PJ, 1987, AM J PHYSIOL, V253, pE40, DOI 10.1152/ajpendo.1987.253.1.E40; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Ijas H, 2010, BJOG, P880; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Lindberg K, 2005, J MOL ENDOCRINOL, V35, P231, DOI 10.1677/jme.1.01840; Mao PZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029343; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; Nasir I, 2005, MOL CELL ENDOCRINOL, V233, P1, DOI 10.1016/j.mce.2005.02.001; Ouhilal S, 2012, AM J PHYSIOL-ENDOC M, V302, pE522, DOI 10.1152/ajpendo.00420.2011; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; PERSSON B, 1993, BAILLIERE CLIN ENDOC, V7, P731, DOI 10.1016/S0950-351X(05)80216-2; Reece E A, 1994, Obstet Gynecol Surv, V49, P64, DOI 10.1097/00006254-199401000-00027; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; SMOAK IW, 1990, AM J OBSTET GYNECOL, V163, P619, DOI 10.1016/0002-9378(90)91213-V; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; ter Braak EWMT, 2002, DIABETES-METAB RES, V18, P96, DOI 10.1002/dmrr.271; Valsamakis G, 2010, EUR J ENDOCRINOL, V162, P897, DOI 10.1530/EJE-10-0047; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Vuguin PM, 2006, ENDOCRINOLOGY, V147, P3995, DOI 10.1210/en.2005-1410; Watanabe C, 2012, DIABETES, V61, P74, DOI 10.2337/db11-0739	35	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43745	10.1371/journal.pone.0043745	http://dx.doi.org/10.1371/journal.pone.0043745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928026	Green Published, gold, Green Submitted			2022-12-27	WOS:000308224700024
J	Chow, BSM; Chew, EGY; Zhao, CX; Bathgate, RAD; Hewitson, TD; Samuel, CS				Chow, Bryna Suet Man; Chew, Elaine Guo Yan; Zhao, Chongxin; Bathgate, Ross A. D.; Hewitson, Tim D.; Samuel, Chrishan S.			Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS	PLOS ONE			English	Article							NITRIC-OXIDE PATHWAY; SMOOTH-MUSCLE-CELLS; INTERSTITIAL FIBROSIS; TISSUE INHIBITORS; HORMONE RELAXIN; RENAL FIBROSIS; LUNG FIBROSIS; GROWTH; FIBROBLASTS; COLLAGEN	The hormone, relaxin, inhibits aberrant myofibroblast differentiation and collagen deposition by disrupting the TGF-beta 1/Smad2 axis, via its cognate receptor, Relaxin Family Peptide Receptor 1 (RXFP1), extracellular signal-regulated kinase (ERK) 1/2 phosphorylation (pERK) and a neuronal nitric oxide (NO) synthase (nNOS)-NO-cyclic guanosine monophosphate (cGMP)dependent pathway. However, the signalling pathways involved in its additional ability to increase matrix metalloproteinase (MMP) expression and activity remain unknown. This study investigated the extent to which the NO pathway was involved in human gene-2 (H2) relaxin's ability to positively regulate MMP-1 and its rodent orthologue, MMP-13, MMP-2 and MMP-9 (the main collagen-degrading MMPs) in TGF-beta 1-stimulated human dermal fibroblasts and primary renal myofibroblasts isolated from injured rats; by gelatin zymography (media) and Western blotting (cell layer). H2 relaxin (10-100 ng/ml) significantly increased MMP-1 (by similar to 50%), MMP-2 (by similar to 80%) and MMP-9 (by similar to 80%) in TGF-beta 1-stimulated human dermal fibroblasts; and MMP-13 (by similar to 90%), MMP-2 (by similar to 130%) and MMP-9 (by similar to 115%) in rat renal myofibroblasts (all p<0.01 vs untreated cells) over 72 hours. The relaxin-induced up-regulation of these MMPs, however, was significantly blocked by a non-selective NOS inhibitor (L-nitroarginine methyl ester (hydrochloride); L-NAME; 75-100 mu M), and specific inhibitors to nNOS (N-propyl-L-arginine; NPLA; 0.2-2 mu M), iNOS (1400W; 0.5-1 mu M) and guanylyl cyclase (ODQ; 5 mu M) (all p<0.05 vs H2 relaxin alone), but not eNOS (L-N-(1-iminoethyl) ornithine dihydrochloride; L-NIO; 0.5-5 mu M). However, neither of these inhibitors affected basal MMP expression at the concentrations used. Furthermore, of the NOS isoforms expressed in renal myofibroblasts (nNOS and iNOS), H2 relaxin only stimulated nNOS expression, which in turn, was blocked by the ERK1/2 inhibitor (PD98059; 1 mu M). These findings demonstrated that H2 relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to mediate its anti-fibrotic actions, and additionally signals through iNOS to up-regulate MMPs; the latter being suppressed by TGF-beta 1 in myofibroblasts, but released upon H2 relaxin-induced inhibition of the TGF-beta 1/Smad2 axis.	[Chow, Bryna Suet Man; Chew, Elaine Guo Yan; Zhao, Chongxin; Bathgate, Ross A. D.; Samuel, Chrishan S.] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Chow, Bryna Suet Man; Bathgate, Ross A. D.; Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Hewitson, Tim D.] Royal Melbourne Hosp, Dept Nephrol, Parkville, Vic 3050, Australia; [Hewitson, Tim D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne; Monash University	Chow, BSM (corresponding author), Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia.	tim.hewitson@mh.org.au; chrishan.samuel@monash.edu	Bathgate, Ross/ABE-6471-2020	Bathgate, Ross/0000-0001-6301-861X; Hewitson, Tim/0000-0002-1994-2423; Chew, Elaine/0000-0001-9763-703X	National Health and Medical Research Council of Australia (NHMRC) [628634]; NHMRC Senior Research Fellowship; National Heart Foundation of Australia/NHMRC; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia/NHMRC(National Health and Medical Research Council (NHMRC) of AustraliaNational Heart Foundation of Australia); Victorian Government's Operational Infrastructure Support Program	This study was supported by a National Health and Medical Research Council of Australia (NHMRC) Project Grant (628634) to Chrishan S. Samuel and Tim D. Hewitson; a NHMRC Senior Research Fellowship to Ross A. D. Bathgate; a National Heart Foundation of Australia/NHMRC R. D. Wright Fellowship to Chrishan S. Samuel; and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Baccari MC, 2005, ANN NY ACAD SCI, V1041, P308, DOI 10.1196/annals.1282.047; Bani D, 1998, HYPERTENSION, V31, P1240, DOI 10.1161/01.HYP.31.6.1240; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Bathgate RAD, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P679; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; Bennett RG, 2003, BIOCHEM PHARMACOL, V66, P867, DOI 10.1016/S0006-2952(03)00403-9; Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; Conrad KP, 2011, AM J PHYSIOL-REG I, V301, pR267, DOI 10.1152/ajpregu.00156.2011; Diamond JR, 1998, SEMIN NEPHROL, V18, P594; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Ferreira VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004845; Filippin LI, 2011, NITRIC OXIDE-BIOL CH, V24, P43, DOI 10.1016/j.niox.2010.11.003; Franchi A, 2002, CANCER-AM CANCER SOC, V95, P1902, DOI 10.1002/cncr.10916; Franklin TJ, 1997, INT J BIOCHEM CELL B, V29, P79, DOI 10.1016/S1357-2725(96)00121-5; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hossain MA, 2011, J BIOL CHEM, V286, P37555, DOI 10.1074/jbc.M111.282194; Hossain MA, 2011, BIOCHEMISTRY-US, V50, P1368, DOI 10.1021/bi1013968; Huang XW, 2011, AM J PATHOL, V179, P2751, DOI 10.1016/j.ajpath.2011.08.018; Jeyabalan A, 2007, ADV EXP MED BIOL, V612, P65; JUNQUERO DC, 1992, J PHYSIOL-LONDON, V454, P451, DOI 10.1113/jphysiol.1992.sp019273; Kang EH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3218; Lekgabe ED, 2005, HYPERTENSION, V46, P412, DOI 10.1161/01.HYP.0000171930.00697.2f; Li YY, 2000, CARDIOVASC RES, V46, P214, DOI 10.1016/S0008-6363(00)00003-1; Masini E, 2002, BRIT J PHARMACOL, V137, P337, DOI 10.1038/sj.bjp.0704879; Masterson R, 2004, NEPHROL DIAL TRANSPL, V19, P544, DOI 10.1093/ndt/gfg598; McGuane JT, 2011, ENDOCRINOLOGY, V152, P2786, DOI 10.1210/en.2010-1126; Miyazaki D, 2011, HUM MOL GENET, V20, P1787, DOI 10.1093/hmg/ddr062; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mookerjee I, 2009, FASEB J, V23, P1219, DOI 10.1096/fj.08-120857; Moore XL, 2007, ENDOCRINOLOGY, V148, P1582, DOI 10.1210/en.2006-1324; Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Naqvi T, 2005, ARTHRITIS RES THER, V7, pR1, DOI 10.1186/ar1451; Nistri Silvia, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P101, DOI 10.2174/187152507780363179; Palejwala S, 2001, ENDOCRINOLOGY, V142, P3405, DOI 10.1210/en.142.8.3405; Persichini T, 2006, ANTIOXID REDOX SIGN, V8, P949, DOI 10.1089/ars.2006.8.949; Pini A, 2010, J PHARMACOL EXP THER, V335, P589, DOI 10.1124/jpet.110.170977; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; RODEMANN HP, 1990, P SOC EXP BIOL MED, V195, P57; Royce SG, 2009, ENDOCRINOLOGY, V150, P2692, DOI 10.1210/en.2008-1457; Samuel CS, 2007, CELL MOL LIFE SCI, V64, P1539, DOI 10.1007/s00018-007-6543-y; Samuel CS, 2008, ENDOCRINOLOGY, V149, P3286, DOI 10.1210/en.2008-0250; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Teichman SL, 2009, HEART FAIL REV, V14, P321, DOI 10.1007/s10741-008-9129-3; Unemori EN, 2000, WOUND REPAIR REGEN, V8, P361, DOI 10.1111/j.1524-475X.2000.00361.x; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720	61	79	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42714	10.1371/journal.pone.0042714	http://dx.doi.org/10.1371/journal.pone.0042714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936987	Green Published, gold			2022-12-27	WOS:000308286300023
J	Pasto, A; Marchesi, M; Diamantini, A; Frasson, C; Curtarello, M; Lago, C; Pilotto, G; Parenti, AR; Esposito, G; Agostini, M; Nitti, D; Amadori, A				Pasto, Anna; Marchesi, Maddalena; Diamantini, Adamo; Frasson, Chiara; Curtarello, Matteo; Lago, Claudia; Pilotto, Giorgia; Parenti, Anna Rosita; Esposito, Giovanni; Agostini, Marco; Nitti, Donato; Amadori, Alberto			PKH26 Staining Defines Distinct Subsets of Normal Human Colon Epithelial Cells at Different Maturation Stages	PLOS ONE			English	Article							CANCER STEM-CELLS; SMALL-INTESTINE; IN-VITRO; MARKERS; POPULATIONS; EXPRESSION; DIVISIONS; SKIN	Background and Aim: Colon crypts are characterized by a hierarchy of cells distributed along the crypt axis. Aim of this paper was to develop an in vitro system for separation of epithelial cell subsets in different maturation stages from normal human colon. Methodology and Major Findings: Dissociated colonic epithelial cells were stained with PKH26, which allows identification of distinct populations based on their proliferation rate, and cultured in vitro in the absence of serum. The cytofluorimetric expression of CK20, Msi-1 and Lgr5 was studied. The mRNA levels of several stemness-associated genes were also compared in cultured cell populations and in three colon crypt populations isolated by microdissection. A PKHpos population survived in culture and formed spheroids; this population included subsets with slow (PKHhigh) and rapid (PKHlow) replicative rates. Molecular analysis revealed higher mRNA levels of both Msi-1 and Lgr-5 in PKHhigh cells; by cytofluorimetric analysis, Msi-1(+)/Lgr5(+) cells were only found within PKHhigh cells, whereas Msi-1(+)/Lgr5(-) cells were also observed in the PKHlow population. As judged by qRT-PCR analysis, the expression of several stemness-associated markers (Bmi-1, EphB2, EpCAM, ALDH1) was highly enriched in Msi-1(+)/Lgr5(+) cells. While CK20 expression was mainly found in PKHlow and PKHneg cells, a small PKHhigh subset co-expressed both CK20 and Msi-1, but not Lgr5; cells with these properties also expressed Mucin, and could be identified in vivo in colon crypts. These results mirrored those found in cells isolated from different crypt portions by microdissection, and based on proliferation rates and marker expression they allowed to define several subsets at different maturation stages: PKHhigh/Lgr5(+)/Msi-1(+)/CK20(-), PKHhigh/Lgr5(-)/Msi-1(+)/CK20(+), PKHlow/Lgr5(-)/Msi-1(+)/Ck20(-), and PKHlow/Lgr5(-)/Msi-1(-)/CK20(+) cells. Conclusions: Our data show the possibility of deriving in vitro, without any selection strategy, several distinct cell subsets of human colon epithelial cells, which recapitulate the phenotypic and molecular profile of cells in a discrete crypt location.	[Pasto, Anna; Marchesi, Maddalena; Diamantini, Adamo; Lago, Claudia; Pilotto, Giorgia; Agostini, Marco; Nitti, Donato; Amadori, Alberto] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Frasson, Chiara] Univ Padua, Dept Pediat, Hematooncol Lab, Padua, Italy; [Curtarello, Matteo; Esposito, Giovanni; Amadori, Alberto] IRCCS Ist Oncol Veneto, Padua, Italy; [Parenti, Anna Rosita] Univ Padua, Dept Diagnost Sci & Special Therapies, Padua, Italy	University of Padua; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua	Pasto, A (corresponding author), Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy.	albido@unipd.it	Curtarello, Matteo/P-8120-2019; agostini, marco/AAC-3408-2019; agostini, marco ma/K-2449-2018; Curtarello, Matteo/K-4021-2016	Curtarello, Matteo/0000-0003-3133-4807; agostini, marco/0000-0001-7578-1233; agostini, marco ma/0000-0001-7578-1233; Curtarello, Matteo/0000-0003-3133-4807; Esposito, Giovanni/0000-0003-1019-6476; , Anna/0000-0002-5783-0668	Associazione Italiana per la Ricerca sul Cancro (AIRC); Ministry of Health; Ministry of Education; PRIN, Regione Veneto	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministry of Health; Ministry of Education; PRIN, Regione Veneto(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC), Ministry of Health, Ministry of Education 60% and PRIN, Regione Veneto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADORI A, 1989, J IMMUNOL, V143, P2146; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; BJERKNES M, 1981, AM J ANAT, V160, P93, DOI 10.1002/aja.1001600108; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dangles-Marie V, 2007, J CLIN ONCOL, V25; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Ghisi M, 2011, BLOOD, V117, P7053, DOI 10.1182/blood-2010-12-326629; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; MacNicol AM, 2008, BIOCHEM SOC T, V36, P528, DOI 10.1042/BST0360528; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Moserle L, 2010, CANCER LETT, V288, P1, DOI 10.1016/j.canlet.2009.05.020; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schulenburg A, 2007, J PATHOL, V213, P152, DOI 10.1002/path.2220; Shaker A, 2010, TRANSL RES, V156, P180, DOI 10.1016/j.trsl.2010.06.003; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takeda K, 2011, ANTICANCER RES, V31, P263; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	40	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43379	10.1371/journal.pone.0043379	http://dx.doi.org/10.1371/journal.pone.0043379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927961	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300047
J	Peng, H; Wu, YY; Zhang, Y				Peng, Hui; Wu, Yongyan; Zhang, Yong			Efficient Delivery of DNA and Morpholinos into Mouse Preimplantation Embryos by Electroporation	PLOS ONE			English	Article							GENE-TRANSFER; TRANSIENT EXPRESSION; TRANSCRIPTION FACTOR; PLASMID DNA; ZEBRAFISH; SYSTEM; CELLS; RNA; OVO; TRANSFECTION	Mouse preimplantation development is characterized by three major transitions and two lineage segregations. Each transition or lineage segregation entails pronounced changes in the pattern of gene expression. Thus, research into the function of genes with obvious changes in expression pattern will shed light on the molecular basis of preimplantation development. We have described a simplified and effective method-electroporation-of introducing plasmid DNA and morpholinos into mouse preimplantation embryos and verified effectiveness of this approach by testing the procedure on the endogenous gene Oct4. Before electroporation, the zona pellucida was weakened by the treatment of acid Tyrode's solution. Then we optimized the parameters such as voltage, pulse duration, number of pulses and repeats, and applied these parameters to subsequent experiments. Compared with the control groups, the number of apoptotic cells and the expression and localization of OCT3/4 or CDX2 was not significantly changed in blastocysts developed from 1-cell embryos, which were electroporated with pIRES2-AcGFP1-Nuc eukaryotic expression vector or mismatched morpholino oligonucleotides. Furthermore, electroporated plasmid DNA and morpholinos targeting the endogenous gene Oct4 were able to sharply down regulate expression of OCT4 protein and actually cause expected phenotypes in mouse preimplantation embryos. In conclusion, plasmid DNA and morpholinos could be efficient delivered into mouse preimplantation embryos by electroporation and exert their functions, and normal development of preimplantation embryos was not affected.	[Peng, Hui; Wu, Yongyan; Zhang, Yong] NW A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Peng, H (corresponding author), NW A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China.	zhy1956@126.com	Wu, Yongyan/AAH-1471-2019; Zhang, Yong/K-7945-2016	Wu, Yongyan/0000-0003-1669-3860; Zhang, Yong/0000-0001-8642-4071	National Major Project for Production of Transgenic Breeding, People's Republic of China [2011ZX08007-004]	National Major Project for Production of Transgenic Breeding, People's Republic of China	This work was supported by the National Major Project for Production of Transgenic Breeding, People's Republic of China (No. 2011ZX08007-004) (http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Baron S, 2000, J IMMUNOL METHODS, V242, P115, DOI 10.1016/S0022-1759(00)00242-8; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Buono Russel J., 1992, Molecular Marine Biology and Biotechnology, V1, P271; Cerda GA, 2006, METHODS, V39, P207, DOI 10.1016/j.ymeth.2005.12.009; Coonrod SA, 2001, GENESIS, V30, P198, DOI 10.1002/gene.1065; Das ZC, 2010, CELL REPROGRAM, V12, P95, DOI 10.1089/cell.2009.0068; Eide FF, 2000, FEBS LETT, V486, P29, DOI 10.1016/S0014-5793(00)02124-4; Engstrom PE, 2001, ANTICANCER RES, V21, P1817; Fakhrai H, 1996, P NATL ACAD SCI USA, V93, P2909, DOI 10.1073/pnas.93.7.2909; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gershon E, 2008, DEV BIOL, V313, P1, DOI 10.1016/j.ydbio.2007.08.041; Grabarek JB, 2002, GENESIS, V32, P269, DOI 10.1002/gene.10076; Haraguchi S, 2004, MOL REPROD DEV, V68, P17, DOI 10.1002/mrd.20047; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; Jedrusik A, 2010, DEV BIOL, V344, P66, DOI 10.1016/j.ydbio.2010.04.017; Johnson CW, 2011, DEV BIOL, V357, P269, DOI 10.1016/j.ydbio.2011.06.034; Kamdar K P, 1995, Methods Mol Biol, V48, P239; Kim MH, 2002, BIOCHEM BIOPH RES CO, V296, P1372, DOI 10.1016/S0006-291X(02)02070-3; LAWITTS JA, 1991, J REPROD FERTIL, V91, P543, DOI 10.1530/jrf.0.0910543; Leopold RA, 1996, GENET ANAL-BIOMOL E, V12, P197, DOI 10.1016/1050-3862(96)00136-2; Li HM, 2008, MOL BIOL CELL, V19, P4804, DOI 10.1091/mbc.E08-03-0294; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Mellitzer G, 2002, MECH DEVELOP, V118, P57, DOI 10.1016/S0925-4773(02)00191-0; MONTANO X, 1995, CELL GROWTH DIFFER, V6, P597; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; MULLER F, 1993, FEBS LETT, V324, P27, DOI 10.1016/0014-5793(93)81525-5; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Nabti I, 2008, DEV BIOL, V321, P379, DOI 10.1016/j.ydbio.2008.06.036; Nakamura H, 2004, MECH DEVELOP, V121, P1137, DOI 10.1016/j.mod.2004.05.013; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NEMEC L A, 1989, Theriogenology, V31, P233, DOI 10.1016/0093-691X(89)90641-9; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishi T, 1996, CANCER RES, V56, P1050; Osumi N, 2001, METHODS, V24, P35, DOI 10.1006/meth.2001.1154; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; RICHARDSON JH, 1995, TRENDS BIOTECHNOL, V13, P306, DOI 10.1016/S0167-7799(00)88970-2; Rols MP, 1998, NAT BIOTECHNOL, V16, P168, DOI 10.1038/nbt0298-168; SHEN YM, 1982, MOL CELL BIOL, V2, P1145, DOI 10.1128/MCB.2.9.1145; Smith C, 1992, J Hematother, V1, P155, DOI 10.1089/scd.1.1992.1.155; Su JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023805; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tewari D, 1998, J IMMUNOL, V161, P2642; Timmer J, 2001, GENESIS, V29, P123, DOI 10.1002/gene.1015; Tucker RP, 2001, DEV DYNAM, V222, P115, DOI 10.1002/dvdy.1171; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Yamanaka K, 2009, J REPROD DEVELOP, V55, P638, DOI 10.1262/jrd.20245	51	26	28	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43748	10.1371/journal.pone.0043748	http://dx.doi.org/10.1371/journal.pone.0043748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928027	gold, Green Published, Green Submitted			2022-12-27	WOS:000307789700050
J	St Paul, M; Paolucci, S; Barjesteh, N; Wood, RD; Schat, KA; Sharif, S				St Paul, Michael; Paolucci, Sarah; Barjesteh, Neda; Wood, R. Darren; Schat, Karel A.; Sharif, Shayan			Characterization of Chicken Thrombocyte Responses to Toll-Like Receptor Ligands	PLOS ONE			English	Article							DENDRITIC CELLS; ACTIVATED PLATELETS; T-CELLS; EXPRESSION; LIPOPOLYSACCHARIDE; OLIGONUCLEOTIDES; SALMONELLA; INDUCTION; DISTINCT; SUBSETS	Thrombocytes are the avian equivalent to mammalian platelets. In addition to their hemostatic effects, mammalian platelets rely in part on pattern recognition receptors, such as the Toll-like receptors (TLR), to detect the presence of pathogens and signal the release of certain cytokines. Ligands for TLRs include lipopolysaccharide (LPS), which is bound by TLR4, as well as unmethylated CpG DNA motifs, which are bound by TLR9 in mammals and TLR21 in chickens. Similar to mammalian platelets, avian thrombocytes have been shown to express TLR4 and secrete some pro-inflammatory cytokines in response to LPS treatment. However, the full extent of the contributions made by thrombocytes to host immunity has yet to be elucidated. Importantly, the mechanisms by which TLR stimulation may modulate thrombocyte effector functions have not been well characterized. As such, the objective of the present study was to gain further insight into the immunological role of thrombocytes by analyzing their responses to treatment with ligands for TLR4 and TLR21. To this end, we quantified the relative expression of several immune system genes at 1, 3, 8 and 18 hours post-treatment using real-time RT-PCR. Furthermore, production of nitric oxide and phagocytic activity of thrombocytes was measured after their activation with TLR ligands. We found that thrombocytes constitutively express transcripts for both pro-and anti-inflammatory cytokines, in addition to those associated with anti-viral responses and antigen presentation. Moreover, we found that both LPS and CpG oligodeoxynucleotides (ODN) induced robust pro-inflammatory responses in thrombocytes, as characterized by more than 100 fold increase in interleukin (IL)-1 beta, IL-6 and IL-8 transcripts, while only LPS enhanced nitric oxide production and phagocytic capabilities. Future studies may be aimed at examining the responses of thrombocytes to other TLR ligands.	[St Paul, Michael; Paolucci, Sarah; Barjesteh, Neda; Wood, R. Darren; Sharif, Shayan] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Schat, Karel A.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	University of Guelph; Cornell University	St Paul, M (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada.	shayan@uoguelph.ca		St. Paul, Michael/0000-0002-5213-6415	Natural Sciences and Engineering Research Council of Canada; Poultry Industry Council; Ontario Ministry of Agriculture, Food and Rural Affairs	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Poultry Industry Council; Ontario Ministry of Agriculture, Food and Rural Affairs	This research was funded by the Natural Sciences and Engineering Research Council of Canada, Poultry Industry Council, and Ontario Ministry of Agriculture, Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623; CARLSON HC, 1968, AVIAN DIS, V12, P700, DOI 10.2307/1588457; CHANG CF, 1979, J RETICULOENDOTH SOC, V25, P585; Ciraci C, 2011, DEV COMP IMMUNOL, V35, P392, DOI 10.1016/j.dci.2010.11.012; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Ferdous F, 2008, POULTRY SCI, V87, P61, DOI 10.3382/ps.2007-00356; GRANT RA, 1973, AM J PHYSIOL, V225, P340, DOI 10.1152/ajplegacy.1973.225.2.340; He HQ, 2006, MOL IMMUNOL, V43, P783, DOI 10.1016/j.molimm.2005.07.002; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Iqbal M, 2005, VET IMMUNOL IMMUNOP, V104, P117, DOI 10.1016/j.vetimm.2004.11.003; Karpala AJ, 2011, J INTERF CYTOK RES, V31, P393, DOI 10.1089/jir.2010.0069; Keestra AM, 2010, J IMMUNOL, V185, P460, DOI 10.4049/jimmunol.0901921; Kogut MH, 2005, DEV COMP IMMUNOL, V29, P791, DOI 10.1016/j.dci.2005.02.002; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; KUNICKI TJ, 1985, P NATL ACAD SCI USA, V82, P7319, DOI 10.1073/pnas.82.21.7319; Liang SL, 2006, IUBMB LIFE, V58, P508, DOI 10.1080/15216540600838232; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Ling Y, 2007, EUR J HAEMATOL, V79, P310, DOI 10.1111/j.1600-0609.2007.00917.x; MacKinnon KM, 2009, VET IMMUNOL IMMUNOP, V127, P371, DOI 10.1016/j.vetimm.2008.10.001; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Moser B, 2006, TRENDS IMMUNOL, V27, P112, DOI 10.1016/j.it.2006.01.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SALOMONSENJ, 1991, P NATL ACAD SCI USA, V88, P1359, DOI 10.1073/pnas.88.4.1359; Schat KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030960; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; Seliger C, 2012, VET IMMUNOL IMMUNOP, V145, P86, DOI 10.1016/j.vetimm.2011.10.010; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Senn JJ, 2005, J PHARMACOL EXP THER, V314, P972, DOI 10.1124/jpet.105.084004; St Paul M, 2011, VET IMMUNOL IMMUNOP, V144, P228, DOI 10.1016/j.vetimm.2011.09.004; Tregaskes CA, 2005, DEV COMP IMMUNOL, V29, P361, DOI 10.1016/j.dci.2004.09.001; Villanueva AI, 2011, DEV COMP IMMUNOL, V35, P28, DOI 10.1016/j.dci.2010.08.001; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; Wigley P, 1999, AVIAN PATHOL, V28, P567, DOI 10.1080/03079459994353; Wu ZG, 2010, IMMUNOLOGY, V129, P133, DOI 10.1111/j.1365-2567.2009.03129.x	36	54	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43381	10.1371/journal.pone.0043381	http://dx.doi.org/10.1371/journal.pone.0043381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916253	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800062
J	Ve, T; Mathisen, K; Helland, R; Karlsen, OA; Fjellbirkeland, A; Rohr, AK; Andersson, KK; Pedersen, RB; Lillehaug, JR; Jensen, HB				Ve, Thomas; Mathisen, Karina; Helland, Ronny; Karlsen, Odd A.; Fjellbirkeland, Anne; Rohr, Asmund K.; Andersson, K. Kristoffer; Pedersen, Rolf-Birger; Lillehaug, Johan R.; Jensen, Harald B.			The Methylococcus capsulatus (Bath) Secreted Protein, MopE*, Binds Both Reduced and Oxidized Copper	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; PARTICULATE METHANE MONOOXYGENASE; STRUCTURAL IMPLICATIONS; METHANOBACTIN; MEMBRANE; SITES; SPECTRA; COMPLEXES; SURFACE; ION	Under copper limiting growth conditions the methanotrophic bacterium Methylococcus capsulatus (Bath) secrets essentially only one protein, MopE*, to the medium. MopE* is a copper-binding protein whose structure has been determined by X-ray crystallography. The structure of MopE* revealed a unique high affinity copper binding site consisting of two histidine imidazoles and one kynurenine, the latter an oxidation product of Trp130. In this study, we demonstrate that the copper ion coordinated by this strong binding site is in the Cu(I) state when MopE* is isolated from the growth medium of M. capsulatus. The conclusion is based on X-ray Near Edge Absorption spectroscopy (XANES), and Electron Paramagnetic Resonance (EPR) studies. EPR analyses demonstrated that MopE*, in addition to the strong copper-binding site, also binds Cu(II) at two weaker binding sites. Both Cu(II) binding sites have properties typical of non-blue type II Cu (II) centres, and the strongest of the two Cu(II) sites is characterised by a relative high hyperfine coupling of copper (A(parallel to) = 20 mT). Immobilized metal affinity chromatography binding studies suggests that residues in the N-terminal part of MopE* are involved in forming binding site(s) for Cu(II) ions. Our results support the hypothesis that MopE plays an important role in copper uptake, possibly making use of both its high (Cu(I) and low Cu(II) affinity properties.	[Ve, Thomas; Karlsen, Odd A.; Fjellbirkeland, Anne; Lillehaug, Johan R.; Jensen, Harald B.] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Mathisen, Karina] Norwegian Univ Sci & Technol, Dept Chem, N-7034 Trondheim, Norway; [Helland, Ronny] Univ Tromso, Fac Sci, Norwegian Struct Biol Ctr, Tromso, Norway; [Rohr, Asmund K.; Andersson, K. Kristoffer] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Pedersen, Rolf-Birger] Univ Bergen, Dept Earth Sci, Ctr Geobiol, Bergen, Norway; [Ve, Thomas] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Bergen; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University of Oslo; University of Bergen; University of Queensland	Ve, T (corresponding author), Univ Bergen, Dept Mol Biol, Bergen, Norway.	harald.jensen@mbi.uib.no	Kjendseth, Åsmund Røhr/O-2543-2016; Ve, Thomas/AEK-1006-2022; Mathisen, Karina/I-3772-2013; Ve, Thomas/F-9820-2011	Kjendseth, Åsmund Røhr/0000-0002-4956-4865; Ve, Thomas/0000-0002-0113-1905; Mathisen, Karina/0000-0001-8199-7559	Functional Genomics Program (FUGE) of the Research Council of Norway (RCN); NRC [101742]; RCN [177661/V30, 214239/F20]; EMBIO program at University of Oslo	Functional Genomics Program (FUGE) of the Research Council of Norway (RCN); NRC(National Research Centre (NRC)); RCN; EMBIO program at University of Oslo	The study was supported by the Functional Genomics Program (FUGE) (www.fuge.no) of the Research Council of Norway (RCN), by NRC Grant 101742 to OAK, by RCN Grant 177661/V30 and 214239/F20 to KKA, and by the EMBIO program at University of Oslo to AKR, by RCN to RH for provision of beam time at the Swiss-Norwegian Beamlines, European Synchrotron Radiation Facility, Grenoble, France, and for travel support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; Balasubramanian R, 2008, CURR OPIN CHEM BIOL, V12, P245, DOI 10.1016/j.cbpa.2008.01.043; Basu P, 2003, BIOCHEM J, V369, P417, DOI 10.1042/BJ20020823; Boas JF, 2008, EUR BIOPHYS J BIOPHY, V37, P281, DOI 10.1007/s00249-008-0261-8; BROWN GM, 1969, ACTA CRYSTALL B-STRU, VB 25, P676, DOI 10.1107/S0567740869002810; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Cereghetti GM, 2004, J BIOL CHEM, V279, P36497, DOI 10.1074/jbc.M404341200; Choi DW, 2008, J INORG BIOCHEM, V102, P1571, DOI 10.1016/j.jinorgbio.2008.02.003; Choi DW, 2010, J INORG BIOCHEM, V104, P1240, DOI 10.1016/j.jinorgbio.2010.08.002; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Choi DW, 2005, MICROBIOL-SGM, V151, P3417, DOI 10.1099/mic.0.28169-0; Choi DW, 2006, BIOCHEMISTRY-US, V45, P1442, DOI 10.1021/bi051815t; COOKSEY DA, 1994, FEMS MICROBIOL REV, V14, P381, DOI 10.1016/0168-6445(94)90056-6; DiSpirito AA, 1998, J BACTERIOL, V180, P3606, DOI 10.1128/JB.180.14.3606-3613.1998; Douzou P, 1978, Adv Protein Chem, V32, P77, DOI 10.1016/S0065-3233(08)60575-6; Dudzik CG, 2011, BIOCHEMISTRY-US, V50, P1771, DOI 10.1021/bi101912q; Fee J A, 1978, Methods Enzymol, V49, P512; FISCHER BE, 1979, EUR J BIOCHEM, V94, P523, DOI 10.1111/j.1432-1033.1979.tb12921.x; FITCH MW, 1993, APPL ENVIRON MICROB, V59, P2771, DOI 10.1128/AEM.59.9.2771-2776.1993; Fjellbirkeland A, 1997, ARCH MICROBIOL, V168, P128, DOI 10.1007/s002030050478; Fjellbirkeland A, 2001, ARCH MICROBIOL, V176, P197, DOI 10.1007/s002030100307; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Hatcher LQ, 2008, J PHYS CHEM B, V112, P8160, DOI 10.1021/jp710806s; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Helland R, 2008, J BIOL CHEM, V283, P13897, DOI 10.1074/jbc.M800340200; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Hureau C, 2008, J BIOL INORG CHEM, V13, P1055, DOI 10.1007/s00775-008-0389-0; Karlsen OA, 2008, MOL MICROBIOL, V70, P15, DOI 10.1111/j.1365-2958.2008.06380.x; Karlsen OA, 2005, FEBS J, V272, P2428, DOI 10.1111/j.1742-4658.2005.04663.x; Karlsen OA, 2005, FEBS J, V272, P6324, DOI 10.1111/j.1742-4658.2005.05020.x; Karlsen OA, 2003, APPL ENVIRON MICROB, V69, P2386, DOI 10.1128/AEM.69.4.2386-2388.2003; Karlsen OA, 2011, FEMS MICROBIOL LETT, V323, P97, DOI 10.1111/j.1574-6968.2011.02365.x; Katterle B, 2002, BIOCHEM J, V363, P677, DOI 10.1042/0264-6021:3630677; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Kim HJ, 2005, BIOCHEMISTRY-US, V44, P5140, DOI 10.1021/bi047367r; Koch KA, 1997, CHEM BIOL, V4, P549, DOI 10.1016/S1074-5521(97)90241-6; LAMBLE G, 1994, J CHEM SOC FARADAY T, V90, P2211, DOI 10.1039/ft9949002211; LEIGH JS, 1971, J PHYS CHEM-US, V75, P1202, DOI 10.1021/j100679a003; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Mash HE, 2003, ANAL CHEM, V75, P671, DOI 10.1021/ac0261101; More C, 1999, BIOSPECTROSCOPY, V5, pS3, DOI 10.1002/(SICI)1520-6343(1999)5:5+<S3::AID-BSPY2>3.0.CO;2-P; Murrell JC, 2000, TRENDS MICROBIOL, V8, P221, DOI 10.1016/S0966-842X(00)01739-X; Narindrasorasak S, 2007, BIOCHEMISTRY-US, V46, P3116, DOI 10.1021/bi0620656; Nielsen AK, 1996, MICROBIOL-UK, V142, P1289, DOI 10.1099/13500872-142-5-1289; Nielsen AK, 1997, MOL MICROBIOL, V25, P399, DOI 10.1046/j.1365-2958.1997.4801846.x; PALMER G, 2000, PHYS METHODS BIOINOR, P121; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; RESTORI R, 1986, ACTA CRYSTALLOGR B, V42, P201, DOI 10.1107/S0108768186098336; ROSS RT, 1965, J CHEM PHYS, V42, P3919, DOI 10.1063/1.1695859; Sawada T, 1996, CHEM PHARM BULL, V44, P1009; SCHOLL HJ, 1992, J PHYS CHEM-US, V96, P9684, DOI 10.1021/j100203a023; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; SKOTLAND T, 1980, EUR J BIOCHEM, V103, P5, DOI 10.1111/j.1432-1033.1980.tb04282.x; SOLOMON EI, 1992, CHEM REV, V92, P521, DOI 10.1021/cr00012a003; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; Tellez CM, 1998, APPL ENVIRON MICROB, V64, P1115; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Vunnum S, 1997, BIOTECHNOL BIOENG, V54, P373, DOI 10.1002/(SICI)1097-0290(19970520)54:4<373::AID-BIT11>3.0.CO;2-H; Wernimont AK, 2004, J BIOL CHEM, V279, P12269, DOI 10.1074/jbc.M311213200; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Zahn JA, 1996, J BACTERIOL, V178, P1018, DOI 10.1128/jb.178.4.1018-1029.1996; Zhang Q, 2003, GENE, V318, P45, DOI 10.1016/S0378-1119(03)00753-4	67	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43146	10.1371/journal.pone.0043146	http://dx.doi.org/10.1371/journal.pone.0043146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916218	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800049
J	Yan, NH; Liao, X; Cai, SP; Lan, CJ; Wang, Y; Zhou, XM; Yin, Y; Yu, WH; Liu, XY				Yan, Naihong; Liao, Xuan; Cai, Su-Ping; Lan, Changjun; Wang, Yun; Zhou, Xiaomin; Yin, Yan; Yu, Wenhan; Liu, Xuyang			A Novel Nonsense Mutation of the GPR143 Gene Identified in a Chinese Pedigree with Ocular Albinism	PLOS ONE			English	Article							LINKED CONGENITAL NYSTAGMUS; OA1 GENE; FAMILY; TYPE-1; DELETION; SYSTEM; TIME	Background: The purpose of this study was to elucidate the molecular basis of ocular albinism type I in a Chinese pedigree. Methodology/Principal Findings: Complete ophthalmologic examinations were performed on 4 patients, 7 carriers and 17 unaffected individuals in this five-generation family. All coding exons of four-point-one (4.1), ezrin, radixin, moesin (FERM) domain-containing 7 (FRMD7) and G protein-coupled receptor 143 (GPR143) genes were amplified by polymerase chain reaction (PCR), sequenced and compared with a reference database. Ocular albinism and nystagmus were found in all patients of this family. Macular hypoplasia was present in the patients including the proband. A novel nonsense hemizygous mutation c.807T>A in the GPR143 gene was identified in four patients and the heterozygous mutation was found in seven asymptomatic individuals. This mutation is a substitution of tyrosine for adenine which leads to a premature stop codon at position 269 (p.Y269X) of GPR143. Conclusions/Significance: This is the first report that p.Y269X mutation of GPR143 gene is responsible for the pathogenesis of familial ocular albinism. These results expand the mutation spectrum of GPR143, and demonstrate the clinical characteristics of ocular albinism type I in Chinese population.	[Yan, Naihong; Liao, Xuan; Wang, Yun; Zhou, Xiaomin; Yin, Yan; Yu, Wenhan] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Ophthalm Labs,Dept Ophthalmol,Translat Neurosci C, Chengdu 610064, Peoples R China; [Liao, Xuan; Lan, Changjun] N Sichuan Med Coll, Dept Ophthalmol, Nanchong, Peoples R China; [Cai, Su-Ping; Liu, Xuyang] Jinan Univ, Shenzhen Eye Hosp, Shenzhen, Peoples R China	Sichuan University; North Sichuan Medical University; Jinan University	Yan, NH (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Ophthalm Labs,Dept Ophthalmol,Translat Neurosci C, Chengdu 610064, Peoples R China.	xliu1213@yahoo.com.cn		XUAN, LIAO/0000-0003-0097-684X; Yu, Wenhan/0000-0002-0125-4358	National Natural Science Foundation of China (NSFC) [30901635, 81000370]; Research to Prevent Blindness	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by grants from the National Natural Science Foundation of China (NSFC grant no. 30901635 and 81000370), from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSI MT, 1995, NAT GENET, V10, P13, DOI 10.1038/ng0595-13; Camand Olivier, 2003, Ophthalmic Genet, V24, P167, DOI 10.1076/opge.24.3.167.15605; CHARLES SJ, 1993, BRIT J OPHTHALMOL, V77, P222, DOI 10.1136/bjo.77.4.222; CREEL D, 1978, SCIENCE, V201, P931, DOI 10.1126/science.684419; d'Addio M, 2000, HUM MOL GENET, V9, P3011, DOI 10.1093/hmg/9.20.3011; Fang SH, 2008, MOL VIS, V14, P1974; Faugere V, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-1; Ilia M, 1999, J COMP NEUROL, V405, P394, DOI 10.1002/(SICI)1096-9861(19990315)405:3<394::AID-CNE9>3.0.CO;2-Y; Ilia M, 2000, J COMP NEUROL, V420, P437; Kerrison JB, 1999, AM J HUM GENET, V64, P600, DOI 10.1086/302244; Liu JY, 2007, J HUM GENET, V52, P565, DOI 10.1007/s10038-007-0152-3; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Mayeur H, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-41; ODONNELL FE, 1976, ARCH OPHTHALMOL-CHIC, V94, P1883, DOI 10.1001/archopht.1976.03910040593001; ODONNELL FE, 1978, ARCH OPHTHALMOL-CHIC, V96, P1189, DOI 10.1001/archopht.1978.03910060023005; Oetting WS, 2002, HUM MUTAT, V19, P85, DOI 10.1002/humu.10034; Peng YY, 2009, MOL VIS, V15, P810; Preising M, 2001, BRIT J OPHTHALMOL, V85, P1098, DOI 10.1136/bjo.85.9.1098; Preising MN, 2011, MOL VIS, V17, P939; Rosenberg T, 1998, EUR J HUM GENET, V6, P570, DOI 10.1038/sj.ejhg.5200226; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P2319, DOI 10.1093/hmg/4.12.2319; Schnur RE, 1998, AM J HUM GENET, V62, P800, DOI 10.1086/301776; Schorderet Daniel F, 2007, Hum Mutat, V28, P525, DOI 10.1002/humu.9492; Zhou PT, 2008, MOL VIS, V14, P1015	25	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43177	10.1371/journal.pone.0043177	http://dx.doi.org/10.1371/journal.pone.0043177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916221	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800051
J	El Hage, C; Rappeneau, V; Etievant, A; Morel, AL; Scarna, H; Zimmer, L; Berod, A				El Hage, Cynthia; Rappeneau, Virginie; Etievant, Adeline; Morel, Anne-Laure; Scarna, Helene; Zimmer, Luc; Berod, Anne			Enhanced Anxiety Observed in Cocaine Withdrawn Rats Is Associated with Altered Reactivity of the Dorsomedial Prefrontal Cortex	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; CORTICOTROPIN-RELEASING-FACTOR; VENTRAL TEGMENTAL AREA; PRELIMBIC CORTEX; ACTIVATION PATTERNS; CENTRAL INJECTIONS; RESTRAINT STRESS; EXTENDED ACCESS; FOS EXPRESSION; DRUG-ADDICTION	Discontinuation of drug intake in cocaine abusers commonly produces a variety of adverse withdrawal symptoms among which anxiety and depression-related behavior are prevailing during the initial period of abstinence. The aim of this study was to provide further insight into the neurobiological dysregulations that might contribute to these pathological states. Rats were treated with cocaine or saline for 14 days (20 mg/kg; i.p) and anxiety-related behavior was assessed in different paradigms (elevated plus-maze (EPM), confinement to an open arm of the EPM and shock-probe burying tests) for up to 4 weeks after withdrawal. Depression-like behavior was assessed by the forced swim test and sucrose preference test. Altogether our results demonstrated that cocaine withdrawal induced persistent heightened levels of anxiety that last for at least 28 days but did not affect depression-like behavior. We then used Fos immunohistochemistry to map neuronal activation patterns in withdrawn rats confined to one open arm of an EPM, and a double labeling procedure using Fos immunohistochemistry and in situ hybridization of glutamic acid decarboxylase or vesicular glutamate transporter mRNAs to identify the phenotype of the activated neurons. Our data showed that the exacerbated anxiety observed in cocaine withdrawn rats exposed to an elevated open arm was accompanied by an altered reactivity of the dorsal part of the medial prefrontal cortex (anterior cingulate and dorsal prelimbic cortices), the paraventricular thalamic nucleus and the lateral and anterior areas of the hypothalamus. In the medial prefrontal cortex, we evidenced a negative correlation between Fos expression in its dorsal part and open arm-induced freezing in NaCl-treated rats but not in cocaine withdrawn rats. We also found that more than 65% of activated neurons were glutamatergic projection neurons. The present study provides new insights into the neuroanatomical regions and neuronal cell types that may underlie pathological anxiety during cocaine withdrawal.	[El Hage, Cynthia; Rappeneau, Virginie; Morel, Anne-Laure; Berod, Anne] INSERM, U1028, Lyon Neurosci Res Ctr, Physiopathol Neuronal Network Responsible Sleep W, F-69008 Lyon, France; [El Hage, Cynthia; Rappeneau, Virginie; Morel, Anne-Laure; Berod, Anne] CNRS, UMR5292, Lyon Neurosci Res Ctr, Physiopathol Neuronal Network Responsible Sleep W, Lyon, France; [Zimmer, Luc] INSERM, U1028, Lyon Neurosci Res Ctr, BioRan Pharmaceut & Neurochem Biomarkers Team, F-69008 Lyon, France; [El Hage, Cynthia; Rappeneau, Virginie; Etievant, Adeline; Morel, Anne-Laure; Scarna, Helene; Zimmer, Luc; Berod, Anne] Univ Lyon 1, F-69365 Lyon, France; [Zimmer, Luc] CNRS, UMR5292, Lyon Neurosci Res Ctr, BioRan Pharmaceut & Neurochem Biomarkers Team, Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	El Hage, C (corresponding author), INSERM, U1028, Lyon Neurosci Res Ctr, Physiopathol Neuronal Network Responsible Sleep W, F-69008 Lyon, France.	anne.berod@univ-lyon1.fr	ZIMMER, Luc/G-6538-2011; ZIMMER, Luc/AAG-1986-2019	ZIMMER, Luc/0000-0002-2805-7098; ZIMMER, Luc/0000-0002-2805-7098; Etievant, Adeline/0000-0002-2577-6724; MOREL, Anne-Laure/0000-0001-7200-1123	Universite Claude Bernard Lyon I, Centre National pour la Recherche Scientifique et la Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie; la Societe Francaise de Pharmacologie et de Therapeutique	Universite Claude Bernard Lyon I, Centre National pour la Recherche Scientifique et la Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie; la Societe Francaise de Pharmacologie et de Therapeutique	This work was supported by several grants from the Universite Claude Bernard Lyon I, Centre National pour la Recherche Scientifique et la Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie. CE was supported by la Societe Francaise de Pharmacologie et de Therapeutique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechet-Souza L, 2009, NEUROSCIENCE, V164, P387, DOI 10.1016/j.neuroscience.2009.08.038; Aujla H, 2008, NEUROPSYCHOPHARMACOL, V33, P1818, DOI 10.1038/sj.npp.1301588; Basso AM, 1999, PSYCHOPHARMACOLOGY, V145, P21, DOI 10.1007/s002130051028; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bowers MS, 2003, EUR J NEUROSCI, V17, P1273, DOI 10.1046/j.1460-9568.2003.02537.x; Canteras NS, 2010, CURR TOP BEHAV NEURO, V2, P77, DOI 10.1007/7854_2009_7; Chaplin TM, 2010, HUM PSYCHOPHARM CLIN, V25, P368, DOI 10.1002/hup.1127; Chartoff E, 2012, NEUROPHARMACOLOGY, V62, P167, DOI 10.1016/j.neuropharm.2011.06.014; Colussi-Mas J, 2007, EUR J NEUROSCI, V26, P1011, DOI 10.1111/j.1460-9568.2007.05738.x; Contoreggi C, 2003, NEUROENDOCRINOLOGY, V78, P154, DOI 10.1159/000072797; D'Souza MS, 2010, CURR TOP BEHAV NEURO, V3, P119, DOI 10.1007/7854_2009_20; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; DeVries AC, 1998, BRAIN RES, V786, P39, DOI 10.1016/S0006-8993(97)01328-0; Duncan GE, 1996, BRAIN RES, V713, P79, DOI 10.1016/0006-8993(95)01486-1; Erb S, 2006, PHARMACOL BIOCHEM BE, V85, P206, DOI 10.1016/j.pbb.2006.08.002; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Etkin A, 2010, CURR TOP BEHAV NEURO, V2, P251, DOI 10.1007/7854_2009_5; Filip M, 2006, BRAIN RES, V1071, P218, DOI 10.1016/j.brainres.2005.11.099; Fox HC, 2005, PSYCHONEUROENDOCRINO, V30, P880, DOI 10.1016/j.psyneuen.2005.05.002; Fox HC, 2008, NEUROPSYCHOPHARMACOL, V33, P796, DOI 10.1038/sj.npp.1301470; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Frankowska M, 2010, EUR J PHARMACOL, V627, P142, DOI 10.1016/j.ejphar.2009.10.049; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; George O, 2008, NEUROPSYCHOPHARMACOL, V33, P2474, DOI 10.1038/sj.npp.1301626; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goussakov I, 2006, EUR J NEUROSCI, V23, P239, DOI 10.1111/j.1460-9568.2005.04538.x; Hall BJ, 2010, NEUROSCI LETT, V474, P84, DOI 10.1016/j.neulet.2010.03.011; HARRIS GC, 1993, PSYCHOPHARMACOLOGY, V113, P131, DOI 10.1007/BF02244345; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Jinks AL, 1997, BRAIN RES, V772, P181, DOI 10.1016/S0006-8993(97)00810-X; JU G, 1989, J COMP NEUROL, V280, P587, DOI 10.1002/cne.902800409; JULIEN JF, 1987, NEUROSCI LETT, V73, P173, DOI 10.1016/0304-3940(87)90013-9; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kupferschmidt DA, 2012, NEUROSCIENCE, V204, P125, DOI 10.1016/j.neuroscience.2011.07.022; Lejuez CW, 2008, BEHAV RES THER, V46, P811, DOI 10.1016/j.brat.2008.03.010; Leriche M, 2008, NEUROSCIENCE, V153, P259, DOI 10.1016/j.neuroscience.2008.01.069; Li S, 2012, BRAIN STRUCT FUNCT, V217, P257, DOI 10.1007/s00429-011-0360-7; Li YH, 2010, PSYCHOPHARMACOLOGY, V212, P251, DOI 10.1007/s00213-010-1948-y; Makris N, 2004, NEURON, V44, P729, DOI 10.1016/j.neuron.2004.10.027; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; Muigg P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005346; O'Mahony CM, 2010, BEHAV BRAIN RES, V213, P148, DOI 10.1016/j.bbr.2010.04.038; Paine TA, 2002, BEHAV PHARMACOL, V13, P511, DOI 10.1097/00008877-200211000-00001; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perrine SA, 2008, NEUROPHARMACOLOGY, V54, P355, DOI 10.1016/j.neuropharm.2007.10.007; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; PORSOLT RD, 1978, EUR J PHARMACOL, V51, P291, DOI 10.1016/0014-2999(78)90414-4; Radley JJ, 2006, J NEUROSCI, V26, P12967, DOI 10.1523/JNEUROSCI.4297-06.2006; Ren H, 2011, MOL PSYCHIAT; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; RISOLD PY, 1994, J COMP NEUROL, V348, P1, DOI 10.1002/cne.903480102; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rudoy CA, 2007, PROG NEURO-PSYCHOPH, V31, P1119, DOI 10.1016/j.pnpbp.2007.04.005; Salome N, 2004, BIOL PSYCHIAT, V55, P715, DOI 10.1016/j.biopsych.2003.10.021; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; SARNYAI Z, 1995, BRAIN RES, V675, P89, DOI 10.1016/0006-8993(95)00043-P; Sato SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021783; Shah AA, 2004, BRAIN RES, V996, P31, DOI 10.1016/j.brainres.2003.10.015; SILVEIRA MCL, 1993, BEHAV BRAIN RES, V56, P115, DOI 10.1016/0166-4328(93)90028-O; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Sinha R, 2006, ARCH GEN PSYCHIAT, V63, P324, DOI 10.1001/archpsyc.63.3.324; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Stern CAJ, 2010, NEUROSCIENCE, V170, P214, DOI 10.1016/j.neuroscience.2010.06.080; Tanabe J, 2009, BIOL PSYCHIAT, V65, P160, DOI 10.1016/j.biopsych.2008.07.030; Tavares RF, 2009, J NEUROSCI RES, V87, P2601, DOI 10.1002/jnr.22070; Tomasi D, 2007, PSYCHIAT RES-NEUROIM, V155, P189, DOI 10.1016/j.pscychresns.2007.03.002; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099	78	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43535	10.1371/journal.pone.0043535	http://dx.doi.org/10.1371/journal.pone.0043535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916276	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300054
J	van Dongen, EV; Thielen, JW; Takashima, A; Barth, M; Fernandez, G				van Dongen, Eelco V.; Thielen, Jan-Willem; Takashima, Atsuko; Barth, Markus; Fernandez, Guillen			Sleep Supports Selective Retention of Associative Memories Based on Relevance for Future Utilization	PLOS ONE			English	Article							ENHANCES MEMORY; CONSOLIDATION; CONSEQUENCES; HIPPOCAMPAL	An outstanding question is whether memory consolidation occurs passively or involves active processes that selectively stabilize memories based on future utility. Here, we differentially modulated the expected future relevance of two sets of picture-location associations after learning. Participants first studied two sets of picture-location associations. After a baseline memory test, they were instructed that only one set of associations would be retested after a 14-hour delay. For half of the participants, this test-retest delay contained a night of sleep; for the other half the delay included a normal working day. At retest, participants were re-instructed and against their expectations tested on both sets of associations. Our results show that post-learning instruction about subsequent relevance selectively improves memory retention for specific associative memories. This effect was sleep-dependent; it was present only in the group of subjects for which the test-retest delay contained sleep. Moreover, time spent asleep for participants in this sleep group correlated with retention of relevant but not irrelevant associations; participants who slept longer forgot fewer associations from the relevant category. In contrast, participants that did not sleep forgot more relevant than irrelevant associations across the test-retest delay. In summary, our results indicate that it is possible to modulate the retention of selected memories after learning with simple verbal instructions on their future relevance. The finding that this effect depends on sleep demonstrates this state's active role in memory consolidation and may have utility for educational settings.	[van Dongen, Eelco V.; Thielen, Jan-Willem; Barth, Markus; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [van Dongen, Eelco V.; Fernandez, Guillen] Radboud Univ Nijmegen Med Ctr, Dept Cognit Neurosci, Nijmegen, Netherlands; [Takashima, Atsuko] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Dongen, EV (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	e.vandongen@donders.ru.nl	Barth, Markus/B-8446-2008; van Dongen, Eelco V/G-4232-2010; Takashima, Atsuko/E-7880-2012; Fernandez, Guillen/B-3771-2009	Barth, Markus/0000-0002-0520-1843; van Dongen, Eelco V/0000-0002-2031-8759; Takashima, Atsuko/0000-0003-1114-6526; Fernandez, Guillen/0000-0002-5522-0604	Dutch Organization for Scientific Research (NWO) [400-06-110]; European Research Council [2010-AdG 268800 - Neuroschema]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	Eelco van Dongen was supported by a grant from the Dutch Organization for Scientific Research (NWO, grant no. 400-06-110, http://www.nwo.nl). Guillen Fernandez was supported by a grant from the European Research Council (2010-AdG 268800 - Neuroschema, http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cairney SA, 2011, EXP BRAIN RES, V214, P83, DOI 10.1007/s00221-011-2808-7; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Nieuwenhuis ILC, 2012, CEREB CORTEX, V22, P2622, DOI 10.1093/cercor/bhr338; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; Robertson EM, 2012, CURR BIOL, V22, pR66, DOI 10.1016/j.cub.2011.11.051; Saletin Jared M, 2012, Front Neurol, V3, P59, DOI 10.3389/fneur.2012.00059; Saletin JM, 2011, CEREB CORTEX, V21, P2534, DOI 10.1093/cercor/bhr034; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Takashima A, 2009, J NEUROSCI, V29, P10087, DOI 10.1523/JNEUROSCI.0799-09.2009; van der Helm E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027421; van Dongen EV, 2011, NEUROIMAGE, V57, P262, DOI 10.1016/j.neuroimage.2011.04.019; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Winocur G, 2011, J INT NEUROPSYCH SOC, V17, P766, DOI 10.1017/S1355617711000683	28	73	73	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43426	10.1371/journal.pone.0043426	http://dx.doi.org/10.1371/journal.pone.0043426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916259	Green Published, gold			2022-12-27	WOS:000307824300048
J	Vidal-Infer, A; Roger-Sanchez, C; Daza-Losada, M; Aguilar, MA; Minarro, J; Rodriguez-Arias, M				Vidal-Infer, Antonio; Roger-Sanchez, Concepcion; Daza-Losada, Manuel; Aguilar, Maria A.; Minarro, Jose; Rodriguez-Arias, Marta			Role of the Dopaminergic System in the Acquisition, Expression and Reinstatement of MDMA-Induced Conditioned Place Preference in Adolescent Mice	PLOS ONE			English	Article							FREELY-MOVING RATS; NUCLEUS-ACCUMBENS SHELL; LOCOMOTOR-ACTIVITY; RECEPTOR BLOCKADE; COCAINE-SEEKING; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; BEHAVIORAL SENSITIZATION; ECSTASY USERS; D1 RECEPTORS; DRUG	Background: The rewarding effects of 3,4-methylenedioxy-metamphetamine (MDMA) have been demonstrated in conditioned place preference (CPP) procedures, but the involvement of the dopaminergic system in MDMA-induced CPP and reinstatement is poorly understood. Methodology/Principal Findings: In this study, the effects of the DA D1 antagonist SCH 23390 (0.125 and 0.250 mg/kg), the DA D2 antagonist Haloperidol (0.1 and 0.2 mg/kg), the D2 antagonist Raclopride (0.3 and 0.6 mg/kg) and the dopamine release inhibitor CGS 10746B (3 and 10 mg/kg) on the acquisition, expression and reinstatement of a CPP induced by 10 mg/kg of MDMA were evaluated in adolescent mice. As expected, MDMA significantly increased the time spent in the drug-paired compartment during the post-conditioning (Post-C) test, and a priming dose of 5 mg/kg reinstated the extinguished preference. The higher doses of Haloperidol, Raclopride and CGS 10746B and both doses of SCH 23390 blocked acquisition of the MDMA-induced CPP. However, only Haloperidol blocked expression of the CPP. Reinstatement of the extinguished preference was not affected by any of the drugs studied. Analysis of brain monoamines revealed that the blockade of CPP acquisition was accompanied by an increase in DA concentration in the striatum, with a concomitant decrease in DOPAC and HVA levels. Administration of haloperidol during the Post-C test produced increases in striatal serotonin, DOPAC and HVA concentrations. In mice treated with the higher doses of haloperidol and CGS an increase in SERT concentration in the striatum was detected during acquisition of the CPP, but no changes in DAT were observed. Conclusions/Significance: These results demonstrate that, in adolescent mice, the dopaminergic system is involved in the acquisition and expression of MDMA-induced CPP, but not in its reinstatement.	[Vidal-Infer, Antonio; Roger-Sanchez, Concepcion; Daza-Losada, Manuel; Aguilar, Maria A.; Minarro, Jose; Rodriguez-Arias, Marta] Univ Valencia, Unit Res Psychobiol Drug Dependence, Valencia, Spain	University of Valencia	Vidal-Infer, A (corresponding author), Univ Valencia, Unit Res Psychobiol Drug Dependence, Valencia, Spain.	marta.rodriguez@uv.es	Aguilar, Maria A/D-3416-2011; Roger-Sánchez, Concepción/I-7657-2012; Vidal-Infer, Antonio/D-2314-2015; Rodriguez-Arias, Marta/B-5163-2011; Minarro, Jose/B-4414-2011; Vidal-Infer, Antonio/AAR-6567-2021	Aguilar, Maria A/0000-0002-1935-6619; Roger-Sánchez, Concepción/0000-0002-1442-9751; Vidal-Infer, Antonio/0000-0002-7860-8652; Minarro, Jose/0000-0002-5731-7821; 	Ministerio de Ciencia e Innovacion and Direccion General de Investigacion [PSI2008-00101/PSIC]; Instituto de Salud "Carlos III'' (FIS), RETICS, Red de Trastornos Adictivos [RD06/001/0016]; Generalitat Valenciana, Conselleria de Educacion [PROMETEO/2009/072]; Programa Nacional de formacion de Profesorado Universitario [AP2006-04048]; MICINN, Spain	Ministerio de Ciencia e Innovacion and Direccion General de Investigacion; Instituto de Salud "Carlos III'' (FIS), RETICS, Red de Trastornos Adictivos(Instituto de Salud Carlos III); Generalitat Valenciana, Conselleria de Educacion(Center for Forestry Research & Experimentation (CIEF)); Programa Nacional de formacion de Profesorado Universitario(Spanish Government); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding provided by Ministerio de Ciencia e Innovacion and Direccion General de Investigacion (PSI2008-00101/PSIC), Instituto de Salud "Carlos III'' (FIS), RETICS, Red de Trastornos Adictivos (RD06/001/0016); Generalitat Valenciana, Conselleria de Educacion (PROMETEO/2009/072); Programa Nacional de formacion de Profesorado Universitario (AP2006-04048), MICINN, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg M, 2007, NEUROTOXICOL TERATOL, V29, P37, DOI 10.1016/j.ntt.2006.09.002; ACQUAS E, 1989, PSYCHOPHARMACOLOGY, V99, P151, DOI 10.1007/BF00442800; ACQUAS E, 1994, BEHAV PHARMACOL, V5, P555, DOI 10.1097/00008877-199410000-00001; Adams JU, 2001, BEHAV PHARMACOL, V12, P603, DOI 10.1097/00008877-200112000-00004; Aguilar MA, 2009, BRAIN RES REV, V59, P253, DOI 10.1016/j.brainresrev.2008.08.002; ALTAR CA, 1986, LIFE SCI, V39, P699, DOI 10.1016/0024-3205(86)90017-2; Ball KT, 2007, PHARMACOL BIOCHEM BE, V87, P420, DOI 10.1016/j.pbb.2007.05.018; Ball KT, 2003, BRAIN RES, V994, P203, DOI 10.1016/j.brainres.2003.09.037; BENINGER RJ, 1989, ARCH GERONTOL GERIAT, P71; Benturquia N, 2008, BRAIN RES, V1211, P1, DOI 10.1016/j.brainres.2008.03.016; Bilsky EJ, 1998, PHARMACOL BIOCHEM BE, V59, P215, DOI 10.1016/S0091-3057(97)00424-3; BLAHA CD, 1984, EUR J PHARMACOL, V98, P113, DOI 10.1016/0014-2999(84)90115-8; Brennan KA, 2009, BEHAV PHARMACOL, V20, P688, DOI 10.1097/FBP.0b013e328333a28d; BUNNEY BS, 1978, LIFE SCI, V23, P1715, DOI 10.1016/0024-3205(78)90471-X; Cadoni C, 2005, BRAIN RES, V1055, P143, DOI 10.1016/j.brainres.2005.07.002; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; CALLAWAY CW, 1992, J PHARMACOL EXP THER, V263, P318; Chen LP, 2010, J NEUROCHEM, V114, P530, DOI 10.1111/j.1471-4159.2010.06775.x; Colado MI, 2004, PSYCHOPHARMACOLOGY, V173, P249, DOI 10.1007/s00213-004-1788-8; Colussi-Mas J, 2008, EUR J NEUROSCI, V28, P1895, DOI 10.1111/j.1460-9568.2008.06467.x; Colussi-Mas J, 2010, INT J NEUROPSYCHOPH, V13, P1315, DOI 10.1017/S1461145710000283; Daniela E, 2004, PHARMACOL BIOCHEM BE, V77, P745, DOI 10.1016/j.pbb.2004.01.008; Daza-Losada M, 2008, EUR J PHARMACOL, V590, P204, DOI 10.1016/j.ejphar.2008.06.025; Daza-Losada M, 2007, NEUROPSYCHOPHARMACOL, V32, P1750, DOI 10.1038/sj.npp.1301309; Daza-Losada M, 2009, ADDICT BIOL, V14, P447, DOI 10.1111/j.1369-1600.2009.00173.x; De Vries TJ, 2002, NEUROPSYCHOPHARMACOL, V26, P18, DOI 10.1016/S0893-133X(01)00293-7; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Do Couto BR, 2011, PHYSIOL BEHAV, V103, P585, DOI 10.1016/j.physbeh.2011.02.012; Do Couto BR, 2005, BRAIN RES BULL, V64, P493, DOI 10.1016/j.brainresbull.2004.10.005; DRAGUNOW M, 1991, EUR J PHARM-MOLEC PH, V206, P255, DOI 10.1016/S0922-4106(05)80027-6; Escobedo I, 2005, BRIT J PHARMACOL, V144, P231, DOI 10.1038/sj.bjp.0706071; Ettenberg A, 1996, PSYCHOPHARMACOLOGY, V124, P205, DOI 10.1007/BF02246658; Fenu S, 2001, J NEUROSCI, V21, P6897, DOI 10.1523/JNEUROSCI.21-17-06897.2001; George J, 2010, DRUG ALCOHOL REV, V29, P243, DOI 10.1111/j.1465-3362.2009.00159.x; GOUGH B, 1991, PHARMACOL BIOCHEM BE, V39, P619, DOI 10.1016/0091-3057(91)90137-Q; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Gudelsky GA, 1996, J NEUROCHEM, V66, P243; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; HIRAMATSU M, 1990, NEUROPHARMACOLOGY, V29, P269, DOI 10.1016/0028-3908(90)90012-G; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; IMPERATO A, 1984, J NEUROSCI, V4, P966; Kalivas PW, 1998, NEUROPSYCHOPHARMACOL, V18, P469, DOI 10.1016/S0893-133X(97)00195-4; Kankaanpaa A, 1998, PHARMACOL BIOCHEM BE, V59, P1003, DOI 10.1016/S0091-3057(97)00527-3; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Kehne JH, 1996, NEUROPSYCHOPHARMACOL, V15, P116, DOI 10.1016/0893-133X(95)00160-F; lan Nacional sobre Drogas, 1994, ESTUDES ENCUESTA EST; LAWLEY SI, 1990, PHARMACOL BIOCHEM BE, V36, P531, DOI 10.1016/0091-3057(90)90252-D; Leung KS, 2008, CURR OPIN PSYCHIATR, V21, P234, DOI 10.1097/YCO.0b013e3282f9b1f1; Liao RM, 1998, CHINESE J PHYSIOL, V41, P85; LIDSKY TI, 1993, J PHARMACOL EXP THER, V265, P1193; Liechti ME, 2000, EUR NEUROPSYCHOPHARM, V10, P289, DOI 10.1016/S0924-977X(00)00086-9; Manzanedo C, 2001, BEHAV BRAIN RES, V121, P189, DOI 10.1016/S0166-4328(01)00164-4; Manzanedo C, 2001, BEHAV BRAIN RES, V126, P23, DOI 10.1016/S0166-4328(01)00237-6; Nair SG, 2004, BRAIN RES, V1013, P168, DOI 10.1016/j.brainres.2004.04.007; O'Shea E, 2005, NEUROPSYCHOPHARMACOL, V30, P1312, DOI 10.1038/sj.npp.1300673; Ramos M, 2004, PSYCHOPHARMACOLOGY, V177, P100, DOI 10.1007/s00213-004-1937-0; Ratzenboeck E, 2001, PHARMACOLOGY, V62, P138, DOI 10.1159/000056086; Ribeiro Do Couto B, 2011, ADDICT BIOL IN PRESS; Robledo P, 2004, EUR J NEUROSCI, V20, P853, DOI 10.1111/j.1460-9568.2004.03532.x; Robledo P, 2004, N-S ARCH PHARMACOL, V369, P338, DOI 10.1007/s00210-003-0862-9; Schenk S, 2011, BRIT J PHARMACOL, V162, P1770, DOI 10.1111/j.1476-5381.2010.01193.x; Schenk S, 2003, PSYCHOPHARMACOLOGY, V169, P21, DOI 10.1007/s00213-003-1407-0; Schenk S, 2008, DRUG ALCOHOL DEPEN, V96, P249, DOI 10.1016/j.drugalcdep.2008.03.014; SCHMIDT CJ, 1987, BIOCHEM PHARMACOL, V36, P747, DOI 10.1016/0006-2952(87)90729-5; Schneider M, 2008, ADDICT BIOL, V13, P253, DOI 10.1111/j.1369-1600.2008.00110.x; Sershen H, 2010, BRAIN RES BULL, V81, P120, DOI 10.1016/j.brainresbull.2009.07.015; Shaham Y, 1996, PSYCHOPHARMACOLOGY, V125, P385, DOI 10.1007/BF02246022; Shirayama Y, 2000, EUR J PHARMACOL, V402, P215, DOI 10.1016/S0014-2999(00)00521-5; Simantov R, 2004, LIFE SCI, V74, P803, DOI 10.1016/j.lfs.2003.08.002; Simon VM, 2000, EUR NEUROPSYCHOPHARM, V10, P159, DOI 10.1016/S0924-977X(00)00070-5; SOLOWIJ N, 1992, BRIT J ADDICT, V87, P1161; Trigo JM, 2006, PSYCHOPHARMACOLOGY, V184, P212, DOI 10.1007/s00213-005-0229-7; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Weitemier AZ, 2009, EUR J NEUROSCI, V29, P1015, DOI 10.1111/j.1460-9568.2009.06652.x; WHITE SR, 1994, NEUROSCIENCE, V62, P41, DOI 10.1016/0306-4522(94)90313-1; Xu M, 2000, BRAIN RES, V852, P198, DOI 10.1016/S0006-8993(99)02258-1; YAMAMOTO BK, 1988, EUR J PHARMACOL, V148, P195, DOI 10.1016/0014-2999(88)90564-X	78	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43107	10.1371/journal.pone.0043107	http://dx.doi.org/10.1371/journal.pone.0043107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916213	Green Submitted, Green Published, gold			2022-12-27	WOS:000307824300029
J	Georgiev, D; Gonzalez-Burgos, G; Kikuchi, M; Minabe, Y; Lewis, DA; Hashimoto, T				Georgiev, Danko; Gonzalez-Burgos, Guillermo; Kikuchi, Mitsuru; Minabe, Yoshio; Lewis, David A.; Hashimoto, Takanori			Selective Expression of KCNS3 Potassium Channel alpha-Subunit in Parvalbumin-Containing GABA Neurons in the Human Prefrontal Cortex	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; K+ CHANNEL; NETWORK OSCILLATIONS; STRIATAL NEURONS; SCHIZOPHRENIA; HIPPOCAMPAL; RAT; CHOLECYSTOKININ; BINDING; KV2.1	The cognitive deficits of schizophrenia appear to be associated with altered cortical GABA neurotransmission in the subsets of inhibitory neurons that express either parvalbumin (PV) or somatostatin (SST). Identification of molecular mechanisms that operate selectively in these neurons is essential for developing targeted therapeutic strategies that do not influence other cell types. Consequently, we sought to identify, in the human cortex, gene products that are expressed selectively by PV and/or SST neurons, and that might contribute to their distinctive functional properties. Based on previously reported expression patterns in the cortex of mice and humans, we selected four genes: KCNS3, LHX6, KCNAB1, and PPP1R2, encoding K+ channel Kv9.3 modulatory alpha-subunit, LIM homeobox protein 6, K+ channel Kv beta 1 subunit, and protein phosphatase 1 regulatory subunit 2, respectively, and examined their colocalization with PV or SST mRNAs in the human prefrontal cortex using dual-label in situ hybridization with S-35-and digoxigenin-labeled antisense riboprobes. KCNS3 mRNA was detected in almost all PV neurons, but not in SST neurons, and PV mRNA was detected in >90% of KCNS3 mRNA-expressing neurons. LHX6 mRNA was detected in almost all PV and >90% of SST neurons, while among all LHX6 mRNA-expressing neurons 50% expressed PV mRNA and >44% expressed SST mRNA. KCNAB1 and PPP1R2 mRNAs were detected in much larger populations of cortical neurons than PV or SST neurons. These findings indicate that KCNS3 is a selective marker of PV neurons, whereas LHX6 is expressed by both PV and SST neurons. KCNS3 and LHX6 might be useful for characterizing cell-type specific molecular alterations of cortical GABA neurotransmission and for the development of novel treatments targeting PV and/or SST neurons in schizophrenia.	[Georgiev, Danko; Kikuchi, Mitsuru; Minabe, Yoshio; Hashimoto, Takanori] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Gonzalez-Burgos, Guillermo; Lewis, David A.; Hashimoto, Takanori] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Kikuchi, Mitsuru; Minabe, Yoshio] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Lewis, David A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Kanazawa University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kanazawa University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Georgiev, D (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan.	takanori@med.kanazawa-u.ac.jp	Lewis, David A/G-4053-2014; Georgiev, Danko D./E-8676-2017	Lewis, David A/0000-0002-3225-6778; Georgiev, Danko D./0000-0001-6846-1194; Gonzalez-Burgos, Guillermo/0000-0002-1650-8111	Japan Society for the Promotion of Science [21390332, 21.09141]; National Institutes of Health [MH043784, MH084053]; National Institutes of Health; Commonwealth of Pennsylvania; Bristol-Myers Squibb; Curridium Ltd; Pfizer; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043784, R37MH043784, P50MH084053] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Bristol-Myers Squibb(Bristol-Myers Squibb); Curridium Ltd; Pfizer(Pfizer); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Japan Society for the Promotion of Science (Postdoctoral Fellowship to DG and Grants-in-Aid 21390332, 21.09141 to TH) and National Institutes of Health (Grants MH043784, MH084053 to DAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: DAL currently receives investigator-initiated research support from the National Institutes of Health, Commonwealth of Pennsylvania, Bristol-Myers Squibb, Curridium Ltd and Pfizer and in 2010-2012 served as a consultant in the areas of target identification and validation and new compound development to BioLine RX, Bristol-Myers Squibb, and Merck. TH served as a consultant for Ono Pharmaceutical Co., Ltd. in 2012. None of above funders was involved in the study design; collection, analysis, and interpretation of data; writing of the paper; or decision to submit for publication of this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Allen Institute for Brain Science, 2009, ALL BRAIN ATL; Arango V, 2001, NEUROPSYCHOPHARMACOL, V25, P892, DOI 10.1016/S0893-133X(01)00310-4; Beasley CL, 2002, BIOL PSYCHIAT, V52, P708, DOI 10.1016/S0006-3223(02)01360-4; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; BRAHIC M, 1978, P NATL ACAD SCI USA, V75, P6125, DOI 10.1073/pnas.75.12.6125; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Daviss SR, 1995, PSYCHIAT RES, V59, P81, DOI 10.1016/0165-1781(95)02720-3; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; GERFEN CR, 1991, J NEUROSCI, V11, P1016; Glantz LA, 2000, BIOL PSYCHIAT, V48, P389, DOI 10.1016/S0006-3223(00)00923-9; Gonzalez-Albo MC, 2001, CEREB CORTEX, V11, P1170, DOI 10.1093/cercor/11.12.1170; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kerschensteiner D, 2003, J BIOL CHEM, V278, P18154, DOI 10.1074/jbc.M213117200; Kubota Y, 1997, BRAIN RES, V752, P175, DOI 10.1016/S0006-8993(96)01446-1; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Maylie B, 2002, J NEUROSCI, V22, P4786, DOI 10.1523/JNEUROSCI.22-12-04786.2002; MORINO P, 1994, EUR J NEUROSCI, V6, P681, DOI 10.1111/j.1460-9568.1994.tb00980.x; Morris HM, 2008, CEREB CORTEX, V18, P1575, DOI 10.1093/cercor/bhm186; Ohnuma T, 1999, NEUROSCIENCE, V93, P441, DOI 10.1016/S0306-4522(99)00189-X; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Pierri JN, 1999, AM J PSYCHIAT, V156, P1709; Rhodes KJ, 1996, J NEUROSCI, V16, P4846; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sarmiere PD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-112; SCHIFFMANN SN, 1991, J COMP NEUROL, V304, P219, DOI 10.1002/cne.903040206; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P46535, DOI 10.1074/jbc.M206960200; Volk DW, 2001, AM J PSYCHIAT, V158, P256, DOI 10.1176/appi.ajp.158.2.256; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Volk DW, 2012, AM J PSYCHI IN PRESS; Wonders C, 2005, NAT NEUROSCI, V8, P979, DOI 10.1038/nn0805-979; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772	53	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43904	10.1371/journal.pone.0043904	http://dx.doi.org/10.1371/journal.pone.0043904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937123	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000308225500122
J	Graef, C; Schacherl, M; Waltersperger, S; Baumann, U				Graef, Christine; Schacherl, Magdalena; Waltersperger, Sandro; Baumann, Ulrich			Crystal Structures of Archaemetzincin Reveal a Moldable Substrate-Binding Site	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CATALYTIC DOMAIN; INHIBITOR; METHIONINE; COMPLEX; PROTEIN; METZINCINS; FAMILY	Background: Archaemetzincins are metalloproteases occurring in archaea and some mammalia. They are distinct from all the other metzincins by their extended active site consensus sequence HEXXHXXGXXHCX(4)CXMX(17)CXXC featuring four conserved cysteine residues. Very little is known about their biological importance and structure-function relationships. Principal Findings: Here we present three crystal structures of the archaemetzincin AfAmzA (Uniprot O29917) from Archaeoglobus fulgidus, revealing a metzincin architecture featuring a zinc finger-like structural element involving the conserved cysteines of the consensus motif. The active sites in all three structures are occluded to different extents rendering the enzymes proteolytically inactive against a large variety of tested substrates. Owing to the different ligand binding there are significant differences in active site architecture, revealing a large flexibility of the loops covering the active site cleft. Conclusions: The crystal structures of AfAmzA provide the structural basis for the lack of activity in standard proteolytic assays and imply a triggered activity onset upon opening of the active site cleft.	[Graef, Christine; Schacherl, Magdalena; Waltersperger, Sandro; Baumann, Ulrich] Univ Bern, Dept Chem & Biochem, Bern, Switzerland	University of Bern	Graef, C (corresponding author), Blutspendedienst SRK Bern AG, Bern, Switzerland.	ubaumann@uni-koeln.de	Baumann, Ulrich/B-1220-2013; Schacherl, Magdalena/AAT-6362-2021; Schacherl, Magdalena/M-1590-2014	Schacherl, Magdalena/0000-0002-5478-2509; Schacherl, Magdalena/0000-0002-5478-2509; Henny, Christine/0000-0001-9716-5810	Swiss National Science Foundation [A3100-120174]; Berner Hochschulstiftung; Bern University	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Berner Hochschulstiftung; Bern University	This work has been supported by the Swiss National Science Foundation (www.snf.ch), Grant No. A3100-120174, the Berner Hochschulstiftung (www.forschungsstiftung.ch) and Bern University (www.uni-bern.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUMANN U, 1995, J MOL BIOL, V248, P653, DOI 10.1006/jmbi.1995.0249; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diaz-Perales A, 2005, J BIOL CHEM, V280, P30367, DOI 10.1074/jbc.M504533200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Gomis-Ruth FX, 2003, MOL BIOTECHNOLOGY, V24; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guevara T, 2010, J BIOL CHEM; Hege T, 2001, J BIOL CHEM, V276, P35087, DOI 10.1074/jbc.M104020200; Hege T, 2001, J MOL BIOL, V314, P181, DOI 10.1006/jmbi.2001.5125; Janda I, 2004, STRUCTURE, V12, P1901, DOI 10.1016/j.str.2004.08.003; JIANG WP, 1992, FEBS LETT, V312, P110, DOI 10.1016/0014-5793(92)80916-5; Kuzin A, 2010, CRYSTAL STRUCTURE ZI; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Oberholzer AE, 2009, BIOL CHEM, V390, P875, DOI 10.1515/BC.2009.100; Orth P, 2004, J MOL BIOL, V335, P129, DOI 10.1016/j.jmb.2003.10.037; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Penalver-Mellado M, 2006, MOL MICROBIOL, V61, P910, DOI 10.1111/j.1365-2958.2006.05289.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Roe RR, 1999, J MOL MODEL, V5, P134, DOI 10.1007/s008940050113; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tallant C, 2010, J BIOL CHEM, V285, P13951, DOI 10.1074/jbc.M109.083378; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Waltersperger S, 2010, PROTEINS, V78, P2720, DOI 10.1002/prot.22777; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Zaric SD, 2000, CHEM-EUR J, V6, P3935, DOI 10.1002/1521-3765(20001103)6:21<3935::AID-CHEM3935>3.0.CO;2-J; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	42	3	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43863	10.1371/journal.pone.0043863	http://dx.doi.org/10.1371/journal.pone.0043863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937112	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500114
J	Hawlitschek, O; Nagy, ZT; Glaw, F				Hawlitschek, Oliver; Nagy, Zoltan T.; Glaw, Frank			Island Evolution and Systematic Revision of Comoran Snakes: Why and When Subspecies Still Make Sense	PLOS ONE			English	Article							INTEGRATIVE TAXONOMIC REVISION; BODY-SIZE EVOLUTION; SEXUAL DICHROMATISM; SPECIES CONCEPTS; PHYLOGENETIC-RELATIONSHIPS; CROTAPHYTUS-COLLARIS; GEOGRAPHIC-VARIATION; MAXIMUM-LIKELIHOOD; EMPIRICAL-EVIDENCE; NOSED SNAKE	Species delimitation and species concepts have been a matter of debate among biodiversity researchers in the last decades, resulting in integrative taxonomy approaches and the use of modern species concepts, such as the phylogenetic, evolutionary or general lineage species concepts. The discussion of subspecies status and concepts has been addressed much less extensively, with some researchers completely refraining from recognizing subspecies. However, allopatric insular populations that are particularly differentiated have traditionally been assigned subspecies status. We studied the molecular phylogeny and morphology of endemic Comoran tree snakes of the genus Lycodryas. Taking an integrative taxonomic approach, we used the concept of independent lines of evidence to discriminate between evidence for specific and subspecific status. Molecular (mtDNA) and morphological data provided sufficient evidence to support four different taxa within Comoran Lycodryas. In a revision of this group, we propose two species, each with two subspecies. We present a discussion of the strong sexual dichromatism unique to Comoran Lycodryas within the genus and related genera that may be explained by sexual selection in combination with the absence of major predators. Then, we discuss the effects of insular evolution and the "island rule" on morphological traits in Comoran Lycodryas and in Liophidium mayottensis, another snake endemic to the Comoros. The absence of larger-bodied snakes may have promoted an increase in body size and the number of dorsal scale rows in these species. Finally, we discuss the subspecies concept, its applications and its significance for integrative taxonomy and for limiting taxonomic inflation. We emphasize that taxon descriptions should be based on an integrative approach using several lines of evidence, preferably in combination with statements on the underlying species concepts or operational criteria, to increase the objectivity and comparability of descriptions.	[Hawlitschek, Oliver; Glaw, Frank] Zool Staatssammlung Munchen, Munich, Germany; [Nagy, Zoltan T.] Royal Belgian Inst Nat Sci, Joint Expt Mol Unit, Brussels, Belgium	Royal Belgian Institute of Natural Sciences	Hawlitschek, O (corresponding author), Zool Staatssammlung Munchen, Munich, Germany.	oliver.hawlitschek@gmx.de	Nagy, Zoltan T./C-6737-2011	Nagy, Zoltan T./0000-0002-8455-040X; Hawlitschek, Oliver/0000-0001-8010-4157	Mohamed bin Zayed Species Conservation Fund [0925157]; DAAD [D/09/49634]; "Deutsche Forschungsgemeinschaft" DFG [GL 314/1, BA2152/7-1]; Freunde der Zoologischen Staatssammlung Munchen; Society of the University of Munich; University of Munich;  [MNHNFR-TAF-2988]	Mohamed bin Zayed Species Conservation Fund; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); "Deutsche Forschungsgemeinschaft" DFG(German Research Foundation (DFG)); Freunde der Zoologischen Staatssammlung Munchen; Society of the University of Munich; University of Munich; 	The research was financially supported by the Mohamed bin Zayed Species Conservation Fund (project 0925157) to FG and OH (http://www.mbzspeciesconservation.org/), by DAAD grant D/09/49634 to OH (http://www.daad.de/en/), the "Deutsche Forschungsgemeinschaft" DFG GL 314/1 to FG and BA2152/7-1 to Michael Balke (http://www.dfg.de/en/index.jsp). The "Freunde der Zoologischen Staatssammlung Munchen" (http://www.zsm.mwn. de/freunde/), the Society of the University of Munich (http://www.unigesellschaft.de/home.php) and EES funding program of the University of Munich (http://www.eeslmu.de/eeswiki/Main_ Page) provided additional financial support. The work at MNHN was financially supported by Synthesys grant FR-TAF-2988 to OH (http://www.synthesys.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Santos S.M., 2002, BIOL VIPERS, P445; AMADON DEAN, 1949, CONDOR, V51, P250, DOI 10.2307/1364805; ANDERSSON L, 1990, TAXON, V39, P375, DOI 10.2307/1223084; Andriatsimietry R, 2009, J ZOOL, V279, P410, DOI 10.1111/j.1469-7998.2009.00633.x; Auliya M, 2002, NATURWISSENSCHAFTEN, V89, P201, DOI 10.1007/s00114-002-0320-4; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Barton NH, 1996, PHILOS T R SOC B, V351, P785, DOI 10.1098/rstb.1996.0073; BAUM DA, 1995, SYST BOT, V20, P560, DOI 10.2307/2419810; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; Boback SM, 2003, EVOLUTION, V57, P345; Boettger O., 1913, P269; Boggs CL, 2001, INT ENCY SOCIAL BEHA, P14855; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; BOHME W, 1978, Z ZOOL SYST EVOL, V16, P256; Bohme W, 1983, VERT HUNG, V21, P47; Boulenger G.A, 1896, CATALOGUE SNAKES BRI, VIII; Brammah M, 2010, HERPETOL J, V20, P91; BROWN RP, 1991, NATURE, V352, P60, DOI 10.1038/352060a0; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; CAPULA M, 1994, BIOL J LINN SOC, V52, P177; Carpenter C.C., 1977, P335; Carretero Miguel A., 2005, Herpetological Bulletin, V91, P19; CARSON HL, 1976, ANNU REV ECOL SYST, V7, P311, DOI 10.1146/annurev.es.07.110176.001523; Cirer AM, 1997, MONOGRAFIA HERPETOLO, V3, P542; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cole NC, 2005, BIOL CONSERV, V125, P467, DOI 10.1016/j.biocon.2005.04.017; Cooper WE, 1992, BIOL REPTILIA HORMON, V18, P298; Cracraft J., 1983, Current Ornithology, V1, P159; Darwin C.R., 1859, ORIGIN SPECIES MEANS; DARWIN CR, 1845, VOYAGE BEAGLE; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Desjardins J, 1831, ANN SCI NAT, V22, P292; Diamond J.M., 1984, P824; Diamond J.M., 1984, P191; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; DOMERGUE C A, 1970, Bulletin du Museum National d'Histoire Naturelle, V42, P449; Domergue CA, 1995, ARCH I PASTEUR MADAG, V61, P121; DUARTE MR, 1995, STUD NEOTROP FAUNA E, V30, P1, DOI 10.1080/01650529509360936; Eldredge N., 1980, P1; Elliot DG, 1874, IBIS, V16, P330; Fitzpatrick John W., 2010, Ornithological Monographs, V67, P54; Font E, 2009, BIOL J LINN SOC, V97, P766, DOI 10.1111/j.1095-8312.2009.01251.x; FROST DR, 1990, HERPETOLOGICA, V46, P87; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Futuyma DJ, 1979, EVOLUTIONARY BIOL; Galan P, 2008, ANIM BIOL, V58, P173, DOI 10.1163/157075608X328026; Giribet G., 2005, SYST BIOL, V54, P176, DOI DOI 10.1080/10635150590905830; GLAW F, 2007, FIELDGUIDE AMPHIBIAN; Glaw F, 2007, ZOOL SCR, V36, P291, DOI 10.1111/j.1463-6409.2007.00278.x; Glaw Frank, 2010, Zootaxa, V2383, P1; GOODMAN S M, 1991, Bonner Zoologische Beitraege, V42, P21; Goodman SM, 1998, WILSON BULL, V110, P417; Gosliner T, 2009, ENCY ISLANDS, P357; Greene H. W., 1997, SNAKES EVOLUTION MYS; Gunther A., 1879, Annals of Natural History, V(5), P215; Gunther A, 1858, CATALOGUE COLUBRINE; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris DJ, 2005, TRENDS ECOL EVOL, V20, P6, DOI 10.1016/j.tree.2004.11.004; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Haszprunar G, 2011, ORG DIVERS EVOL, V11, P249, DOI 10.1007/s13127-011-0047-1; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Hawkins CE, 2008, J MAMMAL, V89, P64, DOI 10.1644/06-MAMM-A-366.1; Hawlitschek O, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.144.1648; HEANEY LR, 1978, EVOLUTION, V32, P29, DOI 10.1111/j.1558-5646.1978.tb01096.x; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Helbig AJ, 2002, IBIS, V144, P518, DOI 10.1046/j.1474-919X.2002.00091.x; HELLMICH WC, 1951, EVOLUTION, V5, P359, DOI 10.2307/2405681; Henle K., 1986, P254; Hennig W., 1966, P263; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horner Paul, 2007, Beagle, P21; HORTON DR, 1972, SYST ZOOL, V21, P441, DOI 10.2307/2412438; Hume J., 2008, LOST LAND DODO; Inger RF, 1961, VERTEBRATE SPECIATIO, P262; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Jesus J, 2006, HERPETOL J, V16, P291; Karpanty SM, 1999, J RAPTOR RES, V33, P313; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kearney M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P447, DOI 10.1007/978-90-481-2770-2_21; Keogh JS, 2005, EVOLUTION, V59, P226; Knapp S, 2005, TRENDS ECOL EVOL, V20, P7, DOI 10.1016/j.tree.2004.11.001; Krysko KL, 2005, AFR J HERPETOL, V54, P195, DOI 10.1080/21564574.2005.9635534; Kuhnelt W., 1943, Biologia Generalis Wien, V17, P106; Kuriyama T, 2011, J BIOGEOGR, V38, P259, DOI 10.1111/j.1365-2699.2010.02403.x; LeBas NR, 2000, P ROY SOC B-BIOL SCI, V267, P445, DOI 10.1098/rspb.2000.1020; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; Louette M, 2004, STUDIES AFROTROPICAL, V293; Louette M, 2008, STUDIES AFROTROPICAL, V294; Luiselli L, 2006, OIKOS, V114, P193, DOI 10.1111/j.2006.0030-1299.14064.x; Macedonia JM, 2004, J HERPETOL, V38, P340, DOI 10.1670/183-03A; Macedonia JM, 2002, BIOL J LINN SOC, V77, P67, DOI 10.1046/j.1095-8312.2002.00092.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P8, DOI 10.1016/j.tree.2004.11.002; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mallet J, 2004, SYST BIODIVERS, V1, P441; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Manier MK, 2004, BIOL J LINN SOC, V83, P65, DOI 10.1111/j.1095-8312.2004.00373.x; Marques OAV, 2002, HERPETOLOGICA, V58, P303, DOI 10.1655/0018-0831(2002)058[0303:ANISOP]2.0.CO;2; Mason RT, 2010, J COMP PHYSIOL A, V196, P729, DOI 10.1007/s00359-010-0551-3; Mayden R. L., 1997, V54, P381; Mayr E., 1942, P1; MAYR E, 1982, AUK, V99, P593; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; Mayr E., 1963, ANIMAL SPECIES EVOLU; MEIER H, 1986, Salamandra, V22, P11; Meiri S, 2011, J BIOGEOGR, V38, P89, DOI 10.1111/j.1365-2699.2010.02390.x; MEIRTE D, 2004, STUDIES AFROTROPICAL, V293, P199; Meirte D, 1992, BRIT HERPETOL SOC B, V39, P3; Mertens R, 1934, INSEL REPTILIEN IHRE; Michener C. D., 1970, EVOL BIOL, V4, P1; Miller M.A., 2010, P GAT COMP ENV WORKS; Miralles A, 2011, ZOOL SCR, V40, P16, DOI 10.1111/j.1463-6409.2010.00453.x; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Mulcahy DG, 2008, MOL PHYLOGENET EVOL, V46, P1095, DOI 10.1016/j.ympev.2007.12.012; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Nagy ZT, 2010, ZOOL SCR, V39, P426, DOI 10.1111/j.1463-6409.2010.00435.x; Nagy ZT, 2007, ORG DIVERS EVOL, V7, P241, DOI 10.1016/j.ode.2006.07.003; Nagy ZT, 2003, P ROY SOC B-BIOL SCI, V270, P2613, DOI 10.1098/rspb.2003.2547; Nunn P., 1994, OCEANIC ISLANDS; Padial JM, 2006, SYST BIOL, V55, P859, DOI 10.1080/1063515060081588; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Pascal O, 2002, PATRIMOINES NATURELS, V53; Patten Michael A., 2010, Ornithological Monographs, V67, P35; Pelzeln A, 1882, UEBER SENDUNG SAUGET, V1; Peters WCH, 1874, VORLAUFIGE MITTHEILU, P792; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pough HF, 2001, HERPETOLOGY; Price JP, 2002, P ROY SOC B-BIOL SCI, V269, P2429, DOI 10.1098/rspb.2002.2175; Price JP, 2009, ENCY ISLANDS, P397; Rambaut A., 2007, TRACER V1 4; Rassmann K, 1997, MOL PHYLOGENET EVOL, V7, P158, DOI 10.1006/mpev.1996.0386; Remsen J.V. Jr, 2010, Ornithological Monographs, V67, P62; Rocha S, 2006, J BIOGEOGR, V33, P13, DOI 10.1111/j.1365-2699.2005.01375.x; Rocha S, 2009, MOL PHYLOGENET EVOL, V52, P530, DOI 10.1016/j.ympev.2009.03.032; Rocha S, 2007, MOL PHYLOGENET EVOL, V43, P685, DOI 10.1016/j.ympev.2006.07.010; Rocha Sara, 2010, Zootaxa, V2429, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Runemark A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-269; Salvador A., 1986, HDB REPTILIEN AMPHIB, V2, P231; Sanders KL, 2004, J EVOLUTION BIOL, V17, P721, DOI 10.1111/j.1420-9101.2004.00735.x; Schleip WD, 2010, ZOOKEYS, P29, DOI [10.3897/zookeys.66.683, 10.3897/zookeys.66.367]; Sclater PL, 1857, P ZOOL SOC L, V25, P15; Shine Richard, 1993, P49; Sillman AJ, 1997, J COMP PHYSIOL A, V181, P89, DOI 10.1007/s003590050096; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takahashi K, 2001, MOL BIOL EVOL, V18, P2057, DOI 10.1093/oxfordjournals.molbev.a003747; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Templeton A.R., 1989, P3; TEMPLETON AR, 1992, GENETICS, V132, P619; Thebaud C, 2009, ENCY ISLANDS, P612; THORPE RS, 1987, EVOLUTION, V41, P256, DOI 10.1111/j.1558-5646.1987.tb05795.x; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vasconcelos R, 2012, ZOOL J LINN SOC-LOND, V164, P328, DOI 10.1111/j.1096-3642.2011.00768.x; Vences Miguel, 2004, Salamandra, V40, P161; Vieites DR, 2010, SALAMANDRA, V46, P1; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wallace A. R., 1865, Linn Trans, Vvol. xxv, P1; Warren BH, 2006, MOL ECOL, V15, P3769, DOI 10.1111/j.1365-294X.2006.03058.x; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wiens JJ, 2006, EVOLUTION, V60, P2585; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	174	48	50	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42970	10.1371/journal.pone.0042970	http://dx.doi.org/10.1371/journal.pone.0042970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937005	Green Published, gold			2022-12-27	WOS:000308225500024
J	Liu, HM; Aizaki, H; Machida, K; Ou, JHJ; Lai, MMC				Liu, Helene Minyi; Aizaki, Hideki; Machida, Keigo; Ou, J. -H. James; Lai, Michael M. C.			Hepatitis C Virus Translation Preferentially Depends on Active RNA Replication	PLOS ONE			English	Article							TRACT-BINDING PROTEIN; VIRAL TRANSLATION; CELL-LINES; POLIOVIRUS; COMPLEX; TRANSCRIPTION; POLYMERASE; MEMBRANE; DOMAIN; SITE	Hepatitis C virus (HCV) RNA initiates its replication on a detergent-resistant membrane structure derived from the endoplasmic reticulum (ER) in the HCV replicon cells. By performing a pulse-chase study of BrU-labeled HCV RNA, we found that the newly-synthesized HCV RNA traveled along the anterograde-membrane traffic and moved away from the ER. Presumably, the RNA moved to the site of translation or virion assembly in the later steps of viral life cycle. In this study, we further addressed how HCV RNA translation was regulated by HCV RNA trafficking. When the movement of HCV RNA from the site of RNA synthesis to the Golgi complex was blocked by nocodazole, an inhibitor of ER-Golgi transport, HCV protein translation was surprisingly enhanced, suggesting that the translation of viral proteins occurred near the site of RNA synthesis. We also found that the translation of HCV proteins was dependent on active RNA synthesis: inhibition of viral RNA synthesis by an NS5B inhibitor resulted in decreased HCV viral protein synthesis even when the total amount of intracellular HCV RNA remained unchanged. Furthermore, the translation activity of the replication-defective HCV replicons or viral RNA with an NS5B mutation was greatly reduced as compared to that of the corresponding wildtype RNA. By performing live cell labeling of newly synthesized HCV RNA and proteins, we further showed that the newly synthesized HCV proteins colocalized with the newly synthesized viral RNA, suggesting that HCV RNA replication and protein translation take place at or near the same site. Our findings together indicate that the translation of HCV RNA is coupled to RNA replication and that the both processes may occur at the same subcellular membrane compartments, which we term the replicasome.	[Liu, Helene Minyi; Aizaki, Hideki; Machida, Keigo; Ou, J. -H. James; Lai, Michael M. C.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Lai, Michael M. C.] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	University of Southern California; Academia Sinica - Taiwan	Liu, HM (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	michlai@gate.sinica.edu.tw	Lai, Michael M. C./I-7001-2012; Liu, Helene Minyi/Y-1834-2019	Liu, Helene Minyi/0000-0003-4837-5373; Machida, Keigo/0000-0002-9721-8553	National Institutes of Health [AI40038, CA108302]; Academia Sinica Institutional Fund; NATIONAL CANCER INSTITUTE [R01CA108302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academia Sinica Institutional Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants AI40038, CA108302, and Academia Sinica Institutional Fund. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aizaki H, 2006, J BIOMED SCI, V13, P469, DOI 10.1007/s11373-006-9088-4; Ali N, 2000, J BIOL CHEM, V275, P27531; Annamalai P, 2006, J VIROL, V80, P10096, DOI 10.1128/JVI.01186-06; Bartenschlager R, 2006, CURR OPIN MICROBIOL, V9, P416, DOI 10.1016/j.mib.2006.06.012; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bost AG, 2003, J VIROL, V77, P4401, DOI 10.1128/JVI.77.7.4401-4408.2003; Chang KS, 2006, VIRUS RES, V115, P1, DOI 10.1016/j.virusres.2005.06.012; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Domitrovich AM, 2005, VIROLOGY, V335, P72, DOI 10.1016/j.virol.2005.02.009; Egger D, 2000, J VIROL, V74, P6570, DOI 10.1128/JVI.74.14.6570-6580.2000; Egger D, 2005, J GEN VIROL, V86, P707, DOI 10.1099/vir.0.80442-0; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; GOLDBERG IH, 1962, P NATL ACAD SCI USA, V48, P2094, DOI 10.1073/pnas.48.12.2094; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Goueslain L, 2009, J VIROL; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Hirashima S, 2006, J MED CHEM, V49, P4721, DOI 10.1021/jm060269e; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; IOST I, 1994, NATURE, V372, P193, DOI 10.1038/372193a0; Ito T, 1999, VIROLOGY, V254, P288, DOI 10.1006/viro.1998.9541; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kieft JS, 2002, NAT STRUCT BIOL, V9, P370, DOI 10.1038/nsb781; Kim JH, 2004, MOL CELL BIOL, V24, P7878, DOI 10.1128/MCB.24.18.7878-7890.2004; Lee KJ, 2004, J VIROL, V78, P3797, DOI 10.1128/JVI.78.7.3797-3802.2004; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; Liu HM, 2009, VIROLOGY, V386, P249, DOI 10.1016/j.virol.2009.01.018; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Manna D, 2009, VIROLOGY; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; NOVAK JE, 1994, GENE DEV, V8, P1726, DOI 10.1101/gad.8.14.1726; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Sanz MA, 2007, J VIROL, V81, P7061, DOI 10.1128/JVI.02529-06; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Sir D, 2012, J BIOL CHEM IN PRESS; Tedesco R, 2006, J MED CHEM, V49, P971, DOI 10.1021/jm050855s; Toyoda H, 2007, J VIROL, V81, P10017, DOI 10.1128/JVI.00516-07; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08	48	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43600	10.1371/journal.pone.0043600	http://dx.doi.org/10.1371/journal.pone.0043600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937067	Green Submitted, gold, Green Published			2022-12-27	WOS:000308225500068
J	Risebro, HL; Breton, L; Aird, H; Hooper, A; Hunter, PR				Risebro, Helen L.; Breton, Lynette; Aird, Heather; Hooper, Alan; Hunter, Paul R.			Contaminated Small Drinking Water Supplies and Risk of Infectious Intestinal Disease: A Prospective Cohort Study	PLOS ONE			English	Article							MICROBIOLOGICAL QUALITY; GASTROINTESTINAL ILLNESS; UNITED-KINGDOM; COMMUNITY; CHILDREN; DIARRHEA; ENGLAND; IID2; UK	Background: This study sought to identify whether elevated risk of infectious intestinal disease (IID) exists in contaminated small water supply consumers compared with consumers drinking from small supplies complying with current standards and whether this effect is modified by age. Methodology and Principal Findings: A prospective cohort study of 611 individuals receiving small supplies in England was conducted. Water supplies received sanitary inspection and examination for indicator bacteria and participants maintained a daily record of IID. Regression modeling with generalized estimating equations that included interaction terms between age and indicators of fecal pollution was performed. Crude IID prevalence was 9.3 days with symptoms/1000 person days (95% CI: 8.4, 10.1) and incidence was 3.2 episodes/1000 person days (95% CI, 2.7, 3.7) or 1.2 episodes per person year. Although there was no overall association between IID risk and indicator presence, there was strong interaction between age and indicator presence. In children under ten, relative risk (RR) of IID in those drinking from enterococci contaminated supplies was 4.8 (95% CI: 1.5, 15.3) for incidence and 8.9 (95% CI: 2.8, 27.5) for prevalence. In those aged 10 to 59, IID risk was lower but not statistically significant. Conclusions: Contaminated small water supplies pose a substantial risk of IID to young children who live in homes reliant on these supplies. By contrast older children and adults do not appear to be at increased risk. Health care professionals with responsibility for children living in homes provided by very small water supplies should make parents aware of the risk.	[Risebro, Helen L.; Breton, Lynette; Hunter, Paul R.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Aird, Heather] Norfolk & Norwich Univ Hosp NHS Trust, Food Water & Environm Lab, Norwich, Norfolk, England; [Hooper, Alan] Hereford Cty Hosp, Dept Microbiol & Immunol, Hereford, England	University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust	Risebro, HL (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	Paul.Hunter@uea.ac.uk	Hunter, Paul/N-9021-2019; Hunter, Paul/A-7172-2008; Risebro, Helen/S-5693-2016	Hunter, Paul/0000-0002-5608-6144; Hunter, Paul/0000-0002-5608-6144; Risebro, Helen/0000-0003-4389-748X	European Commission for the HEALTHY WATER project [FOOD-CT-2006-036306]; Danone Beverages Ltd.	European Commission for the HEALTHY WATER project; Danone Beverages Ltd.	This work was supported by funds from the European Commission for the HEALTHY WATER project (grant number: FOOD-CT-2006-036306). The authors are solely responsible for the content of this publication. It does not represent the opinion of the European Commission. The European Commission is not responsible for any use that might be made of data appearing therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: PRH has been chair of science advisory committee for Suez Environment, Paris and has been funded to attend meetings with Danone Beverages. PRH is chair of the board of directors of the Institute of Public Health and Water Research, Chicago. PRH was chair of Science Advisory Committee for Suez Environment until 2010, and has attended meetings funded by Danone Beverages Ltd. HLR and PRH have completed consultancy work for 1001 Fontaines. The other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Al-Ghamdi MA, 2009, J WATER HEALTH, V7, P380, DOI 10.2166/wh.2009.058; [Anonymous], 2010, PRIV WAT SUPPL; Borchardt MA, 2003, ENVIRON HEALTH PERSP, V111, P742, DOI 10.1289/ehp.5914; Colford JM, 2009, AM J PUBLIC HEALTH, V99, P1988, DOI 10.2105/AJPH.2008.153619; Desinor OY, 2000, ENQUETE MORTALITE IN, V10, P407; European Commission, 1998, OFF J EUR COMMUN L, VL330, P32; FERLEY JP, 1986, REV EPIDEMIOL SANTE, V34, P89; Fewtrell L, 1998, J CHART INST WATER E, V12, P45; Fleisher JM, 2006, MAR POLLUT BULL, V52, P264, DOI 10.1016/j.marpolbul.2005.08.019; Frost FJ, 2005, J INFECT DIS, V191, P809, DOI 10.1086/427561; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hennessy TW, 2008, AM J PUBLIC HEALTH, V98, P2072, DOI 10.2105/AJPH.2007.115618; Hulsmann A., 2005, SMALL SYSTEMS LARGE; Hunter PR, 2004, EMERG INFECT DIS, V10, P1241, DOI 10.3201/eid1007.030582; Kay D, 2007, J WATER HEALTH, V5, P523, DOI 10.2166/wh.2007.042; Marsh David, 1993, JPMA (Journal of the Pakistan Medical Association), V43, P226; O'Brien SJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-39; PAYMENT P, 2001, WATER QUALITY GUIDEL; Raina PS, 1999, CAN J PUBLIC HEALTH, V90, P172, DOI 10.1007/BF03404501; Reid DC, 2003, WATER RES, V37, P245, DOI 10.1016/S0043-1354(02)00266-X; Rogan WJ, 2009, PEDIATRICS, V123, pE1123, DOI 10.1542/peds.2009-0752; Rutter M, 2000, EPIDEMIOL INFECT, V124, P417, DOI 10.1017/S0950268899003970; Said B, 2003, EPIDEMIOL INFECT, V130, P469, DOI 10.1017/S0950268803008495; Sethi D, 1999, Commun Dis Public Health, V2, P101; SIGNORINI DF, 1991, BIOMETRIKA, V78, P446; Strauss B, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-8; Swift L, 2004, EUR J EPIDEMIOL, V19, P219, DOI 10.1023/B:EJEP.0000020453.84296.f6; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; UK Biobank Co-ordinating Centre, 2006, UK BIOB REP INT PIL; United States Environmental Protection Agency, 2009, FACTOIDS DRINK WAT G; Yip-Richardson H, 2009, WATER RES, V43, P2159	31	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42762	10.1371/journal.pone.0042762	http://dx.doi.org/10.1371/journal.pone.0042762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936989	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500015
J	Wang, MJ; Zhao, XM; Takemoto, K; Xu, HS; Li, Y; Akutsu, T; Song, JN				Wang, Mingjun; Zhao, Xing-Ming; Takemoto, Kazuhiro; Xu, Haisong; Li, Yuan; Akutsu, Tatsuya; Song, Jiangning			FunSAV: Predicting the Functional Effect of Single Amino Acid Variants Using a Two-Stage Random Forest Model	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; SUPPORT VECTOR MACHINES; NUCLEOTIDE POLYMORPHISMS; GENOME SEQUENCE; DISEASE; MUTATIONS; INFORMATION; BIOINFORMATICS; COVARIATION; RESOURCE	Single amino acid variants (SAVs) are the most abundant form of known genetic variations associated with human disease. Successful prediction of the functional impact of SAVs from sequences can thus lead to an improved understanding of the underlying mechanisms of why a SAV may be associated with certain disease. In this work, we constructed a high-quality structural dataset that contained 679 high-quality protein structures with 2,048 SAVs by collecting the human genetic variant data from multiple resources and dividing them into two categories, i.e., disease-associated and neutral variants. We built a two-stage random forest (RF) model, termed as FunSAV, to predict the functional effect of SAVs by combining sequence, structure and residue-contact network features with other additional features that were not explored in previous studies. Importantly, a two-step feature selection procedure was proposed to select the most important and informative features that contribute to the prediction of disease association of SAVs. In cross-validation experiments on the benchmark dataset, FunSAV achieved a good prediction performance with the area under the curve (AUC) of 0.882, which is competitive with and in some cases better than other existing tools including SIFT, SNAP, Polyphen2, PANTHER, nsSNPAnalyzer and PhD-SNP. The sourcecodes of FunSAV and the datasets can be downloaded at http://sunflower.kuicr.kyoto-u.ac.jp/similar to sjn/FunSAV.	[Wang, Mingjun; Xu, Haisong; Li, Yuan; Song, Jiangning] Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Wang, Mingjun; Xu, Haisong; Li, Yuan; Song, Jiangning] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Zhao, Xing-Ming] Tongji Univ, Dept Comp Sci, Sch Elect & Informat Engn, Shanghai 200092, Peoples R China; [Takemoto, Kazuhiro] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan; [Akutsu, Tatsuya; Song, Jiangning] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan; [Song, Jiangning] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Tongji University; Kyushu Institute of Technology; Kyoto University; Monash University	Wang, MJ (corresponding author), Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China.	Jiangning.Song@monash.edu	Song, Jiangning/F-9787-2010; wang, mingjun/C-8042-2013; Takemoto, Kazuhiro/H-2915-2019	Song, Jiangning/0000-0001-8031-9086; Takemoto, Kazuhiro/0000-0002-6355-1366; Akutsu, Tatsuya/0000-0001-9763-797X	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council (ARC); Japan Society for the Promotion of Science (JSPS); Hundred Talents Program of the Chinese Academy of Sciences (CAS); Knowledge Innovation Program of CAS [KSCX2-EW-G-8]; Tianjin Municipal Science & Technology Commission [10ZCKFSY05600]; Hundred Talents Program of CAS; JSPS Short-term Invitation Fellowship to the Bioinformatics Center, Kyoto University, Japan	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hundred Talents Program of the Chinese Academy of Sciences (CAS); Knowledge Innovation Program of CAS(Knowledge Innovation Program of the Chinese Academy of Sciences); Tianjin Municipal Science & Technology Commission; Hundred Talents Program of CAS(Chinese Academy of Sciences); JSPS Short-term Invitation Fellowship to the Bioinformatics Center, Kyoto University, Japan	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC), the Australian Research Council (ARC), the Japan Society for the Promotion of Science (JSPS), the Hundred Talents Program of the Chinese Academy of Sciences (CAS), the Knowledge Innovation Program of CAS (No. KSCX2-EW-G-8) and Tianjin Municipal Science & Technology Commission (No. 10ZCKFSY05600). JS is an NHMRC Peter Doherty Fellow and the Recipient of the Hundred Talents Program of CAS and the JSPS Short-term Invitation Fellowship to the Bioinformatics Center, Kyoto University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Bao L, 2005, BIOINFORMATICS, V21, P2185, DOI 10.1093/bioinformatics/bti365; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bork P, 1999, J MOL MED, V77, P754; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cline MS, 2011, BIOINFORMATICS, V27, P441, DOI 10.1093/bioinformatics/btq695; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dobson RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-217; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ebina T, 2011, BIOINFORMATICS, V27, P487, DOI 10.1093/bioinformatics/btq700; Fernald GH, 2011, BIOINFORMATICS, V27, P1741, DOI 10.1093/bioinformatics/btr295; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gao S, 2009, HUM MUTAT, V30, P1161, DOI 10.1002/humu.21039; Gong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009186; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hamelryck T, 2005, PROTEINS, V59, P38, DOI 10.1002/prot.20379; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hardin C, 2002, CURR OPIN STRUC BIOL, V12, P176, DOI 10.1016/S0959-440X(02)00306-8; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-14; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Martinez MA, 2005, MOL GENET METAB, V84, P317, DOI 10.1016/j.ymgme.2004.11.011; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mingjun Wang, 2011, 2011 IEEE International Conference on Systems Biology (ISB), P18, DOI 10.1109/ISB.2011.6033115; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Sadras V, 2004, FIELD CROP RES, V90, P303, DOI 10.1016/j.fcr.2004.04.003; Samanta U, 2008, J BIOL CHEM, V283, P31617, DOI 10.1074/jbc.M804750200; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Schubert HL, 2006, BIOCHEMISTRY-US, V45, P15188, DOI 10.1021/bi061396f; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song JN, 2008, BIOINFORMATICS, V24, P1489, DOI 10.1093/bioinformatics/btn222; Song JN, 2007, BIOINFORMATICS, V23, P3147, DOI 10.1093/bioinformatics/btm505; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Stitziel NO, 2003, J MOL BIOL, V327, P1021, DOI 10.1016/S0022-2836(03)00240-7; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Wainreb G, 2010, NUCLEIC ACIDS RES, V38, P7869, DOI 10.1093/nar/gkq1208; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026767; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Ye ZQ, 2007, BIOINFORMATICS, V23, P1444, DOI 10.1093/bioinformatics/btm119; Yip YL, 2004, HUM MUTAT, V23, P464, DOI 10.1002/humu.20021; Yuan Z, 2005, PROTEINS, V58, P905, DOI 10.1002/prot.20375; Zhao XM, 2005, NEURAL NETWORKS, V18, P1019, DOI 10.1016/j.neunet.2005.07.002	72	39	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43847	10.1371/journal.pone.0043847	http://dx.doi.org/10.1371/journal.pone.0043847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937107	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500109
J	Nemeth, E; Kempenaers, B; Matessi, G; Brumm, H				Nemeth, Erwin; Kempenaers, Bart; Matessi, Giuliano; Brumm, Henrik			Rock Sparrow Song Reflects Male Age and Reproductive Success	PLOS ONE			English	Article							SOUND PRESSURE LEVEL; EXTRAPAIR PATERNITY; DAWN SONG; AMPLITUDE REGULATION; FIELD CRICKETS; MALE QUALITY; BIRD SONG; SIGNAL; NOISE; TITS	The evolution of mating signals is closely linked to sexual selection. Acoustic ornaments are often used as secondary sexual traits that signal the quality of the signaller. Here we show that song performance reflects age and reproductive success in the rock sparrow (Petronia petronia). In an Alpine population in south-east France, we recorded the songs of males and assessed their genetic breeding success by microsatellite analysis. In addition to temporal and spectral song features, we also analysed for the first time whether the sound pressure level of bird song reflects reproductive success. Males with higher breeding success sang at a lower rate and with a higher maximum frequency. We found also that older males gained more extra-pair young and had a higher overall breeding success, although they also differed almost significantly by having a higher loss of paternity in their own nests. Older males could be distinguished from yearlings by singing at lower rate and higher amplitudes. Our findings suggest that song rate may be used as a signal of age and together with song pitch as a signal of reproductive success in this species. Alternatively, younger and less successful males might try to compensate their inferior status by increased song rates and lower pitch. Independent of age and quality, high-amplitude songs correlated with paternity loss in the own nest, suggesting that in this species song amplitude is not an indicator of male quality but high-intensity songs may be rather a response to unfaithful social mates.	[Nemeth, Erwin; Kempenaers, Bart; Brumm, Henrik] Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany; [Nemeth, Erwin] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Matessi, Giuliano] Univ Copenhagen, Dept Biol, Anim Behav Grp, Copenhagen, Denmark	Max Planck Society; University of Vienna; University of Copenhagen	Nemeth, E (corresponding author), Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany.	enemeth@orn.mpg.de		Nemeth, Erwin/0000-0001-9438-1411; Kempenaers, Bart/0000-0002-7505-5458	Max Planck Society; Deutsche Forschungsgemeinschaft [BR 2309/6-1]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the Max Planck Society and the Deutsche Forschungsgemeinschaft (award BR 2309/6-1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson RC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1267, DOI 10.1007/s00265-007-0357-7; Andersson Malte, 1994; Araya-Ajoy YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008137; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Ballentine B, 2009, ANIM BEHAV, V77, P973, DOI 10.1016/j.anbehav.2008.12.027; Botero CA, 2009, ANIM BEHAV, V77, P701, DOI 10.1016/j.anbehav.2008.11.020; Bouwman KM, 2007, ANIM BEHAV, V73, P15, DOI 10.1016/j.anbehav.2006.01.031; Brumm H, 2004, ANIM BEHAV, V67, P281, DOI 10.1016/j.anbehav.2003.06.006; Brumm H, 2011, BEHAV ECOL, V22, P310, DOI 10.1093/beheco/arq205; Brumm H, 2002, ANIM BEHAV, V63, P891, DOI 10.1006/anbe.2001.1968; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, 2006, ANIM BEHAV, V72, P699, DOI 10.1016/j.anbehav.2006.01.020; Brumm H, 2011, ANIM BEHAV, V81, P653, DOI 10.1016/j.anbehav.2010.12.015; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Brumm H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1157, DOI 10.1007/s00265-009-0743-4; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Burmeister SS, 2002, ANIM BEHAV, V64, P715, DOI 10.1006/anbe.2002.4012; Byers BE, 2007, BEHAV ECOL, V18, P130, DOI 10.1093/beheco/arl058; CATCHPOLE CK, 1984, NATURE, V312, P563, DOI 10.1038/312563a0; Crawley M.J., 2007, R BOOK; Cynx J, 1998, ANIM BEHAV, V56, P107, DOI 10.1006/anbe.1998.0746; DABELSTEEN T, 1981, Z TIERPSYCHOL, V56, P137; Dabelsteen Torben, 1998, Bioacoustics, V9, P89; de Kort SR, 2009, BEHAV ECOL, V20, P200, DOI 10.1093/beheco/arn135; de Kort SR, 2009, P ROY SOC B-BIOL SCI, V276, P2315, DOI 10.1098/rspb.2009.0127; Fitzsimmons LP, 2011, BEHAVIOUR, V148, P1045, DOI 10.1163/000579511X588812; Forstmeier W, 2004, BEHAV ECOL, V15, P555, DOI 10.1093/beheco/arh051; Garamszegi LZ, 2007, ETHOLOGY, V113, P246, DOI 10.1111/j.1439-0310.2007.01337.x; Garamszegi LZ, 2005, BEHAV ECOL, V16, P580, DOI 10.1093/beheco/ari029; Geberzahn N, 2009, BEHAV ECOL SOCIOBIOL, V64, P193, DOI 10.1007/s00265-009-0836-0; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Geslin T, 2004, BIRD STUDY, V51, P178, DOI 10.1080/00063650409461350; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Grapputo A, 2006, MOL ECOL NOTES, V6, P1070, DOI 10.1111/j.1471-8286.2006.01437.x; Griggio M, 2005, ANIM BEHAV, V69, P1243, DOI 10.1016/j.anbehav.2004.10.004; Griggio M, 2009, J EVOLUTION BIOL, V22, P2077, DOI 10.1111/j.1420-9101.2009.01823.x; Griggio M, 2007, BEHAV ECOL SOCIOBIOL, V61, P423, DOI 10.1007/s00265-006-0270-5; Hofstad E, 2002, CAN J ZOOL, V80, P524, DOI 10.1139/Z02-033; Jacot A, 2007, ETHOLOGY, V113, P615, DOI 10.1111/j.1439-0310.2007.01360.x; Judge KA, 2011, ANIM BEHAV, V81, P185, DOI 10.1016/j.anbehav.2010.09.032; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Kempenaers B, 1998, ANIM BEHAV, V55, P845, DOI 10.1006/anbe.1997.0667; Kiefer S, 2006, ETHOLOGY, V112, P1217, DOI 10.1111/j.1439-0310.2006.01283.x; Kipper S, 2010, ADV STUD BEHAV, V41, P77, DOI 10.1016/S0065-3454(10)41003-7; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Matessi G, 2005, BEHAVIOUR, V142, P507, DOI 10.1163/1568539054012010; Matessi G, 2007, BEHAVIOUR, V144, P735, DOI 10.1163/156853907781476382; Matessi G, 2009, BEHAVIOUR, V146, P209, DOI 10.1163/156853909X410748; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Murphy MT, 2008, ANIM BEHAV, V75, P1075, DOI 10.1016/j.anbehav.2007.08.020; Nemeth E, 2004, BIOACOUSTICS, V14, P225, DOI 10.1080/09524622.2004.9753527; Patricelli GL, 2008, ANIM BEHAV, V76, P1389, DOI 10.1016/j.anbehav.2008.07.005; Pilastro A, 2003, ANIM BEHAV, V66, P265, DOI 10.1006/anbe.2003.2203; Pilastro A, 2002, ANIM BEHAV, V63, P967, DOI 10.1006/anbe.2002.1987; Poesel A, 2006, ANIM BEHAV, V72, P531, DOI 10.1016/j.anbehav.2005.10.022; Price JJ, 2006, ANIM BEHAV, V71, P799, DOI 10.1016/j.anbehav.2005.05.025; RADESATER T, 1987, ANIM BEHAV, V35, P1645, DOI 10.1016/S0003-3472(87)80057-X; Ripmeester EAP, 2007, ETHOLOGY, V113, P1021, DOI 10.1111/j.1439-0310.2007.01398.x; Ritschard M, 2012, EVOL ECOL, V26, P801, DOI 10.1007/s10682-011-9541-3; Ritschard M, 2011, ANIM BEHAV, V82, P1415, DOI 10.1016/j.anbehav.2011.09.026; Ritschard M, 2010, ANIM BEHAV, V79, P877, DOI 10.1016/j.anbehav.2009.12.038; Ritschard M, 2012, ETHOLOGY, V118, P197, DOI 10.1111/j.1439-0310.2011.01999.x; Rivera-Gutierrez HF, 2010, ANIM BEHAV, V80, P451, DOI 10.1016/j.anbehav.2010.06.002; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Schmoll T, 2007, BEHAV ECOL, V18, P1073, DOI 10.1093/beheco/arm082; SEARCY WA, 1984, Z TIERPSYCHOL, V66, P128; Searcy WA, 1996, ETHOLOGY, V102, P187; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Soma M, 2011, BEHAV ECOL, V22, P363, DOI 10.1093/beheco/arq219; Suter SM, 2009, ANIM BEHAV, V77, P473, DOI 10.1016/j.anbehav.2008.11.002; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Vallet E, 1998, ANIM BEHAV, V55, P291, DOI 10.1006/anbe.1997.0631; Verburgt L, 2011, ANIM BEHAV, V81, P19, DOI 10.1016/j.anbehav.2010.09.010; WAGNER WE, 1992, ANIM BEHAV, V44, P449, DOI 10.1016/0003-3472(92)90055-E; Welling PP, 1997, BEHAVIOUR, V134, P891, DOI 10.1163/156853997X00214; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032	77	35	36	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43259	10.1371/journal.pone.0043259	http://dx.doi.org/10.1371/journal.pone.0043259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927955	Green Submitted, Green Published, gold			2022-12-27	WOS:000308224700013
J	De Marco, L; Manzini, P; Trevisan, M; Gillio-Tos, A; Danielle, F; Balloco, C; Pizzi, A; De Filippo, E; D'Antico, S; Violante, B; Valfre, A; Curti, F; Merletti, F; Richiardi, L				De Marco, Laura; Manzini, Paola; Trevisan, Morena; Gillio-Tos, Anna; Danielle, Franca; Balloco, Cinzia; Pizzi, Alessandra; De Filippo, Eleonora; D'Antico, Sergio; Violante, Beatrice; Valfre, Adriano; Curti, Franco; Merletti, Franco; Richiardi, Lorenzo			Prevalence and Follow-Up of Occult HCV Infection in an Italian Population Free of Clinically Detectable Infectious Liver Disease	PLOS ONE			English	Article							HEPATITIS-C VIRUS; BLOOD MONONUCLEAR-CELLS; MIXED CRYOGLOBULINEMIA; B-VIRUS; PERSISTENCE; COMPARTMENTALIZATION; SERUM; RNA	Background: Occult hepatitis C virus infection (OCI) is a recently described phenomenon characterized by undetectable levels of HCV-RNA in serum/plasma by current laboratory assays, with identifiable levels in peripheral blood mononuclear cells (PBMCs) and/or liver tissue by molecular tests with enhanced sensitivity. Previous results from our group showed an OCI prevalence of 3.3% in a population unselected for hepatic disease. The present study aimed to evaluate OCI prevalence in a larger cohort of infectious liver disease-free (ILDF) subjects. Clinical follow-up of OCI subjects was performed to investigate the natural history of the infection. Methods and Findings: 439 subjects referred to a Turin Blood Bank for phlebotomy therapy were recruited. They included 314 ILDF subjects, 40 HCV-positive subjects and 85 HBV-positive subjects, of whom 7 were active HBV carriers. Six subjects (4/314 ILDF subjects [1.27%] and 2/7 active HBV carriers [28%]) were positive for HCV-RNA in PBMCs, but negative for serological and virological markers of HCV, indicating OCI. HCV genotypes were determined in the PBMCs of 3/6 OCI subjects two had type 1b; the other had type 2a/2c. OCI subjects were followed up for at least 2 years. After 12 months only one OCI persisted, showing a low HCV viral load (3.73x10(1) UI/ml). By the end of follow-up all OCI subjects were negative for HCV. No seroconversion, alteration of liver enzyme levels, or reduction of liver synthesis occurred during follow-up. Conclusions: This study demonstrated the existence of OCI in ILDF subjects, and suggested a high OCI prevalence among active HBV carriers. Follow-up suggested that OCI could be transient, with a trend toward the decrease of HCV viral load to levels undetectable by conventional methods after 12-18 months. Confirmation studies with a longer follow-up period are needed for identification of the OCI clearance or recurrence rates, and to characterize the viruses involved.	[De Marco, Laura; Trevisan, Morena; Gillio-Tos, Anna; Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Canc Epidemiol Unit, CERMS, Turin, Italy; [Manzini, Paola; Danielle, Franca; Balloco, Cinzia; Pizzi, Alessandra; De Filippo, Eleonora; D'Antico, Sergio; Violante, Beatrice; Valfre, Adriano; Curti, Franco] AOU S Giovanni Battista, Blood Bank, Turin, Italy; [Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Ctr Oncol Prevent, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	De Marco, L (corresponding author), Univ Turin, Canc Epidemiol Unit, CERMS, Turin, Italy.	gilliotos.demarco@cpo.it	Trevisan, Morena/J-9088-2016; De Marco, Laura/J-7254-2016; richiardi, lorenzo/J-3480-2018	Trevisan, Morena/0000-0001-7982-7411; De Marco, Laura/0000-0003-2167-9270; richiardi, lorenzo/0000-0003-0316-9402; Gillio-Tos, Anna/0000-0001-6553-5362	Italian Association for Cancer Research; Compagnia di San Paolo/FIRMS (International Foundation for Research in Experimental Medicine); Piedmont Region; Italian Ministry of University and Research (MIUR); European Union; Italian Ministry of Health	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo/FIRMS (International Foundation for Research in Experimental Medicine)(Compagnia di San Paolo); Piedmont Region(Regione Piemonte); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported in part by the Italian Association for Cancer Research, the Compagnia di San Paolo/FIRMS (International Foundation for Research in Experimental Medicine), the Piedmont Region and the Italian Ministry of University and Research (MIUR), European Union, Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barril G, 2008, J AM SOC NEPHROL, V19, P2288, DOI 10.1681/ASN.2008030293; Bartolome J, 2007, J VIROL, V81, P7710, DOI 10.1128/JVI.02750-06; Bokharaei-Salim F, 2011, J MED VIROL, V83, P989, DOI 10.1002/jmv.22044; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; Carreno V, 2008, REV MED VIROL, V18, P139, DOI 10.1002/rmv.569; Carreno V, 2006, WORLD J GASTROENTERO, V12, P6922, DOI 10.3748/wjg.v12.i43.2000; Casato M, 2003, J VIRAL HEPATITIS, V10, P455, DOI 10.1046/j.1365-2893.2003.00462.x; Castillo I, 2004, J INFECT DIS, V189, P7, DOI 10.1086/380202; Castillo I, 2005, GUT, V54, P682, DOI 10.1136/gut.2004.057281; Castillo I, 2011, LIVER INT, V31, P1519, DOI 10.1111/j.1478-3231.2011.02613.x; Castillo I, 2009, J MED VIROL, V81, P1198, DOI 10.1002/jmv.21483; Coppola N, 2011, HEPATOLOGY, V54, P1487, DOI 10.1002/hep.24436; De Marco L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008128; Di Liberto G, 2006, GASTROENTEROLOGY, V131, P76, DOI 10.1053/j.gastro.2006.04.016; Giannini C, 2006, HEPATOLOGY, V43, P1166, DOI 10.1002/hep.21132; Halfon P, 2008, J CLIN MICROBIOL, V46, P2106, DOI 10.1128/JCM.00345-08; Halfon P, 2009, HEPATOLOGY, V50, P1675, DOI 10.1002/hep.23113; Jamma Shailaja, 2010, Curr Hepat Rep, V9, P260, DOI 10.1007/s11901-010-0060-4; Muazzam Ambreen G, 2011, Genet Vaccines Ther, V9, P14, DOI 10.1186/1479-0556-9-14; Nicot F, 2010, TRANSPL INT, V23, P594, DOI 10.1111/j.1432-2277.2009.01025.x; Pardo M, 2006, ALIMENT PHARM THER, V23, P1153, DOI 10.1111/j.1365-2036.2006.02886.x; Pham TNQ, 2007, J VIRAL HEPATITIS, V14, P537, DOI 10.1111/j.1365-2893.2006.00834.x; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Pham TN, 2008, WORLD J GASTROENTERO, V14, P2789, DOI 10.3748/wjg.14.2789; Pham TNQ, 2010, LIVER INT, V30, P502, DOI 10.1111/j.1478-3231.2009.02193.x; Radkowski M, 2005, J INFECT DIS, V191, P1730, DOI 10.1086/429834; Ramirez S, 2009, AM J TRANSPLANT, V9, P1591, DOI 10.1111/j.1600-6143.2009.02666.x; Richiardi L, 2010, CANCER EPIDEMIOL, V34, P709, DOI 10.1016/j.canep.2010.07.014; Roque-Afonso AM, 2005, J VIROL, V79, P6349, DOI 10.1128/JVI.79.10.6349-6357.2005; Welker MW, 2009, HEPATOLOGY, V49, P665, DOI 10.1002/hep.22706	30	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43541	10.1371/journal.pone.0043541	http://dx.doi.org/10.1371/journal.pone.0043541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927986	gold, Green Published			2022-12-27	WOS:000308286300065
J	Kim, KS; Lee, YH				Kim, Kyoung Su; Lee, Yong-Hwan			Gene Expression Profiling during Conidiation in the Rice Blast Pathogen Magnaporthe oryzae	PLOS ONE			English	Article							INFECTION-RELATED MORPHOGENESIS; ASPERGILLUS-NIDULANS; APPRESSORIUM DIFFERENTIATION; TRANSCRIPTION FACTOR; NEUROSPORA-CRASSA; CELL-TYPES; GRISEA; FUNGUS; PROTEIN; SPORULATION	Conidiation of phytopathogenic fungi is a key developmental process that plays a central role in their life cycles and in epidemics. However, there is little information on conidiation-induced molecular changes in the rice blast fungus Magnaporthe oryzae. As a first step to understand conidiogenesis in this fungus, we measured genome-wide gene expression profiles during conidiation using a whole genome oligonucleotide microarray. At a two-fold expression difference, approximately 4.42% and 4.08% of genes were upregulated and downregulated, respectively, during conidiation. The differentially expressed genes were functionally categorized by gene ontology (GO) term analysis, which demonstrated that the gene set encoded proteins that function in metabolism, cell wall biosynthesis, transcription, and molecule transport. To define the events of the complicated process of conidiogenesis, another set of microarray experiments was performed using a deletion mutant for MoHOX2, a stage-specific transcriptional regulator essential for conidial formation, which was expressed de novo in a conidiation-specific manner in M. oryzae. Gene expression profiles were compared between the wild-type and the Delta Mohox2 mutant during conidiation. This analysis defined a common gene set that was upregulated in the wild-type and downregulated in the Delta Mohox2 mutant during conidiation; this gene set is expected to include conidiation-related downstream genes of MoHOX2. We identified several hundred genes that are differentially-expressed during conidiation; our results serve as an important resource for understanding the conidiation, a process in M. oryzae, which is critical for disease development.	[Kim, Kyoung Su] Kangwon Natl Univ, Res Inst Agr & Life Sci, Coll Agr & Life Sci, Dept Appl Biol, Chunchon, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Plant Genom & Breeding Inst, Ctr Fungal Genet Resources, Ctr Fungal Pathogenesis,Dept Agr Biotechnol,Ctr A, Seoul, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Kangwon National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, KS (corresponding author), Kangwon Natl Univ, Res Inst Agr & Life Sci, Coll Agr & Life Sci, Dept Appl Biol, Chunchon, South Korea.	yonglee@snu.ac.kr		Kim, Kyoung Su/0000-0002-0827-0844	Kangwon National University; National Research Foundation of Korea; Korea government [2012-0001149, 2012-0000141]; Technology Development Program for Agriculture and Forestry [309015-04-SB020]; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea [PJ00821201]	Kangwon National University; National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government); Technology Development Program for Agriculture and Forestry; Next-Generation BioGreen 21 Program of Rural Development Administration in Korea	This work was supported by the 2011 Research Grant from Kangwon National University, the National Research Foundation of Korea grant funded by the Korea government (2012-0001149 and 2012-0000141), the Technology Development Program for Agriculture and Forestry (309015-04-SB020) and the Next-Generation BioGreen 21 Program of Rural Development Administration in Korea (PJ00821201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Choi J, 2009, FUNGAL GENET BIOL, V46, P243, DOI 10.1016/j.fgb.2008.11.010; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Donofrio NM, 2006, FUNGAL GENET BIOL, V43, P605, DOI 10.1016/j.fgb.2006.03.005; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; HAMER JE, 1989, GENETICS, V122, P351; Kamakura T, MOL PLANT MICROBE IN, V15, P437; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Lau GW, 1998, FUNGAL GENET BIOL, V24, P228, DOI 10.1006/fgbi.1998.1053; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Li D, 2005, GENETICS, V170, P1091, DOI 10.1534/genetics.104.036772; Liu WD, 2010, MOL PLANT MICROBE IN, V23, P366, DOI 10.1094/MPMI-23-4-0366; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Odenbach D, 2007, MOL MICROBIOL, V64, P293, DOI 10.1111/j.1365-2958.2007.05643.x; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; Ou SH, 1985, RICE DIS, P97; Park SY, 2010, PLANT PATHOLOGY J, V26, P313, DOI 10.5423/PPJ.2010.26.4.313; Shi ZX, 1998, MOL PLANT MICROBE IN, V11, P199, DOI 10.1094/MPMI.1998.11.3.199; SPRINGER ML, 1993, BIOESSAYS, V15, P365, DOI 10.1002/bies.950150602; Takano Y, 2003, MOL PLANT PATHOL, V4, P337, DOI [10.1046/j.1364-3703.2003.00182.x, 10.1046/J.1364-3703.2003.00182.X]; Yang J, 2010, MOL PLANT MICROBE IN, V23, P112, DOI 10.1094/MPMI-23-1-0112; Yu JH, 2006, EUKARYOT CELL, V5, P1577, DOI 10.1128/EC.00193-06; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402	33	19	20	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43202	10.1371/journal.pone.0043202	http://dx.doi.org/10.1371/journal.pone.0043202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927950	Green Submitted, Green Published, gold			2022-12-27	WOS:000307789700026
J	Cornella, M; Leung, S; Grimm, S; Escera, C				Cornella, Miriam; Leung, Sumie; Grimm, Sabine; Escera, Carles			Detection of Simple and Pattern Regularity Violations Occurs at Different Levels of the Auditory Hierarchy	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY MMN; SOUND LOCATION; EVOKED-POTENTIALS; CORTEX; SEQUENCES; ATTENTION; TRACKING	Auditory deviance detection in humans is indexed by the mismatch negativity (MMN), a component of the auditory evoked potential (AEP) of the electroencephalogram (EEG) occurring at a latency of 100-250 ms after stimulus onset. However, by using classic oddball paradigms, differential responses to regularity violations of simple auditory features have been found at the level of the middle latency response (MLR) of the AEP occurring within the first 50 ms after stimulus (deviation) onset. These findings suggest the existence of fast deviance detection mechanisms for simple feature changes, but it is not clear whether deviance detection among more complex acoustic regularities could be observed at such early latencies. To test this, we examined the pre-attentive processing of rare stimulus repetitions in a sequence of tones alternating in frequency in both long and middle latency ranges. Additionally, we introduced occasional changes in the interaural time difference (ITD), so that a simple-feature regularity could be examined in the same paradigm. MMN was obtained for both repetition and ITD deviants, occurring at 150 ms and 100 ms after stimulus onset respectively. At the level of the MLR, a difference was observed between standards and ITD deviants at the Na component (20-30 ms after stimulus onset), for 800 Hz tones, but not for repetition deviants. These findings suggest that detection mechanisms for deviants to simple regularities, but not to more complex regularities, are already activated in the MLR range, supporting the view that the auditory deviance detection system is organized in a hierarchical manner.	[Cornella, Miriam; Leung, Sumie; Grimm, Sabine; Escera, Carles] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Catalonia, Spain; [Cornella, Miriam; Leung, Sumie; Grimm, Sabine; Escera, Carles] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Cognit Neurosci Res Grp, Catalonia, Spain	University of Barcelona; University of Barcelona	Cornella, M (corresponding author), Univ Barcelona, Inst Brain Cognit & Behav IR3C, Catalonia, Spain.	cescera@ub.edu	2010, BRAINGLOT Consolider Ingenio/D-1235-2009; Grimm, Sabine/AAO-1547-2021; Escera, Carles/A-8658-2010	Escera, Carles/0000-0001-8203-2951; Leung, Sumie/0000-0003-3082-8936; Cornella, Miriam/0000-0002-2745-4518; Grimm, Sabine/0000-0002-9071-5944	Spanish Ministry of Science and Innovation (Programa Euroinvestigacion) [EUI2009-04086]; program Consolider-Ingenio [CDS2007-00012]; Juan de la Cierva fellowship [JCI-2009-04401]; Catalan Government [SGR2009-11]; ICREA Academia Distinguished Professorship	Spanish Ministry of Science and Innovation (Programa Euroinvestigacion); program Consolider-Ingenio; Juan de la Cierva fellowship; Catalan Government; ICREA Academia Distinguished Professorship(ICREA)	This work was supported by the Spanish Ministry of Science and Innovation (Programa Euroinvestigacion - EUI2009-04086, ERANET-NEURON PANS Project), the program Consolider-Ingenio 2010 (CDS2007-00012), a Juan de la Cierva fellowship awarded to Sabine Grimm (JCI-2009-04401), a grant from the Catalan Government (SGR2009-11), and the ICREA Academia Distinguished Professorship awarded to Carles Escera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 1994, NEUROREPORT, V6, P140, DOI 10.1097/00001756-199412300-00036; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Althen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028522; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Costa-Faidella J, 2011, PSYCHOPHYSIOLOGY, V48, P774, DOI 10.1111/j.1469-8986.2010.01144.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deouell LY, 2007, J PSYCHOPHYSIOL, V21, P188, DOI 10.1027/0269-8803.21.34.188; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Grimm S, 2012, BIOL PSYCHOL, V89, P232, DOI 10.1016/j.biopsycho.2011.10.014; Grimm S, 2012, INT J PSYCHOPHYSIOL, V85, P88, DOI 10.1016/j.ijpsycho.2011.05.012; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; Horvath J, 2001, COGNITIVE BRAIN RES, V12, P131, DOI 10.1016/S0926-6410(01)00038-6; Kaiser J, 2000, J NEUROSCI, V20, P6631, DOI 10.1523/JNEUROSCI.20-17-06631.2000; Kleiner M, 2007, PERC 36 ECVP S; Leung S, 2012, PSYCHOPHYSIOLOGY, V49, P933, DOI 10.1111/j.1469-8986.2012.01375.x; Lewald J, 2008, EUR J NEUROSCI, V27, P1261, DOI 10.1111/j.1460-9568.2008.06094.x; Maess B, 2007, NEUROIMAGE, V37, P561, DOI 10.1016/j.neuroimage.2007.05.040; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Muller MM, 2001, EXP BRAIN RES, V136, P474, DOI 10.1007/s002210000597; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Nager W, 2003, NEUROSCI LETT, V344, P181, DOI 10.1016/S0304-3940(03)00439-7; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; NORDBY H, 1988, PSYCHOPHYSIOLOGY, V25, P262, DOI 10.1111/j.1469-8986.1988.tb01239.x; PAAVILAINEN P, 1989, ELECTROEN CLIN NEURO, V73, P129, DOI 10.1016/0013-4694(89)90192-2; Pakarinen S, 2007, CLIN NEUROPHYSIOL, V118, P177, DOI 10.1016/j.clinph.2006.09.001; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; RITTER W, 1992, ELECTROEN CLIN NEURO, V83, P306, DOI 10.1016/0013-4694(92)90090-5; Sculthorpe LD, 2008, BRAIN RES, V1234, P78, DOI 10.1016/j.brainres.2008.07.031; Slabu L, 2012, J NEUROSCI, V32, P1447, DOI 10.1523/JNEUROSCI.2557-11.2012; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Sonnadara RR, 2006, BRAIN RES, V1076, P187, DOI 10.1016/j.brainres.2005.12.093; Sussman E, 1998, BRAIN RES, V793, P95, DOI 10.1016/S0006-8993(98)00164-4; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Todorovic A, 2011, J NEUROSCI, V31, P9118, DOI 10.1523/JNEUROSCI.1425-11.2011; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Umbricht D, 2002, BIOL PSYCHIAT, V51, P400, DOI 10.1016/S0006-3223(01)01242-2; Winkler I, 1998, NEUROREPORT, V9, P3809, DOI 10.1097/00001756-199812010-00008; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Yvert B, 2005, NEUROIMAGE, V28, P140, DOI 10.1016/j.neuroimage.2005.05.056; Yvert B, 2001, CEREB CORTEX, V11, P411, DOI 10.1093/cercor/11.5.411	48	48	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43604	10.1371/journal.pone.0043604	http://dx.doi.org/10.1371/journal.pone.0043604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916282	Green Published, gold			2022-12-27	WOS:000307733800081
J	Miller, KR; Koide, A; Leung, B; Fitzsimmons, J; Yoder, B; Yuan, H; Jay, M; Sidhu, SS; Koide, S; Collins, EJ				Miller, Keith R.; Koide, Akiko; Leung, Brenda; Fitzsimmons, Jonathan; Yoder, Bryan; Yuan, Hong; Jay, Michael; Sidhu, Sachdev S.; Koide, Shohei; Collins, Edward J.			T Cell Receptor-Like Recognition of Tumor In Vivo by Synthetic Antibody Fragment	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MHC CLASS-I; BREAST-CANCER; METASTATIC MELANOMA; INFILTRATING LYMPHOCYTES; RECOMBINANT ANTIBODIES; RESTRICTED SPECIFICITY; MONOCLONAL-ANTIBODIES; BIOLOGICAL EVALUATION; ESCHERICHIA-COLI	A major difficulty in treating cancer is the inability to differentiate between normal and tumor cells. The immune system differentiates tumor from normal cells by T cell receptor (TCR) binding of tumor-associated peptides bound to Major Histocompatibility Complex (pMHC) molecules. The peptides, derived from the tumor-specific proteins, are presented by MHC proteins, which then serve as cancer markers. The TCR is a difficult protein to use as a recombinant protein because of production issues and has poor affinity for pMHC; therefore, it is not a good choice for use as a tumor identifier outside of the immune system. We constructed a synthetic antibody-fragment (Fab) library in the phage-display format and isolated antibody-fragments that bind pMHC with high affinity and specificity. One Fab, fE75, recognizes our model cancer marker, the Human Epidermal growth factor Receptor 2 (HER2/neu) peptide, E75, bound to the MHC called Human Leukocyte Antigen-A2 (HLA-A2), with nanomolar affinity. The fE75 bound selectively to E75/HLA-A2 positive cancer cell lines in vitro. The fE75 Fab conjugated with Cu-64 selectively accumulated in E75/HLA-A2 positive tumors and not in E75/HLA-A2 negative tumors in an HLA-A2 transgenic mouse as probed using positron emission tomography/computed tomography (PET/CT) imaging. Considering that hundreds to thousands of different peptides bound to HLA-A2 are present on the surface of each cell, the fact that fE75 arrives at the tumor at all shows extraordinary specificity. These antibody fragments have great potential for diagnosis and targeted drug delivery in cancer.	[Koide, Akiko; Leung, Brenda; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biophys, Chicago, IL 60637 USA; [Miller, Keith R.; Collins, Edward J.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Fitzsimmons, Jonathan; Jay, Michael] Univ N Carolina, Dept Pharmaceut Sci, Chapel Hill, NC USA; [Yoder, Bryan; Yuan, Hong] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Collins, Edward J.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University of North Carolina; University of North Carolina Chapel Hill	Koide, S (corresponding author), Univ Chicago, Dept Biochem & Mol Biophys, Chicago, IL 60637 USA.	skoide@uchicago.edu; edward_collins@med.unc.edu	, PEP-MX Core/AGV-4051-2022; , UNC Flow Cytometry Core/AGU-9839-2022	Yuan, Hong/0000-0002-0535-3214; Koide, Shohei/0000-0001-5473-4358	National Institutes of Health [AI088081]; NIH [R01-GM072688, P30 AI50410]; University of Chicago Comprehensive Cancer Center; DANA Foundation; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR); University of North Carolina University Cancer Research Fund pilot project award; NCI Center Core Support Grant [P30CA06086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, R21AI088081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center; DANA Foundation; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR); University of North Carolina University Cancer Research Fund pilot project award; NCI Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health AI088081 (EJC), NIH R01-GM072688 (AK), the University of Chicago Comprehensive Cancer Center, the DANA Foundation (http://www.dana.org), the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded program P30 AI50410 and a University of North Carolina University Cancer Research Fund pilot project award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ashutosh Tripathy, scientific director of the Macromolecular Interactions Facility at the University of North Carolina at Chapel Hill for his assistance in collecting our SPR data and Drs. Erica Duguid and Chuan He at the University of Chicago for their assistance in oligonucleotide synthesis. We also thank the UNC Flow Cytometry Core Facility, supported in part by an NCI Center Core Support Grant (P30CA06086) to the UNC Lineberger Comprehensive Cancer Center.	ABASTADO JP, 1989, RES IMMUNOL, V140, P581, DOI 10.1016/0923-2494(89)90121-1; Alberti S, 1996, IMMUNOL CELL BIOL, V74, P292, DOI 10.1038/icb.1996.51; Andersen PS, 1996, P NATL ACAD SCI USA, V93, P1820, DOI 10.1073/pnas.93.5.1820; Anikeeva N, 2009, CLIN IMMUNOL, V130, P98, DOI 10.1016/j.clim.2008.08.025; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; Brossart P, 2000, BLOOD, V96, P3102, DOI 10.1182/blood.V96.9.3102.h8003102_3102_3108; Capala J, 2010, CURR OPIN ONCOL, V22, P559, DOI 10.1097/CCO.0b013e32833f8c3a; CHATZIIOANNOU AF, 2005, P AM THORAC SOC, V2, P510; Chatziioannou Arion F, 2005, Proc Am Thorac Soc, V2, P533, DOI 10.1513/pats.200508-079DS; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; Cohen CJ, 2003, J IMMUNOL, V170, P4349, DOI 10.4049/jimmunol.170.8.4349; Colcher D, 1998, Q J NUCL MED, V42, P225; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Denkberg G, 2002, P NATL ACAD SCI USA, V99, P9421, DOI 10.1073/pnas.132285699; Dogan I, 2004, EUR J IMMUNOL, V34, P598, DOI 10.1002/eji.200324721; DUC HT, 1993, INT IMMUNOL, V5, P427, DOI 10.1093/intimm/5.4.427; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Edwards LJ, 2011, IMMUNOL RES, V50, P39, DOI 10.1007/s12026-011-8204-3; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Engberg J, 1999, IMMUNOTECHNOLOGY, V4, P273; Falkenburg JHF, 2011, BLOOD, V117, P4164, DOI 10.1182/blood-2011-03-335943; Faure F, 1998, CRIT REV IMMUNOL, V18, P77, DOI 10.1615/CritRevImmunol.v18.i1-2.90; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; FISK B, 1995, J EXP MED, V181, P2109, DOI 10.1084/jem.181.6.2109; FROSCHER BG, 1986, J EXP MED, V164, P196, DOI 10.1084/jem.164.1.196; FUJIMORI K, 1989, CANCER RES, V49, P5656; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Gonzalez-Angulo AM, 2007, ADV EXPT MED BIOL; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Hawkins O, 2011, J IMMUNOL, V186, P6607, DOI 10.4049/jimmunol.1003995; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Heneweer C, 2011, J NUCL MED, V52, P625, DOI 10.2967/jnumed.110.083998; HOLTON OD, 1987, J IMMUNOL, V139, P3041; Homola J, 2006, SPRINGER SER CHEM SE, V4, P1, DOI 10.1007/b100321; Hoogenboom HR, 1998, IMMUNOTECHNOLOGY, V4, P1, DOI 10.1016/S1380-2933(98)00007-4; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Hulsmeyer M, 2005, J BIOL CHEM, V280, P2972, DOI 10.1074/jbc.M411323200; IOANNIDES CG, 1993, CLIN IMMUNOL IMMUNOP, V66, P91, DOI 10.1006/clin.1993.1012; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; Kelly MP, 2008, CANCER BIOTHER RADIO, V23, P411, DOI 10.1089/cbr.2007.0450; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Klechevsky E, 2008, CANCER RES, V68, P6360, DOI 10.1158/0008-5472.CAN-08-0928; Knutson KL, 2002, CLIN CANCER RES, V8, P1014; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Kono K, 2002, CLIN CANCER RES, V8, P3394; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Lane SR, 2010, NUCL MED BIOL, V37, P751, DOI 10.1016/j.nucmedbio.2010.04.016; LE AXT, 1989, J IMMUNOL, V142, P1366; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Lewis MR, 2001, BIOCONJUGATE CHEM, V12, P320, DOI 10.1021/bc0000886; Leyland-Jones B, 2002, LANCET ONCOL, V3, P137, DOI 10.1016/S1470-2045(02)00676-9; Lo BKC, 2003, ANTIBODY ENG; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Lohrisch C, 2008, CLIN BREAST CANCER, V2, P129; Luft T, 2001, J IMMUNOL, V167, P2529, DOI 10.4049/jimmunol.167.5.2529; Mareeva T, 2004, J BIOL CHEM, V279, P44243, DOI 10.1074/jbc.M407021200; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; MELIEF CJM, 1992, ADV CANCER RES, V58, P143, DOI 10.1016/S0065-230X(08)60294-8; Michaeli Y, 2009, J IMMUNOL, V182, P6328, DOI 10.4049/jimmunol.0801898; Miles J., 2001, APPL REGRESSION CORR; Mittendorf EA, 2006, CANCER-AM CANCER SOC, V106, P2309, DOI 10.1002/cncr.21849; Mohsin H, 2007, NUCL MED BIOL, V34, P493, DOI 10.1016/j.nucmedbio.2007.03.006; Morgan RA, 2010, CANCER J, V16, P336, DOI 10.1097/PPO.0b013e3181eb3879; Murray JL, 2002, CLIN CANCER RES, V8, P3407; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Neumann F, 2009, IMMUNOL LETT, V125, P86, DOI 10.1016/j.imlet.2009.06.002; Nishimura R, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-131; Orlova A, 2007, CANCER BIOTHER RADIO, V22, P573, DOI 10.1089/cbr.2006.004-U; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Phan GQ, 2001, EXPERT OPIN BIOL TH, V1, P511, DOI 10.1517/14712598.1.3.511; Pinthus JH, 2004, J CLIN INVEST, V114, P1774, DOI 10.1172/JCI200422284; Plaksin D, 1997, J IMMUNOL, V158, P2218; Polakova K, 2000, J IMMUNOL, V165, P5703, DOI 10.4049/jimmunol.165.10.5703; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reiter Y, 1997, P NATL ACAD SCI USA, V94, P4631, DOI 10.1073/pnas.94.9.4631; ROSENBERG SA, 1988, ANN SURG, V208, P121, DOI 10.1097/00000658-198808000-00001; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; SHIRAI M, 1995, J IMMUNOL, V154, P2733; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Somasundaram R, 2004, CLIN EXP IMMUNOL, V135, P247, DOI 10.1111/j.1365-2249.2003.02366.x; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; TAMMINEN WL, 1987, EUR J IMMUNOL, V17, P999, DOI 10.1002/eji.1830170716; Topalian S L, 1990, Important Adv Oncol, P19; Toseland CP, 2005, IMMUNOME RES, V1, P1; Verma B, 2010, J IMMUNOL, V184, P2156, DOI 10.4049/jimmunol.0902414; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; VOSE BM, 1985, SEMIN HEMATOL, V22, P27; Wang LJ, 2009, MOL PHARMACEUT, V6, P231, DOI 10.1021/mp800150r; Weidanz JA, 2006, J IMMUNOL, V177, P5088, DOI 10.4049/jimmunol.177.8.5088; WHITESIDE TL, 1994, IMMUNOL SER, V61, P137; Whitfield-Larry F, 2011, DIABETES, V60, P1726, DOI 10.2337/db10-1287; Willemsen R, 2008, CYTOM PART A, V73A, P1093, DOI 10.1002/cyto.a.20644; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; WULFING C, 1994, J MOL BIOL, V242, P655, DOI 10.1006/jmbi.1994.1615; WYLIE DE, 1982, J EXP MED, V155, P403, DOI 10.1084/jem.155.2.403; Xue SA, 2005, BLOOD, V106, P3062, DOI 10.1182/blood-2005-01-0146; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhu XK, 2010, IMMUNOL CELL BIOL, V88, P667, DOI 10.1038/icb.2010.21	104	50	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43746	10.1371/journal.pone.0043746	http://dx.doi.org/10.1371/journal.pone.0043746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916301	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800099
J	Seto, WK; Wong, DKH; Fung, J; Ip, PPC; Yuen, JCH; Hung, IFN; Lai, CL; Yuen, MF				Seto, Wai-Kay; Wong, Danny Ka-Ho; Fung, James; Ip, Philip P. C.; Yuen, John Chi-Hang; Hung, Ivan Fan-Ngai; Lai, Ching-Lung; Yuen, Man-Fung			High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B	PLOS ONE			English	Article							SERUM ALANINE AMINOTRANSFERASE; NATURAL-HISTORY; LIVER HISTOLOGY; HBEAG; DNA; SEVERITY	Introduction: There is no data on the relationship between hepatitis B surface antigen (HBsAg) levels and liver fibrosis in hepatitis B e antigen (HBeAg)-positive patients with chronic hepatitis B (CHB). Methods: Serum HBsAg and HBV DNA levels in HBeAg-positive CHB patients with liver biopsies were analyzed. The upper limit of normal (ULN) of alanine aminotransferase (ALT) was 30 and 19 U/L for men and women respectively. Histologic assessment was based on Ishak fibrosis staging for fibrosis and Knodell histologic activity index (HAI) for necroinflammation. Results: 140 patients (65% male, median age 32.7 years) were recruited. 56 (40%) had ALT <= 2xULN. 72 (51.4%) and 42 (30%) had fibrosis score <= 1 and necroinflammation grading <= 4 respectively. Patients with fibrosis score <= 1, when compared to patients with fibrosis score >1, had significantly higher median HBsAg levels (50,320 and 7,820 IU/mL respectively, p<0.001). Among patients with ALT <= 2xULN, serum HBsAg levels achieved an area under receiver operating characteristic curve of 0.869 in predicting fibrosis score <= 1. HBsAg levels did not accurately predict necroinflammation score. HBsAg >= 25,000 IU/mL was independently associated with fibrosis score <= 1 (p = 0.025, odds ratio 9.042). Using this cut-off HBsAg level in patients with ALT <= 2xULN, positive and negative predictive values for predicting fibrosis score <= 1 were 92.7% and 60.0% respectively. HBV DNA levels had no association with liver histology. Conclusion: Among HBeAg-positive patients with ALT <= 2xULN, high serum HBsAg levels can accurately predict fibrosis score <= 1, and could potentially influence decisions concerning treatment commencement and reduce the need for liver biopsy.	[Seto, Wai-Kay; Wong, Danny Ka-Ho; Fung, James; Yuen, John Chi-Hang; Hung, Ivan Fan-Ngai; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ip, Philip P. C.] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Seto, WK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Ip, Philip/AAV-5995-2021; Wong, Danny/S-6230-2019; SETO, Wai-Kay/H-4452-2012; Fung, James/AAG-4832-2020; Wong, Danny/H-6819-2016; Hung, Ivan FN/ABD-5916-2021	Ip, Philip/0000-0002-0493-9838; SETO, Wai-Kay/0000-0002-9012-313X; Hung, Ivan FN/0000-0002-1556-2538; Fung, James/0000-0002-1286-8902; Lai, Ching-Lung/0000-0002-5927-2436; /0000-0001-9078-5005				Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Chen CJ, 2011, HEPATOLOGY, V54, p881A; Colloredo G, 1999, J VIRAL HEPATITIS, V6, P429, DOI 10.1046/j.1365-2893.1999.00171.x; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Fung J, 2011, HEPATOL INT, V5, P868, DOI 10.1007/s12072-011-9288-5; Fung J, 2010, EXPERT REV ANTI-INFE, V8, P717, DOI 10.1586/ERI.10.45; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mani H, 2009, HEPATOLOGY, V49, pS61, DOI 10.1002/hep.22930; Martinot-Peignoux M, 2012, J HEPATOL, V56, pS211, DOI 10.1016/S0168-8278(12)60545-5; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pollicino T, 2012, HEPATOLOGY; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032622; Seto WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023077; Seto WK, 2012, HEPATOLOGY; Sumi H, 2003, HEPATOLOGY, V37, P19, DOI 10.1053/jhep.2003.50036; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Wai CT, 2006, LIVER INT, V26, P666, DOI 10.1111/j.1478-3231.2006.01287.x; Wiegand J, 2008, ANTIVIR THER, V13, P547; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Yuen MF, 2005, J VIRAL HEPATITIS, V12, P513, DOI 10.1111/j.1365-2893.2005.00629.x; Yuen MF, 2005, ALIMENT PHARM THERAP, V21, P841, DOI 10.1111/j.1365-2036.2005.02410.x; Yuen MF, 2004, AM J GASTROENTEROL, V99, P2032, DOI 10.1111/j.1572-0241.2004.40440.x; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960	39	60	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43087	10.1371/journal.pone.0043087	http://dx.doi.org/10.1371/journal.pone.0043087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916211	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800046
J	Borte, S; Janzi, M; Pan-Hammarstrom, Q; von Dobeln, U; Nordvall, L; Winiarski, J; Fasth, A; Hammarstrom, L				Borte, Stephan; Janzi, Magdalena; Pan-Hammarstrom, Qiang; von Dobeln, Ulrika; Nordvall, Lennart; Winiarski, Jacek; Fasth, Anders; Hammarstrom, Lennart			Placental Transfer of Maternally-Derived IgA Precludes the Use of Guthrie Card Eluates as a Screening Tool for Primary Immunodeficiency Diseases	PLOS ONE			English	Article							COMBINED IMMUNE-DEFICIENCY; ADENOSINE-DEAMINASE DEFICIENCY; X-LINKED AGAMMAGLOBULINEMIA; BONE-MARROW-TRANSPLANTATION; COMPLETE DIGEORGE-SYNDROME; STEM-CELL TRANSPLANTATION; ATAXIA-TELANGIECTASIA PATIENTS; ACUTE LYMPHOBLASTIC-LEUKEMIA; EPSTEIN-BARR-VIRUS; PRE-B-CELLS	There is a need for neonatal screening tools to improve the long-term clinical outcome of patients with primary immunodeficiency diseases (PID). Recently, a PCR-based screening method for both TRECs and KRECs using Guthrie card samples has been developed. However, the applicability of these excision circle assays is limited to patients with severe T or B cell lymphopenia (SCID, XLA and A-T), whereas the most common forms of PID are not detected. Absence of serum IgA is seen in a major fraction of patients with immunological defects. As serum IgA in newborns is considered to be of fetal origin, eluates from routinely collected dried blood spot samples might thus be suitable for identification of children with PID. To assess the applicability of such screening assays, stored Guthrie card samples were obtained from 47 patients with various forms of primary immunodeficiency diseases (SCID, XLA, A-T, HIGM and IgAD), 20 individuals with normal serum IgA levels born to IgA-deficient mothers and 51 matched healthy newborns. Surprisingly, normal serum IgA levels were found in all SCID, XLA, A-T and HIGM patients and, additionally, in all those IgAD patients born to IgA-sufficient mothers. Conversely, no serum IgA was found in any of the 16 IgAD patients born by IgA-deficient mothers. Moreover, half of the IgA-sufficient individuals born by IgA-deficient mothers also lacked IgA at birth whereas no IgA-deficient individuals were found among the controls. IgA in neonatal dried blood samples thus appears to be of both maternal and fetal origin and precludes its use as a reliable marker for neonatal screening of primary immunodeficiency diseases.	[Borte, Stephan; Janzi, Magdalena; Pan-Hammarstrom, Qiang; Hammarstrom, Lennart] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Immunol & Transfus Med, Stockholm, Sweden; [Borte, Stephan] Univ Leipzig, Translat Ctr Regenerat Med TRM, Leipzig, Germany; [Borte, Stephan] Hosp St Georg gGmbH Leipzig, Jeffrey Modell Diagnost & Res Ctr Primary Immunod, ImmunoDeficiencyCtr Leipzig IDCL, Leipzig, Germany; [von Dobeln, Ulrika] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Metab Dis, Stockholm, Sweden; [Nordvall, Lennart] Uppsala Univ, Acad Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Winiarski, Jacek] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Pediat CLINTEC, Stockholm, Sweden; [Fasth, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Pediat, Gothenburg, Sweden	Karolinska Institutet; Karolinska University Hospital; Leipzig University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg	Borte, S (corresponding author), Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Immunol & Transfus Med, Stockholm, Sweden.	stephan.borte@ki.se; lennart.hammarstrom@ki.se	hammarstrom, qiang pan/ABA-4589-2021; Fasth, Anders/I-1109-2019	Fasth, Anders/0000-0002-0033-740X; pan-hammarstrom, qiang/0000-0003-1990-8804	Jeffrey Modell Foundation; Swedish Primary Immunodeficiency Organisation (PIO); Gillbergska Foundation; Karolinska Institutet; Swedish Research Council; European Union [223293]; German Federal Ministry of Education and Research (BMBF) [PtJ-Bio 0315883]; National Research School in Health and Caring Science	Jeffrey Modell Foundation; Swedish Primary Immunodeficiency Organisation (PIO); Gillbergska Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Research School in Health and Caring Science	The herein presented research was supported in part by the Jeffrey Modell Foundation (to S. B. and L. H.), the Swedish Primary Immunodeficiency Organisation (PIO), the Gillbergska Foundation, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet, the Swedish Research Council, the European Union (Euro-Gene-Scan, project 223293) and the German Federal Ministry of Education and Research (BMBF, PtJ-Bio 0315883). M.J. was supported by an educational grant from the National Research School in Health and Caring Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMANOLIS DP, 1979, J NEUROPATH EXP NEUR, V38, P475, DOI 10.1097/00005072-197909000-00003; Akha AAS, 1999, MEDICINE, V78, P370, DOI 10.1097/00005792-199911000-00002; Al-Tamemi S, 2005, PEDIATRICS, V116, pE457, DOI 10.1542/peds.2005-0371; ANDERSSON U, 1980, EUR J IMMUNOL, V10, P888, DOI 10.1002/eji.1830101115; AVRECH OM, 1994, INT ARCH ALLERGY IMM, V103, P160, DOI 10.1159/000236622; Ben-Hur H, 2005, INT J MOL MED, V16, P401; Ben-Hur Herzl, 1997, Human Antibodies, V8, P119; Berlucchi M, 2008, J PEDIATR-US, V153, P293, DOI 10.1016/j.jpeds.2008.03.008; BILLINGTON WD, 1992, BAILLIERE CLIN OB GY, V6, P417, DOI 10.1016/S0950-3552(05)80004-5; Bjerkli IH, 1996, INT J PEDIATR OTORHI, V36, P205, DOI 10.1016/0165-5876(96)01344-4; BORDIGONI P, 1982, LANCET, V2, P293; Borte S, 2012, BLOOD, V119, P2552, DOI 10.1182/blood-2011-08-371021; Borte S, 2011, ANN NY ACAD SCI, V1246, P118, DOI 10.1111/j.1749-6632.2011.06350.x; BORZY MS, 1989, J CLIN IMMUNOL, V9, P386, DOI 10.1007/BF00917103; Butte MJ, 2007, CLIN IMMUNOL, V125, P159, DOI 10.1016/j.clim.2007.06.007; CEDERQVIST LL, 1974, J IMMUNOL, V112, P1605; CEDERQVIST LL, 1978, AM J OBSTET GYNECOL, V131, P520, DOI 10.1016/0002-9378(78)90113-8; CEDERQVIST LL, 1977, AM J OBSTET GYNECOL, V129, P687, DOI 10.1016/0002-9378(77)90653-6; COHEN LE, 1984, J AM ACAD DERMATOL, V10, P431, DOI 10.1016/S0190-9622(84)80089-4; Collard HR, 1999, CLIN IMMUNOL, V91, P156, DOI 10.1006/clim.1999.4691; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Cossu F, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-76; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; Durandy A, 2005, IMMUNOL REV, V203, P67, DOI 10.1111/j.0105-2896.2005.00222.x; Dvorak CC, 2008, J PEDIAT HEMATOL ONC, V30, P396, DOI 10.1097/MPH.0b013e318168e7a0; Ehl S, 2005, J CLIN INVEST, V115, P3140, DOI 10.1172/JCI25221; FIORILLI M, 1986, J CLIN IMMUNOL, V6, P21, DOI 10.1007/BF00915360; FIORILLI M, 1983, J CLIN IMMUNOL, V3, P135, DOI 10.1007/BF00915484; Forte W C Neves, 2005, Allergol Immunopathol (Madr), V33, P199; FRAIS MA, 1979, J MED GENET, V16, P160, DOI 10.1136/jmg.16.2.160; Fried AJ, 2009, CLIN MICROBIOL REV, V22, P396, DOI 10.1128/CMR.00001-09; Gaspar HB, 2006, MOL THER, V14, P505, DOI 10.1016/j.ymthe.2006.06.007; GATHINGS WE, 1977, EUR J IMMUNOL, V7, P804, DOI 10.1002/eji.1830071112; GATTI RA, 1968, LANCET, V2, P1366; Giliani S, 2006, J PEDIATR-US, V148, P272, DOI 10.1016/j.jpeds.2005.10.004; Giliani S, 2005, IMMUNOL REV, V203, P110, DOI 10.1111/j.0105-2896.2005.00234.x; Ginn Samantha L, 2004, Hum Mutat, V23, P522; GOLDSOBEL AB, 1987, J PEDIATR-US, V111, P40, DOI 10.1016/S0022-3476(87)80339-6; Graziani S, 2008, CLIN IMMUNOL, V128, P322, DOI 10.1016/j.clim.2008.05.012; Gruber TA, 2009, PEDIATR TRANSPLANT, V13, P244, DOI 10.1111/j.1399-3046.2008.00970.x; Gudmundsson KO, 1999, SCAND J IMMUNOL, V50, P21; Gurevich P, 2001, Early Pregnancy, V5, P191; GUSDON JP, 1969, AM J OBSTET GYNECOL, V103, P895, DOI 10.1016/S0002-9378(16)34434-9; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; Hartel C, 2004, KLIN PADIATR, V216, P24, DOI 10.1055/5-2004-817993; HIRSCHHORN R, 1991, AM J HUM GENET, V49, P878; HIRSCHHORN R, 1993, CELL IMMUNOL, V152, P383, DOI 10.1006/cimm.1993.1299; Honig M, 2007, BLOOD, V109, P3595, DOI 10.1182/blood-2006-07-034678; Huang Kuei-Yu, 2001, Journal of Microbiology Immunology and Infection, V34, P71; Huang LH, 2005, ASIAN PAC J ALLERGY, V23, P221; HUMPHREYS MW, 1989, HUM GENET, V83, P79, DOI 10.1007/BF00274154; Hunter HL, 2008, CLIN EXP DERMATOL, V33, P148, DOI 10.1111/j.1365-2230.2007.02582.x; Janda A, 2007, PEDIATR TRANSPLANT, V11, P441, DOI 10.1111/j.1399-3046.2007.00702.x; Janic D, 2007, J PEDIAT HEMATOL ONC, V29, P713, DOI 10.1097/MPH.0b013e31814d67f4; Janzi M, 2009, PLOS ONE, pe5321; Jiang CK, 1997, HUM MOL GENET, V6, P2271, DOI 10.1093/hmg/6.13.2271; Jo EK, 2004, INT J HEMATOL, V80, P332, DOI 10.1532/IJH97.04026; Karaca NE, 2009, CLIN EXP MED, V9, P339, DOI 10.1007/s10238-009-0053-1; Kasasbeh E, 2008, CLIN MOL ALLERGY, V6, P1; Kellermayer R, 2006, J HUM GENET, V51, P495, DOI 10.1007/s10038-006-0386-5; Khumalo NP, 2001, BRIT J DERMATOL, V144, P369, DOI 10.1046/j.1365-2133.2001.04029.x; LANDRETH KS, 1985, J CLIN IMMUNOL, V5, P84, DOI 10.1007/BF00915005; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Malek A, 1996, AM J REPROD IMMUNOL, V36, P248; Malek A, 1998, AM J REPROD IMMUNOL, V40, P347; Markert ML, 1998, J PEDIATR-US, V132, P15, DOI 10.1016/S0022-3476(98)70478-0; Markert ML, 1997, J IMMUNOL, V158, P998; Matsumoto T, 1998, BONE MARROW TRANSPL, V22, P927, DOI 10.1038/sj.bmt.1701475; McDonald PS, 1998, PEDIATR DEVEL PATHOL, V1, P319, DOI 10.1007/s100249900046; Mella P, 2000, CLIN IMMUNOL, V95, P39, DOI 10.1006/clim.2000.4842; MESHRAM CM, 1986, J NEUROL, V233, P304, DOI 10.1007/BF00314163; Meyts I, 2003, PEDIATR ALLERGY IMMU, V14, P330, DOI 10.1034/j.1399-3038.2003.00037.x; Mitsui T, 2006, INT J HEMATOL, V84, P154, DOI 10.1532/IJH97.06095; MITSUYA H, 1981, CLIN IMMUNOL IMMUNOP, V19, P383, DOI 10.1016/0090-1229(81)90081-7; MIYAGI K, 1995, ACTA NEUROCHIR, V135, P87, DOI 10.1007/BF02307420; MIYAWAKI T, 1988, J IMMUNOL, V140, P3887; Moin M, 2007, PEDIATR NEUROL, V37, P21, DOI 10.1016/j.pediatrneurol.2007.03.002; Mustillo P, 2008, PEDIATR BLOOD CANCER, V51, P706, DOI 10.1002/pbc.21651; NELSON DL, 1983, J IMMUNOL, V130, P2629; Noordzij JG, 2009, ARCH DIS CHILD, V94, P448, DOI 10.1136/adc.2008.149351; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; OCHS HD, 1992, BLOOD, V80, P1163; Ohm-Laursen L, 2008, J CLIN IMMUNOL, V28, P588, DOI 10.1007/s10875-008-9210-7; Onodera M, 1998, BLOOD, V91, P30, DOI 10.1182/blood.V91.1.30.30_30_36; Otabor IA, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-29; OXELIUS VA, 1979, CLIN EXP IMMUNOL, V36, P112; Ozdemir O, 2006, ALLERGY ASTHMA PROC, V27, P172; OZER NK, 1985, CLIN EXP IMMUNOL, V61, P118; Ozsahin H, 1997, BLOOD, V89, P2849, DOI 10.1182/blood.V89.8.2849; Palmer K, 2007, J ALLERGY CLIN IMMUN, V120, P423, DOI 10.1016/j.jaci.2007.02.047; Pan-Hammarstrom Q, 2008, EUR J IMMUNOL, V38, P327, DOI 10.1002/eji.200737927; Pasic S, 2009, ACTA PAEDIATR, V98, P1062, DOI 10.1111/j.1651-2227.2009.01250.x; Pirovano S, 2003, IMMUNOL LETT, V86, P93, DOI 10.1016/S0165-2478(02)00291-2; Ponda P, 2006, ANN ALLERG ASTHMA IM, V97, P755, DOI 10.1016/S1081-1206(10)60965-9; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Quan CP, 1998, EUR J IMMUNOL, V28, P4001, DOI 10.1002/(SICI)1521-4141(199812)28:12<4001::AID-IMMU4001>3.3.CO;2-T; Quartier P, 1995, J PEDIAT, V134, P589; QUIE PG, 1990, SEMIN PERINATOL, V14, P2; Ramos JT, 1999, ARCH DIS CHILD, V81, P444, DOI 10.1136/adc.81.5.444; RIVATPERAN L, 1981, CLIN IMMUNOL IMMUNOP, V20, P99, DOI 10.1016/0090-1229(81)90166-5; Roberts JL, 2004, BLOOD, V103, P2009, DOI 10.1182/blood-2003-06-2104; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/ror.0.0040081; Samarghitean Crina, 2007, Immunome Res, V3, P6, DOI 10.1186/1745-7580-3-6; Sanka M, 2007, J ALLERGY CLIN IMMUN, V120, P952, DOI 10.1016/j.jaci.2007.08.013; Sharma LM, 2008, PEDIATR HEMAT ONCOL, V25, P473, DOI 10.1080/08880010802106614; SILBER GM, 1987, CLIN IMMUNOL IMMUNOP, V44, P317, DOI 10.1016/0090-1229(87)90075-4; Sirianni MC, 2006, INT ARCH ALLERGY IMM, V140, P82, DOI 10.1159/000092139; Staples ER, 2008, CLIN EXP IMMUNOL, V153, P214, DOI 10.1111/j.1365-2249.2008.03684.x; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Strauss KA, 2008, CLIN IMMUNOL, V128, P31, DOI 10.1016/j.clim.2008.02.016; Stray-Pedersen A, 2004, CLIN EXP IMMUNOL, V137, P179, DOI 10.1111/j.1365-2249.2004.02492.x; Tabori U, 2004, CLIN GENET, V65, P322, DOI 10.1111/j.1399-0004.2004.00227.x; Trahair TN, 2008, PEDIATR BLOOD CANCER, V50, P366, DOI 10.1002/pbc.20887; Trimis G G, 2004, J Postgrad Med, V50, P270; TSUKAHARA M, 1986, EUR J PEDIATR, V145, P121, DOI 10.1007/BF00441871; UEDA H, 1980, TOHOKU J EXP MED, V132, P31, DOI 10.1620/tjem.132.31; Usui K, 2001, RESPIR RES, V2, P188, DOI 10.1186/rr56; VANDERMEER JWM, 1993, LANCET, V341, P1439, DOI 10.1016/0140-6736(93)90883-I; Verhagen MMM, 2009, NEUROLOGY, V73, P430, DOI 10.1212/WNL.0b013e3181af33bd; VETRO S W, 1989, Fetal Therapy, V4, P82; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Wada T, 2005, BLOOD, V106, P2099, DOI 10.1182/blood-2005-03-0936; WALDMANN TA, 1983, J CLIN INVEST, V71, P282, DOI 10.1172/JCI110768; Wang LJ, 2004, ASIAN PAC J ALLERGY, V22, P25; Wang Y, 2009, J CLIN IMMUNOL, V29, P352, DOI 10.1007/s10875-008-9262-8; WATANABE A, 1977, TOHOKU J EXP MED, V121, P127, DOI 10.1620/tjem.121.127; WEDGWOOD JF, 1994, MT SINAI J MED, V61, P406; WEINBERG K, 1993, J CLIN INVEST, V92, P596, DOI 10.1172/JCI116626; WILLEMS PJ, 1993, AM J MED GENET, V45, P777, DOI 10.1002/ajmg.1320450624; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; YING KL, 1981, CANCER GENET CYTOGEN, V4, P311, DOI 10.1016/0165-4608(81)90027-3; YOUNT WJ, 1978, AM J MED, V65, P847, DOI 10.1016/0002-9343(78)90805-7	133	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43419	10.1371/journal.pone.0043419	http://dx.doi.org/10.1371/journal.pone.0043419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916257	Green Submitted, Green Published, gold			2022-12-27	WOS:000307824300046
J	Walter, J; Fletcher, E; Moussaoui, R; Gandhi, K; Weirauch, C				Walter, Jan; Fletcher, Erin; Moussaoui, Roba; Gandhi, Kumar; Weirauch, Christiane			Do Bites of Kissing Bugs Cause Unexplained Allergies? Results from a Survey in Triatomine-Exposed and Unexposed Areas in Southern California	PLOS ONE			English	Article							INSECT BITES; PROTRACTA; HETEROPTERA; ANAPHYLAXIS; REDUVIIDAE; COMMUNITY; DISEASE	Background: The bite of Triatominae can cause cutaneous allergic reactions and even anaphylaxis. Since the early 1980s, no population-based surveys have been done in Southern California, and none was ever carried out in inland Los Angeles or Riverside Counties. Objectives: To measure the frequency of insect sightings, bites and allergic reactions in a suburban area of eastern Los Angeles County and along with rural and urban sites in Riverside County. Methods: A door-to-door survey was done in triatomine exposed and unexposed areas. Logistic regression modeling was used for the analysis, and study participants were asked to collect insects. Results: Out of the 221 study participants in the exposed areas, 46 (20%) knew about the presence of Triatominae in their neighborhood. Fifteen (7%) persons reported triatomine sightings in their house during the month preceding the interview. Also, 15 (7%) participants reported ever being bitten by a triatomine. Ten (5%) participants collected either a Triatoma protracta Uhler and/or Paratriatoma hirsuta Barber in and around their house. Twenty-nine (13%) persons in the rural Riverside County reported symptoms compatible with allergy to triatomine bites. This was 4 times higher than in the urban control area where only 4 (3%) of 115 persons reported these symptoms. The association between living in a triatomine-exposed area and self-reported symptoms suggestive of allergies increased slightly when adjusted for the participant's sex and the age of their house (adjusted odds ratio: 5.1, 95% confidence interval: 1.2 to 22.0). Reporting these symptoms was associated with seeing Triatominae in the neighborhood and having been bitten. Conclusion: Allergies to triatomine bites could be a significant problem in inland Southern California. Further investigations, a diagnostic test and better information of persons living in triatomine-exposed areas are needed.	[Walter, Jan; Fletcher, Erin; Moussaoui, Roba; Gandhi, Kumar] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Weirauch, Christiane] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Walter, J (corresponding author), Zeltinger Str 64A, Berlin, Germany.	jan.walter@email.de		Walter, Jan/0000-0003-2247-5560	University of California Riverside	University of California Riverside(University of California System)	The authors acknowledge the University of California Riverside for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Galvaao C, 2004, ZOOTAXA, V202, P1; Ibarra-Cerdena CN, 2009, ACTA TROP, V110, P178, DOI 10.1016/j.actatropica.2008.11.012; Jones JP., 1962, CALIF VECTOR VIEWS, V9, P33; Klotz JH, 2010, CLIN INFECT DIS, V50, P1629, DOI 10.1086/652769; Lane RS, 1999, AM J TROP MED HYG, V61, P850, DOI 10.4269/ajtmh.1999.61.850; Lent H., 1979, Bulletin of the American Museum of Natural History, V163, P125; Lo Vecchio F, 2004, AM J EMERG MED, V22, P631, DOI 10.1016/j.ajem.2004.09.020; LYNCH PJ, 1978, CUTIS, V22, P585; MARSHALL N, 1986, J MED ENTOMOL, V23, P117, DOI 10.1093/jmedent/23.2.117; MARSHALL NA, 1986, J ALLERGY CLIN IMMUN, V78, P430, DOI 10.1016/0091-6749(86)90029-1; Moffitt JE, 2003, ANN ALLERG ASTHMA IM, V91, P122, DOI 10.1016/S1081-1206(10)62165-5; NICHOLS N, 1963, CALIF MED, V98, P267; Paddock CD, 2001, J IMMUNOL, V167, P2694, DOI 10.4049/jimmunol.167.5.2694; PINNAS JL, 1986, J ALLERGY CLIN IMMUN, V77, P364, DOI 10.1016/S0091-6749(86)80119-1; Reisenman CE, 2010, EMERG INFECT DIS, V16, P400, DOI 10.3201/eid1603.090648; ROHR AS, 1984, J ALLERGY CLIN IMMUN, V73, P369, DOI 10.1016/0091-6749(84)90410-X; RYCKMAN R E, 1981, Bulletin of the Society of Vector Ecologists, V6, P167; RYCKMAN RAYMOND E., 1962, UNIV CALIF PUBLICATION ENTOMOL, V27, P93; TEO SK, 1973, J TROP MED HYG, V76, P161; Wood SF, 1941, AM J HYG, V34, P1; Wood SF, 1951, B SO CALIF ACAD SCI, V50, P108	21	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44016	10.1371/journal.pone.0044016	http://dx.doi.org/10.1371/journal.pone.0044016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937146	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600070
J	Cleret-Buhot, A; Mathieu, J; Tournier, JN; Quesnel-Hellmann, A				Cleret-Buhot, Aurelie; Mathieu, Jacques; Tournier, Jean-Nicolas; Quesnel-Hellmann, Anne			Both Lethal and Edema Toxins of Bacillus anthracis Disrupt the Human Dendritic Cell Chemokine Network	PLOS ONE			English	Article							INFECTION; SPORES; INHIBITION; RESPONSES	Bacillus anthracis, the agent of anthrax, produces two main virulence factors: a capsule and two toxins. Both lethal toxin (LT) and edema toxin (ET) paralyze the immune defense system. Here, we analyze the effects of LT and ET on the capacity of human monocyte-derived dendritic cells (MoDC) to produce proinflammatory chemokines. We show that both toxins disrupt proinflammatory chemokine production. LT has more pronounced effects than ET on CXCL8 production, which is correlated with impaired recruitment of neutrophils in vitro. Finally, we show that both toxins also differentially disrupt IL-12p70, IL-10, and TNF-alpha production. Taken together, these results demonstrate that both B. anthracis toxins alter MoDC functions and the activation of the innate immune system.	[Cleret-Buhot, Aurelie; Mathieu, Jacques; Tournier, Jean-Nicolas; Quesnel-Hellmann, Anne] Inst Rech Biomed Armees, Dept Microbiol, Unite Interact Hote Agents Pathogenes, La Tronche, France		Cleret-Buhot, A (corresponding author), Univ Montreal, Dept Microbiol & Immunol, Fac Med, Hop St Luc,CRCHUM, Pavillon Edouard Asselin, Montreal, PQ H3C 3J7, Canada.	quesnelhellmann@gmail.com	Tournier, Jean-Nicolas/A-7332-2011; Quesnel-Hellmann, Anne/M-7696-2014	Tournier, Jean-Nicolas/0000-0002-4542-2421; Quesnel-Hellmann, Anne/0000-0002-7589-8834	Delegation Generale pour l'Armement [CO010808]; Service de Sante des Armees [135OP3B LFR EMA]	Delegation Generale pour l'Armement; Service de Sante des Armees	This work was supported by grants from Delegation Generale pour l'Armement (CO010808) and Service de Sante des Armees (135OP3B LFR EMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Brittingham KC, 2005, J IMMUNOL, V174, P5545, DOI 10.4049/jimmunol.174.9.5545; Cleret A, 2007, J IMMUNOL, V178, P7994, DOI 10.4049/jimmunol.178.12.7994; Cleret A, 2006, J INFECT DIS, V194, P86, DOI 10.1086/504686; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Duverger A, 2006, J IMMUNOL, V176, P1776, DOI 10.4049/jimmunol.176.3.1776; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Garraud K, 2012, INFECT IMMUN, V80, P131, DOI 10.1128/IAI.05988-11; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Joshi SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000588; Klezovich-Benard M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002481; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Maldonado-Arocho FJ, 2009, INFECT IMMUN, V77, P2036, DOI 10.1128/IAI.01329-08; Moayeri M, 2012, MICROBES INFECT, V14, P392, DOI 10.1016/j.micinf.2011.12.005; Paccani SR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000325; Pickering AK, 2004, INFECT IMMUN, V72, P6382, DOI 10.1128/IAI.72.11.6382-6389.2004; Quesnel-Hellmann A, 2006, VACCINE, V24, P699, DOI 10.1016/j.vaccine.2005.08.065; Raymond B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000359; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Tang WJ, 2009, MOL ASPECTS MED, V30, P423, DOI 10.1016/j.mam.2009.06.001; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tournier JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/j.mam.2009.06.002; Tournier JN, 2005, J IMMUNOL, V174, P4934, DOI 10.4049/jimmunol.174.8.4934; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	28	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43266	10.1371/journal.pone.0043266	http://dx.doi.org/10.1371/journal.pone.0043266			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937027	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500036
J	Tse, H; Tsang, AKL; Tsoi, HW; Leung, ASP; Ho, CC; Lau, SKP; Woo, PCY; Yuen, KY				Tse, Herman; Tsang, Alan K. L.; Tsoi, Hoi-Wah; Leung, Andy S. P.; Ho, Chi-Chun; Lau, Susanna K. P.; Woo, Patrick C. Y.; Yuen, Kwok-Yung			Identification of a Novel Bat Papillomavirus by Metagenomics	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CORONAVIRUSES REVEALS; BINDING DOMAIN; VIRUS; E2; DIVERSITY; ALIGNMENT; PROTEIN; PICORNAVIRUSES; COEXISTENCE	The discovery of novel viruses in animals expands our knowledge of viral diversity and potentially emerging zoonoses. High-throughput sequencing (HTS) technology gives millions or even billions of sequence reads per run, allowing a comprehensive survey of the genetic content within a sample without prior nucleic acid amplification. In this study, we screened 156 rectal swab samples from apparently healthy bats (n = 96), pigs (n = 9), cattles (n = 9), stray dogs (n = 11), stray cats (n = 11) and monkeys (n = 20) using a HTS metagenomics approach. The complete genome of a novel papillomavirus (PV), Miniopterus schreibersii papillomavirus type 1 (MscPV1), with L1 of 60% nucleotide identity to Canine papillomavirus (CPV6), was identified in a specimen from a Common Bent- wing Bat (M. schreibersii). It is about 7.5kb in length, with a G+C content of 45.8% and a genomic organization similar to that of other PVs. Despite the higher nucleotide identity between the genomes of MscPV1 and CPV6, maximum-likelihood phylogenetic analysis of the L1 gene sequence showed that MscPV1 and Erethizon dorsatum papillomavirus (EdPV1) are most closely related. Estimated divergence time of MscPV1 from the EdPV1/MscPV1 common ancestor was approximately 60.2-91.9 millions of years ago, inferred under strict clocks using the L1 and E1 genes. The estimates were limited by the lack of reliable calibration points from co-divergence because of possible host shifts. As the nucleotide sequence of this virus only showed limited similarity with that of related animal PVs, the conventional approach of PCR using consensus primers would be unlikely to have detected the novel virus in the sample. Unlike the first bat papillomavirus RaPV1, MscPV1 was found in an asymptomatic bat with no apparent mucosal or skin lesions whereas RaPV1 was detected in the basosquamous carcinoma of a fruit bat Rousettus aegyptiacus. We propose MscPV1 as the first member of the novel Dyolambda-papillomavirus genus.	[Tse, Herman; Tsang, Alan K. L.; Tsoi, Hoi-Wah; Leung, Andy S. P.; Ho, Chi-Chun; Lau, Susanna K. P.; Woo, Patrick C. Y.; Yuen, Kwok-Yung] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, State Key Lab Emerging Infect Dis, Pok Fu Lam, Hong Kong, Peoples R China	University of Hong Kong	Tse, H (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, State Key Lab Emerging Infect Dis, Pok Fu Lam, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	Lau, Susanna Kar Pui/AAJ-6848-2020; Woo, Patrick Chiu Yat/C-4449-2009	Lau, Susanna Kar Pui/0000-0002-1383-7374; Woo, Patrick Chiu Yat/0000-0001-9401-1832; Yuen, Kwok-yung/0000-0002-2083-1552	Research Grant Council; University Development Fund and Strategic Research Theme Fund; University of Hong Kong; Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau; Providence Foundation Limited; Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Disease for the HKSAR Department of Health	Research Grant Council(Hong Kong Research Grants Council); University Development Fund and Strategic Research Theme Fund; University of Hong Kong(University of Hong Kong); Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau; Providence Foundation Limited; Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Disease for the HKSAR Department of Health	This work is partly supported by the Research Grant Council, University Development Fund and Strategic Research Theme Fund, The University of Hong Kong; the Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; the HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau; the Providence Foundation Limited, in memory of the late Dr. Lui Hac Minh; and the Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Disease for the HKSAR Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baylis SA, 2011, VACCINE, V29, P690, DOI 10.1016/j.vaccine.2010.11.028; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Dahiya A, 2000, MOL CELL BIOL, V20, P6799, DOI 10.1128/MCB.20.18.6799-6805.2000; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DiMaio D, 2001, ONCOGENE, V20, P7866, DOI 10.1038/sj.onc.1204915; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endy TP, 2011, EXP BIOL MED, V236, P897, DOI 10.1258/ebm.2011.011i01; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Gottschling M, 2011, MOL BIOL EVOL, V28, P2101, DOI 10.1093/molbev/msr030; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Hegde RS, 2002, ANNU REV BIOPH BIOM, V31, P343, DOI 10.1146/annurev.biophys.31.100901.142129; HIRT L, 1991, VIRUS RES, V18, P179, DOI 10.1016/0168-1702(91)90017-P; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kunz TH, 2003, BAT ECOLOGY, P3; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Lau SKP, 2007, VIROLOGY, V367, P428, DOI 10.1016/j.virol.2007.06.009; Lau SKP, 2012, J VIROL, V86, P395, DOI 10.1128/JVI.06253-11; Lau SKP, 2011, J GEN VIROL, V92, P2047, DOI 10.1099/vir.0.033688-0; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Lau SKP, 2010, J VIROL, V84, P11385, DOI 10.1128/JVI.01121-10; Lau SKP, 2010, VIROLOGY, V404, P106, DOI 10.1016/j.virol.2010.03.049; Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; LI R, 1989, GENE DEV, V3, P510, DOI 10.1101/gad.3.4.510; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Ng TFF, 2011, J GEN VIROL, V92, P1318, DOI 10.1099/vir.0.029678-0; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Rector A, 2005, VIROLOGY, V331, P449, DOI 10.1016/j.virol.2004.10.033; Rector A, 2006, VET MICROBIOL, V117, P267, DOI 10.1016/j.vetmic.2006.06.010; ROBERTS S, 1994, J VIROL, V68, P6432, DOI 10.1128/JVI.68.10.6432-6445.1994; Rosario K, 2011, J GEN VIROL, V92, P1302, DOI 10.1099/vir.0.030338-0; Shah SD, 2010, MOL BIOL EVOL, V27, P1301, DOI 10.1093/molbev/msq015; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Sullivan PF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-2; Tachezy R, 2002, VIROLOGY, V301, P313, DOI 10.1006/viro.2002.1566; Tachezy R, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-19; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; Tokarz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021844; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025619; Tse H, 2011, J GEN VIROL, V92, P1888, DOI 10.1099/vir.0.030817-0; Van Ranst M, 1995, MOL BASIS VIRUS EVOL, P455; VANRANST M, 1992, VIROLOGY, V190, P587, DOI 10.1016/0042-6822(92)90896-W; White PW, 2001, J BIOL CHEM, V276, P22426, DOI 10.1074/jbc.M101932200; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06; Woo PCY, 2006, VIROLOGY, V351, P180, DOI 10.1016/j.virol.2006.02.041; Woo PCY, 2011, J VIROL, V85, P13473, DOI 10.1128/JVI.06356-11; Woo PCY, 2010, J GEN VIROL, V91, P2433, DOI 10.1099/vir.0.021717-0; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08; Woo PC, 2012, J VIROL; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	72	31	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43986	10.1371/journal.pone.0043986	http://dx.doi.org/10.1371/journal.pone.0043986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937142	Green Published, gold			2022-12-27	WOS:000308225500133
J	Acharya, G; Lee, CH; Lee, Y				Acharya, Gayathri; Lee, Chi H.; Lee, Yugyung			Optimization of Cardiovascular Stent against Restenosis: Factorial Design-Based Statistical Analysis of Polymer Coating Conditions	PLOS ONE			English	Article							DRUG-DELIVERY-SYSTEMS; S-NITROSO-GLUTATHIONE; NITRIC-OXIDE; NEOINTIMAL PROLIFERATION; OVERSTRETCH INJURY; IN-VITRO; NITROSOGLUTATHIONE; INHIBITION; MODEL; BIOCOMPATIBILITY	The objective of this study was to optimize the physicodynamic conditions of polymeric system as a coating substrate for drug eluting stents against restenosis. As Nitric Oxide (NO) has multifunctional activities, such as regulating blood flow and pressure, and influencing thrombus formation, a continuous and spatiotemporal delivery of NO loaded in the polymer based nanoparticles could be a viable option to reduce and prevent restenosis. To identify the most suitable carrier for S-Nitrosoglutathione (GSNO), a NO prodrug, stents were coated with various polymers, such as poly (lactic-co-glycolic acid) (PLGA), polyethylene glycol (PEG) and polycaprolactone (PCL), using solvent evaporation technique. Full factorial design was used to evaluate the effects of the formulation variables in polymer-based stent coatings on the GSNO release rate and weight loss rate. The least square regression model was used for data analysis in the optimization process. The polymer-coated stents were further assessed with Differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy analysis (FTIR), Scanning electron microscopy (SEM) images and platelet adhesion studies. Stents coated with PCL matrix displayed more sustained and controlled drug release profiles than those coated with PLGA and PEG. Stents coated with PCL matrix showed the least platelet adhesion rate. Subsequently, stents coated with PCL matrix were subjected to the further optimization processes for improvement of surface morphology and enhancement of the drug release duration. The results of this study demonstrated that PCL matrix containing GSNO is a promising system for stent surface coating against restenosis.	[Acharya, Gayathri; Lee, Chi H.] Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA; [Lee, Yugyung] Univ Missouri, Sch Comp & Engn, Dept Comp Sci & Elect Engn, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Acharya, G (corresponding author), Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA.	leech@umkc.edu; leeyu@umkc.edu	Acharya, Gayathri/U-3930-2019		Missouri Life Science Research Board Grant [09-117]	Missouri Life Science Research Board Grant	This work was supported by Missouri Life Science Research Board Grant (09-117; http://lifesciences.mo.gov/summary.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2012, J BIOMED MATER RES A, V100A, P1151, DOI 10.1002/jbm.a.34055; [Anonymous], J MINISTRY AGR; Berg R, 2007, CATHETER CARDIO INTE, V70, P871, DOI 10.1002/ccd.21299; Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7; Box GE., 1978, STAT EXPT; Brieger D, 1997, CARDIOVASC RES, V35, P405, DOI 10.1016/S0008-6363(97)00155-7; Cho HH, 2008, BIOMATERIALS, V29, P884, DOI 10.1016/j.biomaterials.2007.10.052; DEBELDER AJ, 1994, CARDIOVASC RES, V28, P691; Do YS, 2004, RADIOLOGY, V230, P377, DOI 10.1148/radiol.2302020417; EPSTEIN SE, 1994, J AM COLL CARDIOL, V23, P1278, DOI 10.1016/0735-1097(94)90368-9; Fischell TA, 1996, CIRCULATION, V94, P1494, DOI 10.1161/01.CIR.94.7.1494; Fisher RA, 1990, STAT METHODS EXPT DE; Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006; George SJ, 2010, ATHEROSCLEROSIS: MOLECULAR AND CELLULAR MECHANISMS, P1, DOI 10.1002/9783527629589; Gonzalez-Rodriguez ML, 2007, INT J PHARMACEUT, V337, P336, DOI 10.1016/j.ijpharm.2007.01.024; Hou DM, 2005, CARDIOVASC INTER RAD, V28, P60, DOI 10.1007/s00270-004-0206-2; Kallinteri P, 2002, BIOMATERIALS, V23, P4819, DOI 10.1016/S0142-9612(02)00233-8; Kaposzta Z, 2001, CIRCULATION, V103, P2371; LANGFORD EJ, 1994, LANCET, V344, P1458, DOI 10.1016/S0140-6736(94)90287-9; Lee CH, 2011, DRUG DELIV TRANSL RE, V1, P201, DOI 10.1007/s13346-011-0026-2; Liu Y, 2011, J BIOMED MATER RES A, V99A, P485, DOI 10.1002/jbm.a.33209; Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042; Montgomery D.C., 2012, DESIGN ANAL EXPT; Pan CJ, 2007, J MATER SCI-MATER M, V18, P2193, DOI 10.1007/s10856-007-3075-9; Pan CJ, 2010, COLLOID SURFACE B, V77, P155, DOI 10.1016/j.colsurfb.2010.01.019; RAMSAY B, 1995, BRIT J CLIN PHARMACO, V40, P101, DOI 10.1111/j.1365-2125.1995.tb04545.x; Reichenbach Gustavo, 2005, Curr Drug Targets Cardiovasc Haematol Disord, V5, P65; Rhee YS, 2008, INT J PHARMACEUT, V364, P14, DOI 10.1016/j.ijpharm.2008.07.029; Shah M, 2010, AAPS PHARMSCITECH, V11, P489, DOI 10.1208/s12249-010-9414-z; Singh B, 2005, CRIT REV THER DRUG, V22, P27, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i1.20; Singh B, 2005, CRIT REV THER DRUG, V22, P215, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i3.10; Sorragi CD, 2011, CELL BIOCHEM FUNCT, V29, P207, DOI 10.1002/cbf.1738; Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u; Vilahur G, 2004, CARDIOVASC RES, V61, P806, DOI 10.1016/j.cardiores.2003.11.034; Vodovotz Y, 2000, INT J RADIAT ONCOL, V48, P1167, DOI 10.1016/S0360-3016(00)00730-6; Westedt U, 2006, J CONTROL RELEASE, V111, P235, DOI 10.1016/j.jconrel.2005.12.012; Yoo JW, 2010, J BIOMED MATER RES A, V92A, P1233, DOI 10.1002/jbm.a.32434; Yoo JW, 2009, BIOMATERIALS, V30, P3978, DOI 10.1016/j.biomaterials.2009.04.004; Yoon J, 2002, YONSEI MED J, V43, P242, DOI 10.3349/ymj.2002.43.2.242	39	35	37	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43100	10.1371/journal.pone.0043100	http://dx.doi.org/10.1371/journal.pone.0043100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937015	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300034
J	Philippi, CL; Feinstein, JS; Khalsa, SS; Damasio, A; Tranel, D; Landini, G; Williford, K; Rudrauf, D				Philippi, Carissa L.; Feinstein, Justin S.; Khalsa, Sahib S.; Damasio, Antonio; Tranel, Daniel; Landini, Gregory; Williford, Kenneth; Rudrauf, David			Preserved Self-Awareness following Extensive Bilateral Brain Damage to the Insula, Anterior Cingulate, and Medial Prefrontal Cortices	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; DEFAULT NETWORK; CORTEX; CONSCIOUSNESS; RECOGNITION; PERSONALITY; RELEVANCE; CONFLICT; FEELINGS; EMOTION	It has been proposed that self-awareness (SA), a multifaceted phenomenon central to human consciousness, depends critically on specific brain regions, namely the insular cortex, the anterior cingulate cortex (ACC), and the medial prefrontal cortex (mPFC). Such a proposal predicts that damage to these regions should disrupt or even abolish SA. We tested this prediction in a rare neurological patient with extensive bilateral brain damage encompassing the insula, ACC, mPFC, and the medial temporal lobes. In spite of severe amnesia, which partially affected his "autobiographical self", the patient's SA remained fundamentally intact. His Core SA, including basic self-recognition and sense of self-agency, was preserved. His Extended SA and Introspective SA were also largely intact, as he has a stable self-concept and intact higher-order metacognitive abilities. The results suggest that the insular cortex, ACC and mPFC are not required for most aspects of SA. Our findings are compatible with the hypothesis that SA is likely to emerge from more distributed interactions among brain networks including those in the brainstem, thalamus, and posteromedial cortices.	[Philippi, Carissa L.; Feinstein, Justin S.; Tranel, Daniel; Rudrauf, David] Univ Iowa, Dept Neurol, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA; [Khalsa, Sahib S.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Damasio, Antonio] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA; [Damasio, Antonio] Univ So Calif, Dornsife Cognit Neurosci Imaging Ctr, Los Angeles, CA USA; [Landini, Gregory] Univ Iowa, Dept Philosophy, Iowa City, IA USA; [Williford, Kenneth] Univ Texas Arlington, Dept Philosophy, Arlington, TX 76019 USA	University of Iowa; University of California System; University of California Los Angeles; University of Southern California; University of Southern California; University of Iowa; University of Texas System; University of Texas Arlington	Philippi, CL (corresponding author), Univ Iowa, Dept Neurol, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA.	justin-feinstein@uiowa.edu; david.rudrauf@gmail.com	Khalsa, Sahib S./ABA-8359-2020; Khalsa, Sahib S. S/Q-1434-2018; Damasio, Antonio/AAD-1342-2019	Khalsa, Sahib S./0000-0003-2124-8585; Khalsa, Sahib S. S/0000-0003-2124-8585; Tranel, Daniel/0000-0002-1338-1389; Rudrauf, David/0000-0002-9621-1800	National Institute of Neurological Disorders and Stroke (NINDS) [P01 NS19632]; National Institute on Drug Abuse (NIDA) [R01 DA022549]; Mathers Foundation; University of Iowa, College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022549] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Mathers Foundation; University of Iowa, College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institute of Neurological Disorders and Stroke (NINDS, P01 NS19632), National Institute on Drug Abuse (NIDA, R01 DA022549), and the Mathers Foundation, and by funds from the University of Iowa, College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2008, NEUROIMAGE, V42, P535, DOI 10.1016/j.neuroimage.2008.05.047; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Barrash J, 2011, J CLIN EXP NEUROPSYC, V33, P833, DOI 10.1080/13803395.2011.561300; BARRIS RW, 1953, NEUROLOGY, V3, P44, DOI 10.1212/WNL.3.1.44; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Berlucchi G, 2010, EXP BRAIN RES, V200, P25, DOI 10.1007/s00221-009-1970-7; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Churchland PS, 2002, SCIENCE, V296, P308, DOI 10.1126/science.1070564; Cohen RA, 1999, J NEUROPSYCH CLIN N, V11, P444, DOI 10.1176/jnp.11.4.444; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Craig AD, 2009, DO YOU FEEL NOW ANTE; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio A. R., 1983, NEUROPSYCHOLOGY HUMA, P85; Damasio A, 2013, CEREB CORTEX, V23, P833, DOI 10.1093/cercor/bhs077; Damasio Antonio, 2010, SELF COMES MIND CONS; Damasio Antonio R, 1999, FEELING WHAT HAPPENS; Dastjerdi M, 2011, P NATL ACAD SCI USA, V108, P3023, DOI 10.1073/pnas.1017098108; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 1998, P NATL ACAD SCI USA, V100, P8520; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Feinstein JS, 2010, J CLIN EXP NEUROPSYC, V32, P88, DOI 10.1080/13803390903066873; Fornito A, 2006, NEUROIMAGE, V33, P843, DOI 10.1016/j.neuroimage.2006.06.061; Fransson P, 1999, NEUROIMAGE, V9, P611, DOI 10.1006/nimg.1999.0438; Friedman L, 2006, NEUROIMAGE, V32, P1656, DOI 10.1016/j.neuroimage.2006.03.062; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Goldstein Z R, 2009, NEUROCIRCUITRY IMPAI; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Harlow J. M., 1868, RECOVERY PASSAGE IRO, V2, P327, DOI [10.1177/ 0957154X9300401407, DOI 10.1177/0957154X9300401407]; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; HOSIE JA, 1988, PERCEPTION, V17, P461, DOI 10.1068/p170461; John O.P., 1991, BIG 5 INVENTORY VERS; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Khalsa SS, 2009, NAT NEUROSCI, V12, P1494, DOI 10.1038/nn.2411; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Klein SB, 2010, ANN NY ACAD SCI, V1191, P1, DOI 10.1111/j.1749-6632.2010.05441.x; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Mayr U, 2004, TRENDS COGN SCI, V8, P145, DOI 10.1016/j.tics.2004.02.006; McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321; Merker B, 2007, BEHAV BRAIN SCI, V30, P63, DOI 10.1017/S0140525X07000891; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2008, TRENDS COGN SCI, V12, P259, DOI 10.1016/j.tics.2008.04.007; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Panksepp J, 2009, CONSCIOUS COGN, V18, P193, DOI 10.1016/j.concog.2008.03.002; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Philippi CL, 2012, J COGNITIVE NEUROSCI, V24, P475, DOI 10.1162/jocn_a_00138; Pieper S, 2006, I S BIOMED IMAGING, P698; Platek SM, 2008, BRAIN RES, V1232, P173, DOI 10.1016/j.brainres.2008.07.010; POVINELLI DJ, 1993, J COMP PSYCHOL, V107, P347, DOI 10.1037/0735-7036.107.4.347; Prigatano G.P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R, P96; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; SCHEIER MF, 1985, J APPL SOC PSYCHOL, V15, P687, DOI 10.1111/j.1559-1816.1985.tb02268.x; SCHLENKER BR, 1990, J PERS SOC PSYCHOL, V58, P855, DOI 10.1037/0022-3514.58.5.855; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Seeley WW, 2010, BRAIN STRUCT FUNCT, V214, P465, DOI 10.1007/s00429-010-0263-z; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soddu A, 2009, PROG BRAIN RES, V177, P261, DOI 10.1016/S0079-6123(09)17718-X; SPIKER D, 1984, CHILD DEV, V55, P214, DOI 10.1111/j.1467-8624.1984.tb00285.x; Spreng RN, 2008, J COGN NEUROSCI; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Sturm VE, 2006, BRAIN, V129, P2508, DOI 10.1093/brain/awl145; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Tisserand DJ, 2002, NEUROIMAGE, V17, P657, DOI 10.1006/nimg.2002.1173; Tranel D, 2012, J CLIN EXP NEUROPSYC, V34, P117, DOI 10.1080/13803395.2011.633897; Troje NF, 1999, PERCEPTION, V28, P483, DOI 10.1068/p2901; TULVING E, 1984, BEHAV BRAIN SCI, V7, P223, DOI 10.1017/S0140525X0004440X; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Vanhaudenhuyse A, 2010, J COGNITIVE NEUROSCI, V0, P1; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Williford K, 2006, CONSCIOUS AWARENESS, P173; Wilson BA, 2008, NEUROPSYCHOL REHABIL, V18, P527, DOI 10.1080/09602010802141889; Wilson TD, 2009, PERSPECT PSYCHOL SCI, V4, P384, DOI 10.1111/j.1745-6924.2009.01143.x; Woods SA, 2005, EUR J PERSONALITY, V19, P373, DOI 10.1002/per.542; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	114	78	79	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e38413	10.1371/journal.pone.0038413	http://dx.doi.org/10.1371/journal.pone.0038413			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22927899	gold, Green Published			2022-12-27	WOS:000308286300001
J	Binder, A; Nakajima, S; Kloft, M; Muller, C; Samek, W; Brefeld, U; Muller, KR; Kawanabe, M				Binder, Alexander; Nakajima, Shinichi; Kloft, Marius; Mueller, Christina; Samek, Wojciech; Brefeld, Ulf; Mueller, Klaus-Robert; Kawanabe, Motoaki			Insights from Classifying Visual Concepts with Multiple Kernel Learning	PLOS ONE			English	Article							MACHINES; FEATURES	Combining information from various image features has become a standard technique in concept recognition tasks. However, the optimal way of fusing the resulting kernel functions is usually unknown in practical applications. Multiple kernel learning (MKL) techniques allow to determine an optimal linear combination of such similarity matrices. Classical approaches to MKL promote sparse mixtures. Unfortunately, 1-norm regularized MKL variants are often observed to be outperformed by an unweighted sum kernel. The main contributions of this paper are the following: we apply a recently developed non-sparse MKL variant to state-of-the-art concept recognition tasks from the application domain of computer vision. We provide insights on benefits and limits of non-sparse MKL and compare it against its direct competitors, the sum-kernel SVM and sparse MKL. We report empirical results for the PASCAL VOC 2009 Classification and ImageCLEF2010 Photo Annotation challenge data sets. Data sets (kernel matrices) as well as further information are available at http://doc.ml.tuberlin.de/image_mkl/(Accessed 2012 Jun 25).	[Binder, Alexander; Kloft, Marius; Mueller, Christina; Samek, Wojciech; Mueller, Klaus-Robert] Berlin Inst Technol, Machine Learning Grp, Berlin, Germany; [Binder, Alexander; Samek, Wojciech] Fraunhofer Inst FIRST, Berlin, Germany; [Nakajima, Shinichi] Nikon Inc, Opt Res Lab, Tokyo, Japan; [Brefeld, Ulf] Univ Bonn, Knowledge Discovery & Machine Learning Grp, Bonn, Germany; [Brefeld, Ulf] Zalando GmbH, Berlin, Germany; [Mueller, Klaus-Robert] Bernstein Focus Neurotechnol Berlin, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Kawanabe, Motoaki] ATR Res, Kyoto, Japan	Technical University of Berlin; Fraunhofer Gesellschaft; Nikon Corporation; University of Bonn; Korea University	Binder, A (corresponding author), Berlin Inst Technol, Machine Learning Grp, Berlin, Germany.	alexander.binder@tu-berlin.de	Samek, Wojciech/C-5107-2014; Mueller, Klaus-Robert/Y-3547-2019; Samek, Wojciech/AAZ-2156-2021; Muller, Klaus R/C-3196-2013	Mueller, Klaus-Robert/0000-0002-3861-7685; Samek, Wojciech/0000-0002-6283-3265; Binder, Alexander/0000-0001-9605-6209	Federal Ministry of Economics and Technology of Germany (BMWi) under the project THESEUS [FKZ 01MQ07018]; Federal Ministry of Education and Research of Germany (BMBF) under the project REMIND [FKZ 01-IS07007A]; German National Science Foundation (DFG) [GA 1615/1-1, MU 987/6-1, RA 1894/1-1]; FP7-ICT program of the European Community, under the PASCAL2 Network of Excellence [ICT-216886]; German Academic Exchange Service (DAAD); World Class University Program through the National Research Foundation of Korea; Korean Ministry of Education, Science, and Technology [R31-10008]	Federal Ministry of Economics and Technology of Germany (BMWi) under the project THESEUS; Federal Ministry of Education and Research of Germany (BMBF) under the project REMIND(Federal Ministry of Education & Research (BMBF)); German National Science Foundation (DFG)(German Research Foundation (DFG)); FP7-ICT program of the European Community, under the PASCAL2 Network of Excellence; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); World Class University Program through the National Research Foundation of Korea(National Research Foundation of Korea); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by the Federal Ministry of Economics and Technology of Germany (BMWi) under the project THESEUS (FKZ 01MQ07018), by Federal Ministry of Education and Research of Germany (BMBF) under the project REMIND (FKZ 01-IS07007A), by the German National Science Foundation (DFG) under references GA 1615/1-1, MU 987/6-1 and RA 1894/1-1 and by the FP7-ICT program of the European Community, under the PASCAL2 Network of Excellence (ICT-216886). Marius Kloft acknowledges a scholarship by the German Academic Exchange Service (DAAD). This work was also supported by the World Class University Program through the National Research Foundation of Korea funded by the Korean Ministry of Education, Science, and Technology, under Grant R31-10008. Part of this work was done while KRM was at the Institute of Pure and Applied Mathematics, University of California Los Angeles, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach F, 2004, INT C MACH LEARN; Binder A, 2010, LECT NOTES COMPUT SC, V6242, P269, DOI 10.1007/978-3-642-15751-6_33; Binder A, 2012, INT J COMPUT VISION, V99, P281, DOI 10.1007/s11263-010-0417-8; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401, DOI [10.1145/1282280.1282340, DOI 10.1145/1282280, DOI 10.1145/1282280.1282340]; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Cai D., 2007, P INT C DAT MIN ICDM; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cao LL, 2009, IEEE I CONF COMP VIS, P1095, DOI 10.1109/ICCV.2009.5459401; Chapelle O, 1999, IEEE T NEURAL NETWOR, V10, P1055, DOI 10.1109/72.788646; Chapelle O., 2008, P NIPS WORKSH KERN L; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cortes C., 2008, P NIPS WORKSH KERN L; Cortes C., 2010, ICML, P239; Cortes C., 2009, P INT C UNC ART INT; Cristianini N, 2002, ADV NEUR IN, V14, P367; Csurka G., 2004, WORKSHOP STAT LEARNI, P1, DOI DOI 10.1234/12345678; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Everingham M, 2009, PASCAL VISUAL OBJECT; Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4; Galleguillos C, 2010, PROC CVPR IEEE, P113, DOI 10.1109/CVPR.2010.5540223; Gehler Peter Vincent, 2009, 2009 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2836, DOI 10.1109/CVPRW.2009.5206592; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Gonen M, 2010, P 20 IAPR INT C PATT; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Jaakkola TS, 1999, ADV NEUR IN, V11, P487; Kloft M, 2008, P NIPS WORKSH KERN L; Kloft M, 2011, J MACH LEARN RES, V12, P953; Kumar A, 2007, IEEE I CONF COMP VIS, P1855; Lampert CH, 2011, ADV NEURAL INFORM PR, P289; Lampert CH, 2008, LECT NOTES COMPUT SC, V5096, P31, DOI 10.1007/978-3-540-69321-5_4; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Li FF, 2006, IEEE T PATTERN ANAL, V28, P594, DOI 10.1109/TPAMI.2006.79; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Marius K., 2009, NIPS, P997; Marszalek M., LEARNING REPRESENTAT; Mika S, 2003, IEEE T PATTERN ANAL, V25, P623, DOI 10.1109/TPAMI.2003.1195996; Mika S., 1999, Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468), P41, DOI 10.1109/NNSP.1999.788121; Moosmann F, 2006, ADV NEURAL INFORM PR; Moosmann F, 2008, IEEE T PATTERN ANAL, V30, P1632, DOI 10.1109/TPAMI.2007.70822; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nowak S., 2010, CLEF NOTEBOOK PAPERS; Orabona F, 2010, PROC CVPR IEEE, P787, DOI 10.1109/CVPR.2010.5540137; Rakotomamonjy A., 2007, P 24 INT C MACH LEAR, V227, P775, DOI DOI 10.1145/1273496.1273594; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Scholkopf B., 2002, LEARNING KERNELS; Smeaton A. F., 2006, MIR 2006 P 8 ACM INT, DOI [DOI 10.1145/1178677.1178722, 10.1145/1178677.1178722]; Sonnenburg S., 2010, J MACHINE LEARNING R; Sonnenburg S, 2006, J MACH LEARN RES, V7, P1531; van de Sande KEA, 2010, IEEE T PAT ANAL MACH; van de Sande KEA, 2011, IEEE I CONF COMP VIS, P1879, DOI 10.1109/ICCV.2011.6126456; Vapnik V., 2013, NATURE STAT LAERNING; Vapnik V., 1998, STAT LEARNING THEORY; Varma M., 2009, ICML; Vedaldi A, 2009, IEEE I CONF COMP VIS, P606, DOI 10.1109/ICCV.2009.5459183; Yan F, 2010, PROC CVPR IEEE, P3626, DOI 10.1109/CVPR.2010.5539916; Yan F, 2009, IEEE DATA MINING, P1064, DOI 10.1109/ICDM.2009.84; Yang JJ, 2009, IEEE I CONF COMP VIS, P436, DOI 10.1109/ICCV.2009.5459172; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4; Zien A, 2000, BIOINFORMATICS, V16, P799, DOI 10.1093/bioinformatics/16.9.799; Zien A., 2007, P 24 INT C MACH LEAR, P1191, DOI DOI 10.1145/1273496.1273646	62	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e38897	10.1371/journal.pone.0038897	http://dx.doi.org/10.1371/journal.pone.0038897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936970	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500003
J	Ferlazzo, F; Sdoia, S				Ferlazzo, Fabio; Sdoia, Stefano			Measuring Nepotism through Shared Last Names: Are We Really Moving from Opinions to Facts?	PLOS ONE			English	Article							RECRUITMENT; CAREER	Nepotistic practices are detrimental for academia. An analysis of shared last names among academics was recently proposed to measure the diffusion of nepotism, the results of which have had a huge resonance. This method was thus proposed to orient the decisions of policy makers concerning cuts and funding. Because of the social relevance of this issue, the validity of this method must be assessed. Thus, we compared results from an analysis of Italian and United Kingdom academic last names, and of Italian last and given names. The results strongly suggest that the analysis of shared last names is not a measure of nepotism, as it is largely affected by social capital, professional networking and demographic effects, whose contribution is difficult to assess. Thus, the analysis of shared last names is not useful for guiding research policy.	[Ferlazzo, Fabio; Sdoia, Stefano] Univ Roma La Sapienza, Dept Psychol, Rome, Italy	Sapienza University Rome	Ferlazzo, F (corresponding author), Univ Roma La Sapienza, Dept Psychol, Rome, Italy.	fabio.ferlazzo@uniroma1.it		SDOIA, STEFANO/0000-0001-9275-8350				Adler PS, 2002, ACAD MANAGE REV, V27, P17, DOI 10.2307/4134367; Allesina S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021160; Arru A., 2003, ITALIA MIGRAZIONI IN; Bingley P, 2011, IZA DP, P1; Bowles S, 2005, UNEQUAL CHANCES: FAMILY BACKGROUND AND ECONOMIC SUCCESS, P1; Colombier N, 2008, SMALL BUS ECON, V30, P423, DOI 10.1007/s11187-007-9059-9; Corak M, 2010, IZA DP, P1; Datcher Loury L, 2006, DISCUSSION PAPERS SE; Dennett AR, 2010, THESIS U LEEDS LEEDS; Di Nocera F, 2000, BEHAV RES METH INS C, V32, P111, DOI 10.3758/BF03200793; Dunn T, 2000, J LABOR ECON, V18, P282, DOI 10.1086/209959; Durante R, 2009, C EUR EC ASS EC SOC; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Groothuis PA, 2008, J SPORT ECON, V9, P250, DOI 10.1177/1527002507309990; KURTZ DM, 1995, SOC SCI J, V32, P441, DOI 10.1016/0362-3319(95)90031-4; LABAND DN, 1985, ECON INQ, V23, P395, DOI 10.1111/j.1465-7295.1985.tb01775.x; LABAND DN, 1992, J LABOR ECON, V10, P182, DOI 10.1086/298284; Loury G., 1992, HARVARD J AFRICAN AM, V1, P91; Pain E, 2011, SCI CAREER BLOG 0803; Pinchot S, 2008, J SURG RES, V147, P253, DOI 10.1016/j.jss.2008.03.002; Schiebinger L.L., 2008, DUAL CAREER ACAD COU; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; van Liefferinge H, 2009, ACTA POLIT, V44, P125, DOI 10.1057/ap.2008.20	24	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43574	10.1371/journal.pone.0043574	http://dx.doi.org/10.1371/journal.pone.0043574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937063	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500064
J	van Kampen, SC; Oskam, L; Tuijn, CJ; Klatser, PR				van Kampen, Sanne C.; Oskam, Linda; Tuijn, Coosje J.; Klatser, Paul R.			Survey of the Diagnostic Retooling Process in National TB Reference Laboratories, with Special Focus on Rapid Speciation Tests Endorsed by WHO in 2007	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS COMPLEX; CAPILIA TB; IDENTIFICATION; PERFORMANCE; CULTURE; ASSAY	Background: Successful integration of new diagnostics in national tuberculosis (TB) control programs, also called 'retooling', is highly dependent on operational aspects related to test availability, accessibility and affordability. This survey aimed to find out whether recommendations to use new diagnostics lead to successful retooling in high TB endemic countries, using immunochromatographic tests (ICTs) for TB culture speciation as a case study. ICTs are recommended to accurately confirm the presence of bacteria of the Mycobacterium tuberculosis complex in liquid culture isolates. Methods and Findings: Questionnaires were sent to national TB reference laboratories (NRLs) in 42 high TB endemic countries to address their access to information on ICT implementation, logistics related to availability, accessibility and affordability of ICTs, and testing algorithms. Results from 16 responding countries indicated that half of the NRLs were aware of the contents of WHO guidance documents on liquid culture and ICT implementation, as well as their eligibility for a negotiated pricing agreement for ICT procurement. No major issues with availability and accessibility of ICTs were raised. When asked about testing algorithms, ICTs were not used as stand-alone or first test for TB culture identification as recommended by WHO. Conclusions: The low response rate was a limitation of this survey and together with NRLs managers' unawareness of global guidance, suggests a lack of effective communication between partners of the global laboratory network and NRLs. TB tests could become more affordable to high TB endemic countries, if the possibility to negotiate lower prices for commercial products is communicated to them more successfully. NRLs need additional guidance to identify where available technologies can be most usefully implemented and in what order, taking into account long-term laboratory strategies.	[van Kampen, Sanne C.; Oskam, Linda; Tuijn, Coosje J.; Klatser, Paul R.] Royal Trop Inst Biomed Res, Royal Trop Inst, Amsterdam, Netherlands		van Kampen, SC (corresponding author), Royal Trop Inst Biomed Res, Royal Trop Inst, Amsterdam, Netherlands.	sanne.vankampen@gmail.com		van Kampen, Sanne/0000-0002-1519-5248; Klatser, Paul/0000-0003-3868-2409; Klatser, Paul/0000-0003-2127-9138	World Health Organization/TDR	World Health Organization/TDR(World Health Organization)	Funding for this work was provided by World Health Organization/TDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORK PLAN 2010 2011; BD Diagnostic, 2009, DB MGIT TBC ID TEST; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Fabre M, 2011, PATHOL BIOL, V59, P26, DOI 10.1016/j.patbio.2010.08.007; Foundation for Innovative New Diagnostics, 2009, FIND PRIC BACTEC MGI; Global Laboratory Initiative, 2012, GLI TB LAB NETW LAB; Global Laboratory Initiative, 2010, ROADM ENS QUAL TUB D; Muyoyeta M, 2010, J CLIN MICROBIOL, V48, P3773, DOI 10.1128/JCM.01688-09; Ngamlert K, 2009, TROP MED INT HEALTH, V14, P748, DOI 10.1111/j.1365-3156.2009.02284.x; Retooling Taskforce of the Stop TB Partnership, 2008, CHECKL KEY ACT US LI; Said HM, 2011, J CLIN MICROBIOL, V49, P1939, DOI 10.1128/JCM.01906-10; Scarparo C, 2001, J CLIN MICROBIOL, V39, P3222, DOI 10.1128/JCM.39.9.3222-3227.2001; SD BIO Standard Diagnostics India, 2011, TB AG MPT64 TB AB; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Tauns, 2011, M TUBERCULOSIS COMPL; TREAT TB, 2010, DIAGNOSTIC TOOLS INI; van Kampen SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011649; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2007, POL STAT US LIQ MED; World Health Organization, 2010, EXPAND TB EXP ACC AC; World Health Organization, 2007, WHO POL US LIQ MED C	22	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43439	10.1371/journal.pone.0043439	http://dx.doi.org/10.1371/journal.pone.0043439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937050	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500051
J	Lennertz, RC; Kossyreva, EA; Smith, AK; Stucky, CL				Lennertz, Richard C.; Kossyreva, Elena A.; Smith, Amanda K.; Stucky, Cheryl L.			TRPA1 Mediates Mechanical Sensitization in Nociceptors during Inflammation	PLOS ONE			English	Article							CUTANEOUS SENSORY NEURONS; ION-CHANNEL TRPA1; PERIPHERAL INFLAMMATION; NEUROGENIC INFLAMMATION; CAPSAICIN RECEPTOR; SPINAL NEURONS; INFLAMED RATS; TRPV1; PAIN; HYPERALGESIA	Inflammation is a part of the body's natural response to tissue injury which initiates the healing process. Unfortunately, inflammation is frequently painful and leads to hypersensitivity to mechanical stimuli, which is difficult to treat clinically. While it is well established that altered sensory processing in the spinal cord contributes to mechanical hypersensitivity (central sensitization), it is still debated whether primary afferent neurons become sensitized to mechanical stimuli after tissue inflammation. We induced inflammation in C57BL/6 mice via intraplantar injection of Complete Freund's Adjuvant. Cutaneous C fibers exhibited increased action potential firing to suprathreshold mechanical stimuli. We found that abnormal responses to intense mechanical stimuli were completely suppressed by acute incubation of the receptive terminals with the TRPA1 inhibitor, HC-030031. Further, elevated responses were predominantly exhibited by a specific subgroup of C fibers, which we determined to be C-Mechano Cold sensitive fibers. Thus, in the presence of HC-030031, C fiber mechanical responses in inflamed mice were not different than responses in saline-injected controls. We also demonstrate that injection of the HC-030031 compound into the hind paw of inflamed mice alleviates behavioral mechanical hyperalgesia without affecting heat hyperalgesia. Further, we pharmacologically anesthetized the TRPA1-expressing fibers in vivo by co-injecting the membrane-impermeable sodium channel inhibitor QX-314 and the TRPA1 agonist cinnamaldehyde into the hind paw. This approach also alleviated behavioral mechanical hyperalgesia in inflamed mice but left heat hypersensitivity intact. Our findings indicate that C-Mechano Cold sensitive fibers exhibit enhanced firing to suprathreshold mechanical stimuli in a TRPA1-dependent manner during inflammation, and that input from these fibers drives mechanical hyperalgesia in inflamed mice.	[Lennertz, Richard C.; Kossyreva, Elena A.; Smith, Amanda K.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Lennertz, RC (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	cstucky@mcw.edu			National Institutes of Health [NS40538, NS070711]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070711, R01NS040538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health grants NS40538 and NS070711 to CLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 1999, J NEUROPHYSIOL, V82, P2649, DOI 10.1152/jn.1999.82.5.2649; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bishop T, 2010, PAIN, V150, P141, DOI 10.1016/j.pain.2010.04.018; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Brierley SM, 2011, J PHYSIOL-LONDON, V589, P3575, DOI 10.1113/jphysiol.2011.206789; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; COOPER B, 1991, J NEUROPHYSIOL, V66, P1280, DOI 10.1152/jn.1991.66.4.1280; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; Garcia-Anoveros J., 2007, V179, P347; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hillery CA, 2011, BLOOD, V118, P3376, DOI 10.1182/blood-2010-12-327429; HYLDEN JLK, 1989, PAIN, V37, P229, DOI 10.1016/0304-3959(89)90135-8; Kanai Y, 2005, NEUROPHARMACOLOGY, V49, P977, DOI 10.1016/j.neuropharm.2005.05.003; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; KOCHER L, 1987, PAIN, V29, P363, DOI 10.1016/0304-3959(87)90051-0; Koerber HR, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-58; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Malin S, 2011, J NEUROSCI, V31, P10516, DOI 10.1523/JNEUROSCI.2992-10.2011; McGaraughty S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-14; McGaraughty S, 2008, J NEUROPHYSIOL, V100, P3158, DOI 10.1152/jn.90768.2008; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; REEH PW, 1986, BRAIN RES, V384, P42, DOI 10.1016/0006-8993(86)91217-5; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Sisignano M, 2012, J NEUROSCI, V32, P6364, DOI 10.1523/JNEUROSCI.5793-11.2012; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Vilceanu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012177; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wei H, 2012, ANESTHESIOLOGY, V117, P137, DOI 10.1097/ALN.0b013e31825adb0e; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	46	108	108	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43597	10.1371/journal.pone.0043597	http://dx.doi.org/10.1371/journal.pone.0043597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927999	Green Published, gold, Green Submitted			2022-12-27	WOS:000308224700019
J	Seet, WT; Maarof, M; Anuar, KK; Chua, KH; Irfan, AWA; Ng, MH; Aminuddin, BS; Ruszymah, BHI				Seet, Wan Tai; Maarof, Manira; Anuar, Khairoji Khairul; Chua, Kien-Hui; Irfan, Abdul Wahab Ahmad; Ng, Min Hwei; Aminuddin, Bin Saim; Ruszymah, Bt Hj Idrus			Shelf-Life Evaluation of Bilayered Human Skin Equivalent, MyDerm (TM)	PLOS ONE			English	Article							CLINICAL-EVALUATION; ARTIFICIAL SKIN; IN-VITRO; FIBROBLASTS; APLIGRAF; EFFICACY; DESIGN; MATRIX	Skin plays an important role in defense against infection and other harmful biological agents. Due to its fragile structure, skin can be easily damaged by heat, chemicals, traumatic injuries and diseases. An autologous bilayered human skin equivalent, MyDerm (TM), was engineered to provide a living skin substitute to treat critical skin loss. However, one of the disadvantages of living skin substitute is its short shelf-life, hence limiting its distribution worldwide. The aim of this study was to evaluate the shelf-life of MyDerm (TM) through assessment of cell morphology, cell viability, population doubling time and functional gene expression levels before transplantation. Skin samples were digested with 0.6% Collagenase Type I followed by epithelial cells dissociation with TrypLE Select. Dermal fibroblasts and keratinocytes were culture-expanded to obtain sufficient cells for MyDerm (TM) construction. MyDerm (TM) was constructed with plasma-fibrin as temporary biomaterial and evaluated at 0, 24, 48 and 72 hours after storage at 4 degrees C for its shelf-life determination. The morphology of skin cells derived from MyDerm (TM) remained unchanged across storage times. Cells harvested from MyDerm (TM) after storage appeared in good viability (90.5%+/- 2.7% to 94.9%+/- 1.6%) and had short population doubling time (58.4 +/- 8.7 to 76.9 +/- 19 hours). The modest drop in cell viability and increased in population doubling time at longer storage duration did not demonstrate a significant difference. Gene expression for CK10, CK14 and COL III were also comparable between different storage times. In conclusion, MyDerm (TM) can be stored in basal medium at 4 degrees C for at least 72 hours before transplantation without compromising its functionality.	[Seet, Wan Tai; Maarof, Manira; Anuar, Khairoji Khairul; Chua, Kien-Hui; Irfan, Abdul Wahab Ahmad; Ng, Min Hwei; Aminuddin, Bin Saim; Ruszymah, Bt Hj Idrus] Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Kuala Lumpur, Malaysia; [Chua, Kien-Hui; Ruszymah, Bt Hj Idrus] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Aminuddin, Bin Saim] Ampang Puteri Specialist Hosp, Ear Nose & Throat Consultant Clin, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Seet, WT (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Kuala Lumpur, Malaysia.	ruszyidrus@gmail.com	Ng, Angela Min Hwei/ABC-6726-2020; Maarof, Manira/AAT-3191-2020; Seet, Wan Tai/AAT-3208-2020; chua, kienhui kh/M-7245-2017	Ng, Angela Min Hwei/0000-0002-5791-639X; Kien Hui, Chua/0000-0002-2595-5087; Maarof, Manira/0000-0002-2154-7852; Seet, Wan Tai/0000-0003-3788-6602	Malaysian Technology Development Corporation (MTDC) [UKM-MTDC-BF-0001-2008]; Universiti Kebangsaan Malaysia	Malaysian Technology Development Corporation (MTDC); Universiti Kebangsaan Malaysia	This study is made possible by a grant from Malaysian Technology Development Corporation (MTDC), grant number UKM-MTDC-BF-0001-2008, Universiti Kebangsaan Malaysia (http://www.mtdc.com.my/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3; Bar-Meir E, 2006, ISR MED ASSOC J, V8, P188; BERNSTAM L I, 1990, Journal of Dermatological Science, V1, P173, DOI 10.1016/0923-1811(90)90129-2; Cheng W, 2011, AFR J BIOTECHNOL, V10, P2524; Coulomb B, 1998, PLAST RECONSTR SURG, V101, P1891, DOI 10.1097/00006534-199806000-00018; Dinh TL, 2006, PLAST RECONSTR SURG, V117, p152S, DOI 10.1097/01.prs.0000222534.79915.d3; Edmonds M, 2009, INT J LOW EXTR WOUND, V8, P11, DOI 10.1177/1534734609331597; Furukawa K, 1998, CYTOTECHNOLOGY, V26, P153, DOI 10.1023/A:1007934216507; HANSBROUGH JF, 1992, SURGERY, V111, P438; HANSBROUGH JF, 1994, SURGERY, V115, P633; HARRIGER M D, 1992, Journal of Burn Care and Rehabilitation, V13, P187, DOI 10.1097/00004630-199203000-00002; Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800; Kumar RJ, 2004, ANZ J SURG, V74, P622, DOI 10.1111/j.1445-1433.2004.03106.x; LEVINE JF, 1985, J CELL BIOL, V100, P1415, DOI 10.1083/jcb.100.5.1415; Lewis M. P., 2006, PHARM TECHNOLOGY EUR, P50; MacNeil S, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70087-7; Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701; Mast B.A., 1999, SKIN WOUND HEALING B; Mazlyzam AL, 2007, BURNS, V33, P355, DOI 10.1016/j.burns.2006.08.022; Mazlyzam AL, 2008, ARCH MED RES, V39, P743, DOI 10.1016/j.arcmed.2008.09.001; Moiemen NS, 2006, PLAST RECONSTR SURG, V117, p160S, DOI 10.1097/01.prs.0000222609.40461.68; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; PURKIS PE, 1990, J CELL SCI, V97, P39; Schon M, 1996, BRIT J DERMATOL, V135, P696; Schurr MJ, 2009, J TRAUMA, V66, P866, DOI 10.1097/TA.0b013e31819849d6; Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1; TAVIS MJ, 1980, BURNS, V7, P123, DOI 10.1016/0305-4179(80)90038-8; THIVOLET J, 1986, TRANSPLANTATION, V42, P274, DOI 10.1097/00007890-198609000-00010; Tilden E, 2010, FACTS ORGAN DONATION; Wainwright David, 1996, Journal of Burn Care and Rehabilitation, V17, P124, DOI 10.1097/00004630-199603000-00006; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108; YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203	33	40	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e40978	10.1371/journal.pone.0040978	http://dx.doi.org/10.1371/journal.pone.0040978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927903	gold, Green Published, Green Submitted			2022-12-27	WOS:000308224700001
J	Wang, PP; Xie, DY; Liang, XJ; Peng, L; Zhang, GL; Ye, YN; Xie, C; Gao, ZL				Wang, Pei-pei; Xie, Dong-ying; Liang, Xu-jing; Peng, Liang; Zhang, Geng-lin; Ye, Yi-nong; Xie, Chan; Gao, Zhi-liang			HGF and Direct Mesenchymal Stem Cells Contact Synergize to Inhibit Hepatic Stellate Cells Activation through TLR4/NF-kB Pathway	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; BONE-MARROW-CELLS; LIVER FIBROSIS; TRANSPLANTATION; EXPRESSION; CIRRHOSIS; TERM	Aims: Bone marrow-derived mesenchymal stem cells (BMSCs) can reduce liver fibrosis. Apart from the paracrine mechanism by which the antifibrotic effects of BMSCs inhibit activated hepatic stellate cells (HSCs), the effects of direct interplay and juxtacrine signaling between the two cell types are poorly understood. The purpose of this study was to explore the underlying mechanisms by which BMSCs modulate the function of activated HSCs. Methods: We used BMSCs directly and indirectly co-culture system with HSCs to evaluate the anti-fibrosis effect of BMSCs. Cell proliferation and activation were examined in the presence of BMSCs and HGF. c-met was knockdown in HSCs to evaluate the effect of HGF secreted by BMSCs. The TLR4 and Myeloid differentiation primary response gene 88(MyD88) mRNA levels and the NF-kB pathway activation were determined by real-time PCR and western blotting analyses. The effect of BMSCs on HSCs activation was investigated in vitro in either MyD88 silencing or overexpression in HSCs. Liver fibrosis in rats fed CCl4 with and without BMSCs supplementation was compared. Histopathological examinations and serum biochemical tests were compared between the two groups. Results: BMSCs remarkably inhibited the proliferation and activation of HSCs by interfering with LPS-TLR4 pathway through a cell-cell contact mode that was partially mediated by HGF secretion. The NF-kB pathway is involved in HSCs activation inhibition by BMSCs. MyD88 over expression reduced the BMSC inhibition of NF-kB luciferase activation. BMSCs protected liver fibrosis in vivo. Conclusion: BMSCs modulate HSCs in vitro via TLR4/MyD88/NF-kB signaling pathway through cell-cell contact and secreting HGF. BMSCs have therapeutic effects on cirrhosis rats. Our results provide new insights into the treatment of hepatic fibrosis with BMSCs.	[Wang, Pei-pei; Xie, Dong-ying; Peng, Liang; Zhang, Geng-lin; Xie, Chan; Gao, Zhi-liang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Xu-jing] Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Ye, Yi-nong] First Peoples Hosp Foshan City, Dept Infect Dis, Foshan, Guangdong, Peoples R China; [Wang, Pei-pei; Xie, Dong-ying; Xie, Chan; Gao, Zhi-liang] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Jinan University; Sun Yat Sen University	Wang, PP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China.	happyxiechan@gmail.com; gaozl@yahoo.com.cn			Natural Science Foundation of China [81101864/H1617]; Baiyang liver cirrhosis grand [2010-004]; Fundamental Research Funds for the Central Universities [09 ykzs07, 10 ykzs04]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Baiyang liver cirrhosis grand; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Grant Support: The Natural Science Foundation of China (No. 81101864/H1617), Baiyang liver cirrhosis grand (No. 2010-004), the Fundamental Research Funds for the Central Universities (09 ykzs07,10 ykzs04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baertschiger RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006657; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Brun P, 2005, AM J PHYSIOL-GASTR L, V289, pG571, DOI 10.1152/ajpgi.00537.2004; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Gaia S, 2006, J HEPATOL, V45, P13, DOI 10.1016/j.jhep.2006.02.018; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; Gordon MY, 2006, STEM CELLS, V24, P1822, DOI 10.1634/stemcells.2005-0629; GRINKO I, 1995, J HEPATOL, V23, P449, DOI 10.1016/0168-8278(95)80204-5; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; Liu YB, 2006, J SURG RES, V136, P336, DOI 10.1016/j.jss.2006.07.037; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NOLAN JP, 1978, GASTROENTEROLOGY, V75, P445; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Payne C, 2007, HEPATOLOGY, V46, p710A; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; ROOS F, 1992, ENDOCRINOLOGY, V131, P2540, DOI 10.1210/en.131.6.2540; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Sakaida Isao, 2005, Medical Molecular Morphology, V38, P197, DOI 10.1007/s00795-005-0298-z; Schiff ER, 2011, CLIN GASTROENTEROL H, V9, P274, DOI 10.1016/j.cgh.2010.11.040; Schwabe RF, 2001, J IMMUNOL, V166, P6812, DOI 10.4049/jimmunol.166.11.6812; Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Xie C, 2009, CELL BIOL INT, V33, P493, DOI 10.1016/j.cellbi.2009.01.006	30	24	31	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43408	10.1371/journal.pone.0043408	http://dx.doi.org/10.1371/journal.pone.0043408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927965	Green Submitted, gold, Green Published			2022-12-27	WOS:000308224700014
J	Brandalise, F; Gerber, U; Rossi, P				Brandalise, Federico; Gerber, Urs; Rossi, Paola			Golgi Cell-Mediated Activation of Postsynaptic GABA(B) Receptors Induces Disinhibition of the Golgi Cell-Granule Cell Synapse in Rat Cerebellum	PLOS ONE			English	Article							LONG-TERM POTENTIATION; INPUT STAGE; WHOLE-CELL; GABAERGIC INHIBITION; TONIC ACTIVATION; NMDA RECEPTORS; TRANSMISSION; CURRENTS; NEURONS; CORTEX	In the cerebellar glomerulus, GABAergic synapses formed by Golgi cells regulate excitatory transmission from mossy fibers to granule cells through feed-forward and feedback mechanisms. In acute cerebellar slices, we found that stimulating Golgi cell axons with a train of 10 impulses at 100 Hz transiently inhibited both the phasic and the tonic components of inhibitory responses recorded in granule cells. This effect was blocked by the GABA(B) receptor blocker CGP35348, and could be mimicked by bath-application of baclofen (30 mu M). This depression of IPSCs was prevented when granule cells were dialyzed with GDP beta S. Furthermore, when synaptic transmission was blocked, GABA(A) currents induced in granule cells by localized muscimol application were inhibited by the GABA(B) receptor agonist baclofen. These findings indicate that postsynaptic GABA(B) receptors are primarily responsible for the depression of IPSCs. This inhibition of inhibitory events results in an unexpected excitatory action by Golgi cells on granule cell targets. The reduction of Golgi cell-mediated inhibition in the cerebellar glomerulus may represent a regulatory mechanism to shift the balance between excitation and inhibition in the glomerulus during cerebellar information processing.	[Brandalise, Federico; Rossi, Paola] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Brandalise, Federico; Gerber, Urs] Univ Zurich, Brain Res Inst, Zurich, Switzerland	University of Pavia; University of Zurich	Brandalise, F (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	paola.rossi@unipv.it	Rossi, Paola/A-4083-2016	Rossi, Paola/0000-0002-1134-4111; BRANDALISE, FEDERICO/0000-0002-2033-5719	European Community; SENSOPAC (Sensorimotor structuring of Perception and Action (EU framework 6)) [FP6-IST028056]; CNISM (Consorzio Nazionale Interuniversitario per le Scienze Fisiche della Materia); MIUR (Ministero Istruzione Universita Ricerca) of Italy; FAR (Progetto di Ricerca Finalizzata)	European Community(European Commission); SENSOPAC (Sensorimotor structuring of Perception and Action (EU framework 6)); CNISM (Consorzio Nazionale Interuniversitario per le Scienze Fisiche della Materia); MIUR (Ministero Istruzione Universita Ricerca) of Italy(Ministry of Education, Universities and Research (MIUR)); FAR (Progetto di Ricerca Finalizzata)	This work was supported by the European Community, SENSOPAC (Sensorimotor structuring of Perception and Action (EU framework 6)) FP6-IST028056, by the CNISM (Consorzio Nazionale Interuniversitario per le Scienze Fisiche della Materia, which provided funding for the grant called NEUROIMAGE) grant, NEUROIMAGE, by MIUR (Ministero Istruzione Universita Ricerca, which provided funding for the grants) of Italy, PRIN (Progetti di Rilevante Interesse Nazionale) and FAR (Progetto di Ricerca Finalizzata) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramian AM, 2010, J BIOL CHEM, V285, P41795, DOI 10.1074/jbc.M110.149229; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 1999, J NEUROSCI, V19, P2960; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chang EH, 2003, J NEUROPHYSIOL, V90, P1479, DOI 10.1152/jn.00386.2003; CHEN QX, 1995, J PHYSIOL-LONDON, V482, P353, DOI 10.1113/jphysiol.1995.sp020522; D'Angelo E, 1999, J NEUROPHYSIOL, V81, P277, DOI 10.1152/jn.1999.81.1.277; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DANGELO E, 1993, NEUROSCIENCE, V53, P121, DOI 10.1016/0306-4522(93)90290-V; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; Eccles JC, 1967, CEREBELLUM NEURONAL; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; EDGLEY SA, 1987, J PHYSIOL-LONDON, V392, P315, DOI 10.1113/jphysiol.1987.sp016782; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gall D, 2005, J NEUROSCI, V25, P4813, DOI 10.1523/JNEUROSCI.0410-05.2005; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Heine SA, 2010, J NEUROSCI, V30, P17004, DOI 10.1523/JNEUROSCI.3513-10.2010; Holtzman T, 2011, J PHYSIOL-LONDON, V589, P3837, DOI 10.1113/jphysiol.2011.207167; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Ige AO, 2000, MOL BRAIN RES, V83, P72, DOI 10.1016/S0169-328X(00)00199-6; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kia A, 2011, J NEUROCHEM, V116, P1043, DOI 10.1111/j.1471-4159.2010.07156.x; Komatsu Y, 1996, J NEUROSCI, V16, P6342; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; Kotak VC, 2001, J NEUROPHYSIOL, V86, P536, DOI 10.1152/jn.2001.86.1.536; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Lei SB, 2003, J PHYSIOL-LONDON, V546, P439, DOI 10.1113/jphysiol.2002.034017; Liang FY, 2000, J COMP NEUROL, V416, P475, DOI 10.1002/(SICI)1096-9861(20000124)416:4<475::AID-CNE5>3.0.CO;2-V; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Maffei A, 2002, J NEUROPHYSIOL, V88, P627, DOI 10.1152/jn.2002.88.2.627; Mapelli J, 2007, J NEUROSCI, V27, P1285, DOI 10.1523/JNEUROSCI.4873-06.2007; Mapelli J, 2010, J NEUROPHYSIOL, V103, P250, DOI 10.1152/jn.00642.2009; Mapelli L, 2009, J NEUROPHYSIOL, V101, P3089, DOI 10.1152/jn.91190.2008; MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K; MORISHITA W, 1995, NEUROSCIENCE, V68, P1127, DOI 10.1016/0306-4522(95)00206-X; Patenaude C, 2003, J PHYSIOL-LONDON, V553, P155, DOI 10.1113/jphysiol.2003.049015; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Rossi P, 2006, EUR J NEUROSCI, V24, P419, DOI 10.1111/j.1460-9568.2006.04914.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; Tia S, 1996, NEUROPHARMACOLOGY, V35, P1375, DOI 10.1016/S0028-3908(96)00018-4; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Vos BP, 1999, EUR J NEUROSCI, V11, P2621, DOI 10.1046/j.1460-9568.1999.00678.x; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Yamada K, 1999, J NEUROPHYSIOL, V81, P2875, DOI 10.1152/jn.1999.81.6.2875	54	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43417	10.1371/journal.pone.0043417	http://dx.doi.org/10.1371/journal.pone.0043417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937048	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300050
J	Greene, JM; Chin, EN; Budde, ML; Lhost, JJ; Hines, PJ; Burwitz, BJ; Broman, KW; Nelson, JE; Friedrich, TC; O'Connor, DH				Greene, Justin M.; Chin, Emily N.; Budde, Melisa L.; Lhost, Jennifer J.; Hines, Paul J.; Burwitz, Benjamin J.; Broman, Karl W.; Nelson, Jennifer E.; Friedrich, Thomas C.; O'Connor, David H.			Ex Vivo SIV-Specific CD8 T Cell Responses in Heterozygous Animals Are Primarily Directed against Peptides Presented by a Single MHC Haplotype	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MAURITIAN CYNOMOLGUS MACAQUES; PLASMA VIRAL LOAD; CLASS-I ALLELES; RHESUS MACAQUES; SIVMAC239 REPLICATION; RELATIVE DOMINANCE; IMMUNE-RESPONSES; INFECTION	The presence of certain MHC class I alleles is correlated with remarkable control of HIV and SIV, indicating that specific CD8 T cell responses can effectively reduce viral replication. It remains unclear whether epitopic breadth is an important feature of this control. Previous studies have suggested that individuals heterozygous at the MHC class I loci survive longer and/or progress more slowly than those who are homozygous at these loci, perhaps due to increased breadth of the CD8 T cell response. We used Mauritian cynomolgus macaques with defined MHC haplotypes and viral inhibition assays to directly compare CD8 T cell efficacy in MHC-heterozygous and homozygous individuals. Surprisingly, we found that cells from heterozygotes suppress viral replication most effectively on target cells from animals homozygous for only one of two potential haplotypes. The same heterozygous effector cells did not effectively inhibit viral replication as effectively on the target cells homozygous for the other haplotype. These results indicate that the greater potential breadth of CD8 T cell responses present in heterozygous animals does not necessarily lead to greater antiviral efficacy and suggest that SIV-specific CD8 T cell responses in heterozygous animals have a skewed focus toward epitopes restricted by a single haplotype.	[Greene, Justin M.; Lhost, Jennifer J.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Chin, Emily N.; O'Connor, David H.] Univ Wisconsin, Dept Cellular & Mol Biol, Madison, WI USA; [Budde, Melisa L.; Hines, Paul J.; Burwitz, Benjamin J.; Nelson, Jennifer E.; Friedrich, Thomas C.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Broman, Karl W.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Greene, JM (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	david.h.oconnor@gmail.com		o'connor, david/0000-0003-2139-470X; Friedrich, Thomas/0000-0001-9831-6895; Broman, Karl/0000-0002-4914-6671	National Institutes of Health [R01 AI084787, R01 AI077376-04A1, R33 AI082880-03]; National Center for Research Resources [RR000167]; Office of Research Infrastructure Programs (ORIP) [P51OD011106]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459, P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI082880, R01AI084787, R01AI077376] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was made possible in part by National Institutes of Health grants R01 AI084787, R01 AI077376-04A1, and R33 AI082880-03; and it was supported by National Center for Research Resources grant RR000167 and the Office of Research Infrastructure Programs (ORIP) grant P51OD011106. The research was conducted, in part, at a facility constructed with support from Research Facilities Improvement Program grants RR15459-01 and RR020141-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Budde ML, 2012, J VIROL; BUDDE ML, 2011, J VIROL; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cline AN, 2005, J MED PRIMATOL, V34, P303; Day CL, 2001, J VIROL, V75, P6279, DOI 10.1128/JVI.75.14.6279-6291.2001; Day EB, 2011, J IMMUNOL, V186, P6319, DOI 10.4049/jimmunol.1000883; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Greene JM, 2010, J VIROL, V84, P3362, DOI 10.1128/JVI.02028-09; Hollsberg P, 2002, SCAND J IMMUNOL, V55, P189, DOI 10.1046/j.0300-9475.2001.01043.x; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lacey SF, 2003, HUM IMMUNOL, V64, P440, DOI 10.1016/S0198-8859(03)00028-4; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08; Maness NJ, 2010, J IMMUNOL, V184, P67, DOI 10.4049/jimmunol.0903118; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; Mee ET, 2010, TISSUE ANTIGENS, V76, P223, DOI 10.1111/j.1399-0039.2010.01500.x; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Penn DJ, 2002, ETHOLOGY, V108, P1, DOI 10.1046/j.1439-0310.2002.00768.x; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Saah AJ, 1998, AIDS, V12, P2107, DOI 10.1097/00002030-199816000-00005; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Smith MZ, 2005, J VIROL, V79, P684, DOI 10.1128/JVI.79.2.684-695.2005; Stebbings R, 2005, J VIROL, V79, P12264, DOI 10.1128/JVI.79.19.12264-12272.2005; Tourdot S, 2002, J IMMUNOL, V169, P5615, DOI 10.4049/jimmunol.169.10.5615; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JW, 2005, IMMUNOL REV, V207, P8	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43690	10.1371/journal.pone.0043690	http://dx.doi.org/10.1371/journal.pone.0043690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928016	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300081
J	Guardia, D; Conversy, L; Jardri, R; Lafargue, G; Thomas, P; Dodin, V; Cottencin, O; Luyat, M				Guardia, Dewi; Conversy, Lea; Jardri, Renaud; Lafargue, Gilles; Thomas, Pierre; Dodin, Vincent; Cottencin, Olivier; Luyat, Marion			Imagining One's Own and Someone Else's Body Actions: Dissociation in Anorexia Nervosa	PLOS ONE			English	Article							EATING-DISORDERS; MOTOR IMAGERY; MENTAL REPRESENTATION; VISUAL GUIDANCE; VIRTUAL-REALITY; SIZE PERCEPTION; PARIETAL CORTEX; PHANTOM LIMB; WEIGHT; SELF	Background: Patients with anorexia nervosa (AN) usually report feeling larger than they really are. This body overestimation appears to be related not only to the patient's body image but also to an abnormal representation of the body in action. In previous work on a body-scaled anticipation task, anorexic patients judged that they could not pass through a door-like aperture even when it was easily wide enough - suggesting the involvement of the body schema. In the present study, we sought to establish whether this erroneous judgment about action is specifically observed when it concerns one's own body or whether it is symptomatic of a general impairment in perceptual discrimination. Methods: Twenty-five anorexic participants and 25 control participants were presented with a door-like aperture. They had to judge whether or not the aperture was wide enough for them to pass through (i.e. first-person perspective, 1PP) and for another person present in the testing room to pass through (i.e. third-person perspective, 3PP). Results: We observed a higher passability ratio (i.e. the critical aperture size to shoulder width ratio) in AN patients for 1PP but not for 3PP. Moreover, the magnitude of the passability ratio was positively correlated not only with the extent of the patient's body and eating concerns but also with the body weight prior to disease onset. Our results suggest that body overestimation can affect judgments about the capacity for action but only when they concern the patient's own body. This could be related to impairments of the overall network involved in the emergence of the body schema and in one's own perspective judgments. Conclusion: Overestimation of the body schema might occur because the central nervous system has not updated the new, emaciated body, with maintenance of an incorrect representation based on the patient's pre-AN body dimensions.	[Guardia, Dewi; Conversy, Lea; Jardri, Renaud; Lafargue, Gilles; Thomas, Pierre; Cottencin, Olivier; Luyat, Marion] Univ Lille Nord France, EA 4559, Lab Neurosci Fonct & Pathol, Lille, France; [Guardia, Dewi; Cottencin, Olivier] CHRU Lille, Hop Calmette, Serv Addictol, Lille, France; [Thomas, Pierre] CHRU Lille, Hop Fontan, Psychiat Serv, Lille, France; [Dodin, Vincent] Hop St Vincent de Paul, Psychiat Serv, Lille, France; [Luyat, Marion] Univ Lille Nord France, Dept Psychol, Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Guardia, D (corresponding author), Univ Lille Nord France, EA 4559, Lab Neurosci Fonct & Pathol, Lille, France.	dewi.guardia@chru-lille.fr	Jardri, Renaud/J-9202-2012; Jardri, Renaud/ABE-5841-2021; Luyat, Marion/HIR-3502-2022; /I-4024-2015	Jardri, Renaud/0000-0003-4596-1502; Luyat, Marion/0000-0002-5640-5002; /0000-0003-3663-1405	Federation pour la Recherche Medicale	Federation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The present work was funded by the Federation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bakker M, 2008, NEUROIMAGE, V41, P998, DOI 10.1016/j.neuroimage.2008.03.020; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Case LK, 2012, EXP BRAIN RES, V217, P79, DOI 10.1007/s00221-011-2974-7; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Cohen RG, 2011, NEUROPSYCHOLOGIA, V49, P3981, DOI 10.1016/j.neuropsychologia.2011.10.014; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; Daprati E, 2010, NEUROPSYCHOLOGIA, V48, P756, DOI 10.1016/j.neuropsychologia.2009.10.008; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Decety J, 1996, BEHAV BRAIN RES, V72, P127; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Exterkate CC, 2009, EAT BEHAV, V10, P16, DOI 10.1016/j.eatbeh.2008.10.002; Ferrer-Garcia M, 2012, BODY IMAGE, V9, P1, DOI 10.1016/j.bodyim.2011.10.001; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Franko DL, 2002, J PSYCHOSOM RES, V53, P975, DOI 10.1016/S0022-3999(02)00490-7; Gardner RM, 2010, PERS INDIV DIFFER, V48, P107, DOI 10.1016/j.paid.2009.08.017; Gardner RM, 1999, PERCEPT MOTOR SKILL, V89, P981, DOI 10.2466/PMS.89.7.981-993; Garner D.M, 1991, EDI 2 EATING DISORDE; Giummarra MJ, 2010, BRIT J PSYCHOL, V101, P791, DOI 10.1348/000712610X492558; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Grunwald M, 2002, ARCH CLIN NEUROPSYCH, V17, P485, DOI 10.1016/S0887-6177(01)00131-7; Grunwald M, 2001, INT J EAT DISORDER, V29, P417, DOI 10.1002/eat.1038; Guardia D, 2012, PSYCHIAT RES, V195, P56, DOI 10.1016/j.psychres.2011.08.003; Guardia D, 2010, NEUROPSYCHOLOGIA, V48, P3961, DOI 10.1016/j.neuropsychologia.2010.09.004; HEILBRUN AB, 1990, J CLIN PSYCHOL, V46, P398, DOI 10.1002/1097-4679(199007)46:4<398::AID-JCLP2270460404>3.0.CO;2-5; Hesslow G, 2002, TRENDS COGN SCI, V6, P242, DOI 10.1016/S1364-6613(02)01913-7; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Keizer A, 2011, PSYCHIAT RES, V190, P115, DOI 10.1016/j.psychres.2011.04.031; KOHL RM, 1980, J MOTOR BEHAV, V12, P197; Linkenauger SA, 2010, PSYCHOL SCI, V21, P1318, DOI 10.1177/0956797610380700; LUCAS AR, 1991, AM J PSYCHIAT, V148, P917; Meyer C, 2009, EUR EAT DISORD REV, V17, P366, DOI 10.1002/erv.950; Morgado N, 2011, PERCEPTION, V40, P877, DOI 10.1068/p6830; Nico D, 2010, PSYCHOL MED, V40, P1531, DOI 10.1017/S0033291709991851; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; Perpina C, 2003, EUR EAT DISORD REV, V11, P261, DOI 10.1002/erv.520; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; PIERLOOT RA, 1978, PSYCHOL MED, V8, P317, DOI 10.1017/S0033291700014367; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Riva G, 2004, ST HEAL T, V99, P121; Riva G, 2012, MED HYPOTHESES, V78, P254, DOI 10.1016/j.mehy.2011.10.039; Roth R, 1996, NEUROREPORT, V7, P1280, DOI 10.1097/00001756-199605170-00012; Santonastaso P, 2009, INT J EAT DISORDER, V42, P464, DOI 10.1002/eat.20706; Schneider N, 2009, EUR EAT DISORD REV, V17, P468, DOI 10.1002/erv.956; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; Stefanucci JK, 2010, ATTEN PERCEPT PSYCHO, V72, P1338, DOI 10.3758/APP.72.5.1338; Stefanucci JK, 2009, PERCEPTION, V38, P1782, DOI 10.1068/p6437; Stevens JA, 2005, COGNITION, V95, P329, DOI 10.1016/j.cognition.2004.02.008; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Tomasino SJ, 1996, J NERV MENT DIS, V184, P758, DOI 10.1097/00005053-199612000-00007; Urgesi C, 2012, INT J EAT DISORDER, V45, P501, DOI 10.1002/eat.20982; Vartanian LR, 2011, BODY IMAGE, V8, P415, DOI 10.1016/j.bodyim.2011.06.007; Vartanian LR, 2004, INT J EAT DISORDER, V36, P69, DOI 10.1002/eat.20014; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Wentz E, 2009, BRIT J PSYCHIAT, V194, P168, DOI 10.1192/bjp.bp.107.048686	65	60	62	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43241	10.1371/journal.pone.0043241	http://dx.doi.org/10.1371/journal.pone.0043241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22937025	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300037
J	Poell, JB; van Haastert, RJ; de Gunst, T; Schultz, IJ; Gommans, WM; Verheul, M; Cerisoli, F; van Noort, PI; Prevost, GP; Schaapveld, RQJ; Cuppen, E				Poell, Jos B.; van Haastert, Rick J.; de Gunst, Thijs; Schultz, Iman J.; Gommans, Willemijn M.; Verheul, Mark; Cerisoli, Francesco; van Noort, Paula I.; Prevost, Gregoire P.; Schaapveld, Roel Q. J.; Cuppen, Edwin			A Functional Screen Identifies Specific MicroRNAs Capable of Inhibiting Human Melanoma Cell Viability	PLOS ONE			English	Article							LINEAGE SURVIVAL; PROTEIN; KINASE; MIR-16; MITF; BRAF; RNA; DIFFERENTIATION; METASTASIS; RESISTANCE	Malignant melanoma is an aggressive form of skin cancer with poor prognosis. Despite improvements in awareness and prevention of this disease, its incidence is rapidly increasing. MicroRNAs (miRNAs) are a class of small RNA molecules that regulate cellular processes by repressing messenger RNAs (mRNAs) with partially complementary target sites. Several miRNAs have already been shown to attenuate cancer phenotypes, by limiting proliferation, invasiveness, tumor angiogenesis, and stemness. Here, we employed a genome-scale lentiviral human miRNA expression library to systematically survey which miRNAs are able to decrease A375 melanoma cell viability. We highlight the strongest inhibitors of melanoma cell proliferation, including the miR-15/16, miR-141/200a and miR-96/182 families of miRNAs and miR-203. Ectopic expression of these miRNAs resulted in long-term inhibition of melanoma cell expansion, both in vitro and in vivo. We show specifically miR-16, miR-497, miR-96 and miR-182 are efficient effectors when introduced as synthetic miRNAs in several melanoma cell lines. Our study provides a comprehensive interrogation of miRNAs that interfere with melanoma cell proliferation and viability, and offers a selection of miRNAs that are especially promising candidates for application in melanoma therapy.	[Poell, Jos B.; Cuppen, Edwin] Canc Genom Ctr, Hubrecht Inst, Univ Med Ctr Utrecht, Utrecht, Netherlands; [van Haastert, Rick J.; de Gunst, Thijs; Schultz, Iman J.; Gommans, Willemijn M.; Verheul, Mark; Cerisoli, Francesco; van Noort, Paula I.; Prevost, Gregoire P.; Schaapveld, Roel Q. J.; Cuppen, Edwin] InteRNA Technol BV, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Poell, JB (corresponding author), Canc Genom Ctr, Hubrecht Inst, Univ Med Ctr Utrecht, Utrecht, Netherlands.	e.cuppen@hubrecht.eu	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Poell, Jos/0000-0003-1776-3779	Cancer Genomics Center through Netherlands Genomics Initiative	Cancer Genomics Center through Netherlands Genomics Initiative	This work was financially supported by the Cancer Genomics Center through grants from the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Broderick JA, 2011, RNA; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cohen C, 2002, CLIN CANCER RES, V8, P3728; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Glud M, 2011, MELANOMA RES, V21, P253, DOI 10.1097/CMR.0b013e328345333b; Gommans WM, 2012, METHODS MOL BIOL, V786, P167, DOI 10.1007/978-1-61779-292-2_10; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Huynh C, 2011, ONCOGENE, V30, P1481, DOI 10.1038/onc.2010.523; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mckenzie JA, 2012, ANTICANCER RES, V32, P397; Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Noguchi S, 2012, J BIOL CHEM, V287, P11769, DOI 10.1074/jbc.M111.325027; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Poell JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-546; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rigel DS, 2000, CA-CANCER J CLIN, V50, P215, DOI 10.3322/canjclin.50.4.215; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharma A, 2006, CANCER RES, V66, P8200, DOI 10.1158/0008-5472.CAN-06-0809; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	47	45	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43569	10.1371/journal.pone.0043569	http://dx.doi.org/10.1371/journal.pone.0043569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927992	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300066
J	Rodriguez-Martinez, G; Molina-Hernandez, A; Velasco, I				Rodriguez-Martinez, Griselda; Molina-Hernandez, Anayansi; Velasco, Ivan			Activin A Promotes Neuronal Differentiation of Cerebrocortical Neural Progenitor Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; STEM-CELLS; DOPAMINERGIC-NEURONS; SELF-RENEWAL; IN-VIVO; SURVIVAL; CNS; NEUROGENESIS; INDUCTION; SMAD	Background: Activin A is a protein that participates principally in reproductive functions. In the adult brain, Activin is neuroprotective, but its role in brain development is still elusive. Methodology/Principal Findings: We studied if Activin A influences proliferation, differentiation or survival in rat cerebrocortical neural progenitor cells (NPC). After stimulation of NPC with Activin A, phosphorylation and nuclear translocation of Smad 2/3 were induced. In proliferating NPC, Activin produced a significant decrease in cell area and also a discrete increase in the number of neurons in the presence of the mitogen Fibroblast Growth Factor 2. The percentages of cells incorporating BrdU, or positive for the undifferentiated NPC markers Nestin and Sox2, were unchanged after incubation with Activin. In differentiating conditions, continuous treatment with Activin A significantly increased the number of neurons without affecting astroglial differentiation or causing apoptotic death. In cells cultured by extended periods, Activin treatment produced further increases in the proportion of neurons, excluding premature cell cycle exit. In clonal assays, Activin significantly increased neuronal numbers per colony, supporting an instructive role. Activin-induced neurogenesis was dependent on activation of its receptors, since incubation with the type I receptor inhibitor SB431542 or the ligand-trap Follistatin prevented neuronal differentiation. Interestingly, SB431542 or Follistatin by themselves abolished neurogenesis and increased astrogliogenesis, to a similar extent to that induced by Bone Morphogenetic Protein (BMP) 4. Co-incubation of these Activin inhibitors with the BMP antagonist Dorsomorphin restored neuronal and astrocytic differentiation to control levels. Conclusions: Our results show an instructive neuronal effect of Activin A in cortical NPC in vitro, pointing out to a relevant role of this cytokine in the specification of NPC towards a neuronal phenotype.	[Rodriguez-Martinez, Griselda; Molina-Hernandez, Anayansi; Velasco, Ivan] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Rodriguez-Martinez, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, DF, Mexico.	ivelasco@ifc.unam.mx	Velasco, Ivan/AAE-4249-2019; Velasco, Iván/D-3593-2014	Velasco, Ivan/0000-0002-8953-6578; Velasco, Iván/0000-0002-8953-6578; Rodriguez-Martinez, Griselda/0000-0002-3727-6743	PAPIIT (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica) from Universidad Nacional Autonoma de Mexico [IN224207, IN224210]; CONACYT	PAPIIT (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica) from Universidad Nacional Autonoma de Mexico; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by PAPIIT (Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica) grants IN224207 and IN224210 from Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Raquel Martinez-Mendez, Diana Alatriste-Gonzalez and Dr. Rodrigo Lopez-Gonzalez for excellent technical assistance, and also to Dr. Marina Macias-Silva and Dr. Jesus Chimal-Monroy for advice during the elaboration of the experiments and the preparation of the manuscript. The authors also thank t o M. Sc. Elli Marinopoulou for the advices given during the writing of the manuscript. G. R.-M. received a CONACYT Ph.D. fellowship. This work represents a partial fulfillment of G. R.-M. Ph.D. program in Biomedical Sciences at Universidad Nacional Autonoma de Mexico.	Abdipranoto-Cowley A, 2009, STEM CELLS, V27, P1330, DOI 10.1002/stem.80; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; ANDREASSON K, 1995, NEUROSCIENCE, V69, P781, DOI 10.1016/0306-4522(95)00245-E; Briones-Orta MA, 2006, BIOCHEM BIOPH RES CO, V341, P889, DOI 10.1016/j.bbrc.2006.01.041; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Funaba M, 1997, J NEUROENDOCRINOL, V9, P105, DOI 10.1046/j.1365-2826.1997.00558.x; Gajavelli S, 2004, EXP NEUROL, V188, P205, DOI 10.1016/j.expneurol.2004.03.026; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; HASHIMOTO M, 1990, BIOCHEM BIOPH RES CO, V173, P193, DOI 10.1016/S0006-291X(05)81040-X; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Iwahori Y, 1997, BRAIN RES, V760, P52, DOI 10.1016/S0006-8993(97)00275-8; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Kupershmidt L, 2007, J NEUROCHEM, V103, P962, DOI 10.1111/j.1471-4159.2007.04785.x; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lopez-Gonzalez R, 2011, IUBMB LIFE, V63, P930, DOI 10.1002/iub.560; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Massague J, 2000, GENE DEV, V14, P627; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massirer KB, 2010, WILEY INTERDISCIP RE, V3, P107; MATHEWS LS, 1993, RECEPTOR, V3, P173; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; Misumi S, 2008, EUR J NEUROSCI, V28, P1049, DOI 10.1111/j.1460-9568.2008.06420.x; Molina-Hernandez A, 2008, J NEUROCHEM, V106, P706, DOI 10.1111/j.1471-4159.2008.05424.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mujtaba T, 1998, DEV BIOL, V200, P1, DOI 10.1006/dbio.1998.8913; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rodriguez-Rivera NS, 2009, INT J DEV BIOL, V53, P947, DOI 10.1387/ijdb.092869nr; Roussa E, 2004, NEUROBIOL DIS, V16, P300, DOI 10.1016/j.nbd.2004.03.006; Roussa E, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0514; Sailer MHM, 2005, J CELL SCI, V118, P5849, DOI 10.1242/jcs.02708; Sekiguchi M, 2009, NEUROSCI LETT, V452, P232, DOI 10.1016/j.neulet.2009.01.074; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegenthaler JA, 2005, J NEUROSCI, V25, P8627, DOI 10.1523/JNEUROSCI.1876-05.2005; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun YR, 2011, J CELL SCI, V124, P1867, DOI 10.1242/jcs.085506; Suzuki K, 2010, BIOCHEM BIOPH RES CO, V394, P639, DOI 10.1016/j.bbrc.2010.03.039; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Vale W, 1986, Methods Enzymol, V124, P389; Vazquez-Macias A, 2005, FEBS LETT, V579, P3701, DOI 10.1016/j.febslet.2005.05.057; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549	51	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43797	10.1371/journal.pone.0043797	http://dx.doi.org/10.1371/journal.pone.0043797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928036	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300092
J	Gutierrez, NL; Valencia, SR; Branch, TA; Agnew, DJ; Baum, JK; Bianchi, PL; Cornejo-Donoso, J; Costello, C; Defeo, O; Essington, TE; Hilborn, R; Hoggarth, DD; Larsen, AE; Ninnes, C; Sainsbury, K; Selden, RL; Sistla, S; Smith, ADM; Stern-Pirlot, A; Teck, SJ; Thorson, JT; Williams, NE				Gutierrez, Nicolas L.; Valencia, Sarah R.; Branch, Trevor A.; Agnew, David J.; Baum, Julia K.; Bianchi, Patricia L.; Cornejo-Donoso, Jorge; Costello, Christopher; Defeo, Omar; Essington, Timothy E.; Hilborn, Ray; Hoggarth, Daniel D.; Larsen, Ashley E.; Ninnes, Chris; Sainsbury, Keith; Selden, Rebecca L.; Sistla, Seeta; Smith, Anthony D. M.; Stern-Pirlot, Amanda; Teck, Sarah J.; Thorson, James T.; Williams, Nicholas E.			Eco-Label Conveys Reliable Information on Fish Stock Health to Seafood Consumers	PLOS ONE			English	Article							FISHERIES; IMPACTS; CERTIFICATION; STEWARDSHIP; BIODIVERSITY; BARRIERS	Concerns over fishing impacts on marine populations and ecosystems have intensified the need to improve ocean management. One increasingly popular market-based instrument for ecological stewardship is the use of certification and eco-labeling programs to highlight sustainable fisheries with low environmental impacts. The Marine Stewardship Council (MSC) is the most prominent of these programs. Despite widespread discussions about the rigor of the MSC standards, no comprehensive analysis of the performance of MSC-certified fish stocks has yet been conducted. We compared status and abundance trends of 45 certified stocks with those of 179 uncertified stocks, finding that 74% of certified fisheries were above biomass levels that would produce maximum sustainable yield, compared with only 44% of uncertified fisheries. On average, the biomass of certified stocks increased by 46% over the past 10 years, whereas uncertified fisheries increased by just 9%. As part of the MSC process, fisheries initially go through a confidential pre-assessment process. When certified fisheries are compared with those that decline to pursue full certification after pre-assessment, certified stocks had much lower mean exploitation rates (67% of the rate producing maximum sustainable yield vs. 92% for those declining to pursue certification), allowing for more sustainable harvesting and in many cases biomass rebuilding. From a consumer's point of view this means that MSC-certified seafood is 3-5 times less likely to be subject to harmful fishing than uncertified seafood. Thus, MSC-certification accurately identifies healthy fish stocks and conveys reliable information on stock status to seafood consumers.	[Gutierrez, Nicolas L.; Agnew, David J.; Bianchi, Patricia L.; Hoggarth, Daniel D.; Ninnes, Chris; Stern-Pirlot, Amanda] Marine Stewardship Council, London, England; [Valencia, Sarah R.; Costello, Christopher] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Branch, Trevor A.; Essington, Timothy E.; Hilborn, Ray; Thorson, James T.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Baum, Julia K.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Cornejo-Donoso, Jorge] Univ Calif Santa Barbara, Inst Marine Sci, Interdept Grad Program Marine Sci, Santa Barbara, CA 93106 USA; [Cornejo-Donoso, Jorge] Univ Austral Chile, Ctr Trapananda, Coyhaique, Chile; [Defeo, Omar] Fac Ciencias, UNDECIMAR, Montevideo, Uruguay; [Larsen, Ashley E.; Selden, Rebecca L.; Sistla, Seeta; Teck, Sarah J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Sainsbury, Keith] Univ Tasmania, Tasmanian Aquaculture & Fisheries Inst, Taroona, Tas, Australia; [Smith, Anthony D. M.] CSIRO, Wealth Oceans Flagship, Hobart, Tas, Australia; [Williams, Nicholas E.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of Washington; University of Washington Seattle; University of Victoria; University of California System; University of California Santa Barbara; Universidad Austral de Chile; Universidad de la Republica, Uruguay; University of California System; University of California Santa Barbara; University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Santa Barbara	Gutierrez, NL (corresponding author), Marine Stewardship Council, London, England.	nicolas.gutierrez@msc.org	Smith, Tony D/A-4017-2012; Thorson, James T/O-7937-2014; Thorson, James T/H-8771-2019; Hilborn, Ray W/D-6332-2013	Thorson, James T/0000-0001-7415-1010; Thorson, James T/0000-0001-7415-1010; Larsen, Ashley/0000-0001-7491-9245; Cornejo-Donoso, Jorge F./0000-0002-4244-2865; Defeo, Omar/0000-0001-8318-528X; Baum, Julia/0000-0002-9827-1612; Selden, Rebecca/0000-0001-7956-5984	National Science Foundation (NSF) [EF-0553768, 1041570]; University of California, Santa Barbara; State of California	National Science Foundation (NSF)(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California	SRV, JCD, AEL, RLS, SS, SJT, and NEW thank the Henry Luce Foundation and the National Center for Ecological Analysis and Synthesis, which is funded by National Science Foundation (NSF) Grant EF-0553768, the University of California, Santa Barbara, and the State of California. TAB was funded by NSF grant 1041570. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branch TA, 2011, CONSERV BIOL, V25, P777, DOI 10.1111/j.1523-1739.2011.01687.x; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; Dichmont CM, 2010, P NATL ACAD SCI USA, V107, P16, DOI 10.1073/pnas.0912091107; Eero M, 2012, MAR POLICY, V36, P235, DOI 10.1016/j.marpol.2011.05.010; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Froese R, 2011, FISH FISH, V12, P340, DOI 10.1111/j.1467-2979.2010.00387.x; Gulbrandsen LH, 2009, MAR POLICY, V33, P654, DOI 10.1016/j.marpol.2009.01.002; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hilborn R, 2011, FISH RES, V108, P235, DOI 10.1016/j.fishres.2010.12.030; Hilborn R, 2010, NATURE, V467, P531, DOI 10.1038/467531c; Hilborn R, 2010, FISHERIES, V35, P113, DOI 10.1577/1548-8446-35.3.113; Hilborn R, 2010, MAR POLICY, V34, P193, DOI 10.1016/j.marpol.2009.04.013; Hixon MA, 2007, J EXP MAR BIOL ECOL, V344, P23, DOI 10.1016/j.jembe.2006.12.026; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Ianelli JN, 2010, ASSESSMENT WALLEYE P; ICES, 2011, REP ICES ADV COMM 20; ICES, 2011, REP ICES ADV COMM 20; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Jacquet J, 2010, NATURE, V467, P28, DOI 10.1038/467028a; Jacquet JL, 2007, MAR POLICY, V31, P308, DOI 10.1016/j.marpol.2006.09.003; Mangel M, 2002, B MAR SCI, V70, P763; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marine Stewardship Council, 2011, MSC CERT REQ V1; Marko PB, 2011, CURR BIOL, V21, pR621, DOI 10.1016/j.cub.2011.07.006; Martin SM, 2012, REV FISH SCI, V20, P61, DOI 10.1080/10641262.2011.654287; Martinsohn JT, 2011, WOODHEAD PUBL FOOD S, P259; Parkes G, 2010, REV FISH SCI, V18, P344, DOI 10.1080/10641262.2010.516374; Perez-Ramirez M, 2012, OCEAN COAST MANAGE, V63, P24, DOI 10.1016/j.ocecoaman.2012.03.009; Perez-Ramirez M, 2012, MAR POLICY, V36, P297, DOI 10.1016/j.marpol.2011.06.013; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Ponte S, 2006, ECOLABELS FISH TRADE, V66; Ponte S., 2008, SEAFOOD ECOLABELLING, P287, DOI [10.1002/9781444301380.ch14, DOI 10.1002/9781444301380.CH14]; Potts T., 2007, Environment, Development and Sustainability, V9, P91, DOI 10.1007/s10668-005-9006-3; Punt A., 2001, CONSERVATION EXPLOIT, P41; Rademeyer RA, 2012, FISHHERIES2012AUGSWG; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Roheim CA, 2011, J AGR ECON, V62, P655, DOI 10.1111/j.1477-9552.2011.00299.x; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; UNFSA, 1995, AGR IMPL PROV UN CON, P1; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Ward T.J., 2008, SEAFOOD ECOLABELLING, V1st ed.; Ward TJ, 2008, FISH FISH, V9, P169, DOI 10.1111/j.1467-2979.2008.00277.x; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zhou SJ, 2010, P NATL ACAD SCI USA, V107, P9485, DOI 10.1073/pnas.0912771107	47	102	102	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43765	10.1371/journal.pone.0043765	http://dx.doi.org/10.1371/journal.pone.0043765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22928029	Green Published, gold			2022-12-27	WOS:000307789700051
J	Cobo, T; Kacerovsky, M; Palacio, M; Hornychova, H; Hougaard, DM; Skogstrand, K; Jacobsson, B				Cobo, Teresa; Kacerovsky, Marian; Palacio, Montse; Hornychova, Helena; Hougaard, David M.; Skogstrand, Kristin; Jacobsson, Bo			Intra-Amniotic Inflammatory Response in Subgroups of Women with Preterm Prelabor Rupture of the Membranes	PLOS ONE			English	Article							MICROBIAL INVASION; PREMATURE RUPTURE; AMNIOTIC-FLUID; INTRAUTERINE INFECTION; MULTIPLE-PROTEINS; LABOR ANALYSIS; PREDICTION; CHORIOAMNIONITIS; INTERLEUKIN-6; FUNISITIS	Background: To evaluate the influence of microbial invasion of the amniotic cavity (MIAC) and histological chorioamnionitis (HCA) on the magnitude of intra-amniotic inflammatory response in preterm prelabor rupture of membranes (PPROM). Methodology/Principal Finding: A prospective cohort study was performed in 107 women with PPROM between 23.0 and 36.6 weeks of gestational age. Twenty-six proteins were assayed by multiple immunoassay in amniotic fluid. The policy for PPROM in Czech Republic is active, and 90% of the women were delivered within 96 hours of membrane rupture. Histopathological placental findings were evaluated based on the Salafia classification. Data were analyzed in four subgroups of population according to the presence of MIAC and/or HCA. Results were stratified by gestational age at PPROM (< or >= 34.0 weeks). The rates of MIAC and HCA were 44% and 57%, respectively. Regardless of gestational age at PPROM, intra-amniotic inflammatory response was higher when MIAC and HCA were both present. There were no differences in the intra-amniotic inflammatory response between women with MIAC or HCA alone and women without infection. Conclusion: A higher intra-amniotic inflammatory response was identified when both HCA and MIAC were detected.	[Cobo, Teresa; Palacio, Montse] Univ Barcelona, Hosp Clin, Maternal Fetal Med Dept, ICGON, Barcelona, Spain; [Cobo, Teresa; Palacio, Montse] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Fetal & Perinatal Med Res Grp, Barcelona, Spain; [Cobo, Teresa; Palacio, Montse] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Kacerovsky, Marian] Charles Univ Praque, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Biomed Res Ctr,Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Hornychova, Helena] Univ Hosp Hradec Kralove, Fingerlands Dept Pathol, Hradec Kralove, Czech Republic; [Hougaard, David M.; Skogstrand, Kristin] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Inst Publ Hlth, Oslo, Norway	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Statens Serum Institut; Sahlgrenska University Hospital	Cobo, T (corresponding author), Univ Barcelona, Hosp Clin, Maternal Fetal Med Dept, ICGON, Barcelona, Spain.	tcobo@clinic.ub.es	Jacobsson, Bo/O-8007-2014; Kacerovsky, Marian/ABE-3437-2020; Hornychová, Helena/M-9470-2017; Hougaard, David/AAD-6368-2019; Cobo, Teresa/K-2770-2017; Kacerovsky, Marian/A-7586-2011	Jacobsson, Bo/0000-0001-5079-2374; Hornychová, Helena/0000-0002-2487-1754; Skogstrand, Kristin/0000-0002-0026-3711; Cobo, Teresa/0000-0003-3130-1829; Palacio, Montse/0000-0002-5869-4629; Kacerovsky, Marian/0000-0001-9858-7900	Instituto de Salud Carlos III in Spain [CM09/00213]; Czech Science Foundation [304-09-0494]; Ministry of Health of the Czech Republic [NS 10382-3/2009, MZO 00179906]; Swedish Medical Society [SLS 2008-21198, ALFGBG-2863, ALFGBG-11522]; Spanish government [FISPI10/01308]	Instituto de Salud Carlos III in Spain(Instituto de Salud Carlos III); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Swedish Medical Society; Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by a Rio Hortega grant from Instituto de Salud Carlos III in Spain (CM09/00213); by grants from the Czech Science Foundation (no. 304-09-0494), Ministry of Health of the Czech Republic (NS 10382-3/2009) and by a research project of Ministry of Health of the Czech Republic (MZO 00179906). Additional support came from grants from the Swedish Medical Society (SLS 2008-21198, ALFGBG-2863, ALFGBG-11522) and grants from Spanish government (FISPI10/01308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Buhimschi IA, 2010, CLIN PERINATOL, V37, P355, DOI 10.1016/j.clp.2010.03.002; Cobo T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.050; Davies JK, 2000, AM J OBSTET GYNECOL, V183, P1088, DOI 10.1067/mob.2000.108888; Ghidini A, 1998, J Matern Fetal Med, V7, P238; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Holst RM, 2011, BJOG-INT J OBSTET GY, V118, P240, DOI 10.1111/j.1471-0528.2010.02765.x; Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P423, DOI 10.1034/j.1600-0412.2003.00157.x; Jun JK, 2000, AM J OBSTET GYNECOL, V183, P868, DOI 10.1067/mob.2000.109034; Kacerovsky M, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.004; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Kacerovsky M, 2009, NEUROENDOCRINOL LETT, V30, P733; Katzman PJ, 2010, PEDIATR DEVEL PATHOL, V13, P265, DOI 10.2350/09-02-0604-OA.1; Lee SE, 2006, J MATERN-FETAL NEO M, V19, P693, DOI 10.1080/14767050600927353; Menon R, 2011, OBSTET GYNECOL, V118, P121, DOI 10.1097/AOG.0b013e3182204eaa; Park CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P839, DOI 10.1016/0002-9378(93)90014-A; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2011, J MATERN-FETAL NEO M, V24, P1444, DOI 10.3109/14767058.2011.591460; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Skogstrand K, 2011, METHODS; The czech society of obstetrics and gynecology, 2007, CLIN GUID OBST; Vogel I, 2007, J REPROD IMMUNOL, V75, P133, DOI 10.1016/j.jri.2007.02.008	30	51	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43677	10.1371/journal.pone.0043677	http://dx.doi.org/10.1371/journal.pone.0043677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916296	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800094
J	Gilmour, S; Li, JH; Shibuya, K				Gilmour, Stuart; Li, Jinghua; Shibuya, Kenji			Projecting HIV Transmission in Japan	PLOS ONE			English	Article							RISK BEHAVIORS; MEN; SEX; PREVALENCE; SURVEILLANCE; INFECTION; AUSTRALIA	Background: Little is known about the epidemiology of HIV in Japan, though newly-identified cases amongst men who have sex with men (MSM) show an increasing trend. Predictions of future trends in the HIV epidemic are essential to identify suitable interventions. Methods: A deterministic, compartmental model was developed that incorporated risk groups, disease stages, and treatment and testing parameters. This model was calibrated against current figures on new infections and run over 30 years to identify trends in prevalence amongst MSM, low-risk men and low-risk women. Multivariate sensitivity analysis was used to estimate sensitivity ranges for all outcomes. Results: Without new interventions amongst MSM in Japan, HIV prevalence will climb from its current rate of 2.1% to 10.4% (sensitivity range 7.4% to 18.7%), while HIV prevalence among low-risk men and women will likely decline. With small changes in safer sex behavior and testing rates, HIV prevalence can remain stable or even decline amongst MSM. Conclusions: Japan is at risk of an epidemic of HIV amongst MSM unless significant changes are made to its current public health intervention framework. More research is necessary to understand the key drivers of the epidemic in Japan.	[Gilmour, Stuart; Li, Jinghua; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan	University of Tokyo	Gilmour, S (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan.	sgilmour@m.u-tokyo.ac.jp		Shibuya, Kenji/0000-0003-2528-7530	Ministry of Health, Labour and Welfare, Japan [08150755]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Research on HIV/AIDS in Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan (No. 08150755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2011, 2010 NAT DRUG STRAT; Bureau PaFS, 2011, HIV ANT TEST BLOOD D; Bureau PaFS, 2011, ANT TEST PUBL HLTH C; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P329; Curran James W, 2011, MMWR Suppl, V60, P64; Foundation KF, 2009, NAT HIV PREV INV STA; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guy RJ, 2007, MED J AUSTRALIA, V187, P437, DOI 10.5694/j.1326-5377.2007.tb01353.x; Ichikawa S, 2010, COMBINED RES REPORTS; Ichikawa S, 2011, SEX HEALTH, V8, P123, DOI 10.1071/SH10073; Iversen J, 2010, AUSTR NSP SURVEY NAT; Kaneko N, 2007, JAPANESE J NURSING R, V30, P37; Kihara M, 2003, JAIDS-J ACQ IMM DEF, V32, pS55, DOI 10.1097/00126334-200302011-00009; Koerner J, 2011, SURVEY INVESTIGATING; Koerner J, 2011, INTERSECTIONS-GENDER; Koibuchi T, 2011, ANTIHIV TREATMENT GU; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Kretzschmar MEE, 2012, AIDS, V26, P247, DOI 10.1097/QAD.0b013e32834e1592; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; MCDONALD AM, 1994, AM J PUBLIC HEALTH, V84, P1923, DOI 10.2105/AJPH.84.12.1923; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Munakata T, 1996, AIDS EDUC PREV, V8, P115; Network APaI, 2011, CLASS REP HIV AIDS I; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; Research NCiHEaC, 2010, HIV VIR HEP SEX TRAN; Research NCiHEaC, 1997, HIV AIDS REL DIS AUS; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; UNAIDS, 2005, INT HIV PREV UNAIDS; UNGASS, 2010, JAP 2010 COUNTR PROG; Waller LA, 2003, ECOL MODEL, V164, P49, DOI 10.1016/S0304-3800(03)00011-5; Wand H, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-19; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081	32	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43473	10.1371/journal.pone.0043473	http://dx.doi.org/10.1371/journal.pone.0043473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916268	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800072
J	Liberman, J; Sartelet, H; Flahaut, M; Muhlethaler-Mottet, A; Coulon, A; Nyalendo, C; Vassal, G; Joseph, JM; Gross, N				Liberman, Julie; Sartelet, Herve; Flahaut, Marjorie; Muehlethaler-Mottet, Annick; Coulon, Aurelie; Nyalendo, Carine; Vassal, Gilles; Joseph, Jean-Marc; Gross, Nicole			Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR7; BREAST-CANCER METASTASIS; NEURO-BLASTOMA CELLS; CREST STEM-CELLS; PROSTATE-CANCER; TUMOR-GROWTH; IN-VITRO; SIGNALING PATHWAYS; RETINOIC ACID; EXPRESSION	Neuroblastoma (NB) is a typical childhood and heterogeneous neoplasm for which efficient targeted therapies for high-risk tumors are not yet identified. The chemokine CXCL12, and its receptors CXCR4 and CXCR7 have been involved in tumor progression and dissemination. While CXCR4 expression is associated to undifferentiated tumors and poor prognosis, the role of CXCR7, the recently identified second CXCL12 receptor, has not yet been elucidated in NB. In this report, CXCR7 and CXCL12 expressions were evaluated using a tissue micro-array including 156 primary and 56 metastatic NB tissues. CXCL12 was found to be highly associated to NB vascular and stromal structures. In contrast to CXCR4, CXCR7 expression was low in undifferentiated tumors, while its expression was stronger in matured tissues and specifically associated to differentiated neural tumor cells. As determined by RT-PCR, CXCR7 expression was mainly detected in N-and S-type NB cell lines, and was slightly induced upon NB cell differentiation in vitro. The relative roles of the two CXCL12 receptors were further assessed by overexpressing CXCR7 or CXCR4 receptor alone, or in combination, in the IGR-NB8 and the SH-SY5Y NB cell lines. In vitro functional analyses indicated that, in response to their common ligand, both receptors induced activation of ERK1/2 cascade, but not Akt pathway. CXCR7 strongly reduced in vitro growth, in contrast to CXCR4, and impaired CXCR4/CXCL12-mediated chemotaxis. Subcutaneous implantation of CXCR7-expressing NB cells showed that CXCR7 also significantly reduced in vivo growth. Moreover, CXCR7 affected CXCR4-mediated orthotopic growth in a CXCL12-producing environment. In such model, CXCR7, in association with CXCR4, did not induce NB cell metastatic dissemination. In conclusion, the CXCR7 and CXCR4 receptors revealed specific expression patterns and distinct functional roles in NB. Our data suggest that CXCR7 elicits anti-tumorigenic functions, and may act as a regulator of CXCR4/CXCL12-mediated signaling in NB.	[Liberman, Julie; Flahaut, Marjorie; Muehlethaler-Mottet, Annick; Coulon, Aurelie; Gross, Nicole] Univ Lausanne, Lausanne Univ Hosp CHUV, Dept Pediat, Pediat Oncol Res Unit, Lausanne, Switzerland; [Sartelet, Herve] St Justine Univ Hosp, Dept Pathol, Montreal, PQ, Canada; [Nyalendo, Carine] St Justine Univ Hosp, Dept Mol Med, Montreal, PQ, Canada; [Vassal, Gilles] Inst Gustave Roussy, UPRES UE 3535, Villejuif, France; [Vassal, Gilles] Inst Gustave Roussy, Dept Pediat Oncol, Villejuif, France; [Joseph, Jean-Marc] Univ Lausanne, Univ Lausanne Hosp, Dept Pediat, Div Pediat Surg, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite de Montreal; Universite de Montreal; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Liberman, J (corresponding author), Univ Lausanne, Lausanne Univ Hosp CHUV, Dept Pediat, Pediat Oncol Res Unit, Lausanne, Switzerland.	Nicole.Gross@chuv.ch	Mühlethaler-Mottet, Annick/H-2848-2019	Mühlethaler-Mottet, Annick/0000-0001-8274-0907	Swiss National Scientific Foundation [31003A-127063]; FORCE Foundation for Children Cancer Research; Hubert Gouin association	Swiss National Scientific Foundation(Swiss National Science Foundation (SNSF)); FORCE Foundation for Children Cancer Research; Hubert Gouin association	This study was supported by grants from the Swiss National Scientific Foundation #31003A-127063, the FORCE Foundation for Children Cancer Research, and the Hubert Gouin association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-12; Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Arscott WT, 2009, ONCOGENE, V28, P479, DOI 10.1038/onc.2008.402; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2003, SEMIN IMMUNOL, V15, P49, DOI 10.1016/S1044-5323(02)00127-6; Beleta H, 2009, CANCER, V115, P2792; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; CICCARONE V, 1989, CANCER RES, V49, P219; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; DECAILLOT FM, 2011, J BIOL CHEM; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; GROSS N, 1987, INT J CANCER, V39, P521, DOI 10.1002/ijc.2910390420; Grymula K, 2010, INT J CANCER, V127, P2554, DOI 10.1002/ijc.25245; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Harunann TN, 2008, JLEUKOCBIOL; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Hawkins OE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3092; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Joseph JM, 2005, INT J CANCER, V113, P881, DOI 10.1002/ijc.20681; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kim B, 2004, ONCOGENE, V23, P130, DOI 10.1038/sj.onc.1206924; Kollmar O, 2010, INT J CANCER, V126, P1302, DOI 10.1002/ijc.24956; Kryczek I, 2005, CANCER RES, V65, P465; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li JK, 2008, WORLD J GASTROENTERO, V14, P2308, DOI 10.3748/wjg.14.2308; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2012, ONCOGENE; Ma M, 2011, CANCER LETT, V312, P1, DOI 10.1016/j.canlet.2011.06.028; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Monnier J, 2011, EUR J CANC; Muhlethaler-Mottet A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-214; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Odemis V, 2011, GLIA; Odemis V, 2010, J CELL SCI, V123, P1081, DOI 10.1242/jcs.062810; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Ross R A, 1994, Prog Clin Biol Res, V385, P253; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Russell HV, 2004, J PEDIATR SURG, V39, P1506, DOI 10.1016/j.jpedsurg.2004.06.019; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; Somasundaram R, 2008, SEMIN CANC BIOL; SUGIMOTO T, 1988, CANCER RES, V48, P2531; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Thelen M, 2010, CURR OPIN PHARMACOL, V10, P38, DOI 10.1016/j.coph.2009.09.004; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; Tiveron MC, 2010, J NEUROIMMUNOL, V224, P72, DOI 10.1016/j.jneuroim.2010.05.011; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Xu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027399; Yu SH, 2011, DEV DYNAM, V240, P384, DOI 10.1002/dvdy.22549; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73; Zeelenberg IS, 2003, CANCER RES, V63, P3833	68	57	60	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43665	10.1371/journal.pone.0043665	http://dx.doi.org/10.1371/journal.pone.0043665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916293	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800091
J	Glover, KA; Quintela, M; Wennevik, V; Besnier, F; Sorvik, AGE; Skaala, O				Glover, Kevin A.; Quintela, Maria; Wennevik, Vidar; Besnier, Francois; Sorvik, Anne G. E.; Skaala, Oystein			Three Decades of Farmed Escapees in the Wild: A Spatio-Temporal Analysis of Atlantic Salmon Population Genetic Structure throughout Norway	PLOS ONE			English	Article							SALAR L.; LINKAGE DISEQUILIBRIUM; GENOTYPING ERRORS; LOCAL ADAPTATION; NORTH-AMERICAN; MICROSATELLITE MARKERS; ALLELE FREQUENCIES; TEMPORAL VARIATION; FRESH-WATER; DNA MARKERS	Each year, hundreds of thousands of domesticated farmed Atlantic salmon escape into the wild. In Norway, which is the world's largest commercial producer, many native Atlantic salmon populations have experienced large numbers of escapees on the spawning grounds for the past 15-30 years. In order to study the potential genetic impact, we conducted a spatio-temporal analysis of 3049 fish from 21 populations throughout Norway, sampled in the period 1970-2010. Based upon the analysis of 22 microsatellites, individual admixture, F-ST and increased allelic richness revealed temporal genetic changes in six of the populations. These changes were highly significant in four of them. For example, 76% and 100% of the fish comprising the contemporary samples for the rivers Vosso and Opo were excluded from their respective historical samples at P = 0.001. Based upon several genetic parameters, including simulations, genetic drift was excluded as the primary cause of the observed genetic changes. In the remaining 15 populations, some of which had also been exposed to high numbers of escapees, clear genetic changes were not detected. Significant population genetic structuring was observed among the 21 populations in the historical (global F-ST = 0.038) and contemporary data sets (global F-ST = 0.030), although significantly reduced with time (P = 0.008). This reduction was especially distinct when looking at the six populations displaying temporal changes (global F-ST dropped from 0.058 to 0.039, P = 0.006). We draw two main conclusions: 1. The majority of the historical population genetic structure throughout Norway still appears to be retained, suggesting a low to modest overall success of farmed escapees in the wild; 2. Genetic introgression of farmed escapees in native salmon populations has been strongly population-dependent, and it appears to be linked with the density of the native population.	[Glover, Kevin A.; Wennevik, Vidar; Besnier, Francois; Sorvik, Anne G. E.; Skaala, Oystein] Inst Marine Res, Sect Populat Genet & Ecol, N-5024 Bergen, Norway; [Quintela, Maria] Univ A Coruna, Dept Anim Biol Plant Biol & Ecol, La Coruna, Spain	Institute of Marine Research - Norway; Universidade da Coruna	Glover, KA (corresponding author), Inst Marine Res, Sect Populat Genet & Ecol, POB 1870, N-5024 Bergen, Norway.	Kevin.glover@imr.no	Quintela, María/E-2908-2012		Norwegian Minitry of Fisheries	Norwegian Minitry of Fisheries	This study is financed by the Norwegian Minitry of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, VEDLEGGSRAPPORT MERD; [Anonymous], 1992, NOREGS OFISIELLE S C, pC56; [Anonymous], 2011, STATUS NORSKE LAKSEB; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Arnaud-Haond S, 2004, MOL ECOL, V13, P2001, DOI 10.1111/j.1365-294X.2004.02188.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Besnier F, 2011, AQUACULT ENV INTERAC, V2, P75, DOI 10.3354/aei00032; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; BURI P, 1956, EVOLUTION, V10, P367, DOI 10.1111/j.1558-5646.1956.tb02864.x; Butler JRA, 2005, FISHERIES MANAG ECOL, V12, P149, DOI 10.1111/j.1365-2400.2005.00437.x; Clifford SL, 1998, CAN J FISH AQUAT SCI, V55, P358, DOI 10.1139/cjfas-55-2-358; Clifford SL, 1998, J FISH BIOL, V52, P118, DOI 10.1111/j.1095-8649.1998.tb01557.x; Cornuet JM, 1999, GENETICS, V153, P1989; Crozier WW, 2000, FISHERIES MANAG ECOL, V7, P437, DOI 10.1046/j.1365-2400.2000.00219.x; CROZIER WW, 1993, AQUACULTURE, V113, P19, DOI 10.1016/0044-8486(93)90337-X; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dillane E, 2008, MOL ECOL, V17, P4786, DOI 10.1111/j.1365-294X.2008.03939.x; Dillane E, 2007, FISHERIES MANAG ECOL, V14, P209, DOI 10.1111/j.1365-2400.2007.00544.x; Dionne M, 2008, MOL ECOL, V17, P2382, DOI 10.1111/j.1365-294X.2008.03771.x; Dionne M, 2009, CONSERV GENET, V10, P869, DOI 10.1007/s10592-008-9647-5; Diserud O. H., 2012, 782 NINA; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Ferguson A., 2007, P357, DOI 10.1002/9780470995846.ch12; Fiske P., 2001, NINA OPPDRAGSMELDING, V704, P1; Fiske P, 2006, ICES J MAR SCI, V63, P1182, DOI 10.1016/j.icesjms.2006.04.006; Fleming IA, 1996, J APPL ECOL, V33, P893, DOI 10.2307/2404960; Fleming IA, 1997, BEHAV ECOL, V8, P470, DOI 10.1093/beheco/8.5.470; Fleming IA, 1997, ICES J MAR SCI, V54, P1051, DOI 10.1006/jmsc.1997.0289; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gilbey J, 2005, ICES J MAR SCI, V62, P1609, DOI 10.1016/j.icesjms.2005.07.001; GJEDREM T, 1991, AQUACULTURE, V98, P41, DOI 10.1016/0044-8486(91)90369-I; Glover KA, 2008, ICES J MAR SCI, V65, P912, DOI 10.1093/icesjms/fsn056; Glover KA, 2012, FISH FISH, V13, P313, DOI 10.1111/j.1467-2979.2011.00447.x; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Glover KA, 2009, AQUACULTURE, V290, P37, DOI 10.1016/j.aquaculture.2009.01.034; Glover KA, 2009, AQUACULTURE, V286, P203, DOI 10.1016/j.aquaculture.2008.09.023; Glover KA, 2011, AQUAC RES, V42, P1323, DOI 10.1111/j.1365-2109.2010.02720.x; Griffiths AM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-31; Grimholt U, 2002, IMMUNOGENETICS, V54, P570, DOI 10.1007/s00251-002-0499-8; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Haaland OA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-36; Hansen LP, 2006, ICES J MAR SCI, V63, P1211, DOI 10.1016/j.icesjms.2006.04.022; Hansen MM, 2009, MOL ECOL, V18, P2549, DOI 10.1111/j.1365-294X.2009.04198.x; HEGGBERGET TG, 1993, FISH RES, V18, P123, DOI 10.1016/0165-7836(93)90044-8; HINDAR K, 1991, CAN J FISH AQUAT SCI, V48, P945, DOI 10.1139/f91-111; Hindar K, 2006, ICES J MAR SCI, V63, P1234, DOI 10.1016/j.icesjms.2006.04.025; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jonsson B, 2006, ICES J MAR SCI, V63, P1162, DOI 10.1016/j.icesjms.2006.03.004; Joost S, 2008, MOL ECOL RESOUR, V8, P957, DOI 10.1111/j.1755-0998.2008.02162.x; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Jorde PE, 2012, MOL ECOL RESOUR, V12, P476, DOI 10.1111/j.1755-0998.2011.03111.x; Borrell YJ, 2008, CONSERV GENET, V9, P807, DOI 10.1007/s10592-007-9400-5; Karlsson S, 2011, MOL ECOL RESOUR, V11, P247, DOI 10.1111/j.1755-0998.2010.02959.x; King TL, 2005, MOL ECOL NOTES, V5, P130, DOI 10.1111/j.1471-8286.2005.00860.x; King TL, 2001, MOL ECOL, V10, P807, DOI 10.1046/j.1365-294X.2001.01231.x; Lubieniecki KP, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-105; LUND R A, 1991, Aquaculture and Fisheries Management, V22, P499, DOI 10.1111/j.1365-2109.1991.tb00763.x; LURA H, 1991, AQUACULTURE, V98, P151, DOI 10.1016/0044-8486(91)90380-P; Lura H, 1995, THESIS U BERGEN NORW; Marie AD, 2010, MOL ECOL, V19, P2025, DOI 10.1111/j.1365-294X.2010.04628.x; Martinez-Cruz B, 2007, MOL ECOL, V16, P477, DOI 10.1111/j.1365-294X.2007.03147.x; MCCONNELL SK, 1995, CAN J FISH AQUAT SCI, V52, P1863, DOI 10.1139/f95-779; McGinnity P, 1997, ICES J MAR SCI, V54, P998, DOI 10.1016/S1054-3139(97)80004-5; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Milner NJ, 2003, FISHERIES MANAG ECOL, V10, P403, DOI 10.1111/j.1365-2400.2003.00348.x; MORK J, 1991, AQUACULTURE, V98, P267, DOI 10.1016/0044-8486(91)90391-J; Morris MRJ, 2008, CAN J FISH AQUAT SCI, V65, P2807, DOI 10.1139/F08-181; Naylor R, 2005, BIOSCIENCE, V55, P427, DOI 10.1641/0006-3568(2005)055[0427:FSATRO]2.0.CO;2; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; OReilly PT, 1996, CAN J FISH AQUAT SCI, V53, P2292, DOI 10.1139/cjfas-53-10-2292; Palstra FP, 2010, CAN J FISH AQUAT SCI, V67, P225, DOI 10.1139/F09-176; Parrish DL, 1998, CAN J FISH AQUAT SCI, V55, P281, DOI 10.1139/cjfas-55-S1-281; Paterson S, 2004, MOL ECOL NOTES, V4, P160, DOI 10.1111/j.1471-8286.2004.00598.x; Perrier C, 2011, MOL ECOL, V20, P4231, DOI 10.1111/j.1365-294X.2011.05266.x; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 2000, GENETICS, V155, P945; Pudovkin AI, 1996, GENETICS, V144, P383; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roberge C, 2006, MOL ECOL, V15, P9, DOI 10.1111/j.1365-294X.2005.02807.x; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Saegrov H, 1997, ICES J MAR SCI, V54, P1166, DOI 10.1016/S1054-3139(97)80023-9; Sanchez JA, 1996, HEREDITY, V77, P423, DOI 10.1038/hdy.1996.162; Sandoval-Castellanos E, 2010, GENET RES, V92, P309, DOI 10.1017/S0016672310000339; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2; Skaala O, 2004, AQUACULTURE, V240, P131, DOI 10.1016/j.aquaculture.2004.07.009; Skaala O, 2006, ICES J MAR SCI, V63, P1224, DOI 10.1016/j.icesjms.2006.04.005; SLETTAN A, 1995, ANIM GENET, V26, P281, DOI 10.1111/j.1365-2052.1995.tb03262.x; STABELL OB, 1984, BIOL REV, V59, P333, DOI 10.1111/j.1469-185X.1984.tb00709.x; STAHL G, 1987, POPULATION GENETICS, P121; Stet RJM, 2002, IMMUNOGENETICS, V54, P320, DOI 10.1007/s00251-002-0477-1; Taggart JB, 1995, CAN J FISH AQUAT SCI, V52, P2305, DOI 10.1139/f95-822; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Tatara CP, 2012, ENVIRON BIOL FISH, V94, P7, DOI 10.1007/s10641-011-9906-z; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Tessier N, 1999, MOL ECOL, V8, P169, DOI 10.1046/j.1365-294X.1999.00547.x; Tonteri A, 2008, MOL ECOL RESOUR, V8, P1486, DOI 10.1111/j.1755-0998.2008.02317.x; Tonteri A, 2009, CAN J FISH AQUAT SCI, V66, P717, DOI 10.1139/F09-010; Vaha JP, 2007, MOL ECOL, V16, P2638, DOI 10.1111/j.1365-294X.2007.03329.x; Vasemagi A, 2005, MOL ECOL NOTES, V5, P282, DOI 10.1111/j.1471-8286.2005.00902.x; Verspoor E, 2005, J FISH BIOL, V67, P3, DOI 10.1111/j.0022-1112.2005.00838.x; Walker AM, 2006, ICES J MAR SCI, V63, P1201, DOI 10.1016/j.icesjms.2006.04.018; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WAPLES RS, 1989, EVOLUTION, V43, P1236, DOI 10.2307/2409359; Weir LK, 2004, J ANIM ECOL, V73, P1069, DOI 10.1111/j.0021-8790.2004.00876.x; Wennevik V, 2004, ENVIRON BIOL FISH, V69, P143, DOI 10.1023/B:EBFI.0000022890.15512.29; Whoriskey FG, 2006, ICES J MAR SCI, V63, P1218, DOI 10.1016/j.icesjms.2006.04.002	125	157	159	1	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43129	10.1371/journal.pone.0043129	http://dx.doi.org/10.1371/journal.pone.0043129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916215	Green Published, gold, Green Submitted			2022-12-27	WOS:000307823600049
J	Mello, MLS; Vidal, BC				Mello, Maria Luiza S.; Vidal, B. C.			Changes in the Infrared Microspectroscopic Characteristics of DNA Caused by Cationic Elements, Different Base Richness and Single-Stranded Form	PLOS ONE			English	Article							AMIDE-I-BAND; CRITICAL ELECTROLYTE CONCENTRATION; POSSIBLE COMMON BIOMARKERS; NUCLEIC-ACIDS; MID-IR; FT-IR; SPECTROSCOPY; PROTAMINE; COLLAGEN; HETEROCHROMATIN	Background: The infrared (IR) analysis of dried samples of DNA and DNA-polypeptide complexes is still scarce. Here we have studied the FT-IR profiles of these components to further the understanding of the FT-IR signatures of chromatin and cell nuclei. Methodology/Principal Findings: Calf thymus and salmon testis DNA, and complexes of histone H1, protamine, poly-L-lysine and poly-L-arginine (histone-mimic macromolecules) with DNA were analyzed in an IR microspectroscope equipped with an attenuated total reflection diamond objective and Grams software. Conditions including polypeptides bound to the DNA, DNA base composition, and single-stranded form were found to differently affect the vibrational characteristics of the chemical groups (especially, PO2-) in the nucleic acid. The antisymmetric stretching (nu(as)) of the DNA PO2- was greater than the symmetric stretching (nu(s)) of these groups and increased in the polypeptide-DNA complexes. A shift of the nas of the DNA PO2- to a lower frequency and an increased intensity of this vibration were induced especially by lysine-rich histones. Lysine richness additionally contributed to an increase in the vibrational stretching of the amide I group. Even in simple molecules such as inorganic phosphates, the vibrational characteristics of the phosphate anions were differently affected by different cations. As a result of the optimization of the DNA conformation by binding to arginine-rich polypeptides, enhancements of the vibrational characteristics in the FT-IR fingerprint could be detected. Although different profiles were obtained for the DNA with different base compositions, this situation was no longer verified in the polypeptide-DNA complexes and most likely in isolated chromatin or cell nuclei. However, the nu(as) PO2-/nu(s) PO2- ratio could discriminate DNA with different base compositions and DNA in a single-stranded form. Conclusions/Significance: FT-IR spectral profiles are a valuable tool for establishing the vibrational characteristics of individualized chromatin components, such as DNA and DNA-polypeptide complexes in dried samples.	[Mello, Maria Luiza S.; Vidal, B. C.] Univ Campinas Unicamp, Inst Biol, Dept Struct & Physiol Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Mello, MLS (corresponding author), Univ Campinas Unicamp, Inst Biol, Dept Struct & Physiol Biol, Sao Paulo, Brazil.	camposvi@unicamp.br	Mello, Maria Luiza Silveira/D-9158-2012; Vidal, Benedicto/I-3227-2012; de Campos Vidal, Benedicto/ABH-6617-2020	Mello, Maria Luiza Silveira/0000-0003-1629-5619; Vidal, Benedicto/0000-0003-1629-5619; de Campos Vidal, Benedicto/0000-0003-0285-1653	Sao Paulo State Research Foundation (FAPESP) [2010/50015-6, 2007/58251-8]; Brazilian Council for Research and Development (CNPq) [472936/2009-7]; CNPq [301943/2009-5]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants no. 2010/50015-6 and 2007/58251-8 from the Sao Paulo State Research Foundation (FAPESP) and grant no. 472936/2009-7 from the Brazilian Council for Research and Development (CNPq). MLSM received a research fellowship from CNPq (301943/2009-5). The funders had no role in study deign, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Anastassopoulou J, 2009, VIB SPECTROSC, V51, P270, DOI 10.1016/j.vibspec.2009.07.005; Argov S, 2002, J BIOMED OPT, V7, P248, DOI 10.1117/1.1463051; Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8; Bird B, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-8; BLOCH DP, 1969, GENETICS, V61, P93; Brewer L, 2003, J BIOL CHEM, V278, P42403, DOI 10.1074/jbc.M303610200; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; CHARGAFF E, 1951, J BIOL CHEM, V192, P223; Cherng JY, 2009, J PHARM PHARM SCI, V12, P346, DOI 10.18433/J3859K; Cheung KT, 2011, ANALYST, V136, P2047, DOI 10.1039/c0an00972e; Clark J., 2000, FINGERPRINT REGION I; Cree LH, 2011, PROTEIN PEPTIDE LETT, V18, P802; Diem M, 2004, ANALYST, V129, P880, DOI 10.1039/b408952a; DIEM M, 2008, VIBRATIONAL SPECTROS; Dukor R.K., 2002, BIOMEDICAL APPL, V5, P3335, DOI [DOI 10.1002/0470027320.S8107, 10.1002/0470027320.s8107]; Froehlich E, 2011, BIOMACROMOLECULES, V12, P511, DOI 10.1021/bm1013102; Hembram KPSS, 2009, MAT SCI ENG C-BIO S, V29, P1093, DOI 10.1016/j.msec.2008.09.021; Holton SE, 2011, BIOPHYS J, V101, P1513, DOI 10.1016/j.bpj.2011.07.055; Kanakis CD, 2009, J PHOTOCH PHOTOBIO B, V95, P204, DOI 10.1016/j.jphotobiol.2009.03.006; LAZAREV YA, 1985, BIOPOLYMERS, V24, P1449, DOI 10.1002/bip.360240804; Le-Tien C, 2007, TALANTA, V71, P1969, DOI 10.1016/j.talanta.2006.09.003; Li MJ, 2002, ULTRASTRUCT PATHOL, V26, P365, DOI 10.1080/01913120290104674; LIQUIER J, 1991, SPECTROCHIM ACTA A, V47, P177, DOI 10.1016/0584-8539(91)80089-2; LIQUIERS J, 1990, J BIOMOL STRUCT DYN, V8, P295, DOI 10.1080/07391102.1990.10507806; Marty R, 2009, NUCLEIC ACIDS RES, V37, P849, DOI 10.1093/nar/gkn1003; MELLO MLS, 1989, CYTOBIOS, V59, P87; Mordechai S, 2004, J MICROSC-OXFORD, V215, P86, DOI 10.1111/j.0022-2720.2004.01356.x; PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105; Pijanka JK, 2009, ANALYST, V134, P1176, DOI 10.1039/b821112d; PIVEC L, 1972, BIOCHIM BIOPHYS ACTA, V272, P179, DOI 10.1016/0005-2787(72)90242-0; Poplineau M, 2011, EPIGENOMICS-UK, V3, P785, DOI [10.2217/EPI.11.102, 10.2217/epi.11.102]; Sahu RK, 2008, BIOPOLYMERS, V89, P993, DOI 10.1002/bip.21048; Sahu RK, 2010, FUTURE ONCOL, V6, P1653, DOI 10.2217/FON.10.120; Sahu RK, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2080368; Sahu RK, 2004, TECHNOL CANCER RES T, V3, P629, DOI 10.1177/153303460400300613; Singh B, 2012, CURR SCI INDIA, V102, P232; TAILLANDIER E, 1992, METHOD ENZYMOL, V211, P307; VIDAL BC, 1972, BEITR PATHOL, V145, P269; VIDAL BD, 1989, ACTA HISTOCHEM CYTOC, V22, P471; VIDAL BDC, 1979, HISTOCHEMISTRY, V60, P309; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; Yang Y, 2005, BIOPOLYMERS, V78, P311, DOI 10.1002/bip.20297; Zelig U, 2011, BBA-GEN SUBJECTS, V1810, P827, DOI 10.1016/j.bbagen.2011.06.010	45	105	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43169	10.1371/journal.pone.0043169	http://dx.doi.org/10.1371/journal.pone.0043169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937023	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500035
J	Shamu, S; Abrahams, N; Temmerman, M; Shefer, T; Zarowsky, C				Shamu, Simukai; Abrahams, Naeemah; Temmerman, Marleen; Shefer, Tamara; Zarowsky, Christina			"That Pregnancy Can Bring Noise into the Family'': Exploring Intimate Partner Sexual Violence during Pregnancy in the Context of HIV in Zimbabwe	PLOS ONE			English	Article							ANTENATAL CLINICS; WOMEN; RAPE; BEHAVIOR; COERCION; AFRICA; GENDER; HEALTH; ABUSE; POWER	Background: Globally, studies report a high prevalence of intimate partner sexual violence (IPSV) and an association with HIV infection. Despite the criminalisation of IPSV and deliberate sexual HIV infection in Zimbabwe, IPSV remains common. This study explored women's and health workers' perspectives and experiences of sexuality and sexual violence in pregnancy, including in relation to HIV testing. Methods: This qualitative study was part of a larger study of the dynamics of intimate partner violence and HIV in pregnancy in Zimbabwe. Key informant interviews were conducted with health workers and focus group discussions were held with 64 pregnant or nursing mothers attending antenatal and postnatal care clinics in low-income neighbourhoods of Harare, covering the major thematic areas of validated sexual violence research instruments. Thematic content analysis of audio-recorded and transcribed data was conducted. Results: While women reported some positive experiences of sex in pregnancy, most participants commonly experienced coercive sexual practices. They reported that men failed to understand, or refused to accept, pregnancy and its associated emotional changes, and often forced painful and degrading sexual acts on them, usually while the men were under the influence of alcohol or illicit drugs. Men often refused or delayed HIV testing, and participants reported accounts of HIV-positive men not disclosing their status to their partners and deliberately infecting or attempting to infect them. Women's passive acceptance of sexual violence was influenced by advice they received from other females to subordinate to their partners and to not deprive men of their conjugal sexual rights. Conclusions: Cultural and societal factors, unequal gender norms and practices, women's economic vulnerability, and men's failure to understand pregnancy and emotional changes, influence men to perpetrate IPSV, leading to high risk of HIV infection.	[Shamu, Simukai; Abrahams, Naeemah; Zarowsky, Christina] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Abrahams, Naeemah] MRC, Gender & Hlth Res Unit, Cape Town, South Africa; [Temmerman, Marleen] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium	University of the Western Cape; Ghent University	Shamu, S (corresponding author), Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa.	shamuts@yahoo.com	Abrahams, Naeemah/AAF-1144-2020; Abrahams, Naeemah/C-5577-2013	Shamu, Simukai/0000-0002-2290-0515; Zarowsky, Christina/0000-0002-0850-6212; Abrahams, Naeemah/0000-0002-6138-6256	University of the Western Cape; University of the Western Cape's Faculty Research grant	University of the Western Cape; University of the Western Cape's Faculty Research grant	The first author received funding for PhD studies from the Flemish Inter-University cooperation with the University of the Western Cape to which this paper contributes, whilst fieldwork for this paper was supported by the University of the Western Cape's Faculty Research grant (through Professor CZ). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Chirawu S, 2006, CARDOZO J LAW GENDER, V13; Clowes L, 2009, AGENDA-EMPOWER WOMEN, V23, P22, DOI 10.1080/10130950.2009.9676236; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Gielen AC, 2002, AIDS BEHAV, V6; Guo SF, 2004, INT J GYNECOL OBSTET, V84, P281, DOI 10.1016/j.ijgo.2003.08.019; Heise L, 2002, INT J GYNECOLOGY OBS, V78; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R, 2001, S AFR MED J, V91, P421; Jewkes R., 2009, UNDERSTANDING MENS H; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Kahn L, 2008, SEXUAL SUBJECTS FEMI; Kambarami M, 2006, FEMININITY SEXUALITY; Koenig MA, 2004, INT FAM PLAN PERSPEC, V30, P156, DOI 10.1363/3015604; Lesch E, 2004, S AFR J PSYCHOL, V34, P464, DOI 10.1177/008124630403400308; [Macro International Inc Central Statistical Office (CSO) [Zimbabwe]], 2007, ZIMB DEM HLTH SURV 2; Mahoney P., 2007, SEXUAL ASSAULT MARRI; Mlay R, 2008, AIDS CARE, V20, P356, DOI 10.1080/09540120701561304; Njovana Eunice, 1996, REPROD HEALTH MATTER, V4, P46, DOI DOI 10.1016/S0968-8080(96)90005-1; Osirim M, 2002, AFRICAN STUDIES Q, V7; Pronyk PM, 2008, AIDS, V22, P1659, DOI 10.1097/QAD.0b013e328307a040; Reddy S, 2007, SEXUALITIES, V10, P157, DOI DOI 10.1177/1363460707075797; Roelens K, 2008, EUR J OBSTET GYN R B, V137, P37, DOI 10.1016/j.ejogrb.2007.04.013; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Shefer T, 2009, INTERSECTIONS GENDER; Shefer T, 2009, S AFRICAN J PSYCHOL, V30, P28; Shefer T, 2002, CULTURE HLTH SEXUALI, V3, P375; Shefer T, 2008, FEM PSYCHOL, V18, P157, DOI 10.1177/0959353507088265; Shefer T, 2012, AJAR-AFR J AIDS RES, V11, P113, DOI 10.2989/16085906.2012.698078; Silberschmidt M, 2001, WORLD DEV, V29, P657, DOI 10.1016/S0305-750X(00)00122-4; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Stesyfin K, 2008, BRIEF OVERVIEW RECEN; Swidler A, 2007, STUD FAMILY PLANN, V38, P147, DOI 10.1111/j.1728-4465.2007.00127.x; von Sydow K, 1999, J PSYCHOSOM RES, V47, P27, DOI 10.1016/S0022-3999(98)00106-8; WATTS C, 1998, REPROD HEALTH MATTER, V6, P57, DOI DOI 10.1016/S0968-8080(98)90008-8; WHO, 2005, MULT STUD WOM HLTH D; Wood K, 2005, CULT HEALTH SEX, V7, P303, DOI 10.1080/13691050500100724; Wood K, 1998, LOVE IS DANGEROUS TH; Wood K, 2007, MED ANTHROPOL Q, V21, P277, DOI 10.1525/maq.2007.21.3.277; World Health Organization, 2001, WHOFCHGWH011	44	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43148	10.1371/journal.pone.0043148	http://dx.doi.org/10.1371/journal.pone.0043148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937018	Green Published, gold			2022-12-27	WOS:000308225500031
J	Lipinski, RJ; Hammond, P; O'Leary-Moore, SK; Ament, JJ; Pecevich, SJ; Jiang, Y; Budin, F; Parnell, SE; Suttie, M; Godin, EA; Everson, JL; Dehart, DB; Oguz, I; Holloway, HT; Styner, MA; Johnson, GA; Sulik, KK				Lipinski, Robert J.; Hammond, Peter; O'Leary-Moore, Shonagh K.; Ament, Jacob J.; Pecevich, Stephen J.; Jiang, Yi; Budin, Francois; Parnell, Scott E.; Suttie, Michael; Godin, Elizabeth A.; Everson, Joshua L.; Dehart, Deborah B.; Oguz, Ipek; Holloway, Hunter T.; Styner, Martin A.; Johnson, G. Allan; Sulik, Kathleen K.			Ethanol-Induced Face-Brain Dysmorphology Patterns Are Correlative and Exposure-Stage Dependent	PLOS ONE			English	Article							FETAL-ALCOHOL-SYNDROME; MAGNETIC-RESONANCE; SPECTRUM DISORDERS; FACIAL MORPHOLOGY; OCULAR MANIFESTATIONS; ACUTE INSULT; MOUSE MODEL; MICE; SCHIZOPHRENIA; ABNORMALITIES	Prenatal ethanol exposure is the leading preventable cause of congenital mental disability. Whereas a diagnosis of fetal alcohol syndrome (FAS) requires identification of a specific pattern of craniofacial dysmorphology, most individuals with behavioral and neurological sequelae of heavy prenatal ethanol exposure do not exhibit these defining facial characteristics. Here, a novel integration of MRI and dense surface modeling-based shape analysis was applied to characterize concurrent face-brain phenotypes in C57Bl/6J fetuses exposed to ethanol on gestational day (GD)7 or GD8.5. The facial phenotype resulting from ethanol exposure depended upon stage of insult and was predictive of unique patterns of corresponding brain abnormalities. Ethanol exposure on GD7 produced a constellation of dysmorphic facial features characteristic of human FAS, including severe midfacial hypoplasia, shortening of the palpebral fissures, an elongated upper lip, and deficient philtrum. In contrast, ethanol exposure on GD8.5 caused mild midfacial hypoplasia and palpebral fissure shortening, a shortened upper lip, and a preserved philtrum. These distinct, stage-specific facial phenotypes were associated with unique volumetric and shape abnormalities of the septal region, pituitary, and olfactory bulbs. By demonstrating that early prenatal ethanol exposure can cause more than one temporally-specific pattern of defects, these findings illustrate the need for an expansion of current diagnostic criteria to better capture the full range of facial and brain dysmorphology in fetal alcohol spectrum disorders.	[Lipinski, Robert J.; O'Leary-Moore, Shonagh K.; Ament, Jacob J.; Pecevich, Stephen J.; Parnell, Scott E.; Godin, Elizabeth A.; Everson, Joshua L.; Dehart, Deborah B.; Holloway, Hunter T.; Sulik, Kathleen K.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA; [O'Leary-Moore, Shonagh K.; Budin, Francois; Oguz, Ipek; Styner, Martin A.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Hammond, Peter; Suttie, Michael] UCL, Inst Child Hlth, London, England; [Jiang, Yi; Johnson, G. Allan] Duke Univ, Ctr In Vivo Microscopy, Durham, NC USA; [Parnell, Scott E.; Dehart, Deborah B.; Sulik, Kathleen K.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Lipinski, RJ (corresponding author), Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA.	lipinski@med.unc.edu	Styner, Martin/AAS-9949-2020; (CHANL), Chapel Hill Analytical and Nanofabrication Laboratory/AAA-9271-2022	Styner, Martin/0000-0002-8747-5118; Johnson, G.Allan/0000-0002-7606-5447; Lipinski, Robert/0000-0002-1994-4090; Everson, Josh/0000-0002-2887-8574; Suttie, Michael/0000-0002-5538-8431	National Institutes of Health [AA011605, AA017124, AA007573, DE-16215-05, U24 CA092656, U24 RR021760, T90DE021986-01, P41 EB015897, P30 HD003110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U24CA092656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA011605, P50AA011605, R00AA018697, U01AA017124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants AA011605, AA017124, AA007573, DE-16215-05, U24 CA092656, U24 RR021760, T90DE021986-01, P41 EB015897, and P30 HD003110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1986, LANCET, V2, P1222; Akers KG, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-29; AMMANN AJ, 1982, AM J DIS CHILD, V136, P906, DOI 10.1001/archpedi.1982.03970460036008; Astley SJ, 2000, ALCOHOL ALCOHOLISM, V35, P400, DOI 10.1093/alcalc/35.4.400; Astley SJ, 2009, ALCOHOL CLIN EXP RES, V33, P1671, DOI 10.1111/j.1530-0277.2009.01004.x; Beaton EA, 2010, PSYCHIAT RES-NEUROIM, V181, P108, DOI 10.1016/j.pscychresns.2009.10.009; Brisch R, 2007, EUR ARCH PSY CLIN N, V257, P140, DOI 10.1007/s00406-006-0697-8; Brisch R, 2008, PSYCHIAT RES-NEUROIM, V164, P265, DOI 10.1016/j.pscychresns.2007.12.007; CHAN T, 1991, BRIT J OPHTHALMOL, V75, P524, DOI 10.1136/bjo.75.9.524; Chen YY, 2011, ALCOHOL CLIN EXP RES, V35, P1293, DOI 10.1111/j.1530-0277.2011.01465.x; CLARREN SK, 1978, NEW ENGL J MED, V298, P1063, DOI 10.1056/NEJM197805112981906; Downing C, 2009, ALCOHOL CLIN EXP RES, V33, P1238, DOI 10.1111/j.1530-0277.2009.00949.x; Dunty WC, 2001, ALCOHOL CLIN EXP RES, V25, P1523, DOI 10.1111/j.1530-0277.2001.tb02156.x; Famy C, 1998, AM J PSYCHIAT, V155, P552, DOI 10.1176/ajp.155.4.552; Galarza M, 2004, J NEUROPSYCH CLIN N, V16, P41, DOI 10.1176/appi.neuropsych.16.1.41; Gilliam DM, 1996, ALCOHOL, V13, P47, DOI 10.1016/0741-8329(95)02010-1; Godin EA, 2010, ALCOHOL CLIN EXP RES, V34, P98, DOI 10.1111/j.1530-0277.2009.01071.x; Hammond P, 2008, MOL PSYCHIATR, V13, P614, DOI 10.1038/mp.2008.18; Hammond P, 2005, AM J HUM GENET, V77, P999, DOI 10.1086/498396; Hammond P, 2004, AM J MED GENET A, V126A, P339, DOI 10.1002/ajmg.a.20665; Hammond P, 2011, ALCOHOLISM CLIN EXPT, V35, p266A; Hammond P, 2012, HUM MUTAT, V33, P817, DOI 10.1002/humu.22054; Hammond P, 2012, EUR J HUM GENET, V20, P33, DOI 10.1038/ejhg.2011.135; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Hutton TJ, 2003, IEEE T MED IMAGING, V22, P747, DOI 10.1109/TMI.2003.814784; Johnson GA, 2007, NEUROIMAGE, V37, P82, DOI 10.1016/j.neuroimage.2007.05.013; Jolin EM, 2009, CURR PSYCHIAT REP, V11, P99, DOI 10.1007/s11920-009-0016-y; Keen CL, 2010, BIOFACTORS, V36, P125, DOI 10.1002/biof.89; KOTCH LE, 1992, INT J DEV NEUROSCI, V10, P273, DOI 10.1016/0736-5748(92)90016-S; KRETSCHM.R, 1968, NEW ENGL J MED, V279, P1295, DOI 10.1056/NEJM196812122792401; LOHR JB, 1989, SCHIZOPHRENIA BULL, V15, P595, DOI 10.1093/schbul/15.4.595; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; O'Leary-Moore SK, 2010, BIRTH DEFECTS RES A, V88, P953, DOI 10.1002/bdra.20719; Oguz I, 2011, P SOC PHOTOOPTICAL I, V7962; Parnell SE, 2006, ALCOHOL CLIN EXP RES, V30, P1791, DOI 10.1111/j.1530-0277.2006.00212.x; Parnell SE, 2009, ALCOHOL CLIN EXP RES, V33, P1001, DOI 10.1111/j.1530-0277.2009.00921.x; Parsons TE, 2011, DEV DYNAM, V240, P2233, DOI 10.1002/dvdy.22729; Ribeiro IM, 2007, EUR J OPHTHALMOL, V17, P104, DOI 10.1177/112067210701700114; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Sulik KK, 2005, EXP BIOL MED, V230, P366, DOI 10.1177/15353702-0323006-04; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717; Swayze VW, 1997, PEDIATRICS, V99, P232, DOI 10.1542/peds.99.2.232; Yang Y, 2011, CEREBRAL CORTEX; Yang Y, 2011, ALCOHOLISM CLIN EXPT; Zhou DM, 2011, NEUROIMAGE, V58, P16, DOI 10.1016/j.neuroimage.2011.06.026	49	101	102	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43067	10.1371/journal.pone.0043067	http://dx.doi.org/10.1371/journal.pone.0043067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937012	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300033
J	Rueger, MA; Keuters, MH; Walberer, M; Braun, R; Klein, R; Sparing, R; Fink, GR; Graf, R; Schroeter, M				Rueger, Maria Adele; Keuters, Meike Hedwig; Walberer, Maureen; Braun, Ramona; Klein, Rebecca; Sparing, Roland; Fink, Gereon Rudolf; Graf, Rudolf; Schroeter, Michael			Multi-Session Transcranial Direct Current Stimulation (tDCS) Elicits Inflammatory and Regenerative Processes in the Rat Brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; NONINVASIVE CORTICAL STIMULATION; CURRENT ELECTRIC-FIELDS; HUMAN MOTOR CORTEX; PROGENITOR CELLS; IN-VIVO; CEREBRAL-CORTEX; ADULT BRAIN; STROKE; MIGRATION	Transcranial direct current stimulation (tDCS) is increasingly being used in human studies as an adjuvant tool to promote recovery of function after stroke. However, its neurobiological effects are still largely unknown. Electric fields are known to influence the migration of various cell types in vitro, but effects in vivo remain to be shown. Hypothesizing that tDCS might elicit the recruitment of cells to the cortex, we here studied the effects of tDCS in the rat brain in vivo. Adult Wistar rats (n = 16) were randomized to either anodal or cathodal stimulation for either 5 or 10 consecutive days (500 mu A, 15 min). Bromodeoxyuridine (BrdU) was given systemically to label dividing cells throughout the experiment. Immunohistochemical analyses ex vivo included stainings for activated microglia and endogenous neural stem cells (NSC). Multi-session tDCS with the chosen parameters did not cause a cortical lesion. An innate immune response with early upregulation of Iba1-positive activated microglia occurred after both cathodal and anodal tDCS. The involvement of adaptive immunity as assessed by ICAM1-immunoreactivity was less pronounced. Most interestingly, only cathodal tDCS increased the number of endogenous NSC in the stimulated cortex. After 10 days of cathodal stimulation, proliferating NSC increased by similar to 60%, with a significant effect of both polarity and number of tDCS sessions on the recruitment of NSC. We demonstrate a pro-inflammatory effect of both cathodal and anodal tDCS, and a polarity-specific migratory effect on endogenous NSC in vivo. Our data suggest that tDCS in human stroke patients might also elicit NSC activation and modulate neuroinflammation.	[Rueger, Maria Adele; Keuters, Meike Hedwig; Walberer, Maureen; Braun, Ramona; Klein, Rebecca; Sparing, Roland; Fink, Gereon Rudolf; Schroeter, Michael] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Braun, Ramona] Univ Hosp Cologne, Ctr Med Expt, Cologne, Germany; [Rueger, Maria Adele; Keuters, Meike Hedwig; Walberer, Maureen; Klein, Rebecca; Graf, Rudolf; Schroeter, Michael] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Fink, Gereon Rudolf] Res Ctr Juelich, Inst Neurosci & Med INM 3, Cognit Neurol Sect, Julich, Germany	University of Cologne; University of Cologne; Max Planck Society; Helmholtz Association; Research Center Julich	Rueger, MA (corresponding author), Univ Hosp Cologne, Dept Neurol, Cologne, Germany.	adele.rueger@uk-koeln.de	Fink, Gereon R./E-1616-2012; Fink, Gereon R./AFW-9377-2022; Keuters, Meike/AAQ-2165-2021	Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Keuters, Meike Hedwig/0000-0003-4216-1024	Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany [143/2011]	Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany	This work was supported by the Koeln Fortune Program / Faculty of Medicine, University of Cologne, Germany (143/2011). The authors gratefully acknowledge a personal grant by Mr. U. Eichrodt to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Antal A, 2004, EUR J NEUROSCI, V19, P2888, DOI 10.1111/j.1460-9568.2004.03367.x; Ariza CA, 2010, STEM CELL REV REP, V6, P585, DOI 10.1007/s12015-010-9171-0; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Babona-Pilipos R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023808; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; BINDMAN LJ, 1962, NATURE, V196, P584, DOI 10.1038/196584a0; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; Butefisch CM, 2004, J NEUROPHYSIOL, V91, P2110, DOI 10.1152/jn.01038.2003; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Feng JF, 2012, STEM CELLS, V30, P349, DOI 10.1002/stem.779; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Li L, 2008, STEM CELLS, V26, P2193, DOI 10.1634/stemcells.2007-1022; Liebetanz D, 2006, NEUROSCI LETT, V398, P85, DOI 10.1016/j.neulet.2005.12.058; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Liebetanz D, 2009, CLIN NEUROPHYSIOL, V120, P1161, DOI 10.1016/j.clinph.2009.01.022; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Maysami S, 2008, J CEREBR BLOOD F MET, V28, P1104, DOI 10.1038/jcbfm.2008.4; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nishimura KY, 1996, J CELL SCI, V109, P199; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; RAPP B, 1988, EUR BIOPHYS J BIOPHY, V16, P313, DOI 10.1007/BF00254068; Rueger MA, 2010, J NEUROSCI, V30, P6454, DOI 10.1523/JNEUROSCI.6092-09.2010; Ruohonen J, 2012, CLIN NEUROPHYSIOL; Ryu JK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-39; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Schweid L, 2008, EXP BRAIN RES, V186, P409, DOI 10.1007/s00221-007-1245-0; Song B, 2007, NAT PROTOC, V2, P1479, DOI 10.1038/nprot.2007.205; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Wachter D, 2011, EXP NEUROL, V227, P322, DOI 10.1016/j.expneurol.2010.12.005; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Zhang JP, 2011, STEM CELL REV REP, V7, P987, DOI 10.1007/s12015-011-9247-5	44	88	91	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43776	10.1371/journal.pone.0043776	http://dx.doi.org/10.1371/journal.pone.0043776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928032	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300088
J	March-Villalba, JA; Martinez-Jabaloyas, JM; Herrero, MJ; Santamaria, J; Alino, SF; Dasi, F				March-Villalba, Jose A.; Martinez-Jabaloyas, Jose M.; Herrero, Maria J.; Santamaria, Jose; Alino, Salvador F.; Dasi, Francisco			Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics	PLOS ONE			English	Article							REAL-TIME QUANTIFICATION; NUCLEIC-ACIDS; PREVALENCE; BIOMARKERS; MORTALITY; DISEASE	Background: Serum prostate-specific antigen (PSA) is the most widely used marker for diagnosing prostate cancer (PCa). It lacks specificity and predictive value, resulting in inaccurate diagnoses and overtreatment of the disease. The aim of this study was to assess the usefulness of plasma telomerase reverse transcriptase (hTERT) mRNA as a diagnostic and prognostic tool for PCa and its association with clinicopathological parameters of tumors. Principal Findings: Plasma hTERT mRNA levels were determined by qRT-PCR in 105 consecutive patients with elevated PSA levels and in 68 healthy volunteers. The diagnostic accuracy, the efficacy as a prognostic factor of biochemical recurrence and the association with tumor clinicopathological parameters of plasma hTERT mRNA and serum PSA tests were determined using univariate and multivariate analyses. The results show that plasma hTERT mRNA is a non-invasive biomarker for PCa diagnosis that shows higher sensitivity (85% vs. 83%), specificity (90% vs. 47%), positive predictive value (83% vs. 56%), and negative predictive value (92% vs. 77%) than serum PSA. Plasma hTERT mRNA is significantly associated with poor prognosis tumor clinicopathological parameters and is a significant independent predictor of PCa (p<0.0001). Univariate analysis identified plasma hTERT mRNA (but not serum PSA) as a significant prognostic factor of biochemical recurrence. Plasma hTERT mRNA Kaplan-Meier curves confirmed the significant differences between groups and patients with higher levels than the cut-off value showed diminished recurrence-free survival (p = 0.004), whereas no differences were observed with serum PSA (p = 0.38). Multivariate analysis indicated that plasma hTERT mRNA (but not serum PSA) and stage were significantly associated with biochemical recurrence. Conclusions: Overall, these findings indicate that hTERT mRNA is a useful non-invasive tumor marker for the molecular diagnosis of PCa, affording a greater diagnostic and prognostic accuracy than the PSA assay and may be of relevance in the follow-up of the disease.	[March-Villalba, Jose A.; Martinez-Jabaloyas, Jose M.; Santamaria, Jose; Dasi, Francisco] Hosp Clin Univ Valencia, Fdn Invest, Inst Invest INCLIVA, Valencia, Spain; [March-Villalba, Jose A.; Martinez-Jabaloyas, Jose M.; Santamaria, Jose] Hosp Clin Univ Valencia, Urol Unite, Valencia, Spain; [Herrero, Maria J.; Alino, Salvador F.] Univ Valencia, Sch Med, Dept Pharmacol, Valencia, Spain; [Dasi, Francisco] Univ Valencia, Sch Med, Dept Physiol, Valencia, Spain	University of Valencia; University of Valencia	March-Villalba, JA (corresponding author), Hosp Clin Univ Valencia, Fdn Invest, Inst Invest INCLIVA, Valencia, Spain.	Francisco.Dasi@uv.es	Dasi, Francisco/D-1885-2012; Herrero, Maria Jose/M-1649-2014	Dasi, Francisco/0000-0003-2938-2965; Herrero, Maria Jose/0000-0002-6042-4185; Alino Pellicer, Salvador Francisco/0000-0002-7830-8713				Altimari A, 2008, AM J CLIN PATHOL, V129, P756, DOI 10.1309/DBPX1MFNDDJBW1FL; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bjartell A, 2011, ACTA ONCOL, V50, P76, DOI 10.3109/0284186X.2010.531284; Carbonare LD, 2013, UROL ONCOL-SEMIN ORI, V31, P205, DOI 10.1016/j.urolonc.2010.12.017; Dasi F, 2006, ANN NY ACAD SCI, V1075, P204, DOI 10.1196/annals.1368.028; Dasi F, 2001, LAB INVEST, V81, P767, DOI 10.1038/labinvest.3780285; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Gomella LG, 2011, CAN J UROL, V18, P5875; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Hoffman RM, 2011, NEW ENGL J MED, V365, P2013, DOI 10.1056/NEJMcp1103642; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lledo S M, 2004, Colorectal Dis, V6, P236, DOI 10.1111/j.1463-1318.2004.00627.x; March-Villalba JA, 2012, EXPERT OPIN BIOL TH, V12, pS69, DOI 10.1517/14712598.2012.685716; Miura N, 2007, ONCOLOGY-BASEL, V72, P45, DOI 10.1159/000111706; Miura N, 2007, ONCOL REP, V17, P541; Miura N, 2006, CANCER SCI, V97, P1366, DOI 10.1111/j.1349-7006.2006.00342.x; Miura N, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-46; Roobol MJ, 2011, ACTA ONCOL, V50, P85, DOI 10.3109/0284186X.2010.524935; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shariat SF, 2011, ACTA ONCOL, V50, P61, DOI 10.3109/0284186X.2010.542174; Silva JM, 2001, CLIN CANCER RES, V7, P2821; Terrin L, 2008, CLIN CANCER RES, V14, P7444, DOI 10.1158/1078-0432.CCR-08-0478; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tricoli JV, 2004, CLIN CANCER RES, V10, P3943, DOI 10.1158/1078-0432.CCR-03-0200; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209	28	59	67	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43470	10.1371/journal.pone.0043470	http://dx.doi.org/10.1371/journal.pone.0043470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916267	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800071
J	Pal, S; Saha, C; Hossain, M; Dey, SK; Kumar, GS				Pal, Sandip; Saha, Chabita; Hossain, Maidul; Dey, Subrata Kumar; Kumar, Gopinatha Suresh			Influence of Galloyl Moiety in Interaction of Epicatechin with Bovine Serum Albumin: A Spectroscopic and Thermodynamic Characterization	PLOS ONE			English	Article							STRUCTURE-AFFINITY RELATIONSHIP; DRUG BINDING-SITES; FLUORESCENCE; FLAVONOIDS; QUERCETIN; BSA; PUERARIN; ACID; RING	The health benefits stemming from green tea are well known, but the exact mechanism of its biological activity is not elucidated. Epicatechin (EC) and epicatechin gallate (ECG) are two dietary catechins ubiquitously present in green tea. Serum albumins functionally carry these catechins through the circulatory system and eliminate reactive oxygen species (ROS) induced injury. In the present study ECG is observed to have higher antioxidant activity; which is attributed to the presence of galloyl moiety. The binding affinity of these catechins to bovine serum albumin (BSA) will govern the efficacy of their biological activity. EC and ECG bind with BSA with binding constants 1.0x10(6) M-1 and 6.6x10(7) M-1, respectively. Changes in secondary structure of BSA on interaction with EC and ECG have been identified by circular dichroism (CD) and Fourier transform infrared (FT-IR) spectroscopy. Thermodynamic characterization reveals the binding process to be exothermic, spontaneous and entropy driven. Mixed binding forces (hydrophobic, electrostatic and hydrogen bonding) exist between ECG and BSA. Binding site for EC is primarily site-II in sub-domain IIIA of BSA and for ECG; it is site-I in subdomain IIA. ECG with its high antioxidant activity accompanied by high affinity for BSA could be a model in drug designing.	[Pal, Sandip; Saha, Chabita; Dey, Subrata Kumar] W Bengal Univ Technol, Sch Biotechnol & Biol Sci, Kolkata, India; [Hossain, Maidul; Kumar, Gopinatha Suresh] Indian Inst Chem Biol, CSIR, Div Chem, Biophys Chem Lab, Kolkata, India	Maulana Abul Kalam Azad University of Technology; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Pal, S (corresponding author), W Bengal Univ Technol, Sch Biotechnol & Biol Sci, Kolkata, India.	k.chabita@gmail.com	KUMAR, P. SURESH/AAT-8951-2020; Kumar, Gopinatha Suresh/W-1461-2019; Kumar, Dr Suresh/HHZ-2615-2022; Saha, chabita/AAW-5020-2021; Hossain, Maidul/AAW-7669-2021	KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Dr Suresh/0000-0002-2539-6553; Hossain, Maidul/0000-0003-1408-2273	National Tea Research Foundation (NTRF), India; Department of Science and Technology, Govt. of India; NTRF, India; Research Associateship of the Council of Scientific and Industrial Research (CSIR), Govt. of India	National Tea Research Foundation (NTRF), India; Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); NTRF, India; Research Associateship of the Council of Scientific and Industrial Research (CSIR), Govt. of India	This work is supported by National Tea Research Foundation (NTRF), India. Dr. Chabita Saha is thankful to Department of Science and Technology, Govt. of India for the financial support. Mr. Sandip Pal, Junior Research Fellow is financially supported by NTRF, India and is thankful to the same. Dr. Maidul Hossain is a recipient of the Research Associateship of the Council of Scientific and Industrial Research (CSIR), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 1999, J PHARMACOL TOXICOL, V41, P55, DOI 10.1016/S1056-8719(98)00038-0; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chakraborty B, 2009, J LUMIN, V129, P34, DOI 10.1016/j.jlumin.2008.07.012; Cote J, 2010, CRIT REV FOOD SCI, V50, P666, DOI 10.1080/10408390903044107; Forster T., 1965, MODERN QUANTUM CHEM; Ghosh D, 2013, J BIOMOL STRUCT DYN, V31, P331, DOI 10.1080/07391102.2012.698190; Ghosh D, 2012, DNA CELL BIOL, V31, P377, DOI 10.1089/dna.2011.1299; Ghosh S, 2009, NANOSCALE RES LETT, V4, P937, DOI 10.1007/s11671-009-9339-1; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hossain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018333; Jha NS, 2009, THERMOCHIM ACTA, V482, P21, DOI 10.1016/j.tca.2008.10.012; Jiang M, 2004, J MOL STRUCT, V692, P71, DOI 10.1016/j.molstruc.2004.01.003; Kandagal PB, 2006, J PHARMACEUT BIOMED, V41, P393, DOI 10.1016/j.jpba.2005.11.037; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; Li JH, 2008, J MOL STRUCT, V885, P64, DOI 10.1016/j.molstruc.2007.10.020; Liu EH, 2010, MOLECULES, V15, P9092, DOI 10.3390/molecules15129092; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; Mishra B, 2005, J CHEM SCI, V117, P641, DOI 10.1007/BF02708293; Nair CKK, 2008, MUTAT RES-GEN TOX EN, V650, P48, DOI 10.1016/j.mrgentox.2007.10.001; Natella F, 2010, BIOCHIMIE, V92, P1147, DOI 10.1016/j.biochi.2010.04.019; Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X; Rahmelow K, 1996, ANAL BIOCHEM, V241, P5, DOI 10.1006/abio.1996.0369; Roy A.S., 2010, J BIOPHYS CHEM, V01, P141, DOI [DOI 10.4236/JBPC.2010.13017, 10.4236/jbpc.2010.13017]; Sengupta B, 2002, BIOCHEM BIOPH RES CO, V299, P400, DOI 10.1016/S0006-291X(02)02667-0; Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096; Shi J, 2011, REV BRAS FARMACOGN, V21, P594, DOI 10.1590/S0102-695X2011005000118; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TERAO J, 1994, ARCH BIOCHEM BIOPHYS, V308, P278, DOI 10.1006/abbi.1994.1039; Tian JN, 2004, J PHOTOCH PHOTOBIO B, V74, P39, DOI 10.1016/j.jphotobiol.2004.01.001; Turkmen N, 2006, FOOD CHEM, V99, P835, DOI 10.1016/j.foodchem.2005.08.034; Wang HF, 2000, TRENDS FOOD SCI TECH, V11, P152, DOI 10.1016/S0924-2244(00)00061-3; Wang YQ, 2007, J PHARMACEUT BIOMED, V43, P1869, DOI 10.1016/j.jpba.2007.01.001; WANWIMOLRUK S, 1983, MOL PHARMACOL, V24, P458; Xiao JB, 2008, J AGR FOOD CHEM, V56, P2350, DOI 10.1021/jf7037295; Xiao JB, 2007, J PHARMACEUT BIOMED, V45, P609, DOI 10.1016/j.jpba.2007.08.032; Xiao JB, 2011, MOL NUTR FOOD RES, V55, P310, DOI 10.1002/mnfr.201000208; Xiao JB, 2010, MOL NUTR FOOD RES, V54, pS253, DOI 10.1002/mnfr.200900454; Yang F, 2011, FOOD FUNCT, V2, P137, DOI 10.1039/c0fo00092b; Zhao JY, 2011, ARCH BIOL SCI, V63, P325, DOI 10.2298/ABS1102325Z	41	37	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43321	10.1371/journal.pone.0043321	http://dx.doi.org/10.1371/journal.pone.0043321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916242	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800060
J	Saluja, R; Delin, I; Nilsson, GP; Adner, M				Saluja, Rohit; Delin, Ingrid; Nilsson, Gunnar P.; Adner, Mikael			Fc epsilon R-1-Mediated Mast Cell Reactivity Is Amplified through Prolonged Toll-Like Receptor-Ligand Treatment	PLOS ONE			English	Article							ASTHMA EXACERBATIONS; INNATE IMMUNITY; TLR2; ACTIVATION; CYTOKINES; STIMULATION; INFECTIONS; RESPONSES; VIRUS	Background: Mast cell-derived mediators mediate several of the pathological features of asthma. Microbial infections induce asthma exacerbations in which the contribution of mast cells remains incomprehensible. Principal Findings: In this study we have investigated the characteristic expression pattern of Toll-like receptors (TLRs) 1-9 and the effect of TLR ligand treatment on IgE-receptor mediated mast cell reactivity. For the studies we employed in vitro differentiated connective tissue like mast cells (CTLMC) and mucosal like mast cells (MLMC) from mice. Both phenotypes were treated for 24 h or 96 h with ligands for TLR1/2, TLR2/6, TLR3 and TLR4, before activation with IgE and antigen. Prolonged exposure (96 h) with TLR-ligands promoted mast cell reactivity following IgE-receptor activation. TLR4 activation with LPS generated the most pronounced effect, with an enhanced degranulation and secretion of leukotrienes, cytokines and chemokines, in both CTLMC and MLMC. The effect of LPS was mediated through a Myd88-dependent pathway and the increased effect involved JNK-dependent pathway. Conclusion: We find that prolonged exposure of mast cells to pathogens/TLR-ligands modulates their effector responses by priming them for increased release of several inflammatory mediators when subsequently activated by IgE-receptors. These data suggest that infections might exaggerate the severity of allergic reactions such as in asthma, by enhancing mediator release from mast cells.	[Saluja, Rohit; Nilsson, Gunnar P.] Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden; [Delin, Ingrid; Adner, Mikael] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Nilsson, Gunnar P.; Adner, Mikael] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Saluja, R (corresponding author), Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden.	Gunnar.P.Nilsson@ki.se		Delin, Ingrid/0000-0003-3716-4589	Swedish Research Council Medicine; Swedish Heart and Lung Foundation; Centre for Allergy Research at Karolinska Institutet; King Gustaf V's 80-years Foundation; Ollie and Elof Ericsson's foundation; Hans von Kantzow's foundation; Ellen, Walter and Lennart Hesselman's foundation	Swedish Research Council Medicine(Swedish Research Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Centre for Allergy Research at Karolinska Institutet(Karolinska Institutet); King Gustaf V's 80-years Foundation; Ollie and Elof Ericsson's foundation; Hans von Kantzow's foundation; Ellen, Walter and Lennart Hesselman's foundation	The study was supported by the Swedish Research Council Medicine, The Swedish Heart and Lung Foundation, the Centre for Allergy Research at Karolinska Institutet, King Gustaf V's 80-years Foundation, Ollie and Elof Ericsson's foundation, Hans von Kantzow's foundation, and Ellen, Walter and Lennart Hesselman's foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; Ekoff M, 2007, J IMMUNOL, V178, P4177, DOI 10.4049/jimmunol.178.7.4177; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Fehrenbach K, 2007, MOL IMMUNOL, V44, P2087, DOI 10.1016/j.molimm.2006.09.011; Kasakura K, 2009, INT ARCH ALLERGY IMM, V150, P359, DOI 10.1159/000226237; Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049; Martin RJ, 2006, CLIN CHEST MED, V27, P87, DOI 10.1016/j.ccm.2005.10.004; Matsushima H, 2004, J IMMUNOL, V173, P531, DOI 10.4049/jimmunol.173.1.531; McAlpine SM, 2011, J INNATE IMMUN, V3, P120, DOI 10.1159/000323350; McCurdy JD, 2003, J IMMUNOL, V170, P1625, DOI 10.4049/jimmunol.170.4.1625; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; Mrabet-Dahbi S, 2009, EXP DERMATOL, V18, P437, DOI 10.1111/j.1600-0625.2009.00878.x; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Okayama Y, 2007, CURR OPIN IMMUNOL, V19, P687, DOI 10.1016/j.coi.2007.07.018; Poulakou G, 2011, CLIN MICROBIOL INFEC; Qiao HH, 2006, BLOOD, V107, P610, DOI 10.1182/blood-2005-06-2271; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Roquet A, 1997, AM J RESP CRIT CARE, V155, P1856, DOI 10.1164/ajrccm.155.6.9196086; Selander C, 2009, J IMMUNOL, V182, P4208, DOI 10.4049/jimmunol.0800885; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Varadaradjalou S, 2003, EUR J IMMUNOL, V33, P899, DOI 10.1002/eji.200323830; Yang C, 2012, EXP PHYSL; Yoshioka M, 2007, J ALLERGY CLIN IMMUN, V120, P452, DOI 10.1016/j.jaci.2007.03.027; Zanini A, 2007, J ALLERGY CLIN IMMUN, V120, P329, DOI 10.1016/j.jaci.2007.04.021	31	50	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43547	10.1371/journal.pone.0043547	http://dx.doi.org/10.1371/journal.pone.0043547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916277	gold, Green Published, Green Submitted			2022-12-27	WOS:000307824300055
J	Huang, S; Belliveau, JW; Tengshe, C; Ahveninen, J				Huang, Samantha; Belliveau, John W.; Tengshe, Chinmayi; Ahveninen, Jyrki			Brain Networks of Novelty-Driven Involuntary and Cued Voluntary Auditory Attention Shifting	PLOS ONE			English	Article							EVENT-RELATED FMRI; MEDIAL FRONTAL-CORTEX; SCALE NEURAL-NETWORK; SPATIAL ATTENTION; MISMATCH NEGATIVITY; CORTICAL NETWORK; PREFRONTAL CORTEX; PARIETAL CORTEX; ACOUSTIC NOISE; INCREASED DISTRACTIBILITY	In everyday life, we need a capacity to flexibly shift attention between alternative sound sources. However, relatively little work has been done to elucidate the mechanisms of attention shifting in the auditory domain. Here, we used a mixed event-related/sparse-sampling fMRI approach to investigate this essential cognitive function. In each 10-sec trial, subjects were instructed to wait for an auditory "cue" signaling the location where a subsequent "target" sound was likely to be presented. The target was occasionally replaced by an unexpected "novel" sound in the uncued ear, to trigger involuntary attention shifting. To maximize the attention effects, cues, targets, and novels were embedded within dichotic 800-Hz vs. 1500-Hz pure-tone "standard" trains. The sound of clustered fMRI acquisition (starting at t = 7.82 sec) served as a controlled trial-end signal. Our approach revealed notable activation differences between the conditions. Cued voluntary attention shifting activated the superior intra-parietal sulcus (IPS), whereas novelty-triggered involuntary orienting activated the inferior IPS and certain subareas of the precuneus. Clearly more widespread activations were observed during voluntary than involuntary orienting in the premotor cortex, including the frontal eye fields. Moreover, we found -evidence for a frontoinsular-cingular attentional control network, consisting of the anterior insula, inferior frontal cortex, and medial frontal cortices, which were activated during both target discrimination and voluntary attention shifting. Finally, novels and targets activated much wider areas of superior temporal auditory cortices than shifting cues.	[Huang, Samantha; Belliveau, John W.; Tengshe, Chinmayi; Ahveninen, Jyrki] Harvard Univ, Sch Med, Massachusetts Gen Hosp,Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Belliveau, John W.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University	Huang, S (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp,Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.	samhuang@nmr.mgh.harvard.edu			National Institutes of Health [R01MH083744, R21DC010060, R01HD040712, R01NS037462, P41RR14075];  [S10RR014978];  [S10RR021110];  [S10RR019307];  [S10RR023401]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040712] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021110, P41RR014075, S10RR019307, S10RR023401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health awards R01MH083744, R21DC010060, R01HD040712, R01NS037462, and P41RR14075. The research environment was supported by Shared Instrumentation grants S10RR014978, S10RR021110, S10RR019307, and S10RR023401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2009, NEUROPSYCHOLOGIA, V47, P2089, DOI 10.1016/j.neuropsychologia.2009.03.019; Ahveninen J, 2002, NEUROIMAGE, V16, P1052, DOI 10.1006/nimg.2002.1142; Ahveninen J, 2000, AUDIOL NEURO-OTOL, V5, P303, DOI 10.1159/000013896; Ahveninen J, 2000, ALCOHOL CLIN EXP RES, V24, P1850, DOI 10.1097/00000374-200012000-00014; Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Ahveninen J, 2011, P NATL ACAD SCI USA, V108, P4182, DOI 10.1073/pnas.1016134108; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; Alain C, 2008, J COGNITIVE NEUROSCI, V20, P285, DOI 10.1162/jocn.2008.20014; Alain C, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00202; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; Alho K, 1997, NEUROREPORT, V8, P3233, DOI 10.1097/00001756-199710200-00010; ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Anderson JS, 2010, P NATL ACAD SCI USA, V107, P20110, DOI 10.1073/pnas.1011616107; Astafiev SV, 2006, EUR J NEUROSCI, V23, P591, DOI 10.1111/j.1460-9568.2005.04573.x; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Cate AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004645; Cho ZH, 1998, MAGNET RESON MED, V39, P331, DOI 10.1002/mrm.1910390224; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Eckert MA, 2008, HUM BRAIN MAPP, V29, P848, DOI 10.1002/hbm.20560; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Fajardo C, 2008, NEUROSCI LETT, V435, P215, DOI 10.1016/j.neulet.2008.02.048; Falchier A, 2002, J NEUROSCI, V22, P5749; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Garg A, 2007, NEUROPSYCHOLOGIA, V45, P2307, DOI 10.1016/j.neuropsychologia.2007.02.015; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P1584, DOI 10.1162/jocn.2009.21103; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Greenberg AS, 2010, J NEUROSCI, V30, P14330, DOI 10.1523/JNEUROSCI.4248-09.2010; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Hommel B, 2009, ATTEN PERCEPT PSYCHO, V71, P385, DOI 10.3758/APP.71.2.385; Indovina I, 2007, CEREB CORTEX, V17, P1701, DOI 10.1093/cercor/bhl081; Jaaskelainen Iiro P, 2010, Open Neuroimag J, V4, P30, DOI 10.2174/1874440001004020030; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Kahkonen S, 2002, CLIN NEUROPHYSIOL, V113, P1894, DOI 10.1016/S1388-2457(02)00305-X; Kiehl KA, 2001, J PSYCHOPHYSIOL, V15, P221, DOI 10.1027//0269-8803.15.4.221; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; MacSweeney M, 2000, NEUROREPORT, V11, P1729, DOI 10.1097/00001756-200006050-00026; Mayer AR, 2009, HUM BRAIN MAPP, V30, P1652, DOI 10.1002/hbm.20631; Mayer AR, 2004, J COGNITIVE NEUROSCI, V16, P1262, DOI 10.1162/0898929041920531; Mazard A, 2002, J COGNITIVE NEUROSCI, V14, P172, DOI 10.1162/089892902317236821; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Muller BW, 2002, NEUROIMAGE, V17, P231, DOI 10.1006/nimg.2002.1176; NAATANEN R, 1992, NEUROREPORT, V3, P493; Naatanen R, 1980, Prog Brain Res, V54, P343, DOI 10.1016/S0079-6123(08)61645-3; Naatanen R, 2000, AUDIOL NEURO-OTOL, V5, P105, DOI 10.1159/000013874; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Novitski N, 2001, NEUROIMAGE, V14, P244, DOI 10.1006/nimg.2001.0797; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Olulade O, 2011, HEARING RES, V277, P67, DOI 10.1016/j.heares.2011.03.008; Passchier-Vermeer W, 2000, ENVIRON HEALTH PERSP, V108, P123, DOI 10.1289/ehp.00108s1123; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Raij T, 2010, EUR J NEUROSCI, V31, P1772, DOI 10.1111/j.1460-9568.2010.07213.x; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Reuss Heiko, 2011, Adv Cogn Psychol, V7, P82, DOI 10.2478/v10053-008-0091-3; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Rinne T, 2007, NEUROSCI LETT, V416, P247, DOI 10.1016/j.neulet.2007.01.077; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; SanMiguel I, 2010, BIOL PSYCHOL, V83, P143, DOI 10.1016/j.biopsycho.2009.11.012; Schroger E, 1998, COGNITIVE BRAIN RES, V7, P71, DOI 10.1016/S0926-6410(98)00013-5; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Shah NJ, 1999, J MAGN RESON IMAGING, V9, P19, DOI 10.1002/(SICI)1522-2586(199901)9:1<19::AID-JMRI3>3.0.CO;2-K; Shomstein S, 2006, J NEUROSCI, V26, P435, DOI 10.1523/JNEUROSCI.4408-05.2006; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Simpson GV, 2011, J NEUROSCI, V31, P13880, DOI 10.1523/JNEUROSCI.1519-10.2011; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Smith DV, 2010, J COGNITIVE NEUROSCI, V22, P347, DOI 10.1162/jocn.2009.21241; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Stevens FL, 2011, J NEUROPSYCH CLIN N, V23, P120, DOI 10.1176/appi.neuropsych.23.2.121; Strobel A, 2008, NEUROIMAGE, V40, P869, DOI 10.1016/j.neuroimage.2007.10.065; Szczepanski SM, 2010, J NEUROSCI, V30, P148, DOI 10.1523/JNEUROSCI.3862-09.2010; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Voisin J, 2006, J NEUROSCI, V26, P273, DOI 10.1523/JNEUROSCI.2967-05.2006; Weeks R, 2000, J NEUROSCI, V20, P2664; Wilson KD, 2005, NEUROIMAGE, V25, P668, DOI 10.1016/j.neuroimage.2004.07.075; Woods DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005183; WOODS DL, 1986, NEUROLOGY, V36, P212, DOI 10.1212/WNL.36.2.212; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088	115	41	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44062	10.1371/journal.pone.0044062	http://dx.doi.org/10.1371/journal.pone.0044062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937153	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600073
J	Diamantopoulos, AP; Rohde, G; Johnsrud, I; Skoie, IM; Hochberg, M; Haugeberg, G				Diamantopoulos, Andreas P.; Rohde, Gudrun; Johnsrud, Irene; Skoie, Inger M.; Hochberg, Marc; Haugeberg, Glenn			The Epidemiology of Low- and High-Energy Distal Radius Fracture in Middle-Aged and Elderly Men and Women in Southern Norway	PLOS ONE			English	Article							BONE-MINERAL DENSITY; OSTEOPOROTIC FRACTURES; SEASONAL-VARIATION; RISK-FACTOR; POPULATION; URBAN	Background: Distal radius is one of the most frequent sites for fractures in the elderly population. Despite this, there is a paucity of epidemiological data for distal radius fracture, in particular, distinguishing between high-and low-energy fractures. Our aim was to study the epidemiology of high-and low-energy distal radius fracture in middle-aged and elderly men and women in Southern Norway, and search for associates with high-or low-energy distal radius fracture in this population. Methodology/Principal Findings: Patients with distal radius fractures aged >= 50 years were identified from all four hospitals in Southern Norway between 2004 and 2005. Age-adjusted and age-specific incidence rates for men and women were calculated, and potential associates with high-and low-energy distal radius fracture were explored both in univariate and multivariate analyses. A total of 799 individuals (118 men and 681 women) aged >= 50 years with low-energy and 84 (48 men and 36 women) with high-energy distal radius fracture were identified. The overall age-adjusted incidence rate per 10,000 person-years was 18.9 for men (low energy, 12.8 vs. high-energy, 6.1) and 75.1 for women (low energy, 71.1 vs. high energy, 4.0). In multivariate model, younger age, male gender, summer season, and living in a rural area were independently associated with an increased risk of high-energy fracture. Conclusion: An approximately fourfold higher age-adjusted incidence rate for distal radius fracture was found among women, when compared with men. However, the proportion of patients with high-energy distal radius fracture was approximately fivefold higher in men than in women. Our data suggest that younger age, male gender, summer seasons, and living in rural areas are independent risk factors for increased risk of high-energy distal radius fracture.	[Diamantopoulos, Andreas P.; Rohde, Gudrun; Johnsrud, Irene; Skoie, Inger M.; Haugeberg, Glenn] Hosp So Norway, Dept Rheumatol, Kristiansand, Norway; [Rohde, Gudrun] Univ Agder, Fac Hlth & Sport, Kristiansand, Norway; [Hochberg, Marc] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Hochberg, Marc] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Diamantopoulos, Andreas P.; Haugeberg, Glenn] Norwegian Univ Sci & Technol, INM, Dept Neurosci, N-7034 Trondheim, Norway	University of Agder; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Norwegian University of Science & Technology (NTNU)	Diamantopoulos, AP (corresponding author), Hosp So Norway, Dept Rheumatol, Kristiansand, Norway.	andreas.diamantopoulos@sshf.no			Competence Development Fund of Southern Norway; Hospital of Southern Norway HF (HelseForetak-Health trust)	Competence Development Fund of Southern Norway; Hospital of Southern Norway HF (HelseForetak-Health trust)	This work has been supported and funded by the Competence Development Fund of Southern Norway and the Hospital of Southern Norway HF (HelseForetak-Health trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brogren E, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-48; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Diamantopoulos AP, 2011, AGE AGEING; Flinkkila T, 2011, OSTEOPOROSIS INT, V22, P2307, DOI 10.1007/s00198-010-1463-3; HOVE LM, 1995, SCAND J PLAST RECONS, V29, P263, DOI 10.3109/02844319509050137; JONSSON B, 1992, OSTEOPOROSIS INT, V2, P269, DOI 10.1007/BF01623181; Kirkwood BR, 2008, ESSENTIAL MED STAT; Lofthus CM, 2008, OSTEOPOROSIS INT, V19, P781, DOI 10.1007/s00198-007-0499-5; Lunt M, 1997, J BONE MINER RES, V12, P1883, DOI 10.1359/jbmr.1997.12.11.1883; MALLMIN H, 1992, ACTA ORTHOP SCAND, V63, P213, DOI 10.3109/17453679209154826; Meyer HE, 2004, AM J EPIDEMIOL, V160, P1039, DOI 10.1093/aje/kwh337; O'Neill TW, 2001, OSTEOPOROSIS INT, V12, P555, DOI 10.1007/s001980170076; Omsland TK, 2009, OSTEOPOROSIS INT, V20, P631, DOI 10.1007/s00198-008-0699-7; Omsland TK, 2011, J BONE MINER RES, V26, P850, DOI 10.1002/jbmr.280; Oyen J, 2010, OSTEOPOROSIS INT, V21, P1257, DOI 10.1007/s00198-009-1068-x; Oyen J, 2010, OSTEOPOROSIS INT, V21, P1247, DOI 10.1007/s00198-009-1065-0; Oyen J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-67; Oyen J, 2011, J BONE JOINT SURG AM, V93A, P348, DOI 10.2106/JBJS.J.00303; Oyen J, 2011, BONE, V48, P1140, DOI 10.1016/j.bone.2011.01.021; SOLGAARD S, 1985, ACTA ORTHOP SCAND, V56, P391, DOI 10.3109/17453678508994354; Thompson PW, 2004, INJURY, V35, P462, DOI 10.1016/S0020-1383(03)00117-7; Tsai CH, 2011, OSTEOPOROSIS INT, V22, P2809, DOI 10.1007/s00198-010-1489-6	23	66	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43367	10.1371/journal.pone.0043367	http://dx.doi.org/10.1371/journal.pone.0043367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937040	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308225500044
J	Eidemuller, M; Jacob, P; Lane, RSD; Frost, SE; Zablotska, LB				Eidemueller, Markus; Jacob, Peter; Lane, Rachel S. D.; Frost, Stanley E.; Zablotska, Lydia B.			Lung Cancer Mortality (1950-1999) among Eldorado Uranium Workers: A Comparison of Models of Carcinogenesis and Empirical Excess Risk Models	PLOS ONE			English	Article							RADON DAUGHTER EXPOSURE; ATOMIC-BOMB SURVIVORS; INTERCELLULAR INDUCTION; ALPHA-PARTICLES; 2-STAGE MODEL; SOLID CANCER; MINERS; RADIATION; SMOKING; COHORT	Lung cancer mortality after exposure to radon decay products (RDP) among 16,236 male Eldorado uranium workers was analyzed. Male workers from the Beaverlodge and Port Radium uranium mines and the Port Hope radium and uranium refinery and processing facility who were first employed between 1932 and 1980 were followed up from 1950 to 1999. A total of 618 lung cancer deaths were observed. The analysis compared the results of the biologically-based two-stage clonal expansion (TSCE) model to the empirical excess risk model. The spontaneous clonal expansion rate of pre-malignant cells was reduced at older ages under the assumptions of the TSCE model. Exposure to RDP was associated with increase in the clonal expansion rate during exposure but not afterwards. The increase was stronger for lower exposure rates. A radiation-induced bystander effect could be a possible explanation for such an exposure response. Results on excess risks were compared to a linear dose-response parametric excess risk model with attained age, time since exposure and dose rate as effect modifiers. In all models the excess relative risk decreased with increasing attained age, increasing time since exposure and increasing exposure rate. Large model uncertainties were found in particular for small exposure rates.	[Eidemueller, Markus; Jacob, Peter] Helmholtz Zentrum Munchen, Inst Radiat Protect, Neuherberg, Germany; [Lane, Rachel S. D.] Canadian Nucl Safety Commiss, Radiat & Hlth Sci Div, Directorate Environm & Radiat Protect & Assessmen, Ottawa, ON, Canada; [Frost, Stanley E.] Frost&Frost Consultants, Saskatoon, SK, Canada; [Zablotska, Lydia B.] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California San Francisco	Eidemuller, M (corresponding author), Helmholtz Zentrum Munchen, Inst Radiat Protect, Neuherberg, Germany.	markus.eidemueller@helmholtz-muenchen.de			Canadian Nuclear Safety Commission (CNSC); Government of Saskatchewan; Cameco Corporation; AREVA Resources Canada Inc.; CNSC Research and Support Program; European Network of Excellence DoReMi (Low Dose Research towards Multidisciplinary Integration) [249689]; Cameco Corporation Canada Inc.; NATIONAL CANCER INSTITUTE [K07CA132918] Funding Source: NIH RePORTER	Canadian Nuclear Safety Commission (CNSC); Government of Saskatchewan; Cameco Corporation; AREVA Resources Canada Inc.; CNSC Research and Support Program; European Network of Excellence DoReMi (Low Dose Research towards Multidisciplinary Integration); Cameco Corporation Canada Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Updated Eldorado Study was supported (co-funded) by the Canadian Nuclear Safety Commission (CNSC), the Government of Saskatchewan, Cameco Corporation and AREVA Resources Canada Inc. All data checking, analysis, interpretation and report writing were done independently of the mining companies, which had no part in any aspect of the work of the scientific team of the present study. The CNSC acted as project co-ordinator so all the work was coordinated through the CNSC. The current project (TSCE model) received additional funding from the CNSC Research and Support Program. The current project received funding from the European Network of Excellence DoReMi (Low Dose Research towards Multidisciplinary Integration) under grant agreement no. 249689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was received from the mining companies Cameco Corporation and AREVA Resources Canada Inc. SF is an independent consultant and is associated with Frost&Frost Consultants, Saskatoon. He is a retired Eldorado employee. All funds from the mining companies were given to the CNSC's Research Support Program (RSP). All research activities required the approval of an internal RSP committee. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors..	Al-Zoughool M, 2009, INT J RADIAT BIOL, V85, P57, DOI 10.1080/09553000802635054; Amabile JC, 2009, HEALTH PHYS, V97, P613, DOI 10.1097/01.HP.0000363842.62922.58; Bauer G, 2007, INT J RADIAT BIOL, V83, P873, DOI 10.1080/09553000701727523; BEIR VI, 1999, HLTH EFF EXP RAD; Brenner DJ, 2002, INT J RADIAT BIOL, V78, P593, DOI 10.1080/09553000210121740; Brenner DJ, 2001, RADIAT RES, V155, P402, DOI 10.1667/0033-7587(2001)155[0402:TBEIRO]2.0.CO;2; Canadian Cancer Society's Steering Committee on Cancer Statistics, 2011, CAN CANC STAT; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; DARBY SC, 1995, JNCI-J NATL CANCER I, V87, P378, DOI 10.1093/jnci/87.5.378; Doll R, 2004, BMJ-BRIT MED J, V328, P1529, DOI 10.1136/bmj.328.7455.1529; Eidemuller M, 2010, RADIAT ENVIRON BIOPH, V49, P477, DOI 10.1007/s00411-010-0289-x; Eidemuller M, 2009, MUTAT RES-FUND MOL M, V669, P48, DOI 10.1016/j.mrfmmm.2009.04.009; Harley NH, 1996, ENVIRON INT, V22, pS977; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; HOWE GR, 1988, AM J EPIDEMIOL, V128, P1364, DOI 10.1093/oxfordjournals.aje.a115089; Howe GR, 1996, RADIAT RES, V146, P37, DOI 10.2307/3579393; HOWE GR, 1986, J NATL CANCER I, V77, P357; HOWE GR, 1987, J NATL CANCER I, V79, P1255; IARC, 1986, MON EV CARC RISKS HU; IARC, 1980, MON EV CARC RISKS CH; IARC, 2002, MON EV CARC RISKS HU; Jacob P, 2007, RADIAT ENVIRON BIOPH, V46, P383, DOI 10.1007/s00411-007-0117-0; Jacob P, 2010, MUTAT RES-FUND MOL M, V687, P34, DOI 10.1016/j.mrfmmm.2010.01.005; Kai M, 1997, RADIAT RES, V148, P348, DOI 10.2307/3579520; Krewski D, 2005, EPIDEMIOLOGY, V16, P137, DOI 10.1097/01.ede.0000152522.80261.e3; LABBE KA, 1991, HEALTH PHYS, V60, P489, DOI 10.1097/00004032-199104000-00002; Lane RSD, 2010, RADIAT RES, V174, P773, DOI 10.1667/RR2237.1; Leuraud K, 2011, RADIAT RES, V176, P375, DOI 10.1667/RR2377.1; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Luebeck EG, 1999, RADIAT RES, V152, P339, DOI 10.2307/3580219; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Nagasawa H, 1999, RADIAT RES, V152, P552, DOI 10.2307/3580153; Portess DI, 2007, CANCER RES, V67, P1246, DOI 10.1158/0008-5472.CAN-06-2985; Portier C, 1997, Stat Methods Med Res, V6, P305; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Schnelzer M, 2010, HEALTH PHYS, V98, P20, DOI 10.1097/HP.0b013e3181b8ce81; Schubauer-Berigan MK, 2009, AM J EPIDEMIOL, V169, P718, DOI 10.1093/aje/kwn406; Shao CL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-184; Taeger D, 2009, INT ARCH OCC ENV HEA, V82, P867, DOI 10.1007/s00420-008-0386-1; Tomasek L, 2008, RADIAT PROT DOSIM, V130, P98, DOI 10.1093/rpd/ncn117; Tomasek L, 2011, RADIAT PROT DOSIM, V145, P238, DOI 10.1093/rpd/ncr048; Tomasek L, 2008, RADIAT RES, V169, P125, DOI 10.1667/RR0848.1; Trosko JE, 2005, RADIAT ENVIRON BIOPH, V44, P3, DOI 10.1007/s00411-005-0269-8; van Dillen T, 2011, RADIAT RES, V175, P119, DOI 10.1667/RR2102.1; Villeneuve PJ, 2007, HEALTH PHYS, V92, P157, DOI 10.1097/01.HP.0000239127.43136.89; Walsh L, 2010, HEALTH PHYS, V99, P292, DOI 10.1097/HP.0b013e3181cd669d; Walsh L, 2010, RADIAT RES, V173, P79, DOI 10.1667/RR1803.1; Wu LJ, 1999, P NATL ACAD SCI USA, V96, P4959, DOI 10.1073/pnas.96.9.4959; Zhou HN, 2001, P NATL ACAD SCI USA, V98, P14410, DOI 10.1073/pnas.251524798	50	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e41431	10.1371/journal.pone.0041431	http://dx.doi.org/10.1371/journal.pone.0041431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936975	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500006
J	Elliott, GN; Thomas, N; MacRae, M; Campbell, CD; Ogden, ID; Singh, BK				Elliott, Geoffrey N.; Thomas, Nadine; MacRae, Marion; Campbell, Colin D.; Ogden, Iain D.; Singh, Brajesh K.			Multiplex T-RFLP Allows for Increased Target Number and Specificity: Detection of Salmonella enterica and Six Species of Listeria in a Single Test	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; REAL-TIME PCR; RAPID IDENTIFICATION; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; POPULATION-DYNAMICS; BACTERIA; COMMUNITY; DIVERSITY; SEDIMENTS	A multiplex T-RFLP test was developed to detect and identify Salmonella enterica and all six species of Listeria inoculated into milk at minimal levels. Extensive in silico analysis was used to design a fifteen-primer, six-amplimer methodology and in vitro application showed target organism DNA, when amplified individually, yielded the predicted terminal restriction fragments (TRFs) following digestion. Non-target organisms were either not-amplified or yielded TRFs which did not interfere with target identification. Multiple target DNA analysis gave over 86% detection of total TRFs predicted, and this was improved to over 90% detection of total TRFs predicted when only two target DNA extracts were combined analysed. Co-inoculation of milk with five strains each of the target species of S. enterica and L. monocytogenes, along with five strains of the non-target species E. coli was followed by enrichment in SEL medium for M-TRFLP analysis. This allowed for detection of both target species in all samples, with detection of one S. enterica and two Listeria TRFs in all cases, and detection of a second S. enterica TRF in 91% of cases. This was from an initial inoculum of <5 cfu per 25 ml milk with a background of competing E. coli present, and gave a result from sampling of under 20 hours. The ability to increase target species number without loss of sensitivity means that extensive screening can be performed at reduced cost due to a reduction in the number of tests required.	[Elliott, Geoffrey N.; Thomas, Nadine; Campbell, Colin D.] James Hutton Inst, Aberdeen, Scotland; [MacRae, Marion; Ogden, Iain D.] Univ Aberdeen, Dept Med Microbiol, Aberdeen, Scotland; [Singh, Brajesh K.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Campbell, Colin D.] Swedish Univ Agr Sci, Dept Soil & Environm, Uppsala, Sweden	James Hutton Institute; University of Aberdeen; Western Sydney University; Swedish University of Agricultural Sciences	Elliott, GN (corresponding author), James Hutton Inst, Aberdeen, Scotland.	geoff.elliott@hutton.ac.uk	Singh, Brajesh/R-6321-2019; Elliott, Geoff/G-4485-2012; Campbell, Colin D/B-3944-2010	Singh, Brajesh/0000-0003-4413-4185; Campbell, Colin D/0000-0002-5163-7656; Elliott, Geoff/0000-0001-5853-2737	Scottish Enterprise Proof of Concept programme [8-FAD-003]; James Hutton Institute [8-FAD-003]	Scottish Enterprise Proof of Concept programme; James Hutton Institute	This work was jointly funded by the Scottish Enterprise Proof of Concept programme and the James Hutton Institute (formerly the Macaulay Institute) project 8-FAD-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 2009, ALIMENT PHARM THER, V29, P75, DOI 10.1111/j.1365-2036.2008.03860.x; Andronov EE, 2009, MICROBIOLOGY+, V78, P474, DOI 10.1134/S0026261709040110; AVANISSAGHAJANI E, 1994, BIOTECHNIQUES, V17, P144; AvanissAghajani E, 1996, J CLIN MICROBIOL, V34, P98, DOI 10.1128/JCM.34.1.98-102.1996; BAILEY JS, 1992, J FOOD PROTECT, V55, P256, DOI 10.4315/0362-028X-55.4.256; Braker G, 2001, APPL ENVIRON MICROB, V67, P1893, DOI 10.1128/AEM.67.4.1893-1901.2001; Brandal LT, 2007, J MICROBIOL METH, V68, P331, DOI 10.1016/j.mimet.2006.09.013; Bruce KD, 1997, APPL ENVIRON MICROB, V63, P4914, DOI 10.1128/AEM.63.12.4914-4919.1997; Christensen JE, 2003, J CLIN MICROBIOL, V41, P3790, DOI 10.1128/JCM.41.8.3790-3800.2003; Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0; Elizaquivel P, 2008, FOOD MICROBIOL, V25, P705, DOI 10.1016/j.fm.2008.03.002; European commission, 2005, OFFICIAL J EUR UNION, pL338; Hein I, 2006, J MICROBIOL METH, V66, P538, DOI 10.1016/j.mimet.2006.02.008; Hernandez SM, 1999, J CLIN MICROBIOL, V37, P3688, DOI 10.1128/JCM.37.11.3688-3692.1999; Hoorfar J, 2011, APMIS, V119, P1, DOI 10.1111/j.1600-0463.2011.02767.x; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kim HC, 2008, APPL ENVIRON MICROB, V74, P4853, DOI 10.1128/AEM.02756-07; Li XM, 2000, INT J FOOD MICROBIOL, V56, P167, DOI 10.1016/S0168-1605(99)00209-3; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; Marsh TL, 1999, CURR OPIN MICROBIOL, V2, P323, DOI 10.1016/S1369-5274(99)80056-3; Marsh TL, 2000, APPL ENVIRON MICROB, V66, P3616, DOI 10.1128/AEM.66.8.3616-3620.2000; Martin A, 2007, J MICROBIOL METH, V71, P39, DOI 10.1016/j.mimet.2007.07.008; McMahan L, 2011, APPL MICROBIOL BIOT, V92, P1287, DOI 10.1007/s00253-011-3520-z; Mitchell RJ, 2010, PLANT SOIL, V333, P417, DOI 10.1007/s11104-010-0357-7; Mukhopadhyay A, 2007, J MICROBIOL METH, V68, P193, DOI 10.1016/j.mimet.2006.07.009; Nam H M, 2004, Foodborne Pathog Dis, V1, P37, DOI 10.1089/153531404772914446; Nilsson WB, 2002, DIS AQUAT ORGAN, V48, P175, DOI 10.3354/dao048175; Nishizawa T, 2010, MICROBES ENVIRON, V25, P204, DOI 10.1264/jsme2.ME10108; Pandey J, 2007, J MICROBIOL METH, V68, P633, DOI 10.1016/j.mimet.2006.11.012; Rademaker JLW, 2006, INT DAIRY J, V16, P457, DOI 10.1016/j.idairyj.2005.05.009; Rantsiou K, 2008, INT J FOOD MICROBIOL, V121, P99, DOI 10.1016/j.ijfoodmicro.2007.11.006; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Singh B, 2012, United States Patent, Patent No. [8,133,676, 8133676]; Singh BK, 2007, APPL ENVIRON MICROB, V73, P5153, DOI 10.1128/AEM.00620-07; Singh BK, 2006, NAT PROTOC, V1, P2428, DOI 10.1038/nprot.2006.392; Singh BK, 2006, APPL ENVIRON MICROB, V72, P7278, DOI 10.1128/AEM.00510-06; Strategic Consulting Inc., 2008, FOOD MICRO2008 2013; Stres B., 2007, ACTA AGR SLOVENICA, V88, P65; Tom-Petersen A, 2003, FEMS MICROBIOL ECOL, V46, P53, DOI 10.1016/S0168-6496(03)00192-2; Vianna ME, 2009, ORAL MICROBIOL IMMUN, V24, P417, DOI 10.1111/j.1399-302X.2009.00539.x; von Felten A, 2011, J MICROBIOL METH, V84, P379, DOI 10.1016/j.mimet.2010.11.012; Wang M, 2009, J CLIN MICROBIOL, V47, P3178, DOI 10.1128/JCM.00366-09; Whang LM, 2009, WATER SCI TECHNOL, V59, P223, DOI 10.2166/wst.2009.848; Wierner D, 2011, INT J MED MICROBIOL, V301, P577; Yu M, 2009, J PLANT PATHOL, V91, P417; Zhou GP, 2011, INT J FOOD MICROBIOL, V145, P293, DOI 10.1016/j.ijfoodmicro.2011.01.014	47	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43672	10.1371/journal.pone.0043672	http://dx.doi.org/10.1371/journal.pone.0043672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937073	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500075
J	Vandevijvere, S; Amsalkhir, S; Van Oyen, H; Moreno-Reyes, R				Vandevijvere, Stefanie; Amsalkhir, Sihame; Van Oyen, Herman; Moreno-Reyes, Rodrigo			High Prevalence of Vitamin D Deficiency in Pregnant Women: A National Cross-Sectional Survey	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; ELDERLY-WOMEN; D INADEQUACY; RISK; BONE; PREVENTION; HEALTH; CANCER; SUPPLEMENTATION; PHOTOSYNTHESIS	An increasing number of studies suggest that vitamin D deficiency during pregnancy is associated with multiple adverse health outcomes in mothers, neonates and children. There are no representative country data available on vitamin D status of pregnant women in Europe. The aim of this study was to estimate the prevalence of vitamin D deficiency among Belgian pregnant women and to assess the determinants of vitamin D status in the first and third trimester of pregnancy. The women were selected via a multi-stage proportionate-to-size sampling design. Blood samples were collected and a questionnaire was completed face-to-face. 55 obstetric clinics were randomly selected and 1311 pregnant women participated in the study. The median serum 25-hydroxyvitamin D [25-(OH) D] concentration was significantly lower in the first trimester (20.4 ng/ml) than in third trimester (22.7 ng/ml). Of all women, 74.1% (95% CI = 71.8-76.5%) were vitamin D insufficient (25-(OH) D < 30 ng/ml), 44.6% (95% CI = 41.9-47.3%) were vitamin D deficient (25-(OH) D < 20 ng/ml), while 12.1% (95% CI = 10.3-13.8%) were severely vitamin D deficient (25-(OH) D < 10 ng/ml). Of all women included, 62.0% reported taking vitamin D-containing multivitamins, of which only 24.2% started taking those before pregnancy. The risk of vitamin D deficiency (25-(OH) D < 20 ng/ml) was significantly higher for less educated women and women who reported not going on holidays to sunny climates. The risk of severe vitamin D deficiency (25-(OH) D < 10 ng/ml) decreased for women who reported alcohol consumption during pregnancy, decreased with more frequent use of sunscreen lotion and increased for smokers and women who reported preference for shadow. In conclusion, vitamin D deficiency is highly prevalent among pregnant women in Belgium and this raises concerns about the health consequences for the mother and the offspring. A targeted screening strategy to detect and treat women at high risk of severe vitamin D deficiency is needed in Belgium and in Europe.	[Vandevijvere, Stefanie; Van Oyen, Herman] Sci Inst Publ Hlth, Dept Publ Hlth & Surveillance, Brussels, Belgium; [Amsalkhir, Sihame; Moreno-Reyes, Rodrigo] Univ Libre Bruxelles, Hop Erasme, Dept Nucl Med, Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Vandevijvere, S (corresponding author), Sci Inst Publ Hlth, Dept Publ Hlth & Surveillance, Brussels, Belgium.	stefanie.vandevijvere@wiv-isp.be		Van Oyen, Herman/0000-0003-2119-4433	Federal Public Service of Health, Food Chain Safety and Environment; Belgian Fonds de la Recherche Scientifique Medicale [3.4578.09]	Federal Public Service of Health, Food Chain Safety and Environment; Belgian Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS)	The survey was funded by the Federal Public Service of Health, Food Chain Safety and Environment. Rodrigo Moreno-Reyes received support of the Belgian Fonds de la Recherche Scientifique Medicale (Convention no. 3.4578.09). The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen R, 2005, EUR J CLIN NUTR, V59, P533, DOI 10.1038/sj.ejcn.1602108; Barrett H, 2010, BEST PRACT RES CL EN, V24, P527, DOI 10.1016/j.beem.2010.05.010; Bhan A, 2010, ENDOCRIN METAB CLIN, V39, P321, DOI 10.1016/j.ecl.2010.02.001; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Bodnar LM, 2009, J NUTR, V139, P1157, DOI 10.3945/jn.108.103168; BOUILLON RA, 1987, AM J CLIN NUTR, V45, P755, DOI 10.1093/ajcn/45.4.755; Brot C, 1999, EUR J CLIN NUTR, V53, P920, DOI 10.1038/sj.ejcn.1600870; CLEMENS TL, 1982, CLIN CHIM ACTA, V121, P301, DOI 10.1016/0009-8981(82)90239-X; Dijkstra SH, 2007, ARCH DIS CHILD, V92, P750, DOI 10.1136/adc.2006.105577; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dror DK, 2011, CURR OPIN OBSTET GYN, V23, P422, DOI 10.1097/GCO.0b013e32834cb791; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Farrerons J, 1998, BRIT J DERMATOL, V139, P422; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Goswami R, 2000, AM J CLIN NUTR, V72, P472; Grant WB, 2003, AM FAM PHYSICIAN, V67, P465; Grant WB, 2002, J INTERN MED, V252, P178, DOI 10.1046/j.1365-2796.2002.01016.x; Grant WB, 2005, ALTERN MED REV, V10, P94; Grant WB, 2011, BIOL RES NURS, V13, P120, DOI 10.1177/1099800410391243; Hensel KJ, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.013; Hill T R, 2006, Ir Med J, V99, P48; Hill TR, 2008, BRIT J NUTR, V99, P1061, DOI 10.1017/S0007114507842826; Hintzpeter B, 2008, EUR J CLIN NUTR, V62, P1079, DOI 10.1038/sj.ejcn.1602825; Hintzpeter B, 2008, J NUTR, V138, P1482, DOI 10.1093/jn/138.8.1482; Hirani V, 2005, AGE AGEING, V34, P485, DOI 10.1093/ageing/afi153; Hoge Gezondheidsraad, 2009, VOED BELG HERZ 2009; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; HOLICK MF, 1981, J INVEST DERMATOL, V77, P51, DOI 10.1111/1523-1747.ep12479237; HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holick MF, 2010, ENDOCRIN METAB CLIN, V39, P381, DOI [10.1016/j.rdc.2012.03.013, 10.1016/j.ecl.2010.02.016]; Hollis BW, 2007, J BONE MINER RES, V22, pV39, DOI 10.1359/JBMR.07S215; Huybrechts I, 2011, EUR J CLIN NUTR, V65, P1039, DOI 10.1038/ejcn.2011.71; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Jackson C, 2007, QJM-INT J MED, V100, P185, DOI 10.1093/qjmed/hcm005; Jacques PF, 1997, AM J CLIN NUTR, V66, P929, DOI 10.1093/ajcn/66.4.929; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lee K, 2012, NUTR RES PRACT, V6, P86, DOI 10.4162/nrp.2012.6.1.86; Lips P, 2011, BEST PRACT RES CL EN, V25, P585, DOI 10.1016/j.beem.2011.05.002; Lucas RM, 2008, NUTR REV, V66, P710, DOI 10.1111/j.1753-4887.2008.00126.x; Martini LA, 2006, NUTR REV, V64, P479, DOI 10.1111/j.1753-4887.2006.tb00180.x; MCKENNA MJ, 1992, AM J MED, V93, P69, DOI 10.1016/0002-9343(92)90682-2; Milman N, 2012, J PERINAT MED, V40, P57, DOI 10.1515/JPM.2011.120; Moreno-Reyes R, 2009, EUR J NUTR, V48, P31, DOI 10.1007/s00394-008-0756-1; NEED AG, 1993, AM J CLIN NUTR, V58, P882, DOI 10.1093/ajcn/58.6.882; Neuprez A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-64; OOMS ME, 1995, J CLIN ENDOCR METAB, V80, P1052, DOI 10.1210/jc.80.4.1052; Pettifor JM, 2011, BEST PRACT RES CL EN, V25, P573, DOI 10.1016/j.beem.2011.06.010; Sullivan KM, 2000, URINARY IODINE ASSES; Valimaki VV, 2004, J CLIN ENDOCR METAB, V89, P76, DOI 10.1210/jc.2003-030817; van der Meer IM, 2011, OSTEOPOROSIS INT, V22, P1009, DOI 10.1007/s00198-010-1279-1; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; van der Sluis IM, 2002, HORM RES, V57, P170, DOI 10.1159/000058378; Webb AR, 2006, PHOTOCHEM PHOTOBIOL, V82, P1697, DOI 10.1562/2006-09-01-RA-670; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Zittermann A, 2003, BRIT J NUTR, V89, P552, DOI 10.1079/BJN2003837	58	92	97	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43868	10.1371/journal.pone.0043868	http://dx.doi.org/10.1371/journal.pone.0043868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937114	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500116
J	Choi, YJ; Park, YJ; Park, JY; Jeong, HO; Kim, DH; Ha, YM; Kim, JM; Song, YM; Heo, HS; Yu, BP; Chun, P; Moon, HR; Chung, HY				Choi, Yeon Ja; Park, Yun Jung; Park, Ji Young; Jeong, Hyoung Oh; Kim, Dae Hyun; Ha, Young Mi; Kim, Ji Min; Song, Yu Min; Heo, Hyoung-Sam; Yu, Byung Pal; Chun, Pusoon; Moon, Hyung Ryong; Chung, Hae Young			Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion	PLOS ONE			English	Article							CELL-DEATH; PROTEIN-DEGRADATION; SIGNALING PATHWAYS; ARPE-19 CELLS; GLIOMA-CELLS; CHLOROQUINE; MACROAUTOPHAGY; ACCUMULATION; INDUCTION; TRIAZINES	Autophagy is a major degradative process responsible for the disposal of cytoplasmic proteins and dysfunctional organelles via the lysosomal pathway. During the autophagic process, cells form double-membraned vesicles called autophagosomes that sequester disposable materials in the cytoplasm and finally fuse with lysosomes. In the present study, we investigated the inhibition of autophagy by a synthesized compound, MHY1485, in a culture system by using Ac2F rat hepatocytes. Autophagic flux was measured to evaluate the autophagic activity. Autophagosomes were visualized in Ac2F cells transfected with AdGFP-LC3 by live-cell confocal microscopy. In addition, activity of mTOR, a major regulatory protein of autophagy, was assessed by western blot and docking simulation using AutoDock 4.2. In the result, treatment with MHY1485 suppressed the basal autophagic flux, and this inhibitory effect was clearly confirmed in cells under starvation, a strong physiological inducer of autophagy. The levels of p62 and beclin-1 did not show significant change after treatment with MHY1485. Decreased co-localization of autophagosomes and lysosomes in confocal microscopic images revealed the inhibitory effect of MHY1485 on lysosomal fusion during starvation-induced autophagy. These effects of MHY1485 led to the accumulation of LC3II and enlargement of the autophagosomes in a dose-and time-dependent manner. Furthermore, MHY1485 induced mTOR activation and correspondingly showed a higher docking score than PP242, a well-known ATP-competitive mTOR inhibitor, in docking simulation. In conclusion, MHY1485 has an inhibitory effect on the autophagic process by inhibition of fusion between autophagosomes and lysosomes leading to the accumulation of LC3II protein and enlarged autophagosomes. MHY1485 also induces mTOR activity, providing a possibility for another regulatory mechanism of autophagy by the MHY compound. The significance of this study is the finding of a novel inhibitor of autophagy with an mTOR activating effect.	[Choi, Yeon Ja; Jeong, Hyoung Oh; Kim, Dae Hyun; Ha, Young Mi; Kim, Ji Min; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan, South Korea; [Park, Yun Jung; Park, Ji Young; Song, Yu Min; Moon, Hyung Ryong] Pusan Natl Univ, Coll Pharm, Med Chem Lab, Pusan, South Korea; [Heo, Hyoung-Sam] KRIBB, Plant Syst Engn Ctr, Taejon, South Korea; [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Chun, Pusoon] Inje Univ, Coll Pharm, Gimhae, Gyeongnam, South Korea	Pusan National University; Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Texas System; University of Texas Health San Antonio; Inje University	Choi, YJ (corresponding author), Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan, South Korea.	mhr108@pusan.ac.kr; hyjung@pusan.ac.kr			National Research Foundation of Korea (NRF); Korean government (MEST) [2009-0083538]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2009-0083538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, BIOORG MED CHEM LETT, V15, P531, DOI 10.1016/j.bmcl.2004.11.052; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Chen PM, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-10; Cho YS, 2010, ARCH PHARM RES, V33, P1881, DOI 10.1007/s12272-010-1201-6; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hiruma H, 2011, FOLIA HISTOCHEM CYTO, V49, P272, DOI 10.5603/FHC.2011.0038; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Kolmakov KA, 2008, J HETEROCYCLIC CHEM, V45, P1215, DOI 10.1002/jhet.5570450446; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Oh M, 2008, BIOCHEM BIOPH RES CO, V369, P1179, DOI 10.1016/j.bbrc.2008.03.019; Pous C, 2011, NAT CELL BIOL, V13, P342, DOI 10.1038/ncb0411-342; Ramser B, 2009, J INVEST DERMATOL, V129, P2419, DOI 10.1038/jid.2009.80; Richard DJ, 2010, BIOORG MED CHEM LETT, V20, P2654, DOI 10.1016/j.bmcl.2010.02.029; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Salminen A, 2009, TRENDS MOL MED, V15, P217, DOI 10.1016/j.molmed.2009.03.004; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005; Wang XM, 2011, J MOL CELL BIOL, V3, P206, DOI 10.1093/jmcb/mjq038; Wang Yao, 2011, Chin J Cancer, V30, P690, DOI 10.5732/cjc.011.10056; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yuk JM, 2012, EXP MOL MED, V44, P99, DOI 10.3858/emm.2012.44.2.032; Zask A, 2010, BIOORG MED CHEM LETT, V20, P2644, DOI 10.1016/j.bmcl.2010.02.045; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	155	159	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43418	10.1371/journal.pone.0043418	http://dx.doi.org/10.1371/journal.pone.0043418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927967	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300051
J	Fieseler, L; Schmitter, S; Teiserskas, J; Loessner, MJ				Fieseler, Lars; Schmitter, Sibylle; Teiserskas, Justinas; Loessner, Martin J.			Rhamnose-Inducible Gene Expression in Listeria monocytogenes	PLOS ONE			English	Article							ESCHERICHIA-COLI; AUTO-REGULATION; MECHANISM; INFECTION; DELIVERY; VECTOR; CELLS; COMPLEMENTATION; DIFFERENTIATION; CONSTRUCTION	Acid production from rhamnose is a characteristic phenotype of Listeria monocytogenes. We report the identification of the rhamnose transport and utilization operon located at lmo2846 to lmo2851, including the rhamnose-dependent promoter P-rha. Expression of reporter genes under control of P-rha on a single copy integration vector demonstrated its suitability for inducible gene expression in L. monocytogenes. Transcription initiation from P-rha is dose dependent, and a concentration as low as 100 mu M rhamnose was found sufficient for induction. Moreover, P-rha is subject to glucose catabolite repression, which provides additional options for strict control of expression. Infection of human THP1 macrophages revealed that P-rha is repressed in intracellular L. monocytogenes, which is explained by the absence of rhamnose in the cytosol and possible interference by catabolite repression. The P-rha promoter provides a novel and useful tool for triggering gene expression in extracellular L. monocytogenes, whereas intracellular conditions prevent transcription from this promoter.	[Fieseler, Lars; Schmitter, Sibylle; Teiserskas, Justinas; Loessner, Martin J.] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Fieseler, L (corresponding author), Zurich Univ Appl Sci, Inst Food & Beverage Innovat, Wadenswil, Switzerland.	martin.loessner@ethz.ch	Teišerskas, Justinas/AAE-2795-2020; Loessner, Martin J/B-4316-2012	Loessner, Martin J/0000-0002-8162-2631; Teiserskas, Justinas/0000-0002-8314-8865	Feodor-Lynen Research Fellowship of the Alexander von Humboldt Foundation, Bonn, Germany; ETH Zurich	Feodor-Lynen Research Fellowship of the Alexander von Humboldt Foundation, Bonn, Germany; ETH Zurich(ETH Zurich)	LF was financially supported by a Feodor-Lynen Research Fellowship of the Alexander von Humboldt Foundation, Bonn, Germany, and JT was enrolled in the Biology Undergraduate Summer School (BUSS) at ETH Zurich and University of Zurich. This study was funded by resources from ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Allerberger F, 2003, FEMS IMMUNOL MED MIC, V35, P183, DOI 10.1016/S0928-8244(02)00447-9; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bhavsar AP, 2001, APPL ENVIRON MICROB, V67, P403, DOI 10.1128/AEM.67.1.403-410.2001; Bockmann R, 1996, MOL MICROBIOL, V22, P643, DOI 10.1046/j.1365-2958.1996.d01-1722.x; Brewster DR, 1997, ARCH DIS CHILD, V76, P236, DOI 10.1136/adc.76.3.236; Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Dancz CE, 2002, J BACTERIOL, V184, P5935, DOI 10.1128/JB.184.21.5935-5945.2002; Dietrich G, 1998, NAT BIOTECHNOL, V16, P181, DOI 10.1038/nbt0298-181; EGAN SM, 1993, J MOL BIOL, V234, P87, DOI 10.1006/jmbi.1993.1565; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Glaser P, 2001, SCIENCE, V294, P849; Gopal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010349; Graves LM, 2009, INT J SYST EVOL MICR; Grundling A, 2004, P NATL ACAD SCI USA, V101, P12318, DOI 10.1073/pnas.0404924101; Hagens S, 2007, APPL MICROBIOL BIOT, V76, P513, DOI 10.1007/s00253-007-1031-8; Korndorfer IP, 2000, J MOL BIOL, V300, P917, DOI 10.1006/jmbi.2000.3896; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; LEE NL, 1981, P NATL ACAD SCI-BIOL, V78, P752, DOI 10.1073/pnas.78.2.752; MIYADA CG, 1984, P NATL ACAD SCI-BIOL, V81, P4120, DOI 10.1073/pnas.81.13.4120; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Monk IR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-96; MORALEJO P, 1993, J BACTERIOL, V175, P5585, DOI 10.1128/JB.175.17.5585-5594.1993; MUIRY JAR, 1993, BIOCHEM J, V290, P833, DOI 10.1042/bj2900833; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Pilgrim S, 2003, GENE THER, V10, P2036, DOI 10.1038/sj.gt.3302105; Prabhu P, 2010, APPL MICROBIOL BIOTE; Shahabi V, 2011, CANCER GENE THER, V18, P53, DOI 10.1038/cgt.2010.48; Soussi N, 2000, INFECT IMMUN, V68, P1498, DOI 10.1128/IAI.68.3.1498-1506.2000; Wallecha A, 2009, CLIN VACCINE IMMUNOL, V16, P96, DOI 10.1128/CVI.00274-08; Wegerer A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-2; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Xue JF, 2008, APPL ENVIRON MICROB, V74, P7073, DOI 10.1128/AEM.01074-08; Yoshida H, 2010, FEBS J, V277, P1045, DOI 10.1111/j.1742-4658.2009.07548.x; Yoshimura K, 2006, CANCER RES, V66, P1096, DOI 10.1158/0008-5472.CAN-05-2307	37	9	9	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43444	10.1371/journal.pone.0043444	http://dx.doi.org/10.1371/journal.pone.0043444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927968	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300052
J	Hervera, A; Leanez, S; Negrete, R; Motterlini, R; Pol, O				Hervera, Arnau; Leanez, Sergi; Negrete, Roger; Motterlini, Roberto; Pol, Olga			Carbon Monoxide Reduces Neuropathic Pain and Spinal Microglial Activation by Inhibiting Nitric Oxide Synthesis in Mice	PLOS ONE			English	Article							HEME OXYGENASE-1; TACTILE ALLODYNIA; FORMALIN TEST; UP-REGULATION; NERVE INJURY; RAT; MODEL; MOLECULE; HYPERALGESIA; DEGRADATION	Background: Carbon monoxide (CO) synthesized by heme oxygenase 1 (HO-1) exerts antinociceptive effects during inflammation but its role during neuropathic pain remains unknown. Our objective is to investigate the exact contribution of CO derived from HO-1 in the modulation of neuropathic pain and the mechanisms implicated. Methodology/Principal Findings: We evaluated the antiallodynic and antihyperalgesic effects of CO following sciatic nerve injury in wild type (WT) or inducible nitric oxide synthase knockout (NOS2-KO) mice using two carbon monoxide-releasing molecules (CORM-2 and CORM-3) and an HO-1 inducer (cobalt protoporphyrin IX, CoPP) daily administered from days 10 to 20 after injury. The effects of CORM-2 and CoPP on the expression of HO-1, heme oxygenase 2 (HO-2), neuronal nitric oxide synthase (NOS1) and NOS2 as well as a microglial marker (CD11b/c) were also assessed at day 20 after surgery in WT and NOS2-KO mice. In WT mice, the main neuropathic pain symptoms induced by nerve injury were significantly reduced in a time-dependent manner by treatment with CO-RMs or CoPP. Both CORM-2 and CoPP treatments increased HO-1 expression in WT mice, but only CoPP stimulated HO-1 in NOS2-KO animals. The increased expression of HO-2 induced by nerve injury in WT, but not in NOS2-KO mice, remains unaltered by CORM-2 or CoPP treatments. In contrast, the overexpression of CD11b/c, NOS1 and NOS2 induced by nerve injury in WT, but not in NOS2-KO mice, were significantly decreased by both CORM-2 and CoPP treatments. These data indicate that CO alleviates neuropathic pain through the reduction of spinal microglial activation and NOS1/NOS2 over-expression. Conclusions/Significance: This study reports that an interaction between the CO and nitric oxide (NO) systems is taking place following sciatic nerve injury and reveals that increasing the exogenous (CO-RMs) or endogenous (CoPP) production of CO may represent a novel strategy for the treatment of neuropathic pain.	[Hervera, Arnau; Leanez, Sergi; Negrete, Roger; Pol, Olga] Univ Autonoma Barcelona, Grp Neurofarmacol Mol, Inst Invest Biomed St Pau, E-08193 Barcelona, Spain; [Hervera, Arnau; Leanez, Sergi; Negrete, Roger; Pol, Olga] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Motterlini, Roberto] Univ Paris Est, INSERM, U955, Equipe 3,Fac Med, Creteil, France	Autonomous University of Barcelona; Autonomous University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Hervera, A (corresponding author), Univ Autonoma Barcelona, Grp Neurofarmacol Mol, Inst Invest Biomed St Pau, E-08193 Barcelona, Spain.	opol@santpau.es	Motterlini, Roberto/Q-1890-2019; Motterlini, Roberto/G-2489-2013; abad, Arnau Hervera/V-5435-2017; Pol, Olga/O-2146-2019	Motterlini, Roberto/0000-0003-2684-2612; Motterlini, Roberto/0000-0003-2684-2612; abad, Arnau Hervera/0000-0001-8362-369X; Pol, Olga/0000-0002-4621-8457	Fundacio La Marato de TV3 Barcelona [070810]; Fondo de Investigacion Sanitaria, Madrid, Spain [PS0900968]	Fundacio La Marato de TV3 Barcelona; Fondo de Investigacion Sanitaria, Madrid, Spain(Instituto de Salud Carlos III)	This work was supported by the Fundacio La Marato de TV3 Barcelona [Grant: 070810] and Fondo de Investigacion Sanitaria, Madrid [Grant: PS0900968], Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz MJ, 2000, BRIT J PHARMACOL, V130, P57, DOI 10.1038/sj.bjp.0703281; Bani-Hani Mohamed G, 2006, Pharmacol Rep, V58 Suppl, P132; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; De Alba J, 2006, PAIN, V120, P170, DOI 10.1016/j.pain.2005.10.028; Devesa I, 2005, ARTHRITIS RHEUM-US, V52, P3230, DOI 10.1002/art.21356; Fan WG, 2011, J NEUROSCI RES, V89, P802, DOI 10.1002/jnr.22613; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Gordh T, 2000, AMINO ACIDS, V19, P373, DOI 10.1007/s007260070068; Guillen MI, 2008, RHEUMATOLOGY, V47, P1323, DOI 10.1093/rheumatology/ken264; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014321; Hervera A, 2010, J PHARMACOL EXP THER, V334, P887, DOI 10.1124/jpet.110.167585; KIM YM, 1995, J BIOL CHEM, V270, P5710, DOI 10.1074/jbc.270.11.5710; Kuboyama K, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-50; LaBuda CJ, 2006, EUR J PAIN, V10, P505, DOI 10.1016/j.ejpain.2005.07.004; Lee SK, 2007, CANCER LETT, V249, P283, DOI 10.1016/j.canlet.2006.09.012; Levy D, 1998, EUR J NEUROSCI, V10, P1846, DOI 10.1046/j.1460-9568.1998.00186.x; Li XQ, 2003, J PAIN, V4, P101, DOI 10.1054/jpai.2003.18; Li XQ, 2000, ANESTH ANALG, V90, P677, DOI 10.1097/00000539-200003000-00031; Maicas N, 2010, EUR J PHARMACOL, V634, P184, DOI 10.1016/j.ejphar.2010.02.028; Megias J, 2009, BIOCHEM PHARMACOL, V77, P1806, DOI 10.1016/j.bcp.2009.03.009; MELLER ST, 1992, NEUROSCIENCE, V50, P7, DOI 10.1016/0306-4522(92)90377-E; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Naik AK, 2006, EUR J PHARMACOL, V530, P59, DOI 10.1016/j.ejphar.2005.11.029; Nascimento CGO, 2007, EUR J PHARMACOL, V556, P55, DOI 10.1016/j.ejphar.2006.10.009; Rosa AO, 2008, PAIN, V137, P332, DOI 10.1016/j.pain.2007.09.015; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Schmidtko A, 2008, J NEUROSCI, V28, P8568, DOI 10.1523/JNEUROSCI.2128-08.2008; Steiner AA, 2001, BRIT J PHARMACOL, V132, P1673, DOI 10.1038/sj.bjp.0704014; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wilkinson WJ, 2011, PURINERG SIGNAL, V7, P57, DOI 10.1007/s11302-010-9213-8	37	61	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43693	10.1371/journal.pone.0043693	http://dx.doi.org/10.1371/journal.pone.0043693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928017	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300082
J	Kaiyala, KJ; Morton, GJ; Thaler, JP; Meek, TH; Tylee, T; Ogimoto, K; Wisse, BE				Kaiyala, Karl J.; Morton, Gregory J.; Thaler, Joshua P.; Meek, Thomas H.; Tylee, Tracy; Ogimoto, Kayoko; Wisse, Brent E.			Acutely Decreased Thermoregulatory Energy Expenditure or Decreased Activity Energy Expenditure Both Acutely Reduce Food Intake in Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; DIET-INDUCED THERMOGENESIS; LOCOMOTOR-ACTIVITY; RUNNING WHEEL; TEMPERATURE; HOMEOSTASIS; OBESITY; LEPTIN; MOUSE; COLD	Despite the suggestion that reduced energy expenditure may be a key contributor to the obesity pandemic, few studies have tested whether acutely reduced energy expenditure is associated with a compensatory reduction in food intake. The homeostatic mechanisms that control food intake and energy expenditure remain controversial and are thought to act over days to weeks. We evaluated food intake in mice using two models of acutely decreased energy expenditure: 1) increasing ambient temperature to thermoneutrality in mice acclimated to standard laboratory temperature or 2) exercise cessation in mice accustomed to wheel running. Increasing ambient temperature (from 21 degrees C to 28 degrees C) rapidly decreased energy expenditure, demonstrating that thermoregulatory energy expenditure contributes to both light cycle (40 +/- 1%) and dark cycle energy expenditure (15 +/- 3%) at normal ambient temperature (21 degrees C). Reducing thermoregulatory energy expenditure acutely decreased food intake primarily during the light cycle (65 +/- 7%), thus conflicting with the delayed compensation model, but did not alter spontaneous activity. Acute exercise cessation decreased energy expenditure only during the dark cycle (14 +/- 2% at 21 degrees C; 21 +/- 4% at 28 degrees C), while food intake was reduced during the dark cycle (0.9 +/- 0.1 g) in mice housed at 28 degrees C, but during the light cycle (0.3 +/- 0.1 g) in mice housed at 21 degrees C. Cumulatively, there was a strong correlation between the change in daily energy expenditure and the change in daily food intake (R-2 = 0.51, p<0.01). We conclude that acutely decreased energy expenditure decreases food intake suggesting that energy intake is regulated by metabolic signals that respond rapidly and accurately to reduced energy expenditure.	[Kaiyala, Karl J.] Univ Washington, Dept Dent, Seattle, WA 98195 USA; [Morton, Gregory J.; Thaler, Joshua P.; Meek, Thomas H.; Tylee, Tracy; Ogimoto, Kayoko; Wisse, Brent E.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaiyala, KJ (corresponding author), Univ Washington, Dept Dent, Seattle, WA 98195 USA.	bewisse@u.washington.edu			National Institutes of Health [DK071784]; Clinical Nutrition and Research Unit [P30DK035816]; Diabetes Endocrinology Research Center at the University of Washington [P30DK17047]; Seattle Metabolic Mouse Phenotyping Core (MMPC) [U24 DK076126]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076126, T32DK007247, F32DK097859, R01DK089056, P30DK017047, R01DK074758, P30DK035816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition and Research Unit; Diabetes Endocrinology Research Center at the University of Washington; Seattle Metabolic Mouse Phenotyping Core (MMPC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health to BEW (DK071784), the Clinical Nutrition and Research Unit (P30DK035816) and the Diabetes Endocrinology Research Center (P30DK17047) at the University of Washington, and the Seattle Metabolic Mouse Phenotyping Core (MMPC, U24 DK076126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; BROBECK JR, 1948, YALE J BIOL MED, V20, P545; Cabanac M, 2001, INT J OBESITY, V25, pS7, DOI 10.1038/sj.ijo.0801904; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Castaneda TR, 2005, J NUTR, V135, P1314, DOI 10.1093/jn/135.5.1314; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; EDHOLM OG, 1955, BRIT J NUTR, V9, P286, DOI 10.1079/BJN19550040; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; GIRARDIER L, 1995, J PHYSIOL-LONDON, V488, P779, DOI 10.1113/jphysiol.1995.sp021009; GORDON CJ, 1985, PHYSIOL BEHAV, V34, P687, DOI 10.1016/0031-9384(85)90365-8; HAMILTON CL, 1963, J COMP PHYSIOL PSYCH, V56, P476, DOI 10.1037/h0046241; Harri M, 1999, LAB ANIM SCI, V49, P401; HIMMSHAGEN J, 1978, BIOCHEM BIOPH RES CO, V83, P628, DOI 10.1016/0006-291X(78)91036-7; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; JAKUBCZAK LF, 1976, PHYSIOL BEHAV, V17, P251, DOI 10.1016/0031-9384(76)90073-1; Jung AP, 2010, MED SCI SPORT EXER, V42, P355, DOI 10.1249/MSS.0b013e3181a6d88f; Jurgens HS, 2006, PHYSIOL GENOMICS, V25, P234, DOI 10.1152/physiolgenomics.00252.2005; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Leon LR, 2005, AM J PHYSIOL-REG I, V288, pR197, DOI 10.1152/ajpregu.00046.2004; Levitsky DA, 2005, PHYSIOL BEHAV, V86, P623, DOI 10.1016/j.physbeh.2005.08.053; Lighton JRB, 2008, J EXP BIOL, V211, P563, DOI 10.1242/jeb.010041; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; Marrif H, 2005, ENDOCRINOLOGY, V146, P2872, DOI 10.1210/en.2004-1544; Melnyk A, 1997, AM J PHYSIOL-REG I, V272, pR1088, DOI 10.1152/ajpregu.1997.272.4.R1088; Melnyk A, 1998, AM J PHYSIOL-REG I, V274, pR1131, DOI 10.1152/ajpregu.1998.274.4.R1131; Mesaros A, 2008, CELL METAB, V7, P236, DOI 10.1016/j.cmet.2008.01.007; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; Murgatroyd PR, 1999, INT J OBESITY, V23, P1269, DOI 10.1038/sj.ijo.0801062; Nehrenberg DL, 2009, OBESITY, V17, P1402, DOI 10.1038/oby.2009.51; Nogueiras R, 2008, ENDOCRINOLOGY, V149, P3009, DOI 10.1210/en.2007-1684; Novak CM, 2007, J NEUROENDOCRINOL, V19, P923, DOI 10.1111/j.1365-2826.2007.01606.x; Novak CM, 2010, HORM BEHAV, V58, P355, DOI 10.1016/j.yhbeh.2010.03.013; Overton JM, 2011, INT J OBES LOND S2, V34, pS53; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; ROTHWELL NJ, 1986, BRIT J NUTR, V56, P123, DOI 10.1079/BJN19860092; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; Seeley RJ, 1996, AM J PHYSIOL-REG I, V271, pR819, DOI 10.1152/ajpregu.1996.271.3.R819; Sims E A, 1973, Recent Prog Horm Res, V29, P457; Speakman JR, 2011, DIS MODEL MECH, V4, P733, DOI 10.1242/dmm.008698; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; THORNE A, 1990, ACTA CHIR SCAND, P6; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Uceyler N, 2011, INT J OBES LOND, V34, P701; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; Westerterp KR, 2010, NUTR REV, V68, P148, DOI 10.1111/j.1753-4887.2010.00270.x; Williams TD, 2002, AM J PHYSIOL-REG I, V282, pR1459, DOI 10.1152/ajpregu.00612.2001; Wisse BE, 2006, PEPTIDES, V27, P265, DOI 10.1016/j.peptides.2005.08.020; WRIGHT GL, 1976, J APPL PHYSIOL, V40, P683, DOI 10.1152/jappl.1976.40.5.683; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com	58	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41473	10.1371/journal.pone.0041473	http://dx.doi.org/10.1371/journal.pone.0041473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936977	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300008
J	Malenke, JR; Magnanou, E; Thomas, K; Dearing, MD				Malenke, Jael R.; Magnanou, Elodie; Thomas, Kirk; Dearing, M. Denise			Cytochrome P450 2B Diversity and Dietary Novelty in the Herbivorous, Desert Woodrat (Neotoma lepida)	PLOS ONE			English	Article							SUBSTRATE RECOGNITION SITES; P4502B4 ACTIVE-SITE; AMINO-ACID; DIRECTED MUTAGENESIS; LARREA-TRIDENTATA; MOLECULAR-BASIS; EVOLUTION; GENE; ENZYMES; SPECIFICITY	Detoxification enzymes play a key role in plant-herbivore interactions, contributing to the on-going evolution of ecosystem functional diversity. Mammalian detoxification systems have been well studied by the medical and pharmacological industries to understand human drug metabolism; however, little is known of the mechanisms employed by wild herbivores to metabolize toxic plant secondary compounds. Using a wild rodent herbivore, the desert woodrat (Neotoma lepida), we investigated genomic structural variation, sequence variability, and expression patterns in a multigene subfamily involved in xenobiotic metabolism, cytochrome P450 2B (CYP2B). We hypothesized that differences in CYP2B expression and sequence diversity could explain differential abilities of woodrat populations to consume native plant toxins. Woodrats from two distinct populations were fed diets supplemented with either juniper (Juniperus osteosperma) or creosote bush (Larrea tridentata), plants consumed by woodrats in their respective desert habitats. We used Southern blot and quantitative PCR to determine that the genomic copy number of CYP2B in both populations was equivalent, and similar in number to known rodent copy number. We compared CYP2B expression patterns and sequence diversity using cloned hepatic CYP2B cDNA. The resulting sequences were very diverse, and clustered into four major clades by amino acid similarity. Sequences from the experimental treatments were distributed non-randomly across a CYP2B tree, indicating unique expression patterns from woodrats on different diets and from different habitats. Furthermore, within each major CYP2B clade, sequences shared a unique combination of amino acid residues at 13 sites throughout the protein known to be important for CYP2B enzyme function, implying differences in the function of each major CYP2B variant. This work is the most comprehensive investigation of the genetic diversity of a detoxification enzyme subfamily in a wild mammalian herbivore, and contributes an initial genetic framework to our understanding of how a wild herbivore responds to critical changes in its diet.	[Malenke, Jael R.; Magnanou, Elodie; Dearing, M. Denise] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Magnanou, Elodie] Univ Paris 06, Lab ARAGO, Banyuls Sur Mer, France; [Magnanou, Elodie] Ctr Natl Rech Sci, Banyuls Sur Mer, France; [Thomas, Kirk] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Utah System of Higher Education; University of Utah	Malenke, JR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	malenke@biology.utah.edu		Magnanou, Elodie/0000-0002-8375-9682	NSF [IOS 0817527]; Direct For Biological Sciences [0817527] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this project was provided by an NSF (http://www.nsf.gov/) grant (IOS 0817527) to MDD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ADAMS RP, 1981, BIOCHEM SYST ECOL, V9, P93, DOI 10.1016/0305-1978(81)90025-9; Al-Omari A, 2007, J PHARM PRACT, V20, P206, DOI DOI 10.1177/0897190007304821; Babik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-390; Baker ME, 2005, INTEGR COMP BIOL, V45, P172, DOI 10.1093/icb/45.1.172; Bodin L, 2005, J BIOMED BIOTECHNOL, P248, DOI 10.1155/JBB.2005.248; Daly AK, 1998, TOXICOL LETT, V103, P143, DOI 10.1016/S0378-4274(98)00299-9; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond A., 2011, GENEIOUS V5 5; El-Merhibi A., 2007, Australasian Journal of Ecotoxicology, V13, P53; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; Gonzalez-Duarte R, 2005, HEREDITY, V95, P184, DOI 10.1038/sj.hdy.6800723; GOTOH O, 1992, J BIOL CHEM, V267, P83; GOTOH O, 1994, CYTOCHROME P450, P279; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Haley SL, 2008, PHYSIOL BIOCHEM ZOOL, V81, P584, DOI 10.1086/589951; HALPERT JR, 1993, J BIOL CHEM, V268, P4453; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; HASLER JA, 1994, MOL PHARMACOL, V46, P338; HE YA, 1992, BIOCHEMISTRY-US, V31, P9220, DOI 10.1021/bi00153a015; HE YA, 1994, BIOCHEMISTRY-US, V33, P4419, DOI 10.1021/bi00180a040; HE YQ, 1995, CHEM RES TOXICOL, V8, P574, DOI 10.1021/tx00046a011; Hernandez CE, 2006, ARCH BIOCHEM BIOPHYS, V455, P61, DOI 10.1016/j.abb.2006.08.024; Hu SY, 2008, GENETICA, V133, P215, DOI 10.1007/s10709-007-9206-x; Hunter KL, 2001, GLOBAL ECOL BIOGEOGR, V10, P521, DOI 10.1046/j.1466-822X.2001.00254.x; Ingelman-Sundberg M, 1999, TRENDS PHARMACOL SCI, V20, P342, DOI 10.1016/S0165-6147(99)01363-2; Jinno H, 2003, DRUG METAB DISPOS, V31, P398, DOI 10.1124/dmd.31.4.398; KARASOV WH, 1989, PHYSIOL ZOOL, V62, P1351, DOI 10.1086/physzool.62.6.30156217; KEDZIE KM, 1991, J BIOL CHEM, V266, P22515; Kirischian N, 2011, J MOL EVOL, V72, P56, DOI 10.1007/s00239-010-9402-7; KLAASSEN CD, 2001, CARARETT DOULLS TOXI; Kobayashi Y, 1998, BIOCHEMISTRY-US, V37, P6679, DOI 10.1021/bi9731450; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lamb JG, 2001, J CHEM ECOL, V27, P845, DOI 10.1023/A:1010366322299; Lamba JK, 2002, PHARMACOGENETICS, V12, P121, DOI 10.1097/00008571-200203000-00006; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Ma Q, 2008, CURR DRUG METAB, V9, P374, DOI 10.2174/138920008784746337; Mabry T.J., 1977, CREOSOTE BUSH BIOL C, P115; Magnanou E, 2009, MOL ECOL, V18, P2401, DOI 10.1111/j.1365-294X.2009.04171.x; Mangione AM, 2004, J CHEM ECOL, V30, P1409, DOI 10.1023/B:JOEC.0000037748.19927.a1; Mangione AM, 2001, J CHEM ECOL, V27, P2559, DOI 10.1023/A:1013639817958; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Muralidhara BK, 2008, J MOL BIOL, V377, P232, DOI 10.1016/j.jmb.2007.12.068; NEBERT DW, 1989, XENOBIOTICA, V19, P1149, DOI 10.3109/00498258909043167; Nelson David R., 2009, Human Genomics, V4, P59; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; NELSON DR, 1987, MOL BIOL EVOL, V4, P572; Ngo S, 2000, COMP BIOCHEM PHYS C, V127, P327, DOI 10.1016/S0742-8413(00)00160-2; Ohta T, 2000, GENE, V259, P45, DOI 10.1016/S0378-1119(00)00428-5; Patton J.L., 2008, EVOLUTIONARY HIST SY, V135; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Sachse C, 1997, AM J HUM GENET, V60, P284; Spatzenegger M, 2001, MOL PHARMACOL, V59, P475, DOI 10.1124/mol.59.3.475; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Stupans I, 1999, COMP BIOCHEM PHYS C, V123, P67, DOI 10.1016/S0742-8413(99)00012-2; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; SZKLARZ GD, 1995, BIOCHEMISTRY-US, V34, P14312, DOI 10.1021/bi00044a008; Szklarz GD, 1996, ARCH BIOCHEM BIOPHYS, V327, P308, DOI 10.1006/abbi.1996.0127; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Van Devender T.R., 1990, PACKRAT MIDDENS LAST, P104; Watanabe T, 2010, PHARMACOGENET GENOM, V20, P459, DOI 10.1097/FPC.0b013e32833bba0e; Wen ZM, 2005, PROTEIN ENG DES SEL, V18, P191, DOI 10.1093/protein/gzi023; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57	70	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41510	10.1371/journal.pone.0041510	http://dx.doi.org/10.1371/journal.pone.0041510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927909	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300010
J	Sosic-Vasic, Z; Ulrich, M; Ruchsow, M; Vasic, N; Gron, G				Sosic-Vasic, Zrinka; Ulrich, Martin; Ruchsow, Martin; Vasic, Nenad; Groen, Georg			The Modulating Effect of Personality Traits on Neural Error Monitoring: Evidence from Event-Related fMRI	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; COGNITIVE CONTROL; RESPONSE-INHIBITION; PERFORMANCE; NEGATIVITY; TASK; CONFLICT; EXTROVERSION; NEUROTICISM	The present study investigated the association between traits of the Five Factor Model of Personality (Neuroticism, Extraversion, Openness for Experiences, Agreeableness, and Conscientiousness) and neural correlates of error monitoring obtained from a combined Eriksen-Flanker-Go/NoGo task during event-related functional magnetic resonance imaging in 27 healthy subjects. Individual expressions of personality traits were measured using the NEO-PI-R questionnaire. Conscientiousness correlated positively with error signaling in the left inferior frontal gyrus and adjacent anterior insula (IFG/aI). A second strong positive correlation was observed in the anterior cingulate gyrus (ACC). Neuroticism was negatively correlated with error signaling in the inferior frontal cortex possibly reflecting the negative inter-correlation between both scales observed on the behavioral level. Under present statistical thresholds no significant results were obtained for remaining scales. Aligning the personality trait of Conscientiousness with task accomplishment striving behavior the correlation in the left IFG/aI possibly reflects an inter-individually different involvement whenever task-set related memory representations are violated by the occurrence of errors. The strong correlations in the ACC may indicate that more conscientious subjects were stronger affected by these violations of a given task-set expressed by individually different, negatively valenced signals conveyed by the ACC upon occurrence of an error. Present results illustrate that for predicting individual responses to errors underlying personality traits should be taken into account and also lend external validity to the personality trait approach suggesting that personality constructs do reflect more than mere descriptive taxonomies.	[Sosic-Vasic, Zrinka; Ulrich, Martin; Vasic, Nenad; Groen, Georg] Univ Hosp Ulm Leimgrubenweg, Dept Psychiat & Psychotherapy 3, Ulm, Germany; [Sosic-Vasic, Zrinka] Univ Hosp Ulm, TransferCtr Neurosci & Learning, Ulm, Germany; [Ruchsow, Martin] Christophsbad Hosp Goppingen Faurndauer, Dept Psychiat, Goppingen, Germany; [Ulrich, Martin; Groen, Georg] Univ Ulm Leimgrubenweg, Sect Neuropsychol & Funct Imaging, Ulm, Germany	Ulm University	Sosic-Vasic, Z (corresponding author), Univ Hosp Ulm Leimgrubenweg, Dept Psychiat & Psychotherapy 3, Ulm, Germany.	zrinka.sosic@uni-ulm.de		Gron, Georg/0000-0002-0282-3575; Ulrich, Martin/0000-0002-1237-0426				Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Badre D, 2005, CEREB CORTEX, V15, P2003, DOI 10.1093/cercor/bhi075; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Borkenau P, 2008, NEO 5 FACTORS INVENT; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Canli T, 2004, J PERS, V72, P1105, DOI 10.1111/j.1467-6494.2004.00292.x; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Compton RJ, 2007, BRAIN COGNITION, V64, P247, DOI 10.1016/j.bandc.2007.03.006; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; Cremers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028421; Cremers HR, 2010, NEUROIMAGE, V49, P963, DOI 10.1016/j.neuroimage.2009.08.023; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Dikman ZV, 2000, PSYCHOPHYSIOLOGY, V37, P43, DOI 10.1017/S0048577200980983; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Eysenck HJ, 1981, MODEL PERSONALITY, p1~37, DOI DOI 10.1007/978-3-642-67783-0_1; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Graf H, 2011, BIOL PSYCHIAT, V69, P890, DOI 10.1016/j.biopsych.2010.10.018; Haas BW, 2008, NEUROIMAGE, V42, P385, DOI 10.1016/j.neuroimage.2008.04.027; Hajcak G, 2004, BRAIN COGNITION, V56, P189, DOI 10.1016/j.bandc.2003.11.001; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Kerns JG, 2004, NEURON, V43, P283, DOI 10.1016/j.neuron.2004.06.032; Mathalon DH, 2003, BIOL PSYCHOL, V64, P119, DOI 10.1016/S0301-0511(03)00105-4; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olvet D. M., 2011, SOC COGN AFFECT NEUR; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Pailing PE, 2004, PSYCHOPHYSIOLOGY, V41, P84, DOI 10.1111/1469-8986.00124; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rodriguez-Fornells A, 2002, J NEUROSCI, V22, P9990; Ruchsow M, 2005, COGNITIVE BRAIN RES, V24, P317, DOI 10.1016/j.cogbrainres.2005.02.003; Saucier G, 2001, J PERS, V69, P847, DOI 10.1111/1467-6494.696167; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Tops M, 2006, PSYCHONEUROENDOCRINO, V31, P847, DOI 10.1016/j.psyneuen.2006.04.001; Tops M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00330; Tops M, 2010, COGN AFFECT BEHAV NE, V10, P441, DOI 10.3758/CABN.10.4.441; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; Vasic N, 2012, J ATTENTION IN PRESS; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	55	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42930	10.1371/journal.pone.0042930	http://dx.doi.org/10.1371/journal.pone.0042930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937001	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300030
J	Vieira, AS; Bueno, OC; Camargo-Mathias, MI				Vieira, Alexsandro Santana; Bueno, Odair Correa; Camargo-Mathias, Maria Izabel			Morphophysiological Differences between the Metapleural Glands of Fungus-Growing and Non-Fungus-Growing Ants (Hymenoptera, Formicidae)	PLOS ONE			English	Article							DISEASE RESISTANCE; SECRETION; EVOLUTION; TRANSITION; MARKING; QUEENS	The metapleural gland is an organ exclusive to ants. Its main role is to produce secretions that inhibit the proliferation of different types of pathogens. The aim of the present study was to examine the morphophysiological differences between the metapleural gland of 3 non-fungus-growing ants of the tribes Ectatommini, Myrmicini, and Blepharidattini and that of 5 fungus-growing ants from 2 basal and 3 derived attine genera. The metapleural gland of the non-fungus-growing ants and the basal attine ants has fewer secretory cells than that of the derived attine ants (leaf-cutting ants). In addition, the metapleural gland of the latter had more clusters of secretory cells and sieve plates, indicating a greater storage capacity and demand for secretion in these more advanced farming ants. The glands of the derived attine ants also produced higher levels of polysaccharides and acidic lipids than those of Myrmicini, Blepharidattini, and basal attines. Our results confirm morphophysiological differences between the metapleural glands of the derived attines and those of the basal attines and non-fungus-growing ants, suggesting that the metapleural glands of the derived attines (leaf-cutting ants) are more developed in morphology and physiology, with enhanced secretion production (acidic lipids and protein) to protect against the proliferation of unwanted fungi and bacteria in the fungal garden, it is possible that leaf-cutting ants may have evolved more developed metapleural glands in response to stronger pressure from parasites.	[Vieira, Alexsandro Santana; Camargo-Mathias, Maria Izabel] Univ Estadual Paulista, Dept Biol, Inst Biociencias, Sao Paulo, Brazil; [Bueno, Odair Correa] Univ Estadual Paulista, Ctr Estudos Insetos Sociais, Inst Biociencias, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Vieira, AS (corresponding author), Univ Estadual Paulista, Dept Biol, Inst Biociencias, Sao Paulo, Brazil.	micm@rc.unesp.br	Pragas, Inct/I-2193-2013; Vieira, Alexsandro/E-4385-2012; Mathias, Maria Izabel Camargo/K-2756-2012; Camargo-Mathias, Bel/G-2040-2014	Camargo-Mathias, Bel/0000-0002-9418-8934	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2008/54301-3]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) (grant # 2008/54301-3) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AJ, 1987, ANAIS SOC NORDESTINA, V1, P175; BILLEN J P J, 1987, Revue de Zoologie Africaine, V101, P31; Bolton Barry, 2003, Memoirs of the American Entomological Institute (Gainesville), V71, P1; Bot ANM, 2001, INSECT SOC, V48, P63, DOI 10.1007/PL00001747; Bot ANM, 2002, INSECT SOC, V49, P363, DOI 10.1007/PL00012660; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Cammaerts MC, 2001, J INSECT BEHAV, V14, P247, DOI 10.1023/A:1007893812963; de Souza ALB, 2006, SOCIOBIOLOGY, V47, P19; Emery C, 1899, Q REV BIOL, V8, P488; FANFANI A, 1991, ETHOL ECOL EVOL, P95; Fernandez-Marin H, 2006, P ROY SOC B-BIOL SCI, V273, P1689, DOI 10.1098/rspb.2006.3492; Gadau J, 2003, MOL ECOL, V12, P1931, DOI 10.1046/j.1365-294X.2003.01853.x; Graystock P, 2011, BEHAV ECOL SOCIOBIOL, V65, P2319, DOI 10.1007/s00265-011-1242-y; Gusmao L.G., 2000, THESIS; GUSMAO LG, 2001, IHERINGIA, V91, P33; Hamilton W.D., 1987, P81; Holldobler B., 1990, pi; Hughes WOH, 2008, EVOLUTION, V62, P1252, DOI 10.1111/j.1558-5646.2008.00347.x; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Hu┬lldobler, 1985, PSYCHE CAMBRIDGE, V91, P201, DOI DOI 10.1155/1984/70141; JAFFE K, 1984, J INSECT PHYSIOL, V30, P265, DOI 10.1016/0022-1910(84)90126-4; JAFFE K, 1986, INSECT SOC, V33, P105, DOI 10.1007/BF02224591; Johnson RN, 2003, MOL PHYLOGENET EVOL, V29, P317, DOI 10.1016/S1055-7903(03)00114-3; JUNQUEIRA L. C., 2008, HISTOLOGIA BASICA, P524; Junqueira LCU., 1983, TECNICAS BASICAS CIT, P48; Lison L, 1960, HISTOCHIMIE CYTOCHIM; Longino John T., 2007, Memoirs of the American Entomological Institute (Gainesville), V80, P271; MASCHWITZ U, 1970, J INSECT PHYSIOL, V16, P387, DOI 10.1016/0022-1910(70)90180-0; MCMANUS JFA, 1946, NATURE, V158, P202, DOI 10.1038/158202a0; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Nascimento RRD, 1996, J CHEM ECOL, V22, P987, DOI 10.1007/BF02029949; NOIROT C, 1991, ANN SOC ENTOMOL FR, V27, P123; North RD, 1997, TRENDS ECOL EVOL, V12, P386, DOI 10.1016/S0169-5347(97)87381-8; Ortius-Lechner D, 2000, J CHEM ECOL, V26, P1667, DOI 10.1023/A:1005543030518; Pearse A.G.E., 1985, HISTOCHEMISTRY THEOR, Vfourth; Poulsen M, 2003, NATURWISSENSCHAFTEN, V90, P406, DOI 10.1007/s00114-003-0450-3; Poulsen M, 2002, BEHAV ECOL SOCIOBIOL, V52, P151, DOI 10.1007/s00265-002-0489-8; Schmid-Hempel P, 2000, MICROBES INFECT, V2, P515, DOI 10.1016/S1286-4579(00)00316-6; SCHOETERS E, 1993, BELG J ZOOL, V123, P67; SCHOETERS E., 1992, EUR C SOC INS LO LEU, V1, P239; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Sumner S, 2004, NATURE, V428, P35, DOI 10.1038/428035a; Sumner S, 2003, BEHAV ECOL SOCIOBIOL, V54, P256, DOI 10.1007/s00265-003-0633-0; TULLOCH G. S., 1962, BULL BROOKLYN ENTOMOL SOC, V57, P91; Vieira AS, 2010, MICRON, V41, P149, DOI 10.1016/j.micron.2009.08.012; Vieira AS, 2012, ANIM BIOL, V62, P1, DOI 10.1163/157075511X597575; Vieira AS, 2011, MICROSC RES TECHNIQ, V74, P76, DOI 10.1002/jemt.20876; Villesen P, 2002, P ROY SOC B-BIOL SCI, V269, P1541, DOI 10.1098/rspb.2002.2044; Walker TN, 2011, ECOL ENTOMOL, V36, P588, DOI 10.1111/j.1365-2311.2011.01312.x; Weber N.A., 1972, Memoirs Am phil Soc, V92, P1; Wilson EO, 1971, INSECT SOC, P514; Yek SH, 2011, BIOL REV, V86, P774, DOI 10.1111/j.1469-185X.2010.00170.x	52	11	11	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43570	10.1371/journal.pone.0043570	http://dx.doi.org/10.1371/journal.pone.0043570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927993	Green Published, gold			2022-12-27	WOS:000308286300067
J	Mendu, SK; Bhandage, A; Jin, Z; Birnir, B				Mendu, Suresh K.; Bhandage, Amol; Jin, Zhe; Birnir, Bryndis			Different Subtypes of GABA-A Receptors Are Expressed in Human, Mouse and Rat T Lymphocytes	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; GENE-EXPRESSION; CELL; SUBUNIT; AUTOIMMUNITY; ANESTHETICS; INHIBITION; RESPONSES; EFFECTOR; LIGAND	gamma-aminobutyric acid (GABA) is the most prominent neuroinhibitory transmitter in the brain, where it activates neuronal GABA-A receptors (GABA-A channels) located at synapses and outside of synapses. The GABA-A receptors are primary targets of many clinically useful drugs. In recent years, GABA has been shown to act as an immunomodulatory molecule. We have examined in human, mouse and rat CD4(+) and CD8(+) T cells which subunit isoforms of the GABA-A channels are expressed. The channel physiology and drug specificity is dictated by the GABA-A receptor subtype, which in turn is determined by the subunit isoforms that make the channel. There were 5, 8 and 13 different GABA-A subunit isoforms identified in human, mouse and rat CD4(+) and CD8(+) T cells, respectively. Importantly, the gamma 2 subunit that imposes benzodiazepine sensitivity on the GABA-A receptors, was only detected in the mouse T cells. Immunoblots and immunocytochemistry showed abundant GABA-A channel proteins in the T cells from all three species. GABA-activated whole-cell transient and tonic currents were recorded. The currents were inhibited by picrotoxin, SR95531 and bicuculline, antagonists of GABA-A channels. Clearly, in both humans and rodents T cells, functional GABA-A channels are expressed but the subtypes vary. It is important to bear in mind the interspecies difference when selecting the appropriate animal models to study the physiological role and pharmacological properties of GABA-A channels in CD4(+) and CD8(+) T cells and when selecting drugs aimed at modulating the human T cells function.	[Mendu, Suresh K.; Bhandage, Amol; Jin, Zhe; Birnir, Bryndis] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Mendu, SK (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	bryndis.birnir@neuro.uu.se	Bhandage, Amol/O-1869-2016; Jin, Zhe/C-5150-2008; Bhandage, Amol K./AAY-2435-2020	Bhandage, Amol/0000-0002-7116-0939; Jin, Zhe/0000-0002-4717-1558; Bhandage, Amol K./0000-0002-7116-0939; Birnir, Bryndis/0000-0002-1763-0266; Mendu, Suresh Kumar/0000-0002-6785-0806	Swedish national strategic research initiative EXODIAB (Excellence of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation; Swedish Research Council; Swedish Diabetes Research Foundation; Ernfors Foundation; Uppsala University; EXODIAB; Swedish Association for Medical Research (SSMF)	Swedish national strategic research initiative EXODIAB (Excellence of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Research Foundation; Ernfors Foundation; Uppsala University; EXODIAB; Swedish Association for Medical Research (SSMF)	Human pancreatic lymph nodes were obtained from The Nordic network for Clinical Islet Transplantation, supported by the Swedish national strategic research initiative EXODIAB (Excellence of Diabetes Research in Sweden) and the Juvenile Diabetes Research Foundation. The authors thank the Swedish Research Council, Swedish Diabetes Research Foundation, The Ernfors Foundation, Uppsala University and EXODIAB for financial support. ZJ held a postdoctoral fellowship sponsored by EXODIAB and The Swedish Association for Medical Research (SSMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakuijala A, 2005, EUR J NEUROSCI, V21, P692, DOI 10.1111/j.1460-9568.2005.03880.x; Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bhat R, 2009, NEURON, V64, P123, DOI 10.1016/j.neuron.2009.09.015; Birnir B, 1997, J MEMBRANE BIOL, V155, P157, DOI 10.1007/s002329900167; Birnir B, 2007, CURR PHARM DESIGN, V13, P3169, DOI 10.2174/138161207782341330; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Chiffoleau E, 2007, INT IMMUNOL, V19, P193, DOI 10.1093/intimm/dxl136; Condamine T, 2010, J LEUKOCYTE BIOL, V87, P451, DOI 10.1189/jlb.0609410; Dionisio L, 2011, NEUROPHARMACOLOGY, V60, P513, DOI 10.1016/j.neuropharm.2010.11.007; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; ERDO SL, 1990, J NEUROCHEM, V54, P363, DOI 10.1111/j.1471-4159.1990.tb01882.x; GERBER JC, 1980, BRAIN RES BULL, V5, P341, DOI 10.1016/0361-9230(80)90055-6; Reyes-Garcia MG, 2009, J NEUROIMMUNOL, V216, P20, DOI 10.1016/j.jneuroim.2009.06.024; Halonen LM, 2009, NEUROCHEM INT, V55, P389, DOI 10.1016/j.neuint.2009.04.008; Hillebrands JL, 2006, J IMMUNOL, V177, P7820, DOI 10.4049/jimmunol.177.11.7820; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jin Z, 2011, AMINO ACIDS; Jin Z, 2012, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00030; Kim MY, 2006, J IMMUNOL, V177, P3074, DOI 10.4049/jimmunol.177.5.3074; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lupberger J, 2002, MOL CELL PROBE, V16, P25, DOI 10.1006/mcpr.2001.0392; Mendu SK, 2011, MOL IMMUNOL, V48, P399, DOI 10.1016/j.molimm.2010.08.005; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; PETTY F, 1984, J AFFECT DISORDERS, V6, P131, DOI 10.1016/0165-0327(84)90018-1; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; Reyes-Garcia MG, 2007, J NEUROIMMUNOL, V188, P64, DOI 10.1016/j.jneuroim.2007.05.013; Sidorkiewicz M, 2011, EUR J CLIN MICROBIOL; Soltani N, 2011, P NATL ACAD SCI US; Tian J, 1999, J NEUROIMMUNOL, V96, P21, DOI 10.1016/S0165-5728(98)00264-1; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; WANG TL, 1994, J NEUROSCI, V14, P6524; Wang Y, 2008, J IMMUNOL, V181, P8226, DOI 10.4049/jimmunol.181.12.8226; Wheeler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017152; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	38	70	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42959	10.1371/journal.pone.0042959	http://dx.doi.org/10.1371/journal.pone.0042959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927941	Green Published, gold			2022-12-27	WOS:000307789700016
J	Hirano, K; Sasaki, N; Ichimiya, T; Miura, T; Van Kuppevelt, TH; Nishihara, S				Hirano, Kazumi; Sasaki, Norihiko; Ichimiya, Tomomi; Miura, Taichi; Van Kuppevelt, Toin H.; Nishihara, Shoko			3-O-Sulfated Heparan Sulfate Recognized by the Antibody HS4C3 Contribute to the Differentiation of Mouse Embryonic Stem Cells via Fas Signaling	PLOS ONE			English	Article							SELF-RENEWAL; MEDIATED APOPTOSIS; PLURIPOTENCY; EXPRESSION; MAINTAINS; SURFACE; TERATOCARCINOMA; PROTEOGLYCANS; MAINTENANCE; ACTIVATION	Maintenance of self-renewal and pluripotency in mouse embryonic stem cells (mESCs) is regulated by the balance between several extrinsic signaling pathways. Recently, we demonstrated that heparan sulfate (HS) chains play important roles in the maintenance and differentiation of mESCs by regulating extrinsic signaling. Sulfated HS structures are modified by various sulfotransferases during development. However, the significance of specific HS structures during development remains unclear. Here, we show that 3-O-sulfated HS structures synthesized by HS 3-O-sulfotransferases (3OSTs) and recognized by the antibody HS4C3 increase during differentiation of mESCs. Furthermore, expression of Fas on the cell surface of the differentiated cells also increased. Overexpression of the HS4C3-binding epitope in mESCs induced apoptosis and spontaneous differentiation even in the presence of LIF and serum. These data showed that the HS4C3-binding epitope was required for differentiation of mESCs. Up-regulation of the HS4C3-binding epitope resulted in the recruitment of Fas from the cytoplasm to lipid rafts on the cell surface followed by activation of Fas signaling. Indeed, the HS4C3-binding epitope interacted with a region that included the heparin-binding domain (KLRRRVH) of Fas. Reduced self-renewal capability in cells overexpressing 3OST resulted from the degradation of Nanog by activated caspase-3, which is downstream of Fas signaling, and was rescued by the inhibition of Fas signaling. We also found that knockdown of 3OST and inhibition of Fas signaling reduced the potential for differentiation into the three germ layers during embryoid body formation. This is the first demonstration that activation of Fas signaling is mediated by an increase in the HS4C3-binding epitope and indicates a novel signaling pathway for differentiation in mESCs.	[Hirano, Kazumi; Sasaki, Norihiko; Ichimiya, Tomomi; Miura, Taichi; Nishihara, Shoko] Soka Univ, Fac Engn, Dept Bioinformat, Cell Biol Lab, Hachioji, Tokyo, Japan; [Van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	Soka University; Radboud University Nijmegen	Hirano, K (corresponding author), Soka Univ, Fac Engn, Dept Bioinformat, Cell Biol Lab, Hachioji, Tokyo, Japan.	shoko@soka.ac.jp	van Kuppevelt, A.H.M.S.M./L-4463-2015; Hirano, Kazumi/R-5290-2019; Hirano, Kazumi/L-7031-2018	Hirano, Kazumi/0000-0001-9717-5904; Hirano, Kazumi/0000-0001-9717-5904; Nishihara, Shoko/0000-0002-1668-2603	Ministry of Education, Culture, Sports, Science and Technology [20370051]; Matching Fund for Private Universities [S0901015]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Matching Fund for Private Universities	This research was partially supported by funds from Ministry of Education, Culture, Sports, Science and Technology, the Grant-in-Aid for Scientific Research (B) to SN, 20370051, 2008-2010, and from Ministry of Education, Culture, Sports, Science and Technology, the Matching Fund for Private Universities, S0901015, 2009-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brunlid G, 2007, STEM CELLS, V25, P2551, DOI 10.1634/stemcells.2006-0745; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Duval D, 2004, CELL DEATH DIFFER, V11, P331, DOI 10.1038/sj.cdd.4401337; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Ko YG, 1999, J IMMUNOL, V162, P7217; Kraushaar DC, 2010, J BIOL CHEM, V285, P5907, DOI 10.1074/jbc.M109.066837; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Legembre P, 2002, CELL DEATH DIFFER, V9, P329, DOI 10.1038/sj.cdd.4400960; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Mochizuki H, 2008, J BIOL CHEM, V283, P31237, DOI 10.1074/jbc.M801586200; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Sasaki N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008262; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smits NC, 2006, METHOD ENZYMOL, V416, P61, DOI 10.1016/S0076-6879(06)16005-X; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Villena J, 2006, APOPTOSIS, V11, P2065, DOI 10.1007/s10495-006-0193-7; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	43	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43440	10.1371/journal.pone.0043440	http://dx.doi.org/10.1371/journal.pone.0043440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916262	gold, Green Published			2022-12-27	WOS:000307824300050
J	Lin, LF; Chiu, SP; Wu, MJ; Chen, PY; Yen, JH				Lin, Lian-Fang; Chiu, Szu-Ping; Wu, Ming-Jiuan; Chen, Pei-Yi; Yen, Jui-Hung			Luteolin Induces microRNA-132 Expression and Modulates Neurite Outgrowth in PC12 Cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; EPIDERMAL-GROWTH-FACTOR; FLAVONOID LUTEOLIN; ADULT HIPPOCAMPUS; INDUCED TOXICITY; MESSENGER-RNAS; CREB; NEURONS; CAMP	Luteolin (3',4',5,7-tetrahydroxyflavone), a food-derived flavonoid, has been reported to exert neurotrophic properties that are associated with its capacity to promote neuronal survival and neurite outgrowth. In this study, we report for the first time that luteolin induces the persistent expression of microRNA-132 (miR-132) in PC12 cells. The correlation between miR-132 knockdown and a decrease in luteolin-mediated neurite outgrowth may indicate a mechanistic link by which miR-132 functions as a mediator for neuritogenesis. Furthermore, we find that luteolin led to the phosphorylation and activation of cAMP response element binding protein (CREB), which is associated with the up-regulation of miR-132 and neurite outgrowth. Moreover, luteolin-induced CREB activation, miR-132 expression and neurite outgrowth were inhibited by adenylate cyclase, protein kinase A (PKA) and MAPK/ERK kinase 1/2 (MEK1/2) inhibitors but not by protein kinase C (PKC) or calcium/calmodulin-dependent protein kinase II (CaMK II) inhibitors. Consistently, we find that luteolin treatment increases ERK phosphorylation and PKA activity in PC12 cells. These results show that luteolin induces the up-regulation of miR-132, which serves as an important regulator for neurotrophic actions, mainly acting through the activation of cAMP/PKA- and ERK-dependent CREB signaling pathways in PC12 cells.	[Lin, Lian-Fang; Chiu, Szu-Ping; Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Wu, Ming-Jiuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Chen, Pei-Yi] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chen, Pei-Yi] Buddhist Tzu Chi Gen Hosp, Ctr Med Genet, Hualien, Taiwan	Tzu Chi University; Chia Nan University of Pharmacy & Science; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Lin, LF (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	imyenjh@mail.tcu.edu.tw		Wu, Ming-Jiuan/0000-0003-3327-828X	National Science Council, Taiwan, ROC [NSC-97-2320-B-320-011-MY3, NSC-99-2320-B-041-005-MY3]; Tzu Chi University [TCMRC-P-100006]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Tzu Chi University	This study was supported by grant NSC-97-2320-B-320-011-MY3 and NSC-99-2320-B-041-005-MY3 from National Science Council, Taiwan, ROC; and by grant TCMRC-P-100006 from Tzu Chi University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng HY, 2010, PHYTOTHER RES, V24, pS102, DOI 10.1002/ptr.2940; Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gueorguiev VD, 2006, J BIOL CHEM, V281, P10188, DOI 10.1074/jbc.M513806200; Hansen KF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015497; Hong JT, 2009, TOXICOL APPL PHARM, V237, P59, DOI 10.1016/j.taap.2009.02.014; Hougee S, 2005, BIOCHEM PHARMACOL, V69, P241, DOI 10.1016/j.bcp.2004.10.002; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lai HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028280; Liao KK, 2012, J AGR FOOD CHEM, V60, P433, DOI 10.1021/jf203290r; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x; Liu R, 2009, NEUROSCIENCE, V162, P1232, DOI 10.1016/j.neuroscience.2009.05.009; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Middleton E, 2000, PHARMACOL REV, V52, P673; Nagase H, 2005, BIOCHEM BIOPH RES CO, V337, P1330, DOI 10.1016/j.bbrc.2005.10.001; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Pavlica S, 2010, LIFE SCI, V86, P79, DOI 10.1016/j.lfs.2009.10.017; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Reznichenko L, 2005, J NEUROCHEM, V93, P1157, DOI 10.1111/j.1471-4159.2005.03085.x; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Romanova D, 2001, NEOPLASMA, V48, P104; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seelinger G, 2008, MOLECULES, V13, P2628, DOI 10.3390/molecules13102628; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z; Spencer JPE, 2009, ARCH BIOCHEM BIOPHYS, V492, P1, DOI 10.1016/j.abb.2009.10.003; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Su JD, 2012, FREE RADICAL BIO MED, V52, P126, DOI 10.1016/j.freeradbiomed.2011.10.002; Tsai FS, 2007, LIFE SCI, V80, P1692, DOI 10.1016/j.lfs.2007.01.055; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang JY, 2008, J NEUROCHEM, V107, P1544, DOI 10.1111/j.1471-4159.2008.05714.x; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Xu B, 2010, EUR J PHARMACOL, V627, P99, DOI 10.1016/j.ejphar.2009.10.038; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421	58	46	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43304	10.1371/journal.pone.0043304	http://dx.doi.org/10.1371/journal.pone.0043304			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916239	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300038
J	Capitan, JA; Borge-Holthoefer, J; Gomez, S; Martinez-Romo, J; Araujo, L; Cuesta, JA; Arenas, A				Capitan, Jose A.; Borge-Holthoefer, Javier; Gomez, Sergio; Martinez-Romo, Juan; Araujo, Lourdes; Cuesta, Jose A.; Arenas, Alex			Local-Based Semantic Navigation on a Networked Representation of Information	PLOS ONE			English	Article							COMPLEX NETWORKS	The size and complexity of actual networked systems hinders the access to a global knowledge of their structure. This fact pushes the problem of navigation to suboptimal solutions, one of them being the extraction of a coherent map of the topology on which navigation takes place. In this paper, we present a Markov chain based algorithm to tag networked terms according only to their topological features. The resulting tagging is used to compute similarity between terms, providing a map of the networked information. This map supports local-based navigation techniques driven by similarity. We compare the efficiency of the resulting paths according to their length compared to that of the shortest path. Additionally we claim that the path steps towards the destination are semantically coherent. To illustrate the algorithm performance we provide some results from the Simple English Wikipedia, which amounts to several thousand of pages. The simplest greedy strategy yields over an 80% of average success rate. Furthermore, the resulting content-coherent paths most often have a cost between one- and threefold compared to shortest-path lengths.	[Capitan, Jose A.; Gomez, Sergio; Arenas, Alex] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain; [Capitan, Jose A.] Consejo Super Invest Cient INTA, Ctr Astrobiol, Madrid, Spain; [Capitan, Jose A.; Cuesta, Jose A.] Grp Interdisciplinar Sistemas Complejos, Madrid, Spain; [Borge-Holthoefer, Javier; Arenas, Alex] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos, Zaragoza, Spain; [Martinez-Romo, Juan; Araujo, Lourdes] Univ Nacl Educ Distancia, Dept Lenguajes & Sistemas Informat, E-28040 Madrid, Spain; [Cuesta, Jose A.] Univ Carlos III Madrid, Escuela Politecn Super, Dept Matemat, Madrid, Spain	Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Zaragoza; Universidad Nacional de Educacion a Distancia (UNED); Universidad Carlos III de Madrid	Capitan, JA (corresponding author), Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain.	joseangel.capitan@cab.inta-csic.es	Arenas, Alex/A-5216-2009; Cuesta, Jose A/A-7157-2008; Araujo, Lourdes/G-6272-2015; Cuesta, Jose A/Z-4696-2019; Borge-Holthoefer, Javier/J-9187-2013; Gómez, Sergio/B-2113-2010; Capitan, Jose A./D-8669-2012; Martinez-Romo, Juan/R-9483-2019	Arenas, Alex/0000-0003-0937-0334; Cuesta, Jose A/0000-0001-9890-9367; Araujo, Lourdes/0000-0002-7657-4794; Borge-Holthoefer, Javier/0000-0001-9036-8463; Gómez, Sergio/0000-0003-1820-0062; Capitan, Jose A./0000-0002-6245-0088; Martinez-Romo, Juan/0000-0002-6905-7051	Ministerio de Educacion y Ciencia in Spain [FIS2008-01240, FIS2009-13364-C02-01]; Holopedia from Ministerio de Educacion y Ciencia in Spain [TIN2010-21128-C02-01]; MOSAICO from Ministerio de Educacion y Ciencia in Spain [FIS2006-01485]; PRODIEVO from Ministerio de Educacion y Ciencia in Spain [FIS2011-22449]; Research Networks MODELICO-CM [S2009/ESP-1691]; MA2VICMR from Comunidad de Madrid [S2009/TIC-1542]; Generalitat de Catalunya [Network 2009-SGR-838]	Ministerio de Educacion y Ciencia in Spain(Spanish Government); Holopedia from Ministerio de Educacion y Ciencia in Spain(German Research Foundation (DFG)); MOSAICO from Ministerio de Educacion y Ciencia in Spain(German Research Foundation (DFG)); PRODIEVO from Ministerio de Educacion y Ciencia in Spain(German Research Foundation (DFG)); Research Networks MODELICO-CM; MA2VICMR from Comunidad de Madrid; Generalitat de Catalunya(Generalitat de Catalunya)	The authors acknowledge financial support through Grant No. FIS2008-01240, FIS2009-13364-C02-01, Holopedia (Grant No. TIN2010-21128-C02-01), MOSAICO (Grant No. FIS2006-01485), PRODIEVO (Grant No. FIS2011-22449), and Complexity-NET RESINEE, all of them from Ministerio de Educacion y Ciencia in Spain, as well as support from Research Networks MODELICO-CM (Grant No. S2009/ESP-1691) and MA2VICMR (Grant No. S2009/TIC-1542) from Comunidad de Madrid, and Network 2009-SGR-838 from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; Alvarez-Hamelin J.I., 2006, ADV NEURAL INFORM PR, P41; Arenas A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053009; ATKINSON AB, 1970, J ECON THEORY, V2, P244, DOI 10.1016/0022-0531(70)90039-6; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Blondel VD, 2004, SIAM REV, V46, P647, DOI 10.1137/S0036144502415960; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1063; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Borge-Holthoefer J, 2010, EUR PHYS J B, V74, P265, DOI 10.1140/epjb/e2010-00058-9; Borge-Holthoefer J, 2010, ENTROPY-SWITZ, V12, P1264, DOI 10.3390/e12051264; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; Costa LD, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016102; Erola P, 2012, INT J BIFUR IN PRESS; Erola P., 2011, INT J COMPUT SYST SC, V1, P37; Guimera R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248701; Holme P, 2009, MODEL SIMUL SCI ENG, P189, DOI 10.1007/978-0-8176-4751-3_11; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P241, DOI DOI 10.5169/SEALS-266440; Jeh G., 2002, P 8 ACM SIGKDD INT C, P538, DOI DOI 10.1145/775047.775126; Jiang J.J., 1997, P INT C RES COMP LIN, P19; Kleinberg J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P163, DOI 10.1145/335305.335325; Kleinberg J., 2006, P INT C MATH ICM EUR, V3, P1019; Lambiotte R, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.017102; Lee SH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.128701; Lee S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.017102; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Martinez-Romo J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046108; Milgram S., 1967, PSYCHOL TODAY, V2; Miller G., 1990, INT J LEXICOGR, V3, P235, DOI DOI 10.1093/IJL/3.4.235; MILLER GA, 1991, LANG COGNITIVE PROC, V6, P1, DOI 10.1080/01690969108406936; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; QUILLIAN MR, 1967, BEHAV SCI, V12, P410, DOI 10.1002/bs.3830120511; Ravasz E, 2002, HIERARCHICAL ORG MOD; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Salton G., 1989, AUTOMATIC TEXT PROCE, VVolume 169; Salton G, 1983, INTRO MODERN INFORM; Sinatra R, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.030103; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Yang SJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016107	44	15	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43694	10.1371/journal.pone.0043694	http://dx.doi.org/10.1371/journal.pone.0043694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937081	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500083
J	Chang, JR; Chen, YY; Huang, TS; Huang, WF; Kuo, SC; Tseng, FC; Su, IJ; Lin, CH; Chen, YS; Sun, JR; Chiueh, TS; Dou, HY				Chang, Jia-Ru; Chen, Yih-Yuan; Huang, Tsi-Shu; Huang, Wei-Feng; Kuo, Shu-Chen; Tseng, Fan-Chen; Su, Ih-Jen; Lin, Chien-Hsing; Chen, Yao-Shen; Sun, Jun-Ren; Chiueh, Tzong-Shi; Dou, Horng-Yunn			Clonal Expansion of Both Modern and Ancient Genotypes of Mycobacterium tuberculosis in Southern Taiwan	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; BEIJING GENOTYPE; ASSOCIATION; SETTLEMENT	We present the first comprehensive analysis of Mycobacterium tuberculosis isolates circulating in the Kaohsiung region of southern Taiwan. The major spoligotypes found in the 224 isolates studied were Beijing lineages (n = 97; 43.3%), EAI lineages (n = 72; 32.1%) and Haarlem lineages (n = 18; 8.0%). By 24 MIRU-VNTR typing, 174 patterns were identified, including 24 clusters of 74 isolates and 150 unique patterns. The combination of spoligotyping and 12-MIRU-VNTR revealed that 129 (57.6%) of the 224 isolates were clustered in 18 genotypes. Moreover, 63.6% (7/11) of infected persons younger than 30 years had a Beijing strain, which could suggest recent spread among younger persons by this family of TB strains in Kaohsiung. Among the 94 Beijing family (SIT1, SIT250 and SIT1674) isolates further analyzed for SNPs by mass spectrometry, the most frequent strain found was ST10 (n = 49; 52%), followed by ST22 (n = 17; 18%) and ST19 (n = 11; 12%). Among the EAI-Manila family isolates analyzed by region deletion-based subtyping, the most frequent strain found was RD type 1 (n = 63; 87.5%), followed by RD type 2 (n = 9; 12.5%). In our previous study, the proportion of modern Beijing strains (52.5%) in northern Taiwan was significantly higher than the proportion of EAI strains (11%). In contrast, in the present study, EAI strains comprised up to 32% of Beijing strains in southern Taiwan. In conclusion, both 'modern' (Beijing) and 'ancient' (EAI) M. tuberculosis strains are prevalent in the Kaohsiung region, perhaps suggesting that both strains are somehow more adapted to southern Taiwan. It will be interesting to investigate the dynamics of the lineage composition by different selection pressures.	[Chang, Jia-Ru; Chen, Yih-Yuan; Huang, Wei-Feng; Kuo, Shu-Chen; Tseng, Fan-Chen; Su, Ih-Jen; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan; [Lin, Chien-Hsing] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan; [Huang, Tsi-Shu; Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Microbiol, Kaohsiung, Taiwan; [Sun, Jun-Ren; Chiueh, Tzong-Shi] Tri Serv Gen Hosp, Div Clin Pathol, Dept Pathol, Taipei, Taiwan; [Sun, Jun-Ren; Chiueh, Tzong-Shi] Natl Def Med Ctr, Taipei, Taiwan; [Dou, Horng-Yunn] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Kaohsiung Veterans General Hospital; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University	Chang, JR (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan.	hydou@nhri.org.tw	Kuo, Shu-Chen/G-9108-2011; Dou, horng-yunn/F-1966-2015; Dou, Horng-Yunn/B-2652-2010; Su, Ih-Jen/B-2655-2010; Tseng, Fan-Chen/D-2097-2010	Sun, jun-ren/0000-0002-8769-9170; Chen, Yih-Yuan/0000-0001-9507-291X	National Health Research Institutes; National Science Council, Taiwan [NSC 100-3111-B-400-001]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This project was supported by grants from the National Health Research Institutes and National Science Council (NSC 100-3111-B-400-001), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Chang JR, 2011, CLIN MICROBIOL INFEC, V17, P1391, DOI 10.1111/j.1469-0691.2010.03436.x; Clinical and Laboratory Standards Institute, 2005, CLIN LAB STAND I DOC; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Frink S, 2011, J CLIN MICROBIOL, V49, P1951, DOI 10.1128/JCM.01338-10; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; Huang SF, 2012, INFECT GENET EVOL, V12, P28, DOI 10.1016/j.meegid.2011.10.001; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; KOLK AHJ, 1992, J CLIN MICROBIOL, V30, P2567, DOI 10.1128/JCM.30.10.2567-2575.1992; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Li WM, 2005, INT J TUBERC LUNG D, V9, P1314; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Pope KO, 2008, J BIOGEOGR, V35, P1, DOI 10.1111/j.1365-2699.2007.01797.x; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Soolingen D, 2001, EMERG INFECT DIS, V7, P763; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190	30	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43018	10.1371/journal.pone.0043018	http://dx.doi.org/10.1371/journal.pone.0043018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937008	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500026
J	Mikonranta, L; Friman, VP; Laakso, J				Mikonranta, Lauri; Friman, Ville-Petri; Laakso, Jouni			Life History Trade-Offs and Relaxed Selection Can Decrease Bacterial Virulence in Environmental Reservoirs	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CAMPYLOBACTER-JEJUNI; GALLERIA-MELLONELLA; SHIGA TOXIN; EVOLUTION; SERRATIA; MULTIPLE; HOST; AGGRESSIVENESS; PATHOGENICITY	Pathogen virulence is usually thought to evolve in reciprocal selection with the host. While this might be true for obligate pathogens, the life histories of opportunistic pathogens typically alternate between within-host and outside-host environments during the infection-transmission cycle. As a result, opportunistic pathogens are likely to experience conflicting selection pressures across different environments, and this could affect their virulence through life-history trait correlations. We studied these correlations experimentally by exposing an opportunistic bacterial pathogen Serratia marcescens to its natural protist predator Tetrahymena thermophila for 13 weeks, after which we measured changes in bacterial traits related to both anti-predator defence and virulence. We found that anti-predator adaptation (producing predator-resistant biofilm) caused a correlative attenuation in virulence. Even though the direct mechanism was not found, reduction in virulence was most clearly connected to a predator-driven loss of a red bacterial pigment, prodigiosin. Moreover, life-history trait evolution was more divergent among replicate populations in the absence of predation, leading also to lowered virulence in some of the 'predator absent' selection lines. Together these findings suggest that the virulence of non-obligatory, opportunistic bacterial pathogens can decrease in environmental reservoirs through life history trade-offs, or random accumulation of mutations that impair virulence traits under relaxed selection.	[Mikonranta, Lauri; Friman, Ville-Petri; Laakso, Jouni] Univ Jyvaskyla, Ctr Excellence Biol Interact, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Friman, Ville-Petri; Laakso, Jouni] Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland; [Friman, Ville-Petri] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Jyvaskyla; University of Helsinki; University of Oxford	Mikonranta, L (corresponding author), Univ Jyvaskyla, Ctr Excellence Biol Interact, Dept Biol & Environm Sci, Jyvaskyla, Finland.	lauri.mikonranta@jyu.fi	Laakso, Jouni/I-7794-2013	Laakso, Jouni/0000-0001-8245-9912; Friman, Ville-Petri/0000-0002-1592-157X	Finnish Academy [1130724]; Finnish Cultural Foundation [12256]; Marie Curie Intra European Fellowship within the 7th European Community Framework Programme	Finnish Academy(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Marie Curie Intra European Fellowship within the 7th European Community Framework Programme(European Commission)	The study was funded by the Finnish Academy (http://www.aka.fi/en-GB/A/Project #1130724, J.L.), the Finnish Cultural Foundation (http://www.skr.fi/default.asp?docId = 12256 L.M.), and Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (V.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2011, TRENDS MICROBIOL, V19, P24, DOI 10.1016/j.tim.2010.09.005; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Barrett LG, 2011, ECOL LETT, V14, P1149, DOI 10.1111/j.1461-0248.2011.01687.x; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Brown SP, 2009, EVOL APPL, V2, P32, DOI 10.1111/j.1752-4571.2008.00059.x; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Carson ML, 1998, PLANT DIS, V82, P1043, DOI 10.1094/PDIS.1998.82.9.1043; Casadevall A, 2007, EUKARYOT CELL, V6, P2169, DOI 10.1128/EC.00308-07; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Coulthurst SJ, 2004, MICROBIOL-SGM, V150, P1901, DOI 10.1099/mic.0.26946-0; Deorukhkar AA, 2007, RES MICROBIOL, V158, P399, DOI 10.1016/j.resmic.2007.02.010; Duriez P, 2008, APPL ENVIRON MICROB, V74, P3935, DOI 10.1128/AEM.02710-07; Fenner L, 2006, CRIT CARE MED, V34, P823, DOI 10.1097/01.CCM.0000201878.51343.F1; Fineran PC, 2007, J BACTERIOL, V189, P7653, DOI 10.1128/JB.00671-07; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; Friman VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017651; Friman VP, 2011, AM NAT, V177, P334, DOI 10.1086/658364; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Hall AR, 2008, J EVOLUTION BIOL, V21, P610, DOI 10.1111/j.1420-9101.2007.01473.x; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Hershberg R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r164; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kannan P, 2009, CURR MICROBIOL, V59, P641, DOI 10.1007/s00284-009-9486-8; Kimura M., 1983, NEUTRAL THEORY MOL E; KROLL JS, 1988, J BACTERIOL, V170, P859, DOI 10.1128/jb.170.2.859-864.1988; Lahti DC, 2009, TRENDS ECOL EVOL, V24, P487, DOI 10.1016/j.tree.2009.03.010; Lainhart W, 2009, J BACTERIOL, V191, P5116, DOI 10.1128/JB.00508-09; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lenski RE, 2011, NAT GENET, V43, P1174, DOI 10.1038/ng.1011; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Loriia Zh K, 1977, Mikrobiologiia, V46, P647; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Malik-Kale P, 2007, APPL ENVIRON MICROB, V73, P3123, DOI 10.1128/AEM.01399-06; Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004; Matsuyama T, 2011, MICROBIOL MONOGR, V20, P93, DOI 10.1007/978-3-642-14490-5_4; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Maynard Smith J, 1989, EVOLUTIONARY PROGR; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Meyer JR, 2007, NATURE, V446, P432, DOI 10.1038/nature05599; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Montarry J, 2007, FUNCT ECOL, V21, P603, DOI 10.1111/j.1365-2435.2007.01252.x; NEWELL DG, 1985, J HYG-CAMBRIDGE, V94, P45, DOI 10.1017/S0022172400061118; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Racey D, 2010, EVOLUTION, V64, P515, DOI 10.1111/j.1558-5646.2009.00821.x; Rasmussen MA, 2005, INFECT IMMUN, V73, P4668, DOI 10.1128/IAI.73.8.4668-4675.2005; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Tan MW, 2002, ANNU REV MICROBIOL, V56, P539, DOI 10.1146/annurev.micro.56.012302.161110; Thelaus J, 2009, FEMS MICROBIOL ECOL, V67, P69, DOI 10.1111/j.1574-6941.2008.00612.x; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vial L, 2010, ISME J, V4, P49, DOI 10.1038/ismej.2009.95	62	35	36	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43801	10.1371/journal.pone.0043801	http://dx.doi.org/10.1371/journal.pone.0043801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937098	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500100
J	Nakanishi, A; Kobayashi, N; Suzuki-Hirano, A; Nishihara, H; Sasaki, T; Hirakawa, M; Sumiyama, K; Shimogori, T; Okada, N				Nakanishi, Akiko; Kobayashi, Naoki; Suzuki-Hirano, Asuka; Nishihara, Hidenori; Sasaki, Takeshi; Hirakawa, Mika; Sumiyama, Kenta; Shimogori, Tomomi; Okada, Norihiro			A SINE-Derived Element Constitutes a Unique Modular Enhancer for Mammalian Diencephalic Fgf8	PLOS ONE			English	Article							MOBILE ELEMENTS; GENE-REGULATION; EVOLUTION; EXPRESSION; SEQUENCES; GENOME; OXYTOCIN; SYSTEM; IDENTIFICATION; TELENCEPHALON	Transposable elements, including short interspersed repetitive elements (SINEs), comprise nearly half the mammalian genome. Moreover, they are a major source of conserved non-coding elements (CNEs), which play important functional roles in regulating development-related genes, such as enhancing and silencing, serving for the diversification of morphological and physiological features among species. We previously reported a novel SINE family, AmnSINE1, as part of mammalian-specific CNEs. One AmnSINE1 locus, named AS071, showed an enhancer property in the developing mouse diencephalon. Indeed, AS071 appears to recapitulate the expression of diencephalic fibroblast growth factor 8 (Fgf8). Here we established three independent lines of AS071-transgenic mice and performed detailed expression profiling of AS071-enhanced lacZ in comparison with that of Fgf8 across embryonic stages. We demonstrate that AS071 is a distal enhancer that directs Fgf8 expression in the developing diencephalon. Furthermore, enhancer assays with constructs encoding partially deleted AS071 sequence revealed a unique modular organization in which AS071 contains at least three functionally distinct sub-elements that cooperatively direct the enhancer activity in three diencephalic domains, namely the dorsal midline and the lateral wall of the diencephalon, and the ventral midline of the hypothalamus. Interestingly, the AmnSINE1-derived sub-element was found to specify the enhancer activity to the ventral midline of the hypothalamus. To our knowledge, this is the first discovery of an enhancer element that could be separated into respective sub-elements that determine regional specificity and/or the core enhancing activity. These results potentiate our understanding of the evolution of retroposon-derived cis-regulatory elements as well as the basis for future studies of the molecular mechanism underlying the determination of domain-specificity of an enhancer.	[Nakanishi, Akiko; Kobayashi, Naoki; Nishihara, Hidenori; Sasaki, Takeshi; Okada, Norihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan; [Suzuki-Hirano, Asuka; Shimogori, Tomomi] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Hirakawa, Mika] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan; [Sumiyama, Kenta] Natl Inst Genet, Mishima, Shizuoka 411, Japan	Tokyo Institute of Technology; RIKEN; Kyoto University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Nakanishi, A (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan.	nokada@bio.titech.ac.jp	Sumiyama, Kenta/ABD-5577-2020; Shimogori, Tomomi/L-2893-2013; Sumiyama, Kenta/L-5902-2013; Nishihara, Hidenori/B-9324-2015	Sumiyama, Kenta/0000-0001-8785-5439; Shimogori, Tomomi/0000-0002-6931-5401; Sumiyama, Kenta/0000-0001-8785-5439; Nishihara, Hidenori/0000-0002-5843-9994	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23123504] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (S) and a Grant-in-Aid for Scientific Research on Innovative Areas "Genetic Bases for the Evolution of Complex Adaptive Traits" from the Ministry of Education, Culture, Sports, Science and Technology of Japan to NO. This work was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Neural Diversity and neocortical Organization" from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HN, and Grant-in-Aid for JSPS follows to ASH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beermann F, 2006, GENESIS, V44, P1, DOI 10.1002/gene.20177; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brooks LR, 2010, ENDOCRINE, V38, P174, DOI 10.1007/s12020-010-9366-9; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; Choleris E, 2009, FRONT NEUROENDOCRIN, V30, P442, DOI 10.1016/j.yfrne.2009.05.003; COLLIN JP, 1989, ARCH HISTOL CYTOL, V52, P441, DOI 10.1679/aohc.52.Suppl_441; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Echevarria D, 2005, BRAIN RES REV, V49, P150, DOI 10.1016/j.brainresrev.2004.12.035; Falcon J, 2009, ANN NY ACAD SCI, V1163, P101, DOI 10.1111/j.1749-6632.2009.04435.x; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Franchini LF, 2011, P NATL ACAD SCI USA, V108, P15270, DOI 10.1073/pnas.1104997108; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fukada Y, 2002, MOL NEUROBIOL, V25, P19, DOI 10.1385/MN:25:1:019; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Girard L, 1999, DEV GENET, V25, P291, DOI 10.1002/(SICI)1520-6408(1999)25:4<291::AID-DVG2>3.0.CO;2-5; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hirakawa M, 2009, GENE, V441, P100, DOI 10.1016/j.gene.2008.12.009; Hobert O, 2010, CURR BIOL, V20, pR697, DOI 10.1016/j.cub.2010.07.035; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Inoue F, 2008, DEV BIOL, V316, P471, DOI 10.1016/j.ydbio.2008.01.013; Kataoka A, 2008, DEVELOPMENT, V135, P2873, DOI 10.1242/dev.021618; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Komisarczuk AZ, 2009, DEV BIOL, V336, P301, DOI 10.1016/j.ydbio.2009.09.029; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Martinez S, 1999, DEVELOPMENT, V126, P1189; Martinez-Ferre A, 2009, J NEUROSCI, V29, P13389, DOI 10.1523/JNEUROSCI.2625-09.2009; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; Okada N, 2010, GENES CELLS, V15, P801, DOI 10.1111/j.1365-2443.2010.01429.x; Pedersen CA, 2006, GENES BRAIN BEHAV, V5, P274, DOI 10.1111/j.1601-183X.2005.00162.x; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Shinya M, 2001, DEVELOPMENT, V128, P4153; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; Suda Y, 2010, DEVELOPMENT, V137, P2939, DOI 10.1242/dev.048843; Suzuki-Hirano A, 2009, SEMIN CELL DEV BIOL, V20, P719, DOI 10.1016/j.semcdb.2009.04.002; Tashiro K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028497; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Tsai PS, 2011, FRONT NEUROENDOCRIN, V32, P95, DOI 10.1016/j.yfrne.2010.11.002; Tsujimura T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001245; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Young KA, 2011, FRONT NEUROENDOCRIN, V32, P53, DOI 10.1016/j.yfrne.2010.07.006	62	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43785	10.1371/journal.pone.0043785	http://dx.doi.org/10.1371/journal.pone.0043785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937095	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500097
J	Nikitina, IY; Kondratuk, NA; Kosmiadi, GA; Amansahedov, RB; Vasilyeva, IA; Ganusov, VV; Lyadova, IV				Nikitina, Irina Yu; Kondratuk, Natalya A.; Kosmiadi, George A.; Amansahedov, Rasul B.; Vasilyeva, Irina A.; Ganusov, Vitaly V.; Lyadova, Irina V.			Mtb-Specific CD27(low) CD4 T Cells as Markers of Lung Tissue Destruction during Pulmonary Tuberculosis in Humans	PLOS ONE			English	Article							IFN-GAMMA; ACTIVE TUBERCULOSIS; CUTTING EDGE; INFECTION; DIAGNOSIS; RESPONSES; ASSAY; ANTIGEN; BLOOD	Background: Effector CD4 T cells represent a key component of the host's anti-tuberculosis immune defense. Successful differentiation and functioning of effector lymphocytes protects the host against severe M. tuberculosis (Mtb) infection. On the other hand, effector T cell differentiation depends on disease severity/activity, as T cell responses are driven by antigenic and inflammatory stimuli released during infection. Thus, tuberculosis (TB) progression and the degree of effector CD4 T cell differentiation are interrelated, but the relationships are complex and not well understood. We have analyzed an association between the degree of Mtb-specific CD4 T cell differentiation and severity/activity of pulmonary TB infection. Methodology/Principal Findings: The degree of CD4 T cell differentiation was assessed by measuring the percentages of highly differentiated CD27(low) cells within a population of Mtb-specific CD4 T lymphocytes ("CD27(low) IFN-gamma(+)" cells). The percentages of CD27(low) IFN-gamma(+) cells were low in healthy donors (median, 33.1%) and TB contacts (21.8%) but increased in TB patients (47.3%, p<0.0005). Within the group of patients, the percentages of CD27(low) IFN-gamma(+) cells were uniformly high in the lungs (>76%), but varied in blood (12-92%). The major correlate for the accumulation of CD27(low) IFN-gamma(+) cells in blood was lung destruction (r = 0.65, p = 2.7x10(-7)). A cutoff of 47% of CD27(low) IFN-gamma(+) cells discriminated patients with high and low degree of lung destruction (sensitivity 89%, specificity 74%); a decline in CD27(low) IFN-gamma(+) cells following TB therapy correlated with repair and/or reduction of lung destruction (p<0.01). Conclusions: Highly differentiated CD27(low) Mtb-specific (CD27(low) IFN-gamma(+)) CD4 T cells accumulate in the lungs and circulate in the blood of patients with active pulmonary TB. Accumulation of CD27(low) IFN-gamma(+) cells in the blood is associated with lung destruction. The findings indicate that there is no deficiency in CD4 T cell differentiation during TB; evaluation of CD27(low) IFN-gamma(+) cells provides a valuable means to assess TB activity, lung destruction, and tissue repair following TB therapy.	[Nikitina, Irina Yu; Kondratuk, Natalya A.; Kosmiadi, George A.; Lyadova, Irina V.] Cent TB Res Inst, Dept Immunol, Moscow, Russia; [Amansahedov, Rasul B.] Cent TB Res Inst, Dept Radiol, Moscow, Russia; [Vasilyeva, Irina A.] Cent TB Res Inst, Dept Phtisiol, Moscow, Russia; [Ganusov, Vitaly V.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Ganusov, Vitaly V.] Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Nikitina, IY (corresponding author), Cent TB Res Inst, Dept Immunol, Moscow, Russia.	ivlyadova@mail.ru	Nikitina, Irina/U-2226-2017; Lyadova, Irina V/T-7806-2017	Nikitina, Irina/0000-0002-9232-5210; Lyadova, Irina V/0000-0003-3147-5386; Ganusov, Vitaly/0000-0001-6572-1691	CTRI RAMS; National Institutes of Health grant [1RO1AI078899]; Russian Foundation for Basic Research grant [10-04-01128]; National Institute for Mathematical and Biological Synthesis [EF-0832858]; University of Tennessee, Knoxville; ISTC grant [4072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078899] Funding Source: NIH RePORTER	CTRI RAMS; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research grant(Russian Foundation for Basic Research (RFBR)); National Institute for Mathematical and Biological Synthesis; University of Tennessee, Knoxville; ISTC grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by CTRI RAMS; National Institutes of Health grant # 1RO1AI078899 (IL) (www.nih.gov); Russian Foundation for Basic Research grant #10-04-01128 (IL) (www.rfbr.ru); National Institute for Mathematical and Biological Synthesis, award #EF-0832858, with additional support from The University of Tennessee, Knoxville (IN and VG) (www.nimbios.org); and partially by ISTC grant # 4072 (IL) (www.istc.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; APT AS, 1993, CLIN EXP IMMUNOL, V94, P322, DOI 10.1111/j.1365-2249.1993.tb03451.x; Baars PA, 2005, EUR J IMMUNOL, V35, P3131, DOI 10.1002/eji.200425770; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; de Bree GJ, 2007, J INFECT DIS, V195, P1718, DOI 10.1086/517612; den Hertog AL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002207; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Hamann D, 1999, INT IMMUNOL, V11, P1027, DOI 10.1093/intimm/11.7.1027; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jiang J, 2010, J CLIN IMMUNOL, V30, P566, DOI 10.1007/s10875-010-9418-1; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lyadova IV, 2004, CLIN EXP IMMUNOL, V138, P21, DOI 10.1111/j.1365-2249.2004.02573.x; Marzo AL, 2007, J IMMUNOL, V179, P36, DOI 10.4049/jimmunol.179.1.36; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; Menzies D, 2008, ANN INTERN MED, V148, P398, DOI 10.7326/0003-4819-148-5-200803040-00011; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; O'Kane CM, 2010, AM J RESP CELL MOL, V43, P465, DOI 10.1165/rcmb.2009-0211OC; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Pinto LM, 2011, MED PRIN PRACT, V21, P4, DOI 10.1159/000331583; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Schuetz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027284; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Streitz M, 2011, J INFECT DIS, V203, P378, DOI 10.1093/infdis/jiq065; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Zikos TA, 2011, CANCER IMMUNOL IMMUN, V60, P819, DOI 10.1007/s00262-011-0996-4	37	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43733	10.1371/journal.pone.0043733	http://dx.doi.org/10.1371/journal.pone.0043733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937086	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500088
J	Siqueira, T; Bini, LM; Roque, FO; Cottenie, K				Siqueira, Tadeu; Bini, Luis M.; Roque, Fabio O.; Cottenie, Karl			A Metacommunity Framework for Enhancing the Effectiveness of Biological Monitoring Strategies	PLOS ONE			English	Article							TAXONOMIC SUFFICIENCY; BIODIVERSITY SURVEYS; COMMUNITY ECOLOGY; INDICATOR GROUPS; AQUATIC INSECTS; SPECIES DATA; CONSERVATION; PATTERNS; NICHE; TRICHOPTERA	Because of inadequate knowledge and funding, the use of biodiversity indicators is often suggested as a way to support management decisions. Consequently, many studies have analyzed the performance of certain groups as indicator taxa. However, in addition to knowing whether certain groups can adequately represent the biodiversity as a whole, we must also know whether they show similar responses to the main structuring processes affecting biodiversity. Here we present an application of the metacommunity framework for evaluating the effectiveness of biodiversity indicators. Although the metacommunity framework has contributed to a better understanding of biodiversity patterns, there is still limited discussion about its implications for conservation and biomonitoring. We evaluated the effectiveness of indicator taxa in representing spatial variation in macroinvertebrate community composition in Atlantic Forest streams, and the processes that drive this variation. We focused on analyzing whether some groups conform to environmental processes and other groups are more influenced by spatial processes, and on how this can help in deciding which indicator group or groups should be used. We showed that a relatively small subset of taxa from the metacommunity would represent 80% of the variation in community composition shown by the entire metacommunity. Moreover, this subset does not have to be composed of predetermined taxonomic groups, but rather can be defined based on random subsets. We also found that some random subsets composed of a small number of genera performed better in responding to major environmental gradients. There were also random subsets that seemed to be affected by spatial processes, which could indicate important historical processes. We were able to integrate in the same theoretical and practical framework, the selection of biodiversity surrogates, indicators of environmental conditions, and more importantly, an explicit integration of environmental and spatial processes into the selection approach.	[Siqueira, Tadeu] Univ Estadual Paulista, UNESP, Dept Ecol, Sao Paulo, Brazil; [Bini, Luis M.] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil; [Roque, Fabio O.] Univ Fed Mato Grosso do Sul, Dept Biol, Campo Grande, MS, Brazil; [Cottenie, Karl] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Universidade Estadual Paulista; Universidade Federal de Goias; Universidade Federal de Mato Grosso do Sul; University of Guelph	Siqueira, T (corresponding author), Univ Estadual Paulista, UNESP, Dept Ecol, Sao Paulo, Brazil.	tsiqueira@rc.unesp.br	Bini, Luis Mauricio/D-5865-2013; Siqueira, Tadeu/A-6978-2009; Roque, Fabio/B-5514-2013	Bini, Luis Mauricio/0000-0003-3398-9399; Siqueira, Tadeu/0000-0001-5069-2904; Cottenie, Karl/0000-0001-9498-8483	CNPq [150922/2010-8, 303293/2009-8]; NSERC	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	TS was supported by a CNPq postdoctoral grant (process 150922/2010-8). FOR receives a productivity grant from the CNPq (process 303293/2009-8). KC was supported by a NSERC discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Bonada N, 2006, ANNU REV ENTOMOL, V51, P495, DOI 10.1146/annurev.ento.51.110104.151124; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown J. H., 1998, BIOGEOGRAPHY; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Economo EP, 2011, AM NAT, V177, pE167, DOI 10.1086/659946; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Fleishman E, 2009, CONSERV BIOL, V23, P1109, DOI 10.1111/j.1523-1739.2009.01246.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Halley JM, 2011, P NATL ACAD SCI USA, V108, P2316, DOI 10.1073/pnas.1011217108; Heino J, 2008, LANDSCAPE ECOL, V23, P417, DOI 10.1007/s10980-008-9199-6; Heino Jani, 2009, Freshwater Reviews, V2, P1, DOI 10.1608/FRJ-2.1.1; Hering D, 2009, AQUAT SCI, V71, P3, DOI 10.1007/s00027-009-9159-5; Hitt NP, 2011, J N AM BENTHOL SOC, V30, P296, DOI 10.1899/09-155.1; Holzenthal RW, 2007, ZOOTAXA, P639; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Hubbell Stephen P., 2001, V32, pi; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Johnson RK, 2006, HYDROBIOLOGIA, V566, P115, DOI 10.1007/s10750-006-0101-8; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Landeiro VL, 2012, ECOL INDIC, V23, P366, DOI 10.1016/j.ecolind.2012.04.023; Larsen FW, 2009, DIVERS DISTRIB, V15, P70, DOI 10.1111/j.1472-4642.2008.00507.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Lopes PM, 2011, ECOL INDIC, V11, P1171, DOI 10.1016/j.ecolind.2010.12.017; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; Melo AS, 2005, ARCH HYDROBIOL, V164, P309, DOI 10.1127/0003-9136/2005/0164-0309; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Ng ISY, 2009, HYDROBIOLOGIA, V619, P133, DOI 10.1007/s10750-008-9605-8; Pawar SS, 2007, DIVERS DISTRIB, V13, P53, DOI 10.1111/j.1472-4642.2006.00298.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabeni CF, 2001, ENVIRON MONIT ASSESS, V71, P177, DOI 10.1023/A:1017523115381; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Roque FO, 2010, FRESHWATER BIOL, V55, P847, DOI 10.1111/j.1365-2427.2009.02314.x; Rosenberg D.M.., 1993, FRESHWATER BIOMONITO; Siqueira T, 2008, AUSTRAL ECOL, V33, P902, DOI 10.1111/j.1442-9993.2008.01885.x; Siqueira T, 2012, ECOGRAPHY, V35, P183, DOI 10.1111/j.1600-0587.2011.06875.x; Siqueira T, 2009, HYDROBIOLOGIA, V636, P163, DOI 10.1007/s10750-009-9945-z; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Statzner B, 2011, INT REV HYDROBIOL, V96, P121, DOI 10.1002/iroh.201111325; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Suriano MT, 2011, ENVIRON MONIT ASSESS, V175, P87, DOI 10.1007/s10661-010-1495-3; Terlizzi A, 2003, MAR POLLUT BULL, V46, P556, DOI 10.1016/S0025-326X(03)00066-3; Tognelli MF, 2005, BIOL CONSERV, V121, P409, DOI 10.1016/j.biocon.2004.05.013; Vellend M, 2008, J APPL ECOL, V45, P161, DOI 10.1111/j.1365-2664.2007.01413.x; Vinson MR, 1998, ANNU REV ENTOMOL, V43, P271, DOI 10.1146/annurev.ento.43.1.271; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Winegardner AK, 2012, TRENDS ECOL EVOL, V27, P253, DOI 10.1016/j.tree.2012.01.007	62	62	64	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43626	10.1371/journal.pone.0043626	http://dx.doi.org/10.1371/journal.pone.0043626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937068	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500069
J	Shiozaki, A; Shen-Tu, G; Bai, XH; Iitaka, D; De Falco, V; Santoro, M; Keshavjee, S; Liu, MY				Shiozaki, Atsushi; Shen-Tu, Grace; Bai, Xiaohui; Iitaka, Daisuke; De Falco, Valentina; Santoro, Massimo; Keshavjee, Shaf; Liu, Mingyao			XB130 Mediates Cancer Cell Proliferation and Survival through Multiple Signaling Events Downstream of Akt	PLOS ONE			English	Article							PROTEIN-KINASE B; FORKHEAD TRANSCRIPTION FACTOR; LUNG EPITHELIAL-CELLS; THYROID-CARCINOMA; ADAPTER PROTEIN; IN-VIVO; PHOSPHORYLATION; ACTIVATION; EXPRESSION; APOPTOSIS	XB130, a novel adaptor protein, mediates RET/PTC chromosome rearrangement-related thyroid cancer cell proliferation and survival through phosphatidyl-inositol-3-kinase (PI3K)/Akt pathway. Recently, XB130 was found in different cancer cells in the absence of RET/PTC. To determine whether RET/PTC is required of XB130-related cancer cell proliferation and survival, WRO thyroid cancer cells (with RET/PTC mutation) and A549 lung cancer cells (without RET/PTC) were treated with XB130 siRNA, and multiple Akt down-stream signals were examined. Knocking-down of XB130 inhibited G(1)-S phase progression, and induced spontaneous apoptosis and enhanced intrinsic and extrinsic apoptotic stimulus-induced cell death. Knocking-down of XB130 reduced phosphorylation of p21Cip1/WAF1, p27Kip1, FOXO3a and GSK3 beta, increased p21Cip1/WAF1protein levels and cleavages of caspase-8 and-9. However, the phosphorylation of FOXO1 and the protein levels of p53 were not affected by XB130 siRNA. We also found XB130 can be phosphorylated by multiple protein tyrosine kinases. These results indicate that XB130 is a substrate of multiple protein tyrosine kinases, and it can regulate cell proliferation and survival through modulating selected down-stream signals of PI3K/Akt pathway. XB130 could be involved in growth and survival of different cancer cells.	[Shiozaki, Atsushi; Shen-Tu, Grace; Bai, Xiaohui; Iitaka, Daisuke; Keshavjee, Shaf; Liu, Mingyao] Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Keshavjee, Shaf; Liu, Mingyao] Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5S 1A1, Canada; [Keshavjee, Shaf; Liu, Mingyao] CNR G Salvatore, Dipartimento Biol & Patol Cellulare & Mol, Ist Endocrinol & Oncol Sperimentale, Naples, Italy	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Shiozaki, A (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada.	mingyao.liu@utoronto.ca	DE FALCO, VALENTINA/C-2061-2015	DE FALCO, VALENTINA/0000-0002-8972-7921; Keshavjee, Shaf/0000-0003-4547-8094; Liu, Mingyao/0000-0002-9188-8417	Canadian Institutes of Health Research [MOP-13270, MOP-42546]; Uehara Memorial Foundation; International Society of Heart and Lung Transplantation; Associazione Italiana Ricerca sul Cancro (AIRC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Uehara Memorial Foundation(Uehara Memorial Foundation); International Society of Heart and Lung Transplantation; Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by operating grants (MOP-13270 and MOP-42546) from Canadian Institutes of Health Research, Research Fellowship Awards from Uehara Memorial Foundation and International Society of Heart and Lung Transplantation for Dr. Atsushi Shiozaki and by Associazione Italiana Ricerca sul Cancro (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Balogh K, 2011, ONCOGENE; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Bernassola F, 1999, CELL DEATH DIFFER, V6, P652, DOI 10.1038/sj.cdd.4400537; Brognard J, 2001, CANCER RES, V61, P3986; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fung SY, 2011, BIOMATERIALS, V32, P4000, DOI 10.1016/j.biomaterials.2011.02.005; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Keane MM, 1996, CANCER RES, V56, P4791; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu W, 2005, MOL ENDOCRINOL, V19, P2349, DOI 10.1210/me.2005-0117; Liu W, 2002, AM J PATHOL, V160, P511, DOI 10.1016/S0002-9440(10)64870-5; Lodyga M, 2002, AM J PHYSIOL-LUNG C, V283, pL265, DOI 10.1152/ajplung.00492.2001; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Lodyga M, 2010, J CELL SCI, V123, P4156, DOI 10.1242/jcs.071050; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Moore SM, 1998, CANCER RES, V58, P5239; Mura M, 2006, CRIT CARE, V10, DOI 10.1186/cc5042; NOGUCHI PD, 1981, CYTOMETRY, V1, P390, DOI 10.1002/cyto.990010607; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Ping B, 2006, INT J ONCOL, V29, P1103; Razzini G, 2000, FASEB J, V14, P1179, DOI 10.1096/fasebj.14.9.1179; Ringel MD, 2001, CANCER RES, V61, P6105; Rokhlin OW, 2002, PROSTATE, V52, P1, DOI 10.1002/pros.10074; ROMANO A, 1994, ONCOGENE, V9, P2923; Santarpia L, 2010, CANCER-AM CANCER SOC, V116, P2974, DOI 10.1002/cncr.25061; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038049; Shiozaki Atsushi, 2011, J Clin Bioinforma, V1, P10, DOI 10.1186/2043-9113-1-10; Shiozaki A, 2011, AM J PATHOL, V178, P391, DOI 10.1016/j.ajpath.2010.11.024; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Tang PS, 2008, AM J PHYSIOL-LUNG C, V294, pL632, DOI 10.1152/ajplung.00262.2007; Tang PS, 2006, J CELL PHYSIOL, V209, P457, DOI 10.1002/jcp.20751; Tartari CJ, 2011, AM J CANCER RES, V1, P716; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yamanaka D, 2012, MOL ENDOCRINOL, V26, P1043, DOI 10.1210/me.2011-1349; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	56	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43646	10.1371/journal.pone.0043646	http://dx.doi.org/10.1371/journal.pone.0043646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928011	gold, Green Published, Green Submitted			2022-12-27	WOS:000308224700021
J	Wang, J; Guo, JS; Wu, S; Feng, HQ; Sun, SJ; Pan, J; Zhang, J; Beebe, SJ				Wang, Jing; Guo, Jinsong; Wu, Shan; Feng, Hongqing; Sun, Shujun; Pan, Jie; Zhang, Jue; Beebe, Stephen J.			Synergistic Effects of Nanosecond Pulsed Electric Fields Combined with Low Concentration of Gemcitabine on Human Oral Squamous Cell Carcinoma In Vitro	PLOS ONE			English	Article							ELECTROPORATION THERAPY; INDUCE APOPTOSIS; HEAD; CALCIUM; MECHANISMS; DEATH; DRUG; TRANSLOCATION; RESISTANCE; SURVIVAL	Treatment of cancer often involves uses of multiple therapeutic strategies with different mechanisms of action. In this study we investigated combinations of nanosecond pulsed electric fields (nsPEF) with low concentrations of gemcitabine on human oral cancer cells. Cells (Cal-27) were treated with pulse parameters (20 pulses, 100 ns in duration, intensities of 10, 30 and 60 kV/cm) and then cultured in medium with 0.01 mu g/ml gemcitabine. Proliferation, apoptosis/necrosis, invasion and morphology of those cells were examined using MTT, flow cytometry, clonogenics, transwell migration and TEM assay. Results show that combination treatments of gemcitabine and nsPEFs exhibited significant synergistic activities versus individual treatments for inhibiting oral cancer cell proliferation and inducing apoptosis and necrosis. However, there was no apparent synergism for cell invasion. By this we demonstrated synergistic inhibition of Cal-27 cells in vitro by nsPEFs and gemcitabine. Synergistic behavior indicates that these two treatments have different sites of action and combination treatment allows reduced doses of gemcitabine and lower nsPEF conditions, which may provide better treatment for patients than either treatment alone while reducing systemic toxicities.	[Wang, Jing; Guo, Jinsong] Lanzhou Univ, Dept Oral Med, Sch Stomatol, Lanzhou, Gansu, Peoples R China; [Guo, Jinsong; Wu, Shan; Feng, Hongqing; Zhang, Jue] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Sun, Shujun; Zhang, Jue] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Pan, Jie] Peking Univ, Sch Stomatol, Dept Gen Dent, Beijing 100871, Peoples R China; [Beebe, Stephen J.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA	Lanzhou University; Peking University; Peking University; Peking University; Old Dominion University	Wang, J (corresponding author), Lanzhou Univ, Dept Oral Med, Sch Stomatol, Lanzhou, Gansu, Peoples R China.	panjie72@sina.com; sbeebe@odu.edu	Feng, Hongqing/I-5222-2019; Zhang, Jue/N-7594-2013; Zhang, Jue/E-2067-2014	Feng, Hongqing/0000-0003-2767-3080; Guo, Jinsong/0000-0002-7379-4708	Gansu Chinese Medicine Funds [GZK-2011-78]; Fundamental Research Funds for the Central Universities [lzujbky-2012-159]; Mr. Fran Reidy, Bioelectrics Inc.	Gansu Chinese Medicine Funds; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Mr. Fran Reidy, Bioelectrics Inc.	This work was supported by Gansu Chinese Medicine Funds (GZK-2011-78), Fundamental Research Funds for the Central Universities (lzujbky-2012-159), and Mr. Fran Reidy, Bioelectrics Inc. The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript. In addition, Mr. Reidy and Bioelectric Inc. have not pre-reviewed or seen the data presented in this manuscript.	Beebe SJ, 2004, PHYSIOL MEAS, V25, P1077, DOI 10.1088/0967-3334/25/4/023; Beebe SJ, 2003, DNA CELL BIOL, V22, P785, DOI 10.1089/104454903322624993; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Beebe SJ, 2002, IEEE T PLASMA SCI, V30, P286, DOI 10.1109/TPS.2002.1003872; Beebe Stephen J, 2010, Cancers (Basel), V2, P1731, DOI 10.3390/cancers2031731; Boyl P, 2008, WORLD CANC REPORT; BRAAKHUIS BJM, 1991, CANCER RES, V51, P211; Buescher ES, 2004, IEEE T PLASMA SCI, V32, P1563, DOI 10.1109/TPS.2004.832643; Burian M, 2003, ACTA OTO-LARYNGOL, V123, P264, DOI 10.1080/00016480310001114; Carmichael J, 1995, BRIT J CANCER, V8, P21; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Chen YW, 2011, MOL BIOSYST, V7, P3065, DOI 10.1039/c1mb05125c; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Dev SB, 2000, IEEE T PLASMA SCI, V28, P206, DOI 10.1109/27.842905; Eguchi Y, 1997, CANCER RES, V57, P1835; Ford WE, 2010, ARCH BIOCHEM BIOPHYS, V497, P82, DOI 10.1016/j.abb.2010.03.008; Frey W, 2006, BIOPHYS J, V90, P3608, DOI 10.1529/biophysj.105.072777; Galmarini Carlos Maria, 2004, BMC Pharmacology, V4, P8, DOI 10.1186/1471-2210-4-8; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V349, P643, DOI 10.1016/j.bbrc.2006.08.097; Hall EH, 2007, APOPTOSIS, V12, P1721, DOI 10.1007/s10495-007-0083-7; Heller LC, 2011, CLINICAL ASPECTS OF ELECTROPORATION, P159, DOI 10.1007/978-1-4419-8363-3_14; Hofmann GA, 1999, IEEE T BIO-MED ENG, V46, P752, DOI 10.1109/10.764952; Hu Q, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031902; HUANG P, 1995, SEMIN ONCOL, V22, P19; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Landstrom FJ, 2010, DERMATOL SURG, V36, P1245, DOI 10.1111/j.1524-4725.2010.01617.x; Lawrence TS, 2001, CLIN CANCER RES, V7, P314; LeBlanc AK, 2004, VET RADIOL ULTRASOUN, V45, P466, DOI 10.1111/j.1740-8261.2004.04080.x; Mir Lluis M., 2008, V423, P3, DOI 10.1007/978-1-59745-194-9_1; Mir LM, 1999, ADV DRUG DELIVER REV, V35, P107, DOI 10.1016/S0169-409X(98)00066-0; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; OKINO M, 1987, JPN J CANCER RES, V78, P1319; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Panesar K, 2011, US PHARM, V36, P7; Pauwels B, 2005, ONCOLOGIST, V10, P34, DOI 10.1634/theoncologist.10-1-34; Petersen PE, 2009, ORAL ONCOL, V45, P454, DOI 10.1016/j.oraloncology.2008.05.023; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; PRAUSNITZ MR, 1993, P NATL ACAD SCI USA, V90, P10504, DOI 10.1073/pnas.90.22.10504; Ren W, 2012, BIOCHEM BIOPH RES CO, V421, P808, DOI 10.1016/j.bbrc.2012.04.094; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; Rhodus N, 2007, INSIDE DENT, V3, P1; Schoenbach KH, 2004, P IEEE, V92, P1122, DOI 10.1109/JPROC.2004.829009; Spielmann M, 2001, ONCOLOGY-BASEL, V60, P303, DOI 10.1159/000058524; Stacey M, 2003, MUTAT RES-GEN TOX EN, V542, P65, DOI 10.1016/j.mrgentox.2003.08.006; Sun C, 2004, C P IEEE ENG MED BIO, V7, P5005; Ueno H, 2007, BRIT J CANCER, V97, P145, DOI 10.1038/sj.bjc.6603860; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2011, IEEE ENG MED BIO, P743, DOI 10.1109/IEMBS.2011.6090169; Vernier PT, 2003, IEEE T DIELECT EL IN, V10, P795, DOI 10.1109/TDEI.2003.1237329; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Wu Y, 2009, CLIN THER, V31, P2416, DOI 10.1016/j.clinthera.2009.11.020	55	60	70	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43213	10.1371/journal.pone.0043213	http://dx.doi.org/10.1371/journal.pone.0043213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927951	Green Published, Green Submitted, gold			2022-12-27	WOS:000308224700012
J	Caballo, C; Palomo, M; Cases, A; Galan, AM; Molina, P; Vera, M; Bosch, X; Escolar, G; Diaz-Ricart, M				Caballo, Carolina; Palomo, Marta; Cases, Aleix; Galan, Ana M.; Molina, Patricia; Vera, Manel; Bosch, Xavier; Escolar, Gines; Diaz-Ricart, Maribel			NF kappa B in the Development of Endothelial Activation and Damage in Uremia: An In Vitro Approach	PLOS ONE			English	Article							GLUCOSE DEGRADATION-PRODUCTS; PERITONEAL-DIALYSIS; CARDIOVASCULAR-DISEASE; HEMODIALYSIS-PATIENTS; DEPENDENT VASODILATION; ADHESION MOLECULES; RENAL-FAILURE; CELLS; DYSFUNCTION; EXPRESSION	Impaired hemostasis coexists with accelerated atherosclerosis in patients with chronic kidney disease (CKD). The elevated frequency of atherothrombotic events has been associated with endothelial dysfunction. The relative contribution of the uremic state and the impact of the renal replacement therapies have been often disregarded. Plasma markers of endothelial activation and damage were evaluated in three groups of patients with CKD: under conservative treatment (predialysis), on hemodialysis, and on peritoneal dialysis. Activation of p38 MAPK and the transcription factor NFkB was assessed in endothelial cell (EC) cultures exposed to pooled sera from each group of patients. Most of the markers evaluated (VCAM-1, ICAM-1, VWF, circulating endothelial cells) were significantly higher in CDK patients than in controls, being significantly more increased in the group of peritoneal dialysis patients. These results correlated with the activation of both p38 MAPK and NFkB in EC cells exposed to the same sera samples, and also to the peritoneal dialysis fluids. Hemodialysis did not further contribute to the endothelial damage induced by the uremic state observed in predialysis patients, probably due to the improved biocompatibility of the hemodialysis technique in recent years, resulting in lower cellular activation. However, peritoneal dialysis seemed to exert a significant proinflammatory effect on the endothelium that could be related to the high glucose concentrations and glucose degradation products present in the dialysis fluid. Although peritoneal dialysis has been traditionally considered a more physiological technique, our results raise some doubts with respect to inflammation and EC damage.	[Caballo, Carolina; Palomo, Marta; Galan, Ana M.; Molina, Patricia; Escolar, Gines; Diaz-Ricart, Maribel] Univ Barcelona, Hemotherapy Hemostasis Dept, Ctr Diagnost Biomed, Inst Invest Biomed August Pi & Sunyer,Hosp Clin, Barcelona, Spain; [Cases, Aleix; Vera, Manel] Univ Barcelona, Dept Nephrol, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Bosch, Xavier] Univ Barcelona, Dept Cardiol, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Caballo, C (corresponding author), Univ Barcelona, Hemotherapy Hemostasis Dept, Ctr Diagnost Biomed, Inst Invest Biomed August Pi & Sunyer,Hosp Clin, Barcelona, Spain.	mdiaz@clinic.ub.es	vera, manel/AAC-7133-2021; Escolar, Gines/I-1530-2015; Palomo, Marta/AAY-5510-2021; Albaladejo, Gines Escolar/AAC-9695-2020; Escolar, Gines/ABF-9003-2021; Bosch, Xavier/E-7890-2014; Palomo, Marta/AAY-4484-2021; Cases, Aleix/N-4736-2018	Escolar, Gines/0000-0002-6658-0381; Albaladejo, Gines Escolar/0000-0002-6658-0381; Bosch, Xavier/0000-0002-0133-1587; Palomo, Marta/0000-0002-3261-6577; Cases, Aleix/0000-0002-6962-8184; DIAZ-RICART, MARIBEL/0000-0003-1122-0052; VERA, MANEL/0000-0001-9937-7235	Ministerio de Economia y Competitividad [SAF2011-28214, SAF 2009-10365]; Fondo de Investigaciones de la Seguridad Social [PI08/0156, CP04-00112, PS09/00664]; German Jose Carreras Leukaemia Foundation [R 07/41v]; Red HERACLES, Instituto de Salud Carlos III [RD06/0009/1003]	Ministerio de Economia y Competitividad(Spanish Government); Fondo de Investigaciones de la Seguridad Social; German Jose Carreras Leukaemia Foundation; Red HERACLES, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been partially supported by grants: SAF2011-28214, SAF 2009-10365 (Ministerio de Economia y Competitividad); PI08/0156, CP04-00112, PS09/00664 (Fondo de Investigaciones de la Seguridad Social); German Jose Carreras Leukaemia Foundation (R 07/41v); and RD06/0009/1003 (Red HERACLES, Instituto de Salud Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AznarSalatti J, 1995, NEPHROL DIAL TRANSPL, V10, P2199, DOI 10.1093/ndt/10.12.2199; Blann A, 2009, HAEMATOLOGICA, V94, P149; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carbo C, 2008, AM J KIDNEY DIS, V51, P603, DOI 10.1053/j.ajkd.2007.11.029; Cheng LT, 2008, PERITON DIALYSIS INT, V28, P397; Cines DB, 1998, BLOOD, V91, P3527; Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; EBERST ME, 1994, AM J MED, V96, P168, DOI 10.1016/0002-9343(94)90138-4; Gordge M P, 1991, Platelets, V2, P115, DOI 10.3109/09537109109006021; GRIS JC, 1994, KIDNEY INT, V46, P807, DOI 10.1038/ki.1994.336; HERBELIN A, 1991, KIDNEY INT, V39, P954, DOI 10.1038/ki.1991.120; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Johnson DW, 2009, CLIN J AM SOC NEPHRO, V4, P1620, DOI 10.2215/CJN.01750309; Koc M, 2005, KIDNEY INT, V67, P1078, DOI 10.1111/j.1523-1755.2005.00173.x; Koc M, 2003, AM J KIDNEY DIS, V42, P704, DOI 10.1016/S0272-6386(03)00906-5; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Konings CJAM, 2002, PERITON DIALYSIS INT, V22, P477; KOYAMA H, 1989, LANCET, V1, P991; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Levey AS, 1999, NEPHROL DIAL TRANSPL, V14, P828, DOI 10.1093/ndt/14.4.828; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Merino A, 2010, CLIN J AM SOC NEPHRO, V5, P227, DOI 10.2215/CJN.03260509; Morgan LW, 2003, KIDNEY INT, V64, P1854, DOI 10.1046/j.1523-1755.2003.00265.x; Muller-Krebs S, 2008, EUR J CLIN INVEST, V38, P296, DOI 10.1111/j.1365-2362.2008.01945.x; Nordfors L, 2000, KIDNEY INT, V57, P1713, DOI 10.1046/j.1523-1755.2000.00016.x; Passauer J, 2000, J AM SOC NEPHROL, V11, P1726, DOI 10.1681/ASN.V1191726; Passlick-Deetjen J, 2001, SEMIN DIALYSIS, V14, P384, DOI 10.1046/j.1525-139X.2001.00100.x; Pecoits-Filho R, 2004, PERITON DIALYSIS INT, V24, P327; PERTOSA G, 1993, KIDNEY INT, V43, pS149; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; Ringoir S, 1997, KIDNEY INT, V52, pS2; Serradell M, 2003, NEPHROL DIAL TRANSPL, V18, P1079, DOI 10.1093/ndt/gfg161; Serradell M, 2002, HAEMATOLOGICA, V87, P1053; Serradell M, 2001, THROMB HAEMOSTASIS, V86, P1099; Sung B, 2010, CANCER RES, V70, P3259, DOI 10.1158/0008-5472.CAN-09-4230; U.S. Renal Data System (USRDS), 2011, USRDS 2011 ANN DAT R; vanGuldener C, 1997, NEPHROL DIAL TRANSPL, V12, P14; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; Witowski J, 2000, J AM SOC NEPHROL, V11, P729, DOI 10.1681/ASN.V114729; Zemel D, 1996, BLOOD PURIFICAT, V14, P198, DOI 10.1159/000170263; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	45	33	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43374	10.1371/journal.pone.0043374	http://dx.doi.org/10.1371/journal.pone.0043374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937042	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300046
J	Drechsler, J; Grotzinger, J; Hermanns, HM				Drechsler, Johannes; Groetzinger, Joachim; Hermanns, Heike M.			Characterization of the Rat Oncostatin M Receptor Complex Which Resembles the Human, but Differs from the Murine Cytokine Receptor	PLOS ONE			English	Article							LEUKEMIA-INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; T-CELL DEVELOPMENT; SWISS-MODEL; FETAL LIVER; INTERLEUKIN-6-TYPE CYTOKINES; RHEUMATOID-ARTHRITIS; SIGNAL-TRANSDUCTION; GROWTH-REGULATOR; IN-VITRO	Evaluation of a pathophysiological role of the interleukin-6-type cytokine oncostatin M (OSM) for human diseases has been complicated by the fact that mouse models of diseases targeting either OSM or the OSM receptor (OSMR) complex cannot fully reflect the human situation. This is due to earlier findings that human OSM utilizes two receptor complexes, glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR) (type I) and gp130/OSMR (type II), both with wide expression profiles. Murine OSM on the other hand only binds to the gp130/OSMR (type II) receptor complex with high affinity. Here, we characterize the receptor usage for rat OSM. Using different experimental approaches (knock-down of the OSMR expression by RNA interference, blocking of the LIFR by LIF-05, an antagonistic LIF variant and stably transfected Ba/F3 cells) we can clearly show that rat OSM surprisingly utilizes both, the type I and type II receptor complex, therefore mimicking the human situation. Furthermore, it displays cross-species activities and stimulates cells of human as well as murine origin. Its signaling capacities closely mimic those of human OSM in cell types of different origin in the way that strong activation of the Jak/STAT, the MAP kinase as well as the PI3K/Akt pathways can be observed. Therefore, rat disease models would allow evaluation of the relevance of OSM for human biology.	[Drechsler, Johannes; Hermanns, Heike M.] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany	German Research Foundation (DFG); University of Wurzburg; University of Kiel	Drechsler, J (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany.	Heike.Hermanns@virchow.uni-wuerzburg.de			Deutsche Forschungsgemeinschaft (DFG) [FZ82]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, FZ82) to H. M. H. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasanz-Puig A, 2011, ATHEROSCLEROSIS, V216, P292, DOI 10.1016/j.atherosclerosis.2011.02.003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Boileau C, 2000, J IMMUNOL, V164, P5713, DOI 10.4049/jimmunol.164.11.5713; Bonifati C, 1998, ARCH DERMATOL RES, V290, P9, DOI 10.1007/s004030050269; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Broxmeyer HE, 2002, IMMUNITY, V16, P815, DOI 10.1016/S1074-7613(02)00319-9; Clahsen T, 2005, CELL SIGNAL, V17, P559, DOI 10.1016/j.cellsig.2004.09.016; Clegg CH, 1996, NATURE, V384, P261, DOI 10.1038/384261a0; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Dreuw A, 2005, J INVEST DERMATOL, V124, P28, DOI 10.1111/j.0022-202X.2004.23499.x; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; Grenier A, 2001, LAB INVEST, V81, P133, DOI 10.1038/labinvest.3780220; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; Hara Takahiko, 1997, Leukemia (Basingstoke), V11, P449; Hermanns HM, 2000, J BIOL CHEM, V275, P40742, DOI 10.1074/jbc.M005408200; Hintzen C, 2008, J IMMUNOL, V181, P7341, DOI 10.4049/jimmunol.181.10.7341; Hintzen C, 2009, ARTHRITIS RHEUM-US, V60, P1932, DOI 10.1002/art.24602; Hohensinner PJ, 2009, FASEB J, V23, P774, DOI 10.1096/fj.08-108035; Hui W, 1997, ANN RHEUM DIS, V56, P184, DOI 10.1136/ard.56.3.184; JEFFERY E, 1993, CYTOKINE, V5, P107, DOI 10.1016/1043-4666(93)90048-A; Juan TSC, 2009, VET PATHOL, V46, P124, DOI 10.1354/vp.46-1-124; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265; Kinoshita T, 2001, EXP HEMATOL, V29, P1091, DOI 10.1016/S0301-472X(01)00686-5; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Langdon C, 2000, AM J PATHOL, V157, P1187, DOI 10.1016/S0002-9440(10)64634-2; Langdon C, 2003, J IMMUNOL, V170, P548, DOI 10.4049/jimmunol.170.1.548; Lee MJ, 2007, INT J BIOCHEM CELL B, V39, P650, DOI 10.1016/j.biocel.2006.11.003; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Lindberg RA, 1998, MOL CELL BIOL, V18, P3357, DOI 10.1128/MCB.18.6.3357; LINSLEY PS, 1990, MOL CELL BIOL, V10, P1882, DOI 10.1128/MCB.10.5.1882; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; MALIK N, 1995, MOL CELL BIOL, V15, P2349; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Okaya A, 2005, AM J PATHOL, V166, P709, DOI 10.1016/S0002-9440(10)62292-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plater-Zyberk C, 2001, ARTHRITIS RHEUM, V44, P2697, DOI 10.1002/1529-0131(200111)44:11<2697::AID-ART450>3.0.CO;2-#; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Suda T, 2002, CYTOKINE, V17, P335, DOI 10.1006/cyto.2002.1023; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vasse M, 1999, ARTERIOSCL THROM VAS, V19, P1835, DOI 10.1161/01.ATV.19.8.1835; Vernallis AB, 1997, J BIOL CHEM, V272, P26947, DOI 10.1074/jbc.272.43.26947; Wallace PM, 1999, J IMMUNOL, V162, P5547; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	51	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43155	10.1371/journal.pone.0043155	http://dx.doi.org/10.1371/journal.pone.0043155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937020	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300035
J	Shahsavar, A; Kastrup, JS; Nielsen, EO; Kristensen, JL; Gajhede, M; Balle, T				Shahsavar, Azadeh; Kastrup, Jette S.; Nielsen, Elsebet O.; Kristensen, Jesper L.; Gajhede, Michael; Balle, Thomas			Crystal Structure of Lymnaea stagnalis AChBP Complexed with the Potent nAChR Antagonist DH beta E Suggests a Unique Mode of Antagonism	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; BINDING-PROTEIN; COMPETITIVE ANTAGONIST; DETERMINANTS; AGONISTS; DIVERSITY	Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels that belong to the Cys-loop receptor superfamily. These receptors are allosteric proteins that exist in different conformational states, including resting (closed), activated (open), and desensitized (closed) states. The acetylcholine binding protein (AChBP) is a structural homologue of the extracellular ligand-binding domain of nAChRs. In previous studies, the degree of the C-loop radial extension of AChBP has been assigned to different conformational states of nAChRs. It has been suggested that a closed C-loop is preferred for the active conformation of nAChRs in complex with agonists whereas an open C-loop reflects an antagonist-bound (closed) state. In this work, we have determined the crystal structure of AChBP from the water snail Lymnaea stagnalis (Ls) in complex with dihydro-beta-erythroidine (DH beta E), which is a potent competitive antagonist of nAChRs. The structure reveals that binding of DH beta E to AChBP imposes closure of the C-loop as agonists, but also a shift perpendicular to previously observed C-loop movements. These observations suggest that DH beta E may antagonize the receptor via a different mechanism compared to prototypical antagonists and toxins.	[Shahsavar, Azadeh; Kastrup, Jette S.; Kristensen, Jesper L.; Gajhede, Michael; Balle, Thomas] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nielsen, Elsebet O.] NeuroSearch AS, Ballerup, Denmark	University of Copenhagen	Shahsavar, A (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark.	thomas.balle@sydney.edu.au	Kristensen, Jesper/AAP-4439-2021; Kristensen, Jesper/E-3581-2010	Kristensen, Jesper/0000-0002-5613-1267; Kristensen, Jesper/0000-0002-5613-1267; Shahsavar, Azadeh/0000-0001-5405-597X; Gajhede, Michael/0000-0001-9864-2287; Kastrup, Jette Sandholm/0000-0003-2654-1510; Balle, Thomas/0000-0002-0233-8350	Danscatt; Novo Nordisk Foundation; Danish Research Agency for Science Technology and Innovation	Danscatt; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Agency for Science Technology and Innovation	This work was supported by Danscatt, The Novo Nordisk Foundation, and The Danish Research Agency for Science Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; [Anonymous], 2011, MACROMODEL VERS 9 9; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Bourne Y, 2010, P NATL ACAD SCI USA, V107, P6076, DOI 10.1073/pnas.0912372107; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DECKER MW, 1995, EUR J PHARMACOL, V280, P79, DOI 10.1016/0014-2999(95)00191-M; DECKER MW, 1995, LIFE SCI, V56, P545, DOI 10.1016/0024-3205(94)00488-E; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harvey SC, 1996, J NEUROSCI, V16, P3798; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Iturriaga-Vasquez P, 2010, MOL PHARMACOL, V78, P366, DOI 10.1124/mol.110.065490; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGehee DS, 1999, ANN NY ACAD SCI, V868, P565, DOI 10.1111/j.1749-6632.1999.tb11330.x; Papke RL, 2008, NEUROPHARMACOLOGY, V54, P1189, DOI 10.1016/j.neuropharm.2008.03.010; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Schrodinger LLC, 2011, MAESTR VERS 9 2; Talley TT, 2008, P NATL ACAD SCI USA, V105, P7606, DOI 10.1073/pnas.0802197105	32	39	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e40757	10.1371/journal.pone.0040757	http://dx.doi.org/10.1371/journal.pone.0040757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927902	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300004
J	Hayakawa, T; Sugawara, T; Go, Y; Udono, T; Hirai, H; Imai, H				Hayakawa, Takashi; Sugawara, Tohru; Go, Yasuhiro; Udono, Toshifumi; Hirai, Hirohisa; Imai, Hiroo			Eco-Geographical Diversification of Bitter Taste Receptor Genes (TAS2Rs) among Subspecies of Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							WILD CHIMPANZEES; MAHALE MOUNTAINS; HAPLOTYPE RECONSTRUCTION; VERNONIA-AMYGDALINA; STATISTICAL-METHOD; NATIONAL-PARK; SENSITIVITY; EVOLUTION; FAMILY; ALLELES	Chimpanzees (Pan troglodytes) have region-specific difference in dietary repertoires from East to West across tropical Africa. Such differences may result from different genetic backgrounds in addition to cultural variations. We analyzed the sequences of all bitter taste receptor genes (cTAS2Rs) in a total of 59 chimpanzees, including 4 putative subspecies. We identified genetic variations including single-nucleotide variations (SNVs), insertions and deletions (indels), gene-conversion variations, and copy-number variations (CNVs) in cTAS2Rs. Approximately two-thirds of all cTAS2R haplotypes in the amino acid sequence were unique to each subspecies. We analyzed the evolutionary backgrounds of natural selection behind such diversification. Our previous study concluded that diversification of cTAS2Rs in western chimpanzees (P. t. verus) may have resulted from balancing selection. In contrast, the present study found that purifying selection dominates as the evolutionary form of diversification of the so-called human cluster of cTAS2Rs in eastern chimpanzees (P. t. schweinfurthii) and that the other cTAS2Rs were under no obvious selection as a whole. Such marked diversification of cTAS2Rs with different evolutionary backgrounds among subspecies of chimpanzees probably reflects their subspecies-specific dietary repertoires.	[Hayakawa, Takashi; Sugawara, Tohru; Go, Yasuhiro; Hirai, Hirohisa; Imai, Hiroo] Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Mol Biol Sect, Inuyama, Aichi 484, Japan; [Hayakawa, Takashi] Japan Soc Promot Sci, Tokyo, Japan; [Udono, Toshifumi] Kyoto Univ, Wildlife Res Ctr, Kumamoto, Japan	Kyoto University; Japan Society for the Promotion of Science; Kyoto University	Hayakawa, T (corresponding author), Kyoto Univ, Primate Res Inst, Dept Cellular & Mol Biol, Mol Biol Sect, Inuyama, Aichi 484, Japan.	imai.hiroo.5m@kyoto-u.ac.jp	Imai, Hiroo/AAP-2393-2020; Hayakawa, Takashi/U-9518-2018; Go, Yasuhiro/AAD-3313-2020; Sugawara, Tohru/W-5304-2019	Imai, Hiroo/0000-0003-0729-0322; Hayakawa, Takashi/0000-0002-1037-0350; Go, Yasuhiro/0000-0003-4581-0325; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21370109, 22247036, 22247037, 22650053, 22770233, 24370096, 24405018, 244270, A06]; Environment Research and Technology Development Fund from the Ministry of the Environment of Japan [D-1007]; Inamori Foundation; Takeda Foundation for Science; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [22247037, 24650234] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Environment Research and Technology Development Fund from the Ministry of the Environment of Japan; Inamori Foundation; Takeda Foundation for Science; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by Grants-in-Aid for Scientific Research (21370109, 22247036, 22247037, 22650053, 22770233, 24370096, 24405018, 244270, and Global COE Program A06) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Environment Research and Technology Development Fund (D-1007) from the Ministry of the Environment of Japan, and grants from the Inamori Foundation to YG and from the Takeda Foundation for Science and the Suzuken Memorial Foundation to HI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Betran E, 1997, GENETICS, V146, P89; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Campbell MC, 2012, MOL BIOL EVOL, V29, P1141, DOI 10.1093/molbev/msr293; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; CHIARELLI B., 1963, FOLIA PRIMATOLOGICA [BASEL], V1, P88, DOI 10.1159/000165784; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Fisher RA, 1939, NATURE, V144, P750, DOI 10.1038/144750a0; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Gonder MK, 1997, NATURE, V388, P337, DOI 10.1038/41005; Groves C.P., 2001, PRIMATE TAXONOMY; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; HUFFMAN MA, 1989, PRIMATES, V30, P51, DOI 10.1007/BF02381210; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Imai H, 2012, BIOL LETT IN PRESS; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; KOSHIMIZU K, 1993, INT J PRIMATOL, V14, P345, DOI 10.1007/BF02192637; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCGREW WC, 1988, AM J PRIMATOL, V16, P213, DOI 10.1002/ajp.1350160304; Meyerhof W, 2011, FLAVOUR FRAG J, V26, P260, DOI 10.1002/ffj.2041; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nishida, 2012, CHIMPANZEES LAKESHOR; NISHIDA T, 1983, J HUM EVOL, V12, P467, DOI 10.1016/S0047-2484(83)80142-0; Nishida T, 2000, CURR ANTHROPOL, V41, P431, DOI 10.1086/300149; Nishida T., 1983, AFR STUD MONOGR, V3, P109, DOI DOI 10.14989/67987; Oates JF, 2009, PRIMATES, V50, P78, DOI 10.1007/s10329-008-0116-z; OHIGASHI H, 1994, J CHEM ECOL, V20, P541, DOI 10.1007/BF02059596; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Roudnitzky N, 2011, HUM MOL GENET, V20, P3437, DOI 10.1093/hmg/ddr252; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Snyder LH, 1931, SCIENCE, V74, P151, DOI 10.1126/science.74.1910.151; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sugawara T, 2011, MOL BIOL EVOL, V28, P921, DOI 10.1093/molbev/msq279; SUGIYAMA Y, 1987, PRIMATES, V28, P133, DOI 10.1007/BF02382192; Sugiyama Yukimaru, 1992, African Study Monographs, V13, P127; Suzuki N, 2010, PRIMATES, V51, P285, DOI 10.1007/s10329-010-0209-3; TAJIMA F, 1989, GENETICS, V123, P585; van Lawick-Goodall J., 1968, Animal Behaviour Monographs, V1, P161; Wegmann D, 2010, MOL BIOL EVOL, V27, P1425, DOI 10.1093/molbev/msq028; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wooding S, 2006, NATURE, V440, P930, DOI 10.1038/nature04655; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743	60	18	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43277	10.1371/journal.pone.0043277	http://dx.doi.org/10.1371/journal.pone.0043277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916235	Green Submitted, gold, Green Published			2022-12-27	WOS:000307824300036
J	Schneider, T; Herzig, A; Koinig, KA; Sommaruga, R				Schneider, Tobias; Herzig, Alois; Koinig, Karin A.; Sommaruga, Ruben			Copepods in Turbid Shallow Soda Lakes Accumulate Unexpected High Levels of Carotenoids	PLOS ONE			English	Article							FRESH-WATER ZOOPLANKTON; ULTRAVIOLET-RADIATION; AMINO-ACIDS; PHOTOPROTECTIVE COMPOUNDS; UV-RADIATION; ADAPTIVE SIGNIFICANCE; DIAPTOMUS COPEPODA; PIGMENTATION; PHYTOPLANKTON; PROTECTION	Carotenoids are protective pigments present in many aquatic organisms that reduce the photooxidative stress induced by short-wavelenght solar radiation, yet increase their susceptibility to predators. Arctodiaptomus spinosus, a calanoid copepod typically found in many fishless shallow soda lakes, shows large between-lake differences in pigmentation. Here, we attribute these differences to the environmental state of these ecosystems, namely, 'dark water' lakes with submersed vegetation and turbid 'white' lakes lacking macrophytes. Copepod carotenoid concentration in the turbid 'white' lakes was significantly (about 20-fold) higher than in the 'dark water' ones, although the latter systems were characterized by higher transparency. In addition, males had on a dry weight basis around three times higher carotenoid concentrations than females. Mycosporine-like amino acids (direct UV screening substances) were found in all cases, but in low concentration. The environmental conditions in these ecosystems were largely shaped by the presence/absence of submersed macrophytes Thus, in the turbid lakes, the strong wind-driven mixis allows for copepods to be brought to the surface and being exposed to solar radiation, whereas in 'dark water' ones, macrophytes reduce water turbulence and additionally provide shelter. Our results explain the counter-intuitive notion of strong red pigmentation in copepods from a turbid ecosystem and suggest that factors other than high UV transparency favor carotenoid accumulation in zooplankton.	[Herzig, Alois] Biol Res Stn Neusiedler See, Illmitz, Austria; [Schneider, Tobias; Sommaruga, Ruben] Univ Innsbruck, Inst Ecol, Lab Aquat Photobiol & Plankton Ecol, A-6020 Innsbruck, Austria	University of Innsbruck	Schneider, T (corresponding author), Univ Quebec Chicoutimi, Dept Sci Fondamentales, Saguenay, PQ, Canada.	ruben.sommaruga@uibk.ac.at	Koinig, Karin/F-2542-2013; Sommaruga, Ruben/P-6626-2019; Sommaruga, Ruben/E-5335-2011	Koinig, Karin/0000-0002-3659-4934; Sommaruga, Ruben/0000-0002-1055-2461; Sommaruga, Ruben/0000-0002-1055-2461; Schneider, Tobias/0000-0002-4793-4762	Institute of Ecology; University of Innsbruck; Biological Research Station Neusiedler See	Institute of Ecology; University of Innsbruck; Biological Research Station Neusiedler See	Funding was provided by the Institute of Ecology, University of Innsbruck and the Biological Research Station Neusiedler See. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2004, LIMNOL OCEANOGR, V49, P225, DOI 10.4319/lo.2004.49.1.0225; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andersson M, 2003, MAR ECOL PROG SER, V254, P213, DOI 10.3354/meps254213; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; BYRON ER, 1982, ECOLOGY, V63, P1871, DOI 10.2307/1940127; BYRON ER, 1981, P NATL ACAD SCI-BIOL, V78, P1765, DOI 10.1073/pnas.78.3.1765; Cerbin S, 2003, HYDROBIOLOGIA, V491, P111, DOI 10.1023/A:1024491011742; CHEESMAN DF, 1967, BIOL REV, V42, P131, DOI 10.1111/j.1469-185X.1967.tb01343.x; Cockell CS, 1999, BIOL REV, V74, P311, DOI 10.1017/S0006323199005356; Eiler A, 2003, MICROB ECOL, V46, P43, DOI 10.1007/s00248-002-2041-9; Einsle U, 1993, CRUSTACEA COPEPODA C, P208; Garcia PE, 2008, J PLANKTON RES, V30, P817, DOI 10.1093/plankt/fbn041; Gaviria S., 1998, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V100, P539; HAIRSTON NG, 1976, P NATL ACAD SCI USA, V73, P971, DOI 10.1073/pnas.73.3.971; HAIRSTON NG, 1979, LIMNOL OCEANOGR, V24, P15, DOI 10.4319/lo.1979.24.1.0015; HAIRSTON NG, 1979, LIMNOL OCEANOGR, V24, P38, DOI 10.4319/lo.1979.24.1.0038; HAIRSTON NG, 1981, HYDROBIOLOGIA, V81-2, P151, DOI 10.1007/BF00048712; Hansson LA, 2004, ECOLOGY, V85, P1005, DOI 10.1890/02-0525; Hansson LA, 2007, ECOLOGY, V88, P1932, DOI 10.1890/06-2038.1; HERZIG A, 1974, OECOLOGIA, V15, P127, DOI 10.1007/BF00345741; HESSEN D O, 1990, Aqua Fennica, V20, P165; Hylander S, 2009, LIMNOL OCEANOGR, V54, P1883, DOI 10.4319/lo.2009.54.6.1883; Krachler R., 2000, BURGENLANDISCHE HEIM, V62, P3; KRINSKY NI, 1979, PURE APPL CHEM, V51, P649, DOI 10.1351/pac197951030649; Laurion I, 2002, AQUAT MICROB ECOL, V26, P283, DOI 10.3354/ame026283; Lee KW, 2012, COMP BIOCHEM PHYS A, V161, P145, DOI 10.1016/j.cbpa.2011.10.019; Leech DM, 2003, COMP SER PHOTOCHEM, V1, P455; LOFFLER H., 1957, VERH ZOO BOT GES WIE, V97, P27; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Lotocka M, 2004, J PLANKTON RES, V26, P159, DOI 10.1093/plankt/fbh021; Meerhoff M., 2009, ENCY INLAND WATERS, V2, P645, DOI DOI 10.1016/B978-012370626-3.00041-7; Miralto A, 1996, J PLANKTON RES, V18, P1033, DOI 10.1093/plankt/18.6.1033; Moeller RE, 2005, LIMNOL OCEANOGR, V50, P427, DOI 10.4319/lo.2005.50.2.0427; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; Nemeth B, 2009, HYDROBIOLOGIA, V632, P91; Oren A, 2007, FEMS MICROBIOL LETT, V269, P1, DOI 10.1111/j.1574-6968.2007.00650.x; Persaud AD, 2007, FRESHWATER BIOL, V52, P2121, DOI 10.1111/j.1365-2427.2007.01833.x; Rautio Milla, 2010, Freshwater Reviews, V3, P105, DOI 10.1608/FRJ-3.2.157; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; Scheffer M., 2004, ECOLOGY SHALLOW LAKE; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Sommaruga R, 2010, HYDROBIOLOGIA, V648, P143, DOI 10.1007/s10750-010-0141-y; Tartarotti B, 2001, LIMNOL OCEANOGR, V46, P1546, DOI 10.4319/lo.2001.46.6.1546; Tartarotti B, 2006, LIMNOL OCEANOGR, V51, P1530, DOI 10.4319/lo.2006.51.3.1530; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Trenzado CE, 2009, COMP BIOCHEM PHYS C, V149, P440, DOI 10.1016/j.cbpc.2008.10.105; Van der Veen IT, 2005, J EVOLUTION BIOL, V18, P992, DOI 10.1111/j.1420-9101.2005.00903.x; Wolfram G, 1999, HYDROBIOLOGIA, V408, P193, DOI 10.1023/A:1017011414599; Zagarese HE, 1998, J PLANKTON RES, V20, P1423, DOI 10.1093/plankt/20.8.1423	49	11	11	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43063	10.1371/journal.pone.0043063	http://dx.doi.org/10.1371/journal.pone.0043063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916208	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300028
J	Wang, WZ; Li, F; Wang, KZ; Cheng, B; Guo, X				Wang, Weizhuo; Li, Fang; Wang, Kunzheng; Cheng, Bin; Guo, Xiong			PAPSS2 Promotes Alkaline Phosphates Activity and Mineralization of Osteoblastic MC3T3-E1 Cells by Crosstalk and Smads Signal Pathways	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SPONDYLOEPIMETAPHYSEAL DYSPLASIA; GENE-EXPRESSION; ENDEMIC OSTEOARTHRITIS; ARTICULAR-CARTILAGE; MOLECULAR-BIOLOGY; DIFFERENTIATION; BONE; DISEASE; MOUSE	Several studies have indicated that PAPSS2 (3'-phosphoadenosine-5'-phosphosulfate synthetase 2) activity is important to normal skeletal development. Mouse PAPSS2 is predominantly expressed during the formation of the skeleton and cartilaginous elements of the mouse embryo and in newborn mice. However, the role and mechanism of PAPSS2 in bone formation remains largely unidentified. By analyzing the expression pattern of the PAPSS2 gene, we have found that PAPSS2 is expressed in bone tissue and bone formation. PAPSS2 transcripts increase during osteoblast differentiation and are in less level in RANKL-induced osteoclast like cells. By using lentivirus-mediated RNA interference (RNAi) technology, we knocked down PAPSS2 expression in MC3T3-E1 osteoblast. Silencing of PAPSS2 expression significantly decreases ALP activity and cell mineralization, inhibits expression of osteoblast marker osteopontin (OPN) and collagen I. Conversely, overexpression of PAPSS2 promotes the MC3T3-E1 to differentiate into osteoblast and mineralization. Moreover, compared to that in the control cells, the mRNA level and protein expression of phosphorylated Smad 2/3, which is a key transcriptional factor in the Smad osteoblast differentiation pathway, showed significant decreases in PAPSS2-silenced cells and increases in PAPSS2-overexpression cells. These results suggest that PAPSS2 might regulate osteoblast ALP activity and cell mineralization, probably through Smads signal pathways.	[Wang, Weizhuo; Wang, Kunzheng; Cheng, Bin] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Orthoped Surg, Xian, Shaanxi, Peoples R China; [Li, Fang] Fourth Mil Univ, Sch Stomatol, Dept Prosthodont, Xian, Shaanxi, Peoples R China; [Guo, Xiong] Xi An Jiao Tong Univ, Key Lab Environm & Gene Related Dis, Minist Educ, Fac Publ Hlth,Coll Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University	Wang, WZ (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Orthoped Surg, Xian, Shaanxi, Peoples R China.	wangweizhuo@mail.xjtu.edu.cn		Wang, Kunzheng/0000-0002-1981-4237	Natural Scientific Fund of China [81001225]; Xian Jiaotong University, China; Xian Jiaotong University, US [08143004]; Fundamental Research Funds for the Central Universities [08140003]	Natural Scientific Fund of China; Xian Jiaotong University, China(Xi'an Jiaotong University); Xian Jiaotong University, US; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This project was supported by the Natural Scientific Fund of China (81001225), the international Co-operative Fund in Xian Jiaotong University, China and US (08143004), and the Fundamental Research Funds for the Central Universities (08140003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 1998, AM J MED GENET, V78, P468; Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Beckmann M P, 2000, SCIENCE, V77, P34; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Ford-Hutchinson AF, 2005, OSTEOARTHR CARTILAGE, V13, P418, DOI 10.1016/j.joca.2004.12.011; Fukunishi N, 2010, NEOPLASIA, V12, P969, DOI 10.1593/neo.101054; Genevieve D, 2005, EUR J HUM GENET, V13, P541, DOI 10.1038/sj.ejhg.5201339; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Ikeda T, 2001, J HUM GENET, V46, P538, DOI 10.1007/s100380170036; Kaji H, 2006, HORM METAB RES, V38, P740, DOI 10.1055/s-2006-955085; Kaji H, 2008, HORM METAB RES, V40, P746, DOI 10.1055/s-0028-1082051; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Ma WJ, 2011, PROTEOMICS, V11, P2881, DOI 10.1002/pmic.201000636; MATSUI M, 1994, INT J BIOCHEM, V26, P1237; MERRY K, 1993, J CELL SCI, V104, P1013; Noordam C, 2009, NEW ENGL J MED, V360, P2310, DOI 10.1056/NEJMoa0810489; Ovchinnikov D, 2009, COLD SPRING HARB PRO, V2009, DOI [10.1101/pdb. prot5170, DOI 10.1101/PDB.PROT5170]; Ozcaka O, 2011, INFLAMMATION; Ozeki K, 2008, J MATER SCI-MATER M, V19, P1753, DOI 10.1007/s10856-007-3288-y; Pessah M, 2001, P NATL ACAD SCI USA, V98, P6198, DOI 10.1073/pnas.101579798; Ramaswamy G, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3762; Reinholz GG, 2000, CANCER RES, V60, P6001; Rossi A, 1996, J BIOL CHEM, V271, P18456, DOI 10.1074/jbc.271.31.18456; RUNGBY J, 1993, HISTOCHEM J, V25, P446, DOI 10.1007/BF00157809; Schneider GB, 1999, BONE, V24, P321, DOI 10.1016/S8756-3282(99)00007-1; Shinto O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-652; Sowa H, 2002, J BONE MINER RES, V17, P1190, DOI 10.1359/jbmr.2002.17.7.1190; Sowa H, 2003, J BIOL CHEM, V278, P52240, DOI 10.1074/jbc.M302566200; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Steenhard BM, 2010, AM J PATHOL, V177, P84, DOI 10.2353/ajpath.2010.090767; Stelzer C, 2007, DEV DYNAM, V236, P1313, DOI 10.1002/dvdy.21137; Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Venkatachalam KV, 2003, IUBMB LIFE, V55, P1, DOI 10.1080/1521654031000072148; Wan M, 2001, J BIOL CHEM, V276, P10119, DOI 10.1074/jbc.M006918200; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028439; Wang WZ, 2009, OSTEOARTHR CARTILAGE, V17, P83, DOI 10.1016/j.joca.2008.05.008; Wang WZ, 2008, J RHEUMATOL, V35, P696; Wang Yuntao, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P68; Weller NJ, 2007, HLTH AG LONG 3 INT C, Vxv; Wrana JL, 1998, MINER ELECTROL METAB, V24, P120, DOI 10.1159/000057359; Xu ZH, 2002, PHARMACOGENETICS, V12, P11, DOI 10.1097/00008571-200201000-00003; Yamakawa K, 2003, J RHEUMATOL, V30, P1032; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107; Zheng Qixin, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P674; Zheng ZH, 2009, J BIOMED MATER RES A, V89A, P453, DOI 10.1002/jbm.a.31979	47	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43475	10.1371/journal.pone.0043475	http://dx.doi.org/10.1371/journal.pone.0043475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916269	Green Submitted, Green Published, gold			2022-12-27	WOS:000307824300051
J	Hersmus, R; Stoop, H; van de Geijn, GJ; Eini, R; Biermann, K; Oosterhuis, JW; DHooge, C; Schneider, DT; Meijssen, IC; Dinjens, WNM; Dubbink, HJ; Drop, SLS; Looijenga, LHJ				Hersmus, Remko; Stoop, Hans; van de Geijn, Gert Jan; Eini, Ronak; Biermann, Katharina; Oosterhuis, J. Wolter; DHooge, Catharina; Schneider, Dominik T.; Meijssen, Isabelle C.; Dinjens, Winand N. M.; Dubbink, Hendrikus Jan; Drop, Stenvert L. S.; Looijenga, Leendert H. J.			Prevalence of c-KIT Mutations in Gonadoblastoma and Dysgerminomas of Patients with Disorders of Sex Development (DSD) and Ovarian Dysgerminomas	PLOS ONE			English	Article							GERM-CELL TUMORS; GASTROINTESTINAL STROMAL TUMORS; GENOME-WIDE ASSOCIATION; Y-CHROMOSOME; TESTICULAR SEMINOMA; INTERSTITIAL-CELLS; EXPRESSION; GENE; RECEPTOR; FEMALE	Activating c-KIT mutations (exons 11 and 17) are found in 10-40% of testicular seminomas, the majority being missense point mutations (codon 816). Malignant ovarian dysgerminomas represent similar to 3% of all ovarian cancers in Western countries, resembling testicular seminomas, regarding chromosomal aberrations and c-KIT mutations. DSD patients with specific Y-sequences have an increased risk for Type II Germ Cell Tumor/Cancer, with gonadoblastoma as precursor progressing to dysgerminoma. Here we present analysis of c-KIT exon 8, 9, 11, 13 and 17, and PDGFRA exon 12, 14 and 18 by conventional sequencing together with mutational analysis of c-KIT codon 816 by a sensitive and specific LightCycler melting curve analysis, confirmed by sequencing. The results are combined with data on TSPY and OCT3/4 expression in a series of 16 DSD patients presenting with gonadoblastoma and dysgerminoma and 15 patients presenting pure ovarian dysgerminomas without DSD. c-KIT codon 816 mutations were detected in five out of the total of 31 cases (all found in pure ovarian dysgerminomas). A synonymous SNP (rs 5578615) was detected in two patients, one DSD patient (with bilateral disease) and one patient with dysgerminoma. Next to these, three codon N822K mutations were detected in the group of 15 pure ovarian dysgerminomas. In total activating c-KIT mutations were found in 53% of ovarian dysgerminomas without DSD. In the group of 16 DSD cases a N505I and D820E mutation was found in a single tumor of a patient with gonadoblastoma and dysgerminoma. No PDGFRA mutations were found. Positive OCT3/4 staining was present in all gonadoblastomas and dysgerminomas investigated, TSPY expression was only seen in the gonadoblastoma/dysgerminoma lesions of the 16 DSD patients. This data supports the existence of two distinct but parallel pathways in the development of dysgerminoma, in which mutational status of c-KIT might parallel the presence of TSPY.	[Hersmus, Remko; Stoop, Hans; van de Geijn, Gert Jan; Eini, Ronak; Biermann, Katharina; Oosterhuis, J. Wolter; Looijenga, Leendert H. J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Josephine Nefkens Inst, Dr Daniel Den Hoed Canc Ctr, Rotterdam, Netherlands; [DHooge, Catharina] Univ Hosp Ghent, Div Pediat Hematooncol, Dept Pediat, Ghent, Belgium; [Schneider, Dominik T.] Municipal Hosp Dortmund, Pediat Clin, Dortmund, Germany; [Meijssen, Isabelle C.; Dinjens, Winand N. M.; Dubbink, Hendrikus Jan] Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Josephine Nefkens Inst, Rotterdam, Netherlands; [Drop, Stenvert L. S.] Sophia Childrens Univ Hosp, Erasmus MC Univ Med Ctr Rotterdam, Dept Pediat Endocrinol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Hersmus, R (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Josephine Nefkens Inst, Dr Daniel Den Hoed Canc Ctr, Rotterdam, Netherlands.	l.looijenga@erasmusmc.nl	Hersmus, Remko/AAE-9953-2019; Looijenga, Leendert/B-8145-2019	Looijenga, Leendert/0000-0002-8146-1911; Hersmus, Remko/0000-0001-5250-3572; Schneider, Dominik T./0000-0001-8153-1601	Translational Research Grant Erasmus MC; Dutch Cancer Society [3607]; EuroDSD	Translational Research Grant Erasmus MC; Dutch Cancer Society(KWF Kankerbestrijding); EuroDSD	This work was financially supported by Translational Research Grant Erasmus MC 2006 (RH), the Dutch Cancer Society project 2006 #3607 (RE), and supported by the EuroDSD (www.euroDSD.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto C, 2010, P NATL ACAD SCI USA, V107, P19891, DOI 10.1073/pnas.1010307107; Biermann K, 2007, J PATHOL, V213, P311, DOI 10.1002/path.2225; Cheng L, 2004, AM J SURG PATHOL, V28, P1341, DOI 10.1097/01.pas.0000135528.03942.1f; Cheng L, 2011, CANCER-AM CANCER SOC, V117, P2096, DOI 10.1002/cncr.25794; Cools M, 2006, ENDOCR REV, V27, P468, DOI 10.1210/er.2006-0005; Cools M, 2006, J CLIN ENDOCR METAB, V91, P2404, DOI 10.1210/jc.2005-2554; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Dalgaard MD, 2012, J MED GENET, V49, P58, DOI 10.1136/jmedgenet-2011-100174; de Jong J, 2005, J PATHOL, V206, P242, DOI 10.1002/path.1766; Feng F, 2003, WORLD J GASTROENTERO, V9, P2548; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; Galani E, 2005, GYNECOL ONCOL, V96, P254, DOI 10.1016/j.ygyno.2004.09.047; Guo TH, 2009, CLIN CANCER RES, V15, P6862, DOI 10.1158/1078-0432.CCR-09-1315; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Hersmus R, 2008, J PATHOL, V215, P31, DOI 10.1002/path.2335; Hersmus R, 2008, MOL CELL ENDOCRINOL, V291, P1, DOI 10.1016/j.mce.2008.02.028; Hoei-Hansen CE, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-12; Honecker F, 2004, J PATHOL, V203, P849, DOI 10.1002/path.1587; Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI [10.1136/adc.2006.098319, 10.1016/j.jpurol.2006.03.004]; Joensuu H, 2002, LANCET ONCOL, V3, P655, DOI 10.1016/S1470-2045(02)00899-9; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kido T, 2005, GENESIS, V42, P263, DOI 10.1002/gene.20147; Kitamura Y, 2001, MUTAT RES-FUND MOL M, V477, P165, DOI 10.1016/S0027-5107(01)00117-8; Kraggerud SM, 2000, CANCER RES, V60, P3025; Lau YFC, 2000, CYTOGENET CELL GENET, V91, P160, DOI 10.1159/000056838; Lau YFC, 2009, BIRTH DEFECTS RES C, V87, P114, DOI 10.1002/bdrc.20144; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; McIntyre A, 2005, CANCER RES, V65, P8085, DOI 10.1158/0008-5472.CAN-05-0471; Nakai Y, 2005, BIOCHEM BIOPH RES CO, V337, P289, DOI 10.1016/j.bbrc.2005.09.042; Pedersini R, 2007, LANCET ONCOL, V8, P1039, DOI 10.1016/S1470-2045(07)70344-3; Przygodzki RM, 2002, LAB INVEST, V82, P1369, DOI 10.1097/01.LAB.0000032410.46986.7B; Rajpert-De Meyts E, 2004, HUM REPROD, V19, P1338, DOI 10.1093/humrep/deh265; Rapley EA, 2004, BRIT J CANCER, V90, P2397, DOI 10.1038/sj.bjc.6601880; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Reilly JT, 2002, BRIT J HAEMATOL, V116, P744, DOI 10.1046/j.0007-1048.2001.03294.x; Robinson TL, 2000, AM J PATHOL, V156, P1157, DOI 10.1016/S0002-9440(10)64984-X; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Sakuma Y, 2004, CANCER SCI, V95, P716, DOI 10.1111/j.1349-7006.2004.tb03251.x; Shahsiah R, 2011, J CLIN PATHOL, V64, P973, DOI 10.1136/jcp.2011.090738; Stoop H, 2005, HUM REPROD, V20, P1466, DOI 10.1093/humrep/deh800; Tu JJ, 2007, REPRODUCTION, V134, P757, DOI 10.1530/REP-07-0161; Verzijl A, 2007, DERMATOLOGY, V214, P15, DOI 10.1159/000096907; Went PT, 2004, J CLIN ONCOL, V22, P4514, DOI 10.1200/JCO.2004.10.125; Willmore C, 2004, AM J CLIN PATHOL, V122, P206, DOI 10.1309/4E6UYBY62N2FCA6N; Willmore-Payne C, 2006, MOD PATHOL; WOODWARD PJ, 2004, WHO CLASSIFICATION T, P217; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	52	28	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43952	10.1371/journal.pone.0043952	http://dx.doi.org/10.1371/journal.pone.0043952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937135	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600063
J	Cutillo, L; Carissimo, A; Figini, S				Cutillo, Luisa; Carissimo, Annamaria; Figini, Silvia			Network Selection: A Method for Ranked Lists Selection	PLOS ONE			English	Article							MICROARRAY EXPERIMENTS	We consider the problem of finding the set of rankings that best represents a given group of orderings on the same collection of elements (preference lists). This problem arises from social choice and voting theory, in which each voter gives a preference on a set of alternatives, and a system outputs a single preference order based on the observed voters' preferences. In this paper, we observe that, if the given set of preference lists is not homogeneous, a unique true underling ranking might not exist. Moreover only the lists that share the highest amount of information should be aggregated, and thus multiple rankings might provide a more feasible solution to the problem. In this light, we propose Network Selection, an algorithm that, given a heterogeneous group of rankings, first discovers the different communities of homogeneous rankings and then combines only the rank orderings belonging to the same community into a single final ordering. Our novel approach is inspired by graph theory; indeed our set of lists can be loosely read as the nodes of a network. As a consequence, only the lists populating the same community in the network would then be aggregated. In order to highlight the strength of our proposal, we show an application both on simulated and on two real datasets, namely a financial and a biological dataset. Experimental results on simulated data show that Network Selection can significantly outperform existing related methods. The other way around, the empirical evidence achieved on real financial data reveals that Network Selection is also able to select the most relevant variables in data mining predictive models, providing a clear superiority in terms of predictive power of the models built. Furthermore, we show the potentiality of our proposal in the bioinformatics field, providing an application to a biological microarray dataset.	[Cutillo, Luisa] Univ Naples Parthenope, Dept Stat & Math Econ Res, Naples, Italy; [Cutillo, Luisa; Carissimo, Annamaria] Telethon Inst Genet & Med, Bioinformat Core, Naples, Italy; [Figini, Silvia] Univ Pavia, I-27100 Pavia, Italy	Parthenope University Naples; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Pavia	Cutillo, L (corresponding author), Univ Naples Parthenope, Dept Stat & Math Econ Res, Naples, Italy.	luisa.cutillo@uniparthenope.it	figini, silvia/ABH-3448-2020	figini, silvia/0000-0001-5756-7831; Carissimo, Annamaria/0000-0003-4636-3969; Cutillo, Luisa/0000-0002-2205-0338				Adams NM, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P167, DOI 10.1007/978-3-7908-2604-3_15; Altman EI, 2006, J FINANCIAL SERVICES; Arrow KJ, 1950, J POLIT ECON, V58, P328, DOI 10.1086/256963; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borda JC, 1781, MEMOIRE ELECTIONS SE; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Critchlow DE, 1980, LECT NOTES STAT; Datta S, 2008, GENOMICS, V92, P400; DeConde R, 2006, STAT APPL GENET MOL, V5; Dobson A, 2003, CHAPMAN HALL CRC TEX; Dwork C., 2001, P 10 INT C WORLD WID, P613, DOI DOI 10.1145/371920.372165; Feller W., 2008, INTRO PROBABILITY TH, V2; Figini S, 2011, J OPER RES SOC, V62, P1067, DOI 10.1057/jors.2010.41; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Giudici P, 2009, APPL DATA MINING; Hand D., 2001, ADAP COMP MACH LEARN; Hand D, 2009, J OPERATIONAL RES SO, V61, P1540; Karrer B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046119; KEMENY JG, 1959, DAEDALUS, V88, P577; Krzanowski WJ, 2009, MONOGR STAT APPL PRO, V111, P1; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046110; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lin SL, 2010, WILEY INTERDISCIP RE, V2, P555, DOI 10.1002/wics.111; Lin SL, 2009, BIOMETRICS, V65, P9, DOI 10.1111/j.1541-0420.2008.01044.x; MacKay D. J. C., 2003, INFORM THEORY INFERE; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Meila M, 2010, J MACH LEARN RES, V11, P3481; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pihur V, 2008, GENOMICS, V92, P400, DOI 10.1016/j.ygeno.2008.05.003; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43678	10.1371/journal.pone.0043678	http://dx.doi.org/10.1371/journal.pone.0043678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937075	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500077
J	Elnakish, MT; Hassona, MDH; Alhaj, MA; Moldovan, L; Janssen, PML; Khan, M; Hassanain, HH				Elnakish, Mohammad T.; Hassona, Mohamed D. H.; Alhaj, Mazin A.; Moldovan, Leni; Janssen, Paul M. L.; Khan, Mahmood; Hassanain, Hamdy H.			Rac-Induced Left Ventricular Dilation in Thyroxin-Treated ZmRacD Transgenic Mice: Role of Cardiomyocyte Apoptosis and Myocardial Fibrosis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; HEART-FAILURE; INDUCED CARDIOTOXICITY; SYSTOLIC FUNCTION; CELLULAR BASIS; CARVEDILOL; PRAVASTATIN; ACTIVATION	The pathways inducing the critical transition from compensated hypertrophy to cardiac dilation and failure remain poorly understood. The goal of our study is to determine the role of Rac-induced signaling in this transition process. Our previous results showed that Thyroxin (T4) treatment resulted in increased myocardial Rac expression in wild-type mice and a higher level of expression in Zea maize RacD (ZmRacD) transgenic mice. Our current results showed that T4 treatment induced physiologic cardiac hypertrophy in wild-type mice, as demonstrated by echocardiography and histopathology analyses. This was associated with significant increases in myocardial Rac-GTP, superoxide and ERK1/2 activities. Conversely, echocardiography and histopathology analyses showed that T4 treatment induced dilated cardiomyopathy along with compensatory cardiac hypertrophy in ZmRacD mice. These were linked with further increases in myocardial Rac-GTP, superoxide and ERK1/2 activities. Additionally, there were significant increases in caspase-8 expression and caspase-3 activity. However, there was a significant decrease in p38-MAPK activity. Interestingly, inhibition of myocardial Rac-GTP activity and superoxide generation with pravastatin and carvedilol, respectively, attenuated all functional, structural, and molecular changes associated with the T4-induced cardiomyopathy in ZmRacD mice except the compensatory cardiac hypertrophy. Taken together, T4-induced ZmRacD is a novel mouse model of dilated cardiomyopathy that shares many characteristics with the human disease phenotype. To our knowledge, this is the first study to show graded Rac-mediated O-2 center dot(-) results in cardiac phenotype shift in-vivo. Moreover, Rac-mediated O-2 center dot(-) generation, cardiomyocyte apoptosis, and myocardial fibrosis seem to play a pivotal role in the transition from cardiac hypertrophy to cardiac dilation and failure. Targeting Rac signaling could represent valuable therapeutic strategy not only in saving the failing myocardium but also to prevent this transition process.	[Elnakish, Mohammad T.; Hassona, Mohamed D. H.; Alhaj, Mazin A.; Hassanain, Hamdy H.] Ohio State Univ, Dept Anesthesiol, Columbus, OH 43210 USA; [Elnakish, Mohammad T.; Hassona, Mohamed D. H.; Alhaj, Mazin A.; Moldovan, Leni; Janssen, Paul M. L.; Khan, Mahmood; Hassanain, Hamdy H.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Elnakish, Mohammad T.; Janssen, Paul M. L.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Moldovan, Leni] Ohio State Univ, Dept Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Khan, Mahmood] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University; Ohio State University	Elnakish, MT (corresponding author), Ohio State Univ, Dept Anesthesiol, Columbus, OH 43210 USA.	dr.hamdyhassanain@gmail.com	Janssen, Paul ML/E-3307-2011	Moldovan, Leni/0000-0003-1967-2408; Khan, Mahmood/0000-0003-3430-374X; Akcelrud, Leni/0000-0003-2498-1678; Janssen, Paul/0000-0002-9682-3014	Department of Anesthesiology, The Ohio State University; The Egyptian Government	Department of Anesthesiology, The Ohio State University; The Egyptian Government	This work was supported by Startup fund, Department of Anesthesiology, The Ohio State University. Mohammad T. Elnakish was supported by a scholarship from The Egyptian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2002, CYTOKINE, V18, P179, DOI 10.1006/cyto.2001.1007; Araujo ASR, 2008, J MOL ENDOCRINOL, V41, P423, DOI 10.1677/JME-08-0024; Arozal W, 2010, TOXICOLOGY, V274, P18, DOI 10.1016/j.tox.2010.05.003; Balakumar P, 2006, BASIC CLIN PHARMACOL, V99, P418, DOI 10.1111/j.1742-7843.2006.pto_569.x; BELTRAMI CA, 1995, J MOL CELL CARDIOL, V27, P291, DOI 10.1016/S0022-2828(08)80028-4; Berenji K, 2005, AM J PHYSIOL-HEART C, V289, pH8, DOI 10.1152/ajpheart.01303.2004; Brower GL, 2001, AM J PHYSIOL-HEART C, V280, pH674, DOI 10.1152/ajpheart.2001.280.2.H674; Carlson DL, 2005, CRIT CARE MED, V33, P1021, DOI 10.1097/01.CCM.0000163398.79679.66; Cheng CF, 2008, APOPTOSIS, V13, P883, DOI 10.1007/s10495-008-0214-9; Chua S, 2008, INT HEART J, V49, P605, DOI 10.1536/ihj.49.605; Communal C, 2002, J CARD FAIL, V8, P86, DOI 10.1054/jcaf.2002.32755; Corradi D, 2009, CIRCULATION, V120, pE38, DOI 10.1161/CIRCULATIONAHA.108.840660; Araujo ASD, 2010, J CARDIOVASC PHARM, V56, P513, DOI 10.1097/FJC.0b013e3181f50a70; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Dong Y, 2006, J CARDIOTHORAC REN R, V1, P123; Dorn GW, 2009, NAT REV CARDIOL, V6, P283, DOI 10.1038/nrcardio.2009.12; Elnakish MT, 2011, AM J PHYSIOL-HEART C, V301, pH868, DOI 10.1152/ajpheart.00807.2010; Fentzke RC, 1998, J CLIN INVEST, V101, P2415, DOI 10.1172/JCI2950; Feuerstein GZ, 1996, EUR HEART J, V17, P24, DOI 10.1093/eurheartj/17.suppl_B.24; FLORINI JR, 1973, J GERONTOL, V28, P293, DOI 10.1093/geronj/28.3.293; Freeman K, 2001, AM J PHYSIOL-HEART C, V280, pH151, DOI 10.1152/ajpheart.2001.280.1.H151; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Hassona MDH, 2011, J CARDIOVASC PHARM, V57, P550, DOI 10.1097/FJC.0b013e318212b1c2; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Helms SA, 2010, INT J BIOL SCI, V6, P475; Ichihara S, 2006, CARDIOVASC RES, V69, P726, DOI 10.1016/j.cardiores.2005.08.001; Klein L, 2003, AM J CARDIOL, V91, p18F, DOI 10.1016/S0002-9149(02)03336-2; KORECKY B, 1978, AM J PHYSIOL, V234, pH123, DOI 10.1152/ajpheart.1978.234.2.H123; Kuzman JA, 2005, J MOL CELL CARDIOL, V39, P251, DOI 10.1016/j.yjmcc.2005.03.020; Kuzman JA, 2007, ENDOCRINOLOGY, V148, P3477, DOI 10.1210/en.2007-0099; Lemke LE, 2001, J MOL CELL CARDIOL, V33, P1527, DOI 10.1006/jmcc.2001.1415; Lezoualc'h F, 2008, J MOL CELL CARDIOL, V44, P623, DOI 10.1016/j.yjmcc.2008.01.011; Li B, 2006, INT J CARDIOL, V111, P247, DOI 10.1016/j.ijcard.2005.08.065; Lips DJ, 2003, EUR HEART J, V24, P883, DOI 10.1016/S0195-668X(02)00829-1; Lu XR, 2006, CRIT CARE MED, V34, P484, DOI 10.1097/01.CCM.0000199079.64231.C1; Maack C, 2003, CIRCULATION, V108, P1567, DOI 10.1161/01.CIR.0000091084.46500.BB; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Nakamura K, 2011, PHARMACEUTICALS, V4, P1088, DOI 10.3390/ph4081088; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Ojamaa K, 2010, VASC PHARMACOL, V52, P113, DOI 10.1016/j.vph.2009.11.008; Palazzuoli A, 2002, EUR J HEART FAIL, V4, P765, DOI 10.1016/S1388-9842(02)00114-9; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Philipp S, 2004, EUR J HEART FAIL, V6, P845, DOI 10.1016/j.ejheart.2004.01.014; Pierres C, 2009, CONCENTRATED LIQUID; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Samuel MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017143; Schaefer WH, 1998, DRUG METAB DISPOS, V26, P958; Selvetella G, 2004, CARDIOVASC RES, V63, P373, DOI 10.1016/j.cardiores.2004.04.031; Siwik DA, 1999, CIRC RES, V85, P147, DOI 10.1161/01.RES.85.2.147; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; Tenhunen O, 2006, FASEB J, V20, P1907, DOI 10.1096/fj.05-5618fje; Watanabe K, 2000, BRIT J PHARMACOL, V130, P1489, DOI 10.1038/sj.bjp.0703450; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Worou ME, 2011, CARDIOVASC RES, V91, P320, DOI 10.1093/cvr/cvr072; Xu Z, 2008, J CARDIOVASC PHARM, V51, P62, DOI 10.1097/FJC.0b013e31815bb629; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yaoita H, 2002, CIRCULATION, V105, P975, DOI 10.1161/hc0802.104503; YOKOYAMA T, 1993, J CLIN INVEST, V92, P2303, DOI 10.1172/JCI116834; Zhao H, 2008, HYPERTENS RES, V31, P1977, DOI 10.1291/hypres.31.1977; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	61	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42500	10.1371/journal.pone.0042500	http://dx.doi.org/10.1371/journal.pone.0042500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936985	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500013
J	Johnson, EK; Zhang, LW; Adams, ME; Phillips, A; Freitas, MA; Froehner, SC; Green-Church, KB; Montanaro, F				Johnson, Eric K.; Zhang, Liwen; Adams, Marvin E.; Phillips, Alistair; Freitas, Michael A.; Froehner, Stanley C.; Green-Church, Kari B.; Montanaro, Federica			Proteomic Analysis Reveals New Cardiac-Specific Dystrophin-Associated Proteins	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DUCHENNE MUSCULAR-DYSTROPHY; DECOY SEARCH STRATEGY; DILATED CARDIOMYOPATHY; SKELETAL-MUSCLE; ALPHA-DYSTROBREVIN; GLYCOPROTEIN COMPLEX; SYNTROPHIN BINDING; MASS-SPECTROMETRY; ANIMAL-MODELS	Mutations affecting the expression of dystrophin result in progressive loss of skeletal muscle function and cardiomyopathy leading to early mortality. Interestingly, clinical studies revealed no correlation in disease severity or age of onset between cardiac and skeletal muscles, suggesting that dystrophin may play overlapping yet different roles in these two striated muscles. Since dystrophin serves as a structural and signaling scaffold, functional differences likely arise from tissue-specific protein interactions. To test this, we optimized a proteomics-based approach to purify, identify and compare the interactome of dystrophin between cardiac and skeletal muscles from as little as 50 mg of starting material. We found selective tissue-specific differences in the protein associations of cardiac and skeletal muscle full length dystrophin to syntrophins and dystrobrevins that couple dystrophin to signaling pathways. Importantly, we identified novel cardiac-specific interactions of dystrophin with proteins known to regulate cardiac contraction and to be involved in cardiac disease. Our approach overcomes a major challenge in the muscular dystrophy field of rapidly and consistently identifying bona fide dystrophin-interacting proteins in tissues. In addition, our findings support the existence of cardiac-specific functions of dystrophin and may guide studies into early triggers of cardiac disease in Duchenne and Becker muscular dystrophies.	[Johnson, Eric K.; Montanaro, Federica] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA; [Johnson, Eric K.; Montanaro, Federica] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Zhang, Liwen; Green-Church, Kari B.] Ohio State Univ, Ctr Biomed EPR Spect & Imaging, Columbus, OH 43210 USA; [Adams, Marvin E.; Froehner, Stanley C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Phillips, Alistair] Cincinnati Childrens Hosp, Inst Heart, Div Cardiothorac Surg, Cincinnati, OH USA; [Freitas, Michael A.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Montanaro, Federica] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle; Cincinnati Children's Hospital Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Johnson, EK (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA.	montanaf@pediatrics.ohio-state.edu	Zhang, Liwen/P-1111-2016; Freitas, Michael/C-8953-2009; Montanaro, Federica/GRJ-5139-2022	Freitas, Michael/0000-0002-3103-8410; Montanaro, Federica/0000-0002-3338-0498	Parent Project Muscular Dystrophy grant; Research Institute at Nationwide Children's Hospital; American Heart Association; National Institutes of Health [RO1 NS33145, PO1 NS046788]; NICHD; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS046788, R01NS033145] Funding Source: NIH RePORTER	Parent Project Muscular Dystrophy grant; Research Institute at Nationwide Children's Hospital(Ohio State University); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Parent Project Muscular Dystrophy grant and the Research Institute at Nationwide Children's Hospital (to F. M.), an American Heart Association fellowship (to E.K.J.), and National Institutes of Health grants RO1 NS33145 and PO1 NS046788 (to S. C. F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. C. Miranda, P. Martin, and D. Guttridge for their critical review of this manuscript and C. Penton, R. Orellana and A. Macke for helpful discussions and technical assistance. The hybridoma cell lines for the MANDYS1 and MANDAG2 antibodies developed by Glenn E. Morris (Center for Inherited Neuromuscular Disease, RJAH Orthopedic Hospital, Oswestry, UK) and for the MW8 antibody developed by Paul H. Patterson (Division of Biology, California Institute of Technology, Pasadena, CA) were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Blake DJ, 1996, J BIOL CHEM, V271, P7802, DOI 10.1074/jbc.271.13.7802; Bostick B, 2009, MOL THER, V17, P253, DOI 10.1038/mt.2008.264; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chu V, 2002, MUSCLE NERVE, V26, P513, DOI 10.1002/mus.10223; Cohen N, 2004, HEART, V90, P835, DOI 10.1136/hrt.2003.023390; Colinge J, 2005, ANAL CHEM, V77, P596, DOI 10.1021/ac0488513; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Ervasti JM, 2008, INT REV CYTOL, V265, P191, DOI 10.1016/S0074-7696(07)65005-0; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Haase H, 2005, FASEB J, V19, P1969, DOI 10.1096/fj.05-3997com; Hershberger RE, 2008, CTS-CLIN TRANSL SCI, V1, P21, DOI 10.1111/j.1752-8062.2008.00017.x; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Judge DP., 2011, AM J CARDIOVASC DRUG; Kaspar RW, 2009, CIRC-CARDIOVASC GENE, V2, P544, DOI 10.1161/CIRCGENETICS.109.867242; Kaspar RW, 2009, J AM ACAD NURSE PRAC, V21, P241, DOI 10.1111/j.1745-7599.2009.00404.x; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Lewis C, 2010, ANAL BIOCHEM, V404, P197, DOI 10.1016/j.ab.2010.05.017; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; MAN NT, 1993, AM J HUM GENET, V52, P1057; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nakamori M, 2008, NEUROLOGY, V70, P677, DOI 10.1212/01.wnl.0000302174.08951.cf; Newey SE, 2000, CURR BIOL, V10, P1295, DOI 10.1016/S0960-9822(00)00760-0; NIGRO G, 1994, NEUROMUSCULAR DISORD, V4, P371, DOI 10.1016/0960-8966(94)90073-6; Percival JM, 2010, J CLIN INVEST, V120, P816, DOI 10.1172/JCI40736; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Reilich P, 2010, NEUROMUSCULAR DISORD, V20, P255, DOI 10.1016/j.nmd.2010.01.012; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sacconi S, 2012, NEUROMUSCULAR DISORD, V22, P66, DOI 10.1016/j.nmd.2011.07.004; Santana LF, 1997, J PHYSIOL-LONDON, V503, P21, DOI 10.1111/j.1469-7793.1997.021bi.x; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Townsend D, 2007, MOL THER, V15, P1086, DOI 10.1038/sj.mt.6300144; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Yoshida M, 2000, HUM MOL GENET, V9, P1033, DOI 10.1093/hmg/9.7.1033; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	52	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43515	10.1371/journal.pone.0043515	http://dx.doi.org/10.1371/journal.pone.0043515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937058	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500059
J	Kumar, S; Badireddy, S; Pal, K; Sharma, S; Arora, C; Garg, SK; Alam, MS; Agrawal, P; Anand, GS; Swaminathan, K				Kumar, Shiva; Badireddy, Suguna; Pal, Kuntal; Sharma, Shikha; Arora, Chandni; Garg, Saurabh K.; Alam, Mohamed Suhail; Agrawal, Pushpa; Anand, Ganesh Srinivasan; Swaminathan, Kunchithapadam			Interaction of Mycobacterium tuberculosis RshA and SigH Is Mediated by Salt Bridges	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR A3(2); STRESS-RESPONSE; OXIDATIVE STRESS; GENE-EXPRESSION; I-TASSER; TRANSCRIPTIONAL CONTROL; FACTOR SIGMA(H); REDOX SWITCH; HEAT-SHOCK; PROTEIN	The alternate sigma factor sigH of Mycobacterium tuberculosis is expressed under stress and acts as a major regulator of several genes, including some other sigma factors and redox systems. While it is auto-regulated by its own promoter at the transcriptional level, its regulation at the post-translational level is through its cognate protein, an anti-sigma factor, RshA. Hither before RshA was believed to be a zinc-associated anti-sigma factor (ZAS) and the binding of RshA to SigH is redox dependent. Here, we show that RshA coordinates a [2Fe-2S] cluster using cysteines as ligands and native RshA has more affinity to [2Fe-2S] cluster than to zinc. Furthermore, we used amide hydrogen deuterium exchange mass spectrometry (HDX-MS), followed by site-directed mutagenesis in SigH and RshA, to elucidate the interaction mechanism of RshA and SigH and the potential role of metal ion clustering in SigH regulation. Three regions in SigH, comprising of residues 1-25, 58-69, 90-111, 115-132 and 157-196 and residues 35-57 of RshA show decreased deuterium exchange and reflect decreased solvent accessibility upon complexation with SigH. Of the three RshA mutants, created based on the HDX results, the RsHA E37A mutant shows stronger interaction with SigH, relative to WT RshA, while the H49A mutant abolishes interactions and the C(53) XXC(56) AXXA mutant has no effect on complexation with SigH. The D22A, D160A and E162 SigH mutants show significantly decreased binding to RshA and the E168A mutant completely abolished interactions with RshA, indicating that the SigH-RshA interaction is mediated by salt bridges. In addition, SigH-RshA interaction does not require clustering of metal ions. Based on our results, we propose a molecular model of the SigH-RshA interaction.	[Kumar, Shiva; Badireddy, Suguna; Pal, Kuntal; Anand, Ganesh Srinivasan; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Sharma, Shikha; Arora, Chandni; Garg, Saurabh K.; Alam, Mohamed Suhail; Agrawal, Pushpa] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh, India	National University of Singapore; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kumar, S (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	pushpa@imtech.res.in; dbsgsa@nus.edu.sg; dbsks@nus.edu.sg	Pal, Kuntal/W-6348-2019; sarkar, sabyasachi/A-9896-2010; Anand, Ganesh/H-8473-2012	sarkar, sabyasachi/0000-0002-8954-4375; PAL, KUNTAL/0000-0001-7094-2456	Ministry of Education (Faculty Research Council) [R154-000-439-112]; Biomedical Research Council, Singapore [R154-000-424-305]; Council of Scientific and Industrial Research (CSIR) [SIP-10]	Ministry of Education (Faculty Research Council); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	KS acknowledges the funding support from the Ministry of Education (Faculty Research Council, R154-000-439-112) and Biomedical Research Council (R154-000-424-305), Singapore. PA acknowledges the funding support from the SIP-10 project of Council of Scientific and Industrial Research (CSIR) for this project and for SS. Both SKG and MSA were recipients of the CSIR, India Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x; Badireddy S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.110.004390; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bateman RH, 2002, J AM SOC MASS SPECTR, V13, P792, DOI 10.1016/S1044-0305(02)00420-8; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Fernandes ND, 1999, J BACTERIOL, V181, P4266, DOI 10.1128/JB.181.14.4266-4274.1999; Gaskell AA, 2007, J BIOL CHEM, V282, P31812, DOI 10.1074/jbc.M705160200; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Hahn MY, 2005, J BACTERIOL, V187, P7062, DOI 10.1128/JB.187.20.7062-7071.2005; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hu JM, 1999, J BACTERIOL, V181, P469, DOI 10.1128/JB.181.2.469-476.1999; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jeong EH, 2006, BIOCHEM BIOPH RES CO, V339, P392, DOI 10.1016/j.bbrc.2005.11.032; Jung YG, 2011, NUCLEIC ACIDS RES, V39, P7586, DOI 10.1093/nar/gkr477; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Lane WJ, 2006, PLOS BIOL, V4, P1491, DOI 10.1371/journal.pbio.0040269; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li W, 2002, J MOL BIOL, V323, P225, DOI 10.1016/S0022-2836(02)00948-8; Li XJ, 2003, BRIT J DERMATOL, V149, P642, DOI 10.1046/j.1365-2133.2003.05564.x; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Newman TA, 2001, BRAIN, V124, P2203, DOI 10.1093/brain/124.11.2203; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Raghava GPS, 2000, BIOTECHNIQUES, V29, P108, DOI 10.2144/00291bc02; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrook J., 2001, MOL CLONING LAB MANU, P1881; Shen Z, 2009, MOL CELL PROTEOMICS, V8, P2443, DOI 10.1074/mcp.M900187-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Stewart GR, 2002, COMPAR FUNCT GENOM, V3, P348, DOI 10.1002/cfg.183; Takano H, 2003, GENE, V320, P127, DOI 10.1016/S0378-1119(03)00818-7; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Wu QL, 1997, J BACTERIOL, V179, P2922, DOI 10.1128/jb.179.9.2922-2929.1997; Zdanowski K, 2006, BIOCHEMISTRY-US, V45, P8294, DOI 10.1021/bi060711v; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004	52	7	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43676	10.1371/journal.pone.0043676	http://dx.doi.org/10.1371/journal.pone.0043676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937074	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500076
J	Lee, YT; Su, TH; Lo, WC; Lyu, PC; Sue, SC				Lee, Yun-Tzai; Su, Tz-Hsiang; Lo, Wei-Cheng; Lyu, Ping-Chiang; Sue, Shih-Che			Circular Permutation Prediction Reveals a Viable Backbone Disconnection for Split Proteins: An Approach in Identifying a New Functional Split Intein	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SYNECHOCYSTIS SP PCC6803; BETA-LACTAMASE; DNAE INTEIN; DIHYDROFOLATE-REDUCTASE; NOSTOC-PUNCTIFORME; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; IN-VIVO; RESOLUTION	Split-protein systems have emerged as a powerful tool for detecting biomolecular interactions and reporting biological reactions. However, reliable methods for identifying viable split sites are still unavailable. In this study, we demonstrated the feasibility that valid circular permutation (CP) sites in proteins have the potential to act as split sites and that CP prediction can be used to search for internal permissive sites for creating new split proteins. Using a protein ligase, intein, as a model, CP predictor facilitated the creation of circular permutants in which backbone opening imposes the least detrimental effects on intein folding. We screened a series of predicted intein CPs and identified stable and native-fold CPs. When the valid CP sites were introduced as split sites, there was a reduction in folding enthalpy caused by the new backbone opening; however, the coincident loss in entropy was sufficient to be compensated, yielding a favorable free energy for self-association. Since split intein is exploited in protein semi-synthesis, we tested the related protein trans-splicing (PTS) activities of the corresponding split inteins. Notably, a novel functional split intein composed of the N-terminal 36 residues combined with the remaining C-terminal fragment was identified. Its PTS activity was shown to be better than current reported two-piece intein with a short N-terminal segment. Thus, the incorporation of in silico CP prediction facilitated the design of split intein as well as circular permutants.	[Lee, Yun-Tzai; Su, Tz-Hsiang; Lo, Wei-Cheng; Lyu, Ping-Chiang; Sue, Shih-Che] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Sue, Shih-Che] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Lyu, Ping-Chiang] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Lo, Wei-Cheng] Natl Chiao Tung Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University	Lee, YT (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	pclyu@mx.nthu.edu.tw; scsue@life.nthu.edu.tw		Lo, Wei-Cheng/0000-0001-8865-5113	National Science Council (NSC), Taiwan [NSC 100-2627-B-007-006, NSC 100-2627-B-007-011, NSC 100-2627-B-007-019]; NTHU; NSC	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); NTHU; NSC(Ministry of Science and Technology, Taiwan)	The authors thank the National Science Council (NSC), Taiwan, for support [NSC 100-2627-B-007-006, NSC 100-2627-B-007-011 and NSC 100-2627-B-007-019]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the NMR facility at NTHU, which is supported by NTHU and NSC.	Aranko AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005185; Busche AEL, 2009, ANGEW CHEM INT EDIT, V48, P6128, DOI 10.1002/anie.200901488; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Carey J, 2007, PROTEIN SCI, V16, P2317, DOI 10.1110/ps.072985007; Chatani E, 2002, PROTEIN SCI, V11, P72, DOI 10.1101/ps.31102; Cody V, 1998, ANTI-CANCER DRUG DES, V13, P307; CUNNINGHAM BA, 1979, P NATL ACAD SCI USA, V76, P3218, DOI 10.1073/pnas.76.7.3218; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Goddard TD, SPARKY 3; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; HEINEMANN U, 1995, TRENDS BIOCHEM SCI, V20, P349, DOI 10.1016/S0968-0004(00)89073-8; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Lo WC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r11; Lo WC, 2012, NUCLEIC ACIDS RES, V40, pW232, DOI 10.1093/nar/gks529; Lo WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031791; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; Lo WC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-307; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Martin DD, 2001, BIOCHEMISTRY-US, V40, P1393, DOI 10.1021/bi001786g; METZLER WJ, 1993, BIOCHEMISTRY-US, V32, P13818, DOI 10.1021/bi00213a010; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Oeemig JS, 2009, FEBS LETT, V583, P1451, DOI 10.1016/j.febslet.2009.03.058; Ooi AT, 2006, BIOCHEMISTRY-US, V45, P3620, DOI 10.1021/bi0517032; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Pieper U, 1997, BIOCHEMISTRY-US, V36, P8767, DOI 10.1021/bi9705117; Porter JR, 2008, J AM CHEM SOC, V130, P6488, DOI 10.1021/ja7114579; Qian Z, 2005, J AM CHEM SOC, V127, P13466, DOI 10.1021/ja053932h; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; Shah NH, 2011, ANGEW CHEM INT EDIT, V50, P6511, DOI 10.1002/anie.201102909; Shi JX, 2005, J AM CHEM SOC, V127, P6198, DOI 10.1021/ja042287w; Stains CI, 2005, J AM CHEM SOC, V127, P10782, DOI 10.1021/ja051969w; Stephen P, 2012, CHEM COMMUN, V48, P2612, DOI 10.1039/c2cc17376j; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Sun WC, 2004, J BIOL CHEM, V279, P35281, DOI 10.1074/jbc.M405491200; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Vila-Perello M, 2010, CELL, V143, P191, DOI 10.1016/j.cell.2010.09.031; Whitehead TA, 2009, PROTEIN ENG DES SEL, V22, P607, DOI 10.1093/protein/gzp034; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004	50	14	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43820	10.1371/journal.pone.0043820	http://dx.doi.org/10.1371/journal.pone.0043820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937103	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500105
J	Thorne, LH; Johnston, DW; Urban, DL; Tyne, J; Bejder, L; Baird, RW; Yin, S; Rickards, SH; Deakos, MH; Mobley, JR; Pack, AA; Hill, MC				Thorne, Lesley H.; Johnston, David W.; Urban, Dean L.; Tyne, Julian; Bejder, Lars; Baird, Robin W.; Yin, Suzanne; Rickards, Susan H.; Deakos, Mark H.; Mobley, Joseph R., Jr.; Pack, Adam A.; Hill, Marie Chapla			Predictive Modeling of Spinner Dolphin (Stenella longirostris) Resting Habitat in the Main Hawaiian Islands	PLOS ONE			English	Article							SPECIES DISTRIBUTION; MAXIMUM-ENTROPY; DISTRIBUTIONS; PREY; PERFORMANCE; DIVERSITY; PATTERNS; PORPOISE; BEHAVIOR	Predictive habitat models can provide critical information that is necessary in many conservation applications. Using Maximum Entropy modeling, we characterized habitat relationships and generated spatial predictions of spinner dolphin (Stenella longirostris) resting habitat in the main Hawaiian Islands. Spinner dolphins in Hawai'i exhibit predictable daily movements, using inshore bays as resting habitat during daylight hours and foraging in offshore waters at night. There are growing concerns regarding the effects of human activities on spinner dolphins resting in coastal areas. However, the environmental factors that define suitable resting habitat remain unclear and must be assessed and quantified in order to properly address interactions between humans and spinner dolphins. We used a series of dolphin sightings from recent surveys in the main Hawaiian Islands and a suite of environmental variables hypothesized as being important to resting habitat to model spinner dolphin resting habitat. The model performed well in predicting resting habitat and indicated that proximity to deep water foraging areas, depth, the proportion of bays with shallow depths, and rugosity were important predictors of spinner dolphin habitat. Predicted locations of suitable spinner dolphin resting habitat provided in this study indicate areas where future survey efforts should be focused and highlight potential areas of conflict with human activities. This study provides an example of a presence-only habitat model used to inform the management of a species for which patterns of habitat availability are poorly understood.	[Thorne, Lesley H.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Thorne, Lesley H.; Johnston, David W.; Bejder, Lars] Duke Univ, Marine Lab, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Johnston, David W.; Yin, Suzanne; Rickards, Susan H.; Deakos, Mark H.; Pack, Adam A.; Hill, Marie Chapla] Pacific Islands Photo Identificat Network, Honolulu, HI USA; [Johnston, David W.; Tyne, Julian; Bejder, Lars] Murdoch Univ, Cetacean Res Unit, Ctr Fish Fisheries & Aquat Ecosyst Res, Murdoch, WA 6150, Australia; [Urban, Dean L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Baird, Robin W.] Cascadia Res Collect, Olympia, WA USA; [Yin, Suzanne; Rickards, Susan H.] Hawaii Marine Mammal Consortium, Kamuela, HI USA; [Deakos, Mark H.] Hawaii Assoc Marine Educ & Res Inc, Lahaina, HI USA; [Deakos, Mark H.; Pack, Adam A.] Dolphin Inst, Honolulu, HI USA; [Mobley, Joseph R., Jr.] Marine Mammal Res Consultants, Honolulu, HI USA; [Pack, Adam A.] Univ Hawaii, Dept Psychol, Hilo, HI 96720 USA; [Pack, Adam A.] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [Hill, Marie Chapla] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Duke University; Murdoch University; Duke University; University of Hawaii System; University Hawaii Hilo; University of Hawaii System; University Hawaii Hilo; University of Hawaii System; University of Hawaii Manoa	Thorne, LH (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	lesley.thorne@stonybrook.edu	Bejder, Lars/D-1772-2017; Johnston, David/AAJ-5013-2020; Baird, Robin/Y-8230-2019	Bejder, Lars/0000-0001-8138-8606; Johnston, David/0000-0003-2424-036X; Tyne, Julian/0000-0002-0676-5659; Thorne, Lesley/0000-0002-6297-0091; Baird, Robin/0000-0002-9419-6336	LeBurta Atherton	LeBurta Atherton	Portions of this research were supported by LeBurta Atherton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KR, 2010, MOL ECOL, V19, P732, DOI 10.1111/j.1365-294X.2010.04521.x; Andrews KR, 2009, THESIS U HAWAII HONO; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Benoit-Bird KJ, 2004, MAR BIOL, V145, P435, DOI 10.1007/s00227-004-1339-1; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Berger AL, 1996, COMPUT LINGUIST, V22, P39; Buse J, 2007, BIOL CONSERV, V137, P372, DOI 10.1016/j.biocon.2007.02.025; Carroll C, 1999, CONSERV BIOL, V13, P1344, DOI 10.1046/j.1523-1739.1999.98364.x; Courbis S, 2007, TOURISM MARINE ENV, V4, P1, DOI DOI 10.3727/154427307784835697; Courbis S, 2009, MAR MAMMAL SCI, V25, P430, DOI 10.1111/j.1748-7692.2008.00254.x; Danil Kerri, 2005, Aquatic Mammals, V31, P403, DOI 10.1578/AM.31.4.2005.403; DUKAS R, 1995, ECOLOGY, V76, P1320, DOI 10.2307/1940938; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FITCH JE, 1968, J FISH RES BOARD CAN, V25, P2561, DOI 10.1139/f68-227; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hu WY, 2009, MAR RESOUR ECON, V24, P61, DOI 10.1086/mre.24.1.42629645; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Johnston David W., 2008, Journal of Cetacean Research and Management, V10, P59; Karczmarski L, 2005, BEHAV ECOL, V16, P675, DOI 10.1093/beheco/ari028; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kuffner IB, 2007, ENVIRON BIOL FISH, V78, P71, DOI 10.1007/s10641-006-9078-4; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Lammers Marc O., 2004, Aquatic Mammals, V30, P237, DOI 10.1578/AM.30.2.2004.237; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Moura AE, 2012, ACTA OECOL, V38, P24, DOI 10.1016/j.actao.2011.08.006; Norris K.S., 1994, HAWAIIAN SPINNER DOL; NORRIS KS, 1980, FISH B-NOAA, V77, P821; Notarbartolo di Sciara G, 2008, J MAR BIOL ASSOC UK, V89, P211; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PERRIN WF, 1973, FISH B-NOAA, V71, P1077; Perrin WF, 1999, MAR MAMMAL SCI, V15, P1029, DOI 10.1111/j.1748-7692.1999.tb00876.x; PERRIN WF, 1990, P BIOL SOC WASH, V103, P453; Perrin William F., 1998, Mammalian Species, V599, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; POOLE M, 1995, THESIS U CALIFORNIA; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; REID SB, 1991, MAR BIOL, V109, P427, DOI 10.1007/BF01313508; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Wilson MFJ, 2007, MAR BIOL, V15; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004	59	52	57	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43167	10.1371/journal.pone.0043167	http://dx.doi.org/10.1371/journal.pone.0043167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937022	Green Published, gold			2022-12-27	WOS:000308225500034
J	Wium, E; Dulhunty, AF; Beard, NA				Wium, Elize; Dulhunty, Angela F.; Beard, Nicole A.			A Skeletal Muscle Ryanodine Receptor Interaction Domain in Triadin	PLOS ONE			English	Article							RETICULUM GLYCOPROTEIN TRIADIN; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; BIOCHEMICAL-CHARACTERIZATION; LUMINAL CA2+; BETA-STRAND; CALSEQUESTRIN; JUNCTIN; BINDING; PROTEIN	Excitation-contraction coupling in skeletal muscle depends, in part, on a functional interaction between the ligand-gated ryanodine receptor (RyR1) and integral membrane protein Trisk 95, localized to the sarcoplasmic reticulum membrane. Various domains on Trisk 95 can associate with RyR1, yet the domain responsible for regulating RyR1 activity has remained elusive. We explored the hypothesis that a luminal Trisk 95 KEKE motif (residues 200-232), known to promote RyR1 binding, may also form the RyR1 activation domain. Peptides corresponding to Trisk 95 residues 200-232 or 200-231 bound to RyR1 and increased the single channel activity of RyR1 by 1.49 +/- 0.11-fold and 1.8 +/- 0.15-fold respectively, when added to its luminal side. A similar increase in [H-3] ryanodine binding, which reflects open probability of the channels, was also observed. This RyR1 activation is similar to activation induced by full length Trisk 95. Circular dichroism showed that both peptides were intrinsically disordered, suggesting a defined secondary structure is not necessary to mediate RyR1 activation. These data for the first time demonstrate that Trisk 959s 200-231 region is responsible for RyR1 activation. Furthermore, it shows that no secondary structure is required to achieve this activation, the Trisk 95 residues themselves are critical for the Trisk 95-RyR1 interaction.	[Wium, Elize; Dulhunty, Angela F.; Beard, Nicole A.] John Curtin Sch Med Res, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research	Wium, E (corresponding author), John Curtin Sch Med Res, Canberra, ACT, Australia.	nicole.beard@anu.edu.au	Dulhunty, Angela/AAO-5421-2020	Dulhunty, Angela/0000-0001-9493-4944	Australian Research Council [DP1094219]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (DP1094219 to A.F.D. and N.A.B.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard NA, 2005, BIOPHYS J, V88, P3444, DOI 10.1529/biophysj.104.051441; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Beard NA, 2008, CELL CALCIUM, V44, P363, DOI 10.1016/j.ceca.2008.01.005; Caswell AH, 1999, BIOCHEMISTRY-US, V38, P90, DOI 10.1021/bi981306+; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106; Fan GC, 2007, BIOCHEM BIOPH RES CO, V352, P617, DOI 10.1016/j.bbrc.2006.11.093; Goonasekera SA, 2007, J GEN PHYSIOL, V130, P365, DOI 10.1085/jgp.200709790; Guo W, 1996, J BIOL CHEM, V271, P458, DOI 10.1074/jbc.271.1.458; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P441, DOI 10.1073/pnas.85.2.441; Kimura T, 2007, BIOCHEM J, V401, P317, DOI 10.1042/BJ20060686; KNUDSON CM, 1993, J BIOL CHEM, V268, P12637; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lan W, 2009, CELL CALCIUM, V45, P474, DOI 10.1016/j.ceca.2009.03.006; LAVER DR, 1995, J MEMBRANE BIOL, V147, P7; Lee HG, 2001, J BIOL CHEM, V276, P39533, DOI 10.1074/jbc.M010664200; Lee JM, 2004, J BIOL CHEM, V279, P6994, DOI 10.1074/jbc.M312446200; LIU GH, 1994, J BIOL CHEM, V269, P33028; Marty I, 2009, J PHYSIOL-LONDON, V587, P3117, DOI 10.1113/jphysiol.2009.171892; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; NAGESH N, 1995, J BIOCHEM BIOPH METH, V30, P1, DOI 10.1016/0165-022X(94)00057-K; OSTERMAN DG, 1985, J CELL BIOCHEM, V29, P57, DOI 10.1002/jcb.240290202; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; REALINI C, 1994, FEBS LETT, V348, P109, DOI 10.1016/0014-5793(94)00569-9; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Shin DW, 2000, FEBS LETT, V486, P178, DOI 10.1016/S0014-5793(00)02246-8; Thevenon D, 2003, BIOCHEM BIOPH RES CO, V303, P669, DOI 10.1016/S0006-291X(03)00406-6; Vassilopoulos S, 2005, J BIOL CHEM, V280, P28601, DOI 10.1074/jbc.M501484200; Wang Y, 2009, CELL CALCIUM, V45, P29, DOI 10.1016/j.ceca.2008.05.006; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; Wei L, 2009, INT J BIOCHEM CELL B, V41, P2214, DOI 10.1016/j.biocel.2009.04.017; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	38	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43817	10.1371/journal.pone.0043817	http://dx.doi.org/10.1371/journal.pone.0043817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937102	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500104
J	Xu, Y				Xu, Yong			Quaternion-Based Discriminant Analysis Method for Color Face Recognition	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; ALGORITHMS; MATRICES; SIGNAL	Pattern recognition techniques have been used to automatically recognize the objects, personal identities, predict the function of protein, the category of the cancer, identify lesion, perform product inspection, and so on. In this paper we propose a novel quaternion-based discriminant method. This method represents and classifies color images in a simple and mathematically tractable way. The proposed method is suitable for a large variety of real-world applications such as color face recognition and classification of the ground target shown in multispectrum remote images. This method first uses the quaternion number to denote the pixel in the color image and exploits a quaternion vector to represent the color image. This method then uses the linear discriminant analysis algorithm to transform the quaternion vector into a lower-dimensional quaternion vector and classifies it in this space. The experimental results show that the proposed method can obtain a very high accuracy for color face recognition.	[Xu, Yong] Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China; [Xu, Yong] Key Lab Network Oriented Intelligent Computat, Shenzhen, Peoples R China	Harbin Institute of Technology; University Town of Shenzhen	Xu, Y (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen, Guangdong, Peoples R China.	laterfall2@yahoo.com.cn			Program for New Century Excellent Talents in University [NCET-08-0156]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was partially supported by Program for New Century Excellent Talents in University (NCET-08-0156). No additional external funding was received for this study.	Angulo J, 2009, LECT NOTES COMPUT SC, V5646, P91, DOI 10.1007/978-3-642-03265-3_10; Chengjun L, 2008, IEEE T INFORM FORENS, V3; Choi JY, 2012, IEEE T IMAGE PROCESS, V21, P1366, DOI 10.1109/TIP.2011.2168413; Denis P, 2007, COMPUT VIS IMAGE UND, V107, P74, DOI 10.1016/j.cviu.2006.11.019; Felsberg M, 1999, LECT NOTES COMPUT SC, V1689, P209; Hypercomplex BT, 1999, SPECTRAL SIGNAL REPR; Janovska D, 2008, WORLD ACAD SCI ENG T, V47, P141; Jones CF, 2004, EURASIP J APPL SIG P, V2004, P522, DOI 10.1155/S1110865704401073; Kittler J, 2004, LECT NOTES COMPUT SC, V3077, P354; Le Bihan N, 2004, SIGNAL PROCESS, V84, P1177, DOI 10.1016/j.sigpro.2004.04.001; Le Bihan N, 2002, QUATERNION SUBSPACE, P637; Le Bihan N, 2003, P 2003 INT C IM PROC; Lilong S, 2008, QUATERNION COLOR CUR, P338; Liu ZM, 2008, IEEE T IMAGE PROCESS, V17, P1975, DOI 10.1109/TIP.2008.2002837; Miron S, 2006, IEEE T SIGNAL PROCES, V54, P1218, DOI 10.1109/TSP.2006.870630; Neagoe V.E., 2006, WSEAS T SIGNAL PROCE, V2; Sangwine SJ, 1998, ELECTRON LETT, V34, P969, DOI 10.1049/el:19980697; Sangwine SJ, 2006, APPL MATH COMPUT, V182, P727, DOI 10.1016/j.amc.2006.04.032; Shi LL, 2007, COMPUT VIS IMAGE UND, V107, P88, DOI 10.1016/j.cviu.2006.11.014; Shih PC, 2006, IEEE IMAGE PROC, P1001, DOI 10.1109/ICIP.2006.312668; Soo C, 2003, P 2003 INT C IM PROC; Soo-Chang P, 2001, IEEE T SIGNAL PROCES, V49; Soo-Chang P, 1997, IEEE T COMMUNICATION, V45; Soo-Chang P., 2004, IEEE T SIGNAL PROCES, V52; Suhre A, 2011, OPT ENG, V50, DOI 10.1117/1.3574071; Tsagaris V, 2009, OPT ENG, V48, DOI 10.1117/1.3153331; Wang SJ, 2012, IEEE T NEUR NET LEAR, V23, P876, DOI 10.1109/TNNLS.2012.2191620; Wang SJ, 2011, IEEE T IMAGE PROCESS, V20, P2490, DOI 10.1109/TIP.2011.2121084; Xu Y, 2007, NEUROCOMPUTING, V70, P1056, DOI 10.1016/j.neucom.2006.09.005; Yang J, 2008, IEEE T NEURAL NETWOR, V19, P2088, DOI 10.1109/TNN.2008.2003187; Yihui Y, 2011, OPTICAL ENG, V50; Yong X, 2003, PATTERN RECOGNITION, V36; Yong X, 2008, NEUROCOMPUTING, V71; Yong X, 2010, PATTERN RECOGNITION, V43; Zhang D., 2008, ADV PATTERN RECOGNIT; Zhang FZ, 1997, LINEAR ALGEBRA APPL, V251, P21, DOI 10.1016/0024-3795(95)00543-9; Zhiming L, 2010, PATTERN RECOGNITION, V43	38	6	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43493	10.1371/journal.pone.0043493	http://dx.doi.org/10.1371/journal.pone.0043493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937054	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500055
J	Folco, EG; Lee, CS; Dufu, K; Yamazaki, T; Reed, R				Folco, Eric G.; Lee, Chung-Sheng; Dufu, Kobina; Yamazaki, Tomohiro; Reed, Robin			The Proteins PDIP3 and ZC11A Associate with the Human TREX Complex in an ATP-Dependent Manner and Function in mRNA Export	PLOS ONE			English	Article							UAP56	The conserved TREX complex, which contains UAP56, Aly, CIP29, and the multi-subunit THO complex, functions in mRNA export. Recently, several putative new components of the human TREX complex were identified by mass spectrometry. Here, we investigated the function of two of these, PDIP3 and ZC11A. Our data indicate that both of these proteins are components of a common TREX complex and function in mRNA export. Recently, we found that both CIP29 and Aly associate with the DEAD box helicase UAP56 and with the TREX complex in an ATP-dependent manner. We now show that this is also the case for PDIP3 and ZC11A. Thus, together with previous work, our data indicate that the TREX complex participates in multiple ATP-dependent interactions.	[Folco, Eric G.; Lee, Chung-Sheng; Dufu, Kobina; Yamazaki, Tomohiro; Reed, Robin] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Harvard University; Harvard Medical School	Folco, EG (corresponding author), Inst Albert Bonniot, INSERM U823, Grenoble, France.	rreed@hms.harvard.edu	Folco, Eric/M-2665-2013	Dufu, Kobina/0000-0001-5450-4157	NIH [GM043375]; Toyobo Biotechnology Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM043375, R01GM043375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Toyobo Biotechnology Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH grant (GM043375) to RR. TY is supported by a grant-in-aid from Toyobo Biotechnology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Hautbergue GM, 2009, CURR BIOL, V19, P1918, DOI 10.1016/j.cub.2009.09.041; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Jimeno S, 2006, MOL CELL BIOL, V26, P4387, DOI 10.1128/MCB.00234-06; Kapadia F, 2006, GENE, V384, P37, DOI 10.1016/j.gene.2006.07.010; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Okada M, 2008, P NATL ACAD SCI USA, V105, P8649, DOI 10.1073/pnas.0802533105; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Strasser K, 2002, NATURE, V28, P28; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	18	33	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43804	10.1371/journal.pone.0043804	http://dx.doi.org/10.1371/journal.pone.0043804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928037	gold, Green Published			2022-12-27	WOS:000308224700025
J	Bruder, JM; Pfeiffer, ZA; Ciriello, JM; Horrigan, DM; Wicks, NL; Flaherty, B; Oancea, E				Bruder, Jan M.; Pfeiffer, Zachary A.; Ciriello, Jonathan M.; Horrigan, Diana M.; Wicks, Nadine L.; Flaherty, Benjamin; Oancea, Elena			Melanosomal Dynamics Assessed with a Live-Cell Fluorescent Melanosomal Marker	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEM; SKIN PIGMENTATION; MYOSIN-VA; MELANIN TRANSFER; OCULAR ALBINISM; MEMBRANE DYNAMICS; MODEL SYSTEM; IN-VITRO; MELANOCYTES; PROTEIN	Melanocytes present in skin and other organs synthesize and store melanin pigment within membrane-delimited organelles called melanosomes. Exposure of human skin to ultraviolet radiation (UV) stimulates melanin production in melanosomes, followed by transfer of melanosomes from melanocytes to neighboring keratinocytes. Melanosomal function is critical for protecting skin against UV radiation, but the mechanisms underlying melanosomal movement and transfer are not well understood. Here we report a novel fluorescent melanosomal marker, which we used to measure real-time melanosomal dynamics in live human epidermal melanocytes (HEMs) and transfer in melanocyte-keratinocyte co-cultures. A fluorescent fusion protein of Ocular Albinism 1 (OA1) localized to melanosomes in both B16-F1 cells and HEMs, and its expression did not significantly alter melanosomal distribution. Live-cell tracking of OA1-GFP-tagged melanosomes revealed a bimodal kinetic profile, with melanosomes exhibiting combinations of slow and fast movement. We also found that exposure to UV radiation increased the fraction of melanosomes exhibiting fast versus slow movement. In addition, using OA1-GFP in live co-cultures, we monitored melanosomal transfer using time-lapse microscopy. These results highlight OA1-GFP as a specific and effective melanosomal marker for live-cell studies, reveal new aspects of melanosomal dynamics and transfer, and are relevant to understanding the skin's physiological response to UV radiation.	[Bruder, Jan M.; Pfeiffer, Zachary A.; Ciriello, Jonathan M.; Horrigan, Diana M.; Wicks, Nadine L.; Flaherty, Benjamin; Oancea, Elena] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University	Bruder, JM (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany.	elena_oancea@brown.edu	Bruder, Jan/AGN-4025-2022; Bruder, Jan/AAM-4165-2021	Bruder, Jan/0000-0003-3126-0625; Bruder, Jan/0000-0003-3126-0625				Abdel-Malek ZA, 2010, PIGM CELL MELANOMA R, V23, P171, DOI 10.1111/j.1755-148X.2010.00679.x; Ando H, 2009, PIGMENT CELL MELANOM; Aspengren S, 2009, INT REV CEL MOL BIO, V272, P245, DOI 10.1016/S1937-6448(08)01606-7; Beaumont KA, 2011, TRAFFIC, V12, P627, DOI 10.1111/j.1600-0854.2011.01172.x; Berens W, 2005, PIGM CELL RES, V18, P370, DOI 10.1111/j.1600-0749.2005.00263.x; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; Boissy RE, 2003, EXP DERMATOL, V12, P5, DOI 10.1034/j.1600-0625.12.s2.1.x; Brito FC, 2008, PIGM CELL MELANOMA R, V21, P464, DOI 10.1111/j.1755-148X.2008.00459.x; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Ebanks JP, 2009, INT J MOL SCI, V10, P4066, DOI 10.3390/ijms10094066; FITZPATRICK T B, 1963, Dermatol Wochenschr, V147, P481; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; GOLDGEIER MH, 1984, J INVEST DERMATOL, V82, P235, DOI 10.1111/1523-1747.ep12260111; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; HILDING DA, 1977, ACTA OTO-LARYNGOL, V84, P24, DOI 10.3109/00016487709123939; Hume AN, 2007, J CELL SCI, V120, P3111, DOI 10.1242/jcs.010207; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Innamorati G, 2006, PIGM CELL RES, V19, P125, DOI 10.1111/j.1600-0749.2006.00292.x; Lavado A, 2006, FRONT BIOSCI-LANDMRK, V11, P743, DOI 10.2741/1832; Lee CW, 2008, MOL BIOL CELL, V19, P150, DOI 10.1091/mbc.E07-05-0515; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Lubeck RP, 2008, EXP DERMATOL, V17, P228; Mahmoud BH, 2010, J INVEST DERMATOL, V130, P2092, DOI 10.1038/jid.2010.95; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Meng S, 2008, BIOPHYS J, V95, P4396, DOI 10.1529/biophysj.108.135756; Minwalla L, 2001, J INVEST DERMATOL, V117, P341, DOI 10.1046/j.0022-202x.2001.01411.x; Minwalla L, 2001, PIGM CELL RES, V14, P185, DOI 10.1034/j.1600-0749.2001.140308.x; MOTTAZ JH, 1967, J INVEST DERMATOL, V49, P605, DOI 10.1038/jid.1967.187; Nordlund J. J., 1998, PIGMENTARY SYSTEM; OKAZAKI K, 1976, J INVEST DERMATOL, V67, P541, DOI 10.1111/1523-1747.ep12664554; Palmisano I, 2008, HUM MOL GENET; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; Schiaffino MV, 2005, PIGM CELL RES, V18, P227, DOI 10.1111/j.1600-0749.2005.00240.x; Scott G, 2002, J CELL SCI, V115, P1441; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Seiberg M, 2001, PIGM CELL RES, V14, P236, DOI 10.1034/j.1600-0749.2001.140402.x; SEIJI M, 1963, NATURE, V197, P1082, DOI 10.1038/1971082a0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHEETZ MP, 1989, NATURE, V340, P284, DOI 10.1038/340284a0; Singh SK, 2010, FASEB J; Singh SK, 2008, EXP DERMATOL, V17, P418, DOI 10.1111/j.1600-0625.2008.00702.x; Singh SK, 2010, FASEB J, V24, P3756, DOI 10.1096/fj.10-159046; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Sone M, 2007, EXP EYE RES, V85, P806, DOI 10.1016/j.exer.2007.08.016; Spitz, 2004, GEN CLIN GUID GEN SK; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; SWIFT JA, 1964, NATURE, V203, P976, DOI 10.1038/203976b0; Tachibana M, 1999, PIGM CELL RES, V12, P344, DOI 10.1111/j.1600-0749.1999.tb00518.x; Toriello HV, 2011, ADV OTO-RHINO-LARYNG, V70, P50, DOI 10.1159/000322471; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Wicks NL, 2011, CURR BIOL; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yajima I, 2008, PIGM CELL MELANOMA R, V21, P471, DOI 10.1111/j.1755-148X.2008.00483.x; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; YAMAMOTO O, 1994, PIGM CELL RES, V7, P158, DOI 10.1111/j.1600-0749.1994.tb00044.x; Yoshida Y, 2007, FASEB J, V21, P2829, DOI 10.1096/fj.06-6845com; Zecca L, 2002, J NEURAL TRANSM, V109, P663, DOI 10.1007/s007020200055	69	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43465	10.1371/journal.pone.0043465	http://dx.doi.org/10.1371/journal.pone.0043465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927970	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300054
J	D'Alvise, PW; Lillebo, S; Prol-Garcia, MJ; Wergeland, HI; Nielsen, KF; Bergh, O; Gram, L				D'Alvise, Paul W.; Lillebo, Siril; Prol-Garcia, Maria J.; Wergeland, Heidrun I.; Nielsen, Kristian F.; Bergh, Oivind; Gram, Lone			Phaeobacter gallaeciensis Reduces Vibrio anguillarum in Cultures of Microalgae and Rotifers, and Prevents Vibriosis in Cod Larvae	PLOS ONE			English	Article							TROPODITHIETIC ACID BIOSYNTHESIS; ALGA ULVA-AUSTRALIS; GADUS-MORHUA; LISTONELLA-ANGUILLARUM; BRACHIONUS-PLICATILIS; PROBIOTIC BACTERIA; RAINBOW-TROUT; PATHOGENIC BACTERIA; MARINE LARVICULTURE; INHIBITORY-ACTIVITY	Phaeobacter gallaeciensis can antagonize fish-pathogenic bacteria in vitro, and the purpose of this study was to evaluate the organism as a probiont for marine fish larvae and their feed cultures. An in vivo mechanism of action of the antagonistic probiotic bacterium is suggested using a non-antagonistic mutant. P. gallaeciensis was readily established in axenic cultures of the two microalgae Tetraselmis suecica and Nannochloropsis oculata, and of the rotifer Brachionus plicatilis. P. gallaeciensis reached densities of 10(7) cfu/ml and did not adversely affect growth of algae or rotifers. Vibrio anguillarum was significantly reduced by wild-type P. gallaeciensis, when introduced into these cultures. A P. gallaeciensis mutant that did not produce the antibacterial compound tropodithietic acid (TDA) did not reduce V. anguillarum numbers, suggesting that production of the antibacterial compound is important for the antagonistic properties of P. gallaeciensis. The ability of P. gallaeciensis to protect fish larvae from vibriosis was determined in a bath challenge experiment using a multidish system with 1 larva per well. Unchallenged larvae reached 40% accumulated mortality which increased to 100% when infected with V. anguillarum. P. gallaeciensis reduced the mortality of challenged cod larvae (Gadus morhua) to 10%, significantly below the levels of both the challenged and the unchallenged larvae. The TDA mutant reduced mortality of the cod larvae in some of the replicates, although to a much lesser extent than the wild type. It is concluded that P. gallaeciensis is a promising probiont in marine larviculture and that TDA production likely contributes to its probiotic effect.	[D'Alvise, Paul W.; Prol-Garcia, Maria J.; Gram, Lone] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Lillebo, Siril; Wergeland, Heidrun I.] Univ Bergen, Dept Biol, Bergen, Norway; [Nielsen, Kristian F.] Tech Univ Denmark, Dept Syst Biol, Ctr Microbiol Biotechnol, DK-2800 Lyngby, Denmark; [Bergh, Oivind] Inst Marine Res, N-5024 Bergen, Norway	Technical University of Denmark; University of Bergen; Technical University of Denmark; Institute of Marine Research - Norway	D'Alvise, PW (corresponding author), Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark.	gram@food.dtu.dk	Nielsen, Kristian Fog/C-7233-2011; Bergh, Øivind/AIE-3508-2022	Nielsen, Kristian Fog/0000-0002-5848-0911; Bergh, Øivind/0000-0002-9849-025X; Gram, Lone/0000-0002-1076-5723	Danish Research Council for Technology and Production [09-066524]	Danish Research Council for Technology and Production	This study was funded by the Danish Research Council for Technology and Production to the project 09-066524 (Bioactive bacterial biofilm surfaces in aquaculture - disease prevention without antibiotics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; BAO Y, 1991, GENE, V109, P167, DOI 10.1016/0378-1119(91)90604-A; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Carnevali O, 2004, AQUACULT INT, V12, P377, DOI 10.1023/B:AQUI.0000042141.85977.bb; Conceicao LEC, 2010, AQUAC RES, V41, P613, DOI 10.1111/j.1365-2109.2009.02242.x; Croxatto A, 2007, ENVIRON MICROBIOL, V9, P370, DOI 10.1111/j.1462-2920.2006.01147.x; D'Alvise PW, 2010, APPL ENVIRON MICROB, V76, P2366, DOI 10.1128/AEM.02717-09; Dimitroglou A, 2011, FISH SHELLFISH IMMUN, V30, P1, DOI 10.1016/j.fsi.2010.08.009; Douillet PA, 1999, AQUACULTURE, V170, P113, DOI 10.1016/S0044-8486(98)00398-6; Eddy SD, 2002, AQUACULTURE, V211, P9, DOI 10.1016/S0044-8486(01)00882-1; Gatesoupe FJ, 2002, AQUACULTURE, V212, P347, DOI 10.1016/S0044-8486(02)00138-2; Geng HF, 2008, APPL ENVIRON MICROB, V74, P1535, DOI 10.1128/AEM.02339-07; Geng HF, 2010, J BACTERIOL, V192, P4377, DOI 10.1128/JB.00410-10; Gram L, 2010, MAR BIOTECHNOL, V12, P439, DOI 10.1007/s10126-009-9233-y; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HANSEN PJ, 1989, MAR ECOL PROG SER, V53, P105, DOI 10.3354/meps053105; Harzevili ARS, 1997, AQUACULT INT, V5, P183; Hjelm M, 2004, SYST APPL MICROBIOL, V27, P360, DOI 10.1078/0723-2020-00256; Irianto A, 2002, J FISH DIS, V25, P633, DOI 10.1046/j.1365-2761.2002.00422.x; Kesarcodi-Watson A, 2008, AQUACULTURE, V274, P1, DOI 10.1016/j.aquaculture.2007.11.019; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; MANGORJENSEN A, 1987, FISH PHYSIOL BIOCHEM, V3, P99, DOI 10.1007/BF02183004; Marques A, 2005, APPL ENVIRON MICROB, V71, P4307, DOI 10.1128/AEM.71.8.4307-4317.2005; Marques A, 2006, AQUACULTURE, V258, P116, DOI 10.1016/j.aquaculture.2006.04.021; Martens T, 2006, INT J SYST EVOL MICR, V56, P1293, DOI 10.1099/ijs.0.63724-0; Martinez-Diaz SF, 2003, AQUACULT INT, V11, P95, DOI 10.1023/A:1024117109362; Munro PD, 1999, AQUACULTURE, V170, P229, DOI 10.1016/S0044-8486(98)00419-0; MUNRO PD, 1995, APPL ENVIRON MICROB, V61, P4425, DOI 10.1128/AEM.61.12.4425-4428.1995; NAAS KE, 1992, AQUACULTURE, V105, P143, DOI 10.1016/0044-8486(92)90126-6; NORQVIST A, 1990, INFECT IMMUN, V58, P3731, DOI 10.1128/IAI.58.11.3731-3736.1990; NORQVIST A, 1989, APPL ENVIRON MICROB, V55, P1400, DOI 10.1128/AEM.55.6.1400-1405.1989; Olafsen JA, 2001, AQUACULTURE, V200, P223, DOI 10.1016/S0044-8486(01)00702-5; Perez-Sanchez T, 2011, FISH SHELLFISH IMMUN, V31, P196, DOI 10.1016/j.fsi.2011.05.005; Picchietti S, 2007, FISH SHELLFISH IMMUN, V22, P57, DOI 10.1016/j.fsi.2006.03.009; Planas M, 2006, AQUACULTURE, V255, P323, DOI 10.1016/j.aquaculture.2005.11.039; Planas M, 2004, AQUACULTURE, V240, P313, DOI 10.1016/j.aquaculture.2004.07.016; Porsby CH, 2008, APPL ENVIRON MICROB, V74, P7356, DOI 10.1128/AEM.01738-08; Porsby CH, 2011, ANTIMICROB AGENTS CH, V55, P1332, DOI 10.1128/AAC.01222-10; Prado S, 2009, INT MICROBIOL, V12, P107, DOI 10.2436/20.1501.01.87; Prol MJ, 2009, J APPL MICROBIOL, V106, P1292, DOI 10.1111/j.1365-2672.2008.04096.x; Rao D, 2005, APPL ENVIRON MICROB, V71, P1729, DOI 10.1128/AEM.71.4.1729-1736.2005; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Rao D, 2006, APPL ENVIRON MICROB, V72, P5547, DOI 10.1128/AEM.00449-06; Reid HI, 2009, AQUACULTURE, V288, P36, DOI 10.1016/j.aquaculture.2008.11.022; Rollo A, 2006, FISH PHYSIOL BIOCHEM, V32, P167, DOI 10.1007/s10695-006-0009-2; Ruiz-Ponte C, 1998, INT J SYST BACTERIOL, V48, P537, DOI 10.1099/00207713-48-2-537; Salvesen I, 2000, AQUACULT INT, V8, P275, DOI 10.1023/A:1009200926452; Samuelsen OB, 2004, AQUACULTURE, V235, P27, DOI 10.1016/S0044-8486(03)00446-0; Sandlund N, 2008, DIS AQUAT ORGAN, V81, P203, DOI 10.3354/dao01934; Sandlund N, 2010, DIS AQUAT ORGAN, V89, P29, DOI 10.3354/dao02176; Seljestokken B, 2006, J FISH DIS, V29, P737, DOI 10.1111/j.1365-2761.2006.00773.x; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI [10.1038/nchem.1002, 10.1038/NCHEM.1002]; Skjermo J, 1999, AQUACULTURE, V177, P333, DOI 10.1016/S0044-8486(99)00096-4; Skjermo J, 1997, AQUACULT INT, V5, P13, DOI 10.1007/BF02764784; Sobecky PA, 1997, APPL ENVIRON MICROB, V63, P888, DOI 10.1128/AEM.63.3.888-895.1997; Tinh NTN, 2008, MAR BIOTECHNOL, V10, P1, DOI 10.1007/s10126-007-9054-9; Tinh NTN, 2006, AQUACULTURE, V253, P421, DOI 10.1016/j.aquaculture.2005.09.006; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Vik-Mo FT, 2005, DIS AQUAT ORGAN, V67, P87, DOI 10.3354/dao067087; Vine NG, 2006, FEMS MICROBIOL REV, V30, P404, DOI 10.1111/j.1574-6976.2006.00017.x; Wang YB, 2008, AQUACULTURE, V281, P1, DOI 10.1016/j.aquaculture.2008.06.002; Wietz M, 2010, AQUAT MICROB ECOL, V61, P179, DOI 10.3354/ame01443	65	81	83	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43996	10.1371/journal.pone.0043996	http://dx.doi.org/10.1371/journal.pone.0043996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928051	gold, Green Published			2022-12-27	WOS:000308286300100
J	Saussine, A; Tazi, A; Feuillet, S; Rybojad, M; Juillard, C; Bergeron, A; Dessirier, V; Bouhidel, F; Janin, A; Bensussan, A; Bagot, M; Bouaziz, JD				Saussine, Anne; Tazi, Abdellatif; Feuillet, Severine; Rybojad, Michel; Juillard, Caroline; Bergeron, Anne; Dessirier, Valerie; Bouhidel, Fatiha; Janin, Anne; Bensussan, Armand; Bagot, Martine; Bouaziz, Jean-David			Active Chronic Sarcoidosis is Characterized by Increased Transitional Blood B Cells, Increased IL-10-Producing Regulatory B Cells and High BAFF Levels	PLOS ONE			English	Article							LYMPHOCYTE STIMULATOR; PULMONARY SARCOIDOSIS; T-CELLS; MICE; SCLEROSIS; RITUXIMAB; DISEASES; CD4(+)	Background: Sarcoidosis is a multisystemic disease of unknown etiology characterized by a disproportionate Th1 granulomatous immune response in the organs involved. Plasmatic hypergammaglobulinemia and B cell accumulation in granulomatous lesions suggest the possible role of humoral immune responses in the pathogenesis of sarcoidosis. The purpose of this study is to describe B cell peripheral compartment in sarcoidosis. Methodology/Principal Findings: We analyzed blood B cell subsets and BAFF levels in 33 patients with chronic sarcoidosis (active sarcoidosis n = 18; inactive sarcoidosis n = 15) and 18 healthy donors. Active chronic sarcoidosis patients had significantly less circulating memory B cells (p<0.01), more transitional (p<0.01) and increased numbers of IL-10-producing regulatory B cells (p<0.05) compared with healthy donors and patients with inactive sarcoidosis. BAFF serum levels were significantly higher in patients with active sarcoidosis (p<0.01 versus healthy donors and inactive sarcoidosis patients) and strongly correlated with serum hypergammaglobulinemia (r = 0.53, p<0.01) and angiotensin converting enzyme levels (r = 0.61, p =< 0.01). Conclusions/Significance: These data show that there is an altered B cell homeostasis in active sarcoidosis and suggest BAFF antagonist drugs as potential new treatments of this disease.	[Saussine, Anne; Dessirier, Valerie; Bensussan, Armand; Bagot, Martine; Bouaziz, Jean-David] INSERM, U976, Paris, France; [Saussine, Anne; Dessirier, Valerie; Bensussan, Armand; Bagot, Martine; Bouaziz, Jean-David] Univ Paris Diderot, Lab Immunol Dermatol & Oncol, UMR S 976, Paris, France; [Saussine, Anne; Rybojad, Michel; Juillard, Caroline; Bagot, Martine; Bouaziz, Jean-David] Hop St Louis, Serv Dermatol, F-75475 Paris, France; [Tazi, Abdellatif; Feuillet, Severine; Bergeron, Anne] Hop St Louis, Serv Pneumol, Paris, France; [Tazi, Abdellatif; Feuillet, Severine; Bergeron, Anne] Univ Paris Diderot, AP HP, Paris, France; [Bouhidel, Fatiha; Janin, Anne] Hop St Louis, Serv Anatomopathol, Paris, France; [Bouhidel, Fatiha; Janin, Anne] Univ Paris Diderot Sorbonne Paris Cite, Lab Pahol, UMR S 728, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Saussine, A (corresponding author), INSERM, U976, Paris, France.	Armand.Bensussan@inserm.fr; jean-david.bouaziz@sls.aphp.fr		Bensussan, Armand/0000-0002-0409-2497; Bergeron, Anne/0000-0003-2156-254X	Bourse du Fonds d'Etudes et de Recherche du Corps Medical de l'AP-HP, Societe francaise de Dermatologie (SFD), Societe francaise de Recherche Dermatologique (SRD), Legs Poix	Bourse du Fonds d'Etudes et de Recherche du Corps Medical de l'AP-HP, Societe francaise de Dermatologie (SFD), Societe francaise de Recherche Dermatologique (SRD), Legs Poix	Bourse du Fonds d'Etudes et de Recherche du Corps Medical de l'AP-HP, Societe francaise de Dermatologie (SFD), Societe francaise de Recherche Dermatologique (SRD), Legs Poix. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, EUR RESP J, V7, P624; [Anonymous], 1999, AM J RESP CRIT CARE, V160, P736; Baumer I, 1997, AM J RESP CELL MOL, V16, P171; Belkhou A, 2008, JOINT BONE SPINE, V75, P511, DOI 10.1016/j.jbspin.2008.01.025; Bergeron A, 1997, J IMMUNOL, V159, P3034; Bertheau P, 1998, J CLIN PATHOL, V51, P370, DOI 10.1136/jcp.51.5.370; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bouaziz J-D, 2012, CURRENT MOL MED; Bouaziz JD, 2010, EUR J IMMUNOL; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Boudouin SV, 1994, SARCOIDOSIS OTHER GR, P573; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Dasilva V, 2010, JOINT BONE SPINE, V77, P82, DOI 10.1016/j.jbspin.2009.11.005; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; FAZEL SB, 1992, THORAX, V47, P964, DOI 10.1136/thx.47.11.964; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Gottenberg JE, 2005, ANN RHEUM DIS, V64, P913, DOI 10.1136/ard.2004.029694; HUNNINGHAKE GW, 1981, J CLIN INVEST, V67, P86, DOI 10.1172/JCI110036; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Landolt-Marticorena C, 2011, J RHEUMATOL, V38, P642, DOI 10.3899/jrheum.100214; Lee NS, 2011, CLIN VACCINE IMMUNOL, V18, P1306, DOI 10.1128/CVI.05118-11; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Matsushita T, 2006, ARTHRITIS RHEUM-US, V54, P192, DOI 10.1002/art.21526; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Medoff BD, 2005, ANN NY ACAD SCI, V1062, P220, DOI 10.1196/annals.1358.026; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; QUISMORIO FP, 1977, BRIT J DERMATOL, V97, P635, DOI 10.1111/j.1365-2133.1977.tb14270.x; Wahlstrom J, 2001, AM J RESP CRIT CARE, V163, P115, DOI 10.1164/ajrccm.163.1.9906071; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6; Zissel G, 2010, SEMIN RESP CRIT CARE, V31, P390, DOI 10.1055/s-0030-1262208	37	62	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43588	10.1371/journal.pone.0043588	http://dx.doi.org/10.1371/journal.pone.0043588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927996	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300069
J	Spronk, M; Vogel, EK; Jonkman, LM				Spronk, Marjolein; Vogel, Edward K.; Jonkman, Lisa M.			Electrophysiological Evidence for Immature Processing Capacity and Filtering in Visuospatial Working Memory in Adolescents	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; IRRELEVANT INFORMATION; INDIVIDUAL-DIFFERENCES; FLUID INTELLIGENCE; NEURAL MECHANISMS; SPATIAL ATTENTION; STORAGE CAPACITY; PARIETAL CORTEX; CHILDHOOD	The present study investigated the development of visuospatial working memory (VSWM) capacity and the efficiency of filtering in VSWM in adolescence. To this end, a group of IQ-matched adults and adolescents performed a VSWM change detection task with manipulations of WM-load and distraction, while performance and electrophysiological contralateral delay activity (CDA) were measured. The CDA is a lateralized ERP marker of the number of targets and distracters that are selectively encoded/maintained in WM from one hemifield of the memory display. Significantly lower VSWM-capacity (Cowan's K) was found in adolescents than adults, and adolescents' WM performance (in terms of accuracy and speed) also suffered more from the presence of distracters. Distracter-related CDA responses were partly indicative of higher distracter encoding/maintenance in WM in adolescents and were positively correlated with performance measures of distracter interference. This correlation suggests that the higher interference of distracters on WM performance in adolescents was caused by an inability to block distracters from processing and maintenance in WM. The lower visuospatial WM-capacity (K) in adolescents in the high load (3 items) condition was accompanied by a trend (p<.10) towards higher CDA amplitudes in adolescents than adults, whereas CDA amplitudes in the low load (1 item) condition were comparable between adolescents and adults. These findings point to immaturity of frontal-parietal WM-attention networks that support visuospatial WM processing in adolescence.	[Spronk, Marjolein; Jonkman, Lisa M.] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Vogel, Edward K.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	Maastricht University; University of Oregon	Spronk, M (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.	marjoleinspronk@gmail.com	Vogel, Edward K/AAW-9466-2021		Netherlands Organization of Scientific Research (NWO) [400-05-132]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization of Scientific Research (NWO), Open Competition programme, grant number 400-05-132 awarded to L. M. Jonkman (http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; Achenbach TM, 2003, MANUAL ASEBA ADULT F; ANDERER P, 1992, PSYCHIAT RES-NEUROIM, V45, P79, DOI 10.1016/0925-4927(92)90002-L; [Anonymous], 1991, MANUAL CHILD BEHAV C; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Brisson B, 2007, PSYCHOPHYSIOLOGY, V44, P323, DOI 10.1111/j.1469-8986.2007.00503.x; Bunge SA, 2007, CURR OPIN NEUROBIOL, V17, P243, DOI 10.1016/j.conb.2007.02.005; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Cowan N, 2006, TRENDS COGN SCI, V10, P139, DOI 10.1016/j.tics.2006.02.001; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2010, DEVELOPMENTAL SCI, V13, P120, DOI 10.1111/j.1467-7687.2009.00864.x; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Delvenne JF, 2011, PSYCHOPHYSIOLOGY, V48, P333, DOI 10.1111/j.1469-8986.2010.01079.x; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Emrich SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008042; Fukuda K, 2010, PSYCHON B REV, V17, P673, DOI 10.3758/17.5.673; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Gao ZF, 2009, J VISION, V9, DOI 10.1167/9.7.17; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2006, J CHILD PSYCHOL PSYC, V47, P4, DOI 10.1111/j.1469-7610.2005.01446.x; Grimault S, 2009, HUM BRAIN MAPP, V30, P3378, DOI 10.1002/hbm.20759; Hill BD, 2010, J CLIN EXP NEUROPSYC, V32, P315, DOI 10.1080/13803390903032529; HITCH GJ, 1989, MEM COGNITION, V17, P175, DOI 10.3758/BF03197067; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jeyakumar SLE, 2004, EDUC PSYCHOL MEAS, V64, P71, DOI 10.1177/0013164403258407; Jost K, 2011, CEREB CORTEX, V21, P1147, DOI 10.1093/cercor/bhq185; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Lee EY, 2010, BRAIN, V133, P2677, DOI 10.1093/brain/awq197; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; Luciana M, 2005, CHILD DEV, V76, P697, DOI 10.1111/j.1467-8624.2005.00872.x; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Riggs KJ, 2006, J EXP CHILD PSYCHOL, V95, P18, DOI 10.1016/j.jecp.2006.03.009; Robitaille N, 2007, BRAIN RES, V1185, P158, DOI 10.1016/j.brainres.2007.09.004; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Sander MC, 2011, CONTRALATERAL DELAY; Schleepen TMJ, 2010, DEV NEUROPSYCHOL, V35, P37, DOI 10.1080/87565640903325733; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Spreen O, 1998, COMPENDIUM NEUROPSYC; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Van Leijenhorst L, 2007, CHILD DEV, V78, P987, DOI 10.1111/j.1467-8624.2007.01045.x; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D., 1997, WECHSLER ADULT INTEL; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009	55	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42262	10.1371/journal.pone.0042262	http://dx.doi.org/10.1371/journal.pone.0042262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22927923	Green Submitted, gold, Green Published			2022-12-27	WOS:000308286300019
J	Fortington, LV; Geertzen, JHB; Bosmans, JC; Dijkstra, PU				Fortington, Lauren V.; Geertzen, Jan H. B.; Bosmans, Joline C.; Dijkstra, Pieter U.			Bias in Amputation Research; Impact of Subjects Missed from a Prospective Study	PLOS ONE			English	Article							PHANTOM-LIMB PAIN; AMPUTEES; HEALTH	For research findings to be generalized, a sample must be representative of the actual population of interest. Lower limb amputation is most frequently performed in older patients with vascular disease, a population that is often underrepresented in research. The aim of this study was to explore the impact of selection bias by comparing characteristics from a sample included in a prospective study of phantom pain with the actual population who underwent amputation. Only 27% of all potential patients were referred during the first year of the prospective study. The referred patients were 8 years younger (p<0.001) and less likely to have had amputation because of a vascular condition, diabetes or infection (p = 0.003) than those not referred. There was also a significant difference in one year survival between the groups; 67% of referred patients survived compared with just 40% of non-referred patients (p = 0.004). The biased population in the phantom pain study may have resulted in an underestimation of phantom pain in the original study and subsequent protective factors should be considered within the context of the younger population reported. Selection bias is common in amputation research, and research methods to minimize its impact must be given greater attention.	[Fortington, Lauren V.; Geertzen, Jan H. B.; Bosmans, Joline C.; Dijkstra, Pieter U.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, NL-9713 AV Groningen, Netherlands; [Dijkstra, Pieter U.] Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Fortington, LV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, NL-9713 AV Groningen, Netherlands.	l.v.fortington@umcg.nl	Fortington, Lauren/E-9002-2015	Fortington, Lauren/0000-0003-2760-9249	OIM Foundation, Assen; Beatrixoord Foundation North Netherlands, Haren	OIM Foundation, Assen; Beatrixoord Foundation North Netherlands, Haren	This study was funded in part by grants provided by the OIM Foundation, Assen and the Beatrixoord Foundation North Netherlands, Haren. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH S, 1988, PAIN, V33, P297, DOI 10.1016/0304-3959(88)90288-6; Bosmans JC, 2010, J REHABIL RES DEV, V47, P457, DOI 10.1682/JRRD.2009.06.0078; Bosmans JC, 2010, CLIN REHABIL, V24, P444, DOI 10.1177/0269215509360645; Casale R, 2009, J REHABIL MED, V41, P418, DOI 10.2340/16501977-0353; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Dijkstra PU, 2002, J PAIN SYMPTOM MANAG, V24, P578, DOI 10.1016/S0885-3924(02)00538-9; Ehde DM, 2000, ARCH PHYS MED REHAB, V81, P1039, DOI 10.1053/apmr.2000.7583; Euser SM, 2008, EPIDEMIOLOGY, V19, P440, DOI 10.1097/EDE.0b013e31816a1d31; Fletcher B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000496; Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1; Geertzen JHB, 2005, DISABIL REHABIL, V27, P101, DOI 10.1080/09638280400009345; Halbert J, 2002, CLIN J PAIN, V18, P84, DOI 10.1097/00002508-200203000-00003; Hardy SE, 2009, J AM GERIATR SOC, V57, P722, DOI 10.1111/j.1532-5415.2008.02168.x; Hernan MA, 2008, EPIDEMIOLOGY, V19, P448, DOI 10.1097/EDE.0b013e31816bbe14; Hirsh AT, 2010, J PAIN, V11, P79, DOI 10.1016/j.jpain.2009.06.004; JAHANGIRI M, 1994, ANN ROY COLL SURG, V76, P324; JENSEN TS, 1985, PAIN, V21, P267, DOI 10.1016/0304-3959(85)90090-9; Miller WC, 2002, PHYS THER, V82, P856, DOI 10.1093/ptj/82.9.856; Nikolajsen L, 2001, BRIT J ANAESTH, V87, P107, DOI 10.1093/bja/87.1.107; O'Neill BF, 2009, DISABIL REHABIL, V31, P1083, DOI 10.1080/09638280802509579; Patrick K, 2011, PAIN MED, V12, P794, DOI 10.1111/j.1526-4637.2011.01105.x; Rayegani SM, 2010, JPO, V22, P162, DOI DOI 10.1097/JP0.0B013E3181EB3C8C; Richardson C, 2006, CLIN J PAIN, V22, P353, DOI 10.1097/01.ajp.0000177793.01415.bd; Subedi B, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/864605; Unwin J, 2009, CLIN REHABIL, V23, P1044, DOI 10.1177/0269215509339001; van der Schans CP, 2002, J PAIN SYMPTOM MANAG, V24, P429, DOI 10.1016/S0885-3924(02)00511-0; Wolff A, 2011, PAIN PRACT, V11, P403, DOI 10.1111/j.1533-2500.2011.00454.x	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43629	10.1371/journal.pone.0043629	http://dx.doi.org/10.1371/journal.pone.0043629			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	991WJ	22916286	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800085
J	Fuller, JC; Jackson, RM; Edwards, TA; Wilson, AJ; Shirts, MR				Fuller, Jonathan C.; Jackson, Richard M.; Edwards, Thomas A.; Wilson, Andrew J.; Shirts, Michael R.			Modeling of Arylamide Helix Mimetics in the p53 Peptide Binding Site of hDM2 Suggests Parallel and Anti-Parallel Conformations Are Both Stable	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; AB-INITIO; MOLECULAR SIMULATION; FREE-ENERGIES; MDM2 BINDING; FORCE-FIELDS; RECOGNITION; ANTAGONISTS; FOLDAMERS; DYNAMICS	The design of novel alpha-helix mimetic inhibitors of protein-protein interactions is of interest to pharmaceuticals and chemical genetics researchers as these inhibitors provide a chemical scaffold presenting side chains in the same geometry as an alpha-helix. This conformational arrangement allows the design of high affinity inhibitors mimicking known peptide sequences binding specific protein substrates. We show that GAFF and AutoDock potentials do not properly capture the conformational preferences of alpha-helix mimetics based on arylamide oligomers and identify alternate parameters matching solution NMR data and suitable for molecular dynamics simulation of arylamide compounds. Results from both docking and molecular dynamics simulations are consistent with the arylamides binding in the p53 peptide binding pocket. Simulations of arylamides in the p53 binding pocket of hDM2 are consistent with binding, exhibiting similar structural dynamics in the pocket as simulations of known hDM2 binders Nutlin-2 and a benzodiazepinedione compound. Arylamide conformations converge towards the same region of the binding pocket on the 20 ns time scale, and most, though not all dihedrals in the binding pocket are well sampled on this timescale. We show that there are two putative classes of binding modes for arylamide compounds supported equally by the modeling evidence. In the first, the arylamide compound lies parallel to the observed p53 helix. In the second class, not previously identified or proposed, the arylamide compound lies anti-parallel to the p53 helix.	[Fuller, Jonathan C.; Jackson, Richard M.; Edwards, Thomas A.; Wilson, Andrew J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Fuller, Jonathan C.; Shirts, Michael R.] Univ Virginia, Dept Chem Engn, Charlottesville, VA USA; [Wilson, Andrew J.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Virginia; University of Leeds	Fuller, JC (corresponding author), Heidelberg Inst Theoret Studies, Heidelberg, Germany.	michael.shirts@virginia.edu	; Andrew, Wilson/P-1545-2014	Fuller, Jonathan/0000-0001-8801-149X; Andrew, Wilson/0000-0001-9852-6366; edwards, thomas/0000-0002-1467-3674	Biotechnology and Biological Sciences Research Council (BBSRC); Collaborative Computational Project for Biomolecular Simulation (CCPB); European Research Council [ERC-StG-240324]; Yorkshire Cancer Research [L348]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Collaborative Computational Project for Biomolecular Simulation (CCPB); European Research Council(European Research Council (ERC)European Commission); Yorkshire Cancer Research	The authors thank the Biotechnology and Biological Sciences Research Council (BBSRC) for funding JCF in the form of a PhD studentship and the Collaborative Computational Project for Biomolecular Simulation (CCPB) in the form of a USPA Travel award for visiting the University of Virginia. AJW and TAE acknowledge the financial support of the European Research Council [ERC-StG-240324]. AJW, TAE and RJM acknowledge the financial support of Yorkshire Cancer Research [L348]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Bottger V, 1996, ONCOGENE, V13, P2141; Campbell F, 2010, ORG BIOMOL CHEM, V8, P2344, DOI 10.1039/c001164a; Carotti A, 2009, PROTEINS, V77, P524, DOI 10.1002/prot.22464; Case D., 2004, AMBER; Dickens MP, 2010, SEMIN CANCER BIOL, V20, P10, DOI 10.1016/j.semcancer.2009.10.003; Ding K, 2005, J AM CHEM SOC, V127, P10130, DOI 10.1021/ja051147z; Edwards TA, 2011, AMINO ACIDS, V41, P743, DOI 10.1007/s00726-011-0880-8; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Fry DC, 2004, J BIOMOL NMR, V30, P163, DOI 10.1023/B:JNMR.0000048856.84603.9b; Fuller JC, 2012, J PHYS CHEM B, V116, P10856, DOI 10.1021/jp209041x; Fuller JC, 2009, DRUG DISCOV TODAY, V14, P155, DOI 10.1016/j.drudis.2008.10.009; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Harker EA, 2009, BIOORGAN MED CHEM, V17, P2038, DOI 10.1016/j.bmc.2009.01.039; Henchey LK, 2010, CHEMBIOCHEM, V11, P2104, DOI 10.1002/cbic.201000378; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Kalid O, 2009, J CHEM INF MODEL, V49, P865, DOI 10.1021/ci800352c; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Laue ED, ACPYPE ANTECHA UNPUB; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu ZW, 2011, J COMPUT CHEM, V32, P1846, DOI 10.1002/jcc.21767; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mobley DL, 2007, J CHEM THEORY COMPUT, V3, P1231, DOI 10.1021/ct700032n; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plante J, 2008, ORG BIOMOL CHEM, V6, P138, DOI 10.1039/b712606a; Plante JP, 2009, CHEM COMMUN, P5091, DOI 10.1039/b908207g; Pophristic V, 2006, J PHYS CHEM B, V110, P3517, DOI 10.1021/jp054306+; Prabhakaran P, 2012, TETRAHEDRON, V68, P4485, DOI 10.1016/j.tet.2011.11.078; Sadowsky JD, 2007, J AM CHEM SOC, V129, P139, DOI 10.1021/ja0662523; Shaginian A, 2009, J AM CHEM SOC, V131, P5564, DOI 10.1021/ja810025g; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vemparala S, 2006, J COMPUT CHEM, V27, P693, DOI 10.1002/jcc.20382; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Yuan Y, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-16; Zhong HZ, 2005, PROTEINS, V58, P222, DOI 10.1002/prot.20275	49	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43253	10.1371/journal.pone.0043253	http://dx.doi.org/10.1371/journal.pone.0043253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916232	Green Submitted, Green Published, gold			2022-12-27	WOS:000307733800057
J	Birkenfeld, AL; Boschmann, M; Engeli, S; Moro, C; Arafat, AM; Luft, FC; Jordan, J				Birkenfeld, Andreas L.; Boschmann, Michael; Engeli, Stefan; Moro, Cedric; Arafat, Ayman M.; Luft, Friedrich C.; Jordan, Jens			Atrial Natriuretic Peptide and Adiponectin Interactions in Man	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; LIPID MOBILIZATION; HUMAN ADIPOCYTES; ADIPOSE-TISSUE; ASSOCIATION; EXPRESSION; HUMANS; RISK; GENE	Reduced circulating natriuretic peptide concentrations are independently associated with insulin resistance and type 2 diabetes, while increased natriuretic peptide levels appear to be protective. Observations in vitro and in heart failure patients suggest that atrial natriuretic peptide (ANP) promotes adiponectin release, an adipokine with insulin sensitizing properties. We tested the hypothesis that ANP acutely raises adiponectin levels in 12 healthy men. We infused ANP intravenously over 135 minutes while collecting venous blood and adipose tissue microdialysates at baseline and at the end of ANP-infusion. We obtained blood samples at identical time-points without ANP infusion in 7 age and BMI matched men. With infusion, venous ANP concentrations increased similar to 10 fold. Systemic and adipose tissue glycerol concentrations increased 70% and 80%, respectively (P<0.01). ANP infusion increased total adiponectin 14 +/- 5% and high molecular-weight (HMW)-adiponectin 13 +/- 5% (P<0.05). Adiponectin did not change in the control group (P<0.05 vs. infusion). ANP-induced changes in HMW adiponectin and adipose tissue lipolysis were directly correlated with each other, possibly suggesting a common mechanism. Our data show that ANP acutely increases systemic total and HMW-adiponectin concentrations in healthy subjects. Our study could have implications for the physiological regulation of adiponectin and for disease states associated with altered natriuretic peptide availability.	[Birkenfeld, Andreas L.; Arafat, Ayman M.] Charite Univ Sch Med Berlin, CCR, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Birkenfeld, Andreas L.; Boschmann, Michael; Luft, Friedrich C.] Expt & Clin Res Ctr, Berlin, Germany; [Moro, Cedric] Univ Toulouse 3, Inst Metab & Cardiovasc Dis, Inserm UMR1048, F-31062 Toulouse, France; [Engeli, Stefan; Jordan, Jens] Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Hannover Medical School	Birkenfeld, AL (corresponding author), Charite Univ Sch Med Berlin, CCR, Dept Endocrinol Diabet & Nutr, Berlin, Germany.	jordan.jens@mh-hannover.de	Moro, Cedric/N-5754-2017; Birkenfeld, Andreas L./U-3954-2019	Birkenfeld, Andreas L./0000-0003-1407-9023; Arafat, Ayman/0000-0003-3069-8385; Luft, Friedrich/0000-0002-8635-1199; Moro, Cedric/0000-0003-4294-0597	Deutsche Forschungsgemeinschaft [BI 1292/4-1, JO 284/5-2]; collaborative research grant of the European Commission (SICA-HF, FP7) [241558]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); collaborative research grant of the European Commission (SICA-HF, FP7)	Our work was supported in part by a grant from the Deutsche Forschungsgemeinschaft to ALB (BI 1292/4-1), JJ (JO 284/5-2) and a collaborative research grant of the European Commission (SICA-HF, FP7 241558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkenfeld AL, 2005, J CLIN ENDOCR METAB, V90, P3622, DOI 10.1210/jc.2004-1953; Birkenfeld AL, 2006, J CLIN ENDOCR METAB, V91, P5069, DOI 10.1210/jc.2006-1084; Birkenfeld AL, 2011, HYPERTENSION, V57, pE4, DOI 10.1161/HYPERTENSIONAHA.110.165159; Birkenfeld AL, 2008, DIABETES, V57, P3199, DOI 10.2337/db08-0649; Brunner-La Rocca HP, 2001, J AM COLL CARDIOL, V37, P1221, DOI 10.1016/S0735-1097(01)01172-X; Fasshauer M, 2001, FEBS LETT, V507, P142, DOI 10.1016/S0014-5793(01)02960-X; Halberg N, 2009, DIABETES, V58, P1961, DOI 10.2337/db08-1750; Khan AM, 2011, J CLIN ENDOCR METAB, V96, P3242, DOI 10.1210/jc.2011-1182; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Lafontan M, 2008, TRENDS ENDOCRIN MET, V19, P130, DOI 10.1016/j.tem.2007.11.006; Magnusson M, 2011, J CLIN ENDOCRINOL ME; Meirhaeghe A, 2007, HUM MOL GENET, V16, P1343, DOI 10.1093/hmg/ddm084; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Nakatsuji H, 2010, BIOCHEM BIOPH RES CO, V392, P100, DOI 10.1016/j.bbrc.2010.01.008; Ohara T, 2011, J CARDIOL, V58, P181, DOI 10.1016/j.jjcc.2011.06.010; Polak J, 2011, J AM COLL CARDIOL, V58, P1119, DOI 10.1016/j.jacc.2011.05.042; Sarzani R, 1996, J ENDOCRINOL INVEST, V19, P581; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Souza SC, 2011, BIOCHEM BIOPH RES CO, V410, P398, DOI 10.1016/j.bbrc.2011.05.143; Tsukamoto O, 2009, J AM COLL CARDIOL, V53, P2070, DOI 10.1016/j.jacc.2009.02.038; Wang TJ, 2007, CIRCULATION, V115, P1345, DOI 10.1161/CIRCULATIONAHA.106.655142	21	64	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43238	10.1371/journal.pone.0043238	http://dx.doi.org/10.1371/journal.pone.0043238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916229	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000307824300033
J	Chon, SH; Douglass, JD; Zhou, YX; Malik, N; Dixon, JL; Brinker, A; Quadro, L; Storch, J				Chon, Su-Hyoun; Douglass, John D.; Zhou, Yin Xiu; Malik, Nashmia; Dixon, Joseph L.; Brinker, Anita; Quadro, Loredana; Storch, Judith			Over-Expression of Monoacylglycerol Lipase (MGL) in Small Intestine Alters Endocannabinoid Levels and Whole Body Energy Balance, Resulting in Obesity	PLOS ONE			English	Article							MONOGLYCERIDE LIPASE; DIACYLGLYCEROL ACYLTRANSFERASE; TRIGLYCERIDE SYNTHESIS; ADIPOSE-TISSUE; PLASMA LEPTIN; FOOD-INTAKE; MICE; ENZYME; IDENTIFICATION; METABOLISM	The function of small intestinal monoacylglycerol lipase (MGL) is unknown. Its expression in this tissue is surprising because one of the primary functions of the small intestine is to convert diet-derived MGs to triacylglycerol (TG), and not to degrade them. To elucidate the function of intestinal MGL, we generated transgenic mice that over-express MGL specifically in small intestine (iMGL mice). After only 3 weeks of high fat feeding, iMGL mice showed an obese phenotype; body weight gain and body fat mass were markedly higher in iMGL mice, along with increased hepatic and plasma TG levels compared to wild type littermates. The iMGL mice were hyperphagic and displayed reduced energy expenditure despite unchanged lean body mass, suggesting that the increased adiposity was due to both increased caloric intake and systemic effects resulting in a hypometabolic rate. The presence of the transgene resulted in lower levels of most MG species in intestinal mucosa, including the endocannabinoid 2-arachidonoyl glycerol (2-AG). The results therefore suggest a role for intestinal MGL, and intestinal 2-AG and perhaps other MG species, in whole body energy balance via regulation of food intake as well as metabolic rate.	[Chon, Su-Hyoun; Douglass, John D.; Zhou, Yin Xiu; Malik, Nashmia; Dixon, Joseph L.; Brinker, Anita; Storch, Judith] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Quadro, Loredana] Rutgers State Univ, Dept Food Sci Rutgers, New Brunswick, NJ 08903 USA; [Chon, Su-Hyoun; Douglass, John D.; Zhou, Yin Xiu; Malik, Nashmia; Dixon, Joseph L.; Brinker, Anita; Quadro, Loredana; Storch, Judith] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Chon, SH (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA.	storch@aesop.rutgers.edu	Zhou, yixin/HGE-2329-2022	Storch, Judith/0000-0001-5482-1777	National Institutes of Health [DK38389]; New Jersey Agricultural Experiment Station; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038389, R01DK038389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Agricultural Experiment Station; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health grant DK38389 (JS) and by funds from the New Jersey Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley RL, 1999, DIABETES, V48, P272, DOI 10.2337/diabetes.48.2.272; Breen DM, 2011, DIABETES-METAB RES, V27, P113, DOI 10.1002/dmrr.1160; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Chen HC, 2003, AM J PHYSIOL-ENDOC M, V284, pE213, DOI 10.1152/ajpendo.00248.2002; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; Chon SH, 2007, J BIOL CHEM, V282, P33346, DOI 10.1074/jbc.M706994200; COHN SM, 1992, J CELL BIOL, V119, P27, DOI 10.1083/jcb.119.1.27; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; Douglass JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00025; Duncan M, 2008, AM J PHYSIOL-GASTR L, V295, pG1255, DOI 10.1152/ajpgi.90500.2008; FOLCH J, 1957, J BIOL CHEM, V226, P497; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Gomez R, 2002, J NEUROSCI, V22, P9612; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Ho SY, 2002, J BIOL CHEM, V277, P1816, DOI 10.1074/jbc.M108027200; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Johansson A, 2010, OBESITY, V18, P803, DOI 10.1038/oby.2009.359; JOHNSTON JM, 1967, BIOCHIM BIOPHYS ACTA, V137, P578, DOI 10.1016/0005-2760(67)90140-3; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; KAYDEN HJ, 1967, J CLIN INVEST, V46, P1695, DOI 10.1172/JCI105660; Krempler F, 1998, ARTERIOSCL THROM VAS, V18, P1686, DOI 10.1161/01.ATV.18.11.1686; Luan Y, 2002, DIABETES RES CLIN PR, V57, P75, DOI 10.1016/S0168-8227(02)00026-8; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Poirier H, 1997, AM J PHYSIOL-GASTR L, V273, pG289, DOI 10.1152/ajpgi.1997.273.2.G289; Ranganathan S, 1998, J LIPID RES, V39, P724; Russell CD, 1998, AM J PHYSIOL-ENDOC M, V275, pE507, DOI 10.1152/ajpendo.1998.275.3.E507; Saario SM, 2007, CHEM BIODIVERS, V4, P1903, DOI 10.1002/cbdv.200790158; Satoh Y, 2006, AM J PHYSIOL-REG I, V290, pR1276, DOI 10.1152/ajpregu.00775.2005; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Storch J., 2001, Nutrient-gene interactions in health and disease, P101; Storch J, 2008, J LIPID RES, V49, P1762, DOI 10.1194/jlr.M800116-JLR200; Storr MA, 2007, CURR OPIN PHARMACOL, V7, P575, DOI 10.1016/j.coph.2007.08.008; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; TORNQVIST H, 1974, J LIPID RES, V15, P291; TORNQVIST H, 1976, J BIOL CHEM, V251, P813; Tso P, 2002, BIOCH PHYSL ASPECTS, P125; Ueno N, 2007, ENDOCRINE, V32, P192, DOI 10.1007/s12020-007-9016-z; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P2388, DOI 10.1194/jlr.M500168-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899	59	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43962	10.1371/journal.pone.0043962	http://dx.doi.org/10.1371/journal.pone.0043962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937137	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600065
J	Ban, L; Tata, LJ; West, J; Fiaschi, L; Gibson, JE				Ban, Lu; Tata, Laila J.; West, Joe; Fiaschi, Linda; Gibson, Jack E.			Live and Non-Live Pregnancy Outcomes among Women with Depression and Anxiety: A Population-Based Study	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; SPONTANEOUS-ABORTION; ANTIDEPRESSANT USE; MATERNAL USE; RISK; MULTICENTER; EXPOSURE; FLUOXETINE; CHLORDIAZEPOXIDE; BENZODIAZEPINES	Background: Women taking antidepressant or anti-anxiety medications during early pregnancy have high risks of non-live pregnancy outcomes, although the contribution of the underlying illnesses to these risks remains unclear. We examined the impacts of antenatal depression and anxiety and of commonly prescribed treatments on the risks of non-live pregnancy outcomes. Methods: We identified all pregnancies and their outcome (live birth, perinatal death, miscarriage or termination) among women aged 15-45 years between 1990 and 2009 from a large primary care database in the United Kingdom. Women were grouped according to whether they had no history of depression and anxiety, a diagnosis of such illness prior to pregnancy, illness during pregnancy and illness during pregnancy with use of medication (stratified by medication type). Multinomial logistic regression models were used to compare risks of non-live outcomes among these groups, adjusting for major socio-demographic and lifestyle characteristics. Results: Among 512,574 pregnancies in 331,414 women, those with antenatal drug exposure showed the greatest increased risks for all non-live pregnancy outcomes, relative to those with no history of depression or anxiety, although women with prior (but not currently medicated) illness also showed modest increased risks. Compared with un-medicated antenatal morbidity, there was weak evidence of an excess risk in women taking tricyclic antidepressants, and stronger evidence for other medications. Conclusions: Women with depression or anxiety have higher risks of miscarriage, perinatal death and decisions to terminate a pregnancy if prescribed psychotropic medication during early pregnancy than if not. Although underlying disease severity could also play a role, avoiding or reducing use of these drugs during early pregnancy may be advisable.	[Ban, Lu; Tata, Laila J.; West, Joe; Fiaschi, Linda; Gibson, Jack E.] Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [West, Joe] Nottingham Univ Hosp Natl Hlth Serv Trust, Nottingham Digest Dis Ctr, Natl Inst Hlth Res, Biomed Res Unit,Queens Med Ctr, Nottingham, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham	Ban, L (corresponding author), Univ Nottingham, City Hosp Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	mcxlb4@nottingham.ac.uk; jack.gibson@nottingham.ac.uk	Fiaschi, Linda/AAB-4905-2022; Gibson, Jack E/A-5746-2009; West, Joe/M-3867-2019; West, Joe/I-6637-2012; Tata, Laila/J-5227-2012	Fiaschi, Linda/0000-0002-3780-5895; Gibson, Jack E/0000-0003-1717-0252; West, Joe/0000-0002-1135-9356; West, Joe/0000-0002-1135-9356; Ban, Lu/0000-0001-9388-9141; Tata, Laila/0000-0002-6404-8658	University of Nottingham/National Institute for Health Research (NIHR)	University of Nottingham/National Institute for Health Research (NIHR)	JW is supported by a University of Nottingham/National Institute for Health Research (NIHR) Senior Clinical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; [Anonymous], 2014, BRIT NATL FORMULARY; Blackmore ER, 2011, BRIT J PSYCHIAT, V198, P373, DOI 10.1192/bjp.bp.110.083105; Bonari L, 2004, CAN J PSYCHIAT, V49, P726, DOI 10.1177/070674370404901103; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; Chun-Fai-Chan B, 2005, AM J OBSTET GYNECOL, V192, P932, DOI 10.1016/j.ajog.2004.09.027; Clark DA, 1996, AM J REPROD IMMUNOL, V35, P330; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; COSTE J, 1991, HUM REPROD, V6, P1332, DOI 10.1093/oxfordjournals.humrep.a137535; Dayan J, 2002, AM J EPIDEMIOL, V155, P293, DOI 10.1093/aje/155.4.293; Department of Health, 2009, AB STAT ENGL WAL 200; Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x; Einarson A, 2001, J PSYCHIATR NEUROSCI, V26, P44; Einarson A, 2001, AM J PSYCHIAT, V158, P1728, DOI 10.1176/appi.ajp.158.10.1728; Einarson A, 2009, J OBSTET GYNAECOL CA, V31, P452, DOI 10.1016/S1701-2163(16)34177-9; Einarson A, 2003, CAN J PSYCHIAT, V48, P106, DOI 10.1177/070674370304800207; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; HARTZ SC, 1975, NEW ENGL J MED, V292, P726, DOI 10.1056/NEJM197504032921405; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Klieger-Grossmann C, 2012, J CLIN PHARMACOL, V52, P766, DOI 10.1177/0091270011405524; Kulin NA, 1998, JAMA-J AM MED ASSOC, V279, P609, DOI 10.1001/jama.279.8.609; Kurki T, 2000, OBSTET GYNECOL, V95, P487, DOI 10.1016/S0029-7844(99)00602-X; LAEGREID L, 1992, NEUROPEDIATRICS, V23, P18, DOI 10.1055/s-2008-1071305; Lennestal R, 2007, J CLIN PSYCHOPHARM, V27, P607, DOI 10.1097/jcp.0b013e31815ac4d2; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; MILKOVICH L, 1974, NEW ENGL J MED, V291, P1268, DOI 10.1056/NEJM197412122912402; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; NHS Direct Wales, MISC; Office for National Statistics, 2009, BIRTH STAT ENGL WAL; Ornoy A, 1998, REPROD TOXICOL, V12, P511, DOI 10.1016/S0890-6238(98)00035-5; PASTUSZAK A, 1993, JAMA-J AM MED ASSOC, V269, P2246, DOI 10.1001/jama.269.17.2246; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Santone G, 2009, EPIDEMIOL PSICHIAT S, V18, P240, DOI 10.1017/S1121189X0000052X; Swann C, 2003, TEENAGE PREGNANCY PA; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Wen SW, 2006, AM J OBSTET GYNECOL, V194, P961, DOI 10.1016/j.ajog.2006.02.019; Wikner BN, 2007, PHARMACOEPIDEM DR S, V16, P1203, DOI 10.1002/pds.1457; Yonkers KA, 2011, EPIDEMIOLOGY, V22, P848, DOI 10.1097/EDE.0b013e3182306847; Zhu SH, 2002, ADDICT BEHAV, V27, P649, DOI 10.1016/S0306-4603(01)00199-X	41	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43462	10.1371/journal.pone.0043462	http://dx.doi.org/10.1371/journal.pone.0043462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937052	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500053
J	Cohen, I; Birnbaum, RY; Leibson, K; Taube, R; Sivan, S; Birk, OS				Cohen, Idan; Birnbaum, Ramon Y.; Leibson, Keren; Taube, Ran; Sivan, Sara; Birk, Ohad S.			ZNF750 Is Expressed in Differentiated Keratinocytes and Regulates Epidermal Late Differentiation Genes	PLOS ONE			English	Article							PROTEIN; DERMATITIS; CELLS	Disrupted skin barrier due to altered keratinocyte differentiation is common in pathologic conditions such as atopic dermatitis, ichthyosis and psoriasis. However, the molecular cascades governing keratinocyte terminal differentiation are poorly understood. We have previously demonstrated that a dominant mutation in ZNF750 leads to a clinical phenotype reminiscent of psoriasis and seborrheic dermatitis. Here we show that ZNF750 is a nuclear protein bearing a functional C-terminal nuclear localization signal. ZNF750 was specifically expressed in the epidermal suprabasal layers and its expression was augmented during differentiation, both in human skin and in-vitro, peaking in the granular layer. Silencing of ZNF750 in Ca2+-induced HaCaT keratinocytes led to morphologically apparent arrest in the progression of late differentiation, as well as diminished apoptosis and sustained proliferation. ZNF750 knockdown cells presented with markedly reduced expression of epidermal late differentiation markers, including gene subsets of epidermal differentiation complex and skin barrier formation such as FLG, LOR, SPINK5, ALOX12B and DSG1, known to be mutated in various human skin diseases. Furthermore, overexpression of ZNF750 in undifferentiated cells induced terminal differentiation genes. Thus, ZNF750 is a regulator of keratinocyte terminal differentiation and with its downstream targets can serve in future elucidation of therapeutics for common diseases of skin barrier.	[Cohen, Idan; Leibson, Keren; Sivan, Sara; Birk, Ohad S.] Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Cohen, Idan; Leibson, Keren; Taube, Ran; Sivan, Sara; Birk, Ohad S.] Ben Gurion Univ Negev, Dept Mol Genet & Virol, IL-84105 Beer Sheva, Israel; [Birnbaum, Ramon Y.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Birnbaum, Ramon Y.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Birk, Ohad S.] Soroka Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ben Gurion University; Soroka Medical Center	Cohen, I (corresponding author), Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.	obirk@bgu.ac.il		Birnbaum, Ramon/0000-0002-3792-1095; Taube, Ran/0000-0002-2062-4537; Cohen, Idan/0000-0002-5524-2344; Birk, Ohad/0000-0003-1430-1296	Israel Science Foundation (ISF); Morris Kahn Family Foundation	Israel Science Foundation (ISF)(Israel Science Foundation); Morris Kahn Family Foundation	This study was funded through a grant of the Israel Science Foundation (ISF) and through the generosity of the Morris Kahn Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birnbaum RY, 2006, NAT GENET, V38, P749, DOI 10.1038/ng1813; Birnbaum RY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-167; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Descargues P, 2008, EMBO J, V27, P2639, DOI 10.1038/emboj.2008.196; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Du LP, 2006, TOXICOL APPL PHARM, V213, P135, DOI 10.1016/j.taap.2005.10.003; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hoffjan S, 2007, BRIT J DERMATOL, V157, P441, DOI 10.1111/j.1365-2133.2007.07999.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalinin A, 2001, J CELL SCI, V114, P3069; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; STEVEN AC, 1994, J CELL SCI, V107, P693; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	26	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42628	10.1371/journal.pone.0042628	http://dx.doi.org/10.1371/journal.pone.0042628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936986	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500014
J	Kang, W; Shin, EC				Kang, Wonseok; Shin, Eui-Cheol			Colorimetric Focus-Forming Assay with Automated Focus Counting by Image Analysis for Quantification of Infectious Hepatitis C Virions	PLOS ONE			English	Article							CELL-CULTURE; VIRUS-INFECTION; PLAQUE-ASSAY; REPLICATION; SYSTEM	Hepatitis C virus (HCV) infection is the leading cause of liver transplantation in Western countries. Studies of HCV infection using cell culture-produced HCV (HCVcc) in vitro systems require quantification of infectious HCV virions, which has conventionally been performed by immunofluorescence-based focus-forming assay with manual foci counting; however, this is a laborious and time-consuming procedure with potentially biased results. In the present study, we established and optimized a method for convenient and objective quantification of HCV virions by colorimetric focus-forming assay with automated focus counting by image analysis. In testing different enzymes and chromogenic substrates, we obtained superior foci development using alkaline phosphatase-conjugated secondary antibody with BCIP/NBT chromogenic substrate. We additionally found that type I collagen coating minimized cell detachment during vigorous washing of the assay plate. After the colorimetric focus-forming assay, the foci number was determined using an ELISpot reader and image analysis software. The foci number and the calculated viral titer determined by this method strongly correlated with those determined by immunofluorescence-based focus-forming assay and manual foci counting. These results indicate that colorimetric focus-forming assay with automated focus counting by image analysis is applicable as a more-efficient and objective method for quantification of infectious HCV virions.	[Kang, Wonseok; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kang, W (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea.	ecshin@kaist.ac.kr	Shin, Eui-Cheol/C-1690-2011	Shin, Eui-Cheol/0000-0002-6308-9503	National Research Foundation from the Korean government (Ministry of Education, Science, and Technology) [2010-0004539, 2010-0030075]; Korea Health Technology R&D Project, of the Ministry of Health and Welfare, Republic of Korea [A110279]; KAIST (Korea Advanced Institute of Science and Technology) Future Systems Healthcare Project from the Ministry of Education, Science, and Technology	National Research Foundation from the Korean government (Ministry of Education, Science, and Technology); Korea Health Technology R&D Project, of the Ministry of Health and Welfare, Republic of Korea; KAIST (Korea Advanced Institute of Science and Technology) Future Systems Healthcare Project from the Ministry of Education, Science, and Technology	This work was supported by National Research Foundation grants from the Korean government (Ministry of Education, Science, and Technology) (2010-0004539 and 2010-0030075), and a grant from the Korea Health Technology R&D Project, of the Ministry of Health and Welfare, Republic of Korea (A110279). This work was also partly supported by the KAIST (Korea Advanced Institute of Science and Technology) Future Systems Healthcare Project from the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; ANDERSON DA, 1987, J MED VIROL, V22, P35, DOI 10.1002/jmv.1890220106; Anderson DA, 1997, J MED VIROL, V52, P354, DOI 10.1002/(SICI)1096-9071(199708)52:4&lt;354::AID-JMV2&gt;3.0.CO;2-0; Chang DY, 2009, J LEUKOCYTE BIOL, V86, P33, DOI [10.1189/jlb.1208772, 10.1189/JLB.1208772]; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Jensen TB, 2008, J INFECT DIS, V198, P1756, DOI 10.1086/593021; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2001, J MED VIROL, V64, P334, DOI 10.1002/jmv.1055; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Rodrigo WWSI, 2009, AM J TROP MED HYG, V80, P61; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yang DP, 1998, CLIN DIAGN LAB IMMUN, V5, P780, DOI 10.1128/CDLI.5.6.780-783.1998; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zielinska E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-84	19	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43960	10.1371/journal.pone.0043960	http://dx.doi.org/10.1371/journal.pone.0043960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937136	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500129
J	Miyamoto, M; Tsuboi, Y; Honda, K; Kobayashi, M; Takamiya, K; Huganir, RL; Kondo, M; Shinoda, M; Sessle, BJ; Katagiri, A; Kita, D; Suzuki, I; Oi, Y; Iwata, K				Miyamoto, Makiko; Tsuboi, Yoshiyuki; Honda, Kuniya; Kobayashi, Masayuki; Takamiya, Kogo; Huganir, Richard L.; Kondo, Masahiro; Shinoda, Masamichi; Sessle, Barry J.; Katagiri, Ayano; Kita, Daiju; Suzuki, Ikuko; Oi, Yoshiyuki; Iwata, Koichi			Involvement of AMPA Receptor GluR2 and GluR3 Trafficking in Trigeminal Spinal Subnucleus Caudalis and C1/C2 Neurons in Acute-Facial Inflammatory Pain	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; TOOTH-PULP STIMULATION; DORSAL-HORN NEURONS; TEMPOROMANDIBULAR-JOINT; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; NERVE LIGATION; CORD; PHOSPHORYLATION	To evaluate the involvement of trafficking of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) GluR2 and GluR3 subunits in an acute inflammatory orofacial pain, we analyzed nocifensive behavior, phosphorylated extracellular signal-regulated kinase (pERK) and Fos expression in Vi/Vc, Vc and C1/C2 in GluR2 delta7 knock-in (KI), GluR3 delta7 KI mice and wild-type mice. We also studied Vc neuronal activity to address the hypothesis that trafficking of GluR2 and GluR3 subunits plays an important role in Vi/Vc, Vc and C1/C2 neuronal activity associated with orofacial inflammation in these mice. Late nocifensive behavior was significantly depressed in GluR2 delta7 KI and GluR3 delta7 KI mice. In addition, the number of pERK-immunoreactive (IR) cells was significantly decreased bilaterally in the Vi/Vc, Vc and C1/C2 in GluR2 delta7 KI and GluR3 delta7 KI mice compared to wild-type mice at 40 min after formalin injection, and was also significantly smaller in GluR3 delta7 KI compared to GluR2 delta7 KI mice. The number of Fos protein-IR cells in the ipsilateral Vi/Vc, Vc and C1/C2 was also significantly smaller in GluR2 delta7 KI and GluR3 delta7 KI mice compared to wild-type mice 40 min after formalin injection. Nociceptive neurons functionally identified as wide dynamic range neurons in the Vc, where pERK- and Fos protein-IR cell expression was prominent, showed significantly lower spontaneous activity in GluR2 delta7 KI and GluR3 delta7 KI mice than wild-type mice following formalin injection. These findings suggest that GluR2 and GluR3 trafficking is involved in the enhancement of Vi/Vc, Vc and C1/C2 nociceptive neuronal excitabilities at 16-60 min following formalin injection, resulting in orofacial inflammatory pain.	[Miyamoto, Makiko; Oi, Yoshiyuki] Nihon Univ, Sch Dent, Dept Anesthesiol, Chiyoda Ku, Tokyo 101, Japan; [Miyamoto, Makiko; Tsuboi, Yoshiyuki; Honda, Kuniya; Kondo, Masahiro; Shinoda, Masamichi; Katagiri, Ayano; Kita, Daiju; Suzuki, Ikuko; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Chiyoda Ku, Tokyo 101, Japan; [Tsuboi, Yoshiyuki; Kondo, Masahiro; Shinoda, Masamichi; Iwata, Koichi] Nihon Univ, Sch Dent, Dent Res Ctr, Div Funct Morphol,Chiyoda Ku, Tokyo 101, Japan; [Honda, Kuniya] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Chiyoda Ku, Tokyo 101, Japan; [Kobayashi, Masayuki] Nihon Univ, Sch Dent, Dept Pharmacol, Chiyoda Ku, Tokyo 101, Japan; [Takamiya, Kogo] Miyazaki Univ, Fac Med, Grad Sch Med, Dept Med Sci,Sect Integrat Physiol, Miyazaki, Japan; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; [Sessle, Barry J.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; University of Miyazaki; Howard Hughes Medical Institute; Johns Hopkins University; University of Toronto	Miyamoto, M (corresponding author), Nihon Univ, Sch Dent, Dept Anesthesiol, Chiyoda Ku, Tokyo 101, Japan.	iwata-k@dent.nihon-u.ac.jp	Sessle, Barry/AAD-7771-2022; Kondo, Mari/N-2461-2015	Takamiya, Kogo/0000-0001-7240-6307	Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science, and Technology; National Institutes of Health [DE015420]; Japan-Canada (CIHR) Joint Health Research Program; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015420] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24659832] Funding Source: KAKEN	Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan-Canada (CIHR) Joint Health Research Program(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Research Grants from Sato and Uemura Funds from Nihon University School of Dentistry, and a grant from the Dental Research Center, Nihon University School of Dentistry; a Nihon University multidisciplinary research grant for KI; grants from the Ministry of Education, Culture, Sports, Science, and Technology to promote the multidisciplinary research project "Translational Research Network on Orofacial Neurological Disorders" at Nihon University School of Dentistry; Japan-Canada (CIHR) Joint Health Research Program, and National Institutes of Health grant DE015420. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atianjoh FE, 2010, PAIN, V151, P226, DOI 10.1016/j.pain.2010.07.017; Chiang CY, 1998, J NEUROPHYSIOL, V80, P2621, DOI 10.1152/jn.1998.80.5.2621; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Dai Y, 2002, J NEUROSCI, V22, P7737; Engelman HS, 1999, J NEUROSCI, V19, P2081; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Honda K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-59; Hu JW, 2005, BRAIN RES, V1044, P93, DOI 10.1016/j.brainres.2005.03.004; Imbe H, 2001, CELLS TISSUES ORGANS, V169, P238, DOI 10.1159/000047887; Iwata K, 1999, J NEUROPHYSIOL, V82, P1244, DOI 10.1152/jn.1999.82.3.1244; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Katano T, 2008, EUR J NEUROSCI, V27, P3161, DOI 10.1111/j.1460-9568.2008.06293.x; Larsson M, 2009, MOL NEUROBIOL, V40, P260, DOI 10.1007/s12035-009-8086-8; Lin Q, 2002, J NEUROPHYSIOL, V88, P214, DOI 10.1152/jn.2002.88.1.214; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Luccarini P, 2006, J PAIN, V7, P908, DOI 10.1016/j.jpain.2006.04.010; Ma WY, 2002, PAIN, V99, P175, DOI 10.1016/S0304-3959(02)00097-0; Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Okada-Ogawa A, 2009, J NEUROSCI, V29, P15828, DOI 10.1523/JNEUROSCI.3623-09.2009; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Polgar E, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-5; Shimizu K, 2006, BRAIN RES, V1072, P99, DOI 10.1016/j.brainres.2005.12.040; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Suzuki I, 2007, J OROFAC PAIN, V21, P225; Takeda M, 2005, EXP BRAIN RES, V160, P107, DOI 10.1007/s00221-004-1990-2; Youn DH, 2008, PAIN, V136, P158, DOI 10.1016/j.pain.2007.07.001; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	30	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e44055	10.1371/journal.pone.0044055	http://dx.doi.org/10.1371/journal.pone.0044055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937151	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500137
J	Rasala, BA; Lee, PA; Shen, ZX; Briggs, SP; Mendez, M; Mayfield, SP				Rasala, Beth A.; Lee, Philip A.; Shen, Zhouxin; Briggs, Steven P.; Mendez, Michael; Mayfield, Stephen P.			Robust Expression and Secretion of Xylanase1 in Chlamydomonas reinhardtii by Fusion to a Selection Gene and Processing with the FMDV 2A Peptide	PLOS ONE			English	Article							FLUORESCENT PROTEIN GFP; NUCLEAR TRANSFORMATION; HSP70A PROMOTER; FOREIGN GENE; MICROALGAE; TRANSGENE; RESISTANCE; ALGAE; BIOTECHNOLOGY; CLEAVAGE	Microalgae have recently received attention as a potential low-cost host for the production of recombinant proteins and novel metabolites. However, a major obstacle to the development of algae as an industrial platform has been the poor expression of heterologous genes from the nuclear genome. Here we describe a nuclear expression strategy using the foot-and-mouth-disease-virus 2A self-cleavage peptide to transcriptionally fuse heterologous gene expression to antibiotic resistance in Chlamydomonas reinhardtii. We demonstrate that strains transformed with ble-2A-GFP are zeocin-resistant and accumulate high levels of GFP that is properly 'cleaved' at the FMDV 2A peptide resulting in monomeric, cytosolic GFP that is easily detectable by in-gel fluorescence analysis or fluorescent microscopy. Furthermore, we used our ble2A nuclear expression vector to engineer the heterologous expression of the industrial enzyme, xylanase. We demonstrate that linking xyn1 expression to ble2A expression on the same open reading frame led to a dramatic (similar to 100-fold) increase in xylanase activity in cells lysates compared to the unlinked construct. Finally, by inserting an endogenous secretion signal between the ble2A and xyn1 coding regions, we were able to target monomeric xylanase for secretion. The novel microalgae nuclear expression strategy described here enables the selection of transgenic lines that are efficiently expressing the heterologous gene-of-interest and should prove valuable for basic research as well as algal biotechnology.	[Rasala, Beth A.; Lee, Philip A.; Shen, Zhouxin; Briggs, Steven P.; Mayfield, Stephen P.] Univ Calif San Diego, San Diego Ctr Algae Biotechnol, San Diego, CA 92103 USA; [Rasala, Beth A.; Lee, Philip A.; Shen, Zhouxin; Briggs, Steven P.; Mayfield, Stephen P.] Univ Calif San Diego, Div Mol Biol, San Diego, CA 92103 USA; [Lee, Philip A.; Mendez, Michael] Sapphire Energy, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Rasala, BA (corresponding author), Univ Calif San Diego, San Diego Ctr Algae Biotechnol, San Diego, CA 92103 USA.	smayfield@ucsd.edu			U.S. Department of Energy [DE-EE0003373]; California Energy Commission (CILMSF) [500-10-039]	U.S. Department of Energy(United States Department of Energy (DOE)); California Energy Commission (CILMSF)	This work was supported by the U.S. Department of Energy (DE-EE0003373) (http://energy.gov/) and California Energy Commission (CILMSF #500-10-039) (http://www.energy.ca.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Beer LL, 2009, CURR OPIN BIOTECH, V20, P264, DOI 10.1016/j.copbio.2009.06.002; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Cerutti H, 1997, PLANT CELL, V9, P925, DOI 10.1105/tpc.9.6.925; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; DAY A, 1990, PHYSIOL PLANTARUM, V78, P254; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; De Wilde C, 2000, PLANT MOL BIOL, V43, P347, DOI 10.1023/A:1006464304199; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Dreesen IAJ, 2010, J BIOTECHNOL, V145, P273, DOI 10.1016/j.jbiotec.2009.12.006; DUMAS P, 1994, EMBO J, V13, P2483, DOI 10.1002/j.1460-2075.1994.tb06535.x; Eichler-Stahlberg A, 2009, PLANTA, V229, P873, DOI 10.1007/s00425-008-0879-x; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Ge Y, 2007, ANAL BIOCHEM, V362, P63, DOI 10.1016/j.ab.2006.11.034; Gong YM, 2011, J IND MICROBIOL BIOT, V38, P1879, DOI 10.1007/s10295-011-1032-6; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Hallmann A., 2007, TRANSGENIC PLANT J, V1, P81, DOI DOI 10.3390/IJMS12010633; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Harris E.H, 2009, INTRO CHLAMYDOMONAS; He DM, 2007, COLLOID SURFACE B, V55, P26, DOI 10.1016/j.colsurfb.2006.10.042; Jones CS, 2011, CURR OPIN BIOTECHNOL; Leon R, 2007, ADV EXP MED BIOL, V616, P1; Leon-Banares R, 2004, TRENDS BIOTECHNOL, V22, P45, DOI 10.1016/j.tibtech.2003.11.003; Lodha M, 2008, EUKARYOT CELL, V7, P172, DOI 10.1128/EC.00055-07; Luke GA, 2010, BIOTECHNOL GENET ENG, V26, P223; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Manuell AL, 2007, PLANT BIOTECHNOL J, V5, P402, DOI 10.1111/j.1467-7652.2007.00249.x; Mayfield SP, 2005, VACCINE, V23, P1828, DOI 10.1016/j.vaccine.2004.11.013; Mayfield SP, 2003, P NATL ACAD SCI USA, V100, P438, DOI 10.1073/pnas.0237108100; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; Meslet-Cladiere L, 2011, EUKARYOT CELL, V10, P1670, DOI 10.1128/EC.05043-11; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Rasala Beth A, 2011, Bioeng Bugs, V2, P50, DOI 10.4161/bbug.2.1.13423; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Rosales-Mendoza S, 2012, PLANT CELL REP, V31, P479, DOI 10.1007/s00299-011-1186-8; Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Schroda M, 2002, PLANT J, V31, P445, DOI 10.1046/j.1365-313X.2002.01371.x; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x; Shaver S, 2010, EPIGENETICS-US, V5, P301, DOI 10.4161/epi.5.4.11608; Shimogawara K, 1998, GENETICS, V148, P1821; Specht E, 2010, BIOTECHNOL LETT, V32, P1373, DOI 10.1007/s10529-010-0326-5; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Stevens DR, 1996, MOL GEN GENET, V251, P23; Sun M, 2003, BIOTECHNOL LETT, V25, P1087, DOI 10.1023/A:1024140114505; Surzycki R, 2009, BIOLOGICALS, V37, P133, DOI 10.1016/j.biologicals.2009.02.005; TAM LW, 1993, GENETICS, V135, P375; TENKANEN M, 1992, ENZYME MICROB TECH, V14, P566, DOI 10.1016/0141-0229(92)90128-B; Tran M, 2009, BIOTECHNOL BIOENG, V104, P663, DOI 10.1002/bit.22446; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Wang XF, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-87; Wu JX, 2008, CHIN J OCEANOL LIMN, V26, P242, DOI 10.1007/s00343-008-0242-x; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yang ZQ, 2006, CHINESE SCI BULL, V51, P1703, DOI 10.1007/s11434-006-2041-0; Yu WL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-91	59	164	171	6	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43349	10.1371/journal.pone.0043349	http://dx.doi.org/10.1371/journal.pone.0043349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937037	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500042
J	Kim, YI; Park, JE; Kwon, KH; Hong, CY; Yi, AK				Kim, Young-In; Park, Jeoung-Eun; Kwon, Ki Han; Hong, Cheol Yi; Yi, Ae-Kyung			Interleukin-1 Receptor-Associated Kinase 2-and Protein Kinase D1-Dependent Regulation of IRAK-Monocyte Expression by CpG DNA	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; SIGNALING PATHWAYS; ADAPTER PROTEIN; CROSS-TOLERANCE; BACTERIAL-DNA; LIVER-INJURY; MICE LACKING; ACTIVATION; INDUCTION	As a part of the negative feedback mechanism, CpG DNA induces IRAK-M expression in monocytic cells. In the present study we investigated a biochemical signaling pathway and the transcription factors responsible for CpG DNA-mediated Irak-m gene expression. CpG DNA-induced Irak-m expression did not require new protein synthesis and was regulated at the transcriptional level through an endosomal pH-sensitive TLR9/MyD88 signaling pathway. Over-expression of the dominant negative (DN) form of or gene-specific knockdown of signaling modulators in the TLR9 pathway demonstrated that IRAK4, IRAK1, IRAK2, and PKD1 are required for Irak-m transcription induced by CpG DNA. Over-expression of DN-IRAK1 only partially, but significantly, inhibited CpG DNA-induced Irak-m promoter activity. While IRAK1 was critical for the initial phase, IRAK2 was required for the late phase of TLR9 signaling by sustaining activation of PKD1 that leads to activation of NF-kappa B and MAPKs. Irak-m promoter-luciferase reporters with alterations in the predicted cis-acting transcriptional regulatory elements revealed that the NF-kappa B consensus site in the Irak-m promoter region is absolutely required for Irak-m gene expression. AP-1 and CREB binding sites also contributed to the optimal Irak-m expression by CpG DNA. Collectively, our results demonstrate that IRAK2 plays a key role in the TLR9-mediated transcriptional regulation of Irak-m expression by sustaining activation of PKD1 and NF-kappa B.	[Kim, Young-In; Park, Jeoung-Eun; Kwon, Ki Han; Yi, Ae-Kyung] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Kim, Young-In; Park, Jeoung-Eun; Kwon, Ki Han; Yi, Ae-Kyung] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Hong, Cheol Yi] Chonnam Natl Univ, Specialized Res Ctr Canc Immunotherapy, Jeonnam, South Korea; [Yi, Ae-Kyung] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; Chonnam National University; University of Tennessee System; University of Tennessee Health Science Center	Kim, YI (corresponding author), Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA.	ayi@uthsc.edu			Children's Foundation Research Center at Le Bonheur Children's Medical Center; NIH [AI053137]; Le Bonheur Children's Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053137] Funding Source: NIH RePORTER	Children's Foundation Research Center at Le Bonheur Children's Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Le Bonheur Children's Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AKY was supported by the Children's Foundation Research Center at Le Bonheur Children's Medical Center and a grant from NIH (AI053137). YIK and JEP were supported by grants from Le Bonheur Children's Medical Center. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, the Children's Foundation of Memphis, or Le Bonheur Children's Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Dalpke AH, 2005, IMMUNOLOGY, V116, P203, DOI 10.1111/j.1365-2567.2005.02211.x; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kim YI, 2008, J BIOL CHEM, V283, P15258, DOI 10.1074/jbc.M709549200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lenert P, 2003, ANTISENSE NUCLEIC A, V13, P143, DOI 10.1089/108729003768247600; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Lye E, 2004, J BIOL CHEM, V279, P40653, DOI 10.1074/jbc.M402666200; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Park JE, 2008, J IMMUNOL, V181, P2044, DOI 10.4049/jimmunol.181.3.2044; Park JE, 2009, J IMMUNOL, V182, P6316, DOI 10.4049/jimmunol.0804239; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Thomas JA, 1999, J IMMUNOL, V163, P978; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yeo SJ, 2003, J BIOL CHEM, V278, P22563, DOI 10.1074/jbc.M302076200; Yeo SJ, 2003, J IMMUNOL, V170, P1052, DOI 10.4049/jimmunol.170.2.1052; Yi AK, 2006, J BIOL CHEM, V281, P15001, DOI 10.1074/jbc.M601337200; Yi AK, 1998, J IMMUNOL, V160, P1240; Yi AK, 2003, INT IMMUNOL, V15, P577, DOI 10.1093/intimm/dxg058; Yi AK, 1998, J IMMUNOL, V161, P4493; Yi AK, 1996, J IMMUNOL, V156, P558; Yi AK, 2001, INT IMMUNOL, V13, P1391, DOI 10.1093/intimm/13.11.1391; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711	49	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43970	10.1371/journal.pone.0043970	http://dx.doi.org/10.1371/journal.pone.0043970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928050	Green Published, Green Submitted, gold			2022-12-27	WOS:000308224700030
J	Lohberger, B; Rinner, B; Stuendl, N; Absenger, M; Liegl-Atzwanger, B; Walzer, SM; Windhager, R; Leithner, A				Lohberger, Birgit; Rinner, Beate; Stuendl, Nicole; Absenger, Markus; Liegl-Atzwanger, Bernadette; Walzer, Sonja M.; Windhager, Reinhard; Leithner, Andreas			Aldehyde Dehydrogenase 1, a Potential Marker for Cancer Stem Cells in Human Sarcoma	PLOS ONE			English	Article							TUMOR-GROWTH; IDENTIFICATION; PREDICTOR; PARADIGM; ALDH1	Tumors contain a small population of cancer stem cells (CSC) proposed to be responsible for tumor maintenance and relapse. Aldehyde dehydrogenase 1 (ALDH1) activity has been used as a functional stem cell marker to isolate CSCs in different cancer types. This study used the Aldefluor (R) assay and fluorescence-activated cell sorting (FACS) analysis to isolate ALDH1(high) cells from five human sarcoma cell lines and one primary chordoma cell line. ALDH1(high) cells range from 0.3% (MUG-Chor1) to 4.1% (SW-1353) of gated cells. Immunohistochemical staining, analysis of the clone formation efficiency, and xCELLigence microelectronic sensor technology revealed that ALDH1(high) cells from all sarcoma cell lines have an increased proliferation rate compared to ALDH1(low) cells. By investigating of important regulators of stem cell biology, real-time RT-PCR data showed an increased expression of c-Myc, beta-catenin, and SOX-2 in the ALDH1(high) population and a significant higher level of ABCG2. Statistical analysis of data demonstrated that ALDH1(high) cells of SW-982 and SW-1353 showed higher resistance to commonly used chemotherapeutic agents like doxorubicin, epirubicin, and cisplatin than ALDH1(low) cells. This study demonstrates that in different sarcoma cell lines, high ALDH1 activity can be used to identify a subpopulation of cells characterized by a significantly higher proliferation rate, increased colony forming, increased expression of ABC transporter genes and stemness markers compared to control cells. In addition, enhanced drug resistance was demonstrated.	[Lohberger, Birgit; Stuendl, Nicole; Leithner, Andreas] Med Univ Graz, Dept Orthopaed Surg, Graz, Austria; [Rinner, Beate; Absenger, Markus] Med Univ Graz, Med Res Ctr, Graz, Austria; [Liegl-Atzwanger, Bernadette] Med Univ Graz, Inst Pathol, Graz, Austria; [Walzer, Sonja M.; Windhager, Reinhard] Med Univ Vienna, Dept Orthopaed Surg, Vienna, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Vienna	Lohberger, B (corresponding author), Med Univ Graz, Dept Orthopaed Surg, Graz, Austria.	birgit.lohberger@medunigraz.at		Windhager, Reinhard/0000-0002-6321-1804; Walzer, Sonja Maria/0000-0002-9056-4330	Medical University of Graz (START grant); OENB grant [14356]; "EccoCell" grant	Medical University of Graz (START grant); OENB grant; "EccoCell" grant	Financial support by the Medical University of Graz (START grant), OENB grant (#14356) and "EccoCell" grant is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2009, EXPERT OPIN DRUG MET, V5, P1529, DOI 10.1517/17425250903228834; Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943; Balicki D, 2007, CELL STEM CELL, V1, P485, DOI 10.1016/j.stem.2007.10.015; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Gangemi R, 2009, CURR MED CHEM, V16, P1688, DOI 10.2174/092986709788186147; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hajj M, 2004, ONCOGENE, V23, P7274; Hellsten R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022118; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Moreb JS, 2008, CURR STEM CELL RES T, V3, P237, DOI 10.2174/157488808786734006; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rinner B, 2012, INT J ONCOL, V40, P443, DOI 10.3892/ijo.2011.1235; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Wang L, 2011, INT J CANCER, V128, P294, DOI 10.1002/ijc.25331; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Yang M, 2010, BIOCHEM BIOPH RES CO, V391, P1062, DOI 10.1016/j.bbrc.2009.12.020	37	69	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43664	10.1371/journal.pone.0043664	http://dx.doi.org/10.1371/journal.pone.0043664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928012	Green Submitted, gold, Green Published			2022-12-27	WOS:000308224700022
J	Usuyama, M; Ushida, C; Shingai, R				Usuyama, Mamoru; Ushida, Chisato; Shingai, Ryuzo			A Model of the Intracellular Response of an Olfactory Neuron in Caenorhabditis elegans to Odor Stimulation	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; PROTEIN; CA2+	We developed a mathematical model of a hypothetical neuronal signal transduction pathway to better understand olfactory perception in Caenorhabditis elegans. This worm has only three pairs of olfactory receptor neurons. Intracellular Ca2+ decreases in one pair of olfactory neurons in C. elegans, the AWC neurons, following application of an attractive odor and there is a transient increase in intracellular Ca2+ following removal of odor. The magnitude of this increase is positively correlated with the duration of odor stimulation. Additionally, this Ca2+ transient is induced by a cGMP second messenger system. We identified likely candidates for the signal transduction molecules functioning in this system based on available gene expression and physiological data from AWCs. Our model incorporated a G-protein-coupled odor receptor, a G-protein, a guanylate cyclase as the G-protein effector, and a single phosphodiesterase. Additionally, a cyclic-nucleotidegated ion channel and a voltage-gated ion channel that mediated calcium influx were incorporated into the model. We posited that, upon odor stimulation, guanylate cyclase was suppressed by the G-protein and that, upon cessation of the stimulus, the G-protein-induced suppression ceased and cGMP synthesis was restored. A key element of our model was a Ca2+-dependent negative feedback loop that ensured that the calcium increases were transient. Two guanylate cyclase-activating proteins acted on the effector guanylate cyclase to negatively regulate cGMP signaling and the resulting calcium influx. Our model was able to closely replicate in silico three important features of the calcium dynamics of AWCs. Specifically, in our simulations, [Ca2+] increased rapidly and reached its peak within 10 s after the odor stimulus was removed, peak [Ca2+] increased with longer odor exposure, and [Ca2+] decreased during a second stimulus that closely followed an initial stimulus. However, application of random background signal ('noise') showed that certain components of the pathway were particularly sensitive to this noise.	[Usuyama, Mamoru; Shingai, Ryuzo] Iwate Univ, Fac Engn, Lab Biosci, Morioka, Iwate 020, Japan; [Ushida, Chisato] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan; [Ushida, Chisato] Hirosaki Univ, Fac Agr & Life Sci, Dept Biochem & Mol Biol, Hirosaki, Aomori, Japan; [Ushida, Chisato] Hirosaki Univ, RNA Res Ctr, Hirosaki, Aomori, Japan	Iwate University; Iwate University; Hirosaki University; Hirosaki University	Usuyama, M (corresponding author), Iwate Univ, Fac Engn, Lab Biosci, Morioka, Iwate 020, Japan.	shingai@iwate-u.ac.jp			MEXT KAKENHI [20115004]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supporter by MEXT KAKENHI Grant Number 20115004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manscript.	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Dougherty DP, 2005, P NATL ACAD SCI USA, V102, P10415, DOI 10.1073/pnas.0504099102; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; Hatt H, 2004, CHEM BIODIVERS, V1, P1857, DOI 10.1002/cbdv.200490142; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Kotera J, 2004, J BIOL CHEM, V279, P4366, DOI 10.1074/jbc.M308471200; Kwon HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004260; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Mathews EA, 2003, J NEUROSCI, V23, P6537; Mellem JE, 2008, NAT NEUROSCI, V11, P865, DOI 10.1038/nn.2131; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P731, DOI 10.1113/jphysiol.1988.sp016943; Nickell WT, 2002, J MEMBRANE BIOL, V189, P55, DOI 10.1007/s00232-002-1004-x; O'Halloran DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031614; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1	24	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42907	10.1371/journal.pone.0042907	http://dx.doi.org/10.1371/journal.pone.0042907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927938	Green Published, gold			2022-12-27	WOS:000308224700008
J	Cabral, EV; Vieira, LD; Silva, PA; Nascimento, WS; Aires, RS; Oliveira, FST; Luzardo, R; Vieyra, A; Paixao, ADO				Cabral, Edjair V.; Vieira-Filho, Leucio D.; Silva, Paulo A.; Nascimento, Williams S.; Aires, Regina S.; Oliveira, Fabiana S. T.; Luzardo, Ricardo; Vieyra, Adalberto; Paixao, Ana D. O.			Perinatal Na+ Overload Programs Raised Renal Proximal Na+ Transport and Enalapril-Sensitive Alterations of Ang II Signaling Pathways during Adulthood	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; PROTEIN-KINASE-A; OXIDATIVE STRESS; BLOOD-PRESSURE; DIETARY SALT; PLASMA-MEMBRANE; KIDNEY; HYPERTENSION; ATPASE; RATS	Background: High Na+ intake is a reality in nowadays and is frequently accompanied by renal and cardiovascular alterations. In this study, renal mechanisms underlying perinatal Na+ overload-programmed alterations in Na+ transporters and the renin/angiotensin system (RAS) were investigated, together with effects of short-term treatment with enalapril in terms of reprogramming molecular alterations in kidney. Methodology/Principal Findings: Male adult Wistar rats were obtained from dams maintained throughout pregnancy and lactation on a standard diet and drinking water (control) or 0.17 M NaCl (saline group). Enalapril (100 mg/l), an angiotensin converting enzyme inhibitor, was administered for three weeks after weaning. Ninety day old offspring from dams that drank saline presented with proximal tubules exhibiting increased (Na++ K+) ATPase expression and activity. Ouabain-insensitive Na+-ATPase activity remained unchanged but its response to angiotensin II (Ang II) was lost. PKC, PKA, renal thiobarbituric acid reactive substances (TBARS), macrophage infiltration and collagen deposition markedly increased, and AT(2) receptor expression decreased while AT(1) expression was unaltered. Early treatment with enalapril reduced expression and activity of (Na++ K+) ATPase, partially recovered the response of Na+-ATPase to Ang II, and reduced PKC and PKA activities independently of whether offspring were exposed to high perinatal Na+ or not. In addition, treatment with enalapril per se reduced AT(2) receptor expression, and increased TBARS, macrophage infiltration and collagen deposition. The perinatally Na+-overloaded offspring presented high numbers of Ang II-positive cortical cells, and significantly lower circulating Ang I, indicating that programming/reprogramming impacted systemic and local RAS. Conclusions/Significance: Maternal Na+ overload programmed alterations in renal Na+ transporters and in its regulation, as well as severe structural lesions in adult offspring. Enalapril was beneficial predominantly through its influence on Na+ pumping activities in adult offspring. However, side effects including down-regulation of PKA, PKC and AT(2) receptors and increased TBARS could impair renal function in later life.	[Cabral, Edjair V.; Vieira-Filho, Leucio D.; Nascimento, Williams S.; Aires, Regina S.; Oliveira, Fabiana S. T.; Paixao, Ana D. O.] Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil; [Silva, Paulo A.; Luzardo, Ricardo; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, BR-21941 Rio De Janeiro, Brazil; [Cabral, Edjair V.; Vieira-Filho, Leucio D.; Silva, Paulo A.; Luzardo, Ricardo; Vieyra, Adalberto; Paixao, Ana D. O.] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil	Universidade Federal de Pernambuco; Universidade Federal do Rio de Janeiro	Cabral, EV (corresponding author), Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil.	adpaixao@ufpe.br		Vieira, Leucio/0000-0002-6041-1720; Aires, Regina/0000-0002-1881-8957; Nascimento de Siqueira, Williams/0000-0001-6073-5875	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Institutos Nacionais de Ciencia e Tecnologia, Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Institutos Nacionais de Ciencia e Tecnologia, Brazil	This work has been funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Institutos Nacionais de Ciencia e Tecnologia, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil I, 2005, ACTA HISTOCHEM, V107, P291, DOI 10.1016/j.acthis.2005.06.011; Axelband F, 2009, REGUL PEPTIDES, V155, P81, DOI 10.1016/j.regpep.2009.03.014; Balbi APC, 2004, PEDIATR NEPHROL, V19, P1212, DOI 10.1007/s00467-004-1586-x; Banday AA, 2007, J AM SOC NEPHROL, V18, P1446, DOI 10.1681/ASN.2006121373; Beltowski J, 2007, CLIN EXP HYPERTENS, V29, P189, DOI 10.1080/10641960701361585; Bertorello A, 1988, Prog Clin Biol Res, V268B, P353; Boesch DM, 2001, AM J PHYSIOL-REG I, V281, pR861, DOI 10.1152/ajpregu.2001.281.3.R861; Buege J A, 1978, Methods Enzymol, V52, P302; Cabral LMP, 2007, J BIOL CHEM, V282, P24599, DOI 10.1074/jbc.M701669200; Cardoso HD, 2009, PEDIATR NEPHROL, V24, P1959, DOI 10.1007/s00467-009-1247-1; Carranza ML, 1998, J PHYSIOL-LONDON, V511, P235, DOI 10.1111/j.1469-7793.1998.235bi.x; Caruso-Neves C, 2000, BBA-BIOMEMBRANES, V1468, P107, DOI 10.1016/S0005-2736(00)00248-0; Chabrashvili T, 2003, AM J PHYSIOL-REG I, V285, pR117, DOI 10.1152/ajpregu.00476.2002; Contreras RJ, 2000, PHYSIOL BEHAV, V71, P173, DOI 10.1016/S0031-9384(00)00331-0; da Silva AA, 2003, NUTR METAB CARDIOVAS, V13, P133, DOI 10.1016/S0939-4753(03)80172-2; Feraille E, 2000, MOL BIOL CELL, V11, P39, DOI 10.1091/mbc.11.1.39; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Finch JL, 2012, AM J PHYSIOL-RENAL, V302, pF141, DOI 10.1152/ajprenal.00293.2011; FRIBERG P, 1994, KIDNEY INT, V45, P485, DOI 10.1038/ki.1994.63; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lara LS, 2012, AM J PHYSIOL-RENAL, V302, pF85, DOI 10.1152/ajprenal.00351.2011; Lara LS, 2010, ARCH BIOCHEM BIOPHYS, V496, P117, DOI 10.1016/j.abb.2010.02.005; Laube GF, 2007, ARCH DIS CHILD-FETAL, V92, P402, DOI 10.1136/adc.2006.101717; Li XC, 2011, KIDNEY INT, V80, P620, DOI 10.1038/ki.2011.161; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maia JCC, 1993, LAB MANUAL, P146; Manning J, 2005, AM J PHYSIOL-REG I, V288, pR80, DOI 10.1152/ajpregu.00309.2004; Manning RD, 2005, AM J NEPHROL, V25, P311, DOI 10.1159/000086411; Matos André Costa, 2003, Arq. Bras. Cardiol., V81, P297; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Miura K, 2009, PEDIATR NEPHROL, V24, P1235, DOI 10.1007/s00467-008-1091-8; Naito T, 2010, AM J PHYSIOL-RENAL, V298, pF683, DOI 10.1152/ajprenal.00503.2009; PROVERBIO F, 1981, BIOCHIM BIOPHYS ACTA, V646, P99, DOI 10.1016/0005-2736(81)90276-5; Quan A, 2006, EARLY HUM DEV, V82, P23, DOI 10.1016/j.earlhumdev.2005.11.001; Queiroz-Madeira EP, 2010, BBA-BIOMEMBRANES, V1798, P360, DOI 10.1016/j.bbamem.2009.06.018; Rangel LBA, 2005, REGUL PEPTIDES, V127, P177, DOI 10.1016/j.regpep.2004.12.007; Rocafull MA, 2011, BBA-BIOMEMBRANES, V1808, P1684, DOI 10.1016/j.bbamem.2011.02.010; Rodriguez-Iturbe B, 2004, AM J PHYSIOL-RENAL, V286, pF606, DOI 10.1152/ajprenal.00269.2003; Sanchez SI, 2008, EUR J PHARMACOL, V588, P114, DOI 10.1016/j.ejphar.2008.04.014; Marin ECS, 2008, RENAL FAILURE, V30, P547, DOI 10.1080/08860220802060448; Thomson SC, 2006, J CLIN INVEST, V116, P1110, DOI 10.1172/JCI26092; Tian N, 2007, AM J PHYSIOL-HEART C, V293, pH3388, DOI 10.1152/ajpheart.00981.2007; Tonkiss J, 1998, HYPERTENSION, V32, P108, DOI 10.1161/01.HYP.32.1.108; TUFROMCREDDIE A, 1995, AM J PHYSIOL-RENAL, V269, pF110, DOI 10.1152/ajprenal.1995.269.1.F110; Vehaskari VM, 2007, PEDIATR NEPHROL, V22, P490, DOI 10.1007/s00467-006-0353-6; Vieira LD, 2011, PEDIATR NEPHROL, V26, P2019, DOI 10.1007/s00467-011-1908-8; Vieira LD, 2011, ARCH BIOCHEM BIOPHYS, V505, P91, DOI 10.1016/j.abb.2010.09.025; VIEYRA A, 1986, J BIOL CHEM, V261, P4247; Wang CT, 2003, J HYPERTENS, V21, P353, DOI 10.1097/00004872-200302000-00027; Wang ZC, 2011, KIDNEY INT, V79, P300, DOI 10.1038/ki.2010.326; WHITTEMB.G, 1970, PFLUG ARCH EUR J PHY, V316, P1, DOI 10.1007/BF00587893; Yang LE, 2008, AM J PHYSIOL-RENAL, V295, pF1003, DOI 10.1152/ajprenal.90235.2008; Zhang LN, 2008, FUND CLIN PHARMACOL, V22, P615, DOI 10.1111/j.1472-8206.2008.00620.x	53	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43791	10.1371/journal.pone.0043791	http://dx.doi.org/10.1371/journal.pone.0043791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928034	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300090
J	Chege, D; Chai, YJ; Huibner, S; Kain, T; Wachihi, C; Kimani, M; Barasa, S; McKinnon, LR; Muriuki, FK; Kariri, A; Jaoko, W; Anzala, O; Kimani, J; Ball, TB; Plummer, FA; Kaul, R				Chege, Duncan; Chai, Yijie; Huibner, Sanja; Kain, Taylor; Wachihi, Charles; Kimani, Makubo; Barasa, Samson; McKinnon, Lyle R.; Muriuki, Festus K.; Kariri, Anthony; Jaoko, Walter; Anzala, Omu; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.; Kaul, Rupert			Blunted IL17/IL22 and Pro-Inflammatory Cytokine Responses in the Genital Tract and Blood of HIV-Exposed, Seronegative Female Sex Workers in Kenya	PLOS ONE			English	Article							CD4(+) T-CELLS; REAL-TIME PCR; IMMUNODEFICIENCY VIRUS-INFECTION; MESSENGER-RNA EXPRESSION; TH17 CELLS; INTEGRIN ALPHA(4)BETA(7); SUSCEPTIBILITY; RESISTANCE; TRANSMISSION; PROTEIN	Background: Identifying the immune correlates of reduced susceptibility to HIV remains a key goal for the HIV vaccine field, and individuals who are HIV-exposed, seronegative (HESN) may offer important clues. Reduced systemic immune activation has been described in HESN individuals. Conversely, pro-inflammatory T cell subsets, particularly CD4+ T cells producing the cytokine IL17 (Th17 cells), may represent a highly susceptible target for HIV infection after sexual exposure. Therefore, we characterized the cellular pro-inflammatory and IL17/IL22 cytokine immune milieu in the genital mucosa and blood of HESN female sex workers (FSWs). Methods and Results: Blinded lab personnel characterized basal and mitogen-induced gene and cytokine immune responses in the cervix and blood of HESN FSWs (n = 116) and non-FSW controls (n = 17) using qPCR and ELISA. IL17 and IL22 production was significantly reduced in both the cervix and blood of HESNs, both in resting cells and after mitogen stimulation. In addition, HESN participants demonstrated blunted production of both pro-inflammatory cytokines and beta-chemokines. Discussion and Conclusions: We conclude that HIV exposure without infection was associated with blunted IL17/IL22 and pro-inflammatory responses, both systemically and at the site of mucosal HIV exposure. It will be important for further studies to examine the causal nature of the association and to define the cell subsets responsible for these differences.	[Chege, Duncan; Chai, Yijie; Huibner, Sanja; Kain, Taylor; McKinnon, Lyle R.; Kaul, Rupert] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada; [Wachihi, Charles; Kimani, Makubo; Barasa, Samson; McKinnon, Lyle R.; Muriuki, Festus K.; Kariri, Anthony; Jaoko, Walter; Anzala, Omu; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.; Kaul, Rupert] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, T. Blake; Plummer, Francis A.] Publ Hlth Agcy Canada, Lab HIV Immunol, Natl HIV & Retrovirol Labs, Winnipeg, MB, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Nairobi; University of Manitoba; University of Manitoba; Public Health Agency of Canada	Chege, D (corresponding author), Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada.	duncan.chege@utoronto.ca; rupert.kaul@utoronto.ca	Jaoko, Walter/AAN-5048-2020; Kain, Taylor/ABF-9338-2021	McKinnon, Lyle/0000-0002-7157-0700; Jaoko, Walter/0000-0002-7134-6581; Kain, Taylor/0000-0002-9680-6679; barasa, samson/0000-0002-4929-0737; Kaul, Rupert/0000-0002-1586-4093	Bill and Melinda Gates Foundation; Canadian Institutes of Health Research through the Grand Challenges in Global Health Initiative [37873]; Banting and Best CIHR scholarship; Canadian Research Chair Program	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institutes of Health Research through the Grand Challenges in Global Health Initiative(Canadian Institutes of Health Research (CIHR)); Banting and Best CIHR scholarship(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair Program(Canada Research Chairs)	This work was in part supported by the Bill and Melinda Gates Foundation and the Canadian Institutes of Health Research through the Grand Challenges in Global Health Initiative (grant #37873); The Banting and Best CIHR scholarship (DC salary) and the Canadian Research Chair Program (RK salary support). The funders had no role in study design, data collection, analysis and decision to publish, or preparation of the manuscript.	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Baltzer H, 2009, CURR HIV RES, V7, P504, DOI 10.2174/157016209789346336; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Cecchinato V, 2010, CURR OPIN HIV AIDS, V5, P141, DOI 10.1097/COH.0b013e32833653ec; Chege D, 2011, AIDS, V25, P741, DOI 10.1097/QAD.0b013e328344cefb; Chege D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013077; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cohen J, 2009, SCIENCE, V326, P1476, DOI 10.1126/science.326.5959.1476; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; DAWOOD MR, 1992, J CLIN MICROBIOL, V30, P2279, DOI 10.1128/JCM.30.9.2279-2283.1992; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hirbod T, 2008, AIDS, V22, P727, DOI 10.1097/QAD.0b013e3282f56b64; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Horton RE, 2010, J INFECT DIS, V202, pS377, DOI 10.1086/655971; Horton RE, 2009, AIDS RES HUM RETROV, V25, P83, DOI 10.1089/aid.2008.0207; Iqbal SM, 2005, J INFECT DIS, V192, P728, DOI 10.1086/432482; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Kaul R, 2011, SEX TRANSM INFECT, V87, P125, DOI 10.1136/sti.2009.040931; Kaul R, 2002, J ACQ IMMUN DEF SYND, V30, P69, DOI 10.1097/00042560-200205010-00009; Kaul R, 2001, IMMUNOL LETT, V79, P3, DOI 10.1016/S0165-2478(01)00260-7; Kim CJ, 2011, MUCOSAL IMM IN PRESS; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Lajoie J, 2012, MUCOSAL IMMUNOLOGY; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Listvanova S, 2003, J IMMUNOL METHODS, V281, P27, DOI 10.1016/S0022-1759(03)00267-9; Lundgren A, 2012, VACCINE, V30, P3897, DOI 10.1016/j.vaccine.2012.03.082; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; McKinnon LR, 2011, CURRENT OPI IN PRESS; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Nazli A, 2011, POSSIBLE PROTE UNPUB; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Piacentini L, 2008, VACCINE, V26, P3002, DOI 10.1016/j.vaccine.2007.11.062; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Rebbapragada A, 2008, J ACQUIR IMMUNE DEFI; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Roberts L, 2011, CROI 2011 BOST MASS; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Stordeur P, 2002, J IMMUNOL METHODS, V259, P55, DOI 10.1016/S0022-1759(01)00489-6; UNAIDS, 2009, AIDS EPIDEMIC UPDATE; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl400; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	58	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43670	10.1371/journal.pone.0043670	http://dx.doi.org/10.1371/journal.pone.0043670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928014	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300080
J	Pinto, Y; Scholte, HS; Lamme, VAF				Pinto, Yair; Scholte, H. Steven; Lamme, V. A. F.			Tracking Moving Identities: After Attending the Right Location, the Identity Does Not Come for Free	PLOS ONE			English	Article							MULTIPLE OBJECT TRACKING; HUMAN VISUAL-CORTEX; RESTING-STATE; FUNCTIONAL SPECIALIZATION; WORKING-MEMORY; BRAIN IMAGES; ATTENTION; SYSTEM; ROBUST; FMRI	Although tracking identical moving objects has been studied since the 1980' s, only recently the study into tracking moving objects with distinct identities has started (referred to as Multiple Identity Tracking, MIT). So far, only behavioral studies into MIT have been undertaken. These studies have left a fundamental question regarding MIT unanswered, is MIT a one-stage or a two-stage process? According to the one-stage model, after a location has been attended, the identity is released without effort. However, according to the two-stage model, there are two effortful stages in MIT, attending to a location, and attending to the identity of the object at that location. In the current study we investigated this question by measuring brain activity in response to tracking familiar and unfamiliar targets. Familiarity is known to automate effortful processes, so if attention to identify the object is needed, this should become easier. However, if no such attention is needed, familiarity can only affect other processes (such as memory for the target set). Our results revealed that on unfamiliar trials neural activity was higher in both attentional networks, and visual identification networks. These results suggest that familiarity in MIT automates attentional identification processes, thus suggesting that attentional identification is needed in MIT. This then would imply that MIT is essentially a two-stage process, since after attending the location, the identity does not seem to come for free.	[Pinto, Yair; Scholte, H. Steven; Lamme, V. A. F.] Univ Amsterdam, Psychon Dept, Amsterdam, Netherlands	University of Amsterdam	Pinto, Y (corresponding author), Univ Amsterdam, Psychon Dept, Amsterdam, Netherlands.	y.pinto@uva.nl	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788	European Research Council (ERC)	European Research Council (ERC)(European Research Council (ERC))	This research was supported by an advanced investigator grant from the European Research Council (ERC) to Dr. Lamme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buchsbaum BR, 2001, COGNITIVE SCI, V25, P663, DOI 10.1207/s15516709cog2505_2; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cohen JD, 1997, TEMPORAL DYNAMICS BR; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Fischer H, 2000, NEUROREPORT, V11, P123, DOI 10.1097/00001756-200001170-00024; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Horowitz TS, 2007, PERCEPT PSYCHOPHYS, V69, P172, DOI 10.3758/BF03193740; HOWE PDL, 2010, J VISION, V10; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; KINGSMITH PE, 1994, VISION RES, V34, P885, DOI 10.1016/0042-6989(94)90039-6; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; MORECRAFT RJ, 1993, ARCH NEUROL-CHICAGO, V50, P279, DOI 10.1001/archneur.1993.00540030045013; Mummery CJ, 2000, ANN NEUROL, V47, P36; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pinto Y, 2010, J VISION, V10; PYLYSHYN Z, 1989, COGNITION, V32, P65, DOI 10.1016/0010-0277(89)90014-0; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Pylyshyn ZW, 2004, VIS COGN, V11, P801, DOI 10.1080/13506280344000518; Scholl BJ, 2009, COMPUTATION, COGNITION, AND PYLYSHYN, P49; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	49	7	9	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42929	10.1371/journal.pone.0042929	http://dx.doi.org/10.1371/journal.pone.0042929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22927940	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300029
J	Zhang, XT; Meng, J; Wang, ZY				Zhang, XinTian; Meng, Jun; Wang, Zhao-Yi			A Switch Role of Src in the Biphasic EGF Signaling of ER-Negative Breast Cancer Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; C-SRC; ADAPTER PROTEIN; PHOSPHORYLATION; PROLIFERATION; EXPRESSION; APOPTOSIS; ARREST; HEAD	It is well established that epidermal growth factor (EGF) is a potent mitogen in cells expressing EGF receptor (EGFR). However, a body of evidence indicated that the effects of mitogenic EGF signaling exhibit a non-monotonic, or biphasic dose response curve; EGF at low concentrations elicits a mitogenic signaling pathway to stimulate cell proliferation while at high concentrations, EGF inhibits cell growth. However, the molecular mechanism underlying this paradoxical effect of EGF on cell proliferation remains largely unknown. Here, we investigated the molecular mechanisms underlying the biphasic EGF signaling in ER-negative breast cancer MDA-MB-231 and MDA-MB-436 cells, both of which express endogenous EGFR. We found that EGF at low concentrations induced the phosphorylation of the Src-Y416 residue, an event to activate Src, while at high concentrations allowed Src-Y527 phosphorylation that inactivates Src. EGF at 10 ng/ml also induced phosphorylation of the MAPK/ERK and activated cyclin D1 promoter activity through the Src/EGFR/STAT5 pathways but not at a higher concentration (500 ng/ml). Our results thus demonstrated that Src functions as a switch of EGF signaling depending on concentrations of EGF.	[Zhang, XinTian; Meng, Jun; Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	Creighton University	Zhang, XT (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA.	zywang@creighton.edu		Migliaccio, Antimo/0000-0002-4197-2055	National Institutes of Health grant [DK070016]; Nebraska Tobacco Settlement Biomedical Research Program Awards [LB-595]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070016] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program Awards; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK070016 and Nebraska Tobacco Settlement Biomedical Research Program Awards (LB-595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Cao L, 2000, J CELL BIOCHEM, V77, P569, DOI 10.1002/(SICI)1097-4644(20000615)77:4<569::AID-JCB5>3.0.CO;2-K; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; FAN Z, 1995, J CELL BIOL, V131, P235, DOI 10.1083/jcb.131.1.235; GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Jakus J, 1996, ONCOGENE, V12, P2369; KAWAMOTO T, 1984, J BIOL CHEM, V259, P7761; KEARSLEY JH, 1990, BRIT J CANCER, V61, P821, DOI 10.1038/bjc.1990.184; KONGER RL, 1993, J CELL PHYSIOL, V156, P515, DOI 10.1002/jcp.1041560310; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; OZANNE B, 1986, J PATHOL, V149, P9, DOI 10.1002/path.1711490104; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sato K, 2003, GENES CELLS, V8, P995, DOI 10.1046/j.1356-9597.2003.00691.x; Sato K, 2002, J BIOL CHEM, V277, P29568, DOI 10.1074/jbc.M203179200; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; STANTON P, 1994, BRIT J CANCER, V70, P427, DOI 10.1038/bjc.1994.322; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Yamashita H, 2003, ONCOGENE, V22, P1638, DOI 10.1038/sj.onc.1206277; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	27	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e41613	10.1371/journal.pone.0041613	http://dx.doi.org/10.1371/journal.pone.0041613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927910	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700004
J	Dawicki-McKenna, JM; Goldman, YE; Ostap, EM				Dawicki-McKenna, Jennine M.; Goldman, Yale E.; Ostap, E. Michael			Sites of Glucose Transporter-4 Vesicle Fusion with the Plasma Membrane Correlate Spatially with Microtubules	PLOS ONE			English	Article							RAT ADIPOSE-CELLS; REGULATABLE GLUCOSE TRANSPORTER; 3T3-L1 ADIPOCYTES; GLUT4 TRANSLOCATION; SUBCELLULAR TRAFFICKING; FLUORESCENT PROTEINS; AMINOPEPTIDASE VP165; INSULIN ACTION; MYOSIN MYO1C; MUSCLE-CELLS	In adipocytes, vesicles containing glucose transporter-4 (GLUT4) redistribute from intracellular stores to the cell periphery in response to insulin stimulation. Vesicles then fuse with the plasma membrane, facilitating glucose transport into the cell. To gain insight into the details of microtubule involvement, we examined the spatial organization and dynamics of microtubules in relation to GLUT4 vesicle trafficking in living 3T3-L1 adipocytes using total internal reflection fluorescence (TIRF) microscopy. Insulin stimulated an increase in microtubule density and curvature within the TIRF-illuminated region of the cell. The high degree of curvature and abrupt displacements of microtubules indicate that substantial forces act on microtubules. The time course of the microtubule density increase precedes that of the increase in intensity of fluorescently-tagged GLUT4 in this same region of the cell. In addition, portions of the microtubules are highly curved and are pulled closer to the cell cortex, as confirmed by Parallax microscopy. Microtubule disruption delayed and modestly reduced GLUT4 accumulation at the plasma membrane. Quantitative analysis revealed that fusions of GLUT4-containing vesicles with the plasma membrane, detected using insulin-regulated aminopeptidase with a pH-sensitive GFP tag (pHluorin), preferentially occur near microtubules. Interestingly, long-distance vesicle movement along microtubules visible at the cell surface prior to fusion does not appear to account for this proximity. We conclude that microtubules may be important in providing spatial information for GLUT4 vesicle fusion.	[Dawicki-McKenna, Jennine M.; Goldman, Yale E.; Ostap, E. Michael] Univ Penn, Perelman Sch Med, Pennsylvania Muscle Inst, Philadelphia, PA 19104 USA; [Dawicki-McKenna, Jennine M.; Goldman, Yale E.; Ostap, E. Michael] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Ostap, EM (corresponding author), Univ Penn, Perelman Sch Med, Pennsylvania Muscle Inst, Philadelphia, PA 19104 USA.	ostap@mail.med.upenn.edu		Dawicki McKenna, Jennine/0000-0002-1293-640X	National Institutes of Health [GM07229]; American Heart Association; NIH [P01 GM087253]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229, P01GM087253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JMDM was supported by a training grant from the National Institutes of Health (GM07229) and a pre-doctoral fellowship from the American Heart Association. This work was also supported through a program project grant from the NIH (P01 GM087253) to YEG and EMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Chen Y, 2008, FEBS J, V275, P705, DOI 10.1111/j.1742-4658.2007.06232.x; Chung LTK, 2010, BIOCHEM BIOPH RES CO, V391, P995, DOI 10.1016/j.bbrc.2009.12.004; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Emoto M, 2001, J BIOL CHEM, V276, P10677, DOI 10.1074/jbc.M010785200; Eyster CA, 2009, VITAM HORM, V80, P193, DOI 10.1016/S0083-6729(08)00608-0; Eyster CA, 2006, J BIOL CHEM, V281, P39719, DOI 10.1074/jbc.M607101200; Faire K, 1999, J CELL SCI, V112, P4243; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Fujita H, 2010, MOL BIOL CELL, V21, P2721, DOI 10.1091/mbc.E10-01-0029; Fulcher FK, 2008, EXP CELL RES, V314, P3264, DOI 10.1016/j.yexcr.2008.08.007; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Huang J, 2005, J BIOL CHEM, V280, P42300, DOI 10.1074/jbc.M510920200; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Imamura T, 2003, MOL CELL BIOL, V23, P4892, DOI 10.1128/MCB.23.14.4892-4900.2003; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Jolly AL, 2010, P NATL ACAD SCI USA, V107, P12151, DOI 10.1073/pnas.1004736107; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469; Lalioti VS, 2009, J CELL PHYSIOL, V218, P416, DOI 10.1002/jcp.21614; Liu LB, 2003, J BIOL CHEM, V278, P30157, DOI 10.1074/jbc.M301511200; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lizunov VA, 2009, J BIOL CHEM, V284, P7914, DOI 10.1074/jbc.M806460200; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Malide D, 1997, FEBS LETT, V409, P461, DOI 10.1016/S0014-5793(97)00563-2; Malide D, 2000, J CELL SCI, V113, P4203; Martin S, 1997, J CELL SCI, V110, P2281; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mentlik AN, 2010, MOL BIOL CELL, V21, P2241, DOI 10.1091/mbc.E09-11-0930; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Molero JC, 2001, J BIOL CHEM, V276, P43829, DOI 10.1074/jbc.M105452200; Olson AL, 2003, ENDOCRINOLOGY, V144, P5030, DOI 10.1210/en.2003-0609; Olson AL, 2001, J BIOL CHEM, V276, P10706, DOI 10.1074/jbc.M007610200; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; SATOH S, 1993, J BIOL CHEM, V268, P17820; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sumitani S, 1997, ENDOCRINOLOGY, V138, P1029, DOI 10.1210/en.138.3.1029; Sun Y, 2009, NANO LETT, V9, P2676, DOI 10.1021/nl901129j; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Toyoda T, 2011, J BIOL CHEM, V286, P4133, DOI 10.1074/jbc.M110.174938; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; YANG J, 1993, J BIOL CHEM, V268, P4600; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; [No title captured]	61	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43662	10.1371/journal.pone.0043662	http://dx.doi.org/10.1371/journal.pone.0043662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916292	gold, Green Published, Green Submitted			2022-12-27	WOS:000307733800090
J	Hideyama, T; Teramoto, S; Hachiga, K; Yamashita, T; Kwak, S				Hideyama, Takuto; Teramoto, Sayaka; Hachiga, Kosuke; Yamashita, Takenari; Kwak, Shin			Co-Occurrence of TDP-43 Mislocalization with Reduced Activity of an RNA Editing Enzyme, ADAR2, in Aged Mouse Motor Neurons	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; RECEPTOR SUBUNITS GLUR2; LOW RELATIVE ABUNDANCE; MOTONEURONS IN-VIVO; MESSENGER-RNA; SYSTEMATIC VARIATIONS; DEATH; BISTABILITY; PARVALBUMIN	TDP-43 pathology in spinal motor neurons is a neuropathological hallmark of sporadic amyotrophic lateral sclerosis (ALS) and has recently been shown to be closely associated with the downregulation of an RNA editing enzyme called adenosine deaminase acting on RNA 2 (ADAR2) in the motor neurons of sporadic ALS patients. Because TDP-43 pathology is found more frequently in the brains of elderly patients, we investigated the age-related changes in the TDP-43 localization and ADAR2 activity in mouse motor neurons. We found that ADAR2 was developmentally upregulated, and its mRNA expression level was progressively decreased in the spinal cords of aged mice. Motor neurons normally exhibit nuclear ADAR2 and TDP-43 immunoreactivity, whereas fast fatigable motor neurons in aged mice demonstrated a loss of ADAR2 and abnormal TDP-43 localization. Importantly, these motor neurons expressed significant amounts of the Q/R site-unedited AMPA receptor subunit 2 (GluA2) mRNA. Because expression of unedited GluA2 has been demonstrated as a lethality-causing molecular abnormality observed in the motor neurons, these results suggest that age-related decreases in ADAR2 activity play a mechanistic role in aging and serve as one of risk factors for ALS.	[Hideyama, Takuto; Teramoto, Sayaka; Yamashita, Takenari; Kwak, Shin] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Hideyama, Takuto; Teramoto, Sayaka; Hachiga, Kosuke; Yamashita, Takenari; Kwak, Shin] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo, Japan; [Hideyama, Takuto] Univ Tokyo, Div Hlth Promot, Bunkyo Ku, Tokyo, Japan; [Teramoto, Sayaka; Yamashita, Takenari; Kwak, Shin] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo, Japan; [Kwak, Shin] Int Univ Hlth & Welf, Clin Res Ctr Med, Ichikawa, Chiba, Japan	Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; University of Tokyo; International University of Health & Welfare	Hideyama, T (corresponding author), Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan.	kwak-tky@umin.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan ALS (Amyotrophic Lateral Sclerosis) Association; Nakabayashi Trust For ALS Research; Grants-in-Aid for Scientific Research [23790978] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan ALS (Amyotrophic Lateral Sclerosis) Association; Nakabayashi Trust For ALS Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Health, Labor (SK), and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (SK), and Research Grants from Japan ALS (Amyotrophic Lateral Sclerosis) Association and from The Nakabayashi Trust For ALS Research (TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2010, ACTA NEUROPATHOL, V120, P75, DOI 10.1007/s00401-010-0678-x; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Atsuta N, 2009, J NEUROL SCI, V276, P163, DOI 10.1016/j.jns.2008.09.024; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Cotel F, 2009, J NEUROSCI, V29, P2748, DOI 10.1523/JNEUROSCI.3462-08.2009; DENGLER R, 1990, MUSCLE NERVE, V13, P545, DOI 10.1002/mus.880130612; HASHIZUME K, 1988, J COMP NEUROL, V269, P425, DOI 10.1002/cne.902690309; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Hideyama T, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00033; Hideyama T, 2010, J NEUROSCI, V30, P11917, DOI 10.1523/JNEUROSCI.2021-10.2010; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hirofuji C, 2000, NEUROREPORT, V11, P823, DOI 10.1097/00001756-200003200-00033; INCE P, 1993, NEUROPATH APPL NEURO, V19, P291, DOI 10.1111/j.1365-2990.1993.tb00443.x; Kadhiresan VA, 1996, J PHYSIOL-LONDON, V493, P543, DOI 10.1113/jphysiol.1996.sp021402; KANDA K, 1989, J NEUROPHYSIOL, V61, P737, DOI 10.1152/jn.1989.61.4.737; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2004, DEV BRAIN RES, V148, P151, DOI 10.1016/j.devbrainres.2003.11.008; Kawahara Y, 2003, EUR J NEUROSCI, V18, P23, DOI 10.1046/j.1460-9568.2003.02718.x; Kawahara Y, 2003, J NEUROCHEM, V85, P680, DOI 10.1046/j.1471-4159.2003.01703.x; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Kwak S, 2008, RNA BIOL, V5, P193, DOI 10.4161/rna.6925; Lee RH, 1998, J NEUROPHYSIOL, V80, P572, DOI 10.1152/jn.1998.80.2.572; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nicholas A, 2010, MECH AGEING DEV, V131, P445, DOI 10.1016/j.mad.2010.06.001; Nishimoto Y, 2008, NEUROSCI RES, V61, P201, DOI 10.1016/j.neures.2008.02.009; PASCHEN W, 1995, J NEUROSCI METH, V56, P21, DOI 10.1016/0165-0270(94)00085-U; PASCHEN W, 1994, J NEUROCHEM, V63, P1596, DOI 10.1046/j.1471-4159.1994.63051596.x; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; STURROCK RR, 1988, J ANAT, V160, P189; STURROCK RR, 1991, J ANAT, V174, P125; Takuma H, 1999, ANN NEUROL, V46, P806, DOI 10.1002/1531-8249(199912)46:6<806::AID-ANA2>3.0.CO;2-S; Van den Bosch L, 2002, EXP NEUROL, V174, P150, DOI 10.1006/exnr.2001.7858; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147	37	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43469	10.1371/journal.pone.0043469	http://dx.doi.org/10.1371/journal.pone.0043469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916266	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800070
J	Kim, H; Jones, KE				Kim, Hojeong; Jones, Kelvin E.			The Retrograde Frequency Response of Passive Dendritic Trees Constrains the Nonlinear Firing Behaviour of a Reduced Neuron Model	PLOS ONE			English	Article							MOTONEURONS IN-VIVO; PERSISTENT INWARD CURRENTS; MOUSE SPINAL MOTONEURONS; PLATEAU POTENTIALS; CALCIUM CURRENTS; SYSTEMATIC VARIATIONS; ELECTRICAL-PROPERTIES; COMPARTMENTAL MODEL; VARIABLE-THRESHOLD; LUMBAR MOTONEURONS	Our goal was to investigate how the propagation of alternating signals (i.e. AC), like action potentials, into the dendrites influenced nonlinear firing behaviour of motor neurons using a systematically reduced neuron model. A recently developed reduced modeling approach using only steady-current (i.e. DC) signaling was analytically expanded to retain features of the frequency-response analysis carried out in multicompartment anatomically reconstructed models. Bifurcation analysis of the extended model showed that the typically overlooked parameter of AC amplitude attenuation was positively correlated with the current threshold for the activation of a plateau potential in the dendrite. Within the multiparameter space map of the reduced model the region demonstrating "fully-bistable'' firing was bounded by directional DC attenuation values that were negatively correlated to AC attenuation. Based on these results we conclude that analytically derived reduced models of dendritic trees should be fit on DC and AC signaling, as both are important biophysical parameters governing the nonlinear firing behaviour of motor neurons.	[Kim, Hojeong; Jones, Kelvin E.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Jones, Kelvin E.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Jones, Kelvin E.] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Kim, H (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.	hojeong@ualberta.ca	Jones, Kelvin/AAJ-6112-2021; Jones, Kelvin/AFW-5002-2022; Jones, Kelvin/M-6487-2019	Jones, Kelvin/0000-0003-4764-7031; 	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The study was supported by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Ballou EW, 2006, J NEUROSCI METH, V156, P257, DOI 10.1016/j.jneumeth.2006.03.014; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bennett DJ, 2001, J NEUROPHYSIOL, V86, P1955, DOI 10.1152/jn.2001.86.4.1955; Booth V, 1997, J NEUROPHYSIOL, V78, P3371, DOI 10.1152/jn.1997.78.6.3371; Booth V, 1995, J COMPUT NEUROSCI, V2, P299, DOI 10.1007/BF00961442; Bui TV, 2006, J NEUROPHYSIOL, V95, P225, DOI 10.1152/jn.00646.2005; Burke RE, 1999, PROG BRAIN RES, V123, P167, DOI 10.1016/S0079-6123(08)62854-X; Carlin KP, 2000, EUR J NEUROSCI, V12, P1635, DOI 10.1046/j.1460-9568.2000.00055.x; Carlin KP, 2000, EUR J NEUROSCI, V12, P1624, DOI 10.1046/j.1460-9568.2000.00050.x; Carnevale N. T., 2005, NEURON BOOK, pXIX; Carnevale NT, 1997, J NEUROPHYSIOL, V78, P703, DOI 10.1152/jn.1997.78.2.703; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P291, DOI 10.1113/jphysiol.1955.sp005411; CULLHEIM S, 1987, J COMP NEUROL, V255, P82, DOI 10.1002/cne.902550107; CULLHEIM S, 1987, J COMP NEUROL, V255, P68, DOI 10.1002/cne.902550106; Doiron B, 2002, J COMPUT NEUROSCI, V12, P5, DOI 10.1023/A:1014921628797; ElBasiouny SM, 2005, J NEUROPHYSIOL, V94, P3961, DOI 10.1152/jn.00391.2005; Grande G, 2007, J NEUROPHYSIOL, V97, P4023, DOI 10.1152/jn.00044.2007; Gutman A. M., 1991, International Journal of Neural Systems, V1, P291, DOI 10.1142/S0129065791000339; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Heckman CJ, 2005, MUSCLE NERVE, V31, P135, DOI 10.1002/mus.20261; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; Hendrickson EB, 2011, J COMPUT NEUROSCI, V30, P301, DOI 10.1007/s10827-010-0258-z; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P591, DOI 10.1113/jphysiol.1988.sp017059; HOUNSGAARD J, 1989, J PHYSIOL-LONDON, V414, P265, DOI 10.1113/jphysiol.1989.sp017687; HOUNSGAARD J, 1985, EXP BRAIN RES, V57, P422; HOUNSGAARD J, 1984, EXP BRAIN RES, V55, P391; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; Izhikevich EM, 2007, DYNAMICAL SYSTEMS NE, p[xvi, 441]; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Jones KE, 2000, NEUROCOMPUTING, V32, P173, DOI 10.1016/S0925-2312(00)00160-0; Kim H, 2011, J COMPUT NEUROSCI, V30, P659, DOI 10.1007/s10827-010-0284-x; Kim H, 2009, J COMPUT NEUROSCI, V27, P321, DOI 10.1007/s10827-009-0145-7; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lee RH, 1998, J NEUROPHYSIOL, V80, P572, DOI 10.1152/jn.1998.80.2.572; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Lee RH, 1999, J NEUROPHYSIOL, V81, P2164, DOI 10.1152/jn.1999.81.5.2164; Lee RH, 1999, J NEUROPHYSIOL, V82, P2518, DOI 10.1152/jn.1999.82.5.2518; Lee RH, 2000, J NEUROSCI, V20, P6734, DOI 10.1523/JNEUROSCI.20-17-06734.2000; Li YR, 2003, J NEUROPHYSIOL, V90, P857, DOI 10.1152/jn.00236.2003; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MCCOMAS AJ, 1995, MUSCLE NERVE, V18, P369, DOI 10.1002/mus.880180402; Meehan CF, 2010, J NEUROPHYSIOL, V103, P2599, DOI 10.1152/jn.00668.2009; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Phillips CL, 2000, FEEDBACK CONTROL SYS, pxiii; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; POWERS RK, 1993, J NEUROPHYSIOL, V70, P246, DOI 10.1152/jn.1993.70.1.246; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; SCHWINDT PC, 1980, J NEUROPHYSIOL, V44, P827, DOI 10.1152/jn.1980.44.4.827; SCHWINDT PC, 1980, J NEUROPHYSIOL, V43, P1700, DOI 10.1152/jn.1980.43.6.1700; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 2008, DENDRITES, pxv; Svirskis G, 1997, J NEUROPHYSIOL, V78, P1740, DOI 10.1152/jn.1997.78.3.1740; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; ZENGEL JE, 1985, J NEUROPHYSIOL, V53, P1323, DOI 10.1152/jn.1985.53.5.1323	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43654	10.1371/journal.pone.0043654	http://dx.doi.org/10.1371/journal.pone.0043654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916290	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800088
J	Lamsoul, I; Erard, M; van der Ven, PFM; Lutz, PG				Lamsoul, Isabelle; Erard, Monique; van der Ven, Peter F. M.; Lutz, Pierre G.			Filamins but Not Janus Kinases Are Substrates of the ASB2 alpha Cullin-Ring E3 Ubiquitin Ligase in Hematopoietic Cells	PLOS ONE			English	Article							MYELOID-LEUKEMIA CELLS; PROTEASOMAL DEGRADATION; CRYSTAL-STRUCTURE; DIFFERENTIATION; COMPLEX; REGULATOR; PROTEINS; ADHESION; PATHWAY; ASB2	The ASB2 alpha protein is the specificity subunit of an E3 ubiquitin ligase complex involved in hematopoietic differentiation and is proposed to exert its effects by regulating the turnover of specific proteins. Three ASB2 alpha substrates have been described so far: the actin-binding protein filamins, the Mixed Lineage Leukemia protein, and the Janus kinases 2 and 3. To determine the degradation of which substrate drives ASB2 alpha biological effects is crucial for the understanding of ASB2 alpha functions in hematopoiesis. Here, we show that neither endogenous nor exogenously expressed ASB2 alpha induces degradation of JAK proteins in hematopoietic cells. Furthermore, we performed molecular modeling to generate the first structural model of an E3 ubiquitin ligase complex of an ASB protein bound to one of its substrates.	[Lamsoul, Isabelle; Erard, Monique; Lutz, Pierre G.] CNRS, IPBS, F-31077 Toulouse, France; [Lamsoul, Isabelle; Erard, Monique; Lutz, Pierre G.] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [van der Ven, Peter F. M.] Univ Bonn, Dept Mol Cell Biol, Inst Cell Biol, Bonn, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Bonn	Lamsoul, I (corresponding author), CNRS, IPBS, 205 Route Narbonne,BP64182, F-31077 Toulouse, France.	Pierre.Lutz@ipbs.fr	Lutz, Pierre/B-8822-2009	Lutz, Pierre/0000-0003-0590-9101; Lamsoul, Isabelle/0000-0002-7769-5627; van der Ven, Peter/0000-0002-9750-8913	Centre National de la Recherche Scientifique; Universite Paul Sabatier; Comite Leucemie de la Fondation de France; Comite Midi-Pyrenees de la Ligue contre le Cancer; Lady TATA Foundation	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; Comite Leucemie de la Fondation de France(Fondation de France); Comite Midi-Pyrenees de la Ligue contre le Cancer; Lady TATA Foundation	This work was supported by Centre National de la Recherche Scientifique and Universite Paul Sabatier and by grants to PGL from the Comite Leucemie de la Fondation de France and from the Comite Midi-Pyrenees de la Ligue contre le Cancer. I. Lamsoul was supported by fellowships from the Lady TATA Foundation and the Comite Leucemie de la Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello NF, 2009, CELL DEATH DIFFER, V16, P921, DOI 10.1038/cdd.2009.27; Biethahn S, 1999, EXP HEMATOL, V27, P885, DOI 10.1016/S0301-472X(99)00017-X; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Burande CF, 2009, MOL CELL PROTEOMICS, V8, P1719, DOI 10.1074/mcp.M800410-MCP200; Guibal FC, 2002, J BIOL CHEM, V277, P218, DOI 10.1074/jbc.M108476200; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Kohroki J, 2001, FEBS LETT, V505, P223, DOI 10.1016/S0014-5793(01)02829-0; Lamsoul I, 2011, J BIOL CHEM, V286, P30571, DOI 10.1074/jbc.M111.220921; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Moog-Lutz C, 2003, BLOOD, V102, P3371, DOI 10.1182/blood-2002-11-3462; Nie L, 2011, CELL RES, V21, P754, DOI 10.1038/cr.2010.165; Okumura F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00010; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Spicuglia S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024176; Wang JY, 2012, BLOOD, V119, P1151, DOI 10.1182/blood-2011-06-362079; Wu W, 2011, J BIOL CHEM, V286, P41153, DOI 10.1074/jbc.M111.273755; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43798	10.1371/journal.pone.0043798	http://dx.doi.org/10.1371/journal.pone.0043798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916308	gold, Green Submitted, Green Published			2022-12-27	WOS:000307733800105
J	Ostermann, E; Tuddenham, L; Macquin, C; Alsaleh, G; Schreiber-Becker, J; Tanguy, M; Bahram, S; Pfeffer, S; Georgel, P				Ostermann, Eleonore; Tuddenham, Lee; Macquin, Cecile; Alsaleh, Ghada; Schreiber-Becker, Julie; Tanguy, Melanie; Bahram, Seiamak; Pfeffer, Sebastien; Georgel, Philippe			Deregulation of Type I IFN-Dependent Genes Correlates with Increased Susceptibility to Cytomegalovirus Acute Infection of Dicer Mutant Mice	PLOS ONE			English	Article							MICRORNAS TARGET; RECOGNITION; DEFENSE; IDENTIFICATION; PREDICTION; RESPONSES; VIRUSES; IMPACT; LIGAND; RNAS	Regulation of gene expression by microRNAs (miRNAs) is now considered as an essential mechanism for cell development and homeostasis. Indeed, numerous studies have reported that modulating their expression, maturation, or activity can affect cell survival, identity or activation. In particular, miRNAs are key players in the tight regulation of signaling cascades, and as such, they appear as perfectly suited immunomodulators. Several immune-related processes, including inflammation, have recently been demonstrated to require specific miRNAs. In addition, the discovery of herpesvirus-encoded miRNAs has reinforced this assumption. To decipher the potential roles of miRNAs in innate antiviral immune response, we developed an in vivo model based on the inoculation of mouse cytomegalovirus (MCMV) in mice. Furthermore, we exploited a mouse line carrying a hypomorphic mutation in the Dicer gene to visualize the impact of impaired miRNA biogenesis upon the anti-MCMV response. Our data indicate that miRNAs are important actors in mounting an efficient response against herpesviruses. We suggest that a rapid and transient interferon response following viral infection requires miRNA-dependent repressor release. In addition, our in vivo efforts identified several miRNA targets, thus providing a conceptual framework for future analyzes on the regulation of specific actors involved in the Type I interferon pathway.	[Ostermann, Eleonore; Macquin, Cecile; Bahram, Seiamak; Georgel, Philippe] Univ Strasbourg, EA 4438, Lab Immunogenet Mol Humaine, Strasbourg, France; [Tuddenham, Lee; Schreiber-Becker, Julie; Tanguy, Melanie; Pfeffer, Sebastien] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, Strasbourg, France; [Alsaleh, Ghada] Univ Strasbourg, EA 4438, Lab Physiopathol Arthrites, Illkirch Graffenstaden, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ostermann, E (corresponding author), Univ Strasbourg, EA 4438, Lab Immunogenet Mol Humaine, Strasbourg, France.	s.pfeffer@ibmc-cnrs.unistra.fr; pgeorgel@unistra.fr	georgel, philippe/P-5676-2016; Pfeffer, Sebastien/A-6512-2010; Pfeffer, Sébastien/H-3212-2019; Bahram, Seiamak/GZA-7150-2022	georgel, philippe/0000-0001-6853-7080; Pfeffer, Sebastien/0000-0002-8458-348X; Pfeffer, Sébastien/0000-0002-8458-348X; Bahram, Seiamak/0000-0002-6928-9952; Ostermann, Eleonore/0000-0002-7539-2155; Tanguy, Melanie/0000-0003-4862-0981; alsaleh, ghada/0000-0002-4211-3420	Agence Nationale de la Recherche (ANR) [ANR-08-MIEN-005-01 DICERPATHO]; Association pour la Recherche sur le Cancer	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by Agence Nationale de la Recherche (ANR) (ANR-08-MIEN-005-01 DICERPATHO) to PG and SP. MT was funded by a fellowship from the Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cicin-Sain L, 2005, J VIROL, V79, P9492, DOI 10.1128/JVI.79.15.9492-9502.2005; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Muller S, 2007, IMMUNITY, V27, P1, DOI 10.1016/j.immuni.2007.07.003; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Rolli V, 2007, FEBS LETT, V581, P394, DOI 10.1016/j.febslet.2006.12.047; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Stark TJ, 2012, J VIROL, V86, P226, DOI 10.1128/JVI.05903-11; Suffert G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002405; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tolfvenstam T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-209; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Tuddenham L, 2012, J VIROL, V86, P1638, DOI 10.1128/JVI.05911-11; Wies E, 2009, J BIOL CHEM, V284, P8525, DOI 10.1074/jbc.M809252200; Ye JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020681; Zucchini N, 2008, J IMMUNOL, V180, P5799, DOI 10.4049/jimmunol.180.9.5799	42	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43744	10.1371/journal.pone.0043744	http://dx.doi.org/10.1371/journal.pone.0043744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916300	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800098
J	Zabini, D; Nagaraj, C; Stacher, E; Lang, IM; Nierlich, P; Klepetko, W; Heinemann, A; Olschewski, H; Balint, Z; Olschewski, A				Zabini, Diana; Nagaraj, Chandran; Stacher, Elvira; Lang, Irene M.; Nierlich, Patrick; Klepetko, Walter; Heinemann, Akos; Olschewski, Horst; Balint, Zoltan; Olschewski, Andrea			Angiostatic Factors in the Pulmonary Endarterectomy Material from Chronic Thromboembolic Pulmonary Hypertension Patients Cause Endothelial Dysfunction	PLOS ONE			English	Article							INTERFERON-INDUCIBLE PROTEIN-10; CHEMOKINE RECEPTOR CXCR3; PROGENITOR CELLS; T-LYMPHOCYTES; IN-VIVO; ANGIOGENESIS; EXPRESSION; GROWTH; NEOVASCULARIZATION; PLATELET-FACTOR-4	Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease with persistent thrombotic occlusion or stenosis of the large pulmonary arteries resulting in pulmonary hypertension. Surgical removal of the neointimal layer of these vessels together with the non-resolved thrombus consisting of organized collagen-rich fibrotic areas with partly recanalized regions is the treatment of choice (pulmonary endarterectomy, PEA). The present study investigates endothelial cells isolated from such material as well as factors present in the surgical PEA material, which may contribute to impairment of recanalization and thrombus non-resolution. We observed muscularized vessels and non-muscularized vessels in the PEA material. The isolated endothelial cells from the PEA material showed significantly different calcium homeostasis as compared to pulmonary artery endothelial cells (hPAECs) from normal controls. In the supernatant (ELISA) as well as on the tissue level (histochemical staining) of the PEA material, platelet factor 4 (PF4), collagen type I and interferon-gamma-inducible 10 kD protein (IP-10) were detected. CXCR3, the receptor for PF4 and IP-10, was particularly elevated in the distal parts of the PEA material as compared to human control lung (RT-PCR). PF4, collagen type I and IP-10 caused significant changes in calcium homeostasis and affected the cell proliferation, migration and vessel formation in hPAECs. The presence of angiostatic factors like PF4, collagen type I and IP-10, as recovered from the surgical PEA material from CTEPH patients, may lead to changes in calcium homeostasis and endothelial dysfunction.	[Zabini, Diana; Nagaraj, Chandran; Balint, Zoltan; Olschewski, Andrea] Med Univ Graz, Dept Anesthesia & Intens Care Med, Graz, Austria; [Stacher, Elvira] Med Univ Graz, Inst Pathol, Graz, Austria; [Lang, Irene M.] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria; [Nierlich, Patrick; Klepetko, Walter] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Olschewski, Horst] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria; [Nagaraj, Chandran; Balint, Zoltan; Olschewski, Andrea] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Vienna; Medical University of Vienna; Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute	Zabini, D (corresponding author), Med Univ Graz, Dept Anesthesia & Intens Care Med, Graz, Austria.	zoltan.balint@lvr.lbg.ac.at	Olschewski, Horst/L-3547-2019; Chandran, Nagaraj/AAP-2007-2020; Bálint, Zoltán/AAJ-3080-2020	Olschewski, Horst/0000-0002-2834-7466; Chandran, Nagaraj/0000-0003-3825-8587; Olschewski, Andrea/0000-0002-8189-3634; Balint, Zoltan/0000-0001-8598-2784; Lang, Irene/0000-0003-0485-2692	Medical University of Graz; EU [LSHM-CT-2005-018725]; Austrian-Hungarian Joint Grant [AT-4/2009]; Austrian Science Fund (FWF) [P 22521] Funding Source: researchfish	Medical University of Graz; EU(European Commission); Austrian-Hungarian Joint Grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by the Medical University of Graz (PhD Program Molecular Medicine) to DZ and CN, EU FP6 "PULMOTENSION'' (LSHM-CT-2005-018725) to AO, HO, IML and WK, and Austrian-Hungarian Joint Grant AT-4/2009 to AO and ZB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo AL, 1996, ANN NY ACAD SCI, V795, P158, DOI 10.1111/j.1749-6632.1996.tb52664.x; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; Bonderman D, 2008, ARTERIOSCL THROM VAS, V28, P678, DOI 10.1161/ATVBAHA.107.156000; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Dartevelle P, 2004, EUR RESPIR J, V23, P637, DOI 10.1183/09031936.04.00079704; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; DIBLE JH, 1958, J PATHOL BACTERIOL, V75, P1, DOI 10.1002/path.1700750102; Distler JHW, 2003, Q J NUCL MED, V47, P149; Ellis CA, 1999, J BIOL CHEM, V274, P13718, DOI 10.1074/jbc.274.19.13718; FILES JC, 1981, BLOOD, V58, P607; Firth AL, 2010, AM J PHYSIOL-CELL PH, V298, pC1217, DOI 10.1152/ajpcell.00416.2009; Firth AL, 2009, AM J PHYSIOL-LUNG C, V296, pL979, DOI 10.1152/ajplung.90412.2008; FUKAMI MH, 2001, HEMOSTASIS THROMBOSI, P561; GARCIA JGN, 1993, J CELL PHYSIOL, V156, P541, DOI 10.1002/jcp.1041560313; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Herve P, 2006, J APPL PHYSIOL, V100, P1101, DOI 10.1152/japplphysiol.01554.2005; Hofer E, 2007, THROMB HAEMOSTASIS, V97, P355, DOI 10.1160/TH06-08-0470; Hosokawa K, 2011, INT HEART J, V52, P377, DOI 10.1536/ihj.52.377; Hou YH, 2006, EXP HEMATOL, V34, P1125, DOI 10.1016/j.exphem.2006.05.021; Humbert M, 2010, EUR RESPIR REV, V19, P59, DOI 10.1183/09059180.00007309; Ji WDR, 1998, FASEB J, V12, P1731, DOI 10.1096/fasebj.12.15.1731; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kimura H, 2001, AM J RESP CRIT CARE, V164, P319, DOI 10.1164/ajrccm.164.2.2006154; LANG IM, 1994, CIRCULATION, V89, P2715, DOI 10.1161/01.CIR.89.6.2715; Lang I, 2010, BRIT J HAEMATOL, V149, P478, DOI 10.1111/j.1365-2141.2010.08142.x; Lang IM, 2008, CURR OPIN CARDIOL, V23, P555, DOI 10.1097/HCO.0b013e328311f254; Lang IM, 2009, REV ESP CARDIOL, V62, P120, DOI 10.1016/S0300-8932(09)70153-8; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; Maruoka M, 2012, INT J CARDIOL, V159, P119, DOI 10.1016/j.ijcard.2011.02.037; Mayer Eckhard, 2006, Proc Am Thorac Soc, V3, P589, DOI 10.1513/pats.200605-120LR; McGuinness CL, 2001, THROMB HAEMOSTASIS, V85, P1018, DOI 10.1055/s-0037-1615957; Morris TA, 2006, AM J RESP CRIT CARE, V173, P1270, DOI 10.1164/rccm.200506-916OC; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; Mueller A, 2008, J LEUKOCYTE BIOL, V83, P875, DOI 10.1189/jlb.1006645; Ogawa A, 2009, AM J PHYSIOL-LUNG C, V297, pL666, DOI 10.1152/ajplung.90548.2008; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Sacks RS, 2006, SEMIN THORAC CARDIOV, V18, P265, DOI 10.1053/j.semtcvs.2006.09.004; Sakao S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-109; Sevitt S, 1970, J PATHOL, V100, pPi; Singh I, 2003, CIRCULATION, V107, P869, DOI 10.1161/01.CIR.0000050149.22928.39; Struyf S, 2011, BLOOD, V117, P480, DOI 10.1182/blood-2009-11-253591; Suntharalingam J, 2008, EUR RESPIR J, V31, P736, DOI 10.1183/09031936.00055107; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Undas A, 2009, BLOOD, V114, P4272, DOI 10.1182/blood-2009-05-222380; van Weering HRJ, 2010, BRAIN BEHAV IMMUN, V24, P768, DOI 10.1016/j.bbi.2009.04.007; Wakefield TW, 1999, J VASC SURG, V30, P885, DOI 10.1016/S0741-5214(99)70013-3; Wolf M, 2000, EUR RESPIR J, V15, P395, DOI 10.1034/j.1399-3003.2000.15b28.x; Wynants M, 2012, EUR RESPIR J, V40, P886, DOI 10.1183/09031936.00197511; Yang LJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-261; Yao WJ, 2009, AM J PHYSIOL-LUNG C, V296, pL870, DOI 10.1152/ajplung.90413.2008; Yi ES, 2000, AM J RESP CRIT CARE, V162, P1577, DOI 10.1164/ajrccm.162.4.9912131; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101	61	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43793	10.1371/journal.pone.0043793	http://dx.doi.org/10.1371/journal.pone.0043793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916307	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800104
J	Gao, LX; Tang, SQ; Zhuge, LQ; Nie, M; Zhu, Z; Li, B; Yang, J				Gao, Lexuan; Tang, Shaoqing; Zhuge, Liqiong; Nie, Ming; Zhu, Zhu; Li, Bo; Yang, Ji			Spatial Genetic Structure in Natural Populations of Phragmites australis in a Mosaic of Saline Habitats in the Yellow River Delta, China	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; SALT TOLERANCE; RELATIVE IMPORTANCE; OSMOTIC ADJUSTMENT; LOCAL ADAPTATION; CANDIDATE LOCI; CLIMATE-CHANGE; WORLD-WIDE; SCALE; DIVERSITY	Determination of spatial genetic structure (SGS) in natural populations is important for both theoretical aspects of evolutionary genetics and their application in species conservation and ecological restoration. In this study, we examined genetic diversity within and among the natural populations of a cosmopolitan grass Phragmites australis (common reed) in the Yellow River Delta (YRD), China, where a mosaic of habitat patches varying in soil salinity was detected. We demonstrated that, despite their close geographic proximity, the common reed populations in the YRD significantly diverged at six microsatellite loci, exhibiting a strong association of genetic variation with habitat heterogeneity. Genetic distances among populations were best explained as a function of environmental difference, rather than geographical distance. Although the level of genetic divergence among populations was relatively low (F'(ST) = 0.073), weak but significant genetic differentiation, as well as the concordance between ecological and genetic landscapes, suggests spatial structuring of genotypes in relation to patchy habitats. These findings not only provided insights into the population dynamics of common reed in changing environments, but also demonstrated the feasibility of using habitat patches in a mosaic landscape as test systems to identify appropriate genetic sources for ecological restoration.	[Gao, Lexuan; Zhu, Zhu; Li, Bo; Yang, Ji] Fudan Univ, Ctr Evolutionary Biol, Shanghai 200433, Peoples R China; [Gao, Lexuan; Zhu, Zhu; Li, Bo; Yang, Ji] Fudan Univ, Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Tang, Shaoqing; Zhuge, Liqiong] Guangxi Normal Univ, Coll Life Sci, Guilin, Peoples R China; [Nie, Ming; Yang, Ji] Nanchang Univ, Ctr Watershed Ecol, Nanchang, Peoples R China	Fudan University; Fudan University; Guangxi Normal University; Nanchang University	Gao, LX (corresponding author), Fudan Univ, Ctr Evolutionary Biol, Shanghai 200433, Peoples R China.	zzhu@fudan.edu.cn	Li, Bo/B-8016-2010; Nie, Ming/F-1880-2010; Li, Bo/AAA-8968-2020; Nie, Ming/F-1880-2010	Li, Bo/0000-0002-0439-5666; Nie, Ming/0000-0003-0702-8009; Li, Bo/0000-0002-7294-6888; Nie, Ming/0000-0003-3898-5389	National Basic Research Program of China [2006CB403305]; National Natural Science Foundation of China [91131901]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2006CB403305) and the National Natural Science Foundation of China (91131901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2006, MAR ECOL PROG SER, V309, P117, DOI 10.3354/meps309117; Bascompte J, 2002, AM NAT, V159, P128, DOI 10.1086/324793; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Becher SA, 2000, THEOR APPL GENET, V101, P643, DOI 10.1007/s001220051526; Bell DJ, 2009, BOTANY, V87, P932, DOI 10.1139/B09-058; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Bond NR, 2000, J ANIM ECOL, V69, P608, DOI 10.1046/j.1365-2656.2000.00420.x; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Brown BL, 2007, HYDROBIOLOGIA, V586, P93, DOI 10.1007/s10750-006-0531-3; Buckley J, 2012, MOL ECOL, V21, P267, DOI 10.1111/j.1365-294X.2011.05388.x; Burdick DM, 2001, ENVIRON EXP BOT, V46, P247, DOI 10.1016/S0098-8472(01)00099-5; Capelle J, 2005, J EVOLUTION BIOL, V18, P1445, DOI 10.1111/j.1420-9101.2005.00951.x; [陈小英 Chen Xiaoying], 2005, [海洋科学进展, Advances in Marine Science], V23, P438; Colling G, 2010, PLANT SYST EVOL, V287, P99, DOI 10.1007/s00606-010-0298-x; Cureton AN, 2006, J APPL ECOL, V43, P1203, DOI 10.1111/j.1365-2664.2006.01236.x; Curn V, 2007, AQUAT BOT, V86, P321, DOI 10.1016/j.aquabot.2006.11.010; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; Engloner AI, 2009, FLORA, V204, P331, DOI 10.1016/j.flora.2008.05.001; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; FAHRIG L, 1992, THEOR POPUL BIOL, V41, P300, DOI 10.1016/0040-5809(92)90031-N; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fang HL, 2005, ENVIRON MANAGE, V35, P72, DOI 10.1007/s00267-004-3066-2; Feng SZL, 2006, HYDROGRAPHIC SURVEYI, V26, P38; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; Garnier-Gere PH, 2001, CONSERV BIOL, V15, P1632, DOI 10.1046/j.1523-1739.2001.00180.x; Gonzales E, 2010, J HERED, V101, P133, DOI 10.1093/jhered/esp101; Guldbrandtsen B, 2000, J HERED, V91, P178, DOI 10.1093/jhered/91.2.178; Guo WH, 2003, BIOCHEM SYST ECOL, V31, P1093, DOI 10.1016/S0305-1978(03)00032-2; Guo XX, 2008, J MOL EVOL, V67, P497, DOI 10.1007/s00239-008-9166-5; Hallatschek O, 2008, THEOR POPUL BIOL, V73, P158, DOI 10.1016/j.tpb.2007.08.008; Hancock AM, 2010, PHILOS T R SOC B, V365, P2459, DOI 10.1098/rstb.2010.0032; Hansen DL, 2007, AQUAT BOT, V86, P269, DOI 10.1016/j.aquabot.2006.11.005; Hargeby A, 2004, EVOLUTION, V58, P81; Hie Qiang, 2008, Yingyong Shengtai Xuebao, V19, P969; Holsinger K.E., 2007, HICKORY PACKAGE ANAL; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Joost S, 2008, MOL ECOL RESOUR, V8, P957, DOI 10.1111/j.1755-0998.2008.02162.x; Kalisz S, 2001, EVOLUTION, V55, P1560, DOI 10.1111/j.0014-3820.2001.tb00675.x; Keller BEM, 2000, AQUAT BOT, V66, P195, DOI 10.1016/S0304-3770(99)00077-7; Kettle CJ, 2011, PERSPECT PLANT ECOL, V13, P45, DOI 10.1016/j.ppees.2010.11.002; Kirk H, 2011, AM J BOT, V98, P1180, DOI 10.3732/ajb.1000278; Koppitz H, 1999, AQUAT BOT, V64, P209, DOI 10.1016/S0304-3770(99)00051-0; Korpelainen H, 2011, EVOL ECOL, V25, P45, DOI 10.1007/s10682-010-9378-1; Lambertini C, 2008, AQUAT BOT, V88, P160, DOI 10.1016/j.aquabot.2007.10.002; Li M, 2009, ANN APPL BIOL, V154, P43, DOI 10.1111/j.1744-7348.2008.00269.x; MANTEL N, 1967, CANCER RES, V27, P209; MATOH T, 1988, PHYSIOL PLANTARUM, V72, P8, DOI 10.1111/j.1399-3054.1988.tb06615.x; Mauchamp A, 2001, AQUAT BOT, V70, P39, DOI 10.1016/S0304-3770(00)00140-6; McCairns RJS, 2008, MOL ECOL, V17, P3901, DOI 10.1111/j.1365-294X.2008.03884.x; McCormick MK, 2010, WETLANDS, V30, P67, DOI 10.1007/s13157-009-0007-0; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; Nie M, 2010, J HAZARD MATER, V174, P156, DOI 10.1016/j.jhazmat.2009.09.030; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Obbard DJ, 2006, HEREDITY, V97, P296, DOI 10.1038/sj.hdy.6800862; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Parisod C, 2010, ANN BOT-LONDON, V105, P655, DOI 10.1093/aob/mcq014; Paul J, 2011, HYDROBIOLOGIA, V665, P107, DOI 10.1007/s10750-011-0608-5; Pfeifer M, 2006, FOLIA GEOBOT, V41, P3, DOI 10.1007/BF02805258; Pritchard JK, 2000, GENETICS, V155, P945; Richards LA., 1954, DIAGNOSIS IMPROVEMEN; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Sagnard F, 2011, TREE GENET GENOMES, V7, P37, DOI 10.1007/s11295-010-0313-y; Saltonstall K, 2003, ESTUARIES, V26, P444, DOI 10.1007/BF02823721; Saltonstall K, 2003, MOL ECOL, V12, P1689, DOI 10.1046/j.1365-294X.2003.01849.x; Saltonstall K, 2010, INVAS PLANT SCI MANA, V3, P495, DOI 10.1614/IPSM-09-053.1; Sambatti JBM, 2006, EVOLUTION, V60, P696, DOI 10.1111/j.0014-3820.2006.tb01149.x; Schlotterer C, 2004, P ROY SOC B-BIOL SCI, V271, P869, DOI 10.1098/rspb.2003.2662; Slatkin M, 2012, GENETICS, V191, P171, DOI 10.1534/genetics.112.139022; Spies B., 2005, SALINITY MAPPING MET; Sun JK, 2011, PLANT SOIL ENVIRON, V57, P139, DOI 10.17221/227/2010-PSE; Suzuki RO, 2005, ANN BOT-LONDON, V96, P1009, DOI 10.1093/aob/mci253; TAYLOR CE, 1976, GENETICS, V83, P887; Troupin D, 2006, MOL ECOL, V15, P3617, DOI 10.1111/j.1365-294X.2006.03047.x; Van Dongen S, 1998, HEREDITY, V80, P92, DOI 10.1046/j.1365-2540.1998.00278.x; Vasquez EA, 2006, AM J BOT, V93, P1784, DOI 10.3732/ajb.93.12.1784; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Volis S, 2010, HEREDITY, V105, P384, DOI 10.1038/hdy.2009.168; Wang W., 2007, YELLOW RIVER, V29, p[27, 32]; [王兆印 WANG Zhaoyin], 2006, [泥沙研究, Journal of Sediment Research], P76; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Williams BL, 2003, MOL ECOL, V12, P11, DOI 10.1046/j.1365-294X.2003.01700.x; Yao RongJiang, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P61; Zhang TT, 2010, INT ARCH PHOTOGRAMM, V38, P947; Zhao KF, 1999, ESTUAR COAST SHELF S, V49, P37, DOI 10.1016/S0272-7714(99)80006-7; Zhao Y., 1995, YELLOW RIVER DELTA N	90	21	26	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43334	10.1371/journal.pone.0043334	http://dx.doi.org/10.1371/journal.pone.0043334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916244	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300040
J	Arefin, AS; Riveros, C; Berretta, R; Moscato, P				Arefin, Ahmed Shamsul; Riveros, Carlos; Berretta, Regina; Moscato, Pablo			GPU-FS-kNN: A Software Tool for Fast and Scalable kNN Computation Using GPUs	PLOS ONE			English	Article							DIMENSIONALITY REDUCTION; NEIGHBOR; ALGORITHM; SIGNATURE; NETWORKS; SEARCH; CANCER; GRAPH	Background: The analysis of biological networks has become a major challenge due to the recent development of high-throughput techniques that are rapidly producing very large data sets. The exploding volumes of biological data are craving for extreme computational power and special computing facilities (i.e. super-computers). An inexpensive solution, such as General Purpose computation based on Graphics Processing Units (GPGPU), can be adapted to tackle this challenge, but the limitation of the device internal memory can pose a new problem of scalability. An efficient data and computational parallelism with partitioning is required to provide a fast and scalable solution to this problem. Results: We propose an efficient parallel formulation of the k-Nearest Neighbour (kNN) search problem, which is a popular method for classifying objects in several fields of research, such as pattern recognition, machine learning and bioinformatics. Being very simple and straightforward, the performance of the kNN search degrades dramatically for large data sets, since the task is computationally intensive. The proposed approach is not only fast but also scalable to large-scale instances. Based on our approach, we implemented a software tool GPU-FS-kNN (GPU-based Fast and Scalable k-Nearest Neighbour) for CUDA enabled GPUs. The basic approach is simple and adaptable to other available GPU architectures. We observed speed-ups of 50-60 times compared with CPU implementation on a well-known breast microarray study and its associated data sets. Conclusion: Our GPU-based Fast and Scalable k-Nearest Neighbour search technique (GPU-FS-kNN) provides a significant performance improvement for nearest neighbour computation in large-scale networks. Source code and the software tool is available under GNU Public License (GPL) at https://sourceforge.net/p/gpufsknn/.	[Arefin, Ahmed Shamsul; Riveros, Carlos; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Riveros, Carlos; Berretta, Regina; Moscato, Pablo] John Hunter Hosp, Informat Based Med Program, Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Moscato, Pablo] Australian Res Council, Ctr Excellence Bioinformat, Callaghan, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Arefin, AS (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013; Arefin, Ahmed Shamsul/G-8130-2013; Riveros, Carlos/A-6880-2013	Arefin, Ahmed Shamsul/0000-0002-9290-3551; Riveros, Carlos/0000-0002-2551-7618; Berretta, Regina/0000-0002-4420-3446; Moscato, Pablo/0000-0003-2570-5966	ARC Centre of Excellence in Bioinformatics; University of Newcastle	ARC Centre of Excellence in Bioinformatics(Australian Research Council); University of Newcastle	The project had partial support from the ARC Centre of Excellence in Bioinformatics and from The University of Newcastle, supporting ASA with a PhD scholarship. The other authors are employees of The University of Newcastle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefin AS, 2011, LECT NOTES COMPUT SC, V7017, P375, DOI 10.1007/978-3-642-24669-2_36; Arefin AS, 2012, LECT NOTES COMPUT SC, V7333, P71, DOI 10.1007/978-3-642-31125-3_6; Arya S, 1998, J ACM, V45, P891, DOI 10.1145/293347.293348; Baya AE, 2010, CORRABS10062734; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bell N, 2009, STUDENTS GUIDE TO THE MA TESOL, P1; BENTLEY JL, 1975, COMMUN ACM, V18, P509, DOI 10.1145/361002.361007; Berretta R, 2007, J RES PRACT INF TECH, V39, P4; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Boulay PL, 2011, ONCOGENE, V30, P3846, DOI 10.1038/onc.2011.100; Brito MR, 1997, STAT PROBABIL LETT, V35, P33, DOI 10.1016/S0167-7152(96)00213-1; Chandra R., 2001, PARALLEL PROGRAMMING; Chang D, 2008, P IASTED INT S COMP, P278; Chang DJ, 2009, SNPD 2009: 10TH ACIS INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, ARTIFICIAL INTELLIGENCES, NETWORKING AND PARALLEL DISTRIBUTED COMPUTING, PROCEEDINGS, P501, DOI 10.1109/SNPD.2009.34; Choset HM., 2005, PRINCIPLES ROBOT MOT; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Connor M, 2010, IEEE T VIS COMPUT GR, V16, P599, DOI 10.1109/TVCG.2010.9; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; COTTA C, 2007, HDB APPROXIMATION AL; Dasarathy B. V., 2002, HDB DATA MINING KNOW, P288; de Paula MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017481; Dementiev R, 2008, SOFTWARE PRACT EXPER, V38, P589, DOI 10.1002/spe.844; Fayyad UM, 1993, MACH LEARN, V2, P1022; Garcia Vincent, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563100; Graham N, 2009, D91 SECURESCM; Huttenhower C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-250; Inostroza-Ponta M, 2008, THESIS U NEWCASTLE A; Jung HY, 2002, BIOINFORMATICS, V18, pS141, DOI 10.1093/bioinformatics/18.suppl_2.S141; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Knuth D. E., 1973, ART COMPUTER PROGRAM, V3; Kuang QS, 2009, PROCEEDINGS OF INTERNATIONAL SYMPOSIUM ON COMPUTER SCIENCE AND COMPUTATIONAL TECHNOLOGY (ISCSCT 2009), P151; Liang SS, 2009, 2009 IEEE YOUTH CONFERENCE ON INFORMATION, COMPUTING AND TELECOMMUNICATION, PROCEEDINGS, P415, DOI 10.1109/YCICT.2009.5382329; Maier M, 2007, D91 SECURESCM; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; NVIDIA Corporation, 2007, NVIDIA CUDA COMP UN; Pavlopoulos GA, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-12; Pike R., 2005, SCI PROGRAMMING-NETH, V13, P277, DOI DOI 10.1145/1873951.1873987; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Plaku E, 2007, J PARALLEL DISTR COM, V67, P346, DOI 10.1016/j.jpdc.2006.10.004; Pogribny IP, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2641; Qi Li, 2010, 2010 Ninth International Conference on Machine Learning and Applications (ICMLA 2010), P208, DOI 10.1109/ICMLA.2010.38; Ravetti MG, 2009, STUD COMPUT INTELL, V205, P149; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Samet H., 2006, FDN MULTIDIMENSIONAL; Sankaranarayanan J, 2007, COMPUT GRAPH-UK, V31, P157, DOI 10.1016/j.cag.2006.11.011; Satish N, 2009, INT PARALL DISTRIB P, P257; Siek J, 2000, BOOST RANDOM NUMBER; Sun L, 2010, TERA GRID POSTER; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	50	38	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44000	10.1371/journal.pone.0044000	http://dx.doi.org/10.1371/journal.pone.0044000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937144	Green Submitted, gold, Green Published			2022-12-27	WOS:000308213600067
J	Raphel, L; Talasila, A; Cheung, C; Sinha, S				Raphel, Linda; Talasila, Amarnath; Cheung, Christine; Sinha, Sanjay			Myocardin Overexpression Is Sufficient for Promoting the Development of a Mature Smooth Muscle Cell-Like Phenotype from Human Embryonic Stem Cells	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; REGULATOR; COFACTOR; SWITCH	Background: Myocardin is thought to have a key role in smooth muscle cell (SMC) development by acting on CArG-dependent genes. However, it is unclear whether myocardin-induced SMC maturation and increases in agonist-induced calcium signalling are also associated with increases in the expression of non-CArG-dependent SMC-specific genes. Moreover, it is unknown whether myocardin promotes SMC development from human embryonic stem cells. Methodology/Principal: Findings The effects of adenoviral-mediated myocardin overexpression on SMC development in human ESC-derived embryoid bodies were investigated using immunofluorescence, flow cytometry and real time RT-PCR. Myocardin overexpression from day 10 to day 28 of embryoid body differentiation increased the number of smooth muscle alpha-actin(+) and smooth muscle myosin heavy chain(+) SMC-like cells and increased carbachol-induced contractile function. However, myocardin was found to selectively regulate only CArG-dependent SMC-specific genes. Nevertheless, myocardin expression appeared to be sufficient to specify the SMC lineage. Conclusions/Significance: Myocardin increases the development and maturation of SMC-like cells from human embryonic stem cells despite not activating the full repertoire of SMC genes. These findings have implications for vascular tissue engineering and other applications requiring large numbers of functional SMCs.	[Raphel, Linda; Talasila, Amarnath; Cheung, Christine; Sinha, Sanjay] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England	University of Cambridge	Raphel, L (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England.	ss661@cam.ac.uk	Cheung, Christine/J-9721-2017; Sinha, Sanjay/AAF-1692-2021	Cheung, Christine/0000-0001-7127-9107; Sinha, Sanjay/0000-0001-5900-1209	Wellcome Trust [GR078390MA]; British Heart Foundation [PG/10/007]; Cambridge Biomedical Research Centre; MRC [G0800784, G1000847] Funding Source: UKRI; British Heart Foundation [PG/10/007/28184] Funding Source: researchfish; Medical Research Council [G1000847, G0800784] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Cambridge Biomedical Research Centre(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust (Intermediate Fellowship GR078390MA) (http://www.wellcome.ac.uk/), British Heart Foundation (Project grant PG/10/007) (http://www.bhf.org.uk/), and Cambridge Biomedical Research Centre (http://cambridge-brc.org.uk/new/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Cheung C, 2011, J MOL CELL CARDIOL, V51, P651, DOI 10.1016/j.yjmcc.2011.07.014; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Hoofnagle MH, 2011, AM J PHYSIOL-HEART C, V300, pH1707, DOI 10.1152/ajpheart.01192.2010; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Ooboshi H, 1997, AM J PHYSIOL-HEART C, V273, pH265, DOI 10.1152/ajpheart.1997.273.1.H265; Pipes GCT, 2005, DEV BIOL, V288, P502, DOI 10.1016/j.ydbio.2005.10.014; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09	23	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44052	10.1371/journal.pone.0044052	http://dx.doi.org/10.1371/journal.pone.0044052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937150	Green Submitted, gold, Green Published			2022-12-27	WOS:000308213600072
J	Koga, T; Kai, Y; Fukuda, R; Morino-Koga, S; Suico, MA; Koyama, K; Sato, T; Shuto, T; Kai, H				Koga, Tomoaki; Kai, Yukari; Fukuda, Ryosuke; Morino-Koga, Saori; Suico, Mary Ann; Koyama, Kosuke; Sato, Takashi; Shuto, Tsuyoshi; Kai, Hirofumi			Mild Electrical Stimulation and Heat Shock Ameliorates Progressive Proteinuria and Renal Inflammation in Mouse Model of Alport Syndrome	PLOS ONE			English	Article							NF-KAPPA-B; GLOMERULAR PODOCYTE; EPITHELIAL-CELLS; HEME OXYGENASE-1; IV COLLAGEN; DISEASE; BLOCKADE; INJURY; HSP72; MICE	Alport syndrome is a hereditary glomerulopathy with proteinuria and nephritis caused by defects in genes encoding type IV collagen in the glomerular basement membrane. All male and most female patients develop end-stage renal disease. Effective treatment to stop or decelerate the progression of proteinuria and nephritis is still under investigation. Here we showed that combination treatment of mild electrical stress (MES) and heat stress (HS) ameliorated progressive proteinuria and renal injury in mouse model of Alport syndrome. The expressions of kidney injury marker neutrophil gelatinase-associated lipocalin and pro-inflammatory cytokines interleukin-6, tumor necrosis factor-a and interleukin-1 beta were suppressed by MES+HS treatment. The anti-proteinuric effect of MES+ HS treatment is mediated by podocytic activation of phosphatidylinositol 3-OH kinase (PI3K)-Akt and heat shock protein 72 (Hsp72)-dependent pathways in vitro and in vivo. The anti-inflammatory effect of MES+ HS was mediated by glomerular activation of c-jun NH2-terminal kinase 1/2 (JNK1/2) and p38-dependent pathways ex vivo. Collectively, our studies show that combination treatment of MES and HS confers anti-proteinuric and anti-inflammatory effects on Alport mice likely through the activation of multiple signaling pathways including PI3K-Akt, Hsp72, JNK1/2, and p38 pathways, providing a novel candidate therapeutic strategy to decelerate the progression of patho-phenotypes in Alport syndrome.	[Koga, Tomoaki; Kai, Yukari; Fukuda, Ryosuke; Morino-Koga, Saori; Suico, Mary Ann; Koyama, Kosuke; Sato, Takashi; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Dept Mol Med, Grad Sch Pharmaceut Sci, Kumamoto, Japan; [Koga, Tomoaki; Kai, Yukari; Fukuda, Ryosuke; Morino-Koga, Saori; Suico, Mary Ann; Koyama, Kosuke; Sato, Takashi; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan; [Koga, Tomoaki] Japan Soc Promot Sci, Tokyo, Japan; [Koga, Tomoaki] Kyushu Univ, Dept Med Biochem, Grad Sch Med Sci, Fukuoka 812, Japan	Kumamoto University; Kumamoto University; Japan Society for the Promotion of Science; Kyushu University	Koga, T (corresponding author), Kumamoto Univ, Dept Mol Med, Grad Sch Pharmaceut Sci, Kumamoto, Japan.	hirokai@gpo.kumamoto-u.ac.jp	Sato, Takashi/AHB-5258-2022	Sato, Takashi/0000-0003-4203-0999; Suico, Mary Ann/0000-0002-6751-8352; Shuto, Tsuyoshi/0000-0003-1275-4988	Ministry of Education, Science, Sports and Culture (MEXT) of Japan [19390045]; Global COE Program (Cell Fate Regulation Research and Education Unit); JSPS [20-8140]	Ministry of Education, Science, Sports and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Cell Fate Regulation Research and Education Unit)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Science, Sports and Culture (MEXT) of Japan (#19390045), from the Global COE Program (Cell Fate Regulation Research and Education Unit) to H.K., and grant-in-aid from JSPS Research fellow (20-8140) to T.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Chuang PY, 2009, NEPHRON PHYSIOL, V111, P9, DOI 10.1159/000191075; Clauss S, 2009, J PATHOL, V218, P40, DOI 10.1002/path.2505; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Endemann M, 2007, AM J PHYSIOL-RENAL, V292, pF47, DOI 10.1152/ajprenal.00503.2005; Furst R, 2006, J PHARMACOL EXP THER, V318, P389, DOI 10.1124/jpet.106.102251; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gross O, 2003, KIDNEY INT, V63, P438, DOI 10.1046/j.1523-1755.2003.00779.x; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Jedlicka J, 2010, HUM PATHOL, V41, P582, DOI 10.1016/j.humpath.2009.08.024; Jo SK, 2006, J AM SOC NEPHROL, V17, P3082, DOI 10.1681/ASN.2005101077; Kai H, 2009, INT J HYPERTHER, V25, P655, DOI 10.3109/02656730903039605; Kaito H, 2006, PEDIATR NEPHROL, V21, P1824, DOI 10.1007/s00467-006-0270-8; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kietzmann T, 2003, J BIOL CHEM, V278, P17927, DOI 10.1074/jbc.M203929200; Kondo T, 2010, OBES RES CLIN PRACT, V4, pE101, DOI 10.1016/j.orcp.2009.09.007; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Meehan DT, 2009, KIDNEY INT, V76, P968, DOI 10.1038/ki.2009.324; Morino S, 2008, J PHARMACOL SCI, V108, P222, DOI 10.1254/jphs.08180SC; Morino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004068; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Ninichuk V, 2005, J AM SOC NEPHROL, V16, P977, DOI 10.1681/ASN.2004100871; Oba M, 2010, J SURG RES, V162, P213, DOI 10.1016/j.jss.2009.03.093; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Proesmans W, 2004, PEDIATR NEPHROL, V19, P271, DOI 10.1007/s00467-003-1366-z; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Ruchalski K, 2003, AM J PHYSIOL-CELL PH, V285, pC1483, DOI 10.1152/ajpcell.00049.2003; Sanchez-Wandelmer J, 2009, BBA-BIOMEMBRANES, V1788, P1731, DOI 10.1016/j.bbamem.2009.05.002; Sayers R, 1999, KIDNEY INT, V56, P1662, DOI 10.1046/j.1523-1755.1999.00744.x; Seegers JC, 2001, MED HYPOTHESES, V57, P224, DOI 10.1054/mehy.2001.1292; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Wang YH, 2001, AM J PHYSIOL-CELL PH, V281, pC1667, DOI 10.1152/ajpcell.2001.281.5.C1667; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	42	19	20	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43852	10.1371/journal.pone.0043852	http://dx.doi.org/10.1371/journal.pone.0043852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937108	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500110
J	Patel, A; Dong, JC; Trost, B; Richardson, JS; Tohme, S; Babiuk, S; Kusalik, A; Kung, SKP; Kobinger, GP				Patel, Ami; Dong, Jessica C.; Trost, Brett; Richardson, Jason S.; Tohme, Sarah; Babiuk, Shawn; Kusalik, Anthony; Kung, Sam K. P.; Kobinger, Gary P.			Pentamers Not Found in the Universal Proteome Can Enhance Antigen Specific Immune Responses and Adjuvant Vaccines	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; NK CELLS; T-CELLS; PEPTIDE; SEQUENCES; VIRUS; CPG; EPITOPES; MOTIFS; AGE	Certain short peptides do not occur in humans and are rare or non-existent in the universal proteome. Antigens that contain rare amino acid sequences are in general highly immunogenic and may activate different arms of the immune system. We first generated a list of rare, semi-common, and common 5-mer peptides using bioinformatics tools to analyze the UniProtKB database. Experimental observations indicated that rare and semi-common 5-mers generated stronger cellular responses in comparison with common-occurring sequences. We hypothesized that the biological process responsible for this enhanced immunogenicity could be used to positively modulate immune responses with potential application for vaccine development. Initially, twelve rare 5-mers, 9-mers, and 13-mers were incorporated in frame at the end of an H5N1 hemagglutinin (HA) antigen and expressed from a DNA vaccine. The presence of some 5-mer peptides induced improved immune responses. Adding one 5-mer peptide exogenously also offered improved clinical outcome and/or survival against a lethal H5N1 or H1N1 influenza virus challenge in BALB/c mice and ferrets, respectively. Interestingly, enhanced anti-HBsAg antibody production by up to 25-fold in combination with a commercial Hepatitis B vaccine (Engerix-B, GSK) was also observed in BALB/c mice. Mechanistically, NK cell activation and dependency was observed with enhancing peptides ex vivo and in NK-depleted mice. Overall, the data suggest that rare or non-existent oligopeptides can be developed as immunomodulators and supports the further evaluation of some 5-mer peptides as potential vaccine adjuvants.	[Patel, Ami; Dong, Jessica C.; Richardson, Jason S.; Tohme, Sarah; Kobinger, Gary P.] Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB, Canada; [Patel, Ami; Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Dong, Jessica C.; Babiuk, Shawn; Kung, Sam K. P.; Kobinger, Gary P.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Trost, Brett; Kusalik, Anthony] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK S7N 0W0, Canada; [Babiuk, Shawn] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Saskatchewan; Canadian Food Inspection Agency	Patel, A (corresponding author), San Raffaele Telethon Inst Gene Therapy, Milan, Italy.	gary_kobinger@phac-aspc.gc.ca	Trost, Brett/K-4127-2016	Trost, Brett/0000-0003-4863-7273	Public Health Agency of Canada grant [531252]; Canadian Institutes of Health Research	Public Health Agency of Canada grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The research in this manuscript was supported by the Public Health Agency of Canada grant #531252 and a grant from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackman MA, 2011, CURR OPIN IMMUNOL, V23, P537, DOI 10.1016/j.coi.2011.05.005; Blondelle SE, 2008, BIOPOLYMERS, V90, P683, DOI 10.1002/bip.21020; Bresell A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-346; Capone G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-383; CHALUFOUR A, 1987, ANN INST PASTEUR IMM, V138, P671, DOI 10.1016/S0769-2625(87)80023-5; CLAVERIE JM, 1988, EUR J IMMUNOL, V18, P1547, DOI 10.1002/eji.1830181012; Coban C, 2005, J LEUKOCYTE BIOL, V78, P647, DOI 10.1189/jlb.1104627; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Frasca D, 2009, CURR OPIN IMMUNOL, V21, P425, DOI 10.1016/j.coi.2009.06.001; Fu XP, 2010, HUM GENE THER, V21, P1687, DOI 10.1089/hum.2010.080; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Jennings P, 2009, J IMMUNOL, V182, P2879, DOI 10.4049/jimmunol.0803220; Kanduc D, 2008, CURR PHARM DESIGN, V14, P289, DOI 10.2174/138161208783413257; Kanduc D, 2008, ADV EXP MED BIOL, V640, P198, DOI 10.1007/978-0-387-09789-3_15; Kanduc D, 2008, CANCER IMMUNOL IMMUN, V57, P1215, DOI 10.1007/s00262-008-0456-y; Kanduc D, 2010, PEPTIDES, V31, P983, DOI 10.1016/j.peptides.2010.02.003; Kobinger GP, 2010, J INFECT DIS, V201, P1000, DOI 10.1086/651171; Kusalik A, 2009, PEPTIDES, V30, P1940, DOI 10.1016/j.peptides.2009.06.035; Landrigan A, 2011, J IMMUNOL, V187, P3033, DOI 10.4049/jimmunol.1003414; Lucchese G, 2007, AMINO ACIDS, V33, P703, DOI 10.1007/s00726-006-0458-z; Mahnke YD, 2011, VACCINE, V29, P8606, DOI 10.1016/j.vaccine.2011.09.019; Mariani E, 1998, INT IMMUNOL, V10, P981, DOI 10.1093/intimm/10.7.981; Narni-Mancinelli E, 2011, INT IMMUNOL, V23, P427, DOI 10.1093/intimm/dxr035; Nicholls EF, 2010, ANN NY ACAD SCI, V1213, P46, DOI 10.1111/j.1749-6632.2010.05787.x; Ogata K, 1997, CLIN IMMUNOL IMMUNOP, V84, P269, DOI 10.1006/clin.1997.4401; Otaki JM, 2005, PROTEIN SCI, V14, P617, DOI 10.1110/ps.041092605; Otaki JM, 2008, BIOTECHNOL ANN REV, V14, P109, DOI 10.1016/S1387-2656(08)00004-5; Patel A, 2009, VACCINE, V27, P3083, DOI 10.1016/j.vaccine.2009.03.023; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Pillet S, 2011, VACCINE, V29, P6793, DOI 10.1016/j.vaccine.2010.12.059; Saenz R, 2010, VACCINE, V28, P7556, DOI 10.1016/j.vaccine.2010.08.054; SANSONI P, 1993, BLOOD, V82, P2767; Sivori S, 2006, EUR J IMMUNOL, V36, P961, DOI 10.1002/eji.200535781; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Sweet C, 1999, FERRET ANIMAL MODEL; Tuller T, 2007, PROTEIN SCI, V16, P2251, DOI 10.1110/ps.073067607; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Weeratna R, 2003, IMMUNOL CELL BIOL, V81, P59, DOI 10.1046/j.1440-1711.2003.01135.x	43	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43802	10.1371/journal.pone.0043802	http://dx.doi.org/10.1371/journal.pone.0043802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937099	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500101
J	Rathcke, CN; Thomsen, SB; Linneberg, A; Vestergaard, H				Rathcke, Camilla Noelle; Thomsen, Stine Brinkloev; Linneberg, Allan; Vestergaard, Henrik			Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and Prediction of Fatal and Non-fatal Ischemic Stroke	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; HELICOBACTER-PYLORI INFECTION; ALL-CAUSE MORTALITY; PLASMA YKL-40; GENERAL-POPULATION; DANISH ADULTS; SERUM-LEVELS; ASSOCIATION; BIOMARKER	Background: Polymorphisms of CHI3L1 are associated with inter-individual YKL-40 levels and YKL-40 is associated with an increased mortality and is elevated in patients with cardiovascular disease. We investigated the association between single nucleotide polymorphisms (SNPs) of CHI3L1, serum YKL-40 levels and all-cause and cardiovascular mortality and first-time incidence of myocardial infarction, ischemic heart disease (IHD) and stroke. Methodology/Principal Findings: 12 SNPs of CHI3L1 were genotyped and serum YKL-40 was measured in 2656 Danes representative of the general population. Median follow-up period was 15 (0-16) years. Admission data and deaths were ascertained from registers from the Danish National Board of Health. Fourth quartile YKL-40 levels were associated with an increased mortality risk of ischemic stroke (HR 2.44 (1.01-5.88), p = 0.041) and so were homozygotes of the minor allele of rs872129 (HR 9.35 (1.25-69.87, p = 0.022)). Both continuous YKL-40 levels and 4th quartile YKL-40 values (>85 ng/ml) were associated with all-cause mortality (HRs 1.22 (95% CI, 1.10-1.35), p<0.0001, and 1.40 (1.15-1.71), p<0.0001), an increased risk of first-time stroke (HR 1.16 (1.01-1.33), p = 0.04, and 1.63 (1.23-2.16), p = 0.001) and a decreased risk of incidence of IHD (HR 0.77 (0.65-0.91), p = 0.002, and 0.61 (0.44-0.85), p = 0.003). Conclusions/Signficance: High YKL-40 levels (. 85 ng/ml) and rs872129 were associated with an increased mortality risk of ischemic stroke, but high YKL-40 levels were also inverse related with the risk of incidence of IHD. This could be a chance finding but could also elucidate that YKL-40 plays different roles in development of thromboembolisms versus the formation of local thrombosis.	[Rathcke, Camilla Noelle; Thomsen, Stine Brinkloev; Vestergaard, Henrik] Copenhagen Univ Hosp Herlev, Ctr Endocrinol & Metab, Copenhagen, Denmark; [Rathcke, Camilla Noelle] Copenhagen Univ Hosp Hilleroed, Dept Cardiol & Endocrinol, Copenhagen, Denmark; [Linneberg, Allan] Copenhagen Univ Hosp Glostrup, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Vestergaard, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Rathcke, CN (corresponding author), Copenhagen Univ Hosp Herlev, Ctr Endocrinol & Metab, Copenhagen, Denmark.	cnr@dadlnet.dk		Vestergaard, Henrik/0000-0003-3090-269X; Linneberg, Allan/0000-0002-0994-0184	Danish Council for Independent Research, Medical Sciences, of the Danish Agency for Science, Technology and Innovation, Ministry of Science, Technology and Innovation	Danish Council for Independent Research, Medical Sciences, of the Danish Agency for Science, Technology and Innovation, Ministry of Science, Technology and Innovation	The study was supported by a grant from The Danish Council for Independent Research, Medical Sciences, of the Danish Agency for Science, Technology and Innovation, Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bojesen SE, 2011, CLIN CHIM ACTA, V412, P709, DOI 10.1016/j.cca.2011.01.022; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Hedegaard A, 2010, SCAND J CLIN LAB INV, V70, P80, DOI 10.3109/00365510903518191; Henningsen KM, 2010, INFLAMM RES, V59, P463, DOI 10.1007/s00011-009-0146-z; Henningsen KM, 2009, EUROPACE, V11, P1032, DOI 10.1093/europace/eup103; Hu FB, 2007, ARCH INTERN MED, V167, P875, DOI 10.1001/archinte.167.9.875; Johansen JS, 2008, CLIN EXP IMMUNOL, V151, P260, DOI 10.1111/j.1365-2249.2007.03561.x; Johansen JS, 2006, DAN MED BULL, V53, P172; Johansen JS, 2010, CLIN CHEM, V56, P1580, DOI 10.1373/clinchem.2010.146530; JORGENSEN T, 1987, AM J EPIDEMIOL, V126, P912, DOI 10.1093/oxfordjournals.aje.a114728; Kastrup J, 2009, EUR HEART J, V30, P1066, DOI 10.1093/eurheartj/ehp049; Kjaergaard AD, 2010, ANN NEUROL, V68, P672, DOI 10.1002/ana.22220; Kruit A, 2007, RESP MED, V101, P1563, DOI 10.1016/j.rmed.2006.12.006; Kucur M, 2007, CORONARY ARTERY DIS, V18, P391, DOI 10.1097/MCA.0b013e328241d991; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Michelsen AE, 2010, ATHEROSCLEROSIS, V211, P589, DOI 10.1016/j.atherosclerosis.2010.02.035; Nojgaard C, 2008, CORONARY ARTERY DIS, V19, P257, DOI 10.1097/MCA.0b013e3282f40dd5; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Rathcke CN, 2010, INT J CARDIOL, V143, P35, DOI 10.1016/j.ijcard.2009.01.043; Rathcke CN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006106; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; Rosenstock S, 1997, GUT, V41, P169, DOI 10.1136/gut.41.2.169; ROSENSTOCK SJ, 1995, GUT, V36, P819, DOI 10.1136/gut.36.6.819; Rosenstock SJ, 2000, SCAND J PUBLIC HEALT, V28, P32, DOI 10.1080/713797374; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; ROWE DJF, 1990, ANN CLIN BIOCHEM, V27, P297, DOI 10.1177/000456329002700404; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; Wang YZ, 2008, SCAND CARDIOVASC J, V42, P295, DOI 10.1080/14017430802220567; Zheng JL, 2011, CYTOKINE, V54, P51, DOI 10.1016/j.cyto.2010.12.018; Zheng JL, 2010, ATHEROSCLEROSIS, V210, P590, DOI 10.1016/j.atherosclerosis.2009.12.016	36	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43498	10.1371/journal.pone.0043498	http://dx.doi.org/10.1371/journal.pone.0043498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937056	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500057
J	Wen, LB; He, KW; Xiao, Q; Yu, ZY; Mao, AH; Ni, YX; Zhang, XH; Li, B; Wang, XM; Guo, RL; Zhou, JM; Lv, LX; Jiang, JY				Wen, Libin; He, Kongwang; Xiao, Qi; Yu, Zhengyu; Mao, Aihua; Ni, Yanxiu; Zhang, Xuehan; Li, Bin; Wang, Xiaomin; Guo, Rongli; Zhou, Junming; Lv, Lixin; Jiang, Jieyuan			A Novel Porcine Circovirus-Like Agent P1 Is Associated with Wasting Syndromes in Pigs	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TYPE-2 PCV2; SYNDROME PMWS; EXPERIMENTAL INFECTIONS; NEPHROPATHY SYNDROME; WEANED PIGS; DISEASE; LESIONS; DNA; IDENTIFICATION	A novel porcine pathogen tentatively named P1, which was obtained from the sera of the pigs exhibiting clinical signs of postweaning multisystemic wasting syndrome (PMWS) experimentally caused the classical clinic signs and pathologic lesions of the disease in pigs by direct in vivo injection with P1 DNA plasmids. Twenty colostrum-fed (CF) pigs that were free of PCV2 and P1 at 1 month of age were randomly designated equally to two groups. Group 1 pigs were each injected with 400 mu g of the cloned P1 plasmid DNA into the superficial inguinal lymph nodes and Group 2 were injected with same amount of the empty pSK vector DNA and served as controls. Viremias were positively detected in 8 of 10 P1 infected pigs from 14-21 days post-inoculation (dpi). The 8 infected animals showed pallor of skin and diarrhea. Gross lesions in the pigs euthanized on 35 dpi were similarly characterized by encephalemia, haemorrhage of the bladder mucosa, haemorrhage of the superficial inguinal lymph nodes, lung atrophy and haemorrhage. Histopathological lesions were arteriectasis and telangiectasia of the cavitas subarachnoidealis, interstitial pneumonia, mild atrophy of the cardiac muscle cells, histiocytic hyperplasia of the follicles in the tonsils, and haemorrhage of the inguinal lymph nodes. P1 DNA and antigens were confirmed by PCR and immunohistochemistry in the tissues and organs of the infected pigs, including the pancreas, bladders, testicles/ovaries, brains, lungs and liver. There were no obvious clinical signs and pathological lesions in the control pigs. This study demonstrated that P1 infection is one of the important pathologic agents on pig farms.	[Wen, Libin; He, Kongwang; Xiao, Qi; Yu, Zhengyu; Mao, Aihua; Ni, Yanxiu; Zhang, Xuehan; Li, Bin; Wang, Xiaomin; Guo, Rongli; Zhou, Junming; Lv, Lixin; Jiang, Jieyuan] Jiangsu Acad Agr Sci, Natl Ctr Engn Res Vet Bioprod, Inst Vet Med, Key Lab Vet Biol Engn & Technol,Minist Agr, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Wen, LB (corresponding author), Jiangsu Acad Agr Sci, Natl Ctr Engn Res Vet Bioprod, Inst Vet Med, Key Lab Vet Biol Engn & Technol,Minist Agr, Nanjing, Jiangsu, Peoples R China.	kwh2003@yeah.net			National Natural Science Foundation of China [30972184]; Fund for Independent Innovation of Agricultural Sciences in Jiangsu province [CX(11)2060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Independent Innovation of Agricultural Sciences in Jiangsu province	This work was supported by a grant from the National Natural Science Foundation of China (30972184) and Fund for Independent Innovation of Agricultural Sciences in Jiangsu province (CX(11)2060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan G, 1998, VET REC, V142, P467; Allan GM, 2004, VET MICROBIOL, V98, P165, DOI 10.1016/j.vetmic.2003.10.009; Allan GM, 1999, J COMP PATHOL, V121, P1, DOI 10.1053/jcpa.1998.0295; Allan GM, 1998, J VET DIAGN INVEST, V10, P3, DOI 10.1177/104063879801000102; ALLAN GM, 1995, VET MICROBIOL, V44, P49, DOI 10.1016/0378-1135(94)00136-K; Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Balasch M, 1999, J COMP PATHOL, V121, P139, DOI 10.1053/jcpa.1999.0310; Borel N, 2001, SCHWEIZ ARCH TIERH, V143, P249; Celer V, 2002, J VET MED B, V49, P155, DOI 10.1046/j.1439-0450.2002.00547.x; Choi C, 2000, J VET DIAGN INVEST, V12, P151, DOI 10.1177/104063870001200209; DULAC GC, 1989, CAN J VET RES, V53, P431; EDWARDS S, 1994, VET REC, V134, P680, DOI 10.1136/vr.134.26.680; Ellis J, 1998, CAN VET J, V39, P44; Fenaux M, 2002, J VIROL, V76, P541, DOI 10.1128/JVI.76.2.541-551.2002; Hamel AL, 1998, J VIROL, V72, P5262, DOI 10.1128/JVI.72.6.5262-5267.1998; Harding JCS, 1997, SWINE HEALTH PROD, V5, P201; Harding JCS, 1998, SWINE HEALTH PROD, V6, P249; Harms PA, 1999, P 7 ANN IOW SWIN DIS, P43; Hines R. K., 1995, Swine Health and Production, V3, P71; Jemersic L, 2004, RES VET SCI, V77, P171, DOI 10.1016/j.rvsc.2004.04.003; Kennedy S, 1998, VET REC, V142, P495; Kiupel M, 1998, VET PATHOL, V35, P303, DOI 10.1177/030098589803500411; Larochelle R, 1999, VET REC, V145, P140, DOI 10.1136/vr.145.5.140; Lukert P, 1995, VIRUS TAXONOMY, P166; Magar R, 2000, J COMP PATHOL, V123, P258, DOI 10.1053/jcpa.2000.0413; Maldonado J, 2004, J VET MED SCI, V66, P533, DOI 10.1292/jvms.66.533; Mankertz A, 2000, VIRUS RES, V66, P65, DOI 10.1016/S0168-1702(99)00122-7; Mankertz A, 1998, J GEN VIROL, V79, P381, DOI 10.1099/0022-1317-79-2-381; Mankertz A, 1997, J VIROL, V71, P2562, DOI 10.1128/JVI.71.3.2562-2566.1997; Meehan BM, 1998, J GEN VIROL, V79, P2171, DOI 10.1099/0022-1317-79-9-2171; Morozov I, 1998, J CLIN MICROBIOL, V36, P2535, DOI 10.1128/JCM.36.9.2535-2541.1998; Nayar GPS, 1999, CAN VET J, V40, P277; Onuki A, 1999, J VET MED SCI, V61, P1119, DOI 10.1292/jvms.61.1119; Opriessnig T, 2006, VET PATHOL, V43, P281, DOI 10.1354/vp.43-3-281; Pesch S, 2000, P INT PIG VET SOC C, V16, P581; Pogranichnyy RM, 2000, VIRAL IMMUNOL, V13, P143, DOI 10.1089/vim.2000.13.143; Roca M, 2004, J GEN VIROL, V85, P1259, DOI 10.1099/vir.0.79836-0; Rosell C, 2000, VET REC, V146, P40, DOI 10.1136/vr.146.2.40; Saoulidis K, 2002, J VET MED B, V49, P202, DOI 10.1046/j.1439-0450.2002.00480.x; Sarradell J., 2004, Rev. argent. microbiol., V36, P118; Segales J, 2004, VET MICROBIOL, V98, P137, DOI 10.1016/j.vetmic.2003.10.006; Spillane P, 1998, VET REC, V143, P511; Terregino C, 2001, VET REC, V149, P340; THACKER B, 2000, PIG PROG, P16; TISCHER I, 1995, ARCH VIROL, V140, P1427, DOI 10.1007/BF01322669; TISCHER I, 1986, ARCH VIROL, V91, P271, DOI 10.1007/BF01314286; TISCHER I, 1974, ZBL BAKT-INT J MED M, V226, P153; TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0; Tomas A, 2008, VET MICROBIOL, V132, P260, DOI 10.1016/j.vetmic.2008.05.023; Toplak I, 2004, VET REC, V155, P178, DOI 10.1136/vr.155.6.178; Wallgren P, 2004, VET QUART, V26, P170, DOI 10.1080/01652176.2004.9695179; Wellenberg GJ, 2000, VET QUART, V22, P167, DOI 10.1080/01652176.2000.9695049; Wen L, 2012, ACTA AGR BOREALI SIN, V27, P42; Wen LB, 2012, J VIROL, V86, P5963, DOI 10.1128/JVI.00494-12; Wen LB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-543; Wen LB, 2012, J VIROL, V86, P639, DOI 10.1128/JVI.06469-11; West KH, 1999, J VET DIAGN INVEST, V11, P530, DOI 10.1177/104063879901100608; Yang Zong-Zhao, 2007, Journal of Zhejiang University-Science B, V8, P162, DOI 10.1631/jzus.2007.B0162	58	26	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e41565	10.1371/journal.pone.0041565	http://dx.doi.org/10.1371/journal.pone.0041565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936978	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500007
J	Huang, HL; Lee, HY; Tsai, AC; Peng, CY; Lai, MJ; Wang, JC; Pan, SL; Teng, CM; Liou, JP				Huang, Han-Lin; Lee, Hsueh-Yun; Tsai, An-Chi; Peng, Chieh-Yu; Lai, Mei-Jung; Wang, Jing-Chi; Pan, Shiow-Lin; Teng, Che-Ming; Liou, Jing-Ping			Anticancer Activity of MPT0E028, a Novel Potent Histone Deacetylase Inhibitor, in Human Colorectal Cancer HCT116 Cells In Vitro and In Vivo	PLOS ONE			English	Article							MEDIATED APOPTOSIS; HDAC INHIBITORS; LEUKEMIA-CELLS; COLON-CANCER; EXPRESSION; AGENTS; ANGIOGENESIS; THERAPY; ARREST; GROWTH	Recently, histone deacetylase (HDAC) inhibitors have emerged as a promising class of drugs for treatment of cancers, especially subcutaneous T-cell lymphoma. In this study, we demonstrated that MPT0E028, a novel N-hydroxyacrylamide-derived HDAC inhibitor, inhibited human colorectal cancer HCT116 cell growth in vitro and in vivo. The results of NCI-60 screening showed that MPT0E028 inhibited proliferation in both solid and hematological tumor cell lines at micromolar concentrations, and was especially potent in HCT116 cells. MPT0E028 had a stronger apoptotic activity and inhibited HDACs activity more potently than SAHA, the first therapeutic HDAC inhibitor proved by FDA. In vivo murine model, the growth of HCT116 tumor xenograft was delayed and inhibited after treatment with MPT0E028 in a dose-dependent manner. Based on in vivo study, MPT0E028 showed stronger anti-cancer efficacy than SAHA. No significant body weight difference or other adverse effects were observed in both MPT0E028-and SAHA-treated groups. Taken together, our results demonstrate that MPT0E028 has several properties and is potential as a promising anti-cancer therapeutic drug.	[Huang, Han-Lin; Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Lee, Hsueh-Yun; Lai, Mei-Jung; Liou, Jing-Ping] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Tsai, An-Chi; Wang, Jing-Chi; Pan, Shiow-Lin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Town, Miaoli County, Taiwan; [Pan, Shiow-Lin] Taipei Med Univ, Dept Pharmacol, Taipei, Taiwan; [Peng, Chieh-Yu] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan	National Taiwan University; Taipei Medical University; National Health Research Institutes - Taiwan; Taipei Medical University; China Medical University Taiwan	Huang, HL (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	apan0826@nhri.org.tw; cmteng@ntu.edu.tw; jpl@tmu.edu.tw	Pan, Shiow-Lin/C-1372-2010	TENG, CHE-MING/0000-0002-9719-7334	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by a grant from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beumer JH, 2010, CURR CLIN PHARMACOL, V5, P196, DOI 10.2174/157488410791498770; Chang JY, 2006, J MED CHEM, V49, P6656, DOI 10.1021/jm061076u; Chang JY, 2010, MEDCHEMCOMM, V1, P152, DOI 10.1039/c0md00052c; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Darvas K, 2010, INT J CANCER, V127, P1384, DOI 10.1002/ijc.25170; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Hassig CA, 2008, MOL CANCER THER, V7, P1054, DOI 10.1158/1535-7163.MCT-07-2347; Jazirehi AR, 2010, ANTI-CANCER DRUG, V21, P805, DOI 10.1097/CAD.0b013e32833dad91; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Khosravi-Far R, 2007, HISTONE DEACETYLASE, P261; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Martinez-Iglesias O, 2008, CLIN TRANSL ONCOL, V10, P395, DOI 10.1007/s12094-008-0221-x; Nakagawa M, 2007, ONCOL REP, V18, P769; Nishioka C, 2008, LEUKEMIA, V22, P2159, DOI 10.1038/leu.2008.243; Paris M, 2008, J MED CHEM, V51, P1505, DOI 10.1021/jm7011408; Paull K, 1995, CANC CHEMOTHERAPEUTI; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Srivastava RK, 2010, MOL CANCER THER, V9, P3254, DOI 10.1158/1535-7163.MCT-10-0582; Takai N, 2007, CURR MED CHEM, V14, P2548, DOI 10.2174/092986707782023299; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tsapis M, 2007, INT J BIOCHEM CELL B, V39, P1500, DOI 10.1016/j.biocel.2007.03.009; Venugopal B, 2011, CURR MED CHEM, V18, P1658, DOI 10.2174/092986711795471284; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; Zopf S, 2007, INT J ONCOL, V31, P1391	25	25	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43645	10.1371/journal.pone.0043645	http://dx.doi.org/10.1371/journal.pone.0043645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928010	gold, Green Submitted, Green Published			2022-12-27	WOS:000308286300078
J	Li, SK; Lu, XF; Xue, YP; Lei, JY; Zheng, T; Wang, C				Li, Shangkun; Lu, Xiaofeng; Xue, Yanpeng; Lei, Junyu; Zheng, Tian; Wang, Ce			Fabrication of Polypyrrole/Graphene Oxide Composite Nanosheets and Their Applications for Cr(VI) Removal in Aqueous Solution	PLOS ONE			English	Article							HEXAVALENT CHROMIUM; GRAPHENE; POLYANILINE; REDUCTION; ION; ADSORPTION; SULFATE; GROWTH	In this paper, we report on the simple, reliable synthesis of polypyrrole (PPy)/graphene oxide (GO) composite nanosheets by using sacrificial-template polymerization method. Herein, MnO2 nanoslices were chosen as a sacrificial-template to deposit PPy, which served as the oxidant as well. During the polymerization of pyrrole on surface of GO nanosheets, MnO2 component was consumed incessantly. As a result, the PPy growing on the surface of GO nanosheets has the morphology just like the MnO2 nanoslices. This method can provide the fabrication of PPy nanostructures more easily than conventional route due to its independence of removing template, which usually is a complex and tedious experimental process. The as-prepared PPy/GO composite nanosheets exhibited an enhanced properties for Cr(VI) ions removal in aqueous solution based on the synergy effect. The adsorption capacity of the PPy/GO composite nanosheets is about two times as large as that of conventional PPy nanoparticles. We believe that our findings can open a new and effective avenue to improve the adsorption performance in removing heavy metal ions from waste water.	[Li, Shangkun; Lu, Xiaofeng; Xue, Yanpeng; Lei, Junyu; Zheng, Tian; Wang, Ce] Jilin Univ, Coll Chem, Alan G MacDiarmid Inst, Changchun 130023, Peoples R China	Jilin University	Li, SK (corresponding author), Jilin Univ, Coll Chem, Alan G MacDiarmid Inst, Changchun 130023, Peoples R China.	xflu@jlu.edu.cn		Zheng, Tian/0000-0002-3019-9618; Li, Shangkun/0000-0002-0247-2883	National 973 Project [S2009061009]; National Natural Science Foundation of China [20904015, 50973038]; Jilin Science and Technology Department project [20100101, 201115014]; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Dong Hua University	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Science and Technology Department project; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Dong Hua University	This work was supported by the research grants from the National 973 Project (S2009061009), the National Natural Science Foundation of China (20904015,50973038), Jilin Science and Technology Department project (20100101, 201115014) and State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Dong Hua University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandkumar J, 2009, J HAZARD MATER, V168, P633, DOI 10.1016/j.jhazmat.2009.02.136; Ansari R, 2007, REACT FUNCT POLYM, V67, P367, DOI 10.1016/j.reactfunctpolym.2007.02.001; Bhaumik M, 2012, CHEM ENG J, V181, P323, DOI 10.1016/j.cej.2011.11.088; Bhaumik M, 2011, J HAZARD MATER, V190, P381, DOI 10.1016/j.jhazmat.2011.03.062; Bora C, 2012, POLYMER, V53, P923, DOI 10.1016/j.polymer.2011.12.054; Chen Y, 2007, MATER RES BULL, V42, P1935, DOI 10.1016/j.materresbull.2006.12.005; Cote LJ, 2009, J AM CHEM SOC, V131, P1043, DOI 10.1021/ja806262m; Dai TY, 2006, NANOTECHNOLOGY, V17, P3028, DOI 10.1088/0957-4484/17/12/036; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Golder AK, 2007, SEP SCI TECHNOL, V42, P2177, DOI 10.1080/01496390701446464; Gupta S, 2006, P INT S 59 ANN SESS, P27; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043; Huang LM, 2006, ELECTROCHIM ACTA, V52, P1058, DOI 10.1016/j.electacta.2006.06.040; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Kampalanonwat P, 2010, ACS APPL MATER INTER, V2, P3619, DOI 10.1021/am1008024; Khalil LB, 1998, APPL CATAL B-ENVIRON, V17, P267, DOI 10.1016/S0926-3373(98)00020-4; Konwer S, 2011, J ELECTRON MATER, V40, P2248, DOI 10.1007/s11664-011-1749-z; Kovtyukhova NI, 1992, RUSS J INORG CHEM, V37, P566; Lalvani SB, 1998, CARBON, V36, P1219, DOI 10.1016/S0008-6223(98)00102-X; Lee HT, 2006, J POLYM SCI POL CHEM, V44, P2724, DOI 10.1002/pola.21385; Leonavicius K, 2011, LANGMUIR, V27, P10970, DOI 10.1021/la201962a; Liu AR, 2010, J PHYS CHEM C, V114, P22783, DOI 10.1021/jp108826e; Liu SY, 2012, APPL SURF SCI, V258, P5299, DOI 10.1016/j.apsusc.2012.02.023; Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060; Pugazhenthi G, 2005, J MEMBRANE SCI, V254, P229, DOI 10.1016/j.memsci.2005.01.011; Qin G, 2005, ENVIRON SCI TECHNOL, V39, P6321, DOI 10.1021/es050486p; Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678; Schmuhl R, 2001, WATER SA, V27, P1; Shchukin DG, 2006, J AM CHEM SOC, V128, P4560, DOI 10.1021/ja061028z; Shevchenko N, 2008, ENVIRON SCI TECHNOL, V42, P6922, DOI 10.1021/es800677b; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Tan CK, 2000, SENSOR ACTUAT B-CHEM, V71, P184, DOI 10.1016/S0925-4005(00)00615-8; TRIVEDI DC, 1993, SYNTHETIC MET, V59, P267, DOI 10.1016/0379-6779(93)91036-2; Wang YQ, 2012, J MATER CHEM, V22, P9034, DOI 10.1039/c2jm30440f; Wang YY, 2005, POLYM ADVAN TECHNOL, V16, P344, DOI 10.1002/pat.589; WEI C, 1993, J ELECTROCHEM SOC, V140, pL60, DOI 10.1149/1.2056247; Wu ZS, 2010, ACS NANO, V4, P5835, DOI 10.1021/nn101754k; Xue YK, 2010, CLIM DYNAM, V35, P1, DOI 10.1007/s00382-010-0831-1; Yang CH, 2007, POLYMER, V48, P3237, DOI 10.1016/j.polymer.2007.04.013; Yao TJ, 2009, J COLLOID INTERF SCI, V338, P573, DOI 10.1016/j.jcis.2009.05.001; Zhang S, 2011, ACS APPL MATER INTER, V3, P3633, DOI 10.1021/am200839m; ZHAO H, 1994, REACT POLYM, V23, P213, DOI 10.1016/0923-1137(94)90023-X; Zhou YF, 2011, WATER AIR SOIL POLL, V215, P631, DOI 10.1007/s11270-010-0505-y	44	114	124	2	225	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43328	10.1371/journal.pone.0043328	http://dx.doi.org/10.1371/journal.pone.0043328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927957	Green Published, gold			2022-12-27	WOS:000308286300042
J	Maeda, A; Leung, MKK; Conroy, L; Chen, YH; Bu, JC; Lindsay, PE; Mintzberg, S; Virtanen, C; Tsao, J; Winegarden, NA; Wang, YC; Morikawa, L; Vitkin, IA; Jaffray, DA; Hill, RP; DaCosta, RS				Maeda, Azusa; Leung, Michael K. K.; Conroy, Leigh; Chen, Yonghong; Bu, Jiachuan; Lindsay, Patricia E.; Mintzberg, Shani; Virtanen, Carl; Tsao, Julissa; Winegarden, Neil A.; Wang, Yanchun; Morikawa, Lily; Vitkin, I. Alex; Jaffray, David A.; Hill, Richard P.; DaCosta, Ralph S.			In Vivo Optical Imaging of Tumor and Microvascular Response to Ionizing Radiation	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; RADIOCHROMIC FILM; BLOOD-VESSELS; ANGIOGENESIS; IRRADIATION; THERAPY; CANCER; MICROENVIRONMENT; RADIOTHERAPY	Radiotherapy is a widely used cancer treatment. However, understanding how ionizing radiation affects tumor cells and their vasculature, particularly at cellular, subcellular, genetic, and protein levels, has been limited by an inability to visualize the response of these interdependent components within solid tumors over time and in vivo. Here we describe a new preclinical experimental platform combining intravital multimodal optical microscopy for cellular-level longitudinal imaging, a small animal x-ray microirradiator for reproducible spatially-localized millimeter-scale irradiations, and laser-capture microdissection of ex vivo tissues for transcriptomic profiling. Using this platform, we have developed new methods that exploit the power of optically-enabled microscopic imaging techniques to reveal the important role of the tumor microvasculature in radiation response of tumors. Furthermore, we demonstrate the potential of this preclinical platform to study quantitatively - with cellular and sub-cellular details - the spatio-temporal dynamics of the biological response of solid tumors to ionizing radiation in vivo.	[Maeda, Azusa; Leung, Michael K. K.; Conroy, Leigh; Chen, Yonghong; Bu, Jiachuan; Mintzberg, Shani; Virtanen, Carl; Tsao, Julissa; Winegarden, Neil A.; Vitkin, I. Alex; Jaffray, David A.; Hill, Richard P.; DaCosta, Ralph S.] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Maeda, Azusa; Leung, Michael K. K.; Conroy, Leigh; Chen, Yonghong; Bu, Jiachuan; Mintzberg, Shani; Virtanen, Carl; Tsao, Julissa; Winegarden, Neil A.; Vitkin, I. Alex; Jaffray, David A.; Hill, Richard P.; DaCosta, Ralph S.] Princess Margaret Hosp, Campbell Family Inst Canc Res, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Maeda, Azusa; Leung, Michael K. K.; Conroy, Leigh; Vitkin, I. Alex; Jaffray, David A.; Hill, Richard P.; DaCosta, Ralph S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Lindsay, Patricia E.; Vitkin, I. Alex; Jaffray, David A.; Hill, Richard P.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Jaffray, David A.; DaCosta, Ralph S.] STTARR Innovat Ctr, Radiat Med Program, Toronto, ON, Canada; [Mintzberg, Shani; Virtanen, Carl; Tsao, Julissa; Winegarden, Neil A.] Univ Hlth Network Microarray Ctr, Toronto, ON, Canada; [Wang, Yanchun; Morikawa, Lily] Mt Sinai Hosp, Ctr Modelling Human Dis, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Maeda, A (corresponding author), Ontario Canc Inst, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	rdacosta@uhnres.utoronto.ca	Vitkin, Alex/I-8166-2012	Vitkin, Alex/0000-0001-5495-8888; Hill, Richard Peter/0000-0001-5331-8045; Winegarden, Neil/0000-0001-5964-5899; Conroy, Leigh/0000-0003-0055-3660; Jaffray, David/0000-0001-7378-7543	Canadian Institutes of Health Research [192131]; Cancer Care Ontario Research Chair in Cancer Imaging; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Care Ontario Research Chair in Cancer Imaging; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was funded by a Canadian Institutes of Health Research operating grant (#192131) and a Cancer Care Ontario Research Chair in Cancer Imaging to RSD. This research was also funded, in part, by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER D B, 1991, Eye (London), V5, P239; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bussink J, 2000, RADIAT RES, V153, P398, DOI 10.1667/0033-7587(2000)153[0398:CIBPAH]2.0.CO;2; Butson MJ, 2005, PHYS MED BIOL, V50, pN135, DOI 10.1088/0031-9155/50/13/N02; Cairns RA, 2004, CLIN EXP METASTAS, V21, P275, DOI 10.1023/B:CLIN.0000037729.75981.9e; Choi P, 2008, ARCH OTOLARYNGOL, V134, P539, DOI 10.1001/archotol.134.5.539; Clarkson R, 2011, MED PHYS, V38, P845, DOI 10.1118/1.3533947; Devic S, 2005, MED PHYS, V32, P2245, DOI 10.1118/1.1929253; di Tomaso E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005123; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gaugler M-H, 2005, BRIT J RADIOL, V78, P100, DOI [10.1259/bjr/24511652, DOI 10.1259/BJR/24511652]; Gaugler MH, 2004, J THROMB HAEMOST, V2, P2020, DOI 10.1111/j.1538-7836.2004.00951.x; Gervaz P, 2009, CURR MOL MED, V9, P273, DOI 10.2174/156652409787847164; Hayashi T, 2008, PFLUG ARCH EUR J PHY, V456, P1239, DOI 10.1007/s00424-008-0466-9; HERMAN IM, 1985, J CELL BIOL, V101, P43, DOI 10.1083/jcb.101.1.43; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Kawamoto A, 2012, ONCOL REP, V27, P51, DOI 10.3892/or.2011.1485; Kim DWN, 2006, J ULTRAS MED, V25, P1507, DOI 10.7863/jum.2006.25.12.1507; Kufe D, 2003, CANCER BIOL THER, V2, P326, DOI 10.4161/cbt.2.4.495; Li ML, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-5; Manti L, 2010, MUTAT RES-REV MUTAT, V704, P115, DOI 10.1016/j.mrrev.2010.03.005; Mariampillai A, 2008, OPT LETT, V33, P1530, DOI 10.1364/OL.33.001530; Mariampillai A, 2010, OPT LETT, V35, P1257, DOI 10.1364/OL.35.001257; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Mouthon MA, 2003, RADIAT RES, V160, P593, DOI 10.1667/3068; O'Reilly MS, 2006, SEMIN RADIAT ONCOL, V16, P45, DOI 10.1016/j.semradonc.2005.08.006; OWEN JB, 1992, INT J RADIAT ONCOL, V24, P983, DOI 10.1016/0360-3016(92)90483-X; Quarmby S, 1999, INT J CANCER, V82, P385, DOI 10.1002/(SICI)1097-0215(19990730)82:3<385::AID-IJC12>3.0.CO;2-5; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rink A, 2005, MED PHYS, V32, P2510, DOI 10.1118/1.1951447; Sabatasso S, 2011, INT J RADIAT ONCOL, V80, P1522, DOI 10.1016/j.ijrobp.2011.03.018; Sckell A, 2001, METH MOLEC MED, V46, P95, DOI 10.1385/1-59259-143-4:095; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Shiao SL, 2010, J MAMMARY GLAND BIOL, V15, P411, DOI 10.1007/s10911-010-9194-9; Sonveaux P, 2003, CANCER RES, V63, P1012; Timke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-134; Tipton K, 2011, ANN INTERN MED, V154, P737, DOI 10.7326/0003-4819-154-11-201106070-00343; Tsai JH, 2005, CANCER BIOL THER, V4, P1395, DOI 10.4161/cbt.4.12.2331; Tsukamoto H, 2007, GYNECOL ONCOL, V107, P500, DOI 10.1016/j.ygyno.2007.08.058; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; VERHEIJ M, 1994, RADIAT RES, V137, P202, DOI 10.2307/3578813; Wachsberger P, 2003, CLIN CANCER RES, V9, P1957; Wang JR, 2007, WORLD J GASTROENTERO, V13, P3047, DOI 10.3748/wjg.v13.i22.3047; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Zheng HC, 2006, ANTICANCER RES, V26, P3579	55	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42133	10.1371/journal.pone.0042133	http://dx.doi.org/10.1371/journal.pone.0042133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927920	Green Submitted, gold, Green Published			2022-12-27	WOS:000308286300017
J	Pickett, W; Davison, C; Torunian, M; McFaull, S; Walsh, P; Thompson, W				Pickett, William; Davison, Colleen; Torunian, Michael; McFaull, Steven; Walsh, Patricia; Thompson, Wendy			Drinking, Substance Use and the Operation of Motor Vehicles by Young Adolescents in Canada	PLOS ONE			English	Article							ALCOHOL; DRIVERS	Background: Impaired driving is a recognized cause of major injury. Contemporary data are lacking on exposures to impaired driving behaviours and related injury among young adolescents, as well as inequities in these youth risk behaviours. Methods and Findings: Cycle 6 (2009/10) of the Health Behaviour in School-Aged Children survey involved 26,078 students enrolled in 436 Canadian schools. We profiled cross-sectionally the reported use of alcohol, marijuana, or other illicit drugs by on-road and off-road vehicle operators when young adolescents (mean age 13.3 (+/- 1.6) years) were either driving or riding as a passenger. Comparisons were made across vulnerable subgroups. Multi-level logistic regression analyses were used to quantify the effects of the driving behaviours on risks for motor vehicle-related injury. Attributable risk fractions were also estimated. A total of 10% (+/- 3%) of participants reported recent operation of an on-road or off-road motor vehicle after consuming alcohol, marijuana, or other illicit drugs, while 21% (+/- 3%) reported riding as a passenger with a driver under the same conditions. Larger proportions of youth reporting these risk behaviours were males, and from older age groups, rural communities, and socio-economically disadvantaged populations. The behaviours were consistently associated with increased risks for motor vehicle-related injury at the individual level (RR 2.35; 95% CI: 1.54 to 3.58 for frequent vs. no exposure as a driver; RR 1.68; 95% CI: 1.20 to 2.36 for frequent vs. no exposure as a passenger) and at the population level (Attributable Risk Fraction: 7.1% for drivers; 14.0% for passengers). The study was limited mainly by its reliance on self-reported data. Conclusion: Impaired driving is an important health priority among young adolescents in Canada. Inequities in the involvement of younger adolescents in these risk behaviours suggest the need for targeted interventions for specific subgroups such as youth from rural communities, and among socially disadvantaged populations.	[Pickett, William] Queens Univ, Dept Emergency Med, Kingston, ON, Canada; [Pickett, William; Davison, Colleen] Kingston Gen Hosp, Clin Res Ctr, Kingston, ON K7L 2V7, Canada; [Pickett, William; Davison, Colleen] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Torunian, Michael; Walsh, Patricia] Publ Hlth Agcy Canada, Strateg Policy & Res Sect, Div Childhood & Adolescence, Ottawa, ON, Canada; [McFaull, Steven; Thompson, Wendy] Publ Hlth Agcy Canada, Injury Sect, Hlth Surveillance & Epidemiol Div, Ottawa, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Public Health Agency of Canada; Public Health Agency of Canada	Pickett, W (corresponding author), Queens Univ, Dept Emergency Med, Kingston, ON, Canada.	will.pickett@queensu.ca	Davison, Colleen M/L-3157-2016	Davison, Colleen M/0000-0002-0410-3352; thompson, wendy/0000-0002-0177-998X	Public Health Agency of Canada; Health Canada; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation (HSF); CIHR [MOP 97962]; CIHR/HSF [PCR 101415]; CIHR Team in Child and Youth Injury Prevention; Injury Section, Health Surveillance and Epidemiology Division of the Public Health Agency of Canada [4500267124]; Public Health Improvement Research Network (PHIRN)	Public Health Agency of Canada; Health Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation (HSF)(Heart & Stroke Foundation of Canada); CIHR(Canadian Institutes of Health Research (CIHR)); CIHR/HSF(Canadian Institutes of Health Research (CIHR)); CIHR Team in Child and Youth Injury Prevention(Canadian Institutes of Health Research (CIHR)); Injury Section, Health Surveillance and Epidemiology Division of the Public Health Agency of Canada; Public Health Improvement Research Network (PHIRN)	Financial support for this study was provided by the Public Health Agency of Canada (http://www.phac-aspc.gc.ca/index-eng.php) and Health Canada (www.hc-sc.gc.ca/index-eng.php), who funded Cycle 6 of the Health Behaviour in School-Aged Children Survey in Canada. Additional support for this analysis included operating grants from the Canadian Institutes of Health Research (CIHR; www.cihr-irsc.gc.ca) and Heart and Stroke Foundation (HSF; www.heartandstroke.com) (CIHR Grant MOP 97962; CIHR/HSF Grant PCR 101415), the CIHR Team in Child and Youth Injury Prevention (http://childinjuryprevention.ca/), support from the Injury Section, Health Surveillance and Epidemiology Division of the Public Health Agency of Canada (Contract 4500267124), and a new investigator fellowship award to Dr. Davison from the Public Health Improvement Research Network (PHIRN; www.rrasp-phirn.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript (although four authors work as professional staff for the Public Health Agency of Canada).	Adrian M, 2001, SUBST USE MISUSE, V36, P1923, DOI 10.1081/JA-100108433; Angus DE, 1997, EC BURDEN UNINTENTIO; Barry AE, 2011, J SAFETY RES, V42, P137, DOI 10.1016/j.jsr.2011.03.001; Canadian Institute for Health Information, 2011, NAT TRAUM REG REP MA; Canadian Institute for Health Information, 2011, NAT TRAUM REG 2011 R; Cardinal M, 2007, MORTALITY PERSON YEA; Cartwright J, 2011, J STUD ALCOHOL DRUGS, V72, P86, DOI 10.15288/jsad.2011.72.86; CHAIT LD, 1994, PSYCHOPHARMACOLOGY, V115, P340, DOI 10.1007/BF02245075; Chamberlain EA, 2006, YOUTH IMPAIRED DRIVI; Chamberlain EAL, 2008, CAN J PUBLIC HEALTH, V99, P267, DOI 10.1007/BF03403752; CHRISTOFFEL KK, 1992, PEDIATRICS, V89, P1027; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Currie C, 2009, INT J PUBLIC HEALTH, V54, P131, DOI 10.1007/s00038-009-5404-x; Dunsire M, 1999, ALCOHOL ALCOHOLISM, V34, P59, DOI 10.1093/alcalc/34.1.59; Elliott MR, 2006, J STUD ALCOHOL, V67, P252, DOI 10.15288/jsa.2006.67.252; Health Canada, 2001, UN INT INJ PROF AB P; Hingson R, 2003, ALCOHOL RES HEALTH, V27, P63; Lawson JA, 2011, ANN ALLERG ASTHMA IM, V107, P220, DOI 10.1016/j.anai.2011.06.014; Leitch K.K., 2007, REACHING TOP REPORT; Mann RE, 2003, IMPACTS CANNABIS DRI; National Survey on Drug Use and Health, 2011, DAT SPOTL AD LIV PAR; Pedersen SL, 2008, PSYCHOL ADDICT BEHAV, V22, P340, DOI 10.1037/0893-164X.22.3.340; Penning Renske, 2010, Curr Drug Abuse Rev, V3, P23; Public Health Agency of Canada, 2009, CHILD YOUTH INJ REV; Robbe H, 1998, HUM PSYCHOPHARM CLIN, V13, pS70, DOI 10.1002/(SICI)1099-1077(1998110)13:2+<S70::AID-HUP50>3.0.CO;2-R; Robertson R, 2009, J SAFETY RES, V40, P25, DOI 10.1016/j.jsr.2008.12.001; Safe Kids Canada, 2009, CHILD YOUTH UN INJ A; Sibley Aaron K, 2002, CJEM, V4, P263; SMARTRISK, 2005, END CAN INV EP STRAT; Soundappan SSV, 2010, PEDIATR EMERG CARE, V26, P909, DOI 10.1097/PEC.0b013e3181ff0d11; Statistics Canada, 2011, DAILY           1101; Traffic Injury Research Foundation of Canada, 2011, ALC CRASH PROBL CAN; Vingilis E, 2002, TRAFFIC INJ PREV, V3, P1, DOI DOI 10.1080/15389580210522; Warda L, 1998, Inj Prev, V4, P44; Whitehead M., 1991, HEALTH PROMOT INT, V6, P217, DOI [10.1093/heapro/6.3.217, DOI 10.1093/HEAPRO/6.3.217, 10.2190/986llhq6-2vte-yrrn, DOI 10.2190/986LLHQ6-2VTE-YRRN]	35	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e42807	10.1371/journal.pone.0042807	http://dx.doi.org/10.1371/journal.pone.0042807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22936992	Green Published, gold			2022-12-27	WOS:000308286300025
J	Shuo, T; Koshikawa, N; Hoshino, D; Minegishi, T; Ao-Kondo, H; Oyama, M; Sekiya, S; Iwamoto, S; Tanaka, K; Seiki, M				Shuo, Takuya; Koshikawa, Naohiko; Hoshino, Daisuke; Minegishi, Tomoko; Ao-Kondo, Hiroko; Oyama, Masaaki; Sekiya, Sadanori; Iwamoto, Shinichi; Tanaka, Koichi; Seiki, Motoharu			Detection of the Heterogeneous O-Glycosylation Profile of MT1-MMP Expressed in Cancer Cells by a Simple MALDI-MS Method	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; MASS-SPECTROMETRY; MEMBRANE; PROTEINS; GLYCANS; SURFACE; COLON; DRUG	Background: Glycosylation is an important and universal post-translational modification for many proteins, and regulates protein functions. However, simple and rapid methods to analyze glycans on individual proteins have not been available until recently. Methods/Principal Findings: A new technique to analyze glycopeptides in a highly sensitive manner by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) using the liquid matrix 3AQ/CHCA was developed recently and we optimized this technique to analyze a small amount of transmembrane protein separated by SDS-PAGE. We used the MALDI-MS method to evaluate glycosylation status of membrane-type 1 matrix metalloproteinase (MT1-MMP). O-glycosylation of MT1-MMP is reported to modulate its protease activity and thereby to affect cancer cell invasion. MT1-MMP expressed in human fibrosarcoma HT1080 cells was immunoprecipitated and resolved by SDS-PAGE. After in-gel tryptic digestion of the protein, a single droplet of the digest was applied directly to the liquid matrix on a MALDI target plate. Concentration of hydrophilic glycopeptides within the central area occurred due to gradual evaporation of the sample solution, whereas nonglycosylated hydrophobic peptides remained at the periphery. This specific separation and concentration of the glycopeptides enabled comprehensive analysis of the MT1-MMP O-glycosylation. Conclusions/Significance: We demonstrate, for the first time, heterogeneous O-glycosylation profile of a protein by a whole protein analysis using MALDI-MS. Since cancer cells are reported to have altered glycosylation of proteins, this easy-to-use method for glycopeptide analysis opens up the possibility to identify specific glycosylation patterns of proteins that can be used as new biomarkers for malignant tumors.	[Shuo, Takuya; Koshikawa, Naohiko; Hoshino, Daisuke; Minegishi, Tomoko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan; [Ao-Kondo, Hiroko; Oyama, Masaaki] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan; [Sekiya, Sadanori; Iwamoto, Shinichi; Tanaka, Koichi] Shimadzu Co Ltd, Koichi Tanaka Mass Spectrometry Res Lab, Nakagyo Ku, Kyoto, Japan	University of Tokyo; University of Tokyo; Shimadzu Corporation	Shuo, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan.	mseiki@ims.u-tokyo.ac.jp	Sekiya, Sadanori/AAT-9089-2021; Seiki, Motoharu/K-9443-2015; Koshikawa, Naohiko/S-7306-2017	Koshikawa, Naohiko/0000-0002-4539-888X; Oyama, Masaaki/0000-0001-6478-3735	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22700375, 22220014]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Young Scientists (B) [22700375] (to TS), a Grant-in-Aid for Scientific Research (S) [22220014] (to MS) and Global COE Program "Center of Education and Research for the Advanced Genome - Based Medicine - For personalized medicine and the control of worldwide infectious diseases'' (to TS and MS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2009, CURR OPIN CHEM BIOL, V13, P421, DOI 10.1016/j.cbpa.2009.07.022; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Iwai T, 2005, P NATL ACAD SCI USA, V102, P4572, DOI 10.1073/pnas.0407983102; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kim S, 2010, BBA-MOL CELL RES, V1803, P1287, DOI 10.1016/j.bbamcr.2010.06.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu CH, 2011, J PHARMACEUT BIOMED, V54, P27, DOI 10.1016/j.jpba.2010.07.044; Ludwig T, 2008, J BIOL CHEM, V283, P35410, DOI 10.1074/jbc.M801816200; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Rozanov DV, 2004, J BIOL CHEM, V279, P46551, DOI 10.1074/jbc.M405284200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sekiya S, 2012, RAPID COMMUN MASS SP, V26, P693, DOI 10.1002/rcm.6148; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STAHL B, 1991, ANAL CHEM, V63, P1463, DOI 10.1021/ac00014a022; Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [10.1002/RCM.1290020802, DOI 10.1002/RCM.1290020802, 10.1002/rcm.1290020802]; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Wada Y, 2010, MOL CELL PROTEOMICS, V9, P719, DOI 10.1074/mcp.M900450-MCP200; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200	27	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43751	10.1371/journal.pone.0043751	http://dx.doi.org/10.1371/journal.pone.0043751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928028	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300086
J	Thi, EP; Lambertz, U; Reiner, NE				Thi, Emily P.; Lambertz, Ulrike; Reiner, Neil E.			Class IA Phosphatidylinositol 3-Kinase p110 alpha Regulates Phagosome Maturation	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; MYCOBACTERIUM-TUBERCULOSIS PHAGOSOME; HOPS TETHERING COMPLEX; RAB5 EFFECTOR EEA1; HUMAN MACROPHAGES; MEMBRANE-FUSION; CATHEPSIN-D; LYSOSOMAL PROTEINS; ENDOCYTIC PATHWAY; ENDOSOME FUSION	Of the various phosphatidylinositol 3- kinases (PI3Ks), only the class III enzyme Vps34 has been shown to regulate phagosome maturation. During studies of phagosome maturation in THP-1 cells deficient in class IA PI3K p110 alpha, we discovered that this PI3K isoform is required for vacuole maturation to progress beyond acquisition of Rab7 leading to delivery of lysosomal markers. Bead phagosomes from THP-1 cells acquired p110 alpha and contained PI3P and PI(3,4,5) P3; however, p110 alpha and PI(3,4,5) P3 levels in phagosomes from p110 alpha knockdown cells were decreased. Phagosomes from p110 alpha knock down cells showed normal acquisition of both Rab5 and EEA-1, but were markedly deficient in the lysosomal markers LAMP-1 and LAMP-2, and the lysosomal hydrolase, beta-galactosidase. Phagosomes from p110 alpha deficient cells also displayed impaired fusion with Texas Red dextran-loaded lysosomes. Despite lacking lysosomal components, phagosomes from p110 alpha deficient cells recruited normal levels of Rab7, Rab-interacting lysosomal protein (RILP) and homotypic vacuole fusion and protein sorting (HOPs) components Vps41 and Vps16. The latter observations demonstrated that phagosomal Rab7 was active and capable of recruiting effectors involved in membrane fusion. Nevertheless, active Rab7 was not sufficient to bring about the delivery of lysosomal proteins to the maturing vacuole, which is shown for the first time to be dependent on a class I PI3K.	[Thi, Emily P.; Lambertz, Ulrike; Reiner, Neil E.] Univ British Columbia, Dept Med, Expt Med Program, Div Infect Dis, Vancouver, BC, Canada; [Thi, Emily P.; Lambertz, Ulrike; Reiner, Neil E.] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute	Thi, EP (corresponding author), Univ British Columbia, Dept Med, Expt Med Program, Div Infect Dis, Vancouver, BC, Canada.	ethan@mail.ubc.ca			Canadian Institutes of Health Research [MOP-84582]; Canada Graduate Scholarship Doctoral Award [CGD-87892]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Graduate Scholarship Doctoral Award	Funding provided by a Canadian Institutes of Health Research grant (MOP-84582) to N.R. and a Canada Graduate Scholarship Doctoral Award (CGD-87892) to E.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Atlashkin V, 2003, MOL CELL BIOL, V23, P5198, DOI 10.1128/MCB.23.15.5198-5207.2003; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; BERMUDEZ LE, 1991, INFECT IMMUN, V59, P1697, DOI 10.1128/IAI.59.5.1697-1702.1991; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bohdanowicz M, 2010, J CELL BIOL, V191, P999, DOI 10.1083/jcb.201004005; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Clague MJ, 2009, EXP CELL RES, V315, P1627, DOI 10.1016/j.yexcr.2008.10.005; Clague MJ, 1999, BIOCHEM SOC T, V27, P662, DOI 10.1042/bst0270662; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Falasca M, 2009, BBA-MOL CELL RES, V1793, P1795, DOI 10.1016/j.bbamcr.2009.10.003; Fortier A, 2007, CELL MICROBIOL, V9, P910, DOI 10.1111/j.1462-5822.2006.00839.x; Fratti RA, 2002, J BIOL CHEM, V277, P17320, DOI 10.1074/jbc.M200335200; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Hoffmann E, 2010, EUR J CELL BIOL, V89, P693, DOI 10.1016/j.ejcb.2010.04.006; Howe D, 2010, INFECT IMMUN, V78, P3465, DOI 10.1128/IAI.00406-10; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Huynh KK, 2008, J BIOL CHEM, V283, P35745, DOI 10.1074/jbc.M806232200; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; KOSTER A, 1993, EMBO J, V12, P5219, DOI 10.1002/j.1460-2075.1993.tb06217.x; Laage R, 2001, MOL BIOL CELL, V12, P3375, DOI 10.1091/mbc.12.11.3375; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; Lawe DC, 2003, MOL BIOL CELL, V14, P2935, DOI 10.1091/mbc.E02-09-0591; Lee JS, 2004, J BIOL CHEM, V279, P9379, DOI 10.1074/jbc.M310638200; Lu L, 2009, BIOSCIENCE REP, V29, P261, DOI 10.1042/BSR20090043; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; LUKACS GL, 1992, J BIOL CHEM, V267, P14568; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2009, BIOCHEM SOC T, V37, P1019, DOI 10.1042/BST0371019; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Malik ZA, 2001, J IMMUNOL, V166, P3392, DOI 10.4049/jimmunol.166.5.3392; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mills IG, 2001, J CELL SCI, V114, P1959; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Purdy GE, 2005, CELL MICROBIOL, V7, P1627, DOI 10.1111/j.1462-5822.2005.00580.x; Robinson N, 2008, TRAFFIC, V9, P1936, DOI 10.1111/j.1600-0854.2008.00804.x; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seeger EM, 2010, FEMS MICROBIOL LETT, V307, P113, DOI 10.1111/j.1574-6968.2010.01976.x; Seto S, 2011, TRAFFIC; Seto S, 2009, BIOCHEM BIOPH RES CO, V387, P272, DOI 10.1016/j.bbrc.2009.06.152; Shaw JD, 2003, TRAFFIC, V4, P479, DOI 10.1034/j.1600-0854.2003.t01-1-00106.x; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; STOKES RW, 1993, J IMMUNOL, V151, P7067; Sun Jim, 2009, V531, P57, DOI 10.1007/978-1-59745-396-7_5; Tsang AW, 2000, J LEUKOCYTE BIOL, V68, P487; Ullrich HJ, 1999, EUR J CELL BIOL, V78, P739, DOI 10.1016/S0171-9335(99)80042-9; Utermoehlen O, 2010, INNATE IMMUN; Verhage M, 2009, P NATL ACAD SCI USA, V106, P19745, DOI 10.1073/pnas.0911425106; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Villeneuve C, 2005, J LIPID RES, V46, P475, DOI 10.1194/jlr.M400308-JLR200; Vinet AF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000628; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Xu H, 2010, J BIOL CHEM; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099	92	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43668	10.1371/journal.pone.0043668	http://dx.doi.org/10.1371/journal.pone.0043668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928013	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300079
J	Uyeki, TM; Nguyen, DC; Rowe, T; Lu, XH; Hu-Primmer, J; Huynh, LP; Hang, NLK; Katz, JM				Uyeki, Timothy M.; Nguyen, Doan C.; Rowe, Thomas; Lu, Xiuhua; Hu-Primmer, Jean; Huynh, Lien P.; Hang, Nguyen L. K.; Katz, Jacqueline M.			Seroprevalence of Antibodies to Avian Influenza A (H5) and A (H9) Viruses among Market Poultry Workers, Hanoi, Vietnam, 2001	PLOS ONE			English	Article							HIGHLY PATHOGENIC H5N1; HONG-KONG; HUMAN INFECTION; RISK-FACTORS; CHINA; ILLNESS; VACCINE	Background: The frequency of avian influenza A virus infections among poultry workers is not well understood. Methods: A seroprevalence study of market poultry workers and persons without occupational poultry exposure was conducted during 2001 in Hanoi, Vietnam. Sera were tested for avian influenza H5 and H9 antibodies by microneutralization and Western blot assays. Results: Seroprevalence of H5 and H9 antibodies was 4% and 3% in poultry workers and 1% and 3.5% in non-poultry workers, respectively. Conclusions: Seroprevalence of H5 and H9 antibodies was low among Hanoi market poultry workers in 2001, but can serve as a baseline for additional studies.	[Uyeki, Timothy M.; Rowe, Thomas; Lu, Xiuhua; Hu-Primmer, Jean; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Nguyen, Doan C.; Huynh, Lien P.; Hang, Nguyen L. K.] Natl Inst Hyg & Epidemiol, Dept Virol, Minist Hlth, Hanoi, Vietnam	Centers for Disease Control & Prevention - USA; National Institute of Hygiene & Epidemiology (NIHE)	Uyeki, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA.	tuyeki@cdc.gov	Rowe, Thomas/AAW-4899-2020		Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention (CDC). CDC staff were involved in study design, data collection and analysis, preparation of the manuscript, and decision to publish. No other external funding was received.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P93; Atmar RL, 2011, VACCINE, V29, P8066, DOI 10.1016/j.vaccine.2011.08.044; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Buchy P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010864; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chen Y, 2011, CLIN MICROBIOL INFEC, V17, P1347, DOI 10.1111/j.1469-0691.2011.03538.x; Cheng VCC, 2011, J INFECTION, V62, P394, DOI 10.1016/j.jinf.2011.02.007; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; FAO Food and Agriculture Organization of the United Nations, 2011, APPR CONTR PREV EL H; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Hadipour MM, 2011, ASIAN J ANIM VET ADV, V6, P196, DOI 10.3923/ajava.2011.196.200; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Li Chuan-hua, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P213; Liu Yang, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1111; Lu CT, 2008, INT J ARTIF INTELL T, V17, P1; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; Pawar SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036374; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Shinya K, 2005, J VIROL, V79, P9926, DOI 10.1128/JVI.79.15.9926-9932.2005; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Uyeki TM, 2002, EMERG INFECT DIS, V8, P154, DOI 10.3201/eid0802.010148; Wan XF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003462; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; *WHO, 2006, WHO CAS DEF HUM INF; WHO, 2012, CUM NUMB CONF HUM CA; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	29	55	58	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43948	10.1371/journal.pone.0043948	http://dx.doi.org/10.1371/journal.pone.0043948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928049	Green Published, gold, Green Submitted			2022-12-27	WOS:000307789700054
J	Chabot, AA; Hobson, KA; Van Wilgenburg, SL; McQuat, GJ; Lougheed, SC				Chabot, Amy A.; Hobson, Keith A.; Van Wilgenburg, Steven L.; McQuat, Gregory J.; Lougheed, Stephen C.			Advances in Linking Wintering Migrant Birds to Their Breeding-Ground Origins Using Combined Analyses of Genetic and Stable Isotope Markers	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; DELTA-D; NEOTROPICAL MIGRANT; MITOCHONDRIAL-DNA; MICROSATELLITE VARIATION; POPULATION-STRUCTURE; DISPERSAL DISTANCES; NORTHERN PINTAIL; MIGRATORY BIRDS; NATAL DISPERSAL	An enduring problem in avian ecology and conservation is linking breeding and wintering grounds of migratory species. As migratory species and populations vary in the degree to which individuals from distinct breeding locales mix on stop-over sites and wintering grounds, establishing migratory connectivity informs our understanding of population demography and species management. We present a new Bayesian approach for inferring breeding grounds of wintering birds of unknown origins in North America. We incorporate prior information from analysis of genetic markers into geographic origin assignment based upon stable-hydrogen isotope analysis of feathers (delta H-2(f)), using the Loggerhead Shrike (Lanius ludovicianus). Likely geographic origins derived from analyses of DNA microsatellites were used as priors for Bayesian analyses in which birds were assigned to a breeding-ground origin using their delta H-2(f) values. As with most applications of Bayesian methods, our approach greatly improved the results (i.e. decreased the size of the potential area of origin). Area of origin decreased by 3 to 5-fold on average, but ranged up to a 10-fold improvement. We recommend this approach in future studies of migratory connectivity and suggest that our methodology could be applied more broadly to the study of dispersal, sources of productivity of migratory populations, and a range of evolutionary phenomena.	[Chabot, Amy A.; Lougheed, Stephen C.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Hobson, Keith A.; Van Wilgenburg, Steven L.] Environm Canada, Saskatoon, SK, Canada; [McQuat, Gregory J.] Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Environment & Climate Change Canada; Queens University - Canada	Chabot, AA (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	steve.lougheed@queensu.ca	Hobson, Keith/Q-9306-2019	Van Wilgenburg, Steven/0000-0002-6742-4567	Environment Canada's Canadian Wildlife Service, Environment Canada's Strategic Technologies Application of Genomics in the Environment Research Fund; Endangered Species Recovery Fund through the World Wildlife Fund of Canada; Interdepartmental Recovery Fund; Natural Sciences and Engineering Research Council; Ontario Ministry of Training, Colleges and Universities (Ontario Graduate Scholarship); Queen's University (Duncan and Urlla Carmichael Fellowship); Wildlife Preservation Canada	Environment Canada's Canadian Wildlife Service, Environment Canada's Strategic Technologies Application of Genomics in the Environment Research Fund; Endangered Species Recovery Fund through the World Wildlife Fund of Canada; Interdepartmental Recovery Fund; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Training, Colleges and Universities (Ontario Graduate Scholarship); Queen's University (Duncan and Urlla Carmichael Fellowship); Wildlife Preservation Canada	Funding was provided by Environment Canada's Canadian Wildlife Service, Environment Canada's Strategic Technologies Application of Genomics in the Environment Research Fund, the Endangered Species Recovery Fund through the World Wildlife Fund of Canada, the Interdepartmental Recovery Fund, the Natural Sciences and Engineering Research Council (grant to Lougheed and Post Graduate Scholarship to Chabot), the Ontario Ministry of Training, Colleges and Universities (Ontario Graduate Scholarship to Chabot), Queen's University (Duncan and Urlla Carmichael Fellowship to Chabot) and Wildlife Preservation Canada. Additional funding for stable isotope work was provided by an operating grant to Hobson by Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley P, 2010, AVIAN CONSERV ECOL, V5; Avise J, 2004, MOL MARKERS NATURAL; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Bairlein F, 2001, ARDEA, V89, P7; Barr KR, 2008, MOL ECOL, V17, P3628, DOI 10.1111/j.1365-294X.2008.03868.x; BERLANGA H., 2010, SAVING OUR SHARED BI; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Boulet Marylene, 2006, Ornithological Monographs, V61, P29, DOI 10.1642/0078-6594(2006)61[29:IAOGSI]2.0.CO;2; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Brawn JD, 1996, CONDOR, V98, P547; Brewer AD, 2000, CANADIAN ATLAS BIRDS, V1; Bulgin NL, 2003, MOL ECOL, V12, P831, DOI 10.1046/j.1365-294X.2003.01774.x; Chabot AA, 2011, THESIS QUEENS U; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; Clegg SM, 2003, MOL ECOL, V12, P819, DOI 10.1046/j.1365-294X.2003.01757.x; Coulton DW, 2010, WATERBIRDS, V33, P10, DOI 10.1675/063.033.0102; Coxon A, 2011, CONSERV GENET RESOUR, V4, P503; Craig Susan H., 1997, North American Bird Bander, V22, P124; Esler D, 2000, CONSERV BIOL, V14, P366, DOI 10.1046/j.1523-1739.2000.98147.x; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Gibbs HL, 2000, MOL ECOL, V9, P2137, DOI 10.1046/j.1365-294X.2000.01136.x; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Grimmer J, 2010, POLIT ANAL, V18, P1, DOI [10.1093/pan/mpp034, 10.1093/pan/mpq027]; Gunnarsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035679; HANSKI I, 1997, METAPOPULATION BIOL; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Hebert CE, 2005, WILDLIFE SOC B, V33, P92, DOI 10.2193/0091-7648(2005)33[92:FSIIWN]2.0.CO;2; Henaux V, 2011, METHODS ECOL EVOL, V2, P489, DOI 10.1111/j.2041-210X.2011.00107.x; Hijmans R. J., 2011, GEOGRAPHIC ANAL MODE; Hobson KA, 2005, DIVERS DISTRIB, V11, P157, DOI 10.1111/j.1366-9516.2005.00149.x; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2009, J RAPTOR RES, V43, P325, DOI 10.3356/JRR-08-74.1; Hobson KA, 2009, J GEOCHEM EXPLOR, V102, P63, DOI 10.1016/j.gexplo.2009.02.002; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Howell S. N, 1997, IDENTIFICATION GUIDE; Kelly JF, 2005, ECOL APPL, V15, P1487, DOI 10.1890/04-1704; Kimura M, 2002, MOL ECOL, V11, P1605, DOI 10.1046/j.1365-294X.2002.01551.x; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Losos JB, 1997, NATURE, V387, P70, DOI 10.1038/387070a0; Lott CA, 2006, AUK, V123, P822, DOI 10.1642/0004-8038(2006)123[822:AGATET]2.0.CO;2; Lovette IJ, 2004, CONSERV BIOL, V18, P156, DOI 10.1111/j.1523-1739.2004.00239.x; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; MILLER ALDEN H., 1928, UNIV CALIFORNIA PUBL ZOOL, V30, P393; Mundy NI, 1997, P ROY SOC B-BIOL SCI, V264, P869, DOI 10.1098/rspb.1997.0121; Norris D. Ryan, 2006, Ornithological Monographs, V61, P14; Oyler-McCance SJ, 2007, CONSERV GENET, V8, P1339, DOI 10.1007/s10592-006-9282-y; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pearce JM, 2000, J WILDLIFE MANAGE, V64, P863, DOI 10.2307/3802757; Perez GE, 2006, THESIS U SASKATCHEWA; Perez GE, 2006, CONDOR, V108, P877, DOI 10.1650/0010-5422(2006)108[877:IEOIMI]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2018, R LANG ENV STAT COMP; Ramos MA, 1980, MIGRANT BIRDS NEOTRO; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RICH T, 2006, BIRDING, V38, P30; Royle JA, 2004, ECOL APPL, V14, P1780; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Smith Thomas B., 2005, P222; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; TAYLOR LR, 1977, NATURE, V265, P415, DOI 10.1038/265415a0; Temple HJ, 2006, MOL ECOL, V15, P3449, DOI 10.1111/j.1365-294X.2006.03006.x; Tiedemann R, 2004, MOL ECOL, V13, P1481, DOI 10.1111/j.1365-294X.2004.02168.x; Tsuji Y, 2009, J CLIN PHARM THER, V34, P465, DOI 10.1111/j.1365-2710.2008.01015.x; Van Wilgenburg Steven L., 2012, Endangered Species Research, V16, P17, DOI 10.3354/esr00383; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; VICKERY PD, 1992, AUK, V109, P706, DOI 10.2307/4088146; Walters JR, 2000, CONDOR, V102, P479, DOI 10.1650/0010-5422(2000)102[0479:DBAOF]2.0.CO;2; Wassenaar L. I., 2003, ISOT ENVIRON HEALT S, V39, P1; Wassenaar LI, 2008, TERR ECOL SER, V2, P21, DOI 10.1016/S1936-7961(07)00002-4; Webster Michael S., 2005, P199; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wenink PW, 1996, AUK, V113, P744, DOI 10.2307/4088854; Wennerberg L, 2001, MOL ECOL, V10, P1111, DOI 10.1046/j.1365-294X.2001.01256.x; Wilson GA, 2003, GENETICS, V163, P1177; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x; WRIGHT S, 1946, GENETICS, V31, P39; Wright S, 1943, GENETICS, V28, P114; Wunder WB, 2009, UNDERSTANDING MOVEME; Zhan XW, 2006, IEEE T GEOSCI REMOTE, V44, P1534, DOI 10.1109/TGRS.2005.863319; Zhou HF, 2008, STAT MED, V27, P5907, DOI 10.1002/sim.3409	87	58	63	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43627	10.1371/journal.pone.0043627	http://dx.doi.org/10.1371/journal.pone.0043627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916285	Green Published, Green Submitted, gold			2022-12-27	WOS:000307733800084
J	Rangam, G; Schmitz, KM; Cobb, AJA; Petersen-Mahrt, SK				Rangam, Gopinath; Schmitz, Kerstin-Maike; Cobb, Alexander J. A.; Petersen-Mahrt, Svend K.			AID Enzymatic Activity Is Inversely Proportional to the Size of Cytosine C5 Orbital Cloud	PLOS ONE			English	Article							THYMINE-DNA GLYCOSYLASE; MAMMALIAN DNA; DEMETHYLATION; 5-METHYLCYTOSINE; DEAMINASE; 5-CARBOXYLCYTOSINE; EXCISION; TET1; MICE	Activation induced deaminase (AID) deaminates cytosine to uracil, which is required for a functional humoral immune system. Previous work demonstrated, that AID also deaminates 5-methylcytosine (5 mC). Recently, a novel vertebrate modification (5-hydroxymethylcytosine - 5 hmC) has been implicated in functioning in epigenetic reprogramming, yet no molecular pathway explaining the removal of 5 hmC has been identified. AID has been suggested to deaminate 5 hmC, with the 5 hmU product being repaired by base excision repair pathways back to cytosine. Here we demonstrate that AID's enzymatic activity is inversely proportional to the electron cloud size of C5-cytosine - H > F > methyl >> hydroxymethyl. This makes AID an unlikely candidate to be part of 5 hmC removal.	[Rangam, Gopinath; Schmitz, Kerstin-Maike; Petersen-Mahrt, Svend K.] Fdn Ist FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy; [Rangam, Gopinath; Petersen-Mahrt, Svend K.] London Res Inst, Clare Hall Labs, DNA Editing Lab, S Mimms, Herts, England; [Cobb, Alexander J. A.] Univ Reading, Sch Pharm, Reading, Berks, England	IFOM - FIRC Institute of Molecular Oncology; University of Reading	Rangam, G (corresponding author), Fdn Ist FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy.	svend.petersen-mahrt@ifom.eu	Cobb, Alexander/Q-5702-2016; Rangam, Gopinath/J-8832-2019	Cobb, Alexander/0000-0002-3397-9636; Rangam, Gopinath/0000-0001-5081-5804	Fondazione Istituto FIRC di Oncologia Molecolare (IFOM-FIRC), Milan, Italy; London Research Institute / Cancer Research United Kingdom, United Kingdom; Cancer Research United Kingdom; IFOM-FIRC; Marie-Curie post-doc fellowship [274627]	Fondazione Istituto FIRC di Oncologia Molecolare (IFOM-FIRC), Milan, Italy; London Research Institute / Cancer Research United Kingdom, United Kingdom; Cancer Research United Kingdom(Cancer Research UK); IFOM-FIRC; Marie-Curie post-doc fellowship	SKPM was supported by, Fondazione Istituto FIRC di Oncologia Molecolare (IFOM-FIRC), Milan, Italy and the London Research Institute / Cancer Research United Kingdom, United Kingdom core lab funding - (facilities, materials, and salary). GR was supported by post-doctoral fellowship from Cancer Research United Kingdom and IFOM-FIRC core funding (salary). KMS was supported by Marie-Curie post-doc fellowship #274627 (materials and salary). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Coker HA, 2007, DNA REPAIR, V6, P235, DOI 10.1016/j.dnarep.2006.10.001; Coker HA, 2006, METHOD ENZYMOL, V408, P156, DOI 10.1016/S0076-6879(06)08010-4; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hashimoto H, 2012, NUCL ACIDS RES; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Kemmerich K., 2012, NUCL ACIDS RES; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Mol CD, 2002, J MOL BIOL, V315, P373, DOI 10.1006/jmbi.2001.5264; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nabel CS, 2012, NATURE CHEM IN PRESS; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Zhao YH, 2003, J ORG CHEM, V68, P7368, DOI 10.1021/jo034808o	22	54	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43279	10.1371/journal.pone.0043279	http://dx.doi.org/10.1371/journal.pone.0043279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916236	Green Accepted, Green Published, gold			2022-12-27	WOS:000307733800058
J	Kanamarlapudi, V; Owens, SE; Saha, K; Pope, RJ; Mundell, SJ				Kanamarlapudi, Venkateswarlu; Owens, Sian E.; Saha, Keya; Pope, Robert J.; Mundell, Stuart J.			ARF6-Dependent Regulation of P2Y Receptor Traffic and Function in Human Platelets	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; PROTEIN-COUPLED RECEPTOR; GTPASE-ACTIVATING PROTEIN; BINDING PROTEIN; GOLGI MEMBRANES; ARF PROTEINS; ENDOCYTOSIS; CENTAURIN-ALPHA(1); INTERNALIZATION; CLATHRIN	Adenosine diphosphate (ADP) is a critical regulator of platelet activation, mediating its actions through two G protein-coupled receptors, the P2Y(1) and P2Y(12) purinoceptors. Recently, we demonstrated that P2Y(1) and P2Y(12) purinoceptor activities are rapidly and reversibly modulated in human platelets, revealing that the underlying mechanism requires receptor internalization and subsequent trafficking as an essential part of this process. In this study we investigated the role of the small GTP-binding protein ADP ribosylation factor 6 (ARF6) in the internalization and function of P2Y(1) and P2Y(12) purinoceptors in human platelets. ARF6 has been implicated in the internalization of a number of GPCRs, although its precise molecular mechanism in this process remains unclear. In this study we show that activation of either P2Y(1) or P2Y(12) purinoceptors can stimulate ARF6 activity. Further blockade of ARF6 function either in cell lines or human platelets blocks P2Y purinoceptor internalization. This blockade of receptor internalization attenuates receptor resensitization. Furthermore, we demonstrate that Nm23-H1, a nucleoside diphosphate (NDP) kinase regulated by ARF6 which facilitates dynamin-dependent fission of coated vesicles during endocytosis, is also required for P2Y purinoceptor internalization. These data describe a novel function of ARF6 in the internalization of P2Y purinoceptors and demonstrate the integral importance of this small GTPase upon platelet ADP receptor function.	[Kanamarlapudi, Venkateswarlu; Owens, Sian E.; Saha, Keya] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Pope, Robert J.; Mundell, Stuart J.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	Swansea University; University of Bristol	Kanamarlapudi, V (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	s.j.mundell@bristol.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483; Owens, Sian-Eleri/0000-0003-1806-5235; Mundell, Stuart/0000-0001-7754-3271	BBSRC UK (Biotechnology and Biological Sciences Research Council); MRC UK; British Heart Foundation Senior Research Fellowship; MRC [G0401232, G1000432] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C515455/2] Funding Source: researchfish; British Heart Foundation [FS/11/49/28751] Funding Source: researchfish; Medical Research Council [G0401232, G1000432] Funding Source: researchfish	BBSRC UK (Biotechnology and Biological Sciences Research Council); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Senior Research Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by funding from BBSRC UK (Biotechnology and Biological Sciences Research Council) (to VK), MRC UK (to VK) and a British Heart Foundation Senior Research Fellowship (to SJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOMAN AL, 1995, TRENDS BIOCHEM SCI, V20, P147, DOI 10.1016/S0968-0004(00)88991-4; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; Conery AR, 2010, P NATL ACAD SCI USA, V107, P15461, DOI 10.1073/pnas.1010633107; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; El Annan J, 2004, AM J PHYSIOL-CELL PH, V286, pC768, DOI 10.1152/ajpcell.00250.2003; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Goto S, 2006, J AM COLL CARDIOL, V47, P155, DOI 10.1016/j.jacc.2005.08.055; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Hsu T, 2006, J BIOL CHEM, V281, P12069, DOI 10.1074/jbc.M511621200; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Kanamarlapudi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037954; Kanamarlapudi V, 2012, J BIOL CHEM, V287, P20443, DOI 10.1074/jbc.M112.362087; Karim ZA, 2008, J BIOL CHEM, V283, P11995, DOI 10.1074/jbc.M800146200; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Kunapuli SP, 2003, CURR PHARM DESIGN, V9, P2303, DOI 10.2174/1381612033453947; Lawrence J, 2005, MOL PHARMACOL, V67, P1822, DOI 10.1124/mol.105.011338; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; Mundell SJ, 2008, J THROMB HAEMOST, V6, P1393, DOI 10.1111/j.1538-7836.2008.03039.x; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Poupart ME, 2007, CELL SIGNAL, V19, P2370, DOI 10.1016/j.cellsig.2007.07.015; Rochdi MD, 2004, J BIOL CHEM, V279, P18981, DOI 10.1074/jbc.M312621200; Smyth SS, 2009, ARTERIOSCL THROM VAS, V29, P449, DOI 10.1161/ATVBAHA.108.176388; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Venkateswarlu K, 2005, J CELL SCI, V118, P2471, DOI 10.1242/jcs.02369; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200	37	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43532	10.1371/journal.pone.0043532	http://dx.doi.org/10.1371/journal.pone.0043532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916275	gold, Green Published, Green Submitted			2022-12-27	WOS:000307824300053
J	Shin, SC; Kim, SJ; Lee, JK; Ahn, DH; Kim, MG; Lee, H; Lee, J; Kim, BK; Park, H				Shin, Seung Chul; Kim, Su Jin; Lee, Jong Kyu; Ahn, Do Hwan; Kim, Min Gyu; Lee, Hyoungseok; Lee, Jungeun; Kim, Bum-Keun; Park, Hyun			Transcriptomics and Comparative Analysis of Three Antarctic Notothenioid Fishes	PLOS ONE			English	Article							EXPRESSION; GENE; EVOLUTION; BLOOD; NEUROGLOBIN; MYOGLOBIN; REMNANTS; ICEFISH; HSP70	For the past 10 to 13 million years, Antarctic notothenioid fish have undergone extraordinary periods of evolution and have adapted to a cold and highly oxygenated Antarctic marine environment. While these species are considered an attractive model with which to study physiology and evolutionary adaptation, they are poorly characterized at the molecular level, and sequence information is lacking. The transcriptomes of the Antarctic fishes Notothenia coriiceps, Chaenocephalus aceratus, and Pleuragramma antarcticum were obtained by 454 FLX Titanium sequencing of a normalized cDNA library. More than 1,900,000 reads were assembled in a total of 71,539 contigs. Overall, 40% of the contigs were annotated based on similarity to known protein or nucleotide sequences, and more than 50% of the predicted transcripts were validated as full-length or putative full-length cDNAs. These three Antarctic fishes shared 663 genes expressed in the brain and 1,557 genes expressed in the liver. In addition, these cold-adapted fish expressed more Ub-conjugated proteins compared to temperate fish; Ub-conjugated proteins are involved in maintaining proteins in their native state in the cold and thermally stable Antarctic environments. Our transcriptome analysis of Antarctic notothenioid fish provides an archive for future studies in molecular mechanisms of fundamental genetic questions, and can be used in evolution studies comparing other fish.	[Shin, Seung Chul; Lee, Jong Kyu; Ahn, Do Hwan; Kim, Min Gyu; Lee, Hyoungseok; Lee, Jungeun; Park, Hyun] Korea Polar Res Inst, Inchon, South Korea; [Kim, Su Jin] Korea Univ, Coll Life Sci & Biotechnol, Seoul, South Korea; [Ahn, Do Hwan; Park, Hyun] Univ Sci & Technol, Taejon, South Korea; [Kim, Bum-Keun] Korea Food Res Inst, Songnam, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Korea University; Korea Food Research Institute (KFRI)	Shin, SC (corresponding author), Korea Polar Res Inst, Inchon, South Korea.	hpark@kopri.re.kr		Kim, Bum-Keun/0000-0002-9752-741X; Lee, Hyoungseok/0000-0002-5831-6345	Functional Genomics on Polar Organisms grant [PE12020]; Korea Polar Research Institute (KOPRI)	Functional Genomics on Polar Organisms grant; Korea Polar Research Institute (KOPRI)(Korea Polar Research Institute of Marine Research Placement (KOPRI))	This work was supported by a Functional Genomics on Polar Organisms grant (PE12020) funded by the Korea Polar Research Institute (KOPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber C, 2009, NATURE, V458, P9; Albertson RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-4; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BARBER DL, 1981, J FISH BIOL, V19, P11, DOI 10.1111/j.1095-8649.1981.tb05807.x; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Cheng CHC, 2009, IUBMB LIFE, V61, P184, DOI 10.1002/iub.138; Cheng CHC, 1999, NATURE, V401, P443, DOI 10.1038/46721; COCCA E, 1995, P NATL ACAD SCI USA, V92, P1817, DOI 10.1073/pnas.92.6.1817; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Detrich HW, 2010, J EXP ZOOL PART B, V314B, P369, DOI 10.1002/jez.b.21341; Detrich HW, 2000, HEMOGLOBIN FUNCTION IN VERTEBRATES, P39; di Prisco G, 2002, GENE, V295, P185, DOI 10.1016/S0378-1119(02)00691-1; Eastman Joseph T., 1998, P3; Eastman JT, 2005, POLAR BIOL, V28, P93, DOI 10.1007/s00300-004-0667-4; Eastman JT, 2000, ANTARCT SCI, V12, P276, DOI 10.1017/S0954102000000341; Eastman JT, 1993, ANTARCTIC FISH BIOL; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hofmann GE, 2000, J EXP BIOL, V203, P2331; JAENICKE R, 1990, PHILOS T R SOC B, V326, P535, DOI 10.1098/rstb.1990.0030; Li SZ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r115; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Moylan TJ, 2000, J EXP BIOL, V203, P1277; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Place S, 2005, POLAR BIOL, V28, P261, DOI 10.1007/s00300-004-0697-y; Place SP, 2004, AM J PHYSIOL-REG I, V287, pR429, DOI 10.1152/ajpregu.00223.2004; RUUD JT, 1954, NATURE, V173, P848, DOI 10.1038/173848a0; Sidell BD, 1997, P NATL ACAD SCI USA, V94, P3420, DOI 10.1073/pnas.94.7.3420; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vacchi M, 2012, POLAR BIOL, V35, P1573, DOI 10.1007/s00300-012-1199-y; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zhao YQ, 1998, J BIOL CHEM, V273, P14745, DOI 10.1074/jbc.273.24.14745	38	56	58	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43762	10.1371/journal.pone.0043762	http://dx.doi.org/10.1371/journal.pone.0043762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916302	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300057
J	Holl, EK; Roney, KE; Allen, IC; Steinbach, E; Arthur, JC; Buntzman, A; Plevy, S; Frelinger, J; Ting, JPY				Holl, Eda K.; Roney, Kelly E.; Allen, Irving C.; Steinbach, Erin; Arthur, Janelle C.; Buntzman, Adam; Plevy, Scott; Frelinger, Jeffrey; Ting, Jenny P. -Y.			Plexin-B2 and Plexin-D1 in Dendritic Cells: Expression and IL-12/IL-23p40 Production	PLOS ONE			English	Article							IV SEMAPHORIN CD100; NONREDUNDANT ROLES; IMMUNE-RESPONSES; B-CELL; FAMILY; GROWTH; RECEPTORS; GUIDANCE; SYSTEM; SEMA4A	Plexins are a family of genes (A,B,C, and D) that are expressed in many organ systems. Plexins expressed in the immune system have been implicated in cell movement and cell-cell interaction during the course of an immune response. In this study, the expression pattern of Plexin-B2 and Plexin-D1 in dendritic cells (DCs), which are central in immune activation, was investigated. Plexin-B2 and Plexin-D1 are reciprocally expressed in myeloid and plasmacytoid DC populations. Plasmacytoid DCs have high Plexin-B2 but low Plexin-D1, while the opposite is true of myeloid DCs. Expression of Plexin-B2 and Plexin-D1 is modulated upon activation of DCs by TLR ligands, TNF alpha, and anti-CD40, again in a reciprocal fashion. Semaphorin3E, a ligand for Plexin-D1 and Plexin-B2, is expressed by T cells, and interestingly, is dramatically higher on Th2 cells and on DCs. The expression of Plexins and their ligands on DCs and T cells suggest functional relevance. To explore this, we utilized chimeric mice lacking Plxnb2 or Plxnd1. Absence of Plexin-B2 and Plexin-D1 on DCs did not affect the ability of these cells to upregulate costimulatory molecules or the ability of these cells to activate antigen specific T cells. Additionally, Plexin-B2 and Plexin-D1 were dispensable for chemokine-directed in-vitro migration of DCs towards key DC chemokines, CXCL12 and CCL19. However, the absence of either Plexin-B2 or Plexin-D1 on DCs leads to constitutive expression of IL-12/IL-23p40. This is the first report to show an association between Plexin-B2 and Plexin-D1 with the negative regulation of IL-12/IL-23p40 in DCs. This work also shows the presence of Plexin-B2 and Plexin-D1 on mouse DC subpopulations, and indicates that these two proteins play a role in IL-12/IL-23p40 production that is likely to impact the immune response.	[Holl, Eda K.; Roney, Kelly E.; Arthur, Janelle C.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Holl, Eda K.; Roney, Kelly E.; Allen, Irving C.; Arthur, Janelle C.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Steinbach, Erin; Plevy, Scott] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Buntzman, Adam; Frelinger, Jeffrey] Univ Arizona, Dept Immunobiol, Tucson, AZ USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Arizona	Holl, EK (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	jenny_ting@med.unc.edu	Frelinger, Jeffrey A/F-2448-2014	Frelinger, Jeffrey A/0000-0002-2503-6267; Buntzman, Adam/0000-0003-1067-4618; Steinbach, Erin/0000-0002-6165-8928; Allen, Irving/0000-0001-9573-5250; Arthur, Janelle/0000-0002-4796-0207	University of North Carolina Developmental Biology Training Program Grant [HD046369]; National Institutes of Health Grant [AI29564]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI029564, R37AI029564, R01AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK089692, K01DK092355] Funding Source: NIH RePORTER	University of North Carolina Developmental Biology Training Program Grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by University of North Carolina Developmental Biology Training Program Grant HD046369 (to E.K.H.) and National Institutes of Health Grant AI29564 (to J.P. and Y.T.). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Choi YI, 2008, IMMUNITY; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Holl EK, 2011, J IMMUNOL, V186, P5603, DOI 10.4049/jimmunol.1003464; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kumanogoh A, 2005, IMMUNITY, V22, P305, DOI 10.1016/j.immuni.2005.01.014; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Lamont RE, 2009, DEV BIOL, V331, P199, DOI 10.1016/j.ydbio.2009.04.037; Masuda K, 2004, GENES CELLS, V9, P821, DOI 10.1111/j.1365-2443.2004.00766.x; Mizui M, 2009, J CLIN IMMUNOL, V29, P1, DOI 10.1007/s10875-008-9263-7; O'Connor BP, 2008, P NATL ACAD SCI USA, V105, P13015, DOI 10.1073/pnas.0803386105; Sakurai A, 2010, MOL CELL BIOL; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Smith EP, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-30; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Takamatsu H, 2010, CELL MOL IMMUNOL, V7, P83, DOI 10.1038/cmi.2009.111; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; van Deventer HW, 2002, J IMMUNOL, V169, P1634, DOI 10.4049/jimmunol.169.3.1634; Walzer T, 2005, INT IMMUNOL, V17, P943, DOI 10.1093/intimm/dxh274; Walzer T, 2005, J IMMUNOL, V174, P51, DOI 10.4049/jimmunol.174.1.51; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Yamamoto M, 2008, INT IMMUNOL, V20, P413, DOI 10.1093/intimm/dxn006; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Yu D, 2008, IMMUNOL CELL BIOL, V86, P3, DOI 10.1038/sj.icb.7100123; Yukawa K, 2010, INT J MOL MED, V25, P225, DOI 10.3892/ijmm_00000334; Zielonka M, 2010, EXP CELL RES	41	32	34	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43333	10.1371/journal.pone.0043333	http://dx.doi.org/10.1371/journal.pone.0043333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916243	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600069
J	Kemp, AH; Quintana, DS; Kuhnert, RL; Griffiths, K; Hickie, IB; Guastella, AJ				Kemp, Andrew H.; Quintana, Daniel S.; Kuhnert, Rebecca-Lee; Griffiths, Kristi; Hickie, Ian B.; Guastella, Adam J.			Oxytocin Increases Heart Rate Variability in Humans at Rest: Implications for Social Approach-Related Motivation and Capacity for Social Engagement	PLOS ONE			English	Article								Context: Oxytocin (OT) plays a key regulatory role in human social behaviour. While prior studies have examined the effects of OT on observable social behaviours, studies have seldom examined the effects of OT on psychophysiological markers such as heart rate variability (HRV), which provides an index of individual's motivation for social behaviour. Furthermore, no studies have examined the impact of OT on HRV under resting conditions, which provides an index of maximal capacity for social engagement. Objective: To examine the effects of OT on HRV measures in healthy male participants while at rest. OT was hypothesised to increase HRV, compared to placebo, and that the effects would be greatest for a non-linear measure of HRV (the detrended fluctuation scaling exponent). Methods: Twenty-one male participants were recruited for this study. Participants were non-smokers, not on any medications and reported no history of psychiatric illness, neurological disorder, or any other serious medical condition (e. g. diabetes, cardiovascular disease). The study employed a randomised, placebo-controlled, within-subject, crossover, experimental design. Main Outcome Measures: HRV was calculated from electrocardiography under a standardized, 10-minute, resting state condition. Results: As hypothesised, OT increased HRV and these effects were largest using the detrended fluctuation scaling exponent, a non-linear measure. These changes were observed in the absence of any change in state mood, as measured by the profile of mood states. Importantly, participants were unable to correctly guess which treatment they had been assigned at either of the two assessments. Conclusions: Together with the broader literature on OT and HRV, findings suggest that acute administration of OT may facilitate a fundamental psychophysiological feature of social behaviour, increasing capacity for social engagement. Findings also suggest that HRV changes may provide a novel biomarker of response to OT nasal spray that can be incorporated into research on response to treatment.	[Kemp, Andrew H.; Quintana, Daniel S.; Kuhnert, Rebecca-Lee] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Griffiths, Kristi; Hickie, Ian B.; Guastella, Adam J.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Kemp, Andrew H.] Univ Sydney, Sydney Med Sch, Discipline Psychiat, CADE Clin, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Kemp, AH (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	andrew.kemp@sydney.edu.au	Hickie, Ian B/K-8975-2015; Quintana, Daniel S./H-2726-2019; Kemp, Andrew Haddon/C-7984-2012	Hickie, Ian B/0000-0001-8832-9895; Quintana, Daniel S./0000-0003-2876-0004; Kemp, Andrew Haddon/0000-0003-1146-3791	National Health and Medical Research Council (NHMRC) [571101, 632634, 632625]; Australian Rotary Health/Hooton family Scholarship; Australian Research Council (ARC) [LP110100513]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Rotary Health/Hooton family Scholarship; Australian Research Council (ARC)(Australian Research Council)	The authors AHK and DSQ are supported by a National Health and Medical Research Council (NHMRC) Career Development Award Fellowship (571101) and an Australian Rotary Health/Hooton family Scholarship, respectively. This study was further supported by NHMRC (632634; 632625) and Australian Research Council (ARC) linkage (LP110100513) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Bartz JA, 2010, P NATL ACAD SCI USA, V107, P21371, DOI 10.1073/pnas.1012669107; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Davis M, 2001, MOL PSYCHIAT; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; Geisler FCM, 2010, PERS INDIV DIFFER, V49, P723, DOI 10.1016/j.paid.2010.06.015; Graustella AJ, 2012, HORM BEHAV, V61, P410, DOI [10.1016/j.yhbeh.2012.01.002, 10.1016/j.yhbeh.2012.04.008]; Grippo A, 2009, PSYCHONEUROENDOCRINO, DOI [10.1016/j.psyneuen.2009.05.017, DOI 10.1016/J.PSY-NEUEN.2009.05.017]; Grippo AJ, 2012, STRESS, V15, P149, DOI 10.3109/10253890.2011.605486; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Huikuri HV, 2009, PHILOS T R SOC A, V367, P1223, DOI 10.1098/rsta.2008.0294; Jankowski M, 2004, P NATL ACAD SCI USA, V101, P13074, DOI 10.1073/pnas.0405324101; Kemp A. H., 2012, PLOS ONE; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; Kemp AH, 2011, CURR DIR PSYCHOL SCI, V20, P222, DOI 10.1177/0963721411417547; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Lorr M, 1971, J CLIN PSYCHIAT, V60, P89; Luft CD, 2009, BIOL PSYCHOL, V82, P196, DOI 10.1016/j.biopsycho.2009.07.007; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; McNair DM, 1992, EDIITS MANUAL PROFIL; Norman GJ, 2011, BIOL PSYCHOL, V86, P174, DOI 10.1016/j.biopsycho.2010.11.006; Oveis C, 2009, EMOTION, V9, P265, DOI 10.1037/a0015383; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; Porges SW, 2011, POLYVAGAL THEORY NEU; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; TRIBOLLET E, 1992, ANN NY ACAD SCI, V652, P29, DOI 10.1111/j.1749-6632.1992.tb34343.x; Tulppo MP, 2005, CIRCULATION, V112, P314, DOI 10.1161/CIRCULATIONAHA.104.523712; Zink CF, 2012, HORM BEHAV, V61, P400, DOI 10.1016/j.yhbeh.2012.01.016	30	79	79	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e44014	10.1371/journal.pone.0044014	http://dx.doi.org/10.1371/journal.pone.0044014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998CA	22937145	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600069
J	Brumme, CJ; Swenson, LC; Wynhoven, B; Yip, B; Skinner, S; Lima, VD; Montaner, JSG; Harrigan, PR				Brumme, Chanson J.; Swenson, Luke C.; Wynhoven, Brian; Yip, Benita; Skinner, Stuart; Lima, Viviane Dias; Montaner, Julio S. G.; Harrigan, P. Richard			Technical and Regulatory Shortcomings of the TaqMan Version 1 HIV Viral Load Assay	PLOS ONE			English	Article							ROCHE COBAS AMPLICOR; VIRUS TYPE-1 RNA; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; PCR ASSAY; PLASMA; QUANTIFICATION; INDIVIDUALS; RECOMMENDATIONS; INTERMITTENT	Background: The lower limit of detection of the original Roche Amplicor HIV plasma viral load (pVL) assay (50 copies/mL) has defined HIV treatment success. The Amplicor assay, however, has been replaced by the Roche TaqMan assay(s). Changes to the limits of detection and calibration have not been validated for clinical utility. Sudden increases in the number of patients with detectable pVL have been reported following the introduction of the TaqMan version 1 assay. Methods: Between October 2009 and April 2010 all routine pVL samples from British Columbia, Canada, with 40250 copies/mL by TaqMan were re-tested by Amplicor (N = 1198). Subsequent short-term virological and resistance outcomes were followed in patients with unchanged therapy (N = 279; median 3.2 months follow-up). Results: TaqMan and Amplicor values correlated poorly at low pVL values. Low-level pVL by TaqMan was not associated with impending short-term virological failure; only 17% of patients with 40-250 copies/mL by TaqMan had detectable pVL by Amplicor at follow-up. During the follow-up period only 20% of patients had an increase in pVL by TaqMan (median [IQR]: 80 [36-283] copies/mL). In addition, in similar to 2.4% of samples pVL was dramatically underestimated by TaqMan due to poor binding of the proprietary TaqMan primers. Conclusions: The replacement of Amplicor with the TaqMan assay has altered the previously accepted definition of HIV treatment failure without any evidence to support the clinical relevance of the new definition. Given the systematic differences in measurement in the low pVL range the British Columbia HIV treatment guidelines now use a threshold of >250 copies/mL by TaqMan to define treatment failure.	[Brumme, Chanson J.; Swenson, Luke C.; Wynhoven, Brian; Yip, Benita; Lima, Viviane Dias; Montaner, Julio S. G.; Harrigan, P. Richard] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Skinner, Stuart] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada; [Lima, Viviane Dias; Montaner, Julio S. G.; Harrigan, P. Richard] Univ British Columbia, Div Aids, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of Saskatchewan; University of British Columbia	Brumme, CJ (corresponding author), St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	prharrigan@cfenet.ubc.ca	Montaner, Julio/K-7621-2012; Swenson, Luke/E-8549-2014	Swenson, Luke/0000-0001-5381-7709; Brumme, Chanson/0000-0003-2722-5288	Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship; Michael Smith Foundation for Health Research; GlaxoSmithKline/CIHR Chair in Clinical Virology	Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); GlaxoSmithKline/CIHR Chair in Clinical Virology(GlaxoSmithKline)	Some for the Amplicor v1.5 and TaqMan v2 testing were donated by Roche Molecular Diagnostics (Laval, Quebec, Canada). Kits for the Abbott RealTime assay were donated by Abbott Molecular Canada (Toronto, Ontario, Canada). CJB is supported by a Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR). LCS is supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship. VDL is supported through a fellowship from the Michael Smith Foundation for Health Research. PRH is supported through a GlaxoSmithKline/CIHR Chair in Clinical Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CS, 2001, AIDS, V15, P601, DOI 10.1097/00002030-200103300-00009; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Chui C, 2006, AIDS RES HUM RETROV, V22, P615, DOI 10.1089/aid.2006.22.615; Damond F, 2007, J CLIN MICROBIOL, V45, P3436, DOI 10.1128/JCM.00973-07; De Bel A, 2010, J CLIN MICROBIOL, V48, P1337, DOI 10.1128/JCM.01226-09; Department of agriculture forestry and fisheries, 2012, GUID US ANT AG HIV 1, P1; Do T, 2011, J CLIN VIROL, V52, pS83, DOI 10.1016/j.jcv.2011.09.022; Doyle T, 2012, CLIN INFECT DIS, V54, P724, DOI 10.1093/cid/cir936; Garcia-Gasco P, 2008, J ANTIMICROB CHEMOTH, V61, P699, DOI 10.1093/jac/dkm516; Grennan JT, 2012, J INFECT DIS, V205, P1230, DOI 10.1093/infdis/jis104; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Lima V, 2009, JAIDS-J ACQ IMM DEF, V51, P3, DOI 10.1097/QAI.0b013e31819e721b; Manavi K, 2008, HIV CLIN TRIALS, V9, P283, DOI 10.1310/hct0904-283; Montaner J, 2011, THERAPEUTIC GUIDELIN; Oliver AR, 2007, J CLIN MICROBIOL, V45, P3616, DOI 10.1128/JCM.00221-07; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Schumacher W, 2007, J CLIN VIROL, V38, P304, DOI 10.1016/j.jcv.2006.12.022; Smit E, 2009, JAIDS-J ACQ IMM DEF, V51, P364, DOI 10.1097/QAI.0b013e3181aa13b3; Sun R, 1998, J CLIN MICROBIOL, V36, P2964, DOI 10.1128/JCM.36.10.2964-2969.1998; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Verhofstede C, 2007, J MED VIROL, V79, P1254, DOI 10.1002/jmv.20950; Willig JH, 2010, JAIDS-J ACQ IMM DEF, V54, P442, DOI 10.1097/QAI.0b013e3181d01d1d; Wirden M, 2011, J CLIN MICROBIOL, V49, P2700, DOI 10.1128/JCM.00061-11	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43882	10.1371/journal.pone.0043882	http://dx.doi.org/10.1371/journal.pone.0043882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937116	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500118
J	Gorochowski, TE; Matyjaszkiewicz, A; Todd, T; Oak, N; Kowalska, K; Reid, S; Tsaneva-Atanasova, KT; Savery, NJ; Grierson, CS; di Bernardo, M				Gorochowski, Thomas E.; Matyjaszkiewicz, Antoni; Todd, Thomas; Oak, Neeraj; Kowalska, Kira; Reid, Stephen; Tsaneva-Atanasova, Krasimira T.; Savery, Nigel J.; Grierson, Claire S.; di Bernardo, Mario			BSim: An Agent-Based Tool for Modeling Bacterial Populations in Systems and Synthetic Biology	PLOS ONE			English	Article							QUORUM; DISCRETE; NETWORK	Large-scale collective behaviors such as synchronization and coordination spontaneously arise in many bacterial populations. With systems biology attempting to understand these phenomena, and synthetic biology opening up the possibility of engineering them for our own benefit, there is growing interest in how bacterial populations are best modeled. Here we introduce BSim, a highly flexible agent-based computational tool for analyzing the relationships between single-cell dynamics and population level features. BSim includes reference implementations of many bacterial traits to enable the quick development of new models partially built from existing ones. Unlike existing modeling tools, BSim fully considers spatial aspects of a model allowing for the description of intricate micro-scale structures, enabling the modeling of bacterial behavior in more realistic three-dimensional, complex environments. The new opportunities that BSim opens are illustrated through several diverse examples covering: spatial multicellular computing, modeling complex environments, population dynamics of the lac operon, and the synchronization of genetic oscillators. BSim is open source software that is freely available from http://bsim-bccs.sf.net and distributed under the Open Source Initiative (OSI) recognized MIT license. Developer documentation and a wide range of example simulations are also available from the website. BSim requires Java version 1.6 or higher.	[Gorochowski, Thomas E.; Matyjaszkiewicz, Antoni; Todd, Thomas; Oak, Neeraj; Reid, Stephen] Univ Bristol, Dept Engn Math, Bristol Ctr Complex Sci, Bristol, Avon, England; [Savery, Nigel J.] Univ Walk, Sch Biochem, Bristol, Avon, England; [Grierson, Claire S.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [di Bernardo, Mario] Univ Naples Federico II, Dept Syst & Comp Engn, Naples, Italy	University of Bristol; University of Bristol; University of Bristol; University of Naples Federico II	Gorochowski, TE (corresponding author), Univ Bristol, Dept Engn Math, Bristol Ctr Complex Sci, Bristol, Avon, England.	thomas.gorochowski@bristol.ac.uk	di Bernardo, Mario/AAL-9311-2021; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; di Bernardo, Mario/I-2805-2012	di Bernardo, Mario/0000-0002-2171-4745; Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Savery, Nigel/0000-0002-0803-4075; Gorochowski, Thomas/0000-0003-1702-786X; Matyjaszkiewicz, Antoni/0000-0002-8647-5773	Engineering and Physical Sciences Research Council (EPSRC) United Kingdom [EP/E501214/1, EP/I018638/1]; Biotechnology and Biological Sciences Research Council United Kingdom, Cell Signalling Network SIGNET; Faculty of Engineering, University of Bristol, United Kingdom; EPSRC [EP/I018638/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I018638/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC) United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council United Kingdom, Cell Signalling Network SIGNET(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Faculty of Engineering, University of Bristol, United Kingdom; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	TEG, SR, TT and NO were supported by Engineering and Physical Sciences Research Council (EPSRC) United Kingdom Grant No. EP/E501214/1. AM was supported by the Biotechnology and Biological Sciences Research Council United Kingdom, Cell Signalling Network SIGNET. KK was supported by an EPSRC Summer Vacation Bursary from the Faculty of Engineering, University of Bristol, United Kingdom. KTT-A was supported by EPSRC United Kingdom Grant No. EP/I018638/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Jacob E, 1998, ANNU REV MICROBIOL, V52, P779, DOI 10.1146/annurev.micro.52.1.779; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Chen BS, 2009, BIOINFORMATICS, V25, P1822, DOI 10.1093/bioinformatics/btp310; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Chung JD, 1996, CHEM ENG SCI, V51, P1509, DOI 10.1016/0009-2509(95)00306-1; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Emonet T, 2005, BIOINFORMATICS, V21, P2714, DOI 10.1093/bioinformatics/bti391; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Fozard J, 2012, BIOSYSTEMS; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Heinemann M, 2006, BIOINFORMATICS, V22, P2790, DOI 10.1093/bioinformatics/btl469; Holcombe M, 2012, INTEGR BIOL-UK, V4, P53, DOI 10.1039/c1ib00042j; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Misfeld M, 2007, PHILOS T R SOC B, V362, P1421, DOI 10.1098/rstb.2007.2125; Picioreanu C, 1998, BIOTECHNOL BIOENG, V57, P718, DOI 10.1002/(SICI)1097-0290(19980320)57:6<718::AID-BIT9>3.0.CO;2-O; Picioreanu C, 2004, APPL ENVIRON MICROB, V70, P3024, DOI 10.1128/AEM.70.5.3024-3040.2004; Pitt-Francis J, 2009, COMPUT PHYS COMMUN, V180, P2452, DOI 10.1016/j.cpc.2009.07.019; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Sneddon MW, 2011, NAT METHODS, V8, P177, DOI [10.1038/nmeth.1546, 10.1038/NMETH.1546]; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Tisue S, 2004, NETLOGO SAMPLE ENV M; van Loosdrecht MCM, 2002, ANTON LEEUW INT J G, V81, P245, DOI 10.1023/A:1020527020464; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125	34	59	59	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42790	10.1371/journal.pone.0042790	http://dx.doi.org/10.1371/journal.pone.0042790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936991	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500017
J	Henning, F; Meyer, A				Henning, Frederico; Meyer, Axel			Eggspot Number and Sexual Selection in the Cichlid Fish Astatotilapia burtoni	PLOS ONE			English	Article							ARTIFICIAL SELECTION; EGG-SPOTS; MATING PREFERENCES; WATER TURBIDITY; MANIPULATION; EVOLUTION; DUMMIES; CHOICE	Sexual selection on male coloration is one of the main mechanisms proposed to explain the explosive speciation rates in East African cichlid fish. True eggspots are color patterns characteristic of the most species-rich lineage of cichlids, the Haplochromini, and have been suggested to be causally related to the speciation processes. Eggspots are thought to have originated by sensory exploitation and subsequently gained several roles in sexual advertisement. However, for most of these functions the evidence is equivocal. In addition, the genetic architecture of this trait still is largely unknown. We conducted bidirectional selective breeding experiments for eggspot numbers in the model cichlid, Astatotilapia burtoni. After two generations, low lines responded significantly, whereas the high lines did not. Body size was both phenotypically and genotypically correlated with eggspot number and showed correlated response to selection. Males with higher numbers of eggspots were found to sire larger offspring. Despite the potential to act as honest indicators of fitness, the behavioral experiments showed no evidence of a role in either intra- or inter-sexual selection. Visual-based female preference was instead explained by courtship intensity. The evolution of this trait has been interpreted in light of adaptive theories of sexual selection, however the present and published results suggest the influence of non-adaptive factors such as sensory exploitation, environmental constraints and sexual antagonism.	[Henning, Frederico; Meyer, Axel] Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolutionsbiol, Constance, Germany	University of Konstanz	Henning, F (corresponding author), Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolutionsbiol, Constance, Germany.	axel.meyer@uni-konstanz.de	Meyer, Axel/C-9826-2009; Henning, Frederico/M-8042-2017; Henning, Frederico/AAS-2090-2020	Meyer, Axel/0000-0002-0888-8193; Henning, Frederico/0000-0002-5359-504X; Henning, Frederico/0000-0002-5359-504X	Brazilian National Counsel of Technological and Scientific Development (CNPq)/German Academic Exchange Program (DAAD) cooperation program [GDE 290049/2007-5]; Deutsche Forschungsgemeinschaft; University of Konstanz	Brazilian National Counsel of Technological and Scientific Development (CNPq)/German Academic Exchange Program (DAAD) cooperation program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Konstanz	FH is supported by the Brazilian National Counsel of Technological and Scientific Development (CNPq)/German Academic Exchange Program (DAAD) cooperation program (GDE 290049/2007-5). AM is funded by the Deutsche Forschungsgemeinschaft and the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Arnqvist G, 2006, PHILOS T R SOC B, V361, P375, DOI 10.1098/rstb.2005.1790; Baer CF, 2000, EVOLUTION, V54, P238, DOI 10.1111/j.0014-3820.2000.tb00024.x; Baerends GP, 1950, AN INTRODUCTION TO T; Castillo Cajas Ruth F, 2012, Int J Evol Biol, V2012, P161306, DOI 10.1155/2012/161306; Couldridge VCK, 2002, J FISH BIOL, V60, P726, DOI 10.1006/jfbi.2002.1896; Couldridge VCK, 2001, J FISH BIOL, V59, P667, DOI 10.1006/jfbi.2001.1679; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Crapon de Caprona M, 1983, NETH J ZOOL, V34, P503; Egger B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025601; Endler JA, 2001, AM NAT, V158, P36, DOI 10.1086/320862; Engstrom-Ost J, 2007, BEHAV ECOL, V18, P393, DOI 10.1093/beheco/arl097; Falconer D. S., 1996, Introduction to quantitative genetics.; FERNALD R D, 1977, Environmental Biology of Fishes, V2, P299, DOI 10.1007/BF00005997; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; Frommen JG, 2006, BIOL LETTERS, V2, P232, DOI 10.1098/rsbl.2005.0432; Fuller RC, 2005, INTEGR COMP BIOL, V45, P391, DOI 10.1093/icb/45.3.391; GOLDSCHMIDT T, 1990, ACTA BIOTHEOR, V38, P125, DOI 10.1007/BF00047549; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HERT E, 1989, ANIM BEHAV, V37, P726, DOI 10.1016/0003-3472(89)90058-4; HERT E, 1991, J FISH BIOL, V38, P951, DOI 10.1111/j.1095-8649.1991.tb03634.x; Heule C, 2011, J FISH BIOL, V78, P1588, DOI 10.1111/j.1095-8649.2011.02944.x; HILL WG, 1992, ANNU REV ECOL SYST, V23, P287, DOI 10.1146/annurev.es.23.110192.001443; HOUDE AE, 1994, P ROY SOC B-BIOL SCI, V256, P125, DOI 10.1098/rspb.1994.0059; Jarvenpaa M, 2004, P ROY SOC B-BIOL SCI, V271, P2361, DOI 10.1098/rspb.2004.2870; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konings A., 2016, MALAWI CICHLIDS THEI; Konings A, 2015, TANGANYIKA CICHLIDS; Kotiaho JS, 2008, TRENDS ECOL EVOL, V23, P1, DOI 10.1016/j.tree.2007.09.012; Lehtonen TK, 2008, ANIM BEHAV, V75, P55, DOI 10.1016/j.anbehav.2007.04.011; Lehtonen TK, 2011, P ROY SOC B-BIOL SCI, V278, P2318, DOI 10.1098/rspb.2010.2483; Lynch Michael, 1998; Maruska KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037612; Mulimbwa N, 2010, AQUAT ECOSYST HEALTH, V13, P11, DOI 10.1080/14634981003627342; NICOLETTO PF, 1991, BEHAV ECOL SOCIOBIOL, V28, P365, DOI 10.1007/BF00164386; R Core Team, 2020, R LANG ENV STAT COMP; Rowland WJ, 1995, BEHAVIOUR, V132, P951, DOI 10.1163/156853995X00388; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-51; Schielzeth H, 2012, EVOLUTION, V66, P18, DOI 10.1111/j.1558-5646.2011.01431.x; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Theis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029878; Tobler Michael, 2006, Zeitschrift fuer Fischkunde, V8, P39; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; WICKLER W, 1962, NATURE, V194, P1092, DOI 10.1038/1941092a0; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09	49	9	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43695	10.1371/journal.pone.0043695	http://dx.doi.org/10.1371/journal.pone.0043695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937082	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500084
J	Lei, B				Lei, Bo			Rod-Driven OFF Pathway Responses in the Distal Retina: Dark-Adapted Flicker Electroretinogram in Mouse	PLOS ONE			English	Article							CONE BIPOLAR CELLS; STATIONARY NIGHT BLINDNESS; RHODOPSIN KNOCKOUT MOUSE; OSCILLATORY POTENTIALS; MAMMALIAN RETINA; IN-VIVO; MODEL; ERG; PHOTORECEPTORS; GENE	Purpose: The rodent retina does not exhibit a positive OFF-response in the electroretinogram (ERG), which makes it difficult to evaluate its OFF-pathway functions in vivo. We studied the rod-driven OFF pathway responses by using a dark-adapted 10-Hz flicker ERG procedure in mouse. Materials and Methods: Conventional ERGs and 10-Hz dark-adapted flicker ERGs were obtained in wild-type mice (C57BL/6), in mice with pure rod (cpfl1) or pure cone (rho(-/-)) function, and in nob1 mice which have a selective ON-pathway defect. To isolate the response from ON or OFF pathway, glutamate analogs 2-amino-4-phosphobutyric acid (APB, an ON pathway blocker) and cis-2, 3-piperidine-dicarboxylic acid (PDA, an OFF pathway blocker), were injected intravitreally. Results: The amplitude-intensity profile of the dark-adapted 10-Hz flicker ERG in the wild-type mice exhibits two peaks at middle and high light intensities. The two peaks represent rod-and cone-driven responses respectively. In APB-treated C57BL/6 mice and in nob1 mice, the dark-adapted ERG b-waves were absent. However, both rod-and cone-driven OFF pathway responses were evident with flicker ERG recording. At middle light intensities that activate only rod system, the flicker ERG responses in saline-injected nob1 mice were similar to those in APB-injected cpfl1 mice and wild-type mice. These responses are sensitive to PDA. The amplitudes of these rod-driven OFF pathway responses were approximately 20% of the total rod-driven flicker ERG responses. Conclusion: We demonstrate that the rod-OFF bipolar cell pathway is functional in the outer retina. The dark-adapted flicker ERG is practical for the evaluation of rod-and cone-driven responses, and the residual OFF pathway signals in subjects with ON pathway defects.	[Lei, Bo] Chongqing Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol,Chongqing Eye Inst, Chongqing, Peoples R China; [Lei, Bo] Univ Missouri, Dept Ophthalmol, Dept Vet Med & Surg, Columbia, MO USA	Chongqing Medical University; University of Missouri System; University of Missouri Columbia	Lei, B (corresponding author), Chongqing Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol,Chongqing Eye Inst, Chongqing, Peoples R China.	bolei99@126.com		Lei, Bo/0000-0002-5497-0905	National Natural Science Foundation (NNSF) of China [30973251]; Chongqing Municipal Health Bureau [2010-113]; University of Missouri Research Board [1912]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008 CA5003]	National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC)); Chongqing Municipal Health Bureau; University of Missouri Research Board; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC)	Supported in part by National Natural Science Foundation (NNSF) of China (30973251, www.nsfc.gov.cn), Chongqing Municipal Health Bureau (2010-113, www.cqwsj.gov.cn), University of Missouri Research Board (# 1912 research.missouri.edu/funding/board) and the Project of Chongqing Key Laboratory of Ophthalmology (CSTC, 2008 CA5003, www.ctin.ac.cn). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KR, 1992, INVEST OPHTH VIS SCI, V33, P477; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Fyk-Kolodziej B, 2003, J COMP NEUROL, V464, P104, DOI 10.1002/cne.10784; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Kondo M, 2002, INVEST OPHTH VIS SCI, V43, P2500; Kondo M, 2001, INVEST OPHTH VIS SCI, V42, P305; Krishna VR, 2002, J NEUROPHYSIOL, V87, P42, DOI 10.1152/jn.00489.2001; Lei B, 2000, INVEST OPHTH VIS SCI, V41, P262; Lei B, 2006, INVEST OPHTH VIS SCI, V47, P2732, DOI 10.1167/iovs.05-1461; Li W, 2004, J COMP NEUROL, V474, P1, DOI 10.1002/cne.20075; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; Miyake Y, 1996, JPN J OPHTHALMOL, V40, P511; Nusinowitz S, 2007, EXP EYE RES, V84, P1104, DOI 10.1016/j.exer.2007.02.009; Pang JJ, 2010, P NATL ACAD SCI USA, V107, P395, DOI 10.1073/pnas.0907178107; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Protti DA, 2005, J NEUROPHYSIOL, V93, P3479, DOI 10.1152/jn.00839.2004; Ridder WH, 2006, VISION RES, V46, P902, DOI 10.1016/j.visres.2005.09.006; Robson JG, 2004, VISION RES, V44, P3253, DOI 10.1016/j.visres.2004.09.002; Rodieck R.W., 1998, 1 STEPS SEEING; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Scholl HPN, 2002, INVEST OPHTH VIS SCI, V43, P1248; Scholl HPN, 2001, INVEST OPHTH VIS SCI, V42, P2728; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Sharma S, 2005, VISUAL NEUROSCI, V22, P631, DOI 10.1017/S0952523805225129; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; SHARPE LT, 1993, VISION RES, V33, P2705, DOI 10.1016/0042-6989(93)90230-T; SIEVING PA, 1994, VISUAL NEUROSCI, V11, P519, DOI 10.1017/S0952523800002431; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Strettoi E, 2010, PROG RETIN EYE RES, V29, P272, DOI 10.1016/j.preteyeres.2010.03.005; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Tsukamoto Y, 2007, J NEUROSCI, V27, P6261, DOI 10.1523/JNEUROSCI.5646-06.2007; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Yao G, 2006, CURR EYE RES, V31, P925, DOI 10.1080/02713680600932308; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zhang K, 2007, DOC OPHTHALMOL, V115, P85, DOI 10.1007/s10633-007-9061-1	44	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43856	10.1371/journal.pone.0043856	http://dx.doi.org/10.1371/journal.pone.0043856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937111	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500113
J	Wang, RJ; Jian, FC; Zhang, LX; Ning, CS; Liu, AQ; Zhao, JF; Feng, YY; Qi, M; Wang, HL; Lv, CC; Zhao, GH; Xiao, LH				Wang, Rongjun; Jian, Fuchun; Zhang, Longxian; Ning, Changshen; Liu, Aiqin; Zhao, Jinfeng; Feng, Yaoyu; Qi, Meng; Wang, Helei; Lv, Chaochao; Zhao, Guanghui; Xiao, Lihua			Multilocus Sequence Subtyping and Genetic Structure of Cryptosporidium muris and Cryptosporidium andersoni	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; POPULATION STRUCTURES; MOLECULAR ANALYSIS; NATURAL INFECTION; APICOMPLEXA; PREVALENCE; GENOTYPE; IDENTIFICATION; INDIVIDUALS; PARASITES	In this study, nine C. muris and 43 C. andersoni isolates from various animals in China were subtyped by a multilocus sequence typing (MLST) tool. DNA sequence analyses showed the presence of 1-2 subtypes of C. muris and 2-6 subtypes of C. andersoni at each of the four loci (MS1, MS2, MS3, and MS16), nine of which represented new subtypes. Altogether, two C. muris and 10 C. andersoni MLST subtypes were detected. Linkage disequilibrium analysis indicated although the overall population structure of the two parasites was clonal, the Chinese C. andersoni in cattle has an epidemic structure. Three and two clusters were produced in the C. muris and C. andersoni populations by Structure 2.3.3 analysis, with Chinese C. muris and C. andersoni substructures differing from other countries. Thus, this study suggested the prevalence of C. andersoni in China is not attributed to the introduction of dairy cattle. More studies involving more genetic loci and systematic sampling are needed to better elucidate the population genetic structure of C. muris and C. andersoni in the world and the genetic basis for the difference in host specificity among the two most common gastric parasites.	[Wang, Rongjun; Jian, Fuchun; Zhang, Longxian; Ning, Changshen; Zhao, Jinfeng; Qi, Meng; Wang, Helei; Lv, Chaochao] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Liu, Aiqin] Harbin Med Univ, Dept Parasitol, Harbin, Peoples R China; [Feng, Yaoyu] E China Univ Sci & Technol, Sch Resource & Environm Engn, Shanghai 200237, Peoples R China; [Zhao, Guanghui] NW A&F Univ, Coll Vet Med, Yangling, Peoples R China; [Xiao, Lihua] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Henan Agricultural University; Harbin Medical University; East China University of Science & Technology; Northwest A&F University - China; Centers for Disease Control & Prevention - USA	Wang, RJ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	zhanglx8999@yahoo.com.cn; lxiao@cdc.gov	Feng, Yaoyu/S-1979-2019; Zhang, Longxian/R-7799-2019; Zhang, Longxian/I-9223-2019; Xiao, Lihua/B-1704-2013; Zhang, Longxian/HGE-1918-2022; Feng, Yaoyu/B-3076-2014	Feng, Yaoyu/0000-0002-8380-1246; Zhang, Longxian/0000-0002-5706-131X; Xiao, Lihua/0000-0001-8532-2727; Feng, Yaoyu/0000-0002-8380-1246	National Natural Science Foundation of China [31172311, 31101805]; Key National Science and Technology Specific Projects [2012ZX10004220-001]; International Cooperation and Exchange of the National Natural Science Foundation of China [31110103901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National Science and Technology Specific Projects; International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (No. 31172311, 31101805)(http://www.nsfc.gov.cn/Portal0/default152.htm); the Key National Science and Technology Specific Projects (No. 2012ZX10004220-001)(http://www.nmp.gov.cn/); the International Cooperation and Exchange of the National Natural Science Foundation of China (No. 31110103901)(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Brikan Faten A., 2008, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V38, P645; Dubey JP, 2002, VET PATHOL, V39, P363, DOI 10.1354/vp.39-3-363; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feng YY, 2011, J CLIN MICROBIOL, V49, P34, DOI 10.1128/JCM.01329-10; Gatei W, 2002, EMERG INFECT DIS, V8, P204, DOI 10.3201/eid0802.010256; Gatei W, 2003, J CLIN MICROBIOL, V41, P1458, DOI 10.1128/JCM.41.4.1458-1462.2003; Gatei W, 2006, AM J TROP MED HYG, V75, P78, DOI 10.4269/ajtmh.2006.75.78; Guyot K, 2001, J CLIN MICROBIOL, V39, P3472, DOI 10.1128/JCM.39.10.3472-3480.2001; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hikosaka K, 2005, PARASITOL RES, V97, P373, DOI 10.1007/s00436-005-1459-7; Hurkova L, 2003, J WILDLIFE DIS, V39, P441; Jiang XS, 1989, J SW U, V15, P18; Katsumata T, 2000, AM J TROP MED HYG, V62, P70, DOI 10.4269/ajtmh.2000.62.70; Kodadkova A, 2010, J PARASITOL, V96, P211, DOI 10.1645/GE-2212.1; Kvac M, 2008, VET PARASITOL, V153, P363, DOI 10.1016/j.vetpar.2008.01.033; Kvac M, 2009, VET PARASITOL, V160, P319, DOI 10.1016/j.vetpar.2008.11.007; Leoni F, 2006, J MED MICROBIOL, V55, P703, DOI 10.1099/jmm.0.46251-0; Lindsay DS, 2000, J EUKARYOT MICROBIOL, V47, P91, DOI 10.1111/j.1550-7408.2000.tb00016.x; Lupo PJ, 2008, AM J TROP MED HYG, V78, P917, DOI 10.4269/ajtmh.2008.78.917; Lv CC, 2009, APPL ENVIRON MICROB, V75, P7692, DOI 10.1128/AEM.01386-09; Mallon M, 2003, J MOL EVOL, V56, P407, DOI 10.1007/s00239-002-2412-3; Matsubayashi M, 2005, VET PARASITOL, V129, P165, DOI 10.1016/j.vetpar.2005.01.003; Morgan UM, 2000, PARASITOLOGY, V120, P457, DOI 10.1017/S0031182099005703; Morse TD, 2007, EPIDEMIOL INFECT, V135, P1307, DOI 10.1017/S0950268806007758; Muthusamy D, 2006, J CLIN MICROBIOL, V44, P632, DOI 10.1128/JCM.44.2.632-634.2006; Ng J, 2006, APPL ENVIRON MICROB, V72, P7548, DOI 10.1128/AEM.01352-06; Ngouanesavanh T, 2006, J EUKARYOT MICROBIOL, V53, pS33, DOI 10.1111/j.1550-7408.2006.00166.x; Palmer CJ, 2003, EMERG INFECT DIS, V9, P1174; Pavlasek I, 2007, VET PARASITOL, V144, P349, DOI 10.1016/j.vetpar.2006.10.005; Santin M, 2005, J PARASITOL, V91, P712, DOI 10.1645/GE-3438RN; Santin M, 2006, VET PARASITOL, V141, P334, DOI 10.1016/j.vetpar.2006.06.004; Tanriverdi S, 2008, APPL ENVIRON MICROB, V74, P7227, DOI 10.1128/AEM.01576-08; Tiangtip R, 2002, TROP MED INT HEALTH, V7, P357, DOI 10.1046/j.1365-3156.2002.00855.x; Wang RJ, 2008, PARASITOL RES, V102, P915, DOI 10.1007/s00436-007-0851-x; Wang RJ, 2011, PARASITOL INT, V60, P1, DOI 10.1016/j.parint.2010.09.002; Wang RJ, 2011, J CLIN MICROBIOL, V49, P1077, DOI 10.1128/JCM.02194-10; Wang YL, 2010, PARASITOL RES, V106, P341, DOI 10.1007/s00436-009-1664-x; Warren KS, 2003, AUST VET J, V81, P739, DOI 10.1111/j.1751-0813.2003.tb14602.x; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao Lihua, 2007, P119; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Zhang KZ, 2003, CHINA ANIMAL HUSBAND, V11, P26; Zintl A, 2007, PARASITOLOGY, V134, P1575, DOI 10.1017/S0031182007002983	43	32	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43782	10.1371/journal.pone.0043782	http://dx.doi.org/10.1371/journal.pone.0043782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937094	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500096
J	Ardanuy, C; Marimon, JM; Calatayud, L; Gimenez, M; Alonso, M; Grau, I; Pallares, R; Perez-Trallero, E; Linares, J				Ardanuy, Carmen; Maria Marimon, Jose; Calatayud, Laura; Gimenez, Montserrat; Alonso, Marta; Grau, Immaculada; Pallares, Roman; Perez-Trallero, Emilio; Linares, Josefina			Epidemiology of Invasive Pneumococcal Disease in Older People in Spain (2007-2009): Implications for Future Vaccination Strategies	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE SEROTYPES; CONJUGATE VACCINE; ANTIMICROBIAL RESISTANCE; TEMPORAL TRENDS; DRUG-RESISTANT; UNITED-STATES; EMERGENCE; 19A; REPLACEMENT; CHILDREN	Background: Recently, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended for adults. We analyzed the epidemiology of invasive pneumococcal disease (IPD) in older adults in Spain before PCV13 introduction. Methodology/Principal Findings: IPD episodes, defined as clinical findings together with an invasive pneumococcal isolate, were prospectively collected from patients aged over 65 years in three hospitals in Spain from 2007 to 2009. A total of 335 IPD episodes were collected. Pneumonia was the main clinical syndrome, while chronic obstructive pulmonary disease, diabetes mellitus and cancer were the main underlying diseases. Pneumococcal isolates were serotyped and the molecular typing was performed by PFGE/MLST. PCV13 serotypes accounted for 59.3% of isolates, the most prevalent being serotypes 19A (15.1%), 3 (9.6%), 7F (7.5%), 14 (6.9%) and 1 (5.4%). The most frequent non-PCV13 serotypes were serotypes 16F (4.5%), 22F (3.6%), 24F (3.3%) and 6C (2.1%). The most common genotypes were CC230 (8.5%, serotypes 19A and 24F), CC156 (8.2%, serotypes 9V and 14), ST191 (7.9%, serotype 7F), CC260 (6.6%, serotype 3), ST306 (5.2%, serotype 1), CC30 (4.6%, serotype 16F) and ST433 (3.6%, serotype 22F). Comparing the 335 IPD isolates to 174 invasive pneumococci collected at the same hospitals in 1999-2000, PCV7 serotypes decreased (45.4% vs 18.4%, p<0.001), non-PCV7 serotypes included in PCV13 increased (26.4% vs 41.0%, p = 0.001) and two non-PCV13 serotypes increased (serotype 6C 0% vs 2.1%, p = 0.05; serotype 24F 0.6% vs 3.3%, p = 0.04,). Conclusion: In our older adult population two serotypes (19A and 3) included in PCV13 accounted for about a quarter of IPD episodes in people >= 65 years. Non-PCV13 emerging serotypes should be carefully monitored in future surveillance studies.	[Ardanuy, Carmen; Calatayud, Laura; Linares, Josefina] Univ Barcelona, Dept Microbiol, Hosp Univ Bellvitge, IDIBELL, Barcelona, Spain; [Ardanuy, Carmen; Maria Marimon, Jose; Calatayud, Laura; Gimenez, Montserrat; Alonso, Marta; Grau, Immaculada; Pallares, Roman; Perez-Trallero, Emilio; Linares, Josefina] CIBER Enfermedades Resp CIBERES ISCII, Madrid, Spain; [Maria Marimon, Jose; Alonso, Marta; Perez-Trallero, Emilio] Hosp Univ Donostia, Dept Microbiol, Donostia San Sebastian, Spain; [Gimenez, Montserrat] Hosp Badalona Germans Trias & Pujol, Dept Microbiol, Barcelona, Spain; [Grau, Immaculada; Pallares, Roman] Univ Barcelona, Dept Infect Dis, Hosp Univ Bellvitge, IDIBELL, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Germans Trias i Pujol; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Ardanuy, C (corresponding author), Univ Barcelona, Dept Microbiol, Hosp Univ Bellvitge, IDIBELL, Barcelona, Spain.	c.ardanuy@bellvitgehospital.cat	PALLARES, Roman/B-5710-2008; MARIMON, JOSE MARIA/AAM-5581-2021; Ardanuy, Carmen/C-4463-2015; Liñares, Josefina/N-9450-2014	PALLARES, Roman/0000-0003-3262-8508; MARIMON, JOSE MARIA/0000-0002-2787-7094; Grau, Imma/0000-0002-3040-8184; Ardanuy, Carmen/0000-0003-0225-607X; Gimenez, Montserrat/0000-0001-8841-810X; Alonso, Marta/0000-0002-8909-4968	Fondo de Investigaciones Sanitarias [PI081922, PI090104, PI1000127, PI11/0763]; Basque Government [2009/111012]; CIBER de Enfermedades Respiratorias (CIBERES)	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Basque Government(Basque Government); CIBER de Enfermedades Respiratorias (CIBERES)	This work was supported by grants from the "Fondo de Investigaciones Sanitarias" (PI081922, PI090104, PI1000127, and PI11/0763), the Basque Government 2009/111012 and by CIBER de Enfermedades Respiratorias (CIBERES), a project run by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2012, 8 INT S PNEUM PNEUM; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Calatayud L, 2010, J CLIN MICROBIOL, V48, P1310, DOI 10.1128/JCM.01868-09; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Clinical and Laboratory Standard Institute, 2009, M7A8 CLSINCCLS, V29; Clinical Laboratory Standard Institute, 2011, M100S21 CLSINCCLS, V31; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Fenoll A, 1997, J CLIN MICROBIOL, V35, P764, DOI 10.1128/JCM.35.3.764-766.1997; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Grall N, 2011, EUR J CLIN MICROBIOL, V30, P1511, DOI 10.1007/s10096-011-1251-9; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Marimon JM, 2010, J MICROBIOL METH, V80, P274, DOI 10.1016/j.mimet.2010.01.011; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Nuorti J. P., 2010, Morbidity and Mortality Weekly Report, V59, P1102; Obando I, 2008, EMERG INFECT DIS, V14, P1390, DOI 10.3201/eid1409.071094; Pantosti A, 2002, CLIN INFECT DIS, V35, P205, DOI 10.1086/341250; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Perez-Trallero E, 2009, EUR J CLIN MICROBIOL, V28, P731, DOI 10.1007/s10096-008-0693-1; Picazo J, 2012, 8 INT S PNEUM PNEUM; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; van der Linden M., 2012, 8 INT S PNEUM PNEUM; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	33	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43619	10.1371/journal.pone.0043619	http://dx.doi.org/10.1371/journal.pone.0043619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928005	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300075
J	Jasuja, S; Thompson, ND; Peters, PJ; Khudyakov, YE; Patel, MT; Linchangco, P; Thai, HT; Switzer, WM; Shankar, A; Heneine, W; Hu, DJ; Moorman, AC; Gerber, SI				Jasuja, Supriya; Thompson, Nicola D.; Peters, Philip J.; Khudyakov, Yury E.; Patel, Megan T.; Linchangco, Purisima; Thai, Hong T.; Switzer, William M.; Shankar, Anupama; Heneine, Walid; Hu, Dale J.; Moorman, Anne C.; Gerber, Susan I.			Investigation of Hepatitis B Virus and Human Immunodeficiency Virus Transmission among Severely Mentally Ill Residents at a Long Term Care Facility	PLOS ONE			English	Article							BLOOD-BORNE INFECTIONS; UNITED-STATES; HIV; ILLNESS; HEALTH; RECOMMENDATIONS; OUTBREAK; ADULTS	Background: A high prevalence of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections have been reported among persons with severe mental illness. In October, 2009, the Cook County Department of Public Health (CCDPH) initiated an investigation following notification of a cluster of HBV infections among mentally ill residents at a long term care facility (LTCF). Methods: LTCF staff were interviewed and resident medical records were reviewed. Residents were offered testing for HBV, HCV, and HIV. Serum specimens from residents diagnosed with HBV or HIV infection were sent to the Centers for Disease Control and Prevention (CDC) for analysis. Results: Eleven newly diagnosed HBV infections were identified among mentally ill residents at the LTCF. Of these 11 infections, 4 serum specimens were available for complete HBV genome sequencing; all 4 genomes were found to be closely related. Four newly diagnosed HIV infections were identified within this same population. Upon molecular analysis, 2 of 4 HIV sequences from these new infections were found to be nearly identical and formed a tight phylogenetic cluster. Conclusions: HBV and HIV transmission was identified among mentally ill residents of this LTCF. Continued efforts are needed to prevent bloodborne pathogen transmission among mentally ill residents in LTCFs.	[Jasuja, Supriya; Patel, Megan T.; Linchangco, Purisima; Gerber, Susan I.] Cook Cty Dept Publ Hlth, Oak Forest, IL USA; [Thompson, Nicola D.; Khudyakov, Yury E.; Thai, Hong T.; Hu, Dale J.; Moorman, Anne C.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA; [Peters, Philip J.; Switzer, William M.; Shankar, Anupama; Heneine, Walid] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Jasuja, S (corresponding author), Cook Cty Dept Publ Hlth, Oak Forest, IL USA.	sjasuja@cookcountyhhs.org; sgerber@cookcountyhhs.org		Moorman, Anne/0000-0003-2411-2798				Angelino Andrew F, 2008, Top HIV Med, V16, P99; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brooks JT, 2006, AIDS, V20, P923, DOI 10.1097/01.aids.0000218558.82402.59; Brunette MF, 2003, PSYCHIAT SERV, V54, P860, DOI 10.1176/appi.ps.54.6.860; de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Jafa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005416; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Rosenberg SD, 2001, AM J PUBLIC HEALTH, V91, P31, DOI 10.2105/AJPH.91.1.31; Rosenberg SD, 2003, PSYCHIAT SERV, V54, P827, DOI 10.1176/appi.ps.54.6.827; Thompson ND, 2009, ANN INTERN MED, V150, P33, DOI 10.7326/0003-4819-150-1-200901060-00007; Willenbring ML, 2005, AIDS, V19, pS227, DOI 10.1097/01.aids.0000192094.84624.c2; Wise ME, 2012, AM J INFECT CONTROL, V40, P16, DOI 10.1016/j.ajic.2011.04.331	13	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43252	10.1371/journal.pone.0043252	http://dx.doi.org/10.1371/journal.pone.0043252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937026	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300038
J	Mars, F; Navarro, J				Mars, Franck; Navarro, Jordan			Where We Look When We Drive with or without Active Steering Wheel Control	PLOS ONE			English	Article							MANUO-OCULAR COORDINATION; EYE-MOVEMENTS; TARGET TRACKING; VISION; HAND; MODEL; TIME; FLOW	Current theories on the role of visuomotor coordination in driving agree that active sampling of the road by the driver informs the arm-motor system in charge of performing actions on the steering wheel. Still under debate, however, is the nature of visual cues and gaze strategies used by drivers. In particular, the tangent point hypothesis, which states that drivers look at a specific point on the inside edge line, has recently become the object of controversy. An alternative hypothesis proposes that drivers orient gaze toward the desired future path, which happens to be often situated in the vicinity of the tangent point. The present study contributed to this debate through the analyses of the distribution of gaze orientation with respect to the tangent point. The results revealed that drivers sampled the roadway in the close vicinity of the tangent point rather than the tangent point proper. This supports the idea that drivers look at the boundary of a safe trajectory envelop near the inside edge line. Furthermore, the study investigated for the first time the reciprocal influence of manual control on gaze control in the context of driving. This was achieved through the comparison of gaze behavior when drivers actively steered the vehicle or when steering was performed by an automatic controller. The results showed an increase in look-ahead fixations in the direction of the bend exit and a small but consistent reduction in the time spent looking in the area of the tangent point when steering was passive. This may be the consequence of a change in the balance between cognitive and sensorimotor anticipatory gaze strategies. It might also reflect bidirectional coordination control between the eye and arm-motor systems, which goes beyond the common assumption that the eyes lead the hands when driving.	[Mars, Franck] LUNAM Univ, IRCCyN Inst Rech Commun & Cybernet Nantes, Nantes, France; [Mars, Franck] CNRS, Nantes, France; [Navarro, Jordan] Univ Lyon 2, Lab Etud Mecanismes Cognitifs, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite Lyon 2	Mars, F (corresponding author), LUNAM Univ, IRCCyN Inst Rech Commun & Cybernet Nantes, Nantes, France.	franck.mars@irccyn.ec-nantes.fr	Mars, Franck/O-8100-2019; Navarro, Jordan/H-2956-2017; Mars, Franck/A-8889-2011	Mars, Franck/0000-0002-4140-0049; Navarro, Jordan/0000-0002-1360-9523; 	Agence Nationale de la Recherche (PREVENSOR project) [ANR-05-PDIT-010-01]	Agence Nationale de la Recherche (PREVENSOR project)(French National Research Agency (ANR))	This research was supported by a grant from Agence Nationale de la Recherche (PREVENSOR project, ANR-05-PDIT-010-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariff G, 2002, J NEUROSCI, V22, P7721; Authie CN, 2011, VISION RES, V51, P1791, DOI 10.1016/j.visres.2011.06.010; Bekkering H, 2002, PROG BRAIN RES, V140, P365; Chaib S, 2004, 2004 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P139; Espie S, 2003, DRIV SIM C 2003 N AM; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Hayhoe MM, 2011, WIRES COGN SCI, V2, P158, DOI 10.1002/wcs.113; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kandil FI, 2010, J VISION, V10, DOI 10.1167/10.4.24; Kandil FI, 2009, J VISION, V9, DOI 10.1167/9.1.11; Kim NG, 1999, ECOL PSYCHOL, V11, P233, DOI 10.1207/s15326969eco1103_3; LAND M, 1995, NATURE, V377, P339, DOI 10.1038/377339a0; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Lazzari S, 1997, BIOL CYBERN, V77, P257, DOI 10.1007/s004220050386; Lecoutre B, 1992, PROGRAMME ANAL COMP; Marple-Horvat DE, 2005, EXP BRAIN RES, V163, P411, DOI 10.1007/s00221-004-2192-7; Mars Franck, 2008, Proceedings of the Human Factors and Ergonomics Society. 52nd Annual Meeting, P1541; Mars F., 2011, P HUMAN FACTORS ERGO, V55, P1422, DOI DOI 10.1177/1071181311551296; Mars F, 2008, J VISION, V8, DOI 10.1167/8.11.10; Mennie N, 2007, EXP BRAIN RES, V179, P427, DOI 10.1007/s00221-006-0804-0; Miall RC, 2002, BRAIN COGNITION, V48, P212, DOI 10.1006/brcg.2001.1314; MOURANT RR, 1972, HUM FACTORS, V14, P325, DOI 10.1177/001872087201400405; Panerai F, 2007, INGENIEURS AUTOMOBIL, V786, P55; Reina GA, 2003, HUM MOVEMENT SCI, V22, P137, DOI 10.1016/S0167-9457(02)00156-2; Robertshaw KD, 2008, J VISION, V8, DOI 10.1167/8.4.18; Rouanet H, 1996, PSYCHOL BULL, V119, P149; Saleh L, 2011, 18 WORLD C IFAC, V44, P4368, DOI DOI 10.3182/20110828-6-IT-1002.02349; Salvucci DD, 2004, PERCEPTION, V33, P1233, DOI 10.1068/p5343; Sentouh C, 2009, IEEE INT C SYST MAN, DOI [10.1109/ICSMC.2009.5346350, DOI 10.1109/ICSMC.2009.5346350]; STEINBACH MJ, 1969, J EXP PSYCHOL, V82, P366, DOI 10.1037/h0028115; Summala H, 1996, HUM FACTORS, V38, P442, DOI 10.1518/001872096778701944; VERCHER JL, 1988, EXP BRAIN RES, V73, P155, DOI 10.1007/BF00279669; Vercher JL, 1997, BIOL CYBERN, V77, P267, DOI 10.1007/s004220050387; Wann J, 2000, TRENDS COGN SCI, V4, P319, DOI 10.1016/S1364-6613(00)01513-8; Wann JP, 2000, NAT NEUROSCI, V3, P647, DOI 10.1038/76602; Wilkie RM, 2010, EXP BRAIN RES, V204, P539, DOI 10.1007/s00221-010-2321-4; Wilkie RM, 2003, J VISION, V3, P677, DOI 10.1167/3.11.3; Wilson M, 2007, EXP BRAIN RES, V176, P397, DOI 10.1007/s00221-006-0623-3	40	50	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43858	10.1371/journal.pone.0043858	http://dx.doi.org/10.1371/journal.pone.0043858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22928043	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300094
J	Nagarkatti, R; Bist, V; Sun, S; de Araujo, FF; Nakhasi, HL; Debrabant, A				Nagarkatti, Rana; Bist, Vaibhav; Sun, Sirena; de Araujo, Fernanda Fortes; Nakhasi, Hira L.; Debrabant, Alain			Development of an Aptamer-Based Concentration Method for the Detection of Trypanosoma cruzi in Blood	PLOS ONE			English	Article							IN-VITRO SELECTION; CHAGAS-DISEASE PATIENTS; RNA APTAMERS; AFRICAN TRYPANOSOMES; PCR; POLYMERASE; SURFACE; ASSAY; LIGANDS; SAMPLES	Trypanosoma cruzi, a blood-borne parasite, is the etiological agent of Chagas disease. T. cruzi trypomastigotes, the infectious life cycle stage, can be detected in blood of infected individuals using PCR-based methods. However, soon after a natural infection, or during the chronic phase of Chagas disease, the number of parasites in blood may be very low and thus difficult to detect by PCR. To facilitate PCR-based detection methods, a parasite concentration approach was explored. A whole cell SELEX strategy was utilized to develop serum stable RNA aptamers that bind to live T. cruzi trypomastigotes. These aptamers bound to the parasite with high affinities (8-25 nM range). The highest affinity aptamer, Apt68, also demonstrated high specificity as it did not interact with the insect stage epimastigotes of T. cruzi nor with other related trypanosomatid parasites, L. donovani and T. brucei, suggesting that the target of Apt68 was expressed only on T. cruzi trypomastigotes. Biotinylated Apt68, immobilized on a solid phase, was able to capture live parasites. These captured parasites were visible microscopically, as large motile aggregates, formed when the aptamer coated paramagnetic beads bound to the surface of the trypomastigotes. Additionally, Apt68 was also able to capture and aggregate trypomastigotes from several isolates of the two major genotypes of the parasite. Using a magnet, these parasite-bead aggregates could be purified from parasite-spiked whole blood samples, even at concentrations as low as 5 parasites in 15 ml of whole blood, as detected by a real-time PCR assay. Our results show that aptamers can be used as pathogen specific ligands to capture and facilitate PCR-based detection of T. cruzi in blood.	[Nagarkatti, Rana; Bist, Vaibhav; Sun, Sirena; de Araujo, Fernanda Fortes; Nakhasi, Hira L.; Debrabant, Alain] US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Nagarkatti, R (corresponding author), US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	alain.debrabant@fda.hhs.gov			FDA under FDA Critical Path Initiative	FDA under FDA Critical Path Initiative	This work was supported by FDA internal funding under the FDA Critical Path Initiative. No external funding sources were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NW, 1987, EXP PARASITOL, V64, P474, DOI 10.1016/0014-4894(87)90062-2; Bern C, 2008, CURR OPIN INFECT DIS, V21, P476, DOI 10.1097/QCO.0b013e32830ef5b6; Bern C, 2011, ADV PARASIT, V75, P19, DOI 10.1016/B978-0-12-385863-4.00002-2; Brasil PEAA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-337; Britto CC, 2009, MEM I OSWALDO CRUZ, V104, P122, DOI 10.1590/S0074-02762009000900018; Cordero EM, 2009, J PROTEOME RES, V8, P3642, DOI 10.1021/pr800887u; Debrabant A, 2000, J BIOL CHEM, V275, P16366, DOI 10.1074/jbc.M908725199; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; DIAZ C, 1992, AM J TROP MED HYG, V46, P616, DOI 10.4269/ajtmh.1992.46.616; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; FAUCHER JF, 1995, PARASITOL RES, V81, P441, DOI 10.1007/BF00931508; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Gorlin J, 2008, TRANSFUSION, V48, P531, DOI 10.1111/j.1537-2995.2007.01566.x; Guthrie JW, 2006, METHODS, V38, P324, DOI 10.1016/j.ymeth.2006.01.001; Homann M, 1999, NUCLEIC ACIDS RES, V27, P2006, DOI 10.1093/nar/27.9.2006; Huang FQ, 2008, NAT PROTOC, V3, P1848, DOI 10.1038/nprot.2008.185; Huang Y, 1997, BIOCHEMISTRY-US, V36, P8231, DOI 10.1021/bi962674l; Jhaveri SD, 2001, CURR PROTOC NUCL ACI; Keefe AD, 2008, CURR OPIN CHEM BIOL, V12, P448, DOI 10.1016/j.cbpa.2008.06.028; Lescure FX, 2010, LANCET INFECT DIS, V10, P556, DOI 10.1016/S1473-3099(10)70098-0; LINGNER J, 1993, NUCLEIC ACIDS RES, V21, P2917, DOI 10.1093/nar/21.12.2917; Lorger M, 2003, EUKARYOT CELL, V2, P84, DOI 10.1128/EC.2.1.84-94.2003; Marro ML, 2006, BIOCHEM BIOPH RES CO, V349, P270, DOI 10.1016/j.bbrc.2006.08.029; Martin JA, 2011, MOL BIOSYST, V7, P1720, DOI 10.1039/c0mb00311e; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Padilla R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf138; Andreu GLP, 2009, ARZNEIMITTELFORSCH, V59, P207; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Takemura K, 2006, EXP BIOL MED, V231, P204; Teixeira ARL, 2006, POSTGRAD MED J, V82, P788, DOI 10.1136/pgmj.2006.047357; Torres-Chavolla E, 2009, BIOSENS BIOELECTRON, V24, P3175, DOI 10.1016/j.bios.2008.11.010; Ulrich H, 2002, J BIOL CHEM, V277, P20756, DOI 10.1074/jbc.M111859200; Vant-Hull B., 2000, CURR PROTOC NUCL ACI; VOLLER A, 1977, T ROY SOC TROP MED H, V71, P431, DOI 10.1016/0035-9203(77)90046-3; Zuker M, 1994, Methods Mol Biol, V25, P267; Zulantay I, 2011, J ANTIMICROB CHEMOTH, V66, P2224, DOI 10.1093/jac/dkr313	40	35	39	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43533	10.1371/journal.pone.0043533	http://dx.doi.org/10.1371/journal.pone.0043533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927983	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300063
J	Fagundo, AB; de la Torre, R; Jimenez-Murcia, S; Aguera, Z; Granero, R; Tarrega, S; Botella, C; Banos, R; Fernandez-Real, JM; Rodriguez, R; Forcano, L; Fruhbeck, G; Gomez-Ambrosi, J; Tinahones, FJ; Fernandez-Garcia, JC; Casanueva, FF; Fernandez-Aranda, F				Fagundo, Ana B.; de la Torre, Rafael; Jimenez-Murcia, Susana; Agueera, Zaida; Granero, Roser; Tarrega, Salome; Botella, Cristina; Banos, Rosa; Fernandez-Real, Jose M.; Rodriguez, Roser; Forcano, Laura; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Tinahones, Francisco J.; Fernandez-Garcia, Jose C.; Casanueva, Felipe F.; Fernandez-Aranda, Fernando			Executive Functions Profile in Extreme Eating/Weight Conditions: From Anorexia Nervosa to Obesity	PLOS ONE			English	Article							IOWA-GAMBLING-TASK; EATING-DISORDERS; DECISION-MAKING; COGNITIVE FUNCTION; SHARED RISK; OVERWEIGHT; BULIMIA; UNDERWEIGHT; ADDICTION; DEFICITS	Background: Extreme weight conditions (EWC) groups along a continuum may share some biological risk factors and intermediate neurocognitive phenotypes. A core cognitive trait in EWC appears to be executive dysfunction, with a focus on decision making, response inhibition and cognitive flexibility. Differences between individuals in these areas are likely to contribute to the differences in vulnerability to EWC. The aim of the study was to investigate whether there is a common pattern of executive dysfunction in EWC while comparing anorexia nervosa patients (AN), obese subjects (OB) and healthy eating/weight controls (HC). Methods: Thirty five AN patients, fifty two OB and one hundred thirty seven HC were compared using the Wisconsin Card Sorting Test (WCST); Stroop Color and Word Test (SCWT); and Iowa Gambling Task (IGT). All participants were female, aged between 18 and 60 years. Results: There was a significant difference in IGT score (F(1.79); p<.001), with AN and OB groups showing the poorest performance compared to HC. On the WCST, AN and OB made significantly more errors than controls (F(25.73); p<.001), and had significantly fewer correct responses (F(2.71); p<.001). Post hoc analysis revealed that the two clinical groups were not significantly different from each other. Finally, OB showed a significant reduced performance in the inhibition response measured with the Stroop test (F(5.11); p<.001) compared with both AN and HC. Conclusions: These findings suggest that EWC subjects (namely AN and OB) have similar dysfunctional executive profile that may play a role in the development and maintenance of such disorders.	[Fagundo, Ana B.; Jimenez-Murcia, Susana; Fernandez-Aranda, Fernando] Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain; [de la Torre, Rafael; Jimenez-Murcia, Susana; Agueera, Zaida; Granero, Roser; Tarrega, Salome; Botella, Cristina; Banos, Rosa; Fernandez-Real, Jose M.; Rodriguez, Roser; Forcano, Laura; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Tinahones, Francisco J.; Fernandez-Garcia, Jose C.; Casanueva, Felipe F.; Fernandez-Aranda, Fernando] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain; [de la Torre, Rafael] IMIM Hosp Mar Res Inst, Neurosci Res Program, Human Pharmacol & Clin Neurosci Res Grp, Barcelona, Spain; [Jimenez-Murcia, Susana; Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, E-08007 Barcelona, Spain; [Granero, Roser; Tarrega, Salome] Univ Autonoma Barcelona, Dept Psicobiol & Metodol, Lab Estadist Aplicada, Barcelona, Spain; [Botella, Cristina] Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain; [Banos, Rosa] Univ Valencia, Dept Pyschol Personal Evaluat & Treatment, E-46003 Valencia, Spain; [Fernandez-Real, Jose M.; Rodriguez, Roser] Hosp Dr Josep Trueta, Inst Invest Biomed Girona IdlBGi, Serv Diabet Endocrinol & Nutr, Girona, Spain; [Fruehbeck, Gema; Gomez-Ambrosi, Javier] Univ Navarra, Dept Endocrinol, E-31080 Pamplona, Spain; [Tinahones, Francisco J.; Fernandez-Garcia, Jose C.] Hosp Clin Univ Virgen de Victoria, Serv Diabet Endocrinol & Nutr, Malaga, Spain; [Casanueva, Felipe F.] Univ Santiago de Compostela, Complejo Hosp U de Santiago, Div Endocrine, Santiago De Compostela, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Barcelona; Autonomous University of Barcelona; Universitat Jaume I; University of Valencia; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Navarra; Universidade de Santiago de Compostela	Fagundo, AB (corresponding author), Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain.	ffernandez@bellvitgehospital.cat	García, José Carlos Fernández/B-3723-2013; JIMENEZ-MURCIA, SUSANA/L-9786-2014; Fernandez-Aranda, Fernando/L-9762-2014; de la Torre, Rafael/D-3561-2018; Botella, Cristina/F-9230-2010; Gómez-Ambrosi, Javier/D-2984-2017; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Larrea, Salomé Tárrega/AAE-2684-2020; Gamazo, Laura Forcano/B-1154-2017; Tárrega, Salomé/D-8876-2011; Fernandez-Garcia, Jose Carlos/B-5312-2013; Granero, Roser/S-3529-2019; BAÑOS, ROSA MARIA/C-6077-2011; García, José Carlos Fernández/X-3910-2019; Granero, Roser/F-9492-2016; Tinahones, Francisco José/AAB-2882-2020; FORCANO, LAURA/AAP-1933-2020; Fernández-Real, Jose Manuel/AGH-3599-2022; AGÜERA, ZAIDA/K-9771-2014	García, José Carlos Fernández/0000-0003-2308-2865; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; Fernandez-Aranda, Fernando/0000-0002-2968-9898; de la Torre, Rafael/0000-0002-6765-1866; Botella, Cristina/0000-0001-8783-6959; Gómez-Ambrosi, Javier/0000-0001-5601-1604; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Larrea, Salomé Tárrega/0000-0002-5820-6795; Gamazo, Laura Forcano/0000-0002-8478-1451; Tárrega, Salomé/0000-0002-5820-6795; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; BAÑOS, ROSA MARIA/0000-0003-0626-7665; García, José Carlos Fernández/0000-0003-2308-2865; Granero, Roser/0000-0001-6308-3198; FORCANO, LAURA/0000-0002-8478-1451; Fernández-Real, Jose Manuel/0000-0002-7442-9323; AGÜERA, ZAIDA/0000-0003-4453-4939; Fagundo, Ana Beatriz/0000-0003-1703-9457; Tinahones, Francisco J/0000-0001-6871-4403	Fondo de Investigacion Sanitaria -FIS [PI081714, PI11/210]; AGAUR [2009SGR1554, 2009SGR718]; Ministerio de Ciencia e Innovacion Subprograma Juan de la Cierva [JCI-2011-09248]; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn); CIBER Salud Mental (CIBERsam); initiative of ISCIII	Fondo de Investigacion Sanitaria -FIS(Instituto de Salud Carlos III); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministerio de Ciencia e Innovacion Subprograma Juan de la Cierva(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn); CIBER Salud Mental (CIBERsam); initiative of ISCIII	Financial support was received from Fondo de Investigacion Sanitaria -FIS (PI081714; PI11/210) and AGAUR (2009SGR1554, 2009SGR718); Ministerio de Ciencia e Innovacion Subprograma Juan de la Cierva (JCI-2011-09248); CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn) and CIBER Salud Mental (CIBERsam), are an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna C, 2010, NEUROTOX RES, V18, P416, DOI 10.1007/s12640-010-9194-y; Altamirano LJ, 2010, PSYCHOL SCI, V21, P1377, DOI 10.1177/0956797610381505; Anderluh MB, 2003, AM J PSYCHIAT, V160, P242, DOI 10.1176/appi.ajp.160.2.242; APA, 2000, DSM 4 TR DIAGN STAT; Avena NM, 2008, NEUROSCIENCE, V156, P865, DOI 10.1016/j.neuroscience.2008.08.017; Avena NM, 2011, NEUROPHARMACOLOGY; Bayless John D, 2002, Ann Clin Psychiatry, V14, P203, DOI 10.1023/A:1021905916252; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Boeka AG, 2006, J INT NEUROPSYCH SOC, V12, P741, DOI 10.1017/S1355617706060887; Bosanac P, 2007, INT J EAT DISORDER, V40, P613, DOI 10.1002/eat.20412; Brogan A, 2010, J INT NEUROPSYCH SOC, V16, P711, DOI 10.1017/S1355617710000354; Bulik CM, 2003, AM J PSYCHIAT, V160, P366, DOI 10.1176/appi.ajp.160.2.366; Bulik CM, 2003, INT J EAT DISORDER, V33, P293, DOI 10.1002/eat.10140; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Carter FA, 2012, APPETITE; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Cavedini P, 2006, PSYCHIAT RES, V145, P179, DOI 10.1016/j.psychres.2004.12.014; Cohen JI, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000175; Danner UN, 2012, EUR EAT DISORD REV, V20, pe56, DOI 10.1002/erv.1098; Davis C, 2009, APPETITE, V53, P1, DOI 10.1016/j.appet.2009.05.018; Derogatis L, 1990, SCL 90 R BIBLIOGRAPH; Eddy KT, 2011, AM J PSYCHIAT, V168, P1139, DOI 10.1176/appi.ajp.2011.11071125; Fassino S, 2002, INT J EAT DISORDER, V31, P274, DOI 10.1002/eat.10028; Figlewicz DP, 2011, AM J PHYSIOL-REG I, V300, pR876, DOI 10.1152/ajpregu.00655.2010; First M. D., 1996, USERS GUIDE STRUCTUR; Garner DM, 1991, EATING DISORDER INVE; Gillberg IC, 2010, J CLIN EXP NEUROPSYC, V32, P358, DOI 10.1080/13803390903066857; Golden C.J., 1978, STROOP COLOR WORD TE; Goldschmidt AB, 2008, BEHAV RES THER, V46, P777, DOI 10.1016/j.brat.2008.03.004; Goldschmidt AB, 2008, OBESITY, V16, P257, DOI 10.1038/oby.2007.48; Goossens L, 2009, EUR EAT DISORD REV, V17, P68, DOI 10.1002/erv.892; Grunwald M, 2001, INT J EAT DISORDER, V29, P417, DOI 10.1002/eat.1038; Haines J, 2006, HEALTH EDUC RES, V21, P770, DOI 10.1093/her/cyl094; Haines J, 2010, ARCH PEDIAT ADOL MED, V164, P336, DOI 10.1001/archpediatrics.2010.19; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Heaton, 1981, WISCONSIN CARD SORTI; Hill AJ, 2007, OBES REV, V8, P151, DOI 10.1111/j.1467-789X.2007.00335.x; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jauregui-Lobera I, 2012, NEUROPSYCH DIS TREAT, V8, P1, DOI 10.2147/NDT.S27302; Jauregui-Lobera I, 2011, NEUROPSYCH DIS TREAT, V7, P577, DOI 10.2147/NDT.S25186; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Lauer CJ, 1999, J PSYCHIATR RES, V33, P129, DOI 10.1016/S0022-3956(98)00020-X; Lee EB, 2011, ANN NY ACAD SCI, V1243, P15, DOI 10.1111/j.1749-6632.2011.06274.x; Lena SM, 2004, NEUROPSYCHOL REV, V14, P99, DOI 10.1023/B:NERV.0000028081.40907.de; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Loeb C, 2012, EAT DISORD, V20, P173, DOI 10.1080/10640266.2012.654063; Lopez C, 2008, INT J EAT DISORDER, V41, P143, DOI 10.1002/eat.20478; Maayan L, 2011, OBESITY, V19, P1382, DOI 10.1038/oby.2011.15; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mobbs O, 2010, PATIENT EDUC COUNS, V79, P372, DOI 10.1016/j.pec.2010.03.003; Moser DJ, 2003, INT J EAT DISORDER, V33, P64, DOI 10.1002/eat.10108; Narita K, 2009, BIOL PSYCHIAT, V65, P992, DOI 10.1016/j.biopsych.2008.10.006; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pieters G, 2003, J PSYCHIATR RES, V37, P501, DOI 10.1016/S0022-3956(03)00067-0; Pignatti R, 2006, Eat Weight Disord, V11, P126; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P689, DOI 10.3233/JAD-2010-091663; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Roemmich JN, 2011, EAT BEHAV, V12, P309, DOI 10.1016/j.eatbeh.2011.07.003; Rose M, 2012, EUR EAT DISORD REV, V20, P32, DOI 10.1002/erv.1095; Rothemund Y, 2011, NEUROSCIENCE, V197, P242, DOI 10.1016/j.neuroscience.2011.09.016; Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023; Siervo M, 2011, OBES REV, V12, P968, DOI 10.1111/j.1467-789X.2011.00903.x; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Steinglass JE, 2006, J INT NEUROPSYCH SOC, V12, P431, DOI 10.1017/S1355617706060528; Tchanturia K, 2005, INT J EAT DISORDER, V37, pS72, DOI 10.1002/eat.20119; Tchanturia Kate, 2007, Ann Gen Psychiatry, V6, P14, DOI 10.1186/1744-859X-6-14; Tchanturia K, 2007, J INT NEUROPSYCH SOC, V13, P635, DOI 10.1017/S1355617707070798; Tchanturia K, 2012, EUR EAT DISORD REV, V20, P169, DOI 10.1002/erv.1154; Van Den Eynde F, 2009, CHILD ADOL PSYCH CL, V18, P95, DOI 10.1016/j.chc.2008.07.016; Villarejo C, 2012, EUR EAT DISORD REV, V20, P250, DOI 10.1002/erv.2166; Volkow N. D., 2011, CURR TOP BEHAV NEURO; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wilbertz G, 2012, NEUROIMAGE, V60, P353, DOI 10.1016/j.neuroimage.2011.12.011; Williamson DA, 2002, AM J PSYCHIAT, V159, P412, DOI 10.1176/appi.ajp.159.3.412; Wilsdon A, 2006, J PSYCHIATR RES, V40, P746, DOI 10.1016/j.jpsychires.2005.10.006; Wilson GT, 2010, EUR EAT DISORD REV, V18, P341, DOI 10.1002/erv.1048; Zelazo P. D., 2007, HDB EMOTION REGULATI, P135; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	81	153	154	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43382	10.1371/journal.pone.0043382	http://dx.doi.org/10.1371/journal.pone.0043382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22927962	Green Published, gold, Green Submitted			2022-12-27	WOS:000307789700032
J	Horne, AW; Brown, JK; Tong, S; Kaitu'u-Lino, T				Horne, Andrew W.; Brown, Jeremy K.; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha			Evaluation of ADAM-12 as a Diagnostic Biomarker of Ectopic Pregnancy in Women with a Pregnancy of Unknown Location	PLOS ONE			English	Article							MANAGEMENT	Background: Ectopic pregnancy (EP) remains the most life-threatening acute condition in modern gynaecology. It remains difficult to diagnose early and accurately. Women often present at emergency departments in early pregnancy with a 'pregnancy of unknown location' (PUL) and diagnosis/exclusion of EP is challenging due to a lack of reliable biomarkers. Recent studies suggest that serum levels of a disintegrin and metalloprotease protein-12 (ADAM-12) can be used differentiate EP from viable intrauterine pregnancy (VIUP). Here we describe a prospective study evaluating the performance of ADAM-12 in differentiating EP from the full spectrum of alternative PUL outcomes in an independent patient cohort. Methodology/Principal Findings: Sera were collected from 120 patients at their first clinical presentation with a PUL and assayed for ADAM-12 by ELISA. Patients were categorized according to final pregnancy outcomes. Serum ADAM-12 concentrations were increased in women with histologically-confirmed EP (median 442 pg/mL; 25%-75% percentile 232783 pg/mL) compared to women with VIUP (256 pg/mL; 168-442 pg/mL) or miscarriage (192 pg/mL; 133-476 pg/mL). Serum ADAM-12 did not differentiate histologically-confirmed EP from spontaneously resolving PUL (srPUL) (416 pg/mL; 154-608 pg/mL). The diagnostic potential of ADAM-12 was only significant when 'ambiguous' PUL outcomes were excluded from the analysis (AROC = 0.6633; P = 0.03901). Conclusions/Significance: When measured in isolation, ADAM-12 levels had limited value as a diagnostic biomarker for EP in our patient cohort. The development of a reliable serum biomarker-based test for EP remains an ongoing challenge.	[Horne, Andrew W.; Brown, Jeremy K.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha] Mercy Hosp Women, Translat Obstet Grp, Heidelberg, Vic, Australia	University of Edinburgh	Horne, AW (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	andrew.horne@ed.ac.uk		Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Tong, Stephen/0000-0002-2319-0586; Horne, Andrew/0000-0002-9656-493X	Australian National Health and Medical Research Council [1008276, 606611]; United Kingdom Medical Research Council (MRC) [G0802808]; MRC [G1002033, G0802808] Funding Source: UKRI; Medical Research Council [G0802808, G1002033] Funding Source: researchfish	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the Australian National Health and Medical Research Council (#1008276; #606611) and by the United Kingdom Medical Research Council (MRC G0802808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart K, 2011, EXPERT REV MOL DIAGN, V11, P759, DOI [10.1586/erm.11.72, 10.1586/ERM.11.72]; Barnhart K, 2011, FERTIL STERIL, V95, P857, DOI 10.1016/j.fertnstert.2010.09.006; Condous G, 2004, HUM REPROD, V19, P1900, DOI 10.1093/humrep/deh341; Horne AW, 2010, ACTA OBSTET GYN SCAN, V89, P299, DOI 10.3109/00016340903568191; Jurkovic D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3397; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; Laigaard J, 2006, PRENATAL DIAG, V26, P973, DOI 10.1002/pd.1540; Rausch ME, 2011, FERTIL STERIL, V95, P1373, DOI 10.1016/j.fertnstert.2010.12.040; Sahraravand M, 2011, PLACENTA, V32, P999, DOI 10.1016/j.placenta.2011.10.005; Sivalingam VN, 2011, J FAM PLAN REPROD H, V37, P231, DOI 10.1136/jfprhc-2011-0073; Torring N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-129; Wedderburn CJ, 2010, HUM REPROD, V25, P328, DOI 10.1093/humrep/dep397; Wiwanitkit V, 2011, FERTIL STERIL, V95, pE21, DOI 10.1016/j.fertnstert.2011.02.027	13	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e41442	10.1371/journal.pone.0041442	http://dx.doi.org/10.1371/journal.pone.0041442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927907	Green Published, gold			2022-12-27	WOS:000307789700003
J	O'Rorke, R; Lavery, S; Chow, S; Takeyama, H; Tsai, P; Beckley, LE; Thompson, PA; Waite, AM; Jeffs, AG				O'Rorke, Richard; Lavery, Shane; Chow, Seinen; Takeyama, Haruko; Tsai, Peter; Beckley, Lynnath E.; Thompson, Peter A.; Waite, Anya M.; Jeffs, Andrew G.			Determining the Diet of Larvae of Western Rock Lobster (Panulirus cygnus) Using High-Throughput DNA Sequencing Techniques	PLOS ONE			English	Article							PHYLLOSOMA LARVAE; JASUS-EDWARDSII; COLONIAL RADIOLARIAN; MOLECULAR ANALYSIS; SAGITTA GAZELLAE; STAGE PHYLLOSOMA; LEEUWIN CURRENT; FECAL PELLETS; PREY DNA; SP-NOV	The Western Australian rock lobster fishery has been both a highly productive and sustainable fishery. However, a recent dramatic and unexplained decline in post-larval recruitment threatens this sustainability. Our lack of knowledge of key processes in lobster larval ecology, such as their position in the food web, limits our ability to determine what underpins this decline. The present study uses a high-throughput amplicon sequencing approach on DNA obtained from the hepatopancreas of larvae to discover significant prey items. Two short regions of the 18S rRNA gene were amplified under the presence of lobster specific PNA to prevent lobster amplification and to improve prey amplification. In the resulting sequences either little prey was recovered, indicating that the larval gut was empty, or there was a high number of reads originating from multiple zooplankton taxa. The most abundant reads included colonial Radiolaria, Thaliacea, Actinopterygii, Hydrozoa and Sagittoidea, which supports the hypothesis that the larvae feed on multiple groups of mostly transparent gelatinous zooplankton. This hypothesis has prevailed as it has been tentatively inferred from the physiology of larvae, captive feeding trials and co-occurrence in situ. However, these prey have not been observed in the larval gut as traditional microscopic techniques cannot discern between transparent and gelatinous prey items in the gut. High-throughput amplicon sequencing of gut DNA has enabled us to classify these otherwise undetectable prey. The dominance of the colonial radiolarians among the gut contents is intriguing in that this group has been historically difficult to quantify in the water column, which may explain why they have not been connected to larval diet previously. Our results indicate that a PCR based technique is a very successful approach to identify the most abundant taxa in the natural diet of lobster larvae.	[O'Rorke, Richard; Lavery, Shane; Jeffs, Andrew G.] Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand; [Lavery, Shane; Tsai, Peter] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Chow, Seinen] Natl Res Inst Fisheries Sci, Yokosuka, Kanagawa, Japan; [Takeyama, Haruko] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Beckley, Lynnath E.] Murdoch Univ, Sch Environm Sci, Murdoch, WA 6150, Australia; [Thompson, Peter A.] Australian Commonwealth Sci Ind & Res Org, Hobart, Tas, Australia; [Waite, Anya M.] Univ Western Australia, Sch Environm Syst Engn, Crawley, WA, Australia; [Waite, Anya M.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia	University of Auckland; University of Auckland; Japan Fisheries Research & Education Agency (FRA); Waseda University; Murdoch University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Western Australia	O'Rorke, R (corresponding author), Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand.	roro002@aucklanduni.ac.nz	Thompson, Peter A/A-2361-2012; O'Rorke, Richard/C-9281-2011; Jeffs, Andrew G/D-9474-2012; Waite, Anya M/A-5492-2015; Lavery, Shane/AFX-7929-2022	Thompson, Peter A/0000-0002-9504-5433; O'Rorke, Richard/0000-0002-9304-2677; Waite, Anya M/0000-0003-2965-0296; Lavery, Shane/0000-0003-3038-292X; Tsai, Peter/0000-0002-9930-9029; Jeffs, Andrew/0000-0002-8504-1949	Fisheries Research and Development Council Australia under FRDC PROJECT [2010/047]; Australian Marine National Facility [SS05-2010]; Fisheries WA	Fisheries Research and Development Council Australia under FRDC PROJECT; Australian Marine National Facility; Fisheries WA	The experimental component of this project was funded by a grant from the Fisheries Research and Development Council Australia (http://www.frdc.com.au/) under FRDC PROJECT NUMBER: 2010/047, and ship time was provided by the Australian Marine National Facility under grant SS05-2010 (http://www.csiro.au/Organisation-Structure/National-Facilities/Marine-National-Facility.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Captain, crew and scientific team of R. V. Southern Surveyor voyage 2010-05. Liam Williams of the University of Auckland CGP (now a part of NZGL) for his knowledgeable input into the sequencing process. Nick Caputi and Fisheries WA for their support and advice.	ABARES, 2011, AUSTR FISH STAT 2010; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; ANGEL DL, 1991, SYMBIOSIS, V10, P195; Armougom F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-576; Baier CT, 1997, MAR ECOL PROG SER, V146, P37, DOI 10.3354/meps146037; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Braine SJ, 1979, ILLUSTRATED KEY NOTE, P1; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Brown R. S., 2009, W ROCK LOBSTER LOW P, P1; Budowle B, 2009, FORENS SCI INT-GEN S, V2, P551, DOI 10.1016/j.fsigss.2009.08.082; Caputi N, 2001, MAR FRESHWATER RES, V52, P1167, DOI 10.1071/MF01180; Caputi N, 2008, FISH OCEANOGR, V17, P147, DOI 10.1111/j.1365-2419.2008.00471.x; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; Cox SL, 2004, MAR FRESHWATER RES, V55, P145, DOI 10.1071/MF03175; Cox SL, 2003, REV FISH SCI, V11, P89, DOI 10.1080/713610924; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dennett MR, 2002, J PLANKTON RES, V24, P797, DOI 10.1093/plankt/24.8.797; Dilling L, 1998, MAR ECOL PROG SER, V170, P189, DOI 10.3354/meps170189; DILLING L, 1993, MAR ECOL PROG SER, V92, P51, DOI 10.3354/meps092051; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Froneman PW, 1998, POLAR BIOL, V19, P242, DOI 10.1007/s003000050241; Gast RJ, 2004, APPL ENVIRON MICROB, V70, P2028, DOI 10.1128/AEM.70.4.2028-2037.2004; Giesecke R, 2010, POLAR BIOL, V33, P293, DOI 10.1007/s00300-009-0704-4; Hardy CM, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04411.x; Harwood JD, 2008, ENVIRON ENTOMOL, V37, P990, DOI 10.1603/0046-225X(2008)37[990:ASNSAP]2.0.CO;2; HERRNKIND W, 1976, B MAR SCI, V26, P110; Holland SM, 2009, ANAL RAREFACTION 2 0; Janssen J, 2009, J MAR BIOL ASSOC UK, V61, P917; Jeffs AG, 2004, COMP BIOCHEM PHYS B, V137, P487, DOI 10.1016/j.cbpc.2004.02.003; Jeffs AG, 2001, MAR FRESHWATER RES, V52, P1211, DOI 10.1071/MF01182; JEFFS AG, 2001, P INT S LOBST HLTH M, P64; Jeffs Andrew, 2007, Bulletin of Fisheries Research Agency, P9; Johnston DJ, 2004, COMP BIOCHEM PHYS B, V138, P137, DOI 10.1016/j.cbpc.2004.02.013; Johnston M, 2008, J CRUSTACEAN BIOL, V28, P46, DOI 10.1651/06-2814R.1; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Larsen JB, 2005, MAR BIOL, V146, P1119, DOI 10.1007/s00227-004-1524-2; LEMMENS JWTJ, 1994, J MORPHOL, V220, P271, DOI 10.1002/jmor.1052200306; Limbourn AJ, 2009, MAR FRESHWATER RES, V60, P810, DOI 10.1071/MF08244; Limbourn AJ, 2009, COMP BIOCHEM PHYS B, V152, P292, DOI 10.1016/j.cbpb.2008.12.009; McWilliam PS, 2007, REV FISH BIOL FISHER, V17, P615, DOI 10.1007/s11160-007-9067-5; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mitchell J, 1971, FOOD PREFERENCES FEE, P110; Mochioka N, 1996, MAR BIOL, V125, P447; NISHIDA S, 1990, J CRUSTACEAN BIOL, V10, P293, DOI 10.2307/1548488; O'Rorke R, 2012, MOL ECOL RESOUR, V12, P5, DOI 10.1111/j.1755-0998.2011.03091.x; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; PEARCE AF, 1988, J CONSEIL, V45, P13; Phillips BF, 2006, COMP BIOCHEM PHYS B, V143, P219, DOI 10.1016/j.cbpb.2005.11.009; PHILLIPS BF, 1979, AUST J MAR FRESH RES, V30, P773; Phillips BF, 2009, REV FISH BIOL FISHER, V19, P193, DOI 10.1007/s11160-008-9099-5; Phleger CF, 2001, MAR FRESHWATER RES, V52, P1475, DOI 10.1071/MF01071; POMEROY LR, 1984, B MAR SCI, V35, P426; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; RITZ DA, 1972, MAR BIOL, V13, P309, DOI 10.1007/BF00348078; Roche, 2010, GS JUN SYST GUID AMP; Roche, 2011, TECHN B GS FLX SYST; Saunders MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036580; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Shojima Y., 1963, Bulletin of the Japanese Society of Scientific Fisheries, V29, P349; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Stemmann L, 2008, ICES J MAR SCI, V65, P433, DOI 10.1093/icesjms/fsn010; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Suzuki N, 2008, MAR BIOTECHNOL, V10, P49, DOI 10.1007/s10126-007-9038-9; Suzuki N, 2006, FISHERIES SCI, V72, P342, DOI 10.1111/j.1444-2906.2006.01155.x; Suzuki Nobuaki, 2007, Bulletin of Fisheries Research Agency, P1; SWANBERG NR, 1981, DEEP-SEA RES, V28, P1033, DOI 10.1016/0198-0149(81)90016-9; SWANBERG NR, 1980, DEEP-SEA RES, V27, P715, DOI 10.1016/0198-0149(80)90024-2; Terahara T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025715; THOMAS LR, 1963, NATURE, V198, P208, DOI 10.1038/198208a0; TIPPER JC, 1979, PALEOBIOLOGY, V5, P423, DOI 10.1017/S0094837300016924; Tong LJ, 1997, MAR FRESHWATER RES, V48, P935, DOI 10.1071/MF97073; Turner JT, 2002, AQUAT MICROB ECOL, V27, P57, DOI 10.3354/ame027057; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; van Oorschot Roland Ah, 2010, Investig Genet, V1, P14, DOI 10.1186/2041-2223-1-14; VANDERAUWERA G, 1994, FEBS LETT, V338, P133, DOI 10.1016/0014-5793(94)80350-1; Vestheim H, 2011, METHODS MOL BIOL, V687, P265, DOI 10.1007/978-1-60761-944-4_19; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Waite AM, 2007, DEEP-SEA RES PT II, V54, P1055, DOI 10.1016/j.dsr2.2006.12.010; Wilkin JL., 2011, LIMNOLOGY OCEANOGRAP, V1, P163, DOI [10.1215/21573698-1504363, DOI 10.1215/21573698-1504363]; Zettler LAA, 1999, MAR MICROPALEONTOL, V36, P67, DOI 10.1016/S0377-8398(98)00028-0	92	74	76	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42757	10.1371/journal.pone.0042757	http://dx.doi.org/10.1371/journal.pone.0042757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927937	gold, Green Published			2022-12-27	WOS:000307789700015
J	Shi, YY; Wu, XB; Huang, ZY; Wang, ZL; Yan, WY; Zeng, ZJ				Shi, Yuan Yuan; Wu, Xiao Bo; Huang, Zachary Y.; Wang, Zi Long; Yan, Wei Yu; Zeng, Zhi Jiang			Epigenetic Modification of Gene Expression in Honey Bees by Heterospecific Gland Secretions	PLOS ONE			English	Article							DIVISION-OF-LABOR; APIS-MELLIFERA; NEUREXIN-I; MICRORNAS; TRANSCRIPTOMES; NEUROLIGINS; BIOGENESIS; MECHANISMS; GENOMICS; QUEEN	Background: In the honey bee (Apis mellifera), queen and workers have different behavior and reproductive capacity despite possessing the same genome. The primary substance that leads to this differentiation is royal jelly (RJ), which contains a range of proteins, amino acids, vitamins and nucleic acids. MicroRNA (miRNA) has been found to play an important role in regulating the expression of protein-coding genes and cell biology. In this study, we characterized the miRNAs in RJ from two honey bee sister species and determined their possible effect on transcriptome in one species. Methodology/Principal Findings: We sequenced the miRNAs in RJ either from A. mellifera (RJM) or A. cerana (RJC). We then determined the global transcriptomes of adult A. mellifera developed from larvae fed either with RJM (mRJM) or RJC (mRJC). Finally we analyzed the target genes of those miRNA that are species specific or differentially expressed in the two honey bee species. We show that there were differences in miRNA between RJM and RJC, and that transcriptomes of adult A. mellifera were affected by the two types of RJ. A high proportion (23.3%) of the affected genes were target genes of differential miRNAs. Conclusion: We show for the first time that there are differences in miRNAs in RJ between A. mellifera and A. cerana. Further, the differences in transcriptomes of bees reared from these two RJs might be related to miRNA differences of the two species. This study provides the first evidence that heterospecific royal jelly can modify gene expression in honey bees through an epigenetic mechanism.	[Shi, Yuan Yuan; Wu, Xiao Bo; Wang, Zi Long; Yan, Wei Yu; Zeng, Zhi Jiang] Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Jiangxi, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Huang, Zachary Y.] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA	Jiangxi Agricultural University; Michigan State University; Michigan State University	Shi, YY (corresponding author), Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Jiangxi, Peoples R China.	bees1965@sina.com	Huang, Zachary/D-5485-2011; Wang, Zhiquan/HHS-6768-2022	Huang, Zachary/0000-0001-5354-5547; 	Earmarked Fund for China Agriculture Research System [CARS-45-KXJ12]; National Natural Science Foundation of China [31060327]; Doctoral Fund of Ministry of Education of China [20103603110003]	Earmarked Fund for China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by the Earmarked Fund for China Agriculture Research System (No. CARS-45-KXJ12), the National Natural Science Foundation of China (No. 31060327) and Doctoral Fund of Ministry of Education of China (No. 20103603110003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behura SK, 2010, INSECT MOL BIOL, V19, P431, DOI 10.1111/j.1365-2583.2010.01010.x; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Biswas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009133; Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Blum MS, 2000, J CHEM ECOL, V26, P801, DOI 10.1023/A:1005476405192; Chen X, 2010, INSECT MOL BIOL, V19, P799, DOI 10.1111/j.1365-2583.2010.01039.x; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Chittka A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000532; de Azevedo SV, 2008, J INSECT PHYSIOL, V54, P1064, DOI 10.1016/j.jinsphys.2008.04.009; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Fang Y, 2010, J PROTEOME RES, V9, P2207, DOI 10.1021/pr900979h; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Greenberg JK, 2012, GENES BRAIN BEHAV, DOI [10.1111/j.1601-183X.2012.00782-x, DOI 10.1111/J.1601-183X.2012.00782-X]; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guo XQ, 2010, DEV MOL MECH QUEEN W; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hepburn HR, 2011, HONEYBEES OF ASIA, P1, DOI 10.1007/978-3-642-16422-4; Hori S, 2011, APIDOLOGIE, V42, P89, DOI 10.1051/apido/2010032; Jung-Hoffmann I., 1966, BIENENFORSCH, V8, P296; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kucharski R., 2007, Invertebrate Neuroscience, V7, P99, DOI 10.1007/s10158-007-0045-3; Laubinger S, 2010, P NATL ACAD SCI USA, V107, P17466, DOI 10.1073/pnas.1012891107; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu F, 2012, INSECT MOL BIOL, V21, P297, DOI 10.1111/j.1365-2583.2012.01135.x; Maleszka R, 2008, EPIGENETICS-US, V3, P188, DOI 10.4161/epi.3.4.6697; Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Odronitz F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-173; Oldroyd BP, 2006, ASIAN HONEY HEES BIO; Ragan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005745; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Robinson GE, 2002, AM NAT, V160, pS160, DOI 10.1086/342901; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Schwander T, 2010, TRENDS ECOL EVOL, V25, P275, DOI 10.1016/j.tree.2009.12.001; SEELEY TD, 1989, AM SCI, V77, P546; Shi YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018808; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Tan K, 2012, J COMP PHYSIOL A, V198, P319, DOI 10.1007/s00359-012-0710-9; Tautz J, 2008, BUZZ BEES; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Viuda-Martos M, 2008, J FOOD SCI, V73, pR117, DOI 10.1111/j.1750-3841.2008.00966.x; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; WEAVER N, 1966, ANNU REV ENTOMOL, V11, P79, DOI 10.1146/annurev.en.11.010166.000455; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Winston M.L., 1991, BIOL HONEY BEE; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yang GH, 1983, APIS CERANA; Zeng Z.-J, 2009, AGRICULTURE; Zeng ZhiJiang, 2006, Indian Bee Journal, V68, P18	53	18	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43727	10.1371/journal.pone.0043727	http://dx.doi.org/10.1371/journal.pone.0043727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928024	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700049
J	Shin, H; Lee, JH; Kim, H; Choi, Y; Heu, S; Ryu, S				Shin, Hakdong; Lee, Ju-Hoon; Kim, Hyeryen; Choi, Younho; Heu, Sunggi; Ryu, Sangryeol			Receptor Diversity and Host Interaction of Bacteriophages Infecting Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; LYTIC BACTERIOPHAGES; PHAGE; RESISTANCE; BACTERIA; IDENTIFICATION; THERAPY; BINDING; GENES	Background: Salmonella enterica subspecies enterica serovar Typhimurium is a Gram-negative pathogen causing salmonellosis. Salmonella Typhimurium-targeting bacteriophages have been proposed as an alternative biocontrol agent to antibiotics. To further understand infection and interaction mechanisms between the host strains and the bacteriophages, the receptor diversity of these phages needs to be elucidated. Methodology/Principal Findings: Twenty-five Salmonella phages were isolated and their receptors were identified by screening a Tn5 random mutant library of S. Typhimurium SL1344. Among them, three types of receptors were identified flagella (11 phages), vitamin B-12 uptake outer membrane protein, BtuB (7 phages) and lipopolysaccharide-related O-antigen (7 phages). TEM observation revealed that the phages using flagella (group F) or BtuB (group B) as a receptor belong to Siphoviridae family, and the phages using O-antigen of LPS as a receptor (group L) belong to Podoviridae family. Interestingly, while some of group F phages (F-I) target FliC host receptor, others (F-II) target both FliC and FljB receptors, suggesting that two subgroups are present in group F phages. Cross-resistance assay of group B and L revealed that group L phages could not infect group B phage-resistant strains and reversely group B phages could not infect group L SPN9TCW-resistant strain. Conclusions/Significance: In this report, three receptor groups of 25 newly isolated S. Typhimurium-targeting phages were determined. Among them, two subgroups of group F phages interact with their host receptors in different manner. In addition, the host receptors of group B or group L SPN9TCW phages hinder other group phage infection, probably due to interaction between receptors of their groups. This study provides novel insights into phage-host receptor interaction for Salmonella phages and will inform development of optimal phage therapy for protection against Salmonella.	[Shin, Hakdong; Kim, Hyeryen; Choi, Younho; Ryu, Sangryeol] Seoul Natl Univ, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Seoul, South Korea; [Shin, Hakdong; Kim, Hyeryen; Choi, Younho; Ryu, Sangryeol] Seoul Natl Univ, Ctr Agr Biomat, Seoul, South Korea; [Lee, Ju-Hoon] Kyung Hee Univ, Dept Food Sci & Biotechnol, Yongin, South Korea; [Heu, Sunggi] Rural Dev Adm, Natl Acad Agr Sci, Microbial Safety Div, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Rural Development Administration (RDA)	Shin, H (corresponding author), Seoul Natl Univ, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Seoul, South Korea.	sangryu@snu.ac.kr	Lee, Ju-Hoon/AAK-7256-2020; Choi, Younho/Y-7282-2019	Choi, Younho/0000-0003-4719-3279; Shin, Hakdong/0000-0001-7615-9809	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20090078983]; Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (No. 20090078983) and the Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 1987, VIRUSES PROKARYOTES, V1; Anany H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-242; Andreatti RL, 2007, POULTRY SCI, V86, P1904, DOI 10.1093/ps/86.9.1904; Atterbury RJ, 2007, APPL ENVIRON MICROB, V73, P4543, DOI 10.1128/AEM.00049-07; Berngruber TW, 2010, J VIROL, V84, P10200, DOI 10.1128/JVI.00865-10; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Cairns BJ, 2008, ANTIMICROB AGENTS CH, V52, P4344, DOI 10.1128/AAC.00574-08; Cann A.J., 1993, PRINCIPLES MOL VIROL, P173; Carey-Smith GV, 2006, FEMS MICROBIOL LETT, V258, P182, DOI 10.1111/j.1574-6968.2006.00217.x; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; *CDC, 2008, SALM SURV ANN SUMM 2; CDC (Centers for Disease Control and Prevention), 2007, CDC ANN REP 2005; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Erickson M, 2009, FEMS MICROBIOL LETT, V294, P37, DOI 10.1111/j.1574-6968.2009.01554.x; Ernst RK, 2001, MICROBES INFECT, V3, P1327, DOI 10.1016/S1286-4579(01)01494-0; Fauquet CM, 2005, VIRUS TAXONOMY CLASS; Garcia P, 2008, LETT APPL MICROBIOL, V47, P479, DOI 10.1111/j.1472-765X.2008.02458.x; Greer GG, 2005, J FOOD PROTECT, V68, P1102, DOI 10.4315/0362-028X-68.5.1102; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; HELLER K, 1982, J VIROL, V41, P222, DOI 10.1128/JVI.41.1.222-227.1982; Higgins JP, 2008, AVIAN DIS, V52, P139, DOI 10.1637/8017-050807-ResNote; HILL C, 1989, APPL ENVIRON MICROB, V55, P2416, DOI 10.1128/AEM.55.9.2416-2419.1989; Ho TD, 2001, J BACTERIOL, V183, P1495, DOI 10.1128/JB.183.4.1495-1498.2001; HOFER B, 1995, J BACTERIOL, V177, P3080, DOI 10.1128/jb.177.11.3080-3086.1995; Hong J, 2008, FEMS MICROBIOL LETT, V289, P202, DOI 10.1111/j.1574-6968.2008.01397.x; Hudson JA, 2005, J FOOD PROTECT, V68, P426, DOI 10.4315/0362-028X-68.2.426; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022300; ISRAEL V, 1972, J VIROL, V10, P1152, DOI 10.1128/JVI.10.6.1152-1158.1972; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P535; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; KAGAWA H, 1984, J BACTERIOL, V157, P649, DOI 10.1128/JB.157.2.649-654.1984; Kim M, 2011, APPL ENVIRON MICROB, V77, P2042, DOI 10.1128/AEM.02504-10; Kropinski AM, 2007, VIROLOGY, V369, P234, DOI 10.1016/j.virol.2007.07.027; KRUGER DH, 1981, MICROBIOL REV, V45, P9; Kutsukake K, 2006, J BACTERIOL, V188, P950, DOI 10.1128/JB.188.3.950-957.2006; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lee JH, 2011, J VIROL, V85, P13470, DOI 10.1128/JVI.06344-11; Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McLaughlin MR, 2008, CURR MICROBIOL, V56, P208, DOI 10.1007/s00284-007-9057-9; McLaughlin MR, 2006, J ENVIRON QUAL, V35, P522, DOI 10.2134/jeq2005.0080; MEAD PS, 1999, FOOD RELATED ILLNESS; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; O'Flynn G, 2006, J APPL MICROBIOL, V101, P251, DOI 10.1111/j.1365-2672.2005.02792.x; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; Park M, 2012, APPL ENVIRON MICROB, V78, P58, DOI 10.1128/AEM.06231-11; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pickard D, 2010, J BACTERIOL, V192, P5746, DOI 10.1128/JB.00659-10; Poppe C, 1998, CAN VET J, V39, P559; Ricci V, 2010, APPL ENVIRON MICROB, V76, P1704, DOI 10.1128/AEM.02681-09; Salgado CJ, 2004, VIRUS GENES, V29, P87, DOI 10.1023/B:VIRU.0000032792.86188.fb; Samuel ADT, 1999, P NATL ACAD SCI USA, V96, P9863, DOI 10.1073/pnas.96.17.9863; Santos SB, 2011, J VIROL, V85, P11265, DOI 10.1128/JVI.01769-10; SCHADE SYLVIA Z., 1967, J VIROL, V1, P599; Serwer Philip, 2009, V501, P55, DOI 10.1007/978-1-60327-164-6_6; Shin H, 2012, J VIROL, V86, P1284, DOI 10.1128/JVI.06696-11; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Villafane R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-227; Wang JB, 2005, VIROLOGY, V332, P45, DOI 10.1016/j.virol.2004.10.049; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Ye J, 2010, J FOOD PROTECT, V73, P9, DOI 10.4315/0362-028X-73.1.9; Zhang JY, 2010, FOODBORNE PATHOG DIS, V7, P1415, DOI 10.1089/fpd.2010.0621; Zhang X, 1997, INFECT IMMUN, V65, P5381, DOI 10.1128/IAI.65.12.5381-5387.1997	70	70	72	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43392	10.1371/journal.pone.0043392	http://dx.doi.org/10.1371/journal.pone.0043392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927964	gold, Green Published, Green Submitted			2022-12-27	WOS:000307789700034
J	Zhang, W; Niu, YQ; Xiong, Y; Zhao, M; Yu, RW; Liu, J				Zhang, Wen; Niu, Yanqing; Xiong, Yi; Zhao, Meng; Yu, Rongwei; Liu, Juan			Computational Prediction of Conformational B-Cell Epitopes from Antigen Primary Structures by Ensemble Learning	PLOS ONE			English	Article							BINDING RESIDUES; PROTEINS; SERVER; SITES; ALGORITHM; SELECTION; TOOL; SVM	Motivation: The conformational B-cell epitopes are the specific sites on the antigens that have immune functions. The identification of conformational B-cell epitopes is of great importance to immunologists for facilitating the design of peptide-based vaccines. As an attempt to narrow the search for experimental validation, various computational models have been developed for the epitope prediction by using antigen structures. However, the application of these models is undermined by the limited number of available antigen structures. In contrast to the most of available structure-based methods, we here attempt to accurately predict conformational B-cell epitopes from antigen sequences. Methods: In this paper, we explore various sequence-derived features, which have been observed to be associated with the location of epitopes or ever used in the similar tasks. These features are evaluated and ranked by their discriminative performance on the benchmark datasets. From the perspective of information science, the combination of various features can usually lead to better results than the individual features. In order to build the robust model, we adopt the ensemble learning approach to incorporate various features, and develop the ensemble model to predict conformational epitopes from antigen sequences. Results: Evaluated by the leave-one-out cross validation, the proposed method gives out the mean AUC scores of 0.687 and 0.651 on two datasets respectively compiled from the bound structures and unbound structures. When compared with publicly available servers by using the independent dataset, our method yields better or comparable performance. The results demonstrate the proposed method is useful for the sequence-based conformational epitope prediction. Availability: The web server and datasets are freely available at http://bcell.whu.edu.cn.	[Zhang, Wen; Xiong, Yi; Zhao, Meng; Yu, Rongwei; Liu, Juan] Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China; [Niu, Yanqing] S Cent Univ Nationalities, Sch Math & Stat, Wuhan, Peoples R China; [Yu, Rongwei] Minist Educ, Key Lab Aerosp Informat Secur & Trust Comp, Wuhan, Peoples R China	Wuhan University; South Central Minzu University	Zhang, W (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China.	zhangwen@whu.edu.cn	Zhang, Wen/W-7471-2019; Xiong, Yi/F-7377-2012	Zhang, Wen/0000-0001-5221-2628; Xiong, Yi/0000-0003-2910-6725	National Science Foundation of China [60970063, 61103126]; Ph.D. Programs Foundation of Ministry of Education of China [20090141110026, 20100141120049]; Program for New Century Excellent Talents in University [NCET-10-0644]; Natural Science Foundation of Hubei Province [2011CDB454]; Fundamental Research Funds for the Central Universities of China [6081007, 3101054]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work is supported by the National Science Foundation of China (60970063, 61103126, http://www.nsfc.gov.cn/), the Ph.D. Programs Foundation of Ministry of Education of China (20090141110026, 20100141120049, http://www.moe.gov.cn/), Program for New Century Excellent Talents in University (NCET-10-0644, http://www.moe.gov.cn/), Natural Science Foundation of Hubei Province (No. 2011CDB454, http://www.hbstd.gov.cn/) and the Fundamental Research Funds for the Central Universities of China (6081007, 3101054, http://kfy.whu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Deng L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-426; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Enshell-Seijffers D, 2003, J MOL BIOL, V334, P87, DOI 10.1016/j.jmb.2003.09.002; Flower DR., 2007, IMMUNOINFORMATICS PR; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hu JJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-342; Jain A, 2005, PATTERN RECOGN, V38, P2270, DOI 10.1016/j.patcog.2005.01.012; Jain P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-364; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; Liang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-302; Liu R., 2011, J PROTEOM BIOINFORM, V4, P10; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Netzer M, 2009, BIOINFORMATICS, V25, P941, DOI 10.1093/bioinformatics/btp093; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; PONNUSWAMY PK, 1980, BIOCHIM BIOPHYS ACTA, V623, P301, DOI 10.1016/0005-2795(80)90258-5; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sikic M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000278; Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771; Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Van Regenmortel MHV, 2001, VACCINE, V19, P2369, DOI 10.1016/S0264-410X(00)00456-4; VANREGENMORTEL MHV, 1989, PHILOS T ROY SOC B, V323, P451; WALTER G, 1986, J IMMUNOL METHODS, V88, P149, DOI 10.1016/0022-1759(86)90001-3; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xiong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028440; Xiong Y, 2011, PROTEINS, V79, P509, DOI 10.1002/prot.22898; Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341	49	48	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43575	10.1371/journal.pone.0043575	http://dx.doi.org/10.1371/journal.pone.0043575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927994	gold, Green Published			2022-12-27	WOS:000307789700041
J	Kaplan, F; Zhao, W; Richards, JT; Wheeler, RM; Guy, CL; Levine, LH				Kaplan, Fatma; Zhao, Wei; Richards, Jeffrey T.; Wheeler, Raymond M.; Guy, Charles L.; Levine, Lanfang H.			Transcriptional and Metabolic Insights into the Differential Physiological Responses of Arabidopsis to Optimal and Supraoptimal Atmospheric CO2	PLOS ONE			English	Article							ELEVATED CO2; GENE-EXPRESSION; PHOTOSYNTHETIC ACCLIMATION; STOMATAL CONDUCTANCE; SIGNAL-TRANSDUCTION; RISING CO2; GROWTH; SUGAR; PLANTS; CARBON	Background: In tightly closed human habitats such as space stations, locations near volcano vents and closed culture vessels, atmospheric CO2 concentration may be 10 to 20 times greater than Earth's current ambient levels. It is known that super-elevated (SE) CO2 (>1,200 mu mol mol(-1)) induces physiological responses different from that of moderately elevated CO2 (up to 1,200 mu mol mol(-1)), but little is known about the molecular responses of plants to supra-optimal [CO2]. Methodology/Principal Findings: To understand the underlying molecular causes for differential physiological responses, metabolite and transcript profiles were analyzed in aerial tissue of Arabidopsis plants, which were grown under ambient atmospheric CO2 (400 mmol mol(-1)), elevated CO2 (1,200 mmol mol(-1)) and SE CO2 (4,000 mu mol mol(-1)), at two developmental stages early and late vegetative stage. Transcript and metabolite profiling revealed very different responses to elevated versus SE [CO2]. The transcript profiles of SE CO2 treated plants were closer to that of the control. Development stage had a clear effect on plant molecular response to elevated and SE [CO2]. Photosynthetic acclimation in terms of down-regulation of photosynthetic gene expression was observed in response to elevated [CO2], but not that of SE [CO2] providing the first molecular evidence that there appears to be a fundamental disparity in the way plants respond to elevated and SE [CO2]. Although starch accumulation was induced by both elevated and SE [CO2], the increase was less at the late vegetative stage and accompanied by higher soluble sugar content suggesting an increased starch breakdown to meet sink strength resulting from the rapid growth demand. Furthermore, many of the elevated and SE CO2-responsive genes found in the present study are also regulated by plant hormone and stress. Conclusions/Significance: This study provides new insights into plant acclimation to elevated and SE [CO2] during development and how this relates to stress, sugar and hormone signaling.	[Kaplan, Fatma] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Zhao, Wei] MedImmune LLC, Gaithersburg, MD USA; [Richards, Jeffrey T.; Levine, Lanfang H.] Enterprise Advisory Serv Inc, QinetiQ N Amer Engn Serv Contract ESC, Sustainable Syst Appl Res, Kennedy Space Ctr, Kennedy Space Ctr, FL USA; [Wheeler, Raymond M.] NASA, Engn Directorate, Kennedy Space Ctr, Kennedy Space Ctr, FL USA; [Guy, Charles L.] Univ Florida, Inst Food & Agr Sci, Dept Environm Hort, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA	United States Department of Agriculture (USDA); AstraZeneca; Medimmune; National Aeronautics & Space Administration (NASA); State University System of Florida; University of Florida	Kaplan, F (corresponding author), Res LLC, Gainesville, FL USA.	fkaplan@ufl.edu; lanfang.h.levine@nasa.gov	Kaplan, Fatma/AAJ-7666-2020	Kaplan, Fatma/0000-0002-9565-0211				Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Ainsworth EA, 2006, PLANT PHYSIOL, V142, P135, DOI 10.1104/pp.106.086256; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; Berkel N. van, 1984, Acta Horticulturae, P101; BOWES G, 1993, ANNU REV PLANT PHYS, V44, P309, DOI 10.1146/annurev.pp.44.060193.001521; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Browse J, 2008, PLANT PHYSIOL, V146, P832, DOI 10.1104/pp.107.115683; Caldana C, 2011, PLANT J, V67, P869, DOI 10.1111/j.1365-313X.2011.04640.x; Cheng SH, 1998, PLANT PHYSIOL, V116, P715, DOI 10.1104/pp.116.2.715; Choudhury Ananyo, 2008, In Silico Biol, V8, P511; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Druart N, 2006, FUNCT PLANT BIOL, V33, P121, DOI 10.1071/FP05139; EHRET DL, 1985, CAN J BOT, V63, P2015, DOI 10.1139/b85-281; Estiarte M, 1999, PHYSIOL PLANTARUM, V105, P423, DOI 10.1034/j.1399-3054.1999.105306.x; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Grimmer C, 1999, PLANT CELL ENVIRON, V22, P1275, DOI 10.1046/j.1365-3040.1999.00481.x; Grotenhuis T, 1997, ADV SPACE RES, V20, P1901, DOI 10.1016/S0273-1177(97)00858-2; Gupta P, 2005, NEW PHYTOL, V167, P129, DOI 10.1111/j.1469-8137.2005.01422.x; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Kanani Harin, 2010, BMC Syst Biol, V4, P177, DOI 10.1186/1752-0509-4-177; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; KIMBALL BA, 1993, VEGETATIO, V104, P65, DOI 10.1007/BF00048145; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leakey ADB, 2009, P NATL ACAD SCI USA, V106, P3597, DOI 10.1073/pnas.0810955106; Levine LH, 2008, ADV SPACE RES, V42, P1917, DOI 10.1016/j.asr.2008.07.014; Levine LH, 2009, J PLANT PHYSIOL, V166, P903, DOI 10.1016/j.jplph.2008.11.006; Li PH, 2008, PLANT CELL ENVIRON, V31, P1673, DOI 10.1111/j.1365-3040.2008.01874.x; Li PH, 2006, PLANT MOL BIOL, V62, P593, DOI 10.1007/s11103-006-9041-y; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; Ludewig F, 1998, FEBS LETT, V429, P147, DOI 10.1016/S0014-5793(98)00580-8; Ludewig F, 2000, FEBS LETT, V479, P19, DOI 10.1016/S0014-5793(00)01873-1; Mackowiak CL, 1996, J PLANT PHYSIOL, V149, P205, DOI 10.1016/S0176-1617(96)80196-9; Majeau N, 1996, PLANT PHYSIOL, V112, P569, DOI 10.1104/pp.112.2.569; Miyazaki S, 2004, FIELD CROP RES, V90, P47, DOI 10.1016/j.fcr.2004.07.010; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moore BD, 1998, PLANT CELL ENVIRON, V21, P905, DOI 10.1046/j.1365-3040.1998.00324.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; NIE GY, 1995, PLANT PHYSIOL, V108, P975, DOI 10.1104/pp.108.3.975; Nikiforova VJ, 2004, J EXP BOT, V55, P1861, DOI 10.1093/jxb/erh177; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Penuelas J, 1996, J EXP BOT, V47, P1463, DOI 10.1093/jxb/47.9.1463; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Prins A, 2011, PLANT CELL ENVIRON, V34, P314, DOI 10.1111/j.1365-3040.2010.02245.x; Rogers A, 2002, PLANT CELL ENVIRON, V25, P851, DOI 10.1046/j.1365-3040.2002.00868.x; Roitsch T, 1999, CURR OPIN PLANT BIOL, V2, P198, DOI 10.1016/S1369-5266(99)80036-3; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rook F, 2001, PLANT J, V26, P421, DOI 10.1046/j.1365-313X.2001.2641043.x; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Taylor G, 2005, NEW PHYTOL, V167, P143, DOI 10.1111/j.1469-8137.2005.01450.x; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; TRIPP KE, 1991, J AM SOC HORTIC SCI, V116, P876, DOI 10.21273/JASHS.116.5.876; Urban O, 2003, PHOTOSYNTHETICA, V41, P9, DOI 10.1023/A:1025891825050; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Wheeler RM, 1999, ANN BOT-LONDON, V83, P243, DOI 10.1006/anbo.1998.0813; WHEELER RM, 1993, J PLANT PHYSIOL, V142, P173, DOI 10.1016/S0176-1617(11)80959-4	65	48	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43583	10.1371/journal.pone.0043583	http://dx.doi.org/10.1371/journal.pone.0043583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916280	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800079
J	Morone, S; Lo-Buono, N; Parrotta, R; Giacomino, A; Nacci, G; Brusco, A; Larionov, A; Ostano, P; Mello-Grand, M; Chiorino, G; Ortolan, E; Funaro, A				Morone, Simona; Lo-Buono, Nicola; Parrotta, Rossella; Giacomino, Alice; Nacci, Giulia; Brusco, Alfredo; Larionov, Alexey; Ostano, Paola; Mello-Grand, Maurizia; Chiorino, Giovanna; Ortolan, Erika; Funaro, Ada			Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation	PLOS ONE			English	Article							CELL-ADHESION; TRANSITIONS; EXPRESSION; GROWTH; METALLOPROTEINASES; BIOINFORMATICS; RESISTANCE; MIGRATION; BIOLOGY; ANOIKIS	Epithelial ovarian carcinoma (EOC) is an aggressive tumor often diagnosed at an advanced stage, when there is little or no prospect of cure. Despite advances in surgical and chemotherapeutic strategies, only marginal improvements in patient outcome have been obtained. Hence, unraveling the biological mechanisms underpinning EOC progression is critical for improving patients' survival. Recently, we reported that CD157 (an ectoenzyme regulating leukocyte diapedesis) is expressed in EOC and that high expression of the molecule is negatively correlated with the disease outcome in patients. Here, we demonstrate that forced overexpression of CD157 in OVCAR-3, TOV-21G, A2780 and OV-90 ovarian cancer cell lines promotes morphological and phenotypic changes characterized by disruption of intercellular junctions, downregulation of epithelial markers and upregulation of mesenchymal ones. These changes in cell shape and phenotype bring to reduced sensitivity to anoikis, increased anchorage-independent growth, cell motility and mesothelial invasion. Conversely, knockdown of CD157 in OV-90 and OC314 cells reverts the mesenchymal phenotype and reduces the cells' migratory potential. Transcriptome profiling analysis highlighted 378 significantly differentially expressed genes, representing the signature of CD157-overexpressing OVCAR-3 and OV-90 cells. The modulation of selected genes translates into alteration of protein expression that give cells a highly malignant phenotype. The overall picture deduced from the analysis of the modulated transcripts is that high expression of CD157 strengthens a number of biological processes favoring tumor progression (including development and cell motility), and weakens several biological processes hindering tumor progression (such as apoptosis, cell death and response to stress). Together, these findings implicate CD157 in the progression of EOC to metastatic disease and suggest that CD157 may represent a valuable therapeutic target.	[Morone, Simona; Lo-Buono, Nicola; Parrotta, Rossella; Giacomino, Alice; Nacci, Giulia; Brusco, Alfredo; Larionov, Alexey; Ortolan, Erika; Funaro, Ada] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Ostano, Paola; Mello-Grand, Maurizia; Chiorino, Giovanna] Fdn Edo & Elvo Tempia Valenta, Lab Canc Genom, Biella, Italy; [Ortolan, Erika; Funaro, Ada] Univ Turin, Res Ctr Expt Med CeRMS, Turin, Italy	University of Turin; University of Turin	Morone, S (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	erika.ortolan@unito.it; ada.funaro@unito.it	Ostano, Paola/K-1979-2018; Lo Buono, Nicola/F-4817-2013; Chiorino, Giovanna/K-5037-2016; Brusco, Alfredo/A-1811-2013; Funaro, Ada/AAC-3203-2019	Ostano, Paola/0000-0002-4000-2954; Lo Buono, Nicola/0000-0001-5538-6869; Chiorino, Giovanna/0000-0002-9502-6400; Brusco, Alfredo/0000-0002-8318-7231; Funaro, Ada/0000-0001-6341-1817; ORTOLAN, Erika/0000-0003-2287-9020; Larionov, Alexey/0000-0001-6902-8878	Italian Association for Cancer Research (AIRC) [MFAG6312, IG 11602]; Italian Ministry for University and Scientific Research; International Foundation for Research in Experimental Medicine	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); International Foundation for Research in Experimental Medicine	Supported by grants from the Italian Association for Cancer Research (AIRC, MFAG6312 and IG 11602 to EO), from the Italian Ministry for University and Scientific Research (PRIN and 60% Projects to AF) and from the International Foundation for Research in Experimental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Chikh A, 2011, EMBO J, V30, P4261, DOI 10.1038/emboj.2011.302; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Davidson B, 2002, MOL CELL ENDOCRINOL, V187, P39, DOI 10.1016/S0303-7207(01)00709-2; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Funaro A, 2009, FRONT BIOSCI-LANDMRK, V14, P929, DOI 10.2741/3287; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOLDSTEIN SC, 1993, TISSUE ANTIGENS, V41, P214, DOI 10.1111/j.1399-0039.1993.tb02007.x; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; HAMILTON TC, 1987, CANCER, V60, P2054, DOI 10.1002/1097-0142(19901015)60:8+<2054::AID-CNCR2820601518>3.0.CO;2-0; HAMILTON TC, 1983, CANCER RES, V43, P5379; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ishihara K, 2000, CHEM IMMUNOL, V75, P235; ITO A, 1995, BRIT J CANCER, V71, P1039, DOI 10.1038/bjc.1995.200; KAISHO T, 1994, P NATL ACAD SCI USA, V91, P5325, DOI 10.1073/pnas.91.12.5325; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kenny HA, 2009, CELL CYCLE, V8, P683, DOI 10.4161/cc.8.5.7703; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kwon Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018872; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1733, DOI 10.1111/j.1525-1438.2006.00660.x; Lavagno L, 2007, J BIOL REG HOMEOS AG, V21, P5; Legrand C, 2001, EXP CELL RES, V264, P326, DOI 10.1006/excr.2000.5125; Liang F, 2001, FEBS LETT, V506, P207, DOI 10.1016/S0014-5793(01)02912-X; Lo Buono N, 2011, J BIOL CHEM, V286, P18681, DOI 10.1074/jbc.M111.227876; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Ortolan E, 2010, JNCI-J NATL CANCER I, V102, P1160, DOI 10.1093/jnci/djq256; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sasaki CY, 2000, CANCER RES, V60, P7057; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Tang MKS, 2010, NEOPLASIA, V12, P128, DOI 10.1593/neo.91438; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Ween MP, 2011, INT J MOL SCI, V12, P1009, DOI 10.3390/ijms12021009; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zeechini S, 2008, CANCER RES, V68, P1110, DOI 10.1158/0008-5472.CAN-07-2897; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zietarska M, 2007, MOL CARCINOGEN, V46, P872, DOI 10.1002/mc.20315	53	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43649	10.1371/journal.pone.0043649	http://dx.doi.org/10.1371/journal.pone.0043649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916288	gold, Green Published, Green Submitted			2022-12-27	WOS:000307733800087
J	Hermann, GJ; Scavarda, E; Weis, AM; Saxton, DS; Thomas, LL; Salesky, R; Somhegyi, H; Curtin, TP; Barrett, A; Foster, OK; Vine, A; Erlich, K; Kwan, E; Rabbitts, BM; Warren, K				Hermann, Greg J.; Scavarda, Emily; Weis, Allison M.; Saxton, Daniel S.; Thomas, Laura L.; Salesky, Rebecca; Somhegyi, Hannah; Curtin, Thomas P.; Barrett, Alec; Foster, Olivia K.; Vine, Annalise; Erlich, Katherine; Kwan, Elizabeth; Rabbitts, Beverley M.; Warren, Kaila			C. elegans BLOC-1 Functions in Trafficking to Lysosome-Related Gut Granules	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; PROTEIN SECONDARY STRUCTURE; CAENORHABDITIS-ELEGANS; ORGANELLE BIOGENESIS; INTESTINAL-CELLS; SYNDROME GENES; COMPLEX; AP-3; MELANOSOMES; PREDICTION	The human disease Hermansky-Pudlak syndrome results from defective biogenesis of lysosome-related organelles (LROs) and can be caused by mutations in subunits of the BLOC-1 complex. Here we show that C. elegans glo-2 and snpn-1, despite relatively low levels of amino acid identity, encode Pallidin and Snapin BLOC-1 subunit homologues, respectively. BLOC-1 subunit interactions involving Pallidin and Snapin were conserved for GLO-2 and SNPN-1. Mutations in glo-2 and snpn-1, or RNAi targeting 5 other BLOC-1 subunit homologues in a genetic background sensitized for glo-2 function, led to defects in the biogenesis of lysosome-related gut granules. These results indicate that the BLOC-1 complex is conserved in C. elegans. To address the function of C. elegans BLOC-1, we assessed the intracellular sorting of CDF-2::GFP, LMP-1, and PGP-2 to gut granules. We validated their utility by analyzing their mislocalization in intestinal cells lacking the function of AP-3, which participates in an evolutionarily conserved sorting pathway to LROs. BLOC-1(-) intestinal cells missorted gut granule cargo to the plasma membrane and conventional lysosomes and did not have obviously altered function or morphology of organelles composing the conventional lysosome protein sorting pathway. Double mutant analysis and comparison of AP-3(-) and BLOC-1(-) phenotypes revealed that BLOC-1 has some functions independent of the AP-3 adaptor complex in trafficking to gut granules. We discuss similarities and differences of BLOC-1 activity in the biogenesis of gut granules as compared to mammalian melanosomes, where BLOC-1 has been most extensively studied for its role in sorting to LROs. Our work opens up the opportunity to address the function of this poorly understood complex in cell and organismal physiology using the genetic approaches available in C. elegans.	[Hermann, Greg J.; Scavarda, Emily; Weis, Allison M.; Saxton, Daniel S.; Salesky, Rebecca; Somhegyi, Hannah; Warren, Kaila] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA; [Hermann, Greg J.; Thomas, Laura L.; Curtin, Thomas P.; Barrett, Alec; Foster, Olivia K.; Vine, Annalise; Erlich, Katherine; Kwan, Elizabeth; Rabbitts, Beverley M.] Lewis & Clark Coll, Program Biochem & Mol Biol, Portland, OR 97219 USA		Hermann, GJ (corresponding author), Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA.	hermann@lclark.edu	Hermann, Greg/AAA-7862-2020; Rabbitts, Beverley M./W-1376-2019; Weis, Allison/O-8184-2016	Hermann, Greg/0000-0002-0278-6356; Rabbitts, Beverley M./0000-0002-0896-6024; Foster, Olivia/0000-0001-7782-7995; Kwan, Elizabeth/0000-0002-5858-7110; Weis, Allison/0000-0001-9991-1661	National Science Foundation [MCB-0716280, MCB-1120835]; Howard Hughes Medical Institute; James F. and Marion L. Miller Foundation; John S. Rogers Summer Research Program; Direct For Biological Sciences [0922613, 1120835] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); James F. and Marion L. Miller Foundation; John S. Rogers Summer Research Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (MCB-0716280 and MCB-1120835), the Howard Hughes Medical Institute, the James F. and Marion L. Miller Foundation and the John S. Rogers Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Audhya A, 2007, J CELL BIOL, V178, P1309, DOI 10.1083/jcb.20070113920070911c; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BOSSINGER O, 1992, DEVELOPMENT, V114, P317; Britton C, 2004, J CELL SCI, V117, P5133, DOI 10.1242/jcs.01387; Caldwell GA, 2006, INTEGRATED GENOMICS; Campbell EM, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-40; Cheli VT, 2010, TRAFFIC, V11, P579, DOI 10.1111/j.1600-0854.2010.01044.x; Cheli VT, 2010, HUM MOL GENET, V19, P861, DOI 10.1093/hmg/ddp555; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Cherqui S, 2001, J BIOL CHEM, V276, P13314, DOI 10.1074/jbc.M010562200; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cullinane AR, 2011, AM J HUM GENET, V88, P778, DOI 10.1016/j.ajhg.2011.05.009; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Currie E, 2007, GENETICS, V177, P1569, DOI 10.1534/genetics.107.080689; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Docampo R, 2011, CELL CALCIUM, V50, P113, DOI 10.1016/j.ceca.2011.05.012; Elowitz MB, 1997, CURR BIOL, V7, P809, DOI 10.1016/S0960-9822(06)00342-3; Falcon-Perez JM, 2002, PIGM CELL RES, V15, P82, DOI 10.1034/j.1600-0749.2002.1r082.x; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Fujii T, 2010, INSECT MOL BIOL, V19, P659, DOI 10.1111/j.1365-2583.2010.01020.x; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; Hayes MJ, 2011, TRAFFIC, V12, P260, DOI 10.1111/j.1600-0854.2010.01151.x; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; HOWELL AM, 1990, GENETICS, V126, P583; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Huang PM, 2007, GENOME RES, V17, P1478, DOI 10.1101/gr.6824707; Huizing M, 2001, MOL BIOL CELL, V12, P2075, DOI 10.1091/mbc.12.7.2075; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; James P, 1996, GENETICS, V144, P1425; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kontani K, 2005, DEV CELL, V8, P787, DOI 10.1016/j.devcel.2005.02.018; Kostich M, 2000, J CELL SCI, V113, P2595; LAUFER JS, 1980, CELL, V19, P569, DOI 10.1016/S0092-8674(80)80033-X; Lee HH, 2012, J BIOL CHEM, V287, P5882, DOI 10.1074/jbc.M111.325746; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Levitte S, 2010, FEBS J, V277, P1420, DOI 10.1111/j.1742-4658.2010.07573.x; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; Mahoney TR, 2008, P NATL ACAD SCI USA, V105, P16350, DOI 10.1073/pnas.0803617105; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Przybylski D, 2002, PROTEINS, V46, P197, DOI 10.1002/prot.10029; Rabbitts BM, 2008, GENETICS, V180, P857, DOI 10.1534/genetics.108.093534; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Salazar G, 2004, MOL BIOL CELL, V15, P575, DOI 10.1091/mbc.E03-06-0401; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Salazar G, 2009, J BIOL CHEM, V284, P1790, DOI 10.1074/jbc.M805991200; Schaheen L, 2006, DEV BIOL, V293, P382, DOI 10.1016/j.ydbio.2006.02.008; Schroeder LK, 2007, MOL BIOL CELL, V18, P995, DOI 10.1091/mbc.E06-08-0685; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; SHARROCK WJ, 1983, DEV BIOL, V96, P182, DOI 10.1016/0012-1606(83)90321-4; Sitaram A, 2012, PHYSIOLOGY, V27, P85, DOI 10.1152/physiol.00043.2011; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Stiernagle T, 2006, WORMBOOK, DOI DOI 10.1895/WORM-BOOK.1.101.1; Tanizawa H, 2008, CHEM BIOINFORMATICS, V8, P96, DOI DOI 10.1273/CBIJ.8.96; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Yang Q, 2012, TRAFFIC; Yang W, 2000, J CELL SCI, V113, P4077; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061	93	23	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43043	10.1371/journal.pone.0043043	http://dx.doi.org/10.1371/journal.pone.0043043			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916203	Green Submitted, Green Published, gold			2022-12-27	WOS:000307823600041
J	Husek, J; Weidinger, K; Adamik, P; Slagsvold, T				Husek, Jan; Weidinger, Karel; Adamik, Peter; Slagsvold, Tore			Impact of Nesting Mortality on Avian Breeding Phenology: A Case Study on the Red-Backed Shrike (Lanius collurio)	PLOS ONE			English	Article							CLUTCH SIZE VARIATION; LIFE-HISTORY; CLIMATE-CHANGE; PREDATION RISK; SEASONAL DECLINES; HABITAT SELECTION; POPULATION-SIZE; ARRIVAL DATE; TITS PARUS; REPRODUCTION	The seasonal timing of avian reproduction is supposed primarily to coincide with favourable feeding conditions. Long-term changes in avian breeding phenology are thus mostly scrutinized in relation to climatic factors and matching of the food supplies, while the role of nesting mortality is largely unexplored. Here we show that higher seasonal mean daily mortality rate leads to a shift in the distribution of breeding times of the successful nests to later dates in an an open-nesting passerine bird, the red-backed shrike Lanius collurio. The effect appeared to be strong enough to enhance or counteract the influence of climatic factors and breeding density on the inter-annual variation in mean hatching dates. Moreover, the seasonal distribution of reproductive output was shifted to larger, or smaller, broods early in the season when the nesting mortality increased, or decreased, respectively, during the season. We suggest that population level changes in timing of breeding caused by a general advancement of spring and of the food supplies might be altered by the seasonality in nesting mortality. Hence, we argue that consideration of nesting mortality is of major importance for understanding long-term trends in avian phenology, particularly in species capable of renesting.	[Husek, Jan; Slagsvold, Tore] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Weidinger, Karel; Adamik, Peter] Palacky Univ, Ornithol Lab, CR-77147 Olomouc, Czech Republic; [Weidinger, Karel; Adamik, Peter] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Adamik, Peter] Museum Nat Hist, Olomouc, Czech Republic	University of Oslo; Palacky University Olomouc; Palacky University Olomouc; National Museum	Husek, J (corresponding author), Univ Oslo, Dept Biol, CEES, Oslo, Norway.	jan.husek@bio.uio.no	Husek, Jan/R-9513-2019; Adamik, Peter/I-2057-2013; Husek, Jan/AAP-8012-2020; Weidinger, Karel/J-6758-2012; Adamik, Peter/AFK-0073-2022	Adamik, Peter/0000-0003-1566-1234; Husek, Jan/0000-0001-9589-8519; Adamik, Peter/0000-0003-1566-1234	Centre for Ecological and Evolutionary Synthesis (CEES), Department of Biology, University of Oslo; Czech Science Foundation [GACR 206/07/0483]; Ministry of Education of the Czech Republic [MSM 6198959212]	Centre for Ecological and Evolutionary Synthesis (CEES), Department of Biology, University of Oslo; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by the Centre for Ecological and Evolutionary Synthesis (CEES), Department of Biology, University of Oslo; by the Czech Science Foundation (GACR 206/07/0483) and by the Ministry of Education of the Czech Republic (MSM 6198959212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamik P, 2008, J ZOOL, V275, P209, DOI 10.1111/j.1469-7998.2008.00415.x; Antczak M, 2009, ETHOL ECOL EVOL, V21, P127, DOI 10.1080/08927014.2009.9522501; ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI [10.2307/2408383, 10.1111/j.1558-5646.1984.tb00344.x]; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; BRINKHOF MWG, 1993, J ANIM ECOL, V62, P577, DOI 10.2307/5206; Chmielewski FM, 2005, INT J BIOMETEOROL, V50, P96, DOI 10.1007/s00484-005-0275-1; Coppack T, 2004, ADV ECOL RES, V35, P131, DOI 10.1016/S0065-2504(04)35007-5; COULSON J. C, 1960, IBIS, V102, P71; Cramp S., 1993, BIRDS W PALEARCTIC, V7; Decker KL, 2012, EVOL ECOL, V26, P683, DOI 10.1007/s10682-011-9521-7; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Fontaine JJ, 2006, AM NAT, V168, P811, DOI 10.1086/508297; GEER TA, 1982, IBIS, V124, P159, DOI 10.1111/j.1474-919X.1982.tb03754.x; Gotmark F, 2002, OECOLOGIA, V130, P25, DOI 10.1007/s004420100769; Hahn TP, 2008, PHILOS T R SOC B, V363, P267, DOI 10.1098/rstb.2007.2139; Hairston N.G. Jr, 1987, P281; Husek Jan, 2006, Sylvia, V42, P38; Husek J, 2008, J ORNITHOL, V149, P97, DOI 10.1007/s10336-007-0222-5; Husek J, 2010, ACTA ORNITHOL, V45, P43, DOI 10.3161/000164510X516074; Husek J, 2009, ANN ZOOL FENN, V46, P439, DOI 10.5735/086.046.0605; LACK D, 1950, IBIS, V92, P288, DOI 10.1111/j.1474-919X.1950.tb01753.x; LANDA K, 1992, EVOLUTION, V46, P121, DOI [10.1111/j.1558-5646.1992.tb01989.x, 10.2307/2409809]; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Li DQ, 2002, P ROY SOC B-BIOL SCI, V269, P2155, DOI 10.1098/rspb.2002.2140; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; MOller AP, 2010, EFFECTS CLIMATE CHAN; Monkkonen M, 2009, BIOL LETTERS, V5, P176, DOI 10.1098/rsbl.2008.0631; Morosinotto C, 2010, J ANIM ECOL, V79, P327, DOI 10.1111/j.1365-2656.2009.01638.x; MORTON ES, 1971, SCIENCE, V171, P920, DOI 10.1126/science.171.3974.920; Muller M, 2005, OECOLOGIA, V143, P37, DOI 10.1007/s00442-004-1770-5; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Nagy LR, 2005, ECOLOGY, V86, P675, DOI 10.1890/04-0155; Nietschke BS, 2007, CROP PROT, V26, P1444, DOI 10.1016/j.cropro.2006.12.006; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; NILSSON JA, 1988, J ANIM ECOL, V57, P917, DOI 10.2307/5101; Perrins CM, 1970, P BIOL SCI, V276, p[112, 288]; PIENKOWSKI MW, 1984, J ZOOL, V202, P83; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Preston KL, 2006, CONDOR, V108, P832, DOI 10.1650/0010-5422(2006)108[832:TROFNP]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; *SAS I INC, 2004, SAS ONL DOC; Scheuerlein A, 2001, P ROY SOC B-BIOL SCI, V268, P1575, DOI 10.1098/rspb.2001.1691; Schmidt KA, 2010, OIKOS, V119, P245, DOI 10.1111/j.1600-0706.2009.17824.x; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; SIH A, 1993, AM NAT, V142, P947, DOI 10.1086/285583; Siriwardena GM, 2000, J APPL ECOL, V37, P128, DOI 10.1046/j.1365-2664.2000.00484.x; SLAGSVOLD T, 1984, J ANIM ECOL, V53, P945, DOI 10.2307/4669; SLAGSVOLD T, 1982, OECOLOGIA, V54, P159, DOI 10.1007/BF00378388; SMITH HG, 1989, J ANIM ECOL, V58, P383, DOI 10.2307/4837; Sparks TH, 2010, ECOL ENTOMOL, V35, P788, DOI 10.1111/j.1365-2311.2010.01226.x; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Svensson E, 1997, EVOLUTION, V51, P1276, DOI 10.1111/j.1558-5646.1997.tb03974.x; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Tryjanowski P, 2003, BELG J ZOOL, V133, P157; Tryjanowski P, 2001, INT J BIOMETEOROL, V45, P217, DOI 10.1007/s00484-001-0112-0; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Varpe O, 2007, OIKOS, V116, P1331, DOI 10.1111/j.2007.0030-1299.15893.x; Vegvari Z, 2010, GLOBAL CHANGE BIOL, V16, P1, DOI 10.1111/j.1365-2486.2009.01876.x; Verboven N, 2001, ARDEA, V89, P387; VERHULST S, 1991, J ANIM ECOL, V60, P269, DOI 10.2307/5459; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser ME, 2009, P ROY SOC B-BIOL SCI, V276, P2323, DOI 10.1098/rspb.2009.0213; Vonesh JR, 2005, OIKOS, V110, P241, DOI 10.1111/j.0030-1299.2005.13759.x; WIKLUND CG, 1984, BEHAV ECOL SOCIOBIOL, V15, P311, DOI 10.1007/BF00292994; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wright LJ, 2009, J ANIM ECOL, V78, P1191, DOI 10.1111/j.1365-2656.2009.01582.x; YOUNG BE, 1994, CONDOR, V96, P341, DOI 10.2307/1369319	73	3	3	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43944	10.1371/journal.pone.0043944	http://dx.doi.org/10.1371/journal.pone.0043944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937131	Green Published, gold, Green Submitted			2022-12-27	WOS:000308213600062
J	Cresswell, K; Morrison, Z; Sheikh, A; Kalra, D				Cresswell, Kathrin; Morrison, Zoe; Sheikh, Aziz; Kalra, Dipak			"There Are Too Many, but Never Enough": Qualitative Case Study Investigating Routine Coding of Clinical Information in Depression	PLOS ONE			English	Article							PRIMARY-CARE; DSM-V; CLASSIFICATION; DISORDERS; SYSTEM; RELIABILITY; DIAGNOSES; UTILITY; PAY	Background: We sought to understand how clinical information relating to the management of depression is routinely coded in different clinical settings and the perspectives of and implications for different stakeholders with a view to understanding how these may be aligned. Materials and Methods: Qualitative investigation exploring the views of a purposefully selected range of healthcare professionals, managers, and clinical coders spanning primary and secondary care. Results: Our dataset comprised 28 semi-structured interviews, a focus group, documents relating to clinical coding standards and participant observation of clinical coding activities. We identified a range of approaches to coding clinical information including templates and order entry systems. The challenges inherent in clearly establishing a diagnosis, identifying appropriate clinical codes and possible implications of diagnoses for patients were particularly prominent in primary care. Although a range of managerial and research benefits were identified, there were no direct benefits from coded clinical data for patients or professionals. Secondary care staff emphasized the role of clinical coders in ensuring data quality, which was at odds with the policy drive to increase real-time clinical coding. Conclusions: There was overall no evidence of clear-cut direct patient care benefits to inform immediate care decisions, even in primary care where data on patients with depression were more extensively coded. A number of important secondary uses were recognized by healthcare staff, but the coding of clinical data to serve these ends was often poorly aligned with clinical practice and patient-centered considerations. The current international drive to encourage clinical coding by healthcare professionals during the clinical encounter may need to be critically examined.	[Cresswell, Kathrin; Morrison, Zoe; Sheikh, Aziz] Univ Edinburgh, EHlth Res Grp, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Kalra, Dipak] UCL, Ctr Hlth Informat & Multiprofess Educ, London, England	University of Edinburgh; University of London; University College London	Cresswell, K (corresponding author), Univ Edinburgh, EHlth Res Grp, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	kathrin.beyer@ed.ac.uk	Kalra, D/H-6661-2019; Sheikh, Aziz/D-2818-2009	Kalra, D/0000-0001-5254-4067; Sheikh, Aziz/0000-0001-7022-3056	National Institute for Health Research through the Comprehensive Clinical Research Network; Primary Care Research Network	National Institute for Health Research through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Primary Care Research Network	We are very grateful to all interviewees who kindly gave their time and to the wider project team including Bernard Fernando, Ann Robertson, Akiko Hemmi and Rosemary Porteous. Throughout the process of undertaking this work we have had helpful support from colleagues at the NHS Connecting for Health Evaluation Programme led by Professor Richard Lilford and supported by Lee Priest, Nathalie Maillard and Jo Foster. Lee Priest kindly also represented the funders on our Independent Project Steering Committee, which was chaired by Professor Simon De Lusignan. We acknowledge the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network and the Primary Care Research Network; and would like to thank the two expert reviewers who have given valuable comments on an earlier draft of this manuscript.	Andrews G, 2008, DEPRESS ANXIETY, V25, P274, DOI 10.1002/da.20489; Andrews G, 2009, PSYCHOL MED, V39, P1993, DOI 10.1017/S0033291709990250; [Anonymous], 2005, MENT HLTH POL SERV G; Begg S., 2007, BURDEN DIS INJURY AU; BLOIS MS, 1980, NEW ENGL J MED, V303, P192, DOI 10.1056/NEJM198007243030405; Brouch Kathy, 2003, J AHIMA, V74, P52; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Clay S, QOF MENTAL HLTH DEPR; Cresswell KM, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-67; Crowe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-100; De Lusignan S, 2005, MED INFORM INTERNET, V30, P89, DOI 10.1080/14639230500298651; Dixon J, 2004, BMJ-BRIT MED J, V328, P969, DOI 10.1136/bmj.328.7446.969; Elphick M, 2000, PSYCHIAT B, V24, P426; Garis Robert I, 2002, Manag Care, V11, P43; Gask L, 2008, EUR PSYCHIAT, V23, P469, DOI 10.1016/j.eurpsy.2008.06.006; Goldberg D, 2010, ADV PSYCHIAT TREAT, V16, P14, DOI DOI 10.1192/APT.BP.109.007120; Herbert Ian, 2007, Inform Prim Care, V15, P193; Joyce PR, 2008, AUST NZ J PSYCHIAT, V42, P851, DOI 10.1080/00048670802363667; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; Mason J., 2002, QUALITATIVE RES; McClelland R., 2002, ADV PSYCHIAT TREATME, V8, P291; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; MODAI I, 1993, J MED SYST, V17, P309, DOI 10.1007/BF01008532; Morrison Z, 2012, EV DIFF LEV STRUCT C; Mort M, 2009, SOCIOLOGY, V43, P215, DOI 10.1177/0038038508101162; Mussigbrodt H, 2000, PSYCHOPATHOLOGY, V33, P94, DOI 10.1159/000029127; NHS Information Centre, NUMB PEOPL US NHS ME; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Office for National Statistics, MENT HLTH; Patel VL, 2000, J AM MED INFORM ASSN, V7, P569, DOI 10.1136/jamia.2000.0070569; Poznyak V, 2011, ADDICTION, V106, P868, DOI 10.1111/j.1360-0443.2011.03381.x; QSR International Pty Ltd, 2020, NVIVO; Rector AL, 1999, METHOD INFORM MED, V38, P239; Reed GM, 2010, PROF PSYCHOL-RES PR, V41, P457, DOI 10.1037/a0021701; Rigby M, 1998, HEALTH POLICY, V45, P57, DOI 10.1016/S0168-8510(98)00028-1; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Sakashita C, 2007, AUST NZ J PSYCHIAT, V41, P17, DOI 10.1080/00048670601050440; Sartorius N., 2010, ADV PSYCHIAT TREAT, V16, P2, DOI [DOI 10.1192/APT.BP.109.007138, 10.1192/apt.bp.109.007138]; Sheikh A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6054; Silverman D., 1985, QUALITATIVE METHODOL; Stake R. E., 1995, ART CASE STUDY RES; Stausberg J, 2008, INT J MED INFORM, V77, P50, DOI 10.1016/j.ijmedinf.2006.11.005; Steel N, 2007, BRIT J GEN PRACT, V57, P449; SYTEMA S, 1989, PSYCHOL MED, V19, P999, DOI 10.1017/S0033291700005729; The Information Centre for Health and Social Care, 2010, NAT REN DAT HUM BEH; Walker Jan, 2005, Health Aff (Millwood), VSuppl Web Exclusives, pW5; Yin R.K., 2017, APPL CASE STUDY RES; Zelingher J, 1995, Proc Annu Symp Comput Appl Med Care, P416; Zimmerman M, 2010, DEPRESS ANXIETY, V27, P977, DOI 10.1002/da.20710	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43831	10.1371/journal.pone.0043831	http://dx.doi.org/10.1371/journal.pone.0043831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	998GM	22937106	Green Published, gold			2022-12-27	WOS:000308225500108
J	LeGoff, J; Rousset, D; Abou-Jaoude, G; Scemla, A; Ribaud, P; Mercier-Delarue, S; Caro, V; Enouf, V; Simon, F; Molina, JM; van der Werf, S				LeGoff, Jerome; Rousset, Dominique; Abou-Jaoude, Georges; Scemla, Anne; Ribaud, Patricia; Mercier-Delarue, Severine; Caro, Valerie; Enouf, Vincent; Simon, Francois; Molina, Jean-Michel; van der Werf, Sylvie			I223R Mutation in Influenza A(H1N1) pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y	PLOS ONE			English	Article							A H1N1 VIRUS; IMMUNOCOMPROMISED CHILD; INFECTION; INHIBITORS; SURVEILLANCE; TRANSMISSION; GENERATION; RECOVERY	Background: Resistance of pandemic A(H1N1) 2009 (H1N1pdm09) virus to neuraminidase inhibitors (NAIs) has remained limited. A new mutation I223R in the neuraminidase (NA) of H1N1pdm09 virus has been reported along with H275Y in immunocompromised patients. The aim of this study was to determine the impact of I223R on oseltamivir and zanamivir susceptibility. Methods: The NA enzymatic characteristics and susceptibility to NAIs of viruses harbouring the mutations I223R and H275Y alone or in combination were analyzed on viruses produced by reverse genetics and on clinical isolates collected from an immunocompromised patient with sustained influenza H1N1pdm09 virus shedding and treated by oseltamivir (days 0-15) and zanamivir (days 15-25 and 70-80). Results: Compared with the wild type, the NA of recombinant viruses and clinical isolates with H275Y or I223R mutations had about two-fold reduced affinity for the substrate. The H275Y and I223R isolates showed decreased susceptibility to oseltamivir (246-fold) and oseltamivir and zanamivir (8.9- and 4.9-fold), respectively. Reverse genetics assays confirmed these results and further showed that the double mutation H275Y and I223R conferred enhanced levels of resistance to oseltamivir and zanamivir (6195- and 15.2-fold). In the patient, six days after initiation of oseltamivir therapy, the mutation H275Y conferring oseltamivir resistance and the I223R mutation were detected in the NA. Mutations were detected concomitantly from day 6-69 but molecular cloning did not show any variant harbouring both mutations. Despite cessation of NAI treatment, the mutation I223R persisted along with additional mutations in the NA and the hemagglutinin. Conclusions: Reduced susceptibility to both oseltamivir and zanamivir was conferred by the I223R mutation which potentiated resistance to both NAIs when associated with the H275Y mutation in the NA. Concomitant emergence of the I223R and H275Y mutations under oseltamivir treatment underlines the importance of close monitoring of treated patients especially those immunocompromised.	[LeGoff, Jerome; Simon, Francois; van der Werf, Sylvie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [LeGoff, Jerome; Mercier-Delarue, Severine; Simon, Francois] Hop St Louis, Microbiol Lab, Assistance Publ Hop Paris, Paris, France; [LeGoff, Jerome; Mercier-Delarue, Severine; Simon, Francois] Inserm, U941, Paris, France; [Rousset, Dominique; Abou-Jaoude, Georges; Enouf, Vincent; van der Werf, Sylvie] Ctr Natl Reference Virus Influenzae Reg Nord, Inst Pasteur, Dept Virol, Unite Genet Mol Virus ARN, Paris, France; [Rousset, Dominique; Abou-Jaoude, Georges; Enouf, Vincent; van der Werf, Sylvie] CNRS, URA3015, Paris, France; [Scemla, Anne; Molina, Jean-Michel] Hop St Louis, Dept Infect Dis, Paris, France; [Ribaud, Patricia] Hop St Louis, Serv Hematol Greffe, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	LeGoff, J (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.	sylvie.van-der-werf@pasteur.fr	LeGoff, jerome/AAP-7880-2021; le goff, jerome/B-3447-2016; Rousset, Dominique/S-5400-2019; ENOUF, Vincent/H-6494-2017	le goff, jerome/0000-0001-7111-1865; Rousset, Dominique/0000-0002-1473-3147; ENOUF, Vincent/0000-0001-7609-4742; van der WERF, Sylvie/0000-0002-1148-4456	Institut Pasteur; Institut de Veille Sanitaire; Centre National de la Recherche Scientifique [URA3015]; University Paris Diderot Paris 7, Assistance Publique-Hopitaux de Paris; European Community under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' EC [223498]; United States Department of Health and Human Services	Institut Pasteur(European Commission); Institut de Veille Sanitaire; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris Diderot Paris 7, Assistance Publique-Hopitaux de Paris; European Community under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' EC; United States Department of Health and Human Services	This work was supported by the Institut Pasteur, funding from the Institut de Veille Sanitaire to the National Influenza Center (Northern-France), the Centre National de la Recherche Scientifique [URA3015], the University Paris Diderot Paris 7, Assistance Publique-Hopitaux de Paris and the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' EC [grant agreement number 223498]. GAJ was supported by a grant from the United States Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2004, ANTIVIR THER, V9, P577; Aoki FY, 2007, ANTIVIR THER, V12, P603; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; CDC, 2011, SEAS INFL WEEKL REP; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Chan P.A., 2010, CLIN MICROBIOL INFEC; Chen HL, 2009, EMERG INFECT DIS, V15, P1970, DOI 10.3201/eid1512.091057; Da Dalt L, 2010, EMERG INFECT DIS, V16, P1813, DOI 10.3201/eid1611.100789; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Deyde VM, 2010, ANTIMICROB AGENTS CH, V54, P1102, DOI 10.1128/AAC.01417-09; Dulek DE, 2010, CLIN INFECT DIS, V50, P1493, DOI 10.1086/652655; Eshaghi A, 2011, EMERG INFECT DIS, V17, P1472, DOI 10.3201/eid1708.102004; Esposito S, 2010, J CLIN VIROL, V48, P62, DOI 10.1016/j.jcv.2010.02.019; Gaur AH, 2010, NEW ENGL J MED, V362, P88, DOI 10.1056/NEJMc0910893; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Harvala H, 2010, EURO SURVEILL, V15; Holmes EC, 2010, SCIENCE, V328, P1243, DOI 10.1126/science.1190994; Hurt AC, 2010, ANTIVIRAL RES; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Moore C, 2011, J INFECT DIS, V203, P18, DOI 10.1093/infdis/jiq007; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Peng AW, 2000, ANTIMICROB AGENTS CH, V44, P1974, DOI 10.1128/AAC.44.7.1974-1976.2000; Pizzorno A, 2012, ANTIMICROB AGENTS CH, V56, P1208, DOI 10.1128/AAC.05994-11; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Rameix-Welti MA, 2011, ANTIVIRAL T IN PRESS, V16; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renaud C, 2011, EMERG INFECT DIS, V17, P653, DOI 10.3201/eid1704.101429; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Tramontana AR, 2010, EMERG INFECT DIS, V16, P1068, DOI 10.3201/eid1607.091691; van der Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002276; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; WHO, 2011, WER, V45, P497; World Health Organization, 2009, WHO INF LAB DIAGN PA	46	39	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e37095	10.1371/journal.pone.0037095	http://dx.doi.org/10.1371/journal.pone.0037095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936969	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500002
J	Caldwell, CA; Smith, K				Caldwell, Christine A.; Smith, Kenny			Cultural Evolution and Perpetuation of Arbitrary Communicative Conventions in Experimental Microsocieties	PLOS ONE			English	Article							CHOICE	Previous studies have shown that iconic graphical signs can evolve into symbols through repeated usage within dyads and interacting communities. Here we investigate the evolution of graphical signs over chains of participants. In these chains (or "replacement microsocieties''), membership of an interacting group changed repeatedly such that the most experienced members were continually replaced by naive participants. Signs rapidly became symbolic, such that they were mutually incomprehensible across experienced members of different chains, and new entrants needed to learn conventionalised meanings. An objective measure of graphical complexity (perimetric complexity) showed that the signs used within the microsocieties were becoming progressively simplified over successive usage. This is the first study to show that the signs that evolve in graphical communication experiments can be transmitted to, and spontaneously adopted by, naive participants. This provides critical support for the view that human communicative symbols could have evolved culturally from iconic representations.	[Caldwell, Christine A.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Smith, Kenny] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Edinburgh, Midlothian, Scotland	University of Stirling; University of Edinburgh	Caldwell, CA (corresponding author), Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland.	c.a.caldwell@stir.ac.uk	Caldwell, Christine/F-3134-2010; Smith, Kenny/B-7046-2009	Caldwell, Christine/0000-0001-7362-2554; Smith, Kenny/0000-0002-4530-6914	ESRC [RES-062-23-1634]; ESRC [ES/G021864/1] Funding Source: UKRI; Economic and Social Research Council [ES/G021864/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by the ESRC (www.esrc.ac.uk), award number RES-062-23-1634. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, MIT ENCY COGNITIVE S; Barr DJ, 2004, COGNITIVE SCI, V28, P937, DOI 10.1016/j.cogsci.2004.07.002; Baum WM, 2004, EVOL HUM BEHAV, V25, P305, DOI 10.1016/j.evolhumbehav.2004.05.003; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Caldwell CA, 2008, PHILOS T R SOC B, V363, P3529, DOI 10.1098/rstb.2008.0133; Caldwell CA, 2008, EVOL HUM BEHAV, V29, P165, DOI 10.1016/j.evolhumbehav.2007.12.001; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; Croft W, LANGUAGE PHENOMENON; Fay N, 2008, PHILOS T R SOC B, V363, P3553, DOI 10.1098/rstb.2008.0130; Fay N, 2010, COGNITIVE SCI, V34, P351, DOI 10.1111/j.1551-6709.2009.01090.x; Galati A, 2010, J MEM LANG, V62, P35, DOI 10.1016/j.jml.2009.09.002; Garrod S, LANGUAGE PHENOMENON; Garrod S, 2010, INTERACTION STUDIES, V11, P52; Garrod S, 2007, COGNITIVE SCI, V31, P961, DOI 10.1080/03640210701703659; GERARD RW, 1956, BEHAV SCI, V1, P6; Kirby S, 2001, IEEE T EVOLUT COMPUT, V5, P102, DOI 10.1109/4235.918430; Kirby S, 2008, P NATL ACAD SCI USA, V105, P10681, DOI 10.1073/pnas.0707835105; Kirby S, 2007, P NATL ACAD SCI USA, V104, P5241, DOI 10.1073/pnas.0608222104; Malt BC, 2004, MEM COGNITION, V32, P1346, DOI 10.3758/BF03206325; Mesoudi A, 2008, PHILOS T R SOC B, V363, P3489, DOI 10.1098/rstb.2008.0129; Perniss P, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00227; Tomasello M, 2008, JEAN NICOD LECT, P1	24	48	47	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e43807	10.1371/journal.pone.0043807	http://dx.doi.org/10.1371/journal.pone.0043807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22928039	gold, Green Published			2022-12-27	WOS:000308224700027
J	Birkhofer, K; Schoning, I; Alt, F; Herold, N; Klarner, B; Maraun, M; Marhan, S; Oelmann, Y; Wubet, T; Yurkov, A; Begerow, D; Berner, D; Buscot, F; Daniel, R; Diekotter, T; Ehnes, RB; Erdmann, G; Fischer, C; Foesel, B; Groh, J; Gutknecht, J; Kandeler, E; Lang, C; Lohaus, G; Meyer, A; Nacke, H; Nather, A; Overmann, J; Polle, A; Pollierer, MM; Scheu, S; Schloter, M; Schulze, ED; Schulze, W; Weinert, J; Weisser, WW; Wolters, V; Schrumpf, M				Birkhofer, Klaus; Schoening, Ingo; Alt, Fabian; Herold, Nadine; Klarner, Bernhard; Maraun, Mark; Marhan, Sven; Oelmann, Yvonne; Wubet, Tesfaye; Yurkov, Andrey; Begerow, Dominik; Berner, Doreen; Buscot, Francois; Daniel, Rolf; Diekoetter, Tim; Ehnes, Roswitha B.; Erdmann, Georgia; Fischer, Christiane; Foesel, Baerbel; Groh, Janine; Gutknecht, Jessica; Kandeler, Ellen; Lang, Christa; Lohaus, Gertrud; Meyer, Annabel; Nacke, Heiko; Naether, Astrid; Overmann, Joerg; Polle, Andrea; Pollierer, Melanie M.; Scheu, Stefan; Schloter, Michael; Schulze, Ernst-Detlef; Schulze, Waltraud; Weinert, Jan; Weisser, Wolfgang W.; Wolters, Volkmar; Schrumpf, Marion			General Relationships between Abiotic Soil Properties and Soil Biota across Spatial Scales and Different Land-Use Types	PLOS ONE			English	Article							MICROARTHROPOD COMMUNITY; BIODIVERSITY; DIVERSITY; RESPONSES; PATTERNS; NITROGEN	Very few principles have been unraveled that explain the relationship between soil properties and soil biota across large spatial scales and different land-use types. Here, we seek these general relationships using data from 52 differently managed grassland and forest soils in three study regions spanning a latitudinal gradient in Germany. We hypothesize that, after extraction of variation that is explained by location and land-use type, soil properties still explain significant proportions of variation in the abundance and diversity of soil biota. If the relationships between predictors and soil organisms were analyzed individually for each predictor group, soil properties explained the highest amount of variation in soil biota abundance and diversity, followed by land-use type and sampling location. After extraction of variation that originated from location or land-use, abiotic soil properties explained significant amounts of variation in fungal, meso-and macrofauna, but not in yeast or bacterial biomass or diversity. Nitrate or nitrogen concentration and fungal biomass were positively related, but nitrate concentration was negatively related to the abundances of Collembola and mites and to the myriapod species richness across a range of forest and grassland soils. The species richness of earthworms was positively correlated with clay content of soils independent of sample location and land-use type. Our study indicates that after accounting for heterogeneity resulting from large scale differences among sampling locations and land-use types, soil properties still explain significant proportions of variation in fungal and soil fauna abundance or diversity. However, soil biota was also related to processes that act at larger spatial scales and bacteria or soil yeasts only showed weak relationships to soil properties. We therefore argue that more general relationships between soil properties and soil biota can only be derived from future studies that consider larger spatial scales and different land-use types.	[Birkhofer, Klaus; Groh, Janine] Lund Univ, Dept Biol Biodivers & Conservat Sci, Lund, Sweden; [Schoening, Ingo; Herold, Nadine; Schulze, Ernst-Detlef; Schrumpf, Marion] Max Planck Inst Biogeochem, Jena, Germany; [Alt, Fabian; Oelmann, Yvonne] Univ Tubingen, Tubingen, Germany; [Klarner, Bernhard; Maraun, Mark; Ehnes, Roswitha B.; Erdmann, Georgia; Pollierer, Melanie M.; Scheu, Stefan] Univ Gottingen, Dept Anim Ecol, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Marhan, Sven; Berner, Doreen; Kandeler, Ellen] Univ Hohenheim, Inst Soil Sci & Land Evaluat, Soil Biol Sect, Hohenheim, Germany; [Wubet, Tesfaye; Buscot, Francois; Gutknecht, Jessica] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Yurkov, Andrey; Begerow, Dominik] Ruhr Univ Bochum, Bochum, Germany; [Buscot, Francois] Univ Leipzig, Inst Biol, Chair Soil Ecol, Leipzig, Germany; [Daniel, Rolf; Nacke, Heiko] Univ Gottingen, Inst Microbiol & Genet, Gottingen, Germany; [Diekoetter, Tim; Wolters, Volkmar] Univ Giessen, Dept Anim Ecol, Giessen, Germany; [Fischer, Christiane] Univ Potsdam, Dept Biodivers Res Systemat Bot, Inst Biochem & Biol, Potsdam, Germany; [Foesel, Baerbel; Overmann, Joerg] Leibniz Inst DSMZ German Collect Microorganism &, Braunschweig, Germany; [Lang, Christa; Lohaus, Gertrud; Polle, Andrea] Univ Gottingen, Busgen Inst, Dept Forest Bot & Tree Physiol, Gottingen, Germany; [Naether, Astrid] Univ Bremen, Dept Microbial Ecophysiol, D-28359 Bremen, Germany; [Meyer, Annabel] Tech Univ Munich, Chair Soil Ecol, Munich, Germany; [Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Munich, Germany; [Schulze, Waltraud] Max Planck Inst Mol Plant Physiol, Jena, Germany; [Weisser, Wolfgang W.] FSU Jena, Inst Ecol, Jena, Germany; [Weinert, Jan] Univ Cologne, Inst Zool, Dept Terr Ecol, Cologne, Germany	Lund University; Max Planck Society; Eberhard Karls University of Tubingen; University of Gottingen; University Hohenheim; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Ruhr University Bochum; Leipzig University; University of Gottingen; Justus Liebig University Giessen; University of Potsdam; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Gottingen; University of Bremen; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Friedrich Schiller University of Jena; University of Cologne	Birkhofer, K (corresponding author), Lund Univ, Dept Biol Biodivers & Conservat Sci, Lund, Sweden.	Klaus.Birkhofer@biol.lu.se	Herold, Nadine/I-7996-2013; Daniel, Rolf/AAQ-5933-2021; Buscot, Francois/A-4125-2016; Wubet, Tesfaye/C-6241-2012; Weisser, Wolfgang W/B-9718-2014; Oelmann, Yvonne/J-8730-2016; Schulze, Waltraud X/E-9800-2011; Wolters, Volkmar/B-4635-2010; Foesel, Baerbel/ABC-6477-2021; Pollierer, Melanie Mira/J-9336-2019; Birkhofer, Klaus/AAA-2374-2021; Foesel, Baerbel/ABC-6483-2021; Scheu, Stefan/H-7049-2015; Schöning, Ingo/D-3341-2009; Schloter, 1Michael/H-9151-2013; Schrumpf, Marion/C-1671-2013; Diekötter, Tim/L-2463-2016; Yurkov, Andrey M./E-7854-2011; Gutknecht, Jessica/AAI-3682-2021; Schulze, Ernst-Detlef/K-9627-2014	Daniel, Rolf/0000-0002-8646-7925; Buscot, Francois/0000-0002-2364-0006; Wubet, Tesfaye/0000-0001-8572-4486; Weisser, Wolfgang W/0000-0002-2757-8959; Oelmann, Yvonne/0000-0003-3513-6568; Schulze, Waltraud X/0000-0001-9957-7245; Wolters, Volkmar/0000-0002-7556-4578; Foesel, Baerbel/0000-0001-8872-836X; Birkhofer, Klaus/0000-0002-9301-2443; Schöning, Ingo/0000-0002-9830-5026; Yurkov, Andrey M./0000-0002-1072-5166; Begerow, Dominik/0000-0002-8286-1597; Nacke, Heiko/0000-0001-6169-6169; Schrumpf, Marion/0000-0003-4219-4125; , Roswitha/0000-0003-2457-7130; Overmann, Jorg/0000-0003-3909-7201; Klarner, Bernhard/0000-0003-1867-4911; Kandeler, Ellen/0000-0002-2854-0012; Polle, Andrea/0000-0001-8697-6394	DFG (Deutsche Forschungsgemeinschaft) [1374]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was funded by the DFG (Deutsche Forschungsgemeinschaft) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bardgett RD., 2005, THE BIOL OF SOIL, DOI [10.1093/acprof:oso/9780198525035.001.0001, DOI 10.1093/ACPROF:OSO/9780198525035.001.0001]; Birkhofer K, 2008, SOIL BIOL BIOCHEM, V40, P2297, DOI 10.1016/j.soilbio.2008.05.007; Birkhofer K, 2011, SOIL BIOL BIOCHEM, V43, P2200, DOI 10.1016/j.soilbio.2011.07.008; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Brussaard L, 1997, AMBIO, V26, P563; Cole L, 2005, SOIL BIOL BIOCHEM, V37, P1707, DOI 10.1016/j.soilbio.2005.02.005; Collins SA, 2004, AGRON J, V96, P1272, DOI 10.2134/agronj2004.1272; Curry J.P., 1994, GRASSLAND INVERTEBRA; Decaens T, 2010, GLOBAL ECOL BIOGEOGR, V19, P287, DOI 10.1111/j.1466-8238.2009.00517.x; Eisenhauer N, 2008, EUR J SOIL BIOL, V44, P141, DOI 10.1016/j.ejsobi.2007.10.002; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2009, SOIL BIOL BIOCHEM, V41, P2249, DOI 10.1016/j.soilbio.2009.06.009; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fountain MT, 2008, B ENTOMOL RES, V98, P283, DOI 10.1017/S000748530700555X; Gorley C.K., 2006, GETTING STARTED PRIM; Hansen B, 2001, AGR ECOSYST ENVIRON, V83, P11, DOI 10.1016/S0167-8809(00)00257-7; Hawkes CV, 2011, GLOBAL CHANGE BIOL, V17, P1637, DOI 10.1111/j.1365-2486.2010.02327.x; HENDRIX PF, 1992, SOIL BIOL BIOCHEM, V24, P1357, DOI 10.1016/0038-0717(92)90118-H; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE; Jandl R, 2003, RESTOR ECOL, V11, P239, DOI 10.1046/j.1526-100X.2003.00179.x; Kappes H, 2011, BIODIVERS CONSERV, V20, P2297, DOI 10.1007/s10531-011-0089-x; Kempson D., 1963, Pedobiologia, V3, P1; Killham K., 1994, SOIL ECOLOGY, V4th ed.; Kooijman AM, 2009, BIOL FERT SOILS, V45, P449, DOI 10.1007/s00374-009-0354-2; Lindberg N, 2004, FOREST ECOL MANAG, V188, P125, DOI 10.1016/j.foreco.2003.07.012; Magill AH, 1997, ECOL APPL, V7, P402, DOI 10.1890/1051-0761(1997)007[0402:BROFET]2.0.CO;2; Maraun M, 2001, BIOL FERT SOILS, V34, P222; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MOSSE B, 1971, J GEN MICROBIOL, V69, P157, DOI 10.1099/00221287-69-2-157; READ DJ, 1991, FRONTIERS IN MYCOLOGY, P101; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; VISHNIAC HS, 1995, MICROBIAL ECOL, V30, P309, DOI 10.1007/BF00171937; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Williams JP, 2009, ENVIRON MICROBIOL, V11, P3292, DOI 10.1111/j.1462-2920.2009.02079.x; Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004	44	114	117	4	286	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43292	10.1371/journal.pone.0043292	http://dx.doi.org/10.1371/journal.pone.0043292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937029	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300039
J	Chang, TH; Chen, SR; Yu, CY; Lin, YS; Chen, YS; Kubota, T; Matsuoka, M; Lin, YL				Chang, Tsung-Hsien; Chen, Siang-Ru; Yu, Chia-Yi; Lin, You-Sheng; Chen, Yao-Shen; Kubota, Toru; Matsuoka, Mayumi; Lin, Yi-Ling			Dengue Virus Serotype 2 Blocks Extracellular Signal-Regulated Kinase and Nuclear Factor-kappa B Activation to Downregulate Cytokine Production	PLOS ONE			English	Article							PREEXISTING ENHANCING ANTIBODIES; I INTERFERON INDUCTION; DENDRITIC CELLS; DEPENDENT ENHANCEMENT; INNATE IMMUNITY; INFECTION; PROTEIN; MACROPHAGES; MECHANISMS; INHIBITION	Background: Dengue virus (DENV) infection is the most common mosquito-borne viral disease threatening human health around the world. Type I interferon (IFN) and cytokine production are crucial in the innate immune system. We previously reported that DENV serotype 2 (DENV-2) induced low levels of interferon regulatory factor 3 and NF-kappa B activation, thus leading to reduced production of IFN-beta in the early phase of infection. Here, we determined whether DENV infection not only hampers type I IFN activation but also cytokine production triggered by Toll-like receptor (TLR) signaling. Methodology/Principal Findings: We used quantitative RT-PCR and found that only low levels of IFN-beta and inflammatory cytokines such as interleukin 10 (IL-10), IL-12 and tumor necrosis factor alpha (TNF alpha) mRNA were detected in DENV-2-infected bone-marrow-derived dendritic cells. Furthermore, DENV-2 infection repressed cytokine production triggered by TLR signaling. To elucidate the molecular mechanisms underlying this suppression event, we measured NF-kappa B activation by p65 nuclear translocation and luciferase reporter assay and found that NF-kappa B activation triggered by TLR ligands was blocked by DENV-2 infection. As well, extracellular signal-regulated kinase (ERK) activity was suppressed by DENV-2 infection. Conclusions/Significance: To downregulate the host innate immunity, DENV-2 by itself is a weak inducer of type I IFN and cytokines, furthermore DENV-2 can also block the TLR-triggered ERK-NF-kappa B activation and cytokine production.	[Chang, Tsung-Hsien; Chen, Siang-Ru; Lin, You-Sheng] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Yu, Chia-Yi; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lin, You-Sheng] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Internal Med, Infect Dis Sect, Kaohsiung, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Microbiol Sect, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Matsuoka, Mayumi] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Kubota, Toru] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan	Kaohsiung Veterans General Hospital; Academia Sinica - Taiwan; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Chang, TH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.	changth@vghks.gov.tw; yll@ibms.sinica.edu.tw	Chang, Tsung-Hsien/AAG-9384-2019; Lin, Yi-Ling/N-7128-2018	Chang, Tsung-Hsien/0000-0003-4806-7864; Lin, Yi-Ling/0000-0002-1838-6410; Yu, Chia-Yi/0000-0002-7567-6481	Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan [VGHKS99-122, VGHKS100-104]; Academia Sinica, Taipei, Taiwan	Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan)	This work was supported by grants (VGHKS99-122, VGHKS100-104) from the Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan (http://www.vghks.gov.tw/English/), and from Academia Sinica, Taipei, Taiwan (http://www.ibms.sinica.edu.tw/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; Chanteux H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-71; Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0; Chase AJ, 2011, J INFECT DIS, V203, P1763, DOI 10.1093/infdis/jir197; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Chen RF, 2005, FEMS IMMUNOL MED MIC, V44, P43, DOI 10.1016/j.femsim.2004.11.012; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Choi SH, 2006, MOL CELL BIOL, V26, P3048, DOI 10.1128/MCB.26.8.3048-3059.2006; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468; Fang XN, 2007, J MED VIROL, V79, P1431, DOI 10.1002/jmv.20953; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kwan WH, 2005, J VIROL, V79, P7291, DOI 10.1128/JVI.79.12.7291-7299.2005; Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liang ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023346; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Modhiran N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000924; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moreno-Altamirano MMB, 2007, INTERVIROLOGY, V50, P237, DOI 10.1159/000100567; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10; Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07; Schuhmann KM, 2011, J VIROL, V85, P3162, DOI 10.1128/JVI.02342-10; Su HL, 2001, VIROLOGY, V282, P141, DOI 10.1006/viro.2000.0820; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; Van Vliet K, 2009, MICROBIOL MOL BIOL R, V73, P730, DOI 10.1128/MMBR.00026-09; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Wati S, 2007, J VIROL, V81, P10161, DOI 10.1128/JVI.00313-07; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Zheng Z, 2011, J IMMUNOL	55	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41635	10.1371/journal.pone.0041635	http://dx.doi.org/10.1371/journal.pone.0041635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927911	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300011
J	Kestens, Y; Lebel, A; Chaix, B; Clary, C; Daniel, M; Pampalon, R; Theriault, M; Subramanian, SVP				Kestens, Yan; Lebel, Alexandre; Chaix, Basile; Clary, Christelle; Daniel, Mark; Pampalon, Robert; Theriault, Marius; Subramanian, S. V. P.			Association between Activity Space Exposure to Food Establishments and Individual Risk of Overweight	PLOS ONE			English	Article							GEOGRAPHIC LIFE ENVIRONMENTS; PHYSICAL-ACTIVITY; NEIGHBORHOOD; HEALTH; LEVEL; RESTAURANTS; CONSUMPTION; DISPARITIES; DISEASE; QUEBEC	Objective: Environmental exposure to food sources may underpin area level differences in individual risk for overweight. Place of residence is generally used to assess neighbourhood exposure. Yet, because people are mobile, multiple exposures should be accounted for to assess the relation between food environments and overweight. Unfortunately, mobility data is often missing from health surveys. We hereby test the feasibility of linking travel survey data with food listings to derive food store exposure predictors of overweight among health survey participants. Methods: Food environment exposure measures accounting for non-residential activity places (activity spaces) were computed and modelled in Montreal and Quebec City, Canada, using travel surveys and food store listings. Models were then used to predict activity space food exposures for 5,578 participants of the Canadian Community Health Survey. These food exposure estimates, accounting for daily mobility, were used to model self-reported overweight in a multilevel framework. Median Odd Ratios were used to assess the proportion of between-neighborhood variance explained by such food exposure predictors. Results: Estimates of food environment exposure accounting for both residential and non-residential destinations were significantly and more strongly associated with overweight than residential-only measures of exposure for men. For women, residential exposures were more strongly associated with overweight than non-residential exposures. In Montreal, adjusted models showed men in the highest quartile of exposure to food stores were at lesser risk of being overweight considering exposure to restaurants (OR = 0.36 [0.21-0.62]), fast food outlets (0.48 [0.30-0.79]), or corner stores (0.52 [0.35-0.78]). Conversely, men experiencing the highest proportion of restaurants being fast-food outlets were at higher risk of being overweight (2.07 [1.25-3.42]). Women experiencing higher residential exposures were at lower risk of overweight. Conclusion: Using residential neighbourhood food exposure measures may underestimate true exposure and observed associations. Using mobility data offers potential for deriving activity space exposure estimates in epidemiological models.	[Kestens, Yan] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Kestens, Yan; Lebel, Alexandre; Clary, Christelle] Montreal Univ Hosp Res Ctr, CRCHUM, Montreal, PQ, Canada; [Lebel, Alexandre; Subramanian, S. V. P.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Daniel, Mark] Univ S Australia, Samson Inst Hlth Res, Adelaide, SA 5001, Australia; [Chaix, Basile] Univ Paris 06, INSERM, Paris, France; [Pampalon, Robert] Quebec Natl Inst Publ Hlth, INSPQ, Quebec City, PQ, Canada; [Theriault, Marius] ESAD, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; Harvard University; Harvard T.H. Chan School of Public Health; University of South Australia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut national de sante publique du Quebec (INSPQ)	Kestens, Y (corresponding author), Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada.	yan.kestens@umontreal.ca	Chaix, Basile/B-8625-2014; Daniel, Mark/A-1151-2009; Kestens, Yan/D-1631-2012	Kestens, Yan/0000-0003-2619-5750; Lebel, Alexandre/0000-0001-6774-7633; Daniel, Mark/0000-0001-9112-134X	Centre Lea Roback; Canadian Institutes of Health Research [MOP-106420]; Fonds de Recherche du Quebec - Sante (FRQ-S)	Centre Lea Roback; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Sante (FRQ-S)	This work was supported by the Centre Lea Roback and by the Canadian Institutes of Health Research (Grant #MOP-106420). YK is supported by an investigator award from Fonds de Recherche du Quebec - Sante (FRQ-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence Metropolitaine de Transport, 2009, ENQ OR DEST 2008 MOB; Akhtar-Danesh N, 2008, OPEN MED, V2, pe83; Apparicio P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-4; Auld J, 2010, RESULTS UTRACS INTER; Auld J, 2009, TRANSP LETT, V1, P59, DOI 10.3328/TL.2009.01.01.59-79; Bertrand L, 2008, CAN J PUBLIC HEALTH, V99, P6, DOI 10.1007/BF03403732; Blazquez Gil G, 2012, INT J DISTRIB SENS N, V2012, P15; Boone-Heinonen J, 2011, ARCH INTERN MED, V171, P1162, DOI 10.1001/archinternmed.2011.283; Brown C, 2011, BROWNS EC DAMAGES NE, V8, P13; BRUNSDON C, 1995, COMPUT GEOSCI-UK, V21, P877, DOI 10.1016/0098-3004(95)00020-9; Carlos HA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-39; Chaix B, 2005, J EPIDEMIOL COMMUN H, V59, P517, DOI 10.1136/jech.2004.025478; Chaix B, 2012, AM J PREV M IN PRESS; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; Charalambous H, 2011, P AM MATH SOC, V139, P2383, DOI 10.1090/S0002-9939-2010-10677-9; Chung CJ, 1999, J CONSUM AFF, V33, P276, DOI 10.1111/j.1745-6606.1999.tb00071.x; Cummins S, 2007, INT J EPIDEMIOL, V36, P355, DOI 10.1093/ije/dym033; Curone D, 2010, IEEE T INF TECHNOL B, V14, P1098, DOI 10.1109/TITB.2010.2050696; Daniel M, 2010, EUR J EPIDEMIOL, V25, P711, DOI 10.1007/s10654-010-9499-4; Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638; Doherty ST, 2006, INTERNET BASED PROMP; Flamm M, 2006, CONCEPT PERSONAL NET; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001; Fraser LK, 2010, INT J ENV RES PUB HE, V7, P2290, DOI 10.3390/ijerph7052290; Gordon-Larsen P, 2011, HEALTH PLACE, V17, P1235, DOI 10.1016/j.healthplace.2011.07.011; Hagerstrand T, 1963, DEPLACEMENTS HUMAINS, P61; Holsten JE, 2009, PUBLIC HEALTH NUTR, V12, P397, DOI 10.1017/S1368980008002267; Inagami S, 2007, SOC SCI MED, V65, P1779, DOI 10.1016/j.socscimed.2007.05.051; Jeffery RW, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-2; Kelly P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-44; Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017; Kestens Y, 2010, HEALTH PLACE, V16, P1094, DOI 10.1016/j.healthplace.2010.06.016; Kestens Y, 2010, AM J PREV MED, V39, P33, DOI 10.1016/j.amepre.2010.03.014; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Lebel A, 2009, CAN J PUBLIC HEALTH, V100, P18, DOI 10.1007/BF03405486; Lebel A, 2012, J OBES, V2012, DOI 10.1155/2012/912645; Marshall K, 2006, PERSPECTIVES LABOUR, V7; Matthews SA, 2008, AM J PREV MED, V34, P257, DOI 10.1016/j.amepre.2007.12.001; Matthews SA, 2011, SOC DISPAR H H CARE, P35, DOI 10.1007/978-1-4419-7482-2_3; McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Oliver LN, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-41; Paez A, 2010, URBAN STUD, V47, P1415, DOI 10.1177/0042098009353626; Paquet C, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-58; Patrick K, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.3.e23; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Pouliot N, 2009, PUBLIC HEALTH NUTR, V12, P2051, DOI 10.1017/S1368980009005369; Roux AVD, 2003, AM J EPIDEMIOL, V157, P315, DOI 10.1093/aje/kwf207; Scully M, 2009, PUBLIC HEALTH NUTR, V12, P105, DOI 10.1017/S1368980008002012; Setton E, 2011, J EXPO SCI ENV EPID, V21, P42, DOI 10.1038/jes.2010.14; Shields Margot, 2008, Health Rep, V19, P61; Shohaimi S, 2004, J EPIDEMIOL COMMUN H, V58, P686, DOI 10.1136/jech.2003.008490; Silverman B.W., 1986, DENSITY ESTIMATION S; Stovel K, 2004, SOCIOL METHOD RES, V32, P559, DOI 10.1177/0049124103262683; Vallee J, 2011, SOC SCI MED, V73, P1133, DOI 10.1016/j.socscimed.2011.08.009; Vallee J, 2010, HEALTH PLACE, V16, P838, DOI 10.1016/j.healthplace.2010.04.009; Yang J, 2010, ADV PATTERN RECOGNIT, P185, DOI 10.1007/978-1-84996-507-1_8; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	61	98	98	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41418	10.1371/journal.pone.0041418	http://dx.doi.org/10.1371/journal.pone.0041418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22936974	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000308286300006
J	Stebbeds, WJD; Lunec, J; Larcombe, LD				Stebbeds, William J. D.; Lunec, Joseph; Larcombe, Lee D.			An In Silico Study of the Differential Effect of Oxidation on Two Biologically Relevant G-Quadruplexes: Possible Implications in Oncogene Expression	PLOS ONE			English	Article							C-MYC; GENE-EXPRESSION; DNA; STABILITY; SEQUENCES; 8-OXOGUANINE; KINETICS; DAMAGE	G-quadruplex structures, formed from guanine rich sequences, have previously been shown to be involved in various physiological processes including cancer-related gene expression. Furthermore, G-quadruplexes have been found in several oncogene promoter regions, and have been shown to play a role in the regulation of gene expression. The mutagenic properties of oxidative stress on DNA have been widely studied, as has the association with carcinogenesis. Guanine is the most susceptible nucleotide to oxidation, and as such, G-rich sequences that form G-quadruplexes can be viewed as potential "hot-spots" for DNA oxidation. We propose that oxidation may destabilise the G-quadruplex structure, leading to its unfolding into the duplex structure, affecting gene expression. This would imply a possible mechanism by which oxidation may impact on oncogene expression. This work investigates the effect of oxidation on two biologically relevant G-quadruplex structures through 500 ns molecular dynamics simulations on those found in the promoter regions of the c-Kit and c-Myc oncogenes. The results show oxidation having a detrimental effect on stability of the structure, substantially destabilising the c-Kit quadruplex, and with a more attenuated effect on the c-Myc quadruplex. Results are suggestive of a novel route for oxidation-mediated oncogenesis and may have wider implications for genome stability.	[Stebbeds, William J. D.; Lunec, Joseph; Larcombe, Lee D.] Cranfield Univ, Cranfield Hlth, Cranfield MK43 0AL, Beds, England	Cranfield University	Stebbeds, WJD (corresponding author), Cranfield Univ, Cranfield Hlth, Cranfield MK43 0AL, Beds, England.	w.j.stebbeds@cranfield.ac.uk		Larcombe, Lee/0000-0003-3150-6445				Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Bejugam M, 2007, J AM CHEM SOC, V129, P12926, DOI 10.1021/ja075881p; Briede JJ, 2010, TOXICOL SCI, V114, P193, DOI 10.1093/toxsci/kfp309; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Dexheimer TS, 2006, RSC BIOMOL SCI, P180; Ghosh A, 2009, J BIOL CHEM, V284, P31074, DOI 10.1074/jbc.M109.027532; Grand CL, 2002, MOL CANCER THER, V1, P565; Gros J, 2007, NUCLEIC ACIDS RES, V35, P3064, DOI 10.1093/nar/gkm111; Guedin A, 2009, NUCLEIC ACIDS RES, V37, P5559, DOI 10.1093/nar/gkp563; Haider S, 2010, METHODS MOL BIOL, V608, P17, DOI 10.1007/978-1-59745-363-9_2; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kawanishi S, 1999, BIOCHEMISTRY-US, V38, P16733, DOI 10.1021/bi990890z; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kumar N, 2008, NUCLEIC ACIDS RES, V36, P4433, DOI 10.1093/nar/gkn402; Kuryavyi V, 2010, NUCLEIC ACIDS RES, V38, P6757, DOI 10.1093/nar/gkq558; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Pelengaris S, 2000, CURR OPIN GENET DEV, V10, P100, DOI 10.1016/S0959-437X(99)00046-5; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Shafer RH, 2001, BIOPOLYMERS, V56, P209, DOI 10.1002/1097-0282(2000/2001)56:3<209::AID-BIP10018>3.0.CO;2-Y; Sherer EC, 1999, J AM CHEM SOC, V121, P5981, DOI 10.1021/ja983715z; Singh V, 2011, CHEM-EUR J, V17, P10838, DOI 10.1002/chem.201100284; Takabayashi F, 2004, GERONTOLOGY, V50, P57, DOI 10.1159/000075556; Vorlickova M, 2012, FEBS J, V279, P29, DOI 10.1111/j.1742-4658.2011.08396.x; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07	37	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43735	10.1371/journal.pone.0043735	http://dx.doi.org/10.1371/journal.pone.0043735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22928025	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300085
J	Stoto, MA				Stoto, Michael A.			The Effectiveness of US Public Health Surveillance Systems for Situational Awareness during the 2009 H1N1 Pandemic: A Retrospective Analysis	PLOS ONE			English	Article							INFLUENZA-A H1N1; UNITED-STATES; APRIL; FLU; EPIDEMIOLOGY; RATES	Background: The 2009 H1N1 outbreak provides an opportunity to learn about the strengths and weaknesses of current U. S. public health surveillance systems and to identify implications for measuring public health emergency preparedness. Methodology/Principal Findings: We adopted a "triangulation" approach in which multiple contemporary data sources, each with different expected biases, are compared to identify time patterns that are likely to reflect biases versus those that are more likely to be indicative of actual infection rates. This approach is grounded in the understanding that surveillance data are the result of a series of decisions made by patients, health care providers, and public health professionals about seeking and providing health care and about reporting cases to health authorities. Although limited by the lack of a gold standard, this analysis suggests that children and young adults are over-represented in many pH1N1 surveillance systems, especially in the spring wave. In addition, the nearly two-month delay between the Northeast and the South in the Fall peak in some surveillance data seems to at least partially reflect regional differences in concerns about pH1N1rather than real differences in pH1N1 infection rates. Conclusions/Significance: Although the extent of the biases suggested by this analysis cannot be known precisely, the analysis identifies underlying problems with surveillance systems - in particular their dependence on patient and provider behavior, which is influenced by a changing information environment - that could limit situational awareness in future public health emergencies. To improve situational awareness in future health emergencies, population-based surveillance systems such as telephone surveys of representative population samples and seroprevalence surveys in well-defined population cohorts are needed.	Georgetown Univ, Dept Hlth Syst Adm, Sch Nursing & Hlth Syst Adm, Washington, DC 20007 USA	Georgetown University	Stoto, MA (corresponding author), Georgetown Univ, Dept Hlth Syst Adm, Sch Nursing & Hlth Syst Adm, Washington, DC 20007 USA.	stotom@georgetown.edu			United States Centers for Disease Control and Prevention (CDC) [5P01TP000307-01]	United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This article was developed with funding support awarded to the Harvard School of Public Health under cooperative agreements with the United States Centers for Disease Control and Prevention (CDC) grant number 5P01TP000307-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; Brown D, 2009, WASHINGTON POST; Casalegno JS, 2011, EUROSURVEILLANCE, V16, P18; Centers for Disease Control and Prevention, 2009, 2009 H1N1 VACC REC; Centers for Disease Control and Prevention, 2010, CDC GUID STAT LOC PU; Centers for Disease Control and Prevention, 2009, 2008 2009 INFL SEAS; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P37; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Centers for Disease Control and Prevention (CDC), 2009, UPD CDC EST 2009 H1N; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Cordova-Villalobos Jose A, 2009, Health Res Policy Syst, V7, P21, DOI 10.1186/1478-4505-7-21; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Farley T, 2009, 2009 NEW YORK CIT DE; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Gilson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001079; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Government Accountability Office (2010) Public health information technology, 2010, GAO1199; Hadler JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011677; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Hodge JG, 2009, BIOSECUR BIOTERROR, V7, P45, DOI 10.1089/bsp.2009.0006; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Keramarou M, 2011, EUROSURVEILLANCE, V16, P17; Kok J, 2011, LANCET INFECT DIS, V11, P423, DOI 10.1016/S1473-3099(11)70120-7; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; McDonnell WM, 2012, AM J EMERG MED, V30, P275, DOI 10.1016/j.ajem.2010.11.027; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Noyes KA, 2011, J PUBLIC HEALTH MAN, V17, P12, DOI 10.1097/PHH.0b013e3181fb0050; Office of Public Health Preparedness and Response (OPHPR), 2010, 2010 REP PUBL HLTH P; Pandemic Influenza Preparedness Team, 2011, UK INFL PAND PREP ST; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Stoto MA, 2005, TR285DHHS RAND; Stoto MA, 2008, GEORGETOWN LAW J, V96, P703; Swerdlow DL, 2011, CLIN INFECT DIS, V52, pS1, DOI 10.1093/cid/ciq005; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Trust for America's Health (TFAH), 2010, READ NOT 2010 PROT P; U.S. Department of Health and Human Services, INT IMPL GUID NAT HL; U.S. Department of Health and Human Services, NAT HLTH SEC STRAT U; U.S. Government Accountability Office, 2010, GAO10645; Zhang Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-591	46	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e40984	10.1371/journal.pone.0040984	http://dx.doi.org/10.1371/journal.pone.0040984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927904	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300005
J	Ghisolfi, L; Keates, AC; Hu, XW; Lee, DK; Li, CJ				Ghisolfi, Laura; Keates, Andrew C.; Hu, Xingwang; Lee, Dong-ki; Li, Chiang J.			Ionizing Radiation Induces Stemness in Cancer Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; INDUCED GENOMIC INSTABILITY; ACUTE MYELOID-LEUKEMIA; SIDE-POPULATION; SELF-RENEWAL; MULTIDRUG-RESISTANCE; MELANOMA-CELLS; DIFFERENTIATION; GROWTH; CARCINOGENESIS	The cancer stem cell (CSC) model posits the presence of a small number of CSCs in the heterogeneous cancer cell population that are ultimately responsible for tumor initiation, as well as cancer recurrence and metastasis. CSCs have been isolated from a variety of human cancers and are able to generate a hierarchical and heterogeneous cancer cell population. CSCs are also resistant to conventional chemo-and radio-therapies. Here we report that ionizing radiation can induce stem cell-like properties in heterogeneous cancer cells. Exposure of non-stem cancer cells to ionizing radiation enhanced spherogenesis, and this was accompanied by upregulation of the pluripotency genes Sox2 and Oct3/4. Knockdown of Sox2 or Oct3/4 inhibited radiation-induced spherogenesis and increased cellular sensitivity to radiation. These data demonstrate that ionizing radiation can activate stemness pathways in heterogeneous cancer cells, resulting in the enrichment of a CSC subpopulation with higher resistance to radiotherapy.	[Ghisolfi, Laura; Keates, Andrew C.; Hu, Xingwang; Li, Chiang J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Skip Ackerman Ctr Mol Therapeut,Div Gastroenterol, Boston, MA 02215 USA; [Lee, Dong-ki] Sungkyunkwan Univ, Dept Chem, Global Res Lab RNAi Med, Suwon, South Korea	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Sungkyunkwan University (SKKU)	Ghisolfi, L (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Skip Ackerman Ctr Mol Therapeut,Div Gastroenterol, Boston, MA 02215 USA.	cli@bidmc.harvard.edu	Hu, Xingwang/ABG-6400-2021; Ghisolfi, Laura/I-8609-2012	Hu, Xingwang/0000-0002-2320-3279	Skip Ackerman Center for Molecular Therapeutics Fund; Global Research Laboratory Award (Ministry of Education Science and Technology, Korea)	Skip Ackerman Center for Molecular Therapeutics Fund; Global Research Laboratory Award (Ministry of Education Science and Technology, Korea)	This study was supported by Skip Ackerman Center for Molecular Therapeutics Fund and Global Research Laboratory Award (Ministry of Education Science and Technology, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Atlasi Y, 2007, INT J CANCER, V120, P1598, DOI 10.1002/ijc.22508; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Blagosklonny MV, 2007, CANCER BIOL THER, V6, P1684, DOI 10.4161/cbt.6.11.5167; Blagosklonny MV, 2006, LEUKEMIA, V20, P385, DOI 10.1038/sj.leu.2404075; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bussolati B, 2009, J CELL MOL MED, V13, P309, DOI 10.1111/j.1582-4934.2008.00338.x; Chen JS, 2006, LARYNGOSCOPE, V116, P401, DOI 10.1097/01.mlg.0000195075.14093.fb; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Collins CA, 2005, CELL CYCLE, V4, P1338, DOI 10.4161/cc.4.10.2114; Debeb BG, 2009, J MAMMARY GLAND BIOL, V14, P11, DOI 10.1007/s10911-009-9114-z; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Haraguchi Naotsugu, 2006, Hum Cell, V19, P24, DOI 10.1111/j.1749-0774.2005.00004.x; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kaup S, 2006, MUTAT RES-FUND MOL M, V597, P87, DOI 10.1016/j.mrfmmm.2005.06.032; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Little JB, 2000, CARCINOGENESIS, V21, P397, DOI 10.1093/carcin/21.3.397; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Madjd Zahra, 2009, Cancer Immun, V9, P4; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Morgan WF, 2005, P NATL ACAD SCI USA, V102, P14127, DOI 10.1073/pnas.0507119102; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Mothersill C, 2003, ONCOGENE, V22, P7028, DOI 10.1038/sj.onc.1206882; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; POSTE G, 1982, Invasion and Metastasis, V2, P137; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Robinson SN, 2005, BONE MARROW TRANSPL, V35, P807, DOI 10.1038/sj.bmt.1704881; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; SELL S, 1994, LAB INVEST, V70, P6; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith LE, 2003, HEALTH PHYS, V85, P23, DOI 10.1097/00004032-200307000-00006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trosko JE, 1998, ENVIRON HEALTH PERSP, V106, P331, DOI 10.2307/3433935; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wicha MS, 2006, CLIN CANCER RES, V12, P5606, DOI 10.1158/1078-0432.CCR-06-1537; WOODRUFF MFA, 1983, BRIT J CANCER, V47, P589, DOI 10.1038/bjc.1983.96; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zobalova R, 2008, BIOCHEM BIOPH RES CO, V373, P567, DOI 10.1016/j.bbrc.2008.06.073	75	152	160	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43628	10.1371/journal.pone.0043628	http://dx.doi.org/10.1371/journal.pone.0043628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928007	Green Submitted, gold, Green Published			2022-12-27	WOS:000307789700043
J	Guo, FG; Lei, JX; Sun, YC; Chi, YH; Ge, F; Patil, BS; Koiwa, H; Zeng, RS; Zhu-Salzman, K				Guo, Fengguang; Lei, Jiaxin; Sun, Yucheng; Chi, Yong Hun; Ge, Feng; Patil, Bhimanagouda S.; Koiwa, Hisashi; Zeng, Rensen; Zhu-Salzman, Keyan			Antagonistic Regulation, Yet Synergistic Defense: Effect of Bergapten and Protease Inhibitor on Development of Cowpea Bruchid Callosobruchus maculatus	PLOS ONE			English	Article							DEPRESSARIA-PASTINACELLA; IMMUNE HOMEOSTASIS; SPODOPTERA-EXIGUA; INSECT HERBIVORES; COUNTER-DEFENSE; SOYACYSTATIN-N; PLANT; DROSOPHILA; FURANOCOUMARINS; EXPRESSION	The furanocoumarin compound bergapten is a plant secondary metabolite that has anti-insect function. When incorporated into artificial diet, it retarded cowpea bruchid development, decreased fecundity, and caused mortality at a sufficient dose. cDNA microarray analysis indicated that cowpea bruchid altered expression of 543 midgut genes in response to dietary bergapten. Among these bergapten-regulated genes, 225 have known functions; for instance, those encoding proteins related to nutrient transport and metabolism, development, detoxification, defense and various cellular functions. Such differential gene regulation presumably facilitates the bruchids' countering the negative effect of dietary bergapten. Many genes did not have homology (E-value cutoff 10(-6)) with known genes in a BLASTX search (206), or had homology only with genes of unknown function (112). Interestingly, when compared with the transcriptomic profile of cowpea bruchids treated with dietary soybean cysteine protease inhibitor N (scN), 195 out of 200 coregulated midgut genes are oppositely regulated by the two compounds. Simultaneous administration of bergapten and scN attenuated magnitude of change in selected oppositely-regulated genes, as well as led to synergistic delay in insect development. Therefore, targeting insect vulnerable sites that may compromise each other's counter-defensive response has the potential to increase the efficacy of the anti-insect molecules.	[Guo, Fengguang; Lei, Jiaxin; Sun, Yucheng; Chi, Yong Hun; Zhu-Salzman, Keyan] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Sun, Yucheng; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China; [Patil, Bhimanagouda S.; Koiwa, Hisashi] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA; [Patil, Bhimanagouda S.; Koiwa, Hisashi; Zhu-Salzman, Keyan] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX USA; [Zeng, Rensen] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China	Texas A&M University System; Texas A&M University College Station; Chinese Academy of Sciences; Institute of Zoology, CAS; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; South China Agricultural University	Guo, FG (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA.	ksalzman@tamu.edu	Guo, Fengguang/M-4482-2019; Zeng, Ren-sen/AAI-2067-2020; Guo, Fengguang/E-1728-2018; Lei, Jiaxin/AAK-8479-2021; Koiwa, Hisashi/AAO-6512-2020; Patil, Bhimu S/C-7620-2013; Koiwa, Hisashi/AAA-8182-2019	Guo, Fengguang/0000-0002-3742-7214; Koiwa, Hisashi/0000-0002-7421-340X; Patil, Bhimu S/0000-0001-7189-0432; Sun, Yucheng/0000-0003-2353-0218; Zeng, Rensen/0000-0002-6435-3054	United States Department of Agriculture (USDA) AFRI [2007-35607-17887]; USDA Cooperative State Research, Education and Extension Service [2009-34402-19831, 2010-34402-20875]; National Natural Science Foundation of China [31028018]	United States Department of Agriculture (USDA) AFRI(United States Department of Agriculture (USDA)); USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the United States Department of Agriculture (USDA) AFRI grant# 2007-35607-17887, USDA Cooperative State Research, Education and Extension Service, grants# 2009-34402-19831 and 2010-34402-20875, as well as National Natural Science Foundation of China (31028018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JE, 2007, INSECT MOL BIOL, V16, P295, DOI 10.1111/j.1365-2583.2007.00726.x; Ahn JE, 2004, INSECT MOL BIOL, V13, P649, DOI 10.1111/j.0962-1075.2004.00523.x; Ahn JE, 2009, J INSECT PHYSIOL, V55, P678, DOI 10.1016/j.jinsphys.2009.04.016; Amirhusin B, 2004, J ECON ENTOMOL, V97, P2095, DOI 10.1603/0022-0493-97.6.2095; Amirhusin B, 2007, J INSECT PHYSIOL, V53, P734, DOI 10.1016/j.jinsphys.2007.03.008; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; AUCOIN R, 1995, ARCH INSECT BIOCHEM, V29, P211, DOI 10.1002/arch.940290210; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Ben Amor T, 2000, INSECT BIOCHEM MOLEC, V30, P915, DOI 10.1016/S0965-1748(00)00072-2; BERENBAUM M, 1978, SCIENCE, V201, P532, DOI 10.1126/science.201.4355.532; BERENBAUM M, 1995, ARCH INSECT BIOCHEM, V29, P119, DOI 10.1002/arch.940290204; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; Bown DP, 1997, INSECT BIOCHEM MOLEC, V27, P625, DOI 10.1016/S0965-1748(97)00043-X; Chi YH, 2009, INSECT MOL BIOL, V18, P97, DOI 10.1111/j.1365-2583.2008.00854.x; Chi YH, 2011, J INSECT PHYSIOL, V57, P220, DOI 10.1016/j.jinsphys.2010.11.011; Cianfrogna JA, 2002, J CHEM ECOL, V28, P1365, DOI 10.1023/A:1016244402019; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Danielson PB, 1997, P NATL ACAD SCI USA, V94, P10797, DOI 10.1073/pnas.94.20.10797; Davies SA, 2012, J INSECT PHYSIOL, V58, P488, DOI 10.1016/j.jinsphys.2012.01.008; De Leo F, 1998, PLANT PHYSIOL, V118, P997, DOI 10.1104/pp.118.3.997; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; DIAWARA MM, 1993, J CHEM ECOL, V19, P2473, DOI 10.1007/BF00980684; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; Huang YF, 2011, J INSECT PHYSIOL, V57, P1033, DOI 10.1016/j.jinsphys.2011.05.001; IVIE GW, 1983, SCIENCE, V221, P374, DOI 10.1126/science.221.4608.374; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Kim BY, 2008, COMP BIOCHEM PHYS B, V149, P183, DOI 10.1016/j.cbpb.2007.09.007; Koiwa H, 2000, FEBS LETT, V471, P67, DOI 10.1016/S0014-5793(00)01368-5; Koiwa H, 1997, TRENDS PLANT SCI, V2, P379, DOI 10.1016/S1360-1385(97)90052-2; Koo YD, 2008, INSECT MOL BIOL, V17, P235, DOI 10.1111/j.1365-2583.2008.00799.x; LEE KW, 1991, INSECT BIOCHEM, V21, P353, DOI 10.1016/0020-1790(91)90001-U; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu YL, 2004, INSECT BIOCHEM MOLEC, V34, P1069, DOI 10.1016/j.ibmb.2004.06.010; MICHAUD D, 1995, ARCH BIOCHEM BIOPHYS, V322, P469, DOI 10.1006/abbi.1995.1490; Nitao JK, 2003, J CHEM ECOL, V29, P671, DOI 10.1023/A:1022872704016; Pan CY, 2009, PESTIC BIOCHEM PHYS, V93, P105, DOI 10.1016/j.pestbp.2008.12.003; Peroutka R, 2007, J SCI FOOD AGR, V87, P2152, DOI 10.1002/jsfa.2979; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Schuler MA, 1996, PLANT PHYSIOL, V112, P1411, DOI 10.1104/pp.112.4.1411; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Scott JG, 1996, INSECT BIOCHEM MOLEC, V26, P645, DOI 10.1016/S0965-1748(96)00008-2; Simon A, 2008, ANTIMICROB AGENTS CH, V52, P1407, DOI 10.1128/AAC.00155-07; Stergiopoulos K, 2009, PHYSIOL GENOMICS, V37, P1, DOI 10.1152/physiolgenomics.90360.2008; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; Stevenson PC, 2003, PHYTOCHEMISTRY, V63, P41, DOI 10.1016/S0031-9422(02)00748-3; VOGEL H, 2011, BMC GENOMICS, V12; Wen ZM, 2003, INSECT BIOCHEM MOLEC, V33, P937, DOI 10.1016/S0965-1748(03)00100-0; Zhu-Salzman K, 2003, INSECT MOL BIOL, V12, P135, DOI 10.1046/j.1365-2583.2003.00395.x; Zhu-Salzman K., 2006, ENCY PEST MANAGEMENT, P1	53	14	15	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e41877	10.1371/journal.pone.0041877	http://dx.doi.org/10.1371/journal.pone.0041877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927917	Green Published, gold, Green Submitted			2022-12-27	WOS:000307789700006
J	Iyer, R; Koleva, S; Graham, J; Ditto, P; Haidt, J				Iyer, Ravi; Koleva, Spassena; Graham, Jesse; Ditto, Peter; Haidt, Jonathan			Understanding Libertarian Morality: The Psychological Dispositions of Self-Identified Libertarians	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; SOCIAL-PSYCHOLOGY; DISGUST; PERSONALITY; MORALIZATION; DISTINCTION; SENSITIVITY; REACTANCE; EMOTIONS; LIBERALS	Libertarians are an increasingly prominent ideological group in U. S. politics, yet they have been largely unstudied. Across 16 measures in a large web-based sample that included 11,994 self-identified libertarians, we sought to understand the moral and psychological characteristics of self-described libertarians. Based on an intuitionist view of moral judgment, we focused on the underlying affective and cognitive dispositions that accompany this unique worldview. Compared to self-identified liberals and conservatives, libertarians showed 1) stronger endorsement of individual liberty as their foremost guiding principle, and weaker endorsement of all other moral principles; 2) a relatively cerebral as opposed to emotional cognitive style; and 3) lower interdependence and social relatedness. As predicted by intuitionist theories concerning the origins of moral reasoning, libertarian values showed convergent relationships with libertarian emotional dispositions and social preferences. Our findings add to a growing recognition of the role of personality differences in the organization of political attitudes.	[Iyer, Ravi; Koleva, Spassena; Graham, Jesse] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Ditto, Peter] Dept Psychol & Social Behav, Irvine, CA USA; [Haidt, Jonathan] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	University of Southern California; University of Virginia	Iyer, R (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	raviiyer@usc.edu	Haidt, Jonathan/B-2835-2013	Koleva, Spassena/0000-0002-7013-2549; Graham, Jesse/0000-0001-8863-7978	John Templeton Foundation; Siemer and Associates; Oakley Fellowship from University of Southern California	John Templeton Foundation; Siemer and Associates; Oakley Fellowship from University of Southern California	During the time the study was completed, general funding for the first author was provided by The John Templeton Foundation http://www.templeton.org/), Siemer and Associates (http://www.siemer.com/), and an Oakley Fellowship from University of Southern California (http://www.usc.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This study was partly funded by Siemer & Associates. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDERSON SW, 2002, SO NEUROSCI SER, P333; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baron-Cohen S, 2007, ESSENTIAL DIFFERENCE; Barriga AQ, 2001, MERRILL PALMER QUART, V47, P532, DOI 10.1353/mpq.2001.0020; BATSON CD, 1988, J PERS SOC PSYCHOL, V55, P52, DOI 10.1037/0022-3514.55.1.52; Berlin Isaiah, 2002, LIBERTY INCORPORATIN; Boaz D, 2009, GALLUPS CONSERVATIVE; Brehm S.S., 1981, PSYCHOL REACTANCE, DOI DOI 10.1016/B978-0-12-129840-1.50005-3; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Campos B., 2002, 2002 W PSYCH ASS IRV; Carney DR, 2008, POLIT PSYCHOL, V29, P807, DOI 10.1111/j.1467-9221.2008.00668.x; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chang L, 2010, PUBLIC OPIN QUART, V74, P154, DOI 10.1093/poq/nfp090; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; CONOVER PJ, 1981, AM J POLIT SCI, V25, P617, DOI 10.2307/2110756; Damasio A, 2000, FEELING WHAT HAPPENS; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DOWD ET, 1994, COGNITIVE THER RES, V18, P601; FORSYTH DR, 1990, J RES PERS, V24, P398, DOI 10.1016/0092-6566(90)90030-A; FORSYTH DR, 1980, J PERS SOC PSYCHOL, V39, P175, DOI 10.1037/0022-3514.39.1.175; FORSYTH DR, 1985, J PERS SOC PSYCHOL, V49, P264, DOI 10.1037/0022-3514.49.1.264; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Glenn Andrea L, 2010, Cellscience, V6, P30; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2010, PERS SOC PSYCHOL REV, V14, P140, DOI 10.1177/1088868309353415; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2009, J EXP SOC PSYCHOL, V45, P581, DOI 10.1016/j.jesp.2009.01.003; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; HAIDT J, 1993, J PERS SOC PSYCHOL, V65, P613, DOI 10.1037/0022-3514.65.4.613; Haidt J., 2010, HDB SOCIAL PSYCHOL, P797, DOI DOI 10.1002/9780470561119.SOCPSY002022; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Haidt J., 2012, RIGHTEOUS MIND WHY G; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Haidt J, 2009, PSYCHOL INQ, V20, P110, DOI 10.1080/10478400903028573; Hong SM, 1996, EDUC PSYCHOL MEAS, V56, P173, DOI 10.1177/0013164496056001014; Horberg EJ, 2009, J PERS SOC PSYCHOL, V97, P963, DOI 10.1037/a0017423; Hunter J. D., 1991, CULTURE WARS STRUGGL; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Inbar Y, 2009, EMOTION, V9, P435, DOI 10.1037/a0015960; James William, 1982, VARIETIES RELIG EXPE; John OP, 1999, HDB PERSONALITY THEO; Jones B., 2010, HAVING YOUR CAKE EAT; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Lakoff George, 2002, MORAL POLITICS LIBER; Lewis GJ, 2011, BRIT J PSYCHOL; Locke J, 1988, 2 TREATISES GOVT, V3rd, P301; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; McAdams D, 1996, PSYCHOL INQ, V7, P295, DOI 10.1207/s15327965pli0704_1; MCADAMS DP, 1995, J PERS, V63, P365, DOI 10.1111/j.1467-6494.1995.tb00500.x; McAdams DP, 2006, AM PSYCHOL, V61, P204, DOI 10.1037/0003-066X.61.3.204; McCain, 2010, WASHINGTON TIMES; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; McCue CP, 2000, WOMEN POLIT, V21, P1; McFarland S., 2008, PSICOL POL T, V36, P37; Mitchell D, 2005, POLIT GEOGR, V24, P77, DOI 10.1016/j.polgeo.2004.06.003; Olatunji BO, 2007, PSYCHOL ASSESSMENT, V19, P281, DOI 10.1037/1040-3590.19.3.281; Paul R, 2008, PERSONAL FREEDOMS IN; Rand A, 1969, OBJECTIVIST, V8; Rand A, 1964, COMMUNICATION    MAR, P35; Rand A, 1961, OBJECTIVIST ETHICS; Rand Ayn, 1964, VIRTUE SELFISHNESS; Rand Ayn, 1994, FOUNTAINHEAD; Rawls J., 1971, THEORY JUSTICE; Read S J, 1997, Pers Soc Psychol Rev, V1, P26, DOI 10.1207/s15327957pspr0101_3; Rozin P, 1997, PSYCHOL SCI, V8, P67, DOI 10.1111/j.1467-9280.1997.tb00685.x; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; Rozin P, 1999, PSYCHOL SCI, V10, P218, DOI 10.1111/1467-9280.00139; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Ryan RM, 2000, PSYCHOL INQ, V11, P319, DOI 10.1207/S15327965PLI1104_03; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; SEARS DO, 1986, J PERS SOC PSYCHOL, V51, P515, DOI 10.1037/0022-3514.51.3.515; Singelis T.M., 1995, CROSS-CULT RES, V29, P240, DOI [10.1177/106939719502900302, DOI 10.1177/106939719502900302]; Singh, 1999, J CONSUM BEHAV, V8, P321, DOI [10.1207/s15327663jcp0803_07, DOI 10.1207/S15327663JCP0803_07]; Sowell T., 2002, CONFLICT VISIONS IDE; Tetlock PE, 2000, J PERS SOC PSYCHOL, V78, P853, DOI 10.1037/0022-3514.78.5.853; Thomas EF, 2009, PERS SOC PSYCHOL REV, V13, P194, DOI 10.1177/1088868309341563; TOI M, 1982, J PERS SOC PSYCHOL, V43, P281, DOI 10.1037/0022-3514.43.2.281; Uhlmann EL, 2009, JUDGM DECIS MAK, V4, P479; Vaisey S., 2010, CHARITABLE GIV UNPUB; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Winter N, 2010, POLITICAL BEHAV; Zernike Kate, 2010, NY TIMES	88	287	288	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42366	10.1371/journal.pone.0042366	http://dx.doi.org/10.1371/journal.pone.0042366			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992PA	22927928	gold, Green Published, Green Submitted			2022-12-27	WOS:000307789700011
J	Charlier, J; Hostens, M; Jacobs, J; Van Ranst, B; Duchateau, L; Vercruysse, J				Charlier, Johannes; Hostens, Miel; Jacobs, Jos; Van Ranst, Bonny; Duchateau, Luc; Vercruysse, Jozef			Integrating Fasciolosis Control in the Dry Cow Management: The Effect of Closantel Treatment on Milk Production	PLOS ONE			English	Article							HEPATICA ANTIBODY-LEVELS; DAIRY-COWS; BOVINE FASCIOLIASIS; CATTLE; RISK; SEROPREVALENCE; ASSOCIATION; INFECTIONS; YIELD; ELISA	The liver fluke Fasciola hepatica is a parasite of ruminants with a worldwide distribution and an apparent increasing incidence in EU member states. Effective control in dairy cattle is hampered by the lack of flukicides with a zero-withdrawal time for milk, leaving the dry period as the only time that preventive treatment can be applied. Here, we present the results of a blinded, randomized and placebo-controlled trial on 11 dairy herds (402 animals) exposed to F. hepatica to 1) assess the effect of closantel treatment at dry-off (or 80-42 days before calving in first-calving heifers) on milk production parameters and 2) evaluate if a number of easy-to-use animal parameters is related to the milk production response after treatment. Closantel treatment resulted in a noticeable decrease of anti-F. hepatica antibody levels from 3-6 months after treatment onwards, a higher peak production (1.06 kg) and a slightly higher persistence (9%) of the lactation, resulting in a 305-day milk production increase of 303 kg. No effects of anthelmintic treatment were found on the average protein and fat content of the milk. Milk production responses after treatment were poor in meagre animals and clinically relevant higher milk production responses were observed in first-lactation animals and in cows with a high (0.3-0.5 optical density ratio (ODR)), but not a very high (>= 0.5 ODR) F. hepatica ELISA result on a milk sample from the previous lactation. We conclude that in dairy herds exposed to F. hepatica, flukicide treatment at dry-off is a useful strategy to reduce levels of exposure and increase milk production in the subsequent lactation. Moreover, the results suggest that treatment approaches that only target selected animals within a herd can be developed based on easy-to-use parameters.	[Charlier, Johannes; Vercruysse, Jozef] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Hostens, Miel] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, Merelbeke, Belgium; [Jacobs, Jos] Elanco Anim Hlth, Vosselaar, Belgium; [Van Ranst, Bonny] Uniform Agri BV, Assen, Netherlands; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Physiol & Biometr, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Charlier, J (corresponding author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	johannes.charlier@ugent.be	Charlier, Johannes/AAC-8990-2019; Charlier, Johannes/A-6487-2009; Hostens, Miel/W-3713-2019	Charlier, Johannes/0000-0002-1332-1458; Hostens, Miel/0000-0001-5376-976X	Agency for Innovation by Science and Technology of Flanders (IWT Vlaanderen) [OZM090697]; E.U. (FP7 GLOWORM project) [288975CP-TP-KBBE.2011.1.3-04]; Elanco Animal Health	Agency for Innovation by Science and Technology of Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); E.U. (FP7 GLOWORM project); Elanco Animal Health	The research of JC was supported by the Agency for Innovation by Science and Technology of Flanders (IWT Vlaanderen, www.iwt.be, projectOZM090697). Additional financial support for this study was received from the E.U. (FP7 GLOWORM project - Grant agreement no 288975CP-TP-KBBE.2011.1.3-04, http://cordis.europa.eu/fp7) and Elanco Animal Health. The funders IWT Vlaanderen and EU FP7 had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Elanco Animal Health played a role in the study design and the writing of the paper and no role in the data collection and analysis and decision to publish.	Agneessens J, 2000, VET PARASITOL, V90, P83, DOI 10.1016/S0304-4017(00)00232-6; Andrews SJ, 1999, FASCIOLOSIS, P1; Bennema S, 2009, VET PARASITOL, V165, P51, DOI 10.1016/j.vetpar.2009.07.006; BLACK NM, 1972, VET REC, V90, P71, DOI 10.1136/vr.90.3.71; Borgsteede FHM, 2000, VET PARASITOL, V89, P287, DOI 10.1016/S0304-4017(00)00219-3; Bossaert K, 1999, ANN MED VET, V143, P201; BOULARD C, 1995, VET RES, V26, P249; Brien BO, 2010, IRISH VET J, V63, P702; Charlier J, 2006, VET PARASITOL, V136, P161, DOI 10.1016/j.vetpar.2005.10.017; Charlier J, 2008, VET PARASITOL, V153, P44, DOI 10.1016/j.vetpar.2008.01.035; Charlier J, 2007, PREV VET MED, V78, P57, DOI 10.1016/j.prevetmed.2006.09.010; Charlier J, 2012, VET PARASITOL, V184, P204, DOI 10.1016/j.vetpar.2011.09.008; Charlier J, 2011, GEOSPATIAL HEALTH, V5, P239, DOI 10.4081/gh.2011.176; Cole JB, 2012, J DAIRY SCI, V95, P4041, DOI 10.3168/jds.2011-4905; DARGIE JD, 1987, INT J PARASITOL, V17, P453, DOI 10.1016/0020-7519(87)90121-4; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Ehrlich J. L., 2011, Bovine Practitioner, V45, P88; Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377; Fairweather I, 2011, VET PARASITOL, V180, P133, DOI 10.1016/j.vetpar.2011.05.034; Fox NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016126; GAASENBEEK CPH, 1992, VET QUART, V14, P140, DOI 10.1080/01652176.1992.9694351; GUERRERO J, 1984, PREV VET MED, V2, P317, DOI 10.1016/0167-5877(84)90075-8; Haine D, 2004, PREV VET MED, V65, P93, DOI 10.1016/j.prevetmed.2004.06.005; Hanna REB, 2006, VET PARASITOL, V142, P78, DOI 10.1016/j.vetpar.2006.06.025; Hostens M, 2012, J DAIRY SCI, V95, P2988, DOI 10.3168/jds.2011-4791; Jongeneel RC, 2010, 2010017 LEI; Khan MK, 2011, J HELMINTHOL, V85, P334, DOI 10.1017/S0022149X10000659; LEVIEUX D, 1992, VET PARASITOL, V45, P81, DOI 10.1016/0304-4017(92)90029-9; MAGE C, 1993, REV MED VET-TOULOUSE, V144, P425; Marcos LA, 2007, J HELMINTHOL, V81, P381, DOI 10.1017/S0022149X07850231; McCann CM, 2010, VET REC, V166, P612, DOI 10.1136/vr.b4836; Mezo M, 2008, VET PARASITOL, V157, P235, DOI 10.1016/j.vetpar.2008.07.032; Mezo M, 2011, VET PARASITOL, V180, P237, DOI 10.1016/j.vetpar.2011.03.009; RANDELL WF, 1980, AM J VET RES, V41, P262; Roche JR, 2009, J DAIRY SCI, V92, P5769, DOI 10.3168/jds.2009-2431; Rondelaud D, 2011, VET PARASITOL, V181, P166, DOI 10.1016/j.vetpar.2011.03.056; ROSS JG, 1970, BRIT VET J, V126, pR13; Salimi-Bejestani MR, 2008, VET REC, V162, P109, DOI 10.1136/vr.162.4.109; Salimi-Bejestani MR, 2007, VET PARASITOL, V149, P290, DOI 10.1016/j.vetpar.2007.08.008; Staquet M, 1990, CANC CLIN TRIALS MET, P260; Torgerson P, 1999, FASCIOLOSIS, P113; van Dijk J, 2010, ANIMAL, V4, P377, DOI 10.1017/S1751731109990991; Wyk JA, 2006, VET PARASITOL, V139, P336, DOI 10.1016/j.vetpar.2006.04.023; ZUKOWSKI SH, 1993, VET PARASITOL, V47, P51, DOI 10.1016/0304-4017(93)90175-M	44	37	37	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43216	10.1371/journal.pone.0043216	http://dx.doi.org/10.1371/journal.pone.0043216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916226	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800054
J	Naish, KR; Harris, G				Naish, Katherine R.; Harris, Gillian			Food Intake Is Influenced by Sensory Sensitivity	PLOS ONE			English	Article							REWARD DEFICIENCY SYNDROME; INDIVIDUAL-DIFFERENCES; PALATABILITY; CHILDREN; OBESITY; CHOCOLATE; APPETITE; ANXIETY	Wide availability of highly palatable foods is often blamed for the rising incidence of obesity. As palatability is largely determined by the sensory properties of food, this study investigated how sensitivity to these properties affects how much we eat. Forty females were classified as either high or low in sensory sensitivity based on their scores on a self-report measure of sensory processing (the Adult Sensory Profile), and their intake of chocolate during the experiment was measured. Food intake was significantly higher for high-sensitivity compared to low-sensitivity individuals. Furthermore, individual scores of sensory sensitivity were positively correlated with self-reported emotional eating. These data could indicate that individuals who are more sensitive to the sensory properties of food have a heightened perception of palatability, which, in turn, leads to a greater food intake.	[Naish, Katherine R.; Harris, Gillian] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Naish, KR (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England.	k.r.naish@pgr.reading.ac.uk	Naish, Katherine/N-6436-2014	Naish, Katherine/0000-0002-8939-8945	University of Birmingham's School of Psychology	University of Birmingham's School of Psychology	The work was not supported by any external sources of funding. Minimal funding (e.g., for printing costs and test materials) was provided by the University of Birmingham's School of Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Blum K, 1996, AM SCI, V84, P132; Blum K, 2006, ADV THER, V23, P1040, DOI 10.1007/BF02850224; Brown C.E., 2002, ADOLESCENT ADULT SEN; Bruinsma K, 1999, J AM DIET ASSOC, V99, P1249, DOI 10.1016/S0002-8223(99)00307-7; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; Coulthard H, 2009, APPETITE, V52, P410, DOI 10.1016/j.appet.2008.11.015; Davis C, 2008, APPETITE, V50, P43, DOI 10.1016/j.appet.2007.05.007; Davis C, 2007, APPETITE, V48, P12, DOI 10.1016/j.appet.2006.05.016; DREWNOWSKI A, 1995, AM J CLIN NUTR, V62, P1081, DOI 10.1093/ajcn/62.5.1081S; Dunn W, 1997, INFANT YOUNG CHILD, V9, P23, DOI 10.1097/00001163-199704000-00005; Dunn W, 1999, SENSORY PROFILE USER; Farrow CV, 2012, APPETITE, V58, P842, DOI 10.1016/j.appet.2012.01.017; Franken IHA, 2005, APPETITE, V45, P198, DOI 10.1016/j.appet.2005.04.004; HYDE RJ, 1993, APPETITE, V21, P1, DOI 10.1006/appe.1993.1032; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Liss M, 2008, PERS INDIV DIFFER, V45, P255, DOI 10.1016/j.paid.2008.04.009; Rolls ET, 2007, P NUTR SOC, V66, P96, DOI 10.1017/S0029665107005332; ROZIN P, 1991, APPETITE, V17, P199, DOI 10.1016/0195-6663(91)90022-K; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Yeomans MR, 1997, APPETITE, V29, P61, DOI 10.1006/appe.1997.0092; Yeomans MR, 1998, P NUTR SOC, V57, P609, DOI 10.1079/PNS19980089	23	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43622	10.1371/journal.pone.0043622	http://dx.doi.org/10.1371/journal.pone.0043622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	991WJ	22916284	gold, Green Published, Green Submitted			2022-12-27	WOS:000307733800083
J	Zapater, P; Gomez-Hurtado, I; Peiro, G; Gonzalez-Navajas, JM; Garcia, I; Gimenez, P; Moratalla, A; Such, J; Frances, R				Zapater, Pedro; Gomez-Hurtado, Isabel; Peiro, Gloria; Manuel Gonzalez-Navajas, Jose; Garcia, Irma; Gimenez, Paula; Moratalla, Alba; Such, Jose; Frances, Ruben			Beta-Adrenergic Receptor 1 Selective Antagonism Inhibits Norepinephrine-Mediated TNF-Alpha Downregulation in Experimental Liver Cirrhosis	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; SPONTANEOUS BACTERIAL PERITONITIS; CARBON-TETRACHLORIDE; TRANSLOCATION; ASCITES; RATS; NORADRENALINE; INFLAMMATION; ADRENORECEPTOR; FIBROGENESIS	Background: Bacterial translocation is a frequent event in cirrhosis leading to an increased inflammatory response. Splanchnic adrenergic system hyperactivation has been related with increased bacterial translocation. We aim at evaluating the interacting mechanism between hepatic norepinephrine and inflammation during liver damage in the presence of bacterial-DNA. Animals and Methods: Forty-six mice were included in a 16-week protocol of CCl4-induced cirrhosis. Laparotomies were performed at weeks 6, 10, 13 and 16. A second set of forty mice injected with a single intraperitoneal dose of CCl4 was treated with saline, 6-hydroxidopamine, Nebivolol or Butoxamine. After 5 days, mice received E. coli-DNA intraperitoneally. Laparotomies were performed 24 hours later. Liver bacterial-DNA, norepinephrine, TNF-alpha, IL-6 and beta-adrenergic receptor levels were measured. Results: Bacterial-DNA translocation was more frequent in CCl4-treated animals compared with controls, and increased as fibrosis progressed. Liver norepinephrine and pro-inflammatory cytokines were significantly higher in mice with vs without bacterial-DNA (319.7 +/- 120.6 vs 120.7 +/- 68.6 pg/g for norepinephrine, 38.4 +/- 6.1 vs 29.7 +/- 4.2 pg/g for TNF-alpha, 41.8 +/- 7.4 vs 28.7 +/- 4.3 pg/g for IL-6). Only beta-adrenergic receptor-1 was significantly increased in treated vs control animals (34.6 +/- 7.3 vs 12.5 +/- 5.3, p = 0.01) and correlated with TNF-alpha, IL-6 and norepinephrine hepatic levels in animals with bacterial-DNA. In the second set of mice, cytokine levels were increased in 6-hydroxidopamine and Nebivolol (beta-adrenergic receptor-1 antagonist) treated mice compared with saline. Butoxamine (beta-adrenergic receptor-2 antagonist) didn't inhibit liver norepinephrine modulation of pro-inflammatory cytokines. Conclusions: Beta-adrenergic receptor-1 mediates liver norepinephrine modulation of the pro-inflammatory response in CCl4-treated mice with bacterial-DNA.	[Zapater, Pedro; Gomez-Hurtado, Isabel; Manuel Gonzalez-Navajas, Jose; Garcia, Irma; Gimenez, Paula; Moratalla, Alba; Such, Jose; Frances, Ruben] Inst Salud Carlos III, Biomed Res Ctr Network, Area Hepat & Digest Disorders CIBERehd, Madrid, Spain; [Zapater, Pedro] Hosp Gen Univ, Serv Farmacol Clin, Alicante, Spain; [Gomez-Hurtado, Isabel; Manuel Gonzalez-Navajas, Jose; Garcia, Irma; Gimenez, Paula; Moratalla, Alba; Such, Jose; Frances, Ruben] Hosp Gen Univ, Unidad Hepat, Alicante, Spain; [Peiro, Gloria] Hosp Gen Univ, Unidad Invest, Alicante, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; General University Hospital of Alicante; General University Hospital of Alicante; General University Hospital of Alicante	Zapater, P (corresponding author), Inst Salud Carlos III, Biomed Res Ctr Network, Area Hepat & Digest Disorders CIBERehd, Madrid, Spain.	frances_rub@gva.es	Zapater, Pedro/H-7277-2017; Francés, Rubén/V-4120-2019; Zapater, Pedro/H-8450-2019; GARCIA-MARTINEZ, IRMA/Q-4763-2018; González-Navajas, Jose Manuel/AAB-1575-2019; Gomez-Hurtado, Isabel/AAA-5815-2019	Zapater, Pedro/0000-0001-7927-858X; Francés, Rubén/0000-0001-5105-1201; Zapater, Pedro/0000-0001-7927-858X; GARCIA-MARTINEZ, IRMA/0000-0002-8828-6888; González-Navajas, Jose Manuel/0000-0002-1591-939X; Gomez-Hurtado, Isabel/0000-0003-4305-9427	Instituto de Salud Carlos III, Madrid, Spain [CP05/0005, PI10/0340, PI11/0962]; Conselleria de Sanitat, Generalitat Valenciana, Spain [AP-026/09, AP-162/11]; Fundacion FCVI-HGUA, Alicante, Spain [C-6/11]; Diputacion Provincial de Alicante, Alicante, Spain	Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Conselleria de Sanitat, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Fundacion FCVI-HGUA, Alicante, Spain; Diputacion Provincial de Alicante, Alicante, Spain	This work has been supported by grants CP05/0005, PI10/0340 and PI11/0962 from Instituto de Salud Carlos III, Madrid, Spain; AP-026/09 and AP-162/11 from Conselleria de Sanitat, Generalitat Valenciana, Spain; C-6/11 from Fundacion FCVI-HGUA, Alicante, Spain; and Diputacion Provincial de Alicante, Alicante, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BERG RD, 1992, J MED, V23, P217; Dubuisson L, 2002, HEPATOLOGY, V35, P325, DOI 10.1053/jhep.2002.31166; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Frances R, 2007, J HEPATOL, V46, P797, DOI 10.1016/j.jhep.2006.11.018; Garcia JJ, 2003, MOL CELL BIOCHEM, V254, P305; Garcia JJ, 2003, MOL CELL BIOCHEM, V254, P299, DOI 10.1023/A:1027345820519; Garcia-Tsao G, 2001, J HEPATOL, V34, P150, DOI 10.1016/S0168-8278(00)00006-4; Gomez-Hurtado I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023037; Gonzalez-Suarez B, 2006, EUR J GASTROEN HEPAT, V18, P49, DOI 10.1097/00042737-200601000-00009; Guarner C, 2005, EUR J GASTROEN HEPAT, V17, P27, DOI 10.1097/00042737-200501000-00006; Guarner C, 1997, J HEPATOL, V26, P1372, DOI 10.1016/S0168-8278(97)80474-6; Guarner C, 2006, HEPATOLOGY, V44, P633, DOI 10.1002/hep.21286; Henriksen JH, 1998, J HEPATOL, V29, P328, DOI 10.1016/S0168-8278(98)80022-6; HENRIKSEN JH, 1984, GUT, V25, P1034, DOI 10.1136/gut.25.10.1034; HSU CT, 1995, J AUTONOM NERV SYST, V51, P135, DOI 10.1016/0165-1838(94)00124-3; HSU CT, 1992, J AUTONOM NERV SYST, V37, P163, DOI 10.1016/0165-1838(92)90038-I; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kershenobich S.D., 2003, ANN HEPATOL, V2, P159; Marra F, 2002, FRONT BIOSCI, V7, pD1899, DOI 10.2741/marra; Mori K, 2011, INTENS CARE MED, V37, P1849, DOI 10.1007/s00134-011-2326-x; Oben JA, 2004, GUT, V53, P438, DOI 10.1136/gut.2003.026658; Perez-Paramo M, 2000, HEPATOLOGY, V31, P43, DOI 10.1002/hep.510310109; Pritchard MT, 2010, J HEPATOL, V53, P655, DOI 10.1016/j.jhep.2010.04.017; Senzolo M, 2009, LIVER INT, V29, P1189, DOI 10.1111/j.1478-3231.2009.02038.x; Serste T, 2010, HEPATOLOGY, V52, P1017, DOI 10.1002/hep.23775; Shilov JI, 2003, IMMUNOL LETT, V86, P229, DOI 10.1016/S0165-2478(03)00027-0; Straub RH, 2005, J INFECT DIS, V192, P560, DOI 10.1086/432134; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Ubeda M, 2010, HEPATOLOGY, V52, P2086, DOI 10.1002/hep.23961; VANDERPOLL T, 1994, INFECT IMMUN, V62, P2046, DOI 10.1128/IAI.62.5.2046-2050.1994; Walker-Brown J, 2009, SHOCK, V32, P541, DOI 10.1097/SHK.0b013e3181a6eda2; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Wong F, 2012, NAT REV GASTRO HEPAT, V9, P382, DOI 10.1038/nrgastro.2012.96; Worlicek M, 2010, GUT, V59, P1127, DOI 10.1136/gut.2009.185413	35	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43371	10.1371/journal.pone.0043371	http://dx.doi.org/10.1371/journal.pone.0043371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916250	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800061
J	Lasky, T; Greenspan, J; Ernst, FR; Gonzalez, L				Lasky, Tamar; Greenspan, Jay; Ernst, Frank R.; Gonzalez, Liliana			Pediatric Vancomycin Use in 421 Hospitals in the United States, 2008	PLOS ONE			English	Article							INFECTIOUS-DISEASES-SOCIETY; AMERICA	Background: Recommendations to prevent the spread of vancomycin resistance have been in place since 1995 and include guidelines for inpatient pediatric use of vancomycin. The emergence of large databases allows us to describe variation in pediatric vancomycin across hospitals. We analyzed a database with hospitalizations for children under 18 at 421 hospitals in 2008. Methodology/Principal Findings: The Premier hospital 2008 database, consisting of records for 877,201 pediatric hospitalizations in 421 hospitals, was analyzed. Stratified analyses and logistic mixed effects models were used to calculate the probability of vancomycin use while considering random effects of hospital variation, hospital fixed effects and patient effects, and the hierarchical structure of the data. Most hospitals (221) had fewer than 10 hospitalizations with vancomycin use in the study period, and 47 hospitals reported no vancomycin use in 17,271 pediatric hospitalizations. At the other end of the continuum, 21 hospitals (5.6% of hospitals) each had over 200 hospitalizations with vancomycin use, and together, accounted for more than 50% of the pediatric hospitalizations with vancomycin use. The mixed effects modeling showed hospital variation in the probability of vancomycin use that was statistically significant after controlling for teaching status, urban or rural location, size, region of the country, patient ethnic group, payor status, and APR-mortality and severity codes. Conclusions/Significance: The number and percentage of pediatric hospitalizations with vancomycin use varied greatly across hospitals and was not explained by hospital or patient characteristics in our logistic models. Public health efforts to reduce vancomycin use should be intensified at hospitals with highest use.	[Lasky, Tamar] MIE Resources, Kingston, RI USA; [Greenspan, Jay] Thomas Jefferson Univ, Nemours Childrens Clin, Wilmington, DE USA; [Ernst, Frank R.] Premier Healthcare Alliance, Premier Res Serv, Clin & Outcomes Res, Charlotte, NC USA; [Gonzalez, Liliana] Univ Rhode Isl, Kingston, RI 02881 USA	Jefferson University; University of Rhode Island	Lasky, T (corresponding author), MIE Resources, Kingston, RI USA.	tlasky@mie-epi.com	Ernst, Frank/AAT-9230-2021; Lasky, Tamar/AAR-3410-2021		AHRQ grant "Measuring Pediatric Inpatient Use" [R03 HS017998]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS017998] Funding Source: NIH RePORTER	AHRQ grant "Measuring Pediatric Inpatient Use"; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funded by AHRQ grant R03 HS017998 "Measuring Pediatric Inpatient Use" to Tamar Lasky, Principal Investigator, http://www.ahrq.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, MMWR Recomm Rep, V44, P1; [Anonymous], 2008, PREM PERSP DAT; Bolon MK, 2005, INFECT CONT HOSP EP, V26, P47, DOI 10.1086/502486; Bowman SM, 2005, JAMA-J AM MED ASSOC, V294, P2611, DOI 10.1001/jama.294.20.2611; Center for Disease Control and Prevention, 2002, 12 STEP PROGR PREV A; Dai J., 2006, SAS C P W US SAS SOF; Di Pentima M, 2010, PEDIAT INFECT DIS J; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Grohskopf LA, 2005, PEDIATR INFECT DIS J, V24, P766, DOI 10.1097/01.inf.0000178064.55193.1c; Halsey NA, 1997, PEDIATRICS, V99, P289, DOI 10.1542/peds.99.2.289; Hersh AL, 2009, INFECT CONT HOSP EP, V30, P1211, DOI 10.1086/648088; Hopkins HA, 2000, INFECT CONT HOSP EP, V21, P48, DOI 10.1086/501698; Hughes J., 2008, MORT MEAS M CAMBR MA; Keyserling HL, 2003, PEDIATRICS, V112, pE104, DOI 10.1542/peds.112.2.e104; KUEHN BM, 2011, JAMA-J AM MED ASSOC, V306, P2661; Leung KM, 1998, AM J PUBLIC HEALTH, V88, P377, DOI 10.2105/AJPH.88.3.377; Li J, 2006, SAS C P W US SAS SOF; Pakyz AL, 2009, INFECT CONT HOSP EP, V30, P600, DOI 10.1086/597545; Patel S, 2009, POWER, V153, P12; Rybak MJ, 2009, PHARMACOTHERAPY, V29, P1275, DOI 10.1592/phco.29.11.1275; SAS Institute Inc, 2009, SAS GRAPH 9 2 STATIS; SAS Institute Inc, 2009, BAS SAS 9 2 PROC GUI; Schabenberger O.., 2005, INTRO GLIMMIX PROCED; Shah SS, 1999, AM J INFECT CONTROL, V27, P482, DOI 10.1016/S0196-6553(99)70025-8; Shlaes DM, 1997, INFECT CONT HOSP EP, V18, P275; Titus A, 2011, NATL ANTIBIOTIC USE; Weiss PF, 2009, J PEDIAT, V155; WENNBERG JE, 2004, HLTH AFF MILLWOOD S, pVAR5	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43258	10.1371/journal.pone.0043258	http://dx.doi.org/10.1371/journal.pone.0043258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916234	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300035
J	Li, LH; Yin, XY; Yao, CY; Zhu, XC; Wu, XH				Li, Lihua; Yin, Xueyan; Yao, Chaoyong; Zhu, Xuechuang; Wu, Xinhua			Vitamin D, Parathyroid Hormone and Their Associations with Hypertension in a Chinese Population	PLOS ONE			English	Article							25-HYDROXYVITAMIN D LEVELS; BLOOD-PRESSURE; INCIDENT HYPERTENSION; METABOLIC SYNDROME; OLDER-ADULTS; PREVALENCE; WOMEN; RISK; DISEASE; SYSTEM	Background: Conflicting reports support or refute an association between vitamin D deficiency with high levels of parathyroid hormone (PTH) and raised blood pressure or hypertension. Objective: To explore the associations of serum vitamin D and PTH levels with blood pressure and risk of hypertension in a Chinese population. Methods: A population-based cross-sectional study was conducted among 1,420 Chinese participants, aged 20-83 years, in 2010. Anthropometric phenotypes and blood pressure were evaluated. Serum lipids, 25-hydroxyvitamin D [25(OH) D] and PTH were measured. Results: One thousand four hundred and twenty participants, including 566 women (39.9%), were evaluated in 2010. Four hundred and eighty seven were hypertensive (34.3%), of whom 214 (43.9%) received antihypertensive treatment. The median concentrations of serum 25(OH) D and PTH were 22.0 ng/ml and 2.83 pmol/l, respectively. Serum 25(OH) D and natural log of PTH levels were not independently associated with blood pressure in a multivariable adjusted linear regression analysis of 1,206 participants not receiving antihypertensive treatment (P>0.05). In logistic regression analyses, serum 25(OH) D levels were not associated with risk of hypertension in single and multiple regression models. One unit increments of natural log of PTH levels were significantly associated with risk of hypertension in the crude model (OR = 1.78, 95% confidence interval 1.38-2.28, P<0.0001) and model adjusted for age and sex (OR = 1.41, 95% confidence interval 1.08-1.83, P = 0.01). However, these associations were attenuated and became nonsignificant (OR = 1.29, 95% confidence interval 0.98-1.70, P = 0.07) after further adjustment for body mass index, current alcohol intake, current smoking, glomerular filtration rate and family history of hypertension. Conclusions: Serum vitamin D and PTH levels are not independently associated with blood pressure or risk of hypertension in a Chinese population.	[Li, Lihua; Yin, Xueyan; Yao, Chaoyong; Zhu, Xuechuang; Wu, Xinhua] Dali Univ Sch Med, Dept Internal Med, Dali, Yunnan Province, Peoples R China	Dali University	Li, LH (corresponding author), Dali Univ Sch Med, Dept Internal Med, Dali, Yunnan Province, Peoples R China.	lilihuayncn@gmail.com	Li, Li-Hua/AAD-7235-2020		Chinese Ministry of Science and Technology [30960137]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	The Chinese Ministry of Science and Technology (30960137, http://www.nsfc.gov.cn/Portal0/default152.htm) supported this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari SK, 2011, J CLIN HYPERTENS, V13, P170, DOI 10.1111/j.1751-7176.2010.00408.x; Chan R, 2012, J HUM HYPERTENS, V26, P20, DOI 10.1038/jhh.2010.126; DELUCA HF, 1979, NUTR REV, V37, P161, DOI 10.1111/j.1753-4887.1979.tb06660.x; Dong J, 2012, EUR HEART J     0411; Dorjgochoo T, 2012, BR J NUTR, P1; Elamin MB, 2011, J CLIN ENDOCR METAB, V96, P1931, DOI 10.1210/jc.2011-0398; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; He JL, 2011, AM J HYPERTENS, V24, P911, DOI 10.1038/ajh.2011.73; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Jorde R, 2010, HYPERTENSION, V55, P792, DOI 10.1161/HYPERTENSIONAHA.109.143990; Kim MK, 2010, CLIN ENDOCRINOL, V73, P330, DOI 10.1111/j.1365-2265.2010.03798.x; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Margolis KL, 2012, AM J EPIDEMIOL, V175, P22, DOI 10.1093/aje/kwr274; Perkovic V, 2003, KIDNEY BLOOD PRESS R, V26, P27, DOI 10.1159/000069761; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Rashid G, 2007, AM J PHYSIOL-RENAL, V292, pF1215, DOI 10.1152/ajprenal.00406.2006; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Rostand SG, 1997, HYPERTENSION, V30, P150, DOI 10.1161/01.HYP.30.2.150; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x; Taylor EN, 2008, J HYPERTENS, V26, P1390, DOI 10.1097/HJH.0b013e3282ffb43b; Vaidya A, 2010, HYPERTENSION, V56, P774, DOI 10.1161/HYPERTENSIONAHA.109.140160; Zhao GX, 2010, J HYPERTENS, V28, P1821, DOI 10.1097/HJH.0b013e32833bc5b4	31	29	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43344	10.1371/journal.pone.0043344	http://dx.doi.org/10.1371/journal.pone.0043344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22937036	Green Submitted, gold, Green Published			2022-12-27	WOS:000307824300041
J	Stark, JH; Cummings, DAT; Ermentrout, B; Ostroff, S; Sharma, R; Stebbins, S; Burke, DS; Wisniewski, SR				Stark, James H.; Cummings, Derek A. T.; Ermentrout, Bard; Ostroff, Stephen; Sharma, Ravi; Stebbins, Samuel; Burke, Donald S.; Wisniewski, Stephen R.			Local Variations in Spatial Synchrony of Influenza Epidemics	PLOS ONE			English	Article							UNITED-STATES; MEASLES METAPOPULATION; TRAVELING-WAVES; DYNAMICS; HIERARCHIES; VACCINATION; PATTERNS; JAPAN	Background: Understanding the mechanism of influenza spread across multiple geographic scales is not complete. While the mechanism of dissemination across regions and states of the United States has been described, understanding the determinants of dissemination between counties has not been elucidated. The paucity of high resolution spatial-temporal influenza incidence data to evaluate disease structure is often not available. Methodology and Findings: We report on the underlying relationship between the spread of influenza and human movement between counties of one state. Significant synchrony in the timing of epidemics exists across the entire state and decay with distance (regional correlation = 62%). Synchrony as a function of population size display evidence of hierarchical spread with more synchronized epidemics occurring among the most populated counties. A gravity model describing movement between two populations is a stronger predictor of influenza spread than adult movement to and from workplaces suggesting that non-routine and leisure travel drive local epidemics. Conclusions: These findings highlight the complex nature of influenza spread across multiple geographic scales.	[Stark, James H.] New York City Dept Hlth & Mental Hyg, Div Epidemiol, New York, NY USA; [Cummings, Derek A. T.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ermentrout, Bard] Univ Pittsburgh, Dept Math, Sch Arts & Sci, Pittsburgh, PA 15260 USA; [Ostroff, Stephen] Penn Dept Hlth, Bur Epidemiol, Harrisburg, PA 17108 USA; [Sharma, Ravi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Stebbins, Samuel; Burke, Donald S.; Wisniewski, Stephen R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	New York City Department of Health & Mental Hygiene; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stark, JH (corresponding author), New York City Dept Hlth & Mental Hyg, Div Epidemiol, New York, NY USA.	jstark@health.nyc.gov	Stark, James/A-2895-2019	Stark, James/0000-0002-0728-876X; Wisniewski, Stephen/0000-0002-3877-9860; /0000-0002-5704-8094	National Institute of General Medical Sciences [U01 GM070708-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070708] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences (U01 GM070708-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Bharti N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001941; Bjornstad ON, 1999, ECOLOGY, V80, P622, DOI 10.2307/176640; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Centers for Disease Control and Prevention, BEHAV RISK FACT SURV; CLIFF A, 1993, MEASLES HIST GEOGRAP; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Grassly NC, 2005, NATURE, V433, P417, DOI 10.1038/nature03072; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Grenfell BT, 1998, ECOL LETT, V1, P63; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jia HM, 2006, AM J PREV MED, V31, P275, DOI 10.1016/j.amepre.2006.06.005; Legendre P., 2012, NUMERICAL ECOLOGY; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Mathews J. H., 2004, NUMERICAL METHODS US; Merrill RM, 2009, MED SCI MONITOR, V15, pPH92; Proff R, 2009, EMERG INFECT DIS, V15, P892, DOI 10.3201/eid1506.081645; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Stark JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034245; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Vora A, 2008, EPIDEMIOL INFECT, V136, P713, DOI 10.1017/S0950268807009193; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	28	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43528	10.1371/journal.pone.0043528	http://dx.doi.org/10.1371/journal.pone.0043528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916274	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300052
J	Melzer, D; Gates, P; Osborn, NJ; Henley, WE; Cipelli, R; Young, A; Money, C; McCormack, P; Schofield, P; Mosedale, D; Grainger, D; Galloway, TS				Melzer, David; Gates, Phil; Osborn, Nicholas J.; Henley, William E.; Cipelli, Ricardo; Young, Anita; Money, Cathryn; McCormack, Paul; Schofield, Peter; Mosedale, David; Grainger, David; Galloway, Tamara S.			Urinary Bisphenol A Concentration and Angiography-Defined Coronary Artery Stenosis	PLOS ONE			English	Article							ENDOTHELIAL SHEAR-STRESS; NATURAL-HISTORY; IN-VIVO; ATHEROSCLEROSIS; EXPOSURE; DISEASE; ADULTS; WOMEN; RISK; ASSOCIATION	Background: Bisphenol A is widely used in food and drinks packaging. There is evidence of associations between raised urinary bisphenol A (uBPA) and increased incidence of reported cardiovascular diagnoses. Methodology/Principal Findings: To estimate associations between BPA exposure and angiographically graded coronary atherosclerosis. 591 patients participating in The Metabonomics and Genomics in Coronary Artery Disease (MaGiCAD) study in Cambridgeshire UK, comparing urinary BPA (uBPA) with grades of severity of coronary artery disease (CAD) on angiography. Linear models were adjusted for BMI, occupational social class and diabetes status. Severe (one to three vessel) CAD was present in 385 patients, 86 had intermediate disease (n = 86) and 120 had normal coronary arteries. The (unadjusted) median uBPA concentration was 1.28 ng/mL with normal coronary arteries, and 1.53 ng/mL with severe CAD. Compared to those with normal coronary arteries, uBPA concentration was significantly higher in those with severe CAD (OR per uBPA SD = 5.96 ng/ml OR = 1.43, CI 1.03 to 1.98, p = 0.033), and near significant for intermediate disease (OR = 1.69, CI 0.98 to 2.94, p = 0.061). There was no significant uBPA difference between patients with severe CAD (needing surgery) and the remaining groups combined. Conclusions/Significance: BPA exposure was higher in those with severe coronary artery stenoses compared to those with no vessel disease. Larger studies are needed to estimate true dose response relationships. The mechanisms underlying the association remain to be established.	[Melzer, David; Gates, Phil] Univ Exeter, Epidemiol & Publ Hlth Grp, Peninsula Coll Med & Dent, Exeter, Devon, England; [Cipelli, Ricardo; Galloway, Tamara S.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Henley, William E.] Univ Plymouth, Sch Math & Stat, Plymouth PL4 8AA, Devon, England; [Young, Anita; Money, Cathryn; McCormack, Paul] Brixham Environm Lab, Brixham, England; [Osborn, Nicholas J.] Univ Exeter, Peninsula Coll Med & Dent, European Ctr Environm & Human Hlth, Truro, England; [Mosedale, David; Grainger, David] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Schofield, Peter] Papworth Hosp NHS Fdn Trust, Cambridge, England	University of Exeter; University of Plymouth; University of Exeter; University of Plymouth; University of Exeter; University of Plymouth; University of Cambridge; Papworth Hospital	Melzer, D (corresponding author), Univ Exeter, Epidemiol & Publ Hlth Grp, Peninsula Coll Med & Dent, Exeter, Devon, England.	david.melzer@pms.ac.uk	Osborne, Nicholas/D-2086-2011	Osborne, Nicholas/0000-0002-6700-2284	University of Exeter; Peninsula Clinical Research facility; British Heart Foundation [PG/09/097]; British Heart Foundation [PG/09/097/28118] Funding Source: researchfish	University of Exeter; Peninsula Clinical Research facility; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	David Melzer and Tamara Galloway's work on BPA has been supported by unrestricted funds from the University of Exeter (www.exeter.ac.uk), the Peninsula Clinical Research facility (www.peninsulacrf.org) and by grant funding from the British Heart Foundation (www.bhf.org.uk - grant reference PG/09/097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Asano S, 2010, BRIT J PHARMACOL, V160, P160, DOI 10.1111/j.1476-5381.2010.00687.x; Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Carwile JL, 2011, ENV RES; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Elsby R, 2001, J PHARMACOL EXP THER, V297, P103; FRANCESCONI RP, 1987, J APPL PHYSIOL, V62, P1271, DOI 10.1152/jappl.1987.62.3.1271; Galloway T, 2010, ENV HLTH PERSPECT, P118; Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001; Koskinas KC, 2010, CIRCULATION, V121, P2092, DOI 10.1161/CIRCULATIONAHA.109.901678; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lind PM, 2011, ATHEROSCLEROSIS, V218, P207, DOI 10.1016/j.atherosclerosis.2011.05.001; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Mastin JP, 2005, CARDIOVASC TOXICOL, V5, P91, DOI 10.1385/CT:5:2:091; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Melzer D, 2011, ENVIRON HEALTH PERSP, V119, P1788, DOI 10.1289/ehp.1103809; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Miller MR, 2009, ENVIRON HEALTH PERSP, V117, P611, DOI 10.1289/ehp.0800235; Mosedale DE, 2004, IRTL REV, V2, P11; Nepomnaschy PA, 2009, ENVIRON RES, V109, P734, DOI 10.1016/j.envres.2009.04.004; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; RINGQVIST I, 1983, J CLIN INVEST, V71, P1854, DOI 10.1172/JCI110941; Ritter SK, 2011, CHEM ENG NEWS, V89, P14; Sieli PT, 2011, ENVIRON HEALTH PERSP, V119, P1260, DOI 10.1289/ehp.1003385; Simeonova PP, 2004, TOXICOL APPL PHARM, V198, P444, DOI 10.1016/j.taap.2003.10.018; Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; WHO, 2010, WHOHSEFOS111 UN FAO; Wohlin M, 2009, ATHEROSCLEROSIS, V205, P486, DOI 10.1016/j.atherosclerosis.2009.01.032; Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058	42	73	78	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43378	10.1371/journal.pone.0043378	http://dx.doi.org/10.1371/journal.pone.0043378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22916252	Green Published, gold			2022-12-27	WOS:000307823600076
J	Li, BQ; Feng, KY; Chen, L; Huang, T; Cai, YD				Li, Bi-Qing; Feng, Kai-Yan; Chen, Lei; Huang, Tao; Cai, Yu-Dong			Prediction of Protein-Protein Interaction Sites by Random Forest Algorithm with mRMR and IFS	PLOS ONE			English	Article							SECONDARY-STRUCTURE; SEQUENCE PROFILE; HOT-SPOTS; CLASSIFICATION; INTERFACES; PROGRAM; RESIDUE; IDENTIFICATION; INFORMATION; DATABASE	Prediction of protein-protein interaction (PPI) sites is one of the most challenging problems in computational biology. Although great progress has been made by employing various machine learning approaches with numerous characteristic features, the problem is still far from being solved. In this study, we developed a novel predictor based on Random Forest (RF) algorithm with the Minimum Redundancy Maximal Relevance (mRMR) method followed by incremental feature selection (IFS). We incorporated features of physicochemical/biochemical properties, sequence conservation, residual disorder, secondary structure and solvent accessibility. We also included five 3D structural features to predict protein-protein interaction sites and achieved an overall accuracy of 0.672997 and MCC of 0.347977. Feature analysis showed that 3D structural features such as Depth Index (DPX) and surface curvature (SC) contributed most to the prediction of protein-protein interaction sites. It was also shown via site-specific feature analysis that the features of individual residues from PPI sites contribute most to the determination of protein-protein interaction sites. It is anticipated that our prediction method will become a useful tool for identifying PPI sites, and that the feature analysis described in this paper will provide useful insights into the mechanisms of interaction.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing; Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Feng, Kai-Yan] Beijing Genom Inst, Shenzhen, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Huang, Tao] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Beijing Genomics Institute (BGI); Shanghai Maritime University; Icahn School of Medicine at Mount Sinai	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 1989, MOL BIOL CELL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Aytuna AS, 2005, BIOINFORMATICS, V21, P2850, DOI 10.1093/bioinformatics/bti443; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bernardes JS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-492; Bradford JR, 2006, J MOL BIOL, V362, P365, DOI 10.1016/j.jmb.2006.07.028; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bunescu R, 2005, ARTIF INTELL MED, V33, P139, DOI 10.1016/j.artmed.2004.07.016; Chen XW, 2009, BIOINFORMATICS, V25, P585, DOI 10.1093/bioinformatics/btp039; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Fariselli P, 2002, EUR J BIOCHEM, V269, P1356, DOI 10.1046/j.1432-1033.2002.02767.x; Gallet X, 2000, J MOL BIOL, V302, P917, DOI 10.1006/jmbi.2000.4092; Grabe M, 2003, BIOPHYS J, V84, P854, DOI 10.1016/S0006-3495(03)74904-2; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Hoskins J, 2006, PROTEIN SCI, V15, P1017, DOI 10.1110/ps.051589106; Jian-Tao Y, 2008, PREDICTION PROTEIN P, P100; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; KINI RM, 1995, BIOCHEM BIOPH RES CO, V212, P1115, DOI 10.1006/bbrc.1995.2084; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Koike A, 2004, PROTEIN ENG DES SEL, V17, P165, DOI 10.1093/protein/gzh020; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Li MH, 2007, BIOINFORMATICS, V23, P597, DOI 10.1093/bioinformatics/btl660; Li N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-553; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Mihel J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-21; Monji H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S39; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Nguyen MN, 2006, PROTEIN PROTEIN INTE, P1; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Sikic M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000278; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Talavera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021053; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Wang B, 2006, FEBS LETT, V580, P380, DOI 10.1016/j.febslet.2005.11.081; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xia JF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-174; Zhou HX, 2001, PROTEINS, V44, P336, DOI 10.1002/prot.1099; Zhou WQ, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S1	54	77	78	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e43927	10.1371/journal.pone.0043927	http://dx.doi.org/10.1371/journal.pone.0043927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	22937126	Green Published, Green Submitted, gold			2022-12-27	WOS:000308213600057
J	Ma, Q; Nie, XM; Yu, M; Wang, ZJ; Yang, SW; Jia, DA; Zhou, YJ				Ma, Qian; Nie, Xiaomin; Yu, Miao; Wang, Zhijian; Yang, Shiwei; Jia, Dean; Zhou, Yujie			Rapamycin Regulates the Expression and Activity of Kruppel-Like Transcription Factor 2 in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							TISSUE FACTOR EXPRESSION; DRUG-ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; NITRIC-OXIDE SYNTHASE; PROGENITOR CELLS; KLF2 EXPRESSION; IN-VIVO; THROMBOSIS; KINASE; ACTIVATION	Background: Although rapamycin has been reported to increase procoagulants and decrease anticoagulants in human umbilical vein endothelial cells (HUVECs), there is no significant difference in the incidence of stent thrombosis between patients with drug-eluting stents (DESs) and those with bare metal stents (BMSs). Kruppel-like transcription factor 2 (KLF2) has been identified as a key regulator of endothelial antithrombotic function. We hypothesized that rapamycin might induce the expression and activity of KLF2, thereby counteracting coronary endothelial dysfunction induced by DESs. Methods and Results: Expression of KLF2, tissue factor (TF) and endothelial NO synthase (eNOS) were assessed in HUVECs treated with rapamycin at concentrations of 2, 20, 200 and 2000 ng/ml for 24 and 48 hours without or with thrombin. Rapamycin strongly induced the expression and activity of KLF2 in high dose groups (p<0.01). Compared with control group, the expression of TF was increased by rapamycin, which inhibited the expression of eNOS after treating for 24 hours (p<0.01). Furthermore, small-interfering RNA-mediated knockdown of KLF2 strongly magnified the ability of rapamycin to induce TF and reduce eNOS accumulation in HUVECs. Conclusions: Rapamycin-dependent induction of KLF2 might partly counteract coronary endothelial dysfunction and thereby provided a novel molecular target to prevent stent thrombosis induced by DESs.	[Ma, Qian; Nie, Xiaomin; Yu, Miao; Wang, Zhijian; Yang, Shiwei; Jia, Dean; Zhou, Yujie] Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing, Peoples R China	Capital Medical University	Ma, Q (corresponding author), Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing, Peoples R China.	azzyj12@163.com	Yang, Wei/HIA-0360-2022; Zhou, Yu/HHN-3071-2022		National Nature Science Foundation of China [30971238]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors disclose receipt of the following financial support for the research, authorship, and/or publication of this article: supported by the National Nature Science Foundation of China (#30971238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bavry AA, 2005, AM J CARDIOL, V95, P1469, DOI 10.1016/j.amjcard.2005.02.015; Bavry AA, 2005, J AM COLL CARDIOL, V45, P941, DOI 10.1016/j.jacc.2004.11.064; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Bu DX, 2010, J CLIN INVEST, V120, P1961, DOI 10.1172/JCI41384; Camenzind E, 2006, WORLD C CARD BARC SP; Camici GG, 2010, EUR HEART J, V31, P236, DOI 10.1093/eurheartj/ehp259; Chen TG, 2006, CELL PROLIFERAT, V39, P117, DOI 10.1111/j.1365-2184.2006.00375.x; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; Gracia-Sancho J, 2010, CARDIOVASC RES, V85, P514, DOI 10.1093/cvr/cvp337; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Huddleson JP, 2006, J BIOL CHEM, V281, P15121, DOI 10.1074/jbc.M513406200; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Jin HK, 2009, BIOL PHARM BULL, V32, P988, DOI 10.1248/bpb.32.988; Kereiakes Dean J, 2004, Rev Cardiovasc Med, V5, P9; Klugherz BD, 2002, CORONARY ARTERY DIS, V13, P183, DOI 10.1097/00019501-200205000-00008; Li JM, 1999, EUR HEART J, V20, P406, DOI 10.1053/euhj.1998.1308; Lin ZY, 2006, ARTERIOSCL THROM VAS, V26, P1185, DOI 10.1161/01.ATV.0000215638.53414.99; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Ma Q, 2012, ANGIOLOGY, V2; MARX SO, 1995, CIRC RES, V76, P412, DOI 10.1161/01.RES.76.3.412; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Moss SC, 2010, J BIOL CHEM, V285, P11991, DOI 10.1074/jbc.M109.066621; Muldowney JAS, 2007, ARTERIOSCL THROM VAS, V27, P400, DOI 10.1161/01.ATV.0000254677.12861.b8; Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086; Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Roque M, 2001, LAB INVEST, V81, P895, DOI 10.1038/labinvest.3780298; Sako K, 2009, J BIOL CHEM, V284, P5592, DOI 10.1074/jbc.M806928200; Schwartz RS, 2004, J AM COLL CARDIOL, V44, P1373, DOI 10.1016/j.jacc.2004.04.060; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Steffel J, 2005, CIRCULATION, V112, P2002, DOI 10.1161/CIRCULATIONAHA.105.569129; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Suzuki T, 2001, CIRCULATION, V104, P1188, DOI 10.1161/hc3601.093987; Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3; *US FDA, CYPHER SIR EL COR ST; van Thienen JV, 2006, CARDIOVASC RES, V72, P231, DOI 10.1016/j.cardiores.2006.07.008; Viswambharan H, 2004, CIRC RES, V94, P918, DOI 10.1161/01.RES.0000124302.20396.B7; Zhao FH, 2008, MED HYPOTHESES, V70, P512, DOI 10.1016/j.mehy.2007.05.055; Zhu Weiwei, 2009, J Bioequivalence Bioavailab, V1, P3	52	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43315	10.1371/journal.pone.0043315	http://dx.doi.org/10.1371/journal.pone.0043315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937032	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500039
J	Mu, DS; Shi, L; Ren, A; Li, MJ; Wu, FL; Jiang, AL; Zhao, MW				Mu, Dashuai; Shi, Liang; Ren, Ang; Li, Mengjiao; Wu, Fengli; Jiang, Ailiang; Zhao, Mingwen			The Development and Application of a Multiple Gene Co-Silencing System Using Endogenous URA3 as a Reporter Gene in Ganoderma lucidum	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MOLECULAR-CLONING; EXPRESSION; FUNGUS; INTERFERENCE; PCR; IDENTIFICATION; TRANSFORMATION; OPTIMIZATION; SUPPRESSION	Ganoderma lucidum is one of the most important medicinal mushrooms; however, molecular genetics research on this species has been limited due to a lack of reliable reverse genetic tools. In this study, the endogenous orotidine 5'-monophosphate decarboxylase gene (URA3) was cloned as a silencing reporter, and four gene-silencing methods using hairpin, sense, antisense, and dual promoter constructs, were introduced into G. lucidum through a simple electroporation procedure. A comparison and evaluation of silencing efficiency demonstrated that all of the four methods differentially suppressed the expression of URA3. Our data unequivocally indicate that the dual promoter silencing vector yields the highest rate of URA3 silencing compared with other vectors (up to 81.9%). To highlight the advantages of the dual promoter system, we constructed a co-silencing system based on the dual promoter method and succeeded in co-silencing URA3 and laccase in G. lucidum. The reduction of the mRNA levels of the two genes were correlated. Thus, the screening efficiency for RNAi knockdown of multiple genes may be improved by the co-silencing of an endogenous reporter gene. The molecular tools developed in this study should facilitate the isolation of genes and the characterization of the functions of multiple genes in this pharmaceutically important species, and these tools should be highly useful for the study of other basidiomycetes.	[Mu, Dashuai; Shi, Liang; Ren, Ang; Li, Mengjiao; Wu, Fengli; Jiang, Ailiang; Zhao, Mingwen] Nanjing Agr Univ, Coll Life Sci, Key Lab Microbiol Engn Agr Environm, Minist Agr, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Mu, DS (corresponding author), Nanjing Agr Univ, Coll Life Sci, Key Lab Microbiol Engn Agr Environm, Minist Agr, Nanjing, Jiangsu, Peoples R China.	mwzhao@njau.edu.cn	Zhao, Ming-Wen/AAS-1510-2020	zhao, mingwen/0000-0002-9413-1743	National Natural Science Foundation of China [30970042]; Fundamental Research Funds for the Central Universities [KYZ201121]; Science and Technology Pillar Program of Jiangsu Province, China [BE2011312]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science and Technology Pillar Program of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (Project No. 30970042), the Fundamental Research Funds for the Central Universities (Project No. KYZ201121), the Science and Technology Pillar Program of Jiangsu Province, China (Project No. BE2011312) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec J, 2009, J SEP SCI, V32, P4052, DOI 10.1002/jssc.200900496; Ah-Fong AMV, 2008, FUNGAL GENET BIOL, V45, P1197, DOI 10.1016/j.fgb.2008.05.009; Bose I, 2011, J MICROBIOL METH, V86, P156, DOI 10.1016/j.mimet.2011.04.014; Carneiro JS, 2010, FUNGAL GENET BIOL, V47, P399, DOI 10.1016/j.fgb.2010.02.005; Chen JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000202; Chuang HW, 2009, FEMS MICROBIOL LETT, V293, P205, DOI 10.1111/j.1574-6968.2009.01533.x; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Costa ASMB, 2009, J MICROBIOL BIOTECHN, V19, P271, DOI 10.4014/jmb.0806.398; Cottrell TR, 2003, TRENDS MICROBIOL, V11, P37, DOI 10.1016/S0966-842X(02)00004-5; de Jong JF, 2006, APPL ENVIRON MICROB, V72, P1267, DOI 10.1128/AEM.72.2.1267-1269.2006; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; Eo SK, 1999, J ETHNOPHARMACOL, V68, P129, DOI 10.1016/S0378-8741(99)00067-7; Fei X, 2006, J MICROBIOL, V44, P515; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Goldoni M, 2004, FUNGAL GENET BIOL, V41, P1016, DOI 10.1016/j.fgb.2004.08.002; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; Harrison BR, 2009, BIOCHEM CELL BIOL, V87, P767, DOI 10.1139/O09-043; Hseu RS, 1996, APPL ENVIRON MICROB, V62, P1354, DOI 10.1128/AEM.62.4.1354-1363.1996; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Janus D, 2007, APPL ENVIRON MICROB, V73, P962, DOI 10.1128/AEM.02127-06; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Joo SS, 2008, MOL CELLS, V25, P112; Kemppainen M, 2009, ENVIRON MICROBIOL, V11, P1878, DOI 10.1111/j.1462-2920.2009.01912.x; Kemppainen MJ, 2010, MICROB BIOTECHNOL, V3, P178, DOI 10.1111/j.1751-7915.2009.00122.x; Keon JPR, 1999, ANTISENSE NUCLEIC A, V9, P101, DOI 10.1089/oli.1.1999.9.101; Kilaru S, 2009, APPL ENVIRON MICROB, V75, P7196, DOI 10.1128/AEM.01151-09; Kim S, 2004, FEMS MICROBIOL LETT, V233, P201, DOI 10.1016/j.femsle.2004.02.010; Kuo CY, 2008, J MICROBIOL METH, V72, P111, DOI 10.1016/j.mimet.2007.11.006; Lin CC, 2011, CANCER IMMUNOL IMMUN, V60, P1019, DOI 10.1007/s00262-011-1016-4; Lin KI, 2006, J BIOL CHEM, V281, P24111, DOI 10.1074/jbc.M601106200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mizushina Y, 1998, BIOCHEM BIOPH RES CO, V249, P17, DOI 10.1006/bbrc.1998.9091; MURASUGI A, 1991, J BIOL CHEM, V266, P2486; Nakade K, 2011, MICROBIOL RES, V166, P484, DOI 10.1016/j.micres.2010.09.004; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Nakayashiki H, 2008, CURR OPIN MICROBIOL, V11, P494, DOI 10.1016/j.mib.2008.10.001; Namekawa SH, 2005, MICROBIOL-SGM, V151, P3669, DOI 10.1099/mic.0.28209-0; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Salame TM, 2011, APPL MICROBIOL BIOT, V89, P501, DOI 10.1007/s00253-010-2928-1; Shang CH, 2008, BIOSCI BIOTECH BIOCH, V72, P1333, DOI 10.1271/bbb.80011; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; Shi L, 2012, MOL BIOL REP, V39, P6149, DOI 10.1007/s11033-011-1431-9; Shi L, 2012, WORLD J MICROB BIOT, V28, P283, DOI 10.1007/s11274-011-0818-z; Shi LA, 2010, APPL MICROBIOL BIOT, V88, P1243, DOI 10.1007/s00253-010-2871-1; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Staab JF, 2003, TRENDS MICROBIOL, V11, P69, DOI 10.1016/S0966-842X(02)00029-X; Sun Li, 2001, Plant Molecular Biology Reporter, V19, P383, DOI 10.1007/BF02772841; Sun SJ, 2006, APPL MICROBIOL BIOT, V72, P537, DOI 10.1007/s00253-005-0299-9; Tsai CC, 2012, J AGR FOOD CHEM, V60, P2830, DOI 10.1021/jf3000339; Wang HX, 2006, PEPTIDES, V27, P27, DOI 10.1016/j.peptides.2005.06.009; Wang SM, 2007, APPL ENVIRON MICROB, V73, P5048, DOI 10.1128/AEM.02973-06; Xu JW, 2012, MOL BIOL REP, V39, P3603, DOI 10.1007/s11033-011-1134-2; Xu JW, 2010, APPL MICROBIOL BIOT, V85, P941, DOI 10.1007/s00253-009-2106-5; Xu YN, 2018, BIOTECHNOL ADV; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106	57	79	90	11	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43737	10.1371/journal.pone.0043737	http://dx.doi.org/10.1371/journal.pone.0043737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937087	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500089
J	Thompson, R; Montano, R; Eastman, A				Thompson, Ruth; Montano, Ryan; Eastman, Alan			The Mre11 Nuclease Is Critical for the Sensitivity of Cells to Chk1 Inhibition	PLOS ONE			English	Article							STRAND BREAK REPAIR; CISPLATIN-INDUCED CYTOTOXICITY; REPLICATION FORK PROGRESSION; DNA-REPLICATION; CHECKPOINT KINASE-1; ATM ACTIVATION; END RESECTION; PHOSPHORYLATION; COMPLEX; PROTEIN	The Chk1 kinase is required for the arrest of cell cycle progression when DNA is damaged, and for stabilizing stalled replication forks. As a consequence, many Chk1 inhibitors have been developed and tested for their potential to enhance DNA damage-induced tumor cell killing. However, inhibition of Chk1 alone, without any additional exogenous agent, can be cytotoxic. Understanding the underlying mechanisms of this sensitivity is critical for defining which patients might respond best to therapy with Chk1 inhibitors. We have investigated the mechanism of sensitivity in U2OS osteosarcoma cells. Upon incubation with the Chk1 inhibitor MK-8776, single-stranded DNA regions (ssDNA) and double-strand breaks (DSB) begin to appear within 6 h. These DSB have been attributed to the structure-specific DNA endonuclease, Mus81. The Mre11/Rad50/Nbs1 complex is known to be responsible for the resection of DSB to ssDNA. However, we show that inhibition of the Mre11 nuclease activity leads, not only to a decrease in the amount of ssDNA following Chk1 inhibition, but also inhibits the formation of DSB, suggesting that DSB are a consequence of ssDNA formation. These findings were corroborated by the discovery that Mre11-deficient ATLD1 cells are highly resistant to MK-8776 and form neither ssDNA nor DSB following treatment. However, once complimented with exogenous Mre11, the cells accumulate both ssDNA and DSB when incubated with MK-8776. Our findings suggest that Mre11 provides the link between aberrant activation of Cdc25A/Cdk2 and Mus81. The results highlight a novel role for Mre11 in the production of DSB and may help define which tumors are more sensitive to MK-8776 alone or in combination with DNA damaging agents.	[Thompson, Ruth; Montano, Ryan; Eastman, Alan] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA; [Thompson, Ruth; Montano, Ryan; Eastman, Alan] Norris Cotton Canc Ctr, Lebanon, NH USA	Dartmouth College; Norris Cotton Cancer Center	Thompson, R (corresponding author), Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA.	Alan.R.Eastman@Dartmouth.edu	Thompson, Ruth/O-4381-2018	Thompson, Ruth/0000-0002-0828-4170	NIH [CA117874]; Cancer Center Support grant [CA23108]; NATIONAL CANCER INSTITUTE [R01CA117874, P30CA023108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant CA117874 (A. Eastman), and Cancer Center Support grant CA23108 to the Norris Cotton Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Bahassi EM, 2008, ONCOGENE, V27, P3977, DOI 10.1038/onc.2008.17; Beck H, 2010, J CELL BIOL, V188, P629, DOI 10.1083/jcb.200905059; Buis J, 2012, NAT STRUCT MOL BIOL, V19, P246, DOI 10.1038/nsmb.2212; Bunch RT, 1996, CLIN CANCER RES, V2, P791; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Delia D, 2004, HUM MOL GENET, V13, P2155, DOI 10.1093/hmg/ddh221; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Forment JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023517; Gagou ME, 2010, MOL BIOL CELL, V21, P739, DOI 10.1091/mbc.E09-07-0618; Gao QL, 2006, APOPTOSIS, V11, P1789, DOI 10.1007/s10495-006-9421-4; Garner KM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-206; Garner KM, 2009, NAT CHEM BIOL, V5, P129, DOI 10.1038/nchembio0309-129; Guzi TJ, 2011, MOL CANCER THER, V10, P591, DOI 10.1158/1535-7163.MCT-10-0928; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Montano R, 2012, MOL CANCER THER, V11, P427, DOI 10.1158/1535-7163.MCT-11-0406; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Peterson SE, 2011, J CELL BIOL, V194, P705, DOI 10.1083/jcb.201103103; RAO J, 1992, ANAL BIOCHEM, V207, P186, DOI 10.1016/0003-2697(92)90521-8; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Scorah J, 2009, CELL CYCLE, V8, P1036, DOI 10.4161/cc.8.7.8040; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Sorensen CS, 2011, NUCL ACIDS RES; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zheng L, 2009, NUCLEIC ACIDS RES, V37, P2645, DOI 10.1093/nar/gkp147	47	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e44021	10.1371/journal.pone.0044021	http://dx.doi.org/10.1371/journal.pone.0044021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937147	gold, Green Submitted, Green Published			2022-12-27	WOS:000308225500135
J	Bergmann, G; Graichen, F; Dymke, J; Rohlmann, A; Duda, GN; Damm, P				Bergmann, Georg; Graichen, Friedmar; Dymke, Joern; Rohlmann, Antonius; Duda, Georg N.; Damm, Philipp			High-Tech Hip Implant for Wireless Temperature Measurements In Vivo	PLOS ONE			English	Article							TELEMETRY SYSTEM; ORTHOPEDIC IMPLANTS; JOINT SIMULATOR; SYNOVIAL-FLUIDS; WEAR; PROSTHESES; REPLACEMENTS; FORCES; LOADS; BONE	When walking long distances, hip prostheses heat up due to friction. The influence of articulating materials and lubricating properties of synovia on the final temperatures, as well as any potential biological consequences, are unknown. Such knowledge is essential for optimizing implant materials, identifying patients who are possibly at risk of implant loosening, and proving the concepts of current joint simulators. An instrumented hip implant with telemetric data transfer was developed to measure the implant temperatures in vivo. A clinical study with 100 patients is planned to measure the implant temperatures for different combinations of head and cup materials during walking. This study will answer the question of whether patients with synovia with poor lubricating properties may be at risk for thermally induced bone necrosis and subsequent implant failure. The study will also deliver the different friction properties of various implant materials and prove the significance of wear simulator tests. A clinically successful titanium hip endoprosthesis was modified to house the electronics inside its hollow neck. The electronics are powered by an external induction coil fixed around the joint. A temperature sensor inside the implant triggers a timer circuit, which produces an inductive pulse train with temperature-dependent intervals. This signal is detected by a giant magnetoresistive sensor fixed near the external energy coil. The implant temperature is measured with an accuracy of 0.1 degrees C in a range between 20 degrees C and 58 degrees C and at a sampling rate of 2-10 Hz. This rate could be considerably increased for measuring other data, such as implant strain or vibration. The employed technique of transmitting data from inside of a closed titanium implant by low frequency magnetic pulses eliminates the need to use an electrical feedthrough and an antenna outside of the implant. It enables the design of mechanically safe and simple instrumented implants.	[Bergmann, Georg; Graichen, Friedmar; Dymke, Joern; Rohlmann, Antonius; Duda, Georg N.; Damm, Philipp] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bergmann, G (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	friedmar.graichen@charite.de	Rohlmann, Antonius/E-4778-2011; Duda, Georg N/H-2085-2016	Rohlmann, Antonius/0000-0002-0083-2793; Duda, Georg N/0000-0001-7605-3908; Damm, Philipp/0000-0001-8471-7284				[Anonymous], 1995, ISO72068; [Anonymous], 2010, ISO72064; [Anonymous], 1992, ISO72066; Bergmann G, 2001, J BIOMECH, V34, P421, DOI 10.1016/S0021-9290(00)00188-3; Bergmann G, 2001, J BIOMECH, V34, P429, DOI 10.1016/S0021-9290(00)00234-7; BERGMANN G, 1988, J BIOMECH, V21, P169, DOI 10.1016/0021-9290(88)90009-7; Brockett C, 2007, J BIOMED MATER RES B, V81B, P508, DOI 10.1002/jbm.b.30691; BROWN RH, 1982, J BIOMECH, V15, P815, DOI 10.1016/0021-9290(82)90046-X; Chikama H, 1985, Nihon Seikeigeka Gakkai Zasshi, V59, P559; Drewniak EI, 2009, J BIOMECH, V42, P1996, DOI 10.1016/j.jbiomech.2009.05.024; Fam H, 2007, BIORHEOLOGY, V44, P59; Fialho JC, 2007, J BIOMECH, V40, P2358, DOI 10.1016/j.jbiomech.2006.12.005; GRAICHEN F, 1991, J BIOMED ENG, V13, P370, DOI 10.1016/0141-5425(91)90016-Z; Graichen F, 1999, J BIOMECH, V32, P1113, DOI 10.1016/S0021-9290(99)00110-4; Graichen F, 2007, IEEE T BIO-MED ENG, V54, P253, DOI 10.1109/TBME.2006.886857; Gronkiewicz K, 2009, J PHYSIOL PHARMACOL, V60, P123; Holland HJ, 2012, P MIKROSYTEM TECHN K, P437; Karrholm J, 2010, ACTA ORTHOP, V81, P3, DOI 10.3109/17453671003635918; LEON SA, 1993, INT J HYPERTHER, V9, P77, DOI 10.3109/02656739309061480; Li S, 1999, J ORTHOP RES, V17, P891, DOI 10.1002/jor.1100170614; Liao YS, 1999, J BIOMED MATER RES, V48, P465; Lu Z, 1997, P I MECH ENG H, V211, P101, DOI 10.1243/0954411971534728; Marschner U, 2009, SENSOR ACTUAT A-PHYS, V156, P145, DOI 10.1016/j.sna.2009.08.025; MORITZ AR, 1947, AM J PATHOL, V23, P695; Moss C, 2010, P 3 INT S APPL SCI B, P1; Moss Ch., 2009, P SOMSED 09, V1, P97; Moss SG, 1998, RADIOLOGY, V208, P43, DOI 10.1148/radiology.208.1.9646791; Pritchett JW, 2006, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000183739.50869.bb; Puers R, 2000, SENSOR ACTUAT A-PHYS, V85, P42, DOI 10.1016/S0924-4247(00)00320-4; Rainer F, 1980, Acta Med Austriaca, V7, P92; Rocchi M, 2007, P I MECH ENG H, V221, P561, DOI 10.1243/09544119JEIM137; Schneider E, 2001, J BIOMECH, V34, P849, DOI 10.1016/S0021-9290(01)00037-9; Smith SL, 2001, P I MECH ENG H, V215, P61, DOI 10.1243/0954411011533535; Streicher R M, 1996, Proc Inst Mech Eng H, V210, P223, DOI 10.1243/PIME_PROC_1996_210_416_02; SWANN DA, 1984, ARTHRITIS RHEUM, V27, P552, DOI 10.1002/art.1780270511; Taylor SJG, 1997, J BIOMECH, V30, P225, DOI 10.1016/S0021-9290(96)00141-8; TEPIC S, 1985, J ORTHOPAED RES, V3, P516, DOI 10.1002/jor.1100030416; Williams S, 2008, J BONE JOINT SURG AM, V90A, P111, DOI 10.2106/JBJS.H.00485; Yoshida K, 2009, CLIN ORAL IMPLAN RES, V20, P782, DOI 10.1111/j.1600-0501.2008.01654.x	39	33	36	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43489	10.1371/journal.pone.0043489	http://dx.doi.org/10.1371/journal.pone.0043489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927973	Green Submitted, Green Published, gold			2022-12-27	WOS:000308286300055
J	Engler, JR; Robinson, AE; Smirnov, I; Hodgson, JG; Berger, MS; Gupta, N; James, CD; Molinaro, A; Phillips, JJ				Engler, Jane R.; Robinson, Aaron E.; Smirnov, Ivan; Hodgson, J. Graeme; Berger, Mitchel S.; Gupta, Nalin; James, C. David; Molinaro, Annette; Phillips, Joanna J.			Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas	PLOS ONE			English	Article							REGULATORY T-CELLS; HIGH-GRADE GLIOMAS; K+ CHANNELS; GLIOBLASTOMA; MACROPHAGES; IDENTIFICATION; OSTEOPONTIN; SURVIVAL; PATTERN; VITRO	Glioblastoma (GBM) is a highly malignant brain tumor with a dismal prognosis. Gene expression profiling of GBM has revealed clinically relevant tumor subtypes, and this provides exciting opportunities to better understand disease pathogenesis. Results from an increasing number of studies demonstrate a role for the immune response in cancer progression, yet it is unclear how the immune response differs across tumor subtypes and how it affects outcome. Utilizing gene expression data from The Cancer Genome Atlas Project and the Gene Expression Omnibus database, we demonstrate an enrichment of immune response-related gene expression in the mesenchymal subtype of adult GBM (n = 173) and pediatric high-grade gliomas (n = 53). In an independent cohort of pediatric astrocytomas (n = 24) from UCSF, we stratified tumors into subtypes and confirmed these findings. Using novel immune cell-specific gene signatures we demonstrate selective enrichment of microglia/macrophage-related genes in adult and pediatric GBM tumors of the mesenchymal subtype. Furthermore, immunostaining of adult GBM tumors showed significantly higher cell numbers of microglia/macrophages in mesenchymal versus non-mesenchymal tumors (p = 0.04). Interestingly, adult GBM tumors with the shortest survival had significant enrichment of microglia/macrophage-related genes but this was not true for pediatric GBMs. Consistent with an association with poor outcome, immune response-related genes were highly represented in an adult poor prognosis gene signature, with the expression of genes related to macrophage recruitment and activation being most strongly associated with survival (p<0.05) using CoxBoost multivariate modeling. Using a microglia/macrophage high gene signature derived from quantification of tumor-infiltrating cells in adult GBM, we identified enrichment of genes characteristic of CD4 T cells, granulocytes, and microglia/macrophages (n = 573). These studies support a role for the immune response, particularly the microglia/macrophage response, in the biology of an important subset of GBM. Identification of this subset may be important for future therapeutic stratification.	[Engler, Jane R.; Robinson, Aaron E.; Smirnov, Ivan; Hodgson, J. Graeme; Berger, Mitchel S.; Gupta, Nalin; James, C. David; Molinaro, Annette; Phillips, Joanna J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Phillips, Joanna J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Molinaro, Annette] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Engler, Jane R.; Robinson, Aaron E.; Berger, Mitchel S.; Gupta, Nalin; James, C. David; Phillips, Joanna J.] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; [Hodgson, J. Graeme] Pfizer, Div Oncol, La Jolla, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pfizer	Engler, JR (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	joanna.phillips@ucsf.edu			National Institue of Health [K08 NS063456]; UCSF Brain Tumor SPORE [CA097257]; Pediatric Brain Tumor Foundation; Preuss Foundation; NATIONAL CANCER INSTITUTE [P50CA097257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS063456] Funding Source: NIH RePORTER	National Institue of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Brain Tumor SPORE; Pediatric Brain Tumor Foundation; Preuss Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by the National Institue of Health (K08 NS063456 to JJP), the UCSF Brain Tumor SPORE (CA097257), the Pediatric Brain Tumor Foundation (NG, CDJ, JJP), and generous funds from the Preuss Foundation. The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Binder H, 2009, BIOINFORMATICS, V25, P890, DOI 10.1093/bioinformatics/btp088; Calboli FCF, 2011, J NATL CANCER I, V103, P1588, DOI 10.1093/jnci/djr361; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; El Andaloussi A, 2006, NEURO-ONCOLOGY, V8, P234, DOI 10.1215/15228517-2006-006; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Fangusaro J, 2009, J CHILD NEUROL, V24, P1409, DOI 10.1177/0883073809338960; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Gerds TA, 2006, BIOMETRICAL J, V48, P1029, DOI 10.1002/bimj.200610301; Giachelli CM, 1998, AM J PATHOL, V152, P353; Hatori K, 2011, J ENDODONT, V37, P781, DOI 10.1016/j.joen.2011.03.009; Heimberger AB, 2008, CLIN CANCER RES, V14, P5166, DOI 10.1158/1078-0432.CCR-08-0320; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JANSON RW, 1991, J IMMUNOL, V147, P4218; Kaczmarek M, 2011, TUMOR BIOL, V32, P1123, DOI 10.1007/s13277-011-0214-1; Kerrigan AM, 2012, J THROMB HAEMOST, V10, P484, DOI 10.1111/j.1538-7836.2011.04614.x; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Lachance DH, 2011, AM J EPIDEMIOL, V174, P574, DOI 10.1093/aje/kwr124; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Ohki E, 2007, BIOL PHARM BULL, V30, P2217, DOI 10.1248/bpb.30.2217; Parney IF, 2009, J NEUROSURG, V110, P572, DOI 10.3171/2008.7.JNS08475; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Piperi C, 2011, CYTOKINE, V55, P387, DOI 10.1016/j.cyto.2011.05.012; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Rom S, 2010, FASEB J, V24, P2292, DOI 10.1096/fj.09-143503; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schwartzbaum JA, 2010, CARCINOGENESIS, V31, P1770, DOI 10.1093/carcin/bgq152; Shin YJ, 2011, GLIA, V59, P413, DOI 10.1002/glia.21110; Simmons GW, 2011, J NEUROPATH EXP NEUR, V70, P51, DOI 10.1097/NEN.0b013e3182032d37; SINGH RP, 1990, J EXP MED, V171, P1931, DOI 10.1084/jem.171.6.1931; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tajima N, 2006, J PHYSIOL-LONDON, V571, P349, DOI 10.1113/jphysiol.2005.096818; TARTOUR E, 1994, CANCER RES, V54, P6243; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Tuck AB, 1998, INT J CANCER, V79, P502, DOI 10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDAMME J, 1992, J EXP MED, V176, P59, DOI 10.1084/jem.176.1.59; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020	57	112	113	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43339	10.1371/journal.pone.0043339	http://dx.doi.org/10.1371/journal.pone.0043339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937035	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300043
J	Kruger, C; Kumar, KG; Mynatt, RL; Volaufova, J; Richards, BK				Kruger, Claudia; Kumar, K. Ganesh; Mynatt, Randall L.; Volaufova, Julia; Richards, Brenda K.			Brain Transcriptional Responses to High-Fat Diet in Acads-Deficient Mice Reveal Energy Sensing Pathways	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; COA DEHYDROGENASE-DEFICIENCY; ACID BETA-OXIDATION; BALB CBYJ MICE; BALB/CBYJ MOUSE; FOOD-INTAKE; HYPOTHALAMIC NUCLEI; ORGANIC ACIDURIA; INDUCED OBESITY; MESSENGER-RNA	Background: How signals from fatty acid metabolism are translated into changes in food intake remains unclear. Previously we reported that mice with a genetic inactivation of Acads (acyl-coenzyme A dehydrogenase, short-chain), the enzyme responsible for mitochondrial beta-oxidation of C4-C6 short-chain fatty acids (SCFAs), shift consumption away from fat and toward carbohydrate when offered a choice between diets. In the current study, we sought to indentify candidate genes and pathways underlying the effects of SCFA oxidation deficiency on food intake in Acads-/- mice. Methodology/Principal Findings: We performed a transcriptional analysis of gene expression in brain tissue of Acads-/- and Acads+/+ mice fed either a high-fat (HF) or low-fat (LF) diet for 2 d. Ingenuity Pathway Analysis revealed three top-scoring pathways significantly modified by genotype or diet: oxidative phosphorylation, mitochondrial dysfunction, and CREB signaling in neurons. A comparison of statistically significant responses in HF Acads-/- vs. HF Acads+/+ (3917) and Acads+/+ HF vs. LF Acads+/+ (3879) revealed 2551 genes or approximately 65% in common between the two experimental comparisons. All but one of these genes were expressed in opposite direction with similar magnitude, demonstrating that HF-fed Acads-deficient mice display transcriptional responses that strongly resemble those of Acads+/+ mice fed LF diet. Intriguingly, genes involved in both AMP-kinase regulation and the neural control of food intake followed this pattern. Quantitative RT-PCR in hypothalamus confirmed the dysregulation of genes in these pathways. Western blotting showed an increase in hypothalamic AMP-kinase in Acads-/- mice and HF diet increased, a key protein in an energy-sensing cascade that responds to depletion of ATP. Conclusions: Our results suggest that the decreased beta-oxidation of short-chain fatty acids in Acads-deficient mice fed HF diet produces a state of energy deficiency in the brain and that AMP-kinase may be the cellular energy-sensing mechanism linking fatty acid oxidation to feeding behavior in this model.	[Kruger, Claudia; Kumar, K. Ganesh; Mynatt, Randall L.; Richards, Brenda K.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA; [Volaufova, Julia] Louisiana State Univ, Sch Publ Hlth, Hlth Sci Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kruger, C (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA.	richarbk@pbrc.edu	Mynatt, Randall L/N-1980-2017	Mynatt, Randall L/0000-0003-4399-0019	National Institutes of Health [DK-53113]; NORC Center [P30 DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK053113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health Grant DK-53113 to B. K. Smith Richards and partially supported by NORC Center Grant P30 DK072476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2001, ENDOCRINOLOGY, V142, P3457, DOI 10.1210/en.142.8.3457; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; AMENDT BA, 1992, PEDIATR RES, V31, P552, DOI 10.1203/00006450-199206000-00003; Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; He MA, 2011, MOL GENET METAB, V102, P418, DOI 10.1016/j.ymgme.2010.12.005; HINSDALE ME, 1993, GENOMICS, V16, P605, DOI 10.1006/geno.1993.1237; Hou J, 2010, CLIN EXP PHARMACOL P, V37, P989, DOI 10.1111/j.1440-1681.2010.05423.x; Iijima K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008498; Kelly CL, 1996, MAMM GENOME, V7, P262, DOI 10.1007/s003359900078; Lopaschuk GD, 2010, PHARMACOL REV, V62, P237, DOI 10.1124/pr.109.002428; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; QURESHI IA, 1993, BIOCHEM MED METAB B, V50, P145, DOI 10.1006/bmmb.1993.1056; REICHMANN H, 1988, J NEUROCHEM, V51, P339, DOI 10.1111/j.1471-4159.1988.tb01044.x; Reue K, 1996, MAMM GENOME, V7, P694, DOI 10.1007/s003359900208; Richards BKS, 2004, AM J PHYSIOL-REG I, V286, pR311, DOI 10.1152/ajpregu.00488.2003; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; SCHARRER E, 1986, AM J PHYSIOL, V250, P1003, DOI 10.1152/ajpregu.1986.250.6.R1003; SCHIFFER SP, 1989, BIOCHEM GENET, V27, P47, DOI 10.1007/BF00563017; Schreurs M, 2010, OBES REV, V11, P380, DOI 10.1111/j.1467-789X.2009.00642.x; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Smith KL, 2008, OBESITY, V16, P2239, DOI 10.1038/oby.2008.366; Spitzer J J, 1973, Physiologist, V16, P55; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; WAHBE VG, 1961, COMP BIOCHEM PHYSIOL, V3, P199, DOI 10.1016/0010-406X(61)90055-X; Wolfgang MJ, 2006, ANNU REV NUTR, V26, P23, DOI 10.1146/annurev.nutr.25.050304.092532; WOOD PA, 1989, PEDIATR RES, V25, P38, DOI 10.1203/00006450-198901000-00010; Wood PA, 1999, ADV EXP MED BIOL, V466, P395; Young PT, 1967, HDB PHYSL 6, V1; Ziotopoulou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE838, DOI 10.1152/ajpendo.2000.279.4.E838	37	8	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e41709	10.1371/journal.pone.0041709	http://dx.doi.org/10.1371/journal.pone.0041709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22936979	gold, Green Published, Green Submitted			2022-12-27	WOS:000308286300013
J	van Tilborg, AAG; Kompier, LC; Lurkin, I; Poort, R; El Bouazzaoui, S; van der Keur, K; Zuiverloon, T; Dyrskjot, L; Orntoft, TF; Roobol, MJ; Zwarthoff, EC				van Tilborg, Angela A. G.; Kompier, Lucie C.; Lurkin, Irene; Poort, Ricardo; El Bouazzaoui, Samira; van der Keur, Kirstin; Zuiverloon, Tahlita; Dyrskjot, Lars; Orntoft, Torben F.; Roobol, Monique J.; Zwarthoff, Ellen C.			Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; VOIDED URINE; MUTATION ANALYSIS; COPY NUMBER; CHROMOSOME-9; TUMORS; SURVEILLANCE; CYTOLOGY; FGFR3; DNA	Microsatellite markers are used for loss-of-heterozygosity, allelic imbalance and clonality analyses in cancers. Usually, tumor DNA is compared to corresponding normal DNA. However, normal DNA is not always available and can display aberrant allele ratios due to copy number variations in the genome. Moreover, stutter peaks may complicate the analysis. To use microsatellite markers for diagnosis of recurrent bladder cancer, we aimed to select markers without stutter peaks and a constant ratio between alleles, thereby avoiding the need for a control DNA sample. We investigated 49 microsatellite markers with tri- and tetranucleotide repeats in regions commonly lost in bladder cancer. Based on analysis of 50 blood DNAs the 12 best performing markers were selected with few stutter peaks and a constant ratio between peaks heights. Per marker upper and lower cut off values for allele ratios were determined. LOH of the markers was observed in 59/104 tumor DNAs. We then determined the sensitivity of the marker panel for detection of recurrent bladder cancer by assaying 102 urine samples of these patients. Sensitivity was 63% when patients were stratified for LOH in their primary tumors. We demonstrate that up-front selection of microsatellite markers obliterates the need for a corresponding blood sample. For diagnosis of bladder cancer recurrences in urine this significantly reduces costs. Moreover, this approach facilitates retrospective analysis of archival tumor samples for allelic imbalance.	[van Tilborg, Angela A. G.; Kompier, Lucie C.; Lurkin, Irene; Poort, Ricardo; El Bouazzaoui, Samira; van der Keur, Kirstin; Zuiverloon, Tahlita; Zwarthoff, Ellen C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Dyrskjot, Lars; Orntoft, Torben F.] Aarhus Univ Hosp, Dept Clin Biochem, Skejby, Denmark; [Roobol, Monique J.] Erasmus MC, Dept Urol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Aarhus University; Erasmus University Rotterdam; Erasmus MC	van Tilborg, AAG (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	e.zwarthoff@erasmusmc.nl	Dyrskjot, Lars/H-4922-2012; van Tilborg, Angela/M-5704-2015	van Tilborg, Angela/0000-0003-3968-5345; Dyrskjot, Lars/0000-0001-7061-9851	European Community [201663]; Dutch Cancer Society [EMCR 2007-3863]	European Community(European Commission); Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by European Community Seventh Framework program FP7/2007-2012, grant agreement no 201663; Dutch Cancer Society grant no. EMCR 2007-3863. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Babjuk M, 2008, EUR UROL; Bartoletti R, 2005, ONCOL REP, V13, P531; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; CAIRNS P, 1993, ONCOGENE, V8, P1083; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Carozzi FM, 2010, LUNG CANCER, V68, P216, DOI 10.1016/j.lungcan.2009.06.015; de Bekker-Grob EW, 2009, BJU INT, V104, P41, DOI 10.1111/j.1464-410X.2008.08323.x; Frigerio S, 2007, INT J CANCER, V121, P329, DOI 10.1002/ijc.22690; Junker K, 2006, CYTOGENET GENOME RES, V114, P279, DOI 10.1159/000094214; Koed K, 2005, CANCER RES, V65, P34; Kompier LC, 2008, J PATHOL; Mao L, 1996, SCIENCE, V271, P659, DOI 10.1126/science.271.5249.659; MATSUYAMA H, 1994, CANCER GENET CYTOGEN, V77, P118, DOI 10.1016/0165-4608(94)90226-7; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Placer J, 2002, EUR UROL, V42, P547, DOI 10.1016/S0302-2838(02)00448-7; Roobol MJ, 2010, UROL ONCOL-SEMIN ORI, V28, P686, DOI 10.1016/j.urolonc.2009.12.002; Sieben NLG, 2000, HUM PATHOL, V31, P1414, DOI 10.1053/hupa.2000.20381; Simon R, 2001, CANCER RES, V61, P4514; Soloway MS, 2003, J UROLOGY, V170, P438, DOI 10.1097/01.ju.0000076621.71247.6c; Steiner G, 1997, NAT MED, V3, P621, DOI 10.1038/nm0697-621; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Talwar R, 2007, UROLOGY, V70, P267, DOI 10.1016/j.urology.2007.03.070; TSAI YC, 1990, CANCER RES, V50, P44; van der Aa MN, 2008, EUR UROL; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; van Rhijn BWG, 2001, CANCER, V92, P768, DOI 10.1002/1097-0142(20010815)92:4<768::AID-CNCR1381>3.0.CO;2-C; van Rhijn BWG, 2005, EUR UROL, V47, P736, DOI 10.1016/j.eururo.2005.03.014; van Rhijn BWG, 2003, CLIN CANCER RES, V9, P257; van Tilborg AAG, 2000, HUM MOL GENET, V9, P2973, DOI 10.1093/hmg/9.20.2973; Van Tilborg AAG, 1998, INT J CANCER, V75, P9, DOI 10.1002/(SICI)1097-0215(19980105)75:1<9::AID-IJC2>3.3.CO;2-I; Wild PJ, 2009, CANCER EPIDEM BIOMAR, V18, P1798, DOI 10.1158/1055-9965.EPI-09-0099; Zuiverloon TCM, 2010, CLIN CANCER RES, V16, P3011, DOI 10.1158/1078-0432.CCR-09-3013; Zuiverloon TC, 2011, J UROL; Zwarthoff EC, 2008, SCAND J UROL NEPHROL, V42, P147, DOI 10.1080/03008880802283953	35	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43345	10.1371/journal.pone.0043345	http://dx.doi.org/10.1371/journal.pone.0043345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22927958	Green Published, Green Submitted, gold			2022-12-27	WOS:000308286300044
J	Ceccom, J; Cosledan, F; Halley, H; Frances, B; Lassalle, JM; Meunier, B				Ceccom, Johnatan; Cosledan, Frederic; Halley, Helene; Frances, Bernard; Lassalle, Jean Michel; Meunier, Bernard			Copper Chelator Induced Efficient Episodic Memory Recovery in a Non-Transgenic Alzheimer's Mouse Model	PLOS ONE			English	Article							AMYLOID-BETA TOXICITY; A-BETA; NEURODEGENERATIVE DISEASES; OLIGOMERS; STRATEGY; AGENTS; NEUROPROTECTION; INVOLVEMENT; NEUROPATHY; MEMANTINE	Alzheimer's disease (AD) is a neurodegenerative syndrom involving many different biological parameters, including the accumulation of copper metal ions in Ab amyloid peptides due to a perturbation of copper circulation and homeostasis within the brain. Copper-containing amyloids activated by endogenous reductants are able to generate an oxidative stress that is involved in the toxicity of abnormal amyloids and contribute to the progressive loss of neurons in AD. Since only few drugs are currently available for the treatment of AD, we decided to design small molecules able to interact with copper and we evaluated these drug-candidates with non-transgenic mice, since AD is mainly an aging disease, not related to genetic disorders. We created a memory deficit mouse model by a single icv injection of A beta(1-42) peptide, in order to mimic the early stage of the disease and the key role of amyloid oligomers in AD. No memory deficit was observed in the control mice with the antisense A beta(42-1) peptide. Here we report the capacity of a new copper- specific chelating agent, a bis-8-aminoquinoline PA1637, to fully reverse the deficit of episodic memory after three weeks of treatment by oral route on non-transgenic amyloid-impaired mice. Clioquinol and memantine have been used as comparators to validate this fast and efficient mouse model.	[Ceccom, Johnatan; Halley, Helene; Frances, Bernard; Lassalle, Jean Michel] Univ Toulouse, UPS, Ctr Rech Cognit Anim, Toulouse, France; [Halley, Helene; Frances, Bernard; Lassalle, Jean Michel] CNRS, Ctr Rech Cognit Anim, Toulouse, France; [Cosledan, Frederic; Meunier, Bernard] Palumed, Castanet Tolosan, France; [Meunier, Bernard] CNRS, Chim Coordinat Lab, F-31077 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Ceccom, J (corresponding author), Univ Toulouse, UPS, Ctr Rech Cognit Anim, Toulouse, France.	lassalle@cict.fr; bmeunier@lcc-toulouse.fr	MEUNIER, Bernard/J-4879-2013	MEUNIER, Bernard/0000-0003-2200-7142	UPS; CNRS; Region Midi-Pyrenees and Palumed	UPS; CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Midi-Pyrenees and Palumed(Region Occitanie)	This work was supported by UPS, CNRS, the Region Midi-Pyrenees and Palumed. Frederic Cosledan (full-time employee of Palumed) and Bernard Meunier (full-time employee of Palumed up to January 2011 and now full-time employee of the CNRS) participated to the study design, the analysis and the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017669; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Arbiser JL, 1998, MOL MED, V4, P665, DOI 10.1007/BF03401927; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; BLANCHARD RJ, 1968, J COMP PHYSIOL PSYCH, V66, P603, DOI 10.1037/h0026511; Boldron C, 2005, CHEMBIOCHEM, V6, P1976, DOI 10.1002/cbic.200500220; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Daumas S, 2005, LEARN MEMORY, V12, P375, DOI 10.1101/lm.81905; Deraeve C, 2005, French Patent Application, Patent No. 0508351; Deraeve C, 2008, CHEM-EUR J, V14, P682, DOI 10.1002/chem.200701024; Deraeve C, 2007, NEW J CHEM, V31, P193, DOI 10.1039/b616085a; Deraeve C, 2008, EUR J INORG CHEM, P5622, DOI 10.1002/ejic.200800924; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Feaga HA, 2011, INORG CHEM, V50, P1614, DOI 10.1021/ic100967s; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jhoo JH, 2004, BEHAV BRAIN RES, V155, P185, DOI 10.1016/j.bbr.2004.04.012; Kitazawa M, 2009, J NEUROCHEM, V108, P1550, DOI 10.1111/j.1471-4159.2009.05901.x; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Martin P, 1988, MEASURING BEHAV INTR; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Miguel-Hidalgo JJ, 2002, BRAIN RES, V958, P210, DOI 10.1016/S0006-8993(02)03731-9; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Perrone L, 2010, CHEMBIOCHEM, V11, P110, DOI 10.1002/cbic.200900474; Quinn JF, 2010, J ALZHEIMERS DIS, V21, P903, DOI 10.3233/JAD-2010-100408; Quinn JF, 2009, EXPERT REV NEUROTHER, V9, P631, DOI 10.1586/ERN.09.27; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Scott LE, 2009, CHEM REV, V109, P4885, DOI 10.1021/cr9000176; Squitti R, 2009, CURR ALZHEIMER RES, V6, P476, DOI 10.2174/156720509790147133; Tateishi J, 2000, NEUROPATHOLOGY, V20, pS20; Van Dam D, 2006, NAT REV DRUG DISCOV, V5, P956, DOI 10.1038/nrd2075; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004	42	73	73	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43105	10.1371/journal.pone.0043105	http://dx.doi.org/10.1371/journal.pone.0043105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927947	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700023
J	Dornbierer, M; Stadelmann, M; Sourdon, J; Gahl, B; Cook, S; Carrel, TP; Tevaearai, HT; Longnus, SL				Dornbierer, Monika; Stadelmann, Mathieu; Sourdon, Joevin; Gahl, Brigitta; Cook, Stephane; Carrel, Thierry P.; Tevaearai, Hendrik T.; Longnus, Sarah L.			Early Reperfusion Hemodynamics Predict Recovery in Rat Hearts: A Potential Approach towards Evaluating Cardiac Grafts from Non-Heart-Beating Donors	PLOS ONE			English	Article							ISCHEMIC HEARTS; TRANSPLANTATION; PROCUREMENT; VIABILITY; DONATION; DEATH	Aims: Cardiac grafts from non-heartbeating donors (NHBDs) could significantly increase organ availability and reduce waiting-list mortality. Reluctance to exploit hearts from NHBDs arises from obligatory delays in procurement leading to periods of warm ischemia and possible subsequent contractile dysfunction. Means for early prediction of graft suitability prior to transplantation are thus required for development of heart transplantation programs with NHBDs. Methods and Results: Hearts (n = 31) isolated from male Wistar rats were perfused with modified Krebs-Henseleit buffer aerobically for 20 min, followed by global, no-flow ischemia (32 degrees C) for 30, 50, 55 or 60 min. Reperfusion was unloaded for 20 min, and then loaded, in working-mode, for 40 min. Left ventricular (LV) pressure was monitored using a micro-tip pressure catheter introduced via the mitral valve. Several hemodynamic parameters measured during early, unloaded reperfusion correlated significantly with LV work after 60 min reperfusion (p<0.001). Coronary flow and the production of lactate and lactate dehydrogenase (LDH) also correlated significantly with outcomes after 60 min reperfusion (p<0.05). Based on early reperfusion hemodynamic measures, a composite, weighted predictive parameter, incorporating heart rate (HR), developed pressure (DP) and end-diastolic pressure, was generated and evaluated against the HR-DP product after 60 min of reperfusion. Effective discriminating ability for this novel parameter was observed for four HR*DP cut-off values, particularly for >= 20 * 10(3) mmHg*beats*min(-1) (p<0.01). Conclusion: Upon reperfusion of a NHBD heart, early evaluation, at the time of organ procurement, of cardiac hemodynamic parameters, as well as easily accessible markers of metabolism and necrosis seem to accurately predict subsequent contractile recovery and could thus potentially be of use in guiding the decision of accepting the ischemic heart for transplantation.	[Dornbierer, Monika; Stadelmann, Mathieu; Sourdon, Joevin; Gahl, Brigitta; Carrel, Thierry P.; Tevaearai, Hendrik T.; Longnus, Sarah L.] Univ Hosp Bern, Inselspital, Dept Cardiovasc Med, CH-3010 Bern, Switzerland; [Dornbierer, Monika; Stadelmann, Mathieu; Sourdon, Joevin; Gahl, Brigitta; Carrel, Thierry P.; Tevaearai, Hendrik T.; Longnus, Sarah L.] Univ Bern, Bern, Switzerland; [Stadelmann, Mathieu; Cook, Stephane] Univ & Hosp, Fribourg, Switzerland; [Sourdon, Joevin] Univ Auvergne, Inst Technol, Clermont Ferrand, France	University of Bern; University Hospital of Bern; University of Bern; Universite Clermont Auvergne (UCA); Universite de Montpellier	Dornbierer, M (corresponding author), Univ Hosp Bern, Inselspital, Dept Cardiovasc Med, CH-3010 Bern, Switzerland.	hendrik.tevaearai@insel.ch	Carrel, Thierry/AAI-5910-2021; Longnus, Sarah/M-1122-2019	Longnus, Sarah/0000-0001-8489-917X	University of Berne's Department of Clinical Research; Olga Mayenfisch Foundation	University of Berne's Department of Clinical Research; Olga Mayenfisch Foundation	This work was supported by a Grant-in-Aid from the University of Berne's Department of Clinical Research and a Research Grant from the Olga Mayenfisch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2009, J HEART LUNG TRANSPL, V28, P290, DOI 10.1016/j.healun.2008.12.014; Almond CSD, 2009, CIRCULATION, V119, P717, DOI 10.1161/CIRCULATIONAHA.108.815712; BARNARD C N, 1967, South African Medical Journal, V41, P1271; Boucek MM, 2008, NEW ENGL J MED, V359, P709, DOI 10.1056/NEJMoa0800660; Collins MJ, 2007, J HEART LUNG TRANSPL, V26, P376, DOI 10.1016/j.healun.2006.12.013; Doenst T, 1998, MOL CELL BIOCHEM, V180, P153, DOI 10.1023/A:1006863728395; Doig CJ, 2003, CAN J ANAESTH, V50, P1069, DOI 10.1007/BF03018376; Ferrera R, 2006, TRANSPL P, V38, P2283, DOI 10.1016/j.transproceed.2006.06.124; FERRERA R, 1995, CIRCULATION, V91, P257, DOI 10.1161/01.CIR.91.2.257; GUNDRY SR, 1992, ANN THORAC SURG, V53, P772, DOI 10.1016/0003-4975(92)91433-A; Hirota M, 2006, J HEART LUNG TRANSPL, V25, P339, DOI 10.1016/j.healun.2005.09.014; Kato G, 2006, GEN THORAC CARDIOVAS, V54, P511, DOI 10.1007/s11748-006-0051-0; Koogler T, 1998, PEDIATRICS, V101, P1049, DOI 10.1542/peds.101.6.1049; LOPASCHUK GD, 1993, J PHARMACOL EXP THER, V264, P135; MACKERSIE RC, 1991, ANN SURG, V213, P143, DOI 10.1097/00000658-199102000-00009; Manno EM, 2005, NEUROCRIT CARE, V3, P111, DOI 10.1385/NCC:3:2:111; Martin J, 1999, J HEART LUNG TRANSPL, V18, P597, DOI 10.1016/S1053-2498(98)00017-5; NEELY JR, 1967, AM J PHYSIOL, V212, P804; Osaki S, 2010, EUR J CARDIO-THORAC, V37, P74, DOI 10.1016/j.ejcts.2009.07.005; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Singhal AK, 2005, J HEART LUNG TRANSPL, V24, P1657, DOI 10.1016/j.healun.2004.11.043; Suehiro K, 2001, ANN THORAC SURG, V71, P278, DOI 10.1016/S0003-4975(00)01939-1; Whetstine L, 2002, CRIT CARE, V6, P192, DOI 10.1186/cc1487; Wood KE, 2007, CURR OPIN ANESTHESIO, V20, P97, DOI 10.1097/ACO.0b013e3280895ac8	24	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43642	10.1371/journal.pone.0043642	http://dx.doi.org/10.1371/journal.pone.0043642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928009	Green Published, Green Submitted, gold			2022-12-27	WOS:000307789700044
J	Madeira, A; da Silva, CL; dos Santos, F; Camafeita, E; Cabral, JMS; Sa-Correia, I				Madeira, Andreia; da Silva, Claudia L.; dos Santos, Francisco; Camafeita, Emilio; Cabral, Joaquim M. S.; Sa-Correia, Isabel			Human Mesenchymal Stem Cell Expression Program upon Extended Ex-Vivo Cultivation, as Revealed by 2-DE-Based Quantitative Proteomics	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; STROMAL CELLS; PROTEINS; APOPTOSIS; VIMENTIN; ADHESION; THERAPY; STRESS; PROLIFERATION; TRANSCRIPTION	Human mesenchymal stem cells (MSC) have been on the focus of intense clinical-oriented research due to their multilineage differentiation potential and immunomodulatory properties. However, to reach the clinically meaningful cell numbers for cellular therapy and tissue engineering applications, MSC ex-vivo expansion is mandatory but sequential cell passaging results in loss of proliferative, clonogenic and differentiation potential. To get clues into the molecular mechanisms underlying cellular senescence resulting from extended ex-vivo cultivation of bone marrow (BM) MSC, we explored a two-dimensional gel electrophoresis (2-DE) based quantitative proteomics to compare the expression programs of Passage 3 cells (P3), commonly used in clinical studies with expanded MSC, and Passage 7 (P7) cells, which already demonstrated significant signs of culture-induced senescence. Proteins of the functional categories "Structural components and cellular cytoskeleton" and "Folding and stress response proteins" are less abundant in P7 cells, compared to P3, while proteins involved in "Energy metabolism", "Cell cycle regulation and aging" and "Apoptosis" are more abundant. The large number of multiple size and charge isoforms with an altered content that were identified in this study in P7 versus P3, namely the cytoskeleton components beta-actin (7 forms) and vimentin (24 forms), also emphasizes the importance of post-transcriptional modification upon long-term cultivation. The differential protein expression registered suggests that cellular senescence occurring during ex-vivo expansion of BM MSC is associated with the impairment of cytoskeleton remodeling and/or organization and the repair of damaged proteins resulting from cell exposure to culture stress. The genome-wide expression approach used in this study has proven useful for getting mechanistic insights into the observed decrease on the proliferative and clonogenic potential of P7 versus P3 cells and paves the way to set up a proteome profiling strategy for quality control to assure safe and clinically effective expanded MSC.	[Madeira, Andreia; da Silva, Claudia L.; dos Santos, Francisco; Cabral, Joaquim M. S.; Sa-Correia, Isabel] Inst Super Tecn, Ctr Biol & Chem Engn, IBB, Lisbon, Portugal; [Madeira, Andreia; da Silva, Claudia L.; dos Santos, Francisco; Cabral, Joaquim M. S.; Sa-Correia, Isabel] Univ Tecn Lisboa, Inst Super Tecn, Dept Bioengn, Lisbon, Portugal; [Camafeita, Emilio] CNIC, Unidad Prote, Madrid, Spain	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Madeira, A (corresponding author), Inst Super Tecn, Ctr Biol & Chem Engn, IBB, Lisbon, Portugal.	isacorreia@ist.utl.pt	da Silva, Claudia L./K-6104-2012; Cabral, Joaquim M S/G-2052-2010; Sá-Correia, Isabel/H-4054-2011; Santos, Francisco F dos/N-9832-2016; Madeira, Andreia S/B-4962-2012	da Silva, Claudia L./0000-0002-1091-7651; Cabral, Joaquim M S/0000-0002-2405-5845; Sá-Correia, Isabel/0000-0003-2208-5183; Santos, Francisco F dos/0000-0002-2046-2742; 	Portuguese Foundation for Science and Technology (FCT) [PEst-OE/EQB/LA0023/2011, PTDC/EQU-EQU/114231/2009, SFRH/BD/37012/2007, SFRH/BD/38719/2007]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was funded by the Portuguese Foundation for Science and Technology (FCT) (PEst-OE/EQB/LA0023/2011_research lines: Systems and Synthetic Biology and Stem Cell Engineering and Regenerative Medicine; PTDC/EQU-EQU/114231/2009; and PhD fellowships SFRH/BD/37012/2007 to Dr. Madeira and SFRH/BD/38719/2007 to Dr. dos Santos. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; DellOrco RT, 1996, EXP GERONTOL, V31, P245, DOI 10.1016/0531-5565(95)02009-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; dos Santos F, 2011, METHODS MOL BIOL, V698, P189, DOI 10.1007/978-1-60761-999-4_15; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Feldmann RE, 2005, ELECTROPHORESIS, V26, P2749, DOI 10.1002/elps.200410406; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Huang HL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-36; Ishitani R, 1996, J NEUROCHEM, V66, P928; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Izzo MW, 1999, J BIOL CHEM, V274, P19498, DOI 10.1074/jbc.274.27.19498; KAPISZEWSKA M, 1991, INT J RADIAT BIOL, V60, P635, DOI 10.1080/09553009114552461; Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49; Kim JS, 2011, EXP GERONTOL, V46, P500, DOI 10.1016/j.exger.2011.02.012; Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1; Kindas-Mugge I, 1998, ANTICANCER RES, V18, P413; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Levchenko A, 2005, NAT BIOTECHNOL, V23, P828, DOI 10.1038/nbt0705-828; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Madeira A, 2011, PROTEOMICS, V11, P1313, DOI 10.1002/pmic.201000457; Martin I, 2011, TISSUE ENG PT A, V17, P2221, DOI [10.1089/ten.tea.2011.0131, 10.1089/ten.TEA.2011.0131]; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rattan SIS, 2005, IUBMB LIFE, V57, P297, DOI 10.1080/15216540500092195; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Sa-Correia I, 2010, EXPERT REV PROTEOMIC, V7, P943, DOI 10.1586/EPR.10.76; Santos PM, 2009, PROTEOMICS, V9, P5101, DOI 10.1002/pmic.200900325; Santos PM, 2009, PROTEOMICS, V9, P657, DOI 10.1002/pmic.200800452; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; SUNAGA K, 1995, NEUROSCI LETT, V200, P133, DOI 10.1016/0304-3940(95)12098-O; Tsukahara F, 2000, MOL PHARMACOL, V58, P1257, DOI 10.1124/mol.58.6.1257; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Tyndall A, 2009, BONE MARROW TRANSPL, V43, P821, DOI 10.1038/bmt.2009.63; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Zhou ZL, 2010, MOL BIOL REP, V37, P2407, DOI 10.1007/s11033-009-9751-8	65	46	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43523	10.1371/journal.pone.0043523	http://dx.doi.org/10.1371/journal.pone.0043523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916271	Green Submitted, gold, Green Published			2022-12-27	WOS:000307733800074
J	Vrentas, CE; Greenlee, JJ; Tatum, TL; Nicholson, EM				Vrentas, Catherine E.; Greenlee, Justin J.; Tatum, Trudy L.; Nicholson, Eric M.			Relationships between PrPSc Stability and Incubation Time for United States Scrapie Isolates in a Natural Host System	PLOS ONE			English	Article							SHEEP PRION PROTEIN; CONFORMATIONAL STABILITY; SUFFOLK SHEEP; TRANSMISSION; GENOTYPE; STRAINS	Transmissible spongiform encephalopathies (TSEs), including scrapie in sheep (Ovis aries), are fatal neurodegenerative diseases caused by the misfolding of the cellular prion protein (PrPC) into a a-rich conformer (PrPSc) that accumulates into higher-order structures in the brain and other tissues. Distinct strains of TSEs exist, characterized by different pathologic profiles upon passage into rodents and representing distinct conformations of PrPSc. One biochemical method of distinguishing strains is the stability of PrPSc as determined by unfolding in guanidine hydrochloride (GdnHCl), which is tightly and positively correlated with the incubation time of disease upon passage into mice. Here, we utilize a rapid, protease-free version of the stability assay to characterize naturally occurring scrapie samples, including a fast-acting scrapie inoculum for which incubation time is highly dependent on the amino acid at codon 136 of the prion protein. We utilize the stability methodology to identify the presence of two distinct isolates in the inoculum, and compare isolate properties to those of a host-stabilized reference scrapie isolate (NADC 13-7) in order to assess the stability/incubation time correlation in a natural host system. We demonstrate the utility of the stability methodology in characterizing TSE isolates throughout serial passage in livestock, which is applicable to a range of natural host systems, including strains of bovine spongiform encephalopathy and chronic wasting disease.	[Vrentas, Catherine E.; Greenlee, Justin J.; Tatum, Trudy L.; Nicholson, Eric M.] USDA ARS, Natl Anim Dis Ctr, Ames, IA 50010 USA	United States Department of Agriculture (USDA)	Vrentas, CE (corresponding author), USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA.	eric.nicholson@ars.usda.gov	Greenlee, Justin/Y-5732-2019	Greenlee, Justin/0000-0003-2202-3054	U.S. Department of Agriculture, Agriculture Research Service	U.S. Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded in its entirety by congressionally appropriated funds to the U.S. Department of Agriculture, Agriculture Research Service. The funders of the work did not influence study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Bossers A, 1997, P NATL ACAD SCI USA, V94, P4931, DOI 10.1073/pnas.94.10.4931; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; Bulgin MS, 2007, JAVMA-J AM VET MED A, V230, P1158, DOI 10.2460/javma.230.8.1158; Bulgin MS, 2006, AM J VET RES, V67, P498, DOI 10.2460/ajvr.67.3.498; Choi YP, 2010, J VIROL, V84, P12030, DOI 10.1128/JVI.01057-10; Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Hamir AN, 2009, VET PATHOL, V46, P1205, DOI 10.1354/vp.08-VP-0258-H-FL; Hamir AN, 2009, VET PATHOL, V46, P39, DOI 10.1354/vp.46-1-39; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Harnir AN, 2008, CAN J VET RES, V72, P63; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Jacobs JG, 2011, J VIROL, V85, P12537, DOI 10.1128/JVI.00448-11; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; ORourke KI, 1997, J GEN VIROL, V78, P975, DOI 10.1099/0022-1317-78-4-975; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sajnani G, 2007, PLOS PATHOG, V8; Sun Y, 2008, J MOL BIOL, V376, P1155, DOI 10.1016/j.jmb.2007.12.053; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thackray AM, 2008, J VIROL, V82, P11197, DOI 10.1128/JVI.01454-08; Thackray AM, 2012, EXP MOL PATHOL, V92, P167, DOI 10.1016/j.yexmp.2011.11.004; Tranulis MA, 2002, APMIS, V110, P33, DOI 10.1034/j.1600-0463.2002.100105.x; Wemheuer WM, 2009, AM J PATHOL, V175, P2566, DOI 10.2353/ajpath.2009.090623; Zampieri M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000420	35	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43060	10.1371/journal.pone.0043060	http://dx.doi.org/10.1371/journal.pone.0043060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22916207	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500800040
J	Ramanujam, R; Xu, YS; Hao, L; Naqvi, NI				Ramanujam, Ravikrishna; Xu Yishi; Hao Liu; Naqvi, Naweed I.			Structure-Function Analysis of Rgs1 in Magnaporthe oryzae: Role of DEP Domains in Subcellular Targeting	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; SACCHAROMYCES-CEREVISIAE; ALPHA-SUBUNITS; CRYPTOCOCCUS-NEOFORMANS; APPRESSORIUM FORMATION; HYDROPHOBIN SYNTHESIS; ASEXUAL SPORULATION; REGULATES PHEROMONE; STRESS-RESPONSE; GRISEA	Background: Rgs1, a prototypical Regulator of G protein Signaling, negatively modulates the cyclic AMP pathway thereby influencing various aspects of asexual development and pathogenesis in the rice-blast fungus Magnaporthe oryzae. Rgs1 possesses tandem DEP motifs (termed DEP-A and DEP-B; for Dishevelled, Egl-10, Pleckstrin) at the N-terminus, and a G alpha-GTP interacting RGS catalytic core domain at the C-terminus. In this study, we focused on gaining further insights into the mechanisms of Rgs1 regulation and subcellular localization by characterizing the role(s) of the individual domains and the full-length protein during asexual development and pathogenesis in Magnaporthe. Methodology/Principal Findings: Utilizing western blot analysis and specific antisera against the N- and C-terminal halves of Rgs1, we identify and report the in vivo endoproteolytic processing/cleavage of full-length Rgs1 that yields an N-terminal DEP and a RGS core domain. Independent expression of the resultant DEP-DEP half (N-Rgs1) or RGS core (C-Rgs1) fragments, failed to complement the rgs1 Delta defects in colony morphology, aerial hyphal growth, surface hydrophobicity, conidiation, appressorium formation and infection. Interestingly, the full-length Rgs1-mCherry, as well as the tagged N-terminal DEP domains (individually or in conjunction) localized to distinct punctate vesicular structures in the cytosol, while the catalytic RGS core motif was predominantly vacuolar. Conclusions/Significance: Based on our data from sequence alignments, immuno-blot and microscopic analysis, we propose that the post-translational proteolytic processing of Rgs1 and the vacuolar sequestration of the catalytic RGS domain represents an important means of down regulating Rgs1 function and thus forming an additional and alternative means of regulating G protein signaling in Magnaporthe. We further hypothesize the prevalence of analogous mechanisms functioning in other filamentous fungi. Furthermore, we conclusively assign a specific vesicular/membrane targeting function for the N-terminal DEP domains of Rgs1 in the rice-blast fungus.	[Ramanujam, Ravikrishna; Xu Yishi; Naqvi, Naweed I.] Temasek Life Sci Lab, Fungal Pathobiol Grp, Singapore, Singapore; [Ramanujam, Ravikrishna; Naqvi, Naweed I.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Hao Liu] Tianjin Univ Sci & Technol, MOE Key Lab Ind Fermentat Microbiol, Coll Biotechnol, Tianjin, Peoples R China; [Naqvi, Naweed I.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tianjin University Science & Technology; National University of Singapore	Ramanujam, R (corresponding author), Temasek Life Sci Lab, Fungal Pathobiol Grp, Singapore, Singapore.	naweed@tll.org.sg	Naqvi, Naweed/CAG-5662-2022	Naqvi, Naweed/0000-0002-3619-4906	Temasek Life Sciences Laboratory (Singapore); National Natural Science Foundation of China [NSFC31170134]; maging Facility at TLL	Temasek Life Sciences Laboratory (Singapore)(National University of Singapore); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); maging Facility at TLL	This work was funded by intramural research grants from the Temasek Life Sciences Laboratory (Singapore). HL acknowledges grants from the project National Natural Science Foundation of China NSFC31170134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Fungal Patho-Biology Group for helpful discussions and suggestions. We gratefully acknowledge support from the Imaging Facility at TLL.	Adachi K, 1998, PLANT CELL, V10, P1361, DOI 10.1105/tpc.10.8.1361; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker LG, 2005, THESIS; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bosch DE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002553; Burchett SA, 2002, J BIOL CHEM, V277, P22156, DOI 10.1074/jbc.M202254200; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; DIETZEL C, 1987, MOL CELL BIOL, V7, P4169, DOI 10.1128/MCB.7.12.4169; Dignard D, 2006, EUKARYOT CELL, V5, P192, DOI 10.1128/EC.5.1.192-202.2006; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dohlman HG, 1998, SEMIN CELL DEV BIOL, V9, P135, DOI 10.1006/scdb.1998.0218; Fang WG, 2007, MICROBIOL-SGM, V153, P1017, DOI 10.1099/mic.0.2006/002105-0; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Hoffman GA, 2000, J BIOL CHEM, V275, P37533, DOI 10.1074/jbc.M005751200; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; LEE BN, 1994, MOL MICROBIOL, V14, P323, DOI 10.1111/j.1365-2958.1994.tb01293.x; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Liu H., 2006, THESIS; Liu H, 2007, EMBO J, V26, P690, DOI 10.1038/sj.emboj.7601536; Liu SH, 1997, MOL PLANT MICROBE IN, V10, P1075, DOI 10.1094/MPMI.1997.10.9.1075; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Mukherjee M, 2011, MOL PLANT PATHOL, V12, P479, DOI 10.1111/j.1364-3703.2010.00686.x; Nishimura M, 2003, MOL MICROBIOL, V50, P231, DOI 10.1046/j.1365-2958.2003.03676.x; Pereira PS, 2001, GENES CELLS, V6, P789, DOI 10.1046/j.1365-2443.2001.00465.x; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Ramanujam R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000897; Sambrook J., 2002, MOL CLONING LAB MANU; Segers GC, 2004, EUKARYOT CELL, V3, P1454, DOI 10.1128/EC.3.6.1454-1463.2004; Shen G, 2008, EUKARYOT CELL, V7, P1540, DOI 10.1128/EC.00154-08; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Watson P, 1999, MOL MICROBIOL, V33, P623, DOI 10.1046/j.1365-2958.1999.01510.x; Xue CY, 2008, MOL MICROBIOL, V70, P379, DOI 10.1111/j.1365-2958.2008.06417.x; Zhang HF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002450	48	17	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2012	7	7							e41084	10.1371/journal.pone.0041084	http://dx.doi.org/10.1371/journal.pone.0041084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981GZ	22927898	Green Published, gold			2022-12-27	WOS:000306956300049
J	Apte, SH; Groves, PL; Skwarczynski, M; Fujita, Y; Chang, CH; Toth, I; Doolan, DL				Apte, Simon H.; Groves, Penny L.; Skwarczynski, Mariusz; Fujita, Yoshio; Chang, Chenghung; Toth, Istvan; Doolan, Denise L.			Vaccination with Lipid Core Peptides Fails to Induce Epitope-Specific T Cell Responses but Confers Non-Specific Protective Immunity in a Malaria Model	PLOS ONE			English	Article							YOELII CIRCUMSPOROZOITE PROTEIN; SYNTHETIC LIPOPEPTIDE VACCINE; GROUP-A STREPTOCOCCUS; LIVER-STAGE ANTIGEN; PLASMODIUM-FALCIPARUM; IN-VIVO; DELIVERY-SYSTEM; CD4 HELP; LYMPHOCYTE RESPONSES; INFECTED HEPATOCYTES	Vaccines against many pathogens for which conventional approaches have failed remain an unmet public health priority. Synthetic peptide-based vaccines offer an attractive alternative to whole protein and whole organism vaccines, particularly for complex pathogens that cause chronic infection. Previously, we have reported a promising lipid core peptide (LCP) vaccine delivery system that incorporates the antigen, carrier, and adjuvant in a single molecular entity. LCP vaccines have been used to deliver several peptide subunit-based vaccine candidates and induced high titre functional antibodies and protected against Group A streptococcus in mice. Herein, we have evaluated whether LCP constructs incorporating defined CD4(+) and/or CD8(+) T cell epitopes could induce epitope-specific T cell responses and protect against pathogen challenge in a rodent malaria model. We show that LCP vaccines failed to induce an expansion of antigen-specific CD8(+) T cells following primary immunization or by boosting. We further demonstrated that the LCP vaccines induced a non-specific type 2 polarized cytokine response, rather than an epitope-specific canonical CD8(+) T cell type 1 response. Cytotoxic responses of unknown specificity were also induced. These non-specific responses were able to protect against parasite challenge. These data demonstrate that vaccination with lipid core peptides fails to induce canonical epitope-specific T cell responses, at least in our rodent model, but can nonetheless confer non-specific protective immunity against Plasmodium parasite challenge.	[Apte, Simon H.; Groves, Penny L.; Doolan, Denise L.] Queensland Inst Med Res, Infect Dis Programme, Herston, Qld 4006, Australia; [Skwarczynski, Mariusz; Fujita, Yoshio; Chang, Chenghung; Toth, Istvan] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Toth, Istvan] Univ Queensland, Sch Pharm, St Lucia, Qld, Australia; [Doolan, Denise L.] Univ Queensland, Sch Med, Herston, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Queensland	Apte, SH (corresponding author), Queensland Inst Med Res, Infect Dis Programme, Bramston Terrace, Herston, Qld 4006, Australia.	Denise.Doolan@qimr.edu.au	Apte, Simon/R-8794-2019; Toth, Istvan/C-1965-2013; Apte, Simon/H-2798-2016; Doolan, Denise L/F-1969-2015; Skwarczynski, Mariusz/A-6707-2009	Apte, Simon/0000-0003-3105-0820; Toth, Istvan/0000-0002-4572-397X; Apte, Simon/0000-0003-3105-0820; Skwarczynski, Mariusz/0000-0001-7257-807X; Doolan, Denise/0000-0001-7354-8817	NHMRC Program [496600]; Pfizer Australia Senior Research Fellowship; Grants-in-Aid for Scientific Research [23790144] Funding Source: KAKEN	NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Australia Senior Research Fellowship(PfizerPfizer Australia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by NHMRC Program Grant 496600. DLD was supported by a Pfizer Australia Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ABM, 2008, J MED CHEM, V51, P167, DOI 10.1021/jm701091d; AICHELE P, 1990, J EXP MED, V171, P1815, DOI 10.1084/jem.171.5.1815; Alexander J, 1998, IMMUNOL RES, V18, P79, DOI 10.1007/BF02788751; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; An LL, 1997, J VIROL, V71, P2292, DOI 10.1128/JVI.71.3.2292-2302.1997; Anders RF, 2010, HUM VACCINES, V6, P39, DOI 10.4161/hv.6.1.10712; [Anonymous], 2008, WORLD MAL REP 2008; Apte SH, 2011, INT J PARASITOL, V41, P1285, DOI 10.1016/j.ijpara.2011.07.010; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Benmohamed L, 2000, VACCINE, V18, P2843, DOI 10.1016/S0264-410X(00)00068-2; BenMohamed L, 2002, EUR J IMMUNOL, V32, P2274, DOI 10.1002/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C; BenMohamed L, 1997, EUR J IMMUNOL, V27, P1242, DOI 10.1002/eji.1830270528; BenMohamed L, 2002, LANCET INFECT DIS, V2, P425, DOI 10.1016/S1473-3099(02)00318-3; Bour H, 1998, J IMMUNOL, V160, P5522; Bourgeois C, 2003, EUR J IMMUNOL, V33, P3225, DOI 10.1002/eji.200324576; Brown Lorena E., 2005, Current Drug Delivery, V2, P383, DOI 10.2174/156720105774370258; Daubersies P, 2000, NAT MED, V6, P1258, DOI 10.1038/81366; DERES K, 1989, NATURE, V342, P561, DOI 10.1038/342561a0; Dobano C, 2007, MOL IMMUNOL, V44, P2235, DOI 10.1016/j.molimm.2006.11.003; Dobano C, 2008, OPEN VACCINE J, V1, P27; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Franke ED, 1997, J IMMUNOL, V159, P3424; Franke ED, 2000, INFECT IMMUN, V68, P3403, DOI 10.1128/IAI.68.6.3403-3411.2000; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Godoy-Ramirez K, 2005, CYTOM PART A, V68A, P71, DOI 10.1002/cyto.a.20189; Goldszmid RS, 2010, CURR OPIN IMMUNOL, V22, P118, DOI 10.1016/j.coi.2010.01.017; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; GRILLOT D, 1990, EUR J IMMUNOL, V20, P1215, DOI 10.1002/eji.1830200604; Hayman WA, 2002, IMMUNOL CELL BIOL, V80, P178, DOI 10.1046/j.1440-1711.2002.01067.x; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Holtappels R, 2008, J VIROL, V82, P5781, DOI 10.1128/JVI.00155-08; HOPP TP, 1984, MOL IMMUNOL, V21, P13, DOI 10.1016/0161-5890(84)90084-1; Ishioka GY, 1999, J IMMUNOL, V162, P3915; Iwasaki A, 1998, CANCER IMMUNOL IMMUN, V45, P273, DOI 10.1007/s002620050443; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Kloverpris H, 2009, AIDS, V23, P1329, DOI 10.1097/QAD.0b013e32832d9b00; Livingston BD, 1999, J IMMUNOL, V162, P3088; Martinez X, 2003, VIROLOGY, V305, P428, DOI 10.1006/viro.2002.1775; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mauduit M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007717; Moyle PM, 2008, CURR MED CHEM, V15, P506, DOI 10.2174/092986708783503249; Moyle PM, 2007, J MED CHEM, V50, P4721, DOI 10.1021/jm070287b; Moyle PM, 2006, INT J PEPT RES THER, V12, P317, DOI 10.1007/s10989-006-9021-8; Olive C, 2003, INFECT IMMUN, V71, P2373, DOI 10.1128/IAI.71.5.2373-2383.2003; Olive C, 2006, J INFECT DIS, V193, P1666, DOI 10.1086/504266; Oukka M, 1996, J IMMUNOL, V157, P3039; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Phillipps KSM, 2009, IMMUNOLOGY, V128, pe582, DOI 10.1111/j.1365-2567.2008.03038.x; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; RENIA L, 1991, P NATL ACAD SCI USA, V88, P7963, DOI 10.1073/pnas.88.18.7963; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Ruckwardt TJ, 2010, J IMMUNOL, V185, P4673, DOI 10.4049/jimmunol.1001606; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; SCHILD H, 1991, EUR J IMMUNOL, V21, P2649, DOI 10.1002/eji.1830211102; SCHILD H, 1991, J EXP MED, V174, P1665, DOI 10.1084/jem.174.6.1665; Schofield L., 1988, Vaccines 88. New chemical and genetic approaches to vaccination: prevention of AIDS and other viral, bacterial and parasitic diseases., P71; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; SEDEGAH M, 1990, B WORLD HEALTH ORGAN, V68, P109; Sedegah M, 1998, P NATL ACAD SCI USA, V95, P7648, DOI 10.1073/pnas.95.13.7648; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; SEDEGAH M, 1992, VACCINE, V10, P578, DOI 10.1016/0264-410X(92)90436-N; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; Skwarczynski M, 2012, LIPO PEPTIDES SACCHA; Skwarczynski M, 2011, METHODS MOL BIOL, V751, P297, DOI 10.1007/978-1-61779-151-2_18; Skwarczynski M, 2010, ANGEW CHEM INT EDIT, V49, P5742, DOI 10.1002/anie.201002221; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Thomson SA, 1996, J IMMUNOL, V157, P822; TOTH I, 1993, TETRAHEDRON LETT, V34, P3925, DOI 10.1016/S0040-4039(00)79265-3; van den Hoorn T, 2011, CURR OPIN IMMUNOL, V23, P88, DOI 10.1016/j.coi.2010.11.002; vanderMost RG, 1996, J IMMUNOL, V157, P5543; WEISS WR, 1990, B WORLD HEALTH ORGAN, V68, P99; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; White K, 2004, IMMUNOL CELL BIOL, V82, P517, DOI 10.1111/j.0818-9641.2004.01269.x; Witney AA, 2001, MOL BIOCHEM PARASIT, V118, P233, DOI 10.1016/S0166-6851(01)00372-3; Yewdell JW, 2010, CURR OPIN IMMUNOL, V22, P402, DOI 10.1016/j.coi.2010.04.002; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zaman Mehfuz, 2010, Current Drug Delivery, V7, P118; Zaman M, 2010, VACCINE, V28, P2243, DOI 10.1016/j.vaccine.2009.12.046; Zhan YF, 2000, J IMMUNOL, V165, P3612, DOI 10.4049/jimmunol.165.7.3612; ZHONG GM, 1993, J IMMUNOL, V151, P3728; Zhong W, 2009, AUST J CHEM, V62, P956, DOI 10.1071/CH09149; Zhu XM, 2004, EUR J IMMUNOL, V34, P3102, DOI 10.1002/eji.200425166	92	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e40928	10.1371/journal.pone.0040928	http://dx.doi.org/10.1371/journal.pone.0040928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936972	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000308225500004
J	Bergot, E; Haustraete, E; Malbruny, B; Magnier, R; Salaun, MA; Zalcman, G				Bergot, Emmanuel; Haustraete, Eglantine; Malbruny, Brigitte; Magnier, Romain; Salauen, Marie-Anne; Zalcman, Gerard			Observational Study of QuantiFERON (R)-TB Gold In-Tube Assay in Tuberculosis Contacts in a Low Incidence Area	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; WITHIN-SUBJECT VARIABILITY; LATENT TUBERCULOSIS; PREDICTIVE-VALUE; SKIN-TEST; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; IMMIGRANT CONTACTS; COST-EFFECTIVENESS; INFECTION	Background: QuantiFERON (R)-TB Gold in-Tube (QFT) assay is a recently developed test to assess latent tuberculosis infection in contagious tuberculosis (TB) contact subjects. To assess the QFT assay in recently exposed contacts of active tuberculosis patients in a French area with low TB incidence but high Bacille Calmette-Guerin coverage, and evaluate progression rates to TB disease. Methodology/Principal Findings: Between January 2007 and December 2009, 687 contacts of culture-confirmed tuberculosis cases underwent the QFT assay, with tuberculin skin test (TST) in 473, and a 34 months mean follow-up. Of 687 contacts, 148 were QFT positive, while 526 were negative and 13 indeterminate. QFT was positive in 35% of individuals with TST >= 10 mm, 47.5% with TST >= 15 mm or phlyctenular, but in 21% of cases in which two-step TST (M0 and M3) remained negative. Conversely, QFT was negative in 69% of cases with two-step TST showing conversion from negative to positive. All indeterminate QFT were associated with TST induration <10 mm in diameter. For 29 QFT-positive subjects, no chemoprophylaxis was given due to medical contraindications. Of the remaining 119 QFT-positive contacts, 97accepted chemoprophylaxis (81.5%), and 79 (81.4%) completed the treatment. Two contacts progressed to TB disease: one subject was QFT positive and had declined chemoprophylaxis, while the other one was QFT negative. QFT positive predictive value for progression to TB was 1.96% (1/51) with a 99.8% (525/526) negative predictive value. Conclusions/Significance: Our results confirm the safety of the QFT-based strategy for assessing the TB chemoprophylaxis indication, as only one contact developed TB disease out of 526 QFT-negative subjects.	[Bergot, Emmanuel; Haustraete, Eglantine; Magnier, Romain; Zalcman, Gerard] CHU Caen, Serv Pneumol, F-14000 Caen, France; [Bergot, Emmanuel; Zalcman, Gerard] CHU Caen, UMR Canc & Prevent 1086, F-14000 Caen, France; [Bergot, Emmanuel; Salauen, Marie-Anne] Ctr Prevent Malad Infect, Caen, France; [Malbruny, Brigitte] CHU Caen, Microbiol Serv, F-14000 Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Bergot, E (corresponding author), CHU Caen, Serv Pneumol, F-14000 Caen, France.	bergot-e@chu-caen.fr	ZALCMAN, Gérard/L-7809-2015; ZALCMAN, Gerard/P-4150-2015; ZALCMAN, Gerard/M-8113-2019	ZALCMAN, Gérard/0000-0002-0343-9575; 	Regional Health Authority (DRASS); Centre de Prevention des Maladies Infectieuses (CPMI); Cellestis	Regional Health Authority (DRASS); Centre de Prevention des Maladies Infectieuses (CPMI); Cellestis	The Regional Health Authority (DRASS) and Centre de Prevention des Maladies Infectieuses (CPMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. E. Bergot had three non-financially supported presentations for Cellestis scientific symposia, organized during French 2009 Annual Meeting of Pulmonology (CPLF), French 2009 Annual Meeting of Infectiology (JNI), and Specific French Cellestis meeting in Paris (2010). He also received partial financial compensation from Cellestis, for travel and accomodation for attending May 2009 International Meeting on IGRAs at Dubrovnik (Croatia). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. No other competing interest for the other authors.	Alfaro EM, 1998, MED CLIN-BARCELONA, V111, P401; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; [Anonymous], 2001, MESURE COUVERTURE VA, P1; [Anonymous], 2007, MED MAL INFECT, V37, P689; [Anonymous], 2003, REV MAL RESPIR, V20, pS27; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Bradshaw L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020770; Deuffic-Burban S, 2010, INT J TUBERC LUNG D, V14, P471; Diel R, 2007, EUR RESPIR J, V30, P321, DOI 10.1183/09031936.00145906; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2012, CHEST; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Erkens CGM, 2010, EUR RESPIR J, V36, P925, DOI 10.1183/09031936.00201609; Figoni J, 2011, B EPIDEMIOL HEBD, V22, P258; Gershon AS, 2004, CLIN INFECT DIS, V39, P667, DOI 10.1086/422995; Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509; Kik SV, 2009, INT J TUBERC LUNG D, V13, P820; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Menzies D, 2008, ANN INTERN MED, V149, P689, DOI 10.7326/0003-4819-149-10-200811180-00003; Page KR, 2006, ARCH INTERN MED, V166, P1863, DOI 10.1001/archinte.166.17.1863; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Sauzullo I, 2011, TUBERCULOSIS, V91, P322, DOI 10.1016/j.tube.2011.05.004; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804	27	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43520	10.1371/journal.pone.0043520	http://dx.doi.org/10.1371/journal.pone.0043520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937059	Green Submitted, Green Published, gold			2022-12-27	WOS:000308225500060
J	Johannesson, B; Hirtz, S; Schatterny, J; Schultz, C; Mall, MA				Johannesson, Bjarki; Hirtz, Stephanie; Schatterny, Jolanthe; Schultz, Carsten; Mall, Marcus A.			CFTR Regulates Early Pathogenesis of Chronic Obstructive Lung Disease in beta ENaC-Overexpressing Mice	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY SURFACE LIQUID; EPITHELIAL NA+ CHANNEL; CYSTIC-FIBROSIS; ION-TRANSPORT; PULMONARY-DISEASE; MOUSE MODEL; EXPRESSION; MUCUS; INFLAMMATION	Background: Factors determining the onset and severity of chronic obstructive pulmonary disease remain poorly understood. Previous studies demonstrated that airway surface dehydration in beta ENaC-overexpressing (beta ENaC-Tg) mice on a mixed genetic background caused either neonatal mortality or chronic obstructive lung disease suggesting that the onset of lung disease was modulated by the genetic background. Methods: To test this hypothesis, we backcrossed beta ENaC-Tg mice onto two inbred strains (C57BL/6 and BALB/c) and studied effects of the genetic background on neonatal mortality, airway ion transport and airway morphology. Further, we crossed beta ENaC-Tg mice with CFTR-deficient mice to validate the role of CFTR in early lung disease. Results: We demonstrate that the C57BL/6 background conferred increased CFTR-mediated Cl- secretion, which was associated with decreased mucus plugging and mortality in neonatal beta ENaC-Tg C57BL/6 compared to beta ENaC-Tg BALB/c mice. Conversely, genetic deletion of CFTR increased early mucus obstruction and mortality in beta ENaC-Tg mice. Conclusions: We conclude that a decrease or absence of CFTR function in airway epithelia aggravates the severity of early airway mucus obstruction and related mortality in beta ENaC-Tg mice. These results suggest that genetic or environmental factors that reduce CFTR activity may contribute to the onset and severity of chronic obstructive pulmonary disease and that CFTR may serve as a novel therapeutic target.	[Johannesson, Bjarki; Hirtz, Stephanie; Schatterny, Jolanthe; Schultz, Carsten; Mall, Marcus A.] Heidelberg Univ, Dept Translat Pulmonol, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Div Pediat Pulmonol & Allergy, Dept Pediat 3, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Cyst Fibrosis Ctr, Dept Pediat 3, Heidelberg, Germany; [Johannesson, Bjarki; Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Johannesson, Bjarki; Schultz, Carsten; Mall, Marcus A.] Heidelberg Univ, Mol Med Partnership Unit, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Johannesson, B (corresponding author), Heidelberg Univ, Dept Translat Pulmonol, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany.	Marcus.Mall@med.uni-heidelberg.de	Mall, Marcus A./AAA-1498-2022	Mall, Marcus A./0000-0002-4057-2199; Schultz, Carsten/0000-0002-5824-2171	German Research Foundation [DFG MA 2081/3-3, MA 2081/4-1]; Federal Ministry of Education and Research (BMBF German Centre for Lung Research [DZL]); European Commission [MEXT-CT-2004-013666]	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF German Centre for Lung Research [DZL]); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the German Research Foundation (DFG MA 2081/3-3 and MA 2081/4-1), the Federal Ministry of Education and Research (BMBF German Centre for Lung Research [DZL]), and the European Commission (MEXT-CT-2004-013666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Anagnostopoulou P, 2010, EUR RESPIR J, V36, P1436, DOI 10.1183/09031936.00181209; Becq F, 2011, J CYST FIBROS, V10, pS129, DOI 10.1016/S1569-1993(11)60018-0; Bodas M, 2011, AM J PHYSIOL-LUNG C, V300, pL811, DOI 10.1152/ajplung.00408.2010; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Boucher Richard C, 2004, Proc Am Thorac Soc, V1, P66, DOI 10.1513/pats.2306018; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Collawn JF, 2012, AM J PHYSIOL-LUNG C, V302, pL1141, DOI 10.1152/ajplung.00036.2012; Cookson William O C, 2011, Proc Am Thorac Soc, V8, P149, DOI 10.1513/pats.201101-003MS; Duerr J, 2011, AM J RESP CELL MOL, V44, P244, DOI 10.1165/rcmb.2009-0115OC; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; GOODMAN RM, 1978, AM REV RESPIR DIS, V117, P205; Grubb BR, 2012, AM J PHYSIOL-LUNG C, V302, pL238, DOI 10.1152/ajplung.00083.2011; HARKEMA JR, 1987, J HISTOCHEM CYTOCHEM, V35, P279, DOI 10.1177/35.3.2434556; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hopf A, 1999, J BIOL CHEM, V274, P13894, DOI 10.1074/jbc.274.20.13894; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kunzelmann K, 2001, CLIN EXP PHARMACOL P, V28, P857, DOI 10.1046/j.1440-1681.2001.03541.x; Livraghi-Butrico A, 2012, PHYSIOL GENOMICS, V44, P470, DOI 10.1152/physiolgenomics.00185.2011; Mall M, 1996, FEBS LETT, V381, P47, DOI 10.1016/0014-5793(96)00079-8; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Mall MA, 2010, J BIOL CHEM, V285, P26945, DOI 10.1074/jbc.M110.151803; Mall MA, 2009, EXP PHYSIOL, V94, P171, DOI 10.1113/expphysiol.2008.042994; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Roth EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024445; Rubenstein RC, 2011, AM J PHYSIOL-LUNG C, V300, pL88, DOI 10.1152/ajplung.00142.2010; SCHERLE W, 1970, Mikroskopie, V26, P57; Silverman Edwin K, 2006, Proc Am Thorac Soc, V3, P405, DOI 10.1513/pats.200603-092AW; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; WELSH MJ, 1983, J CLIN INVEST, V71, P1614, DOI 10.1172/JCI110917; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wielputz MO, 2011, EUR RESPIR J, V38, P1060, DOI 10.1183/09031936.00149810; ZHOU L, 1994, SCIENCE, V266, P1705, DOI 10.1126/science.7527588; Zhou Z, 2011, J CYST FIBROS, V10, pS172, DOI 10.1016/S1569-1993(11)60021-0; Zhou Z, 2008, AM J RESP CRIT CARE, V178, P1245, DOI 10.1164/rccm.200803-442OC	50	40	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e44059	10.1371/journal.pone.0044059	http://dx.doi.org/10.1371/journal.pone.0044059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937152	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500138
J	Sabag, AD; Bode, J; Fink, D; Kigel, B; Kugler, W; Neufeld, G				Sabag, Adi D.; Bode, Julia; Fink, Dorit; Kigel, Boaz; Kugler, Wilfried; Neufeld, Gera			Semaphorin-3D and Semaphorin-3E Inhibit the Development of Tumors from Glioblastoma Cells Implanted in the Cortex of the Brain	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; RECEPTORS; VEGF; NEUROPILIN-1; PROGRESSION; INDUCTION; APOPTOSIS; ISOFORM; GENE	Class-3 semaphorins are secreted axon guidance factors. Some of these semaphorins have recently been characterized as suppressors of tumor progression. To determine if class-3 semaphorins can be used to inhibit the development of glioblastoma-multiforme tumors, we expressed recombinant sema-3A, 3B, 3D, 3E, 3F or 3G in U87MG glioblastoma cells. Sema3A and sema3B expressing cells contracted and changed shape persistently while cells expressing other semaphorins did not. Sema3A and sema3F differed from other semaphorins including sema3B as they also inhibited the proliferation of the cells and the formation of soft agar colonies. With the exception of sema3G and sema3B, expression of these semaphorins in U87MG cells inhibited significantly tumor development from subcutaneously implanted cells. Strong inhibition of tumor development was also observed following implantation of U87MG cells expressing each of the class-3 semaphorins in the cortex of mouse brains. Sema3D and sema3E displayed the strongest inhibitory effects and their expression in U373MG or in U87MG glioblastoma cells implanted in the brains of mice prolonged the survival of the mice by more then two folds. Furthermore, most of the mice that died prior to the end of the experiment did not develop detectable tumors and many of the mice survived to the end of the experiment. Most of the semaphorins that we have used here with the exception of sema3D were characterized previously as inhibitors of angiogenesis. Our results indicate that sema3D also functions as an inhibitor of angiogenesis and suggest that the anti-tumorigenic effects are due primarily to inhibition of tumor angiogenesis. These results indicate that class-3 semaphorins such as sema3D and sema3E could perhaps be used to treat glioblastoma patients.	[Sabag, Adi D.; Fink, Dorit; Kigel, Boaz; Neufeld, Gera] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, IL-31096 Haifa, Israel; [Bode, Julia; Kugler, Wilfried] Univ Gottingen, Dept Pediat Hematol & Oncol, Gottingen, Germany	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Gottingen	Sabag, AD (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, POB 9649, IL-31096 Haifa, Israel.	wkugler@med.uni-goettingen.de; gera@tx.technion.ac.il	Neufeld, Gera/F-1524-2019	Bode, Julia/0000-0002-8081-2425	McDonnel Foundation; Israel-Germany Niedersachsen Foundation; Rappaport Institute for Medical Research	McDonnel Foundation; Israel-Germany Niedersachsen Foundation; Rappaport Institute for Medical Research	This work was funded by grants from the McDonnel Foundation (to GN), Israel-Germany Niedersachsen Foundation (to GN and WK) and the Rappaport Institute for Medical Research (to GN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bagci T, 2009, ONCOGENE, V28, P3537, DOI 10.1038/onc.2009.204; Casazza A, 2012, EMBO MOL MED, V4, P234, DOI 10.1002/emmm.201100205; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; GitayGoren H, 1996, J BIOL CHEM, V271, P5519, DOI 10.1074/jbc.271.10.5519; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P18040, DOI 10.1074/jbc.M909259199; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kigel B, 2011, BLOOD, V118, P4285, DOI 10.1182/blood-2011-03-341388; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Maione F, 2009, J CLIN INVEST, V119, P3356, DOI 10.1172/JCI36308; Moriya J, 2010, CIRC RES, V106, P391, DOI 10.1161/CIRCRESAHA.109.210815; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Salmaggi A, 2003, J NEURO-ONCOL, V62, P297, DOI 10.1023/A:1023367223575; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Vacca A, 2006, BLOOD, V108, P1661, DOI 10.1182/blood-2006-04-014563; Vamesu S, 2007, Rom J Morphol Embryol, V48, P25; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Xiang RH, 2002, CANCER RES, V62, P2637	30	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42912	10.1371/journal.pone.0042912	http://dx.doi.org/10.1371/journal.pone.0042912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936999	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500020
J	Iwasaki, M; Piao, JY; Kimura, A; Sato, S; Inose, H; Ochi, H; Asou, Y; Shinomiya, K; Okawa, A; Takeda, S				Iwasaki, Makiko; Piao, Jinying; Kimura, Ayako; Sato, Shingo; Inose, Hiroyuki; Ochi, Hiroki; Asou, Yoshinori; Shinomiya, Kenichi; Okawa, Atsushi; Takeda, Shu			Runx2 Haploinsufficiency Ameliorates the Development of Ossification of the Posterior Longitudinal Ligament	PLOS ONE			English	Article							SPINAL LIGAMENT; CHONDROCYTE DIFFERENTIATION; CBFA1; ASSOCIATION; CELLS; POLYMORPHISM; EXPRESSION; PROTEINS; GENE	Ossification of the Posterior Longitudinal Ligament (OPLL) is a disease that is characterized by the ectopic calcification of the ligament; however, the pathogenesis of OPLL remains to be investigated. We attempted to identify the in vivo role of Runx2, a master regulator of osteoblast differentiation and skeletal mineralization, in the pathogenesis of OPLL. The expression of Runx2 in the ligament was examined using in situ hybridization and immunohistochemistry and by monitoring the activity of a LacZ gene that was inserted into the Runx2 gene locus. To investigate the functional role of Runx2, we studied ENPP1(ttw/ttw) mice, a mouse model of OPLL, that were crossed with heterozygous Runx2 mice to decrease the expression of Runx2, and we performed histological and quantitative radiological analyses using 3D-micro CT. Runx2 was expressed in the ligament of wild-type mice. The induction of Runx2 expression preceded the development of ectopic calcification in the OPLL-like region of the ENPP1(ttw/ttw) mice. Runx2 haploinsufficiency ameliorated the development of ectopic calcification in the ENPP1(ttw/ttw) mice. Collectively, this study demonstrated that Runx2 is expressed in an OPLL-like region, and its elevation is a prerequisite for developing the complete OPLL-like phenotype in a mouse model of OPLL.	[Iwasaki, Makiko; Piao, Jinying; Sato, Shingo; Inose, Hiroyuki; Asou, Yoshinori; Shinomiya, Kenichi; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthoped Surg, Tokyo, Japan; [Kimura, Ayako; Ochi, Hiroki] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Takeda, Shu] Keio Univ, Sch Med, Dept Internal Med, Sect Nephrol Endocrinol & Metab, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Keio University	Iwasaki, M (corresponding author), Tokyo Med & Dent Univ, Dept Orthoped Surg, Tokyo, Japan.	shu-tky@umin.ac.jp		INOSE, HIROYUKI/0000-0003-4195-2545	Funding Program for Next Generation World-Leading Researchers (NEXT Program); Japan Society for the Promotion of Science; Global Center of Excellence Program from Ministry of Education, Culture, Sports, Science	Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence Program from Ministry of Education, Culture, Sports, Science	The work was supported by Funding Program for Next Generation World-Leading Researchers (NEXT Program), grant-in-aid for scientific research from the Japan Society for the Promotion of Science and a grant for Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Horikoshi T, 2006, HUM GENET, V119, P611, DOI 10.1007/s00439-006-0170-9; Ikeda R, 2005, J BIOL CHEM, V280, P8523, DOI 10.1074/jbc.M409442200; Inamasu J, 2006, NEUROSURGERY, V58, P1027, DOI 10.1227/01.NEU.0000215867.87770.73; Iwasaki K, 2004, CALCIFIED TISSUE INT, V74, P448, DOI 10.1007/s00223-002-0021-1; Kamiya M, 2001, SPINE, V26, P1264, DOI 10.1097/00007632-200106010-00017; Kim DH, 2011, CYTOKINE, V55, P343, DOI 10.1016/j.cyto.2011.05.016; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kishiya M, 2008, J PHARMACOL SCI, V106, P404, DOI 10.1254/jphs.FP0072043; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Kong QQ, 2007, SPINE, V32, P2834, DOI 10.1097/BRS.0b013e31815b761c; Liu Y, 2010, CLIN ORTHOP RELAT R, V468, P3333, DOI 10.1007/s11999-010-1511-5; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ren Y, 2011, J ORTHOP RES; Sakou T, 2000, J Orthop Sci, V5, P310, DOI 10.1007/s007760050169; Sato S, 2008, ARTHRITIS RHEUM, V58, P2764, DOI 10.1002/art.23805; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tanaka H, 2001, RHEUMATOLOGY, V40, P1163, DOI 10.1093/rheumatology/40.10.1163; Tanno M, 2003, BONE, V33, P475, DOI 10.1016/S8756-3282(03)00204-7; YASUI N, 1983, CALCIFIED TISSUE INT, V35, P159, DOI 10.1007/BF02405024; Yoshizawa T, 2004, MOL CELL BIOL, V24, P3460, DOI 10.1128/MCB.24.8.3460-3472.2004	22	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43372	10.1371/journal.pone.0043372	http://dx.doi.org/10.1371/journal.pone.0043372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927960	Green Submitted, Green Published, gold			2022-12-27	WOS:000307789700031
J	Li, CC; Wu, TS; Huang, CF; Jang, LT; Liu, YT; You, ST; Liou, GG; Lee, FJS				Li, Chun-Chun; Wu, Tsung-Sheng; Huang, Chun-Fang; Jang, Li-Ting; Liu, Yu-Tsan; You, Shu-Ting; Liou, Gunn-Guang; Lee, Fang-Jen S.			GTP-Binding-Defective ARL4D Alters Mitochondrial Morphology and Membrane Potential	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; SMALL G-PROTEINS; PLASMA-MEMBRANE; ARF FAMILY; CELL-DEATH; ENDOPLASMIC-RETICULUM; NUCLEOTIDE EXCHANGE; SAR PROTEINS; DOMAIN; TRANSPORT	ARL4D, ARL4A, and ARL4C are closely related members of the ADP-ribosylation factor/ARF-like protein (ARF/ARL) family of GTPases. All three ARL4 proteins contain nuclear localization signals (NLSs) at their C-termini and are primarily found at the plasma membrane, but they are also present in the nucleus and cytoplasm. ARF function and localization depends on their controlled binding and hydrolysis of GTP. Here we show that GTP-binding-defective ARL4D is targeted to the mitochondria, where it affects mitochondrial morphology and function. We found that a portion of endogenous ARL4D and the GTP-binding-defective ARL4D mutant ARL4D(T35N) reside in the mitochondria. The N-terminal myristoylation of ARL4D(T35N) was required for its localization to mitochondria. The localization of ARL4D(T35N) to the mitochondria reduced the mitochondrial membrane potential (Delta Psi m) and caused mitochondrial fragmentation. Furthermore, the C-terminal NLS region of ARL4D(T35N) was required for its effect on the mitochondria. This study is the first to demonstrate that the dysfunctional GTP-binding-defective ARL4D is targeted to mitochondria, where it subsequently alters mitochondrial morphology and membrane potential.	[Li, Chun-Chun; Wu, Tsung-Sheng; Huang, Chun-Fang; Jang, Li-Ting; Liu, Yu-Tsan; You, Shu-Ting; Lee, Fang-Jen S.] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Jang, Li-Ting; Lee, Fang-Jen S.] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Liou, Gunn-Guang] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Li, CC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan.	fangjen@ntu.edu.tw	Liou, Gunn‐Guang/AAI-9787-2020; Liou, Gan-Guang/E-3976-2010	Li, Chun-Chun/0000-0002-3601-838X; LEE, FANG-JEN/0000-0002-2167-2426; Liou, Gan-Guang/0000-0002-2619-8516	National Science Council, Taiwan [NSC 97-3112-B-002-016, NSC-1002325-B-022-028]; National Taiwan University Hospital [99P21-1]; Yung-Shin Biomedical Research Fund [YSP-86-019]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); Yung-Shin Biomedical Research Fund	This work was supported by grants from the National Science Council, Taiwan (NSC 97-3112-B-002-016, NSC-1002325-B-022-028), National Taiwan University Hospital (99P21-1), and the Yung-Shin Biomedical Research Fund (YSP-86-019) to F.-J.S. Lee. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Briere JJ, 2004, BBA-BIOENERGETICS, V1659, P172, DOI 10.1016/j.bbabio.2004.07.002; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Grimm S, 2007, APOPTOSIS, V12, P841, DOI 10.1007/s10495-007-0747-3; Hall B, 2008, ANAL BIOCHEM, V374, P243, DOI 10.1016/j.ab.2007.11.032; Harroun TA, 2005, BBA-BIOMEMBRANES, V1668, P138, DOI 10.1016/j.bbamem.2004.12.003; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Jacobs S, 1999, FEBS LETT, V456, P384, DOI 10.1016/S0014-5793(99)00759-0; Jian X, 2010, MODIFICATIONS C TERM; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; KAHN RA, 1992, J BIOL CHEM, V267, P13039; Katayama T, 2004, CELL MOL NEUROBIOL, V24, P137, DOI 10.1023/B:CEMN.0000012719.12015.ec; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Lin CY, 2000, J BIOL CHEM, V275, P37815, DOI 10.1074/jbc.M002470200; Lin CY, 2002, J CELL SCI, V115, P4433, DOI 10.1242/jcs.00123; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; MOORE KJM, 1993, BIOCHEMISTRY-US, V32, P7451, DOI 10.1021/bi00080a016; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pacheco-Rodriguez G, 1998, J BIOL CHEM, V273, P26543, DOI 10.1074/jbc.273.41.26543; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Vitale N, 1998, J BIOL CHEM, V273, P2553, DOI 10.1074/jbc.273.5.2553; Webster P, 2008, METHOD CELL BIOL, V88, P45, DOI 10.1016/S0091-679X(08)00403-2; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200; Zhou J, 2007, J BIOL CHEM, V282, P7482, DOI 10.1074/jbc.M608289200	41	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43552	10.1371/journal.pone.0043552	http://dx.doi.org/10.1371/journal.pone.0043552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927989	Green Submitted, Green Published, gold			2022-12-27	WOS:000307789700039
J	Sun, L; Yau, HY; Wong, WY; Li, RA; Huang, Y; Yao, XQ				Sun, Lei; Yau, Ho-Yan; Wong, Wei-Yan; Li, Ronald A.; Huang, Yu; Yao, Xiaoqiang			Role of TRPM2 in H2O2-Induced Cell Apoptosis in Endothelial Cells	PLOS ONE			English	Article							PEROXIDE-INDUCED TOXICITY; KAPPA-B ACTIVATION; HYDROGEN-PEROXIDE; ADP-RIBOSE; OXIDATIVE STRESS; CATION CHANNEL; ION-CHANNEL; INOSITOL 1,4,5-TRISPHOSPHATE; CALCIUM INFLUX; CA2+ INFLUX	Melastatin-like transient receptor potential channel 2 (TRPM2) is an oxidant-sensitive and cationic non-selective channel that is expressed in mammalian vascular endothelium. Here we investigated the functional role of TRPM2 channels in hydrogen peroxide (H2O2)-induced cytosolic Ca2+([Ca2+](i)) elavation, whole-cell current increase, and apoptotic cell death in murine heart microvessel endothelial cell line H5V. A TRPM2 blocking antibody (TM2E3), which targets the E3 region near the ion permeation pore of TRPM2, was developed. Treatment of H5V cells with TM2E3 reduced the [Ca2+](i) rise and whole-cell current change in response to H2O2. Suppressing TRPM2 expression using TRPM2-specific short hairpin RNA (shRNA) had similar inhibitory effect. H2O2-induced apoptotic cell death in H5V cells was examined using MTT assay, DNA ladder formation analysis, and DAPI-based nuclear DNA condensation assay. Based on these assays, TM2E3 and TRPM2-specific shRNA both showed protective effect against H2O2-induced apoptotic cell death. TM2E3 and TRPM2-specific shRNA also protect the cells from tumor necrosis factor (TNF)-alpha-induced cell death in MTT assay. In contrast, overexpression of TRPM2 in H5V cells resulted in an increased response in [Ca2+](i) and whole-cell currents to H2O2. TRPM2 overexpression also aggravated the H2O2-induced apoptotic cell death. Downstream pathways following TRPM2 activation was examined. Results showed that TRPM2 activity stimulated caspase-8, caspase-9 and caspase-3. These findings strongly suggest that TRPM2 channel mediates cellular Ca2+ overload in response to H2O2 and contribute to oxidant-induced apoptotic cell death in vascular endothelial cells. Down-regulating endogenous TRPM2 could be a means to protect the vascular endothelial cells from apoptotic cell death.	[Sun, Lei; Yau, Ho-Yan; Wong, Wei-Yan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Sun, Lei; Yau, Ho-Yan; Wong, Wei-Yan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Ronald A.] Univ Hong Kong, Stem Cell & Regenerat Med Consortium, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Sun, L (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk	Huang, Yu/K-2866-2017; Yao, Xiaoqiang/I-5413-2016	Huang, Yu/0000-0002-1277-6784; Yao, Xiaoqiang/0000-0002-0687-8186	Hong Kong RGC [CUHK477408, CUHK479109, CUHK478710]; Chinese University of Hong Kong; National Science Foundation of China [31171100]	Hong Kong RGC(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants CUHK477408, CUHK479109, and CUHK478710 from Hong Kong RGC, Strategic Investment Scheme C and Group Research Grant from Chinese University of Hong Kong, and National Science Foundation of China grant 31171100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Brown RC, 2008, MICROCIRCULATION, V15, P359, DOI 10.1080/10739680701762656; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; DOAN TN, 1994, BIOCHEM J, V297, P209, DOI 10.1042/bj2970209; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Graham S, 2006, J BIOL CHEM, V285, P23466; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hu QH, 2000, J BIOL CHEM, V275, P15749, DOI 10.1074/jbc.M000381200; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kouoh F, 1999, FARMACO, V54, P695, DOI 10.1016/S0014-827X(99)00082-8; Leung PC, 2006, J VASC RES, V43, P367, DOI 10.1159/000094096; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Marasa BS, 2006, BIOCHEM J, V397, P77, DOI 10.1042/BJ20060124; Naziroglu M, 2008, NEUROCHEM RES, V33, P1256, DOI 10.1007/s11064-007-9577-5; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schwerdt G, 2005, TOXICOL SCI, V85, P735, DOI 10.1093/toxsci/kfi117; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Telo P, 1998, J BIOL CHEM, V273, P17565, DOI 10.1074/jbc.273.28.17565; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Waxman AB, 2003, AM J RESP CELL MOL, V29, P513, DOI 10.1165/rcmb.2002-0044OC; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200; Zhang WY, 2006, AM J PHYSIOL-CELL PH, V290, pC1146, DOI 10.1152/ajpcell.00205.2005; Zheng Y, 2005, REDOX REP, V10, P29, DOI 10.1179/135100005X21660	42	52	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43186	10.1371/journal.pone.0043186	http://dx.doi.org/10.1371/journal.pone.0043186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916222	gold, Green Submitted, Green Published			2022-12-27	WOS:000307733800052
J	Colas, S; Afoufa-Bastien, D; Jacquens, L; Clement, C; Baillieul, F; Mazeyrat-Gourbeyre, F; Monti-Dedieu, L				Colas, Steven; Afoufa-Bastien, Damien; Jacquens, Lucile; Clement, Christophe; Baillieul, Fabienne; Mazeyrat-Gourbeyre, Florence; Monti-Dedieu, Laurence			Expression and In Situ Localization of Two Major PR Proteins of Grapevine Berries during Development and after UV-C Exposition	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEINS; DEFENSE-RELATED PROTEINS; PROTEOMIC ANALYSIS; GENE-EXPRESSION; STRUCTURAL-ANALYSIS; XYLEM SAP; CHITINASE; FRUIT; ACCUMULATION; PURIFICATION	In grapevine Vitis vinifera L. cv Pinot noir, the Pathogenesis-Related (PR) proteins CHI4D and TL3 are among the most abundant extractable PR proteins of ripe berries and accumulate during berry ripening from veraison until full maturation. Evidence was supplied in favor of the involvement of these two protein families in plant defense mechanisms and plant development. In order to better understand CHI4D and TL3 function in grapevine, we analyzed their temporal and spatial pattern of expression during maturation and after an abiotic stress (UV-C) by in situ hybridization (ISH) and immunohistolocalization. In ripening berries, CHI4D and TL3 genes were mainly expressed in the exocarp and around vascular bundles of the mesocarp. In UV-C exposed berries, CHI4D and TL3 gene expression was strongly induced before veraison. Corresponding proteins localized in the exocarp and, to a lesser extent, around vascular bundles of the mesocarp. The spatial and temporal accumulation of the two PR proteins during berry maturation and after an abiotic stress is discussed in relation to their putative roles in plant defense.	[Colas, Steven; Afoufa-Bastien, Damien; Jacquens, Lucile; Clement, Christophe; Baillieul, Fabienne; Mazeyrat-Gourbeyre, Florence; Monti-Dedieu, Laurence] Univ Reims, UFR Sci Exactes & Nat, Lab Stress Def & Reprod Plantes, Unite Rech Vignes & Vins Champagne,EA 4707, Reims, France	Universite de Reims Champagne-Ardenne	Colas, S (corresponding author), Univ Reims, UFR Sci Exactes & Nat, Lab Stress Def & Reprod Plantes, Unite Rech Vignes & Vins Champagne,EA 4707, BP 1039, Reims, France.	florence.gourbeyre@univ-reims.fr		JACQUENS, Lucile/0000-0001-7102-5836	Champagne Ardenne Area; FEDER (Fonds Europeen de Developpement Regional)	Champagne Ardenne Area; FEDER (Fonds Europeen de Developpement Regional)(European Commission)	This work was supported by a fund from the Champagne Ardenne Area and the FEDER (Fonds Europeen de Developpement Regional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad LR, 1996, PLANT SCI, V118, P11, DOI 10.1016/0168-9452(96)04420-2; Aguero CB, 2008, AM J ENOL VITICULT, V59, P306; Anzlovar S, 2003, PLANT BIOLOGY, V5, P116, DOI 10.1055/s-2003-40723; Barre A, 2000, PLANTA, V211, P791, DOI 10.1007/s004250000354; Castro AJ, 2005, J EXP BOT, V56, P2783, DOI 10.1093/jxb/eri271; Castro AJ, 2008, PHYSIOL PLANTARUM, V134, P453, DOI 10.1111/j.1399-3054.2008.01151.x; Chatelet DS, 2011, ANN BOT-LONDON, V108, P73, DOI 10.1093/aob/mcr106; CHELLEMI DO, 1992, AM J ENOL VITICULT, V43, P53; Choudhury SR, 2009, PLANT CELL REP, V28, P1641, DOI 10.1007/s00299-009-0764-5; Colas S, 2010, METHODOLOGIES AND RESULTS IN GRAPEVINE RESEARCH, P361, DOI 10.1007/978-90-481-9283-0_26; Dafoe NJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-191; Dafoe NJ, 2009, PHYTOCHEMISTRY, V70, P856, DOI 10.1016/j.phytochem.2009.04.016; Davies C, 2000, PLANT PHYSIOL, V122, P803, DOI 10.1104/pp.122.3.803; DELP CJ, 1954, PHYTOPATHOLOGY, V44, P615; Derckel JP, 1996, PLANT SCI, V119, P31, DOI 10.1016/0168-9452(96)04459-7; Derckel JP, 1998, PHYSIOL PLANTARUM, V104, P56, DOI 10.1034/j.1399-3054.1998.1040108.x; Deytieux C, 2007, J EXP BOT, V58, P1851, DOI 10.1093/jxb/erm049; Dhekney SA, 2011, IN VITRO CELL DEV-PL, V47, P458, DOI 10.1007/s11627-011-9358-3; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; Elad Y., 2004, BOTRYTIS BIOL PATHOL, P119, DOI [10.1007/978-1-4020-2626-3, DOI 10.1007/978-1-4020-2626-3]; Fey SJ, 1997, ELECTROPHORESIS, V18, P1361, DOI 10.1002/elps.1150180811; FilsLycaon BR, 1996, PLANT PHYSIOL, V111, P269, DOI 10.1104/pp.111.1.269; GIANINAZZI S, 1970, CR ACAD SCI D NAT, V270, P2383; Goni O, 2010, POSTHARVEST BIOL TEC, V55, P169, DOI 10.1016/j.postharvbio.2009.11.001; GRAHAM LS, 1994, CAN J BOT, V72, P1057, DOI 10.1139/b94-132; Grenier J, 1999, PLANT J, V19, P473, DOI 10.1046/j.1365-313X.1999.00551.x; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Jacobs AK, 1999, PLANT PATHOL, V48, P325, DOI 10.1046/j.1365-3059.1999.00343.x; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Kavroulakis N, 2006, ANN BOT-LONDON, V98, P555, DOI 10.1093/aob/mcl149; Kim YS, 2002, PLANT MOL BIOL, V49, P125, DOI 10.1023/A:1014995732171; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Libantova J, 2009, MOL BIOL REP, V36, P851, DOI 10.1007/s11033-008-9254-z; Liljeroth E, 2005, J PHYTOPATHOL, V153, P702, DOI 10.1111/j.1439-0434.2005.01043.x; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Manteau S, 2003, AM J ENOL VITICULT, V54, P267; Manteau S, 2003, THESIS U REIMS CHAMP; MAUCH F, 1989, PLANT CELL, V1, P447, DOI 10.2307/3869105; Meier U., 2001, BBCH MONOGRAFIE, P93; Monteiro S, 2003, PHYTOPATHOLOGY, V93, P1505, DOI 10.1094/PHYTO.2003.93.12.1505; Monteiro S, 2003, J AGR FOOD CHEM, V51, P4046, DOI 10.1021/jf020456v; Negri AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-378; Nobrega FM, 2005, PLANT SOIL, V272, P223, DOI 10.1007/s11104-004-4954-1; Palmisano G, 2010, J PROTEOME RES, V9, P6148, DOI 10.1021/pr100298j; Petit AN, 2009, J EXP BOT, V60, P1155, DOI 10.1093/jxb/ern361; Peumans WJ, 2000, EUR J BIOCHEM, V267, P1188, DOI 10.1046/j.1432-1327.2000.01117.x; Pezet R, 2004, ADV PLANT PHYSIOL, V7, P71; Pocock K. F., 1998, Australian Journal of Grape and Wine Research, V4, P23, DOI 10.1111/j.1755-0238.1998.tb00131.x; Pocock KF, 2000, J AGR FOOD CHEM, V48, P1637, DOI 10.1021/jf9905626; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; Robert N, 2002, PLANT SCI, V162, P389, DOI 10.1016/S0168-9452(01)00576-3; Robinson SP, 1997, PLANT PHYSIOL, V114, P771, DOI 10.1104/pp.114.3.771; Roper MC, 2011, MOL PLANT PATHOL, V12, P628, DOI [10.1111/j.1364-3703.2010.00698.x, 10.1111/J.1364-3703.2010.00698.X]; Salzman RA, 1998, PLANT PHYSIOL, V117, P465, DOI 10.1104/pp.117.2.465; Sarry JE, 2004, PROTEOMICS, V4, P201, DOI 10.1002/pmic.200300499; Sassa H, 1998, PLANTA, V205, P514, DOI 10.1007/s004250050350; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; Taira T, 2005, BIOSCI BIOTECH BIOCH, V69, P852, DOI 10.1271/bbb.69.852; Tattersall DB, 1997, PLANT PHYSIOL, V114, P759, DOI 10.1104/pp.114.3.759; ten Have A, 2010, FUNGAL GENET BIOL, V47, P53, DOI 10.1016/j.fgb.2009.10.008; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANLOON LC, 1970, VIROLOGY, V40, P199, DOI 10.1016/0042-6822(70)90395-8; Waters EJ, 1996, J AGR FOOD CHEM, V44, P3, DOI 10.1021/jf9505584; Waters EJ, 1998, J AGR FOOD CHEM, V46, P4950, DOI 10.1021/jf980421o; Yamamoto T, 2000, PLANT CELL REP, V19, P639, DOI 10.1007/s002999900174; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	66	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43681	10.1371/journal.pone.0043681	http://dx.doi.org/10.1371/journal.pone.0043681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937077	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500079
J	Han, XB; Tachado, SD; Koziel, H; Boisvert, WA				Han, Xinbing; Tachado, Souvenir D.; Koziel, Henry; Boisvert, William A.			Leu128(3.43) (L128) and Val247(6.40) (V247) of CXCR1 Are Critical Amino Acid Residues for G Protein Coupling and Receptor Activation	PLOS ONE			English	Article							SMALL-MOLECULE ANTAGONISTS; CHEMOKINE RECEPTORS; CONSTITUTIVE ACTIVATION; CRYSTAL-STRUCTURE; IN-VITRO; INTERLEUKIN-8; IDENTIFICATION; RHODOPSIN; TARGETS; BINDING	CXCR1, a classic GPCR that binds IL-8, plays a key role in neutrophil activation and migration by activating phospholipase C (PLC)beta through G alpha(15) and G alpha(i) which generates diacylglycerol and inositol phosphates (IPs). In this study, two conserved amino acid residues of CXCR1 on the transmembrane domain (TM) 3 and TM6, Leu128(3.43) (L128) and Val247(6.40) (V247), respectively, were selectively substituted with other amino acids to investigate the role of these conserved residues in CXCR1 activation. Although two selective mutants on Leu128, Leu128Ala (L128A) and Leu128Arg (L128R), demonstrated high binding affinity to IL-8, they were not capable of coupling to G proteins and consequently lost the functional response of the receptors. By contrast, among the four mutants at residue Val247 (TM6.40), replacing Val247 with Ala (V247A) and Asn (V247N) led to constitutive activation of mutant receptors when cotransfected with G alpha(15). The V247N mutant also constitutively activated the G alpha(i) protein. These results indicate that L128 on TM3.43 is involved in G protein coupling and receptor activation but is unimportant for ligand binding. On the other hand, V247 on TM6.40 plays a critical role in maintaining the receptor in the inactive state, and the substitution of V247 impaired the receptor constraint and stabilized an active conformation. Functionally, there was an increase in chemotaxis in response to IL-8 in cells expressing V247A and V247N. Our findings indicate that Leu128(3.43) and Val247(6.40) are critical for G protein coupling and activation of signaling effectors, providing a valuable insight into the mechanism of CXCR1 activation.	[Han, Xinbing; Tachado, Souvenir D.; Koziel, Henry] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA; [Han, Xinbing; Boisvert, William A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Vasc Med, Cambridge, MA 02138 USA; [Boisvert, William A.] Univ Hawaii, Cardiovasc Res Ctr, John A Burns Sch Med, Honolulu, HI 96822 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Hawaii System	Han, XB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA.	xhan@rics.bwh.harvard.edu; wab@hawaii.edu		Tachado, Souvenir/0000-0002-8368-6102	National Institutes of Health [R01HL081863, R01HL075677, R01HL063655, R01HL092811]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092811, R01HL063655, R01HL081863, R01HL075677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants (R01HL081863 and R01HL075677 to WAB, R01HL063655 to HK, and R01HL092811 to ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker RA, 2008, MOL PHARMACOL, V73, P94, DOI 10.1124/mol.107.038547; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Bertini R, 2004, P NATL ACAD SCI USA, V101, P11791, DOI 10.1073/pnas.0402090101; Bizzarri C, 2006, PHARMACOL THERAPEUT, V112, P139, DOI 10.1016/j.pharmthera.2006.04.002; Burke SM, 2008, BLOOD, V111, P5467, DOI 10.1182/blood-2007-10-118547; Burnett LA, 2010, J BIOL CHEM, V285, P33662, DOI 10.1074/jbc.M110.156075; Busch-Petersen J, 2006, CURR TOP MED CHEM, V6, P1345, DOI 10.2174/15680266106061345; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Damaj BB, 1996, FASEB J, V10, P1426, DOI 10.1096/fasebj.10.12.8903513; Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510; Fuhrer D, 1997, J CLIN ENDOCR METAB, V82, P4234, DOI 10.1210/jc.82.12.4234; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Han XB, 2009, J BIOL CHEM, V284, P32950, DOI 10.1074/jbc.M109.040899; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; Latronico AC, 2007, MOL CELL ENDOCRINOL, V260, P287, DOI 10.1016/j.mce.2005.11.053; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Luttichau HR, 2010, J BIOL CHEM, V285, P9137, DOI 10.1074/jbc.M109.002774; Munoz LM, 2009, J IMMUNOL, V183, P7337, DOI 10.4049/jimmunol.0901802; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Nasser MW, 2007, J BIOL CHEM, V282, P6906, DOI 10.1074/jbc.M610289200; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Panina P, 2006, CURR DRUG TARGETS, V7, P669, DOI 10.2174/138945006777435272; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Richardson RM, 2003, J IMMUNOL, V170, P2904, DOI 10.4049/jimmunol.170.6.2904; Robinson SW, 1996, J NEUROCHEM, V67, P212; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sabroe I, 2007, NAT MED, V13, P1417, DOI 10.1038/nm1207-1417; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shamaladevi N, 2009, CANCER RES, V69, P8265, DOI 10.1158/0008-5472.CAN-09-0374; Sharma B, 2010, EXPERT OPIN THER TAR, V14, P435, DOI 10.1517/14728221003652471; Singh RK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-57; Singh S, 2009, BRIT J CANCER, V100, P1638, DOI 10.1038/sj.bjc.6605055; Singh S, 2009, CLIN CANCER RES, V15, P2380, DOI 10.1158/1078-0432.CCR-08-2387; Snelgrove RJ, 2011, EUR J PHARMACOL, V667, P1, DOI 10.1016/j.ejphar.2011.05.073; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Vauquelin G, 2005, FUND CLIN PHARMACOL, V19, P45, DOI 10.1111/j.1472-8206.2005.00319.x; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; White CD, 2008, MOL ENDOCRINOL, V22, P2520, DOI 10.1210/me.2008-0122; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Xie W, 1997, J BIOL CHEM, V272, P24948, DOI 10.1074/jbc.272.40.24948; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhao XX, 2009, J IMMUNOL, V182, P3213, DOI 10.4049/jimmunol.0800551	60	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42765	10.1371/journal.pone.0042765	http://dx.doi.org/10.1371/journal.pone.0042765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22936990	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500016
J	Lu, K; Chakroborty, D; Sarkar, C; Lu, TT; Xie, ZL; Liu, ZF; Basu, S				Lu, Kai; Chakroborty, Debanjan; Sarkar, Chandrani; Lu, Tingting; Xie, Zhiliang; Liu, Zhongfa; Basu, Sujit			Triphala and Its Active Constituent Chebulinic Acid Are Natural Inhibitors of Vascular Endothelial Growth Factor-A Mediated Angiogenesis	PLOS ONE			English	Article							AYURVEDIC FORMULATION; ELLAGIC ACID; GALLIC ACID; CANCER; PERMEABILITY; CELLS; BIOAVAILABILITY; COMPOUND; DISEASE; BREAST	Triphala churna (THL) is a combination of three fruits that has been used for many years in India for the treatment of various diseases. There are now reports which indicate that THL can inhibit growth of malignant tumors in animals. However, the mechanisms by which THL mediates its anti-tumor actions are still being explored. Because vascular endothelial growth factor-A (VEGF) induced angiogenesis plays a critical role in the pathogenesis of cancer, we therefore investigated whether tumor inhibitory effects of THL or its active constituents are through suppression of VEGF actions. We herein report that THL and chebulinic (CI) present in THL can significantly and specifically inhibit VEGF induced angiogenesis by suppressing VEGF receptor-2 (VEGFR-2) phosphorylation. These results are of clinical significance as these inexpensive and non-toxic natural products can be used for the prevention and treatment of diseases where VEGF induced angiogenesis has an important role.	[Lu, Kai; Chakroborty, Debanjan; Sarkar, Chandrani; Lu, Tingting; Basu, Sujit] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Xie, Zhiliang; Liu, Zhongfa] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA; [Liu, Zhongfa; Basu, Sujit] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Basu, Sujit] Ohio State Univ, Dorthy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lu, K (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	sujit.basu@osumc.edu	Liu, Zhongfa/G-8549-2013		National Institutes of Health, United States of America [R01 CA124763]; NATIONAL CANCER INSTITUTE [R01CA124763] Funding Source: NIH RePORTER	National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health, United States of America Grant R01 CA124763 to SB. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonescu CR, 2009, CANCER RES, V69, P7175, DOI 10.1158/0008-5472.CAN-09-2068; Baliga MS, 2010, J ALTERN COMPLEM MED, V16, P1301, DOI 10.1089/acm.2009.0633; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Bhattacharya Resham, 2008, J Mol Signal, V3, P14, DOI 10.1186/1750-2187-3-14; Blanchet B, 2010, EXPERT OPIN DRUG SAF, V9, P275, DOI 10.1517/14740330903510608; Chakroborty D, 2011, P NATL ACAD SCI USA, V108, P20730, DOI 10.1073/pnas.1108696108; Deep G, 2005, J EXP CLIN CANC RES, V24, P555; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hussain S, 2008, ANGIOGENESIS, V11, P245, DOI 10.1007/s10456-008-9108-2; Istivan TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024809; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k; Kumar B, 2011, ANGIOGENESIS, V14, P371, DOI 10.1007/s10456-011-9221-5; Labrecque L, 2005, CARCINOGENESIS, V26, P821, DOI 10.1093/carcin/bgi024; Li LX, 2011, APPL ENVIRON MICROB, V77, P2640, DOI 10.1128/AEM.01460-10; London CA, 2003, CANCER GENE THER, V10, P823, DOI 10.1038/sj.cgt.7700642; Mulder K, 2011, EXPERT OPIN BIOL TH, V11, P405, DOI 10.1517/14712598.2011.557657; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; Pal S, 2000, MICROVASC RES, V60, P112, DOI 10.1006/mvre.2000.2246; Pawar V, 2009, INDIAN J PHARM SCI, V71, P382, DOI 10.4103/0250-474X.57286; Pyun BJ, 2008, CANCER RES, V68, P227, DOI 10.1158/0008-5472.CAN-07-2799; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Russell LH, 2011, ANTICANCER RES, V31, P3739; Sandhya T, 2006, CANCER LETT, V231, P206, DOI 10.1016/j.canlet.2005.01.035; Sarkar C, 2008, CLIN CANCER RES, V14, P2502, DOI 10.1158/1078-0432.CCR-07-1778; Seeram NP, 2004, CLIN CHIM ACTA, V348, P63, DOI 10.1016/j.cccn.2004.04.029; Shi Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-294; Singh DP, 2008, PHYTOCHEM ANALYSIS, V19, P164, DOI 10.1002/pca.1032; SMART RC, 1986, CARCINOGENESIS, V7, P1663, DOI 10.1093/carcin/7.10.1663; Wang ZY, 2012, EXPERT OPIN THER TAR, V16, pS79, DOI 10.1517/14728222.2011.642371; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421	33	32	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43934	10.1371/journal.pone.0043934	http://dx.doi.org/10.1371/journal.pone.0043934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937129	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500125
J	Manceau, V; Kremmer, E; Nabel, EG; Maucuer, A				Manceau, Valerie; Kremmer, Elisabeth; Nabel, Elizabeth G.; Maucuer, Alexandre			The Protein Kinase KIS Impacts Gene Expression during Development and Fear Conditioning in Adult Mice	PLOS ONE			English	Article							SPLICING FACTOR SF1; PREPULSE INHIBITION; RNA; SCHIZOPHRENIA; RECOGNITION; SUSCEPTIBILITY; COMPLEX; UHMK1; U2AF; TRANSCRIPTION	The brain-enriched protein kinase KIS (product of the gene UHMK1) has been shown to phosphorylate the human splicing factor SF1 in vitro. This phosphorylation in turn favors the formation of a U2AF(65)-SF1-RNA complex which occurs at the 3' end of introns at an early stage of spliceosome assembly. Here, we analyzed the effects of KIS knockout on mouse SF1 phosphorylation, physiology, adult behavior, and gene expression in the neonate brain. We found SF1 isoforms are differently expressed in KIS-ko mouse brains and fibroblasts. Re-expression of KIS in fibroblasts restores a wild type distribution of SF1 isoforms, confirming the link between KIS and SF1. Microarray analysis of transcripts in the neonate brain revealed a subtle down-regulation of brain specific genes including cys-loop ligand-gated ion channels and metabolic enzymes. Q-PCR analyses confirmed these defects and point to an increase of pre-mRNA over mRNA ratios, likely due to changes in splicing efficiency. While performing similarly in prepulse inhibition and most other behavioral tests, KIS-ko mice differ in spontaneous activity and contextual fear conditioning. This difference suggests that disregulation of gene expression due to KIS inactivation affects specific brain functions.	[Manceau, Valerie; Maucuer, Alexandre] INSERM, UMR S 839, Paris, France; [Manceau, Valerie; Maucuer, Alexandre] Univ Paris 06, Paris, France; [Manceau, Valerie; Maucuer, Alexandre] Inst Fer Moulin, Paris, France; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Nabel, Elizabeth G.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Nabel, Elizabeth G.] Harvard Univ, Sch Med, Boston, MA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Manceau, V (corresponding author), INSERM, UMR S 839, Paris, France.	alexandre.maucuer@inserm.fr	Maucuer, Alexandre/B-1069-2019	Maucuer, Alexandre/0000-0003-2947-6654	Institut National de la Sante et de la Recherche Medicale (INSERM); University Pierre et Marie Curie; Brain and Behavior Research Foundation	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Pierre et Marie Curie; Brain and Behavior Research Foundation	This work was funded by the Institut National de la Sante et de la Recherche Medicale (INSERM), the University Pierre et Marie Curie and The Brain and Behavior Research Foundation (NARSAD 2007 award to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Alexander R, 2010, BIOCHEM SOC T, V38, P1251, DOI 10.1042/BST0381251; Arning S, 1996, RNA, V2, P794; Begou M, 2008, NEUROSCIENCE, V157, P29, DOI 10.1016/j.neuroscience.2008.07.080; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Betcheva ET, 2009, J HUM GENET, V54, P98, DOI 10.1038/jhg.2008.14; Bieche I, 2003, MOL BRAIN RES, V114, P55, DOI 10.1016/S0169-328X(03)00132-3; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Bristow GC, 2009, BRAIN RES, V1301, P197, DOI 10.1016/j.brainres.2009.08.090; Caldwell BD, 1999, J BIOL CHEM, V274, P34646, DOI 10.1074/jbc.274.49.34646; Cambray S, 2009, MOL CELL BIOL, V29, P726, DOI 10.1128/MCB.01180-08; Dumaine A, 2011, PSYCHIAT GENET, V21, P315, DOI 10.1097/YPG.0b013e3283458a37; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Guth S, 2000, J BIOL CHEM, V275, P38059, DOI 10.1074/jbc.M001483200; Joyce CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-203; Kent OA, 2003, J BIOL CHEM, V278, P50572, DOI 10.1074/jbc.M307976200; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; KRAMER A, 1991, EMBO J, V10, P1503, DOI 10.1002/j.1460-2075.1991.tb07670.x; KRAMER A, 1992, MOL CELL BIOL, V12, P4545; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Manceau V, 2008, J MOL BIOL, V381, P748, DOI 10.1016/j.jmb.2008.06.026; Maucuer A, 1997, J BIOL CHEM, V272, P23151, DOI 10.1074/jbc.272.37.23151; MAUCUER A, 1995, P NATL ACAD SCI USA, V92, P3100, DOI 10.1073/pnas.92.8.3100; Mazroui R, 1999, RNA, V5, P1615, DOI 10.1017/S1355838299991872; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Puri V, 2008, EUR J HUM GENET; Puri V, 2007, BIOL PSYCHIAT, V61, P873, DOI 10.1016/j.biopsych.2006.06.014; Qiu Z, 2008, NEURON, V60, P449, DOI 10.1016/j.neuron.2008.10.039; Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Shitashige M, 2007, CANCER SCI, V98, P1862, DOI 10.1111/j.1349-7006.2007.00629.x; Spooren W, 2004, PSYCHOPHARMACOLOGY, V175, P99, DOI 10.1007/s00213-004-1785-y; Steiger JL, 2004, PHARMACOL THERAPEUT, V101, P259, DOI 10.1016/j.pharmthera.2003.12.002; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Valjent E, 2006, P NATL ACAD SCI USA, V103, P2932, DOI 10.1073/pnas.0511030103; Zhu R, 2010, CANCER RES, V70, P7264, DOI 10.1158/0008-5472.CAN-10-0820	42	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43946	10.1371/journal.pone.0043946	http://dx.doi.org/10.1371/journal.pone.0043946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937132	Green Submitted, gold, Green Published			2022-12-27	WOS:000308225500127
J	Okamoto, H; Matsumi, Y; Hoshikawa, Y; Takubo, K; Ryoke, K; Shiota, G				Okamoto, Hideharu; Matsumi, Yoshiaki; Hoshikawa, Yoshiko; Takubo, Kazuko; Ryoke, Kazuo; Shiota, Goshi			Involvement of MicroRNAs in Regulation of Osteoblastic Differentiation in Mouse Induced Pluripotent Stem Cells	PLOS ONE			English	Article							OSTERIX EXPRESSION; RUNX2 EXPRESSION; IN-VITRO; DLX5; MSX2; ACTIVATION; OSTEOGENESIS; COMMITMENT; PROTEINS; PATHWAY	Backgoround: MicroRNAs (miRNAs), which regulate biological processes by annealing to the 3'-untranslated region (3'-UTR) of mRNAs to reduce protein synthesis, have been the subject of recent attention as a key regulatory factor in cell differentiation. The effects of some miRNAs during osteoblastic differentiation have been investigated in mesenchymal stem cells, however they still remains to be determined in pluripotent stem cells. Methodology/Principal Findings: Bone morphogenic proteins (BMPs) are potent activators of osteoblastic differentiation. In the present study, we profiled miRNAs during osteoblastic differentiation of mouse induced pluripotent stem (iPS) cells by BMP-4, in which expression of important osteoblastic markers such as Rux2, osterix, osteopontin, osteocalcin, PTHR1 and RANKL were significantly increased. A miRNA array analysis revealed that six miRNAs including miR-10a, miR-10b, miR-19b, miR-9-3p, miR-124a and miR-181a were significantly downregulated. Interestingly, miR-124a and miR-181a directly target the transcription factors Dlx5 and Msx2, both of which were increased by about 80-and 30-fold, respectively. In addition, transfection of miR-124a and miR-181a into mouse osteo-progenitor MC3T3-E1 cells significantly reduced expression of Dlx5, Runx2, osteocalcin and ALP, and Msx2 and osteocalcin, respectively. Finally, transfection of the anti-miRNAs of these six miRNAs, which are predicted to target Dlx5 and Msx2, into mouse iPS cells resulted in a significant increase in several osteoblastic differentiation markers such as Rux2, Msx2 and osteopontin. Conclusions/Significance: In the present study, we demonstrate that six miRNAs including miR-10a, miR-10b, miR-19b, miR9-3p, miR-124a and miR-181a miRNAs, especially miR-124a and miR-181a, are important regulatory factors in osteoblastic differentiation of mouse iPS cells.	[Okamoto, Hideharu; Matsumi, Yoshiaki; Hoshikawa, Yoshiko; Shiota, Goshi] Tottori Univ, Div Mol & Genet Med, Dept Genet Med & Regenerat Therapeut, Grad Sch Med, Yonago, Tottori, Japan; [Okamoto, Hideharu; Takubo, Kazuko; Ryoke, Kazuo] Tottori Univ, Fac Med, Div Oral & Maxillofacial Biopathol Surg, Dept Med Sensory & Motor Organs,Sch Med, Yonago, Tottori 683, Japan	Tottori University; Tottori University	Okamoto, H (corresponding author), Tottori Univ, Div Mol & Genet Med, Dept Genet Med & Regenerat Therapeut, Grad Sch Med, Yonago, Tottori, Japan.	gshiota@med.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23792280]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Young Scientists (B) (23792280) from The Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bellido T, 1997, ENDOCRINOLOGY, V138, P3666, DOI 10.1210/en.138.9.3666; Bilousova G, 2011, STEM CELLS, V29, P206, DOI 10.1002/stem.566; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Dani C, 1997, J CELL SCI, V110, P1279; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gotoh M, 2002, EUR J PHARMACOL, V451, P19, DOI 10.1016/S0014-2999(02)02183-0; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Karbiener M, 2011, RNA BIOL, V8, P850, DOI 10.4161/rna.8.5.16153; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Tokuzawa Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001019; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Wang F, 2011, CELL RES, V21, P1196, DOI 10.1038/cr.2011.79; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Yang L, 2012, J BONE MINER RES, V27, P1598, DOI 10.1002/jbmr.1621; Yoshizawa T, 2004, MOL CELL BIOL, V24, P3460, DOI 10.1128/MCB.24.8.3460-3472.2004; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	43	48	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43800	10.1371/journal.pone.0043800	http://dx.doi.org/10.1371/journal.pone.0043800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937097	Green Published, Green Submitted, gold			2022-12-27	WOS:000308225500099
J	Rossi, F; Bellini, G; Alisi, A; Alterio, A; Maione, S; Perrone, L; Locatelli, F; del Giudice, EM; Nobili, V				Rossi, Francesca; Bellini, Giulia; Alisi, Anna; Alterio, Arianna; Maione, Sabatino; Perrone, Laura; Locatelli, Franco; del Giudice, Emanuele Miraglia; Nobili, Valerio			Cannabinoid Receptor Type 2 Functional Variant Influences Liver Damage in Children with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							CB2 HEPATOPROTECTIVE PROPERTIES; GLN63ARG POLYMORPHISM; INSULIN-RESISTANCE; OBESE CHILDREN; STEATOHEPATITIS; INFLAMMATION; ASSOCIATION; HIGHLIGHT; INDEXES; CELLS	Non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of disease ranging from simple steatosis to inflammatory steatohepatitis (NASH) with different degrees of fibrosis that can ultimately progress to cirrhosis. Accumulating evidence suggests the involvement of the endocannabinoid-system in liver disease and related complications. In particular, hepatoprotective properties for Cannabinoid Receptor type 2 (CB2) have been shown both through experimental murine models of liver injury and association study between a CB2 functional variant, Q63R, and liver enzymes in Italian obese children with steatosis. Here, in order to clarify the role of CB2 in severity of childhood NAFLD, we have investigated the association of the CB2 Q63R variant, with histological parameters of liver disease severity in 118 Italian children with histologically-proven NAFLD. CB2 Q63R genotype was assigned performing a TaqMan assay and a general linear model analysis was used to evaluate the association between the polymorphism and the histological parameters of liver damage. We have found that whereas CB2 Q63R variant is not associated with steatosis or fibrosis, it is associated with the severity of the inflammation (p = 0.002) and the presence of NASH (p = 0.02). Our findings suggest a critical role for CB2 Q63R variant in modulating hepatic inflammation state in obese children and in the consequent increased predisposition of these patients to liver damage.	[Rossi, Francesca; Perrone, Laura; del Giudice, Emanuele Miraglia] Univ Naples 2, Dept Pediat, Naples, Italy; [Bellini, Giulia; Maione, Sabatino] Univ Naples 2, Dept Expt Med, Naples, Italy; [Rossi, Francesca; Locatelli, Franco] Bambino Gesu Childrens Hosp & Res Inst, Dept Haematol Oncol, Rome, Italy; [Alisi, Anna; Alterio, Arianna; Nobili, Valerio] Bambino Gesu Childrens Hosp & Res Inst, Liver Unit, Rome, Italy; [Locatelli, Franco] Univ Pavia, I-27100 Pavia, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Pavia	Rossi, F (corresponding author), Univ Naples 2, Dept Pediat, Naples, Italy.	fra.rossi76@libero.it	Nobili, Valerio/K-8670-2018; Alisi, Anna/A-6469-2010; del Giudice, Emanuele Muraglia/AAC-2824-2019	Alisi, Anna/0000-0001-7241-6329; Maione, Sabatino/0000-0003-3850-6704; Perrone, Laura/0000-0002-8647-3938; Alterio, Arianna/0000-0002-8561-1868; Rossi, Francesca/0000-0003-2879-6277; nobili, valerio/0000-0002-4570-3979				Al-Serri A, 2012, J HEPATOL, V56, P448, DOI 10.1016/j.jhep.2011.05.029; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Barshop NJ, 2008, ALIMENT PHARM THER, V28, P13, DOI 10.1111/j.1365-2036.2008.03703.x; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Carrasquer A, 2010, PHARMACOGENET GENOM, V20, P157, DOI 10.1097/FPC.0b013e3283367c6b; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; de Alwis NMW, 2007, SEMIN LIVER DIS, V27, P44, DOI 10.1055/s-2006-960170; del Giudice EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027933; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Dunn Winston, 2008, Curr Gastroenterol Rep, V10, P67, DOI 10.1007/s11894-008-0011-1; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Larter CZ, 2010, J GASTROEN HEPATOL, V25, P672, DOI 10.1111/j.1440-1746.2010.06253.x; Lotersztajn S, 2011, HEPATOLOGY, V54, P1102, DOI 10.1002/hep.24476; Manco M, 2008, INT J OBESITY, V32, P381, DOI 10.1038/sj.ijo.0803711; Patel KD, 2010, CURR MED CHEM, V17, P1394, DOI 10.2174/092986710790980041; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rossi F, 2011, HEPATOLOGY, V54, P1102, DOI 10.1002/hep.24440; Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050; Sipe JC, 2005, J LEUKOCYTE BIOL, V78, P231, DOI 10.1189/jlb.0205111; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; Teixeira-Clerc F, 2010, HEPATOLOGY, V52, P1046, DOI 10.1002/hep.23779; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; WANG P, 1994, J IMMUNOL, V153, P811	32	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2012	7	8							e42259	10.1371/journal.pone.0042259	http://dx.doi.org/10.1371/journal.pone.0042259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GE	22927922	Green Published, Green Submitted, gold			2022-12-27	WOS:000308224700004
J	Dahlstrom, O; Backe, S; Ekberg, J; Janson, S; Timpka, T				Dahlstrom, Orjan; Backe, Stefan; Ekberg, Joakim; Janson, Staffan; Timpka, Toomas			Is "Football for All" Safe for All? Cross-Sectional Study of Disparities as Determinants of 1-Year Injury Prevalence in Youth Football Programs	PLOS ONE			English	Article							BODY-MASS INDEX; SOCCER; HEALTH; RISK; OVERWEIGHT; ATHLETE	Background: Football (soccer) is endorsed as a health-promoting physical activity worldwide. When football programs are introduced as part of general health promotion programs, equal access and limitation of pre-participation disparities with regard to injury risk are important. The aim of this study was to explore if disparity with regard to parents' educational level, player body mass index (BMI), and self-reported health are determinants of football injury in community-based football programs, separately or in interaction with age or gender. Methodology/Principal Findings: Four community football clubs with 1230 youth players agreed to participate in the cross-sectional study during the 2006 season. The study constructs (parents' educational level, player BMI, and self-reported health) were operationalized into questionnaire items. The 1-year prevalence of football injury was defined as the primary outcome measure. Data were collected via a postal survey and analyzed using a series of hierarchical statistical computations investigating associations with the primary outcome measure and interactions between the study variables. The survey was returned by 827 (67.2%) youth players. The 1-year injury prevalence increased with age. For youths with parents with higher formal education, boys reported more injuries and girls reported fewer injuries than expected; for youths with lower educated parents there was a tendency towards the opposite pattern. Youths reporting injuries had higher standardized BMI compared with youths not reporting injuries. Children not reporting full health were slightly overrepresented among those reporting injuries and underrepresented for those reporting no injury. Conclusion: Pre-participation disparities in terms of parents' educational level, through interaction with gender, BMI, and self-reported general health are associated with increased injury risk in community-based youth football. When introduced as a general health promotion, football associations should adjust community-based youth programs to accommodate children and adolescents with increased pre-participation injury risk.	[Dahlstrom, Orjan; Ekberg, Joakim; Timpka, Toomas] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Dahlstrom, Orjan; Timpka, Toomas] Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden; [Dahlstrom, Orjan] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Backe, Stefan; Janson, Staffan] Karlstad Univ, Div Publ Hlth Sci, Karlstad, Sweden; [Backe, Stefan; Timpka, Toomas] Skovde Univ, Sch Life Sci, Dept Publ Hlth, Skovde, Sweden	Linkoping University; Linkoping University; Karlstad University	Dahlstrom, O (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	orjan.dahlstrom@liu.se	Timpka, Toomas/E-8065-2018	Dahlstrom, Orjan/0000-0002-3955-0443	Swedish National Centre for Research in Sports (CIF) [2007/82]	Swedish National Centre for Research in Sports (CIF)	The study was supported by a grant (2007/82) from the Swedish National Centre for Research in Sports (CIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Bazelmans C, 2004, EUR J EPIDEMIOL, V19, P1037, DOI 10.1007/s10654-004-0158-5; Brownell MD, 2010, CAN J PUBLIC HEALTH, V101, pS28; Bulik CM, 2001, INT J OBESITY, V25, P1517, DOI 10.1038/sj.ijo.0801742; Carter CW, 2011, BRIT J SPORT MED, V45, P880, DOI 10.1136/bjsports-2011-090201; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; de Mutsert R, 2011, NEPHRON CLIN PRACT, V119, pC154, DOI 10.1159/000327596; de Mutsert R, 2009, KIDNEY INT, V75, P677, DOI 10.1038/ki.2008.645; Dvorak J, 2009, BRIT J SPORT MED, V43, P317, DOI 10.1136/bjsm.2009.059618; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Faude O, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2009.01087.x; Froholdt A, 2009, AM J SPORT MED, V37, P1155, DOI 10.1177/0363546508330132; Fuller CW, 2012, BRIT J SPORT MED, V46, P11, DOI 10.1136/bjsports-2011-090634; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; GOFFMAN E, 1977, THEOR SOC, V4, P301; Jones EG, 1999, J NATL MED ASSOC, V91, P27; Kakavelakis KN, 2003, SCAND J MED SCI SPOR, V13, P175, DOI 10.1034/j.1600-0838.2003.00294.x; Karlberg J, 2001, ACTA PAEDIATR, V90, P1427, DOI 10.1080/08035250152708851; Knowles SB, 2010, BRIT J SPORT MED, V44, P38, DOI 10.1136/bjsm.2009.065763; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01108.x; Lundy T, 2010, GLOB HEALTH PROMOT, V17, P44, DOI 10.1177/1757975910375169; McHugh MP, 2010, BRIT J SPORT MED, V44, P45, DOI 10.1136/bjsm.2009.068106; McNoe BM, 2010, AM J SPORT MED, V38, P2542, DOI 10.1177/0363546510377415; NIXON HL, 1993, SOCIOL SPORT J, V10, P183, DOI 10.1123/ssj.10.2.183; PELLICCIA A, 1995, AM J CARDIOL, V75, P827, DOI 10.1016/S0002-9149(99)80421-4; Peterson L, 2000, AM J SPORT MED, V28, pS51; Pickett W, 2005, INJURY PREV, V11, P213, DOI 10.1136/ip.2004.007021; Rothman K, 2002, EPIDEMIOLOGY INTRO, V1, P168; Soderman K, 2001, SCAND J MED SCI SPOR, V11, P299, DOI 10.1034/j.1600-0838.2001.110508.x; Thompson PD, 2009, CIRCULATION, V119, P1072, DOI 10.1161/CIRCULATIONAHA.108.843862; Timpka T, 2008, EUR J PUBLIC HEALTH, V18, P19, DOI 10.1093/eurpub/ckm050; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; Zonfrillo MR, 2008, AMBUL PEDIATR, V8, P66, DOI 10.1016/j.ambp.2007.08.003	35	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43795	10.1371/journal.pone.0043795	http://dx.doi.org/10.1371/journal.pone.0043795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	999CI	22928035	Green Published, gold			2022-12-27	WOS:000308286300091
J	Volpato, V; Macchiarelli, R; Guatelli-Steinberg, D; Fiore, I; Bondioli, L; Frayer, DW				Volpato, Virginie; Macchiarelli, Roberto; Guatelli-Steinberg, Debbie; Fiore, Ivana; Bondioli, Luca; Frayer, David W.			Hand to Mouth in a Neandertal: Right-Handedness in Regourdou 1	PLOS ONE			English	Article							HUMAN ANTERIOR TEETH; BILATERAL ASYMMETRY; MODERN HUMANS; ATAPUERCA; MIDDLE; EVOLUTION; SIERRA; SIMA; STRIATIONS; LANGUAGE	We describe and analyze a Neandertal postcranial skeleton and dentition, which together show unambiguous signs of right-handedness. Asymmetries between the left and right upper arm in Regourdou 1 were identified nearly 20 years ago, then confirmed by more detailed analyses of the inner bone structure for the clavicle, humerus, radius and ulna. The total pattern of all bones in the shoulder and arm reveals that Regourdou 1 was a right-hander. Confirmatory evidence comes from the mandibular incisors, which display a distinct pattern of right oblique scratches, typical of right-handed manipulations performed at the front of the mouth. Regourdou's right handedness is consistent with the strong pattern of manual lateralization in Neandertals and further confirms a modern pattern of left brain dominance, presumably signally linguistic competence. These observations along with cultural, genetic and morphological evidence indicate language competence in Neandertals and their European precursors.	[Volpato, Virginie] Senckenberg Res Inst Frankfurt, Dept Paleoanthropol & Messel Res, Frankfurt, Germany; [Macchiarelli, Roberto] MNHN, UMR 7194, Dept Prehist, Paris, France; [Macchiarelli, Roberto] Univ Poitiers, Dept Geosci, Poitiers, France; [Guatelli-Steinberg, Debbie] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Fiore, Ivana; Bondioli, Luca; Frayer, David W.] Soprintendenza Museo Nazl Preistor Etnog L Pigori, Rome, Italy; [Frayer, David W.] Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA	Senckenberg Gesellschaft fur Naturforschung (SGN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Universite de Poitiers; University System of Ohio; Ohio State University; University of Kansas	Volpato, V (corresponding author), Senckenberg Res Inst Frankfurt, Dept Paleoanthropol & Messel Res, Frankfurt, Germany.	frayer@ku.edu		Bondlioli, Luca/0000-0002-8511-7667; Fiore, Ivana/0000-0001-5721-0760	TNT European project; French CNRS; Region Poitou-Charentes; Nespos Society; Leakey Foundation	TNT European project; French CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Poitou-Charentes(Region Nouvelle-Aquitaine); Nespos Society; Leakey Foundation	The TNT European project, French CNRS, Region Poitou-Charentes, Nespos Society, and Leakey Foundation provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JE, 1972, HUMAN SKELETON; Bax JS, 1999, INT J OSTEOARCHAEOL, V9, P189, DOI 10.1002/(SICI)1099-1212(199905/06)9:3<189::AID-OA474>3.0.CO;2-N; Bayle P., 2011, WISSENSCHAFTLICHE SC, P29; BEDNARIK RG, 1992, CAMB ARCHAEOL J, V2, P27; Blackburn A, 2011, AM J PHYS ANTHROPOL, V145, P639, DOI 10.1002/ajpa.21555; BONIFAY E, 1962, CR HEBD ACAD SCI, V255, P1635; Brace CL, 1991, STATES HUMAN EVOLUTI; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; Cashmore L, 2009, ANN HUM BIOL, V36, P624, DOI 10.1080/03014460902956733; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; Cavanhie N., 2009, PALEO, V21, P39, DOI DOI 10.4000/PALEO.1742; Chapelain AS, 2011, INT J PRIMATOL, V32, P491, DOI 10.1007/s10764-010-9484-5; Churchill SE, 1997, INT J OSTEOARCHAEOL, V7, P18, DOI 10.1002/(SICI)1099-1212(199701)7:1<18::AID-OA303>3.0.CO;2-R; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; de Lumley MA, 1973, ETUDES Q, V2, P1; DECASTRO JMB, 1988, J HUM EVOL, V17, P403, DOI 10.1016/0047-2484(88)90029-2; Dubois J, 2009, CEREB CORTEX, V19, P414, DOI 10.1093/cercor/bhn097; Fisher J.W., 1995, J ARCHAEOL METHOD TH, V2, P7, DOI [10.1007/bf02228434, DOI 10.1007/BF02228434]; FLANDER LB, 1978, AM J PHYS ANTHROPOL, V49, P103, DOI 10.1002/ajpa.1330490116; Fox CL, 1997, INT J OSTEOARCHAEOL, V7, P133, DOI 10.1002/(SICI)1099-1212(199703)7:2<133::AID-OA326>3.0.CO;2-4; Frayer DW, 2006, PERIOD BIOL, V108, P519; Frayer DW, 2012, LATERALITY, V17, P51, DOI 10.1080/1357650X.2010.529451; Frayer DW, 2010, J ANTHROPOL SCI, V88, P113; Frayer DW, 2000, ORIGINS OF MUSIC, P217; Froehle Andrew W., 2009, Paleoanthropology, V2009, P96; HARDYCK C, 1975, HUM BIOL, V47, P369; Hayden B, 2012, OXFORD J ARCHAEOL, V31, P1, DOI 10.1111/j.1468-0092.2011.00376.x; Henri-Martin H, 1923, HOMMES FOSSILES QUIN; Hepper PG, 2005, NEUROPSYCHOLOGIA, V43, P313, DOI 10.1016/j.neuropsychologia.2004.08.009; Hepper PG, 1998, NEUROPSYCHOLOGIA, V36, P531, DOI 10.1016/S0028-3932(97)00156-5; HEPPER PG, 1991, NEUROPSYCHOLOGIA, V29, P1107, DOI 10.1016/0028-3932(91)90080-R; Holloway R.L., 1985, P319; Kasprian G, 2011, CEREB CORTEX, V21, P1076, DOI 10.1093/cercor/bhq179; Koby F. E., 1956, Verhandlungen der Naturforschenden Gesellschaft in Basel, V67, P1; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Lalueza-Fox C., 1992, INT J OSTEOARCHAEOL, V2, P155, DOI DOI 10.1002/0A.1390020207; Lazuen T, 2012, J ARCHAEOL SCI, V39, P2304, DOI 10.1016/j.jas.2012.02.032; Lozano M, 2008, J HUM EVOL, V55, P713, DOI 10.1016/j.jhevol.2008.04.007; Lozano M, 2009, EVOL HUM BEHAV, V30, P369, DOI 10.1016/j.evolhumbehav.2009.03.001; Lozano-Ruiz M, 2004, J ARCHAEOL SCI, V31, P1127, DOI 10.1016/j.jas.2004.02.005; Lyman R.L., 1994, CAMBRIDGE MANUALS AR; Madelaine S., 2008, PALEO, V20, P101; Martinez I, 2008, J HUM EVOL, V54, P118, DOI 10.1016/j.jhevol.2007.07.006; Martinez I, 2004, P NATL ACAD SCI USA, V101, P9976, DOI 10.1073/pnas.0403595101; Martinez I, 2009, ANTHROPOLOGIE, V113, P255, DOI 10.1016/j.anthro.2009.01.003; Maureille B, 2001, PALEO, V13, P183, DOI DOI 10.4000/PALEO.1043; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; McManus IC, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P37, DOI 10.1017/CBO9780511576744.004; McManus IC, 1992, HDB NEUROPSYCHOLOGY, V6, P116; Meyer V, 2011, AM J PHYS ANTHROPOL, V144, P214; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; OLSEN LS, 1988, J ARCHAEOL SCI, V15, P335; Patte E., 1960, ANTHROPOL, V64, P512; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Puech PF, 1987, HOMINIDAE, P247; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; RUFF CB, 2008, BIOL ANTHR HUMAN SKE, P183, DOI DOI 10.1002/9780470245842.CH6; Shaw CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040349; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Turq A., 2008, PREMIERE HUMANITE GE, P40; Uomini NT, 2009, J HUM EVOL, V57, P411, DOI 10.1016/j.jhevol.2009.02.012; VANDERMEERSCH B, 1995, J HUM EVOL, V28, P439, DOI 10.1006/jhev.1995.1034; Volpato V, 2011, VERTEBR PALEOBIOL PA, P175, DOI 10.1007/978-94-007-0492-3_15; White T.D., 2000, HUMAN OSTEOLOGY; Wolpoff M. H., 1999, PALEOANTHROPOLOGY; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	68	58	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2012	7	8							e43949	10.1371/journal.pone.0043949	http://dx.doi.org/10.1371/journal.pone.0043949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999CI	22937134	Green Published, gold, Green Submitted			2022-12-27	WOS:000308286300099
J	Bennett, JA; Cahill, JF				Bennett, Jonathan A.; Cahill, James F., Jr.			Evaluating the Relationship between Competition and Productivity within a Native Grassland	PLOS ONE			English	Article							STRESS-GRADIENT HYPOTHESIS; BELOW-GROUND COMPETITION; PLANT STRATEGY THEORIES; RESOURCE AVAILABILITY; POSITIVE INTERACTIONS; SHOOT COMPETITION; ABIOTIC STRESS; INTENSITY; DIVERSITY; FACILITATION	Ideas about how plant competition varies with productivity are rooted in classic theories that predict either increasing (Grime) or invariant (Tilman) competition with increasing productivity. Both predictions have received experimental support, although a decade-old meta-analysis supports neither. Attempts to reconcile the conflicting predictions and evidence include: expanding the theory to include other conditions (e. g. stress gradient hypothesis), development of indices to differentiate either the 'intensity' or 'importance' of competition, a focus on resource supply and demand, and explicit recognition that both growth and survival may exhibit different relationships with productivity. To determine which of these theories accurately predict how competition varies with productivity within a native grassland site, we estimated competitive intensity and relative competitive importance using 22 species across the range of productivity naturally occurring within that site. Plant performance was measured as survival and size with and without neighbours and the local environment was quantified according to variability in standing crop, gross water supply, and net water supply. On average, neighbours weakly facilitated seedling survival, but strongly reduced seedling growth. For both seedling survival and growth, relative competitive importance and competitive intensity declined with some measure of productivity; neighbour effects on survival declined with standing crop, while effects on growth declined with gross water supply. These results add to the growing evidence that plant-plant interactions vary among life history components with different life history components contingent upon separate environmental factors. Although the range of productivity measured in this study was not large, our results do not support the theories of Grime or Tilman. However, our results are consistent with the meta-analysis and parts of other theories, although no single theory is capable of explaining the entirety of these results. This suggests that, at least in moderately productive grasslands, new theory needs to be developed.	[Bennett, Jonathan A.; Cahill, James F., Jr.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Bennett, JA (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	jon.bennett@ualberta.ca	Bennett, Jonathan A/J-5839-2013; Bennett, Jonathan/AAH-3191-2021; Bennett, Jonathan/K-4405-2014; Cahill, James/B-6147-2015	Bennett, Jonathan A/0000-0001-5617-7524; Bennett, Jonathan/0000-0001-5617-7524; Bennett, Jonathan/0000-0001-5617-7524; Cahill, James/0000-0002-4110-1516	NSERC Discovery Grant; NSERC Post-Graduate Scholarship	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Post-Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a NSERC Discovery Grant to JFC Jr. and a NSERC Post-Graduate Scholarship to JAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 2002, OIKOS, V96, P531, DOI 10.1034/j.1600-0706.2002.960314.x; ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; [Anonymous], 2001, PLANT STRATEGIES VEG; Arii K, 2001, CAN J BOT, V79, P1486, DOI 10.1139/b01-118; BELCHER JW, 1995, J ECOL, V83, P673, DOI 10.2307/2261635; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker R, 2005, OIKOS, V109, P63, DOI 10.1111/j.0030-1299.2005.13557.x; Brooker RW, 2008, J ECOL, V96, P703, DOI 10.1111/j.1365-2745.2008.01373.x; Cahill JF, 1999, ECOLOGY, V80, P466, DOI 10.1890/0012-9658(1999)080[0466:FEOIBA]2.0.CO;2; Cahill JF, 2003, J ECOL, V91, P532, DOI 10.1046/j.1365-2745.2003.00792.x; Cahill JF, 2003, ECOL LETT, V6, P599, DOI 10.1046/j.1461-0248.2003.00476.x; Cahill JF, 2002, J ECOL, V90, P201, DOI 10.1046/j.0022-0477.2001.00658.x; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; CAMPBELL BD, 1992, ECOLOGY, V73, P15, DOI 10.2307/1938717; Coupe MD, 2009, J VEG SCI, V20, P121, DOI 10.1111/j.1654-1103.2009.05506.x; Craine JM, 2005, J ECOL, V93, P1041, DOI 10.1111/j.1365-2745.2005.01043.x; Craine JM., 2009, RESOURCE STRATEGIES; Craine JM, 2007, J ECOL, V95, P235, DOI 10.1111/j.1365-2745.2007.01212.x; Damgaard C, 2010, J ECOL, V98, P1, DOI 10.1111/j.1365-2745.2009.01587.x; Davis MA, 1998, J ECOL, V86, P652, DOI 10.1046/j.1365-2745.1998.00087.x; Dickson TL, 2011, ECOL LETT, V14, P380, DOI 10.1111/j.1461-0248.2011.01599.x; Dyer AR, 2001, FUNCT ECOL, V15, P85, DOI 10.1046/j.1365-2435.2001.00487.x; Freckleton RP, 2009, J ECOL, V97, P379, DOI 10.1111/j.1365-2745.2009.01497.x; Goldberg D, 1997, J ECOL, V85, P409, DOI 10.2307/2960565; Goldberg D. E., 1990, Perspectives on plant competition., P27; Goldberg DE, 1996, PHILOS T R SOC B, V351, P1377, DOI 10.1098/rstb.1996.0121; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; GRACE JB, 1991, FUNCT ECOL, V5, P583, DOI 10.2307/2389475; GRACE JB, 1995, ECOLOGY, V76, P305, DOI 10.2307/1940651; Grime J. P., 2001, PLANT STRATEGIES VEG; Grime JP, 2007, J ECOL, V95, P227, DOI 10.1111/j.1365-2745.2006.01163.x; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Haag JJ, 2004, J ECOL, V92, P156, DOI 10.1111/j.1365-2745.2004.00847.x; Hacker SD, 2008, ECOLOGY; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Howard TG, 2001, ECOLOGY, V82, P979, DOI 10.1890/0012-9658(2001)082[0979:CRHFGG]2.0.CO;2; Kikvidze Z, 2011, TRENDS ECOL EVOL, V26, P383, DOI 10.1016/j.tree.2011.04.003; Lamb EG, 2008, AM NAT, V171, P777, DOI 10.1086/587528; Lamb EG, 2007, PLANT ECOL, V192, P21, DOI 10.1007/s11258-006-9222-4; Lamb EG, 2009, J ECOL, V97, P155, DOI 10.1111/j.1365-2745.2008.01454.x; Lortie CJ, 2006, J ECOL, V94, P7, DOI 10.1111/j.1365-2745.2005.01066.x; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2006, J ECOL, V94, P17, DOI 10.1111/j.1365-2745.2005.01089.x; Malkinson D, 2010, OIKOS, V119, P1546, DOI 10.1111/j.1600-0706.2010.18375.x; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Molles Jr MC, 2011, ECOLOGY CONCEPTS APP; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Neytcheva MS, 2008, OIKOS, V117, P1298, DOI 10.1111/j.0030-1299.2008.16695.x; Peltzer DA, 1998, AM NAT, V151, P465, DOI 10.1086/286133; READER RJ, 1994, ECOLOGY, V75, P1753, DOI 10.2307/1939634; Rees M, 2012, J ECOL, V100, P577, DOI 10.1111/j.1365-2745.2011.01946.x; Ricklefs R.E., 2008, EC NATURE; Schiffers K, 2006, J ECOL, V94, P336, DOI 10.1111/j.1365-2745.2006.01097.x; Seifan M, 2010, J ECOL, V98, P356, DOI 10.1111/j.1365-2745.2009.01621.x; Stiling PD, 2002, ECOLOGY THEORIES APP; TAYLOR DR, 1990, OIKOS, V58, P239, DOI 10.2307/3545432; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1988; Tilman D, 2007, J ECOL, V95, P231, DOI 10.1111/j.1365-2745.2007.01201.x; TwolanStrutt L, 1996, ECOLOGY, V77, P259, DOI 10.2307/2265675; Weaver JE., 1938, PLANT ECOL, V2; Wilson MV, 2007, J ECOL, V95, P301, DOI 10.1111/j.1365-2745.2007.01215.x; WILSON SD, 1995, ECOLOGY, V76, P1169, DOI 10.2307/1940924; WILSON SD, 1993, ECOLOGY, V74, P599, DOI 10.2307/1939319; WILSON SD, 1991, ECOLOGY, V72, P1050, DOI 10.2307/1940605; WILSON SD, 1993, J ECOL, V81, P445, DOI 10.2307/2261523; Yuan ZY, 2006, OECOLOGIA, V148, P564, DOI 10.1007/s00442-006-0409-0	75	13	15	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43703	10.1371/journal.pone.0043703	http://dx.doi.org/10.1371/journal.pone.0043703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928021	gold, Green Submitted, Green Published			2022-12-27	WOS:000307789700048
J	Gao, HW; Wang, LP; Liang, S; Liu, YX; Tong, SL; Wang, JJ; Li, YP; Wang, XF; Yang, H; Ma, JQ; Fang, LQ; Cao, WC				Gao, Hong-Wei; Wang, Li-Ping; Liang, Song; Liu, Yong-Xiao; Tong, Shi-Lu; Wang, Jian-Jun; Li, Ya-Pin; Wang, Xiao-Feng; Yang, Hong; Ma, Jia-Qi; Fang, Li-Qun; Cao, Wu-Chun			Change in Rainfall Drives Malaria Re-Emergence in Anhui Province, China	PLOS ONE			English	Article							CLIMATE-CHANGE; AFRICAN HIGHLANDS; HUMAN HEALTH; TIME-SERIES; TRANSMISSION; RISK; RESURGENCE; CHILDREN; DISEASES; FUTURE	Malaria is re-emerging in Anhui Province, China after a decade long' low level of endemicity. The number of human cases has increased rapidly since 2000 and reached its peak in 2006. That year, the malaria cases accounted for 54.5% of total cases in mainland China. However, the spatial and temporal patterns of human cases and factors underlying the re-emergence remain unclear. We established a database containing 20 years' (1990-2009) records of monthly reported malaria cases and meteorological parameters. Spearman correlations were used to assess the crude association between malaria incidence and meteorological variables, and a polynomial distributed lag (PDL) time-series regression was performed to examine contribution of meteorological factors to malaria transmission in three geographic regions (northern, mid and southern Anhui Province), respectively. Then, a two-year (2008-2009) prediction was performed to validate the PDL model that was created by using the data collected from 1990 to 2007. We found that malaria incidence decreased in Anhui Province in 1990s. However, the incidence has dramatically increased in the north since 2000, while the transmission has remained at a relatively low level in the mid and south. Spearman correlation analyses showed that the monthly incidences of malaria were significantly associated with temperature, rainfall, relative humidity, and the multivariate El Nino/Southern Oscillation index with lags of 0-2 months in all three regions. The PDL model revealed that only rainfall with a 1-2 month lag was significantly associated with malaria incidence in all three regions. The model validation showed a high accuracy for the prediction of monthly incidence over a 2-year predictive period. Malaria epidemics showed a high spatial heterogeneity in Anhui Province during the 1990-2009 study periods. The change in rainfall drives the reemergence of malaria in the northern Anhui Province.	[Gao, Hong-Wei; Li, Ya-Pin; Yang, Hong; Fang, Li-Qun; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Li-Ping; Wang, Xiao-Feng; Ma, Jia-Qi] Chinese Ctr Dis Control & Prevent, Natl Ctr Publ Hlth Surveillance & Informat Serv, Beijing, Peoples R China; [Liang, Song] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Liang, Song] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Liu, Yong-Xiao; Wang, Jian-Jun] Anhui Ctr Dis Control & Prevent, Hefei, Peoples R China; [Tong, Shi-Lu] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia	Beijing Institute of Microbiology & Epidemiology; Chinese Center for Disease Control & Prevention; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Queensland University of Technology (QUT)	Gao, HW (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	fanglq@bmi.ac.cn; caowc@bmi.ac.cn	Fang, Li-Qun/GWD-0296-2022		National Science Fund for Distinguished Young Scholars [30725032]; Natural Science Foundation of China [81172728, 30972521]; Special Program for Prevention and Control of Infectious Diseases [2008ZX10004-012]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Prevention and Control of Infectious Diseases	The study was funded by the National Science Fund for Distinguished Young Scholars (30725032), Natural Science Foundation of China (81172728, 30972521) and Special Program for Prevention and Control of Infectious Diseases (2008ZX10004-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop Z, 2007, LANCET, V370, P925, DOI 10.1016/S0140-6736(07)61428-7; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Batten DS, 1983, POLYNOMIAL DISTRIBUT; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; China Meteorological Data Sharing Service System, 2011, CHIN MET DAT SHAR SE; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Gupta R, 1996, J Assoc Physicians India, V44, P385; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Haque U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014341; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hu WB, 2006, ECOL MODEL, V196, P505, DOI 10.1016/j.ecolmodel.2006.02.028; Kar S, 2010, NAT REV DRUG DISCOV, V9, P511, DOI 10.1038/nrd3207; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381; Le Menach A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00093; Ledford H, 2010, NATURE, V465, P280, DOI 10.1038/465280a; Li BK, 2010, ANHUI J PRE MED, V116, P427; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; National Oceanic and Atmospheric Administration, 2011, MULT ENSO IND; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Shen YZ, 2006, PATHOGEN BIOL, V1, P301; Singh N, 2002, ANN TROP MED PARASIT, V96, P349, DOI 10.1179/000349802125001113; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Stefani A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-246; Tang LH, 2000, CHINESE MED J-PEKING, V113, P89; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Thomson MC, 2011, NATURE, V471, P440, DOI 10.1038/471440a; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; van der Hoek W, 1997, ANN TROP MED PARASIT, V91, P945, DOI 10.1080/00034989760347; Wang LP, 2008, CHIN J DIS CONTROL P, V12, P156; Wangdi K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-251; World Health Organization, 2012, DIAGN MAL; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhou Shui-Sen, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P439; Zhou Shui-sen, 2006, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V24, P1; 黄荣辉, 1989, Advances in Atmospheric Sciences, V6, P21	46	34	35	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43686	10.1371/journal.pone.0043686	http://dx.doi.org/10.1371/journal.pone.0043686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22928015	Green Published, gold			2022-12-27	WOS:000307789700045
J	Szucs, A; Berton, F; Sanna, PP; Francesconi, W				Szuecs, Attila; Berton, Fulvia; Sanna, Pietro Paolo; Francesconi, Walter			Excitability of jcBNST Neurons Is Reduced in Alcohol-Dependent Animals during Protracted Alcohol Withdrawal	PLOS ONE			English	Article							CENTRAL EXTENDED AMYGDALA; CHRONIC ETHANOL EXPOSURE; STRIA TERMINALIS; BED NUCLEUS; DOPAMINE NEURONS; IN-VIVO; BEHAVIORAL SENSITIZATION; JUXTACAPSULAR NUCLEUS; INDUCED PLASTICITY; PYRAMIDAL NEURONS	Alcohol dependence and withdrawal has been shown to cause neuroadaptive changes at multiple levels of the nervous system. At the neuron level, adaptations of synaptic connections have been extensively studied in a number of brain areas and accumulating evidence also shows the importance of alcohol dependence-related changes in the intrinsic cellular properties of neurons. At the same time, it is still largely unknown how such neural adaptations impact the firing and integrative properties of neurons. To address these problems, here, we analyze physiological properties of neurons in the bed nucleus of stria terminalis (jcBNST) in animals with a history of alcohol dependence. As a comprehensive approach, first we measure passive and active membrane properties of neurons using conventional current clamp protocols and then analyze their firing responses under the action of simulated synaptic bombardment via dynamic clamp. We find that most physiological properties as measured by DC current injection are barely affected during protracted withdrawal. However, neuronal excitability as measured from firing responses under simulated synaptic inputs with the dynamic clamp is markedly reduced in all 3 types of jcBNST neurons. These results support the importance of studying the effects of alcohol and drugs of abuse on the firing properties of neurons with dynamic clamp protocols designed to bring the neurons into a high conductance state. Since the jcBNST integrates excitatory inputs from the basolateral amygdala (BLA) and cortical inputs from the infralimbic and the insular cortices and in turn is believed to contribute to the inhibitory input to the central nucleus of the amygdala (CeA) the reduced excitability of the jcBNST during protracted withdrawal in alcohol-dependent animals will likely affect ability of the jcBNST to shape the activity and output of the CeA.	[Szuecs, Attila] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Szuecs, Attila] Hungarian Acad Sci, Balaton Limnol Res Inst, H-8237 Tihany, Hungary; [Berton, Fulvia; Sanna, Pietro Paolo; Francesconi, Walter] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Berton, Fulvia] Univ Pisa, Dept Biol, Pisa, Italy	University of California System; University of California San Diego; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute; Scripps Research Institute; University of Pisa	Szucs, A (corresponding author), Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA.	aszucs@ucsd.edu			National Institute of Health [RC1AA019195, DA03156601, AA016587, AA013191, AA006420]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC1AA019195, P60AA006420, R01AA016587, R01AA013191, P50AA006420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031566] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute of Health (Grants RC1AA019195, DA03156601 AA016587 AA013191 AA006420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Cooper DC, 2003, J NEUROSCI, V23, P9937; Destexhe A, 2009, DYNAMIC CLAMP; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Dong HW, 2000, BRAIN RES, V859, P1, DOI 10.1016/S0006-8993(99)02246-5; Dumont EC, 2005, NAT NEUROSCI, V8, P413, DOI 10.1038/nn1414; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Faber ESL, 2004, J NEUROSCI, V24, P3031, DOI 10.1523/JNEUROSCI.4496-03.2004; Fellous JM, 2003, CEREB CORTEX, V13, P1232, DOI 10.1093/cercor/bhg098; Francesconi W, 2009, J NEUROSCI; Francesconi W, 2009, PROG NEURO-PSYCHOPH, V33, P1347, DOI 10.1016/j.pnpbp.2009.08.003; Gilpin Nicholas W, 2008, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0929s44; Hammack SE, 2007, J NEUROPHYSIOL, V98, P638, DOI 10.1152/jn.00382.2007; Hazra R, 2011, MOL CELL NEUROSCI, V46, P699, DOI 10.1016/j.mcn.2011.01.011; HEIMER L, 1991, ADV EXP MED BIOL, V295, P1; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Hopf FW, 2007, J NEUROPHYSIOL, V98, P2297, DOI 10.1152/jn.00824.2007; Hur EE, 2005, J COMP NEUROL, V483, P351, DOI 10.1002/cne.20444; Kash TL, 2009, NEUROPSYCHOPHARMACOL, V34, P2420, DOI 10.1038/npp.2009.69; Krawczyk M, 2011, J NEUROSCI, V31, P8928, DOI 10.1523/JNEUROSCI.0377-11.2011; Larriva-Sahd J, 2004, J COMP NEUROL, V475, P220, DOI 10.1002/cne.20185; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lee S, 2000, ALCOHOL CLIN EXP RES, V24, P110, DOI 10.1111/j.1530-0277.2000.tb04560.x; MCDONALD AJ, 1983, BRAIN RES BULL, V10, P111, DOI 10.1016/0361-9230(83)90082-5; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Michaelevski I, 2007, PFLUG ARCH EUR J PHY, V454, P477, DOI 10.1007/s00424-007-0223-5; Mulholland PJ, 2009, ALCOHOL CLIN EXP RES, V33, P1125, DOI 10.1111/j.1530-0277.2009.00936.x; Nowotny T, 2006, J NEUROSCI METH, V158, P287, DOI 10.1016/j.jneumeth.2006.05.034; O'Dell LE, 2004, ALCOHOL CLIN EXP RES, V28, P1676, DOI 10.1097/01.ALC.0000145781.11923.4E; Parkis MA, 2000, J NEUROSCI METH, V96, P77, DOI 10.1016/S0165-0270(99)00186-7; Petrovich GD, 1997, BRAIN RES, V763, P247, DOI 10.1016/S0006-8993(96)01361-3; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Platkiewicz J, PLOS COMPUT BIOL, V7; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Repunte-Canonigo V, 2007, BRAIN RES, V1138, P48, DOI 10.1016/j.brainres.2006.09.115; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sanna PP, 2002, BRAIN RES, V948, P186, DOI 10.1016/S0006-8993(02)03191-8; Shammah-Lagnado SJ, 1999, ANN NY ACAD SCI, V877, P655, DOI 10.1111/j.1749-6632.1999.tb09295.x; Shen WX, 2004, J NEUROPHYSIOL, V91, P1337, DOI 10.1152/jn.00414.2003; Slawecki CJ, 1999, ALCOHOL ALCOHOLISM, V34, P289, DOI 10.1093/alcalc/34.3.289; SUN N, 1993, J COMP NEUROL, V330, P381, DOI 10.1002/cne.903300308; Szucs A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011920; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Veinante P, 1997, NEUROREPORT, V8, P2985, DOI 10.1097/00001756-199709080-00035; Vervaeke K, 2006, NEURON, V49, P257, DOI 10.1016/j.neuron.2005.12.022; Welsh JP, 2011, P NATL ACAD SCI USA, V108, P10314, DOI 10.1073/pnas.1017079108; Wills TA, 2012, P NATL ACAD SCI US; Zsiros V, 2005, J NEUROPHYSIOL, V93, P3248, DOI 10.1152/jn.01027.2004	55	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e42313	10.1371/journal.pone.0042313	http://dx.doi.org/10.1371/journal.pone.0042313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927925	gold, Green Published, Green Submitted			2022-12-27	WOS:000307789700009
J	Zhuo, JL; Tan, EH; Yan, B; Tochhawng, L; Jayapal, M; Koh, S; Tay, HK; Maciver, SK; Hooi, SC; Salto-Tellez, M; Kumar, AP; Goh, YC; Lim, YC; Yap, CT				Zhuo, Jingli; Tan, Ee Hong; Yan, Benedict; Tochhawng, Lalchhandami; Jayapal, Manikandan; Koh, Shiuan; Tay, Hwee Kee; Maciver, Sutherland K.; Hooi, Shing Chuan; Salto-Tellez, Manuel; Kumar, Alan Prem; Goh, Yaw Chong; Lim, Yaw Chyn; Yap, Celestial T.			Gelsolin Induces Colorectal Tumor Cell Invasion via Modulation of the Urokinase-Type Plasminogen Activator Cascade	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX DEGRADATION; ACTIN-BINDING PROTEINS; PROSTATE-CANCER; PROGNOSTIC-FACTOR; CARCINOMA-CELLS; DOWN-REGULATION; GROWTH-FACTOR; EXPRESSION; COLON; PROGRESSION	Gelsolin is a cytoskeletal protein which participates in actin filament dynamics and promotes cell motility and plasticity. Although initially regarded as a tumor suppressor, gelsolin expression in certain tumors correlates with poor prognosis and therapy-resistance. In vitro, gelsolin has anti-apoptotic and pro-migratory functions and is critical for invasion of some types of tumor cells. We found that gelsolin was highly expressed at tumor borders infiltrating into adjacent liver tissues, as examined by immunohistochemistry. Although gelsolin contributes to lamellipodia formation in migrating cells, the mechanisms by which it induces tumor invasion are unclear. Gelsolin's influence on the invasive activity of colorectal cancer cells was investigated using overexpression and small interfering RNA knockdown. We show that gelsolin is required for invasion of colorectal cancer cells through matrigel. Microarray analysis and quantitative PCR indicate that gelsolin overexpression induces the upregulation of invasion-promoting genes in colorectal cancer cells, including the matrix-degrading urokinase-type plasminogen activator (uPA). Conversely, gelsolin knockdown reduces uPA levels, as well as uPA secretion. The enhanced invasiveness of gelsolin-overexpressing cells was attenuated by treatment with function-blocking antibodies to either uPA or its receptor uPAR, indicating that uPA/uPAR activity is crucial for gelsolin-dependent invasion. In summary, our data reveals novel functions of gelsolin in colorectal tumor cell invasion through its modulation of the uPA/uPAR cascade, with potentially important roles in colorectal tumor dissemination to metastatic sites.	[Zhuo, Jingli; Tochhawng, Lalchhandami; Koh, Shiuan; Hooi, Shing Chuan; Lim, Yaw Chyn; Yap, Celestial T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Tan, Ee Hong] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Yan, Benedict; Lim, Yaw Chyn] Natl Univ Singapore Hosp, Dept Pathol, Singapore, Singapore; [Jayapal, Manikandan] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia; [Tay, Hwee Kee] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Maciver, Sutherland K.] Univ Edinburgh, Dept Biomed Sci, Edinburgh, Midlothian, Scotland; [Salto-Tellez, Manuel; Kumar, Alan Prem] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Salto-Tellez, Manuel] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Kumar, Alan Prem] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Kumar, Alan Prem] Curtin Univ Technol, Fac Hlth Sci, Sch Biomed Sci, Bentley, WA 6102, Australia; [Kumar, Alan Prem] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Goh, Yaw Chong] Singapore Gen Hosp, Dept Surg, Singapore 0316, Singapore	National University of Singapore; Beatson Institute; National University of Singapore; King Abdulaziz University; University of Glasgow; University of Edinburgh; National University of Singapore; Queens University Belfast; National University of Singapore; Curtin University; University of North Texas System; University of North Texas Denton; Singapore General Hospital	Zhuo, JL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore.	yawchyn_lim@nuhs.edu.sg; phsyapc@nus.edu.sg	Maciver, Sutherland Kester/H-6284-2019; Kumar, Alan Prem/ABE-7492-2020; Jayapal, Manikandan/H-9847-2012	Maciver, Sutherland Kester/0000-0001-8234-6061; Kumar, Alan Prem/0000-0002-3754-5712; J, manikandan/0000-0001-6744-8852; Tan, Ee Hong/0000-0002-5971-6455; Hooi, Shing Chuan/0000-0003-3249-903X; Salto-Tellez, Manuel/0000-0001-8586-282X	National Medical Research Council (NMRC) [NMRC/1235/2009, NMRC/1058/2006]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore)	This work was funded by the National Medical Research Council (NMRC) (Grant nos: NMRC/1235/2009, NMRC/1058/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHBAROU A, 1994, CANCER RES, V54, P2372; Ambrosino C, 2010, MOL CELL PROTEOMICS, V9, P1352, DOI 10.1074/mcp.M900519-MCP200; Ambrosio EP, 2011, HUM PATHOL; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Archer SK, 2005, BIOESSAYS, V27, P388, DOI 10.1002/bies.20200; Arora PD, 1996, J BIOL CHEM, V271, P20516, DOI 10.1074/jbc.271.34.20516; ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Baker EA, 2000, J CLIN PATHOL-MOL PA, V53, P307; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah MA, 2001, J BIOL CHEM, V276, P47434, DOI 10.1074/jbc.M107494200; Chou J, 2002, INT J BIOCHEM CELL B, V34, P776, DOI 10.1016/S1357-2725(01)00177-7; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; De Corte V, 2004, J CELL SCI, V117, P5283, DOI 10.1242/jcs.01410; De Corte V, 2002, EMBO J, V21, P6781, DOI 10.1093/emboj/cdf680; Delektorskaya VV, 2008, B EXP BIOL MED+, V146, P616, DOI 10.1007/s10517-009-0343-3; Dosaka-Akita H, 1998, CANCER RES, V58, P322; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gay F, 2008, HUM PATHOL, V39, P1420, DOI 10.1016/j.humpath.2008.02.020; Gettemans J, 2005, TRAFFIC, V6, P847, DOI 10.1111/j.1600-0854.2005.00326.x; GRONDAHLHANSEN J, 1991, AM J PATHOL, V138, P111; Harvey SR, 1999, AM J PATHOL, V155, P1115, DOI 10.1016/S0002-9440(10)65214-5; Herszenyi L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-194; HOLLAS W, 1991, CANCER RES, V51, P3690; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Jankun J, 2001, INT J MOL MED, V8, P365; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Kalwat MA, 2012, MOL ENDOCRINOL, V26, P128, DOI 10.1210/me.2011-1112; Katerinaki E, 2003, BRIT J CANCER, V89, P1123, DOI 10.1038/sj.bjc.6601257; Kim MJ, 2010, BIOCHEM PHARMACOL, V80, P2092, DOI 10.1016/j.bcp.2010.08.014; Le DM, 2003, J NEUROSCI, V23, P4034; Monea S, 2002, J CELL PHYSIOL, V192, P160, DOI 10.1002/jcp.10126; Nishimura K, 2003, CANCER RES, V63, P4888; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; PORTER RM, 1993, J PATHOL, V170, P435, DOI 10.1002/path.1711700406; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Rao JY, 2002, MODERN PATHOL, V15, p177A; Renoult C, 2001, EUR J BIOCHEM, V268, P6165, DOI 10.1046/j.0014-2956.2001.02574.x; Shariat SF, 2007, J CLIN ONCOL, V25, P349, DOI 10.1200/JCO.2006.05.6853; Shieh DB, 2006, ORAL ONCOL, V42, P599, DOI 10.1016/j.oraloncology.2005.10.021; Shieh DB, 1999, CANCER-AM CANCER SOC, V85, P47, DOI 10.1002/(SICI)1097-0142(19990101)85:1<47::AID-CNCR7>3.0.CO;2-L; Skelly MM, 1997, CLIN CANCER RES, V3, P1837; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Tanaka H, 2006, INT J CANCER, V118, P1680, DOI 10.1002/ijc.21559; Tapia T, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-6; Tay PN, 2010, INT J ONCOL, V37, P909, DOI 10.3892/ijo_00000742; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thor AD, 2001, CLIN CANCER RES, V7, P2415; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Visapaa H, 2003, UROLOGY, V61, P845, DOI 10.1016/S0090-4295(02)02404-4; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Webber MM, 1995, CLIN CANCER RES, V1, P755; Winston JS, 2001, BREAST CANCER RES TR, V65, P11, DOI 10.1023/A:1006446108411; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0	62	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2012	7	8							e43594	10.1371/journal.pone.0043594	http://dx.doi.org/10.1371/journal.pone.0043594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992PA	22927998	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000307789700042
J	Rivero, MR; Miras, SL; Feliziani, C; Zamponi, N; Quiroga, R; Hayes, SF; Ropolo, AS; Touz, MC				Rivero, Maria R.; Miras, Silvana L.; Feliziani, Constanza; Zamponi, Nahuel; Quiroga, Rodrigo; Hayes, Stanley F.; Ropolo, Andrea S.; Touz, Maria C.			Vacuolar Protein Sorting Receptor in Giardia lamblia	PLOS ONE			English	Article							ACID-PHOSPHATASE-ACTIVITY; CRYSTALLOID ENDOPLASMIC-RETICULUM; COMBINED TRANSMEMBRANE TOPOLOGY; SIGNAL PEPTIDE PREDICTION; CYST WALL PROTEINS; PRIMITIVE EUKARYOTE; LEISHMANIA-DONOVANI; MEMBRANE-PROTEIN; SURFACE PROTEIN; QUANTITATIVE-ANALYSIS	In Giardia, lysosome-like peripheral vacuoles (PVs) need to specifically coordinate their endosomal and lysosomal functions to be able to successfully perform endocytosis, protein degradation and protein delivery, but how cargo, ligands and molecular components generate specific routes to the PVs remains poorly understood. Recently, we found that delivering membrane Cathepsin C and the soluble acid phosphatase (AcPh) to the PVs is adaptin (AP1)-dependent. However, the receptor that links AcPh and AP1 was never described. We have studied protein-binding to AcPh by using H6-tagged AcPh, and found that a membrane protein interacted with AcPh. This protein, named GlVps (for Giardia lamblia Vacuolar protein sorting), mainly localized to the ER-nuclear envelope and in some PVs, probably functioning as the sorting receptor for AcPh. The tyrosine-binding motif found in the C-terminal cytoplasmic tail domain of GlVps was essential for its exit from the endoplasmic reticulum and transport to the vacuoles, with this motif being necessary for the interaction with the medium subunit of AP1. Thus, the mechanism by which soluble proteins, such as AcPh, reach the peripheral vacuoles in Giardia appears to be very similar to the mechanism of lysosomal protein-sorting in more evolved eukaryotic cells.	[Rivero, Maria R.; Miras, Silvana L.; Feliziani, Constanza; Zamponi, Nahuel; Ropolo, Andrea S.; Touz, Maria C.] Univ Nacl Cordoba, Inst Invest Med Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina; [Quiroga, Rodrigo] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina; [Hayes, Stanley F.] NIAID, Rocky Mt Lab, NIH, Hamilton, MT 59840 USA	National University of Cordoba; National University of Cordoba; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rivero, MR (corresponding author), Univ Nacl Cordoba, Inst Invest Med Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina.	ctouz@immf.uncor.edu	Quiroga, Rodrigo/GLT-7145-2022	Quiroga, Rodrigo/0000-0001-5015-0531; TOUZ, MARIA/0000-0002-6769-6896	Fogarty International Center [R01TW00724]; Argentine National Agency for the Promotion of Science and Technology (FONCyT); National Council for Sciences and Technology (CONICET)	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Argentine National Agency for the Promotion of Science and Technology (FONCyT); National Council for Sciences and Technology (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The project was supported by Grant Number R01TW00724 from the Fogarty International Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty International Center or the National Institutes of Health. This research was also supported in part by the Argentine National Agency for the Promotion of Science and Technology (FONCyT), and the National Council for Sciences and Technology (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abodeely M, 2009, EUKARYOT CELL, V8, P1665, DOI 10.1128/EC.00123-09; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Aguirre-Garcia MM, 2007, PARASITOL RES, V101, P85, DOI 10.1007/s00436-006-0457-8; BACA OG, 1993, INFECT IMMUN, V61, P4232, DOI 10.1128/IAI.61.10.4232-4239.1993; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; CEREGHINO JL, 1995, MOL BIOL CELL, V6, P1089, DOI 10.1091/mbc.6.9.1089; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Cox WG, 1999, J HISTOCHEM CYTOCHEM, V47, P1443, DOI 10.1177/002215549904701110; Elmendorf HG, 2001, NUCLEIC ACIDS RES, V29, P4674, DOI 10.1093/nar/29.22.4674; Faso C, 2011, INT J PARASITOL, V41, P471, DOI 10.1016/j.ijpara.2010.12.014; FEELY DE, 1987, J PROTOZOOL, V34, P80, DOI 10.1111/j.1550-7408.1987.tb03137.x; Filgueira L, 2004, J HISTOCHEM CYTOCHEM, V52, P411, DOI 10.1177/002215540405200312; Gabernet-Castello C, 2009, TRAFFIC, V10, P894, DOI 10.1111/j.1600-0854.2009.00910.x; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; GOTTLIEB M, 1981, EXP PARASITOL, V52, P117, DOI 10.1016/0014-4894(81)90067-9; Hehl AB, 2004, MOL MICROBIOL, V53, P19, DOI 10.1111/j.1365-2958.2004.04115.x; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hirst J, 2001, MOL BIOL CELL, V12, P3573, DOI 10.1091/mbc.12.11.3573; House SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002167; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; Jorgensen MU, 1999, EUR J BIOCHEM, V260, P461, DOI 10.1046/j.1432-1327.1999.00176.x; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Lakkaraju A, 2009, J CELL BIOL, V187, P161, DOI 10.1083/jcb.200909100; Lanfredi-Rangel A, 1998, J STRUCT BIOL, V123, P225, DOI 10.1006/jsbi.1998.4035; Leibowitz MP, 2009, VET PARASITOL, V166, P21, DOI 10.1016/j.vetpar.2009.08.005; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Lujan HD, 1996, BIOL CELL, V86, P11, DOI 10.1016/0248-4900(96)89519-0; LUJAN HD, 1995, J BIOL CHEM, V270, P4612, DOI 10.1074/jbc.270.9.4612; Lujan HD, 2003, CELL MICROBIOL, V5, P427, DOI 10.1046/j.1462-5822.2003.00284.x; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; MCCAFFERY JM, 1994, EXP PARASITOL, V79, P220, DOI 10.1006/expr.1994.1086; Meagher J, 2005, J HISTOCHEM CYTOCHEM, V53, P665, DOI 10.1369/jhc.4A6476.2005; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Mowbrey K, 2009, FEBS LETT, V583, P3738, DOI 10.1016/j.febslet.2009.10.025; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; NASH TE, 1995, J EUKARYOT MICROBIOL, V42, P604, DOI 10.1111/j.1550-7408.1995.tb05914.x; NASH TE, 1988, J IMMUNOL, V141, P636; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; Papanastasiou P, 1997, BIOCHEM J, V322, P49, DOI 10.1042/bj3220049; Penarrubia PG, 2005, IEEE T IMAGE PROCESS, V14, P1151, DOI 10.1109/TIP.2005.851699; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; REINER DS, 1990, EUR J CELL BIOL, V53, P142; Ringqvist E, 2008, MOL BIOCH PARASITOL; Rivero M. R., 2010, BIOCH J; Rivero MR, 2011, MOL MICROBIOL, V79, P1204, DOI 10.1111/j.1365-2958.2010.07512.x; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Shakarian AM, 2002, J BIOL CHEM, V277, P17994, DOI 10.1074/jbc.M200114200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SINGLA N, 1992, FEMS MICROBIOL LETT, V94, P221, DOI 10.1111/j.1574-6968.1992.tb05322.x; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Slavin I, 2002, MOL BIOCHEM PARASIT, V122, P95, DOI 10.1016/S0166-6851(02)00065-8; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sun H, 2000, ANAT RECORD, V260, P158, DOI 10.1002/1097-0185(20001001)260:2<158::AID-AR60>3.0.CO;2-V; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; Touz Maria C, 2012, Front Biosci (Elite Ed), V4, P1898; Touz MC, 2005, MOL MICROBIOL, V58, P999, DOI 10.1111/j.1365-2958.2005.04891.x; Touz MC, 2004, MOL BIOL CELL, V15, P3053, DOI 10.1091/mbc.E03-10-0744; Touz MC, 2003, J BIOL CHEM, V278, P6420, DOI 10.1074/jbc.M208354200; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; van Aarle IM, 2005, NEW PHYTOL, V166, P611, DOI 10.1111/j.1469-8137.2005.01340.x; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; von Heijne G, 1999, Q REV BIOPHYS, V32, P285, DOI 10.1017/S0033583500003541; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; Ward W, 1997, CELL, V89, P437, DOI 10.1016/S0092-8674(00)80224-X; WINTHER JR, 1991, EUR J BIOCHEM, V197, P681, DOI 10.1111/j.1432-1033.1991.tb15959.x; YEE J, 1995, P NATL ACAD SCI USA, V92, P5615, DOI 10.1073/pnas.92.12.5615; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhu C, 2005, MICROSC MICROANAL, V11, P244, DOI 10.1017/S143192760505049X; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	85	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43712	10.1371/journal.pone.0043712	http://dx.doi.org/10.1371/journal.pone.0043712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916299	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800097
J	Schneider, RD; Fogaca, NDS; Kmetzsch, L; Schrank, A; Vainstein, MH; Staats, CC				Schneider, Rafael de Oliveira; Sueffert Fogaca, Natully de Souza; Kmetzsch, Livia; Schrank, Augusto; Vainstein, Marilene Henning; Staats, Charley Christian			Zap1 Regulates Zinc Homeostasis and Modulates Virulence in Cryptococcus gattii	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; FUNGAL PATHOGENESIS; GENE-EXPRESSION; NEOFORMANS; IRON; IDENTIFICATION; ACQUISITION; DEFICIENCY; TRANSPORT; REGULON	Zinc homeostasis is essential for fungal growth, as this metal is a critical structural component of several proteins, including transcription factors. The fungal pathogen Cryptococcus gattii obtains zinc from the stringent zinc-limiting milieu of the host during the infection process. To characterize the zinc metabolism in C. gattii and its relationship to fungal virulence, the zinc finger protein Zap1 was functionally characterized. The C. gattii ZAP1 gene is an ortholog of the master regulatory genes zafA and ZAP1 that are found in Aspergillus fumigatus and Saccharomyces cerevisiae, respectively. There is some evidence to support an association between Zap1 and zinc metabolism in C. gattii: (i) ZAP1 expression is highly induced during zinc deprivation, (ii) ZAP1 knockouts demonstrate impaired growth in zinc-limiting conditions, (iii) Zap1 regulates the expression of ZIP zinc transporters and distinct zinc-binding proteins and (iv) Zap1 regulates the labile pool of intracellular zinc. In addition, the deletion of ZAP1 reduces C. gattii virulence in a murine model of cryptococcosis infection. Based on these observations, we postulate that proper zinc metabolism plays a crucial role in cryptococcal virulence.	[Schneider, Rafael de Oliveira; Sueffert Fogaca, Natully de Souza; Kmetzsch, Livia; Schrank, Augusto; Vainstein, Marilene Henning; Staats, Charley Christian] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Schrank, Augusto; Vainstein, Marilene Henning; Staats, Charley Christian] Univ Fed Rio Grande do Sul, Dept Biol Mol & Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Schneider, RD (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.	staats@cbiot.ufrgs.br	Schrank, Augusto/G-4688-2012; Kmetzsch, Livia/H-4033-2015; Vainstein, Marilene H/J-5452-2014; Staats, Charley Christian/J-4283-2014	Schrank, Augusto/0000-0002-5248-4620; Kmetzsch, Livia/0000-0003-3766-5869; Vainstein, Marilene H/0000-0002-3914-2300; Staats, Charley Christian/0000-0002-2433-6903	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [476029/2010-4]; Financiadora de Estudos e Projetos (FINEP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This work was supported by grants from the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ 476029/2010-4), Financiadora de Estudos e Projetos (FINEP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrnes E.J., 2009, F1000 BIOL REP; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; Ding C, 2011, MOL MICROBIOL, V81, P1560, DOI 10.1111/j.1365-2958.2011.07794.x; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Eide DJ, 2003, J NUTR, V133, p1532S, DOI 10.1093/jn/133.5.1532S; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Flohe L, 2011, ANTIOXID REDOX SIGN, V15, P763, DOI 10.1089/ars.2010.3397; Gross NT, 1999, MED MYCOL, V37, P151, DOI 10.1046/j.1365-280X.1999.00209.x; Howard DH, 1999, CLIN MICROBIOL REV, V12, P394, DOI 10.1128/CMR.12.3.394; Huffnagle GB, 1998, J IMMUNOL, V160, P2393; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Jung WH, 2008, CELL MICROBIOL, V10, P277, DOI 10.1111/j.1462-5822.2007.01077.x; Jung WH, 2006, PLOS BIOL, V4, P2282, DOI 10.1371/journal.pbio.0040410; Jung WH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001209; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kim MJ, 2008, J MICROBIOL BIOTECHN, V18, P242; Kmetzsch L, 2011, FUNGAL GENET BIOL, V48, P192, DOI 10.1016/j.fgb.2010.07.011; Kmetzsch L, 2010, EUKARYOT CELL, V9, P1798, DOI 10.1128/EC.00114-10; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; Ma HS, 2009, ADV APPL MICROBIOL, V67, P131, DOI 10.1016/S0065-2164(08)01005-8; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mambula SS, 2000, INFECT IMMUN, V68, P6257, DOI 10.1128/IAI.68.11.6257-6264.2000; Maret W, 2010, METALLOMICS, V2, P117, DOI 10.1039/b915804a; Meinicke P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-409; Missall TA, 2005, MICROBIOL-SGM, V151, P2573, DOI 10.1099/mic.0.28132-0; Moreno MA, 2007, MOL MICROBIOL, V64, P1182, DOI 10.1111/j.1365-2958.2007.05726.x; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Waterman SR, 2007, J CLIN INVEST, V117, P794, DOI 10.1172/JCI30006; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; Winters MS, 2010, J INFECT DIS, V202, P1136, DOI 10.1086/656191; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	56	64	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43773	10.1371/journal.pone.0043773	http://dx.doi.org/10.1371/journal.pone.0043773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916306	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800103
J	Tsagogiorgas, C; Wedel, J; Hottenrott, M; Schneider, MO; Binzen, U; Greffrath, W; Treede, RD; Theisinger, B; Theisinger, S; Waldherr, R; Kramer, BK; Thiel, M; Schnuelle, P; Yard, BA; Hoeger, S				Tsagogiorgas, Charalambos; Wedel, Johannes; Hottenrott, Maximilia; Schneider, Michael O.; Binzen, Uta; Greffrath, Wolfgang; Treede, Rolf-Detlef; Theisinger, Bastian; Theisinger, Sonja; Waldherr, Ruediger; Kraemer, Bernhard K.; Thiel, Manfred; Schnuelle, Peter; Yard, Benito A.; Hoeger, Simone			N-octanoyl-Dopamine Is an Agonist at the Capsaicin Receptor TRPV1 and Mitigates Is Chemia-Induced Acute Kidney Injury in Rat	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; LOW-DOSE DOPAMINE; KAPPA-B ACTIVATION; ISCHEMIA/REPERFUSION-INJURY; IMMUNOSUPPRESSIVE ACTIVITY; POTENTIAL VANILLOID-1; SUBSTANCE-P; IN-VIVO; PRETREATMENT; DYSFUNCTION	Since stimulation of transient receptor potential channels of the vanilloid receptor subtype 1 (TRPV1) mitigates acute kidney injury (AKI) and endogenous N-acyl dopamine derivatives are able to activate TRPV1, we tested if synthetic N-octanoyl-dopamine (NOD) activates TRPV1 and if it improves AKI. These properties of NOD and its intrinsic anti-inflammatory character were compared with those of dopamine (DA). TRPV1 activation and anti-inflammatory properties of NOD and DA were tested using primary cell cultures in vitro. The influence of NOD and DA on AKI was tested in a prospective, randomized, controlled animal study with 42 inbred male Lewis rats (LEW, RT1), treated intravenously with equimolar concentrations of DA or NOD one hour before the onset of warm ischemia and immediately before clamp release. NOD, but not DA, activates TRPV1 channels in isolated dorsal root ganglion neurons (DRG) that innervate several tissues including kidney. In TNF alpha stimulated proximal tubular epithelial cells, inhibition of NFkB and subsequent inhibition of VCAM1 expression by NOD was significantly stronger than by DA. NOD improved renal function compared to DA and saline controls. Histology revealed protective effects of NOD on tubular epithelium at day 5 and a reduced number of monocytes in renal tissue of DA and NOD treated rats. Our data demonstrate that NOD but not DA activates TRPV1 and that NOD has superior anti-inflammatory properties in vitro. Although NOD mitigates deterioration in renal function after AKI, further studies are required to assess to what extend this is causally related to TRPV1 activation and/or desensitization.	[Tsagogiorgas, Charalambos; Hottenrott, Maximilia; Thiel, Manfred] Heidelberg Univ, Fac Med, Univ Med Ctr, Dept Anaesthesiol & Intens Care Med, D-6800 Mannheim, Germany; [Wedel, Johannes; Schneider, Michael O.; Waldherr, Ruediger; Kraemer, Bernhard K.; Schnuelle, Peter; Yard, Benito A.; Hoeger, Simone] Heidelberg Univ, Fac Med, Univ Med Ctr, Dept Med Nephrol Endocrinol Rheumatol 5, D-6800 Mannheim, Germany; [Binzen, Uta; Greffrath, Wolfgang; Treede, Rolf-Detlef] Heidelberg Univ, Fac Med, Ctr Biomed & Med Technol CBTM, Div Neurophysiol, D-6800 Mannheim, Germany; [Theisinger, Bastian; Theisinger, Sonja] Novaliq GmbH, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Tsagogiorgas, C (corresponding author), Heidelberg Univ, Fac Med, Univ Med Ctr, Dept Anaesthesiol & Intens Care Med, D-6800 Mannheim, Germany.	charalambos.tsagogiorgas@medma.uni-heidelberg.de	Treede, Rolf-Detlef/I-3632-2014	Treede, Rolf-Detlef/0000-0001-8065-1708; Wedel, Johannes/0000-0002-3490-8477	Novaliq GmbH, Heidelberg, Germany; Deutsche Forschungsgemeinschaft [INST 91027/10-1 FUGG]; Novaliq GmbH	Novaliq GmbH, Heidelberg, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Novaliq GmbH	This study was partially supported by grants from Novaliq GmbH, Heidelberg, Germany and by the Deutsche Forschungsgemeinschaft (INST 91027/10-1 FUGG). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BT and ST are employed by Novaliq GmbH, Heidelberg. BAY is financially supported by Novaliq GmbH. All other submitting authors declare that they do not have any conflict of interest with this publication. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Alawi K, 2010, PHARMACOL THERAPEUT, V125, P181, DOI 10.1016/j.pharmthera.2009.10.005; Almasi R, 2008, LIFE SCI, V82, P644, DOI 10.1016/j.lfs.2007.12.022; Azuma H, 2003, GENE THER, V10, P415, DOI 10.1038/sj.gt.3301882; Beck GC, 2004, CRIT CARE, V8, P485, DOI 10.1186/cc2879; Bellomo R, 2000, LANCET, V356, P2139; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Brinkkoetter PT, 2006, TRANSPLANTATION, V82, P534, DOI 10.1097/01.tp.0000229396.34362.e2; Cao CC, 2004, KIDNEY INT, V65, P834, DOI 10.1111/j.1523-1755.2004.00463.x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Chen CW, 2003, BRIT J PHARMACOL, V140, P1077, DOI 10.1038/sj.bjp.0705533; Chertow GM, 2006, KIDNEY INT, V70, P1120, DOI 10.1038/sj.ki.5001579; Connor M, 2010, BRIT J PHARMACOL, V160, P1857, DOI 10.1111/j.1476-5381.2010.00862.x; Demirbilek S, 2004, ANESTH ANALG, V99, P1501, DOI 10.1213/01.ANE.0000132975.02854.65; Ditting T, 2009, AM J PHYSIOL-RENAL, V297, pF1427, DOI 10.1152/ajprenal.90599.2008; DUKE GJ, 1992, ANAESTH INTENS CARE, V20, P277, DOI 10.1177/0310057X9202000302; EDELSTEIN CL, 2007, PATHOPHYSIOLOGY ISCH; Feng NH, 2008, AM J PHYSIOL-RENAL, V294, pF316, DOI 10.1152/ajprenal.00308.2007; Friedewald JJ, 2004, KIDNEY INT, V66, P486, DOI 10.1111/j.1523-1755.2004.761_3.x; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; Gottmann U, 2006, KIDNEY INT, V70, P321, DOI 10.1038/sj.ki.5001501; Greffrath W, 2003, NEUROREPORT, V14, P2251, DOI 10.1097/00001756-200312020-00023; Greffrath W, 2001, NEUROSCIENCE, V104, P539, DOI 10.1016/S0306-4522(01)00088-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210, DOI 10.1016/S0005-2760(96)00122-1; Hoeger S, 2007, TRANSPL INT, V20, P790, DOI 10.1111/j.1432-2277.2007.00510.x; Holmes CL, 2003, CHEST, V123, P1266, DOI 10.1378/chest.123.4.1266; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Joannidis M, 2010, INTENS CARE MED, V36, P392, DOI 10.1007/s00134-009-1678-y; Kapper S, 2002, TRANSPLANTATION, V74, P253, DOI 10.1097/00007890-200207270-00017; Katki KA, 2001, HYPERTENSION, V38, P679, DOI 10.1161/hy09t1.095761; Keeble J, 2005, ARTHRITIS RHEUM, V52, P3248, DOI 10.1002/art.21297; Kellum JA, 2001, CRIT CARE MED, V29, P1526, DOI 10.1097/00003246-200108000-00005; Kellum JA, 2008, CRIT CARE MED, V36, pS141, DOI 10.1097/CCM.0b013e318168c4a4; Kim CS, 2003, CELL SIGNAL, V15, P299, DOI 10.1016/S0898-6568(02)00086-4; KindgenMilles D, 1997, ANASTH INTENSIV NOTF, V32, P333, DOI 10.1055/s-2007-995065; Lameire N, 2008, LANCET, V372, P1863, DOI 10.1016/S0140-6736(08)61794-8; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Losel RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009713; Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4; Navarrete CM, 2010, BIOCHEM PHARMACOL, V79, P1805, DOI 10.1016/j.bcp.2010.02.014; Rayamajhi S, 2009, CURR OPIN INVEST DR, V10, P963; Sancho R, 2004, J IMMUNOL, V172, P2341, DOI 10.4049/jimmunol.172.4.2341; Sancho R, 2002, EUR J IMMUNOL, V32, P1753, DOI 10.1002/1521-4141(200206)32:6<1753::AID-IMMU1753>3.0.CO;2-2; Schnuelle P, 2009, JAMA-J AM MED ASSOC, V302, P1067, DOI 10.1001/jama.2009.1310; Singh D, 2006, J MED FOOD, V9, P443, DOI 10.1089/jmf.2006.9.443; Singh S, 1996, J IMMUNOL, V157, P4412; Song H, 2009, BR J PHARM; Surh YJ, 2000, BIOFACTORS, V12, P107, DOI 10.1002/biof.5520120117; Szabo A, 2005, J PHARMACOL EXP THER, V314, P111, DOI 10.1124/jpet.104.082487; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ueda K, 2008, J CARDIOVASC PHARM, V51, P513, DOI 10.1097/FJC.0b013e31816f6884; Wang H, 2010, AM J PHYSIOL-REG I, V298, pR1634, DOI 10.1152/ajpregu.00235.2009; Wang M, 2010, J SURG RES; Yamanobe T, 2007, FREE RADICAL RES, V41, P200, DOI 10.1080/10715760601038791; Zhong BH, 2008, AM J PHYSIOL-HEART C, V295, pH728, DOI 10.1152/ajpheart.00022.2008; Zoja C, 2009, FRONT BIOSCI-LANDMRK, V14, P1815, DOI 10.2741/3343	60	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2012	7	8							e43525	10.1371/journal.pone.0043525	http://dx.doi.org/10.1371/journal.pone.0043525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	991WJ	22916273	Green Published, gold, Green Submitted			2022-12-27	WOS:000307733800076
J	Masiewicz, P; Brzostek, A; Wolanski, M; Dziadek, J; Zakrzewska-Czerwinska, J				Masiewicz, Pawel; Brzostek, Anna; Wolanski, Marcin; Dziadek, Jaroslaw; Zakrzewska-Czerwinska, Jolanta			A Novel Role of the PrpR as a Transcription Factor Involved in the Regulation of Methylcitrate Pathway in Mycobacterium tuberculosis	PLOS ONE			English	Article							CHOLESTEROL CATABOLISM; ISOCITRATE LYASE-1; MACROPHAGES; METABOLISM; SURVIVAL; REQUIRES; GROWTH; PERSISTENCE; EXPRESSION; GLYOXYLATE	Mycobacterium tuberculosis, the pathogen that causes tuberculosis, presumably utilizes fatty acids as a major carbon source during infection within the host. Metabolism of even-chain-length fatty acids yields acetyl-CoA, whereas metabolism of odd-chain-length fatty acids additionally yields propionyl-CoA. Utilization of these compounds by tubercle bacilli requires functional glyoxylate and methylcitrate cycles, respectively. Enzymes involved in both pathways are essential for M. tuberculosis viability and persistence during growth on fatty acids. However, little is known about regulatory factors responsible for adjusting the expression of genes encoding these enzymes to particular growth conditions. Here, we characterized the novel role of PrpR as a transcription factor that is directly involved in regulating genes encoding the key enzymes of methylcitrate (methylcitrate dehydratase [PrpD] and methylcitrate synthase [PrpC]) and glyoxylate (isocitrate lyase [Icl1]) cycles. Using cell-free systems and intact cells, we demonstrated an interaction of PrpR protein with prpDC and icl1 promoter regions and identified a consensus sequence recognized by PrpR. Moreover, we showed that an M. tuberculosis prpR-deletion strain exhibits impaired growth in vitro on propionate as the sole carbon source. Real-time quantitative reverse transcription-polymerase chain reaction confirmed that PrpR acts as a transcriptional activator of prpDC and icl1 genes when propionate is the main carbon source. Similar results were also obtained for a non-pathogenic Mycobacterium smegmatis strain. Additionally, we found that ramB, a prpR paralog that controls the glyoxylate cycle, is negatively regulated by PrpR. Our data demonstrate that PrpR is essential for the utilization of odd-chain-length fatty acids by tubercle bacilli. Since PrpR also acts as a ramB repressor, our findings suggest that it plays a key role in regulating expression of enzymes involved in both glyoxylate and methylcitrate pathways.	[Masiewicz, Pawel; Zakrzewska-Czerwinska, Jolanta] Polish Acad Sci, Dept Microbiol, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Brzostek, Anna; Dziadek, Jaroslaw] Polish Acad Sci, Lab Mycobacterium Genet & Physiol, Inst Med Biol, Lodz, Poland; [Wolanski, Marcin; Zakrzewska-Czerwinska, Jolanta] Univ Wroclaw, Dept Mol Microbiol, Fac Biotechnol, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Wroclaw	Masiewicz, P (corresponding author), Polish Acad Sci, Dept Microbiol, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland.	jolanta.zakrzewska@uni.wroc.pl	Wolański, Marcin/K-8452-2013	Wolański, Marcin/0000-0003-4714-0716; Dziadek, Jaroslaw/0000-0003-1427-884X	WCB EIT+ (POIG 1.1. EIT+) [3.1. BioMed]; Foundation for Polish Science (MISTRZ Programme)	WCB EIT+ (POIG 1.1. EIT+); Foundation for Polish Science (MISTRZ Programme)	This work was supported by the WCB EIT+ (POIG 1.1. EIT+, Project 3.1. BioMed) (http://www.eitplus.pl/language/en/). JZC and PM gratefully acknowledge financial support received from the Foundation for Polish Science (MISTRZ Programme) (http://www.fnp.org.pl/index.php?lng = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Datta P, 2011, J BACTERIOL, V193, P1154, DOI 10.1128/JB.00459-10; Gould TA, 2006, MOL MICROBIOL, V61, P940, DOI 10.1111/j.1365-2958.2006.05297.x; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Horswill AR, 2001, J BIOL CHEM, V276, P19094, DOI 10.1074/jbc.M100244200; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Joshi SM, 2006, P NATL ACAD SCI USA, V103, P11760, DOI 10.1073/pnas.0603179103; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Klinkenberg LG, 2008, J INFECT DIS, V198, P275, DOI 10.1086/589515; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Micklinghoff JC, 2009, J BACTERIOL, V191, P7260, DOI 10.1128/JB.01009-09; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tran SL, 2005, MICROBIOL-SGM, V151, P665, DOI 10.1099/mic.0.27624-0; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344	35	37	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e43651	10.1371/journal.pone.0043651	http://dx.doi.org/10.1371/journal.pone.0043651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22916289	Green Published, gold, Green Submitted			2022-12-27	WOS:000307824300056
J	Xu, Q; Ma, PQ; Hu, CF; Chen, LC; Xue, LY; Wang, ZZ; Liu, M; Zhu, HX; Xu, NZ; Lu, N				Xu, Qing; Ma, Peiqing; Hu, Chenfei; Chen, Lechuang; Xue, Liyan; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi; Lu, Ning			Overexpression of the DEC1 Protein Induces Senescence In Vitro and Is Related to Better Survival in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; TRANSCRIPTION FACTOR; EXPRESSION; STRA13; CANCER; BARRIER; P21(WAF1/CIP1); GENE; DIFFERENTIATION; TUMORIGENESIS	Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related death in China and has limited effective therapeutic options except for early surgery, since the underlying molecular mechanism driving its precursor lesions towards invasive ESCC is not fully understood. Cellular senescence is the state of the permanent growth arrest of a cell, and is considered as the initial barrier of tumor development. Human differentiated embryo chondrocyte expressed gene 1 (Dec1) is an important transcription factor that related to senescence. In this study, DEC1 immunohistochemical analysis was performed on tissue microarray blocks constructed from ESCC combined with adjacent precursor tissues of 241 patients. Compared with normal epithelia, DEC1 expression was significantly increased in intraepithelial neoplasia and DEC1 expression was significantly decreased in ESCC in comparison with intraepithelial neoplasia. In vitro, DEC1 overexpression induced cellular senescence, and it inhibited cell growth and colony formation in ESCC cell line EC9706. Fresh esophagectomy tissue sections from five ESCC patients were detected by immunohistochemistry of DEC1 and senescence-associated beta-galactosidase (SA-beta-Gal) activity, and strongly positive expression of DEC1 was correlated to more senescent cells in these fresh tissue sections. Kaplan - Meier method analysis of the 241 patients revealed that DEC1 expression levels were significantly correlated with the survival of ESCC patients after surgery. The expression levels of DEC1 were also correlated with age, tumor embolus, depth of invasion of ESCC, lymph metastasis status and pTNMs. These results suggest that DEC1 overexpression in precursor lesions of ESCC is a protective mechanism by inducing cellular senescence in ESCC initiation, and DEC1 may be a potential prognostic marker of ESCC.	[Xu, Qing; Hu, Chenfei; Chen, Lechuang; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Inst & Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China; [Xu, Qing; Hu, Chenfei; Chen, Lechuang; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Inst & Canc Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Xu, Qing; Ma, Peiqing; Hu, Chenfei; Chen, Lechuang; Xue, Liyan; Wang, Zaozao; Liu, Mei; Zhu, Hongxia; Xu, Ningzhi; Lu, Ning] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Peiqing; Xue, Liyan; Lu, Ning] Chinese Acad Med Sci, Canc Inst & Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Xu, Q (corresponding author), Chinese Acad Med Sci, Canc Inst & Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China.	ningzhi.xu@gmail.com; nlu03@126.com	Chen, Lechuang/AAF-8351-2020; Wang, Chengshu/A-1656-2011; Xiao, Guohua/G-3083-2013	Wang, Chengshu/0000-0003-1477-1466; Xiao, Guohua/0000-0003-3407-2734	National Natural Science Foundation [81021061, 31171322, 30770973, 39925020]; 863 Project grant [2006AA02A403]; Basic Research Program of CICAMS [JK2011B26]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 863 Project grant; Basic Research Program of CICAMS	This work was funded by National Natural Science Foundation (81021061, 31171322, 30770973, 39925020) (http://www.nsfc.gov.cn/), 863 Project grant (2006AA02A403) (http://www.863.gov.cn/), Basic Research Program of CICAMS (JK2011B26) (http://www.cicams.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campo-Trapero J, 2008, ACTA ONCOL, V47, P1464, DOI 10.1080/02841860802183612; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Chandeck C, 2010, ADV ANAT PATHOL, V17, P42, DOI 10.1097/PAP.0b013e3181c66f4e; Chang MS, 2005, PATHOL RES PRACT, V201, P417, DOI 10.1016/j.prp.2005.04.005; Chen X, 2002, CELL RES, V12, P229, DOI 10.1038/sj.cr.7290129; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cohen DJ, 2011, EXPERT OPIN PHARMACO, V12, P225, DOI 10.1517/14656566.2010.517748; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Decottignies A, 2011, SEMIN CANCER BIOL, V21, P360, DOI 10.1016/j.semcancer.2011.09.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Guillaumond F, 2008, BIOCHEM BIOPH RES CO, V369, P1184, DOI 10.1016/j.bbrc.2008.03.009; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; OGASAWARA S, 1995, CANCER RES, V55, P891; Ohbu M, 2001, HISTOPATHOLOGY, V39, P589, DOI 10.1046/j.1365-2559.2001.01279.x; Ohtani N, 2012, EXP DERMATOL, V21, P1, DOI 10.1111/j.1600-0625.2012.01493.x; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Sakai N, 2010, DIS ESOPHAGUS, V23, P415, DOI 10.1111/j.1442-2050.2009.01026.x; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Shi XH, 2011, WORLD J GASTROENTERO, V17, P2037, DOI 10.3748/wjg.v17.i15.2037; Shirakawa Y, 2000, CLIN CANCER RES, V6, P541; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Tsai MH, 2011, ANN SURG ONCOL, V18, P2662, DOI 10.1245/s10434-011-1603-9; Turley H, 2004, J PATHOL, V203, P808, DOI 10.1002/path.1585; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Vallbohmer D, 2006, DIS ESOPHAGUS, V19, P425, DOI 10.1111/j.1442-2050.2006.00622.x; Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631; Wang WB, 2010, BIOCHEM BIOPH RES CO, V401, P422, DOI 10.1016/j.bbrc.2010.09.070; Xue L, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-296; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014	57	34	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41862	10.1371/journal.pone.0041862	http://dx.doi.org/10.1371/journal.pone.0041862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22937093	Green Published, Green Submitted, gold			2022-12-27	WOS:000306687700160
J	Chen, XJ; Liu, YK; Zhou, YH; Wang, L; Perc, M				Chen, Xiaojie; Liu, Yongkui; Zhou, Yonghui; Wang, Long; Perc, Matjaz			Adaptive and Bounded Investment Returns Promote Cooperation in Spatial Public Goods Games	PLOS ONE			English	Article							RISK SOCIAL DILEMMA; PRISONERS-DILEMMA; REPLICATOR DYNAMICS; EVOLUTIONARY GAMES; DIVERSITY PROMOTES; EMERGENCE; SELECTION; NETWORKS; TRAGEDY; REWARD	The public goods game is one of the most famous models for studying the evolution of cooperation in sizable groups. The multiplication factor in this game can characterize the investment return from the public good, which may be variable depending on the interactive environment in realistic situations. Instead of using the same universal value, here we consider that the multiplication factor in each group is updated based on the differences between the local and global interactive environments in the spatial public goods game, but meanwhile limited to within a certain range. We find that the adaptive and bounded investment returns can significantly promote cooperation. In particular, full cooperation can be achieved for high feedback strength when appropriate limitation is set for the investment return. Also, we show that the fraction of cooperators in the whole population can become larger if the lower and upper limits of the multiplication factor are increased. Furthermore, in comparison to the traditionally spatial public goods game where the multiplication factor in each group is identical and fixed, we find that cooperation can be better promoted if the multiplication factor is constrained to adjust between one and the group size in our model. Our results highlight the importance of the locally adaptive and bounded investment returns for the emergence and dominance of cooperative behavior in structured populations.	[Chen, Xiaojie] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Liu, Yongkui] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China; [Liu, Yongkui] Changan Univ, Sch Elect & Control Engn, Xian, Peoples R China; [Liu, Yongkui] Changan Univ, Ctr Rd Traff Intelligent Detect & Equipment Engn, Xian, Peoples R China; [Zhou, Yonghui] Guizhou Normal Univ, Sch Math & Comp Sci, Guiyang, Peoples R China; [Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, Maribor, Slovenia	International Institute for Applied Systems Analysis (IIASA); Beihang University; Chang'an University; Chang'an University; Guizhou Normal University; Peking University; University of Maribor	Chen, XJ (corresponding author), Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria.	chenx@iiasa.ac.at; matjaz.perc@uni-mb.si	Perc, Matjaz/A-5148-2009; Liu, Yongkui/R-9307-2017; Wang, Long/A-7798-2010; Gao, Y./GWZ-3665-2022	Perc, Matjaz/0000-0002-3087-541X; Liu, Yongkui/0000-0003-2165-775X; Wang, Long/0000-0001-5600-8157; 	Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University; Special Fund for the Basic Research Support Planning of Chang'an University; Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province [CHD2010JC134]; National Natural Science Foundation of China (NSFC) [11161011]; 973 Program [2012CB821203]; NSFC [61020106005, 10972002]; Slovenian Research Agency [J1-4055]	Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University; Special Fund for the Basic Research Support Planning of Chang'an University; Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	YL acknowledges the financial support from the Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University, the Special Fund for the Basic Research Support Planning of Chang'an University, and the Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province (Grant no. CHD2010JC134). YZ acknowledges the financial support from the National Natural Science Foundation of China (NSFC) (grant no. 11161011). LW acknowledges the financial support from 973 Program (2012CB821203) and the NSFC (grant nos. 61020106005 and 10972002). MP acknowledges the financial support from the Slovenian Research Agency (grant J1-4055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Baldassarri D, 2011, P NATL ACAD SCI USA, V108, P11023, DOI 10.1073/pnas.1105456108; Boza G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-336; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Cardillo A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103034; Cressman R, 2012, J THEOR BIOL, V299, P144, DOI 10.1016/j.jtbi.2011.07.030; Deng KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025496; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Fort H, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48008; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Gomez-Gardenes J, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/68003; Gomez-Gardenes J, 2008, J THEOR BIOL, V253, P296, DOI 10.1016/j.jtbi.2008.03.007; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3535579; Greenwood G, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/40006; Guan JY, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056101; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; Hauert C, 2010, J THEOR BIOL, V267, P22, DOI 10.1016/j.jtbi.2010.08.009; Heitzig J, 2011, P NATL ACAD SCI USA, V108, P15739, DOI 10.1073/pnas.1106265108; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Huang ZG, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/28001; Janssen MA, 2006, J THEOR BIOL, V243, P134, DOI 10.1016/j.jtbi.2006.06.012; Kamimura Y, 2008, J THEOR BIOL, V252, P277, DOI 10.1016/j.jtbi.2008.02.017; Kogan L, 2004, J FINANC ECON, V73, P411, DOI 10.1016/j.jfineco.2003.12.002; Lee S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028702; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037102; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pestelacci E, 2008, LECT NOTES COMPUT SC, V5199, P539, DOI 10.1007/978-3-540-87700-4_54; Pestelacci E, 2010, LECT NOTES COMPUT SC, V6239, P512, DOI 10.1007/978-3-642-15871-1_52; Poncela J, 2009, NEW J PHYS, V11; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.047101; Rong ZH, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/30001; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Sasaki T, 2007, P ROY SOC B-BIOL SCI, V274, P2639, DOI 10.1098/rspb.2007.0673; Sasaki T, 2011, J THEOR BIOL, V287, P109, DOI 10.1016/j.jtbi.2011.07.026; Shi DM, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/58003; Short MB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066114; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.047102; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046106; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057101; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tomochi M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026112; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; Vukov J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026109; Vukov J, 2011, J THEOR BIOL, V287, P37, DOI 10.1016/j.jtbi.2011.07.022; Wakano JY, 2007, J THEOR BIOL, V247, P616, DOI 10.1016/j.jtbi.2007.04.008; Wakano JY, 2009, P NATL ACAD SCI USA, V106, P7910, DOI 10.1073/pnas.0812644106; Wang J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016101; Wu T, 2009, EPL, V90, P20001; Wu T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026121; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Xu Z, 2010, EPL, V88, P30011; Yang HX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056107; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	80	68	68	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36895	10.1371/journal.pone.0036895	http://dx.doi.org/10.1371/journal.pone.0036895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22928023	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000305341300038
J	Zhou, X; Marian, C; Makambi, KH; Kosti, O; Kallakury, BVS; Loffredo, CA; Zheng, YL				Zhou, Xin; Marian, Catalin; Makambi, Kepher H.; Kosti, Ourania; Kallakury, Bhaskar V. S.; Loffredo, Christopher A.; Zheng, Yun-Ling			MicroRNA-9 as Potential Biomarker for Breast Cancer Local Recurrence and Tumor Estrogen Receptor Status	PLOS ONE			English	Article							CONSERVING THERAPY; EXPRESSION PROFILES; EPIGENETIC REGULATION; RISK-FACTORS; CELL; CARCINOMAS; MASTECTOMY; SURVIVAL; SURGERY; RADIOTHERAPY	MicroRNAs (miRs) are small, non-protein coding transcripts involved in many cellular functions. Many miRs have emerged as important cancer biomarkers. In the present study, we investigated whether miR levels in breast tumors are predictive of breast cancer local recurrence (LR). Sixty-eight women who were diagnosed with breast cancer at the Lombardi Comprehensive Cancer Center were included in this study. Breast cancer patients with LR and those without LR were matched on year of surgery, age at diagnosis, and type of surgery. Candidate miRs were identified by screening the expression levels of 754 human miRs using miR arrays in 16 breast tumor samples from 8 cases with LR and 8 cases without LR. Eight candidate miRs that showed significant differences between tumors with and without LR were further verified in 52 tumor samples using real-time PCR. Higher expression of miR-9 was significantly associated with breast cancer LR in all cases as well as the subset of estrogen receptor (ER) positive cases (p = 0.02). The AUCs (Area Under Curve) of receiver operating characteristic (ROC) curves of miR-9 for all tumors and ER positive tumors are 0.68 (p = 0.02) and 0.69 (p = 0.02), respectively. In ER positive cases, Kaplan-Meier analysis showed that patients with lower miR-9 levels had significantly better 10-year LR-free survival (67.9% vs 30.8%, p = 0.02). Expression levels of miR-9 and another miR candidate, miR-375, were also strongly associated with ER status (p<0.001 for both). The potential of miR-9 as a biomarker for LR warrants further investigation with larger sample size.	[Zhou, Xin; Marian, Catalin; Makambi, Kepher H.; Kosti, Ourania; Loffredo, Christopher A.; Zheng, Yun-Ling] Georgetown Univ, Canc Prevent & Control Program, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Kallakury, Bhaskar V. S.] Georgetown Univ, Dept Pathol, Lombardi Comprehens Canc Ctr, Washington, DC USA	Georgetown University; Georgetown University	Zhou, X (corresponding author), Georgetown Univ, Canc Prevent & Control Program, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	yz37@georgetown.edu	Marian, Catalin/P-2885-2019; Marian, Catalin/B-1750-2012	Marian, Catalin/0000-0002-7749-1384; Marian, Viorica/0000-0002-8335-1433	Susan G Komen for the Cure [BCTR0707157]; CMESR (Clinical and Molecular Epidemiology Shared Resource); HTSR (Histopathology and Tissue Shared Resource); GESR (Genomics & Epigenomics Shared Resource) of the Lombardi Comprehensive Cancer Center [National Institutes of Health] [P30 CA51008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); CMESR (Clinical and Molecular Epidemiology Shared Resource); HTSR (Histopathology and Tissue Shared Resource); GESR (Genomics & Epigenomics Shared Resource) of the Lombardi Comprehensive Cancer Center [National Institutes of Health]; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from Susan G Komen for the Cure [BCTR0707157 to YZ, ww5.komen.org/] and by the CMESR (Clinical and Molecular Epidemiology Shared Resource), HTSR (Histopathology and Tissue Shared Resource) and GESR (Genomics & Epigenomics Shared Resource) of the Lombardi Comprehensive Cancer Center [National Institutes of Health grant P30 CA51008, www.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Basu Aruna, 2011, Genes Cancer, V2, P108, DOI 10.1177/1947601911409212; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; BORGER J, 1994, J CLIN ONCOL, V12, P653, DOI 10.1200/JCO.1994.12.4.653; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Elkhuizen PHM, 1998, INT J RADIAT ONCOL, V40, P859, DOI 10.1016/S0360-3016(97)00917-6; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Iorio MV, 2008, EUR J CANCER, V44, P2753, DOI 10.1016/j.ejca.2008.09.037; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Kim N, 2011, HEPATOL RES, V41, P170, DOI 10.1111/j.1872-034X.2010.00752.x; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Kong KL, 2011, GUT; Kreike B, 2006, CLIN CANCER RES, V12, P5705, DOI 10.1158/1078-0432.CCR-06-0805; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li XL, 2011, DIGEST DIS SCI, V56, P2849, DOI 10.1007/s10620-011-1711-1; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Magee B, 1996, RADIOTHER ONCOL, V39, P223, DOI 10.1016/0167-8140(96)01747-1; Mazar J, 2011, FEBS LETT, V585, P2467, DOI 10.1016/j.febslet.2011.06.025; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Nuyten DSA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1614; Onnis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012960; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Park CC, 2000, J CLIN ONCOL, V18, P1668, DOI 10.1200/JCO.2000.18.8.1668; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Shigehara K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023584; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tan HX, 2010, MED ONCOL, V27, P654, DOI 10.1007/s12032-009-9264-2; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Voogd AC, 1999, EUR J CANCER, V35, P1828, DOI 10.1016/S0959-8049(99)00220-8; Voogd AC, 2001, J CLIN ONCOL, V19, P1688, DOI 10.1200/JCO.2001.19.6.1688; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Yu L, 2010, INT J CANC; Zhang X, 2011, ANN ONCOL, V22, P2257, DOI 10.1093/annonc/mdq758; Zhu L, 2011, MED ONCOL	54	116	121	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39011	10.1371/journal.pone.0039011	http://dx.doi.org/10.1371/journal.pone.0039011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22916227	Green Published, gold, Green Submitted			2022-12-27	WOS:000305583300080
J	Sejdic, E; Steele, CM; Chau, T				Sejdic, Ervin; Steele, Catriona M.; Chau, Tom			A Method for Removal of Low Frequency Components Associated with Head Movements from Dual-Axis Swallowing Accelerometry Signals	PLOS ONE			English	Article							ACCELERATION; DYSPHAGIA; CHARACTERIZE; ASPIRATION; DIAGNOSIS; DESIGN; PHASE	Head movements can greatly affect swallowing accelerometry signals. In this paper, we implement a spline-based approach to remove low frequency components associated with these motions. Our approach was tested using both synthetic and real data. Synthetic signals were used to perform a comparative analysis of the spline-based approach with other similar techniques. Real data, obtained data from 408 healthy participants during various swallowing tasks, was used to analyze the processing accuracy with and without the spline-based head motions removal scheme. Specifically, we analyzed the segmentation accuracy and the effects of the scheme on statistical properties of these signals, as measured by the scaling analysis. The results of the numerical analysis showed that the spline-based technique achieves a superior performance in comparison to other existing techniques. Additionally, when applied to real data, we improved the accuracy of the segmentation process by achieving a 27% drop in the number of false negatives and a 30% drop in the number of false positives. Furthermore, the anthropometric trends in the statistical properties of these signals remained unaltered as shown by the scaling analysis, but the strength of statistical persistence was significantly reduced. These results clearly indicate that any future medical devices based on swallowing accelerometry signals should remove head motions from these signals in order to increase segmentation accuracy.	[Sejdic, Ervin] Univ Pittsburgh, Dept Elect & Comp Engn, Pittsburgh, PA 15260 USA; [Steele, Catriona M.] Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada; [Steele, Catriona M.] Univ Toronto, Toronto Rehabil Inst, Toronto, ON, Canada; [Steele, Catriona M.; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Steele, Catriona M.; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital	Sejdic, E (corresponding author), Univ Pittsburgh, Dept Elect & Comp Engn, Pittsburgh, PA 15260 USA.	esejdic@ieee.org	Chau, Tom TK/C-8426-2009	Chau, Tom TK/0000-0002-7486-0316; Steele, Catriona/0000-0002-4294-6561; Sejdic, Ervin/0000-0003-4987-8298	Ontario Centres of Excellence; Toronto Rehabilitation Institute; Bloorview Kids Rehab; Canada Research Chairs	Ontario Centres of Excellence; Toronto Rehabilitation Institute(University of Toronto); Bloorview Kids Rehab; Canada Research Chairs(Canada Research ChairsCGIAR)	This research was funded in part by the Ontario Centres of Excellence, the Toronto Rehabilitation Institute, Bloorview Kids Rehab, and the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chau T, 2005, IEEE T NEUR SYS REH, V13, P99, DOI 10.1109/TNSRE.2004.841384; Das A, 2001, COMPUT METH PROG BIO, V64, P87, DOI 10.1016/S0169-2607(00)00099-7; Ekberg O, 2002, DYSPHAGIA, V17, P139, DOI 10.1007/s00455-001-0113-5; Ghaffari A, 2009, COMPUTER METHODS BIO; Hung D, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-25; Ishida R, 2002, DYSPHAGIA, V17, P262, DOI 10.1007/s00455-002-0064-5; Karczewicz M, 1997, SIGNAL PROCESS, V59, P43, DOI 10.1016/S0165-1684(97)00037-6; Kim YS, 2008, DYSPHAGIA, V23, P274, DOI 10.1007/s00455-007-9135-y; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee J, 2008, PHYSIOL MEAS, V29, P1105, DOI 10.1088/0967-3334/29/9/008; Lee J, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-14; Liang HL, 2005, IEEE T BIO-MED ENG, V52, P1692, DOI 10.1109/TBME.2005.855719; Logemann J., 1998, EVALUATION TREATMENT, V2nd, DOI DOI 10.1097/00020840-199812000-00008; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Miller A.J., 1999, NEUROSCIENTIFIC PRIN; Ramsey DJC, 2006, STROKE, V37, P2984, DOI 10.1161/01.STR.0000248758.32627.3b; REDDY NP, 1991, J BIOMED ENG, V13, P379, DOI 10.1016/0141-5425(91)90018-3; Reddy NP, 2000, MED ENG PHYS, V22, P405, DOI 10.1016/S1350-4533(00)00047-3; REDDY NP, 1990, IEEE T BIO-MED ENG, V37, P392, DOI 10.1109/10.52346; REDDY NP, 1988, IEEE ENG MED BIOL, V7, P16, DOI 10.1109/51.7929; Sejdic E., 2010, BMC RES, V3, DOI DOI 10.1186/1756-0500-3-269; Sejdic E, 2011, COMPUT METH PROG BIO, V103, P113, DOI 10.1016/j.cmpb.2010.06.010; Sejdic E, 2010, COMPUT BIOL MED, V40, P839, DOI 10.1016/j.compbiomed.2010.09.002; Sejdic E, 2010, MED ENG PHYS, V32, P668, DOI 10.1016/j.medengphy.2010.04.008; Sejdic E, 2010, PHYSIOL MEAS, V31, pN1, DOI 10.1088/0967-3334/31/1/N01; Sejdic E, 2009, IEEE T BIO-MED ENG, V56, P1090, DOI 10.1109/TBME.2008.2010504; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Steele CM, 2007, CAN J SPEECH-LANG PA, V31, P166; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; UNSER M, 1991, IEEE T PATTERN ANAL, V13, P277, DOI 10.1109/34.75515; UNSER M, 1992, IEEE T INFORM THEORY, V38, P95, DOI 10.1109/18.108253; Unser M, 2002, PROC SPIE, V4684, P225, DOI 10.1117/12.467162; UNSER M, 1993, IEEE T SIGNAL PROCES, V41, P834, DOI 10.1109/78.193221; UNSER M, 1993, IEEE T SIGNAL PROCES, V41, P821, DOI 10.1109/78.193220; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930	35	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33464	10.1371/journal.pone.0033464	http://dx.doi.org/10.1371/journal.pone.0033464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479402	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000304523400024
J	Zhao, MR; Wang, C; Zhang, CL; Wen, YZ; Liu, WP				Zhao, Meirong; Wang, Cui; Zhang, Chunlong; Wen, Yuezhong; Liu, Weiping			Enantioselective Cytotoxicity Profile of o,p '-DDT in PC 12 Cells	PLOS ONE			English	Article							DDT INDUCES APOPTOSIS; IN-VITRO; ORGANOCHLORINE PESTICIDES; OXIDATIVE STRESS; INSECTICIDE ACETOFENATE; NEUROBLASTOMA-CELLS; ESTROGENIC ACTIVITY; MONONUCLEAR-CELLS; RISK-ASSESSMENT; EXPRESSION	Background: The continued uses of dichlordiphenyltrichloroethane (DDT) for indoor vector control in some developing countries have recently fueled intensive debates toward the global ban of this persistent legacy contaminant. Current approaches for ecological and health risk assessment has ignored the chiral nature of DDT. In this study by employing an array of cytotoxicity related endpoints, we investigated the enantioselective cytotoxicity of o,p'-DDT. Principal Findings: we demonstrated for the first time that R-(2)-o,p'-DDT caused more neuron cell death by inducing more severe oxidative stress, which selectively imbalanced the transcription of stress-related genes (SOD1, SOD2, HSP70) and enzyme (superoxide dismutase and lactate dehydrogenase) activities, and greater cellular apoptosis compared to its enantiomer S-(+)-o,p'-DDT at the level comparable to malaria area exposure (parts per million). We further elucidated enantioselective modes of action using microarray combined with enzyme-linked immunosorbent assay. The enantioselective apoptosis might involve three signaling pathways via caspase 3, tumor protein 53 (p53) and NFkB. Conclusions: Based on DDT stereochemistry and results reported for other chiral pesticides, our results pointed to the same directional enantioselectivity of chiral DDT toward mammalian cells. We proposed that risk assessment on DDT should consider the enantiomer ratio and enantioselectivities.	[Zhao, Meirong; Wang, Cui] Zhejiang Univ Technol, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Chunlong] Univ Houston Clear Lake City, Houston, TX 77058 USA; [Wen, Yuezhong; Liu, Weiping] Zhejiang Univ, Inst Environm Sci, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University of Technology; University of Houston System; University of Houston; University of Houston Clear Lake; Zhejiang University	Zhao, MR (corresponding author), Zhejiang Univ Technol, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China.	Wliu@zju.edu.cn	Zhang, Chunlong/N-2564-2014; Liu, Weiping/E-9208-2010; Wen, Yue/GYQ-5844-2022; wen, Yuezhong/A-7651-2011; Zhao, Meirong/E-9679-2014	Zhang, Chunlong/0000-0003-4782-5424; Liu, Weiping/0000-0002-1173-892X; Zhao, Meirong/0000-0003-3132-9223; Zhang, Chun-Lei/0000-0003-1296-1370; zhen, xuechu/0000-0001-7458-2566	National Basic Research Program of China [2009CB421603]; National Natural Science Foundations of China [21077094, 20837002]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2009CB421603) and the National Natural Science Foundations of China (21077094,20837002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria-Torres JA, 2009, TOXICOL IN VITRO, V23, P1000, DOI 10.1016/j.tiv.2009.06.021; Anantharam V, 2007, NEUROCHEM INT, V50, P834, DOI 10.1016/j.neuint.2007.02.003; Bagchi D, 1995, TOXICOLOGY, V104, P129, DOI 10.1016/0300-483X(95)03156-A; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Bollimuntha S, 2005, J BIOL CHEM, V280, P2132, DOI 10.1074/jbc.M407384200; Bosma H, 2000, LANCET, V356, P912, DOI 10.1016/S0140-6736(00)02685-4; BUSER HR, 1995, ANAL CHEM, V67, P2691, DOI 10.1021/ac00111a030; Carlson K, 2000, TOXICOL APPL PHARM, V168, P102, DOI 10.1006/taap.2000.8997; Cohn BA, 2007, ENVIRON HEALTH PERSP, V115, P1406, DOI 10.1289/ehp.10260; de Joode BV, 2001, LANCET, V357, P1014, DOI 10.1016/S0140-6736(00)04249-5; Ennaceur S, 2008, ENVIRON RES, V108, P86, DOI 10.1016/j.envres.2008.05.005; Ennaceur S, 2010, INT J ENVIRON AN CH, V90, P821, DOI 10.1080/03067311003778615; Forsyth D J, 1973, Arch Environ Contam Toxicol, V1, P1, DOI 10.1007/BF02030141; Frigo DE, 2005, TOXICOL LETT, V155, P227, DOI 10.1016/j.toxlet.2004.09.008; Hemish J, 2003, J BIOL CHEM, V278, P42321, DOI 10.1074/jbc.M308192200; Hoekstra PF, 2001, TOXICOL LETT, V125, P75, DOI 10.1016/S0378-4274(01)00410-6; Hu F, 2010, ENVIRON TOXICOL CHEM, V29, P683, DOI 10.1002/etc.73; Jia Z, 2007, FREE RADICAL BIO MED, V42, P288, DOI 10.1016/j.freeradbiomed.2006.10.047; Kedziora-Kornatowska KZ, 2000, IUBMB LIFE, V49, P303; Kurt-Karakus PB, 2007, ENVIRON SCI TECHNOL, V41, P4965, DOI 10.1021/es0620787; Lascombe I, 2000, ENVIRON HEALTH PERSP, V108, P621, DOI 10.2307/3434882; Leber ER, 1994, PATTYS IND HYGIENE B, V2, P1503; Li L, 2010, J ENVIRON SCI-CHINA, V22, P1980, DOI 10.1016/S1001-0742(09)60349-1; Liu HG, 2010, TOXICOLOGY, V276, P115, DOI 10.1016/j.tox.2010.07.018; Liu HG, 2008, TOXICOLOGY, V253, P89, DOI 10.1016/j.tox.2008.08.015; Liu WP, 2005, P NATL ACAD SCI USA, V102, P701, DOI 10.1073/pnas.0408847102; Lu XT, 2011, ENVIRON TOXICOL, V26, P271, DOI 10.1002/tox.20553; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MCBLAIN WA, 1987, LIFE SCI, V40, P215, DOI 10.1016/0024-3205(87)90361-4; MCBLAIN WA, 1977, CAN J ZOOL, V55, P562, DOI 10.1139/z77-071; Moran JM, 2008, J TOXICOL ENV HEAL A, V71, P1457, DOI 10.1080/15287390802329364; OEHME M, 1994, HRC-J HIGH RES CHROM, V17, P583; Perez-Maldonado IN, 2004, ENVIRON RES, V94, P38, DOI 10.1016/S0013-9351(03)00112-9; Qian HF, 2009, CHEMOSPHERE, V76, P885, DOI 10.1016/j.chemosphere.2009.05.009; Qiu XH, 2004, ENVIRON SCI TECHNOL, V38, P1368, DOI 10.1021/es035052d; Rohrdanz E, 1998, FREE RADICAL BIO MED, V24, P27, DOI 10.1016/S0891-5849(97)00159-7; Shi YQ, 2010, TOXICOL LETT, V193, P79, DOI 10.1016/j.toxlet.2009.12.008; Shinomiya N, 2003, TOXICOL LETT, V137, P175, DOI 10.1016/S0378-4274(02)00401-0; Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9; Song Y, 2008, TOXICOLOGY, V253, P53, DOI 10.1016/j.tox.2008.08.013; Stanley Jacob K., 2009, Integrated Environmental Assessment and Management, V5, P364, DOI 10.1897/IEAM_2008-076.1; Stemmler I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041340; Tebourbi O, 1998, B ENVIRON CONTAM TOX, V61, P216, DOI 10.1007/s001289900751; UNEP, 2002, STOCKH CONV PERS ORG; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Van Dyk JC, 2010, SCI TOTAL ENVIRON, V408, P2745, DOI 10.1016/j.scitotenv.2010.03.002; Wang C, 2010, CHIRALITY, V22, P612, DOI 10.1002/chir.20800; Wang LM, 2009, ENVIRON TOXICOL CHEM, V28, P1, DOI 10.1897/08-055.1; Xu C, 2008, CHEM RES TOXICOL, V21, P1050, DOI 10.1021/tx8000016; Yang HY, 2010, CHEMOSPHERE, V80, P652, DOI 10.1016/j.chemosphere.2010.04.052; Zhao MR, 2008, ENVIRON TOXICOL CHEM, V27, P1194, DOI 10.1897/07-482.1; Zhao MR, 2010, ENVIRON POLLUT, V158, P1968, DOI 10.1016/j.envpol.2009.10.027; Zhao MR, 2009, ENVIRON TOXICOL CHEM, V28, P578, DOI 10.1897/08-246.1	54	45	46	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43823	10.1371/journal.pone.0043823	http://dx.doi.org/10.1371/journal.pone.0043823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937105	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500107
J	Chen, QY; Wang, H; Liu, Y; Song, YJ; Lai, LH; Han, Q; Cao, XT; Wang, QQ				Chen, Qingyun; Wang, Hui; Liu, Yang; Song, Yinjing; Lai, Lihua; Han, Quan; Cao, Xuetao; Wang, Qingqing			Inducible MicroRNA-223 Down-Regulation Promotes TLR-Triggered IL-6 and IL-1 beta Production in Macrophages by Targeting STAT3	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL TRANSDUCER; IN-VIVO; TRANSCRIPTION; EXPRESSION; INTERLEUKIN-6; INFLAMMATION; ALPHA; LIPOPOLYSACCHARIDE; DIFFERENTIATION	MicroRNAs are small non-coding RNA molecules that regulate gene expression by either translational inhibition or mRNA degradation. MicroRNAs play pivotal roles in the regulation of both innate and adaptive immune responses, including TLR-triggered inflammatory response. Here we reported that the expression of microRNA-223 (miR-223) was significantly decreased in murine macrophages during activation by lipopolysaccharide (LPS) or poly (I:C) stimulation. The inducible miR-223 down-regulation resulted in the activation of signal transducer and activator of transcription 3 (STAT3), which is directly targeted by miR-223, thus promoting the production of pro-inflammatory cytokines IL-6 and IL-1 beta, but not TNF-alpha. Interestingly, IL-6 was found to be a main factor in inducing the decrease in miR-223 expression after LPS stimulation, which formed a positive feedback loop to regulate IL-6 and IL-1 beta. Herein, our findings provide a new explanation characterizing the molecular mechanism responsible for the regulation of IL-6 production after TLR-triggered macrophage activation.	[Chen, Qingyun; Liu, Yang; Song, Yinjing; Lai, Lihua; Han, Quan; Cao, Xuetao; Wang, Qingqing] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Chinese Peoples Armed Police Force, Coll Med, Tianjin, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University	Chen, QY (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.	wqq@zju.edu.cn	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022		National Natural Science Foundation of China [81072405]; Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China [NCET-08-0486]; Zhejiang Provincial Natural Science Foundation of China [R2100528]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	This work was supported by grants from the National Natural Science Foundation of China (81072405), Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China (NCET-08-0486), grant from Zhejiang Provincial Natural Science Foundation of China (R2100528) and also sponsored by Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; HACK CE, 1989, BLOOD, V74, P1704; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lee C, 2006, MOL PHARMACOL, V69, P1041, DOI 10.1124/mol.105.018481; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; O'Connell RM., 2011, ANN REV IMMUNOL; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Okugawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC399, DOI 10.1152/ajpcell.00026.2003; Prele CM, 2007, CLIN EXP IMMUNOL, V147, P564, DOI 10.1111/j.1365-2249.2006.03291.x; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547	35	231	245	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42971	10.1371/journal.pone.0042971	http://dx.doi.org/10.1371/journal.pone.0042971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22723833	Green Published, gold, Green Submitted			2022-12-27	WOS:000308225500025
J	Chen, QY; Park, HC; Goligorsky, MS; Chander, P; Fischer, SM; Gross, SS				Chen, Qiuying; Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen; Fischer, Steven M.; Gross, Steven S.			Untargeted Plasma Metabolite Profiling Reveals the Broad Systemic Consequences of Xanthine Oxidoreductase Inactivation in Mice	PLOS ONE			English	Article							KYNURENINE PATHWAY ENZYMES; CHRONIC KIDNEY-DISEASE; REPERFUSION INJURY; METABOLOMICS; ALLOPURINOL; OXIDASE; IDENTIFICATION; CHROMATOGRAPHY; DEHYDROGENASE; ERYTHROCYTE	A major challenge in systems biology is integration of molecular findings for individual enzyme activities into a cohesive high-level understanding of cellular metabolism and physiology/pathophysiology. However, meaningful prediction for how a perturbed enzyme activity will globally impact metabolism in a cell, tissue or intact organisms is precluded by multiple unknowns, including in vivo enzymatic rates, subcellular distribution and pathway interactions. To address this challenge, metabolomics offers the potential to simultaneously survey changes in thousands of structurally diverse metabolites within complex biological matrices. The present study assessed the capability of untargeted plasma metabolite profiling to discover systemic changes arising from inactivation of xanthine oxidoreductase (XOR), an enzyme that catalyzes the final steps in purine degradation. Using LC-MS coupled with a multivariate statistical data analysis platform, we confidently surveyed >3,700 plasma metabolites (50-1,000 Da) for differential expression in XOR wildtype vs. mice with inactivated XOR, arising from gene deletion or pharmacological inhibition. Results confirmed the predicted derangements in purine metabolism, but also revealed unanticipated perturbations in metabolism of pyrimidines, nicotinamides, tryptophan, phospholipids, Krebs and urea cycles, and revealed kidney dysfunction biomarkers. Histochemical studies confirmed and characterized kidney failure in xor-nullizygous mice. These findings provide new insight into XOR functions and demonstrate the power of untargeted metabolite profiling for systemic discovery of direct and indirect consequences of gene mutations and drug treatments.	[Chen, Qiuying; Gross, Steven S.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Med, Renal Res Inst, Valhalla, NY 10595 USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Pathol, Renal Res Inst, Valhalla, NY 10595 USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Pharmacol, Renal Res Inst, Valhalla, NY 10595 USA; [Fischer, Steven M.] Agilent Technol, Metab Lab, Santa Clara, CA USA	Cornell University; New York Medical College; Renal Research Institute; New York Medical College; Renal Research Institute; New York Medical College; Renal Research Institute; Agilent Technologies	Chen, QY (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA.	ssgross@med.cornell.edu	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022		NIH (National Institute of Health) [HL87062, HD067244, K45462, tDK84394]	NIH (National Institute of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by NIH (National Institute of Health) grants HL87062 (SSG), HD067244 (SSG), K45462 (MSG) and tDK84394 (MSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, CRIT REV BIOTECHNOL, V31, P264, DOI 10.3109/07388551.2010.527823; Barbas C, 2011, J PHARMACEUT BIOMED, V55, P823, DOI 10.1016/j.jpba.2011.02.001; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Battelli MG, 2011, J BIOL REG HOMEOS AG, V25, P77; Biasioli S, 1987, Nephrol Dial Transplant, V2, P313; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Chohan S, 2009, CURR OPIN RHEUMATOL, V21, P143, DOI 10.1097/BOR.0b013e328325bd94; Cubbon S, 2010, MASS SPECTROM REV, V29, P671, DOI 10.1002/mas.20252; Dawson J, 2009, BRIT J CLIN PHARMACO, V68, P662, DOI 10.1111/j.1365-2125.2009.03497.x; Dewan AK, 2010, PEDIATR DERMATOL, V27, P270, DOI 10.1111/j.1525-1470.2009.00983.x; Drexler DM, 2011, ANAL BIOANAL CHEM, V399, P2645, DOI 10.1007/s00216-010-4370-8; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fiehn O, 2009, QUALITY CONTROL META; Fini MA, 2011, MOL CANCER RES, V9, P1242, DOI 10.1158/1541-7786.MCR-11-0176; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; George Jacob, 2009, Ther Clin Risk Manag, V5, P799; Gibbings S, 2011, J BIOL CHEM, V286, P961, DOI 10.1074/jbc.M110.150847; Gierasch LM, 2009, NAT CHEM BIOL, V5, P774, DOI 10.1038/nchembio.241; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Govani SM, 2010, J CROHNS COLITIS, V4, P444, DOI 10.1016/j.crohns.2010.02.009; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Huang LY, 2010, NITRIC OXIDE-BIOL CH, V22, P191, DOI 10.1016/j.niox.2010.01.004; Igarashi K, 2006, AMINO ACIDS, V31, P477, DOI 10.1007/s00726-006-0264-7; Issaq HJ, 2009, J SEP SCI, V32, P2183, DOI 10.1002/jssc.200900152; Joel D.KoppleSGM, 2004, UREMIC TOXICITY ITS, P682; Kamleh MA, 2008, FEBS LETT, V582, P2916, DOI 10.1016/j.febslet.2008.07.029; Kim AW, 2011, LUNG CANCER, V71, P186, DOI 10.1016/j.lungcan.2010.05.006; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Linder N, 2011, GYNECOL ONCOL; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Martelin E, 2002, AM J PHYSIOL-CELL PH, V283, pC1722, DOI 10.1152/ajpcell.00280.2002; McManaman JL, 2002, J BIOL CHEM, V277, P21261, DOI 10.1074/jbc.M200828200; Meneshian A, 2002, MICROCIRCULATION, V9, P161, DOI 10.1038/sj.mn.7800136; Michopoulos F, 2009, J PROTEOME RES, V8, P2114, DOI 10.1021/pr801045q; Nagrath D, 2011, BBA-BIOENERGETICS, V1807, P650, DOI 10.1016/j.bbabio.2011.03.006; Nishino T, 2002, J BIOCHEM, V132, P597, DOI 10.1093/oxfordjournals.jbchem.a003262; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; Ohtsubo T, 2009, HYPERTENSION, V54, P868, DOI 10.1161/HYPERTENSIONAHA.109.135152; Pawlak D, 2003, J PHYSIOL PHARMACOL, V54, P175; Pesek JJ, 2009, J SEP SCI, V32, P2200, DOI 10.1002/jssc.200900270; Reaves ML, 2011, CURR OPIN BIOTECH, V22, P17, DOI 10.1016/j.copbio.2010.10.001; Roux A, 2011, CLIN BIOCHEM, V44, P119, DOI 10.1016/j.clinbiochem.2010.08.016; Sana TR, 2008, J CHROMATOGR B, V871, P314, DOI 10.1016/j.jchromb.2008.04.030; Sana Theodore R, 2008, J Biomol Tech, V19, P258; Sanders SA, 1999, ANTIOXID REDOX SIGN, V1, P371, DOI 10.1089/ars.1999.1.3-371; Schefold JC, 2009, NEPHROL DIAL TRANSPL, V24, P1901, DOI 10.1093/ndt/gfn739; SPECTOR T, 1986, BIOCHEM PHARMACOL, V35, P3109, DOI 10.1016/0006-2952(86)90394-1; Stamp LK, 2010, ARTHRITIS RHEUM; SWENDSEID ME, 1978, AM J CLIN NUTR, V31, P1581, DOI 10.1093/ajcn/31.9.1581; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Tankiewicz A, 2003, ADV EXP MED BIOL, V527, P409; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Wei XL, 2011, ANAL CHEM, V83, P7668, DOI 10.1021/ac2017025; Weisenberg SA, 2009, J SEP SCI, V32, P2262, DOI 10.1002/jssc.200900256; Yamaoka K, 2006, BIOCHEM BIOPH RES CO, V345, P1240, DOI 10.1016/j.bbrc.2006.04.183; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405; Zhang RL, 1998, FREE RADICAL BIO MED, V24, P66, DOI 10.1016/S0891-5849(97)00165-2; Zhang Z, 1998, FREE RADICAL RES, V28, P151, DOI 10.3109/10715769809065801	60	231	245	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37149	10.1371/journal.pone.0037149	http://dx.doi.org/10.1371/journal.pone.0037149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723833	Green Submitted, gold, Green Published			2022-12-27	WOS:000305583300005
